PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lederle, FA; Cushman, WC; Ferguson, RE; Brophy, MT; Fiore, LD				Lederle, Frank A.; Cushman, William C.; Ferguson, Ryan E.; Brophy, Mary T.; Fiore, Louis D.			Chlorthalidone Versus Hydrochlorothiazide: A New Kind of Veterans Affairs Cooperative Study	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIAL		[Lederle, Frank A.] Minneapolis Vet Affairs Hlth Care Syst, One Vet Dr, Minneapolis, MN 55417 USA; Vet Affairs Med Ctr, Memphis, TN USA; Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Cushman, William C.] Memphis Vet Affairs Med Ctr, 1030 Jefferson Ave, Memphis, TN 38104 USA; [Ferguson, Ryan E.; Brophy, Mary T.; Fiore, Louis D.] Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, 150 South Huntington Ave, Boston, MA 02130 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Lederle, FA (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, One Vet Dr, Minneapolis, MN 55417 USA.	frank.lederle@va.gov						[Anonymous], 2011, LEARN WHAT WORKS INF; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; D'Avolio L, 2012, J AM MED INFORM ASSN, V19, pE170, DOI 10.1136/amiajnl-2011-000623; Ernst ME, 2006, HYPERTENSION, V47, P352, DOI 10.1161/01.HYP.0000203309.07140.d3; Ernst ME, 2010, J CLIN HYPERTENS, V12, P927, DOI 10.1111/j.1751-7176.2010.00373.x; Hernandez AF, 2015, ANN INTERN MED, V163, P635, DOI 10.7326/M15-1460; Pletcher MJ, 2014, JAMA INTERN MED, V174, P668, DOI 10.1001/jamainternmed.2013.13297; Roush GC, 2012, HYPERTENSION, V59, P1110, DOI 10.1161/HYPERTENSIONAHA.112.191106; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Woodman R, 2010, HYPERTENSION, V56, P463, DOI 10.1161/HYPERTENSIONAHA.110.154476	10	23	23	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					663	+		10.7326/M16-1208	http://dx.doi.org/10.7326/M16-1208			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27538129				2022-12-24	WOS:000386908600008
J	Kerse, C; Kalaycioglu, H; Elahi, P; Cetin, B; Kesim, DK; Akcaalan, O; Yavas, S; Asik, MD; Oktem, B; Hoogland, H; Holzwarth, R; Ilday, FO				Kerse, Can; Kalaycioglu, Hamit; Elahi, Parviz; Cetin, Barbaros; Kesim, Denizhan K.; Akcaalan, Onder; Yavas, Seydi; Asik, Mehmet D.; Oktem, Bulent; Hoogland, Heinar; Holzwarth, Ronald; Ilday, Fatih Omer			Ablation-cooled material removal with ultrafast bursts of pulses	NATURE			English	Article							DOPED FIBER AMPLIFIER; HIGH-REPETITION-RATE; FEMTOSECOND LASERS; SYSTEM; SURGERY; METALS	The use of femtosecond laser pulses allows precise and thermal damage -free removal of material (ablation) with wide-ranging scientificl(1,5), medical(6-11) and industrial applications(12). However, its potential is limited by the low speeds at which material can be removed(1,9-11,13) and the complexity of the associated laser technology. The complexity of the laser design arises from the need to overcome the high pulse energy threshold for efficient ablation. However, the use of more powerful lasers to increase the ablation rate results in unwanted effects such as shielding, saturation and collateral damage from heat accumulation at higher laser powers(6,13,14). Here we circumvent this limitation by exploiting ablation cooling, in analogy to a technique routinely used in aerospace engineering(13,16). We apply ultrafast successions (bursts) of laser pulses to ablate the target material before the residual heat deposited by previous pulses diffuses away from the processing region. Proof-of-principle experiments on various substrates demonstrate that extremely high repetition rates, which make ablation cooling possible, reduce the laser pulse energies needed for ablation and increase the efficiency of the removal process by an order of magnitude over previously used laser parameters(17,18). We also demonstrate the removal of brain tissue at two cubic millimetres per minute and dentine at three cubic millimetres per minute without any thermal damage to the bulk(9,11).	[Kerse, Can; Kesim, Denizhan K.; Akcaalan, Onder; Ilday, Fatih Omer] Bilkent Univ, Dept Elect & Elect Engn, TR-06800 Ankara, Turkey; [Kalaycioglu, Hamit; Elahi, Parviz; Ilday, Fatih Omer] Bilkent Univ, Dept Phys, TR-06800 Ankara, Turkey; [Cetin, Barbaros] Bilkent Univ, Dept Mech Engn, TR-06800 Ankara, Turkey; [Yavas, Seydi] FiberLAST Inc, TR-06531 Ankara, Turkey; [Asik, Mehmet D.] Hacettepe Univ, Nanotechnol & Nanomed Dept, TR-06800 Ankara, Turkey; [Oktem, Bulent] ASELSAN, TR-06150 Ankara, Turkey; [Hoogland, Heinar; Holzwarth, Ronald] Menlo Syst GmbH, Kloperspitz 19a, D-82152 Martinsried, Germany; [Hoogland, Heinar] Univ Erlangen Nurnberg, Dept Phys, Lehrstuhl Laserphys, D-91058 Erlangen, Germany	Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University; Hacettepe University; Aselsan; Menlo Systems GmbH; University of Erlangen Nuremberg	Ilday, FO (corresponding author), Bilkent Univ, Dept Elect & Elect Engn, TR-06800 Ankara, Turkey.; Ilday, FO (corresponding author), Bilkent Univ, Dept Phys, TR-06800 Ankara, Turkey.	ilday@bilkent.edu.tr	cetin, barbaros/J-2911-2014; Ilday, Fatih Ö/J-2466-2013; Akcaalan, Onder/J-1266-2019; Cetin, Barbaros/T-7665-2019; Elahi, Parviz/AAD-1261-2020; aşık, Mehmet/J-1587-2013	cetin, barbaros/0000-0001-9824-4000; Ilday, Fatih Ö/0000-0002-9057-5371; Cetin, Barbaros/0000-0001-9824-4000; aşık, Mehmet/0000-0001-9154-2697; Yavas, Seydi/0000-0002-3043-6564; Elahi, Parviz/0000-0003-3545-8436; Kesim, Denizhan Koray/0000-0002-6755-4425	European Research Council (ERC) [ERC-617521 NLL]; European Union (EU) FP7 CROSS TRAP; TUBITAK [112T980, 112T944, TEYDEB-3110216]; TUBITAK - BIDEB [2211]	European Research Council (ERC)(European Research Council (ERC)); European Union (EU) FP7 CROSS TRAP; TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); TUBITAK - BIDEB(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported partially by the European Research Council (ERC) Consolidator Grant ERC-617521 NLL, the European Union (EU) FP7 CROSS TRAP and TUBITAK under projects 112T980, 112T944 and TEYDEB-3110216. C.K. acknowledges funding from TUBITAK - BIDEB 2211. We thank Y. Aykac and V. Aykac for dental experiments, T. Dalkara, M. Yemisci Ozkan, K. Kilic for brain tissue experiments, G. Aykut for animal care and brain slicing, I. Mirza, K. Yavuz, G. Makey and M. Karatok for data acquisition and analyses, S. Karahan for histology analyses, A. Buyuksungur and BIOMATEN (METU, Ankara, Turkey) for micro-CT analyses, H. Koymen for PZT characterisation and S. Ilday, O. Tokel, H. Celik, O. Algin and E. Atalar for critical reading of the manuscript.	Ancona A, 2008, OPT EXPRESS, V16, P8958, DOI 10.1364/OE.16.008958; Bauer F, 2015, OPT EXPRESS, V23, P1035, DOI 10.1364/OE.23.001035; Chichkov BN, 1996, APPL PHYS A-MATER, V63, P109, DOI 10.1007/BF01567637; Cho Y. I., 1998, HDB HEAT TRANSFER, V6.21; Chung SH, 2009, J BIOPHOTONICS, V2, P557, DOI 10.1002/jbio.200910053; Gattass RR, 2008, NAT PHOTONICS, V2, P219, DOI 10.1038/nphoton.2008.47; Hashida M, 2002, APPL SURF SCI, V197, P862, DOI 10.1016/S0169-4332(02)00463-4; Hoy CL, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2287098; Hu WQ, 2010, APPL PHYS A-MATER, V98, P407, DOI 10.1007/s00339-009-5405-x; Juhasz T, 1999, IEEE J SEL TOP QUANT, V5, P902, DOI 10.1109/2944.796309; Kalaycioglu H, 2015, J OPT SOC AM B, V32, P900, DOI 10.1364/JOSAB.32.000900; Kalaycioglu H, 2012, OPT LETT, V37, P2586, DOI 10.1364/OL.37.002586; Kalaycioglu H, 2011, OPT LETT, V36, P3383, DOI 10.1364/OL.36.003383; Lapczyna M, 1999, APPL PHYS A-MATER, V69, pS883, DOI 10.1007/s003390051552; Loesel FH, 1998, APPL PHYS B-LASERS O, V66, P121, DOI 10.1007/s003400050365; Marjoribanks R., 2012, PHOTON LASERS MED, V1, P155, DOI DOI 10.1515/PLM-2012-0020; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; Plech A, 2006, NAT PHYS, V2, P44, DOI 10.1038/nphys191; Rousse A, 2001, NATURE, V410, P65, DOI 10.1038/35065045; Schwoerer H, 2006, NATURE, V439, P445, DOI 10.1038/nature04492; Serbin J, 2002, APPL SURF SCI, V197, P737, DOI 10.1016/S0169-4332(02)00402-6; Steinmeyer JD, 2010, NAT PROTOC, V5, P395, DOI 10.1038/nprot.2010.4; Sutton G. P., 2011, ROCKET PROPULSION EL; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Yang WJ, 2008, NAT PHOTONICS, V2, P99, DOI 10.1038/nphoton.2007.276; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a	27	413	425	57	440	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					84	88		10.1038/nature18619	http://dx.doi.org/10.1038/nature18619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27409814	Green Published			2022-12-24	WOS:000382426900043
J	Habib, N; Li, YQ; Heidenreich, M; Swiech, L; Avraham-Davidi, I; Trombetta, JJ; Hession, C; Zhang, F; Regev, A				Habib, Naomi; Li, Yinqing; Heidenreich, Matthias; Swiech, Lukasz; Avraham-Davidi, Inbal; Trombetta, John J.; Hession, Cynthia; Zhang, Feng; Regev, Aviv			Div-Seq: Single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons	SCIENCE			English	Article							NEURAL STEM-CELLS; SPINAL-CORD; TRANSCRIPTOME	Single-cell RNA sequencing (RNA-Seq) provides rich information about cell types and states. However, it is difficult to capture rare dynamic processes, such as adult neurogenesis, because isolation of rare neurons from adult tissue is challenging and markers for each phase are limited. Here, we develop Div-Seq, which combines scalable single-nucleus RNA-Seq (sNuc-Seq) with pulse labeling of proliferating cells by 5-ethynyl-2'-deoxyuridine (EdU) to profile individual dividing cells. sNuc-Seq and Div-Seq can sensitively identify closely related hippocampal cell types and track transcriptional dynamics of newborn neurons within the adult hippocampal neurogenic niche, respectively. We also apply Div-Seq to identify and profile rare newborn neurons in the adult spinal cord, a noncanonical neurogenic region. sNuc-Seq and Div-Seq open the way for unbiased analysis of diverse complex tissues.	[Habib, Naomi; Li, Yinqing; Heidenreich, Matthias; Swiech, Lukasz; Avraham-Davidi, Inbal; Trombetta, John J.; Hession, Cynthia; Zhang, Feng; Regev, Aviv] Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA; [Habib, Naomi; Li, Yinqing; Heidenreich, Matthias; Swiech, Lukasz; Zhang, Feng] Stanley Ctr Psychiat Res, 75 Ames St, Cambridge, MA 02142 USA; [Habib, Naomi; Li, Yinqing; Heidenreich, Matthias; Swiech, Lukasz; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Li, Yinqing] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Zhang, F; Regev, A (corresponding author), Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), Stanley Ctr Psychiat Res, 75 Ames St, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Regev, A (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zhang@broadinstitute.org; aregev@broadinstitute.org	Habib, Naomi/AAA-8937-2020; Macrae, Rhiannon/AAX-1536-2020	Li, Yinqing/0000-0002-9096-8482	Human Frontier Science Program; Klarman Cell Observatory at the Broad Institute and National Institute of Mental Health (NIMH) [U01MH105960]; NIH through NIMH [5DP1-MH100706, 1R01-MH110049]; NSF; New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; NATIONAL EYE INSTITUTE [R21EY026412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049, DP1MH100706, U01MH105960] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Klarman Cell Observatory at the Broad Institute and National Institute of Mental Health (NIMH); NIH through NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Raw data are deposited to the Gene Expression Omnibus with accession no. GSE84371; annotated data are available at https://portals.broadinstitute.org/single_cell, and software tools are available at https://github.com/yinqingl/nucseq_analysis. We thank N. Friedman, A. Shalek, D. Gennert, T. Blosser, S. Kadosch, O. Rosen, Z. Wang, P. Rogers, and L. Gaffeny for support and J. Campbell for dissociated neurons image. N.H. is a Howard Hughes Medical Institute Fellow of the Helen Hay Whitney Foundation. M.H. is supported by the Human Frontier Science Program. This work was supported by the Klarman Cell Observatory at the Broad Institute and National Institute of Mental Health (NIMH) grant U01MH105960 (F.Z., A.R.). F.Z. is supported by the NIH through NIMH (5DP1-MH100706 and 1R01-MH110049), NSF, the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; and James and Patricia Poitras, Robert Metcalfe, and David Cheng. A.R. is a Howard Hughes Medical Institute Investigator on the scientific advisory board of Syros Pharmaceuticals and Thermo Fisher and a consultant for Driver group. N.H., Y.L., A.R., and F.Z. are inventors on provisional patent application 62/311,129, applied for by the Broad Institute and MIT, that covers the methods described in this paper. All DNA constructs are available from Addgene subject to a material transfer agreement with Addgene.	Agoston Z, 2014, DEVELOPMENT, V141, P28, DOI 10.1242/dev.097295; Cembrowski MS, 2016, NEURON, V89, P351, DOI 10.1016/j.neuron.2015.12.013; Feliciano DM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018846; Horner PJ, 2000, J NEUROSCI, V20, P2218; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moore DL, 2015, SCIENCE, V349, P1334, DOI 10.1126/science.aac9868; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Roques BP, 2012, NAT REV DRUG DISCOV, V11, P292, DOI 10.1038/nrd3673; Rottkamp CA, 2008, DEV BIOL, V314, P23, DOI 10.1016/j.ydbio.2007.10.046; Schouten M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00025; Shechter R, 2007, STEM CELLS, V25, P2277, DOI 10.1634/stemcells.2006-0705; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	20	275	288	7	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					925	928		10.1126/science.aad7038	http://dx.doi.org/10.1126/science.aad7038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27471252	Green Accepted, Green Published			2022-12-24	WOS:000381867700038
J	Korhonen, P; Heintjes, EM; Williams, R; Hoti, F; Christopher, S; Majak, M; Kool-Houweling, L; Strongman, H; Linder, M; Dolin, P; Bahmanyar, S				Korhonen, Pasi; Heintjes, Edith M.; Williams, Rachael; Hoti, Fabian; Christopher, Solomon; Majak, Maila; Kool-Houweling, Leanne; Strongman, Helen; Linder, Marie; Dolin, Paul; Bahmanyar, Shahram			Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; THIAZOLIDINEDIONES; DATABASE; TRIAL	OBJECTIVE To evaluate the association between pioglitazone use and bladder cancer risk in patients with type 2 diabetes. Design Retrospective cohort study using propensity score matched cohorts. Settings Healthcare databases from Finland, the Netherlands, Sweden, and the United Kingdom. Data comprised country specific datasets of linked records on prescriptions, hospitals, general practitioners, cancer, and deaths. Participants Patients with type 2 diabetes who initiated pioglitazone (n=56 337) matched with patients with type 2 diabetes in the same country exposed to diabetes drug treatments other than pioglitazone (n=317 109). Two matched cohorts were created, using a 1: 1 fixed ratio (nearest match cohort) and a 1: 10 variable ratio (multiple match cohort). Patients were matched on treatment history and propensity scores accounting for several variables associated with pioglitazone initiation. Main outcome measures Hazard ratios and 95% confidence intervals were estimated by Cox's proportional hazards model with adjustments for relevant confounders. To assess the robustness of the findings, several sensitivity and stratified analyses were performed. Results In the cohort exposed to pioglitazone treatment, 130 bladder cancers occurred over a mean follow-up time of 2.9 years. In the nearest match and multiple match cohorts not exposed to pioglitazone treatment, 153 and 970 bladder cancers were recorded, with a mean follow-up time of 2.8 and 2.9 years, respectively. With regards to bladder cancer risk, the adjusted hazard ratio for patients ever exposed versus never exposed to pioglitazone was 0.99 (95% confidence interval 0.75 to 1.30) and 1.00 (0.83 to 1.21) in the nearest and multiple match cohorts, respectively. Increasing duration of pioglitazone use and increasing cumulative dose were not associated with risk of bladder cancer (>48 months of pioglitazone use, adjusted hazard ratio 0.86 (0.44 to 1.66); >40 000 mg cumulative dose, 0.65 (0.33 to 1.26) in the nearest match cohort). Conclusions This study shows no evidence of an association between ever use of pioglitzone and risk of bladder cancer compared with never use, which is consistent with results from other recent studies that also included a long follow-up period.	[Korhonen, Pasi; Hoti, Fabian; Christopher, Solomon; Majak, Maila] EPID Res, FI-02130 Espoo, Finland; [Heintjes, Edith M.; Kool-Houweling, Leanne] PHARMO Inst, Utrecht, Netherlands; [Williams, Rachael; Strongman, Helen] Clin Practice Res Datalink, London, England; [Linder, Marie; Bahmanyar, Shahram] Karolinska Inst, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Dolin, Paul] Takeda Dev Ctr Europe, London, England	Karolinska Institutet; Takeda Pharmaceutical Company Ltd; Takeda Development Centre Europe Ltd.	Korhonen, P (corresponding author), EPID Res, FI-02130 Espoo, Finland.	pasi.korhonen@epidresearch.com		Strongman, Helen/0000-0001-8739-4601; Linder, Marie/0000-0003-2619-2189; Bahmanyar, Shahram/0000-0002-9205-6540; Hoti, Fabian/0000-0002-7464-3549	Takeda Development Centre Europe	Takeda Development Centre Europe(Takeda Pharmaceutical Company Ltd)	The European Medicines Agency (EMA) mandated the marketing authorisation holder of Actos (pioglitazone) to conduct this study. The study protocol was reviewed and approved by the EMA, and the study was granted the ENCePP Seal, reflecting transparency and quality in research. The study was fully funded by Takeda Development Centre Europe.	Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Boggon R, 2013, PHARMACOEPIDEM DR S, V22, P168, DOI 10.1002/pds.3374; Bosetti C, 2013, ONCOLOGIST, V18, P148, DOI 10.1634/theoncologist.2012-0302; Colmers IN, 2012, CAN MED ASSOC J, V184, pE675, DOI 10.1503/cmaj.112102; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dregan A, 2012, CANCER EPIDEMIOL, V36, P425, DOI 10.1016/j.canep.2012.05.013; Erdmann E, 2014, DIABETES OBES METAB, V16, P63, DOI 10.1111/dom.12180; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hillaire-Buys D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3500; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; International Agency for Research on Cancer, 2015, SOME DRUGS AND HERBA, V108; Korhonen P, 2002, ACTA ONCOL, V41, P381, DOI 10.1080/028418602760169442; Levin D, 2015, DIABETOLOGIA, V58, P493, DOI 10.1007/s00125-014-3456-9; Lewis JD, 2015, JAMA-J AM MED ASSOC, V314, P265, DOI 10.1001/jama.2015.7996; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Ryder REJ, 2015, BRIT J DIABETES VASC, V15, P46, DOI 10.15277/bjdvd.2015.021; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Tuccori M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1541; Turner RM, 2014, BRIT J CLIN PHARMACO, V78, P258, DOI 10.1111/bcp.12306; Wei L, 2013, BRIT J CLIN PHARMACO, V75, P254, DOI 10.1111/j.1365-2125.2012.04325.x	20	36	37	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i3903	10.1136/bmj.i3903	http://dx.doi.org/10.1136/bmj.i3903			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27530399	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000381806200001
J	Kermode-Scott, B				Kermode-Scott, Barbara			Canadians authorised to use cannabis for medical purposes to be allowed to grow their own again	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Government of Canada, 2016, INF B SAF SEC CONS P; Health Canada, DRUGS HLTH PROD MARK; Health Canada, 2016, MED US CANN INF NEW; Spurgeon D, 2001, BMJ-BRIT MED J, DOI [10.1136/bmj.323.7304.68/b, DOI 10.1136/BMJ.323.7304.68/B]	4	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2016	354								i4480	10.1136/bmj.i4480	http://dx.doi.org/10.1136/bmj.i4480			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GR	27527731				2022-12-24	WOS:000381805400017
J	Lee, TH				Lee, Thomas H.			Coming Back from the Dead	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Thomas H.] Press Ganey, Wakefield, MA 01880 USA; [Lee, Thomas H.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lee, TH (corresponding author), Press Ganey, Wakefield, MA 01880 USA.; Lee, TH (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					507	509		10.1056/NEJMp1606163	http://dx.doi.org/10.1056/NEJMp1606163			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU4OT	27509099				2022-12-24	WOS:000382193100003
J	Plumb, LA; van't Hoff, W; Kleta, R; Reid, C; Ashton, E; Samuels, M; Bockenhauer, D				Plumb, Lucy Anne; van't Hoff, William; Kleta, Robert; Reid, Chris; Ashton, Emma; Samuels, Martin; Bockenhauer, Detlef			Renal apnoea: extreme disturbance of homoeostasis in a child with Bartter syndrome type IV	LANCET			English	Editorial Material							ALKALOSIS		[Plumb, Lucy Anne; van't Hoff, William; Kleta, Robert; Ashton, Emma; Samuels, Martin; Bockenhauer, Detlef] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Kleta, Robert; Bockenhauer, Detlef] UCL Ctr Nephrol, London, England; [Reid, Chris] Evelina Childrens Hosp, London, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Bockenhauer, D (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, UCL Ctr Nephrol, Renal Unit, London WC1N 3JH, England.	d.bockenhauer@ucl.ac.uk	Bockenhauer, Detlef/AAF-6495-2020	Bockenhauer, Detlef/0000-0001-5878-941X; Plumb, Lucy/0000-0002-3873-8567				ANDERSON LE, 1987, SOUTHERN MED J, V80, P729, DOI 10.1097/00007611-198706000-00016; JAVAHERI S, 1982, CHEST, V81, P296, DOI 10.1378/chest.81.3.296; Jeck N, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e5; Kleta R, 2006, NEPHRON PHYSIOL, V104, P73, DOI 10.1159/000094001; MOSTELLAR ME, 1964, J CLIN INVEST, V43, P138, DOI 10.1172/JCI104888	5	12	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					631	632		10.1016/S0140-6736(16)00087-8	http://dx.doi.org/10.1016/S0140-6736(16)00087-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS4NA	27511787	Green Submitted			2022-12-24	WOS:000380756600036
J	Holland, ML; Lowe, R; Caton, PW; Gemma, C; Carbajosa, G; Danson, AF; Carpenter, AAM; Loche, E; Ozanne, SE; Rakyan, VK				Holland, Michelle L.; Lowe, Robert; Caton, Paul W.; Gemma, Carolina; Carbajosa, Guillermo; Danson, Amy F.; Carpenter, Asha A. M.; Loche, Elena; Ozanne, Susan E.; Rakyan, Vardhman K.			Early-life nutrition modulates the epigenetic state of specific rDNA genetic variants in mice	SCIENCE			English	Article							RIBOSOMAL-RNA GENES; DIET	A suboptimal early-life environment, due to poor nutrition or stress during pregnancy, can influence lifelong phenotypes in the progeny. Epigenetic factors are thought to be key mediators of these effects. We show that protein restriction in mice from conception until weaning induces a linear correlation between growth restriction and DNA methylation at ribosomal DNA (rDNA). This epigenetic response remains into adulthood and is restricted to rDNA copies associated with a specific genetic variant within the promoter. Related effects are also found in models of maternal high-fat or obesogenic diets. Our work identifies environmentally induced epigenetic dynamics that are dependent on underlying genetic variation and establishes rDNA as a genomic target of nutritional insults.	[Holland, Michelle L.; Lowe, Robert; Gemma, Carolina; Carbajosa, Guillermo; Danson, Amy F.; Rakyan, Vardhman K.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London E1 2AT, England; [Caton, Paul W.] Kings Coll London, Div Diabet & Nutr Sci, 150 Stamford St, London SE1 9NH, England; [Carpenter, Asha A. M.; Loche, Elena; Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [Carpenter, Asha A. M.; Loche, Elena; Ozanne, Susan E.] Addenbrookes Hosp, MRC Metab Dis Unit, Inst Metab Sci, Cambridge CB2 0QQ, England; [Gemma, Carolina] Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus, London, England; [Carbajosa, Guillermo] Kings Coll London, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England	University of London; Queen Mary University London; University of London; King's College London; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London; University of London; King's College London	Holland, ML; Rakyan, VK (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London E1 2AT, England.	m.holland@qmul.ac.uk; v.rakyan@qmul.ac.uk		Danson, Amy/0000-0002-6882-8723; Holland, Michelle/0000-0003-0775-2902; Ozanne, Susan/0000-0001-8753-5144; Carbajosa, Guillermo/0000-0002-3374-0895; Gemma, Carolina/0000-0002-4890-9972	Biotechnology and Biological Sciences Research Council, UK [BB/M012494/1, BB/G00711/X/1]; Research Council UK Academic Fellowship; EU-FP7 BLUEPRINT; British Heart Foundation [FS/12/64/30001]; Medical Research Council [MC_UU_12012/4]; Queen Mary University of London Research-IT; Engineering and Physical Sciences Research Council [EP/K000128/1]; BBSRC [BB/G00711X/1] Funding Source: UKRI; MRC [MC_UU_12012/4] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G00711X/1] Funding Source: researchfish; British Heart Foundation [FS/09/029/27902] Funding Source: researchfish; Medical Research Council [1649609] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research Council UK Academic Fellowship; EU-FP7 BLUEPRINT; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Queen Mary University of London Research-IT; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the following grants and fellowships: Biotechnology and Biological Sciences Research Council, UK (BB/M012494/1) to V.K.R. and (BB/G00711/X/1) to V.K.R. and C.G.; and a Research Council UK Academic Fellowship to M.L.H. R.L. is supported by EU-FP7 BLUEPRINT. S.E.O. is supported by the British Heart Foundation (FS/12/64/30001) and the Medical Research Council (MC_UU_12012/4). This research used Queen Mary's MidPlus computational facilities, supported by Queen Mary University of London Research-IT and funded by Engineering and Physical Sciences Research Council grant EP/K000128/1. We thank King's College London FWB Genomics Centre and Barts and The London Genome Centre for performing high-throughput sequencing.	Aiken CE, 2016, FASEB J, V30, P1548, DOI 10.1096/fj.15-280800; Aldrich JC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005148; Cannon MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090335; DEV VG, 1977, GENETICS, V86, P389; El Hajj N, 2014, REPRODUCTION, V148, pR111, DOI 10.1530/REP-14-0334; Fernandez-Twinn DS, 2015, SEMIN CELL DEV BIOL, V43, P85, DOI 10.1016/j.semcdb.2015.06.006; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Jack CV, 2015, P NATL ACAD SCI USA, V112, P9674, DOI 10.1073/pnas.1505015112; KASS S, 1987, MOL CELL BIOL, V7, P2891, DOI 10.1128/MCB.7.8.2891; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Santoro R, 2010, EMBO REP, V11, P52, DOI 10.1038/embor.2009.254; Shea JM, 2015, DEV CELL, V35, P750, DOI 10.1016/j.devcel.2015.11.024; Shiao YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022266; Tobi EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6592; Tseng H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001843; Vucetic Z, 2010, NEUROSCIENCE, V168, P359, DOI 10.1016/j.neuroscience.2010.04.010	19	64	65	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					495	498		10.1126/science.aaf7040	http://dx.doi.org/10.1126/science.aaf7040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27386920	Green Submitted, Green Accepted			2022-12-24	WOS:000380583600043
J	Zhou, QH; Li, HM; Li, HZ; Nakagawa, A; Lin, JLJ; Lee, ES; Harry, BL; Skeen-Gaar, RR; Suehiro, Y; William, D; Mitani, S; Yuan, HS; Kang, BH; Xue, D				Zhou, Qinghua; Li, Haimin; Li, Hanzeng; Nakagawa, Akihisa; Lin, Jason L. J.; Lee, Eui-Seung; Harry, Brian L.; Skeen-Gaar, Riley Robert; Suehiro, Yuji; William, Donna; Mitani, Shohei; Yuan, Hanna S.; Kang, Byung-Ho; Xue, Ding			Mitochondrial endonuclease G mediates breakdown of paternal mitochondria upon fertilization	SCIENCE			English	Article							C. ELEGANS; DNA; AUTOPHAGY; INHERITANCE; DEGRADATION; HETEROPLASMY; TRANSMISSION; APOPTOSIS; DISEASE; MTDNA	Mitochondria are inherited maternally in most animals, but the mechanisms of selective paternal mitochondrial elimination (PME) are unknown. While examining fertilization in Caenorhabditis elegans, we observed that paternal mitochondria rapidly lose their inner membrane integrity. CPS-6, a mitochondrial endonuclease G, serves as a paternal mitochondrial factor that is critical for PME. We found that CPS-6 relocates from the intermembrane space of paternal mitochondria to the matrix after fertilization to degrade mitochondrial DNA. It acts with maternal autophagy and proteasome machineries to promote PME. Loss of cps-6 delays breakdown of mitochondrial inner membranes, autophagosome enclosure of paternal mitochondria, and PME. Delayed removal of paternal mitochondria causes increased embryonic lethality, demonstrating that PME is important for normal animal development. Thus, CPS-6 functions as a paternal mitochondrial degradation factor during animal development.	[Zhou, Qinghua; Li, Haimin; Li, Hanzeng; Nakagawa, Akihisa; Lee, Eui-Seung; Harry, Brian L.; Skeen-Gaar, Riley Robert; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Li, Hanzeng] Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA; [Lin, Jason L. J.; Yuan, Hanna S.] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Harry, Brian L.] Univ Colorado, Med Scientist Training Program, Aurora, CO 80045 USA; [Suehiro, Yuji; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Suehiro, Yuji; Mitani, Shohei] Japan Sci & Technol Agcy, CREST, Tokyo 1628666, Japan; [William, Donna] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Kang, Byung-Ho] Chinese Univ Hong Kong, Sch Life Sci, Ctr Cell & Dev Biol, Hong Kong, Hong Kong, Peoples R China; [Kang, Byung-Ho] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Zhou, Qinghua] Jinan Univ, Biomed Translat Res Inst, Affiliated Hosp 1, Guangzhou 510630, Guangdong, Peoples R China	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Academia Sinica - Taiwan; University of Colorado System; University of Colorado Anschutz Medical Campus; Tokyo Women's Medical University; Japan Science & Technology Agency (JST); State University System of Florida; University of Florida; Chinese University of Hong Kong; Chinese University of Hong Kong; Jinan University	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.; Kang, BH (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Cell & Dev Biol, Hong Kong, Hong Kong, Peoples R China.; Kang, BH (corresponding author), Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China.	bkang@cuhk.edu.hk; ding.xue@colorado.edu	Yuan, Hanna S./AAA-4005-2021; Li, Hanzeng/T-7473-2019; Zhou, Qinghua/I-2484-2014; Kang, Byung-Ho/G-9312-2017	Yuan, Hanna S./0000-0001-9671-6967; Zhou, Qinghua/0000-0003-0468-9266; Kang, Byung-Ho/0000-0002-4299-2170	March of Dimes [1-FY14-300]; NIH [GM59083, GM79097, GM118188]; Research Grants Council of Hong Kong [AoE/M-05/12]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088241, R01GM066262, R35GM118188, R01GM059083, R01GM079097, T32GM008497] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Blumenthal, R. Poyton, and K. Krauter for comments and H. Zhang for strains and antibodies. Supported by March of Dimes grant 1-FY14-300 and NIH grants GM59083, GM79097, and GM118188 (D.X.) and Research Grants Council of Hong Kong grant AoE/M-05/12 (B.-H.K.).	Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Cummins J M, 2000, Hum Reprod, V15 Suppl 2, P92; DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021; Jia KL, 2010, ADV EXP MED BIOL, V694, P47; Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051; Levine B, 2011, SCIENCE, V334, P1069, DOI 10.1126/science.1215480; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lin JLJ, 2012, J BIOL CHEM, V287, P7110, DOI 10.1074/jbc.M111.316075; Madura K, 2004, TRENDS BIOCHEM SCI, V29, P637, DOI 10.1016/j.tibs.2004.10.008; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI [10.1139/o02-135, 10.1139/O02-135]; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wang XD, 2001, GENE DEV, V15, P2922; Zhou QH, 2011, CELL RES, V21, P1662, DOI 10.1038/cr.2011.182	22	103	109	6	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2016	353	6297					394	399		10.1126/science.aaf4777	http://dx.doi.org/10.1126/science.aaf4777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HB	27338704	Green Accepted			2022-12-24	WOS:000380583400044
J	Dance, A				Dance, Amber			LIVE FAST, DIE YOUNG	NATURE			English	Editorial Material							FISH NOTHOBRANCHIUS-FURZERI; LIFE-SPAN; PROVIDES INSIGHTS; VERTEBRATE MODEL; EVOLUTION; GENOME											Baumgart M, 2016, CELL SYST, V2, P122, DOI 10.1016/j.cels.2016.01.014; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038; Kirschner J, 2012, AGING CELL, V11, P252, DOI 10.1111/j.1474-9726.2011.00780.x; Petzold A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-185; Reichwald K, 2015, CELL, V163, P1527, DOI 10.1016/j.cell.2015.10.071; Ripa R., 2016, PREPRINT; Terzibasi E, 2009, AGING CELL, V8, P88, DOI 10.1111/j.1474-9726.2009.00455.x; Valenzano DR, 2015, CELL, V163, P1539, DOI 10.1016/j.cell.2015.11.008; Valenzano DR, 2011, G3-GENES GENOM GENET, V1, P531, DOI 10.1534/g3.111.001271; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038	11	7	7	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					453	455		10.1038/535453a	http://dx.doi.org/10.1038/535453a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27443744				2022-12-24	WOS:000380344200047
J	Hoppe, PS; Schwarzfischer, M; Loeffler, D; Kokkaliaris, KD; Hilsenbeck, O; Moritz, N; Endele, M; Filipczyk, A; Gambardella, A; Ahmed, N; Etzrodt, M; Coutu, DL; Rieger, MA; Marr, C; Strasser, MK; Schauberger, B; Burtscher, I; Ermakova, O; Burger, A; Lickert, H; Nerlov, C; Theis, FJ; Schroeder, T				Hoppe, Philipp S.; Schwarzfischer, Michael; Loeffler, Dirk; Kokkaliaris, Konstantinos D.; Hilsenbeck, Oliver; Moritz, Nadine; Endele, Max; Filipczyk, Adam; Gambardella, Adriana; Ahmed, Nouraiz; Etzrodt, Martin; Coutu, Daniel L.; Rieger, Michael A.; Marr, Carsten; Strasser, Michael K.; Schauberger, Bernhard; Burtscher, Ingo; Ermakova, Olga; Burger, Antje; Lickert, Heiko; Nerlov, Claus; Theis, Fabian J.; Schroeder, Timm			Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios	NATURE			English	Article							TRANSCRIPTION FACTOR GATA-1; HEMATOPOIETIC STEM-CELLS; PROGENITOR CELLS; ERYTHROID-DIFFERENTIATION; MULTIPOTENT PROGENITORS; TRANSGENIC MICE; COMMITMENT; SPECIFICATION; ACTIVATION; EXPRESSION	The mechanisms underlying haematopoietic lineage decisions remain disputed. Lineage-affiliated transcription factors(1,2) with the capacity for lineage reprogramming(3), positive auto-regulation(4,5) and mutual inhibition(6,7) have been described as being expressed in uncommitted cell populations(8). This led to the assumption that lineage choice is cell-intrinsically initiated and determined by stochastic switches of randomly fluctuating cross-antagonistic transcription factors(3). However, this hypothesis was developed on the basis of RNA expression data from snapshot and/or population-averaged analyses(9-12). Alternative models of lineage choice therefore cannot be excluded. Here we use novel reporter mouse lines and live imaging for continuous single-cell long-term quantification of the transcription factors GATA1 and PU.1 (also known as SPI1). We analyse individual haematopoietic stem cells throughout differentiation into megakaryocytic-erythroid and granulocytic-monocytic lineages. The observed expression dynamics are incompatible with the assumption that stochastic switching between PU.1 and GATA1 precedes and initiates megakaryocytic-erythroid versus granulocytic-monocytic lineage decision-making. Rather, our findings suggest that these transcription factors are only executing and reinforcing lineage choice once made. These results challenge the current prevailing model of early myeloid lineage choice.	[Hoppe, Philipp S.; Loeffler, Dirk; Kokkaliaris, Konstantinos D.; Hilsenbeck, Oliver; Endele, Max; Ahmed, Nouraiz; Etzrodt, Martin; Coutu, Daniel L.; Schroeder, Timm] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Hoppe, Philipp S.; Loeffler, Dirk; Kokkaliaris, Konstantinos D.; Hilsenbeck, Oliver; Moritz, Nadine; Endele, Max; Filipczyk, Adam; Rieger, Michael A.; Schauberger, Bernhard; Schroeder, Timm] Helmholtz Zentrum Munchen, Res Unit Stem Cell Dynam, D-85764 Neuherberg, Germany; [Schwarzfischer, Michael; Hilsenbeck, Oliver; Marr, Carsten; Strasser, Michael K.; Theis, Fabian J.] Helmholtz Zentrum Munchen, Inst Computat Biol, D-85764 Neuherberg, Germany; [Gambardella, Adriana; Nerlov, Claus] Univ Oxford, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Burtscher, Ingo; Lickert, Heiko] Helmholtz Zentrum Munchen, Inst Diabet & Regenerat Res, Inst Stem Cell Res, Business Campus Garching, D-85748 Garching, Germany; [Ermakova, Olga] CNR, Ist Biol Cellulare & Neurobiol, I-00015 Monterotondo, Italy; [Burger, Antje] Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany; [Lickert, Heiko] Tech Univ Munich, Fac Med, Beta Cell Biol, D-80333 Munich, Germany; [Nerlov, Claus] EMBL Mouse Biol Unit, I-00015 Monterotondo, Italy; [Theis, Fabian J.] Tech Univ Munich, Dept Math, D-85748 Garching, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oxford; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; European Molecular Biology Laboratory (EMBL); Technical University of Munich	Schroeder, T (corresponding author), ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.; Schroeder, T (corresponding author), Helmholtz Zentrum Munchen, Res Unit Stem Cell Dynam, D-85764 Neuherberg, Germany.	timm.schroeder@bsse.ethz.ch	Theis, Fabian J/ABD-5212-2021; Rieger, Michael A/L-8324-2017; Marr, Carsten/B-3696-2013; Coutu, Daniel/AAD-5292-2022; Ermakova, Olga/Z-2037-2018; Ermakova, Olga/K-5712-2019; Kokkaliaris, Konstantinos/GWQ-3400-2022; Etzrodt, Martin/P-3325-2015	Theis, Fabian J/0000-0002-2419-1943; Rieger, Michael A/0000-0002-4158-5872; Marr, Carsten/0000-0003-2154-4552; Coutu, Daniel/0000-0002-4641-0115; Ermakova, Olga/0000-0001-8365-4904; Ermakova, Olga/0000-0001-8365-4904; Loeffler, Dirk/0000-0001-9870-0088; Schauberger, Bernhard/0000-0001-7917-0392; Schroeder, Timm/0000-0001-9320-0252; Etzrodt, Martin/0000-0003-1928-3904; KOKKALIARIS, KONSTANTINOS/0000-0002-9952-3463	EMBO long-term fellowship; 'EUCOMM: Tools for Functional Annotation of the Mouse Genome' (EUCOMMTOOLS) project [FP7-HEALTH-F4-2010-261492]; ERC; German Federal Ministry of Education and Research (BMBF); German Research Foundation (DFG) within the SPP 1395; German Research Foundation (DFG) within the SPP 1356; DFG [SFB 684]; SNF; SystemsX.ch; Medical Research Council [G0701761, MC_UU_12009/7, G0900892] Funding Source: researchfish; MRC [G0701761, G0900892, MC_UU_12009/7] Funding Source: UKRI	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); 'EUCOMM: Tools for Functional Annotation of the Mouse Genome' (EUCOMMTOOLS) project; ERC(European Research Council (ERC)European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG) within the SPP 1395(German Research Foundation (DFG)); German Research Foundation (DFG) within the SPP 1356(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); SNF; SystemsX.ch; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to S. Ammersdoerfer, H. Oiler, C. Raithel, B. Vogel and A. Ziegler for technical support. This work was supported by an EMBO long-term fellowship to M.Et., the 'EUCOMM: Tools for Functional Annotation of the Mouse Genome' (EUCOMMTOOLS) project (FP7-HEALTH-F4-2010-261492) to A.B., the ERC (starting grant Latent Causes), the German Federal Ministry of Education and Research (BMBF), the German Research Foundation (DFG) within the SPPs 1395 (InKoMBio) and 1356 to F.J.T. and DFG SFB 684 to T.S. and the SNF to T.S. T.S. and O.H. acknowledge financial support from SystemsX.ch.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; CHEN HM, 1995, ONCOGENE, V11, P1549; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; Filipczyk A, 2015, NAT CELL BIOL, V17, P1235, DOI 10.1038/ncb3237; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hilsenbeck O., 2016, NAT BIOTECHNOL; Hoppe PS, 2014, NAT CELL BIOL, V16, P919, DOI 10.1038/ncb3042; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Kreutz C, 2007, BIOINFORMATICS, V23, P2747, DOI 10.1093/bioinformatics/btm397; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mancini E, 2012, EMBO J, V31, P351, DOI 10.1038/emboj.2011.390; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Miyawaki K, 2015, STEM CELLS, V33, P976, DOI 10.1002/stem.1906; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Schwarzfischer M., 2011, P MICR IM AN APPL BI; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang P, 2000, BLOOD, V96, P2641	38	137	137	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					299	U266		10.1038/nature18320	http://dx.doi.org/10.1038/nature18320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27411635	Green Submitted			2022-12-24	WOS:000379912600060
J	Faubel, R; Westendorf, C; Bodenschatz, E; Eichele, G				Faubel, Regina; Westendorf, Christian; Bodenschatz, Eberhard; Eichele, Gregor			Cilia-based flow network in the brain ventricles	SCIENCE			English	Article							CEREBROSPINAL-FLUID; LOCOMOTOR-ACTIVITY; 3RD-VENTRICLE; TANYCYTES; PROTEOME; FORCES; SLEEP; CELLS	Cerebrospinal fluid conveys many physiologically important signaling factors through the ventricular cavities of the brain. We investigated the transport of cerebrospinal fluid in the third ventricle of the mouse brain and discovered a highly organized pattern of cilia modules, which collectively give rise to a network of fluid flows that allows for precise transport within this ventricle. We also discovered a cilia-based switch that reliably and periodically alters the flow pattern so as to create a dynamic subdivision that may control substance distribution in the third ventricle. Complex flow patterns were also present in the third ventricles of rats and pigs. Our work suggests that ciliated epithelia can generate and maintain complex, spatiotemporally regulated flow networks.	[Faubel, Regina; Eichele, Gregor] Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany; [Westendorf, Christian; Bodenschatz, Eberhard] Max Planck Inst Dynam & Self Org, Fassberg 17, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Eichele, G (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	gregor.eichele@mpibpc.mpg.de		Westendorf, Christian/0000-0001-7663-6150; Bodenschatz, Eberhard/0000-0002-2901-0144	Max Planck Society	Max Planck Society(Max Planck Society)	We thank A. Bae, A. Pumir, and C. Lo for valuable comments and suggestions; C. Thaller for technical assistance; J. Schroder-Schetelig for providing multirecorder software; and D. Hornung and T. Baig for providing euthanized minipigs. This work was supported by the Max Planck Society.	Bolborea M, 2013, TRENDS NEUROSCI, V36, P91, DOI 10.1016/j.tins.2012.12.008; Brooks ER, 2014, CURR BIOL, V24, pR973, DOI 10.1016/j.cub.2014.08.047; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Chiasserini D, 2014, J PROTEOMICS, V106, P191, DOI 10.1016/j.jprot.2014.04.028; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Ferran JL, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00046; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Freund JB, 2012, DEVELOPMENT, V139, P1229, DOI 10.1242/dev.073593; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Guldbrandsen A, 2014, MOL CELL PROTEOMICS, V13, P3152, DOI 10.1074/mcp.M114.038554; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; Mathew TC, 2008, ANAT HISTOL EMBRYOL, V37, P9, DOI 10.1111/j.1439-0264.2007.00786.x; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Richter C, 2014, ANNU REV NEUROSCI, V37, P503, DOI 10.1146/annurev-neuro-062111-150447; Robins SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3049; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; SHIMADA M, 1973, EXP NEUROL, V41, P163, DOI 10.1016/0014-4886(73)90187-8; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; WORTHINGTON WC, 1966, ANN NY ACAD SCI, V130, P944, DOI 10.1111/j.1749-6632.1966.tb12638.x; Zhang Y, 2015, J PROTEOMICS, V119, P90, DOI 10.1016/j.jprot.2015.01.017	22	142	146	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					176	178		10.1126/science.aae0450	http://dx.doi.org/10.1126/science.aae0450			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27387952				2022-12-24	WOS:000379208400041
J	Han, PD; Bloomekatz, J; Ren, J; Zhang, RL; Grinstein, JD; Zhao, L; Burns, CG; Burns, CE; Anderson, RM; Chi, NC				Han, Peidong; Bloomekatz, Joshua; Ren, Jie; Zhang, Ruilin; Grinstein, Jonathan D.; Zhao, Long; Burns, C. Geoffrey; Burns, Caroline E.; Anderson, Ryan M.; Chi, Neil C.			Coordinating cardiomyocyte interactions to direct ventricular chamber morphogenesis	NATURE			English	Article							REVEALS; TRANSGENESIS; INHIBITION; EXPRESSION; MUTATIONS; MIGRATION; PROMOTER; BEHAVIOR; GROWTH; CELLS	Many organs are composed of complex tissue walls that are structurally organized to optimize organ function. In particular, the ventricular myocardial wall of the heart comprises an outer compact layer that concentrically encircles the ridge-like inner trabecular layer. Although disruption in the morphogenesis of this myocardial wall can lead to various forms of congenital heart disease(1) and non-compaction cardiomyopathies(2), it remains unclear how embryonic cardiomyocytes assemble to form ventricular wall layers of appropriate spatial dimensions and myocardial mass. Here we use advanced genetic and imaging tools in zebrafish to reveal an interplay between myocardial Notch and Erbb2 signalling that directs the spatial allocation of myocardial cells to their proper morphological positions in the ventricular wall. Although previous studies have shown that endocardial Notch signalling non-cell-autonomously promotes myocardial trabeculation through Erbb2 and bone morphogenetic protein (BMP) signalling(3), we discover that distinct ventricular cardiomyocyte clusters exhibit myocardial Notch activity that cell-autonomously inhibits Erbb2 signalling and prevents cardiomyocyte sprouting and trabeculation. Myocardial-specific Notch inactivation leads to ventricles of reduced size and increased wall thickness because of excessive trabeculae, whereas widespread myocardial Notch activity results in ventricles of increased size with a single-cell-thick wall but no trabeculae. Notably, this myocardial Notch signalling is activated non-cell-autonomously by neighbouring Erbb2-activated cardiomyocytes that sprout and form nascent trabeculae. Thus, these findings support an interactive cellular feedback process that guides the assembly of cardiomyocytes to morphologically create the ventricular myocardial wall and more broadly provide insight into the cellular dynamics of how diverse cell lineages organize to create form.	[Han, Peidong; Bloomekatz, Joshua; Ren, Jie; Zhang, Ruilin; Grinstein, Jonathan D.; Chi, Neil C.] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Zhao, Long; Burns, C. Geoffrey; Burns, Caroline E.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Div Cardiol, Dept Med, Charlestown, MA 02129 USA; [Zhao, Long; Burns, C. Geoffrey; Burns, Caroline E.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Anderson, Ryan M.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Dept Pediat, Indianapolis, IN 46202 USA; [Anderson, Ryan M.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Chi, Neil C.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; Harvard University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of California System; University of California San Diego	Chi, NC (corresponding author), Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA.; Chi, NC (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.	nchi@ucsd.edu	Zhao, Long/A-6439-2014; Ren, Jie/AAB-5475-2019	Zhao, Long/0000-0003-2691-7055; Zhang, Ruilin/0000-0002-6594-450X; Grinstein, Jonathan/0000-0003-2911-4506	American Heart Association [14POST20380738]; March of Dimes [1-FY14-327]; NIH/NHLBI [5R01HL127067]; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069305, R01HD085902] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL128773, R01HL127067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); March of Dimes(March of Dimes); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Tedeschi for fish care: B. Le for experimental assistance; S. Evans, D. Yelon, and Chi laboratory members for comments on the manuscript; N. Ninov and D. Stainier for plasmids; B. Link for the d2GFP BMP and d2GFP Notch reporter lines: N. Lawson for the eGFP Notch reporter line; B. Appel for the myomrdial Cerulean line; K. Poss for the myocardial CreFR and Brainbow/priZm lines; and W. Talbot for the erbb2 mutant. This work was supported in part by grants from American Heart Association (14POST20380738) to L.Z.; the March of Dimes (1-FY14-327) to RAM.; the NIH/NHLBI (5R01HL127067) to C.G.B. and C.E.B.; and the National Institutes of Health to N.C.C.	Anderson RM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003650; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Clark BS, 2012, DEVELOPMENT, V139, P1599, DOI 10.1242/dev.078097; Collery RF, 2011, DEV DYNAM, V240, P712, DOI 10.1002/dvdy.22567; D'Amico L, 2007, CURR BIOL, V17, P252, DOI 10.1016/j.cub.2006.12.023; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Gupta V, 2012, NATURE, V484, P479, DOI 10.1038/nature11045; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Liu JD, 2010, DEVELOPMENT, V137, P3867, DOI 10.1242/dev.053736; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Mathews ES, 2014, J NEUROSCI, V34, P3402, DOI 10.1523/JNEUROSCI.4587-13.2014; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Ong LL, 1998, DEV BIOL, V193, P1, DOI 10.1006/dbio.1997.8775; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Peshkovsky C, 2011, DEV DYNAM, V240, P446, DOI 10.1002/dvdy.22526; Rentschler S, 2011, J CLIN INVEST, V121, P525, DOI 10.1172/JCI44470; Samsa LA, 2015, DEVELOPMENT, V142, P4080, DOI 10.1242/dev.125724; Schumacher JA, 2013, DEV BIOL, V383, P214, DOI 10.1016/j.ydbio.2013.09.019; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Staudt DW, 2014, DEVELOPMENT, V141, P585, DOI 10.1242/dev.098632; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Yang JW, 2012, CARDIOVASC RES, V96, P276, DOI 10.1093/cvr/cvs250; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zemrak F, 2014, J AM COLL CARDIOL, V64, P1971, DOI 10.1016/j.jacc.2014.08.035; Zhang RL, 2013, NATURE, V498, P497, DOI 10.1038/nature12322; Zhao C, 2014, DEVELOPMENT, V141, P281, DOI 10.1242/dev.093690; Zhao L, 2014, P NATL ACAD SCI USA, V111, P1403, DOI 10.1073/pnas.1311705111; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	41	49	49	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					700	+		10.1038/nature18310	http://dx.doi.org/10.1038/nature18310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357797	Green Submitted, Green Accepted			2022-12-24	WOS:000378676000040
J	Jain, V				Jain, Vageesh			Medical research in India and the rise of non-communicable disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; CHINA		[Jain, Vageesh] Kings Coll London, London SE1 1UL, England	University of London; King's College London	Jain, V (corresponding author), Kings Coll London, London SE1 1UL, England.	vageesh.jain@kcl.ac.uk						[Anonymous], INT J EPIDEMIOL, DOI DOI 10.1093/IJE/DYL098; [Anonymous], FUND PROGR ANN REP D; [Anonymous], MIN SCI TECHN ANN RE; [Anonymous], HLTH EXP TOT GDP; [Anonymous], PUBL HLTH RES EUR FU; [Anonymous], MIN HLTH FAM WELF AN; [Anonymous], 2009, VALUE IMPORTANCE OVE; [Anonymous], NATIONAL AMBIENT AIR; [Anonymous], 2015, WORLD EC OUTLOOK DAT; [Anonymous], CHRONIC NONCOMMUNICA; [Anonymous], COUNTR PROF ENV BURD; [Anonymous], INT J MED SCI PUBLIC; [Anonymous], GLOBOCAN 2012 V1 0 C; [Anonymous], BUDG ALL NET REC; [Anonymous], HLTH EXP PUBL GDP; [Anonymous], MIN SCI TECHN ANN RE; [Anonymous], GLOB BURD DIS 2013; Chatterji S, 2008, HEALTH AFFAIR, V27, P1052, DOI 10.1377/hlthaff.27.4.1052; Dikid T, 2013, INDIAN J MED RES, V138, P18; Kan HD, 2009, ENVIRON HEALTH PERSP, V117, pA530, DOI 10.1289/ehp.0901615; Pandav CS, 2013, INDIAN J MED RES, V138, P418; Pandve Harshal T, 2009, Indian J Occup Environ Med, V13, P17, DOI 10.4103/0019-5278.50718; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Upadhyay RP, 2012, IRAN J PUBLIC HEALTH, V41, P1; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; WHO, 2016, WHO GLOB URB AMB AIR; World Health Organization, 2005, WORLD HLTH REP 2005	30	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2016	353								i3371	10.1136/bmj.i3371	http://dx.doi.org/10.1136/bmj.i3371			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FV	27358280				2022-12-24	WOS:000379018700001
J	Matthews, A; Herrett, E; Gasparrini, A; Van Staa, T; Goldacre, B; Smeeth, L; Bhaskaran, K				Matthews, Anthony; Herrett, Emily; Gasparrini, Antonio; Van Staa, Tjeerd; Goldacre, Ben; Smeeth, Liam; Bhaskaran, Krishnan			Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; LDL CHOLESTEROL; HEART-DISEASE; LOW-RISK; METAANALYSIS; BENEFITS; MEDICATION; PEOPLE; HEALTH	OBJECTIVE To quantify how a period of intense media coverage of controversy over the risk: benefit balance of statins affected their use. DESIGN Interrupted time series analysis of prospectively collected electronic data from primary care. SETTING Clinical Practice Research Datalink (CPRD) in the United Kingdom. PARTICIPANTS Patients newly eligible for or currently taking statins for primary and secondary cardiovascular disease prevention in each month in January 2011-March 2015. Main outcom e measures Adjusted odds ratios for starting/stopping taking statins after the media coverage (October 2013-March 2014). RESULTS There was no evidence that the period of high media coverage was associated with changes in statin initiation among patients with a high recorded risk score for cardiovascular disease (primary prevention) or a recent cardiovascular event (secondary prevention) (odds ratio 0.99 (95% confidence interval 0.87 to 1.13; P = 0.92) and 1.04 (0.92 to 1.18; P = 0.54), respectively), though there was a decrease in the overall proportion of patients with a recorded risk score. Patients already taking statins were more likely to stop taking them for both primary and secondary prevention after the high media coverage period (1.11 (1.05 to 1.18; P < 0.001) and 1.12 (1.04 to 1.21; P = 0.003), respectively). Stratified analyses showed that older patients and those with a longer continuous prescription were more likely to stop taking statins after the media coverage. In post hoc analyses, the increased rates of cessation were no longer observed after six months. CONCLUSIONS A period of intense public discussion over the risks: benefit balance of statins, covered widely in the media, was followed by a transient rise in the proportion of people who stopped taking statins. This research highlights the potential for widely covered health stories in the lay media to impact on healthcare related behaviour.	[Matthews, Anthony; Herrett, Emily; Goldacre, Ben; Smeeth, Liam; Bhaskaran, Krishnan] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England; [Gasparrini, Antonio] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Keppel St, London WC1E 7HT, England; [Van Staa, Tjeerd] Univ Manchester, Farr Inst Hlth Informat Res, Hlth eRes Ctr, Manchester, Lancs, England; [Van Staa, Tjeerd] Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Manchester; Utrecht University	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	Gasparrini, Antonio/F-7627-2012; Matthews, Anthony/H-9441-2019; Smeeth, Liam/X-5862-2018	Gasparrini, Antonio/0000-0002-2271-3568; Matthews, Anthony/0000-0002-1290-271X; van Staa, Tjeerd/0000-0001-9363-742X; Smeeth, Liam/0000-0002-9168-6022; Bhaskaran, Krishnan/0000-0001-5364-8757	British Heart Foundation; Wellcome Trust; Royal Society [107731/Z/15/Z]; British Heart Foundation [PG/15/80/31781] Funding Source: researchfish; Medical Research Council [MR/K006665/1, MC_PC_13042, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [14/49/159] Funding Source: researchfish; Wellcome Trust [107731/Z/15/Z] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the British Heart Foundation. KB holds a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant No 107731/Z/15/Z). LS is funded by a Wellcome Trust senior fellowship in clinical science. The British Heart Foundation, the Wellcome Trust, and the Royal Society had no role in the design, analysis, or writing up of this study.	Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; [Anonymous], 2014, DAILY MAIL; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Boseley S., 2014, GUARDIAN; British Cardiovascular Association, 2014, STAT MED SURV RES; BRUGTS JJ, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B2376; Campbell J, 2013, PHARMACOEPIDEM DR S, V22, P280; Casey GM, 2013, BRIT J CANCER, V109, P1192, DOI 10.1038/bjc.2013.444; Chapman S, 2005, MED J AUSTRALIA, V183, P247, DOI 10.5694/j.1326-5377.2005.tb07029.x; Denaxas Spiros C, 2012, Int J Epidemiol, V41, P1625, DOI 10.1093/ije/dys188; Faasse K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001607; Fontana M, 2014, CIRCULATION, V129, P2539, DOI 10.1161/CIRCULATIONAHA.113.007595; Fung Vicki, 2010, Perm J, V14, P4; Gale NK, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-59; Grilli R, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000389; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Kelaher M, 2008, INT J EPIDEMIOL, V37, P1326, DOI 10.1093/ije/dyn090; Kocas C, 2015, INT J CARDIOL, V201, P139, DOI 10.1016/j.ijcard.2015.07.095; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Kravitz RL, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S3-S5; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; MacArthur GJ, 2011, J MED SCREEN, V18, P204, DOI 10.1258/jms.2011.011092; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; McCullagh P., 1989, GEN LINEAR MODELS, DOI [10. 1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6, 10.1007/978-1-4899-3242-6]; McDowall D., 1980, INTERRUPTED TIME SER; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Nielsen SF, 2016, EUR HEART J, V37, P908, DOI 10.1093/eurheartj/ehv641; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Saib A, 2013, ARCH CARDIOVASC DIS, V106, P511, DOI 10.1016/j.acvd.2013.06.053; Schaffer AL, 2015, MED J AUSTRALIA, V202, P591, DOI 10.5694/mja15.00103; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; van Hunsel F, 2009, BRIT J CLIN PHARMACO, V67, P558, DOI 10.1111/j.1365-2125.2009.03400.x; Wennberg J E, 1984, Health Manage Q, P6, DOI 10.1377/hlthaff.3.2.6; Will CM, 2015, SOC SCI MED, V131, P280, DOI 10.1016/j.socscimed.2014.04.033; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	38	125	125	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2016	353								i3283	10.1136/bmj.i3283	http://dx.doi.org/10.1136/bmj.i3283			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FP	27353418	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000379018000002
J	Mayer, KH; Shisana, O; Beyrer, C				Mayer, Kenneth H.; Shisana, Olive; Beyrer, Chris			AIDS 2016: from aspiration to implementation	LANCET			English	Editorial Material							HIV-INFECTION; PREVENTION		[Mayer, Kenneth H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA 02215 USA; [Mayer, Kenneth H.; Shisana, Olive; Beyrer, Chris] Int AIDS Soc, Geneva, Switzerland; [Shisana, Olive] Evidence Based Solut, Cape Town, South Africa; [Shisana, Olive] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Hlth & Human Rights, Baltimore, MD USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Fenway Health; University of Cape Town; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mayer, KH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.; Mayer, KH (corresponding author), Fenway Hlth, Fenway Inst, Boston, MA 02215 USA.	kmayer@fenwayhealth.org						Beyrer C, 2015, LANCET, V386, P505, DOI 10.1016/S0140-6736(15)61458-1; Case KK, 2012, B WORLD HEALTH ORGAN, V90, P831, DOI 10.2471/BLT.12.102574; Cohen MS, 2012, CURR OPIN HIV AIDS, V7, P99, DOI 10.1097/COH.0b013e32834f5cf2; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Risher K, 2015, CURR OPIN HIV AIDS, V10, P420, DOI 10.1097/COH.0000000000000200; Sheena M, 2016, LANCET, V387, P53; Shisana O, 2014, S AFRICAN NATL HIV P; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Wang HB, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/503978; World Health Organization, 2015, GUID START ANT THER	12	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2484	2485		10.1016/S0140-6736(16)30621-3	http://dx.doi.org/10.1016/S0140-6736(16)30621-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO7FG	27353669				2022-12-24	WOS:000377947200006
J	Arbore, G; West, EE; Spolski, R; Robertson, AAB; Klos, A; Rheinheimer, C; Dutow, P; Woodruff, TM; Yu, ZX; O'Neill, LA; Coll, RC; Sher, A; Leonard, WJ; Kohl, J; Monk, P; Cooper, MA; Arno, M; Afzali, B; Lachmann, HJ; Cope, AP; Mayer-Barber, KD; Kemper, C				Arbore, Giuseppina; West, Erin E.; Spolski, Rosanne; Robertson, Avril A. B.; Klos, Andreas; Rheinheimer, Claudia; Dutow, Pavel; Woodruff, Trent M.; Yu, Zu Xi; O'Neill, Luke A.; Coll, Rebecca C.; Sher, Alan; Leonard, Warren J.; Koehl, Jorg; Monk, Pete; Cooper, Matthew A.; Arno, Matthew; Afzali, Behdad; Lachmann, Helen J.; Cope, Andrew P.; Mayer-Barber, Katrin D.; Kemper, Claudia			T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells	SCIENCE			English	Article							INNATE LYMPHOID-CELLS; C5A RECEPTOR CD88; INTESTINAL INFLAMMATION; IFN-GAMMA; DIFFERENTIATION; ACTIVATION; C5L2; CYTOKINE; DISEASE; ANTAGONISTS		[Arbore, Giuseppina; Afzali, Behdad; Kemper, Claudia] Kings Coll London, Div Transplant Immunol & Mucosal Biol, MRC Ctr Transplantat, London SE1 9RT, England; [West, Erin E.; Spolski, Rosanne; Leonard, Warren J.; Kemper, Claudia] NHLBI, Lab Mol Immunol, Bldg 10, Bethesda, MD 20892 USA; [Robertson, Avril A. B.; Woodruff, Trent M.; Coll, Rebecca C.; Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Klos, Andreas; Rheinheimer, Claudia; Dutow, Pavel] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, D-30625 Hannover, Germany; [Yu, Zu Xi] NHLBI, Pathol Core, Bldg 10, Bethesda, MD 20892 USA; [O'Neill, Luke A.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Sher, Alan] NIAID, Parasit Dis Lab, Bethesda, MD 20892 USA; [Koehl, Jorg] Med Univ Lubeck, Inst Syst Inflammat Res, D-23538 Lubeck, Germany; [Koehl, Jorg] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Koehl, Jorg] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Monk, Pete] Univ Sheffield, Dept Infect & Immun, Sheffield S10 2RX, S Yorkshire, England; [Arno, Matthew] Kings Coll London, Fac Life Sci & Med, Genom Ctr, London SE1 9NH, England; [Afzali, Behdad] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; [Lachmann, Helen J.] UCL, Div Med, UK Natl Amyloidosis Ctr, Royal Free Campus, London NW3 2PF, England; [Cope, Andrew P.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, Acad Dept Rheumatol, London SE1 1UL, England; [Mayer-Barber, Katrin D.] NIAID, Lab Clin Infect Dis, Inflammat & Innate Immun Unit, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Queensland; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Trinity College Dublin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Lubeck; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Sheffield; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of London; University College London; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kemper, C (corresponding author), Kings Coll London, Div Transplant Immunol & Mucosal Biol, MRC Ctr Transplantat, London SE1 9RT, England.; Kemper, C (corresponding author), NHLBI, Lab Mol Immunol, Bldg 10, Bethesda, MD 20892 USA.	claudia.kemper@kcl.ac.uk	Arbore, Giuseppina/AAN-1899-2020; Coll, Rebecca/J-2124-2014; Leonard, Warren/AAA-1397-2022; Cooper, Matthew A./C-7988-2009; Woodruff, Trent/AAS-4629-2020; Robertson, Avril/A-4043-2012; Koehl, Joerg/C-8531-2011; Afzali, Behdad/H-8565-2013; Woodruff, Trent M/B-4861-2009; Monk, Peter/C-6155-2008	Arbore, Giuseppina/0000-0002-8318-7557; Coll, Rebecca/0000-0002-7359-6023; Cooper, Matthew A./0000-0003-3147-3460; Woodruff, Trent/0000-0003-1382-911X; Robertson, Avril/0000-0002-9652-8357; Koehl, Joerg/0000-0003-1121-3178; Afzali, Behdad/0000-0003-2968-1156; Woodruff, Trent M/0000-0003-1382-911X; Monk, Peter/0000-0003-4637-3059; Kemper, Claudia/0000-0003-4196-1417; Cope, Andrew/0000-0001-6735-5496; Lachmann, Helen/0000-0001-8378-2498; O'Neill, Luke/0000-0002-4333-2748	British Heart Foundation [PG/09/018/25279] Funding Source: Medline; Intramural NIH HHS [ZIA AI001207-01, Z99 AI999999] Funding Source: Medline; Medical Research Council [MR/J006742/1] Funding Source: Medline; Wellcome Trust [109443/Z/15/Z] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005409, ZIGHL006020, ZICHL005904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001207, ZIAAI001044] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bauer C, 2012, DIGEST DIS, V30, P82, DOI 10.1159/000341681; Ben-Sasson SZ, 2013, J EXP MED, V210, P491, DOI 10.1084/jem.20122006; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bock D, 1997, EUR J IMMUNOL, V27, P1522, DOI 10.1002/eji.1830270631; Bruchard M, 2015, NAT IMMUNOL, V16, P859, DOI 10.1038/ni.3202; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Carta S, 2015, P NATL ACAD SCI USA, V112, P2835, DOI 10.1073/pnas.1424741112; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Croker DE, 2013, IMMUNOL CELL BIOL, V91, P625, DOI 10.1038/icb.2013.48; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; Dunkelberger J, 2012, J IMMUNOL, V188, P4032, DOI 10.4049/jimmunol.1103141; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Ghannam A, 2008, J IMMUNOL, V181, P5158, DOI 10.4049/jimmunol.181.7.5158; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; Kastbom A, 2008, RHEUMATOLOGY, V47, P415, DOI 10.1093/rheumatology/kem372; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Le Friec G, 2012, NAT IMMUNOL, V13, P1213, DOI 10.1038/ni.2454; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Monkl PN, 2012, IMMUNOBIOLOGY, V217, P1162, DOI 10.1016/j.imbio.2012.08.097; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Otto M, 2004, J BIOL CHEM, V279, P142, DOI 10.1074/jbc.M310078200; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Samstad EO, 2014, J IMMUNOL, V192, P2837, DOI 10.4049/jimmunol.1302484; Sarma JV, 2012, CELL HEALTH CYTOSKEL, V4, P73, DOI 10.2147/CHC.S27233; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Valatas V, 2013, MUCOSAL IMMUNOL, V6, P601, DOI 10.1038/mi.2012.102; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com; Yamamoto H, 2013, INT J BIOCHEM CELL B, V45, P2808, DOI 10.1016/j.biocel.2013.09.016; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	59	274	277	5	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292							aad1210	10.1126/science.aad1210	http://dx.doi.org/10.1126/science.aad1210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313051	Green Submitted, Green Accepted			2022-12-24	WOS:000377975400040
J	Raaijmakers, JM; Mazzola, M				Raaijmakers, Jos M.; Mazzola, Mark			Soil immune responses Soil microbiomes may be harnessed for plant health	SCIENCE			English	Editorial Material							RHIZOSPHERE MICROBIOME; FUSARIUM-WILT; SUPPRESSION; POPULATIONS		[Raaijmakers, Jos M.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Ecol, Wageningen, Netherlands; [Raaijmakers, Jos M.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Mazzola, Mark] USDA ARS, Wenatchee, WA USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Leiden University; Leiden University - Excl LUMC; United States Department of Agriculture (USDA)	Raaijmakers, JM (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Inst Ecol, Wageningen, Netherlands.; Raaijmakers, JM (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	j.raaijmakers@nioo.knaw.nl	Mazzola, Mark/AAW-1929-2021; Raaijmakers, Jos M/D-1574-2014; KNAW, NIOO-KNAW/A-4320-2012	Raaijmakers, Jos M/0000-0003-1608-6614; KNAW, NIOO-KNAW/0000-0002-3835-159X				Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; Cha JY, 2016, ISME J, V10, P119, DOI 10.1038/ismej.2015.95; Chapelle E, 2016, ISME J, V10, P265, DOI 10.1038/ismej.2015.82; HENRY A. W., 1931, CANADIAN JOUR RES, V4, P69; Kinkel LL, 2012, RES MICROBIOL, V163, P490, DOI 10.1016/j.resmic.2012.07.005; Larkin RP, 1996, PHYTOPATHOLOGY, V86, P812, DOI 10.1094/Phyto-86-812; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; LEMANCEAU P, 1993, BIOCONTROL SCI TECHN, V3, P219, DOI 10.1080/09583159309355278; Mazzola M, 2004, MICROB ECOL, V48, P338, DOI 10.1007/s00248-003-1067-y; Mazzola M, 2015, PHYTOPATHOLOGY, V105, P460, DOI 10.1094/PHYTO-09-14-0247-R; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Mueller UG, 2015, TRENDS MICROBIOL, V23, P606, DOI 10.1016/j.tim.2015.07.009; Olatinwo R, 2006, PHYTOPATHOLOGY, V96, P111, DOI 10.1094/PHYTO-96-0111; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010	14	189	209	13	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1392	1393		10.1126/science.aaf3252	http://dx.doi.org/10.1126/science.aaf3252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313024				2022-12-24	WOS:000377975400021
J	Meeske, AJ; Riley, EP; Robins, WP; Uehara, T; Mekalanos, JJ; Kahne, D; Walker, S; Kruse, AC; Bernhardt, TG; Rudner, DZ				Meeske, Alexander J.; Riley, Eammon P.; Robins, William P.; Uehara, Tsuyoshi; Mekalanos, John J.; Kahne, Daniel; Walker, Suzanne; Kruse, Andrew C.; Bernhardt, Thomas G.; Rudner, David Z.			SEDS proteins are a widespread family of bacterial cell wall polymerases	NATURE			English	Article							PENICILLIN-BINDING PROTEINS; BETA-LACTAM RESISTANCE; BACILLUS-SUBTILIS; PEPTIDOGLYCAN SYNTHESIS; DIVISION; GENE; BIOSYNTHESIS; PRECURSORS; DYNAMICS; FLIPPASE	Elongation of rod-shaped bacteria is mediated by a dynamic peptidoglycan-synthetizing machinery called the Rod complex. Here we report that, in Bacillus subtilis, this complex is functional in the absence of all known peptidoglycan polymerases. Cells lacking these enzymes survive by inducing an envelope stress response that increases the expression of RodA, a widely conserved core component of the Rod complex. RodA is a member of the SEDS (shape, elongation, division and sporulation) family of proteins, which have essential but ill-defined roles in cell wall biogenesis during growth, division and sporulation. Our genetic and biochemical analyses indicate that SEDS proteins constitute a family of peptidoglycan polymerases. Thus, B. subtilis and probably most bacteria use two distinct classes of polymerase to synthesize their exoskeleton. Our findings indicate that SEDS family proteins are core cell wall synthases of the cell elongation and division machinery, and represent attractive targets for antibiotic development.	[Meeske, Alexander J.; Riley, Eammon P.; Robins, William P.; Uehara, Tsuyoshi; Mekalanos, John J.; Walker, Suzanne; Bernhardt, Thomas G.; Rudner, David Z.] Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Kahne, Daniel; Walker, Suzanne; Kruse, Andrew C.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 250 Longwood Ave, Boston, MA 02115 USA; [Kahne, Daniel; Walker, Suzanne] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Bernhardt, TG; Rudner, DZ (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	thomas@hms.harvard.edu; rudner@hms.harvard.edu		Riley, Eammon/0000-0003-4960-7578; Meeske, Alexander/0000-0003-3878-531X; Uehara, Tsuyoshi/0000-0001-6994-4286	National Institute of Health [GM073831, RC2 GM092616, AI083365, AI099144]; Center for Excellence in Translational Research [U19 AI109764]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061, R01AI099144, R37AI018045, R01AI018045, R01AI083365, U19AI109764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073831, RC2GM092616, R01GM076710] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Excellence in Translational Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank past and present members of the Rudner and Bernhardt super group for advice and encouragement, members of the Walker and Kahne labs for help with PGT assays, D. Perlstein for initial characterization of a PGT activity in the aPBP quadruple mutant, and X. Wang for plasmids. Support for this work comes from the National Institute of Health Grants GM073831 (D.Z.R.), RC2 GM092616 (D.Z.R.), AI083365 (T.G.B.), AI099144 (T.G.B. and S.W.), and Center for Excellence in Translational Research (U19 AI109764) (D.Z.R., T.G.B., A.C.K., S.W., D.K., J.J.M.).	Adachi M, 2006, J AM CHEM SOC, V128, P14012, DOI 10.1021/ja065905c; Arbeloa A, 2004, J BACTERIOL, V186, P1221, DOI 10.1128/JB.186.5.1221-1228.2004; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Daniel RA, 1996, J BACTERIOL, V178, P2343, DOI 10.1128/jb.178.8.2343-2350.1996; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Fay A, 2010, J MOL BIOL, V399, P547, DOI 10.1016/j.jmb.2010.04.036; Fraipont C, 2011, MICROBIOL-SGM, V157, P251, DOI 10.1099/mic.0.040071-0; Fujita M, 2000, GENES CELLS, V5, P79, DOI 10.1046/j.1365-2443.2000.00307.x; Gamba P, 2009, J BACTERIOL, V191, P4186, DOI 10.1128/JB.01758-08; Gampe CM, 2011, TETRAHEDRON, V67, P9771, DOI 10.1016/j.tet.2011.09.114; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; ISHINO F, 1986, J BIOL CHEM, V261, P7024; Jeske O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8116; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kus JV, 2008, J BACTERIOL, V190, P7464, DOI 10.1128/JB.01075-08; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mascher T, 2007, J BACTERIOL, V189, P6919, DOI 10.1128/JB.00904-07; Mattei PJ, 2010, CURR OPIN STRUC BIOL, V20, P749, DOI 10.1016/j.sbi.2010.09.014; McPherson DC, 2003, J BACTERIOL, V185, P1423, DOI 10.1128/JB.185.4.1423-1431.2003; Meeske AJ, 2015, P NATL ACAD SCI USA, V112, P6437, DOI 10.1073/pnas.1504967112; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Packiam M, 2015, P NATL ACAD SCI USA, V112, P11660, DOI 10.1073/pnas.1514026112; Pilhofer M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3856; Rice LB, 2009, J BACTERIOL, V191, P3649, DOI 10.1128/JB.01834-08; Robins WP, 2013, P NATL ACAD SCI USA, V110, pE848, DOI 10.1073/pnas.1222538110; Ruiz Natividad, 2015, Lipid Insights, V8, P21, DOI 10.4137/LPI.S31783; Salzberg LI, 2011, J BACTERIOL, V193, P5793, DOI 10.1128/JB.05862-11; SCHMIDT G, 1976, J BACTERIOL, V126, P579, DOI 10.1128/JB.126.2.579-586.1976; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; van Teeseling MCF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7878; Vasudevan P, 2007, MOL MICROBIOL, V65, P1582, DOI 10.1111/j.1365-2958.2007.05896.x; Vasudevan P, 2009, J BACTERIOL, V191, P6012, DOI 10.1128/JB.00604-09; Vollmer J, 2013, INT J MED MICROBIOL, V303, P140, DOI 10.1016/j.ijmm.2013.01.002; Wei YP, 2003, J BACTERIOL, V185, P4717, DOI 10.1128/JB.185.16.4717-4726.2003; WILKINSON RG, 1972, J GEN MICROBIOL, V70, P527, DOI 10.1099/00221287-70-3-527; Ye XY, 2001, J AM CHEM SOC, V123, P3155, DOI 10.1021/ja010028q	47	275	278	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					634	+		10.1038/nature19331	http://dx.doi.org/10.1038/nature19331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27525505	Green Submitted, Green Accepted			2022-12-24	WOS:000384331700040
J	Zimmerman, CA; Lin, YC; Leib, DE; Guo, L; Huey, EL; Daly, GE; Chen, YM; Knight, ZA				Zimmerman, Christopher A.; Lin, Yen-Chu; Leib, David E.; Guo, Ling; Huey, Erica L.; Daly, Gwendolyn E.; Chen, Yiming; Knight, Zachary A.			Thirst neurons anticipate the homeostatic consequences of eating and drinking	NATURE			English	Article							SUBFORNICAL ORGAN; WATER-INTAKE; VASOPRESSIN SECRETION; ANGIOTENSIN-II; BODY-FLUID; RATS; FOOD; CONSCIOUSNESS; POPULATIONS; MECHANISMS	Thirst motivates animals to drink in order to maintain fluid balance. Thirst has conventionally been viewed as a homeostatic response to changes in blood volume or tonicity(1-3). However, most drinking behaviour is regulated too rapidly to be controlled by blood composition directly, and instead seems to anticipate homeostatic imbalances before they arise(4-11). How this is achieved remains unknown. Here we reveal an unexpected role for the subfornical organ (SFO) in the anticipatory regulation of thirst in mice. By monitoring deep-brain calcium dynamics, we show that thirst-promoting SFO neurons respond to inputs from the oral cavity during eating and drinking and then integrate these inputs with information about the composition of the blood. This integration allows SFO neurons to predict how ongoing food and water consumption will alter fluid balance in the future and then to adjust behaviour pre-emptively. Complementary optogenetic manipulations show that this anticipatory modulation is necessary for drinking in several contexts. These findings provide a neural mechanism to explain longstanding behavioural observations, including the prevalence of drinking during meals(10,11), the rapid satiation of thirst(7-9), and the fact that oral cooling is thirst-quenching(12-14).	[Zimmerman, Christopher A.; Lin, Yen-Chu; Leib, David E.; Guo, Ling; Huey, Erica L.; Daly, Gwendolyn E.; Chen, Yiming; Knight, Zachary A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Zimmerman, Christopher A.; Lin, Yen-Chu; Leib, David E.; Guo, Ling; Huey, Erica L.; Daly, Gwendolyn E.; Chen, Yiming; Knight, Zachary A.] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA; [Zimmerman, Christopher A.; Leib, David E.; Guo, Ling; Chen, Yiming; Knight, Zachary A.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Knight, ZA (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.; Knight, ZA (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA.; Knight, ZA (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA.	zachary.knight@ucsf.edu	Core, Vector/CAF-4832-2022	Knight, Zachary/0000-0001-7621-1478; Guo, Ling/0000-0001-8394-4338; Huey, Erica/0000-0002-6055-8095; Zimmerman, Christopher/0000-0002-6286-1485	NSF Graduate Research Fellowship [1144247]; UCSF Discovery Fellowship; New York Stem Cell Foundation; American Diabetes Association; Rita Allen Foundation; McKnight Foundation; Sloan Foundation; Brain and Behavior Research Foundation; Klingenstein Foundation; Program for Breakthrough Biological Research Foundation; NIH [DP2-DK109533, R01-DK106399, R01-NS094781]; UCSF Diabetes and Obesity Centers [U01 DK089541]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL131463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK098722, DP2DK109533, R01DK106399, U01DK089541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094781] Funding Source: NIH RePORTER	NSF Graduate Research Fellowship(National Science Foundation (NSF)); UCSF Discovery Fellowship; New York Stem Cell Foundation; American Diabetes Association(American Diabetes Association); Rita Allen Foundation; McKnight Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Brain and Behavior Research Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Program for Breakthrough Biological Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Diabetes and Obesity Centers; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	C.A.Z. is supported by an NSF Graduate Research Fellowship (grant no. 1144247) and a UCSF Discovery Fellowship. Z.A.K. is a New York Stem Cell Foundation-Robertson Investigator and acknowledges support from the New York Stem Cell Foundation, American Diabetes Association, Rita Allen, McKnight, Sloan, Brain and Behavior Research, Klingenstein, and Program for Breakthrough Biological Research Foundations. This work was supported by an NIH New Innovator Award (DP2-DK109533), R01-DK106399, and R01-NS094781, as well as the UCSF Diabetes and Obesity Centers (U01 DK089541).	ADOLPH EF, 1954, AM J PHYSIOL, V178, P538, DOI 10.1152/ajplegacy.1954.178.3.538; Bellows RT, 1939, AM J PHYSIOL, V125, P87, DOI 10.1152/ajplegacy.1938.125.1.87; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; DEAUX E, 1973, SCIENCE, V181, P1166, DOI 10.1126/science.181.4105.1166; Eccles R, 2013, APPETITE, V71, P357, DOI 10.1016/j.appet.2013.09.011; Egan G, 2003, P NATL ACAD SCI USA, V100, P15241, DOI 10.1073/pnas.2136650100; Farrell MJ, 2011, AM J PHYSIOL-REG I, V301, pR623, DOI 10.1152/ajpregu.00817.2010; FITZSIMO.JT, 1969, J COMP PHYSIOL PSYCH, V67, P273, DOI 10.1037/h0026772; FITZSIMONS J, 1961, J PHYSIOL-LONDON, V159, P297, DOI 10.1113/jphysiol.1961.sp006809; Grob M, 2003, NEUROSCIENCE, V122, P247, DOI 10.1016/j.neuroscience.2003.07.005; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; HSIAO S, 1969, J COMP PHYSIOL PSYCH, V69, P448, DOI 10.1037/h0028192; KAPATOS G, 1972, SCIENCE, V176, P685, DOI 10.1126/science.176.4035.685; LIND RW, 1984, PHYSIOL BEHAV, V32, P69; Mandelblat-Cerf Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07122; McKinley MJ, 2006, SEMIN NEPHROL, V26, P249, DOI 10.1016/j.semnephrol.2006.02.001; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; MENDELSON J, 1970, SCIENCE, V170, P1418, DOI 10.1126/science.170.3965.1418; MISELIS RR, 1979, SCIENCE, V205, P1022, DOI 10.1126/science.472723; OATLEY K, 1969, PSYCHON SCI, V16, P225; Oka Y, 2015, NATURE, V520, P349, DOI 10.1038/nature14108; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; Rowland NE, 1998, NEUROSCI BIOBEHAV R, V23, P49, DOI 10.1016/S0149-7634(97)00068-7; Shizgal P. B., 2013, PRINCIPLES NEURAL SC, P1095; SIMPSON JB, 1973, SCIENCE, V181, P1172, DOI 10.1126/science.181.4105.1172; SMITH RD, 1992, ANNU REV PHARMACOL, V32, P135; Stricker EM, 2007, PHYSIOL BEHAV, V91, P404, DOI 10.1016/j.physbeh.2007.04.007; SZCZEPANSKASADOWSKA E, 1975, PFLUG ARCH EUR J PHY, V358, P259, DOI 10.1007/BF00587222; THRASHER TN, 1981, AM J PHYSIOL, V240, pE394, DOI 10.1152/ajpendo.1981.240.4.E394; Woods SC, 2007, APPETITE, V49, P388, DOI 10.1016/j.appet.2006.09.015	33	149	151	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					680	+		10.1038/nature18950	http://dx.doi.org/10.1038/nature18950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27487211	Green Accepted, Green Submitted			2022-12-24	WOS:000384331700050
J	Nakamura, T; Gehrke, AR; Lemberg, J; Zymaszek, JS; Shubin, NH				Nakamura, Tetsuya; Gehrke, Andrew R.; Lemberg, Justin; Zymaszek, Julie S.; Shubin, Neil H.			Digits and fin rays share common developmental histories	NATURE			English	Article							TRUNK NEURAL CREST; GENE-EXPRESSION; LIMB TRANSITION; PAIRED FINS; HOX-GENES; ZEBRAFISH; ORIGIN; EVOLUTION; FISH; APPENDAGES	Understanding the evolutionary transformation of fish fins into tetrapod limbs is a fundamental problem in biology(1). The search for antecedents of tetrapod digits in fish has remained controversial because the distal skeletons of limbs and fins differ structurally, developmentally, and histologically(2,3). Moreover, comparisons of fins with limbs have been limited by a relative paucity of data on the cellular and molecular processes underlying the development of the fin skeleton. Here, we provide a functional analysis, using CRISPR/Cas9 and fate mapping, of 5' hox genes and enhancers in zebrafish that are indispensable for the development of the wrists and digits of tetrapods(4,5). We show that cells marked by the activity of an autopodial hoxa13 enhancer exclusively form elements of the fin fold, including the osteoblasts of the dermal rays. In hox13 knockout fish, we find that a marked reduction and loss of fin rays is associated with an increased number of endochondral distal radials. These discoveries reveal a cellular and genetic connection between the fin rays of fish and the digits of tetrapods and suggest that digits originated via the transition of distal cellular fates.	[Nakamura, Tetsuya; Gehrke, Andrew R.; Lemberg, Justin; Zymaszek, Julie S.; Shubin, Neil H.] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA	University of Chicago	Shubin, NH (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	nshubin@uchicago.edu		Nakamura, Tetsuya/0000-0003-0183-1685	Uehara Memorial Foundation; Japan Society for the Promotion of Science; Marine Biological Laboratory Research Award; National Institutes of Health [T32 HD055164]; National Science Foundation [1311436]; Brinson Foundation; University of Chicago Biological Sciences Division; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055164] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Marine Biological Laboratory Research Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Brinson Foundation; University of Chicago Biological Sciences Division(University of Chicago); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank J. Westlund for figure preparation and construction, as well as maintenance of zebrafish facilities. M. Coates, M. Davis, R. Ho, I. Ruvinsky, J-L. Gomez Skarmeta, and C. Tabin provided comments and advice. We thank L. I. Zon, C. Mosimann, and C. Lawrence for Tg(ubi:Switch) fish, M. L. Suster for the pCR8GW-Cre-pA-FRT-kan-FRT plasmid, R. Ho and S. Briscoe for insights regarding lineage-tracing experiments, V. Bindokas and the University of Chicago Integrated Light Microscopy Core Facility for assistance with imaging, L. Zhexi for use of the high-energy CT scanning facility of University of Chicago, M. E. Horb and M. C. Salanga of the National Xenopus Resource (RRID:SCR-013731) of the Marine Biological Laboratories for tutelage in applying CRISPR/Cas9, J. Gitlin, A. Latimer and R. Thomason for providing space for zebrafish CRISPR/Cas9 experiments and also maintaining juveniles, and the Marine Resource Center of the Marine Biological Laboratories for assistance with the transfer of mutant zebrafish between University of Chicago and the MBL. This study was supported by the Uehara Memorial Foundation Research Fellowship 2013, Japan Society for the Promotion of Science Postdoctoral Research Fellowship 2012-127, and Marine Biological Laboratory Research Award 2014 (to T.N.); National Institutes of Health Grant T32 HD055164 and National Science Foundation Doctoral Dissertation Improvement Grant 1311436 (to A.R.G.); and the Brinson Foundation and the University of Chicago Biological Sciences Division (to N.H.S.).	Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032; Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026; Berlivet S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004018; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Clack J. A., 2012, GAINING GROUND ORIGI; Clack JA, 2009, ANNU REV EARTH PL SC, V37, P163, DOI 10.1146/annurev.earth.36.031207.124146; Coates MI, 2008, ANNU REV ECOL EVOL S, V39, P571, DOI 10.1146/annurev.ecolsys.38.091206.095546; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; Freitas R, 2012, DEV CELL, V23, P1219, DOI 10.1016/j.devcel.2012.10.015; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gehrke A. R., 2016, SEMIN CELL DEV BIOL; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Lee RTH, 2013, DEVELOPMENT, V140, P2923, DOI 10.1242/dev.093534; Lee RTH, 2013, CURR BIOL, V23, pR336, DOI 10.1016/j.cub.2013.02.055; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Schneider I, 2013, TRENDS GENET, V29, P419, DOI 10.1016/j.tig.2013.01.012; Scotti M, 2015, GENESIS, V53, P366, DOI 10.1002/dvg.22859; SMITH M, 1994, P ROY SOC B-BIOL SCI, V256, P137, DOI 10.1098/rspb.1994.0061; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; THISSE C, 1995, DEV BIOL, V172, P86, DOI 10.1006/dbio.1995.0007; Thorogood P., 1991, DEV TELEOST FIN IMPL; Tulenko FJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22720; Westerfield M., 2000, ZFIN ZEBRAFISH BOOK; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; Yano T, 2012, DEVELOPMENT, V139, P2916, DOI 10.1242/dev.075572; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137	33	79	80	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					225	+		10.1038/nature19322	http://dx.doi.org/10.1038/nature19322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27533041	Green Accepted			2022-12-24	WOS:000382539100046
J	Oh, WC; Lutzu, S; Castillo, PE; Kwon, HB				Oh, Won Chan; Lutzu, Stefano; Castillo, Pablo E.; Kwon, Hyung-Bae			De novo synaptogenesis induced by GABA in the developing mouse cortex	SCIENCE			English	Article							DENDRITIC SPINES; INHIBITORY SYNAPSES; PYRAMIDAL NEURONS; IN-VIVO; HIPPOCAMPAL-NEURONS; ADULT NEOCORTEX; PLASTICITY; GROWTH; MATURATION	Dendrites of cortical pyramidal neurons contain intermingled excitatory and inhibitory synapses. We studied the local mechanisms that regulate the formation and distribution of synapses. We found that local gamma-aminobutyric acid (GABA) release on dendrites of mouse cortical layer 2/3 pyramidal neurons could induce gephyrin puncta and dendritic spine formation via GABA type A receptor activation and voltage-gated calcium channels during early postnatal development. Furthermore, the newly formed inhibitory and excitatory synaptic structures rapidly gained functions. Bidirectional manipulation of GABA release from somatostatin-positive interneurons increased and decreased the number of gephyrin puncta and dendritic spines, respectively. These results highlight a noncanonical function of GABA as a local synaptogenic element shaping the early establishment of neuronal circuitry in mouse cortex.	[Oh, Won Chan; Kwon, Hyung-Bae] Max Planck Florida Inst Neurosci MPFI, Jupiter, FL 33458 USA; [Lutzu, Stefano; Castillo, Pablo E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Kwon, Hyung-Bae] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Yeshiva University; Albert Einstein College of Medicine; Max Planck Society	Kwon, HB (corresponding author), Max Planck Florida Inst Neurosci MPFI, Jupiter, FL 33458 USA.; Kwon, HB (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	hyungbae.kwon@mpfi.org		Castillo, Pablo/0000-0002-9834-1801	MPFI; NARSAD; NIH [MH107460, MH081935, DA017392]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081935, R01MH107460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER	MPFI; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Kwon laboratory for discussion, E. Nedivi for Teal-gephyrin, and H. Taniguchi for Flex-TeTxLC. Supported by the MPFI, a NARSAD Young Investigator grant, and NIH grants MH107460 (H.-B.K.) and MH081935 and DA017392 (P.E.C.). Supplementary materials contain additional data. Author contributions: W.C.O. and H.-B.K. conceived and designed the study; W.C.O. performed and analyzed all experiments except perforated patch-clamp recordings, which were performed and analyzed by S.L. and P.E.C.; W.C.O. prepared the figures; W.C.O. and H.-B.K. wrote the manuscript; and all authors revised the manuscript.	Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Ben-Ari Y, 2014, NEUROSCIENCE, V279, P187, DOI 10.1016/j.neuroscience.2014.08.001; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Cane M, 2014, J NEUROSCI, V34, P2075, DOI 10.1523/JNEUROSCI.3353-13.2014; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chen SX, 2015, NAT NEUROSCI, V18, P1109, DOI 10.1038/nn.4049; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; Dejanovic B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001908; Flores CE, 2015, P NATL ACAD SCI USA, V112, pE65, DOI 10.1073/pnas.1411170112; Hage TA, 2015, J NEUROSCI, V35, P5823, DOI 10.1523/JNEUROSCI.3904-14.2015; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; Hayama T, 2013, NAT NEUROSCI, V16, P1409, DOI 10.1038/nn.3496; Huang ZJ, 2009, J PHYSIOL-LONDON, V587, P1881, DOI 10.1113/jphysiol.2008.168211; Kim T, 2016, P NATL ACAD SCI USA, V113, pE1372, DOI 10.1073/pnas.1513410113; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Matsuzaki M, 2010, NAT CHEM BIOL, V6, P255, DOI [10.1038/nchembio.321, 10.1038/NCHEMBIO.321]; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	29	112	116	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2016	353	6303					1037	1040		10.1126/science.aaf5206	http://dx.doi.org/10.1126/science.aaf5206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9SU	27516412	hybrid, Green Accepted			2022-12-24	WOS:000382558900041
J	Yan, CY; Wan, RX; Bai, R; Huang, GXY; Shi, YG				Yan, Chuangye; Wan, Ruixue; Bai, Rui; Huang, Gaoxingyu; Shi, Yigong			Structure of a yeast activated spliceosome at 3.5 angstrom resolution	SCIENCE			English	Article							U4/U6.U5 TRI-SNRNP; METAL-ION CATALYSIS; CRYO-EM STRUCTURE; G-PATCH PROTEIN; MESSENGER-RNA; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; MOLECULAR ARCHITECTURE; U5 SNRNP; COMPLEX	Pre-messenger RNA (pre-mRNA) splicing is carried out by the spliceosome, which undergoes an intricate assembly and activation process. Here, we report an atomic structure of an activated spliceosome (known as the B-act complex) from Saccharomyces cerevisiae, determined by cryo-electron microscopy at an average resolution of 3.52 angstroms. The final refined model contains U2 and U5 small nuclear ribonucleoprotein particles (snRNPs), U6 small nuclear RNA (snRNA), nineteen complex (NTC), NTC-related (NTR) protein, and a 71-nucleotide pre-mRNA molecule, which amount to 13,505 amino acids from 38 proteins and a combined molecular mass of about 1.6 megadaltons. The 5' exon is anchored by loop I of U5 snRNA, whereas the 5' splice site (5'SS) and the branch-point sequence (BPS) of the intron are specifically recognized by U6 and U2 snRNA, respectively. Except for coordination of the catalytic metal ions, the RNA elements at the catalytic cavity of Prp8 are mostly primed for catalysis. The catalytic latency is maintained by the SF3b complex, which encircles the BPS, and the splicing factors Cwc24 and Prp11, which shield the 5' exon-5'SS junction. This structure, together with those determined earlier, outlines a molecular framework for the pre-mRNA splicing reaction.	[Yan, Chuangye; Wan, Ruixue; Bai, Rui; Huang, Gaoxingyu; Shi, Yigong] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Shi, Yigong/0000-0003-2030-168X; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology [2014ZX09507003006]; National Natural Science Foundation of China [31130002, 31321062]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank D. Wang for his generous support of our research and the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for the research facility. The computation was completed on the "Explorer 100" cluster system of Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from the Ministry of Science and Technology (2014ZX09507003006) and the National Natural Science Foundation of China (31130002 and 31321062). For the B<SUP>act</SUP> complex, the atomic coordinates have been deposited in the Protein Data Bank with the accession code 5GM6, and the EM maps have been deposited in EMDB with the accession code EMD-9524. The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to Y. Shi (shi-lab@tsinghua.edu.cn).	Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Azubel M, 2004, MOL CELL, V15, P833, DOI 10.1016/j.molcel.2004.07.022; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2010, RNA, V16, P2384, DOI 10.1261/rna.2456210; Boehringer D, 2004, NAT STRUCT MOL BIOL, V11, P463, DOI 10.1038/nsmb761; Burge C. B., 1999, RAN WORLD NATURE MOD; Chan RT, 2012, NAT STRUCT MOL BIOL, V19, P555, DOI 10.1038/nsmb.2270; Chen WJ, 2014, RNA, V20, P308, DOI 10.1261/rna.040980.113; Cordin O, 2013, RNA BIOL, V10, P83, DOI 10.4161/rna.22547; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2014, CURR OPIN STRUC BIOL, V25, P57, DOI 10.1016/j.sbi.2013.12.002; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Golas MM, 2010, MOL CELL, V40, P927, DOI 10.1016/j.molcel.2010.11.023; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Grainger RJ, 2009, RNA, V15, P2161, DOI 10.1261/rna.1908309; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Hahn CN, 2012, NAT GENET, V44, P9, DOI 10.1038/ng.1045; Hahn D, 2012, GENE DEV, V26, P2408, DOI 10.1101/gad.199307.112; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Ilagan JO, 2013, RNA, V19, P400, DOI 10.1261/rna.034223.112; Jurica MS, 2004, NAT STRUCT MOL BIOL, V11, P265, DOI 10.1038/nsmb728; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Kim SH, 1996, MOL CELL BIOL, V16, P6810; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Lin PC, 2012, EMBO J, V31, P1579, DOI 10.1038/emboj.2012.7; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Maroney PA, 2000, MOL CELL, V6, P317, DOI 10.1016/S1097-2765(00)00032-0; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Ohi MD, 2007, P NATL ACAD SCI USA, V104, P3195, DOI 10.1073/pnas.0611591104; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pomeranz Krummel Daniel A, 2009, Nature, V458, P475, DOI 10.1038/nature07851; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; ROY J, 1995, RNA, V1, P375; Sander B, 2006, MOL CELL, V24, P267, DOI 10.1016/j.molcel.2006.08.021; Silverman EJ, 2004, MOL CELL BIOL, V24, P10101, DOI 10.1128/MCB.24.23.10101-10110.2004; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Ulrich A, 2014, ACTA CRYSTALLOGR D, V70, P3110, DOI 10.1107/S1399004714021695; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Warkocki Z, 2015, GENE DEV, V29, P94, DOI 10.1101/gad.253070.114; WASSARMAN DA, 1992, SCIENCE, V257, P1918, DOI 10.1126/science.1411506; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Wolf E, 2009, EMBO J, V28, P2283, DOI 10.1038/emboj.2009.171; WYATT JR, 1992, GENE DEV, V6, P2542, DOI 10.1101/gad.6.12b.2542; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhou LJ, 2014, NATURE, V506, P116, DOI 10.1038/nature12803	62	179	186	2	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					904	911		10.1126/science.aag0291	http://dx.doi.org/10.1126/science.aag0291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27445306				2022-12-24	WOS:000381867700033
J	Chung, JH; Granja, I; Taylor, MG; Mpourmpakis, G; Asplin, JR; Rimer, JD				Chung, Jihae; Granja, Ignacio; Taylor, Michael G.; Mpourmpakis, Giannis; Asplin, John R.; Rimer, Jeffrey D.			Molecular modifiers reveal a mechanism of pathological crystal growth inhibition	NATURE			English	Article							CALCIUM-OXALATE MONOHYDRATE; SODIUM-CHLORATE CRYSTALS; KIDNEY-STONES; CRYSTALLIZATION; BIOMINERALIZATION; ENERGY; SHAPE; APPROXIMATION; EQUILIBRIUM; MAGNESIUM	Crystalline materials are crucial to the function of living organisms, in the shells of molluscs(1-3), the matrix of bone(4), the teeth of sea urchins5, and the exoskeletons of coccoliths(6). However, pathological biomineralization can be an undesirable crystallization process associated with human diseases(7-9). The crystal growth of biogenic, natural and synthetic materials may be regulated by the action of modifiers, most commonly inhibitors, which range from small ions and molecules(10,11) to large macromolecules(12). Inhibitors adsorb on crystal surfaces and impede the addition of solute, thereby reducing the rate of growth(13,14). Complex inhibitor-crystal interactions in biomineralization are often not well elucidated(15). Here we show that two molecular inhibitors of calcium oxalate monohydrate crystallization-citrate and hydroxycitrate-exhibit a mechanism that differs from classical theory in that inhibitor adsorption on crystal surfaces induces dissolution of the crystal under specific conditions rather than a reduced rate of crystal growth. This phenomenon occurs even in supersaturated solutions where inhibitor concentration is three orders of magnitude less than that of the solute. The results of bulk crystallization, in situ atomic force microscopy, and density functional theory studies are qualitatively consistent with a hypothesis that inhibitor-crystal interactions impart localized strain to the crystal lattice and that oxalate and calcium ions are released into solution to alleviate this strain. Calcium oxalate monohydrate is the principal component of human kidney stones(16-19) and citrate is an often-used therapy(20), but hydroxycitrate is not. For hydroxycitrate to function as a kidney stone treatment, it must be excreted in urine. We report that hydroxycitrate ingested by non-stone-forming humans at an often-recommended dose leads to substantial urinary excretion. In vitro assays using human urine reveal that the molecular modifier hydroxycitrate is as effective an inhibitor of nucleation of calcium oxalate monohydrate nucleation as is citrate. Our findings support exploration of the clinical potential of hydroxycitrate as an alternative treatment to citrate for kidney stones.	[Chung, Jihae; Rimer, Jeffrey D.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Granja, Ignacio; Asplin, John R.] Litholink Corp, Lab Corp Amer Holdings, Chicago, IL 60612 USA; [Taylor, Michael G.; Mpourmpakis, Giannis] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA	University of Houston System; University of Houston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rimer, JD (corresponding author), Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA.; Asplin, JR (corresponding author), Litholink Corp, Lab Corp Amer Holdings, Chicago, IL 60612 USA.	asplinj@labcorp.com; jrimer@central.uh.edu	Mpourmpakis, Giannis/H-2048-2013	Mpourmpakis, Giannis/0000-0002-3063-0607; Taylor, Michael/0000-0003-4327-2746	National Science Foundation [1207441, ACI-1053575]; Welch Foundation [E-1794]; University of Pittsburgh; Direct For Mathematical & Physical Scien [1207441] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); University of Pittsburgh(University of Pittsburgh); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	J.D.R. acknowledges support from the National Science Foundation (grant 1207441) and the Welch Foundation (grant E-1794). G.M. acknowledges start-up funds from the University of Pittsburgh and computational support from the Center for Simulation and Modeling, and the Extreme Science and Engineering Discovery Environment, which is supported by the National Science Foundation (grant ACI-1053575).	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Asplin JR, 2008, SEMIN NEPHROL, V28, P99, DOI 10.1016/j.semnephrol.2008.01.001; Asplin JR, 1999, KIDNEY INT, V56, P1505, DOI 10.1046/j.1523-1755.1999.00682.x; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BOLL M, 1969, ACTA CHEM SCAND, V23, P286; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; Cabrera N., 1958, GROWTH PERFECTION CR, V393-425; CAHN JW, 1982, ACTA METALL MATER, V30, P51, DOI 10.1016/0001-6160(82)90043-8; ChemAxon, 2016, HYDR AC; CHERNOV AA, 1989, CONTEMP PHYS, V30, P251, DOI 10.1080/00107518908225517; COE FL, 1992, NEW ENGL J MED, V327, P1141, DOI 10.1056/NEJM199210153271607; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057; Dey A, 2010, CHEM SOC REV, V39, P397, DOI 10.1039/b811842f; Dunlop JWC, 2010, ANNU REV MATER RES, V40, P1, DOI 10.1146/annurev-matsci-070909-104421; Ettinger B, 1997, J UROLOGY, V158, P2069, DOI 10.1016/S0022-5347(01)68155-2; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Farmanesh S, 2015, CHEM COMMUN, V51, P13964, DOI 10.1039/c5cc04361a; Farmanesh S, 2014, J AM CHEM SOC, V136, P12648, DOI 10.1021/ja505402r; Farmanesh S, 2014, J AM CHEM SOC, V136, P367, DOI 10.1021/ja410623q; Farmanesh S, 2013, J CRYST GROWTH, V373, P13, DOI 10.1016/j.jcrysgro.2012.09.018; FEYEREISEN M, 1993, CHEM PHYS LETT, V208, P359, DOI 10.1016/0009-2614(93)87156-W; FRANK FC, 1949, DISCUSS FARADAY SOC, P48, DOI 10.1039/df9490500048; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Jung T, 2004, LANGMUIR, V20, P8587, DOI 10.1021/la0488755; Killian CE, 2009, J AM CHEM SOC, V131, P18404, DOI 10.1021/ja907063z; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Linnikov OD, 2000, DESALINATION, V128, P47, DOI 10.1016/S0011-9164(00)00022-9; Loe YCC, 2001, ANAL BIOCHEM, V292, P148, DOI 10.1006/abio.2001.5046; Lovette MA, 2008, IND ENG CHEM RES, V47, P9812, DOI 10.1021/ie800900f; Lupulescu AI, 2014, SCIENCE, V344, P729, DOI 10.1126/science.1250984; Lutsko JF, 2014, CRYST GROWTH DES, V14, P6129, DOI 10.1021/cg501307y; Malivuk DA, 2013, J CRYST GROWTH, V377, P164, DOI 10.1016/j.jcrysgro.2013.05.018; Meldrum FC, 2003, INT MATER REV, V48, P187, DOI 10.1179/095066003225005836; Millan A, 2001, CRYST GROWTH DES, V1, P245, DOI 10.1021/cg0055530; Mpourmpakis G, 2010, NANO LETT, V10, P3408, DOI 10.1021/nl101421q; NANCOLLA.GH, 1974, J CRYST GROWTH, V21, P267, DOI 10.1016/0022-0248(74)90014-1; Olafson KN, 2015, P NATL ACAD SCI USA, V112, P4946, DOI 10.1073/pnas.1501023112; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Parks JH, 2004, KIDNEY INT, V66, P777, DOI 10.1111/j.1523-1755.2004.00803.x; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Phillips R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010057.pub2; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; Rimer JD, 2010, SCIENCE, V330, P337, DOI 10.1126/science.1191968; RISTIC RI, 1988, J CRYST GROWTH, V91, P163, DOI 10.1016/0022-0248(88)90382-X; RYALL RL, 1981, CLIN CHIM ACTA, V112, P349, DOI 10.1016/0009-8981(81)90458-7; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Sizemore JP, 2009, CRYST GROWTH DES, V9, P2637, DOI 10.1021/cg8011124; Smith R. M., 1982, CRITICAL STABILITY S, V5, P329; Snyder RC, 2009, P ROY SOC A-MATH PHY, V465, P1145, DOI 10.1098/rspa.2008.0234; TOMAZIC BB, 1979, INVEST UROL, V16, P329; van Loon LJC, 2000, AM J CLIN NUTR, V72, P1445; VANDERHEIJDEN AEDM, 1992, J CRYST GROWTH, V118, P14, DOI 10.1016/0022-0248(92)90044-J; VORONKOV VV, 1994, J CRYST GROWTH, V144, P107, DOI 10.1016/0022-0248(94)90018-3; Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574; Wang LJ, 2006, CRYST GROWTH DES, V6, P1769, DOI 10.1021/cg050679o; Weigend F, 1998, CHEM PHYS LETT, V294, P143, DOI 10.1016/S0009-2614(98)00862-8; Weigend F, 1997, THEOR CHEM ACC, V97, P331, DOI 10.1007/s002140050269; WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637; Weissbuch I, 2008, CHEM REV, V108, P4899, DOI 10.1021/cr078274t; Wesson JA, 2007, ELEMENTS, V3, P415, DOI 10.2113/GSELEMENTS.3.6.415; Winn D, 2000, AICHE J, V46, P1348, DOI 10.1002/aic.690460709; YOUNG JR, 1992, NATURE, V356, P516, DOI 10.1038/356516a0	65	114	121	11	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					446	+		10.1038/nature19062	http://dx.doi.org/10.1038/nature19062			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27501150				2022-12-24	WOS:000382646600039
J	Soliveres, S; van der Plas, F; Manning, P; Prati, D; Gossner, MM; Renner, SC; Alt, F; Arndt, H; Baumgartner, V; Binkenstein, J; Birkhofer, K; Blaser, S; Bluthgen, N; Boch, S; Bohm, S; Borschig, C; Buscot, F; Diekotter, T; Heinze, J; Holzel, N; Jung, K; Klaus, VH; Kleinebecker, T; Klemmer, S; Krauss, J; Lange, M; Morris, EK; Muller, J; Oelmann, Y; Overmann, J; Pasalic, E; Rillig, MC; Schaefer, HM; Schloter, M; Schmitt, B; Schoning, I; Schrumpf, M; Sikorski, J; Socher, SA; Solly, EF; Sonnemann, I; Sorkau, E; Steckel, J; Steffan-Dewenter, I; Stempfhuber, B; Tschapka, M; Turke, M; Venter, PC; Weiner, CN; Weisser, WW; Werner, M; Westphal, C; Wilcke, W; Wolters, V; Wubet, T; Wurst, S; Fischer, M; Allan, E				Soliveres, Santiago; van der Plas, Fons; Manning, Peter; Prati, Daniel; Gossner, Martin M.; Renner, Swen C.; Alt, Fabian; Arndt, Hartmut; Baumgartner, Vanessa; Binkenstein, Julia; Birkhofer, Klaus; Blaser, Stefan; Bluethgen, Nico; Boch, Steffen; Boehm, Stefan; Boerschig, Carmen; Buscot, Francois; Diekoetter, Tim; Heinze, Johannes; Hoelzel, Norbert; Jung, Kirsten; Klaus, Valentin H.; Kleinebecker, Till; Klemmer, Sandra; Krauss, Jochen; Lange, Markus; Morris, E. Kathryn; Mueller, Joerg; Oelmann, Yvonne; Overmann, Joerg; Pasalic, Esther; Rillig, Matthias C.; Schaefer, H. Martin; Schloter, Michael; Schmitt, Barbara; Schoening, Ingo; Schrumpf, Marion; Sikorski, Johannes; Socher, Stephanie A.; Solly, Emily F.; Sonnemann, Ilja; Sorkau, Elisabeth; Steckel, Juliane; Steffan-Dewenter, Ingolf; Stempfhuber, Barbara; Tschapka, Marco; Tuerke, Manfred; Venter, Paul C.; Weiner, Christiane N.; Weisser, Wolfgang W.; Werner, Michael; Westphal, Catrin; Wilcke, Wolfgang; Wolters, Volkmar; Wubet, Tesfaye; Wurst, Susanne; Fischer, Markus; Allan, Eric			Biodiversity at multiple trophic levels is needed for ecosystem multifunctionality	NATURE			English	Article							LAND-USE INTENSITY; PLANT; DIVERSITY; PRODUCTIVITY; CONSEQUENCES; HERBIVORE; RICHNESS; SERVICES; WEAKENS; IMPACT	Many experiments have shown that loss of biodiversity reduces the capacity of ecosystems to provide the multiple services on which humans depend(1,2). However, experiments necessarily simplify the complexity of natural ecosystems and will normally control for other important drivers of ecosystem functioning, such as the environment or land use. In addition, existing studies typically focus on the diversity of single trophic groups, neglecting the fact that biodiversity loss occurs across many taxa(3,4) and that the functional effects of any trophic group may depend on the abundance and diversity of others(5,6). Here we report analysis of the relationships between the species richness and abundance of nine trophic groups, including 4,600 above-and below-ground taxa, and 14 ecosystem services and functions and with their simultaneous provision (or multifunctionality) in 150 grasslands. We show that high species richness in multiple trophic groups (multitrophic richness) had stronger positive effects on ecosystem services than richness in any individual trophic group; this includes plant species richness, the most widely used measure of biodiversity. On average, three trophic groups influenced each ecosystem service, with each trophic group influencing at least one service. Multitrophic richness was particularly beneficial for 'regulating' and 'cultural' services, and for multifunctionality, whereas a change in the total abundance of species or biomass in multiple trophic groups (the multitrophic abundance) positively affected supporting services. Multitrophic richness and abundance drove ecosystem functioning as strongly as abiotic conditions and land-use intensity, extending previous experimental results(7,8) to real-world ecosystems. Primary producers, herbivorous insects and microbial decomposers seem to be particularly important drivers of ecosystem functioning, as shown by the strong and frequent positive associations of their richness or abundance with multiple ecosystem services. Our results show that multitrophic richness and abundance support ecosystem functioning, and demonstrate that a focus on single groups has led to researchers to greatly underestimate the functional importance of biodiversity.	[Soliveres, Santiago; van der Plas, Fons; Manning, Peter; Prati, Daniel; Blaser, Stefan; Boch, Steffen; Schmitt, Barbara; Fischer, Markus; Allan, Eric] Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland; [van der Plas, Fons; Manning, Peter; Fischer, Markus] Senckenberg Gesell Nat Forsch Biodivers & Climate, Senckenberganlage 25, D-60325 Frankfurt, Germany; [Gossner, Martin M.; Lange, Markus; Pasalic, Esther; Schoening, Ingo; Tuerke, Manfred; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Dornburger Str 159, D-07743 Jena, Germany; [Gossner, Martin M.; Lange, Markus; Pasalic, Esther; Tuerke, Manfred; Weisser, Wolfgang W.] Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Sch Life Sci Weihenstephan, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany; [Renner, Swen C.; Boehm, Stefan] Univ Nat Resources & Life Sci, Inst Zool, Gregor Mendel Str 33, A-1180 Vienna, Austria; [Renner, Swen C.] Natl Zool Pk, Smithsonian Conservat Biol Inst, 1500 Remount Rd, Front Royal, VA 22630 USA; [Alt, Fabian; Oelmann, Yvonne; Sorkau, Elisabeth] Univ Tubingen, Geocol, Ruemelinstr 19-23, Tubingen, Germany; [Arndt, Hartmut; Venter, Paul C.] Univ Cologne, Inst Zool, Zulpicher Str 47b, D-50674 Cologne, Germany; [Baumgartner, Vanessa; Overmann, Joerg; Sikorski, Johannes] Leibniz Inst DSMZ German Collect Microorganisms &, Inhoffenstr 7B, D-38124 Braunschweig, Germany; [Binkenstein, Julia] Univ Freiburg, Fac Environm & Nat Resources, Chair Nat Conservat & Landscape Ecol, Tennenbacher Str 4, D-79106 Freiburg, Germany; [Birkhofer, Klaus] Lund Univ, Dept Biol, Solvegatan 35, D-22362 Lund, Germany; [Bluethgen, Nico; Weiner, Christiane N.] Tech Univ Darmstadt, Biol, Ecol Networks, Schnittspahnstr 3, D-64287 Darmstadt, Germany; [Boch, Steffen; Fischer, Markus] Univ Bern, Bot Gardens, Altenbergrain 21, CH-3013 Bern, Switzerland; [Boerschig, Carmen; Westphal, Catrin] Univ Gottingen, Dept Crop Sci, Agroecol, Grisebachstr 6, D-37077 Gottingen, Germany; [Buscot, Francois; Klemmer, Sandra; Wubet, Tesfaye] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Theodor Lieser Str 4, D-06120 Halle, Saale, Germany; [Buscot, Francois; Tuerke, Manfred; Wubet, Tesfaye] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Diekoetter, Tim] Univ Kiel, Dept Landscape Ecol, Olshausenstr 75, D-24118 Kiel, Germany; [Heinze, Johannes; Mueller, Joerg] Univ Potsdam, Biodivers Res Systemat Bot, Maulbeerallee 1, D-14469 Potsdam, Germany; [Heinze, Johannes; Rillig, Matthias C.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, D-14195 Berlin, Germany; [Hoelzel, Norbert; Klaus, Valentin H.; Kleinebecker, Till] Univ Munster, Inst Landscape Ecol, D-48149 Munster, Germany; [Jung, Kirsten; Tschapka, Marco] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Albert Einstein Allee 11, D-89069 Ulm, Germany; [Krauss, Jochen; Steckel, Juliane; Steffan-Dewenter, Ingolf; Werner, Michael] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, Hubland, D-97074 Wurzburg, Germany; [Lange, Markus; Schoening, Ingo; Schrumpf, Marion; Solly, Emily F.] Max Planck Inst Biogeochem, Hans Knoell Str 10, D-07745 Jena, Germany; [Morris, E. Kathryn] Xavier Univ, Dept Biol, 3800 Victory Pkwy, Cincinnati, OH 45207 USA; [Morris, E. Kathryn; Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Plant Ecol, Altensteinstr 6, D-14195 Berlin, Germany; [Schaefer, H. Martin] Univ Freiburg, Fac Biol, Dept Ecol & Evolutionary Biol, D-79104 Freiburg, Germany; [Schloter, Michael; Stempfhuber, Barbara] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Ingolstadter Landstr 1, D-85758 Oberschleissheim, Germany; [Socher, Stephanie A.] Salzburg Univ, Dept Ecol & Evolut, Hellbrunnerstr 34, A-5020 Salzburg, Austria; [Solly, Emily F.] Swiss Fed Inst Forest Snow & Landscape Res WSL, Zurcherstr 111, CH-8903 Birmensdorf, Switzerland; [Sonnemann, Ilja; Wurst, Susanne] Free Univ Berlin, Inst Biol, Funct Biodivers, Konigin Luise Str 1-3, D-14195 Berlin, Germany; [Tschapka, Marco] Smithsonian Trop Res Inst, Balboa, Panama; [Tuerke, Manfred] Univ Leipzig, Inst Biol, Johannisallee 21, D-04103 Leipzig, Germany; [Wilcke, Wolfgang] KIT, Inst Geog & Geoecol, Reinhard Baumeister Pl 1, D-76131 Karlsruhe, Germany; [Wolters, Volkmar] Univ Giessen, Dept Anim Ecol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany; [Allan, Eric] Univ Bern, Ctr Dev & Environm, Hallerstr 10, CH-3012 Bern, Switzerland	University of Bern; Senckenberg Gesellschaft fur Naturforschung (SGN); Friedrich Schiller University of Jena; Technical University of Munich; University of Natural Resources & Life Sciences, Vienna; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Eberhard Karls University of Tubingen; University of Cologne; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Freiburg; Technical University of Darmstadt; University of Bern; University of Gottingen; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Kiel; University of Potsdam; University of Munster; Ulm University; University of Wurzburg; Max Planck Society; Xavier University; Free University of Berlin; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Salzburg University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Free University of Berlin; Smithsonian Institution; Smithsonian Tropical Research Institute; Leipzig University; Helmholtz Association; Karlsruhe Institute of Technology; Justus Liebig University Giessen; University of Bern	Soliveres, S (corresponding author), Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland.	santiago.soliveres@ips.unibe.ch	Heinze, Johannes/AAH-9895-2020; Hölzel, Norbert/H-8753-2013; Rillig, Matthias C./AAE-6980-2019; Weisser, Wolfgang W/B-9718-2014; Buscot, Francois/A-4125-2016; Codina, Santiago Soliveres/A-2291-2016; Allan, Eric/AAR-9566-2020; Wubet, Tesfaye/C-6241-2012; Fischer, Markus/C-6411-2008; Blüthgen, Nico/F-5983-2010; Schrumpf, Marion/C-1671-2013; Schöning, Ingo/D-3341-2009; Gossner, Martin M./J-2730-2015; Oelmann, Yvonne/J-8730-2016; Wilcke, Wolfgang/P-4620-2016; Arndt, Hartmut/K-9364-2017; Westphal, Catrin/F-9560-2015; van der Plas, Fons/A-2242-2017; Birkhofer, Klaus/AAA-2374-2021; Rillig, Matthias C./B-3675-2009; Wolters, Volkmar/B-4635-2010; Türke, Manfred/AFE-8308-2022; Krauss, Jochen/C-6216-2014; Sikorski, Johannes/AAX-1960-2020; Manning, Peter/I-6523-2012; Schloter, 1Michael/H-9151-2013; Morris, Kathryn/I-4701-2014; Sikorski, Johannes/AAD-9775-2019	Heinze, Johannes/0000-0002-3556-5883; Hölzel, Norbert/0000-0002-6367-3400; Rillig, Matthias C./0000-0003-3541-7853; Weisser, Wolfgang W/0000-0002-2757-8959; Buscot, Francois/0000-0002-2364-0006; Codina, Santiago Soliveres/0000-0001-9661-7192; Allan, Eric/0000-0001-9641-9436; Wubet, Tesfaye/0000-0001-8572-4486; Fischer, Markus/0000-0002-5589-5900; Schöning, Ingo/0000-0002-9830-5026; Gossner, Martin M./0000-0003-1516-6364; Oelmann, Yvonne/0000-0003-3513-6568; Wilcke, Wolfgang/0000-0002-6031-4613; Arndt, Hartmut/0000-0003-2811-3595; Westphal, Catrin/0000-0002-2615-1339; van der Plas, Fons/0000-0003-4680-543X; Birkhofer, Klaus/0000-0002-9301-2443; Rillig, Matthias C./0000-0003-3541-7853; Wolters, Volkmar/0000-0002-7556-4578; Türke, Manfred/0000-0002-8957-5454; Krauss, Jochen/0000-0003-2304-9117; Sikorski, Johannes/0000-0002-1890-5540; Manning, Peter/0000-0002-7940-2023; Morris, Kathryn/0000-0003-3548-444X; /0000-0002-6893-4219; Schrumpf, Marion/0000-0003-4219-4125; Overmann, Jorg/0000-0003-3909-7201; Klaus, Valentin H./0000-0002-7469-6800; Socher, Stephanie/0000-0002-0090-4005; Kleinebecker, Till/0000-0003-1121-2861; Solly, Emily/0000-0002-3157-1805	Deutsche Forschungsgemeinschaft [1374]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank B. Schmid, F. T. Maestre and S. Kefi for comments that helped improve this manuscript. W. Ulrich and N. J. Gotelli provided statistical advice. We thank the people who maintain the Biodiversity Exploratories program: A. Hemp, K. Wells, S. Gockel, K. Wiesner and M. Gorke (local management team); S. Pfeiffer and C. Fischer (central office), B. Konig-Ries and M. Owonibi (central database management); and E. Linsenmair, D. Hessenmoller, J. Nieschulze, E.-D. Schulze and the late E. Kalko for their role in setting up the project. This work was funded by the Deutsche Forschungsgemeinschaft Priority Program 1374 'Infrastructure-Biodiversity Exploratories'. Fieldwork permits were given by the responsible state environmental offices of Baden-Wurttemberg, Thuringen and Brandenburg (according to 72 BbgNatSchG). Figure icons were created by R. D. Manzanedo.	Allan E, 2015, ECOL LETT, V18, P834, DOI 10.1111/ele.12469; Allan E, 2014, P NATL ACAD SCI USA, V111, P308, DOI 10.1073/pnas.1312213111; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Balvanera P, 2014, BIOSCIENCE, V64, P49, DOI 10.1093/biosci/bit003; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Bruno JF, 2008, ECOLOGY, V89, P2518, DOI 10.1890/07-1345.1; Byrnes JEK, 2014, METHODS ECOL EVOL, V5, P111, DOI 10.1111/2041-210X.12143; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Delgado-Baquerizo M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10541; Deraison H, 2015, ECOL LETT, V18, P1346, DOI 10.1111/ele.12529; Douglass JG, 2008, ECOL LETT, V11, P598, DOI 10.1111/j.1461-0248.2008.01175.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Handa IT, 2014, NATURE, V509, P218, DOI 10.1038/nature13247; Hautier Y, 2014, NATURE, V508, P521, DOI 10.1038/nature13014; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Jing X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9159; Lefcheck JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7936; MA (Millennium Ecosystem Assessment), 2005, ECOSYSTEMS HUMAN WEL, P1; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Manning P, 2015, ECOLOGY, V96, P1492, DOI 10.1890/14-1307.1; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; R Development Core Team, 2014, R LANG ENV STAT COMP; Soliveres S, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0269; Tilman D, 2012, P NATL ACAD SCI USA, V109, P10394, DOI 10.1073/pnas.1208240109; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Worm B, 2003, TRENDS ECOL EVOL, V18, P628, DOI 10.1016/j.tree.2003.09.003; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	45	346	362	78	970	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					456	+		10.1038/nature19092	http://dx.doi.org/10.1038/nature19092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27533038	Green Accepted			2022-12-24	WOS:000382646600041
J	Nielsen, J; Hedeholm, RB; Heinemeier, J; Bushnell, PG; Christiansen, JS; Olsen, J; Ramsey, CB; Brill, RW; Simon, M; Steffensen, KF; Steffensen, JF				Nielsen, Julius; Hedeholm, Rasmus B.; Heinemeier, Jan; Bushnell, Peter G.; Christiansen, Jorgen S.; Olsen, Jesper; Ramsey, Christopher Bronk; Brill, Richard W.; Simon, Malene; Steffensen, Kirstine F.; Steffensen, John F.			Eye lens radiocarbon reveals centuries of longevity in the Greenland shark (Somniosus microcephalus)	SCIENCE			English	Article							POST-BOMB RADIOCARBON; FEEDING ECOLOGY; NORTHWEST ATLANTIC; AGE VALIDATION; LAMNA-NASUS; PRE-BOMB; FOOD-WEB; CALIBRATION; OTOLITHS; DELTA-N-15	The Greenland shark (Somniosus microcephalus), an iconic species of the Arctic Seas, grows slowly and reaches >500 centimeters (cm) in total length, suggesting a life span well beyond those of other vertebrates. Radiocarbon dating of eye lens nuclei from 28 female Greenland sharks (81 to 502 cm in total length) revealed a life span of at least 272 years. Only the smallest sharks (220 cm or less) showed signs of the radiocarbon bomb pulse, a time marker of the early 1960s. The age ranges of prebomb sharks (reported as midpoint and extent of the 95.4% probability range) revealed the age at sexual maturity to be at least 156 +/- 22 years, and the largest animal (502 cm) to be 392 +/- 120 years old. Our results show that the Greenland shark is the longest-lived vertebrate known, and they raise concerns about species conservation.	[Nielsen, Julius; Steffensen, Kirstine F.; Steffensen, John F.] Univ Copenhagen, Marine Biol Sect, Strandpromenaden 5, DK-3000 Helsingor, Denmark; [Nielsen, Julius; Hedeholm, Rasmus B.] Greenland Inst Nat Resources, POB 570,Kivioq 2, Nuuk 3900, Greenland; [Nielsen, Julius] Natl Aquarium Denmark, Den Bla Planet, Jacob Fortlingsvej 1, DK-2770 Kastrup, Denmark; [Nielsen, Julius; Christiansen, Jorgen S.] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, N-9037 Tromso, Norway; [Heinemeier, Jan; Olsen, Jesper] Aarhus Univ, Aarhus AMS Ctr, Dept Phys & Astron, Ny Munkegade 120, DK-8000 Aarhus, Denmark; [Bushnell, Peter G.] Indiana Univ South Bend, Dept Biol Sci, 1700 Mishawaka Ave, South Bend, IN USA; [Ramsey, Christopher Bronk] Univ Oxford, Oxford Radiocarbon Accelerator Unit, Dyson Perrins Bldg,South Parks Rd, Oxford OX1 3QY, England; [Brill, Richard W.] NOAA, Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, James J Howard Marine Sci Lab, 74 Magruder Rd, Highlands, NJ 07732 USA; [Brill, Richard W.] Virginia Inst Marine Sci, POB 1346, Gloucester Point, VA 23062 USA; [Simon, Malene] Greenland Inst Nat Resources, Greenland Climate Res Ctr, POB 570,Kivioq 2, Nuuk 3900, Greenland	University of Copenhagen; Greenland Institute of Natural Resources; UiT The Arctic University of Tromso; Aarhus University; Indiana University System; Indiana University South Bend; University of Oxford; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; William & Mary; Virginia Institute of Marine Science; Greenland Institute of Natural Resources	Nielsen, J (corresponding author), Univ Copenhagen, Marine Biol Sect, Strandpromenaden 5, DK-3000 Helsingor, Denmark.; Nielsen, J (corresponding author), Greenland Inst Nat Resources, POB 570,Kivioq 2, Nuuk 3900, Greenland.; Nielsen, J (corresponding author), Natl Aquarium Denmark, Den Bla Planet, Jacob Fortlingsvej 1, DK-2770 Kastrup, Denmark.; Nielsen, J (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, N-9037 Tromso, Norway.	julius.nielsen@bio.ku.dk	Ramsey, Christopher Bronk/AAQ-2227-2021; Steffensen, John F/F-6778-2010; Ramsey, Christopher Bronk/A-3277-2012; Olsen, Jesper/F-1656-2013	Ramsey, Christopher Bronk/0000-0002-8641-9309; Steffensen, John F/0000-0002-4477-8039; Ramsey, Christopher Bronk/0000-0002-8641-9309; Olsen, Jesper/0000-0002-4445-5520; Steffensen, Kirstine Fleng/0000-0001-8404-6425	Commission of Scientific Investigations in Greenland (KVUG); Save Our Seas Foundation; National Geographic Foundation; Carlsberg Foundation; Danish Centre for Marine Research; Den Bla Planet-National Aquarium of Denmark; Greenland Institute of Natural Resources (GINR); Danish Council for Independent Research; Natural Environment Research Council [NRCF010002] Funding Source: researchfish; NERC [NRCF010002] Funding Source: UKRI	Commission of Scientific Investigations in Greenland (KVUG); Save Our Seas Foundation; National Geographic Foundation(National Geographic Society); Carlsberg Foundation(Carlsberg Foundation); Danish Centre for Marine Research; Den Bla Planet-National Aquarium of Denmark; Greenland Institute of Natural Resources (GINR); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful for the contributions from M. B. Backe throughout the manuscript. We thank the Commission of Scientific Investigations in Greenland (KVUG), Save Our Seas Foundation, National Geographic Foundation, Carlsberg Foundation, Danish Centre for Marine Research, Den Bla Planet-National Aquarium of Denmark, Greenland Institute of Natural Resources (GINR), and the Danish Council for Independent Research for financial support. We thank GINR, the University of Copenhagen and the TUNU Programme (UIT, The Arctic University of Norway) for ship time. We are grateful for the collaboration with K.P. Lange. We thank the crews of the RV Pamiut, RV Dana, RV Helmer Hanssen, RV Sanna, and RV Porsild. Three anonymous reviewers provided helpful comments and discussion that improved earlier versions of the manuscript.	BADA JL, 1987, GEOPHYS RES LETT, V14, P1065, DOI 10.1029/GL014i010p01065; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Bigelow H. B., 1948, FISHES W N ATLANTIC, P516; Butler PG, 2013, PALAEOGEOGR PALAEOCL, V373, P141, DOI 10.1016/j.palaeo.2012.01.016; Butler PG, 2009, EARTH PLANET SC LETT, V279, P230, DOI 10.1016/j.epsl.2008.12.043; Campana SE, 2002, CAN J FISH AQUAT SCI, V59, P450, DOI 10.1139/F02-027; Campana SE, 1997, MAR ECOL PROG SER, V150, P49, DOI 10.3354/meps150049; Campana SE, 2006, ENVIRON BIOL FISH, V77, P327, DOI 10.1007/s10641-006-9107-3; Campana SE, 2015, DEEP-SEA RES PT II, V115, P109, DOI 10.1016/j.dsr2.2013.11.001; Christensen JT, 2008, MAR ECOL PROG SER, V368, P1, DOI 10.3354/meps07635; Compagno L, 1984, FAO SPECIES CATALO 1, V4; DEVRIES H, 1958, SCIENCE, V128, P1550, DOI 10.1126/science.128.3338.1550; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Fisk AT, 2002, ECOLOGY, V83, P2162, DOI 10.1890/0012-9658(2002)083[2162:UACASI]2.0.CO;2; Francis MP, 2007, MAR FRESHWATER RES, V58, P10, DOI 10.1071/MF06069; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; Hamady LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084006; Hansen JH, 2012, MAR ECOL PROG SER, V467, P47, DOI 10.3354/meps09945; Hansen P.M., 1963, INT COMMISSION NW AT, P172; Heide-Jorgensen M. P., 1994, BIOSCIENCE, V39, P195; Henriksen S., 2015, NORSK RODLISTE ARTER; Joyce WN, 2002, ICES J MAR SCI, V59, P1263, DOI 10.1006/jmsc.2002.1286; KALISH JM, 1993, EARTH PLANET SC LETT, V114, P549, DOI 10.1016/0012-821X(93)90082-K; Kalish JM, 2001, RADIOCARBON, V43, P843; Kyne PM, 2010, CRC MAR BIOL SER, P37; Lynnerup N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001529; McMeans BC, 2010, CAN J FISH AQUAT SCI, V67, P1428, DOI 10.1139/F10-072; Nielsen J, 2014, POLAR BIOL, V37, P37, DOI 10.1007/s00300-013-1408-3; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Ramsey CB, 2008, QUATERNARY SCI REV, V27, P42, DOI 10.1016/j.quascirev.2007.01.019; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Scourse JD, 2012, RADIOCARBON, V54, P165, DOI 10.2458/azu_js_rc.v54i2.16026; Stewart REA, 2006, CAN J ZOOL, V84, P1840, DOI 10.1139/Z06-182; Stouby R. B., 2011, EKSPORTKRONER SKIDTF, V2; Treble MA, 2008, CAN J FISH AQUAT SCI, V65, P1047, DOI 10.1139/F08-030; Yano K, 2007, J FISH BIOL, V70, P374, DOI 10.1111/j.1095-8649.2007.01308.x	38	158	170	4	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					702	704		10.1126/science.aaf1703	http://dx.doi.org/10.1126/science.aaf1703			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516602	Green Submitted			2022-12-24	WOS:000381561200041
J	Hey, SP; Kesselheim, AS				Hey, Spencer Phillips; Kesselheim, Aaron S.			Countering imprecision in precision medicine	SCIENCE			English	Editorial Material									[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, Boston, MA 02120 USA; Harvard Med Sch, Boston, MA 02120 USA; Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Andre F, 2011, NAT REV CLIN ONCOL, V8, P171, DOI 10.1038/nrclinonc.2011.4; Ballman KV, 2015, J CLIN ONCOL, V33, P3968, DOI 10.1200/JCO.2015.63.3651; de Gramont A, 2015, NAT REV CLIN ONCOL, V12, P197, DOI 10.1038/nrclinonc.2014.202; FDA, 2012, GUID IND ENR STRAT C; Febbo PG, 2011, J NATL COMPR CANC NE, V9, pS1, DOI 10.6004/jnccn.2011.0137; Hayes DF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005950; Hey S. P., 2015, THEORIA, V30; Mallett S, 2010, BRIT J CANCER, V102, P173, DOI 10.1038/sj.bjc.6605462; National Academies of Sciences, 2016, BIOM TESTS MOL TARG; Office of Public Health Strategy and Analysis FDA, 2015, PUBL HLTH EV FDA OV; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Schmidt Charlie, 2011, J Natl Cancer Inst, V103, P87, DOI 10.1093/jnci/djq557	12	24	24	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					448	449		10.1126/science.aaf5101	http://dx.doi.org/10.1126/science.aaf5101			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS2HC	27471295				2022-12-24	WOS:000380583600023
J	Pandya, B; Cullen, S; Walker, F				Pandya, Bejal; Cullen, Shay; Walker, Fiona			CLINICAL UPDATES Congenital heart disease in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR MAGNETIC-RESONANCE; REPAIR; ENDOCARDITIS; PROPHYLAXIS; TETRALOGY		[Pandya, Bejal; Cullen, Shay; Walker, Fiona] St Bartholomews Hosp, Barts Heart Ctr, Grown Up Congenital Heart Dis GUCH Clin, London, England	University of London; Queen Mary University London	Walker, F (corresponding author), St Bartholomews Hosp, Barts Heart Ctr, Grown Up Congenital Heart Dis GUCH Clin, London, England.	fiona.walker@bartshealth.nhs.uk						Chambers JB, 2016, LANCET INFECT DIS, V16, P275, DOI 10.1016/S1473-3099(16)00048-7; Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800; Gatzoulis MA, 2000, AM J CARDIOL, V86, P1352, DOI 10.1016/S0002-9149(00)01241-8; Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8; HANLEY FL, 1993, J THORAC CARDIOV SUR, V106, P387; Kilner PJ, 2010, EUR HEART J, V31, P794, DOI 10.1093/eurheartj/ehp586; Kutty S, 2012, AM J CARDIOL, V109, P1348, DOI 10.1016/j.amjcard.2011.12.031; Oechslin E, 2010, CURR CARDIOL REV, V6, P363, DOI 10.2174/157340310793566127; Owen Andrew R., 2000, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V3, P216; Pennell DJ, 2004, EUR HEART J, V25, P1940, DOI 10.1016/j.ehj.2004.06.040; Public Health England, 2016, MED RAD US DOS MEAS; Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218; Stokes T, 2008, HEART, V94, P930, DOI 10.1136/hrt.2008.147090; Thorne S, 2006, HEART, V92, P1520, DOI 10.1136/hrt.2006.095240; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392	15	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2016	354								i3905	10.1136/bmj.i3905	http://dx.doi.org/10.1136/bmj.i3905			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS6ZO	27470314				2022-12-24	WOS:000380932300003
J	Dorand, RD; Nthale, J; Myers, JT; Barkauskas, DS; Avril, S; Chirieleison, SM; Pareek, TK; Abbott, DW; Stearns, DS; Letterio, JJ; Huang, AY; Petrosiute, A				Dorand, R. Dixon; Nthale, Joseph; Myers, Jay T.; Barkauskas, Deborah S.; Avril, Stefanie; Chirieleison, Steven M.; Pareek, Tej K.; Abbott, Derek W.; Stearns, Duncan S.; Letterio, John J.; Huang, Alex Y.; Petrosiute, Agne			Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity	SCIENCE			English	Article							CYCLIN-DEPENDENT KINASE-5; REGULATORY FACTOR-I; UP-REGULATION; IFN-GAMMA; ACTIVATION; PATHWAY; MECHANISMS; MOLECULES; GENES; CELLS	Cancers often evade immune surveillance by adopting peripheral tissue-tolerance mechanisms, such as the expression of programmed cell death ligand 1 (PD-L1), the inhibition of which results in potent antitumor immunity. Here, we show that cyclin-dependent kinase 5 (Cdk5), a serine-threonine kinase that is highly active in postmitotic neurons and in many cancers, allows medulloblastoma (MB) to evade immune elimination. Interferon-gamma (IFN-gamma)-induced PD-L1 up-regulation on MB requires Cdk5, and disruption of Cdk5 expression in a mouse model of MB results in potent CD4(+) T cell-mediated tumor rejection. Loss of Cdk5 results in persistent expression of the PD-L1 transcriptional repressors, the interferon regulatory factors IRF2 and IRF2BP2, which likely leads to reduced PD-L1 expression on tumors. Our finding highlights a central role for Cdk5 in immune checkpoint regulation by tumor cells.	[Dorand, R. Dixon; Avril, Stefanie; Chirieleison, Steven M.; Abbott, Derek W.; Huang, Alex Y.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Dorand, R. Dixon; Nthale, Joseph; Myers, Jay T.; Barkauskas, Deborah S.; Pareek, Tej K.; Stearns, Duncan S.; Letterio, John J.; Huang, Alex Y.; Petrosiute, Agne] Case Western Reserve Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, Cleveland, OH 44106 USA; [Nthale, Joseph; Myers, Jay T.; Barkauskas, Deborah S.; Pareek, Tej K.; Stearns, Duncan S.; Letterio, John J.; Huang, Alex Y.; Petrosiute, Agne] Angie Fowler Adolescent & Young Adult Canc Inst, Cleveland, OH 44106 USA; [Nthale, Joseph; Myers, Jay T.; Barkauskas, Deborah S.; Pareek, Tej K.; Stearns, Duncan S.; Letterio, John J.; Huang, Alex Y.; Petrosiute, Agne] Univ Hosp, Cleveland, OH 44106 USA; [Nthale, Joseph; Myers, Jay T.; Barkauskas, Deborah S.; Pareek, Tej K.; Stearns, Duncan S.; Letterio, John J.; Huang, Alex Y.; Petrosiute, Agne] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Avril, Stefanie; Abbott, Derek W.; Stearns, Duncan S.; Letterio, John J.; Huang, Alex Y.; Petrosiute, Agne] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University	Huang, AY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.; Huang, AY; Petrosiute, A (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, Cleveland, OH 44106 USA.; Huang, AY; Petrosiute, A (corresponding author), Angie Fowler Adolescent & Young Adult Canc Inst, Cleveland, OH 44106 USA.; Huang, AY; Petrosiute, A (corresponding author), Univ Hosp, Cleveland, OH 44106 USA.; Huang, AY; Petrosiute, A (corresponding author), Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA.; Huang, AY; Petrosiute, A (corresponding author), Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	ayh3@case.edu; axp125@case.edu	Avril, Stefanie/J-6668-2016; Huang, Alex/R-4662-2017; Huang, Alex Y./ABG-8182-2021	Avril, Stefanie/0000-0002-3394-8733; Huang, Alex/0000-0002-5701-4521; Huang, Alex Y./0000-0002-5701-4521; Chirieleison, Steven/0000-0002-3997-5652; Abbott, Derek/0000-0003-4387-8094; Petrosiute, Agne/0000-0003-4010-9898	NIH [F31CA196265, T32GM007250, T32AI089474, R01GM086550, R01CA154656, R21CA181875, R01HL111682, P30CA043703]; Wolstein Research Scholarship; St. Baldrick's Foundation; Hyundai "Hope-on-Wheels" Program; Marc Joseph Fund; Alex's Lemonade Stand Foundation; Angie Fowler Adolescent and Young Adult Cancer Research Initiative at the Case Comprehensive Cancer Center; Theresia G. and Stuart F. Kline Family Foundation in Pediatric Oncology; Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences (NCATS) component of the NIH [UL1TR000439, KL2TR000440]; NATIONAL CANCER INSTITUTE [F31CA196265, P30CA043703, R21CA181875, R01CA154656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, KL2TR000440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222, P30DK097948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086550, T32GM007250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wolstein Research Scholarship; St. Baldrick's Foundation; Hyundai "Hope-on-Wheels" Program; Marc Joseph Fund; Alex's Lemonade Stand Foundation; Angie Fowler Adolescent and Young Adult Cancer Research Initiative at the Case Comprehensive Cancer Center; Theresia G. and Stuart F. Kline Family Foundation in Pediatric Oncology; Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences (NCATS) component of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Scrimieri, G. Valdivieso, A. Awadallah, A. Kresak, D. Schlatzer, and the Case Western Reserve University Center for Proteomics for technical assistance; M. Couce for constructing human MB tissue microarray; and M. Chieppa, D. Askew, and B. Benson for careful review of the manuscript. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by NIH F31CA196265 (R.D.D.), NIH T32GM007250 (R.D.D. and S.M.C.), NIH T32AI089474 (S.M.C.), NIH R01GM086550 (D.W.A.), NIH R01CA154656 (A.Y.H.), NIH R21CA181875 (A.Y.H. and J.J.L.), NIH R01HL111682 (A.Y.H. and J.J.L.), NIH P30CA043703 (A.Y.H. and A.P.), Wolstein Research Scholarship (R.D.D.), St. Baldrick's Foundation (A.P., J.J.L., and A.Y.H.), Hyundai "Hope-on-Wheels" Program (A.P., D.S.S., and A.Y.H.), Marc Joseph Fund (A.Y.H.), Alex's Lemonade Stand Foundation (A.P. and A.Y.H.), the Angie Fowler Adolescent and Young Adult Cancer Research Initiative at the Case Comprehensive Cancer Center (A.P., J.J.L., D.S.S., S.A., and A.Y.H.), and Theresia G. and Stuart F. Kline Family Foundation in Pediatric Oncology (A.Y.H.). This work was supported by the Clinical and Translational Science Collaborative of Cleveland UL1TR000439 (A.P.), and KL2TR000440 (S.A.) from the National Center for Advancing Translational Sciences (NCATS) component of the NIH. Authors declare no competing financial interests. All phosphoproteomics data are available in the supplementary materials.	Arif A, 2012, BIOCHEM PHARMACOL, V84, P985, DOI 10.1016/j.bcp.2012.06.027; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Childs KS, 2003, NUCLEIC ACIDS RES, V31, P3016, DOI 10.1093/nar/gkg431; Contreras-Vallejos E, 2012, CELL SIGNAL, V24, P44, DOI 10.1016/j.cellsig.2011.08.022; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Feldmann G, 2010, CANCER RES, V70, P4460, DOI 10.1158/0008-5472.CAN-09-1107; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Hsu FN, 2011, J BIOL CHEM, V286, P33141, DOI 10.1074/jbc.M111.252080; Jarosinski KW, 2002, J NEUROIMMUNOL, V122, P74, DOI 10.1016/S0165-5728(01)00467-2; Khalil HS, 2015, J BIOTECHNOL, V202, P40, DOI 10.1016/j.jbiotec.2015.02.032; Kim HJ, 2014, CANCER IMMUNOL RES, V2, P91, DOI 10.1158/2326-6066.CIR-13-0216; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pareek TK, 2010, J EXP MED, V207, P2507, DOI 10.1084/jem.20100876; Pham CD, 2016, CLIN CANCER RES, V22, P582, DOI 10.1158/1078-0432.CCR-15-0713; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Salsman VS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020267; Seo HR, 2008, J BIOL CHEM, V283, P15601, DOI 10.1074/jbc.M800987200; Soliman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088557; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Teng ACT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024100; Teng ACT, 2010, FASEB J, V24, P4825, DOI 10.1096/fj.10-167049; Utreras Elias, 2009, Drug Discov Today Ther Strateg, V6, P105, DOI 10.1016/j.ddstr.2009.04.004; Yao S, 2015, MUCOSAL IMMUNOL, V8, P746, DOI 10.1038/mi.2014.106; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	30	208	221	5	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2016	353	6297					399	403		10.1126/science.aae0477	http://dx.doi.org/10.1126/science.aae0477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HB	27463676	Green Accepted			2022-12-24	WOS:000380583400045
J	Okie, S				Okie, Susan			TBI's Long-Term Follow-up - Slow Progress in Science and Recovery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Okie, Susan] Georgetown Univ, Sch Med, Family Med, Washington, DC 20007 USA	Georgetown University	Okie, S (corresponding author), Georgetown Univ, Sch Med, Family Med, Washington, DC 20007 USA.							[Anonymous], 2014, POL BLAST REL INJ TB; [Anonymous], 2015, REP C TRAUM BRAIN IN; Department of Veterans Affairs, POL TBI SYST CAR; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235	5	6	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2016	375	2					180	184		10.1056/NEJMms1604272	http://dx.doi.org/10.1056/NEJMms1604272			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ9KY	27410929				2022-12-24	WOS:000379530000017
J	Fauci, AS				Fauci, Anthony S.			An HIV Vaccine Mapping Uncharted Territory	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fauci, Anthony S.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, Immunoregulat Lab, Bldg 31,Room 7A-03,31 Ctr Dr,MSC 2520, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Burton DR, 2000, NAT MED, V6, P123, DOI 10.1038/72200; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Fauci AS, 2015, SCIENCE, V349, P386, DOI 10.1126/science.aac6300; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223	7	13	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2016	316	2					143	+		10.1001/jama.2016.7538	http://dx.doi.org/10.1001/jama.2016.7538			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ9CW	27404178				2022-12-24	WOS:000379509000006
J	Lyman, GH; Moses, HL				Lyman, Gary H.; Moses, Harold L.			Biomarker Tests for Molecularly Targeted Therapies - The Key to Unlocking Precision Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIANS		[Lyman, Gary H.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Lyman, Gary H.] Univ Washington, Seattle, WA 98195 USA; [Lyman, Gary H.; Moses, Harold L.] Natl Acad Sci Engn & Med, Comm Policy Issues Clin Dev & Use Biomarkers Mole, Washington, DC 20418 USA; [Moses, Harold L.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; National Academies of Sciences, Engineering & Medicine; Vanderbilt University	Lyman, GH (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.; Lyman, GH (corresponding author), Univ Washington, Seattle, WA 98195 USA.; Lyman, GH (corresponding author), Natl Acad Sci Engn & Med, Comm Policy Issues Clin Dev & Use Biomarkers Mole, Washington, DC 20418 USA.		Lyman, Gary H/K-5227-2019	Lyman, Gary H/0000-0002-0823-8086				Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Gray SW, 2014, J CLIN ONCOL, V32, P1317, DOI 10.1200/JCO.2013.52.4298; Hayes DF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005950; Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104; Vassy JL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2401	5	60	61	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2016	375	1					4	6		10.1056/NEJMp1604033	http://dx.doi.org/10.1056/NEJMp1604033			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL8VA	27353537				2022-12-24	WOS:000394897200002
J	Petry, WK; Soule, JD; Iler, AM; Chicas-Mosier, A; Inouye, DW; Miller, TEX; Mooney, KA				Petry, William K.; Soule, Judith D.; Iler, Amy M.; Chicas-Mosier, Ana; Inouye, David W.; Miller, Tom E. X.; Mooney, Kailen A.			Sex-specific responses to climate change in plants alter population sex ratio and performance	SCIENCE			English	Article							POLLEN LIMITATION; EVOLUTION; DIMORPHISM; CONSEQUENCES; INVASIONS	Males and females are ecologically distinct in many species, but whether responses to climate change are sex-specific is unknown. We document sex-specific responses to climate change in the plant Valeriana edulis (valerian) over four decades and across its 1800-meter elevation range. Increased elevation was associated with increased water availability and female frequency, likely owing to sex-specific water use efficiency and survival. Recent aridification caused male frequency to move upslope at 175 meters per decade, a rate of trait shift outpacing reported species' range shifts by an order of magnitude. This increase in male frequency reduced pollen limitation and increased seedset. Coupled with previous studies reporting sex-specific arthropod communities, these results underscore the importance of ecological differences between the sexes in mediating biological responses to climate change.	[Petry, William K.; Mooney, Kailen A.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Petry, William K.; Soule, Judith D.; Iler, Amy M.; Chicas-Mosier, Ana; Inouye, David W.; Mooney, Kailen A.] Rocky Mt Biol Labs, Crested Butte, CO 81224 USA; [Iler, Amy M.] Aarhus Univ, Aarhus Inst Adv Studies, Hoegh Guldbergs Gade 6B, DK-8000 Aarhus C, Denmark; [Chicas-Mosier, Ana] Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA; [Inouye, David W.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Miller, Tom E. X.] Rice Univ, Dept BioSci, Program Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Petry, William K.] ETH, Swiss Fed Inst Technol, Inst Integrat Biol, Univ Str 16, Zurich, Switzerland	University of California System; University of California Irvine; Aarhus University; Oklahoma State University System; Oklahoma State University - Stillwater; University System of Maryland; University of Maryland College Park; Rice University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Petry, WK (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.; Petry, WK (corresponding author), Rocky Mt Biol Labs, Crested Butte, CO 81224 USA.; Petry, WK (corresponding author), ETH, Swiss Fed Inst Technol, Inst Integrat Biol, Univ Str 16, Zurich, Switzerland.	william.petry@usys.ethz.ch	Inouye, David W./C-2997-2011; Iler, Amy Marie/Y-7201-2019	Inouye, David W./0000-0003-2076-7834; Iler, Amy Marie/0000-0002-3354-7593; Petry, William/0000-0002-5230-5987	Direct For Biological Sciences [1457029, 1354104, 1407318] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Calabrese JM, 2008, J ANIM ECOL, V77, P746, DOI 10.1111/j.1365-2656.2008.01385.x; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Dawson T.E., 1999, CONFORMAL INVARIANCE, P175, DOI [DOI 10.1007/978-3-662-03937-3, 10.1007/978-3-662-03937-3]; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Geber MA, 1999, GENDER SEXUAL DIMORP; Hultine KR, 2007, OECOLOGIA, V154, P85, DOI 10.1007/s00442-007-0813-0; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; LANDE R, 1980, EVOLUTION, V34, P292, DOI 10.1111/j.1558-5646.1980.tb04817.x; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Maurer E. P., 2007, EOS T AM GEOPHYS UN, V88, P504, DOI DOI 10.1029/2007EO470006; MEURMAN O, 1925, SOC SCI FENN COMM BI, V0002, P00001; Miller TEX, 2013, ECOL LETT, V16, P354, DOI 10.1111/ele.12049; Miller TEX, 2011, AM NAT, V177, P549, DOI 10.1086/659628; Mooney KA, 2012, ARTHROPOD-PLANT INTE, V6, P553, DOI 10.1007/s11829-012-9204-5; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Petry WK, 2013, ECOLOGY, V94, P2055, DOI 10.1890/12-2170.1; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Shelton AO, 2008, ECOLOGY, V89, P3020, DOI 10.1890/07-1835.1; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Soule J. D., 1981, THESIS; Thompson J, 2013, P NATL ACAD SCI USA, V110, P2893, DOI 10.1073/pnas.1215833110	25	54	55	8	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					69	71		10.1126/science.aaf2588	http://dx.doi.org/10.1126/science.aaf2588			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365446				2022-12-24	WOS:000378816200037
J	Mertens, SFL; Hemmi, A; Muff, S; Groning, O; De Feyter, S; Osterwalder, J; Greber, T				Mertens, Stijn F. L.; Hemmi, Adrian; Muff, Stefan; Groning, Oliver; De Feyter, Steven; Osterwalder, Jurg; Greber, Thomas			Switching stiction and adhesion of a liquid on a solid	NATURE			English	Article							HEXAGONAL BORON-NITRIDE; UNDERPOTENTIAL DEPOSITION; CONTACT-ANGLE; HYDROGEN; RHODIUM; ADSORPTION; DEPENDENCE; NANOMESH; KINETICS; PROTON	When a gecko moves on a ceiling it makes use of adhesion and stiction. Stiction-static friction-is experienced on microscopic and macroscopic scales and is related to adhesion and sliding friction(1). Although important for most locomotive processes, the concepts of adhesion, stiction and sliding friction are often only empirically correlated. A more detailed understanding of these concepts will, for example, help to improve the design of increasingly smaller devices such as micro-and nanoelectromechanical switches(2). Here we show how stiction and adhesion are related for a liquid drop on a hexagonal boron nitride monolayer on rhodium(3), by measuring dynamic contact angles in two distinct states of the solid-liquid interface: a corrugated state in the absence of hydrogen intercalation and an intercalation-induced flat state. Stiction and adhesion can be reversibly switched by applying different electrochemical potentials to the sample, causing atomic hydrogen to be intercalated or not. We ascribe the change in adhesion to a change in lateral electric field of in-plane two-nanometre dipole rings(4), because it cannot be explained by the change in surface roughness known from the Wenzel model(5). Although the change in adhesion can be calculated for the system we study(6), it is not yet possible to determine the stiction at such a solid-liquid interface using ab initio methods. The inorganic hybrid of hexagonal boron nitride and rhodium is very stable and represents a new class of switchable surfaces with the potential for application in the study of adhesion, friction and lubrication.	[Mertens, Stijn F. L.; De Feyter, Steven] Katholieke Univ Leuven, Dept Chem, Celestijnenlaan 200F, B-3001 Leuven, Belgium; [Mertens, Stijn F. L.] Vienna Univ Technol, Inst Angew Phys, Wiedner Hauptstr 8-10-E134, A-1040 Vienna, Austria; [Hemmi, Adrian; Muff, Stefan; Osterwalder, Jurg; Greber, Thomas] Univ Zurich, Phys Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Groning, Oliver] Empa, Swiss Fed Labs Mat Sci & Technol, Uberlandstr 129, CH-8600 Dubendorf, Switzerland	KU Leuven; Technische Universitat Wien; University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Mertens, SFL (corresponding author), Katholieke Univ Leuven, Dept Chem, Celestijnenlaan 200F, B-3001 Leuven, Belgium.; Mertens, SFL (corresponding author), Vienna Univ Technol, Inst Angew Phys, Wiedner Hauptstr 8-10-E134, A-1040 Vienna, Austria.; Greber, T (corresponding author), Univ Zurich, Phys Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	stmerten@gmail.com; greber@physik.uzh.ch	Greber, Thomas/D-9509-2015; Muff, Stefan/T-9202-2017; Mertens, Stijn/B-1266-2012; De Feyter, Steven/K-7245-2014; Gröning, Oliver/J-9727-2012	Greber, Thomas/0000-0002-5234-1937; Mertens, Stijn/0000-0002-5715-0486; De Feyter, Steven/0000-0002-0909-9292; 	Swiss National Science Foundation; FP7 Marie Curie European reintegration grant, ERC grant OxideSurfaces; FWO-Vlaanderen	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); FP7 Marie Curie European reintegration grant, ERC grant OxideSurfaces; FWO-Vlaanderen(FWO)	We acknowledge financial support by the Swiss National Science Foundation within the funding instrument 'Sinergia'. S.F.L.M. acknowledges the receipt of an FP7 Marie Curie European reintegration grant, ERC grant OxideSurfaces and, together with S.D.F., support by FWO-Vlaanderen. We thank M. Schmid for help with the depiction of the STM images, G. Schutz for discussions and A. P Seitsonen for the artwork in Fig. 1g.	Amirfazli A, 2000, LANGMUIR, V16, P2024, DOI 10.1021/la990609h; Berner S, 2007, ANGEW CHEM INT EDIT, V46, P5115, DOI 10.1002/anie.200700234; Brugger T, 2010, ANGEW CHEM INT EDIT, V49, P6120, DOI 10.1002/anie.201001064; Colonell JI, 1996, SURF SCI, V366, P19, DOI 10.1016/0039-6028(96)00807-2; Corso M, 2004, SCIENCE, V303, P217, DOI 10.1126/science.1091979; Cun H, 2014, ACS NANO, V8, P7423, DOI 10.1021/nn502645w; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; Dil H, 2008, SCIENCE, V319, P1824, DOI 10.1126/science.1154179; Ding Y, 2011, J PHYS CHEM C, V115, P13685, DOI 10.1021/jp110235y; EHRLICH G, 1966, J CHEM PHYS, V44, P1039, DOI 10.1063/1.1726787; Evans MG, 1938, T FARADAY SOC, V34, P0011, DOI 10.1039/tf9383400011; Golze D, 2015, PHYS CHEM CHEM PHYS, V17, P14307, DOI 10.1039/c4cp04638b; HANSEN WN, 1979, J ELECTROANAL CHEM, V100, P493, DOI 10.1016/0368-1874(79)85131-X; Hemmi A, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4866648; HOLZSCHUH E, 1992, PHYS LETT B, V287, P381, DOI 10.1016/0370-2693(92)91000-Y; Hu S, 2014, NATURE, V516, P227, DOI 10.1038/nature14015; Iannuzzi M, 2014, PHYS CHEM CHEM PHYS, V16, P12374, DOI 10.1039/c4cp01466a; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; Jerkiewicz G, 1996, J PHYS CHEM-US, V100, P8454, DOI 10.1021/jp960130n; King SW, 2015, SURF INTERFACE ANAL, V47, P798, DOI 10.1002/sia.5781; Koper MTM, 2011, ELECTROCHIM ACTA, V56, P10645, DOI 10.1016/j.electacta.2011.02.001; KRIM J, 1991, PHYS REV LETT, V66, P181, DOI 10.1103/PhysRevLett.66.181; Kwok DY, 1999, ADV COLLOID INTERFAC, V81, P167, DOI 10.1016/S0001-8686(98)00087-6; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Losiewicz B, 2011, ELECTROCHIM ACTA, V56, P5746, DOI 10.1016/j.electacta.2011.04.048; Ma HF, 2012, LANGMUIR, V28, P15246, DOI 10.1021/la302561r; Manukyan G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.014501; Persson B. N. J., 1998, NANOSCI TECHNOL; Schneemilch M, 2000, LANGMUIR, V16, P2924, DOI 10.1021/1a990524g; SCHRADER ME, 1995, LANGMUIR, V11, P3585, DOI 10.1021/la00009a049; Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565; SUNG YE, 1995, J PHYS CHEM-US, V99, P13513, DOI 10.1021/j100036a031; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288; Wagner TJW, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/27/275501; WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015; Widmer R, 2007, ELECTROCHEM COMMUN, V9, P2484, DOI 10.1016/j.elecom.2007.07.019; WILLMAN KW, 1983, ANAL CHEM, V55, P1139, DOI 10.1021/ac00258a036; Zhang Q, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.144114; Zolfaghari A, 1997, J ELECTROCHEM SOC, V144, P3034, DOI 10.1149/1.1837955	40	56	57	5	275	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					676	+		10.1038/nature18275	http://dx.doi.org/10.1038/nature18275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357755	Green Accepted			2022-12-24	WOS:000378676000034
J	Yozwiak, NL; Happi, CT; Grant, DS; Schieffelin, JS; Garry, RF; Sabeti, PC; Andersen, KG				Yozwiak, Nathan L.; Happi, Christian T.; Grant, Donald S.; Schieffelin, John S.; Garry, Robert F.; Sabeti, Pardis C.; Andersen, Kristian G.			Roots, Not Parachutes: Research Collaborations Combat Outbreaks	CELL			English	Editorial Material							SIERRA-LEONE; EBOLA; TRANSMISSION	Recent infectious disease epidemics illustrate how health systems failures anywhere can create disease vulnerabilities everywhere. We must therefore prioritize investments in health care infrastructure in outbreak-prone regions of the world. We describe how "rooted" research collaborations can establish capacity for pathogen surveillance and facilitate rapid outbreak responses.	[Yozwiak, Nathan L.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Yozwiak, Nathan L.; Sabeti, Pardis C.; Andersen, Kristian G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Happi, Christian T.] Redeemers Univ, Dept Biol Sci, Ede, Osun State, Nigeria; [Happi, Christian T.] Redeemers Univ, African Ctr Excellence Genom Infect Dis, Ede, Osun State, Nigeria; [Grant, Donald S.] Kenema Govt Hosp, Kenema, Sierra Leone; [Schieffelin, John S.; Garry, Robert F.] Tulane Univ, Med Ctr, New Orleans, LA 70112 USA; [Sabeti, Pardis C.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Redeemers University; Redeemers University; Kenema Government Hospital; Tulane University; Howard Hughes Medical Institute; Scripps Research Institute; Scripps Research Institute	Yozwiak, NL (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Yozwiak, NL; Andersen, KG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.	nyozwiak@broadinstitute.org; kristian@andersen-lab.com	Sabeti, Pardis/GQH-8610-2022	Happi, Christian/0000-0002-3056-6705; Garry, Robert/0000-0002-5683-3250	NCATS NIH HHS [UL1 TR001114] Funding Source: Medline; NHGRI NIH HHS [U01 HG007480] Funding Source: Medline; NIAID NIH HHS [U19 AI110818, HHSN272201400048C, R01 AI114855, U19 AI115589, R01 AI104621, U19 AI109762] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI115589, R01AI114855, U19AI110818, R01AI104621, U19AI109762] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2015, UNESCO SCI REP 2030; Ariasa A., 2016, VIRUS EVOLUTION; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Blackley DJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600378; Currie J, 2016, SCIENCE, V351, P815, DOI 10.1126/science.aad8521; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Heymann DL, 2016, NEW ENGL J MED, V374, P1504, DOI 10.1056/NEJMp1602278; Marsh K, 2016, AFRICA CAN CLOSE ITS; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680	10	35	35	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					5	8		10.1016/j.cell.2016.06.029	http://dx.doi.org/10.1016/j.cell.2016.06.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368093	Green Accepted, Bronze			2022-12-24	WOS:000380254400003
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: The forgotten problem of incontinence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							URINARY-TRACT SYMPTOMS					davidoliver372@googlemail.com						[Anonymous], 2007, HELP AGED INCONTINEN; Department of Health, 2014, HARD TRUTHS JOURN PU; Hyde N., 2016, GET READING; Fontaine R.E., 1989, Vector Ecology Newsletter, V20, P1; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Lievesley N, 2011, CHANGING ROLE CARE H; Manchester City Council, SUMM MANCH GREAT PLA; National Institute for Health and Care Excellence, 2016, URINARY INCONTINENCE; NHS England, 2015, EXC CONT CAR PRACT G; Perry S, 2000, J PUBLIC HEALTH MED, V22, P427, DOI 10.1093/pubmed/22.3.427; Rees J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3861; Royal College of Physicians, 2015, NAT AUD CONT CAR NAC; Steel N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a957; West Berkshire Council, 2016, BUDG PROP 2016 17 PH; Wood LN, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4531	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2016	353								i3557	10.1136/bmj.i3557	http://dx.doi.org/10.1136/bmj.i3557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FV	27358208	Green Published, Bronze			2022-12-24	WOS:000379018700002
J	Golden, C; Allison, EH; Cheung, WWL; Dey, MM; Halpern, BS; McCauley, DJ; Smith, M; Vaitla, B; Zeller, D; Myers, SS				Golden, Christopher; Allison, Edward H.; Cheung, William W. L.; Dey, Madan M.; Halpern, Benjamin S.; McCauley, Douglas J.; Smith, Matthew; Vaitla, Bapu; Zeller, Dirk; Myers, Samuel S.			Fall in fish catch threatens human health	NATURE			English	Editorial Material							FISHERIES CATCHES; FOOD SECURITY; SEAFOOD		[Golden, Christopher] Harvard Univ, TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA; [Golden, Christopher] Harvard Univ, Ctr Environm, Planetary Hlth Alliance, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Golden, C (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA.; Golden, C (corresponding author), Harvard Univ, Ctr Environm, Planetary Hlth Alliance, Cambridge, MA 02138 USA.	golden@hsph.harvard.edu	Allison, Edward Hugh/B-8615-2009	Smith, Matthew/0000-0001-5207-2370; Golden, Christopher/0000-0002-2258-7493; Zeller, Dirk/0000-0001-7304-4125; Dey, Madan/0000-0001-5273-2789; Allison, Edward/0000-0003-4663-1396	Div Of Biological Infrastructure [1639145, 1052875] Funding Source: National Science Foundation	Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Asche F, 2015, WORLD DEV, V67, P151, DOI 10.1016/j.worlddev.2014.10.013; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Cheung WWL, 2016, ECOL MODEL, V325, P57, DOI 10.1016/j.ecolmodel.2015.12.018; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Costello C, 2016, P NATL ACAD SCI USA, V113, P5125, DOI 10.1073/pnas.1520420113; Dey MM, 2013, FOOD POLICY, V43, P108, DOI [10.1016/j.foodpol.2013.08.0, 10.1016/j.foodpol.2013.08.011]; FAO (Food and Agriculture Organization of the United Nations), 2011, STAT WORLD FISH AQ S; Hall SJ, 2013, P NATL ACAD SCI USA, V110, P8393, DOI 10.1073/pnas.1208067110; OECD/Food and Agriculture Organization of the United Nations, 2015, OECD FAO AGR OUTL 20; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Smith MD, 2010, SCIENCE, V327, P784, DOI 10.1126/science.1185345; Smith MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146976; Thilsted SH, 2016, FOOD POLICY, V61, P126, DOI 10.1016/j.foodpol.2016.02.005; World Bank, 2014, FISH 2030 PROSP FISH; Youn SJ, 2014, GLOB FOOD SECUR-AGR, V3, P142, DOI 10.1016/j.gfs.2014.09.005	15	316	320	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					317	320		10.1038/534317a	http://dx.doi.org/10.1038/534317a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27306172	Green Submitted, Bronze			2022-12-24	WOS:000377856800011
J	Chen, CK; Blanco, M; Jackson, C; Aznauryan, E; Ollikainen, N; Surka, C; Chow, A; Cerase, A; McDonel, P; Guttman, M				Chen, Chun-Kan; Blanco, Mario; Jackson, Constanza; Aznauryan, Erik; Ollikainen, Noah; Surka, Christine; Chow, Amy; Cerase, Andrea; McDonel, Patrick; Guttman, Mitchell			Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing	SCIENCE			English	Article							FACULTATIVE HETEROCHROMATIN; RNA; INACTIVATION; GENOME; CELLS; LOCALIZATION; MOTION; GENES	The Xist long noncoding RNA orchestrates X chromosome inactivation, a process that entails chromosome-wide silencing and remodeling of the three-dimensional (3D) structure of the X chromosome. Yet, it remains unclear whether these changes in nuclear structure are mediated by Xist and whether they are required for silencing. Here, we show that Xist directly interacts with the Lamin B receptor, an integral component of the nuclear lamina, and that this interaction is required for Xist-mediated silencing by recruiting the inactive X to the nuclear lamina and by doing so enables Xist to spread to actively transcribed genes across the X. Our results demonstrate that lamina recruitment changes the 3D structure of DNA, enabling Xist and its silencing proteins to spread across the X to silence transcription.	[Chen, Chun-Kan; Blanco, Mario; Jackson, Constanza; Aznauryan, Erik; Ollikainen, Noah; Surka, Christine; Chow, Amy; Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Cerase, Andrea] European Mol Biol Lab Monterotondo, Via Ramarini 32, I-00015 Monterotondo, RM, Italy; [McDonel, Patrick] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA	California Institute of Technology; European Molecular Biology Laboratory (EMBL); University of Massachusetts System; University of Massachusetts Worcester	Guttman, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mguttman@caltech.edu	Cerase, Andrea/P-4741-2016	Cerase, Andrea/0000-0002-1985-2049	NIH National Research Service Award [T32GM07616]; New York Stem Cell Foundation; NIH Director's Early Independence Award [DP5OD012190]; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; Pew-Steward Scholars program; California Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; NIH Director's Early Independence Award; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; Pew-Steward Scholars program; California Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Plath for extensive discussions; A. Collazo for microscopy help; A. Shur, P. Quintero, and V. Grishkevich for technical help; M. Lai for analytical help; J. Engreitz, S. Quinodoz, M. Garber, I. Amit, and J. Rinn for comments on the manuscript; and S. Knemeyer for illustrations. Imaging was performed in the Biological Imaging Facility, and sequencing was performed in the Millard and Muriel Jacobs Genetics and Genomics Laboratory at the California Institute of Technology. C.-K.C. is supported by a NIH National Research Service Award training grant (T32GM07616). This research was funded by the New York Stem Cell Foundation, a NIH Director's Early Independence Award (DP5OD012190), the Edward Mallinckrodt Foundation, Sontag Foundation, Searle Scholars Program, Pew-Steward Scholars program, and funds from the California Institute of Technology. M.G. is a New York Stem Cell Foundation-Robertson Investigator. Sequencing data are available online from the National Center for Biotechnology Information Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) accession no. GSE80510 (RAP data) and GSE86250 (CLIP data), and additional data and information are available at www.lncRNA.caltech.edu/data.php.	Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Galupa R, 2015, CURR OPIN GENET DEV, V31, P57, DOI 10.1016/j.gde.2015.04.002; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276 aab2276, 10.1126/science.aab2276]; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; Monfort A, 2015, CELL REP, V12, P554, DOI 10.1016/j.celrep.2015.06.067; Pombo A, 2015, NAT REV MOL CELL BIO, V16, P245, DOI 10.1038/nrm3965; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rego A, 2008, J CELL SCI, V121, P1119, DOI 10.1242/jcs.026104; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035	24	159	168	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					468	472		10.1126/science.aae0047	http://dx.doi.org/10.1126/science.aae0047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27492478				2022-12-24	WOS:000387684400042
J	Gunderman, R				Gunderman, Richard			Hospitalists and the Decline of Comprehensive Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gunderman, Richard] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Gunderman, R (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.							Bryant DC, 1999, J GEN INTERN MED, V14, P182, DOI 10.1046/j.1525-1497.1999.00310.x; Meltzer D, 2001, J LEGAL STUD, V30, P589, DOI 10.1086/339294; Pham HH, 2008, HEALTH AFFAIR, V27, P1315, DOI 10.1377/hlthaff.27.5.1315; Taub Ben, 2016, NEW YORKER	4	13	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2016	375	11					1011	1013		10.1056/NEJMp1608289	http://dx.doi.org/10.1056/NEJMp1608289			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV6ZG	27509007	Green Published			2022-12-24	WOS:000383085000002
J	He, R; Hou, SY; Liu, C; Zhang, AL; Bai, Q; Han, M; Yang, Y; Wei, G; Shen, T; Yang, XX; Xu, LF; Chen, XY; Hao, YX; Wang, PC; Zhu, CH; Ou, JJ; Liang, HJ; Ni, T; Zhang, XY; Zhou, XY; Deng, K; Chen, YK; Luo, YD; Xu, JQ; Qi, H; Wu, YZ; Ye, LL				He, Ran; Hou, Shiyue; Liu, Cheng; Zhang, Anli; Bai, Qiang; Han, Miao; Yang, Yu; Wei, Gang; Shen, Ting; Yang, Xinxin; Xu, Lifan; Chen, Xiangyu; Hao, Yaxing; Wang, Pengcheng; Zhu, Chuhong; Ou, Juanjuan; Liang, Houjie; Ni, Ting; Zhang, Xiaoyan; Zhou, Xinyuan; Deng, Kai; Chen, Yaokai; Luo, Yadong; Xu, Jianqing; Qi, Hai; Wu, Yuzhang; Ye, Lilin			Follicular CXCR5-expressing CD8(+) T cells curtail chronic viral infection	NATURE			English	Article							IN-VIVO; DIFFERENTIATION; TRANSCRIPTION; EXHAUSTION; HIV-1; REPLICATION; TOLERANCE; ROLES; FH	During chronic viral infection, virus-specific CD8(+) T cells become exhausted, exhibit poor effector function and lose memory potential(1-4). However, exhausted CD8(+) T cells can still contain viral replication in chronic infections(5-9), although the mechanism of this containment is largely unknown. Here we show that a subset of exhausted CD8(+) T cells expressing the chemokine receptor CXCR5 has a critical role in the control of viral replication in mice that were chronically infected with lymphocytic choriomeningitis virus (LCMV). These CXCR5(+) CD8(+) T cells were able to migrate into B-cell follicles, expressed lower levels of inhibitory receptors and exhibited more potent cytotoxicity than the CXCR5(+) subset. Furthermore, we identified the Id2-E2A signalling axis as an important regulator of the generation of this subset. In patients with HIV, we also identified a virus-specific CXCR5(+) CD8(+) T-cell subset, and its number was inversely correlated with viral load. The CXCR5(+) subset showed greater therapeutic potential than the CXCR5(+) subset when adoptively transferred to chronically infected mice, and exhibited synergistic reduction of viral load when combined with anti-PD-L1 treatment. This study defines a unique subset of exhausted CD8(+) T cells that has a pivotal role in the control of viral replication during chronic viral infection.	[He, Ran; Liu, Cheng; Bai, Qiang; Yang, Xinxin; Xu, Lifan; Chen, Xiangyu; Hao, Yaxing; Wang, Pengcheng; Zhou, Xinyuan; Wu, Yuzhang; Ye, Lilin] Third Mil Med Univ, Inst Immunol, Chongqing 400038, Peoples R China; [Hou, Shiyue; Qi, Hai] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Lab Dynam Immunobiol, Beijing 100084, Peoples R China; [Zhang, Anli; Yang, Yu; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China; [Zhang, Anli; Yang, Yu; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Inst Biomed Sci, Shanghai 201508, Peoples R China; [Han, Miao; Wei, Gang; Shen, Ting; Ni, Ting] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Han, Miao; Wei, Gang; Shen, Ting; Ni, Ting] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, MOE Key Lab Contemporary Anthropol, Shanghai 200438, Peoples R China; [Zhu, Chuhong] Third Mil Med Univ, Sch Basic Med, Dept Anat, Chongqing 400038, Peoples R China; [Ou, Juanjuan; Liang, Houjie] Third Mil Med Univ, Southwestern Hosp, Dept Oncol, Chongqing 400038, Peoples R China; [Deng, Kai] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [Chen, Yaokai; Luo, Yadong] Chongqing Publ Hlth Med Ctr, Chongqing 400000, Peoples R China	Army Medical University; Tsinghua University; Fudan University; Fudan University; Fudan University; Fudan University; Army Medical University; Army Medical University; Sun Yat Sen University	Wu, YZ; Ye, LL (corresponding author), Third Mil Med Univ, Inst Immunol, Chongqing 400038, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Lab Dynam Immunobiol, Beijing 100084, Peoples R China.	qihai@mail.tsinghua.edu.cn; wuyuzhang@tmmu.edu.cn; yelilinlcmv@tmmu.edu.cn	Deng, Kai/AAK-4404-2020; Zhou, Xinyuan/AFS-9817-2022; Luo, Yadong/ABE-6518-2020; BAI, Qiang/O-1069-2019	Deng, Kai/0000-0002-9973-8130; BAI, Qiang/0000-0001-7423-0712; Qi, Hai/0000-0001-5475-3989; Xu, Jianqing/0000-0003-0896-9273; ZHANG, ANLI/0000-0001-7847-6541; Ye, Lilin/0000-0003-0778-3311; Chen, Xiangyu/0000-0001-7947-3211; Wu, Yuzhang/0000-0002-4049-0214; Zhou, Xinyuan/0000-0002-1374-8240	National Basic Research Program of China (973 program) [2013CB531500, 2014CB542501]; National Natural Science Foundation of China [81220108024, 81471624, U1202228, 81425011, 81330070, 31500733]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank R. Ahmed (Emory University) for providing the P14 TCR transgenic mice, retroviral vectors and LCMV Armstrong and Cl13 viruses; Y. Zhuang (Duke University) for providing the Id2<SUP>fl/fl</SUP> mice; the core facility centre of Third Military Medical University for helping us with cell sorting; T. Wu (NIH) for insightful discussion. The work was supported by National Basic Research Program of China (973 program, 2013CB531500, to L.Y.; 2014CB542501 to H.Q.), the National Natural Science Foundation of China (81220108024 to Y.W.; 81471624 to L.Y.; U1202228 to J.X.; No. 81425011, 81330070 to H.Q.; No. 31500733 to Q.B).	Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Belle I, 2014, CURR TOP DEV BIOL, V110, P153, DOI [10.1016/B978-0-12-405943-6.00003-4-X, 10.1016/B978-0-12-405943-6.00004-X]; Connick E, 2007, J IMMUNOL, V178, P6975, DOI 10.4049/jimmunol.178.11.6975; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cyster JG, 2000, IMMUNOL REV, V176, P181; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Fuller MJ, 2013, P NATL ACAD SCI USA, V110, P15001, DOI 10.1073/pnas.1312772110; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Jones RB, 2016, J CLIN INVEST, V126, P455, DOI 10.1172/JCI80566; Kim HJ, 2011, SEMIN IMMUNOL, V23, P446, DOI 10.1016/j.smim.2011.06.001; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Kim PS, 2010, CURR OPIN IMMUNOL, V22, P223, DOI 10.1016/j.coi.2010.02.005; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Miles B, 2016, TRENDS MICROBIOL, V24, P338, DOI 10.1016/j.tim.2016.02.006; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Shaw LA, 2016, NAT IMMUNOL, V17, P834, DOI 10.1038/ni.3461; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Verdeil G., 2015, BIOCH BIOPHYS ACTA; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zehn D, 2016, CURR OPIN VIROL, V16, P49, DOI 10.1016/j.coviro.2016.01.002; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	37	360	370	6	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					412	+		10.1038/nature19317	http://dx.doi.org/10.1038/nature19317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27501245				2022-12-24	WOS:000383098000056
J	Smith, KR; Woodward, A; Lemke, B; Otto, M; Chang, CJ; Mance, AA; Balmes, J; Kjellstrom, T				Smith, Kirk R.; Woodward, Alistair; Lemke, Bruno; Otto, Matthias; Chang, Cindy J.; Mance, Anna A.; Balmes, John; Kjellstrom, Tord			The last Summer Olympics? Climate change, health, and work outdoors	LANCET			English	Editorial Material									[Smith, Kirk R.; Mance, Anna A.; Balmes, John] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Lemke, Bruno; Otto, Matthias] Nelson Marlborough Inst Technol, Digital Technol, Nelson, New Zealand; [Chang, Cindy J.] Univ Calif San Francisco, Dept Orthopaed, San Francisco, CA 94143 USA; [Chang, Cindy J.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Kjellstrom, Tord] Ctr Technol Res & Innovat, Limassol, Cyprus	University of California System; University of California Berkeley; University of Auckland; Nelson Marlborough Institute of Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Smith, KR (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	krksmith@berkeley.edu	Balmes, John/L-6281-2019	Mance, Anna/0000-0001-8658-7866				[Anonymous], 2014, HUMAN THERMAL ENV EF; [Anonymous], 2016, CLIM CHANG LAB IMP H; [Anonymous], 2016, TS3 23 CLIM RES UN T; Baxter K., 2016, LOS ANGELES TIMES; Brinkoff T., 2010, CITY POPULATION STAT; Butler SL, 2016, RUNNERS WORLD; Davey M., 2007, NY TIMES, pA1; Dunne JP, 2013, J CLIMATE, V26, P2247, DOI 10.1175/JCLI-D-12-00150.1; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; King D., 2015, CLIMATE CHANGE RISK; Kjellstrom T, 2016, ASIA-PAC J PUBLIC HE, V28, p28S, DOI 10.1177/1010539514568711; Kjellstrom T, 2009, GLOBAL HEALTH ACTION, V2, DOI [10.3402/gha.v2i0.1958, 10.3402/gha.v2i0.2047]; Meade RD, 2016, MED SCI SPORT EXER, V48, P1187, DOI 10.1249/MSS.0000000000000886; Roberts WO, 2010, MED SCI SPORT EXER, V42, P226, DOI 10.1249/MSS.0b013e3181b1cdcf; Scott D, 2014, FUTURE WINTER OLYMPI; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0157-y, 10.1007/s10584-011-0152-3]; Virgin C, 2016, VIRGIN RUNNING US MA; Woodward A, 2014, LANCET, V383, P1185, DOI 10.1016/S0140-6736(14)60576-6	18	38	38	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					642	644		10.1016/S0140-6736(16)31335-6	http://dx.doi.org/10.1016/S0140-6736(16)31335-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UX	27533426				2022-12-24	WOS:000381268700008
J	Fan, J; Leroux-Coyau, M; Avery, NJS; Strick, TR				Fan, Jun; Leroux-Coyau, Mathieu; Avery, Nigel J. S.; Strick, Terence R.			Reconstruction of bacterial transcription-coupled repair at single-molecule resolution	NATURE			English	Article							RNA-POLYMERASE; DNA-REPAIR; ESCHERICHIA-COLI; STRUCTURAL BASIS; NANOMANIPULATION; INITIATION; COMPLEXES; EXCINUCLEASE; MECHANISM; DAMAGE	Escherichia coli Mfd translocase enables transcription-coupled repair by displacing RNA polymerase (RNAP) stalled on a DNA lesion and then coordinating assembly of the UvrAB(C) components at the damage site(1-4.) Recent studies have shown that after binding to and dislodging stalled RNAP, Mfd remains on the DNA in the form of a stable, slowly translocating complex with evicted RNAP attached(5,6). Here we find, using a series of single-molecule assays, that recruitment of UvrA and UvrAB to Mfd-RNAP arrests the translocating complex and causes its dissolution. Correlative single-molecule nanomanipulation and fluorescence measurements show that dissolution of the complex leads to loss of both RNAP and Mfd. Subsequent DNA incision by UvrC is faster than when only UvrAB(C) are available, in part because UvrAB binds 20-200 times more strongly to Mfd-RNAP than to DNA damage. These observations provide a quantitative framework for comparing complementary DNA repair pathways in vivo.	[Fan, Jun; Leroux-Coyau, Mathieu; Strick, Terence R.] Univ Paris Diderot, CNRS, Inst Jacques Monod, Sorbonne Paris Cite,UMR7592, F-75205 Paris, France; [Avery, Nigel J. S.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol BS8 1TD, Avon, England; [Strick, Terence R.] PSL Res Univ, Ecole Normale Super, INSERM, CNRS,IBENS, F-75005 Paris, France; [Strick, Terence R.] Programme Equipe Labellisees Ligue Contre Canc, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Bristol; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Strick, TR (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, Sorbonne Paris Cite,UMR7592, F-75205 Paris, France.; Strick, TR (corresponding author), PSL Res Univ, Ecole Normale Super, INSERM, CNRS,IBENS, F-75005 Paris, France.; Strick, TR (corresponding author), Programme Equipe Labellisees Ligue Contre Canc, F-75013 Paris, France.	strick@biologie.ens.fr		Strick, Terence/0000-0003-1744-3679; Savery, Nigel/0000-0002-0803-4075; FAN, Jun/0000-0002-1433-7283; Leroux-Coyau, Mathieu/0000-0002-8299-7961	China Scholarship Council; French Agence Nationale pour la Recherche (RepOne); European Science Foundation (EURYI); CNRS; University of Paris Diderot	China Scholarship Council(China Scholarship Council); French Agence Nationale pour la Recherche (RepOne)(French National Research Agency (ANR)); European Science Foundation (EURYI)(European Science Foundation (ESF)); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Paris Diderot	This work was made possible by a China Scholarship Council award to J.F., as well as grants from the French Agence Nationale pour la Recherche (RepOne) and the European Science Foundation (EURYI) to T.R.S., as well as core funding from the CNRS and the University of Paris Diderot. The Strick laboratory is also part of the Programme Equipe Labellisees of the Ligue Contre le Cancer. We thank N. Joly for assistance with protein purification and the Strick laboratory for feedback.	Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Duboc C, 2016, METHODS, V105, P56, DOI 10.1016/j.ymeth.2016.03.028; Graves ET, 2015, NAT STRUCT MOL BIOL, V22, P452, DOI 10.1038/nsmb.3019; Haines NM, 2014, P NATL ACAD SCI USA, V111, P4037, DOI 10.1073/pnas.1322350111; Howan K, 2012, NATURE, V490, P431, DOI 10.1038/nature11430; Kou SC, 2005, J PHYS CHEM B, V109, P19068, DOI 10.1021/jp051490q; Manelyte L, 2010, MOL CELL, V40, P714, DOI 10.1016/j.molcel.2010.11.012; Manelyte L, 2009, DNA REPAIR, V8, P1300, DOI 10.1016/j.dnarep.2009.08.005; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Revyakin A, 2005, NAT METHODS, V2, P127, DOI 10.1038/nmeth0205-127; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2003, METHOD ENZYMOL, V370, P577; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Savery NJ, 2007, TRENDS MICROBIOL, V15, P326, DOI 10.1016/j.tim.2007.05.005; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1990, MUTAT RES, V236, P203, DOI 10.1016/0921-8777(90)90005-P; Smith AJ, 2007, NUCLEIC ACIDS RES, V35, P1802, DOI 10.1093/nar/gkm019; Smith AJ, 2005, NUCLEIC ACIDS RES, V33, P755, DOI 10.1093/nar/gki225; Srivastava DB, 2011, J MOL BIOL, V406, P275, DOI 10.1016/j.jmb.2010.12.004; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; van den Broek B, 2005, NUCLEIC ACIDS RES, V33, P2676, DOI 10.1093/nar/gki565; VANHOUTEN B, 1987, J BIOL CHEM, V262, P13180; Verhoeven EEA, 2001, EMBO J, V20, P601, DOI 10.1093/emboj/20.3.601; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Westblade LF, 2010, NUCLEIC ACIDS RES, V38, P8357, DOI 10.1093/nar/gkq692; WITKIN EM, 1966, SCIENCE, V152, P1345, DOI 10.1126/science.152.3727.1345	28	59	59	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					234	+		10.1038/nature19080	http://dx.doi.org/10.1038/nature19080			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487215	Green Submitted			2022-12-24	WOS:000381472100041
J	Tsementzi, D; Wu, JY; Deutsch, S; Nath, S; Rodriguez, LM; Burns, AS; Ranjan, P; Sarode, N; Malmstrom, RR; Padilla, CC; Stone, BK; Bristow, LA; Larsen, M; Glass, JB; Thamdrup, B; Woyke, T; Konstantinidis, KT; Stewart, FJ				Tsementzi, Despina; Wu, Jieying; Deutsch, Samuel; Nath, Sangeeta; Rodriguez-R, Luis M.; Burns, Andrew S.; Ranjan, Piyush; Sarode, Neha; Malmstrom, Rex R.; Padilla, Cory C.; Stone, Benjamin K.; Bristow, Laura A.; Larsen, Morten; Glass, Jennifer B.; Thamdrup, Bo; Woyke, Tanja; Konstantinidis, Konstantinos T.; Stewart, Frank J.			SAR11 bacteria linked to ocean anoxia and nitrogen loss	NATURE			English	Article							NITRITE-OXIDIZING BACTERIUM; 2ND NITRATE REDUCTASE; METAGENOMIC ANALYSIS; SEASONAL DYNAMICS; SINGLE-CELL; SEQUENCE; GENOME; IDENTIFICATION; QUALITY; GENES	Bacteria of the SAR11 clade constitute up to one half of all microbial cells in the oxygen-rich surface ocean. SAR11 bacteria are also abundant in oxygen minimum zones (OMZs), where oxygen falls below detection and anaerobic microbes have vital roles in converting bioavailable nitrogen to N-2 gas. Anaerobic metabolism has not yet been observed in SAR11, and it remains unknown how these bacteria contribute to OMZ biogeochemical cycling. Here, genomic analysis of single cells from the world's largest OMZ revealed previously uncharacterized SAR11 lineages with adaptations for life without oxygen, including genes for respiratory nitrate reductases (Nar). SAR11 nar genes were experimentally verified to encode proteins catalysing the nitrite-producing first step of denitrification and constituted similar to 40% of OMZ nar transcripts, with transcription peaking in the anoxic zone of maximum nitrate reduction activity. These results link SAR11 to pathways of ocean nitrogen loss, redefining the ecological niche of Earth's most abundant organismal group.	[Tsementzi, Despina; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Civil & Environm Engn, Ford Environm Sci & Technol Bldg,311 Ferst Dr, Atlanta, GA 30332 USA; [Wu, Jieying; Rodriguez-R, Luis M.; Burns, Andrew S.; Ranjan, Piyush; Sarode, Neha; Padilla, Cory C.; Konstantinidis, Konstantinos T.; Stewart, Frank J.] Georgia Inst Technol, Sch Biol Sci, Ford Environm Sci & Technol Bldg,311 Ferst Dr, Atlanta, GA 30332 USA; [Deutsch, Samuel; Nath, Sangeeta; Malmstrom, Rex R.; Woyke, Tanja] Dept Energy Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA; [Stone, Benjamin K.] Bowdoin Coll, Dept Biol, 255 Maine St, Brunswick, ME 04011 USA; [Bristow, Laura A.] Max Planck Inst Marine Microbiol, Biochem Grp, D-28359 Bremen, Germany; [Larsen, Morten; Thamdrup, Bo] Univ Southern Denmark, Dept Biol, Campusvej 55, DK-5230 Odense M, Denmark; [Larsen, Morten; Thamdrup, Bo] Univ Southern Denmark, Nord Ctr Earth Evolut NordCEE, Campusvej 55, DK-5230 Odense M, Denmark; [Glass, Jennifer B.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Ford Environm Sci & Technol Bldg,311 Ferst Dr, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Bowdoin College; Max Planck Society; University of Southern Denmark; University of Southern Denmark; University System of Georgia; Georgia Institute of Technology	Stewart, FJ (corresponding author), Georgia Inst Technol, Sch Biol Sci, Ford Environm Sci & Technol Bldg,311 Ferst Dr, Atlanta, GA 30332 USA.	frank.stewart@biology.gatech.edu	ranjan, piyush/AAI-8587-2020; Rodriguez-R, Luis M./S-6996-2018; Glass, Jennifer/H-5363-2018; Konstantinidis, Kostas/ABE-7113-2020	Rodriguez-R, Luis M./0000-0001-7603-3093; Glass, Jennifer/0000-0003-0775-2486; Konstantinidis, Kostas/0000-0002-0954-4755; Tsementzi, Despina/0000-0002-4578-1918; Ranjan, Piyush/0000-0001-8293-6889; Malmstrom, Rex/0000-0002-4758-7369; Deutsch, Samuel/0000-0001-9456-7101; Bristow, Laura/0000-0003-4865-070X; Stone, Benjamin/0000-0003-3430-6756	National Science Foundation [1151698, 1416673]; NASA Exobiology Program [NNX14AJ87G]; Sloan Foundation [RC944]; Community Science Program grant from the Department of Energy (DOE); European Research Council [267233]; Danish National Research Foundation [DNRF53]; Onassis Foundation Fellowship;  [DE-AC02-05CH11231]; Directorate For Geosciences [1151698] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); Sloan Foundation(Alfred P. Sloan Foundation); Community Science Program grant from the Department of Energy (DOE)(United States Department of Energy (DOE)); European Research Council(European Research Council (ERC)European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Onassis Foundation Fellowship; ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation (1151698 to F.J.S. and 1416673 to K.T.K.), the NASA Exobiology Program (NNX14AJ87G to J.B.G. and F.J.S.), the Sloan Foundation (RC944 to F.J.S.), and a Community Science Program grant from the Department of Energy (DOE; to F.J.S. and K.T.K.). The work conducted by the US DOE Joint Genome Institute, a DOE Office of Science User Facility, is supported under contract no. DE-AC02-05CH11231. L.A.B., M.L. and B.T. were supported by a European Research Council Advanced Grant (OXYGEN, 267233) and by the Danish National Research Foundation (DNRF53). D.T. acknowledges the support of Onassis Foundation Fellowship. We are grateful for the generosity of J. Cole, A. Magalon, C. Sohaskey and F. Sargent for providing E. coli mutant strains, S. Pavlostathis for the ion chromatography methods and J. Spain for his suggestions on the heterologous expression experiment.	Alberge F, 2015, ELIFE, V4, DOI 10.7554/eLife.05357; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bender KS, 2005, J BACTERIOL, V187, P5090, DOI 10.1128/JB.187.15.5090-5096.2005; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dalsgaard T, 2014, MBIO, V5, DOI 10.1128/mBio.01966-14; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Eiler A, 2009, ENVIRON MICROBIOL, V11, P2291, DOI 10.1111/j.1462-2920.2009.01954.x; Ganesh S, 2015, ISME J, V9, P2682, DOI 10.1038/ismej.2015.44; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glass JB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00998; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; Hajaya MG, 2012, BIORESOURCE TECHNOL, V118, P73, DOI 10.1016/j.biortech.2012.05.050; IOBBI C, 1987, EUR J BIOCHEM, V168, P451, DOI 10.1111/j.1432-1033.1987.tb13438.x; IOBBINIVOL C, 1990, EUR J BIOCHEM, V188, P679, DOI 10.1111/j.1432-1033.1990.tb15450.x; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/NGEO1739, 10.1038/ngeo1739]; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Khlebnikov A, 2002, BIOTECHNOL PROGR, V18, P672, DOI 10.1021/bp010141k; King GM, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00438; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Luke C, 2016, PEERJ, V4, DOI 10.7717/peerj.1924; Luo CW, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku169; Luo HW, 2015, ISME J, V9, P1423, DOI 10.1038/ismej.2014.227; Martinez-Espinosa RM, 2007, FEMS MICROBIOL LETT, V276, P129, DOI 10.1111/j.1574-6968.2007.00887.x; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Philippot L, 2002, BBA-GENE STRUCT EXPR, V1577, P355, DOI 10.1016/S0167-4781(02)00420-7; Potter LC, 1999, BIOCHEM J, V344, P77, DOI 10.1042/0264-6021:3440077; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rodriguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Salter I, 2015, ISME J, V9, P347, DOI 10.1038/ismej.2014.129; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sorokin DY, 2012, ISME J, V6, P2245, DOI 10.1038/ismej.2012.70; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starkenburg SR, 2006, APPL ENVIRON MICROB, V72, P2050, DOI 10.1128/AEM.72.3.2050-2063.2006; Stewart FJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r26; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Takami H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030559; Thrash JC, 2014, ISME J, V8, P1440, DOI 10.1038/ismej.2013.243; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Tiano L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105399; Tripp HJ, 2013, J MICROBIOL, V51, P147, DOI 10.1007/s12275-013-2671-2; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Vergin KL, 2013, ISME J, V7, P1322, DOI 10.1038/ismej.2013.32; Viklund J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078858; Yoshimatsu K, 2002, FEBS LETT, V516, P145, DOI 10.1016/S0014-5793(02)02524-3; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	76	92	94	4	139	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					179	+		10.1038/nature19068	http://dx.doi.org/10.1038/nature19068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487207	Green Accepted, Green Submitted			2022-12-24	WOS:000381472100029
J	Anderson, TM; Garcia, AJ; Baertsch, NA; Pollak, J; Bloom, JC; Wei, AD; Rai, KG; Ramirez, JM				Anderson, Tatiana M.; Garcia, Alfredo J., III; Baertsch, Nathan A.; Pollak, Julia; Bloom, Jacob C.; Wei, Aguan D.; Rai, Karan G.; Ramirez, Jan-Marino			A novel excitatory network for the control of breathing	NATURE			English	Article							RESPIRATORY RHYTHM; FUNCTIONAL ARCHITECTURE; NEURONAL CONTROL; COMPLEX; RECONFIGURATION; EXPIRATION; MEDULLA; MICE	Breathing must be tightly coordinated with other behaviours such as vocalization, swallowing, and coughing. These behaviours occur after inspiration, during a respiratory phase termed postinspiration(1). Failure to coordinate postinspiration with inspiration can result in aspiration pneumonia, the leading cause of death in Alzheimer's disease, Parkinson's disease, dementia, and other neurodegenerative diseases(2). Here we describe an excitatory network that generates the neuronal correlate of postinspiratory activity in mice. Glutamatergic-cholinergic neurons form the basis of this network, and GABA (gamma-aminobutyric acid)-mediated inhibition establishes the timing and coordination relative to inspiration. We refer to this network as the postinspiratory complex (PiCo). The PiCo has autonomous rhythm-generating properties and is necessary and sufficient for postinspiratory activity in vivo. The PiCo also shows distinct responses to neuromodulators when compared to other excitatory brainstem networks. On the basis of the discovery of the PiCo, we propose that each of the three phases of breathing is generated by a distinct excitatory network: the pre-Botzinger complex, which has been linked to inspiration(3,4); the PiCo, as described here for the neuronal control of postinspiration; and the lateral parafacial region (pF(L)), which has been associated with active expiration, a respiratory phase that is recruited during high metabolic demand(4,5).	[Anderson, Tatiana M.; Garcia, Alfredo J., III; Baertsch, Nathan A.; Pollak, Julia; Bloom, Jacob C.; Wei, Aguan D.; Rai, Karan G.; Ramirez, Jan-Marino] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Anderson, Tatiana M.] Univ Washington, Sch Med, Grad Program Neurosci, Seattle, WA 98195 USA; [Ramirez, Jan-Marino] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98105 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramirez, JM (corresponding author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA.; Ramirez, JM (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98105 USA.	nino1@uw.edu	Baertsch, Nathan A/C-6325-2013	Anderson, Tatiana/0000-0002-5464-9409; Ramirez, Jan-Marino/0000-0002-5626-3999	National Institute of Health [NS087828-01, HL090554, HL126523-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090554, R01HL126523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS087828] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the National Institute of Health NS087828-01 (to T.M.A.), HL090554 (to J.-M.R.), and HL126523-01 (to J.-M.R.). We thank P. Gray for insights provided throughout the preparation of this manuscript, T. Dashevskiy for creating the heat map of postinspiratory activity, F. Bedogni for obtaining in situ hybridization reagents, and K. Cuthill for cryosectioning. J.-M.R. also thanks D. W. Richter and S. W. Schwarzacher for the inspiration to study postinspiration.	Alheid GF, 2008, RESP PHYSIOL NEUROBI, V164, P3, DOI 10.1016/j.resp.2008.07.014; Burke PGR, 2010, NEUROSCIENCE, V167, P528, DOI 10.1016/j.neuroscience.2010.01.065; Doi A, 2010, J NEUROSCI, V30, P8251, DOI 10.1523/JNEUROSCI.5361-09.2010; Dutschmann M, 2006, EUR J NEUROSCI, V24, P1071, DOI 10.1111/j.1460-9568.2006.04981.x; Evans JA, 2010, BEHAV NEUROSCI, V124, P87, DOI 10.1037/a0018088; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gray PA, 2010, J NEUROSCI, V30, P14883, DOI 10.1523/JNEUROSCI.4031-10.2010; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hilaire G, 2004, RESP PHYSIOL NEUROBI, V143, P187, DOI 10.1016/j.resp.2004.04.016; Hill AA, 2011, J NEUROPHYSIOL, V105, P625, DOI 10.1152/jn.00237.2010; Hirata T, 2009, NAT NEUROSCI, V12, P141, DOI 10.1038/nn.2241; Huckstepp RTR, 2015, J NEUROSCI, V35, P1052, DOI 10.1523/JNEUROSCI.2953-14.2015; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; ONIMARU H, 1989, EXP BRAIN RES, V76, P530, DOI 10.1007/BF00248909; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; Richter DW, 2014, PHYSIOLOGY, V29, P58, DOI 10.1152/physiol.00035.2013; Ruangkittisakul A, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12111; Smith JC, 2007, J NEUROPHYSIOL, V98, P3370, DOI 10.1152/jn.00985.2007; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Stein PSG, 2005, J COMP PHYSIOL A, V191, P213, DOI 10.1007/s00359-004-0568-6; Subramanian HH, 2011, J NEUROPHYSIOL, V105, P2852, DOI 10.1152/jn.00168.2011; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Telgkamp P, 2002, J NEUROPHYSIOL, V88, P206, DOI 10.1152/jn.2002.88.1.206; Troche MS, 2014, J APPL ORAL SCI, V22, P251, DOI 10.1590/1678-775720140132; Wiggin TD, 2012, J NEUROPHYSIOL, V108, P925, DOI 10.1152/jn.00233.2012	30	123	123	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					76	+		10.1038/nature18944	http://dx.doi.org/10.1038/nature18944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27462817	Green Accepted			2022-12-24	WOS:000380999200033
J	Levine, DM; Lipsitz, SR; Linder, JA				Levine, David M.; Lipsitz, Stuart R.; Linder, Jeffrey A.			Trends in Seniors' Use of Digital Health Technology in the United States, 2011-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Levine, David M.; Lipsitz, Stuart R.; Linder, Jeffrey A.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Levine, DM (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 1620 Tremont St,Third Floor, Boston, MA 02120 USA.	dmlevine@partners.org	Linder, Jeffrey/AAF-3424-2021	Linder, Jeffrey/0000-0003-2217-184X	PHS HHS [T32HP10251] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Care Innovations, OLD POP HAV AD TECHN; Centers for Medicare & Medicaid Services, NAT HLTH EXP FACT SH; Fox Susannah, 2013, INFORM TRIAGE; Gordon NP, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5105; Greysen SR, 2014, JAMA INTERN MED, V174, P1188, DOI 10.1001/jamainternmed.2014.1864; National Health and Aging Trends Study, NHATS DAT COLL PROC	6	112	112	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					538	540		10.1001/jama.2016.9124	http://dx.doi.org/10.1001/jama.2016.9124			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27483069	Bronze			2022-12-24	WOS:000381075000022
J	Lei, J; Hansen, G; Nitsche, C; Klein, CD; Zhang, LL; Hilgenfeld, R				Lei, Jian; Hansen, Guido; Nitsche, Christoph; Klein, Christian D.; Zhang, Linlin; Hilgenfeld, Rolf			Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor	SCIENCE			English	Article							NS3 PROTEASE; DENGUE	The ongoing Zika virus (ZIKV) outbreak is linked to severe neurological disorders. ZIKV relies on its NS2B/NS3 protease for polyprotein processing; hence, this enzyme is an attractive drug target. The 2.7 angstrom crystal structure of ZIKV protease in complex with a peptidomimetic boronic acid inhibitor reveals a cyclic diester between the boronic acid and glycerol. The P2 4-aminomethylphenylalanine moiety of the inhibitor forms a salt-bridge with the nonconserved Asp(83) of NS2B; ion-pairing between Asp(83) and the P2 residue of the substrate likely accounts for the enzyme's high catalytic efficiency. The unusual dimer of the ZIKV protease: inhibitor complex seen in the crystal may provide a model for assemblies formed at high local concentrations of protease at the endoplasmatic reticulum membrane, the site of polyprotein processing.	[Lei, Jian; Hansen, Guido; Zhang, Linlin; Hilgenfeld, Rolf] Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, Ratzeburger Allee 160, D-23562 Lubeck, Germany; [Lei, Jian; Zhang, Linlin; Hilgenfeld, Rolf] Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, Lubeck, Germany; [Nitsche, Christoph; Klein, Christian D.] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Med Chem, Neuenheimer Feld 364, D-69120 Heidelberg, Germany; [Nitsche, Christoph] Australian Natl Univ, Sch Chem, Canberra, ACT 2601, Australia	University of Lubeck; German Center for Infection Research; University of Lubeck; Ruprecht Karls University Heidelberg; Australian National University	Hilgenfeld, R (corresponding author), Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, Ratzeburger Allee 160, D-23562 Lubeck, Germany.; Hilgenfeld, R (corresponding author), Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, Lubeck, Germany.	hilgenfeld@biochem.uni-luebeck.de	Nitsche, Christoph/GLT-6287-2022; Hansen, Guido/B-8859-2013	Hansen, Guido/0000-0003-3737-5749; Lei, Jian/0000-0001-9394-8236; Klein, Christian/0000-0003-3522-9182; Nitsche, Christoph/0000-0002-3704-2699; Lei, Jian/0000-0001-9326-0554	German Center for Infection Research [DZIF-TTU01, 8011801911]; Deutsche Forschungsgemeinschaft [KL-1356/3-1]	German Center for Infection Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank S. Zoske and Y. Gul for assistance, S. Anemuller for recording the mass spectra, L. Weigel for the synthesis of precursors of cn-716, and D. Graf for testing this compound for cytotoxicity. We are indebted to the staff of synchrotron beamlines BL 14.1 (BESSY, Berlin) and P11 (DESY, Hamburg) for support. The corresponding coordinates and structure factors are available from the PDB under accession code 5LC0. Funding from the German Center for Infection Research (DZIF-TTU01, grant 8011801911) is gratefully acknowledged. C.D.K. thanks the Deutsche Forschungsgemeinschaft for financial support (KL-1356/3-1).	Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Kuroda D, 2016, BIOINFORMATICS, V32, P2451, DOI 10.1093/bioinformatics/btw197; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014; Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Turker L, 2006, INDIAN J CHEM A, V45, P1339; Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062	16	231	241	4	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					503	505		10.1126/science.aag2419	http://dx.doi.org/10.1126/science.aag2419			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27386922	Green Published			2022-12-24	WOS:000380583600045
J	Almeida, RPP				Almeida, Rodrigo P. P.			Can Apulia's olive trees be saved?	SCIENCE			English	Editorial Material							XYLELLA-FASTIDIOSA; HEALTH; RISK		[Almeida, Rodrigo P. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Almeida, RPP (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	rodrigoalmeida@berkeley.edu	Almeida, Rodrigo/GZH-0682-2022	Almeida, Rodrigo/0000-0003-2888-9617				Abbott A., 2015, NATURE, DOI [10.1038/nature.2015.19078, DOI 10.1038/NATURE.2015.19078]; Abbott A, 2016, NATURE, V533, P299, DOI 10.1038/533299a; Baker R, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3989; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; EFSA, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4061; European and Mediterranean Plant Protection Organization (EPPO), 2012, 1061 EPPO; Giampetruzzi A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2833-9; Mills P, 2011, PHILOS T R SOC B, V366, P2035, DOI 10.1098/rstb.2010.0411; Paini DR, 2016, P NATL ACAD SCI USA, V113, P7575, DOI 10.1073/pnas.1602205113; Saponari M., 2016, EFSA SUPPORTING PUBL; Stokstad E, 2015, SCIENCE, V348, P621; Wingfield MJ, 2015, SCIENCE, V349, P832, DOI 10.1126/science.aac6674	12	41	41	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2016	353	6297					346	348		10.1126/science.aaf9710	http://dx.doi.org/10.1126/science.aaf9710			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HB	27463657	Green Submitted			2022-12-24	WOS:000380583400020
J	Dong, R; Saheki, Y; Swarup, S; Lucast, L; Harper, JW; De Camilli, P				Dong, Rui; Saheki, Yasunori; Swarup, Sharan; Lucast, Louise; Harper, J. Wade; De Camilli, Pietro			Endosome-ER Contacts Control Actin Nucleation and Retromer Function through VAP-Dependent Regulation of PI4P	CELL			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; WASH COMPLEX; PHOSPHATIDYLINOSITOL 4-KINASE; RETROGRADE TRANSPORT; ARP2/3 ACTIVATOR; PROTEIN VAP; BINDING; TRAFFICKING; RECRUITMENT	VAP ( VAPA and VAPB) is an evolutionarily conserved endoplasmic reticulum ( ER)-anchored protein that helps generate tethers between the ER and other membranes through which lipids are exchanged across adjacent bilayers. Here, we report that by regulating PI4P levels on endosomes, VAP affects WASH-dependent actin nucleation on these organelles and the function of the retromer, a protein coat responsible for endosome-to-Golgi traffic. VAP is recruited to retromer budding sites on endosomes via an interaction with the retromer SNX2 subunit. Cells lacking VAP accumulate high levels of PI4P, actin comets, and trans-Golgi proteins on endosomes. Such defects are mimicked by downregulation of OSBP, a VAP interactor and PI4P transporter that participates in VAP-dependent ER-endosomes tethers. These results reveal a role of PI4P in retromer-/WASH-dependent budding from endosomes. Collectively, our data show how the ER can control budding dynamics and association with the cytoskeleton of another membrane by direct contacts leading to bilayer lipid modifications.	[Dong, Rui; Saheki, Yasunori; Lucast, Louise; De Camilli, Pietro] Yale Univ, Sch Med, Dept Neurosci, 333 Cedar St, New Haven, CT 06510 USA; [Dong, Rui; Saheki, Yasunori; Lucast, Louise; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Dong, Rui; Saheki, Yasunori; Lucast, Louise; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Dong, Rui; Saheki, Yasunori; Lucast, Louise; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, 333 Cedar St, New Haven, CT 06510 USA; [Swarup, Sharan; Harper, J. Wade] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Saheki, Yasunori] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Harvard University; Harvard Medical School; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Dept Neurosci, 333 Cedar St, New Haven, CT 06510 USA.; De Camilli, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.; De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.; De Camilli, P (corresponding author), Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA.; De Camilli, P (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, 333 Cedar St, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Saheki, Yasunori/D-5430-2016	Saheki, Yasunori/0000-0002-1229-6668; Harper, Jeffrey/0000-0002-6944-7236; Dong, Rui/0000-0002-9118-3636	NIH [R37NS036251, DK45735, DA018343, DK082700, R37NS083524]; Harvard Brain Institute ALS Seed Grant Program; Biogen Idec ALS consortium; CSC-Yale World Scholars Program scholarship; Japan Society for the Promotion of Science; Canadian Institutes for Health Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK082700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS083524, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Brain Institute ALS Seed Grant Program; Biogen Idec ALS consortium; CSC-Yale World Scholars Program scholarship; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Christopher Burd, Shawn Ferguson, and Jeeyun Chung for reading of the manuscript and discussion, Tim Levine (UCL, London) for sharing information about the FFAT consensus prior to its publication, and Cameron Godecke (Yale Cell Sorting Core Facility) for help in cell sorting. This work was supported in part by grants from the NIH (R37NS036251, DK45735, DA018343 and DK082700 to P.D.C. and R37NS083524 to J.W.H.), by the Harvard Brain Institute ALS Seed Grant Program to J.W.H., by the Biogen Idec ALS consortium to P.D.C. and J.W.H., by a CSC-Yale World Scholars Program scholarship to R.D., a postdoctoral fellowship from the Japan Society for the Promotion of Science to Y.S., and by a post-doctoral fellowship from Canadian Institutes for Health Research to S.S.	Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Bojjireddy N, 2014, J BIOL CHEM, V289, P6120, DOI 10.1074/jbc.M113.531426; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Burgess J, 2012, DEVELOPMENT, V139, P3040, DOI 10.1242/dev.077644; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Dickson EJ, 2016, J CELL BIOL, V213, P33, DOI 10.1083/jcb.201508106; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Hammond GRV, 2015, BBA-MOL CELL BIOL L, V1851, P746, DOI 10.1016/j.bbalip.2015.02.013; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Henmi Y, 2016, MOL BIOL CELL, V27, P990, DOI 10.1091/mbc.E15-08-0564; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Kabashi E, 2013, HUM MOL GENET, V22, P2350, DOI 10.1093/hmg/ddt080; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim S, 2010, J BIOL CHEM, V285, P13839, DOI 10.1074/jbc.M109.097345; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lahiri S, 2015, CURR OPIN CELL BIOL, V33, P82, DOI 10.1016/j.ceb.2014.12.004; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Luo X, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004965; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Merrifield CJ, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016733; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Messa M, 2014, ELIFE, V3, DOI 10.7554/eLife.03311; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Nandez R, 2014, ELIFE, V3, DOI 10.7554/eLife.02975; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Olkkonen VM, 2004, BIOCHEM CELL BIOL, V82, P87, DOI 10.1139/o03-088; Papiani G, 2012, J CELL SCI, V125, P3601, DOI 10.1242/jcs.102137; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Ryder PV, 2013, MOL BIOL CELL, V24, P2269, DOI 10.1091/mbc.E13-02-0088; Saheki Y, 2016, NAT CELL BIOL, V18, P504, DOI 10.1038/ncb3339; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schaub BE, 2006, MOL BIOL CELL, V17, P5153, DOI 10.1091/mbc.E06-08-0665; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Valdmanis PN, 2007, AM J HUM GENET, V80, P152, DOI 10.1086/510782; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Zavodszky E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4828	62	217	220	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					408	423		10.1016/j.cell.2016.06.037	http://dx.doi.org/10.1016/j.cell.2016.06.037			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27419871	Bronze, Green Accepted			2022-12-24	WOS:000380255400018
J	Ley, RE; Gewirtz, AT				Ley, Ruth E.; Gewirtz, Andrew T.			Corralling Colonic Flagellated Microbiota	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERACT; GUT		[Ley, Ruth E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Ley, Ruth E.] Max Planck Inst Dev Biol, Dept Microbiome Sci, Tubingen, Germany; [Gewirtz, Andrew T.] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA	Cornell University; Max Planck Society; University System of Georgia; Georgia State University	Ley, RE (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA.; Ley, RE (corresponding author), Max Planck Inst Dev Biol, Dept Microbiome Sci, Tubingen, Germany.		Ley, Ruth E/M-8542-2014	Ley, Ruth E/0000-0002-9087-1672				Carvalho FA, 2012, ANNU REV PHYSIOL, V74, P177, DOI 10.1146/annurev-physiol-020911-153330; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Okumura R, 2016, NATURE, V532, P117, DOI 10.1038/nature17406; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182	5	6	6	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2016	375	1					85	87		10.1056/NEJMcibr1604801	http://dx.doi.org/10.1056/NEJMcibr1604801			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ1ZP	27406353				2022-12-24	WOS:000379000200011
J	Gao, H; Chakraborty, G; Zhang, ZG; Akalay, I; Gadiya, M; Gao, YQ; Sinha, S; Hu, J; Jiang, CZ; Akram, M; Brogi, E; Leitinger, B; Giancotti, FG				Gao, Hua; Chakraborty, Goutam; Zhang, Zhanguo; Akalay, Intissar; Gadiya, Mayur; Gao, Yaquan; Sinha, Surajit; Hu, Jian; Jiang, Cizhong; Akram, Muzaffar; Brogi, Edi; Leitinger, Birgit; Giancotti, Filippo G.			Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling	CELL			English	Article							L6 ANTIGEN; CANCER; ACTIVATION; MECHANISMS; PROTEIN; INHIBITION; DORMANCY; TARGET; CELLS; BONE	Genetic screening identifies the atypical tetraspanin TM4SF1 as a strong mediator of metastatic reactivation of breast cancer. Intriguingly, TM4SF1 couples the collagen receptor tyrosine kinase DDR1 to the cortical adaptor syntenin 2 and, hence, to PKC alpha. The latter kinase phosphorylates and activates JAK2, leading to the activation of STAT3. This non-canonical mechanism of signaling induces the expression of SOX2 and NANOG; sustains the manifestation of cancer stem cell traits; and drives metastatic reactivation in the lung, bone, and brain. Bioinformatic analyses and pathological studies corroborate the clinical relevance of these findings. We conclude that non-canonical DDR1 signaling enables breast cancer cells to exploit the ubiquitous interstitial matrix component collagen I to undergo metastatic reactivation in multiple target organs.	[Gao, Hua; Gao, Yaquan] Tongji Univ, Shanghai East Hosp, Res Ctr Translat Med,Metastasis Res Inst, Key Lab Arrhythmias,Minist Educ China,Breast Canc, Shanghai 200092, Peoples R China; [Gao, Hua; Gao, Yaquan] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China; [Gao, Hua; Chakraborty, Goutam; Zhang, Zhanguo; Akalay, Intissar; Gadiya, Mayur; Sinha, Surajit; Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Gao, Hua; Chakraborty, Goutam; Zhang, Zhanguo; Akalay, Intissar; Gadiya, Mayur; Sinha, Surajit; Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Ctr Metastasis Res, Sloan Kettering Inst Canc Res, New York, NY 10065 USA; [Gadiya, Mayur] Cornell Univ, Weill Cornell Grad Sch Med Sci, Sloan Kettering Div, New York, NY 10065 USA; [Hu, Jian; Jiang, Cizhong] Tongji Univ, Collaborat Innovat Ctr Brain Sci, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China; [Akram, Muzaffar; Brogi, Edi] Mem Hosp, Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Leitinger, Birgit] Imperial Coll London, Natl Heart & Lung Inst, Mol Med Sect, London SW7 2AZ, England; [Giancotti, Filippo G.] UT MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77054 USA; [Giancotti, Filippo G.] UT MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Houston, TX 77054 USA; [Zhang, Zhanguo] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan 430030, Peoples R China	Ministry of Education, China; Tongji University; Tongji University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Tongji University; Memorial Sloan Kettering Cancer Center; Imperial College London; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Huazhong University of Science & Technology	Gao, H (corresponding author), Tongji Univ, Shanghai East Hosp, Res Ctr Translat Med,Metastasis Res Inst, Key Lab Arrhythmias,Minist Educ China,Breast Canc, Shanghai 200092, Peoples R China.; Gao, H (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China.; Gao, H; Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA.; Gao, H; Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Metastasis Res, Sloan Kettering Inst Canc Res, New York, NY 10065 USA.; Giancotti, FG (corresponding author), UT MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77054 USA.; Giancotti, FG (corresponding author), UT MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Houston, TX 77054 USA.	gaoh@tongji.edu.cn; fggiancotti@mdanderson.org	SINHA, SURAJIT/AAE-9200-2020; Chakraborty, Goutam/U-5559-2019; Gadiya, Mayur/ABB-3418-2020	Gao, Hua/0000-0002-9698-5830	NIH [R01 CA175712, R35 CA197566, P01 CA094060]; Geoffrey Beene Cancer Center of MSKCC; National Basic Research program of China (973 Program) [2015CB964800]; National Natural Science Foundation of China [81372840]; One Thousand Talents Program of Shanghai [SH04020]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81221001]; Program for Professors of Special Appointment at Shanghai Institutions of Higher Learning; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA175712, P30CA008748, R35CA197566, P01CA094060] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Cancer Center of MSKCC; National Basic Research program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Thousand Talents Program of Shanghai; Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professors of Special Appointment at Shanghai Institutions of Higher Learning; China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Levine, J. Massague, C. McCilloch, F. Miller, and M.J. Tang for reagents, A. Barlas, N. Fan, and M. Turkekul for help with some of the staining experiments, H. Erdjument-Bromage for mass spectrometric analyses, the staff of the Genomics Core and the Molecular Cytology Core of MSKCC for their services, and members of the Giancotti laboratory for discussions. This work was supported primarily by grants from the NIH (R01 CA175712, R35 CA197566, and P01 CA094060 Project 4, to F.G.G.). Additional funding was provided by the Geoffrey Beene Cancer Center of MSKCC (to F.G.G.), the National Basic Research program of China (973 Program, 2015CB964800, to H.G.), the National Natural Science Foundation of China (81372840, to H.G.) and the One Thousand Talents Program of Shanghai (SH04020, to H.G.), and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81221001). H.G. received an Eastern Scholarship from the Program for Professors of Special Appointment at Shanghai Institutions of Higher Learning (2013-14), and Z.Z. was partially supported by the China Scholarship Council.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Borrell-Pages M, 2000, MOL BIOL CELL, V11, P4217, DOI 10.1091/mbc.11.12.4217; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Canning P, 2014, J MOL BIOL, V426, P2457, DOI 10.1016/j.jmb.2014.04.014; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Gao D, 2015, CURR OPIN GENET DEV, V30, P42, DOI 10.1016/j.gde.2015.02.007; Gao H, 2014, P NATL ACAD SCI USA, V111, P16532, DOI 10.1073/pnas.1403234111; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Ghajar CM, 2015, NAT REV CANCER, V15, P238, DOI 10.1038/nrc3910; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; HELLSTROM I, 1986, P NATL ACAD SCI USA, V83, P7059, DOI 10.1073/pnas.83.18.7059; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; MARKEN JS, 1992, P NATL ACAD SCI USA, V89, P3503, DOI 10.1073/pnas.89.8.3503; MARKEN JS, 1994, J BIOL CHEM, V269, P7397; Mihai C, 2009, J MOL BIOL, V385, P432, DOI 10.1016/j.jmb.2008.10.067; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sarkar D, 2008, CANCER RES, V68, P3087, DOI 10.1158/0008-5472.CAN-07-6210; Shan YB, 2014, NAT STRUCT MOL BIOL, V21, P579, DOI 10.1038/nsmb.2849; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Toms AV, 2013, NAT STRUCT MOL BIOL, V20, P1221, DOI 10.1038/nsmb.2673; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhao D, 2015, ONCOGENE, V34, P3107, DOI 10.1038/onc.2014.257	42	143	146	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					47	62		10.1016/j.cell.2016.06.009	http://dx.doi.org/10.1016/j.cell.2016.06.009			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368100	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000380254400010
J	Ainsworth, TD; Gates, RD				Ainsworth, Tracy D.; Gates, Ruth D.			Corals' microbial sentinels The coral microbiome will be key to future reef health	SCIENCE			English	Editorial Material									[Ainsworth, Tracy D.] James Cook Univ, IARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Gates, Ruth D.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA	James Cook University; University of Hawaii System; University of Hawaii Manoa	Ainsworth, TD (corresponding author), James Cook Univ, IARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	tracy.ainsworth@jcu.edu.au	Ainsworth, Tracy D/L-7309-2016	Ainsworth, Tracy D/0000-0001-6476-9263				Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Glasl B, 2016, ISME J, V10, P2280, DOI 10.1038/ismej.2016.9; Goodrich JK, 2016, SCIENCE, V352, P532, DOI 10.1126/science.aad9379; Knowlton N, 2015, CORAL REEFS ANTHROPO, P117, DOI DOI 10.1007/978-94-017-7249-5_6; Krause S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00251; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Meyer JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100316; Ogawa D., 2014, THESIS; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; van de Leemput IA, 2016, CORAL REEFS, V35, P857, DOI 10.1007/s00338-016-1439-7; Zaneveld JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11833; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163	15	50	50	9	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1518	1519		10.1126/science.aad9957	http://dx.doi.org/10.1126/science.aad9957			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339969				2022-12-24	WOS:000378346500020
J	Pacheco, O; Beltran, M; Nelson, CA; Valencia, D; Tolosa, N; Farr, SL; Padilla, AV; Tong, VT; Cuevas, EL; Espinosa-Bode, A; Pardo, L; Rico, A; Reefhuis, J; Gonzalez, M; Mercado, M; Chaparro, P; Duran, MM; Rao, CY; Munoz, MM; Powers, AM; Cuellar, C; Helfand, R; Huguett, C; Jamieson, DJ; Honein, MA; Martinez, MLO				Pacheco, Oscar; Beltran, Mauricio; Nelson, Christina A.; Valencia, Diana; Tolosa, Natalia; Farr, Sherry L.; Padilla, Ana V.; Tong, Van T.; Cuevas, Esther L.; Espinosa-Bode, Andres; Pardo, Lissethe; Rico, Angelica; Reefhuis, Jennita; Gonzalez, Maritza; Mercado, Marcela; Chaparro, Pablo; Martinez Duran, Mancel; Rao, Carol Y.; Munoz, Maria M.; Powers, Ann M.; Cuellar, Claudia; Helfand, Rita; Huguett, Claudia; Jamieson, Denise J.; Honein, Margaret A.; Ospina Martinez, Martha L.			Zika Virus Disease in Colombia - Preliminary Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; TRANSMISSION	BACKGROUND Colombia began official surveillance for Zika virus disease (ZVD) in August 2015. In October 2015, an outbreak of ZVD was declared after laboratory-confirmed disease was identified in nine patients. METHODS Using the national population-based surveillance system, we assessed patients with clinical symptoms of ZVD from August 9, 2015, to April 2, 2016. Laboratory test results and pregnancy outcomes were evaluated for a subgroup of pregnant women. Concurrently, we investigated reports of microcephaly for evidence of congenital ZVD. RESULTS By April 2, 2016, there were 65,726 cases of ZVD reported in Colombia, of which 2485 (4%) were confirmed by means of reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay. The overall reported incidence of ZVD among female patients was twice that in male patients. A total of 11,944 pregnant women with ZVD were reported in Colombia, with 1484 (12%) of these cases confirmed on RT-PCR assay. In a subgroup of 1850 pregnant women, more than 90% of women who were reportedly infected during the third trimester had given birth, and no infants with apparent abnormalities, including microcephaly, have been identified. A majority of the women who contracted ZVD in the first or second trimester were still pregnant at the time of this report. Among the cases of microcephaly investigated from January 2016 through April 2016, four patients had laboratory evidence of congenital ZVD; all were born to asymptomatic mothers who were not included in the ZVD surveillance system. CONCLUSIONS Preliminary surveillance data in Colombia suggest that maternal infection with the Zika virus during the third trimester of pregnancy is not linked to structural abnormalities in the fetus. However, the monitoring of the effect of ZVD on pregnant women in Colombia is ongoing.	[Pacheco, Oscar; Beltran, Mauricio; Tolosa, Natalia; Padilla, Ana V.; Cuevas, Esther L.; Pardo, Lissethe; Rico, Angelica; Gonzalez, Maritza; Mercado, Marcela; Chaparro, Pablo; Martinez Duran, Mancel; Huguett, Claudia; Ospina Martinez, Martha L.] Inst Nacl Salud, Bogota, Colombia; [Munoz, Maria M.; Cuellar, Claudia] Minist Salud & Protecc Social, Bogota, Colombia; [Nelson, Christina A.; Valencia, Diana; Farr, Sherry L.; Tong, Van T.; Espinosa-Bode, Andres; Reefhuis, Jennita; Rao, Carol Y.; Powers, Ann M.; Helfand, Rita; Jamieson, Denise J.; Honein, Margaret A.] Ctr Dis Control & Prevent, Atlanta, GA USA	Instituto Nacional de Salud (Colombia); Centers for Disease Control & Prevention - USA	Honein, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd NE, Atlanta, GA 30333 USA.	mhonein@cdc.gov		Rao, Carol/0000-0001-7187-2189; Tong, Van/0000-0002-3970-1440; Helfand, Rita/0000-0001-5734-0258	Colombian Instituto Nacional de Salud; CDC	Colombian Instituto Nacional de Salud; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Colombian Instituto Nacional de Salud and the CDC.	[Anonymous], 2016, EPIDEMIOLOGICAL WEEK; [Anonymous], 2016, NACIMIENTOS AREA OCU; [Anonymous], 2016, CIRCULAR EXTERNA 004; [Anonymous], 2015, POPULATION PROJECTIO; Brasil P., 2016, N ENGL J MED; Calvet G, 2016, LANCET INFECT DIS; Cauchemez S, 2016, LANCET; Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Ojeda G, 2011, NATL DEMOGRAPHIC HLT; Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1; Pan American Health Organization, 2016, CUM ZIK SUSP CONF CA; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290	18	114	115	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6							e44	10.1056/NEJMoa1604037	http://dx.doi.org/10.1056/NEJMoa1604037			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB3TI	27305043	Bronze			2022-12-24	WOS:000560438400009
J	Ndeffo-Mbah, ML; Parpia, AS; Galvani, AP				Ndeffo-Mbah, Martial L.; Parpia, Alyssa S.; Galvani, Alison P.			Mitigating Prenatal Zika Virus Infection in the Americas	ANNALS OF INTERNAL MEDICINE			English	Article							AEDES-AEGYPTI DIPTERA; SEXUAL TRANSMISSION; RELEASE-RECAPTURE; DENGUE; CULICIDAE; AGE; POPULATION; STRATEGIES; DYNAMICS; MODELS	Background: Because of the risk for Zika virus infection in the Americas and the links between infection and microcephaly, other serious neurologic conditions, and fetal death, health ministries across the region have advised women to delay pregnancy. However, the effectiveness of this policy in reducing prenatal Zika virus infection has yet to be quantified. Objective: To evaluate the effectiveness of pregnancy-delay policies on the incidence and prevalence of prenatal Zika virus infection. Design: Vector-borne Zika virus transmission model fitted to epidemiologic data from 2015 to 2016 on Zika virus infection in Colombia. Setting: Colombia, August 2015 to July 2017. Patients: Population of Colombia, stratified by sex, age, and pregnancy status. Intervention: Recommendations to delay pregnancy by 3, 6, 9, 12, or 24 months, at different levels of adherence. Measurements: Weekly and cumulative incidence of prenatal infections and microcephaly cases. Results: With 50% adherence to recommendations to delay pregnancy by 9 to 24 months, the cumulative incidence of prenatal Zika virus infections is likely to decrease by 17% to 44%, whereas recommendations to delay pregnancy by 6 or fewer months are likely to increase prenatal infections by 2% to 7%. This paradoxical exacerbation of prenatal Zika virus exposure is due to an elevated risk for pregnancies to shift toward the peak of the outbreak. Limitation: Sexual transmission was not explicitly accounted for in the model because of limited data but was implicitly subsumed within the overall transmission rate, which was calibrated to observed incidence. Conclusion: Pregnancy delays can have a substantial effect on reducing cases of microcephaly but risks exacerbating the Zika virus outbreak if the duration is not sufficient. Duration of the delay, population adherence, and the timing of initiation of the intervention must be carefully considered.	[Ndeffo-Mbah, Martial L.; Parpia, Alyssa S.; Galvani, Alison P.] Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, 135 Coll St,Suite 200, New Haven, CT 06510 USA; Yale Univ, New Haven, CT USA	Yale University; Yale University	Ndeffo-Mbah, ML (corresponding author), Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, 135 Coll St,Suite 200, New Haven, CT 06510 USA.	Martial.Ndeffo-Mbah@yale.edu		Ndeffo Mbah, Martial/0000-0003-4158-7613	National Institutes of Health [U01 GM087719, U01 GM105627]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM105627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	By the National Institutes of Health (grants U01 GM087719 and U01 GM105627).	Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743; Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085; Blumel JE, 2006, MENOPAUSE, V13, P706, DOI 10.1097/01.gme.0000227338.73738.2d; Bongaarts J, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0058-9; Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Centers for Disease Control and Prevention, 2016, ZIK VIR; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Eskenazi B, 2003, HUM REPROD, V18, P447, DOI 10.1093/humrep/deg107; European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR; FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2; Lardeux F, 2001, MED VET ENTOMOL, V15, P167, DOI 10.1046/j.0269-283x.2001.00305.x; Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8; Majumder MS, 2016, B WORLD HEALTH ORGAN, P1, DOI DOI 10.2471/BLT.16.171009; Mallet HP, 2015, B INFORM SANITAIRES, V20-21, P367; Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033; Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; McNeil DG Jr, 2016, NY TIMES, pD1; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Nac, 2016, NAC UMS FIN SAF AN R, P72; Oehler E, 2014, Euro Surveill, V19; Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3; Pan American Health Organization; World Health Organization, 2016, SUSP CONF ZIK CAS RE; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018; Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517; SAWYER W. A., 1931, JOUR PREV MED, V5, P413; Schuck-Paim C, 2016, PLOS CURR-TREE LIFE, V8, DOI DOI 10.1371/CURRENTS.0UTBREAKS.7038A6813F734C1DB547240C2A0BA291; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042; Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111; Stykes J, 2011, FP1104 NAT CTR FAM M; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27; Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9; United Nations, 2015, ESAPWP241 UN; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6	55	14	15	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2016	165	8					551	+		10.7326/M16-0919	http://dx.doi.org/10.7326/M16-0919			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6BM	27454076				2022-12-24	WOS:000385946600015
J	Nishida, K; Arazoe, T; Yachie, N; Banno, S; Kakimoto, M; Tabata, M; Mochizuki, M; Miyabe, A; Araki, M; Hara, KY; Shimatani, Z; Kondo, A				Nishida, Keiji; Arazoe, Takayuki; Yachie, Nozomu; Banno, Satomi; Kakimoto, Mika; Tabata, Mayura; Mochizuki, Masao; Miyabe, Aya; Araki, Michihiro; Hara, Kiyotaka Y.; Shimatani, Zenpei; Kondo, Akihiko			Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems	SCIENCE			English	Article							CRISPR-CAS SYSTEMS; STRANDED-DNA; CHO-CELLS; NUCLEASES; DEAMINASE; AID; DIVERSIFICATION; CLEAVAGE; ENZYME	The generation of genetic variation (somatic hypermutation) is an essential process for the adaptive immune system in vertebrates. We demonstrate the targeted single-nucleotide substitution of DNA using hybrid vertebrate and bacterial immune systems components. Nuclease-deficient type II CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated) and the activation-induced cytidine deaminase (AID) ortholog PmCDA1 were engineered to form a synthetic complex (Target-AID) that performs highly efficient target-specific mutagenesis. Specific point mutation was induced primarily at cytidines within the target range of five bases. The toxicity associated with the nuclease-based CRISPR/Cas9 system was greatly reduced. Although combination of nickase Cas9(D10A) and the deaminase was highly effective in yeasts, it also induced insertion and deletion (indel) in mammalian cells. Use of uracil DNA glycosylase inhibitor suppressed the indel formation and improved the efficiency.	[Nishida, Keiji; Arazoe, Takayuki; Banno, Satomi; Kakimoto, Mika; Tabata, Mayura; Mochizuki, Masao; Miyabe, Aya; Araki, Michihiro; Shimatani, Zenpei; Kondo, Akihiko] Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan; [Yachie, Nozomu] Univ Tokyo, Synthet Biol Div, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan; [Yachie, Nozomu] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Yachie, Nozomu] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Hara, Kiyotaka Y.] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Dept Environm Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan; [Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan	Kobe University; University of Tokyo; Keio University; Japan Science & Technology Agency (JST); University of Shizuoka; Kobe University	Kondo, A (corresponding author), Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.; Kondo, A (corresponding author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Kondo, Akihiko/A-2130-2015	Banno, Satomi/0000-0002-5853-5003	Ministry of Education, Culture, Sports and Technology (MEXT) of Japan; commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan; JSPS [26119710, 16K14654]; Cross-ministerial Strategic Innovation Promotion Program (SIP); Grants-in-Aid for Scientific Research [26430198, 16K14654] Funding Source: KAKEN	Ministry of Education, Culture, Sports and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cross-ministerial Strategic Innovation Promotion Program (SIP); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Yajima for helpful discussion. This work was supported by a Special Coordination Fund for Promoting Science and Technology, Creation of Innovative Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe) from the Ministry of Education, Culture, Sports and Technology (MEXT) of Japan. This work was also partly supported by the commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan, by JSPS KAKENHI grant numbers 26119710 and 16K14654, and by Cross-ministerial Strategic Innovation Promotion Program (SIP); 'Technologies for creating next-generation agriculture, forestry and fisheries.' Patents have been filed related to this work.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Knisbacher BA, 2016, TRENDS GENET, V32, P16, DOI 10.1016/j.tig.2015.10.005; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lada AG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003736; Lee JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08572; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Shin J, 2015, BIOTECHNOL BIOPROC E, V20, P825, DOI 10.1007/s12257-015-0233-7; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; WANG ZG, 1991, GENE, V99, P31; Zhao B, 2004, NUCLEIC ACIDS RES, V32, P3984, DOI 10.1093/nar/gkh710	27	690	797	23	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2016	353	6305							aaf8729	10.1126/science.aaf8729	http://dx.doi.org/10.1126/science.aaf8729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW2AD	27492474				2022-12-24	WOS:000383444400036
J	Laxminarayan, R; Sridhar, D; Blaser, M; Wang, MG; Woolhouse, M				Laxminarayan, Ramanan; Sridhar, Devi; Blaser, Martin; Wang, Minggui; Woolhouse, Mark			Achieving global targets for antimicrobial resistance	SCIENCE			English	Editorial Material							ANTIBIOTICS; ACCESS		[Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA; [Sridhar, Devi; Woolhouse, Mark] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [Blaser, Martin] NYU, Sch Med, New York, NY 10016 USA; [Wang, Minggui] Fudan Univ, Shanghai 200433, Peoples R China	University of Edinburgh; New York University; Fudan University	Woolhouse, M (corresponding author), Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk	Laxminarayan, Ramanan/ABD-5050-2021; Wang, Minggui/AAR-8281-2020	Wang, Minggui/0000-0001-7682-5859				Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5; Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292; Center for Disease Dynamics Economics and Policy, 2015, STAT WORLDS ANT 2015; Clinton C., 2016, GOVERNING GLOBAL HLT; Czaplewski L, 2016, LANCET INFECT DIS, V16, P239, DOI 10.1016/S1473-3099(15)00466-1; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Laxminarayan R., 2015, OECD FOOD AGR FISH P, V78; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Laxminarayan R, 2014, SCIENCE, V345, P1299, DOI 10.1126/science.1254163; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Laxminarayan R, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000135; Laxminarayan R, 2012, SCIENCE, V338, P615, DOI 10.1126/science.1231010; SRIDHAR D, 2011, GETTING POLITICS RIG; Tougher S., 2012, LANCET, V6736, P1; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083; Woolhouse M, 2014, NATURE, V509, P555, DOI 10.1038/509555a; World Health Organization, 2014, ANT RES GLOB REP SUR	18	161	166	5	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					874	875		10.1126/science.aaf9286	http://dx.doi.org/10.1126/science.aaf9286			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU0CA	27540009	Green Accepted			2022-12-24	WOS:000381867700021
J	Whicher, JR; MacKinnon, R				Whicher, Jonathan R.; MacKinnon, Roderick			Structure of the voltage-gated K+ channel Eag1 reveals an alternative voltage sensing mechanism	SCIENCE			English	Article							GO POTASSIUM CHANNEL; HUMAN-ETHER; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; GATING CHARGE; KCNH-CHANNEL; S4 SEGMENT; ACTIVATION; EXPRESSION; PORE	Voltage-gated potassium (K-v) channels are gated by the movement of the transmembrane voltage sensor, which is coupled, through the helical S4-S5 linker, to the potassium pore. We determined the single-particle cryo-electron microscopy structure of mammalian K(v)10.1, or Eag1, bound to the channel inhibitor calmodulin, at 3.78 angstrom resolution. Unlike previous K-v structures, the S4-S5 linker of Eag1 is a five-residue loop and the transmembrane segments are not domain swapped, which suggest an alternative mechanism of voltage-dependent gating. Additionally, the structure and position of the S4-S5 linker allow calmodulin to bind to the intracellular domains and to close the potassium pore, independent of voltage-sensor position. The structure reveals an alternative gating mechanism for K-v channels and provides a template to further understand the gating properties of Eag1 and related channels.	[Whicher, Jonathan R.; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			NIH [GM43949]; Damon Runyon Cancer Research Foundation [DRG-2212-15]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Ebrahim at the Rockefeller University cryo-EM resource center for help with data collection and J. Chen and members of the MacKinnon laboratory for helpful discussions. This work was supported in part by NIH grant GM43949. J.R.W. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2212-15) and R.M. is an investigator in the Howard Hughes Medical Institute. The low-pass filtered and amplitude-modified three-dimensional cryo-EM density maps for rEag1 have been deposited in the EM Data Bank with accession code EMD-8215. Atomic coordinates for rEag1 have been deposited in the Protein Data Bank under accession code 5K7L. J.R.W. performed functional experiments and expressed, purified, and determined single-particle cryo-EM structure of rEag1. J.R.W. and R.M. designed experiments, analyzed and interpreted results, and wrote the manuscript.	Agarwal JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-18; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bijlenga P, 1998, J PHYSIOL-LONDON, V512, P317, DOI 10.1111/j.1469-7793.1998.317be.x; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; de Queiroz FM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-42; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Garcia-Quiroz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045063; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Hsu PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041203; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Ju M, 2006, BIOCHEM BIOPH RES CO, V342, P1088, DOI 10.1016/j.bbrc.2006.02.062; Ju M, 2002, FEBS LETT, V524, P204, DOI 10.1016/S0014-5793(02)03055-7; Lorinczi E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7672; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Mortensen L. S., 2014, J PHYSL, V593, P181; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 1998, J CELL BIOL, V143, P767, DOI 10.1083/jcb.143.3.767; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	42	193	199	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					664	669		10.1126/science.aaf8070	http://dx.doi.org/10.1126/science.aaf8070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516594	Green Accepted			2022-12-24	WOS:000381561200032
J	Park, IY; Powell, RT; Tripathi, DN; Dere, R; Ho, TH; Blasius, TL; Chiang, YC; Davis, IJ; Fahey, CC; Hacker, KE; Verhey, KJ; Bedford, MT; Jonasch, E; Rathmell, WK; Walker, CL				Park, In Young; Powell, Reid T.; Tripathi, Durga Nand; Dere, Ruhee; Ho, Thai H.; Blasius, T. Lynne; Chiang, Yun-Chen; Davis, Ian J.; Fahey, Catherine C.; Hacker, Kathryn E.; Verhey, Kristen J.; Bedford, Mark T.; Jonasch, Eric; Rathmell, W. Kimryn; Walker, Cheryl Lyn			Dual Chromatin and Cytoskeletal Remodeling by SETD2	CELL			English	Article							RENAL-CELL CARCINOMA; ACUTE LYMPHOBLASTIC-LEUKEMIA; HISTONE H3K36 METHYLATION; RNA-POLYMERASE-II; EPIGENETIC REGULATORS; POSTTRANSLATIONAL MODIFICATIONS; HOMOLOGOUS RECOMBINATION; BRANCHED EVOLUTION; CANCER GENOMICS; TUBULIN CODE	Posttranslational modifications (PTMs) of tubulin specify microtubules for specialized cellular functions and comprise what is termed a "tubulin code.'' PTMs of histones comprise an analogous "histone code,'' although the "readers, writers, and erasers'' of the cytoskeleton and epigenome have heretofore been distinct. We show that methylation is a PTM of dynamic microtubules and that the histone methyltransferase SET-domain-containing 2 (SETD2), which is responsible for H3 lysine 36 trimethylation (H3K36me3) of histones, also methylates a-tubulin at lysine 40, the same lysine that is marked by acetylation on microtubules. Methylation of microtubules occurs during mitosis and cytokinesis and can be ablated by SETD2 deletion, which causes mitotic spindle and cytokinesis defects, micronuclei, and polyploidy. These data now identify SETD2 as a dual-function methyltransferase for both chromatin and the cytoskeleton and show a requirement for methylation in maintenance of genomic stability and the integrity of both the tubulin and histone codes.	[Park, In Young; Powell, Reid T.; Tripathi, Durga Nand; Dere, Ruhee; Walker, Cheryl Lyn] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA; [Ho, Thai H.] Mayo Clin Arizona, Div Hematol Oncol, Scottsdale, AZ 85259 USA; [Blasius, T. Lynne; Verhey, Kristen J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Chiang, Yun-Chen; Davis, Ian J.; Fahey, Catherine C.; Hacker, Kathryn E.; Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Chiang, Yun-Chen; Davis, Ian J.; Fahey, Catherine C.; Hacker, Kathryn E.; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Davis, Ian J.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Jonasch, Eric] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Rathmell, W. Kimryn] Vanderbilt Univ, Div Hematol Oncol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Park, In Young; Powell, Reid T.; Tripathi, Durga Nand; Dere, Ruhee; Walker, Cheryl Lyn] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Mayo Clinic; Mayo Clinic Phoenix; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; Baylor College of Medicine	Walker, CL (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA.; Walker, CL (corresponding author), Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA.	cherylw@bcm.edu	Chiang, Yun/GRJ-5251-2022; Park, In Young/AAN-7901-2020; Tripathi, Durga Nand/H-3247-2019	Park, In Young/0000-0002-0082-1189; Tripathi, Durga Nand/0000-0001-8736-4808; Powell, Reid T./0000-0002-6242-8315; Ho, Thai/0000-0003-0023-2939; Davis, Ian/0000-0002-1552-0960; Fahey, Catherine/0000-0003-4347-361X	Robert E. Welch Foundation [BE-0023]; NIH [RC2ES018789, R01ES008263, R01ES023206, R01CA214052, P30ES023512]; Cancer Prevention and Research Institute of Texas (CPRIT) [DP150086]; V Foundation for Cancer Research award [T2012-008, R01CA166447, T32 GM008719]; NRSA [F30 CA192643-02]; CPRIT [RP110471, K12CA90628]; Gerstner Family Career Development Award; NIH/NCI [P30CA016672];  [R01GM070862];  [R01CA198482]; NATIONAL CANCER INSTITUTE [K12CA090628, R01CA121052, R01CA198482, R01CA166447, F30CA192643, T32CA009156, R01CA203012, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008263, RC2ES018789, P30ES023512, R01ES023206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070862, T32GM008719] Funding Source: NIH RePORTER	Robert E. Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); V Foundation for Cancer Research award; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Gerstner Family Career Development Award; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Claire Walczak (University of Indiana) for valuable discussions concerning mitotic defects, Tia Berry and Xuefei Tong for technical assistance, Austin Hepperla (UNC Chapel Hill) for designing the pipeline used to align the RNA-sequencing data, and Dr. Sung Yun Jung (Baylor College of Medicine) for mass spectrometry analysis. This work was supported in part by grants from the Robert E. Welch Foundation (BE-0023), the NIH (RC2ES018789, R01ES008263, R01ES023206, R01CA214052, and P30ES023512) and the Cancer Prevention and Research Institute of Texas (CPRIT, DP150086) to C.L.W.; grant R01GM070862 to K.J.V.; grant R01CA198482 and R01CA214052 to W.K.R. and I.J.D.; a V Foundation for Cancer Research award (T2012-008) to W.K.R.; grant R01CA166447 to I.J.D.; grant T32 GM008719 and NRSA award F30 CA192643-02 to C.C.F.; grant CPRIT RP110471 to M.T.B.; grant K12CA90628 and a Gerstner Family Career Development Award to T.H.H.; and NIH/NCI grant P30CA016672 to E.J.	Agromayor M, 2013, TRENDS CELL BIOL, V23, P433, DOI 10.1016/j.tcb.2013.04.006; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Bi M, 2016, P NATL ACAD SCI USA, V113, P2170, DOI 10.1073/pnas.1525735113; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen ZZ, 2007, P NATL ACAD SCI USA, V104, P10818, DOI 10.1073/pnas.0704525104; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Ho TH, 2016, ONCOGENE, V35, P1565, DOI 10.1038/onc.2015.221; Ho TH, 2016, MODERN PATHOL, V29, P34, DOI 10.1038/modpathol.2015.123; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Huang K.K., 2015, GUT; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kanu N, 2015, ONCOGENE, V34, P5699, DOI 10.1038/onc.2015.24; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kovac M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7336; Kwok BH, 2007, CURR OPIN CELL BIOL, V19, P36, DOI 10.1016/j.ceb.2006.12.003; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Liao LL, 2015, CANCER GENET-NY, V208, P206, DOI 10.1016/j.cancergen.2015.02.008; Liu WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002004; Magiera MM, 2013, METHOD CELL BIOL, V115, P247, DOI 10.1016/B978-0-12-407757-7.00016-5; Mar BG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4469; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Motulsky H. J., 2016, GRAPHPAD STAT GUIDE; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Rebehmed J, 2014, FEBS LETT, V588, P4431, DOI 10.1016/j.febslet.2014.10.014; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Song YY, 2015, TRENDS CELL BIOL, V25, P125, DOI 10.1016/j.tcb.2014.10.004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	49	133	141	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					950	962		10.1016/j.cell.2016.07.005	http://dx.doi.org/10.1016/j.cell.2016.07.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518565	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000382258700017
J	Brouwer, I; Sitters, G; Candelli, A; Heerema, SJ; Heller, I; de Melo, AJ; Zhang, HS; Normanno, D; Modesti, M; Peterman, EJG; Wuite, GJL				Brouwer, Ineke; Sitters, Gerrit; Candelli, Andrea; Heerema, Stephanie J.; Heller, Iddo; de Melo, Abinadabe J.; Zhang, Hongshan; Normanno, Davide; Modesti, Mauro; Peterman, Erwin J. G.; Wuite, Gijs J. L.			Sliding sleeves of XRCC4-XLF bridge DNA and connect fragments of broken DNA	NATURE			English	Article							STRAND BREAK REPAIR; OPTICAL TWEEZERS; PROTEIN INTERACTIONS; COMPLEX; XLF; LIGATION; DYNAMICS; ENDS	Non-homologous end joining (NHEJ) is the primary pathway for repairing DNA double-strand breaks (DSBs) in mammalian cells(1). Such breaks are formed, for example, during gene-segment rearrangements in the adaptive immune system or by cancer therapeutic agents. Although the core components of the NHEJ machinery are known, it has remained difficult to assess the specific roles of these components and the dynamics of bringing and holding the fragments of broken DNA together. The structurally similar XRCC4 and XLF proteins are proposed to assemble as highly dynamic filaments at (or near) DSBs(2). Here we show, using dual-and quadruple-trap optical tweezers combined with fluorescence microscopy, how human XRCC4, XLF and XRCC4-XLF complexes interact with DNA in real time. We find that XLF stimulates the binding of XRCC4 to DNA, forming heteromeric complexes that diffuse swiftly along the DNA. Moreover, we find that XRCC4-XLF complexes robustly bridge two independent DNA molecules and that these bridges are able to slide along the DNA. These observations suggest that XRCC4-XLF complexes form mobile sleeve-like structures around DNA that can reconnect the broken ends very rapidly and hold them together. Understanding the dynamics and regulation of this mechanism will lead to clarification of how NHEJ proteins are involved in generating chromosomal translocations(3,4).	[Brouwer, Ineke; Sitters, Gerrit; Candelli, Andrea; Heerema, Stephanie J.; Heller, Iddo; Peterman, Erwin J. G.; Wuite, Gijs J. L.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Brouwer, Ineke; Sitters, Gerrit; Candelli, Andrea; Heerema, Stephanie J.; Heller, Iddo; Peterman, Erwin J. G.; Wuite, Gijs J. L.] Vrije Univ Amsterdam, LaserLab, NL-1081 HV Amsterdam, Netherlands; [de Melo, Abinadabe J.; Zhang, Hongshan; Normanno, Davide; Modesti, Mauro] Aix Marseille Univ, Canc Res Ctr Marseille, Inst Paoli Calmettes, CNRS,UMR7258,Inserm,U1068,UM105, F-13273 Marseilles, France; [Sitters, Gerrit; Candelli, Andrea] LUMICKS BV, NL-1081 HV Amsterdam, Netherlands; [Heerema, Stephanie J.] Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Delft University of Technology	Wuite, GJL (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.; Wuite, GJL (corresponding author), Vrije Univ Amsterdam, LaserLab, NL-1081 HV Amsterdam, Netherlands.; Modesti, M (corresponding author), Aix Marseille Univ, Canc Res Ctr Marseille, Inst Paoli Calmettes, CNRS,UMR7258,Inserm,U1068,UM105, F-13273 Marseilles, France.	mauro.modesti@inserm.fr; g.j.l.wuite@vu.nl	Modesti, Mauro/D-6258-2017; Heller, Iddo/D-4231-2009; Peterman, Erwin/G-5529-2010; Candelli, Andrea/AAQ-1890-2020; Brouwer, Ineke/AAU-4213-2020; Zhang, Hongshan/AAW-5348-2021	Modesti, Mauro/0000-0002-4964-331X; Heller, Iddo/0000-0003-4888-2244; Peterman, Erwin/0000-0003-1058-249X; Brouwer, Ineke/0000-0002-9571-0966; Normanno, Davide/0000-0003-4740-5542; wuite, gijs/0000-0002-5706-043X	VICI; VENI; Nederlandse Organisatie voor Wetenschappelijk Onderzoek, a European Research Council; French National Cancer Institute [PLBIO13-103]; ARC Foundation for Cancer Research; A*MIDEX project [ANR-11-IDEX-0001-02]; 'Investissements d'Avenir' French Government program; Brazilian program for Coordination for the Improvement of Higher Education Personnel [0558/12-5]; College of Aix-Marseille Universite	VICI(Netherlands Organization for Scientific Research (NWO)); VENI(Netherlands Organization for Scientific Research (NWO)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek, a European Research Council; French National Cancer Institute(Institut National du Cancer (INCA) France); ARC Foundation for Cancer Research; A*MIDEX project(French National Research Agency (ANR)); 'Investissements d'Avenir' French Government program(French National Research Agency (ANR)); Brazilian program for Coordination for the Improvement of Higher Education Personnel; College of Aix-Marseille Universite	We thank P. Fourquet and S. Audebert from the CRCM Proteomics facility for help with MS analysis and G. King and A. S. Biebricher for help with the optical tweezers instruments. This work was supported by VICI grants (G.J.L.W. and E.J.G.P.), a VENI grant (I.H.) and a Top Talent grant (A.C.) from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek, a European Research Council starting grant (G.J.L.W.), the French National Cancer Institute (grant PLBIO13-103) (M.M.), the ARC Foundation for Cancer Research (M.M.), the A*MIDEX project (no. ANR-11-IDEX-0001-02), the 'Investissements d'Avenir' French Government program (M.M.), fellowship no. 0558/12-5 from the Brazilian program for Coordination for the Improvement of Higher Education Personnel (A.J.M.), and a fellowship from the College of Aix-Marseille Universite (H.Z.)	Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Andres SN, 2012, NUCLEIC ACIDS RES, V40, P1868, DOI 10.1093/nar/gks022; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Candelli A, 2011, PHYS CHEM CHEM PHYS, V13, P7263, DOI 10.1039/c0cp02844d; Cottarel J, 2013, J CELL BIOL, V200, P173, DOI 10.1083/jcb.201203128; Gelot C, 2016, MOL CELL, V61, P15, DOI 10.1016/j.molcel.2015.11.002; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Graham TGW, 2016, MOL CELL, V61, P850, DOI 10.1016/j.molcel.2016.02.010; Gross P, 2010, METHOD ENZYMOL, V475, P427, DOI 10.1016/S0076-6879(10)75017-5; Hammel M, 2011, J BIOL CHEM, V286, P32638, DOI 10.1074/jbc.M111.272641; Hammel M, 2010, STRUCTURE, V18, P1431, DOI 10.1016/j.str.2010.09.009; Heller I, 2014, CHEM REV, V114, P3087, DOI 10.1021/cr4003006; Heller I, 2014, CHEMPHYSCHEM, V15, P727, DOI 10.1002/cphc.201300813; Heller I, 2013, NAT METHODS, V10, P910, DOI [10.1038/NMETH.2599, 10.1038/nmeth.2599]; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mahaney BL, 2013, BIOCHEM CELL BIOL, V91, P31, DOI 10.1139/bcb-2012-0058; Mani RS, 2010, J BIOL CHEM, V285, P37619, DOI 10.1074/jbc.M109.058719; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Reid DA, 2015, P NATL ACAD SCI USA, V112, pE2575, DOI 10.1073/pnas.1420115112; Ropars V, 2011, P NATL ACAD SCI USA, V108, P12663, DOI 10.1073/pnas.1100758108; Roy S, 2015, MOL CELL BIOL, V35, P3017, DOI 10.1128/MCB.01503-14; Roy S, 2012, NUCLEIC ACIDS RES, V40, P1684, DOI 10.1093/nar/gkr1315; van Mameren J, 2009, P NATL ACAD SCI USA, V106, P18231, DOI 10.1073/pnas.0904322106; Wu Q, 2011, BIOCHEM SOC T, V39, P1387, DOI 10.1042/BST0391387	25	99	99	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					566	+		10.1038/nature18643	http://dx.doi.org/10.1038/nature18643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27437582				2022-12-24	WOS:000380856600032
J	Hampoelz, B; Mackmull, MT; Machado, P; Ronchi, P; Bui, KH; Schieber, N; Santarella-Mellwig, R; Necakov, A; Andres-Pons, A; Philippe, JM; Lecuit, T; Schwab, Y; Beck, M				Hampoelz, Bernhard; Mackmull, Marie-Therese; Machado, Pedro; Ronchi, Paolo; Bui, Khanh Huy; Schieber, Nicole; Santarella-Mellwig, Rachel; Necakov, Aleksandar; Andres-Pons, Amparo; Philippe, Jean Marc; Lecuit, Thomas; Schwab, Yannick; Beck, Martin			Pre-assembled Nuclear Pores Insert into the Nuclear Envelope during Early Development	CELL			English	Article							ANNULATE LAMELLAE; CELL-CYCLE; DROSOPHILA EMBRYOS; INNER RING; COMPLEX; DYNAMICS; GENE; HETEROCHROMATIN; PERMEABILITY; ORGANIZATION	Nuclear pore complexes (NPCs) span the nuclear envelope (NE) and mediate nucleocytoplasmic transport. In metazoan oocytes and early embryos, NPCs reside not only within the NE, but also at some endoplasmic reticulum (ER) membrane sheets, termed annulate lamellae (AL). Although a role for AL as NPC storage pools has been discussed, it remains controversial whether and how they contribute to the NPC density at the NE. Here, we show that AL insert into the NE as the ER feeds rapid nuclear expansion in Drosophila blastoderm embryos. We demonstrate that NPCs within AL resemble pore scaffolds that mature only upon insertion into the NE. We delineate a topological model in which NE openings are critical for AL uptake that nevertheless occurs without compromising the permeability barrier of the NE. We finally show that this unanticipated mode of pore insertion is developmentally regulated and operates prior to gastrulation.	[Hampoelz, Bernhard; Mackmull, Marie-Therese; Bui, Khanh Huy; Necakov, Aleksandar; Andres-Pons, Amparo; Beck, Martin] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Machado, Pedro; Ronchi, Paolo; Santarella-Mellwig, Rachel; Schwab, Yannick] European Mol Biol Lab, Elect Microscopy Core Facil, D-69117 Heidelberg, Germany; [Philippe, Jean Marc; Lecuit, Thomas] Aix Marseille Univ, CNRS, IBDM UMR 7288, F-13009 Marseille, France; [Schieber, Nicole; Schwab, Yannick; Beck, Martin] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Bui, Khanh Huy] McGill Univ, Dept Anat & Cell Biol, GRASP, Montreal, PQ H3A 0C7, Canada	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; European Molecular Biology Laboratory (EMBL); McGill University	Beck, M (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.; Beck, M (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	martin.beck@embl.de	Ronchi, Paolo/A-6689-2013; Ronchi, Paolo/AAC-5008-2019; Beck, Martin/B-5589-2011	Bui, Khanh Huy/0000-0003-2814-9889; Schwab, Yannick/0000-0001-8027-1836; Beck, Martin/0000-0002-7397-1321; Hampoelz, Bernhard/0000-0001-7491-0080; Machado, Pedro/0000-0002-7003-0593; Andres-Pons, Amparo/0000-0001-5801-4024; Ronchi, Paolo/0000-0001-9010-533X; Mackmull, Marie-Therese/0000-0003-2928-1144; Schieber, Nicole L./0000-0002-3212-5057	Agence Nationale de la Recherche (ANR) (Programme Blanc) NeMo; European Molecular Biology Organisation (EMBO); Swiss National Science Foundation (SNF); Marie Curie Actions; EMBL; European Research Council [309271-NPCAtlas]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (ANR) (Programme Blanc) NeMo(French National Research Agency (ANR)); European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Marie Curie Actions(European Commission); EMBL; European Research Council(European Research Council (ERC)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Iain Mattaj and Peter Lenart for critical reading of the manuscript and Dr. Yannick Azou-Gros for experimental assistance. We are grateful to our colleagues Drs. V. Doye, N. Dostatni, A. Ephrussi, S. deRenzis, M. Mavrakis, A. Akhtar, G. Krohne, I. Mattaj, and J. Ellenberg for reagents. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. We gratefully acknowledge support by the European Molecular Biology Laboratory (EMBL) advanced light microscopy (ALMF), electron microscopy (EMCF), and proteomic (PCF) core facilities and Petra Riedinger for graphical design. We are grateful to Drs. P. Paul-Gilloteaux, X. Heiligenstein, and S. Mosalaganti for assistance and expertise in correlative light and electron microscopy analysis. B.H. was supported by the Agence Nationale de la Recherche (ANR) (Programme Blanc) NeMo (to T.L) and the European Molecular Biology Organisation (EMBO). K.H.B. was supported by postdoctoral fellowships from the Swiss National Science Foundation (SNF), EMBO, and Marie Curie Actions. M.B. acknowledges funding by EMBL and the European Research Council (309271-NPCAtlas).	Avinoam O, 2015, SCIENCE, V348, P1369, DOI 10.1126/science.aaa9555; Clever M, 2012, NUCLEUS-PHILA, V3, P187, DOI 10.4161/nucl.19595; Cordes VC, 1996, CELL TISSUE RES, V284, P177, DOI 10.1007/s004410050578; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Doucet CM, 2010, CHROMOSOMA, V119, P469, DOI 10.1007/s00412-010-0289-2; Doucet CM, 2010, CELL, V141, P1030, DOI 10.1016/j.cell.2010.04.036; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Dultz E, 2010, J CELL BIOL, V191, P15, DOI 10.1083/jcb.201007076; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fischer J, 2015, NAT STRUCT MOL BIOL, V22, P774, DOI 10.1038/nsmb.3084; FULLILOVE SL, 1971, DEV BIOL, V26, P560, DOI 10.1016/0012-1606(71)90141-2; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019; Katsani KR, 2008, MOL BIOL CELL, V19, P3652, DOI 10.1091/mbc.E07-11-1162; KESSEL RG, 1983, INT REV CYTOL, V82, P181, DOI 10.1016/S0074-7696(08)60826-8; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Lenart P, 2006, METHODS, V38, P17, DOI 10.1016/j.ymeth.2005.07.010; Lenart P, 2003, CURR OPIN CELL BIOL, V15, P88, DOI 10.1016/S0955-0674(02)00011-X; LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; LONGO FJ, 1968, J CELL BIOL, V39, P339, DOI 10.1083/jcb.39.2.339; Mackmull MT, 2015, MOL CELL PROTEOMICS, V14, P1350, DOI 10.1074/mcp.M114.042499; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Onischenko EA, 2005, MOL BIOL CELL, V16, P5152, DOI 10.1091/mbc.E05-07-0642; Onischenko EA, 2004, TRAFFIC, V5, P152, DOI 10.1111/j.1600-0854.2004.0166.x; Ptak C, 2014, CURR OPIN CELL BIOL, V28, P46, DOI 10.1016/j.ceb.2014.02.001; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Solovei I, 2013, CELL, V152, P584, DOI 10.1016/j.cell.2013.01.009; SOUPART P, 1974, FERTIL STERIL, V25, P11; SPINDLER M, 1982, J ULTRA MOL STRUCT R, V81, P341, DOI 10.1016/S0022-5320(82)90062-4; STAFSTROM JP, 1984, EUR J CELL BIOL, V34, P179; STAFSTROM JP, 1984, J CELL BIOL, V98, P699, DOI 10.1083/jcb.98.2.699; Stuwe T, 2015, SCIENCE, V350, P56, DOI 10.1126/science.aac9176; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381	39	63	64	4	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					664	678		10.1016/j.cell.2016.06.015	http://dx.doi.org/10.1016/j.cell.2016.06.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27397507	Green Published, hybrid			2022-12-24	WOS:000380546500017
J	Gopinath, A; Miyazono, E; Faraon, A; Rothemund, PWK				Gopinath, Ashwin; Miyazono, Evan; Faraon, Andrei; Rothemund, Paul W. K.			Engineering and mapping nanocavity emission via precision placement of DNA origami	NATURE			English	Article							PHOTONIC CRYSTAL CAVITY; SINGLE QUANTUM-DOT; NANOSCALE; SHAPES; LIGHT; ARRAYS; PURE	Many hybrid devices integrate functional molecular or nanoparticle components with microstructures, as exemplified by the nanophotonic devices that couple emitters to optical resonators(1) for potential use in single-molecule detection(2,)3, precision magnetometry(4), low threshold lasing(5,6) and quantum information processing(7-12). These systems also illustrate a common difficulty for hybrid devices: although many proof-of-principle devices exist, practical applications face the challenge of how to incorporate large numbers of chemically diverse functional components into microfabricated resonators at precise locations. Here we show that the directed self-assembly(13,14) of DNA origami(15) onto lithographically patterned binding sites allows reliable and controllable coupling of molecular emitters to photonic crystal cavities (PCCs). The precision of this method is sufficient to enable us to visualize the local density of states within PCCs by simple wide-field microscopy and to resolve the antinodes of the cavity mode at a resolution of about one-tenth of a wavelength. By simply changing the number of binding sites, we program the delivery of up to seven DNA origami onto distinct antinodes within a single cavity and thereby digitally vary the intensity of the cavity emission. To demonstrate the scalability of our technique, we fabricate 65,536 independently programmed PCCs on a single chip. These features, in combination with the widely used modularity of DNA origami(16-20), suggest that our method is well suited for the rapid prototyping of a broad array of hybrid nanophotonic devices.	[Gopinath, Ashwin; Rothemund, Paul W. K.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Miyazono, Evan; Faraon, Andrei] CALTECH, Dept Appl Phys & Mat Sci, Pasadena, CA 91125 USA; [Rothemund, Paul W. K.] CALTECH, Comp & Math Sci, Pasadena, CA 91125 USA; [Rothemund, Paul W. K.] CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology	Gopinath, A; Rothemund, PWK (corresponding author), CALTECH, Dept Bioengn, Pasadena, CA 91125 USA.; Rothemund, PWK (corresponding author), CALTECH, Comp & Math Sci, Pasadena, CA 91125 USA.; Rothemund, PWK (corresponding author), CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA.	ashwing@caltech.edu; pwkr@dna.caltech.edu		Faraon, Andrei/0000-0002-8141-391X; Gopinath, Ashwin/0000-0002-2874-9457	Army Research Office [W911NF-11-1-0117]; Office of Naval Research [N000141410702]; Air Force Office of Scientific Research [FA9550-15-1-0252]; US National Science Foundation [0832824, 1317694]	Army Research Office; Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US National Science Foundation(National Science Foundation (NSF))	We acknowledge funding from the Army Research Office (award W911NF-11-1-0117), the Office of Naval Research (award N000141410702), the Air Force Office of Scientific Research (Young Investigator award FA9550-15-1-0252), and the US National Science Foundation (Expeditions in Computing numbers 0832824 and 1317694, Molecular Programming Project; http://molecular-programming.org). We thank J. Fakonas for discussions and B. Fultz for use of his spectrometer. Device fabrication was done at Caltech's Kavli Nanoscience Institute.	Acuna GP, 2012, SCIENCE, V338, P506, DOI 10.1126/science.1228638; Akahane Y, 2003, NATURE, V425, P944, DOI 10.1038/nature02063; Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002; Barth M, 2007, OPT EXPRESS, V15, P17231, DOI 10.1364/OE.15.017231; Barth M, 2009, OPT LETT, V34, P1108, DOI 10.1364/OL.34.001108; Benson O, 2011, NATURE, V480, P193, DOI 10.1038/nature10610; Bui H, 2010, NANO LETT, V10, P3367, DOI 10.1021/nl101079u; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Englund D, 2007, NATURE, V450, P857, DOI 10.1038/nature06234; Englund D, 2010, NANO LETT, V10, P3922, DOI 10.1021/nl101662v; Gopinath A, 2014, ACS NANO, V8, P12030, DOI 10.1021/nn506014s; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Jensen K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.160802; Kershner RJ, 2009, NAT NANOTECHNOL, V4, P557, DOI [10.1038/nnano.2009.220, 10.1038/NNANO.2009.220]; Klein Max. Edward, 2010, THESIS; Knowles HS, 2014, NAT MATER, V13, P21, DOI [10.1038/NMAT3805, 10.1038/nmat3805]; Ko SH, 2013, ANGEW CHEM INT EDIT, V52, P1193, DOI 10.1002/anie.201206253; Louvion N, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.113907; Lyasota A, 2015, J CRYST GROWTH, V414, P192, DOI 10.1016/j.jcrysgro.2014.10.028; Maune HT, 2010, NAT NANOTECHNOL, V5, P61, DOI [10.1038/nnano.2009.311, 10.1038/NNANO.2009.311]; Mivelle M, 2014, OPT EXPRESS, V22, P15075, DOI 10.1364/OE.22.015075; Neu E, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/4/043005; Noy A., 2007, HDB MOL FORCE SPECTR; Rotenberg N, 2014, NAT PHOTONICS, V8, P919, DOI [10.1038/nphoton.2010.285, 10.1038/nphoton.2014.285]; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sapienza L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8833; Sapienza R, 2012, NAT MATER, V11, P781, DOI [10.1038/NMAT3402, 10.1038/nmat3402]; Schreiber R, 2014, NAT NANOTECHNOL, V9, P74, DOI [10.1038/NNANO.2013.253, 10.1038/nnano.2013.253]; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shaw A, 2015, ACS NANO, V9, P4968, DOI 10.1021/nn507035g; Stahl E, 2014, ANGEW CHEM INT EDIT, V53, P12735, DOI 10.1002/anie.201405991; Strauf S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127404; Yakunin S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9056; Yang DQ, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4867254; Zhang T, 2015, J AM CHEM SOC, V137, P9776, DOI 10.1021/jacs.5b04857	35	167	173	12	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					401	+		10.1038/nature18287	http://dx.doi.org/10.1038/nature18287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27398616				2022-12-24	WOS:000380344200036
J	Dunlap, B; Cifu, AS				Dunlap, Beth; Cifu, Adam S.			Clinical Management of Opioid Use Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dunlap, Beth] Northwestern Univ, Chicago, IL USA; [Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	Northwestern University; University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Lofwall MR, 2012, DRUG ALCOHOL DEPEN, V126, P379, DOI 10.1016/j.drugalcdep.2012.05.025; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Mattick RP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub4; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Rosenblatt RA, 2015, ANN FAM MED, V13, P23, DOI 10.1370/afm.1735; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Smyth B P, 2010, Ir Med J, V103, P176; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2015, BEH HLTH TRENDS US R; Wood E, 2015, GUIDELINE CLIN MANAG	9	42	42	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2016	316	3					338	339		10.1001/jama.2016.9795	http://dx.doi.org/10.1001/jama.2016.9795			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR3LN	27434445				2022-12-24	WOS:000379804800021
J	Frokjaer-Jensen, C; Jain, N; Hansen, L; Davis, MW; Li, YB; Zhao, D; Rebora, K; Millet, JRM; Liu, X; Kim, SK; Dupuy, D; Jorgensen, EM; Fire, AZ				Frokjaer-Jensen, Christian; Jain, Nimit; Hansen, Loren; Davis, M. Wayne; Li, Yongbin; Zhao, Di; Rebora, Karine; Millet, Jonathan R. M.; Liu, Xiao; Kim, Stuart K.; Dupuy, Denis; Jorgensen, Erik M.; Fire, Andrew Z.			An Abundant Class of Non-coding DNA Can Prevent Stochastic Gene Silencing in the C. elegans Germline	CELL			English	Article							MESSENGER-RNA; X-CHROMOSOMES; EXPRESSION; INTERFERENCE; DYNAMICS; MEIOSIS; HOMOLOG; PATHWAY; SMU-1; ARMS	Cells benefit from silencing foreign genetic elements but must simultaneously avoid inactivating endogenous genes. Although chromatin modifications and RNAs contribute to maintenance of silenced states, the establishment of silenced regions will inevitably reflect underlying DNA sequence and/or structure. Here, we demonstrate that a pervasive non-coding DNA feature in Caenorhabditis elegans, characterized by 10-base pair periodic A(n)/T-n-clusters ( PATCs), can license transgenes for germline expression within repressive chromatin domains. Transgenes containing natural or synthetic PATCs are resistant to position effect variegation and stochastic silencing in the germline. Among endogenous genes, intron length and PATC-character undergo dramatic changes as orthologs move from active to repressive chromatin over evolutionary time, indicating a dynamic character to the A(n)/T-n periodicity. We propose that PATCs form the basis of a cellular immune system, identifying certain endogenous genes in heterochromatic contexts as privileged while foreign DNA can be suppressed with no requirement for a cellular memory of prior exposure.	[Frokjaer-Jensen, Christian; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA; [Frokjaer-Jensen, Christian; Hansen, Loren; Fire, Andrew Z.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Frokjaer-Jensen, Christian] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Frokjaer-Jensen, Christian] Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, DK-2200 Copenhagen N, Denmark; [Jain, Nimit] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Liu, Xiao; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Rebora, Karine; Millet, Jonathan R. M.; Dupuy, Denis] Univ Bordeaux, IECB, Lab ARNA, INSERM,U869, F-33600 Pessac, France; [Kim, Stuart K.; Fire, Andrew Z.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Li, Yongbin; Zhao, Di; Liu, Xiao] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Stanford University; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; Stanford University; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Stanford University; Tsinghua University	Jorgensen, EM (corresponding author), Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA.; Fire, AZ (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Fire, AZ (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	jorgensen@biology.utah.edu; afire@stanford.edu	Dupuy, Denis/M-7299-2014; Jain, Nimit/HIK-2809-2022; Frøkjær-Jensen, Christian/ABB-4637-2020	Millet, Jonathan/0000-0003-4359-9132; Li, Yongbin/0000-0002-0686-0883; , Nimit/0000-0001-8759-2456; Frokjaer-Jensen, Christian/0000-0002-3178-0906; Fire, Andrew/0000-0001-6217-8312; Dupuy, Denis/0000-0002-4781-5595	Carlsberg Foundation; Direktor Ib Henriksens Foundation; Stanford Graduate Fellowship; NIH [R01GM095817, R01GM37706]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095817, R01GM037706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	Carlsberg Foundation(Carlsberg Foundation); Direktor Ib Henriksens Foundation; Stanford Graduate Fellowship(Stanford University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Feldman, A. Villeneuve, S. Strome, A. Rechtsteiner, J. Lieb, K. Ikegami, C. Engert, S. Klemm, T. Machacek, V. Jantsch, C. Girard, G. Maro, D. Nix, the A.Z.F. and E.M.J. lab members, and K. Hoe for expert technical assistance. This work was supported by the Carlsberg Foundation (C.F.J.), Direktor Ib Henriksens Foundation (C.F.J.), a Stanford Graduate Fellowship (N.J.), NIH grants R01GM095817 (E.M.J) and R01GM37706 (A.Z.F.), and the Howard Hughes Medical Institute (E.M.J.).	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BRENNER S, 1974, GENETICS, V77, P71; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Elgin SCR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017780; Fire A, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P153; Fire A, 2006, GENETICS, V173, P1259, DOI 10.1534/genetics.106.057364; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Garrigues JM, 2015, GENOME RES, V25, P76, DOI 10.1101/gr.180489.114; Guoping S, 2010, CHROMOSOMA, V119, P73, DOI 10.1007/s00412-009-0235-3; Heger P, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-84; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; HOLMQUIST GP, 1994, J MOL EVOL, V39, P436; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Johnson CL, 2011, SCIENCE, V333, P1311, DOI 10.1126/science.1208178; Kelly WG, 1997, GENETICS, V146, P227; Kelly WG, 2002, DEVELOPMENT, V129, P479; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Leopold LE, 2015, P NATL ACAD SCI USA, V112, pE2667, DOI 10.1073/pnas.1501979112; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Ortiz MA, 2014, G3-GENES GENOM GENET, V4, P1765, DOI 10.1534/g3.114.012351; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Spartz AK, 2004, MOL CELL BIOL, V24, P6811, DOI 10.1128/MCB.24.15.6811-6823.2004; Spike CA, 2001, MOL CELL BIOL, V21, P4985, DOI 10.1128/MCB.21.15.4985-4995.2001; Stoeckius M, 2014, EMBO J, V33, P1751, DOI 10.15252/embj.201488769; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; VANWYE JD, 1991, NUCLEIC ACIDS RES, V19, P5253, DOI 10.1093/nar/19.19.5253; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	45	49	51	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					343	357		10.1016/j.cell.2016.05.072	http://dx.doi.org/10.1016/j.cell.2016.05.072			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27374334	Green Accepted, Bronze			2022-12-24	WOS:000380255400013
J	Marchant, J				Marchant, Jo			PLACEBOS Honest fakery	NATURE			English	Editorial Material							ANALGESIA											Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Benedetti F, 2016, J PHYSL; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; DeGrazia D., 2016, PAIN; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; Schafer SM, 2015, J PAIN, V16, P412, DOI 10.1016/j.jpain.2014.12.008; Wager TD, 2015, NAT REV NEUROSCI, V16, P403, DOI 10.1038/nrn3976	10	13	14	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					S14	S15		10.1038/535S14a	http://dx.doi.org/10.1038/535S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR4ZN	27410526	Bronze			2022-12-24	WOS:000379912600010
J	Hallegatte, S; Mach, KJ				Hallegatte, Stephane; Mach, Katharine J.			Make climate-change assessments more relevant	NATURE			English	Editorial Material									[Hallegatte, Stephane] World Bank, Climate Change Policy Team, 1818 H St NW, Washington, DC 20433 USA; [Mach, Katharine J.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA	The World Bank; Carnegie Institution for Science	Hallegatte, S (corresponding author), World Bank, Climate Change Policy Team, 1818 H St NW, Washington, DC 20433 USA.	shallegatte@worldbank.org		Oppenheimer, Michael/0000-0002-9708-5914				Clark PU, 2016, NAT CLIM CHANGE, V6, P360, DOI 10.1038/NCLIMATE2923; Hallegatte S., 2016, CLIMATE CHANGE DEV S; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Kriegler E, 2015, TECHNOL FORECAST SOC, V90, P1, DOI 10.1016/j.techfore.2014.10.012; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Otto FEL, 2015, NAT CLIM CHANGE, V5, P917, DOI 10.1038/NCLIMATE2716; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Rogelj J, 2014, P NATL ACAD SCI USA, V111, P16325, DOI 10.1073/pnas.1415631111; Steinacher M, 2013, NATURE, V499, P197, DOI 10.1038/nature12269; van Vuuren DP, 2011, CLIMATIC CHANGE, V104, P793, DOI 10.1007/s10584-010-0004-6	10	26	26	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					613	615		10.1038/534613a	http://dx.doi.org/10.1038/534613a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP7JV	27357778	Bronze			2022-12-24	WOS:000378676000012
J	Shin, HJR; Kim, H; Oh, S; Lee, JG; Kee, M; Ko, HJ; Kweon, MN; Won, KJ; Baek, SH				Shin, Hi-Jai R.; Kim, Hyunkyung; Oh, Sungryong; Lee, Jun-Gi; Kee, Minjung; Ko, Hyun-Jeong; Kweon, Mi-Na; Won, Kyoung-Jae; Baek, Sung Hee			AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; AMPK; COACTIVATOR; DEGRADATION; HOMEOSTASIS; EXPRESSION; INHIBITOR; COMPLEXES; DISEASE; TFEB	Autophagy is a highly conserved self-digestion process, which is essential for maintaining homeostasis and viability in response to nutrient starvation(1-4). Although the components of autophagy in the cytoplasm have been well studied(5,6), the molecular basis for the transcriptional and epigenetic regulation of autophagy is poorly understood. Here we identify co-activator-associated arginine methyltransferase 1 (CARM1) as a crucial component of autophagy in mammals. Notably, CARM1 stability is regulated by the SKP2-containing SCF (SKP1-cullin1-F-box protein) E3 ubiquitin ligase in the nucleus, but not in the cytoplasm, under nutrient-rich conditions. Furthermore, we show that nutrient starvation results in AMP-activated protein kinase (AMPK)-dependent phosphorylation of FOXO3a in the nucleus, which in turn transcriptionally represses SKP2. This repression leads to increased levels of CARM1 protein and subsequent increases in histone H3 Arg17 dimethylation. Genome-wide analyses reveal that CARM1 exerts transcriptional co-activator function on autophagy-related and lysosomal genes through transcription factor EB (TFEB). Our findings demonstrate that CARM1-dependent histone arginine methylation is a crucial nuclear event in autophagy, and identify a new signalling axis of AMPK-SKP2-CARM1 in the regulation of autophagy induction after nutrient starvation.	[Shin, Hi-Jai R.; Kim, Hyunkyung; Oh, Sungryong; Lee, Jun-Gi; Kee, Minjung; Baek, Sung Hee] Seoul Natl Univ, Sch Biol Sci, Creat Res Initiat Ctr Chromatin Dynam, Seoul, South Korea; [Ko, Hyun-Jeong] Kangwon Natl Univ, Coll Pharm, Lab Microbiol & Immunol, Chunchon, South Korea; [Kweon, Mi-Na] Univ Ulsan, Coll Med, Asan Med Ctr, Mucosal Immunol Lab,Dept Convergence Med, Seoul, South Korea; [Won, Kyoung-Jae] Univ Penn, Perelman Sch Med, Dept Genet, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	Seoul National University (SNU); Kangwon National University; University of Ulsan; Asan Medical Center; University of Pennsylvania; Pennsylvania Medicine	Baek, SH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Creat Res Initiat Ctr Chromatin Dynam, Seoul, South Korea.	sbaek@snu.ac.kr		Ko, Hyun-Jeong/0000-0002-3844-928X; Kim, Hyunkyung/0000-0001-7678-6087; Won, Kyoung Jae/0000-0002-2924-9630; Shin, Hijai Regina/0000-0001-5642-4441	Creative Research Initiatives Program (Research Center for Chromatin Dynamics) [2009-0081563]; National Junior Research Fellowship [NRF-2011-A01496-0001806]; National Research Foundation (NRF) - South Korean government (MSIP) [NRF-2014R1A6A3A0405 7910]; NIH [R01DK106027]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106027] Funding Source: NIH RePORTER	Creative Research Initiatives Program (Research Center for Chromatin Dynamics); National Junior Research Fellowship; National Research Foundation (NRF) - South Korean government (MSIP); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Chromatin Dynamics Research Center for technical assistance and discussions and J. Kim and J. Chung for valuable reagents and discussions. We thank Y. S. Yu for illustrations. The TEM data were analysed in the Korean Basic Science Institute. Carm1 knockout and knock-in MEFs were provided by M. T. Bedford. Ampk DKO MEFs was a gift from B. Viollet, and Foxo1.3.4<SUP>f/f</SUP> MEFs were a gift from R. DePinho and J.-H. Paik. This work was supported by Creative Research Initiatives Program (Research Center for Chromatin Dynamics, 2009-0081563) to S.H.B.; the National Junior Research Fellowship (NRF-2011-A01496-0001806) to H.-J.R.S.; the Basic Science Research Program (NRF-2014R1A6A3A0405 7910) to H.K. from the National Research Foundation (NRF) grant funded by the South Korean government (MSIP); NIH grant (R01DK106027) to K.-J.W.	Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Boo K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7810; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen Z, 2013, BBA-PROTEINS PROTEOM, V1834, P1461, DOI 10.1016/j.bbapap.2013.04.006; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hardie DG, 2011, EMBO J, V30, P634, DOI 10.1038/emboj.2011.12; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim H, 2011, MOL CELL, V44, P797, DOI 10.1016/j.molcel.2011.09.023; Kim IS, 2012, MOL CELL, V46, P260, DOI 10.1016/j.molcel.2012.03.021; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Selvi BR, 2010, J BIOL CHEM, V285, P7143, DOI 10.1074/jbc.M109.063933; Settembre C, 2015, METHOD CELL BIOL, V126, P45, DOI 10.1016/bs.mcb.2014.11.011; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Wang K, 2010, J BIOL CHEM, V285, P16958, DOI 10.1074/jbc.M109.093005; Yang YC, 2014, J THORAC ONCOL, V9, P1305, DOI 10.1097/JTO.0000000000000240; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814	32	268	278	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					553	+		10.1038/nature18014	http://dx.doi.org/10.1038/nature18014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309807	Green Accepted			2022-12-24	WOS:000378270300054
J	Vasek, MJ; Garber, C; Dorsey, D; Durrant, DM; Bollman, B; Soung, A; Yu, JS; Perez-Torres, C; Frouin, A; Wilton, DK; Funk, K; DeMasters, BK; Jiang, XP; Bowen, JR; Mennerick, S; Robinson, JK; Garbow, JR; Tyler, KL; Suthar, MS; Schmidt, RE; Stevens, B; Klein, RS				Vasek, Michael J.; Garber, Charise; Dorsey, Denise; Durrant, Douglas M.; Bollman, Bryan; Soung, Allison; Yu, Jinsheng; Perez-Torres, Carlos; Frouin, Arnaud; Wilton, Daniel K.; Funk, Kristen; DeMasters, Bette K.; Jiang, Xiaoping; Bowen, James R.; Mennerick, Steven; Robinson, John K.; Garbow, Joel R.; Tyler, Kenneth L.; Suthar, Mehul S.; Schmidt, Robert E.; Stevens, Beth; Klein, Robyn S.			A complement-microglial axis drives synapse loss during virus-induced memory impairment	NATURE			English	Article							WEST-NILE-VIRUS; INFECTION; ACTIVATION; CNS; TRAFFICKING; PROTECTS; DEATH	Over 50% of patients who survive neuroinvasive infection with West Nile virus (WNV) exhibit chronic cognitive sequelae(1,2). Although thousands of cases of WNV-mediated memory dysfunction accrue annually(3), the mechanisms responsible for these impairments are unknown. The classical complement cascade, a key component of innate immune pathogen defence, mediates synaptic pruning by microglia during early postnatal development(4,5). Here we show that viral infection of adult hippocampal neurons induces complement-mediated elimination of presynaptic terminals in a murine WNV neuroinvasive disease model. Inoculation of WNV-NS5-E218A, a WNV with a mutant NS5(E218A) protein(6,7) leads to survival rates and cognitive dysfunction that mirror human WNV neuroinvasive disease. WNV-NS5-E218A-recovered mice (recovery defined as survival after acute infection) display impaired spatial learning and persistence of phagocytic microglia without loss of hippocampal neurons or volume. Hippocampi from WNV-NS5-E218A-recovered mice with poor spatial learning show increased expression of genes that drive synaptic remodelling by microglia via complement. C1QA was upregulated and localized to microglia, infected neurons and presynaptic terminals during WNV neuroinvasive disease. Murine and human WNV neuroinvasive disease post-mortem samples exhibit loss of hippocampal CA3 presynaptic terminals, and murine studies revealed microglial engulfment of presynaptic terminals during acute infection and after recovery. Mice with fewer microglia (Il34(-/-) mice with a deficiency in IL-34 production) or deficiency in complement C3 or C3a receptor were protected from WNV-induced synaptic terminal loss. Our study provides a new murine model of WNV-induced spatial memory impairment, and identifies a potential mechanism underlying neurocognitive impairment in patients recovering from WNV neuroinvasive disease.	[Vasek, Michael J.; Garber, Charise; Dorsey, Denise; Durrant, Douglas M.; Bollman, Bryan; Soung, Allison; Funk, Kristen; Klein, Robyn S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Durrant, Douglas M.] Calif State Polytech Univ Pomona, Dept Biol Sci, 3801 West Temple Ave, Pomona, CA 91768 USA; [Yu, Jinsheng] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Perez-Torres, Carlos; Garbow, Joel R.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Frouin, Arnaud; Wilton, Daniel K.; Stevens, Beth] Harvard Univ, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Sch Med,Dept Neurol, Boston, MA 02115 USA; [DeMasters, Bette K.; Tyler, Kenneth L.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO 80045 USA; [Jiang, Xiaoping; Mennerick, Steven] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Bowen, James R.; Suthar, Mehul S.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30329 USA; [Bowen, James R.; Suthar, Mehul S.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Emory Vaccine Ctr,Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Robinson, John K.] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Schmidt, Robert E.; Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); California State University System; California State Polytechnic University Pomona; Washington University (WUSTL); Washington University (WUSTL); Harvard University; Boston Children's Hospital; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; Washington University (WUSTL); Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL); Washington University (WUSTL)	Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	rklein@dom.wustl.edu	Tyler, Kenneth L./J-2420-2019; Mennerick, Steven/O-2806-2017; Funk, Kristen/AAC-6334-2020	Tyler, Kenneth L./0000-0003-3294-5888; Mennerick, Steven/0000-0003-0868-0664; Funk, Kristen/0000-0002-1912-1430; Perez-Torres, Carlos/0000-0003-3352-011X; Soung, Allison/0000-0002-1590-6038; Vasek, Michael/0000-0002-1112-4346	NIH [F31 NS077640, R01 NS052632, U19 AI083019]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101400, U19AI083019, T32AI052066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052632, F31NS077640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F30AA023685] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding for this research was provided by the NIH F31 NS077640 (M.J.V.), R01 NS052632 (R.S.K.), and U19 AI083019 (R.S.K. and M.S.S.). The authors would like to thank J. Atkinson and X. Wu for reagents and M. Diamond for critical reading of the manuscript.	Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Clarke P, 2014, MBIO, V5, DOI 10.1128/mBio.00902-14; Clarke P, 2014, J VIROL, V88, P1080, DOI 10.1128/JVI.02944-13; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Durrant DM, 2013, J EXP MED, V210, P503, DOI 10.1084/jem.20121897; EBENBICHLER CF, 1991, J EXP MED, V174, P1417, DOI 10.1084/jem.174.6.1417; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879; Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016; McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105; Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; Menard C, 2015, NEUROBIOL AGING, V36, P1471, DOI 10.1016/j.neurobiolaging.2014.11.013; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Sadek JR, 2010, J CLIN EXP NEUROPSYC, V32, P81, DOI 10.1080/13803390902881918; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Samuel MA, 2007, J VIROL, V81, P2614, DOI 10.1128/JVI.02311-06; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096442; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Veerhuis R, 1999, EXP NEUROL, V160, P289, DOI 10.1006/exnr.1999.7199; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360	33	339	343	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					538	+		10.1038/nature18283	http://dx.doi.org/10.1038/nature18283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27337340	Green Accepted			2022-12-24	WOS:000378270300051
J	Trentham-Dietz, A; Kerlikowske, K; Stout, NK; Miglioretti, DL; Schechter, CB; Ergun, MA; van den Broek, JJ; Alagoz, O; Sprague, BL; van Ravesteyn, NT; Near, AM; Gangnon, RE; Hampton, JM; Chandler, Y; de Koning, HJ; Mandelblatt, JS; Tosteson, ANA				Trentham-Dietz, Amy; Kerlikowske, Karla; Stout, Natasha K.; Miglioretti, Diana L.; Schechter, Clyde B.; Ergun, Mehmet Ali; van den Broek, Jeroen J.; Alagoz, Oguzhan; Sprague, Brian L.; van Ravesteyn, Nicolien T.; Near, Aimee M.; Gangnon, Ronald E.; Hampton, John M.; Chandler, Young; de Koning, Harry J.; Mandelblatt, Jeanne S.; Tosteson, Anna N. A.		Breast Cancer Surveillance Consor; Cancer Intervention Surveillance M	Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							TASK-FORCE RECOMMENDATION; ESTROGEN PLUS PROGESTIN; COST-EFFECTIVENESS; UNITED-STATES; POSTMENOPAUSAL WOMEN; MAMMOGRAPHY; BENEFITS; HARMS; HEALTH; METAANALYSIS	Background: Biennial screening is generally recommended for average-risk women aged 50 to 74 years, but tailored screening may provide greater benefits. Objective: To estimate outcomes for various screening intervals after age 50 years based on breast density and risk for breast cancer. Design: Collaborative simulation modeling using national incidence, breast density, and screening performance data. Setting: United States. Patients: Women aged 50 years or older with various combinations of breast density and relative risk (RR) of 1.0, 1.3, 2.0, or 4.0. Intervention: Annual, biennial, or triennial digital mammography screening from ages 50 to 74 years (vs. no screening) and ages 65 to 74 years (vs. biennial digital mammography from ages 50 to 64 years). Measurements: Lifetime breast cancer deaths, life expectancy and quality-adjusted life-years (QALYs), false-positive mammo-grams, benign biopsy results, overdiagnosis, cost-effectiveness, and ratio of false-positive results to breast cancer deaths averted. Results: Screening benefits and overdiagnosis increase with breast density and RR. False-positive mammograms and benign results on biopsy decrease with increasing risk. Among women with fatty breasts or scattered fibroglandular density and an RR of 1.0 or 1.3, breast cancer deaths averted were similar for triennial versus biennial screening for both age groups (50 to 74years, median of 3.4 to 5.1 vs. 4.1 to 6.5 deaths averted; 65 to 74 years, median of 1.5 to 2.1 vs. 1.8 to 2.6 deaths averted). Breast cancer deaths averted increased with annual versus biennial screening for women aged 50 to 74 years at all levels of breast density and an RR of 4.0, and those aged 65 to 74 years with heterogeneously or extremely dense breasts and an RR of 4.0. However, harms were almost 2-fold higher. Triennial screening for the average-risk subgroup and annual screening for the highest-risk subgroup cost less than $100 000 per QALY gained. Limitation: Models did not consider women younger than 50 years, those with an RR less than 1, or other imaging methods. Conclusion: Average-risk women with low breast density undergoing triennial screening and higher-risk women with high breast density receiving annual screening will maintain a similar or better balance of benefits and harms than average-risk women receiving biennial screening.	[Trentham-Dietz, Amy; Hampton, John M.] Univ Wisconsin, Carbone Canc Ctr, 610 Walnut St,WARF Room 307, Madison, WI 53726 USA; [Kerlikowske, Karla] VAMC, 4150 Clement St,111A1, San Francisco, CA 94121 USA; [Stout, Natasha K.] Harvard Med Sch, Dept Populat Med, 401 Pk Dr,Suite 401, Boston, MA 02215 USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, Landmark Ctr, 401 Pk Dr,Suite 401, Boston, MA 02215 USA; [Miglioretti, Diana L.] Univ Calif Davis, Dept Publ Hlth Sci, Sch Med, One Shields Ave Med Sci 1C,Room 145, Davis, CA 95616 USA; [Schechter, Clyde B.] Albert Einstein Coll Med, Dept Family & Social Med, 1300 Morris Pk Ave,Block Bldg 406, Bronx, NY 10461 USA; [Ergun, Mehmet Ali; Alagoz, Oguzhan] Univ Wisconsin, Univ Ave, Dept Ind & Sys tems Engn, 1513 Univ Ave, Madison, WI 53706 USA; [van den Broek, Jeroen J.; van Ravesteyn, Nicolien T.; de Koning, Harry J.] Univ Med Ctr Rotterdam, Erasmus Med Ctr, POB 2040, NL-3000 CA Rottterdam, Netherlands; [Sprague, Brian L.] Univ Vermont, Off Hlth Promot Res, 1 South Prospect St, Burlington, VT 05401 USA; [Near, Aimee M.; Chandler, Young; Mandelblatt, Jeanne S.] Georgetown Univ, Lombardi Comprehens Canc Ctr, 3300 Whitehaven St Northwest,Suite 4100, Washington, DC 20007 USA; [Gangnon, Ronald E.] Univ Wisconsin, Dept Populat Hlth Sci, 610 Walnut St, Madison, WI 53726 USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, One Med Ctr Dr HB7505, Lebanon, NH 03756 USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of California System; University of California Davis; Yeshiva University; Albert Einstein College of Medicine; University of Wisconsin System; University of Wisconsin Madison; Erasmus University Rotterdam; Erasmus MC; University of Vermont; Georgetown University; University of Wisconsin System; University of Wisconsin Madison; Dartmouth College	Trentham-Dietz, A (corresponding author), Univ Wisconsin, Carbone Canc Ctr, 610 Walnut St,WARF Room 307, Madison, WI 53726 USA.	trentham@wisc.edu	Ergun, Mehmet/AAB-9782-2019; de+Koning, Harry/AAF-9062-2019	Ergun, Mehmet/0000-0002-2480-8077; de+Koning, Harry/0000-0003-4682-3646; Alagoz, Oguzhan/0000-0002-5133-1382; Heckman-Stoddard, Brandy/0000-0003-1686-7154; Gangnon, Ronald/0000-0003-2587-6714	National Cancer Institute; NATIONAL CANCER INSTITUTE [U01CA152958, P30CA093373, U01CA199218, P01CA154292, P30CA023108, U54CA163303, P30CA014520] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; American College of Radiology, 2003, AM CLOO RAD BREAST I; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Carter SB, 2006, HIST STAT US; Chlebowski RT, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv327; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Cronin KA, 2005, CANCER CAUSE CONTROL, V16, P701, DOI 10.1007/s10552-005-0693-8; Cronin Kathleen A, 2006, J Natl Cancer Inst Monogr, P26, DOI 10.1093/jncimonographs/lgj005; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Dyrstad SW, 2015, BREAST CANCER RES TR, V149, P569, DOI 10.1007/s10549-014-3254-6; Fryback Dennis G, 2006, J Natl Cancer Inst Monogr, P37, DOI 10.1093/jncimonographs/lgj007; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gangnon RE, 2015, CANCER EPIDEM BIOMAR, V24, P905, DOI 10.1158/1055-9965.EPI-14-1286; Giordano L, 2012, J MED SCREEN, V19, P72, DOI 10.1258/jms.2012.012085; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, AL CONS ETH CARB; Kerlikowske K, 2015, JAMA INTERN MED, V175, P1970, DOI 10.1001/jamainternmed.2015.6466; Kerlikowske K, 2015, ANN INTERN MED, V162, P673, DOI 10.7326/M14-1465; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Mandelblatt JCK, 2015, AHRQ PUBLICATION; Mandelblatt Jeanne, 2006, J Natl Cancer Inst Monogr, P47, DOI 10.1093/jncimonographs/lgj008; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Mariotto Angela B, 2006, J Natl Cancer Inst Monogr, P7, DOI 10.1093/jncimonographs/lgj003; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Munoz D, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju289; Munsell MF, 2014, EPIDEMIOL REV, V36, P114, DOI 10.1093/epirev/mxt010; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; National Cancer Institute, 2015, SURV EP END RES PROG; National Cancer Institute, 2015, BREAST CANC SURV CON; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Nelson HD, 2016, ANN INTERN MED, V164, P256, DOI 10.7326/M15-0970; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Rosner B, 1996, J NATL CANCER I, V88, P359, DOI 10.1093/jnci/88.6.359; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Siu AL, 2016, ANN INTERN MED, V164, P301, DOI 10.7326/M15-3065; Sprague BL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju255; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Stout NK, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju092; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; Tice JA, 2015, J CLIN ONCOL, V33, P3137, DOI 10.1200/JCO.2015.60.8869; Trentham-Dietz A, 2014, BREAST CANCER RES TR, V145, P165, DOI 10.1007/s10549-014-2905-y; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; van Ravesteyn NT, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv103; van Ravesteyn NT, 2012, ANN INTERN MED, V156, P609, DOI 10.7326/0003-4819-156-9-201205010-00002; Vilaprinyo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086858; von Karsa L., 2008, CANC SCREENING EUROP; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103	57	77	78	1	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2016	165	10					700	+		10.7326/M16-0476	http://dx.doi.org/10.7326/M16-0476			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC2RB	27548583	Green Accepted			2022-12-24	WOS:000387970500014
J	Mao, LB; Gao, HL; Yao, HB; Liu, L; Colfen, H; Liu, G; Chen, SM; Li, SK; Yan, YX; Liu, YY; Yu, SH				Mao, Li-Bo; Gao, Huai-Ling; Yao, Hong-Bin; Liu, Lei; Colfen, Helmut; Liu, Gang; Chen, Si-Ming; Li, Shi-Kuo; Yan, You-Xian; Liu, Yang-Yi; Yu, Shu-Hong			Synthetic nacre by predesigned matrix-directed mineralization	SCIENCE			English	Article							MECHANICAL-PROPERTIES; CERAMICS; MIMETICS; DESIGN; TOUGH	Although biomimetic designs are expected to play a key role in exploring future structural materials, facile fabrication of bulk biomimetic materials under ambient conditions remains a major challenge. Here, we describe a mesoscale "assembly-and-mineralization" approach inspired by the natural process in mollusks to fabricate bulk synthetic nacre that highly resembles both the chemical composition and the hierarchical structure of natural nacre. The millimeter-thick synthetic nacre consists of alternating organic layers and aragonite platelet layers (91 weight percent) and exhibits good ultimate strength and fracture toughness. This predesigned matrix-directed mineralization method represents a rational strategy for the preparation of robust composite materials with hierarchically ordered structures, where various constituents are adaptable, including brittle and heat-labile materials.	[Mao, Li-Bo; Gao, Huai-Ling; Yao, Hong-Bin; Liu, Lei; Chen, Si-Ming; Li, Shi-Kuo; Yan, You-Xian; Liu, Yang-Yi; Yu, Shu-Hong] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Div Nanomat & Chem, Hefei 230026, Peoples R China; [Mao, Li-Bo; Gao, Huai-Ling; Yao, Hong-Bin; Liu, Lei; Chen, Si-Ming; Li, Shi-Kuo; Yan, You-Xian; Liu, Yang-Yi; Yu, Shu-Hong] Chinese Acad Sci, Univ Sci & Technol China, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Hefei Sci Ctr,Dept Chem,Ctr Excellence Nanosci, Hefei 230026, Peoples R China; [Liu, Lei; Colfen, Helmut] Univ Konstanz, Phys Chem, Univ Str 10, D-78457 Constance, Germany; [Liu, Gang; Yu, Shu-Hong] Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Hefei 230029, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Konstanz; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Yu, SH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Div Nanomat & Chem, Hefei 230026, Peoples R China.; Yu, SH (corresponding author), Chinese Acad Sci, Univ Sci & Technol China, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Hefei Sci Ctr,Dept Chem,Ctr Excellence Nanosci, Hefei 230026, Peoples R China.; Yu, SH (corresponding author), Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Hefei 230029, Peoples R China.	shyu@ustc.edu.cn	Mao, Li-bo/W-3794-2019; Gao, Huai-Ling/J-6295-2012; Yao, Hong-Bin/AAF-9517-2019; Gao, Huai-Ling/P-9709-2019; Liu, Yang-Yi/F-4350-2019; Yao, Hongbin/B-8347-2011; Yu, Shu-Hong/A-1903-2010	Gao, Huai-Ling/0000-0001-8908-1967; Gao, Huai-Ling/0000-0001-8908-1967; Liu, Yang-Yi/0000-0001-5823-828X; Yu, Shu-Hong/0000-0003-3732-1011; Mao, Li-Bo/0000-0002-9249-2449	National Natural Science Foundation of China [21431006]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [21521001]; National Basic Research Program of China [2014CB931800, 2013CB931800]; Users with Excellence and Scientific Research Grant of Hefei Science Center of CAS [2015HSC-UE007, 2015SRG-HSC038]; Key Research Program of Frontier Sciences, CAS [QYZDJ-SSW-SLH036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Users with Excellence and Scientific Research Grant of Hefei Science Center of CAS; Key Research Program of Frontier Sciences, CAS	The authors thank Y. Tian, L. Chen, and Y. Guan for computed tomography imaging, and L. Wang for sample preparation. The authors also thank Y. Ni and Z. Song for discussion about mechanical models. This work was supported by the National Natural Science Foundation of China (grant 21431006), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (grant 21521001), the National Basic Research Program of China (grants 2014CB931800 and 2013CB931800), the Users with Excellence and Scientific Research Grant of Hefei Science Center of CAS (2015HSC-UE007 and 2015SRG-HSC038), and Key Research Program of Frontier Sciences, CAS (Grant QYZDJ-SSW-SLH036). Data are available in the supplementary materials.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Bai H, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500849; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726; Bouville F, 2014, NAT MATER, V13, P508, DOI [10.1038/nmat3915, 10.1038/NMAT3915]; Chec AG, 2009, P NATL ACAD SCI USA, V106, P38, DOI 10.1073/pnas.0808796106; Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; Das P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6967; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Deville S, 2008, ADV ENG MATER, V10, P155, DOI 10.1002/adem.200700270; Finnemore A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1970; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Fratzl P, 2016, CHEM SOC REV, V45, P252, DOI 10.1039/c5cs00598a; Gebauer D, 2009, ADV MATER, V21, P435, DOI 10.1002/adma.200801614; Huang ZW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01693; Jager I, 2000, BIOPHYS J, V79, P1737, DOI 10.1016/S0006-3495(00)76426-5; Ji BH, 2010, ANNU REV MATER RES, V40, P77, DOI 10.1146/annurev-matsci-070909-104424; Kato T, 2000, CHEM LETT, P186, DOI 10.1246/cl.2000.186; Kim Y, 2013, NATURE, V500, P59, DOI 10.1038/nature12401; Laaksonen P, 2011, ANGEW CHEM INT EDIT, V50, P8688, DOI 10.1002/anie.201102973; Le Ferrand H, 2015, NAT MATER, V14, P1172, DOI [10.1038/nmat4419, 10.1038/NMAT4419]; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Rabiei R, 2010, ACTA BIOMATER, V6, P4081, DOI 10.1016/j.actbio.2010.04.008; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/NMAT3115, 10.1038/nmat3115]; Seto J, 2012, P NATL ACAD SCI USA, V109, P3699, DOI 10.1073/pnas.1109243109; Shao Y, 2012, J MECH PHYS SOLIDS, V60, P1400, DOI 10.1016/j.jmps.2012.04.011; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Wang JF, 2012, CHEM SOC REV, V41, P1111, DOI 10.1039/c1cs15106a; Wang Jiwen, 2009, Biomaterials, V30, P6565, DOI 10.1016/j.biomaterials.2009.08.048; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340; Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/nmat4089, 10.1038/NMAT4089]; Weiner S, 2000, MAT SCI ENG C-BIO S, V11, P1, DOI 10.1016/S0928-4931(00)00141-7; Yao HB, 2014, ADV MATER, V26, P163, DOI 10.1002/adma.201303470; Zhu BL, 2015, ANGEW CHEM INT EDIT, V54, P8653, DOI 10.1002/anie.201502323; Zhu FJ, 2013, CHEM-ASIAN J, V8, P3002, DOI 10.1002/asia.201300745	38	524	542	110	1335	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2016	354	6308			SI		107	110		10.1126/science.aaf8991	http://dx.doi.org/10.1126/science.aaf8991			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0GT	27540008	Green Submitted			2022-12-24	WOS:000387777900040
J	Rubin, R				Rubin, Rita			US prisons missing opportunities to tackle HIV in inmates	LANCET			English	Editorial Material													Rubin, Rita/AAD-1259-2020						0	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2016	388	10049					1041	1042		10.1016/S0140-6736(16)31078-9	http://dx.doi.org/10.1016/S0140-6736(16)31078-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV0OD	27427458				2022-12-24	WOS:000382616900013
J	Keren, L; Hausser, J; Lotan-Pompan, M; Slutskin, IV; Alisar, H; Kaminski, S; Weinberger, A; Alon, U; Milo, R; Segal, E				Keren, Leeat; Hausser, Jean; Lotan-Pompan, Maya; Slutskin, Ilya Vainberg; Alisar, Hadas; Kaminski, Sivan; Weinberger, Adina; Alon, Uri; Milo, Ron; Segal, Eran			Massively Parallel Interrogation of the Effects of Gene Expression Levels on Fitness	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; LELOIR PATHWAY; YEAST; PROTEINS; COST; PHOSPHOGLUCOMUTASE; ENZYMES; BINDING; NOISE; TOOL	Data of gene expression levels across individuals, cell types, and disease states is expanding, yet our understanding of how expression levels impact phenotype is limited. Here, we present a massively parallel system for assaying the effect of gene expression levels on fitness in Saccharomyces cerevisiae by systematically altering the expression level of similar to 100 genes at similar to 100 distinct levels spanning a 500-fold range at high resolution. We show that the relationship between expression levels and growth is gene and environment specific and provides information on the function, stoichiometry, and interactions of genes. Wild-type expression levels in some conditions are not optimal for growth, and genes whose fitness is greatly affected by small changes in expression level tend to exhibit lower cell-to-cell variability in expression. Our study addresses a fundamental gap in understanding the functional significance of gene expression regulation and offers a framework for evaluating the phenotypic effects of expression variation.	[Keren, Leeat; Lotan-Pompan, Maya; Slutskin, Ilya Vainberg; Alisar, Hadas; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Keren, Leeat; Hausser, Jean; Lotan-Pompan, Maya; Slutskin, Ilya Vainberg; Alisar, Hadas; Weinberger, Adina; Alon, Uri; Segal, Eran] Weizmann Inst Sci, Mol Cell Biol, IL-76100 Rehovot, Israel; [Kaminski, Sivan] Weizmann Inst Sci, Mol Genet, IL-76100 Rehovot, Israel; [Keren, Leeat; Milo, Ron] Weizmann Inst Sci, Plant & Environm Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Segal, E (corresponding author), Weizmann Inst Sci, Comp Sci & Appl Math, IL-76100 Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Mol Cell Biol, IL-76100 Rehovot, Israel.	eran.segal@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Segal, Eran/0000-0002-6859-1164; Hausser, Jean/0000-0002-3321-7199	European Research Council (ERC); NIH; Kahn Center; Azrieli Center for Systems Biology	European Research Council (ERC)(European Research Council (ERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kahn Center; Azrieli Center for Systems Biology	This work was supported by grants from the European Research Council (ERC) and the NIH to E.S. and student grants from the Kahn Center and Azrieli Center for Systems Biology to L.K. We thank Michal Levo, Shira Weingarten-Gabbay, Dan Davidi, Niv Antonovski, Martin Mikl, David Zeevi, and Eran Kotler for valuable input.	Alon U., 2006, INTRO SYSTEMS BIOL D; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bauer CR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145264; BERNSTEIN M, 1985, J CELL BIOL, V101, P2374, DOI 10.1083/jcb.101.6.2374; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Bro C, 2005, APPL ENVIRON MICROB, V71, P6465, DOI 10.1128/AEM.71.11.6465-6472.2005; Chambers A, 1995, CURR GENET, V29, P1, DOI 10.1007/BF00313187; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Jongh WA, 2008, BIOTECHNOL BIOENG, V101, P317, DOI 10.1002/bit.21890; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Hong KK, 2011, P NATL ACAD SCI USA, V108, P12179, DOI 10.1073/pnas.1103219108; Kafri M, 2016, CELL REP, V14, P22, DOI 10.1016/j.celrep.2015.12.015; Kalisky T, 2007, PHYS BIOL, V4, P229, DOI 10.1088/1478-3975/4/4/001; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Keren L., 2015, GENOME RES; Keren L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.59; KODADEK T, 1993, CELL MOL BIOL RES, V39, P355; Lee KS, 2011, BIOTECHNOL BIOENG, V108, P621, DOI 10.1002/bit.22988; Metzger BPH, 2015, NATURE, V521, P344, DOI 10.1038/nature14244; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Perfeito L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002160; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Rest JS, 2013, MOL BIOL EVOL, V30, P448, DOI 10.1093/molbev/mss248; Sellick CA, 2008, INT REV CEL MOL BIO, V269, P111, DOI 10.1016/S1937-6448(08)01003-4; Shalem O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002934; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Winsor B, 1997, YEAST, V13, P399; Zampar GG, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.11; Zeevi D, 2011, GENOME RES, V21, P2114, DOI 10.1101/gr.119669.110	49	89	89	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1282	+		10.1016/j.cell.2016.07.024	http://dx.doi.org/10.1016/j.cell.2016.07.024			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27545349	Bronze			2022-12-24	WOS:000382259500023
J	Paez-Espino, D; Eloe-Fadrosh, EA; Pavlopoulos, GA; Thomas, AD; Huntemann, M; Mikhailova, N; Rubin, E; Ivanova, NN; Kyrpides, NC				Paez-Espino, David; Eloe-Fadrosh, Emiley A.; Pavlopoulos, Georgios A.; Thomas, Alex D.; Huntemann, Marcel; Mikhailova, Natalia; Rubin, Edward; Ivanova, Natalia N.; Kyrpides, Nikos C.			Uncovering Earth's virome	NATURE			English	Article							MARINE VIRUSES; PHAGE; BACTERIOPHAGE; PROTEIN; SEQUENCES; GENE; ENVIRONMENT; RESISTANCE; ALGORITHM; DATABASE	Viruses are the most abundant biological entities on Earth, but challenges in detecting, isolating, and classifying unknown viruses have prevented exhaustive surveys of the global virome. Here we analysed over 5 Tb of metagenomic sequence data from 3,042 geographically diverse samples to assess the global distribution, phylogenetic diversity, and host specificity of viruses. We discovered over 125,000 partial DNA viral genomes, including the largest phage yet identified, and increased the number of known viral genes by 16-fold. Half of the predicted partial viral genomes were clustered into genetically distinct groups, most of which included genes unrelated to those in known viruses. Using CRISPR spacers and transfer RNA matches to link viral groups to microbial host(s), we doubled the number of microbial phyla known to be infected by viruses, and identified viruses that can infect organisms from different phyla. Analysis of viral distribution across diverse ecosystems revealed strong habitat-type specificity for the vast majority of viruses, but also identified some cosmopolitan groups. Our results highlight an extensive global viral diversity and provide detailed insight into viral habitat distribution and host-virus interactions.	[Paez-Espino, David; Eloe-Fadrosh, Emiley A.; Pavlopoulos, Georgios A.; Thomas, Alex D.; Huntemann, Marcel; Mikhailova, Natalia; Rubin, Edward; Ivanova, Natalia N.; Kyrpides, Nikos C.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Rubin, Edward] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Rubin, Edward] Metabiota Inc, San Francisco, CA 94104 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Kyrpides, NC (corresponding author), Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA.	nckyrpides@lbl.gov	Pavlopoulos, Georgios A./L-7544-2017; Paez-Espino, David/I-8297-2019; Kyrpides, Nikos C./A-6305-2014; Huntemann, Marcel/HCH-8928-2022; Eloe-Fadrosh, Emiley/AAP-8019-2021	Pavlopoulos, Georgios A./0000-0002-4577-8276; Paez-Espino, David/0000-0002-2939-5398; Kyrpides, Nikos C./0000-0002-6131-0462; Huntemann, Marcel/0000-0002-1284-3748; Eloe-Fadrosh, Emiley/0000-0002-8162-1276; Ivanova, Natalia/0000-0002-5802-9485	US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility [DE-AC02-05CH11231]; Office of Science of US Department of Energy	US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility(United States Department of Energy (DOE)); Office of Science of US Department of Energy(United States Department of Energy (DOE))	We thank A. Visel and H. Maughan for critical reading and feedback, A. Pati for help in earlier versions, and the IMG and GOLD teams for their support. This work was conducted by the US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, under contract number DE-AC02-05CH11231 and used resources of the National Energy Research Scientific Computing Center, supported by the Office of Science of the US Department of Energy.	Abeles SR, 2014, J MOL BIOL, V426, P3892, DOI 10.1016/j.jmb.2014.07.002; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Aziz RK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00381; Bailly-Bechet M, 2007, GENOME RES, V17, P1486, DOI 10.1101/gr.6649807; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bondy-Denomy J, 2014, J MICROBIOL, V52, P235, DOI 10.1007/s12275-014-4083-3; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Brum JR, 2015, NAT REV MICROBIOL, V13, P147, DOI 10.1038/nrmicro3404; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chow CET, 2015, ANNU REV VIROL, V2, P41, DOI 10.1146/annurev-virology-031413-085540; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Edwards RA, 2016, FEMS MICROBIOL REV, V40, P258, DOI 10.1093/femsre/fuv048; Emerson JB, 2013, ARCHAEA, V2013, DOI 10.1155/2013/370871; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Goren MG, 2015, TRENDS MICROBIOL, V23, P744, DOI 10.1016/j.tim.2015.10.006; Holmfeldt K, 2007, APPL ENVIRON MICROB, V73, P6730, DOI 10.1128/AEM.01399-07; Huntemann M, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0077-y; Hurwitz BL, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw077; Hurwitz BL, 2015, ISME J, V9, P472, DOI 10.1038/ismej.2014.143; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ignacio-Espinoza J Cesar, 2013, Curr Opin Virol, V3, P566, DOI 10.1016/j.coviro.2013.07.004; Ivanova N, 2010, ENVIRON MICROBIOL, V12, P1803, DOI 10.1111/j.1462-2920.2010.02270.x; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kyrpides NC, 2016, TRENDS MICROBIOL, V24, P425, DOI 10.1016/j.tim.2016.02.011; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lu HJ, 2016, WATER RES, V88, P337, DOI 10.1016/j.watres.2015.10.013; Lum AG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1615-0; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Merchant N, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002342; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mukherjee S, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-18; Peters DL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1848-y; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robles-Sikisaka R, 2013, ISME J, V7, P1710, DOI 10.1038/ismej.2013.63; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; Roux S, 2015, PEERJ, V3, DOI 10.7717/peerj.985; Salazar G, 2016, ISME J, V10, P596, DOI 10.1038/ismej.2015.137; Salmond GPC, 2015, NAT REV MICROBIOL, V13, P777, DOI 10.1038/nrmicro3564; Serwer P, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-21; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; Simmonds P, 2015, J GEN VIROL, V96, P1193, DOI 10.1099/jgv.0.000016; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tschitschko B, 2015, ISME J, V9, P2094, DOI 10.1038/ismej.2015.110; Varghese NJ, 2015, NUCLEIC ACIDS RES, V43, P6761, DOI 10.1093/nar/gkv657; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wylie KM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0071-7	65	507	523	14	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					425	+		10.1038/nature19094	http://dx.doi.org/10.1038/nature19094			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27533034	Green Published			2022-12-24	WOS:000382646600035
J	Schmidt, JC; Zaug, AJ; Cech, TR				Schmidt, Jens C.; Zaug, Arthur J.; Cech, Thomas R.			Live Cell Imaging Reveals the Dynamics of Telomerase Recruitment to Telomeres	CELL			English	Article							TERT PROMOTER MUTATIONS; CHROMOSOME ENDS; LIVING CELLS; DNA-DAMAGE; TEL-PATCH; CANCER; EXPRESSION; SHELTERIN; TPP1; TRAFFICKING	Telomerase maintains genome integrity by adding repetitive DNA sequences to the chromosome ends in actively dividing cells, including 90% of all cancer cells. Recruitment of human telomerase to telomeres occurs during S-phase of the cell cycle, but the molecular mechanism of the process is only partially understood. Here, we use CRISPR genome editing and single-molecule imaging to track telomerase trafficking in nuclei of living human cells. We demonstrate that telomerase uses three-dimensional diffusion to search for telomeres, probing each telomere thousands of times each S-phase but only rarely forming a stable association. Both the transient and stable association events depend on the direct interaction of the telomerase protein TERT with the telomeric protein TPP1. Our results reveal that telomerase recruitment to telomeres is driven by dynamic interactions between the rapidly diffusing telomerase and the chromosome end.	[Schmidt, Jens C.; Zaug, Arthur J.; Cech, Thomas R.] Univ Colorado Boulder, Howard Hughes Med Inst, BioFrontiers Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado Boulder, Howard Hughes Med Inst, BioFrontiers Inst, Dept Chem & Biochem, Boulder, CO 80309 USA.	thomas.cech@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019		NIH [R01 GM099705]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099705, K99GM120386, R00GM120386] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Cech lab members for assistance with experiments and useful discussions, Joe Dragavon and the BioFrontiers Advanced Light Microscopy Core for assistance with imaging, and Luke Lavis and Zhe Liu (HHMI Janelia Research Campus) for providing HaloTag dyes and assistance with data analysis. This work was supported in part by NIH grant R01 GM099705 to T.R.C. J.C.S. is a Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2169-13). T.R.C. is an investigator of the Howard Hughes Medical Institute and is on the board of directors of Merck.	Arnoult N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000920; Bandaria JN, 2016, CELL, V164, P735, DOI 10.1016/j.cell.2016.01.036; Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Borah S, 2015, SCIENCE, V347, P1006, DOI 10.1126/science.1260200; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Cohen SB, 2008, NAT METHODS, V5, P355, DOI 10.1038/NMETH.F.209; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dalby AB, 2015, J MOL BIOL, V427, P1291, DOI 10.1016/j.jmb.2015.01.008; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Egan ED, 2010, MOL CELL BIOL, V30, P2775, DOI 10.1128/MCB.00151-10; Gallardo F, 2011, MOL CELL, V44, P819, DOI 10.1016/j.molcel.2011.09.020; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Lee SS, 2015, CELL REP, V13, DOI 10.1016/j.celrep.2015.10.035; Liu Z, 2014, ELIFE, V3, DOI 10.7554/eLife.04236; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Normanno D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8357; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sauerwald A, 2013, NAT STRUCT MOL BIOL, V20, P454, DOI 10.1038/nsmb.2530; Schmidt JC, 2014, ELIFE, V3, DOI 10.7554/eLife.03563; Schmidt JC, 2015, GENE DEV, V29, P1095, DOI 10.1101/gad.263863.115; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Stern JL, 2015, GENE DEV, V29, P2219, DOI 10.1101/gad.269498.115; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Tong AS, 2015, CELL REP, V13, P1633, DOI 10.1016/j.celrep.2015.10.041; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wang XY, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-4; Weidenfeld I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp108; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Wu RA, 2015, ELIFE, V4, DOI 10.7554/eLife.08363; Xi LH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0791-1; Xi LH, 2014, NUCLEIC ACIDS RES, V42, P8565, DOI 10.1093/nar/gku560; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	51	102	104	0	102	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1188	+		10.1016/j.cell.2016.07.033	http://dx.doi.org/10.1016/j.cell.2016.07.033			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27523609	Green Accepted, Bronze			2022-12-24	WOS:000382259500016
J	Fox, J; Barfield, W				Fox, Jared; Barfield, Wanda			Decreasing Unintended Pregnancy Opportunities Created by the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; CONTRACEPTION; TEENS; COST		[Fox, Jared] Ctr Dis Control & Prevent, Policy, 1600 Clifton Rd NE,MS D-28, Atlanta, GA 30329 USA; [Barfield, Wanda] Ctr Dis Control & Prevent, Div Reprod Hlth, 1600 Clifton Rd NE,MS D-28, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Fox, J (corresponding author), Ctr Dis Control & Prevent, Policy, 1600 Clifton Rd NE,MS D-28, Atlanta, GA 30329 USA.	jaredfox@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Gavin L, 2013, MMWR-MORBID MORTAL W, V62, P249; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P785, DOI 10.1001/jama.2014.9455; Romero L, 2015, MMWR-MORBID MORTAL W, V64, P363; Secura GM, 2014, NEW ENGL J MED, V371, P1316, DOI 10.1056/NEJMoa1400506; Sobel L, COVERAGE CONTRACEPTI; Trussell J, 2007, CONTRACEPTION, V75, P168, DOI 10.1016/j.contraception.2006.11.009	7	21	21	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					815	816		10.1001/jama.2016.8800	http://dx.doi.org/10.1001/jama.2016.8800			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8JL	27455194	Green Accepted			2022-12-24	WOS:000381736200007
J	Mariette, MM; Buchanan, KL				Mariette, Mylene M.; Buchanan, Katherine L.			Prenatal acoustic communication programs offspring for high posthatching temperatures in a songbird	SCIENCE			English	Article							ADAPTIVE SIGNIFICANCE; GROWTH; BEHAVIOR; EMBRYOS	In many species, embryos can perceive and learn external sounds. Yet, the possibility that parents may use these embryonic capacities to alter their offspring's developmental trajectories has not been considered. Here, we demonstrate that zebra finch parents acoustically signal high ambient temperatures (above 26 degrees C) to their embryos. We show that exposure of embryos to these acoustic cues alone adaptively alters subsequent nestling begging and growth in response to nest temperature and influences individuals' reproductive success and thermal preferences as adults. These findings have implications for our understanding of maternal effects, phenotypic plasticity, developmental programming, and the adaptation of endothermic species to a warming world.	[Mariette, Mylene M.; Buchanan, Katherine L.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds Campus,75 Pigdons Rd, Waurn Ponds, Vic 3216, Australia	Deakin University	Mariette, MM (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds Campus,75 Pigdons Rd, Waurn Ponds, Vic 3216, Australia.	m.mariette@deakin.edu.au	Buchanan, Kate/A-8178-2012; Mariette, Mylene M/AAA-9966-2020	Buchanan, Kate/0000-0002-6648-5819; Mariette, Mylene M/0000-0003-0567-4111	Australian Research Council [DP130100417, LP140100691, FT140100131]; Deakin University	Australian Research Council(Australian Research Council); Deakin University	This project was supported by Australian Research Council grants DP130100417 and LP140100691 and Future Fellowship FT140100131 to K.L.B. and a research fellowship from Deakin University to M.M.M. We have no conflict of interest. We thank I. Goedegebuur, K. Pinch, B. Oliver, and N. Wells for assistance with data collection and processing and W. Buttemer, J. Endler, S. Kleindorfer, M. Klaassen, M. Ramenofsky, J. Wingfield, the Centre for Integrative Ecology discussion group, and three anonymous reviewers for providing comments on the manuscript. Data have been deposited in the Dryad Digital Repository (accession number doi:10.5061/dryad.v8969).	BOLHUIS JJ, 1991, BIOL REV, V66, P303, DOI 10.1111/j.1469-185X.1991.tb01145.x; Boncoraglio G, 2006, HORM BEHAV, V50, P442, DOI 10.1016/j.yhbeh.2006.05.005; Brua RB, 1996, AUK, V113, P525, DOI 10.2307/4088972; Colombelli-Negrel D, 2016, AUK, V133, P273, DOI 10.1642/AUK-15-162.1; Colombelli-Negrel D, 2012, CURR BIOL, V22, P2155, DOI 10.1016/j.cub.2012.09.025; Cunningham SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074613; Dantzer B, 2013, SCIENCE, V340, P1215, DOI 10.1126/science.1235765; Donelson JM, 2012, NAT CLIM CHANGE, V2, P30, DOI 10.1038/NCLIMATE1323; Duckworth RA, 2015, SCIENCE, V347, P875, DOI 10.1126/science.1260154; EVANS RM, 1994, AUK, V111, P596; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; GOTTLIEB G, 1965, SCIENCE, V147, P1596, DOI 10.1126/science.147.3665.1596; GROETERS FR, 1988, J EVOLUTION BIOL, V1, P317, DOI 10.1046/j.1420-9101.1988.1040317.x; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Kleindorfer S, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0046; LICKLITER R, 1992, DEV PSYCHOBIOL, V25, P7; Lipar JL, 2000, P ROY SOC B-BIOL SCI, V267, P2005, DOI 10.1098/rspb.2000.1242; Mariette MM, 2015, AM NAT, V185, P270, DOI 10.1086/679441; Mariette MM, 2013, ECOLOGY, V94, P325, DOI 10.1890/12-0572.1; MILLER DB, 1978, ANIM BEHAV, V26, P1178, DOI 10.1016/0003-3472(78)90108-2; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Salinas S, 2012, ECOL LETT, V15, P159, DOI 10.1111/j.1461-0248.2011.01721.x; Sanyal T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067347; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Sheriff MJ, 2013, ECOL LETT, V16, P271, DOI 10.1111/ele.12042; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; van Gils JA, 2016, SCIENCE, V352, P819, DOI 10.1126/science.aad6351; Vedder O, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001605; WOOLF NK, 1976, SCIENCE, V194, P959, DOI 10.1126/science.982054; Zann R. A., 1996, THE ZEBRA FINCH	30	73	74	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					812	814		10.1126/science.aaf7049	http://dx.doi.org/10.1126/science.aaf7049			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540172				2022-12-24	WOS:000381561400043
J	Warner, JC; Ludwig, JK				Warner, John C.; Ludwig, Jennifer K.			Rethink how chemical hazards are tested	NATURE			English	Editorial Material									[Warner, John C.; Ludwig, Jennifer K.] Warner Babcock Inst Green Chem, Wilmington, MA 01887 USA		Warner, JC (corresponding author), Warner Babcock Inst Green Chem, Wilmington, MA 01887 USA.	john.warner@warnerbabcock.com; jennifer.ludwig@warnerbabcock.com		Warner, John/0000-0001-9426-4952				Anastas P. T., 1998, GREEN CHEM THEORY PR; Bengtstrom L, 2016, FOOD ADDIT CONTAM A, V33, P1080, DOI 10.1080/19440049.2016.1184941; Guyton KZ, 2015, LANCET ONCOL, V16, P490, DOI 10.1016/S1470-2045(15)70134-8; Rochester JR, 2015, ENVIRON HEALTH PERSP, V123, P643, DOI 10.1289/ehp.1408989; Schug TT, 2013, GREEN CHEM, V15, P181, DOI 10.1039/c2gc35055f; UNEP, 2011, HFCS CRIT LINK PROT	6	3	3	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					269	270		10.1038/536269a	http://dx.doi.org/10.1038/536269a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535519	Bronze			2022-12-24	WOS:000381804900011
J	Tenaillon, O; Barrick, JE; Ribeck, N; Deatherage, DE; Blanchard, JL; Dasgupta, A; Wu, GC; Wielgoss, S; Cruveiller, S; Medigue, C; Schneider, D; Lenski, RE				Tenaillon, Olivier; Barrick, Jeffrey E.; Ribeck, Noah; Deatherage, Daniel E.; Blanchard, Jeffrey L.; Dasgupta, Aurko; Wu, Gabriel C.; Wielgoss, Sebastien; Cruveiller, Stephane; Medigue, Claudine; Schneider, Dominique; Lenski, Richard E.			Tempo and mode of genome evolution in a 50,000-generation experiment	NATURE			English	Article							TERM EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; BENEFICIAL MUTATIONS; BACTERIAL POPULATION; ADAPTING POPULATIONS; MOLECULAR EVOLUTION; CLONAL INTERFERENCE; POSITIVE SELECTION; GENETIC DRAFT; CODON BIAS	Adaptation by natural selection depends on the rates, effects and interactions of many mutations, making it difficult to determine what proportion of mutations in an evolving lineage are beneficial. Here we analysed 264 complete genomes from 12 Escherichia coli populations to characterize their dynamics over 50,000 generations. The populations that retained the ancestral mutation rate support a model in which most fixed mutations are beneficial, the fraction of beneficial mutations declines as fitness rises, and neutral mutations accumulate at a constant rate. We also compared these populations to mutation-accumulation lines evolved under a bottlenecking regime that minimizes selection. Nonsynonymous mutations, intergenic mutations, insertions and deletions are overrepresented in the long-term populations, further supporting the inference that most mutations that reached high frequency were favoured by selection. These results illuminate the shifting balance of forces that govern genome evolution in populations adapting to a new environment.	[Tenaillon, Olivier] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, IAME,UMR 1137, F-75018 Paris, France; [Barrick, Jeffrey E.; Deatherage, Daniel E.; Dasgupta, Aurko; Wu, Gabriel C.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Dept Mol Biosci,Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Barrick, Jeffrey E.; Ribeck, Noah; Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Ribeck, Noah; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Wielgoss, Sebastien] ETH, Inst Integrat Biol, Univ Str 16, CH-8092 Zurich, Switzerland; [Wielgoss, Sebastien; Schneider, Dominique] Univ Grenoble Alpes, Lab Technol Ingn Med & Complexite Informat Math &, F-38000 Grenoble, France; [Cruveiller, Stephane; Medigue, Claudine] Univ Evry Val dEssonne, CEA, Lab Anal Bioinformat Genom & Metabol, Inst Genom,CNRS,UMR 8030, F-91000 Evry, France; [Schneider, Dominique] CNRS, TIMC IMAG, F-38000 Grenoble, France; [Dasgupta, Aurko] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Austin; Michigan State University; Michigan State University; University of Massachusetts System; University of Massachusetts Amherst; Swiss Federal Institutes of Technology Domain; ETH Zurich; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Washington University (WUSTL)	Lenski, RE (corresponding author), Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA.; Lenski, RE (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	lenski@msu.edu	Blanchard, Jeffrey/AAA-5173-2020; Tenaillon, Olivier/L-9857-2017; Wielgoss, Sébastien/X-3788-2019	Blanchard, Jeffrey/0000-0002-7310-9678; Wielgoss, Sébastien/0000-0002-0127-3380; Lenski, Richard/0000-0002-1064-8375; Tenaillon, Olivier/0000-0002-3796-1601	US National Science Foundation [DEB-1451740]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; European Research Council [310944]; European Union [610427]; French National Funding Agency [ANR-08-GENM-023-001]; French CNRS International Associated Laboratory; US National Institutes of Health [R00-GM087550]; Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM087550] Funding Source: NIH RePORTER; Division Of Environmental Biology [1451740] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); French National Funding Agency; French CNRS International Associated Laboratory; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank N. Hajela for assistance, R. Maddamsetti and Z. Blount for discussions, and M. Lynch for starting the MAE lines. This research was supported by the US National Science Foundation (DEB-1451740 to R.E.L.), BEACON Center for the Study of Evolution in Action (DBI-0939454), European Research Council (FP7 grant 310944 to O.T.), European Union (FP7 grant 610427 to D.S.), French National Funding Agency (ANR-08-GENM-023-001 to D.S., O.T. and C.M.), French CNRS International Associated Laboratory (to D.S. and R.E.L.), and US National Institutes of Health (R00-GM087550 to J.E.B.). D.E.D. was supported by a traineeship from the Cancer Prevention and Research Institute of Texas. We acknowledge the use of high-performance computing resources at the Texas Advanced Computing Center.	Barrick JE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1039; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Burke MK, 2010, NATURE, V467, P587, DOI 10.1038/nature09352; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CHAO L, 1983, NATURE, V303, P633, DOI 10.1038/303633a0; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Cooper TF, 2007, PLOS BIOL, V5, P1899, DOI 10.1371/journal.pbio.0050225; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Deatherage DE, 2014, METHODS MOL BIOL, V1151, P165, DOI 10.1007/978-1-4939-0554-6_12; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gillespie JH, 2000, GENETICS, V155, P909; Good BH, 2014, GENETICS, V198, P1183, DOI 10.1534/genetics.114.170233; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kosheleva K, 2013, GENETICS, V195, P1007, DOI 10.1534/genetics.113.156430; Kvitek DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003972; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Levy SF, 2015, NATURE, V519, P181, DOI 10.1038/nature14279; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Maddamsetti R, 2015, GENETICS, V200, P619, DOI 10.1534/genetics.115.176677; Miskinyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003802; Neher RA, 2011, GENETICS, V188, P975, DOI 10.1534/genetics.111.128876; Oren Y, 2014, P NATL ACAD SCI USA, V111, P16112, DOI 10.1073/pnas.1413272111; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Plucain J, 2014, SCIENCE, V343, P1366, DOI 10.1126/science.1248688; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Satterwhite RS, 2015, EVOLUTION, V69, P2067, DOI 10.1111/evo.12710; Sawyer SA, 2003, J MOL EVOL, V57, pS154, DOI 10.1007/s00239-003-0022-3; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Tenaillon O, 2001, RES MICROBIOL, V152, P11, DOI 10.1016/S0923-2508(00)01163-3; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Whitney KD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001080; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Wielgoss S, 2016, MOL BIOL EVOL, V33, P770, DOI 10.1093/molbev/msv270; Wielgoss S, 2013, P NATL ACAD SCI USA, V110, P222, DOI 10.1073/pnas.1219574110; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	50	230	233	6	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					165	+		10.1038/nature18959	http://dx.doi.org/10.1038/nature18959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27479321	Green Submitted, Green Accepted			2022-12-24	WOS:000381472100027
J	Thomsen, ARB; Plouffe, B; Cahill, TJ; Shukla, AK; Tarrasch, JT; Dosey, AM; Kahsai, AW; Strachan, RT; Pani, B; Mahoney, JP; Huang, LY; Breton, B; Heydenreich, FM; Sunahara, RK; Skiniotis, G; Bouvier, M; Lefkowitz, RJ				Thomsen, Alex R. B.; Plouffe, Bianca; Cahill, Thomas J., III; Shukla, Arun K.; Tarrasch, Jeffrey T.; Dosey, Annie M.; Kahsai, Alem W.; Strachan, Ryan T.; Pani, Biswaranjan; Mahoney, Jacob P.; Huang, Liyin; Breton, Billy; Heydenreich, Franziska M.; Sunahara, Roger K.; Skiniotis, Georgios; Bouvier, Michel; Lefkowitz, Robert J.			GPCR-G Protein-beta-Arrestin Super-Complex Mediates Sustained G Protein Signaling	CELL			English	Article							COUPLED RECEPTOR; VASOPRESSIN RECEPTOR; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; CLATHRIN ADAPTER; ENDOCYTOSIS; BETA-ARRESTIN2; ASSOCIATION; INTERNALIZATION; DETERMINANTS	Classically, G protein-coupled receptor (GPCR) stimulation promotes G protein signaling at the plasma membrane, followed by rapid beta-arrestin-mediated desensitization and receptor internalization into endosomes. However, it has been demonstrated that some GPCRs activate G proteins from within internalized cellular compartments, resulting in sustained signaling. We have used a variety of biochemical, biophysical, and cell-based methods to demonstrate the existence, functionality, and architecture of internalized receptor complexes composed of a single GPCR, beta-arrestin, and G protein. These super-complexes or "megaplexes'' more readily form at receptors that interact strongly with beta-arrestins via a C-terminal tail containing clusters of serine/threonine phosphorylation sites. Single-particle electron microscopy analysis of negative-stained purified megaplexes reveals that a single receptor simultaneously binds through its core region with G protein and through its phosphorylated C-terminal tail with b-arrestin. The formation of such megaplexes provides a potential physicalbasis for thenewlyappreciated sustained G protein signaling from internalized GPCRs.	[Thomsen, Alex R. B.; Cahill, Thomas J., III; Shukla, Arun K.; Kahsai, Alem W.; Strachan, Ryan T.; Pani, Biswaranjan; Huang, Liyin; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Plouffe, Bianca; Breton, Billy; Heydenreich, Franziska M.; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Plouffe, Bianca; Breton, Billy; Heydenreich, Franziska M.; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Cahill, Thomas J., III; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Tarrasch, Jeffrey T.; Dosey, Annie M.; Skiniotis, Georgios] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Mahoney, Jacob P.; Sunahara, Roger K.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Sunahara, Roger K.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Shukla, Arun K.] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Breton, Billy] Domain Therapeut NA, Montreal, PQ H4S 1Z9, Canada; [Heydenreich, Franziska M.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland	Duke University; Universite de Montreal; Universite de Montreal; Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Duke University; Howard Hughes Medical Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Bouvier, M (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.; Bouvier, M (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	michel.bouvier@umontreal.ca; lefko001@receptor-biol.duke.edu	Bouvier, Michel/H-2758-2014; Lefkowitz, Robert/AAW-2649-2021; Pani, Biswaranjan/GLT-9217-2022; Sunahara, Roger/AAJ-8667-2020; Heydenreich, Franziska M/N-6314-2015	Bouvier, Michel/0000-0003-1128-0100; Heydenreich, Franziska M/0000-0002-8049-4383; Skiniotis, Georgios/0000-0003-0238-7846; Plouffe, Bianca/0000-0002-8321-0796; shukla, arun/0000-0003-2910-8288; Thomsen, Alex/0000-0003-1638-8911	Danish Council for Independent Research & Lundbeck Foundation; NIH [F30HL129803, RO1GM083118, T32GM007767, DK090165, HL16037]; CIHR [SNSF P1EZP3_165219, MOP10501]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL129803, R01HL016037, T32HL007101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171, R01GM083118, T32GM007767] Funding Source: NIH RePORTER; Lundbeck Foundation [R172-2014-1468] Funding Source: researchfish	Danish Council for Independent Research & Lundbeck Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lundbeck Foundation(Lundbeckfonden)	We are grateful to L. Barak and B. Kobilka for generous gifts of plasmids encoding mStrawberry-beta arr2 and Nb35, respectively. We thank C.-R. Liang, L.-L. Gu, J.-M. Shan, and X. Chen for synthesizing BI-167107. We thank S. Johnson, C. Le Gouill, A. Laperriere, M. Walters, M. DeLong, M. Plue, T. Milledge, D. Capel, X. Jiang, R. Irannejad, and M. von Zastrow for support and discussion. This work received supported from the Danish Council for Independent Research & Lundbeck Foundation (to A.R.B.T.), NIH grants (F30HL129803 to T.J.C.; RO1GM083118 to R.K.S.; T32GM007767 to J.P.M.; DK090165 to G.S.; and HL16037 to R.J.L.); CIHR grants (post-doctoral fellowship to B. Plouffe; SNSF P1EZP3_165219 to F.M.H.; and MOP10501 to M.B.). R.J.L. is a HHMI Investigator. R.J.L. is a co-founder and shareholder of Trevena. M.B. holds a Canada Research Chair in Signal Transduction and Molecular Pharmacology.	Audet N, 2012, J NEUROSCI, V32, P4827, DOI 10.1523/JNEUROSCI.3734-11.2012; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gilliland CT, 2013, J BIOL CHEM, V288, P32194, DOI 10.1074/jbc.M113.503797; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; JARD S, 1986, MOL PHARMACOL, V30, P171; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Marullo S, 2007, TRENDS PHARMACOL SCI, V28, P362, DOI 10.1016/j.tips.2007.06.007; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; ODONNELL SR, 1980, LIFE SCI, V27, P671, DOI 10.1016/0024-3205(80)90008-9; Peisley Alys, 2015, Methods Mol Biol, V1335, P29, DOI 10.1007/978-1-4939-2914-6_3; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; STAEHELIN M, 1983, J BIOL CHEM, V258, P3496; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108	34	318	324	7	106	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					907	919		10.1016/j.cell.2016.07.004	http://dx.doi.org/10.1016/j.cell.2016.07.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27499021	Green Accepted, Bronze			2022-12-24	WOS:000382258700014
J	van der Linden, V; Rolim, EL; Lins, OG; van der Linden, A; Aragao, MDVV; Brainer-Lima, AM; Cruz, DDS; Rocha, MAW; da Silva, PFS; Carvalho, MDCG; do Amaral, FJ; Gomes, JA; de Medeiros, ICR; Ventura, CV; Ramos, RC				van der Linden, Vanessa; Rolim Filho, Epitacio Leite; Lins, Otavio Gomes; van der Linden, Ana; Viana Vasco Aragao, Maria de Fatima; Brainer-Lima, Alessandra Mertens; Sousa Cruz, Danielle Di Cavalcanti; Wanderley Rocha, Maria Angela; Sobral da Silva, Paula Fabiana; Costa Gomes Carvalho, Maria Durce; do Amaral, Fernando Jose; Gomes, Joelma Arruda; Ribeiro de Medeiros, Igor Colaco; Ventura, Camila V.; Ramos, Regina Coeli			Congenital Zika syndrome with arthrogryposis: retrospective case series study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIPLEX-CONGENITA; VIRUS OUTBREAK	OBJECTIVE To describe the clinical, radiological, and electromyographic features in a series of children with joint contractures (arthrogryposis) associated with congenital infection presumably caused by Zika virus. DESIGN Retrospective case series study. SETTING Association for Assistance of Disabled Children, Pernambuco state, Brazil. PARTICIPANTS Seven children with arthrogryposis and a diagnosis of congenital infection presumably caused by Zika virus during the Brazilian microcephaly epidemic. MAIN OUTCOME MEASURES Main clinical, radiological, and electromyographic findings, and likely correlation between clinical and primary neurological abnormalities. RESULTS The brain images of all seven children were characteristic of congenital infection and arthrogryposis. Two children tested positive for IgM to Zika virus in the cerebrospinal fluid. Arthrogryposis was present in the arms and legs of six children (86%) and the legs of one child (14%). Hip radiographs showed bilateral dislocation in seven children, subluxation of the knee associated with genu valgus in three children (43%), which was bilateral in two (29%). All the children underwent high definition ultrasonography of the joints, and there was no evidence of abnormalities. Moderate signs of remodeling of the motor units and a reduced recruitment pattern were found on needle electromyography (monopolar). Five of the children underwent brain computed tomography (CT) and magnetic resonance imaging (MRI) and the remaining two CT only. All presented malformations of cortical development, calcifications predominantly in the cortex and subcortical white matter (especially in the junction between the cortex and white matter), reduction in brain volume, ventriculomegaly, and hypoplasia of the brainstem and cerebellum. MRI of the spine in four children showed apparent thinning of the cord and reduced ventral roots. CONCLUSIONS Congenital Zika syndrome should be added to the differential diagnosis of congenital infections and arthrogryposis. The arthrogryposis was unrelated to the abnormalities of the joints themselves, but was possibly of neurogenic origin, with chronic involvement of central and peripheral motor neurones leading to deformities as a result of fixed postures in utero. Based on the neurophysiological observations, we suggest two possible mechanisms: tropism of neurones, with involvement of peripheral and central motor neurones, or a relation with vascular disorders.	[van der Linden, Vanessa; Rolim Filho, Epitacio Leite] AACD, Recife, PE, Brazil; [van der Linden, Vanessa; do Amaral, Fernando Jose; Gomes, Joelma Arruda] HBL, Recife, PE, Brazil; [Rolim Filho, Epitacio Leite; Lins, Otavio Gomes] Univ Fed Pernambuco, Recife, PE, Brazil; [van der Linden, Ana; Sousa Cruz, Danielle Di Cavalcanti] Inst Materno Infantil Pernambuco, Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil; [Viana Vasco Aragao, Maria de Fatima] Ctr Diagnost Multimagem, Recife, PE, Brazil; [Viana Vasco Aragao, Maria de Fatima; Brainer-Lima, Alessandra Mertens] Mauricio de Nassau Univ, Recife, PE, Brazil; [Brainer-Lima, Alessandra Mertens] Univ Pernambuco, Recife, PE, Brazil; [Wanderley Rocha, Maria Angela; Sobral da Silva, Paula Fabiana; Costa Gomes Carvalho, Maria Durce; Ramos, Regina Coeli] HUOC, Recife, PE, Brazil; [Ribeiro de Medeiros, Igor Colaco] Hosp Infantil Jorge de Medeiros, Recife, PE, Brazil; [Ventura, Camila V.] FAV, Recife, PE, Brazil; [Ventura, Camila V.] Pernambucos Eye Hosp, Recife, PE, Brazil	Universidade Federal de Pernambuco; Instituto de Medicina Integral Professor Fernando Figueira (IMIP); Universidade de Pernambuco (UPE)	van der Linden, V (corresponding author), AACD, Recife, PE, Brazil.; van der Linden, V (corresponding author), HBL, Recife, PE, Brazil.	vanessavdlinden@hotmail.com	Ventura, Camila V/N-2654-2018	Ventura, Camila V/0000-0002-2927-4684; Silva, Paula/0000-0001-9475-4732				Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281; Besnard M, 2014, Euro Surveill, V19; *BRAS MIN SAUD, PROT VIG RESP OC MIC; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; FEDRIZZI E, 1993, PEDIATR NEUROL, V9, P343, DOI 10.1016/0887-8994(93)90102-I; Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217; Kalampokas Emmanouil, 2012, ISRN Obstet Gynecol, V2012, P264918, DOI 10.5402/2012/264918; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Moller-Madsen B, 2015, THESIS, V9, P425; Moller-Madsen B, 2015, J CHILD ORTHOP, V9, P425, DOI 10.1007/s11832-015-0688-2; Mussi-Pinhata M, 1999, J PEDIAT RIO J, V75, P15; Poduri A, 2010, BRAIN DEV-JPN, V32, P550, DOI 10.1016/j.braindev.2009.08.005; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Tavernise S, 2016, ZIKA VIRUS GLOBAL HL; Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5; Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Volpe J.J., 2008, NEUROLOGY NEWBORN; World Health Organization, 2016, ASS INF MICR CONT ZI; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	28	129	132	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2016	354								i3899	10.1136/bmj.i3899	http://dx.doi.org/10.1136/bmj.i3899			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TU	27509902	hybrid, Green Published			2022-12-24	WOS:000381474800002
J	Stein, MM; Hrusch, CL; Gozdz, J; Igartua, C; Pivniouk, V; Murray, SE; Ledford, JG; dos Santos, MM; Anderson, RL; Metwali, N; Neilson, JW; Maier, RM; Gilbert, JA; Holbreich, M; Thorne, PS; Martinez, FD; von Mutius, E; Vercelli, D; Ober, C; Sperling, AI				Stein, Michelle M.; Hrusch, Cara L.; Gozdz, Justyna; Igartua, Catherine; Pivniouk, Vadim; Murray, Sean E.; Ledford, Julie G.; dos Santos, Mauricius Marques; Anderson, Rebecca L.; Metwali, Nervana; Neilson, Julia W.; Maier, Raina M.; Gilbert, Jack A.; Holbreich, Mark; Thorne, Peter S.; Martinez, Fernando D.; von Mutius, Erika; Vercelli, Donata; Ober, Carole; Sperling, Anne I.			Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDHOOD ASTHMA; DISEASE; EXPOSURE; SUSCEPTIBILITY; ENDOTOXIN; CELLS; SENSITIZATION; NEUTROPHILS; PREVALENCE; ACTIVATION	BACKGROUND The Amish and Hutterites are U.S. agricultural populations whose lifestyles are remarkably similar in many respects but whose farming practices, in particular, are distinct; the former follow traditional farming practices whereas the latter use industrialized farming practices. The populations also show striking disparities in the prevalence of asthma, and little is known about the immune responses underlying these disparities. METHODS We studied environmental exposures, genetic ancestry, and immune profiles among 60 Amish and Hutterite children, measuring levels of allergens and endotoxins and assessing the microbiome composition of indoor dust samples. Whole blood was collected to measure serum IgE levels, cytokine responses, and gene expression, and peripheral-blood leukocytes were phenotyped with flow cytometry. The effects of dust extracts obtained from Amish and Hutterite homes on immune and airway responses were assessed in a murine model of experimental allergic asthma. RESULTS Despite the similar genetic ancestries and lifestyles of Amish and Hutterite children, the prevalence of asthma and allergic sensitization was 4 and 6 times as low in the Amish, whereas median endotoxin levels in Amish house dust was 6.8 times as high. Differences in microbial composition were also observed in dust samples from Amish and Hutterite homes. Profound differences in the proportions, phenotypes, and functions of innate immune cells were also found between the two groups of children. In a mouse model of experimental allergic asthma, the intranasal instillation of dust extracts from Amish but not Hutterite homes significantly inhibited airway hyperreactivity and eosinophilia. These protective effects were abrogated in mice that were deficient in MyD88 and Trif, molecules that are critical in innate immune signaling. CONCLUSIONS The results of our studies in humans and mice indicate that the Amish environment provides protection against asthma by engaging and shaping the innate immune response.	[Stein, Michelle M.; Igartua, Catherine; Anderson, Rebecca L.; Ober, Carole] Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 425, Chicago, IL 60637 USA; [Hrusch, Cara L.; Sperling, Anne I.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [Hrusch, Cara L.; Sperling, Anne I.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Gilbert, Jack A.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, 9700 S Cass Ave, Argonne, IL 60439 USA; [Gozdz, Justyna] Univ Arizona, NIEHS Training Program Environm Toxicol, Tucson, AZ 85721 USA; [Gozdz, Justyna] Univ Arizona, Grad Program Cellular & Mol Med, Tucson, AZ 85721 USA; [Pivniouk, Vadim; Vercelli, Donata] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Ledford, Julie G.] Univ Arizona, Dept Med, Tucson, AZ 85721 USA; [dos Santos, Mauricius Marques] Univ Arizona, Dept Chem & Environm Engn, Tucson, AZ 85721 USA; [Neilson, Julia W.; Maier, Raina M.] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; [Gozdz, Justyna; Pivniouk, Vadim; Murray, Sean E.; Ledford, Julie G.; Martinez, Fernando D.; Vercelli, Donata] Arizona Resp Ctr, Tucson, AZ USA; [Gozdz, Justyna; Pivniouk, Vadim; Murray, Sean E.; Ledford, Julie G.; Martinez, Fernando D.; Vercelli, Donata] Bio5 Inst, Tucson, AZ USA; [Metwali, Nervana; Thorne, Peter S.] Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA; [Holbreich, Mark] Allergy & Asthma Consultants, Indianapolis, IN USA; [von Mutius, Erika] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Iowa; University of Munich	Vercelli, D (corresponding author), Univ Arizona, Arizona Resp Ctr, Inst Bio5, Rm 339,1657 E Helen St, Tucson, AZ 85721 USA.; Ober, C (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 425, Chicago, IL 60637 USA.; Sperling, AI (corresponding author), Univ Chicago, Dept Med, 924 E 57th St,JFK R316, Chicago, IL 60637 USA.	donata@email.arizona.edu; c-ober@genetics.uchicago.edu; asperlin@uchicago.edu	Gilbert, Jack/AAF-3270-2019; Sperling, Anne/ACZ-2351-2022	Sperling, Anne I./0000-0002-4265-9212; Thorne, Peter/0000-0002-5045-0929; Gozdz, Justyna/0000-0003-2273-0533; Stein, Michelle/0000-0002-7680-9012; Maier, Raina/0000-0002-0421-4677; Ober, Carole/0000-0003-4626-9809; von Mutius, Erika/0000-0002-8893-4515	National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL111151, T32HL007605, R01HL125602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694, P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the National Institutes of Health and others.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosco A, 2012, J ALLERGY CLIN IMMUN, V129, P88, DOI 10.1016/j.jaci.2011.10.038; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Cann HM, 2002, SCIENCE, V296, P261; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; Gomez HG, 2014, CRIT CARE MED, V42, P771, DOI 10.1097/CCM.0000000000000100; Holbreich M, 2012, J ALLERGY CLIN IMMUN, V129, P1671, DOI 10.1016/j.jaci.2012.03.016; Hostetler J, 1974, HUTTERITE SOC; Hostetler John, 1993, AMISH SOC, DOI 10.2307/539066; Kim-Schulze S, 2006, J IMMUNOL, V176, P2790, DOI 10.4049/jimmunol.176.5.2790; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Lluis A, 2014, J ALLERGY CLIN IMMUN, V133, P551, DOI 10.1016/j.jaci.2013.06.034; Loss GJ, 2016, AM J RESP CRIT CARE, V193, P889, DOI 10.1164/rccm.201507-1493OC; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Meyers DA, 2014, LANCET RESP MED, V2, P405, DOI 10.1016/S2213-2600(14)70012-8; Motika CA, 2011, J ALLERGY CLIN IMMUN, V128, P774, DOI 10.1016/j.jaci.2011.06.046; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Orden S, 2014, J ANTIMICROB CHEMOTH, V69, P995, DOI 10.1093/jac/dkt468; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Velten FW, 2004, EUR J IMMUNOL, V34, P2800, DOI 10.1002/eji.200324732; Yamada M, 2011, CELL MOL IMMUNOL, V8, P305, DOI 10.1038/cmi.2011.8; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	32	539	550	3	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					411	421		10.1056/NEJMoa1508749	http://dx.doi.org/10.1056/NEJMoa1508749			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7AN	27518660	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000380934900005
J	Schur, FKM; Obr, M; Hagen, WJH; Wan, W; Jakobi, AJ; Kirkpatrick, JM; Sachse, C; Krausslich, HG; Briggs, JAG				Schur, Florian K. M.; Obr, Martin; Hagen, Wim J. H.; Wan, William; Jakobi, Arjen J.; Kirkpatrick, Joanna M.; Sachse, Carsten; Kraeusslich, Hans-Georg; Briggs, John A. G.			An atomic model of HIV-1 capsid-SP1 reveals structures regulating assembly and maturation	SCIENCE			English	Article							TYPE-1 GAG PRECURSOR; CRYSTAL-STRUCTURES; IN-VITRO; PROTEIN; INHIBITOR; POLYPROTEIN; RESISTANCE; BEVIRIMAT; DOMAIN	Immature HIV-1 assembles at and buds from the plasma membrane before proteolytic cleavage of the viral Gag polyprotein induces structural maturation. Maturation can be blocked by maturation inhibitors (MIs), thereby abolishing infectivity. The CA (capsid) and SP1 (spacer peptide 1) region of Gag is the key regulator of assembly and maturation and is the target of MIs. We applied optimized cryo-electron tomography and subtomogram averaging to resolve this region within assembled immature HIV-1 particles at 3.9 angstrom resolution and built an atomic model. The structure reveals a network of intra-and intermolecular interactions mediating immature HIV-1 assembly. The proteolytic cleavage site between CA and SP1 is inaccessible to protease. We suggest that MIs prevent CA-SP1 cleavage by stabilizing the structure, and MI resistance develops by destabilizing CA-SP1.	[Schur, Florian K. M.; Hagen, Wim J. H.; Wan, William; Jakobi, Arjen J.; Sachse, Carsten; Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Schur, Florian K. M.; Obr, Martin; Kraeusslich, Hans-Georg; Briggs, John A. G.] Univ Klinikum Heidelberg, European Mol Biol Lab, Mol Med Partnership Unit, Heidelberg, Germany; [Obr, Martin; Kraeusslich, Hans-Georg] Univ Klinikum Heidelberg, Dept Infect Dis, Virol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany; [Jakobi, Arjen J.] European Mol Biol Lab, DESY Deutsch Elekt Synchrotron, Hamburg Unit, Notkestr 85, D-22607 Hamburg, Germany; [Kirkpatrick, Joanna M.] European Mol Biol Lab, Prote Core Facil, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Kirkpatrick, Joanna M.] Fritz Lipmann Inst, Leibniz Inst Aging, Beutenbergstr 11, D-07745 Jena, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European Molecular Biology Laboratory (EMBL); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Briggs, JAG (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.; Briggs, JAG (corresponding author), Univ Klinikum Heidelberg, European Mol Biol Lab, Mol Med Partnership Unit, Heidelberg, Germany.	john.briggs@embl.de	Sachse, Carsten/H-2727-2012; Sachse, Carsten/AAY-9384-2020	Sachse, Carsten/0000-0002-1168-5143; Sachse, Carsten/0000-0002-1168-5143; /0000-0003-4790-8078; Briggs, John/0000-0003-3990-6910; Jakobi, Arjen/0000-0002-7761-2027; Wan, William/0000-0003-2497-3010; Hagen, Wim/0000-0001-6229-2692; Krausslich, Hans-Georg/0000-0002-8756-329X	Deutsche Forschungsgemeinschaft [BR 3635/2-1, KR 906/7-1]; European Molecular Biology Laboratory (EMBL); Chica und Heinz Schaller Stiftung; European Molecular Biology Organization Long-Term Fellowship [ALTF 748-2014]; EMBL Interdisciplinary Postdoc Program under the Marie Curie Action COFUND [PCOFUND-GA-2008-229597]; Joachim Herz Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Laboratory (EMBL); Chica und Heinz Schaller Stiftung; European Molecular Biology Organization Long-Term Fellowship(European Molecular Biology Organization (EMBO)); EMBL Interdisciplinary Postdoc Program under the Marie Curie Action COFUND; Joachim Herz Stiftung	The authors thank B. Glass for preparation of the immature HIV-1 (D25A) sample; J. Plitzko and D. Tegunov for providing the K2Align software; and S. Mattei, N. Hoffman, F. Thommen, A. Sonnen, and S. Dodonova for technical assistance and/or discussion. This study was supported by Deutsche Forschungsgemeinschaft grants BR 3635/2-1 (to J.A.G.B.) and KR 906/7-1 (to H.-G.K.). The Briggs laboratory acknowledges financial support from the European Molecular Biology Laboratory (EMBL) and from the Chica und Heinz Schaller Stiftung. W.W. was supported by a European Molecular Biology Organization Long-Term Fellowship (ALTF 748-2014). A. J. J. acknowledges support by the EMBL Interdisciplinary Postdoc Program under the Marie Curie Action COFUND (PCOFUND-GA-2008-229597) and by the Joachim Herz Stiftung. This study was technically supported by the EMBL information technology services unit and the EMBL Proteomics Core Facility. F.K.M.S., M.O., H.-G.K., and J.A.G.B. designed the experiments, with J.M.K. assisting in the design of those involving mass spectrometry. F.K.M.S. and M.O. prepared samples. W.J.H.H. implemented tomography acquisition schemes. F.K.M.S. and W. J.H.H. acquired the data. F.K.M.S. and W. W. processed images. F.K.M.S., A. J. J., and C.S. refined the model. F.K.M.S., M.O., and J.A.G.B. analyzed the data. F.K.M.S. and J.A.G.B. wrote the manuscript with support from all authors. Representative tomograms and the final electron microscopy structures have been deposited in the Electron Microscopy Data Bank with accession numbers EMD-4015, EMD-4016, EMD-4017, EMD-4018, EMD-4019, and EMD-4020. The refined HIV-1 CA-SP1 model has been deposited in the Protein Data Bank with accession number 5L93.	Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; Adamson CS, 2006, J VIROL, V80, P10957, DOI 10.1128/JVI.01369-06; Adamson CS, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-36; Adamson CS, 2009, EXPERT OPIN THER TAR, V13, P895, DOI 10.1517/14728220903039714; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Blair WS, 2009, ANTIMICROB AGENTS CH, V53, P5080, DOI 10.1128/AAC.00759-09; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003; Checkley MA, 2010, VIROLOGY, V400, P137, DOI 10.1016/j.virol.2010.01.028; Datta SAK, 2011, J VIROL, V85, P4111, DOI 10.1128/JVI.00006-11; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Grant T., 2015, GRANT, V4; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; Hagen WJH, 2017, J STRUCT BIOL, V197, P191, DOI 10.1016/j.jsb.2016.06.007; Keller PW, 2013, J VIROL, V87, P13655, DOI 10.1128/JVI.01408-13; Keller PW, 2011, J VIROL, V85, P1420, DOI 10.1128/JVI.01926-10; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Margot NA, 2010, ANTIMICROB AGENTS CH, V54, P2345, DOI 10.1128/AAC.01784-09; Melamed D, 2004, J VIROL, V78, P9675, DOI 10.1128/JVI.78.18.9675-9688.2004; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Prabu-Jeyabalan M, 2002, STRUCTURE, V10, P369, DOI 10.1016/S0969-2126(02)00720-7; Sakalian M, 2006, J VIROL, V80, P5716, DOI 10.1128/JVI.02743-05; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wagner JM, 2016, ELIFE, V5, DOI 10.7554/eLife.17063; Waki K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002997; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998	32	237	240	10	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					506	508		10.1126/science.aaf9620	http://dx.doi.org/10.1126/science.aaf9620			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27417497				2022-12-24	WOS:000380583600046
J	Zipperer, A; Konnerth, MC; Laux, C; Berscheid, A; Janek, D; Weidenmaier, C; Burian, M; Schilling, NA; Slavetinsky, C; Marschal, M; Willmann, M; Kalbacher, H; Schittek, B; Brotz-Oesterhelt, H; Grond, S; Peschel, A; Krismer, B				Zipperer, Alexander; Konnerth, Martin C.; Laux, Claudia; Berscheid, Anne; Janek, Daniela; Weidenmaier, Christopher; Burian, Marc; Schilling, Nadine A.; Slavetinsky, Christoph; Marschal, Matthias; Willmann, Matthias; Kalbacher, Hubert; Schittek, Birgit; Broetz-Oesterhelt, Heike; Grond, Stephanie; Peschel, Andreas; Krismer, Bernhard			Human commensals producing a novel antibiotic impair pathogen colonization	NATURE			English	Article								The vast majority of systemic bacterial infections are caused by facultative, often antibiotic-resistant, pathogens colonizing human body surfaces. Nasal carriage of Staphylococcus aureus predisposes to invasive infection, but the mechanisms that permit or interfere with pathogen colonization are largely unknown. Whereas soil microbes are known to compete by production of antibiotics, such processes have rarely been reported for human microbiota. We show that nasal Staphylococcus lugdunensis strains produce lugdunin, a novel thiazolidine-containing cyclic peptide antibiotic that prohibits colonization by S. aureus, and a rare example of a non-ribosomally synthesized bioactive compound from human-associated bacteria. Lugdunin is bactericidal against major pathogens, effective in animal models, and not prone to causing development of resistance in S. aureus. Notably, human nasal colonization by S. lugdunensis was associated with a significantly reduced S. aureus carriage rate, suggesting that lugdunin or lugdunin-producing commensal bacteria could be valuable for preventing staphylococcal infections. Moreover, human microbiota should be considered as a source for new antibiotics.	[Zipperer, Alexander; Laux, Claudia; Janek, Daniela; Slavetinsky, Christoph; Peschel, Andreas; Krismer, Bernhard] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Infect Biol, D-72076 Tubingen, Germany; [Zipperer, Alexander; Laux, Claudia; Janek, Daniela; Weidenmaier, Christopher; Slavetinsky, Christoph; Willmann, Matthias; Broetz-Oesterhelt, Heike; Peschel, Andreas; Krismer, Bernhard] German Ctr Infect Res DZIF, D-72076 Tubingen, Germany; [Konnerth, Martin C.; Schilling, Nadine A.; Grond, Stephanie] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany; [Berscheid, Anne; Broetz-Oesterhelt, Heike] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Microbial Bioact Cpds, D-72076 Tubingen, Germany; [Weidenmaier, Christopher; Marschal, Matthias; Willmann, Matthias] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Med Microbial, D-72076 Tubingen, Germany; [Burian, Marc; Schittek, Birgit] Univ Tubingen, Dept Dermatol, Div Dermatooncol, D-72076 Tubingen, Germany; [Schilling, Nadine A.; Kalbacher, Hubert] Univ Tubingen, Interfac Inst Bioch, D-72076 Tubingen, Germany; Boehringer Ingelheim GmbH & Co KG, Stockholm, Sweden	Eberhard Karls University of Tubingen; German Center for Infection Research; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Boehringer Ingelheim	Peschel, A (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Infect Biol, D-72076 Tubingen, Germany.	andreas.peschel@uni-tuebingen.de	Krismer, Bernhard/O-3741-2019; Krismer, Bernhard/V-1380-2017	Krismer, Bernhard/0000-0002-9505-8285; Grond, Stephanie/0000-0002-7549-4936; Berscheid, Anne/0000-0003-1585-8715; Peschel, Andreas/0000-0002-3209-8626; Schittek, Birgit/0000-0003-0081-2001; Weidenmaier, Christopher/0000-0003-4107-739X	German Research Council [GRK1708, TRR156, Schi510/8-1, PE805/5-1, TRR34, SFB766]; German Center for Infection Research (DZIF)	German Research Council(German Research Foundation (DFG)); German Center for Infection Research (DZIF)	We thank V. Winstel for technical assistance and A. Bobic, S. Heilbronner, W. Hoffmann, A. Jorge, D. Kretschmer, A. Kulik, M. Nega, E. Stegmann, V. Winstel, T. Weber, and W. Wohlleben for assistance and helpful discussions. Thanks to Bruker Daltonics for selected initial high-resolution mass spectrometry analysis and to T. Paululat for NMR experiments. This work was financed by German Research Council grants GRK1708 to S.G. and A.P.; TRR156, Schi510/8-1, and PE805/5-1 to B.S. and A.P.; TRR34 to C.W. and A.P; and SFB766 to C.W., H.B.-O., S.G., and A.P.; and by the German Center for Infection Research (DZIF) to C.W., A.P., B.K., M.W., and H.B.-O.	Andersen PS, 2012, J INFECT DIS, V206, P1178, DOI 10.1093/infdis/jis491; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Bandow JE, 2003, ANTIMICROB AGENTS CH, V47, P948, DOI 10.1128/AAC.47.3.948-955.2003; Bara R, 2013, J MED CHEM, V56, P3257, DOI 10.1021/jm301816a; Baur S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004089; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Bieber L, 2010, CLIN MICROBIOL INFEC, V16, P385, DOI 10.1111/j.1469-0691.2009.02813.x; Bierbaum G, 2014, INT J MED MICROBIOL, V304, P1, DOI 10.1016/j.ijmm.2013.10.003; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Challinor VL, 2015, ANN NY ACAD SCI, V1354, P82, DOI 10.1111/nyas.12954; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Davis MF, 2011, CURR OPIN MICROBIOL, V14, P244, DOI 10.1016/j.mib.2011.04.003; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Geiger T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003016; Heilbronner S, 2011, FEMS MICROBIOL LETT, V322, P60, DOI 10.1111/j.1574-6968.2011.02339.x; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Ho PL, 2014, J CLIN MICROBIOL, V52, P2633, DOI 10.1128/JCM.00706-14; Hobbs JK, 2008, J ANTIMICROB CHEMOTH, V62, P1003, DOI 10.1093/jac/dkn321; Hosaka T, 2009, NAT BIOTECHNOL, V27, P462, DOI 10.1038/nbt.1538; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524; Krismer B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003862; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lincke T, 2010, ANGEW CHEM INT EDIT, V49, P2011, DOI 10.1002/anie.200906114; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Penders J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00087; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; Sanders ME, 2011, J CLIN GASTROENTEROL, V45, pS115, DOI 10.1097/MCG.0b013e318227414a; Sasaki T, 2002, J ANTIBIOT, V55, P249, DOI 10.7164/antibiotics.55.249; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Schloss PD, 2014, NATURE, V514, P44, DOI 10.1038/514044a; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Sidda JD, 2014, CHEM SCI, V5, P86, DOI 10.1039/c3sc52536h; Tacconelli E, 2014, LANCET INFECT DIS, V14, P659, DOI 10.1016/S1473-3099(14)70798-4; Thomas CM, 2010, NAT REV MICROBIOL, V8, P281, DOI 10.1038/nrmicro2278; van der Meer JWM, 2013, LANCET INFECT DIS, V13, P282, DOI 10.1016/S1473-3099(13)70014-8; Walsh CT, 2016, NAT PROD REP, V33, P127, DOI 10.1039/c5np00035a; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wanke I, 2013, EXP DERMATOL, V22, P153, DOI 10.1111/exd.12083; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Weidenmaier C, 2012, TRENDS MICROBIOL, V20, P243, DOI 10.1016/j.tim.2012.03.004; Wenzel M, 2014, P NATL ACAD SCI USA, V111, pE1409, DOI 10.1073/pnas.1319900111; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Winstel V, 2015, APPL ENVIRON MICROB, V81, P2481, DOI 10.1128/AEM.04190-14; World Health Organization, 2014, ANT RES GLOB REP SUR; Zasloff M, 2006, P NATL ACAD SCI USA, V103, P8913, DOI 10.1073/pnas.0603508103; Zervos MJ, 2012, J CLIN MICROBIOL, V50, P238, DOI 10.1128/JCM.05817-11	59	451	471	9	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					511	516		10.1038/nature18634	http://dx.doi.org/10.1038/nature18634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27466123				2022-12-24	WOS:000380856600041
J	Yee, AL; Gilbert, JA				Yee, Alyson L.; Gilbert, Jack A.			Is triclosan harming your microbiome?	SCIENCE			English	Editorial Material							GUT MICROBIOME; EXPOSURE; RISKS		[Yee, Alyson L.] Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA; [Yee, Alyson L.; Gilbert, Jack A.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Yee, Alyson L.] Univ Chicago, Med Scientist Training Program, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Gilbert, JA (corresponding author), Univ Chicago, Dept Surg, Chicago, IL 60637 USA.	gilbert-jack@uchicago.edu	Gilbert, Jack/AAF-3270-2019	Yee, Alyson/0000-0001-7613-2438				Adgent MA, 2015, ENVIRON RES, V142, P66, DOI 10.1016/j.envres.2015.06.017; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P303, DOI 10.1289/ehp.10768; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Dhillon GS, 2015, INT J ENV RES PUB HE, V12, P5657, DOI 10.3390/ijerph120505657; Gaulke CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154632; Hu JZ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0173-2; Kim SA, 2015, J ANTIMICROB CHEMOTH, V70, P3345, DOI 10.1093/jac/dkv275; Lawrence JR, 2015, AQUAT TOXICOL, V161, P253, DOI 10.1016/j.aquatox.2015.02.012; Narrowe AB, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0069-6; Poole AC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00056-15; *TRICL, 2011, TRICLOSAN WHITE PAPE, P21; *US FOOD DRUG ADM, 2013, FDA TAK CLOS LOOK AN; Wesgate R, 2016, AM J INFECT CONTROL, V44, P458, DOI 10.1016/j.ajic.2015.11.009	13	28	28	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2016	353	6297					348	349		10.1126/science.aag2698	http://dx.doi.org/10.1126/science.aag2698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HB	27463658				2022-12-24	WOS:000380583400021
J	Badalyan, A; Stahl, SS				Badalyan, Artavazd; Stahl, Shannon S.			Cooperative electrocatalytic alcohol oxidation with electron-proton-transfer mediators	NATURE			English	Article							MECHANISM; ELECTROOXIDATION; CATALYSIS; ALDEHYDES; AMINES; CELLS	The electrochemical oxidation of alcohols is a major focus of energy and chemical conversion efforts, with potential applications ranging from fuel cells to biomass utilization and fine-chemical synthesis(1-7). Small-molecule electrocatalysts for processes of this type are promising targets for further development(8), as demonstrated by recent advances in nickel catalysts for electrochemical production and oxidation of hydrogen(9-11). Complexes with tethered amines that resemble the active site of hydrogenases(12) have been shown both to catalyse hydrogen production (from protons and electrons) with rates far exceeding those of such enzymes(11,13) and to mediate reversible electrocatalytic hydrogen production and oxidation with enzyme-like performance(14). Progress in electrocatalytic alcohol oxidation has been more modest. Nickel complexes similar to those used for hydrogen oxidation have been shown to mediate efficient electrochemical oxidation of benzyl alcohol, with a turnover frequency of 2.1 per second. These compounds exhibit poor reactivity with ethanol and methanol, however(15). Organic nitroxyls, such as TEMPO (2,2,6,6-tetramethyl-1-piperidine N-oxyl), are the most widely studied electrocatalysts for alcohol oxidation(5-7,16-19). These catalysts exhibit good activity (1-2 turnovers per second) with a wide range of alcohols(18) and have great promise for electro-organic synthesis(7). Their use in energy-conversion applications, however, is limited by the high electrode potentials required to generate the reactive oxoammonium species. Here we report (2,2'-bipyridine) Cu/nitroxyl co-catalyst systems for electrochemical alcohol oxidation that proceed with much faster rates, while operating at an electrode potential a half-volt lower than that used for the TEMPO-only process. The (2,2'-bipyridine) Cu(II) and TEMPO redox partners exhibit cooperative reactivity and exploit the low-potential, proton-coupled TEMPO/TEMPOH redox process rather than the high-potential TEMPO/TEMPO+ process. The results show how electron-proton-transfer mediators, such as TEMPO, may be used in combination with first-row transition metals, such as copper, to achieve efficient two-electron electrochemical processes, thereby introducing a new concept for the development of non-precious-metal electrocatalysts.	[Badalyan, Artavazd; Stahl, Shannon S.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Stahl, SS (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	stahl@chem.wisc.edu	Badalyan, Artavazd/W-2162-2019	Badalyan, Artavazd/0000-0002-6933-6181	Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science) [DE-FC02-07ER64494]	Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science)(United States Department of Energy (DOE))	Financial support for this project was provided by the Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science DE-FC02-07ER64494).	Bianchini C, 2009, CHEM REV, V109, P4183, DOI 10.1021/cr9000995; Bobbitt J.M., 2009, ORGANIC REACTIONS, P103, DOI [DOI 10.1002/0471264180.OR074.02, 10.1002/0471264180.or074.02]; Cha HG, 2015, NAT CHEM, V7, P328, DOI [10.1038/NCHEM.2194, 10.1038/nchem.2194]; Cheung KC, 2007, COORDIN CHEM REV, V251, P2367, DOI 10.1016/j.ccr.2007.04.004; Chirik PJ, 2010, SCIENCE, V327, P794, DOI 10.1126/science.1183281; Ciriminna R, 2015, CHEMCATCHEM, V7, P552, DOI 10.1002/cctc.201402896; Costentin C, 2014, CHEMELECTROCHEM, V1, P1226, DOI 10.1002/celc.201300263; Dijksman A, 2003, ORG BIOMOL CHEM, V1, P3232, DOI 10.1039/b305941c; Dubois MR, 2009, ACCOUNTS CHEM RES, V42, P1974, DOI 10.1021/ar900110c; Francke R, 2014, CHEM SOC REV, V43, P2492, DOI 10.1039/c3cs60464k; Helm ML, 2011, SCIENCE, V333, P863, DOI 10.1126/science.1205864; Hickey DP, 2015, J AM CHEM SOC, V137, P16179, DOI 10.1021/jacs.5b11252; Hickey DP, 2014, J AM CHEM SOC, V136, P15917, DOI 10.1021/ja5098379; Hoover JM, 2013, J AM CHEM SOC, V135, P2357, DOI 10.1021/ja3117203; Huynh MHV, 2007, CHEM REV, V107, P5004, DOI 10.1021/cr0500030; Kakati N, 2014, CHEM REV, V114, P12397, DOI 10.1021/cr400389f; Le Goff A, 2009, SCIENCE, V326, P1384, DOI 10.1126/science.1179773; Rafiee M, 2015, J AM CHEM SOC, V137, P14751, DOI 10.1021/jacs.5b09672; Rauchfuss TB, 2015, ACCOUNTS CHEM RES, V48, P2107, DOI 10.1021/acs.accounts.5b00177; Raugei S, 2016, INORG CHEM, V55, P445, DOI 10.1021/acs.inorgchem.5b02262; Rodriguez-Macia P, 2015, ANGEW CHEM INT EDIT, V54, P12303, DOI 10.1002/anie.201502364; Ryland BL, 2014, J AM CHEM SOC, V136, P12166, DOI 10.1021/ja5070137; Ryland BL, 2014, ANGEW CHEM INT EDIT, V53, P8824, DOI 10.1002/anie.201403110; SEMMELHACK MF, 1986, TETRAHEDRON LETT, V27, P1119, DOI 10.1016/S0040-4039(00)84193-3; SEMMELHACK MF, 1983, J AM CHEM SOC, V105, P4492, DOI 10.1021/ja00351a070; SEMMELHACK MF, 1984, J AM CHEM SOC, V106, P3374, DOI 10.1021/ja00323a064; Trincado M, 2014, ENERG ENVIRON SCI, V7, P2464, DOI 10.1039/c4ee00389f; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Weiss CJ, 2015, CHEM COMMUN, V51, P6172, DOI 10.1039/c5cc01107h; Whittaker JW, 2003, CHEM REV, V103, P2347, DOI 10.1021/cr020425z	30	277	279	48	782	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					406	410		10.1038/nature18008	http://dx.doi.org/10.1038/nature18008			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27350245				2022-12-24	WOS:000380344200037
J	Faivre, D; Bennet, M				Faivre, Damien; Bennet, Mathieu			Magnetic nanoparticles line up	NATURE			English	Editorial Material							BACTERIA	Certain bacteria contain strings of magnetic nanoparticles and therefore align with magnetic fields. Inspired by these natural structures, researchers have now fabricated synthetic one-dimensional arrays of such particles.	[Faivre, Damien; Bennet, Mathieu] Max Planck Inst Colloids & Interfaces, Potsdam Golm Sci Pk, D-14476 Potsdam, Germany	Max Planck Society	Faivre, D (corresponding author), Max Planck Inst Colloids & Interfaces, Potsdam Golm Sci Pk, D-14476 Potsdam, Germany.	damien.faivre@mpikg.mpg.de; mathieu.bennet@mpikg.mpg.de	faivre, damien/D-3713-2009	faivre, damien/0000-0001-6191-3389; bennet, mathieu/0000-0002-1292-7984				Alphandery E, 2009, ACS NANO, V3, P1539, DOI 10.1021/nn900289n; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Faivre D, 2015, ANGEW CHEM INT EDIT, V54, P4728, DOI 10.1002/anie.201408900; Ghosh D, 2012, NAT NANOTECHNOL, V7, P677, DOI [10.1038/NNANO.2012.146, 10.1038/nnano.2012.146]; Jiang X.X., 2016, ADV MAT; Kiani B, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/4/043007; Mishra SR, 2016, NANOSCALE, V8, P1309, DOI 10.1039/c5nr07410j; Yuan JY, 2011, CHEM SOC REV, V40, P640, DOI 10.1039/c0cs00087f	8	18	18	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					235	236		10.1038/535235a	http://dx.doi.org/10.1038/535235a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR4ZN	27411627				2022-12-24	WOS:000379912600043
J	Igarashi, M; Guarente, L				Igarashi, Masaki; Guarente, Leonard			mTORC1 and SIRT1 Cooperate to Foster Expansion of Gut Adult Stem Cells during Calorie Restriction	CELL			English	Article							S6 KINASE; LIFE-SPAN; PHOSPHORYLATION; NAD(+); DIFFERENTIATION; METABOLISM; ACTIVATION; EXPRESSION; STRATEGIES; P70(S6K)	Longevity-promoting caloric restriction is thought to trigger downregulation of mammalian target of rapamycin complex 1 ( mTORC1) signaling and upregulation of SIRT1 activity with associated health benefits. Here, we show that mTORC1 signaling in intestinal stem cells ( ISCs) is instead upregulated during calorie restriction ( CR). SIRT1 deacetylates S6K1, thereby enhancing its phosphorylation by mTORC1, which leads to an increase in protein synthesis and an increase in ISC number. Paneth cells in the ISC niche secrete cyclic ADP ribose that triggers SIRT1 activity and mTORC1 signaling in neighboring ISCs. Notably, the mTOR inhibitor rapamycin, previously reported to mimic effects of CR, abolishes this expansion of ISCs. We suggest that Paneth cell signaling overrides any direct nutrient sensing in ISCs to sculpt the observed response to CR. Moreover, drugs that modulate pathways important in CR may exert opposing effects on different cell types.	[Igarashi, Masaki; Guarente, Leonard] MIT, Dept Biol, Glenn Labs Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Igarashi, Masaki; Guarente, Leonard] MIT, Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, Glenn Labs Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Guarente, L (corresponding author), MIT, Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu			Manpei Suzuki Diabetes Foundation; NIH; Glenn Foundation for Medical Research	Manpei Suzuki Diabetes Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research	We wish to thank Angeliki Chalkiadaki and Eric Williams for comments on the manuscript. We also thank Dr. Inoki (University of Michigan) for S6K1 acetylation mutant expression vector. M.I. was supported by the Manpei Suzuki Diabetes Foundation. L.G. was supported by grants from NIH and the Glenn Foundation for Medical Research. L.G. is a founder of Elysium Health and consults for GSK, Sibelius, and Segterra.	Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brandauer J, 2013, J PHYSIOL-LONDON, V591, P5207, DOI 10.1113/jphysiol.2013.259515; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Fenton TR, 2010, INT J BIOCHEM CELL B, V42, P359, DOI 10.1016/j.biocel.2009.11.022; Fenton TR, 2010, BIOCHEM BIOPH RES CO, V398, P400, DOI 10.1016/j.bbrc.2010.06.081; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gregorieff A, 2010, CURR PROTOC STEM CEL; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hasty P, 2014, CANCER PREV RES, V7, P169, DOI 10.1158/1940-6207.CAPR-13-0299; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hong SK, 2014, J BIOL CHEM, V289, P13132, DOI 10.1074/jbc.M113.520734; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; De Bonis ML, 2014, STEM CELL REP, V2, P690, DOI 10.1016/j.stemcr.2014.03.002; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wen L, 2013, P NATL ACAD SCI USA, V110, pE2420, DOI 10.1073/pnas.1309354110; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	44	166	176	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					436	450		10.1016/j.cell.2016.05.044	http://dx.doi.org/10.1016/j.cell.2016.05.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27345368	Bronze			2022-12-24	WOS:000380255400020
J	Katz, LN; Ates, JLY; Pillow, JW; Huk, AC				Katz, Leor N.; Ates, Jacob L. Y.; Pillow, Jonathan W.; Huk, Alexander C.			Dissociated functional significance of decision-related activity in the primate dorsal stream	NATURE			English	Article							LATERAL INTRAPARIETAL AREA; PARIETAL CORTEX; PERCEPTUAL DECISION; VISUAL-CORTEX; MOTION SIGNALS; MACAQUE MONKEY; NEURAL BASIS; NEURONS; MT; INACTIVATION	During decision making, neurons in multiple brain regions exhibit responses that are correlated with decisions(1-6). However, it remains uncertain whether or not various forms of decision-related activity are causally related to decision making(7-9). Here we address this question by recording and reversibly inactivating the lateral intraparietal (LIP) and middle temporal (MT) areas of rhesus macaques performing a motion direction discrimination task. Neurons in area LIP exhibited firing rate patterns that directly resembled the evidence accumulation process posited to govern decision making(2,10), with strong correlations between their response fluctuations and the animal's choices. Neurons in area MT, in contrast, exhibited weak correlations between their response fluctuations and choices, and had firing rate patterns consistent with their sensory role in motion encoding(1). The behavioural impact of pharmacological inactivation of each area was inversely related to their degree of decision-related activity: while inactivation of neurons in MT profoundly impaired psychophysical performance, inactivation in LIP had no measurable impact on decision-making performance, despite having silenced the very clusters that exhibited strong decision-related activity. Although LIP inactivation did not impair psychophysical behaviour, it did influence spatial selection and oculomotor metrics in a free-choice control task. The absence of an effect on perceptual decision making was stable over trials and sessions and was robust to changes in stimulus type and task geometry, arguing against several forms of compensation. Thus, decision-related signals in LIP do not appear to be critical for computing perceptual decisions, and may instead reflect secondary processes. Our findings highlight a dissociation between decision correlation and causation, showing that strong neuron-decision correlations do not necessarily offer direct access to the neural computations underlying decisions.	[Katz, Leor N.; Ates, Jacob L. Y.; Huk, Alexander C.] Univ Texas Austin, Dept Neurosci, Ctr Perceptual Syst, Austin, TX 78712 USA; [Katz, Leor N.; Ates, Jacob L. Y.; Huk, Alexander C.] Univ Texas Austin, Dept Psychol, Ctr Perceptual Syst, Austin, TX 78712 USA; [Pillow, Jonathan W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA; [Pillow, Jonathan W.] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Princeton University; Princeton University	Katz, LN (corresponding author), Univ Texas Austin, Dept Neurosci, Ctr Perceptual Syst, Austin, TX 78712 USA.; Katz, LN (corresponding author), Univ Texas Austin, Dept Psychol, Ctr Perceptual Syst, Austin, TX 78712 USA.	leor.katz@utexas.edu	Huk, Alexander/A-8031-2016	Huk, Alexander/0000-0003-1430-6935; Pillow, Jonathan/0000-0002-3638-8831	Howard Hughes Medical Institute International Student Research Fellowship; McKnight Foundation; National Eye Institute [R01-EY017366]; National Institutes of Health from the National Institute on Drug Abuse [T32DA018926]; National Institutes of Health from the National Eye Institute [T32EY021462]; NATIONAL EYE INSTITUTE [R01EY017366, T32EY021462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA018926] Funding Source: NIH RePORTER	Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); McKnight Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health from the National Institute on Drug Abuse; National Institutes of Health from the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Krauzlis, C. Brody, E. Seidemann, L. Cormack, and R. Aldrich for comments on the manuscript. We thank the Brody laboratory (particularly C. Brody and J. Erlich) for inspiring the experiments, the Mauk laboratory (particularly M. Mauk. F. Riusech, and H. Halverson) for assistance with muscimol preparation, and K. Mitchell for animal support. This research was supported by the Howard Hughes Medical Institute International Student Research Fellowship to L.N.K.. the McKnight Foundation grant to J.W.P, the National Eye Institute (R01-EY017366) grant to both J.W.P, and A.C.H., and the National Institutes of Health under Ruth L. Kirschstein National Research Service Awards T32DA018926 from the National Institute on Drug Abuse and T32EY021462 from the National Eye Institute.	Arikan R, 2002, J NEUROSCI METH, V118, P51, DOI 10.1016/S0165-0270(02)00143-7; Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chowdhury SA, 2008, NEURON, V60, P367, DOI 10.1016/j.neuron.2008.08.023; Crowe DA, 2013, NAT NEUROSCI, V16, P1484, DOI 10.1038/nn.3509; Cumming BG, 2016, CURR OPIN NEUROBIOL, V37, P126, DOI 10.1016/j.conb.2016.01.009; Ding L, 2013, NEURON, V79, P640, DOI 10.1016/j.neuron.2013.07.042; Eastman KM, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00001; Erlich J. C., 2015, ELIFE, V4, P8166; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Heiss JD, 2010, J NEUROSURG, V112, P790, DOI 10.3171/2009.7.JNS09652; Heitz RP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0071; HESS R, 1974, EXP BRAIN RES, V21, P285; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kubanek J, 2015, P NATL ACAD SCI USA, V112, pE2067, DOI 10.1073/pnas.1418324112; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Li N, 2016, NATURE, V532, P459, DOI 10.1038/nature17643; Liu S, 2013, NAT NEUROSCI, V16, P89, DOI 10.1038/nn.3267; Liu YQ, 2010, NAT NEUROSCI, V13, P495, DOI 10.1038/nn.2496; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Noudoost B, 2011, J NEUROSCI METH, V194, P218, DOI 10.1016/j.jneumeth.2010.10.009; Patel GH, 2010, P NATL ACAD SCI USA, V107, P4728, DOI 10.1073/pnas.0908092107; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pillow JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062123; Pitkow X, 2015, NEURON, V87, P411, DOI 10.1016/j.neuron.2015.06.033; Raposo D, 2014, NAT NEUROSCI, V17, P1784, DOI 10.1038/nn.3865; Sarma A, 2016, NAT NEUROSCI, V19, P143, DOI 10.1038/nn.4168; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Siegel M, 2015, SCIENCE, V348, P1352, DOI 10.1126/science.aab0551; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; Wardak C, 2004, NEURON, V42, P501, DOI 10.1016/S0896-6273(04)00185-0; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilke M, 2012, P NATL ACAD SCI USA, V109, P8274, DOI 10.1073/pnas.1204789109; Yttri EA, 2014, J NEUROPHYSIOL, V111, P520, DOI 10.1152/jn.00058.2013; Zirnsak M., 2015, P C SOC NEUR	51	156	157	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					285	+		10.1038/nature18617	http://dx.doi.org/10.1038/nature18617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27376476	Green Accepted			2022-12-24	WOS:000379912600057
J	Matheoud, D; Sugiura, A; Bellemare-Pelletier, A; Laplante, A; Rondeau, C; Chemali, M; Fazel, A; Bergeron, JJ; Trudeau, LE; Burelle, Y; Gagnon, E; McBride, HM; Desjardins, M				Matheoud, Diana; Sugiura, Ayumu; Bellemare-Pelletier, Angelique; Laplante, Annie; Rondeau, Christiane; Chemali, Magali; Fazel, Ali; Bergeron, John J.; Trudeau, Louis-Eric; Burelle, Yan; Gagnon, Etienne; McBride, Heidi M.; Desjardins, Michel			Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation	CELL			English	Article							PRIMARY BILIARY-CIRRHOSIS; REGULATORY T-CELLS; CLASS-I MOLECULES; MAMMALIAN-CELLS; HEAT-SHOCK; AUTOPHAGY; MITOPHAGY; TRANSPORT; CARGO; RAB9	Antigen presentation is essential for establishing immune tolerance and for immune responses against infectious disease and cancer. Although antigen presentation can be mediated by autophagy, here we demonstrate a pathway for mitochondrial antigen presentation ( MitAP) that relies on the generation and trafficking of mitochondrial-derived vesicles ( MDVs) rather than on autophagy/mitophagy. We find that PINK1 and Parkin, two mitochondrial proteins linked to Parkinson's disease ( PD), actively inhibit MDV formation and MitAP. In absence of PINK1 or Parkin, inflammatory conditions trigger MitAP in immune cells, both in vitro and in vivo. MitAP and the formation of MDVs require Rab9 and Sorting nexin 9, whose recruitment to mitochondria is inhibited by Parkin. The identification of PINK1 and Parkin as suppressors of an immune-response-eliciting pathway provoked by inflammation suggests new insights into PD pathology.	[Matheoud, Diana; Bellemare-Pelletier, Angelique; Laplante, Annie; Rondeau, Christiane; Chemali, Magali; Desjardins, Michel] Univ Montreal, Dept Pathol & Biol Cellulaire, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Sugiura, Ayumu; McBride, Heidi M.] McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada; [Fazel, Ali; Bergeron, John J.] McGill Univ, Dept Med, Hosp Res Inst, Montreal, PQ H4A 3J1, Canada; [Trudeau, Louis-Eric] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Trudeau, Louis-Eric] Univ Montreal, Dept Neurosci, Montreal, PQ H3C 3J7, Canada; [Burelle, Yan] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Gagnon, Etienne] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Gagnon, Etienne] Univ Montreal, Dept Immunol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Desjardins, M (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.; McBride, HM (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	heidi.mcbride@mcgill.ca; michel.desjardins@umontreal.ca	McBride, Heidi M/C-1162-2008; Bergeron, John/AAW-1893-2021; Burelle, Yan/AAF-8104-2021; Sugiura, Ayumu/G-3648-2018; McBride, Heidi M./ABD-5774-2021; Trudeau, Louis-Eric/AAE-4782-2020	McBride, Heidi M/0000-0003-4666-2280; Burelle, Yan/0000-0001-9379-146X; Sugiura, Ayumu/0000-0002-4776-1478; McBride, Heidi M./0000-0003-4666-2280; Trudeau, Louis-Eric/0000-0003-4684-1377; Desjardins, Michel/0000-0002-5684-5980	Canadian Institutes for Health Research (MOP) [133653, 114869, 5605, 133549]; Canada Research Chair; Japan Society for the Promotion of Science	Canadian Institutes for Health Research (MOP)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank F. Carbone, W. Heath (University of Melbourne), and N. Shastri (University of California) for the hybridomas. We thank J. Boulais, H. Soudeyns, and the Fondation Centre de cancerologie Charles-Bruneau for technical support. This work was supported by the Canadian Institutes for Health Research (MOP#133653, MOP#114869, MOP#5605, and MOP#133549), the Canada Research Chair, and the Japan Society for the Promotion of Science.	Baba Y, 2005, PARKINSONISM RELAT D, V11, P493, DOI 10.1016/j.parkreldis.2005.07.005; BAUM H, 1995, BBA-MOL BASIS DIS, V1271, P111, DOI 10.1016/0925-4439(95)00017-X; Bell C, 2013, MOL CELL PROTEOMICS, V12, P2394, DOI 10.1074/mcp.M112.025775; BJORKLAND A, 1991, SCAND J IMMUNOL, V33, P749, DOI 10.1111/j.1365-3083.1991.tb02549.x; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Cebrian C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4633; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Dawson TM, 2008, LANCET NEUROL, V7, P474, DOI 10.1016/S1474-4422(08)70099-1; Dong B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2347; DUTZ JP, 1994, MOL IMMUNOL, V31, P967, DOI 10.1016/0161-5890(94)90091-4; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hasday JD, 2000, CELL STRESS CHAPERON, V5, P471, DOI 10.1379/1466-1268(2000)005<0471:FATHSR>2.0.CO;2; Hernandez D.G., 2016, J NEUROCHEM, DOI 10/1111/jnc.13593; Hirschfield GM, 2013, ANNU REV PATHOL-MECH, V8, P303, DOI 10.1146/annurev-pathol-020712-164014; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Kucera A, 2016, TRAFFIC, V17, P211, DOI 10.1111/tra.12357; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Martin HL, 2016, GLIA, V64, P386, DOI 10.1002/glia.22935; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Mosley RL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009381; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Nivon M, 2009, AUTOPHAGY, V5, P766, DOI 10.4161/auto.8788; Norton M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004374; Olson KE, 2016, CURR OPIN PHARMACOL, V26, P87, DOI 10.1016/j.coph.2015.10.006; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Pisani V, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-188; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Tanaka H, 2014, CLIN EXP IMMUNOL, V178, P253, DOI 10.1111/cei.12415; Tang FL, 2015, CELL REP, V12, P1631, DOI 10.1016/j.celrep.2015.08.001; Tran TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023660; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wang W., 2015, EUR POLYM J, V1, P1, DOI DOI 10.1016/J.IJCARD.2014.10.148; Xu XM, 2013, J BIOL CHEM, V288, P18077, DOI 10.1074/jbc.M113.474650; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014	53	298	307	3	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					314	327		10.1016/j.cell.2016.05.039	http://dx.doi.org/10.1016/j.cell.2016.05.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27345367	Bronze			2022-12-24	WOS:000380255400011
J	Wilbur, MB				Wilbur, MaryAnn B.			Chemotherapy-Induced Nausea and Vomiting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	3	3	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2016	375	2					177	177		10.1056/NEJMclde1607577	http://dx.doi.org/10.1056/NEJMclde1607577			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ9KY	27410928				2022-12-24	WOS:000379530000014
J	Park, SJ; Gazzola, M; Park, KS; Park, S; Di Santo, V; Blevins, EL; Lind, JU; Campbell, PH; Dauth, S; Capulli, AK; Pasqualini, FS; Ahn, S; Cho, A; Yuan, HY; Maoz, BM; Vijaykumar, R; Choi, JW; Deisseroth, K; Lauder, GV; Mahadevan, L; Parker, KK				Park, Sung-Jin; Gazzola, Mattia; Park, Kyung Soo; Park, Shirley; Di Santo, Valentina; Blevins, Erin L.; Lind, Johan U.; Campbell, Patrick H.; Dauth, Stephanie; Capulli, Andrew K.; Pasqualini, Francesco S.; Ahn, Seungkuk; Cho, Alexander; Yuan, Hongyan; Maoz, Ben M.; Vijaykumar, Ragu; Choi, Jeong-Woo; Deisseroth, Karl; Lauder, George V.; Mahadevan, L.; Parker, Kevin Kit			Phototactic guidance of a tissue-engineered soft-robotic ray	SCIENCE			English	Article							BIOLOGICAL MACHINES; BODY WAVES; LOCOMOTION; SWIMMERS; SURFACE; WALKING; FISH	Inspired by the relatively simple morphological blueprint provided by batoid fish such as stingrays and skates, we created a biohybrid system that enables an artificial animal-a tissue-engineered ray-to swim and phototactically follow a light cue. By patterning dissociated rat cardiomyocytes on an elastomeric body enclosing a microfabricated gold skeleton, we replicated fish morphology at 1/10 scale and captured basic fin deflection patterns of batoid fish. Optogenetics allows for phototactic guidance, steering, and turning maneuvers. Optical stimulation induced sequential muscle activation via serpentine-patterned muscle circuits, leading to coordinated undulatory swimming. The speed and direction of the ray was controlled by modulating light frequency and by independently eliciting right and left fins, allowing the biohybrid machine to maneuver through an obstacle course.	[Park, Sung-Jin; Lind, Johan U.; Campbell, Patrick H.; Dauth, Stephanie; Capulli, Andrew K.; Pasqualini, Francesco S.; Ahn, Seungkuk; Cho, Alexander; Yuan, Hongyan; Maoz, Ben M.; Parker, Kevin Kit] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA; [Gazzola, Mattia; Mahadevan, L.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Park, Kyung Soo; Choi, Jeong-Woo] Sogang Univ, Dept Biomol & Chem Engn, Seoul 121742, South Korea; [Park, Kyung Soo; Choi, Jeong-Woo; Parker, Kevin Kit] Sogang Univ, Sogang Harvard Res Ctr Dis Biophys, Seoul 121742, South Korea; [Park, Shirley; Vijaykumar, Ragu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Di Santo, Valentina; Blevins, Erin L.; Lauder, George V.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Mahadevan, L.] Harvard Univ, Kavli Inst Nanobio Sci & Technol, Wyss Inst Biol Inspired Engn, Dept Phys,Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Gazzola, Mattia] Univ Illinois, Dept Engn Sci & Mech, Urbana, IL 61801 USA; [Park, Kyung Soo] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Park, Shirley] Stanford Univ, Med Ctr, Dept Cardiovasc Med, Stanford, CA 94305 USA; [Blevins, Erin L.] Winsor Sch, Boston, MA 02215 USA; [Yuan, Hongyan] Univ Rhode Isl, Dept Mech Ind & Syst Engn, Kingston, RI 02881 USA	Harvard University; Harvard University; Sogang University; Sogang University; Stanford University; Harvard University; Stanford University; Howard Hughes Medical Institute; Stanford University; Harvard University; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan; Stanford University; University of Rhode Island	Parker, KK (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA.; Parker, KK (corresponding author), Sogang Univ, Sogang Harvard Res Ctr Dis Biophys, Seoul 121742, South Korea.	kkparker@seas.harvard.edu	Yuan, Hongyan/C-3816-2011; Pasqualini, Francesco/AAQ-5928-2021; Ahn, Seungkuk/AAP-1105-2020; Gazzola, Mattia/I-5090-2012	Yuan, Hongyan/0000-0001-8225-0211; Pasqualini, Francesco/0000-0001-7038-3121; Maoz, Ben/0000-0002-3823-7682; Gazzola, Mattia/0000-0003-2129-379X; Di Santo, Valentina/0000-0002-5419-3747; Lind, Johan Ulrik/0000-0002-0358-3999	Harvard Paulson School of Engineering and Applied Sciences; Wyss Institute for Biologically Inspired Engineering; National Center for Advancing Translational Sciences [UH3TR000522]; Los Almos National Laboratory under prime DTRA contract [312659, DE-AC52-06NA25396]; National Science Foundation (NSF) [EFRI-0938043]; NSF Materials Research Science and Engineering Center [DMR-1420570]; Office of Naval Research Multidisciplinary University Research Initiative grant [N000141410533]; Swiss National Science Foundation; MacArthur Foundation; Radcliffe Institute; National Research Foundation of Korea [2013K1A4A3055268]; U.S. Army Research Laboratory and Office [W911NF-12-2-0036]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072030] Funding Source: NIH RePORTER	Harvard Paulson School of Engineering and Applied Sciences; Wyss Institute for Biologically Inspired Engineering; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Los Almos National Laboratory under prime DTRA contract; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Materials Research Science and Engineering Center(National Science Foundation (NSF)); Office of Naval Research Multidisciplinary University Research Initiative grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MacArthur Foundation; Radcliffe Institute; National Research Foundation of Korea(National Research Foundation of Korea); U.S. Army Research Laboratory and Office; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Data reported in the paper are included in the supplementary materials. We thank A. P. Nesmith, M. McKenna, and A. Chandler for discussion on design and K. Hudson and Margherita Gazzola for photography and illustrations. This work was funded by the Harvard Paulson School of Engineering and Applied Sciences, the Wyss Institute for Biologically Inspired Engineering, the National Center for Advancing Translational Sciences grant UH3TR000522, subcontract 312659 from Los Almos National Laboratory under prime DTRA contract DE-AC52-06NA25396, the National Science Foundation (NSF) grant EFRI-0938043, NSF Materials Research Science and Engineering Center grant DMR-1420570, Office of Naval Research Multidisciplinary University Research Initiative grant N000141410533, the Swiss National Science Foundation, the MacArthur Foundation, the Radcliffe Institute, the National Research Foundation of Korea grant 2013K1A4A3055268, and the U.S. Army Research Laboratory and Office contract W911NF-12-2-0036. The views and conclusions contained in this Report are those of the authors and should not be interpreted as representing official policies, expressed or implied, of the Army Research Office or Laboratory, the U.S. government, or any other funding agencies. The U.S. government is authorized to reproduce and distribute reprints for government purposes notwithstanding any copyright notation hereon. Portions of this work were performed at the Harvard Center for Nanoscale Systems (NSF 1541959) and at the Neurobiology Imaging Facility (NINDS P30 Core Center NS072030). Certain aspects of the paper are described in U.S. patent 8,492,150 and U.S. patent application 20150182679.	Astley HC, 2015, P NATL ACAD SCI USA, V112, P6200, DOI 10.1073/pnas.1418965112; Blevins EL, 2012, J EXP BIOL, V215, P3231, DOI 10.1242/jeb.068981; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Braitenberg V., 1986, VEHICLES EXPT SYNTHE; Chan V, 2014, LAB CHIP, V14, P653, DOI 10.1039/c3lc50989c; Chan V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00857; Cotel AJ, 2015, INTEGR COMP BIOL, V55, P662, DOI 10.1093/icb/icv085; Di Santo V, 2016, J EXP BIOL, V219, P1804, DOI 10.1242/jeb.136358; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Gazzola M, 2014, NAT PHYS, V10, P758, DOI 10.1038/NPHYS3078; Haberland M, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/1/016010; Hyun DJ, 2014, INT J ROBOT RES, V33, P1417, DOI 10.1177/0278364914532150; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Kim S, 2013, TRENDS BIOTECHNOL, V31, P23, DOI 10.1016/j.tibtech.2013.03.002; Koh JS, 2015, SCIENCE, V349, P517, DOI 10.1126/science.aab1637; Ma HL, 2004, AM J PHYSIOL-CELL PH, V286, pC556, DOI 10.1152/ajpcell.00328.2003; Ma KY, 2013, SCIENCE, V340, P603, DOI 10.1126/science.1231806; Moored KW, 2011, MAR TECHNOL SOC J, V45, P99, DOI 10.4031/MTSJ.45.4.10; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Nawroth JC, 2012, NAT BIOTECHNOL, V30, P792, DOI 10.1038/nbt.2269; Parson JM, 2011, J EXP MAR BIOL ECOL, V402, P12, DOI 10.1016/j.jembe.2011.03.010; Pfeifer R., 2013, P 23 INT JOINT C ART, P5; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Raman R, 2016, P NATL ACAD SCI USA, V113, P3497, DOI 10.1073/pnas.1516139113; Rosenberger LJ, 1999, J EXP BIOL, V202, P3523; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; TRIANTAFYLLOU MS, 1995, SCI AM, V272, P64, DOI 10.1038/scientificamerican0395-64; van Rees WM, 2013, J FLUID MECH, V722, DOI 10.1017/jfm.2013.157; Williams BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4081	31	399	406	36	376	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					158	162		10.1126/science.aaf4292	http://dx.doi.org/10.1126/science.aaf4292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27387948	Green Accepted			2022-12-24	WOS:000379208400036
J	Wernberg, T; Bennett, S; Babcock, RC; de Bettignies, T; Cure, K; Depczynski, M; Dufois, F; Fromont, J; Fulton, CJ; Hovey, RK; Harvey, ES; Holmes, TH; Kendrick, GA; Radford, B; Santana-Garcon, J; Saunders, BJ; Smale, DA; Thomsen, MS; Tuckett, CA; Tuya, F; Vanderklift, MA; Wilson, S				Wernberg, Thomas; Bennett, Scott; Babcock, Russell C.; de Bettignies, Thibaut; Cure, Katherine; Depczynski, Martial; Dufois, Francois; Fromont, Jane; Fulton, Christopher J.; Hovey, Renae K.; Harvey, Euan S.; Holmes, Thomas H.; Kendrick, Gary A.; Radford, Ben; Santana-Garcon, Julia; Saunders, Benjamin J.; Smale, Dan A.; Thomsen, Mads S.; Tuckett, Chenae A.; Tuya, Fernando; Vanderklift, Mathew A.; Wilson, Shaun			Climate-driven regime shift of a temperate marine ecosystem	SCIENCE			English	Article							PHASE-SHIFTS; CORAL-REEFS; KELP BEDS; EL-NINO; RESILIENCE; DIVERSITY; STABILITY; FUTURE	Ecosystem reconfigurations arising from climate-driven changes in species distributions are expected to have profound ecological, social, and economic implications. Here we reveal a rapid climate-driven regime shift of Australian temperate reef communities, which lost their defining kelp forests and became dominated by persistent seaweed turfs. After decades of ocean warming, extreme marine heat waves forced a 100-kilometer range contraction of extensive kelp forests and saw temperate species replaced by seaweeds, invertebrates, corals, and fishes characteristic of subtropical and tropical waters. This community-wide tropicalization fundamentally altered key ecological processes, suppressing the recovery of kelp forests.	[Wernberg, Thomas; Bennett, Scott; Babcock, Russell C.; de Bettignies, Thibaut; Cure, Katherine; Hovey, Renae K.; Holmes, Thomas H.; Kendrick, Gary A.; Santana-Garcon, Julia; Smale, Dan A.; Thomsen, Mads S.; Tuckett, Chenae A.; Wilson, Shaun] Univ Western Australia, Sch Plant Biol, 39 Fairway, Crawley, WA 6009, Australia; [Wernberg, Thomas; Bennett, Scott; Babcock, Russell C.; de Bettignies, Thibaut; Cure, Katherine; Hovey, Renae K.; Holmes, Thomas H.; Kendrick, Gary A.; Santana-Garcon, Julia; Smale, Dan A.; Thomsen, Mads S.; Tuckett, Chenae A.; Wilson, Shaun] Univ Western Australia, Oceans Inst, 39 Fairway, Crawley, WA 6009, Australia; [Bennett, Scott; Harvey, Euan S.; Santana-Garcon, Julia; Saunders, Benjamin J.] Curtin Univ, Sch Sci, Dept Environm & Agr, Bentley, WA 6102, Australia; [Bennett, Scott; Santana-Garcon, Julia] Univ Illes Balears, CSIC, Inst Mediterrani Estudis Avancats, Dept Global Change Res, Esporles, Spain; [Babcock, Russell C.] Commonwealth Sci & Ind Res Org CSIRO Oceans & Atm, Gen POB 2583, Brisbane, Qld 4001, Australia; [de Bettignies, Thibaut] Museum Natl Hist Nat, Serv Patrimoine Nat, 36 Rue Geoffroy St Hilaire CP41, F-75005 Paris, France; [Cure, Katherine; Depczynski, Martial; Radford, Ben] Australian Inst Marine Sci, 39 Fairway, Crawley, WA 6009, Australia; [Dufois, Francois; Vanderklift, Mathew A.] CSIRO Oceans & Atmosphere Flagship, Private Bag 5, Wembley, WA 6913, Australia; [Fromont, Jane] Western Australian Museum, Locked Bag 49, Welshpool Dc, WA 6986, Australia; [Fulton, Christopher J.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Holmes, Thomas H.; Wilson, Shaun] Dept Pk & Wildlife, Marine Sci Program, Div Sci, Kensington, WA 6151, Australia; [Radford, Ben; Smale, Dan A.] Univ Western Australia, Sch Geog & Environm Sci, 39 Fairway, Crawley, WA 6009, Australia; [Thomsen, Mads S.] Marine Biol Assoc United Kingdom Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England; [Tuya, Fernando] Univ Canterbury, Sch Biol Sci, Marine Ecol Grp, Private Bag 4800, Christchurch, New Zealand; Univ Las Palmas Gran Canaria, Inst Univ Ecoaqua, Las Palmas Gran Canaria 35017, Canary Islands, Spain	University of Western Australia; University of Western Australia; Curtin University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Museum National d'Histoire Naturelle (MNHN); Australian Institute of Marine Science; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Western Australian Museum; Australian National University; University of Western Australia; Marine Biological Association United Kingdom; University of Canterbury; Universidad de Las Palmas de Gran Canaria	Wernberg, T (corresponding author), Univ Western Australia, Sch Plant Biol, 39 Fairway, Crawley, WA 6009, Australia.; Wernberg, T (corresponding author), Univ Western Australia, Oceans Inst, 39 Fairway, Crawley, WA 6009, Australia.	thomas.wernberg@uwa.edu.au	Babcock, Russell C/A-3794-2012; Smale, Daniel/Y-2909-2019; Wernberg, Thomas/B-4172-2010; Saunders, Benjamin J/J-5220-2013; Fulton, Christopher/A-5971-2008; Bennett, Scott/A-8747-2016; Dufois, Francois/B-5545-2012; Harvey, Euan/B-2896-2011; Saunders, Benjamin/AAB-6617-2019; Vanderklift, Mathew A/B-1003-2008; Kendrick, Gary Andrew/B-3460-2011; Cure, Katherine/I-3126-2019; Santana-Garcon, Julia/M-1410-2013; depczynski, martial/B-7689-2008	Babcock, Russell C/0000-0002-7756-1290; Smale, Daniel/0000-0003-4157-541X; Wernberg, Thomas/0000-0003-1185-9745; Saunders, Benjamin J/0000-0003-1929-518X; Fulton, Christopher/0000-0002-1140-1999; Bennett, Scott/0000-0003-2969-7430; Dufois, Francois/0000-0002-7135-2893; Harvey, Euan/0000-0002-9069-4581; Saunders, Benjamin/0000-0003-1929-518X; Vanderklift, Mathew A/0000-0002-5170-7546; Kendrick, Gary Andrew/0000-0002-0276-6064; hovey, renae/0000-0003-0308-3609; Santana-Garcon, Julia/0000-0001-7961-3552; Wilson, Shaun/0000-0002-4590-0948; depczynski, martial/0000-0001-8723-0076; de Bettignies, Thibaut/0000-0003-0565-1200	Australian Research Council; Hermon Slade Foundation; U.K. Natural Environment Research Council Independent Research Fellowship; Australian Institute of Marine Science; Australian National University; Western Australian Museum; Department of Parks and Wildlife; CSIRO Oceans and Atmosphere; Fisheries Research and Development Corporation [2008/013]; Marsden Fund of The Royal Society of New Zealand; WA Strategic Research Fund for the Marine Environment; Natural Environment Research Council [NE/K008439/1] Funding Source: researchfish; NERC [NE/K008439/1] Funding Source: UKRI	Australian Research Council(Australian Research Council); Hermon Slade Foundation; U.K. Natural Environment Research Council Independent Research Fellowship; Australian Institute of Marine Science; Australian National University(Australian National University); Western Australian Museum; Department of Parks and Wildlife; CSIRO Oceans and Atmosphere; Fisheries Research and Development Corporation; Marsden Fund of The Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); WA Strategic Research Fund for the Marine Environment; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Australian Research Council (T.W., G.A.K.), the Hermon Slade Foundation (T.W., S.B.), a U.K. Natural Environment Research Council Independent Research Fellowship (D.A.S.), the Australian Institute of Marine Science (T.W., M.D., B.R.), the Australian National University (C.J.F.), the Western Australian Museum (J.F.), the Department of Parks and Wildlife (T.H.H., S.W.), CSIRO Oceans and Atmosphere (R.C.B., F.D., M.A.V.), Fisheries Research and Development Corporation project no. 2008/013 (R.K.H., G.A.K.), The Marsden Fund of The Royal Society of New Zealand (M.S.T.), and the WA Strategic Research Fund for the Marine Environment (R.B., M.A.V., J.F.). T.W. and S.B. conceptualized and wrote the manuscript; T.W., S.B., R.B., T.dB., K.C., M.D., F.D., J.F., C.J.F., J.S.-G., R.K.H., E.S.H., T.H.H., G.K., B.R., B.J.S., D.K.S., M.T., C.T., F.T., M.A.V., and S.W. provided data; and T.W., S.B., R.K.H., J.S.-G., and D.A.S. performed analyses and modeling. All authors discussed the results and commented on the manuscript. The data are provided in the supplementary materials. Additional information can be obtained from T.W. All authors declare no conflicting interests.	[Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; Bennett S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10280; Bennett S, 2016, MAR FRESHWATER RES, V67, P47, DOI 10.1071/MF15232; Bennett S, 2015, ECOL LETT, V18, P714, DOI 10.1111/ele.12450; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cai WJ, 2015, NAT CLIM CHANGE, V5, P132, DOI [10.1038/nclimate2492, 10.1038/NCLIMATE2492]; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; DAYTON PK, 1984, SCIENCE, V224, P283, DOI 10.1126/science.224.4646.283; Feng M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01277; Feng M, 2010, MAR FRESHWATER RES, V61, P1259, DOI 10.1071/MF09275; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Hobday AJ, 2014, REV FISH BIOL FISHER, V24, P415, DOI 10.1007/s11160-013-9326-6; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Lough J., 2012, REPORT CARD MARINE C; Martinez EA, 2003, J PHYCOL, V39, P504, DOI 10.1046/j.1529-8817.2003.02191.x; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/NCLIMATE1958, 10.1038/nclimate1958]; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Steneck RS, 2013, B MAR SCI, V89, P31, DOI 10.5343/bms.2011.1148; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Thomsen MS, 2010, INTEGR COMP BIOL, V50, P158, DOI 10.1093/icb/icq042; Thomson DP, 2012, ESTUAR COAST SHELF S, V96, P105, DOI 10.1016/j.ecss.2011.10.014; Toohey BD, 2007, OIKOS, V116, P1618, DOI 10.1111/j.2007.0030-1299.15689.x; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Zinke J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4607	29	695	700	42	642	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					169	172		10.1126/science.aad8745	http://dx.doi.org/10.1126/science.aad8745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27387951	Green Accepted, Green Submitted			2022-12-24	WOS:000379208400039
J	Terrer, C; Vicca, S; Hungate, BA; Phillips, RP; Prentice, IC				Terrer, Cesar; Vicca, Sara; Hungate, Bruce A.; Phillips, Richard P.; Prentice, I. Colin			Mycorrhizal association as a primary control of the CO2 fertilization effect	SCIENCE			English	Article							ELEVATED CO2; FOREST PRODUCTIVITY; ATMOSPHERIC CO2; ENRICHMENT FACE; CARBON-DIOXIDE; SOIL CARBON; NITROGEN; RESPONSES; GROWTH; ENHANCEMENT	Plants buffer increasing atmospheric carbon dioxide (CO2) concentrations through enhanced growth, but the question whether nitrogen availability constrains the magnitude of this ecosystem service remains unresolved. Synthesizing experiments from around the world, we show that CO2 fertilization is best explained by a simple interaction between nitrogen availability and mycorrhizal association. Plant species that associate with ectomycorrhizal fungi show a strong biomass increase (30 +/- 3%, P < 0.001) in response to elevated CO2 regardless of nitrogen availability, whereas low nitrogen availability limits CO2 fertilization (0 +/- 5%, P = 0.946) in plants that associate with arbuscular mycorrhizal fungi. The incorporation of mycorrhizae in global carbon cyclemodels is feasible, and crucial if we are to accurately project ecosystem responses and feedbacks to climate change.	[Terrer, Cesar; Prentice, I. Colin] Univ London Imperial Coll Sci Technol & Med, AXA Chair Programme Biosphere & Climate Impacts, Dept Life Sci, Silwood Pk Campus, London SW7 2AZ, England; [Vicca, Sara] Univ Antwerp, Dept Biol, Ctr Excellence PLECO Plant & Vegetat Ecol, B-2610 Antwerp, Belgium; [Hungate, Bruce A.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [Hungate, Bruce A.] No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA; [Phillips, Richard P.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Prentice, I. Colin] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia	Imperial College London; University of Antwerp; Northern Arizona University; Northern Arizona University; Indiana University System; Indiana University Bloomington; Macquarie University	Terrer, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, AXA Chair Programme Biosphere & Climate Impacts, Dept Life Sci, Silwood Pk Campus, London SW7 2AZ, England.	c.terrer@imperial.ac.uk	Vicca, Sara/I-3637-2012; Phillips, Richard P/C-6429-2009; Terrer, Cesar/R-1103-2018	Vicca, Sara/0000-0001-9812-5837; Phillips, Richard P/0000-0002-1345-4138; Terrer, Cesar/0000-0002-5479-3486	Imperial College; ClimMani COST Action [ES1308]; European Research Council [ERC-SyG-610028 IMBALANCE-P]; Biological and Environmental Research program, Office of Science, U.S. Department of Energy (DOE) [DE SC0008270]; NSF (Ecosystem Studies Program) [1153401]; DOE (Environmental System Science Program); Royal Netherlands Academy of Arts and Sciences; DOE; INTERFACE; New Phytologist trust; Division Of Environmental Biology [0955771, 1234162] Funding Source: National Science Foundation	Imperial College; ClimMani COST Action(European Cooperation in Science and Technology (COST)); European Research Council(European Research Council (ERC)European Commission); Biological and Environmental Research program, Office of Science, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NSF (Ecosystem Studies Program)(National Science Foundation (NSF)); DOE (Environmental System Science Program)(United States Department of Energy (DOE)); Royal Netherlands Academy of Arts and Sciences; DOE(United States Department of Energy (DOE)); INTERFACE; New Phytologist trust; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Talhelm, A. Finzi, L. Andresen, I. Kappel, C. Calfapietra, B. Sigurdsson, J. Dukes, P. Newton, D. Blumenthal, B. Kimball, J. Heath, P. Reich, R. Norby, C. Korner, N. Chiariello, C. Field, and M. Schneider, who provided additional data and advice. This research is a contribution to the Imperial College initiative Grand Challenges in Ecosystems and the Environment and the AXA Chair Programme in Biosphere and Climate Impacts. C.T. is supported by an Imperial College Ph.D. studentship within this program. C.T. and S.V. acknowledge support of ClimMani COST Action (ES1308). S.V. is a postdoctoral fellow of the Research Foundation-Flanders (FWO) and acknowledges support from the European Research Council grant ERC-SyG-610028 IMBALANCE-P. B.A.H. was supported by the Biological and Environmental Research program, Office of Science, U.S. Department of Energy (DOE) grant DE SC0008270. R.P. acknowledges support from NSF (Ecosystem Studies Program 1153401) and DOE (Environmental System Science Program). R.P. and C.T. thank the Royal Netherlands Academy of Arts and Sciences, DOE, INTERFACE, and the New Phytologist trust for funding the Workshop "Climate models revisited: the biogeochemical consequences of mycorrhizal dynamics." The data reported in this paper are available online as supplementary materials. C.T. conceived the initial idea, collected the data, and conducted the data synthesis and meta-analysis. S.V. developed the nitrogen classification. B.A.H. refined model selection, meta-analysis, and framework. All authors contributed to the development of the conceptual framework and to the writing of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Alberton O, 2005, NEW PHYTOL, V167, P859, DOI 10.1111/j.1469-8137.2005.01458.x; Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Baig S, 2015, GLOBAL CHANGE BIOL, V21, P4303, DOI 10.1111/gcb.12962; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Chaudhary VB, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.28; Ciais P., 2013, CLIMATE CHANGE 2013, P465, DOI [10.1017/CBO9781107415324.015, DOI 10.1017/CBO9781107415324.015]; Cornelissen JHC, 2001, OECOLOGIA, V129, P611, DOI 10.1007/s004420100752; Cotrufo MF, 2015, NAT GEOSCI, V8, P776, DOI [10.1038/ngeo2520, 10.1038/NGEO2520]; de Graaff MA, 2006, GLOBAL CHANGE BIOL, V12, P2077, DOI 10.1111/j.1365-2486.2006.01240.x; Drake JE, 2011, ECOL LETT, V14, P349, DOI 10.1111/j.1461-0248.2011.01593.x; Hovenden MJ, 2014, NATURE, V511, P583, DOI 10.1038/nature13281; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Hungate BA, 2013, NEW PHYTOL, V200, P767, DOI 10.1111/nph.12409; Johnson NC, 2015, NEW PHYTOL, V205, P1473, DOI 10.1111/nph.13172; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P349, DOI 10.5194/essd-7-349-2015; McCarthy HR, 2010, NEW PHYTOL, V185, P514, DOI 10.1111/j.1469-8137.2009.03078.x; Newingham BA, 2013, GLOBAL CHANGE BIOL, V19, P2168, DOI 10.1111/gcb.12177; Norby RJ, 2016, NEW PHYTOL, V209, P17, DOI 10.1111/nph.13593; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Perez-Moreno J, 2000, NEW PHYTOL, V145, P301, DOI 10.1046/j.1469-8137.2000.00569.x; Phillips RP, 2013, NEW PHYTOL, V199, P41, DOI 10.1111/nph.12221; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reich PB, 2013, NAT CLIM CHANGE, V3, P278, DOI [10.1038/nclimate1694, 10.1038/NCLIMATE1694]; Shi M, 2016, GLOBAL CHANGE BIOL, V22, P1299, DOI 10.1111/gcb.13131; Sulman BN, 2014, NAT CLIM CHANGE, V4, P1099, DOI [10.1038/nclimate2436, 10.1038/NCLIMATE2436]; Talhelm AF, 2014, GLOBAL CHANGE BIOL, V20, P2492, DOI 10.1111/gcb.12564; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vicca S, 2012, ECOL LETT, V15, P520, DOI 10.1111/j.1461-0248.2012.01775.x; Wieder WR, 2015, NAT GEOSCI, V8, P441, DOI 10.1038/NGEO2413; Zhu ZC, 2016, NAT CLIM CHANGE, V6, P791, DOI [10.1038/nclimate3004, 10.1038/NCLIMATE3004]	34	295	311	52	609	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					72	74		10.1126/science.aaf4610	http://dx.doi.org/10.1126/science.aaf4610			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365447	Green Accepted, Green Submitted			2022-12-24	WOS:000378816200038
J	Estrada, J; Wong, F; DePace, A; Gunawardena, J				Estrada, Javier; Wong, Felix; DePace, Angela; Gunawardena, Jeremy			Information Integration and Energy Expenditure in Gene Regulation	CELL			English	Article							TRANSCRIPTION FACTORS; MEDIATOR COMPLEX; EXPRESSION; PRECISION; BIOLOGY; BINDING; MODEL	The quantitative concepts used to reason about gene regulation largely derive from bacterial studies. We show that this bacterial paradigm cannot explain the sharp expression of a canonical developmental gene in response to a regulating transcription factor (TF). In the absence of energy expenditure, with regulatory DNA at thermodynamic equilibrium, information integration across multiple TF binding sites can generate the required sharpness, but with strong constraints on the resultant "higher-order cooperativities." Even with such integration, there is a "Hopfield barrier" to sharpness; for n TF binding sites, this barrier is represented by the Hill function with the Hill coefficient n. If, however, energy is expended to maintain regulatory DNA away from thermodynamic equilibrium, as in kinetic proofreading, this barrier can be breached and greater sharpness achieved. Our approach is grounded in fundamental physics, leads to testable experimental predictions, and suggests how a quantitative paradigm for eukaryotic gene regulation can be formulated.	[Estrada, Javier; Wong, Felix; DePace, Angela; Gunawardena, Jeremy] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Wong, Felix] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Gunawardena, J (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	jeremy@hms.harvard.edu		Estrada, Javier/0000-0003-3646-204X; Estrada Diez, Francisco Javier/0000-0001-8918-2573	National Science Foundation (NSF) [GRF DGE1144152]; NIH [U01 GM103804]; NSF CAREER [1452557]; NSF [1462629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM103804] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the editor, Robert Kruger, and the anonymous reviewers for their help. We thank Rebecca Ward for editorial assistance. We gratefully acknowledge the Department of Systems Biology for supporting J.E. F.W. was supported by a National Science Foundation (NSF) grant (GRF DGE1144152); A.D. was supported by an NIH grant (U01 GM103804) and NSF CAREER grant (1452557); and J.G. was supported by an NSF grant (1462629).	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Ahsendorf T, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0102-4; Bialek W., 2015, ARXIV151208954; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Bosveld F, 2008, DEV BIOL, V313, P802, DOI 10.1016/j.ydbio.2007.11.019; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; Davidson EH, 2006, REG GEN GEN REG; Engel P.C., 2013, BIOCHEM J, V2013, P1; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gunawardena J, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-29; Gunawardena J, 2013, MOL BIOL CELL, V24, P1827, DOI 10.1091/mbc.E12-03-0227; Hammar P, 2014, NAT GENET, V46, P405, DOI 10.1038/ng.2905; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Keung AJ, 2015, NAT REV GENET, V16, P159, DOI 10.1038/nrg3900; Lebrecht D, 2005, P NATL ACAD SCI USA, V102, P13176, DOI 10.1073/pnas.0506462102; MAHAN BH, 1975, J CHEM EDUC, V52, P299, DOI 10.1021/ed052p299; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Nussinov R, 2013, ANNU REV BIOPHYS, V42, P169, DOI 10.1146/annurev-biophys-083012-130257; Park JM, 2001, MOL CELL BIOL, V21, P2312, DOI 10.1128/MCB.21.7.2312-2323.2001; Perry MW, 2012, CURR BIOL, V22, P2247, DOI 10.1016/j.cub.2012.09.051; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Ptashne M, 2004, GENETIC SWITCH PHAGE; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Sherman MS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002407; Singh N, 2005, DEV BIOL, V278, P242, DOI 10.1016/j.ydbio.2004.11.011; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003	36	70	70	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					234	244		10.1016/j.cell.2016.06.012	http://dx.doi.org/10.1016/j.cell.2016.06.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368104	Bronze, Green Accepted			2022-12-24	WOS:000380254400024
J	Abrahamsen, B; Eiken, P; Prieto-Alhambra, D; Eastell, R				Abrahamsen, Bo; Eiken, Pia; Prieto-Alhambra, Daniel; Eastell, Richard			Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FEMUR FRACTURES; DIAPHYSEAL FRACTURES; ATYPICAL FRACTURES; BISPHOSPHONATE USE; OSTEOPOROSIS; MORTALITY; EXTENSION; ADHERENCE; THERAPY; RATES	OBJECTIVES To determine the skeletal safety and efficacy of long term (>= 10 years) alendronate use in patients with osteoporosis. DESIGN Open register based cohort study containing two nested case control studies. SETTING Nationwide study of population of Denmark. PARTICIPANTS 61 990 men and women aged 50-94 at the start of treatment, who had not previously taken alendronate, 1996-2007. INTERVENTIONS Treatment with alendronate. MAIN OUTCOME MEASURES Incident fracture of the subtrochanteric femur or femoral shaft (ST/FS) or the hip. Non-fracture controls from the cohort were matched to fracture cases by sex, year of birth, and year of initiation of alendronate treatment. Conditional logistic regression models were fitted to calculate odds ratios with and without adjustment for comorbidity and comedications. Sensitivity analyses investigated subsequent treatment with other drugs for osteoporosis. RESULTS 1428 participants sustained a ST/FS (incidence rate 3.4/1000 person years, 95% confidence interval 3.2 to 3.6), and 6784 sustained a hip fracture (16.2/1000 person years, 15.8 to 16.6). The risk of ST/FS was lower with high adherence to treatment with alendronate (medication possession ratio (MPR, a proxy for compliance) >80%) compared with poor adherence (MPR <50%; odds ratio 0.88, 0.77 to 0.99; P = 0.05). Multivariable adjustment attenuated this association (adjusted odds ratio 0.88, 0.77 to 1.01; P = 0.08). The risk was no higher in long term users (>= 10 dose years; 0.70, 0.44 to 1.11; P = 0.13) or in current compared with past users (0.91, 0.79 to 1.06; P = 0.22). Similarly, MPR >80% was associated with a decreased risk of hip fracture (0.73, 0.68 to 0.78; P < 0.001) as was longer term cumulative use for 5-10 dose years (0.74, 0.67 to 0.83; P < 0.001) or >= 10 dose years (0.74, 0.56 to 0.97; P = 0.03). CONCLUSIONS These findings support an acceptable balance between benefit and risk with treatment with alendronate in terms of fracture outcomes, even for over 10 years of continuous use.	[Abrahamsen, Bo] Univ Southern Denmark, Odense Patient Data Explorat Network, Dept Clin Res, JB Winslows Vej 9 A,3 Sal, DK-5000 Odense, Denmark; [Abrahamsen, Bo] Holbaek Cent Hosp, Dept Med, Smedelundsgade 60, DK-4300 Holbaek, Denmark; [Eiken, Pia] Hillerod Hosp, Dept Cardiol Nephrol & Endocrinol, Dyrehavevej 29, DK-3400 Hillerod, Denmark; [Eiken, Pia] Univ Copenhagen, Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Prieto-Alhambra, Daniel] Univ Oxford, Oxford NIHR Musculoskeletal Biomed Res Unit, NDORMS, Botnar Res Ctr, Oxford OX3 7LD, England; [Prieto-Alhambra, Daniel] Univ Autonoma Barcelona, IMIM Parc Salut Mar, Musculoskeletal Res Unit, Passeig Maritim 25-29, Barcelona 08003, Spain; [Prieto-Alhambra, Daniel] Univ Autonoma Barcelona, RETICEF, Passeig Maritim 25-29, Barcelona 08003, Spain; [Prieto-Alhambra, Daniel] Inst Carlos III FEDER Res Funds, Passeig Maritim 25-29, Barcelona 08003, Spain; [Eastell, Richard] No Gen Hosp, Acad Unit Bone Metab AUBM, Sheffield S5 7AU, S Yorkshire, England; [Eastell, Richard] Univ Sheffield, Sheffield S5 7AU, S Yorkshire, England	University of Southern Denmark; Holbaek Hospital; University of Copenhagen; University of Copenhagen; University of Oxford; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; Northern General Hospital; University of Sheffield	Prieto-Alhambra, D (corresponding author), Univ Oxford, Botnar Res Ctr, NDORMS, Nuffield Orthopaed Ctr, Oxford OX3 7LD, England.	Daniel.prietoalhambra@ndorms.ox.ac.uk	Eastell, Richard/G-5851-2011	Eastell, Richard/0000-0002-0323-3366; Prieto-Alhambra, Daniel/0000-0002-3950-6346; Abrahamsen, Bo/0000-0002-2730-6080	Novartis; UCB; Amgen; NPS Pharmaceuticals; Nycomed; Merck; Eli Lilly; Servier; IDS; Alexian; Roche; Astra Zeneca; Bayer; Fonterra; Janssen; Ono Pharma; Alere; Teijin Pharm; D-STAR; GSK nutrition; Medical Research Council [MR/K006312/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10073] Funding Source: researchfish; MRC [MR/K006312/1] Funding Source: UKRI	Novartis(Novartis); UCB(UCB Pharma SA); Amgen(Amgen); NPS Pharmaceuticals; Nycomed; Merck(Merck & Company); Eli Lilly(Eli Lilly); Servier(Servier); IDS; Alexian; Roche(Roche Holding); Astra Zeneca(AstraZeneca); Bayer(Bayer AG); Fonterra(Fonterra); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Ono Pharma; Alere; Teijin Pharm; D-STAR; GSK nutrition; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; BA receives institutional research grants and has contracts with Novartis and UCB, past institutional research contracts with Amgen and NPS Pharmaceuticals, and past payment for membership of advisory boards from Nycomed, Merck, and Amgen; PE reports grant support from Eli Lilly and payment for educational presentations for Amgen and Eli Lilly, pro bono educational presentations for Boehringer Ingelheim, payment for membership of advisory boards from Amgen, Eli Lilly, and Merck, and stock ownership in Novo Nordisk; DP-A reports institutional research grants from Amgen and Servier and support for conference attendance and speaker fees paid to his institution; RE reports institutional research grants and personal fees from Amgen, IDS, Alexian, and Roche, institutional research grants from Astra Zeneca, and speaker or consulting fees from Bayer, Fonterra, Janssen, Eli Lilly, Ono Pharma, Alere, Teijin Pharm, D-STAR, and GSK nutrition.	Abrahamsen B, 2016, J BONE MINER RES, V31, P488, DOI 10.1002/jbmr.2801; Abrahamsen B, 2010, J CLIN ENDOCR METAB, V95, P5258, DOI 10.1210/jc.2010-1571; Black DM, 2015, J BONE MINER RES, V30, P934, DOI 10.1002/jbmr.2442; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Caro JJ, 2004, OSTEOPOROSIS INT, V15, P1003, DOI 10.1007/s00198-004-1652-z; Chatellier G, 1996, BRIT MED J, V312, P426; Chiang CY, 2013, BONE, V52, P360, DOI 10.1016/j.bone.2012.10.006; Dell RM, 2012, J BONE MINER RES, V27, P2544, DOI 10.1002/jbmr.1719; Feldstein AC, 2012, J BONE MINER RES, V27, P977, DOI 10.1002/jbmr.1550; Gallagher AM, 2008, J BONE MINER RES, V23, P1569, DOI [10.1359/jbmr.080510, 10.1359/JBMR.080510]; Girgis CM, 2010, NEW ENGL J MED, V362, P1848, DOI 10.1056/NEJMc0910389; Giusti A, 2011, BONE, V48, P966, DOI 10.1016/j.bone.2010.12.033; Jarvinen TLN, 2015, J INTERN MED, V277, P662, DOI 10.1111/joim.12366; Jarvinen TLN, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2088; Jha S, 2015, J BONE MINER RES, V30, P2179, DOI 10.1002/jbmr.2565; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; Kharazmi M, 2016, J BONE MINER RES, V31, P491, DOI 10.1002/jbmr.2767; Lalmohamed A, 2012, ARCH INTERN MED, V172, P1229, DOI 10.1001/archinternmed.2012.2713; Meier RPH, 2012, ARCH INTERN MED, V172, P930, DOI 10.1001/archinternmed.2012.1796; Muschitz C, 2015, J CLIN DENSITOM, VS1094-6950, P00126; Napoli N, 2013, J CLIN ENDOCR METAB, V98, P659, DOI 10.1210/jc.2012-1896; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reyes C, 2016, J CELL BIOCHEM, V117, P20, DOI 10.1002/jcb.25266; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Saita Y, 2014, BONE, V66, P105, DOI 10.1016/j.bone.2014.06.008; Schilcher J, 2015, J BONE MINER RES, V30, P2127, DOI 10.1002/jbmr.2547; Schilcher J, 2015, ACTA ORTHOP, V86, P100, DOI 10.3109/17453674.2015.1004149; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Selga J, 2016, OSTEOPOROSIS INT, V27, P827, DOI 10.1007/s00198-015-3355-z; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Siris ES, 2006, MAYO CLIN PROC, V81, P1013, DOI 10.4065/81.8.1013; Svedbom A, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0137-0; Taormina DP, 2014, BONE, V63, P1, DOI 10.1016/j.bone.2014.02.006; Wang Z, 2014, OSTEOPOROSIS INT, V25, P2109, DOI 10.1007/s00198-014-2738-x; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2	35	59	61	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2016	353								i3365	10.1136/bmj.i3365	http://dx.doi.org/10.1136/bmj.i3365			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FP	27353596	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000379018000005
J	Usher-Smith, JA; Sharp, SJ; Griffin, SJ				Usher-Smith, Juliet A.; Sharp, Stephen J.; Griffin, Simon J.			The spectrum effect in tests for risk prediction, screening, and diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROGNOSIS RESEARCH; TEST ACCURACY; SPECIFICITY; SENSITIVITY; BIAS	The spectrum effect describes the variation between settings in performance of tests used to predict, screen for, and diagnose disease. In particular, the predictive use of a test may be different when it is applied in a general population rather than in the study sample in which it was first developed. This article discusses the impact of the spectrum effect on measures of test performance, and its implications for the development, evaluation, application, and implementation of such tests.	[Usher-Smith, Juliet A.; Griffin, Simon J.] Univ Cambridge, Strangeways Res Lab, Primary Care Unit, Cambridge CB1 8RN, England; [Sharp, Stephen J.; Griffin, Simon J.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB1 8RN, England	University of Cambridge; University of Cambridge	Usher-Smith, JA (corresponding author), Univ Cambridge, Strangeways Res Lab, Primary Care Unit, Cambridge CB1 8RN, England.	jau20@medschl.cam.ac.uk		Usher-Smith, Juliet/0000-0002-8501-2531	National Institute of Health; Medical Research Council [MC_UU_12015/1]; MRC [MC_UU_12015/1, MC_U106179474, MC_UU_12015/4] Funding Source: UKRI; Medical Research Council [MC_U106179474, MC_UU_12015/4] Funding Source: researchfish; National Institute for Health Research [CL-2012-14-007] Funding Source: researchfish	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	JUS is supported by a National Institute of Health Research clinical lectureship. The views expressed in this publication are those of the authors and not necessarily those of the NHS, National Institute of Health Research, or the UK Department of Health. SJS is supported by the Medical Research Council (unit programme no MC_UU_12015/1). All researchers were independent of the funding body and the funders had no role in study design; data collection, analysis, and interpretation of data; in the writing of the report; or decision to submit the article, for publication.	ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; COUGHLIN SS, 1992, J CLIN EPIDEMIOL, V45, P1, DOI 10.1016/0895-4356(92)90180-U; DIAMOND GA, 1986, AM J CARDIOL, V57, P1175, DOI 10.1016/0002-9149(86)90694-6; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Hingorani AD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5793; Irwig L, 2002, BRIT MED J, V324, P669, DOI 10.1136/bmj.324.7338.669; Leeflang MMG, 2013, CAN MED ASSOC J, V185, pE537, DOI 10.1503/cmaj.121286; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; MCNEIL BJ, 1984, MED DECIS MAKING, V4, P137, DOI 10.1177/0272989X8400400203; Moons KGM, 1997, EPIDEMIOLOGY, V8, P12, DOI 10.1097/00001648-199701000-00002; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; National Institute for Health and Care Excellence, 2014, LIPID MODIFICATION C; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381	17	120	121	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i3139	10.1136/bmj.i3139	http://dx.doi.org/10.1136/bmj.i3139			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27334281	Green Published, hybrid			2022-12-24	WOS:000378723500005
J	Jepson, PD; Law, RJ				Jepson, Paul D.; Law, Robin J.			MARINE ENVIRONMENT Persistent pollutants, persistent threats	SCIENCE			English	Editorial Material							CONTAMINANTS; WATERS; PCB		[Jepson, Paul D.; Law, Robin J.] Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England; [Law, Robin J.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Pakefield Rd, Lowestoft NR33 0HT, Suffolk, England	Zoological Society of London; Centre for Environment Fisheries & Aquaculture Science	Jepson, PD (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	paul.jepson@ioz.ac.uk						Carson Rachel, 1994, SILENT SPRING; Convention S, 2001, STOCKHOLM CONVENTION; Forney KA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P145; Henry TB, 2015, CRIT REV TOXICOL, V45, P643, DOI 10.3109/10408444.2015.1038498; Houde M, 2005, REV ENVIRON CONTAM T, V184, P1, DOI 10.1007/0-387-27565-7_1; International Council for the Exploration of the Sea, 2016, REP WORK GROUP MAR M; International Union for Conservation of Nature, 2015, IUCN RED LIST THREAT; JENSEN S, 1969, NATURE, V224, P247, DOI 10.1038/224247a0; Jepson PD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18573; Letcher RJ, 2010, SCI TOTAL ENVIRON, V408, P2995, DOI 10.1016/j.scitotenv.2009.10.038; Ma JM, 2011, NAT CLIM CHANGE, V1, P255, DOI 10.1038/NCLIMATE1167; Pinzone M, 2015, ENVIRON RES, V142, P185, DOI 10.1016/j.envres.2015.06.021; Riget F, 2016, ENVIRON POLLUT, V217, P114, DOI 10.1016/j.envpol.2015.11.006; Roos AM, 2012, ENVIRON POLLUT, V170, P268, DOI 10.1016/j.envpol.2012.07.017	14	92	94	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1388	1389		10.1126/science.aaf9075	http://dx.doi.org/10.1126/science.aaf9075			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313021	Green Submitted			2022-12-24	WOS:000377975400018
J	Buffington, SA; Di Prisco, GV; Auchtung, TA; Ajami, NJ; Petrosino, JF; Costa-Mattioli, M				Buffington, Shelly A.; Di Prisco, Gonzalo Viana; Auchtung, Thomas A.; Ajami, Nadim J.; Petrosino, Joseph F.; Costa-Mattioli, Mauro			Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring	CELL			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; GUT MICROBIOME; OXYTOCIN; AUTISM; BEHAVIOR; BRAIN; ASSOCIATION; OBESITY; MOUSE	Maternal obesity during pregnancy has been associated with increased risk of neurodevelopmental disorders, including autism spectrum disorder (ASD), in offspring. Here, we report that maternal high-fat diet (MHFD) induces a shift in microbial ecology that negatively impacts offspring social behavior. Social deficits and gut microbiota dysbiosis in MHFD offspring are prevented by co-housing with offspring of mothers on a regular diet (MRD) and transferable to germ-free mice. In addition, social interaction induces synaptic potentiation (LTP) in the ventral tegmental area (VTA) of MRD, but not MHFD offspring. Moreover, MHFD offspring had fewer oxytocin immunoreactive neurons in the hypothalamus. Using metagenomics and precision microbiota reconstitution, we identified a single commensal strain that corrects oxytocin levels, LTP, and social deficits in MHFD offspring. Our findings causally link maternal diet, gut microbial imbalance, VTA plasticity, and behavior and suggest that probiotic treatment may relieve specific behavioral abnormalities associated with neurodevelopmental disorders.	[Buffington, Shelly A.; Di Prisco, Gonzalo Viana; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Buffington, Shelly A.; Di Prisco, Gonzalo Viana; Costa-Mattioli, Mauro] Baylor Coll Med, Memory & Brain Res Ctr, Houston, TX 77030 USA; [Auchtung, Thomas A.; Ajami, Nadim J.; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Auchtung, Thomas A.; Ajami, Nadim J.; Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Costa-Mattioli, M (corresponding author), Baylor Coll Med, Memory & Brain Res Ctr, Houston, TX 77030 USA.	costamat@bcm.edu	Buffington, Shelly Alexandra/AAD-7637-2022; Petrosino, Joseph F./AAF-1621-2019	Buffington, Shelly Alexandra/0000-0001-7133-0064; Auchtung, Thomas/0000-0002-0135-6266	NIH [NIMH 096816, NINDS 076708]; Alkek Foundation; Baylor College of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alkek Foundation; Baylor College of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Costa-Mattioli laboratory, K. Krnjevic, M. Beauchamp, and H. Dierick for comments on the manuscript; A. Swennes, J. Garcia, D. Quach and J. Auchtung for technical advice. This work was supported by funding from the NIH (NIMH 096816, NINDS 076708) to M. C.-M and the Alkek Foundation and Baylor College of Medicine to the Alkek Center for Meta-genomics and Microbiome Research to J.F.P.	Aye ILMH, 2015, P NATL ACAD SCI USA, V112, P12858, DOI 10.1073/pnas.1515484112; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bilder DA, 2013, PEDIATRICS, V132, pE1276, DOI 10.1542/peds.2013-1188; Bolton JL, 2014, DIALOGUES CLIN NEURO, V16, P307; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Bresnahan M, 2015, JAMA PSYCHIAT, V72, P466, DOI 10.1001/jamapsychiatry.2014.3034; Connolly N., 2016, AUTISM RES; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Davari S, 2013, NEUROSCIENCE, V240, P287, DOI 10.1016/j.neuroscience.2013.02.055; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Galley JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113026; Groppe SE, 2013, BIOL PSYCHIAT, V74, P172, DOI 10.1016/j.biopsych.2012.12.023; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huang W, 2016, ELIFE, V5, DOI 10.7554/eLife.12052; Huang YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003281; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; Ma J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4889; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Mathers JC, 2009, ADV EXP MED BIOL, V646, P119, DOI 10.1007/978-1-4020-9173-5_13; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; Mayer EA, 2014, BIOESSAYS, V36, P933, DOI 10.1002/bies.201400075; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Melis MR, 2007, EUR J NEUROSCI, V26, P1026, DOI 10.1111/j.1460-9568.2007.05721.x; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Modi ME, 2012, HORM BEHAV, V61, P340, DOI 10.1016/j.yhbeh.2011.12.010; Moss BG, 2014, AM J HEALTH PROMOT, V28, P181, DOI 10.4278/ajhp.120705-QUAN-325; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; PEDERSEN CA, 1994, BEHAV NEUROSCI, V108, P1163, DOI 10.1037/0735-7044.108.6.1163; Penagarikano O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010257; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078898; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Sabatier Nancy, 2013, Front Endocrinol (Lausanne), V4, P35, DOI 10.3389/fendo.2013.00035; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Sullivan EL, 2014, PHYSIOL BEHAV, V123, P236, DOI 10.1016/j.physbeh.2012.07.014; Tang YM, 2014, NEUROPHARMACOLOGY, V77, P277, DOI 10.1016/j.neuropharm.2013.10.004; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uvnas-Moberg K, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01529; Wang X, 2002, WORLD J GASTROENTERO, V8, P540, DOI 10.3748/wjg.v8.i3.540; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	55	588	618	11	231	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1762	1775		10.1016/j.cell.2016.06.001	http://dx.doi.org/10.1016/j.cell.2016.06.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315483	Bronze, Green Accepted			2022-12-24	WOS:000378062000025
J	Cho, SH; Raybuck, AL; Stengel, K; Wei, M; Beck, TC; Volanakis, E; Thomas, JW; Hiebert, S; Haase, VH; Boothby, MR				Cho, Sung Hoon; Raybuck, Ariel L.; Stengel, Kristy; Wei, Mei; Beck, Thomas C.; Volanakis, Emmanuel; Thomas, James W.; Hiebert, Scott; Haase, Volker H.; Boothby, Mark R.			Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system	NATURE			English	Article							CLASS SWITCH RECOMBINATION; INDUCIBLE FACTOR-I; FLOW-CYTOMETRY; MTOR; INFLAMMATION; DISEASE; CELLS; ACTIVATION; EXPRESSION; SELECTION	Germinal centres (GCs) promote humoral immunity and vaccine efficacy. In GCs, antigen-activated B cells proliferate, express high-affinity antibodies, promote antibody class switching, and yield B cell memory(1,2). Whereas the cytokine milieu has long been known to regulate effector functions that include the choice of immunoglobulin class(3,4), both cell-autonomous5 and extrinsic(6,7) metabolic programming have emerged as modulators of T-cell-mediated immunity(8). Here we show in mice that GC light zones are hypoxic, and that low oxygen tension (p(O2)) alters B cell physiology and function. In addition to reduced proliferation and increased B cell death, low p(O2) impairs antibody class switching to the pro-inflammatory IgG2c antibody isotype by limiting the expression of activation-induced cytosine deaminase (AID). Hypoxia induces HIF transcription factors by restricting the activity of prolyl hydroxyl dioxygenase enzymes, which hydroxylate HIF-1 alpha and HIF-2 alpha to destabilize HIF by binding the von Hippel-Landau tumour suppressor protein (pVHL)(7). B-cell-specific depletion of pVHL leads to constitutive HIF stabilization, decreases antigen-specific GC B cells and undermines the generation of high-affinity IgG, switching to IgG2c, early memory B cells, and recall antibody responses. HIF induction can reprogram metabolic and growth factor gene expression. Sustained hypoxia or HIF induction by pVHL deficiency inhibits mTOR complex 1 (mTORC1) activity in B lymphoblasts, and mTORC1-haploinsufficient B cells have reduced clonal expansion, AID expression, and capacities to yield IgG2c and high-affinity antibodies. Thus, the normal physiology of GCs involves regional variegation of hypoxia, and HIF-dependent oxygen sensing regulates vital functions of B cells. We propose that the restriction of oxygen in lymphoid organs, which can be altered in pathophysiological states, modulates humoral immunity.	[Cho, Sung Hoon; Raybuck, Ariel L.; Wei, Mei; Beck, Thomas C.; Thomas, James W.; Boothby, Mark R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Stengel, Kristy; Hiebert, Scott] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Volanakis, Emmanuel] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Thomas, James W.; Haase, Volker H.; Boothby, Mark R.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Hiebert, Scott; Haase, Volker H.; Boothby, Mark R.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Hiebert, Scott; Haase, Volker H.; Boothby, Mark R.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Haase, Volker H.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Med & Res Serv, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Boothby, MR (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Boothby, MR (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA.; Boothby, MR (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA.; Boothby, MR (corresponding author), Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.	mark.boothby@vanderbilt.edu	Haase, Volker Hans/A-6758-2013; Haase, Volker Hans/AAJ-5061-2021	Haase, Volker Hans/0000-0002-7051-8994; Stengel, Kristy/0000-0002-8330-5744; Thomas, James/0000-0002-2098-6458; Raybuck, Ariel/0000-0003-3445-2112; Beck, Thomas/0000-0002-8860-5850	National Institutes of Health (NIH) [R01 AI113292, HL106812, CA164605]; Veterans Affairs Merit award [I01 BX002348]; American Cancer Society [PF-13-303-01-DMC]; Cancer Center Support Grant [CA068485]; Diabetes Research Center [DK0205930];  [T32 DK007563]; NATIONAL CANCER INSTITUTE [P30CA068485, T32CA009582, R01CA164605] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113292, R01AI051448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101791, T32DK007563, R01DK081646] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002348] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit award(US Department of Veterans Affairs); American Cancer Society(American Cancer Society); Cancer Center Support Grant; Diabetes Research Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Research funding via National Institutes of Health (NIH) grants R01 AI113292, HL106812 to M.R.B., CA164605 to S.H.; Veterans Affairs Merit award I01 BX002348 to V.H.H., along with support of K.S. by American Cancer Society postdoctoral fellowship PF-13-303-01-DMC, and T.C.B. by T32 DK007563 are gratefully acknowledged, as are O. Davidoff and Q. Liu for expert help with mouse management and with hypoxia chamber usage, respectively, K. Rathmell for critically reading and suggesting manuscript text, P. Young for use of an additional hypoxia chamber, H. Simkins and T. Laufer for guidance on making NP-conjugated fluors, N. Papavasiliou for the AID retrovector, C. Koch for hypoxia detection reagents, and scholarships via the Cancer Center Support Grant (CA068485) and Diabetes Research Center (DK0205930) to help pay for Vanderbilt University cores.	Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Cho SH, 2013, J IMMUNOL, V191, P3169, DOI 10.4049/jimmunol.1301106; Cho SH, 2011, P NATL ACAD SCI USA, V108, P15972, DOI 10.1073/pnas.1017082108; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eustace A, 2013, CLIN CANCER RES, V19, P4879, DOI 10.1158/1078-0432.CCR-13-0542; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Koch CJ, 2008, RADIAT RES, V169, P677, DOI 10.1667/RR1305.1; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; OKEEFFE S, 1991, EUR RESPIR J, V4, P932; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Rush JS, 2005, P NATL ACAD SCI USA, V102, P13242, DOI 10.1073/pnas.0502779102; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Woods ML, 1996, INT J RADIAT ONCOL, V34, P93, DOI 10.1016/0360-3016(95)02006-3; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Zhang SL, 2013, J IMMUNOL, V191, P1692, DOI 10.4049/jimmunol.1201767	35	151	151	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					234	+		10.1038/nature19334	http://dx.doi.org/10.1038/nature19334			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27501247	Green Accepted			2022-12-24	WOS:000382539100048
J	Huang, CD; Rossi, P; Saio, T; Kalodimos, CG				Huang, Chengdong; Rossi, Paolo; Saio, Tomohide; Kalodimos, Charalampos G.			Structural basis for the antifolding activity of a molecular chaperone	NATURE			English	Article							MALTOSE-BINDING PROTEIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CHEMICAL-SHIFTS; QUALITY-CONTROL; SECB CHAPERONE; NMR; SYSTEM; DISAGGREGATION; RECOGNITION	Molecular chaperones act on non-native proteins in the cell to prevent their aggregation, premature folding or misfolding. Different chaperones often exert distinct effects, such as acceleration or delay of folding, on client proteins via mechanisms that are poorly understood. Here we report the solution structure of SecB, a chaperone that exhibits strong antifolding activity, in complex with alkaline phosphatase and maltose-binding protein captured in their unfolded states. SecB uses long hydrophobic grooves that run around its disk-like shape to recognize and bind to multiple hydrophobic segments across the length of non-native proteins. The multivalent binding mode results in proteins wrapping around SecB. This unique complex architecture alters the kinetics of protein binding to SecB and confers strong antifolding activity on the chaperone. The data show how the different architectures of chaperones result in distinct binding modes with non-native proteins that ultimately define the activity of the chaperone.	[Huang, Chengdong; Rossi, Paolo; Saio, Tomohide; Kalodimos, Charalampos G.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kalodimos, CG (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	ckalodim@umn.edu	Huang, Chengdong/G-8454-2018; Kalodimos, Charalampos/Q-9846-2018	Kalodimos, Charalampos/0000-0001-6354-2796; Huang, Chengdong/0000-0002-8997-9459; Saio, Tomohide/0000-0003-3639-7399	National Institutes of Health [GM073854]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health grant GM073854 to C.G.K.	Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Betton JM, 1996, J BIOL CHEM, V271, P8046, DOI 10.1074/jbc.271.14.8046; Betton JM, 1998, J BIOL CHEM, V273, P8897, DOI 10.1074/jbc.273.15.8897; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burmann BM, 2013, NAT STRUCT MOL BIOL, V20, P1265, DOI 10.1038/nsmb.2677; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Castanie-Cornet MP, 2014, BBA-MOL CELL RES, V1843, P1442, DOI 10.1016/j.bbamcr.2013.11.007; CHUN SY, 1993, J BIOL CHEM, V268, P20855; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; Dekker C, 2003, J STRUCT BIOL, V144, P313, DOI 10.1016/j.jsb.2003.09.012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Horwich AL, 2014, CELL, V157, P285, DOI 10.1016/j.cell.2014.03.029; Kerfah R, 2015, CURR OPIN STRUC BIOL, V32, P113, DOI 10.1016/j.sbi.2015.03.009; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mattoo RUH, 2014, CELL MOL LIFE SCI, V71, P3311, DOI 10.1007/s00018-014-1627-y; Milbradt AG, 2015, J BIOMOL NMR, V62, P291, DOI 10.1007/s10858-015-9944-5; Muren EM, 1999, J BIOL CHEM, V274, P19397, DOI 10.1074/jbc.274.27.19397; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Sakr S, 2010, J BIOL CHEM, V285, P23504, DOI 10.1074/jbc.M110.133058; Sala A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00666; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tang Y, 2010, BIOCHEM BIOPH RES CO, V393, P698, DOI 10.1016/j.bbrc.2010.02.062; Tejero R, 2013, J BIOMOL NMR, V56, P337, DOI 10.1007/s10858-013-9753-7; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; Wolff N, 2003, J BIOL CHEM, V278, P38247, DOI 10.1074/jbc.M302322200; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040; Zhou JH, 2003, NAT STRUCT BIOL, V10, P942, DOI 10.1038/nsb980; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	42	100	101	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					202	+		10.1038/nature18965	http://dx.doi.org/10.1038/nature18965			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27501151	Green Accepted			2022-12-24	WOS:000382539100041
J	McCarthy, M				McCarthy, Michael			Incidence of neonatal abstinence syndrome triples in US	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ko JY, 2016, MMWR-MORBID MORTAL W, V65, P799, DOI 10.15585/mmwr.mm6531a2	1	0	0	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2016	354								i4476	10.1136/bmj.i4476	http://dx.doi.org/10.1136/bmj.i4476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GR	27528262				2022-12-24	WOS:000381805400015
J	Glasser, MF; Coalson, TS; Robinson, EC; Hacker, CD; Harwell, J; Yacoub, E; Ugurbil, K; Andersson, J; Beckmann, CF; Jenkinson, M; Smith, SM; Van Essen, DC				Glasser, Matthew F.; Coalson, Timothy S.; Robinson, Emma C.; Hacker, Carl D.; Harwell, John; Yacoub, Essa; Ugurbil, Kamil; Andersson, Jesper; Beckmann, Christian F.; Jenkinson, Mark; Smith, Stephen M.; Van Essen, David C.			A multi-modal parcellation of human cerebral cortex	NATURE			English	Article							HUMAN CONNECTOME PROJECT; RESTING-STATE FMRI; HEMISPHERIC ASYMMETRIES; FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; BRAIN ACTIVITY; MYELIN CONTENT; MRI; AREAS; ORGANIZATION	Understanding the amazingly complex human cerebral cortex requires a map (or parcellation) of its major subdivisions, known as cortical areas. Making an accurate areal map has been a century-old objective in neuroscience. Using multimodal magnetic resonance images from the Human Connectome Project (HCP) and an objective semi-automated neuroanatomical approach, we delineated 180 areas per hemisphere bounded by sharp changes in cortical architecture, function, connectivity, and/or topography in a precisely aligned group average of 210 healthy young adults. We characterized 97 new areas and 83 areas previously reported using post-mortem microscopy or other specialized study-specific approaches. To enable automated delineation and identification of these areas in new HCP subjects and in future studies, we trained a machine-learning classifier to recognize the multi-modal 'fingerprint' of each cortical area. This classifier detected the presence of 96.6% of the cortical areas in new subjects, replicated the group parcellation, and could correctly locate areas in individuals with atypical parcellations. The freely available parcellation and classifier will enable substantially improved neuroanatomical precision for studies of the structural and functional organization of human cerebral cortex and its variation across individuals and in development, aging, and disease.	[Glasser, Matthew F.; Coalson, Timothy S.; Harwell, John; Van Essen, David C.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA; [Robinson, Emma C.; Andersson, Jesper; Jenkinson, Mark; Smith, Stephen M.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, FMRIB Ctr, Oxford OX3 9DU, England; [Robinson, Emma C.] Imperial Coll, Dept Comp, London SW7 2AZ, England; [Hacker, Carl D.] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; [Yacoub, Essa; Ugurbil, Kamil] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Beckmann, Christian F.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands; [Beckmann, Christian F.] Radboud Univ Nijmegen, Med Ctr Nijmegen, Dept Cognit Neurosci, NL-6500 HB Nijmegen, Netherlands	Washington University (WUSTL); University of Oxford; Imperial College London; Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities; Radboud University Nijmegen; Radboud University Nijmegen	Glasser, MF; Van Essen, DC (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA.	glasserm@wustl.edu; vanessen@wustl.edu	Ugurbil, Kamil/AAD-6058-2022; Beckmann, Christian F./E-6374-2012; Glasser, Matthew Frederick/AAE-7291-2019; Van Essen, David/ABA-8888-2020; Yacoub, Essa/AAS-7757-2021; Jenkinson, Mark/AAC-8861-2019	Beckmann, Christian F./0000-0002-3373-3193; Jenkinson, Mark/0000-0001-6043-0166; Robinson, Emma Claire/0000-0002-7886-3426; Smith, Stephen/0000-0001-8166-069X	NIH [F30 MH097312, ROIMH-60974, F30 MH099877]; Human Connectome Project grant from the 16 NIH Institutes and Centers [1U54MH091657]; Wellcome Trust [098369/Z/12/Z]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060974, F30MH099877, U54MH091657, F30MH097312] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Connectome Project grant from the 16 NIH Institutes and Centers; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the members of the WU-Minn-Ox HCP Consortium for invaluable contributions to data acquisition, analysis, and sharing and E. Reid and S. Danker for assistance with preparing the manuscript. Supported by NIH F30 MH097312 (M.F.G.), ROIMH-60974 (D.C.V.E.), NIH F30 MH099877 (C.D.H.), the Human Connectome Project grant (1U54MH091657) from the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research, and the Wellcome Trust Strategic Award 098369/Z/12/Z (S.M.S., J.A., C.F.B., M.J.).	Abdollahi RO, 2014, NEUROIMAGE, V99, P509, DOI 10.1016/j.neuroimage.2014.06.042; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Brodmann, 1909, VERGLEICHENDE LOKALI; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Caspers S, 2013, NEUROIMAGE, V80, P18, DOI 10.1016/j.neuroimage.2013.04.003; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Glasser M. F., NAT NEUROSC IN PRESS; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Hill J, 2010, J NEUROSCI, V30, P2268, DOI 10.1523/JNEUROSCI.4682-09.2010; HOPF A, 1956, J Hirnforsch, V2, P311; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Malikovic A, 2007, CEREB CORTEX, V17, P562, DOI 10.1093/cercor/bhj181; Nieuwenhuys R, 2013, BRAIN STRUCT FUNCT, V218, P303, DOI 10.1007/s00429-012-0460-z; Olman CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032536; Polimeni JR, 2010, NEUROIMAGE, V52, P1334, DOI 10.1016/j.neuroimage.2010.05.005; Robinson EC, 2014, NEUROIMAGE, V100, P414, DOI 10.1016/j.neuroimage.2014.05.069; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Schleicher A, 1999, NEUROIMAGE, V9, P165, DOI 10.1006/nimg.1998.0385; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Tavor I, 2016, SCIENCE, V352, P216, DOI 10.1126/science.aad8127; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; Van Essen D.C., 2016, NEUROIMAGE; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Van Essen DC, 2014, NEUROIMAGE, V93, P157, DOI 10.1016/j.neuroimage.2013.04.095; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Wang L, 2015, CEREB CORTEX, V25, P3911, DOI 10.1093/cercor/bhu277; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776; Zimmermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028716	42	1859	1877	31	471	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					171	+		10.1038/nature18933	http://dx.doi.org/10.1038/nature18933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27437579	Green Accepted, Green Submitted			2022-12-24	WOS:000381472100028
J	Chochinov, HM; Frazee, C				Chochinov, Harvey Max; Frazee, Catherine			Finding a balance: Canada's law on medical assistance in dying	LANCET			English	Editorial Material									[Chochinov, Harvey Max] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada; [Chochinov, Harvey Max] CancerCare Manitoba, Manitoba Palliat Care Res Unit, Winnipeg, MB R3E 0V9, Canada; Ryerson Univ, Sch Disabil Studies, Toronto, ON, Canada	University of Manitoba; CancerCare Manitoba Foundation; Toronto Metropolitan University	Chochinov, HM (corresponding author), Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada.; Chochinov, HM (corresponding author), CancerCare Manitoba, Manitoba Palliat Care Res Unit, Winnipeg, MB R3E 0V9, Canada.	hchochinov@cancercare.mb.ca		Chochinov, Harvey/0000-0003-2656-4704				[Anonymous], 2016, RT QUESTION MOR 0618; Department of Justice Government of Canada., 2015, CONS PHYS ASS DYING; Parliament of Canada, 2016, MED ASS DYING PAT CT; Provincial Territorial Expert Advisory Group on Physician Assisted Dying, 2015, FIN REP NOV 30 PROV; Stone L, 2016, GLOBE MAIL	5	13	13	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					543	545		10.1016/S0140-6736(16)31254-5	http://dx.doi.org/10.1016/S0140-6736(16)31254-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27511771				2022-12-24	WOS:000380756600009
J	Carpenter, B; Nehme, R; Warne, T; Leslie, AGW; Tate, CG				Carpenter, Byron; Nehme, Rony; Warne, Tony; Leslie, Andrew G. W.; Tate, Christopher G.			Structure of the adenosine A(2A) receptor bound to an engineered G protein	NATURE			English	Article							CRYSTAL-STRUCTURE; COUPLED RECEPTOR; AGONIST; INSIGHTS; ACTIVATION; BINDING	G-protein-coupled receptors (GPCRs) are essential components of the signalling network throughout the body. To understand the molecular mechanism of G-protein-mediated signalling, solved structures of receptors in inactive conformations and in the active conformation coupled to a G protein are necessary(1,2). Here we present the structure of the adenosine A(2A) receptor (A(2A)R) bound to an engineered G protein, mini-G(s), at 3.4 angstrom resolution. Mini-G(s) binds to A(2A)R through an extensive interface (1,048 angstrom(2)) that is similar, but not identical, to the interface between G(s) and the beta(2)-adrenergic receptor(3). The transition of the receptor from an agonist-bound active-intermediate state(4,5) to an active G-protein-bound state is characterized by a 14 angstrom shift of the cytoplasmic end of transmembrane helix 6 (H6) away from the receptor core, slight changes in the positions of the cytoplasmic ends of H5 and H7 and rotamer changes of the amino acid side chains Arg(3.50), Tyr(5.58) and Tyr(7.53). There are no substantial differences in the extracellular half of the receptor around the ligand binding pocket. The A(2A)R-mini-G(s) structure highlights both the diversity and similarity in G-protein coupling to GPCRs(6) and hints at the potential complexity of the molecular basis for G-protein specificity.	[Carpenter, Byron; Nehme, Rony; Warne, Tony; Leslie, Andrew G. W.; Tate, Christopher G.] MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Tate, CG (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	cgt@mrc-lmb.cam.ac.uk	Carpenter, Byron/S-5206-2019	Carpenter, Byron/0000-0003-1712-3528; Fichou, Yann/0000-0002-6520-0041; Warne, Tony/0000-0001-9646-6080	Heptares Therapeutics Ltd.; ERC [EMPSI 339995]; Medical Research Council [MC_U105197215, MC_U105184325]; Biotechnology and Biological Sciences Research Council [BB/M017982/1] Funding Source: researchfish; BBSRC [BB/M017982/1] Funding Source: UKRI; MRC [MC_U105197215, MC_U105184325] Funding Source: UKRI	Heptares Therapeutics Ltd.; ERC(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from Heptares Therapeutics Ltd., the ERC (grant EMPSI 339995) and core funding from the Medical Research Council (MC_U105197215 and MC_U105184325). We thank the beamline staff at the European Synchrotron Radiation Facility (beamlines ID23-2, ID30-A3 and ID29) and at Diamond Light Source (beamline I24). We also thank R. Henderson, A. Jazayeri and T. Flock for comments on the manuscript.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Congreve M, 2012, J MED CHEM, V55, P1898, DOI 10.1021/jm201376w; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Lebon G, 2015, MOL PHARMACOL, V87, P907, DOI 10.1124/mol.114.097360; Lebon G, 2012, CURR OPIN STRUC BIOL, V22, P482, DOI 10.1016/j.sbi.2012.03.007; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Miller-Gallacher JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092727; Murphree LJ, 2002, MOL PHARMACOL, V61, P455, DOI 10.1124/mol.61.2.455; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Ye LB, 2016, NATURE, V533, P265, DOI 10.1038/nature17668; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	24	261	268	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					104	+		10.1038/nature18966	http://dx.doi.org/10.1038/nature18966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27462812	Green Accepted			2022-12-24	WOS:000380999200039
J	Hegenauer, V; Furst, U; Kaiser, B; Smoker, M; Zipfel, C; Felix, G; Stahl, M; Albert, M				Hegenauer, Volker; Fuerst, Ursula; Kaiser, Bettina; Smoker, Matthew; Zipfel, Cyril; Felix, Georg; Stahl, Mark; Albert, Markus			Detection of the plant parasite Cuscuta reflexa by a tomato cell surface receptor	SCIENCE			English	Article							MESSENGER-RNA; GENUS CUSCUTA; HOST PLANTS; IMMUNITY; PROTEIN; KINASE; CONVOLVULACEAE; IDENTIFICATION; LOCALIZATION; ASSOCIATION	Parasitic plants are a constraint on agriculture worldwide. Cuscuta reflexa is a stem holoparasite that infests most dicotyledonous plants. One exception is tomato, which is resistant to C. reflexa. We discovered that tomato responds to a small peptide factor occurring in Cuscuta spp. with immune responses typically activated after perception of microbe-associated molecular patterns. We identified the cell surface receptor-like protein CUSCUTA RECEPTOR 1 ( CuRe1) as essential for the perception of this parasite-associated molecular pattern. CuRe1 is sufficient to confer responsiveness to the Cuscuta factor and increased resistance to parasitic C. reflexa when heterologously expressed in otherwise susceptible host plants. Our findings reveal that plants recognize parasitic plants in a manner similar to perception of microbial pathogens.	[Hegenauer, Volker; Fuerst, Ursula; Kaiser, Bettina; Felix, Georg; Stahl, Mark; Albert, Markus] Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany; [Smoker, Matthew; Zipfel, Cyril] Norwich Res Pk, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	Eberhard Karls University of Tubingen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Albert, M (corresponding author), Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany.	markus.albert@zmbp.uni-tuebingen.de	ZIPFEL, CYRIL B/D-7103-2011; ZIPFEL, CYRIL/ABD-5076-2021	ZIPFEL, CYRIL B/0000-0003-4935-8583; ZIPFEL, CYRIL/0000-0003-4935-8583; Kaiser, Bettina/0000-0003-2052-2642; Albert, Markus/0000-0003-4729-2453	Deutsche Forschungsgemeinschaft (DFG) [AL1426/1-1]; DFG [AL1426/1-2, CRC 1101]; German Federal Ministry of Education (BMBF-KBBE project) [031A328 36]; Gatsby Charitable Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); German Federal Ministry of Education (BMBF-KBBE project); Gatsby Charitable Foundation	We thank the Tomato Genetics Resource Center (University of California, Davis) for providing seeds of the tomato introgression lines; N. Sinha and M. Farhi for providing C. pentagona material and seeds; M. H. A. J. Joosten and S. Robatzek for SlSOBIR and SlSOBIR-like constructs; and P. Neumann and I. Bock for technical assistance; and N. Holton and I. Albert for critical reading of the manuscript before submission. Supported by Deutsche Forschungsgemeinschaft (DFG) grant AL1426/1-1 (M.A.), DFG grant AL1426/1-2 (V.H., U.F., and B.K.), the German Federal Ministry of Education (BMBF-KBBE project 031A328 36) (U.F.), and DFG grant CRC 1101 (M. S. and G.F.). Research at the C.Z. laboratory is funded by the Gatsby Charitable Foundation. The authors do not have any competing interests. Supplement contains additional data.	Alakonya A, 2012, PLANT CELL, V24, P3153, DOI 10.1105/tpc.112.099994; Albert I, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.140, 10.1038/NPLANTS.2015.140]; Albert M, 2006, PLANT J, V48, P548, DOI 10.1111/j.1365-313X.2006.02897.x; Bleischwitz M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-227; Chitwood DH, 2013, PLANT CELL, V25, P2465, DOI 10.1105/tpc.113.112391; David-Schwartz R, 2008, NEW PHYTOL, V179, P1133, DOI 10.1111/j.1469-8137.2008.02540.x; Davis CC, 2015, CURR OPIN PLANT BIOL, V26, P14, DOI 10.1016/j.pbi.2015.05.008; Dawson J. H. M., 1994, WEED SCI, V6, P265; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; ESHED Y, 1995, GENETICS, V141, P1147; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Garcia MA, 2014, AM J BOT, V101, P670, DOI 10.3732/ajb.1300449; Gust AA, 2014, CURR OPIN PLANT BIOL, V21, P104, DOI 10.1016/j.pbi.2014.07.007; Hanisch FG, 2001, ANAL BIOCHEM, V290, P47, DOI 10.1006/abio.2000.4955; Haupt S, 2001, J EXP BOT, V52, P173, DOI 10.1093/jexbot/52.354.173; Hibberd JM, 1998, PLANTA, V205, P506, DOI 10.1007/s004250050349; Hibberd JM, 1999, PLANT CELL ENVIRON, V22, P937, DOI 10.1046/j.1365-3040.1999.00462.x; IHL B, 1988, FLORA, V181, P383; Jehle AK, 2013, PLANT CELL, V25, P2330, DOI 10.1105/tpc.113.110833; Jeschke WD, 1997, PLANT CELL ENVIRON, V20, P47, DOI 10.1046/j.1365-3040.1997.d01-2.x; Johnsen HR, 2015, NEW PHYTOL, V207, P805, DOI 10.1111/nph.13378; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaiser B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00045; Kim G, 2015, CURR OPIN PLANT BIOL, V26, P20, DOI 10.1016/j.pbi.2015.05.012; Kim G, 2014, SCIENCE, V345, P808, DOI 10.1126/science.1253122; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Liebrand TWH, 2013, P NATL ACAD SCI USA, V110, P10010, DOI 10.1073/pnas.1220015110; McNeal JR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-55; Postma J, 2016, NEW PHYTOL, V210, P627, DOI 10.1111/nph.13802; Roney JK, 2007, PLANT PHYSIOL, V143, P1037, DOI 10.1104/pp.106.088369; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Spallek T, 2013, MOL PLANT PATHOL, V14, P861, DOI 10.1111/mpp.12058; Thuerig B, 2005, PHYSIOL MOL PLANT P, V67, P180, DOI 10.1016/j.pmpp.2006.01.002; Werner M, 2001, PLANTA, V213, P550, DOI 10.1007/s004250100533; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Zhang WG, 2013, PLANT CELL, V25, P4227, DOI 10.1105/tpc.113.117010; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	37	77	80	7	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					478	481		10.1126/science.aaf3919	http://dx.doi.org/10.1126/science.aaf3919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471302	Green Accepted			2022-12-24	WOS:000380583600038
J	McDermott, JH; Schultz, AF; Undurraga, EA; Godoy, RA				McDermott, Josh H.; Schultz, Alan F.; Undurraga, Eduardo A.; Godoy, Ricardo A.			Indifference to dissonance in native Amazonians reveals cultural variation in music perception	NATURE			English	Article							TONAL CONSONANCE; PREFERENCE; FLUCTUATIONS; FOUNDATIONS; COMPLEXES; INFANTS; BOLIVIA; HEARING; CHORDS; TONES	Music is present in every culture, but the degree to which it is shaped by biology remains debated. One widely discussed phenomenon is that some combinations of notes are perceived by Westerners as pleasant, or consonant, whereas others are perceived as unpleasant, or dissonant(1). The contrast between consonance and dissonance is central to Western music(2,3), and its origins have fascinated scholars since the ancient Greeks(4-10). Aesthetic responses to consonance are commonly assumed by scientists to have biological roots(11-14), and thus to be universally present in humans(15,16). Ethnomusicologists(17) and composers(8), in contrast, have argued that consonance is a creation of Western musical culture(6). The issue has remained unresolved, partly because little is known about the extent of cross-cultural variation in consonance preferences(18). Here we report experiments with the Tsimane'-a native Amazonian society with minimal exposure to Western culture-and comparison populations in Bolivia and the United States that varied in exposure to Western music. Participants rated the pleasantness of sounds. Despite exhibiting Western-like discrimination abilities and Western-like aesthetic responses to familiar sounds and acoustic roughness, the Tsimane' rated consonant and dissonant chords and vocal harmonies as equally pleasant. By contrast, Bolivian city-and town-dwellers exhibited significant preferences for consonance, albeit to a lesser degree than US residents. The results indicate that consonance preferences can be absent in cultures sufficiently isolated from Western music, and are thus unlikely to reflect innate biases or exposure to harmonic natural sounds. The observed variation in preferences is presumably determined by exposure to musical harmony, suggesting that culture has a dominant role in shaping aesthetic responses to music.	[McDermott, Josh H.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Schultz, Alan F.] Baylor Univ, Dept Anthropol, Waco, TX 76798 USA; [Undurraga, Eduardo A.; Godoy, Ricardo A.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02453 USA; [Undurraga, Eduardo A.] Pontificia Univ Catolica Chile, Ctr Intercultural & Indigenous Res, Santiago 7820436, Region Metropol, Chile	Massachusetts Institute of Technology (MIT); Baylor University; Brandeis University; Pontificia Universidad Catolica de Chile	McDermott, JH (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	jhm@mit.edu	Undurraga, Eduardo/I-3739-2014	Undurraga, Eduardo/0000-0002-4425-1253; Schultz, Alan/0000-0002-1249-3178	National Science Foundation; McDonnell Scholar Award; TAPS	National Science Foundation(National Science Foundation (NSF)); McDonnell Scholar Award; TAPS	The authors gratefully acknowledge the support of the National Science Foundation to R.A.G., a McDonnell Scholar Award to J.H.M., the TAPS Bolivia Study Team (particularly T. Huanca), C. Garcia for assistance with Fig. 1a, E. Gibson for logistical help, N. Jacoby and M. Salinas for assistance recording and interviewing Tsimane' musicians, S. Popham and L. Chen for data collection, and D. Boebinger and K. Woods for comments on the manuscript.	Arnal LH, 2015, CURR BIOL, V25, P2051, DOI 10.1016/j.cub.2015.06.043; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Bernstein JG, 2003, J ACOUST SOC AM, V113, P3323, DOI 10.1121/1.1572146; Bidelman GM, 2011, J ACOUST SOC AM, V130, P1488, DOI 10.1121/1.3605559; Bigand E, 1996, PERCEPT PSYCHOPHYS, V58, P125, DOI 10.3758/BF03205482; Bowling DL, 2015, P NATL ACAD SCI USA, V112, P11155, DOI 10.1073/pnas.1505768112; Brown S, 2013, PSYCHOL MUSIC, V41, P229, DOI 10.1177/0305735611425896; BUTLER JW, 1968, J GEN PSYCHOL, V79, P129, DOI 10.1080/00221309.1968.9710460; CAZDEN N, 1980, INT REV AESTHET SOC, V11, P123, DOI 10.2307/836494; Cousineau M, 2012, P NATL ACAD SCI USA, V109, P19858, DOI 10.1073/pnas.1207989109; DARWIN CJ, 1984, J ACOUST SOC AM, V76, P1636, DOI 10.1121/1.391610; Fishman YI, 2001, J NEUROPHYSIOL, V86, P2761, DOI 10.1152/jn.2001.86.6.2761; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Godoy R, 2009, CURR ANTHROPOL, V50, P560, DOI 10.1086/599983; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Helmholtz von H., 1863, LEHRE TONEMPFINDUNGE; Hissink K., 1955, PAEDUMA, V6, P60; Huanca Tomas, 2008, TSIMANE ORAL TRADITI; HURON D, 1994, MUSIC PERCEPT, V11, P289; HUTCHINSON W, 1978, INTERFACE-J NEW MUS, V7, P1, DOI 10.1080/09298217808570246; Kawahara H, 2011, SADHANA-ACAD P ENG S, V36, P713, DOI 10.1007/s12046-011-0043-3; Kumar S, 2008, J ACOUST SOC AM, V124, P3810, DOI 10.1121/1.3006380; Leonard WR, 2015, ECON HUM BIOL, V19, P51, DOI 10.1016/j.ehb.2015.07.004; Lundin RW, 1947, J PSYCHOL, V23, P45, DOI 10.1080/00223980.1947.9917318; MAHER TF, 1976, J CROSS CULT PSYCHOL, V7, P259, DOI 10.1177/002202217673001; Malmberg CF, 1918, PSYCHOL MONOGR, V25, P93, DOI 10.1037/h0093119; McDermott JH, 2010, CURR BIOL, V20, P1035, DOI 10.1016/j.cub.2010.04.019; MOORE BCJ, 1986, J ACOUST SOC AM, V80, P479, DOI 10.1121/1.394043; Parncutt R., 2011, J INTERDISCIPLINARY, V5, P119, DOI [DOI 10.4407/JIMS.2011.11.002, 10.4407/jims.2011.11.002]; Plantinga J, 2014, J EXP PSYCHOL HUMAN, V40, P40, DOI 10.1037/a0033471; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; Riester J., 1978, CANCION PRODUCCION V; ROBERTS LA, 1986, ACUSTICA, V62, P163; RUTSCHMANN J, 1965, J ACOUST SOC AM, V38, P759, DOI 10.1121/1.1909802; Sethares W., 1999, TUNING TIMBRE SPECTR; Stumpf C., 1890, TONPSYCHOLOGIE; Tenney J., 1988, HIST CONSONANCE DISS; TERHARDT E, 1974, ACUSTICA, V30, P201; Trainor LJ, 2002, MUSIC PERCEPT, V20, P187, DOI 10.1525/mp.2002.20.2.187; Tramo MJ, 2001, ANN NY ACAD SCI, V930, P92, DOI 10.1111/j.1749-6632.2001.tb05727.x; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0	41	134	136	4	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					547	+		10.1038/nature18635	http://dx.doi.org/10.1038/nature18635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DS5XP	27409816				2022-12-24	WOS:000380856600028
J	Peters, PJ; Pontones, P; Hoover, KW; Patel, MR; Galang, RR; Shields, J; Blosser, SJ; Spiller, MW; Combs, B; Switzer, WM; Conrad, C; Gentry, J; Khudyakov, Y; Waterhouse, D; Owen, SM; Chapman, E; Roseberry, JC; McCants, V; Weidle, PJ; Broz, D; Samandari, T; Mermin, J; Walthall, J; Brooks, JT; Duwve, JM				Peters, Philip J.; Pontones, Pamela; Hoover, Karen W.; Patel, Monita R.; Galang, Romeo R.; Shields, Jessica; Blosser, Sara J.; Spiller, Michael W.; Combs, Brittany; Switzer, William M.; Conrad, Caitlin; Gentry, Jessica; Khudyakov, Yury; Waterhouse, Dorothy; Owen, S. Michele; Chapman, Erika; Roseberry, Jeremy C.; McCants, Veronica; Weidle, Paul J.; Broz, Dita; Samandari, Taraz; Mermin, Jonathan; Walthall, Jennifer; Brooks, John T.; Duwve, Joan M.		Indiana HIV Outbreak Investigation	HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C VIRUS-INFECTION; UNITED-STATES; RISK BEHAVIORS; YOUNG-ADULTS; HEROIN USE; DRUG USE; NEW-YORK; EPIDEMIC; TRANSMISSION; INCREASES	BACKGROUND In January 2015, a total of 11 new diagnoses of human immunodeficiency virus (HIV) infection were reported in a small community in Indiana. We investigated the extent and cause of the outbreak and implemented control measures. METHODS We identified an outbreak-related case as laboratory-confirmed HIV infection newly diagnosed after October 1, 2014, in a person who either resided in Scott County, Indiana, or was named by another case patient as a syringe-sharing or sexual partner. HIV polymerase (pol) sequences from case patients were phylogenetically analyzed, and potential risk factors associated with HIV infection were ascertained. RESULTS From November 18, 2014, to November 1, 2015, HIV infection was diagnosed in 181 case patients. Most of these patients (87.8%) reported having injected the extended-release formulation of the prescription opioid oxymorphone, and 92.3% were coinfected with hepatitis C virus. Among 159 case patients who had an HIV type 1 pol gene sequence, 157 (98.7%) had sequences that were highly related, as determined by phylogenetic analyses. Contact tracing investigations led to the identification of 536 persons who were named as contacts of case patients; 468 of these contacts (87.3%) were located, assessed for risk, tested for HIV, and, if infected, linked to care. The number of times a contact was named as a syringe-sharing partner by a case patient was significantly associated with the risk of HIV infection (adjusted risk ratio for each time named, 1.9; P< 0.001). In response to this outbreak, a public health emergency was declared on March 26, 2015, and a syringe-service program in Indiana was established for the first time. CONCLUSIONS Injection-drug use of extended-release oxymorphone within a network of persons who inject drugs in Indiana led to the introduction and rapid transmission of HIV. ( Funded by the state government of Indiana and others.)	[Peters, Philip J.; Hoover, Karen W.; Patel, Monita R.; Galang, Romeo R.; Spiller, Michael W.; Switzer, William M.; Khudyakov, Yury; Owen, S. Michele; McCants, Veronica; Weidle, Paul J.; Broz, Dita; Samandari, Taraz; Mermin, Jonathan; Brooks, John T.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA USA; [Pontones, Pamela; Blosser, Sara J.; Conrad, Caitlin; Gentry, Jessica; Chapman, Erika; Roseberry, Jeremy C.; Walthall, Jennifer; Duwve, Joan M.] Indiana Univ Sch Med, Indiana State Dept Hlth, Indianapolis, IN 46202 USA; [Duwve, Joan M.] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Shields, Jessica; Waterhouse, Dorothy] Clark Cty Hlth Dept, Jeffersonville, IN USA; [Combs, Brittany] Scott Cty Hlth Dept, Scottsburg, IN USA	Centers for Disease Control & Prevention - USA; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Peters, PJ (corresponding author), Ctr Dis Control & Prevent, HIV Testing & Biomed Intervent Act, Epidemiol Branch, 1600 Clifton Rd NE,Mailstop E-45, Atlanta, GA 30329 USA.	pjpeters@cdc.gov		Spiller, Michael/0000-0002-7950-6199; Byrd, Kathy/0000-0002-9818-5634	state government of Indiana; Scott and Clark County Health Departments; Department of Health and Human Services	state government of Indiana; Scott and Clark County Health Departments; Department of Health and Human Services	Supported (financially and in kind) by the state government of Indiana, the Scott and Clark County Health Departments, and the Department of Health and Human Services.	[Anonymous], COMMUNICATION; [Anonymous], 2015, VIR HEP SURV US; [Anonymous], 2011, POL IMP PRESCR PAINK; Aspinall EJ, 2014, INT J EPIDEMIOL, V43, P235, DOI 10.1093/ije/dyt243; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Conrad C, 2015, MMWR-MORBID MORTAL W, V64, P443; Department of Health and Human Services, 2013, ADDR PRESCR DRUG AB; Des Jarlais DC, 2015, MMWR-MORBID MORTAL W, V64, P1337, DOI 10.15585/mmwr.mm6448a3; Forbi JC, 2012, J GEN VIROL, V93, P1410, DOI 10.1099/vir.0.042184-0; Havens Jennifer R, 2013, Am J Public Health, V103, pe44, DOI 10.2105/AJPH.2012.300874; Jasuja S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043252; Jones CM, 2013, DRUG ALCOHOL DEPEN, V132, P95, DOI 10.1016/j.drugalcdep.2013.01.007; Kentucky Public Health, 2015, KENT HARM RED SYR EX; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Mateu-Gelabert P, 2015, J SUBST ABUSE TREAT, V48, P13, DOI 10.1016/j.jsat.2014.07.002; Maxwell JC, 2011, DRUG ALCOHOL REV, V30, P264, DOI 10.1111/j.1465-3362.2011.00291.x; Meit M., 2014, 2014 UPDATE RURAL UR; Onofrey Shauna, 2011, Morbidity and Mortality Weekly Report, V60, P537; Paz-Bailey G, 2015, AIDS BEHAV, V19, P2304, DOI 10.1007/s10461-015-1011-4; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; State of Indiana, 2015, 1505 STAT IND; Strathdee SA, 2015, NEW ENGL J MED, V373, P397, DOI 10.1056/NEJMp1507252; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wiedeman Jean, 2012, Morbidity and Mortality Weekly Report, V61, P61; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453; Zibbell JE, 2014, AM J PUBLIC HEALTH, V104, P2226, DOI 10.2105/AJPH.2014.302142	32	425	425	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2016	375	3					229	239		10.1056/NEJMoa1515195	http://dx.doi.org/10.1056/NEJMoa1515195			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0ZL	27468059	Bronze, Green Published			2022-12-24	WOS:000380325400006
J	Loh, KM; Chen, A; Koh, PW; Deng, TDZ; Sinha, R; Tsai, JM; Barkal, AA; Shen, KY; Jain, R; Morganti, RM; Shyh-Chang, N; Fernhoff, NB; George, BM; Wernig, G; Salomon, REA; Chen, ZH; Vogel, H; Epstein, JA; Kundaje, A; Talbot, WS; Beachy, PA; Ang, LT; Weissman, IL				Loh, Kyle M.; Chen, Angela; Koh, Pang Wei; Deng, Tianda Z.; Sinha, Rahul; Tsai, Jonathan M.; Barkal, Amira A.; Shen, Kimberle Y.; Jain, Rajan; Morganti, Rachel M.; Shyh-Chang, Ng; Fernhoff, Nathaniel B.; George, Benson M.; Wernig, Gerlinde; Salomon, Rachel E. A.; Chen, Zhenghao; Vogel, Hannes; Epstein, Jonathan A.; Kundaje, Anshul; Talbot, William S.; Beachy, Philip A.; Ang, Lay Teng; Weissman, Irving L.			Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell Types	CELL			English	Article							EMBRYONIC STEM-CELLS; MOUSE EMBRYO; SCLEROTOME INDUCTION; PRIMITIVE STREAK; SONIC HEDGEHOG; GENE; ZEBRAFISH; DIFFERENTIATION; SPECIFICATION; SEGMENTATION	Stem-cell differentiation to desired lineages requires navigating alternating developmental paths that often lead to unwanted cell types. Hence, comprehensive developmental roadmaps are crucial to channel stem-cell differentiation toward desired fates. To this end, here, we map bifurcating lineage choices leading from pluripotency to 12 human mesodermal lineages, including bone, muscle, and heart. We defined the extrinsic signals controlling each binary lineage decision, enabling us to logically block differentiation toward unwanted fates and rapidly steer pluripotent stem cells toward 80%-99% pure human mesodermal lineages at most branchpoints. This strategy enabled the generation of human bone and heart progenitors that could engraft in respective in vivo models. Mapping stepwise chromatin and single-cell gene expression changes in mesoderm development uncovered somite segmentation, a previously unobservable human embryonic event transiently marked by HOPX expression. Collectively, this roadmap enables navigation of mesodermal development to produce transplantable human tissue progenitors and uncover developmental processes.	[Loh, Kyle M.; Chen, Angela; Deng, Tianda Z.; Sinha, Rahul; Tsai, Jonathan M.; Barkal, Amira A.; Shen, Kimberle Y.; Morganti, Rachel M.; Fernhoff, Nathaniel B.; George, Benson M.; Salomon, Rachel E. A.; Chen, Zhenghao; Talbot, William S.; Beachy, Philip A.; Weissman, Irving L.] Stanford Univ, Dept Dev Biol, Inst Stem Cell Biol & Regenerat Med, Ludwig Ctr Canc Stem Cell Biol & Med,Sch Med, Stanford, CA 94305 USA; [Koh, Pang Wei; Kundaje, Anshul] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Koh, Pang Wei; Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Sch Med, Stanford, CA 94305 USA; [Wernig, Gerlinde; Vogel, Hannes] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Beachy, Philip A.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Jain, Rajan; Epstein, Jonathan A.] Univ Penn, Cardiovasc Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Shyh-Chang, Ng; Ang, Lay Teng] Genome Inst Singapore, Stem Cell & Regenerat Biol Grp, Singapore 138672, Singapore	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Pennsylvania; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Weissman, IL (corresponding author), Stanford Univ, Dept Dev Biol, Inst Stem Cell Biol & Regenerat Med, Ludwig Ctr Canc Stem Cell Biol & Med,Sch Med, Stanford, CA 94305 USA.; Ang, LT (corresponding author), Genome Inst Singapore, Stem Cell & Regenerat Biol Grp, Singapore 138672, Singapore.	anglt1@gis.a-star.edu.sg; irv@stanford.edu	Kundaje, Anshul/Y-2739-2019; Kundaje, Anshul/Y-2598-2019	Kundaje, Anshul/0000-0003-3084-2287; Kundaje, Anshul/0000-0003-3084-2287; , William/0000-0002-2048-7472; Vogel, Otto Hannes/0000-0002-0960-3508; SALOMON, Rachel/0000-0003-4579-6850; Tsai, Jonathan/0000-0001-5868-2305; Loh, Kyle/0000-0002-8042-0149; Shyh-Chang, Ng/0000-0003-3138-9525; Ang, Lay Teng/0000-0002-6783-4662; Chen, Angela/0000-0002-2697-0385	CIRM [RT2-02060, RT3-07683, TB1-01195]; NIH [HL125040, GM007365, HL119553, HL071546, HL100405, NS069375, RR029338, OD018220]; HHMI; Siebel Stem Cell Institute; A*STAR; Hertz Foundation; U.S. National Science Foundation; Davidson Institute for Talent Development; Paul and Daisy Soros Fellowship; Burroughs Wellcome Fund Career Award for Medical Scientists; Sloan Foundation Research Fellowship; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029338] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL119553, R01HL071546, U01HL100405, R56HL125040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018220] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Siebel Stem Cell Institute; A*STAR(Agency for Science Technology & Research (A*STAR)); Hertz Foundation; U.S. National Science Foundation(National Science Foundation (NSF)); Davidson Institute for Talent Development; Paul and Daisy Soros Fellowship; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Sloan Foundation Research Fellowship(Alfred P. Sloan Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank O. Curreri, A. Dainis, B. Brady, L. Stanton, G. Gulati, W. Wenderski, M. Nichane, K.L. Lee, E. Lujan, C. van Neste, N. Neff, and K. Roberts for input. M. Inlay, N. Sever, E.S. Ng, A. Elefanty, and E. Stanley graciously shared re-agents. T. Storm, A. McCarty, P. Lovelace, J. Coller, T. Doyle, and the Stanford Stem Cell Institute FACS, Genomics, Functional Genomics, and In Vivo Imaging Cores provided support. This work was supported by CIRM (RT2-02060, RT3-07683, TB1-01195), NIH (HL125040, GM007365, HL119553, HL071546, HL100405, NS069375, RR029338, OD018220), HHMI, the Siebel Stem Cell Institute, anonymous donors, and A*STAR. K.M.L. was supported by the Hertz Foundation, U.S. National Science Foundation, and Davidson Institute for Talent Development, J.M.T. by the Paul and Daisy Soros Fellowship, R.J. by the Burroughs Wellcome Fund Career Award for Medical Scientists, and A.K. by the Sloan Foundation Research Fellowship.	Ardehali R, 2013, P NATL ACAD SCI USA, V110, P3405, DOI 10.1073/pnas.1220832110; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Christ B, 2008, ADV EXP MED BIOL, V638, P1; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Devine WP, 2014, ELIFE, V3, DOI 10.7554/eLife.03848; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Fan CM, 1997, DEV BIOL, V191, P160, DOI 10.1006/dbio.1997.8713; Gertow K, 2013, STEM CELL REP, V1, P53, DOI 10.1016/j.stemcr.2013.04.002; Giampietro PF, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/152365; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Jain R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6071; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Liu LH, 2002, MECH DEVELOP, V116, P227, DOI 10.1016/S0925-4773(02)00142-9; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Reifers F, 2000, DEVELOPMENT, V127, P225; ROSENQUIST GC, 1970, DEV BIOL, V22, P461, DOI 10.1016/0012-1606(70)90163-6; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Spater D, 2014, DEVELOPMENT, V141, P4418, DOI 10.1242/dev.091538; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; TAM PPL, 1987, DEVELOPMENT, V99, P109; Tanaka M, 2013, DEV GROWTH DIFFER, V55, P149, DOI 10.1111/dgd.12017; Tonegawa A, 1997, DEVELOPMENT, V124, P1975; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Umeda K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00455; Waddington C. H, 1940, ORG AND GENES	42	216	221	3	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					451	467		10.1016/j.cell.2016.06.011	http://dx.doi.org/10.1016/j.cell.2016.06.011			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27419872	Green Accepted, Bronze			2022-12-24	WOS:000380255400021
J	Ankuda, CK; Levine, DA				Ankuda, Claire K.; Levine, Deborah A.			Trends in Caregiving Assistance for Home-Dwelling, Functionally Impaired Older Adults in the United States, 1998-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ankuda, Claire K.] Univ Michigan, Robert Wood Johnson Fdn Clin Scholars Program, 2800 Plymouth Rd,Bldg 10,Room G016, Ann Arbor, MI 48109 USA; [Levine, Deborah A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ankuda, CK (corresponding author), Univ Michigan, Robert Wood Johnson Fdn Clin Scholars Program, 2800 Plymouth Rd,Bldg 10,Room G016, Ann Arbor, MI 48109 USA.	cankuda@umich.edu	Ankuda, Claire/AAB-5902-2021	Ankuda, Claire/0000-0003-1371-8524	NATIONAL INSTITUTE ON AGING [U01AG009740, K23AG040278] Funding Source: NIH RePORTER; NIA NIH HHS [U01 AG009740, U01 AG09740, K23AG040278, K23 AG040278] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Knickman JR, 2002, HEALTH SERV RES, V37, P849, DOI 10.1034/j.1600-0560.2002.56.x; Lynn J, 2005, HASTINGS CENT REP, V35, pS14, DOI 10.1353/hcr.2005.0096; Ornstein KA, 2015, JAMA INTERN MED, V175, P1180, DOI 10.1001/jamainternmed.2015.1849; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067	4	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2016	316	2					218	220		10.1001/jama.2016.6824	http://dx.doi.org/10.1001/jama.2016.6824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ9CW	27404191	Green Accepted, Bronze			2022-12-24	WOS:000379509000019
J	Qian, L				Qian, Li			Hope for the brokenhearted Cellular reprogramming improves cardiac function in a mouse model of myocardial infarction	SCIENCE			English	Editorial Material							INDUCED CARDIOMYOCYTES; FIBROBLASTS		[Qian, Li] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Qian, L (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	li_qian@med.unc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128331] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Liu ZQ, 2016, STEM CELL RES, V16, P507, DOI 10.1016/j.scr.2016.02.037; Ma H, 2015, CARDIOVASC RES, V108, P217, DOI 10.1093/cvr/cvv223; Qian L, 2013, CIRC RES, V113, P915, DOI 10.1161/CIRCRESAHA.112.300625; Qian L, 2013, NAT PROTOC, V8, P1204, DOI 10.1038/nprot.2013.067; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Wang L., 2015, JOVE-J VIS EXP, V105; Wang L, 2015, CIRC RES, V116, P237, DOI 10.1161/CIRCRESAHA.116.305547; Zhou Y, 2016, CELL STEM CELL, V18, P382, DOI 10.1016/j.stem.2016.02.003	8	2	2	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1400	1401		10.1126/science.aag1213	http://dx.doi.org/10.1126/science.aag1213			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313029				2022-12-24	WOS:000377975400026
J	Bournazos, S; Gazumyan, A; Seaman, MS; Nussenzweig, MC; Ravetch, JV				Bournazos, Stylianos; Gazumyan, Anna; Seaman, Michael S.; Nussenzweig, Michel C.; Ravetch, Jeffrey V.			Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency	CELL			English	Article							BROADLY NEUTRALIZING ANTIBODIES; HIV-ANTIBODIES; HUMANIZED MICE; CONFORMATIONAL EPITOPE; GP41-GP120 INTERFACE; CD4 BINDING; IGG; MACAQUES; THERAPY; VIREMIA	Broadly neutralizing antibodies (bNAbs) against the HIV-1 envelope glycoprotein (Env) suppress viremia in animal models of HIV-1 and humans. To achieve potent activity without the emergence of viral escape mutants, co-administration of different bNAbs is necessary to target distinct epitopes essential for viral fitness. Here, we report the development of bispecific anti-Env neutralizing antibodies (biNAbs) with potent activity. Synergistic activity of biNAbs was achieved by combining an engineered hinge domain of IgG3 to increase Fab domain flexibility necessary for hetero-bivalent binding to the Env trimer while retaining the functional properties of the IgG1-Fc. Compared to unmodified biNAbs, hinge domain variants exhibited substantially improved neutralization activity, with particular combinations showing evidence of synergistic neutralization potency in vitro and enhanced in vivo therapeutic activity in HIV-1-infected humanized mice. These findings suggest innovative strategies for generating biNAbs with enhanced neutralization breadth and potency, representing ideal candidate molecules for the control of HIV-1 infection.	[Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Seaman, Michael S.] Harvard Univ, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Nussenzweig, Michel/AAE-7292-2019; Bournazos, Stylianos/ABH-1578-2021	Ravetch, Jeffrey/0000-0003-2024-9041; 	NIAID [AI081677, AI100148]; Bill & Melinda Gates Foundation [OPP1033115, OPP1124068, OPP1032144]; amfAR Mathilde Krim Fellowship in Basic Biomedical Research [108977-57-RKVA]; NIH AIDS Reagent Program [T251-18]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148, P01AI081677] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); amfAR Mathilde Krim Fellowship in Basic Biomedical Research; NIH AIDS Reagent Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank P. Smith, H. Lee, M. Saito, M. Ye, E. Lam, P. Bartel, T. Schoofs, J. Cetrulo-Lorenzi, and L. Nogueira (Rockefeller University) for technical help and advice; M. Louder and J. Mascola (VRC, National Institute of Allergy and Infectious Diseases [NIAID]) for providing the raw neutralization data for the bNAb combinations (Figure S4); and the NIH AIDS Reagent Program for obtaining the T251-18 env construct. Research reported in this publication was supported in part by the NIAID under award numbers AI081677 and AI100148 (to J.V.R. and M.C.N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Research support was also provided by the Bill & Melinda Gates Foundation grants OPP1033115 and OPP1124068 to J.V.R. and M.C.N. and grant OPP1032144 to M.S.S. S.B. was supported by an amfAR Mathilde Krim Fellowship in Basic Biomedical Research (108977-57-RKVA).	Asokan M, 2015, J VIROL, V89, P12501, DOI 10.1128/JVI.02097-15; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bournazos S, 2015, IMMUNOL REV, V268, P88, DOI 10.1111/imr.12343; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chames P, 2009, MABS-AUSTIN, V1, P539, DOI 10.4161/mabs.1.6.10015; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Galimidi RP, 2015, CELL, V160, P433, DOI 10.1016/j.cell.2015.01.016; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14; Lee JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9167; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; MONTEFIORI DC, 2005, CURR PROTOC IMMUNOL, V12; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Pace CS, 2013, P NATL ACAD SCI USA, V110, P13540, DOI 10.1073/pnas.1304985110; Pegu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9447; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Roux KH, 1998, J IMMUNOL, V161, P4083; Roux KH, 1997, J IMMUNOL, V159, P3372; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Sung JAM, 2015, J CLIN INVEST, V125, P4077, DOI 10.1172/JCI82314; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	52	107	108	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1609	1620		10.1016/j.cell.2016.04.050	http://dx.doi.org/10.1016/j.cell.2016.04.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315478	Green Accepted, Bronze			2022-12-24	WOS:000378062000013
J	Branco, T; Tozer, A; Magnus, CJ; Sugino, K; Tanaka, S; Lee, AK; Wood, JN; Sternson, SM				Branco, Tiago; Tozer, Adam; Magnus, Christopher J.; Sugino, Ken; Tanaka, Shinsuke; Lee, Albert K.; Wood, John N.; Sternson, Scott M.			Near-Perfect Synaptic Integration by Na(v)1.7 in Hypothalamic Neurons Regulates Body Weight	CELL			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; SODIUM-CHANNELS; HIPPOCAMPAL-NEURONS; RNA INTERFERENCE; AGRP NEURONS; TIME-COURSE; CURRENTS; NUCLEUS; CIRCUIT; HUNGER	Neurons are well suited for computations on millisecond timescales, but some neuronal circuits set behavioral states over long time periods, such as those involved in energy homeostasis. We found that multiple types of hypothalamic neurons, including those that oppositely regulate body weight, are specialized as near-perfect synaptic integrators that summate inputs over extended timescales. Excitatory postsynaptic potentials (EPSPs) are greatly prolonged, outlasting the neuronal membrane time-constant up to 10-fold. This is due to the voltage-gated sodium channel Na(v)1.7 (Scn9a), previously associated with pain-sensation but not synaptic integration. Scn9a deletion in AGRP, POMC, or paraventricular hypothalamic neurons reduced EPSP duration, synaptic integration, and altered body weight in mice. In vivo whole-cell recordings in the hypothalamus confirmed near-perfect synaptic integration. These experiments show that integration of synaptic inputs over time by Na(v)1.7 is critical for body weight regulation and reveal a mechanism for synaptic control of circuits regulating long term homeostatic functions.	[Branco, Tiago; Magnus, Christopher J.; Sugino, Ken; Tanaka, Shinsuke; Lee, Albert K.; Sternson, Scott M.] Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA; [Branco, Tiago; Tozer, Adam] MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 0QH, England; [Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, Mortimer St, London WC1E 6BT, England	Howard Hughes Medical Institute; MRC Laboratory Molecular Biology; University of London; University College London	Branco, T; Sternson, SM (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.; Branco, T (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 0QH, England.	tbranco@mrc-lmb.cam.ac.uk; sternsons@janelia.hhmi.org		Sternson, Scott/0000-0002-0835-444X	Howard Hughes Medical Institute; HHMI Janelia Research Campus Visitor program; NeuroSeq Project Team; Wellcome Trust/Royal Society Henry Dale Fellowship [098400/Z/12/Z]; Medical Research Council (MRC) grant [MC-UP-1201/1]; MRC grant [G091905]; Wellcome Trust Grant [10154]; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [MC_UP_1201/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [MC_UP_1201/1] Funding Source: researchfish; Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish	Howard Hughes Medical Institute(Howard Hughes Medical Institute); HHMI Janelia Research Campus Visitor program; NeuroSeq Project Team; Wellcome Trust/Royal Society Henry Dale Fellowship; Medical Research Council (MRC) grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Grant(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by the Howard Hughes Medical Institute (to S.M.S.), the HHMI Janelia Research Campus Visitor program (to T.B.), the NeuroSeq Project Team (to K.S.), a Wellcome Trust/Royal Society Henry Dale Fellowship (098400/Z/12/Z) and Medical Research Council (MRC) grant MC-UP-1201/1 (to T.B.), and MRC grant G091905 and Wellcome Trust Grant 10154 (to J.N.W.). We thank H. Su for molecular biology; M. Copeland for RNA-FISH; K. Ritola for virus production; A. Zeladonis and S. Lindo for mouse breeding, genotyping, and histology; L. Jin for mouse weight measurements; and S. Eddy, B. Clark, M. Hausser, A. Roth, and C. Schmidt-Hieber for comments on the manuscript. This paper is dedicated to Professor Stuart L. Schreiber on the occasion of his 60th birthday.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Carter BC, 2012, NEURON, V75, P1081, DOI 10.1016/j.neuron.2012.08.033; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1998, J NEUROSCI, V18, P9607; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Farries MA, 2010, J NEUROSCI, V30, P13180, DOI 10.1523/JNEUROSCI.1909-10.2010; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Henry FE, 2015, ELIFE, V4, DOI 10.7554/eLife.09800; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; IANSEK R, 1973, J PHYSIOL-LONDON, V234, P665, DOI 10.1113/jphysiol.1973.sp010366; Jack J.J.B., 1975, ELECT CURRENT FLOW E; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Matveeva Olga V., 2012, Frontiers in Genetics, V3, P163, DOI 10.3389/fgene.2012.00163; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Prescott SA, 2005, J NEUROSCI, V25, P4743, DOI 10.1523/JNEUROSCI.0356-05.2005; Pressley J, 2009, BIOL CYBERN, V101, P63, DOI 10.1007/s00422-009-0317-6; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Tolson KP, 2010, J NEUROSCI, V30, P3803, DOI 10.1523/JNEUROSCI.5444-09.2010; Uebachs M, 2010, J NEUROSCI, V30, P8489, DOI 10.1523/JNEUROSCI.1534-10.2010; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Vega AV, 2008, NEUROSCI LETT, V442, P69, DOI 10.1016/j.neulet.2008.06.065; Wang DQ, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00040; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039	47	49	50	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1749	1761		10.1016/j.cell.2016.05.019	http://dx.doi.org/10.1016/j.cell.2016.05.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315482	Green Published, hybrid			2022-12-24	WOS:000378062000024
J	Detsky, AS; Gropper, MA				Detsky, Allan S.; Gropper, Michael A.			Why Physician Leaders of Health Care Organizations Should Participate in Direct Patient Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Room 429,600 Univ Ave, Toronto, ON M5G 1X5, Canada; Univ Hlth Network, Toronto, ON, Canada; [Gropper, Michael A.] Univ Calif San Francisco, 500 Parnassus Ave,MUE 410, San Francisco, CA 94143 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Francisco	Detsky, AS (corresponding author), Mt Sinai Hosp, Room 429,600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Annals of Internal Medicine, 2016, INF READ COMM; Cain DM, 2008, JAMA-J AM MED ASSOC, V299, P2893, DOI 10.1001/jama.299.24.2893; Detsky AS, 2011, J GEN INTERN MED, V26, P88, DOI 10.1007/s11606-010-1486-7; Schwendimann R, 2013, AM J MED QUAL, V28, P414, DOI 10.1177/1062860612473635; Teirstein PS, 2015, NEW ENGL J MED, V372, P106, DOI 10.1056/NEJMp1407422	5	5	5	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2016	165	7					519	+		10.7326/M16-0820	http://dx.doi.org/10.7326/M16-0820			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY0EY	27399305				2022-12-24	WOS:000384771300011
J	Im, SJ; Hashimoto, M; Gerner, MY; Lee, J; Kissick, HT; Urger, MCB; Shan, Q; Hale, JS; Lee, J; Nasti, TH; Sharpe, AH; Freeman, GJ; Germain, RN; Nakaya, HI; Xue, HH; Ahmed, R				Im, Se Jin; Hashimoto, Masao; Gerner, Michael Y.; Lee, Junghwa; Kissick, Haydn T.; Urger, Matheus C. B.; Shan, Qiang; Hale, J. Scott; Lee, Judong; Nasti, Tahseen H.; Sharpe, Arlene H.; Freeman, Gordon J.; Germain, Ronald N.; Nakaya, Helder I.; Xue, Hai-Hui; Ahmed, Rafi			Defining CD8(+) T cells that provide the proliferative burst after PD-1 therapy	NATURE			English	Article							CHRONIC VIRAL-INFECTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; TRANSCRIPTION FACTOR; LYMPHOID ORGANS; MEMORY; PERSISTENCE; EFFECTOR; FH; DIFFERENTIATION; EXHAUSTION	Chronic viral infections are characterized by a state of CD8(+) T-cell dysfunction that is associated with expression of the programmed cell death 1 (PD-1) inhibitory receptor(1-4). A better understanding of the mechanisms that regulate CD8(+) T-cell responses during chronic infection is required to improve immunotherapies that restore function in exhausted CD8(+) T cells. Here we identify a population of virus-specific CD8(+) T cells that proliferate after blockade of the PD-1 inhibitory pathway in mice chronically infected with lymphocytic choriomeningitis virus (LCMV). These LCMV-specific CD8(+) T cells expressed the PD-1 inhibitory receptor, but also expressed several costimulatory molecules such as ICOS and CD28. This CD8(+) T-cell subset was characterized by a unique gene signature that was related to that of CD4(+) T follicular helper (T-FH) cells, CD8(+) T cell memory precursors and haematopoietic stem cell progenitors, but that was distinct from that of CD4(+) T(H)1 cells and CD8(+) terminal effectors. This CD8(+) T-cell population was found only in lymphoid tissues and resided predominantly in the T-cell zones along with naive CD8(+) T cells. These PD-1(+) CD8(+) T cells resembled stem cells during chronic LCMV infection, undergoing self-renewal and also differentiating into the terminally exhausted CD8(+) T cells that were present in both lymphoid and non-lymphoid tissues. The proliferative burst after PD-1 blockade came almost exclusively from this CD8(+) T-cell subset. Notably, the transcription factor TCF1 had a cell-intrinsic and essential role in the generation of this CD8(+) T-cell subset. These findings provide a better understanding of T-cell exhaustion and have implications in the optimization of PD-1-directed immunotherapy in chronic infections and cancer.	[Im, Se Jin; Hashimoto, Masao; Lee, Junghwa; Kissick, Haydn T.; Hale, J. Scott; Lee, Judong; Nasti, Tahseen H.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Im, Se Jin; Hashimoto, Masao; Lee, Junghwa; Kissick, Haydn T.; Hale, J. Scott; Lee, Judong; Nasti, Tahseen H.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Gerner, Michael Y.; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gerner, Michael Y.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98109 USA; [Kissick, Haydn T.] Emory Univ, Dept Urol, Sch Med, Atlanta, GA 30322 USA; [Urger, Matheus C. B.; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, BR-05508 Sao Paulo, Brazil; [Shan, Qiang; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Sharpe, Arlene H.] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Sharpe, Arlene H.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Freeman, Gordon J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Dept Med, Boston, MA 02115 USA; [Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Interdisciplinary Immunol Grad Program, Iowa City, IA 52242 USA	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; Emory University; Universidade de Sao Paulo; University of Iowa; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Iowa	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Ahmed, R (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rahmed@emory.edu	Hashimoto, Masao/AAC-9225-2020; Nakaya, Helder/AAF-1738-2020; Freeman, Gordon/AAC-5380-2019; Germain, Ronald/ABE-7090-2020; Nakaya, Helder I/A-1397-2010; Germain, Ronald N./Z-1945-2019; Kissick, Haydn/AAS-6292-2021	Hashimoto, Masao/0000-0002-7120-1390; Nakaya, Helder/0000-0001-5297-9108; Freeman, Gordon/0000-0002-7210-5616; Nakaya, Helder I/0000-0001-5297-9108; Kissick, Haydn/0000-0001-7624-5598; Xue, Hai-Hui/0000-0002-9163-7669; Shan, Qiang/0000-0002-7089-0278; Gerner, Michael/0000-0001-5406-8308	National Institutes of Health [R01 AI30048, P01 AI056299, R01 AI112579, R01 AI121080]; Intramural Research Program of NIAID, NIH; Prostate Cancer Foundation; Swim Across America; CNPq; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001034, R01AI112579, P01AI056299, P01AI080192, R01AI121080, R01AI030048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Prostate Cancer Foundation; Swim Across America; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R01 AI30048 (R.A.), P01 AI056299 (R.A. and A.H.S.), R01 AI112579 (H.H.X.) and R01 AI121080 (H.-H.X.) and also by the Intramural Research Program of NIAID, NIH (R.N.G. and M.Y.G.). H.T.K. is supported by funding from the Prostate Cancer Foundation and Swim Across America. H.I.N. receives a CNPq research fellowship. The authors acknowledge technical support from R. Karaffa and S. Durham for cell sorting.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jung YW, 2010, J IMMUNOL, V185, P5315, DOI 10.4049/jimmunol.1001948; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Miyazaki M, 2015, GENE DEV, V29, P409, DOI 10.1101/gad.255331.114; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wu JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002565; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	37	895	919	12	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					417	+		10.1038/nature19330	http://dx.doi.org/10.1038/nature19330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27501248	Green Accepted			2022-12-24	WOS:000383098000057
J	Zaretsky, JM; Garcia-Diaz, A; Shin, DS; Escuin-Ordinas, H; Hugo, W; Hu-Lieskovan, S; Torrejon, DY; Abril-Rodriguez, G; Sandoval, S; Barthly, L; Saco, J; Moreno, BH; Mezzadra, R; Chmielowski, B; Ruchalski, K; Shintaku, IP; Sanchez, PJ; Puig-Saus, C; Cherry, G; Seja, NPE; Kong, XJ; Pang, J; Berent-Maoz, B; Comin-Anduix, B; Graeber, TG; Tumeh, PC; Schumacher, TNM; Lo, RS; Ribas, A				Zaretsky, Jesse M.; Garcia-Diaz, Angel; Shin, Daniel S.; Escuin-Ordinas, Helena; Hugo, Willy; Hu-Lieskovan, Siwen; Torrejon, Davis Y.; Abril-Rodriguez, Gabriel; Sandoval, Salemiz; Barthly, Lucas; Saco, Justin; Moreno, Blanca Homet; Mezzadra, Riccardo; Chmielowski, Bartosz; Ruchalski, Kathleen; Shintaku, I. Peter; Sanchez, Phillip J.; Puig-Saus, Cristina; Cherry, Grace; Seja, N. P. Elizabeth; Kong, Xiangju; Pang, Jia; Berent-Maoz, Beata; Comin-Anduix, Begona; Graeber, Thomas G.; Tumeh, Paul C.; Schumacher, Ton N. M.; Lo, Roger S.; Ribas, Antoni			Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM SURVIVAL; ADAPTIVE IMMUNE RESISTANCE; GAMMA SIGNAL-TRANSDUCTION; METASTATIC MELANOMA; CANCER-IMMUNOTHERAPY; GENE-EXPRESSION; IPILIMUMAB; CELLS; PEMBROLIZUMAB; RESPONSES	BACKGROUND Approximately 75% of objective responses to anti-programmed death 1 (PD-1) therapy in patients with melanoma are durable, lasting for years, but delayed relapses have been noted long after initial objective tumor regression despite continuous therapy. Mechanisms of immune escape in this context are unknown. METHODS We analyzed biopsy samples from paired baseline and relapsing lesions in four patients with metastatic melanoma who had had an initial objective tumor regression in response to anti-PD-1 therapy (pembrolizumab) followed by disease progression months to years later. RESULTS Whole-exome sequencing detected clonal selection and outgrowth of the acquired resistant tumors and, in two of the four patients, revealed resistance-associated loss-of-function mutations in the genes encoding interferon-receptor-associated Janus kinase 1 (JAK1) or Janus kinase 2 (JAK2), concurrent with deletion of the wild-type allele. A truncating mutation in the gene encoding the antigen-presenting protein beta-2-microglobulin (B2M) was identified in a third patient. JAK1 and JAK2 truncating mutations resulted in a lack of response to interferon gamma, including insensitivity to its antiproliferative effects on cancer cells. The B2M truncating mutation led to loss of surface expression of major histocompatibility complex class I. CONCLUSIONS In this study, acquired resistance to PD-1 blockade immunotherapy in patients with melanoma was associated with defects in the pathways involved in interferon-receptor signaling and in antigen presentation. (Funded by the National Institutes of Health and others.)	[Zaretsky, Jesse M.; Garcia-Diaz, Angel; Shin, Daniel S.; Escuin-Ordinas, Helena; Hugo, Willy; Hu-Lieskovan, Siwen; Torrejon, Davis Y.; Abril-Rodriguez, Gabriel; Sandoval, Salemiz; Barthly, Lucas; Saco, Justin; Moreno, Blanca Homet; Chmielowski, Bartosz; Ruchalski, Kathleen; Shintaku, I. Peter; Sanchez, Phillip J.; Puig-Saus, Cristina; Cherry, Grace; Seja, N. P. Elizabeth; Kong, Xiangju; Pang, Jia; Berent-Maoz, Beata; Comin-Anduix, Begona; Graeber, Thomas G.; Tumeh, Paul C.; Lo, Roger S.; Ribas, Antoni] Univ Calif Los Angeles, Los Angeles, CA USA; [Chmielowski, Bartosz; Comin-Anduix, Begona; Graeber, Thomas G.; Tumeh, Paul C.; Lo, Roger S.; Ribas, Antoni] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA; [Mezzadra, Riccardo; Schumacher, Ton N. M.] Netherlands Canc Inst, Div Immunol, Amsterdam, Netherlands	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; Netherlands Cancer Institute	Ribas, A (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Div Hematol Oncol, Dept Med, 11-934 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	aribas@mednet.ucla.edu	Torrejon, Davis/ABC-5589-2020; Garcia-Diaz, Angel/AAT-9213-2020; Schumacher, Ton/Y-2432-2019	Torrejon, Davis/0000-0002-4864-6236; Garcia-Diaz, Angel/0000-0001-6139-6764; Schumacher, Ton/0000-0003-0517-8804; Puig Saus, Cristina/0000-0002-3014-3649; Graeber, Thomas/0000-0001-8574-9181; Mezzadra, Riccardo/0000-0002-7737-8461; Hugo, Willy/0000-0002-1426-7190	National Institutes of Health; NATIONAL CANCER INSTITUTE [U54CA199090, T32CA009297, P30CA016042, R35CA197633, T32CA009120, P01CA168585, R01CA170689] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR001881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR058921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the National Institutes of Health and others.	Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Atefi M, 2014, CLIN CANCER RES, V20, P3446, DOI 10.1158/1078-0432.CCR-13-2797; Atkins MB, 2000, CANCER J SCI AM, V6, pS11; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Corrales L, 2016, CYTOKINE, V77, P245, DOI 10.1016/j.cyto.2015.08.258; Dunn GP, 2005, CANCER RES, V65, P3447, DOI 10.1158/0008-5472.CAN-04-4316; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Eroglu Z, 2015, EUR J CANCER, V51, P2689, DOI 10.1016/j.ejca.2015.08.012; FINKE JH, 1993, CANCER RES, V53, P5613; Fish EN, 2014, MOL CANCER RES, V12, P1691, DOI 10.1158/1541-7786.MCR-14-0450; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Prieto PA, 2012, CLIN CANCER RES, V18, P2039, DOI 10.1158/1078-0432.CCR-11-1823; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Sucker A, 2014, CLIN CANCER RES, V20, P6593, DOI 10.1158/1078-0432.CCR-14-0567; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	37	1808	1878	7	172	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					819	829		10.1056/NEJMoa1604958	http://dx.doi.org/10.1056/NEJMoa1604958			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9HA	27433843	Green Accepted, Green Published			2022-12-24	WOS:000382526000005
J	Zhu, JP; Vinothkumar, KR; Hirst, J				Zhu, Jiapeng; Vinothkumar, Kutti R.; Hirst, Judy			Structure of mammalian respiratory complex I	NATURE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ACYL CARRIER PROTEIN; CRYSTAL-STRUCTURE; BINDING-SITE; SUBUNIT; FEATURES; DOMAIN; ND1; KDA	Complex I (NADH: ubiquinone oxidoreductase), one of the largest membrane-bound enzymes in the cell, powers ATP synthesis in mammalian mitochondria by using the reducing potential of NADH to drive protons across the inner mitochondrial membrane. Mammalian complex I (ref. 1) contains 45 subunits, comprising 14 core subunits that house the catalytic machinery (and are conserved from bacteria to humans) and a mammalian-specific cohort of 31 supernumerary subunits(1,2). Knowledge of the structures and functions of the supernumerary subunits is fragmentary. Here we describe a 4.2-angstrom resolution single-particle electron cryomicroscopy structure of complex I from Bos taurus. We have located and modelled all 45 subunits, including the 31 supernumerary subunits, to provide the entire structure of the mammalian complex. Computational sorting of the particles identified different structural classes, related by subtle domain movements, which reveal conformationally dynamic regions and match biochemical descriptions of the 'active-to-de-active' enzyme transition that occurs during hypoxia(3,4). Our structures therefore provide a foundation for understanding complex I assembly(5) and the effects of mutations that cause clinically relevant complex I dysfunctions(6), give insights into the structural and functional roles of the supernumerary subunits and reveal new information on the mechanism and regulation of catalysis.	[Zhu, Jiapeng; Hirst, Judy] MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England; [Vinothkumar, Kutti R.] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Zhu, Jiapeng] Nanjing Univ Chinese Med, Nanjing 210023, Jiangsu, Peoples R China	MRC Laboratory Molecular Biology; Nanjing University of Chinese Medicine	Hirst, J (corresponding author), MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.; Vinothkumar, KR (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	vkumar@mrc-lmb.cam.ac.uk; jh@mrc-mbu.cam.ac.uk	Hirst, Judy/F-4803-2011	Hirst, Judy/0000-0001-8667-6797	Medical Research Council [U105184322, U105663141]; MRC [MC_U105663141] Funding Source: UKRI; Medical Research Council [MC_U105663141] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Henderson and G. Murshudov for discussions, J. Grimmett and T. Darling for computational help, S. Chen and C. Savva for electron microscopy help, and J. N. Blaza for quantifying the ratio of de-active and active enzymes in our preparation. This work was supported by The Medical Research Council, grant numbers U105184322 (K.R.V., in R. Henderson's group) and U105663141 (J.H.).	Abdrakhmanova A, 2006, BBA-BIOENERGETICS, V1757, P1676, DOI 10.1016/j.bbabio.2006.09.003; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Babot M, 2014, BBA-BIOENERGETICS, V1837, P929, DOI 10.1016/j.bbabio.2014.02.013; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Brockmann C, 2004, STRUCTURE, V12, P1645, DOI 10.1016/j.str.2004.06.021; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Carroll J, 2013, J BIOL CHEM, V288, P24799, DOI 10.1074/jbc.M113.488106; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cooley RB, 2010, J MOL BIOL, V404, P232, DOI 10.1016/j.jmb.2010.09.034; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Galkin A, 2009, J BIOL CHEM, V284, P36055, DOI 10.1074/jbc.M109.054346; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2016, BBA-BIOENERGETICS, V1857, P872, DOI 10.1016/j.bbabio.2015.12.009; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kmita K, 2015, P NATL ACAD SCI USA, V112, P5685, DOI 10.1073/pnas.1424353112; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Murai M, 2016, BBA-BIOENERGETICS, V1857, P884, DOI 10.1016/j.bbabio.2015.11.009; Murai M, 2011, BIOCHEMISTRY-US, V50, P6901, DOI 10.1021/bi200883c; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; Sanchez-Caballero L, 2016, BBA-BIOENERGETICS, V1857, P980, DOI 10.1016/j.bbabio.2016.03.031; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sharma V, 2015, P NATL ACAD SCI USA, V112, P11571, DOI 10.1073/pnas.1503761112; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Szklarczyk R, 2011, FEBS LETT, V585, P737, DOI 10.1016/j.febslet.2011.01.046; Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Zhu JP, 2015, P NATL ACAD SCI USA, V112, P12087, DOI 10.1073/pnas.1510577112; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	44	341	350	5	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					354	+		10.1038/nature19095	http://dx.doi.org/10.1038/nature19095			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27509854	Green Submitted, Green Accepted			2022-12-24	WOS:000381804900040
J	Kazi, DS; Moran, AE; Coxson, PG; Penko, J; Ollendorf, DA; Pearson, SD; Tice, JA; Guzman, D; Bibbins-Domingo, K				Kazi, Dhruv S.; Moran, Andrew E.; Coxson, Pamela G.; Penko, Joanne; Ollendorf, Daniel A.; Pearson, Steven D.; Tice, Jeffrey A.; Guzman, David; Bibbins-Domingo, Kirsten			Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUBTILISIN/KEXIN TYPE 9; ISCHEMIC-HEART-DISEASE; STATIN THERAPY; GLOBAL BURDEN; RISK PATIENTS; REDUCING LIPIDS; EFFICACY; SAFETY; ALIROCUMAB; EZETIMIBE	IMPORTANCE Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors were recently approved for lowering low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia (FH) or atherosclerotic cardiovascular disease (ASCVD) and have potential for broad ASCVD prevention. Their long-term cost-effectiveness and effect on total health care spending are uncertain. OBJECTIVE To estimate the cost-effectiveness of PCSK9 inhibitors and their potential effect on US health care spending. DESIGN, SETTING, AND PARTICIPANTS The Cardiovascular Disease Policy Model, a simulation model of US adults aged 35 to 94 years, was used to evaluate cost-effectiveness of PCSK9 inhibitors or ezetimibe in heterozygous FH or ASCVD. The model incorporated 2015 annual PCSK9 inhibitor costs of $14 350 (based on mean wholesale acquisition costs of evolocumab and alirocumab); adopted a health-system perspective, lifetime horizon; and included probabilistic sensitivity analyses to explore uncertainty. EXPOSURES Statin therapy compared with addition of ezetimibe or PCSK9 inhibitors. MAIN OUTCOMES AND MEASURES Lifetime major adverse cardiovascular events (MACE: cardiovascular death, nonfatalmyocardial infarction, or stroke), incremental cost per quality-adjusted life-year (QALY), and total effect on US health care spending over 5 years. RESULTS Adding PCSK9 inhibitors to statins in heterozygous FH was estimated to prevent 316 300 MACE at a cost of $503 000 per QALY gained compared with adding ezetimibe to statins (80% uncertainty interval [UI], $493 000-$1 737 000). In ASCVD, adding PCSK9 inhibitors to statins was estimated to prevent 4.3 million MACE compared with adding ezetimibe at $414 000 per QALY (80% UI, $277 000-$1 539 000). Reducing annual drug costs to $4536 per patient or less would be needed for PCSK9 inhibitors to be cost-effective at less than $100 000 per QALY. At 2015 prices, PCSK9 inhibitor use in all eligible patients was estimated to reduce cardiovascular care costs by $29 billion over 5 years, but drug costs increased by an estimated $592 billion (a 38% increase over 2015 prescription drug expenditures). In contrast, initiating statins in these high-risk populations in all statin-tolerant individuals who are not currently using statins was estimated to save $12 billion. CONCLUSIONS AND RELEVANCE Assuming 2015 prices, PCSK9 inhibitor use in patients with heterozygous FH or ASCVD did not meet generally acceptable incremental cost-effectiveness thresholds and was estimated to increase US health care costs substantially. Reducing annual drug prices from more than $14 000 to $4536 would be necessary to meet a $100 000 per QALY threshold.	[Kazi, Dhruv S.; Coxson, Pamela G.; Penko, Joanne; Guzman, David; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, Ctr Vulnerable Populat, San Francisco, CA 94143 USA; [Kazi, Dhruv S.; Coxson, Pamela G.; Penko, Joanne; Tice, Jeffrey A.; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Kazi, Dhruv S.; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kazi, Dhruv S.] Univ Calif San Francisco, Ctr Healthcare Value, San Francisco, CA 94143 USA; [Kazi, Dhruv S.] Zuckerberg San Francisco Gen Hosp, Div Cardiol, San Francisco, CA USA; [Moran, Andrew E.] Columbia Univ, Med Ctr, Div Gen Internal Med, New York, NY USA; [Moran, Andrew E.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Coxson, Pamela G.; Bibbins-Domingo, Kirsten] Zuckerberg San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA USA; [Ollendorf, Daniel A.; Pearson, Steven D.] Inst Clin & Econ Review, Boston, MA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Columbia University	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div Gen Internal Med, POB 1364, San Francisco, CA 94143 USA.	kirsten.bibbins-domingo@ucsf.edu		Tice, Jeffrey/0000-0002-9857-2028	New England States Consortium Systems Organization; Laura and John Arnold Foundation	New England States Consortium Systems Organization; Laura and John Arnold Foundation	Portions of this work were presented to the New England Comparative Effectiveness Public Advisory Council, a program of the Institute for Clinical and Economic Review that is supported by grants from the New England States Consortium Systems Organization and the Laura and John Arnold Foundation.	Agency for Healthcare Research and Quality, MED EXP PAN SURV PUB; Akinboro O, 2014, ANN INTERN MED, V161, P531, DOI [10.7326/L14-5019-2, 10.7326/L14-5019]; Anderson JL, 2014, J AM COLL CARDIOL, V63, P2304, DOI 10.1016/j.jacc.2014.03.016; [Anonymous], 2003, HOSP FIN DAT 1999 20; [Anonymous], 2008, CAL PUBL PAT DISCH D; Ara R, 2008, HEALTH TECHNOL ASSES, V12, P1; Bays H, 2015, J CLIN ENDOCR METAB, V100, P3140, DOI 10.1210/jc.2015-1520; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Blackstone EA, 2013, AM HEALTH DRUG BENEF, V6, P469; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cannon CP, 2015, EUR HEART J, V36, P1186, DOI 10.1093/eurheartj/ehv028; Everett BM, 2015, NEW ENGL J MED, V373, P1588, DOI 10.1056/NEJMp1508120; Farnier M, 2016, ATHEROSCLEROSIS, V244, P138, DOI 10.1016/j.atherosclerosis.2015.11.010; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Gidding SS, 2015, CIRCULATION, V132, P2167, DOI 10.1161/CIR.0000000000000297; Giugliano RP, 2015, J AM COLL CARDIOL, V65, P2638, DOI 10.1016/j.jacc.2015.05.001; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Gold MR, 1996, COST EFFECTIVENESS H; Grundy SM, 2013, ANN INTERN MED, V158, P562, DOI 10.7326/0003-4819-158-7-201304020-00010; Hunt SC, 2000, ARTERIOSCL THROM VAS, V20, P1089, DOI 10.1161/01.ATV.20.4.1089; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kastelein JJP, 2015, EUR HEART J, V36, P2996, DOI 10.1093/eurheartj/ehv370; Kazi DS, 2014, ANN INTERN MED, V160, P221, DOI 10.7326/M13-1999; Kereiakes DJ, 2015, AM HEART J, V169, P906, DOI 10.1016/j.ahj.2015.03.004; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Khazeni N, 2009, ANN INTERN MED, V151, P840, DOI [10.7326/0000605-200912150-00156, 10.7326/0003-4819-151-12-200912150-00156]; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Mikhailidis DP, 2007, CURR MED RES OPIN, V23, P2009, DOI 10.1185/030079907X210507; Moran AE, 2015, NEW ENGL J MED, V372, P447, DOI 10.1056/NEJMsa1406751; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Moriarty PM, 2015, J CLIN LIPIDOL, V9, P758, DOI 10.1016/j.jacl.2015.08.006; Mulcahy AW, COST SAVINGS POTENTI; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Newman CB, 2015, JAMA-J AM MED ASSOC, V313, P1011, DOI 10.1001/jama.2015.1335; Office of the Assistant Secretary for Planning and Evaluation Department of Health and Human Services, OBS TRENDS PRESCR DR; Raal FJ, 2015, LANCET, V385, P341, DOI 10.1016/S0140-6736(14)61374-X; Reinhardt U., PROBING OUR MORAL VA; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Singh S, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-014-0482-5; Tice JA, 2015, PCSK9 INHIBITORS TRE; Truven Health Analytics, RED BOOK ONL; UK National Health Service Medicines Information, NEW DRUGS ONL REP EV; United States National Center for Health Statistics, 2005, NAT HLTH NUTR EX SUR; US Census Bureau, 1998, STAT ABSTR US AV COS, P136; USNational Library of Medicine, LAB PRAL AL INJ SOL; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	51	247	252	4	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					743	753		10.1001/jama.2016.11004	http://dx.doi.org/10.1001/jama.2016.11004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533159	Bronze			2022-12-24	WOS:000381514800020
J	Wise, J				Wise, Jacqui			UK drug appraisal process is restricting access to cancer drugs, say charities	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Breast Cancer Now; Prostate Cancer UK, 2016, INT COMP HLTH TECHN; Hawkes N, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4216	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2016	354								i4465	10.1136/bmj.i4465	http://dx.doi.org/10.1136/bmj.i4465			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GR	27528458				2022-12-24	WOS:000381805400014
J	van der Veeken, J; Gonzalez, AJ; Cho, H; Arvey, A; Hemmers, S; Leslie, CS; Rudensky, AY				van der Veeken, Joris; Gonzalez, Alvaro J.; Cho, Hyunwoo; Arvey, Aaron; Hemmers, Saskia; Leslie, Christina S.; Rudensky, Alexander Y.			Memory of Inflammation in Regulatory T Cells	CELL			English	Article							SELF; COMMITMENT; CHROMATIN; EFFECTOR	Eukaryotic cells can "remember'' transient encounters with a wide range of stimuli, inducing lasting states of altered responsiveness. Regulatory T (Treg) cells are a specialized lineage of suppressive CD4 T cells that act as critical negative regulators of inflammation in various biological contexts. Treg cells exposed to inflammatory conditions acquire strongly enhanced suppressive function. Using inducible genetic tracing, we analyzed the long-term stability of activation-induced transcriptional, epigenomic, and functional changes in Treg cells. We found that the inflammation-experienced Treg cell population reversed many activation-induced changes and lost its enhanced suppressive function over time. The "memory-less'' potentiation of Treg suppressor function may help avoid a state of generalized immunosuppression that could otherwise result from repeated activation.	[van der Veeken, Joris; Arvey, Aaron; Hemmers, Saskia; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [van der Veeken, Joris; Arvey, Aaron; Hemmers, Saskia; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Gonzalez, Alvaro J.; Cho, Hyunwoo; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.; Leslie, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA.	cleslie@cbio.mskcc.org; rudenska@mskcc.org		van der Veeken, Joris/0000-0001-7299-2174; Arvey, Aaron/0000-0002-8789-0290	NIH [R37 AI034206, P30 CA008748, U01 HG007893]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Memorial Sloan Kettering Cancer Center (MSKCC) integrated genomics operation for sequencing RNA-, ChIP-, and ATAC-seq libraries and preprocessing data. CD4<SUP>CreERT2</SUP> mice were generated by S.H. in the laboratory of Thorsten Buch. We thank C. Campbell, S. Dikiy, A. Levine, S. Lee, K. Wu, and W. Hu for help with tissue lymphocyte isolations and all members of the A.Y.R. lab for helpful discussions and technical assistance. This study was supported by NIH grants R37 AI034206, P30 CA008748, and U01 HG007893. A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Legoux FP, 2015, IMMUNITY, V43, P896, DOI 10.1016/j.immuni.2015.10.011; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Liu J, 2014, EUR J IMMUNOL, V44, P1058, DOI 10.1002/eji.201343766; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Monticelli S, 2013, NAT IMMUNOL, V14, P777, DOI 10.1038/ni.2636; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Shafiani S, 2013, IMMUNITY, V38, P1261, DOI 10.1016/j.immuni.2013.06.003; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014	35	91	91	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					977	990		10.1016/j.cell.2016.07.006	http://dx.doi.org/10.1016/j.cell.2016.07.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27499023	Bronze, Green Accepted			2022-12-24	WOS:000382258700019
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Game on for Pokemon Go	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Griffin A., 2016, INDEPENDENT; Grohol J. M., 2016, POKEMON GO REPORTEDL; Khomami N., 2016, GUARDIAN; Morris S, 2016, GUARDIAN; Schilling D., 2016, GUARDIAN	5	47	47	0	53	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2016	354								i4306	10.1136/bmj.i4306	http://dx.doi.org/10.1136/bmj.i4306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TU	27510374	Green Published, Bronze			2022-12-24	WOS:000381474800005
J	Nelson, DA; Deuster, PA; Carter, R; Hill, OT; Wolcott, VL; Kurina, LM				Nelson, D. Alan; Deuster, Patricia A.; Carter, Robert, III; Hill, Owen T.; Wolcott, Vickee L.; Kurina, Lianne M.			Sickle Cell Trait, Rhabdomyolysis, and Mortality among US Army Soldiers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE-RENAL-FAILURE; SUDDEN-DEATH; FATAL RHABDOMYOLYSIS; RISK-FACTOR; EXERTION; RECRUITS; FORCES	BACKGROUND Studies have suggested that sickle cell trait elevates the risks of exertional rhabdomyolysis and death. We conducted a study of sickle cell trait in relation to these outcomes, controlling for known risk factors for exertional rhabdomyolysis, in a large population of active persons who had undergone laboratory tests for hemoglobin AS (HbAS) and who were subject to exertional-injury precautions. METHODS We used Cox proportional-hazards models to test whether the risks of exertional rhabdomyolysis and death varied according to sickle cell trait status among 47,944 black soldiers who had undergone testing for HbAS and who were on active duty in the U.S. Army between January 2011 and December 2014. We used the Stanford Military Data Repository, which contains comprehensive medical and administrative data on all active-duty soldiers. RESULTS There was no significant difference in the risk of death among soldiers with sickle cell trait, as compared with those without the trait (hazard ratio, 0.99; 95% confidence interval [CI], 0.46 to 2.13; P = 0.97), but the trait was associated with a significantly higher adjusted risk of exertional rhabdomyolysis (hazard ratio, 1.54; 95% CI, 1.12 to 2.12; P = 0.008). This effect was similar in magnitude to that associated with tobacco use, as compared with no use (hazard ratio, 1.54; 95% CI, 1.23 to 1.94; P<0.001), and to that associated with having a body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) of 30.0 or more, as compared with a BMI of less than 25.0 (hazard ratio, 1.39; 95% CI, 1.04 to 1.86; P = 0.03). The effect was less than that associated with recent use of a statin, as compared with no use (hazard ratio, 2.89; 95% CI, 1.51 to 5.55; P = 0.001), or an antipsychotic agent (hazard ratio, 3.02; 95% CI, 1.34 to 6.82; P = 0.008). CONCLUSIONS Sickle cell trait was not associated with a higher risk of death than absence of the trait, but it was associated with a significantly higher risk of exertional rhabdomyolysis.	[Nelson, D. Alan; Kurina, Lianne M.] Stanford Univ, Sch Med, Dept Med, 450 Serra Mall,Bldg 20, Stanford, CA 94305 USA; [Deuster, Patricia A.] Uniformed Serv Univ Hlth Sci, Consortium Hlth & Mil Performance, Dept Def Ctr Excellence, Bethesda, MD 20814 USA; [Deuster, Patricia A.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA; [Carter, Robert, III] US Army Inst Surg Res, Ft Sam Houston, TX USA; [Hill, Owen T.] Brooke Army Med Ctr, Extrem Trauma & Amputat Ctr Excellence, Ctr Intrepid, Ft Sam Houston, TX 78234 USA; [Wolcott, Vickee L.] Army Baylor Univ, Grad Program Hlth & Business Adm, Ft Sam Houston, TX USA; [Carter, Robert, III] Univ Texas Hlth Sci Ctr San Antonio, Dept Emergency Med, San Antonio, TX 78229 USA	Stanford University; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; San Antonio Military Medical Center; United States Department of Defense; United States Army; Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio	Kurina, LM (corresponding author), Stanford Univ, Sch Med, Dept Med, 450 Serra Mall,Bldg 20, Stanford, CA 94305 USA.	lkurina@stanford.edu	Deuster, Patricia A/G-3838-2015	Deuster, Patricia A/0000-0002-7895-0888; Kurina, Lianne/0000-0002-2610-126X	National Heart, Lung, and Blood Institute; Uniformed Services University of the Health Sciences	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Uniformed Services University of the Health Sciences	Funded by the National Heart, Lung, and Blood Institute and the Uniformed Services University of the Health Sciences.	Abkowitz JL, 2014, CURR SPORT MED REP, V13, P192, DOI 10.1249/JSR.0000000000000054; [Anonymous], 2016, HEAT ILLN PREV; [Anonymous], 2015, MSMR, V22, P22; Anzalone ML, 2010, MED SCI SPORT EXER, V42, P3, DOI 10.1249/MSS.0b013e3181ae0700; Centers for Disease Control and Prevention (CDC), 2015, AB AD BMI; DAVIS AM, 1988, NEW ENGL J MED, V318, P787; Department of the Army, 2012, FIELD MAN 7 22 ARM P; DIGGS LW, 1984, AVIAT SPACE ENVIR MD, V55, P487; Dincer H Erhan, 2005, WMJ, V104, P67; Eckart RE, 2004, ANN INTERN MED, V141, P829, DOI 10.7326/0003-4819-141-11-200412070-00005; Eichner E Randy, 2007, Curr Sports Med Rep, V6, P134, DOI 10.1007/s11932-007-0016-9; Eichner ER, 2010, CURR SPORT MED REP, V9, P347, DOI 10.1249/JSR.0b013e3181fc73d7; Eichner ER, 2010, CURR SPORT MED REP, V9, P3, DOI 10.1249/JSR.0b013e3181caa9fa; Ferster K, 2012, MIL MED, V177, P56, DOI 10.7205/MILMED-D-11-00106; GARDNER JW, 1994, MIL MED, V159, P160, DOI 10.1093/milmed/159.2.160; GEORGE C, 1979, INTENS CARE MED, V5, P204, DOI 10.1007/BF01683941; Goldsmith JC, 2012, AM J HEMATOL, V87, P340, DOI 10.1002/ajh.22271; Grant AM, 2011, AM J PREV MED, V41, pS435, DOI 10.1016/j.amepre.2011.09.012; Harmon KG, 2012, BRIT J SPORT MED, V46, P325, DOI 10.1136/bjsports-2011-090896; Hill OT, 2012, MED SCI SPORT EXER, V44, P442, DOI 10.1249/MSS.0b013e3182312745; Incidence of sickle cell trait - United States, 2010, MMWR MORB MORTAL WKL, V63, P1155; Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009; KARK JA, 1994, SEMIN HEMATOL, V31, P181; KARK JA, 1987, NEW ENGL J MED, V317, P781, DOI 10.1056/NEJM198709243171301; Kark JA, 2010, 53 AM SOC HEM ANN M; Kerle KK, 1996, MIL MED, V161, P766, DOI 10.1093/milmed/161.12.766; KOPPES GM, 1977, AM J MED, V63, P313, DOI 10.1016/0002-9343(77)90247-9; Makaryus JN, 2007, HEMATOLOGY, V12, P349, DOI 10.1080/10245330701255254; Murray MJ, 1996, MIL MED, V161, P303, DOI 10.1093/milmed/161.5.303; O'Connor FG, 2012, MED SCI SPORT EXER, V44, P2045, DOI 10.1249/MSS.0b013e31826851c2; Packard Kathleen, 2014, J Pharm Pract, V27, P501, DOI 10.1177/0897190013516509; Pretzlaff Robert K., 2002, Pediatr Crit Care Med, V3, P308, DOI 10.1097/00130478-200207000-00023; Scheinin L, 2009, AM J FOREN MED PATH, V30, P204, DOI 10.1097/PAF.0b013e318187dfcd; Scoville SL, 2004, AM J PREV MED, V26, P205, DOI 10.1016/j.amepre.2003.12.003; Thogmartin JR, 2011, J FORENSIC SCI, V56, P1352, DOI 10.1111/j.1556-4029.2011.01774.x; Thompson AA, 2013, HEMATOL-AM SOC HEMAT, P632, DOI 10.1182/asheducation-2013.1.632; Wirthwein DP, 2001, J FORENSIC SCI, V46, P399	37	68	68	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					435	442		10.1056/NEJMoa1516257	http://dx.doi.org/10.1056/NEJMoa1516257			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7AN	27518662	Green Accepted, Bronze			2022-12-24	WOS:000380934900007
J	Kallewaard, NL; Corti, D; Collins, PJ; Neu, U; McAuliffe, JM; Benjamin, E; Wachter-Rosati, L; Palmer-Hill, FJ; Yuan, AQ; Walker, PA; Vorlaender, MK; Bianchi, S; Guarino, B; De Marco, A; Vanzetta, F; Agatic, G; Foglierini, M; Pinna, D; Fernandez-Rodriguez, B; Fruehwirth, A; Silacci, C; Ogrodowicz, RW; Martin, SR; Sallusto, F; Suzich, JA; Lanzavecchia, A; Zhu, Q; Gamblin, SJ; Skehel, JJ				Kallewaard, Nicole L.; Corti, Davide; Collins, Patrick J.; Neu, Ursula; McAuliffe, Josephine M.; Benjamin, Ebony; Wachter-Rosati, Leslie; Palmer-Hill, Frances J.; Yuan, Andy Q.; Walker, Philip A.; Vorlaender, Matthias K.; Bianchi, Siro; Guarino, Barbara; De Marco, Anna; Vanzetta, Fabrizia; Agatic, Gloria; Foglierini, Mathilde; Pinna, Debora; Fernandez-Rodriguez, Blanca; Fruehwirth, Alexander; Silacci, Chiara; Ogrodowicz, Roksana W.; Martin, Stephen R.; Sallusto, Federica; Suzich, JoAnn A.; Lanzavecchia, Antonio; Zhu, Qing; Gamblin, Steven J.; Skehel, John J.			Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes	CELL			English	Article							HUMAN MONOCLONAL-ANTIBODY; MEMORY B-CELLS; IN-VIVO; BINDING SITE; VIRUS; HEMAGGLUTININ; NEUTRALIZATION; EPITOPE; PROTECTION	Influenza virus remains a threat because of its ability to evade vaccine-induced immune responses due to antigenic drift. Here, we describe the isolation, evolution, and structure of a broad-spectrum human monoclonal antibody (mAb), MEDI8852, effectively reacting with all influenza A hemagglutinin (HA) subtypes. MEDI8852 uses the heavy-chain VH6-1 gene and has higher potency and breadth when compared to other anti-stem antibodies. MEDI8852 is effective in mice and ferrets with a therapeutic window superior to that of oseltamivir. Crystallographic analysis of Fab alone or in complex with H5 or H7 HA proteins reveals that MEDI8852 binds through a coordinated movement of CDRs to a highly conserved epitope encompassing a hydrophobic groove in the fusion domain and a large portion of the fusion peptide, distinguishing it from other structurally characterized cross-reactive antibodies. The unprecedented breadth and potency of neutralization by MEDI8852 support its development as immunotherapy for influenza virus-infected humans.	[Kallewaard, Nicole L.; McAuliffe, Josephine M.; Benjamin, Ebony; Wachter-Rosati, Leslie; Palmer-Hill, Frances J.; Suzich, JoAnn A.; Zhu, Qing] MedImmune LLC, Dept Infect Dis & Vaccines, One MedImmune Way, Gaithersburg, MD 20878 USA; [Corti, Davide; Bianchi, Siro; Guarino, Barbara; De Marco, Anna; Vanzetta, Fabrizia; Agatic, Gloria] Humabs BioMed SA, Via Mirasole 1, CH-6500 Bellinzona, Switzerland; [Collins, Patrick J.; Neu, Ursula; Vorlaender, Matthias K.; Gamblin, Steven J.; Skehel, John J.] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England; [Yuan, Andy Q.] MedImmune LLC, Dept Antibody Discovery & Prot Engn, One MedImmune Way, Gaithersburg, MD 20878 USA; [Walker, Philip A.; Ogrodowicz, Roksana W.; Martin, Stephen R.] Francis Crick Inst, Mill Hill Lab, Struct Biol Sci Technol Platform, London NW7 1AA, England; [Foglierini, Mathilde; Pinna, Debora; Fernandez-Rodriguez, Blanca; Fruehwirth, Alexander; Silacci, Chiara; Sallusto, Federica; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Lanzavecchia, Antonio] Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland	AstraZeneca; Medimmune; Francis Crick Institute; AstraZeneca; Medimmune; Francis Crick Institute; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zhu, Q (corresponding author), MedImmune LLC, Dept Infect Dis & Vaccines, One MedImmune Way, Gaithersburg, MD 20878 USA.; Skehel, JJ (corresponding author), Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England.	zhuq@medimmune.com; john.skehel@crick.ac.uk		Zatta, Fabrizia/0000-0003-4945-8058; Ogrodowicz, Roksana/0000-0002-3176-7744; Neu, Ursula/0000-0001-6852-0879; Vorlander, Matthias Kopano/0000-0001-5975-5609; Foglierini, Mathilde/0000-0001-7538-4262; Guarino, Barbara/0000-0003-3759-3252; Bianchi, Siro/0000-0002-5100-8905; Gamblin, Steve/0000-0001-5331-639X	European Research Council [670955 BROADimmune]; Swiss National Science Foundation [160279]; Helmut Horten Foundation; Francis Crick Institute, London; Marie Curie Actions Intra-European Fellowship [629829]; Medical Research Council [G0600522, MC_U117584222] Funding Source: researchfish; The Francis Crick Institute [10015, 10078, 10080] Funding Source: researchfish; MRC [MC_U117584222, G0600522] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Helmut Horten Foundation; Francis Crick Institute, London; Marie Curie Actions Intra-European Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Jose Martinez and the MedImmune Laboratory Animal Resource staff for in vivo study assistance; Robert Woods for additional affinity characterization; and Sandrina Phipps, Arnita Barnes, and Kannaki Senthil for generating HA reagents. This work was supported by the European Research Council (grant 670955 BROADimmune) and the Swiss National Science Foundation (grant 160279). A.L. is supported by the Helmut Horten Foundation. We thank the staff at the Diamond Light Source Synchrotron for assistance and beam-line access under Diamond Light Source Proposal 9826. This work was funded by the Francis Crick Institute, London. U.N. was also funded by a Marie Curie Actions Intra-European Fellowship (grant 629829).	Benjamin E, 2014, J VIROL, V88, P6743, DOI 10.1128/JVI.03562-13; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Dunand CJH, 2015, J CLIN INVEST, V125, P1255, DOI 10.1172/JCI74374; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Koday MT, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005409; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan GS, 2014, J VIROL, V88, P13580, DOI 10.1128/JVI.02289-14; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wright P., 2007, ORTHOMYXOVIRUSES; Wu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8708; Xiong XL, 2015, P NATL ACAD SCI USA, V112, P9430, DOI 10.1073/pnas.1510816112; Yewdell JW, 2013, CURR OPIN VIROL, V3, P316, DOI 10.1016/j.coviro.2013.05.008	30	226	237	0	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					596	608		10.1016/j.cell.2016.05.073	http://dx.doi.org/10.1016/j.cell.2016.05.073			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27453466	Green Published, hybrid			2022-12-24	WOS:000380546500012
J	Dejean, C; Courtin, J; Karalis, N; Chaudun, F; Wurtz, H; Bienvenu, TCM; Herry, C				Dejean, Cyril; Courtin, Julien; Karalis, Nikolaos; Chaudun, Fabrice; Wurtz, Helene; Bienvenu, Thomas C. M.; Herry, Cyril			Prefrontal neuronal assemblies temporally control fear behaviour	NATURE			English	Article							CELL ASSEMBLIES; CORTEX; HIPPOCAMPUS; EXPRESSION; AMYGDALA; OSCILLATIONS; INTERNEURON; CIRCUITS; PATTERNS; RAT	Precise spike timing through the coordination and synchronization of neuronal assemblies is an efficient and flexible coding mechanism for sensory and cognitive processing(1-6). In cortical and subcortical areas, the formation of cell assemblies critically depends on neuronal oscillations, which can precisely control the timing of spiking activity(7,8). Whereas this form of coding has been described for sensory processing and spatial learning(9-12), its role in encoding emotional behaviour remains unknown. Fear behaviour relies on the activation of distributed structures, among which the dorsal medial prefrontal cortex (dmPFC) is known to be critical for fear memory expression(13-16). In the dmPFC, the phasic activation of neurons to threat-predicting cues, a spike-rate coding mechanism, correlates with conditioned fear responses and supports the discrimination between aversive and neutral stimuli(14,17-19). However, this mechanism does not account for freezing observed outside stimuli presentations, and the contribution of a general spike-time coding mechanism for freezing in the dmPFC remains to be established. Here we use a combination of single-unit and local field potential recordings along with optogenetic manipulations to show that, in the dmPFC, expression of conditioned fear is causally related to the organization of neurons into functional assemblies. During fear behaviour, the development of 4 Hz oscillations coincides with the activation of assemblies nested in the ascending phase of the oscillation. The selective optogenetic inhibition of dmPFC neurons during the ascending or descending phases of this oscillation blocks and promotes conditioned fear responses, respectively. These results identify a novel phase-specific coding mechanism, which dynamically regulates the development of dmPFC assemblies to control the precise timing of fear responses.	[Dejean, Cyril; Courtin, Julien; Karalis, Nikolaos; Chaudun, Fabrice; Wurtz, Helene; Bienvenu, Thomas C. M.; Herry, Cyril] Neuroctr Magendie, INSERM, U862, 146 Rue Leo Saignat, F-33077 Bordeaux, France; [Dejean, Cyril; Courtin, Julien; Karalis, Nikolaos; Chaudun, Fabrice; Wurtz, Helene; Bienvenu, Thomas C. M.; Herry, Cyril] Univ Bordeaux, Neuroctr Magendie, U862, 146 Rue Leo Saignat, F-33077 Bordeaux, France; [Courtin, Julien] Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland; [Karalis, Nikolaos] Univ Munich, Fac Med, D-82152 Planegg Martinsried, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Friedrich Miescher Institute for Biomedical Research; University of Munich	Dejean, C; Herry, C (corresponding author), Neuroctr Magendie, INSERM, U862, 146 Rue Leo Saignat, F-33077 Bordeaux, France.; Dejean, C; Herry, C (corresponding author), Univ Bordeaux, Neuroctr Magendie, U862, 146 Rue Leo Saignat, F-33077 Bordeaux, France.	cyril.dejean@scilight.eu; cyril.herry@inserm.fr	courtin, julien/AAH-2380-2022; Karalis, Nikolaos/U-4987-2017; Herry, Cyril/AAP-9902-2020; courtin, julien/AEN-1402-2022	courtin, julien/0000-0002-6454-3245; Karalis, Nikolaos/0000-0002-1804-9756; Herry, Cyril/0000-0003-2973-0843; courtin, julien/0000-0002-6454-3245; Bienvenu, Thomas/0000-0002-7416-0504	French National Research Agency [ANR-10-EQPX-08 OPTOPATH]; French National Research Agency (LABEX BRAIN) [ANR 10-LABX-43]; French National Research Agency (LABEX TRAIL) [ANR 10-LABX-57]; European Research Council (ERC) under European Union/ERC [281168]; Conseil Regional d'Aquitaine	French National Research Agency(French National Research Agency (ANR)); French National Research Agency (LABEX BRAIN)(French National Research Agency (ANR)); French National Research Agency (LABEX TRAIL)(French National Research Agency (ANR)); European Research Council (ERC) under European Union/ERC(European Research Council (ERC)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	We thank the members of the Herry laboratory for comments on the manuscript, and K. Deisseroth and E. Boyden for sharing material. Microscopy was done in the Bordeaux Imaging Center of the CNRS-INSERM and Bordeaux University, a member of France BioImaging. This work was supported by grants from the French National Research Agency (ANR-10-EQPX-08 OPTOPATH; LABEX BRAIN ANR 10-LABX-43, LABEX TRAIL ANR 10-LABX-57), the European Research Council (ERC) under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement number 281168, and the Conseil Regional d'Aquitaine.	Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Chang CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011971; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Dejean C, 2015, BIOL PSYCHIAT, V78, P298, DOI 10.1016/j.biopsych.2015.03.017; Do-Monte FH, 2015, NATURE, V519, P460, DOI 10.1038/nature14030; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Dzirasa K, 2011, J NEUROSCI METH, V195, P36, DOI 10.1016/j.jneumeth.2010.11.014; Dzirasa K, 2010, J NEUROSCI, V30, P16314, DOI 10.1523/JNEUROSCI.4289-10.2010; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; Gire DH, 2013, NEURON, V78, P416, DOI 10.1016/j.neuron.2013.04.033; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Igarashi KM, 2014, NATURE, V510, P143, DOI 10.1038/nature13162; Ito J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4572; Karalis N, 2016, NAT NEUROSCI, V19, P605, DOI 10.1038/nn.4251; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Laurent G, 1996, J NEUROSCI, V16, P3837; Lesting J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021714; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Livneh U, 2012, NEURON, V75, P133, DOI 10.1016/j.neuron.2012.05.016; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Peyrache A, 2010, J COMPUT NEUROSCI, V29, P309, DOI 10.1007/s10827-009-0154-6; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; SIK A, 1995, J NEUROSCI, V15, P6651; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; Stark E, 2013, NEURON, V80, P1263, DOI 10.1016/j.neuron.2013.09.033; Stujenske JM, 2014, NEURON, V83, P919, DOI 10.1016/j.neuron.2014.07.026; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258	37	110	114	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					420	+		10.1038/nature18630	http://dx.doi.org/10.1038/nature18630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27409809				2022-12-24	WOS:000380344200040
J	Martinho, A; Kacelnik, A				Martinho, Antone, III; Kacelnik, Alex			Ducklings imprint on the relational concept of "same or different"	SCIENCE			English	Article							CHICKS; PREFERENCES; MECHANISMS; EXPOSURE; PERIODS; OBJECTS; PIGEONS	The ability to identify and retain logical relations between stimuli and apply them to novel stimuli is known as relational concept learning. This has been demonstrated in a few animal species after extensive reinforcement training, and it reveals the brain's ability to deal with abstract properties. Here we describe relational concept learning in newborn ducklings without reinforced training. Newly hatched domesticated mallards that were briefly exposed to a pair of objects that were either the same or different in shape or color later preferred to follow pairs of new objects exhibiting the imprinted relation. Thus, even in a seemingly rigid and very rapid form of learning such as filial imprinting, the brain operates with abstract conceptual reasoning, a faculty often assumed to be reserved to highly intelligent organisms.	[Martinho, Antone, III; Kacelnik, Alex] Univ Oxford, Dept Zool, South Pk Rd, Oxford OX1 3PS, England	University of Oxford	Martinho, A; Kacelnik, A (corresponding author), Univ Oxford, Dept Zool, South Pk Rd, Oxford OX1 3PS, England.	antone.martinho@zoo.ox.ac.uk; alex.kacelnik@zoo.ox.ac.uk		Martinho, Antone/0000-0002-7895-4379	University of Oxford Department of Zoology	University of Oxford Department of Zoology	We thank the Oxford University Farm for allowing us to use their ducklings for this work, and Poultry Manager M. Colley for providing duckling husbandry and technical help. P. Bateson, E. Wasserman, and H. Smithson gave us valuable advice and recommendations regarding our methods and interpretation. We are also grateful to E. Truswell, who assisted with some experimental trials, and M. Lewis, who acted as an independent "blind" scorer for data analysis. This research was funded with assistance from the University of Oxford Department of Zoology. Materials and methods and a video of sample trials may be found in the supplementary materials. Video recordings of training and testing can be made available on request. Data obtained from video coding are available as supplementary materials on Science Online (table S1). The experiment was devised jointly by A.M. and A.K. Experimentation, data collection, and analysis were performed by A.M. with the advice and support of A.K.. The manuscript was written jointly by A.M. and A.K., and figures were prepared by A.M. and edited by A.K.	BATESON P, 1994, ANIM BEHAV, V48, P695, DOI 10.1006/anbe.1994.1289; BATESON P, 1979, ANIM LEARN BEHAV, V7, P259, DOI 10.3758/BF03209281; BATESON P, 1979, ANIM BEHAV, V27, P470, DOI 10.1016/0003-3472(79)90184-2; BATESON P P G, 1972, Behaviour, V42, P279, DOI 10.1163/156853972X00310; BATESON PPG, 1976, ANIM BEHAV, V24, P386, DOI 10.1016/S0003-3472(76)80048-6; BATESON PPG, 1966, BIOL REV, V41, P177, DOI 10.1111/j.1469-185X.1966.tb01489.x; Cook RG, 2007, PSYCHON B REV, V14, P1107, DOI 10.3758/BF03193099; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; HERRNSTEIN RJ, 1976, J EXP PSYCHOL ANIM B, V2, P285, DOI 10.1037/0097-7403.2.4.285; HESS EH, 1969, PSYCHON SCI, V14, P129; Katz JS, 2002, J EXP PSYCHOL ANIM B, V28, P358, DOI 10.1037//0097-7403.28.4.358; LICKLITER R, 1987, J COMP PSYCHOL, V101, P40, DOI 10.1037/0735-7036.101.1.40; Lorenz KZ, 1935, J ORNITHOL, V83, P289, DOI DOI 10.1007/BF01905572; PEPPERBERG IM, 1987, ANIM LEARN BEHAV, V15, P423, DOI 10.3758/BF03205051; Regolin L, 2000, ANIM COGN, V3, P53, DOI 10.1007/s100710050050; Rosa-Salva O, 2010, DEVELOPMENTAL SCI, V13, P565, DOI 10.1111/j.1467-7687.2009.00914.x; Rugani R, 2010, DEVELOPMENTAL SCI, V13, P790, DOI 10.1111/j.1467-7687.2009.00936.x; Smirnova A, 2015, CURR BIOL, V25, P256, DOI 10.1016/j.cub.2014.11.063; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; WASSERMAN EA, 1993, PSYCHOL BULL, V113, P211, DOI 10.1037/0033-2909.113.2.211; Wasserman EA, 2001, J COMP PSYCHOL, V115, P42, DOI 10.1037/0735-7036.115.1.42; Wood JN, 2015, DEVELOPMENTAL SCI, V18, P194, DOI 10.1111/desc.12198; Wright AA, 2006, BEHAV PROCESS, V72, P234, DOI 10.1016/j.beproc.2006.03.009; Wu W, 2013, J COMP PHYSIOL A, V199, P45, DOI 10.1007/s00359-012-0767-5; Zentall TR, 2008, COMP COGN BEHAV REV, V3, P13, DOI 10.3819/ccbr.2008.30002; Zentall TR, 2002, J EXP ANAL BEHAV, V78, P237, DOI 10.1901/jeab.2002.78-237	26	61	62	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2016	353	6296					286	288		10.1126/science.aaf4247	http://dx.doi.org/10.1126/science.aaf4247			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0EM	27418508	Green Submitted			2022-12-24	WOS:000379580800048
J	Brown, E				Brown, Eryn			GENETICS An incomplete mosaic	NATURE			English	Editorial Material							OPPERA											Bair E, 2016, PAIN, V157, P1266, DOI 10.1097/j.pain.0000000000000518; Bell JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3978; Slade GD, 2013, J PAIN, V14, pT116, DOI 10.1016/j.jpain.2013.09.010	3	3	4	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					S12	S13		10.1038/535S12a	http://dx.doi.org/10.1038/535S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR4ZN	27410525	Bronze			2022-12-24	WOS:000379912600009
J	Zoma, AA				Zoma, Asad A.			Clinical overlap in proximal artery stenosis: two disorders or one?	LANCET			English	Editorial Material									[Zoma, Asad A.] Hairmyres Hosp, Lanarkshire Ctr Rheumatol, E Kilbride G75 8RG, Lanark, Scotland	University Hospital Hairmyres	Zoma, AA (corresponding author), Hairmyres Hosp, Lanarkshire Ctr Rheumatol, E Kilbride G75 8RG, Lanark, Scotland.	asad.zoma@lanarkshire.scot.nhs.uk						Clark T, 2003, CLIN EXP RHEUMATOL, V21, pS124; Jain P, 2016, LANCET, V387, P2349, DOI 10.1016/S0140-6736(16)00584-5; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905	3	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2350	2350		10.1016/S0140-6736(16)30524-4	http://dx.doi.org/10.1016/S0140-6736(16)30524-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27302275				2022-12-24	WOS:000376969100039
J	Abramson, JS; Mason, E				Abramson, Jon S.; Mason, Elizabeth			Strengthening maternal immunisation to improve the health of mothers and infants	LANCET			English	Editorial Material									[Abramson, Jon S.] Wake Forest Sch Med, Dept Pediat, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Mason, Elizabeth] UCL, Inst Global Hlth, London, England	Wake Forest University; University of London; University College London	Abramson, JS (corresponding author), Wake Forest Sch Med, Dept Pediat, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jabrams@wakehealth.edu						[Anonymous], 2013, Wkly Epidemiol Rec, V88, P269; [Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P337; [Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P461; Gruber MF, 2014, CLIN INFECT DIS, V59, pS395, DOI 10.1093/cid/ciu707; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Madjarrad K., 2015, WHO PROD DEV VACC AD; Margarit I, WHO PROD DEV VACC AD; Ropero-Alvarez AM, 2016, HUM VACC IMMUNOTHER, V12, P2206, DOI 10.1080/21645515.2016.1157240; Sobjano-ter Meulen A, 2015, MATERNAL IMMUNIZATIO; UNAIDS, 2014, 2014 PROGR REP GLOB; United Nations Department of Economic and Social Affairs, 2015, SUST DEV KNOWL PLATF; WHO, PROD DEV VACC ADV CO PROD DEV VACC ADV CO; WHO (World Health Organization), 2015, STRAT END PREV MAT M; World Health Organization, 2015, PREGN CHILDB POSTP N; World Health Organization, 2016, MAT NEON TET MNT EL; World Health Organization, 2015, WHO REC ROUT IMM SUM; World Health Organization, 2014, EV NEWB ACT PLAN END	17	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2562	2564		10.1016/S0140-6736(16)30882-0	http://dx.doi.org/10.1016/S0140-6736(16)30882-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC5IA	27372397				2022-12-24	WOS:000388166300032
J	Leslie, WD; Majumdar, SR; Morin, SN; Lix, LM				Leslie, William D.; Majumdar, Sumit R.; Morin, Suzanne N.; Lix, Lisa M.			Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect in Routine Clinical Practice A Registry-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							GOAL-DIRECTED TREATMENT; OSTEOPOROSIS THERAPY; PRECISION ASSESSMENT; DENSITOMETRY; FRACTURES; WOMEN; FRAX; VALIDATION; PREDICTION; TIME	Background: Whether change in bone mineral density (BMD) is an accurate indicator of antifracture effect in clinical practice is unknown. Objective: To evaluate repeated BMD testing as an indicator of treatment-related fracture risk reduction. Design: Registry-based cohort study. Setting: Manitoba, Canada. Patients: 6629 women aged 40 years or older initiating osteoporosis treatment with 2 consecutive dual-energy x-ray absorptiometry scans (mean interval, 4.5 years). Measurements: Change in BMD between the first and second dual-energy x-ray absorptiometry scans categorized as stable, detectable decrease, or detectable increase. Incident fractures were ascertained from health services data. Results: During a mean of 9.2 years, 910 (13.7%) women developed incident fractures, including 198 with hip fractures. After adjustment for baseline fracture probability, women with a detectable decrease in total hip BMD compared with stable BMD had an absolute increase of 2.9% (95% CI, 1.5% to 4.4%) and 5.5% (CI, 2.8% to 8.1%) in the 5- and 10-year cumulative incidence of any fracture, respectively. In contrast, risk for any fracture in women with a detectable increase in total hip BMD was 1.3% (CI, 0.4% to 2.2%) and 2.6% (CI, 0.7% to 4.5%) lower after 5 and 10 years, respectively. Consistent results were seen for change in femoral neck and lumbar spine BMD and across a range of subgroup analyses. Limitation: Lack of standardization in the BMD testing interval. Conclusion: Treatment-related increases in total hip BMD are associated with reduced fracture risk compared with stable BMD, whereas decreases in BMD are associated with greater risk for fractures. Monitoring BMD in clinical practice may help to identify women with a suboptimal response to osteoporosis treatment.	[Leslie, William D.] Univ Manitoba, Dept Med C5121, 409 Tache Ave, Winnipeg, MB R2H 2A6, Canada; [Majumdar, Sumit R.] Univ Alberta, Gen Internal Med, 5-134B Clin Sci Bldg,11350-83rd Ave, Edmonton, AB T6G 2G3, Canada; [Morin, Suzanne N.] McGill Univ, Gen Internal Med, Ctr Hlth, Montreal Gen Hosp, 1650 Cedar Ave,Room B2-118, Montreal, PQ H3G 1A4, Canada; [Lix, Lisa M.] Univ Manitoba, Dept Community Hlth Sci, S113-750 Bannatyne Ave, Winnipeg, MB R3P 2H5, Canada	University of Manitoba; University of Alberta; McGill University; University of Manitoba	Leslie, WD (corresponding author), Univ Manitoba, Dept Med C5121, 409 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	bleslie@sbgh.mb.ca		Morin, Suzanne/0000-0002-4317-492X; Leslie, William/0000-0002-1056-1691	Research Funds of Quebec Health	Research Funds of Quebec Health	Dr. Majumdar is supported by his role as the Endowed Chair in Patient Health Management (Faculties of Medicine and Dentistry and Pharmacy and Pharmaceutical Sciences, University of Alberta). Dr. Morin is supported by her role as Scholar through Research Funds of Quebec Health. Dr. Lix is supported by her role as a Research Manitoba Chair.	Baim S, 2005, J CLIN DENSITOM, V8, P371, DOI 10.1385/JCD:8:4:371; Bell KJL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2266; Berger C, 2008, CAN MED ASSOC J, V178, P1660, DOI 10.1503/cmaj.071416; Bruyere O, 2014, BEST PRACT RES CL EN, V28, P835, DOI 10.1016/j.beem.2014.07.001; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Compston J, 2009, BEST PRACT RES CL RH, V23, P781, DOI 10.1016/j.berh.2009.09.007; Crandall CJ., 2012, AHRQ COMP EFFECTIVEN; Cranney A, 2002, ENDOCR REV, V23, P570, DOI 10.1210/er.2001-9002; Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P1318, DOI 10.1001/jama.283.10.1318; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; Cummings SR, 2013, J BONE MINER RES, V28, P433, DOI 10.1002/jbmr.1854; Ensrud KE, 2011, NEW ENGL J MED, V364, P1634, DOI 10.1056/NEJMcp1009697; Fraser LA, 2011, OSTEOPOROSIS INT, V22, P829, DOI 10.1007/s00198-010-1465-1; Gluer CC, 1999, J BONE MINER RES, V14, P1952, DOI 10.1359/jbmr.1999.14.11.1952; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Gourlay ML, 2015, MENOPAUSE, V22, P589, DOI [10.1097/GME.0000000000000356, 10.1097/gme.0000000000000356]; Hillier TA, 2007, ARCH INTERN MED, V167, P155, DOI 10.1001/archinte.167.2.155; Hochberg MC, 2002, J CLIN ENDOCR METAB, V87, P1586, DOI 10.1210/jc.87.4.1586; Hopkins RB, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-209; JONES G, 1995, J RHEUMATOL, V22, P932; Kanis JA, 2014, OSTEOPOROSIS INT, V25, P2533, DOI 10.1007/s00198-014-2787-1; Kanis JA, 2011, OSTEOPOROSIS INT, V22, P2395, DOI 10.1007/s00198-011-1713-z; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Kanis JA, 2009, BONE, V44, P734, DOI 10.1016/j.bone.2009.01.373; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kozyrskyj AL, 1998, ANN PHARMACOTHER, V32, P1152, DOI 10.1345/aph.18117; Lenchik Leon, 2002, J Clin Densitom, V5 Suppl, pS29, DOI 10.1385/JCD:5:3S:S29; Leslie WD, 2011, OSTEOPOROSIS INT, V22, P817, DOI 10.1007/s00198-010-1464-2; Leslie WD, 2006, BONE, V39, P361, DOI 10.1016/j.bone.2006.02.002; Leslie WD, 2005, OSTEOPOROSIS INT, V16, P773, DOI 10.1007/s00198-004-1756-5; Leslie WD, 2005, J CLIN DENSITOM, V8, P25, DOI 10.1385/JCD:8:1:025; Leslie WD, 2008, J BONE MINER RES, V23, P199, DOI 10.1359/JBMR.071019; Leslie WD, 2007, J CLIN ENDOCR METAB, V92, P77, DOI 10.1210/jc.2006-1415; Leslie WD, 2014, J BONE MINER RES, V29, P1074, DOI 10.1002/jbmr.2151; Leslie WD, 2012, J BONE MINER RES, V27, P1243, DOI 10.1002/jbmr.1582; Leslie WD, 2010, J BONE MINER RES, V25, P2350, DOI 10.1002/jbmr.123; Lix LM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-301; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Raisz LG, 2005, NEW ENGL J MED, V353, P164, DOI 10.1056/NEJMcp042092; Schousboe JT, 2013, J CLIN DENSITOM, V16, P455, DOI 10.1016/j.jocd.2013.08.004; Shepherd JA, 2006, J CLIN DENSITOM, V9, P31, DOI 10.1016/j.jocd.2006.05.005; Silverman S, 2006, RHEUM DIS CLIN N AM, V32, P721, DOI 10.1016/j.rdc.2006.07.003; Storer BE, 2008, LIFETIME DATA ANAL, V14, P484, DOI 10.1007/s10985-008-9098-9; Wasnich RD, 2000, J CLIN ENDOCR METAB, V85, P231, DOI 10.1210/jc.85.1.231; Watts NB, 2004, J CLIN DENSITOM, V7, P255, DOI 10.1385/JCD:7:3:255; Watts NB, 2003, J CLIN ENDOCR METAB, V88, P542, DOI 10.1210/jc.2002-020400	50	30	31	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2016	165	7					465	+		10.7326/M15-2937	http://dx.doi.org/10.7326/M15-2937			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY0EY	27428723				2022-12-24	WOS:000384771300004
J	Murray, DH; Jahnel, M; Lauer, J; Avellaneda, MJ; Brouilly, N; Cezanne, A; Morales-Navarrete, H; Perini, ED; Ferguson, C; Lupas, AN; Kalaidzidis, Y; Parton, RG; Grill, SW; Zerial, M				Murray, David H.; Jahnel, Marcus; Lauer, Janelle; Avellaneda, Mario J.; Brouilly, Nicolas; Cezanne, Alice; Morales-Navarrete, Hernan; Perini, Enrico D.; Ferguson, Charles; Lupas, Andrei N.; Kalaidzidis, Yannis; Parton, Robert G.; Grill, Stephan W.; Zerial, Marino			An endosomal tether undergoes an entropic collapse to bring vesicles together	NATURE			English	Article							MEMBRANE-FUSION; COILED COILS; EEA1; RAB; CONVERSION; COMPLEXES; TRANSPORT; PROTEINS; DOCKING; BINDING	An early step in intracellular transport is the selective recognition of a vesicle by its appropriate target membrane, a process regulated by Rab GTPases via the recruitment of tethering effectors(1-4). Membrane tethering confers higher selectivity and efficiency to membrane fusion than the pairing of SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) alone(5-7). Here we address the mechanism whereby a tethered vesicle comes closer towards its target membrane for fusion by reconstituting an endosomal asymmetric tethering machinery consisting of the dimeric coiled-coil protein EEA1 (refs 6, 7) recruited to phosphatidylinositol 3-phosphate membranes and binding vesicles harbouring Rab5. Surprisingly, structural analysis reveals that Rab5:GTP induces an allosteric conformational change in EEA1, from extended to flexible and collapsed. Through dynamic analysis by optical tweezers, we confirm that EEA1 captures a vesicle at a distance corresponding to its extended conformation, and directly measure its flexibility and the forces induced during the tethering reaction. Expression of engineered EEA1 variants defective in the conformational change induce prominent clusters of tethered vesicles in vivo. Our results suggest a new mechanism in which Rab5 induces a change in flexibility of EEA1, generating an entropic collapse force that pulls the captured vesicle towards the target membrane to initiate docking and fusion.	[Murray, David H.; Jahnel, Marcus; Lauer, Janelle; Avellaneda, Mario J.; Brouilly, Nicolas; Cezanne, Alice; Morales-Navarrete, Hernan; Perini, Enrico D.; Kalaidzidis, Yannis; Grill, Stephan W.; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Jahnel, Marcus; Avellaneda, Mario J.; Perini, Enrico D.; Grill, Stephan W.] Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-49, D-01307 Dresden, Germany; [Jahnel, Marcus; Grill, Stephan W.] Max Planck Inst Phys Komplexer Syst, Nothnitzerstr 38, D-01187 Dresden, Germany; [Ferguson, Charles; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Lupas, Andrei N.] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld 4072, Australia; [Avellaneda, Mario J.] FOM Inst AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands	Max Planck Society; Technische Universitat Dresden; Max Planck Society; University of Queensland; Max Planck Society; University of Queensland; AMOLF	Murray, DH (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Grill, Stephan/D-9427-2012; Morales-Navarrete, Hernan/AAE-2316-2019; Kalaidzidis, Yannis/H-3094-2016; Parton, Robert/C-5673-2009	Morales-Navarrete, Hernan/0000-0002-9578-2556; Kalaidzidis, Yannis/0000-0002-6137-1193; Cezanne, Alice Dimitra/0000-0002-6319-9235; Avellaneda, Mario/0000-0001-6406-524X; Parton, Robert/0000-0002-7494-5248; Jahnel, Marcus/0000-0002-8355-277X	Bohringer Ingelheim Fonds; La Caixa; Deutscher Akademischer Austauschdienst scholarship; National Health and Medical Research Council of Australia [APP1037320, 569452]; Australian Research Council Centre of Excellence [CE140100036]; Deutsche Forschungsgemeinschaft [SPP 1782, GSC 97, GR 3271/2, GR 3271/3, GR 3271/4, Transregio 83]; European Research Council [281903]; Human Frontier Science Program [RGP0023/2014]; Max Planck Society	Bohringer Ingelheim Fonds; La Caixa(La Caixa Foundation); Deutscher Akademischer Austauschdienst scholarship(Deutscher Akademischer Austausch Dienst (DAAD)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank R. Schafer for project support. We acknowledge discussions with J. Morin, U. Coskun, A. Honigmann, S. Sturm and T. Leonard, and F. Julicher, E. Schafer and K. Simons for reading the manuscript. We thank M. Brandstetter and the electron microscopy facility of the Vienna Biocenter. We thank the Light Microscopy, Protein Expression, Chromatography, and High-throughput Technology Development Studio of the Max Planck Institute of Molecular Cell Biology and Genetics. During part of the work, M.J. was supported by a PhD scholarship of the Bohringer Ingelheim Fonds. M.J.A. was supported by the La Caixa and Deutscher Akademischer Austauschdienst scholarship. R.P. was supported by the National Health and Medical Research Council of Australia (program grant APP1037320 and Senior Principal Research Fellowship 569452) and the Australian Research Council Centre of Excellence (CE140100036). We acknowledge the Australian Microscopy & Microanalysis Research Facility at the Center for Microscopy and Microanalysis at The University of Queensland. S.W.G. was supported by the Deutsche Forschungsgemeinschaft (SPP 1782, GSC 97, GR 3271/2, GR 3271/3, GR 3271/4), the European Research Council (grant number 281903) and the Human Frontier Science Program (RGP0023/2014). This research was supported by the Max Planck Society and funds of the Deutsche Forschungsgemeinschaft (Transregio 83).	Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Brown FC, 2010, MOL MEMBR BIOL, V27, P457, DOI 10.3109/09687688.2010.501765; Cheung PYP, 2015, ELIFE, V4, DOI 10.7554/eLife.12790; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Degtyar VE, 2007, P NATL ACAD SCI USA, V104, P15929, DOI 10.1073/pnas.0705406104; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Kiessling V, 2003, BIOPHYS J, V84, P408, DOI 10.1016/S0006-3495(03)74861-9; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Landau L D., 1980, STATISTICAL PHYSIC 1, V5, P396; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905; Mishra A, 2010, P NATL ACAD SCI USA, V107, P10866, DOI 10.1073/pnas.1000843107; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Munro S, 2004, NAT CELL BIOL, V6, P469, DOI 10.1038/ncb0604-469; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Otto O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2790; Perini ED, 2014, TRAFFIC, V15, P1366, DOI 10.1111/tra.12232; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Schmidt H, 2015, NATURE, V518, P435, DOI 10.1038/nature14023; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Taylor KC, 2015, P NATL ACAD SCI USA, V112, pE3806, DOI 10.1073/pnas.1505813112; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	29	79	81	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					107	111		10.1038/nature19326	http://dx.doi.org/10.1038/nature19326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556945	Green Accepted			2022-12-24	WOS:000382426900048
J	Sanchez-Danes, A; Hannezo, E; Larsimont, JC; Liagre, M; Youssef, KK; Simons, BD; Blanpain, C				Sanchez-Danes, Adriana; Hannezo, Edouard; Larsimont, Jean-Christophe; Liagre, Melanie; Youssef, Khalil Kass; Simons, Benjamin D.; Blanpain, Cedric			Defining the clonal dynamics leading to mouse skin tumour initiation	NATURE			English	Article							INTESTINAL STEM-CELLS; LINEAGE; ORIGIN; PROGRESSION; MODEL	The changes in cell dynamics after oncogenic mutation that lead to the development of tumours are currently unknown. Here, using skin epidermis as a model, we assessed the effect of oncogenic hedgehog signalling in distinct cell populations and their capacity to induce basal cell carcinoma, the most frequent cancer in humans. We found that only stem cells, and not progenitors, initiated tumour formation upon oncogenic hedgehog signalling. This difference was due to the hierarchical organization of tumour growth in oncogene-targeted stem cells, characterized by an increase in symmetric self-renewing divisions and a higher p53-dependent resistance to apoptosis, leading to rapid clonal expansion and progression into invasive tumours. Our work reveals that the capacity of oncogene-targeted cells to induce tumour formation is dependent not only on their long-term survival and expansion, but also on the specific clonal dynamics of the cancer cell of origin.	[Sanchez-Danes, Adriana; Larsimont, Jean-Christophe; Liagre, Melanie; Youssef, Khalil Kass; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Hannezo, Edouard; Simons, Benjamin D.] Dept Phys, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England; [Hannezo, Edouard; Simons, Benjamin D.] Univ Cambridge, Canc Res UK Gurdon Inst, Wellcome Trust, Tennis Court Rd, Cambridge CB2 1QN, England; [Hannezo, Edouard; Simons, Benjamin D.] Univ Cambridge, Stem Cell Inst, MRC, Wellcome Trust, Cambridge CB2 1QR, England; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; University of Cambridge; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Wellcome Trust Sanger Institute; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.; Simons, BD (corresponding author), Dept Phys, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.; Simons, BD (corresponding author), Univ Cambridge, Canc Res UK Gurdon Inst, Wellcome Trust, Tennis Court Rd, Cambridge CB2 1QN, England.; Simons, BD (corresponding author), Univ Cambridge, Stem Cell Inst, MRC, Wellcome Trust, Cambridge CB2 1QR, England.; Blanpain, C (corresponding author), Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium.	bds10@cam.ac.uk; Cedric.Blanpain@ulb.ac.be	Simons, Benjamin/AAY-8920-2020; Blanpain, Cedric/ABD-8392-2021; Youssef, Khalil Kass/AAB-6528-2021	Simons, Benjamin/0000-0002-3875-7071; Youssef, Khalil Kass/0000-0002-4572-3160; Hannezo, Edouard/0000-0001-6005-1561; Sanchez-Danes, Adriana/0000-0001-7895-9973	FNRS; FRIA; Wellcome Trust [098357/Z/12/Z, 110326/Z/15/Z]; Trinity College, Cambridge; IUAP program; Fondation contre le Cancer; ULB fondation; foundation Bettencourt Schueller; foundation Baillet Latour; European Research Council; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish; Medical Research Council [MC_PC_12009] Funding Source: researchfish; EPSRC [EP/F032773/1] Funding Source: UKRI	FNRS(Fonds de la Recherche Scientifique - FNRS); FRIA(Fonds de la Recherche Scientifique - FNRS); Wellcome Trust(Wellcome TrustEuropean Commission); Trinity College, Cambridge; IUAP program; Fondation contre le Cancer; ULB fondation; foundation Bettencourt Schueller; foundation Baillet Latour; European Research Council(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We would like to thank J.-M. Vanderwinden and the LiMiF for the help with confocal microscopy. C.B. is an investigator of WELBIO. A.S.-D. and J.C.L. are supported by a fellowship of the FNRS and FRIA respectively. B.D.S. and E.H. are supported by the Wellcome Trust (grant numbers 098357/Z/12/Z and 110326/Z/15/Z). E.H. is supported by a fellowship from Trinity College, Cambridge. This work was supported by the FNRS, the IUAP program, the Fondation contre le Cancer, the ULB fondation, the foundation Bettencourt Schueller, the foundation Baillet Latour, a consolidator grant of the European Research Council.	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Bonilla X, 2016, NAT GENET, V48, P398, DOI 10.1038/ng.3525; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Chen JD, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026104; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Gomez C, 2013, STEM CELL REP, V1, P19, DOI 10.1016/j.stemcr.2013.04.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Snippert HJ, 2014, EMBO REP, V15, P62, DOI 10.1002/embr.201337799; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; White AC, 2011, P NATL ACAD SCI USA, V108, P7425, DOI 10.1073/pnas.1012670108; Wong SY, 2011, P NATL ACAD SCI USA, V108, P4093, DOI 10.1073/pnas.1013098108; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Youssef KK, 2012, NAT CELL BIOL, V14, P1282, DOI 10.1038/ncb2628; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	27	68	69	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					298	+		10.1038/nature19069	http://dx.doi.org/10.1038/nature19069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27459053	Green Accepted			2022-12-24	WOS:000381804900028
J	Boritz, EA; Darko, S; Swaszek, L; Wolf, G; Wells, D; Wu, XL; Henry, AR; Laboune, F; Hu, JF; Ambrozak, D; Hughes, MS; Hoh, R; Casazza, JP; Vostal, A; Bunis, D; Nganou-Makamdop, K; Lee, JS; Migueles, SA; Koup, RA; Connors, M; Moir, S; Schacker, T; Maldarelli, F; Hughes, SH; Deeks, SG; Douek, DC				Boritz, Eli A.; Darko, Samuel; Swaszek, Luke; Wolf, Gideon; Wells, David; Wu, Xiaolin; Henry, Amy R.; Laboune, Farida; Hu, Jianfei; Ambrozak, David; Hughes, Marybeth S.; Hoh, Rebecca; Casazza, Joseph P.; Vostal, Alexander; Bunis, Daniel; Nganou-Makamdop, Krystelle; Lee, James S.; Migueles, Stephen A.; Koup, Richard A.; Connors, Mark; Moir, Susan; Schacker, Timothy; Maldarelli, Frank; Hughes, Stephen H.; Deeks, Steven G.; Douek, Daniel C.			Multiple Origins of Virus Persistence during Natural Control of HIV Infection	CELL			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; ELITE SUPPRESSORS; LATENT RESERVOIR; IN-VIVO; REPLICATION; PROLIFERATION; TYPE-1; LYMPHOCYTES; ACTIVATION	Targeted HIV cure strategies require definition of the mechanisms that maintain the virus. Here, we tracked HIV replication and the persistence of infected CD4 T cells in individuals with natural virologic control by sequencing viruses, T cell receptor genes, HIV integration sites, and cellular transcriptomes. Our results revealed three mechanisms of HIV persistence operating within distinct anatomic and functional compartments. In lymph node, we detected viruses with genetic and transcriptional attributes of active replication in both T follicular helper (T-FH) cells and non-T-FH memory cells. In blood, we detected inducible proviruses of archival origin among highly differentiated, clonally expanded cells. Linking the lymph node and blood was a small population of circulating cells harboring inducible proviruses of recent origin. Thus, HIV replication in lymphoid tissue, clonal expansion of infected cells, and recirculation of recently infected cells act together to maintain the virus in HIV controllers despite effective antiviral immunity.	[Boritz, Eli A.; Darko, Samuel; Swaszek, Luke; Wolf, Gideon; Henry, Amy R.; Laboune, Farida; Hu, Jianfei; Bunis, Daniel; Nganou-Makamdop, Krystelle; Lee, James S.; Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Wells, David; Wu, Xiaolin] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Ambrozak, David; Casazza, Joseph P.; Koup, Richard A.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Hughes, Marybeth S.] NCI, Thorac & Gastrointestinal Oncol Branch, NIH, Bethesda, MD 20892 USA; [Hoh, Rebecca; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Migueles, Stephen A.; Connors, Mark; Moir, Susan] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Maldarelli, Frank; Hughes, Stephen H.] NCI, HIV Dynam & Replicat Program, NIH, Frederick, MD 21702 USA; [Schacker, Timothy] Univ Minnesota, Dept Med, Program HIV Med, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities	Douek, DC (corresponding author), NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	ddouek@mail.nih.gov	Maldarelli, Frank/O-2428-2016; Moir, Susan/AAC-3676-2020	Wolf, Gideon/0000-0003-3272-2588; Jianfei, Hu/0000-0001-8458-6683; Deeks, Steven/0000-0001-6371-747X; Swaszek, Luke/0000-0003-1858-2478	NIH Intramural Research Program; NIAID Division of AIDS; NIH Office of AIDS Research; AIDS Vaccine Discovery grant from the Bill and Melinda Gates Foundation [OPP1032325]; Delaney AIDS Research Enterprise [AI096109]; NIAID [AI069994]; UCSF/Gladstone Institute of Virology & Immunology CFAR [P30 AI027763]; NCI; NATIONAL CANCER INSTITUTE [ZIABC011426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005014, P30AI027763, K24AI069994, ZIAAI000855, ZIAAI000825, U19AI096109] Funding Source: NIH RePORTER	NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Office of AIDS Research; AIDS Vaccine Discovery grant from the Bill and Melinda Gates Foundation; Delaney AIDS Research Enterprise; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCSF/Gladstone Institute of Virology & Immunology CFAR; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the study participants for their involvement in the study. We thank S. Kosakovsky-Pond for help with phylogenetic analysis and C. Petrovas for helpful discussions. D.C.D. and E.A.B. are funded by the NIH Intramural Research Program. D.C.D. is also funded by the NIAID Division of AIDS and the NIH Office of AIDS Research. Additional funding came from AIDS Vaccine Discovery grant OPP1032325 from the Bill and Melinda Gates Foundation (to R.A.K.), the Delaney AIDS Research Enterprise (AI096109 to S.G.D.), NIAID K24 (AI069994 to S.G.D.), the UCSF/Gladstone Institute of Virology & Immunology CFAR (P30 AI027763 to S.G.D.), and federal funds from the NCI (to F.M. and S.H.H.).	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Boufassa F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085516; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2013, J INFECT DIS, V208, P1443, DOI 10.1093/infdis/jit306; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Hatano H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003691; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Julg B, 2010, CLIN INFECT DIS, V51, P233, DOI 10.1086/653677; Kim M, 2016, P NATL ACAD SCI USA, V113, P1692, DOI 10.1073/pnas.1600097113; Krishnan S, 2014, J INFECT DIS, V209, P931, DOI 10.1093/infdis/jit581; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Mens H, 2010, J VIROL, V84, P12971, DOI 10.1128/JVI.00387-10; Migueles SA, 2015, NAT IMMUNOL, V16, P563, DOI 10.1038/ni.3161; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Rothenberger MK, 2015, P NATL ACAD SCI USA, V112, pE1126, DOI 10.1073/pnas.1414926112; Routy JP, 2012, HIV MED, V13, P291, DOI 10.1111/j.1468-1293.2011.00975.x; Salgado M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-94; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Spivak AM, 2014, CLIN INFECT DIS, V58, P883, DOI 10.1093/cid/cit813; von Stockenstrom S, 2015, J INFECT DIS, V212, P596, DOI 10.1093/infdis/jiv092; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	40	123	124	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					1004	1015		10.1016/j.cell.2016.06.039	http://dx.doi.org/10.1016/j.cell.2016.06.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27453467	Bronze, Green Accepted			2022-12-24	WOS:000382258700021
J	Gal, A; Wirth, R; Kopka, J; Fratzl, P; Faivre, D; Scheffel, A				Gal, Assaf; Wirth, Richard; Kopka, Joachim; Fratzl, Peter; Faivre, Damien; Scheffel, Andre			Macromolecular recognition directs calcium ions to coccolith mineralization sites	SCIENCE			English	Article							PLEUROCHRYSIS-CARTERAE; ACIDIC POLYSACCHARIDE; BIOMINERALIZATION; ALGA; CALCIFICATION; SCALES; CRYSTALLIZATION; HAPTONEMOFERA; NUCLEATION; CRYSTALS	Many organisms form elaborate mineralized structures, constituted of highly organized arrangements of crystals and organic macromolecules. The localization of crystals within these structures is presumably determined by the interaction of nucleating macromolecules with the mineral phase. Here we show that, preceding nucleation, a specific interaction between soluble organic molecules and an organic backbone structure directs mineral components to specific sites. This strategy underlies the formation of coccoliths, which are highly ordered arrangements of calcite crystals produced by marine microalgae. On combining the insoluble organic coccolith scaffold with coccolith-associated soluble macromolecules in vitro, we found a massive accretion of calcium ions at the sites where the crystals form in vivo. The in vitro process exhibits profound similarities to the initial stages of coccolith biogenesis in vivo.	[Gal, Assaf; Fratzl, Peter; Faivre, Damien] Max Planck Inst Colloids & Interfaces, D-14476 Potsdam, Germany; [Gal, Assaf; Kopka, Joachim; Scheffel, Andre] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Wirth, Richard] Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany	Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Scheffel, A (corresponding author), Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany.	scheffel@mpimp-golm.mpg.de	Fratzl, Peter/H-9095-2012; Gal, Assaf/L-6104-2019; faivre, damien/D-3713-2009	Fratzl, Peter/0000-0003-4437-7830; Gal, Assaf/0000-0003-1488-1227; faivre, damien/0000-0001-6191-3389; Kopka, Joachim/0000-0001-9675-4883	Max-Planck Society; Deutsche Forschungsgemeinschaft (DFG) [Sche1637/3-1, FA835/9-1]; Alexander von Humboldt postdoctoral fellowship; European Research Council [256915]; Gottfried Wilhelm Leibniz Preis of the DFG	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alexander von Humboldt postdoctoral fellowship(Alexander von Humboldt Foundation); European Research Council(European Research Council (ERC)European Commission); Gottfried Wilhelm Leibniz Preis of the DFG(German Research Foundation (DFG))	We are grateful to A. Skeffington, N. Kroger, and U. Armbruster for critically reading the manuscript; M. Brzezinka for help with SDS-polyacrylamide gel electrophoresis; and A. Erban for gas chromatography-mass spectrometry analysis. This research was supported by the Max-Planck Society, Deutsche Forschungsgemeinschaft (DFG) grants Sche1637/3-1 to A.S., and FA835/9-1 to D.F. A.G. is supported by an Alexander von Humboldt postdoctoral fellowship. D.F. acknowledges financial support from the European Research Council (Starting Grant MB2 No. 256915). P.F. acknowledges financial support from the Gottfried Wilhelm Leibniz Preis of the DFG. All data used to support the conclusions in this manuscript are provided in the supplementary materials.	ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Bonucci E., 2007, BIOL CALCIFICATION; BROWN RM, 1969, SCIENCE, V166, P894, DOI 10.1126/science.166.3907.894; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Gilbert PUPA, 2005, REV MINERAL GEOCHEM, V59, P157, DOI 10.2138/rmg.2005.59.7; Giuffre AJ, 2013, P NATL ACAD SCI USA, V110, P9261, DOI 10.1073/pnas.1222162110; Gong YUT, 2012, P NATL ACAD SCI USA, V109, P6088, DOI 10.1073/pnas.1118085109; Henriksen K, 2004, AM MINERAL, V89, P1709, DOI 10.2138/am-2004-11-1217; Hirokawa Y, 2005, MAR BIOTECHNOL, V7, P634, DOI 10.1007/s10126-004-5148-9; ISENBERG HD, 1965, NATURE, V206, P1153, DOI 10.1038/2061153a0; Kayano K, 2011, MAR BIOTECHNOL, V13, P83, DOI 10.1007/s10126-010-9272-4; MANTON I, 1969, J MAR BIOL ASSOC UK, V49, P1, DOI 10.1017/S0025315400046385; MARSH ME, 1992, J BIOL CHEM, V267, P20507; Marsh ME, 1996, PROTOPLASMA, V190, P181, DOI 10.1007/BF01281317; Marsh ME, 1999, PROTOPLASMA, V207, P54, DOI 10.1007/BF01294713; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Okazaki M, 1998, J MAR BIOTECHNOL, V6, P16; OUTKA DE, 1971, J PROTOZOOL, V18, P285, DOI 10.1111/j.1550-7408.1971.tb03319.x; Ozaki N, 2001, BIOSCI BIOTECH BIOCH, V65, P2330, DOI 10.1271/bbb.65.2330; Ozaki N, 2007, BIOCHEM BIOPH RES CO, V357, P1172, DOI 10.1016/j.bbrc.2007.04.078; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; WILBUR KM, 1963, ANN NY ACAD SCI, V109, P82, DOI 10.1111/j.1749-6632.1963.tb13463.x; YOUNG JR, 1992, NATURE, V356, P516, DOI 10.1038/356516a0; Young JR, 2003, REV MINERAL GEOCHEM, V54, P189, DOI 10.2113/0540189; Young JR, 1999, J STRUCT BIOL, V126, P195, DOI 10.1006/jsbi.1999.4132	27	66	68	8	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					590	593		10.1126/science.aaf7889	http://dx.doi.org/10.1126/science.aaf7889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493186				2022-12-24	WOS:000381560900042
J	Wang, H; Avican, K; Fahlgren, A; Erttmann, SF; Nuss, AM; Dersch, P; Fallman, M; Edgren, T; Wolf-Watz, H				Wang, He; Avican, Kemal; Fahlgren, Anna; Erttmann, Saskia F.; Nuss, Aaron M.; Dersch, Petra; Fallman, Maria; Edgren, Tomas; Wolf-Watz, Hans			Increased plasmid copy number is essential for Yersinia T3SS function and virulence	SCIENCE			English	Article							OUTER-MEMBRANE PROTEINS; TARGET-CELL CONTACT; SALMONELLA-TYPHIMURIUM; PSEUDOTUBERCULOSIS; TRANSLOCATION; EXPRESSION; SECRETION; AMPLIFICATION; TEMPERATURE; RESISTANCE	Pathogenic bacteria have evolved numerous virulence mechanisms that are essential for establishing infections. The enterobacterium Yersinia uses a type III secretion system (T3SS) encoded by a 70-kilobase, low-copy, IncFII-class virulence plasmid. We report a novel virulence strategy in Y. pseudotuberculosis in which this pathogen up-regulates the plasmid copy number during infection. We found that an increased dose of plasmid-encoded genes is indispensable for virulence and substantially elevates the expression and function of the T3SS. Remarkably, we observed direct, tight coupling between plasmid replication and T3SS function. This regulatory pathway provides a framework for further exploration of the environmental sensing mechanisms of pathogenic bacteria.	[Wang, He; Avican, Kemal; Fahlgren, Anna; Erttmann, Saskia F.; Fallman, Maria; Edgren, Tomas; Wolf-Watz, Hans] Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, SE-90187 Umea, Sweden; [Wang, He; Avican, Kemal; Erttmann, Saskia F.; Fallman, Maria; Wolf-Watz, Hans] Umea Univ, Lab Mol Infect Med Sweden MIMS, Dept Mol Biol, SE-90187 Umea, Sweden; [Nuss, Aaron M.; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Germany	Umea University; Umea University; Helmholtz Association; Helmholtz-Center for Infection Research	Edgren, T; Wolf-Watz, H (corresponding author), Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, SE-90187 Umea, Sweden.; Wolf-Watz, H (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, Dept Mol Biol, SE-90187 Umea, Sweden.	tomas.edgren@umu.se; hans.wolf-watz@umu.se		Erttmann, Saskia Friederike/0000-0003-2398-8405; Avican, Kemal/0000-0003-0707-2050	Stiftelsen JC Kempes Minnes Stipendiefond; EMBO grant [ALTF 1629-2011]; Swedish Research Council [2015-02874, 2011-4937, K2014-56X-11222-20-5]; Carl Tryggers Stiftelse for Naturvetenskaplig Forskning; German Center for Infection Research	Stiftelsen JC Kempes Minnes Stipendiefond; EMBO grant(European Molecular Biology Organization (EMBO)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse for Naturvetenskaplig Forskning; German Center for Infection Research	Sequence data used in this study have been deposited in the European Nucleotide Archive with accession number PRJEB13406. Supported by Stiftelsen JC Kempes Minnes Stipendiefond (H.W.-W.), EMBO grant ALTF 1629-2011 (H.W.), the Swedish Research Council (grant 2015-02874, H.W.-W.; grant 2011-4937, T.E.; grant K2014-56X-11222-20-5, M.F.), Carl Tryggers Stiftelse for Naturvetenskaplig Forskning (T.E.), and the German Center for Infection Research (P.D.). This work traces back to Kurt Nordstrom (mentor to H.W.-W.), to whom this paper is dedicated.	Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Amer AAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077767; BERGMAN T, 1994, J BACTERIOL, V176, P2619, DOI 10.1128/JB.176.9.2619-2626.1994; BOLIN I, 1985, INFECT IMMUN, V48, P234; BRUBAKER RR, 1983, REV INFECT DIS, V5, pS748; CORNELIS GR, 1989, MOL MICROBIOL, V3, P1455, DOI 10.1111/j.1365-2958.1989.tb00129.x; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Fahlgren A, 2014, INFECT IMMUN, V82, P3471, DOI 10.1128/IAI.01793-14; FORSBERG A, 1988, MOL MICROBIOL, V2, P121, DOI 10.1111/j.1365-2958.1988.tb00013.x; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; MEYER J, 1979, MOL GEN GENET, V176, P209, DOI 10.1007/BF00273215; MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; Nuss AM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005087; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; PORTNOY DA, 1984, INFECT IMMUN, V43, P108, DOI 10.1128/IAI.43.1.108-114.1984; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; STRALEY SC, 1993, MOL MICROBIOL, V8, P1005, DOI 10.1111/j.1365-2958.1993.tb01644.x; Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998	23	37	40	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					492	495		10.1126/science.aaf7501	http://dx.doi.org/10.1126/science.aaf7501			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27365311	Green Submitted			2022-12-24	WOS:000380583600042
J	Richards, JL; Kramer, MS; Deb-Rinker, P; Rouleau, J; Mortensen, L; Gissler, M; Morken, NH; Skjaerven, R; Cnattingius, S; Johansson, S; Delnord, M; Dolan, SM; Morisaki, N; Tough, S; Zeitlin, J; Kramer, MR				Richards, Jennifer L.; Kramer, Michael S.; Deb-Rinker, Paromita; Rouleau, Jocelyn; Mortensen, Laust; Gissler, Mika; Morken, Nils-Halvdan; Skjaerven, Rolv; Cnattingius, Sven; Johansson, Stefan; Delnord, Marie; Dolan, Siobhan M.; Morisaki, Naho; Tough, Suzanne; Zeitlin, Jennifer; Kramer, Michael R.			Temporal Trends in Late Preterm and Early Term Birth Rates in 6 High-Income Countries in North America and Europe and Association With Clinician-Initiated Obstetric Interventions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; ELECTIVE DELIVERIES; TIME TRENDS; QUALITY; INDUCTION; GESTATION; LABOR	IMPORTANCE Clinicians have been urged to delay the use of obstetric interventions (eg, labor induction, cesarean delivery) until 39 weeks or later in the absence of maternal or fetal indications for intervention. OBJECTIVE To describe recent trends in late preterm and early term birth rates in 6 high-income countries and assess association with use of clinician-initiated obstetric interventions. DESIGN Retrospective analysis of singleton live births from 2006 to the latest available year (ranging from 2010 to 2015) in Canada, Denmark, Finland, Norway, Sweden, and the United States. EXPOSURES Use of clinician-initiated obstetric intervention (either labor induction or prelabor cesarean delivery) during delivery. MAIN OUTCOMES AND MEASURES Annual country-specific late preterm (34-36 weeks) and early term (37-38 weeks) birth rates. RESULTS The study population included 2 415 432 Canadian births in 2006-2014 (4.8% late preterm; 25.3% early term); 305 947 Danish births in 2006-2010 (3.6% late preterm; 18.8% early term); 571 937 Finnish births in 2006-2015 (3.3% late preterm; 16.8% early term); 468 954 Norwegian births in 2006-2013 (3.8% late preterm; 17.2% early term); 737 754 Swedish births in 2006-2012 (3.6% late preterm; 18.7% early term); and 25 788 558 US births in 2006-2014 (6.0% late preterm; 26.9% early term). Late preterm birth rates decreased in Norway (3.9% to 3.5%) and the United States (6.8% to 5.7%). Early term birth rates decreased in Norway (17.6% to 16.8%), Sweden (19.4% to 18.5%), and the United States (30.2% to 24.4%). In the United States, early term birth rates decreased from 33.0% in 2006 to 21.1% in 2014 among births with clinician-initiated obstetric intervention, and from 29.7% in 2006 to 27.1% in 2014 among births without clinician-initiated obstetric intervention. Rates of clinician-initiated obstetric intervention increased among late preterm births in Canada (28.0% to 37.9%), Denmark (22.2% to 25.0%), and Finland (25.1% to 38.5%), and among early term births in Denmark (38.4% to 43.8%) and Finland (29.8% to 40.1%). CONCLUSIONS AND RELEVANCE Between 2006 and 2014, late preterm and early term birth rates decreased in the United States, and an association was observed between early term birth rates and decreasing clinician-initiated obstetric interventions. Late preterm births also decreased in Norway, and early term births decreased in Norway and Sweden. Clinician-initiated obstetric interventions increased in some countries but no association was found with rates of late preterm or early term birth.	[Richards, Jennifer L.; Kramer, Michael S.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd, Atlanta, GA 30322 USA; [Kramer, Michael S.] McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Deb-Rinker, Paromita; Rouleau, Jocelyn] Publ Hlth Agcy Canada, Ctr Chron Dis Prevent, Surveillance & Epidemiol Div, Ottawa, ON, Canada; [Mortensen, Laust] Univ Copenhagen, Sect Social Med, Copenhagen, Denmark; [Gissler, Mika] Natl Inst Hlth & Welf, Informat Serv Dept, Helsinki, Finland; [Morken, Nils-Halvdan] Univ Bergen, Dept Global Publ Hlth, N-5020 Bergen, Norway; [Morken, Nils-Halvdan] Univ Bergen, Dept Primary Care & Clin Sci, N-5020 Bergen, Norway; [Morken, Nils-Halvdan] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Skjaerven, Rolv] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway; [Cnattingius, Sven; Johansson, Stefan] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit,T2, Stockholm, Sweden; [Delnord, Marie; Zeitlin, Jennifer] Paris Descartes Univ, Sorbonne Paris Cite, Ctr Epidemiol & Stat, INSERM UMR 1153, Paris, France; [Dolan, Siobhan M.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Morisaki, Naho] Natl Ctr Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Tough, Suzanne] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada; [Tough, Suzanne] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada	Emory University; Rollins School Public Health; McGill University; McGill University; Public Health Agency of Canada; University of Copenhagen; Finland National Institute for Health & Welfare; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; National Center for Child Health & Development - Japan; University of Calgary; University of Calgary	Richards, JL (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd, Atlanta, GA 30322 USA.	jennifer.richards@emory.edu	Delnord, Marie/AAJ-8970-2021; Kramer, Michael R/A-3195-2013; Zeitlin, Jennifer/G-4973-2017	Delnord, Marie/0000-0002-3168-0219; Kramer, Michael R/0000-0002-6372-6170; Zeitlin, Jennifer/0000-0002-9568-2969; Dolan, Siobhan/0000-0001-8890-8045; Gissler, Mika/0000-0001-8254-7525; Morisaki, Naho/0000-0001-6151-4513; Beauregard, Jennifer/0000-0003-2587-5148; Johansson, Stefan/0000-0001-8832-6918	T32 Predoctoral Training Program in Reproductive, Perinatal, and Pediatric Epidemiology grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) [T32HD052460]; Paris Descartes University; KAKENHI from the Japan Society for the Promotion of Science [26870889]; Japan Ministry of Health, Labour, and Welfare [AMED-6013]; NICHD of the NIH [K01HD074726]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD074726, T32HD052460] Funding Source: NIH RePORTER	T32 Predoctoral Training Program in Reproductive, Perinatal, and Pediatric Epidemiology grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH); Paris Descartes University; KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); NICHD of the NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a T32 Predoctoral Training Program in Reproductive, Perinatal, and Pediatric Epidemiology grant (T32HD052460) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH; Ms Richards); a grant from Paris Descartes University (Ms Delnord); grant KAKENHI 26870889 from the Japan Society for the Promotion of Science (Dr Morisaki); grant AMED-6013 from the Japan Ministry of Health, Labour, and Welfare (Dr Morisaki); and grant K01HD074726 from the NICHD of the NIH (Dr M. R. Kramer).	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; [Anonymous], 2009, Obstet Gynecol, V114, P386, DOI 10.1097/AOG.0b013e3181b48ef5; Bailit JL, 2010, AM J OBSTET GYNECOL, V203; Berrien Kate, 2014, N C Med J, V75, P169; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Danilack VA, 2013, J PERINATOL, V33, P919, DOI 10.1038/jp.2013.90; Dogl M, 2016, ACTA OBSTET GYN SCAN, V95, P112, DOI 10.1111/aogs.12809; Ekeus C, 2016, BIRTH-ISS PERINAT C, V43, P125; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Gyamfi-Bannerman C, 2014, OBSTET GYNECOL, V124, P1069, DOI 10.1097/AOG.0000000000000546; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Iams JD, 2011, AM J OBSTET GYNECOL, V205, P395, DOI 10.1016/j.ajog.2011.08.006; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Korst LM, 2013, PAEDIATR PERINAT EP, V27, P44, DOI 10.1111/ppe.12018; Little SE, 2014, J PERINATOL, V34, P176, DOI 10.1038/jp.2013.166; Little SE, 2015, OBSTET GYNECOL, V126, P1138, DOI 10.1097/AOG.0000000000001109; MacDorman MF, 2010, AM J PUBLIC HEALTH, V100, P2241, DOI 10.2105/AJPH.2009.180570; Martin J, 2010, RECENT DATA NATL VIT, P1; Martin Joyce A, 2013, Natl Vital Stat Rep, V62, P1; Martin Joyce A, 2009, NCHS Data Brief, P1; Oshiro BT, 2013, OBSTET GYNECOL, V121, P1025, DOI 10.1097/AOG.0b013e31828ca096; Oshiro BT, 2009, OBSTET GYNECOL, V113, P804, DOI 10.1097/AOG.0b013e31819b5c8c; Osterman MJK, 2015, NCHS DATA BRIEF RECE; Public Health Agency of Canada, 2013, PER HLTH IND CAN; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schoen CN, 2015, AM J OBSTET GYNECOL, V213, P175, DOI 10.1016/j.ajog.2014.12.011; Shapiro-Mendoza CK, 2012, SEMIN FETAL NEONAT M, V17, P120, DOI 10.1016/j.siny.2012.01.007; Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999; Trembath AN, 2013, CLIN PERINATOL, V40, P777, DOI [10.1016/j.c1p.2013.07.011, 10.1016/j.clp.2013.07.011]; VanderWeele TJ, 2012, SOC SCI MED, V74, P196, DOI 10.1016/j.socscimed.2011.10.031; Wier ML, 2007, PAEDIATR PERINAT EP, V21, P4, DOI 10.1111/j.1365-3016.2007.00856.x; Zeitlin J, 2013, BJOG-INT J OBSTET GY, V120, P1356, DOI 10.1111/1471-0528.12281; Zhang X, 2012, BJOG-INT J OBSTET GY, V119, P1309, DOI 10.1111/j.1471-0528.2012.03453.x	34	59	63	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2016	316	4					410	419		10.1001/jama.2016.9635	http://dx.doi.org/10.1001/jama.2016.9635			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR9MV	27458946	Green Accepted, Bronze			2022-12-24	WOS:000380221700019
J	Bader, E; Migliorini, A; Gegg, M; Moruzzi, N; Gerdes, J; Roscioni, SS; Bakhti, M; Brandl, E; Irmler, M; Beckers, J; Aichler, M; Feuchtinger, A; Leitzinger, C; Zischka, H; Wang-Sattler, R; Jastroch, M; Tschop, M; Machicao, F; Staiger, H; Haring, HU; Chmelova, H; Chouinard, JA; Oskolkov, N; Korsgren, O; Speier, S; Lickert, H				Bader, Erik; Migliorini, Adriana; Gegg, Moritz; Moruzzi, Noah; Gerdes, Jantje; Roscioni, Sara S.; Bakhti, Mostafa; Brandl, Elisabeth; Irmler, Martin; Beckers, Johannes; Aichler, Michaela; Feuchtinger, Annette; Leitzinger, Christin; Zischka, Hans; Wang-Sattler, Rui; Jastroch, Martin; Tschoep, Matthias; Machicao, Fausto; Staiger, Harald; Haering, Hans-Ulrich; Chmelova, Helena; Chouinard, Julie A.; Oskolkov, Nikolay; Korsgren, Olle; Speier, Stephan; Lickert, Heiko			Identification of proliferative and mature beta-cells in the islets of Langerhans	NATURE			English	Article							INSULIN-SECRETION; PANCREATIC-ISLETS; POLARITY; EXPRESSION; MOUSE; LINE; DEDIFFERENTIATION; DIFFERENTIATION; COMMUNICATION; HETEROGENEITY	Insulin-dependent diabetes is a complex multifactorial disorder characterized by loss or dysfunction of beta-cells. Pancreatic beta-cells differ in size, glucose responsiveness, insulin secretion and precursor cell potential(1-5); understanding the mechanisms that underlie this functional heterogeneity might make it possible to develop new regenerative approaches. Here we show that Fltp (also known as Flattop and Cfap126), a Wnt/planar cell polarity (PCP) effector and reporter gene(6), acts as a marker gene that subdivides endocrine cells into two subpopulations and distinguishes proliferation-competent from mature beta-cells with distinct molecular, physiological and ultrastructural features. Genetic lineage tracing revealed that endocrine subpopulations from Fltp-negative and -positive lineages react differently to physiological and pathological changes. The expression of Fltp increases when endocrine cells cluster together to form polarized and mature 3D islet mini-organs(7-9). We show that 3D architecture and Wnt/PCP ligands are sufficient to trigger beta-cell maturation. By contrast, the Wnt/PCP effector Fltp is not necessary for beta-cell development, proliferation or maturation. We conclude that 3D architecture and Wnt/PCP signalling underlie functional beta-cell heterogeneity and induce beta-cell maturation. The identification of Fltp as a marker for endocrine subpopulations sheds light on the molecular underpinnings of islet cell heterogeneity and plasticity and might enable targeting of endocrine subpopulations for the regeneration of functional beta-cell mass in diabetic patients.	[Bader, Erik; Migliorini, Adriana; Gegg, Moritz; Moruzzi, Noah; Gerdes, Jantje; Roscioni, Sara S.; Bakhti, Mostafa; Brandl, Elisabeth; Lickert, Heiko] Helmholtz Zentrum Munchen, Inst Diabet & Regenerat Res, D-85764 Neuherberg, Germany; [Bader, Erik; Migliorini, Adriana; Gegg, Moritz; Lickert, Heiko] Helmholtz Zentrum Munchen, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Bader, Erik; Wang-Sattler, Rui] Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Moruzzi, Noah] Karolinska Univ Hosp, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden; [Irmler, Martin; Beckers, Johannes; Jastroch, Martin; Tschoep, Matthias; Machicao, Fausto; Staiger, Harald; Haering, Hans-Ulrich; Chmelova, Helena; Chouinard, Julie A.; Speier, Stephan; Lickert, Heiko] German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Irmler, Martin; Beckers, Johannes] Helmholtz Zentrum Munchen, Inst Expt Genet, D-85764 Neuherberg, Germany; [Beckers, Johannes; Lickert, Heiko] Tech Univ Munich, Ismaninger Str 22, D-81675 Munich, Germany; [Aichler, Michaela; Feuchtinger, Annette] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, D-85764 Neuherberg, Germany; [Leitzinger, Christin; Zischka, Hans] Helmholtz Zentrum Munchen, Inst Mol Toxicol & Pharmacol, D-85764 Neuherberg, Germany; [Jastroch, Martin; Tschoep, Matthias] Helmholtz Zentrum Munchen, Inst Diabet & Obes, D-85764 Neuherberg, Germany; [Machicao, Fausto; Staiger, Harald; Haering, Hans-Ulrich] Univ Tubingen, Helmholtz Zentrum Munchen, Inst Diabet Res & Metab Dis, D-72076 Tubingen, Germany; [Staiger, Harald; Haering, Hans-Ulrich] Univ Tubingen, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Dept Internal Med, D-72076 Tubingen, Germany; [Chmelova, Helena; Chouinard, Julie A.; Speier, Stephan] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Helmholtz Zentrum Munchen, PLID, D-01307 Dresden, Germany; [Chmelova, Helena; Chouinard, Julie A.; Speier, Stephan] Tech Univ Dresden, Fac Med, DFG Ctr Regenerat Therapies Dresden CRTD, D-01307 Dresden, Germany; [Oskolkov, Nikolay] Lund Univ, Ctr Diabet, Diabet & Endocrinol, S-20502 Malmo, Sweden; [Korsgren, Olle] Uppsala Univ, Dept Immunol Genet & Pathol, S-75105 Uppsala, Sweden	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Karolinska Institutet; Karolinska University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Lund University; Uppsala University	Lickert, H (corresponding author), Helmholtz Zentrum Munchen, Inst Diabet & Regenerat Res, D-85764 Neuherberg, Germany.; Lickert, H (corresponding author), Helmholtz Zentrum Munchen, Inst Stem Cell Res, D-85764 Neuherberg, Germany.; Lickert, H (corresponding author), German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany.; Lickert, H (corresponding author), Tech Univ Munich, Ismaninger Str 22, D-81675 Munich, Germany.	heiko.lickert@helmholtz-muenchen.de	Feuchtinger, Annette/O-4569-2014; Beckers, Johannes/K-7237-2012; Chouinard, Julie A./AAT-4366-2021; Wang-Sattler, Rui/B-5354-2014; Gerdes, Jantje Mareike/M-9868-2014; Oskolkov, Nikolay/AAH-2349-2019; Aichler, Michaela/B-5356-2014; Chouinard, Julie A./Z-4038-2019; Jastroch, Martin/I-7494-2017; Chouinard, Julie/L-7339-2013; Moruzzi, Noah/AAC-8875-2019; Zischka, Hans/M-1490-2017; Speier, Stephan/E-8525-2010	Beckers, Johannes/0000-0001-7874-3822; Chouinard, Julie A./0000-0003-1266-3111; Wang-Sattler, Rui/0000-0002-8794-8229; Gerdes, Jantje Mareike/0000-0001-6885-5441; Chouinard, Julie/0000-0003-1266-3111; Zischka, Hans/0000-0002-4047-1566; Speier, Stephan/0000-0002-4561-7085; Tschoep, Matthias/0000-0002-4744-371X; Moruzzi, Noah/0000-0001-6868-1488; Bakhti, Mostafa/0000-0002-2307-1122; Migliorini, Adriana/0000-0002-1024-6042; Korsgren, Olle/0000-0002-8524-9547; Bader, Erik/0000-0001-9451-7235; Staiger, Harald/0000-0002-9507-5333	Strategic Research Grant from the Swedish Research Council [2009-1039]; Helmholtz post-doctoral fellowship program; Emmy-Noether Fellowship; European Union (ERC starting grant Ciliary Disease); HumEn project from the European Union [602587]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association; Helmholtz Society; Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease; German Research Foundation; German Center for Diabetes Research (DZD e.V.); Emmy-Noether Program; Center for Regenerative Therapies Dresden-DFG Research Center for Regenerative Therapies Dresden; Cluster of Excellence (CRTD); DFG-Collaborative Research Center/Transregio [127]; German Ministry for Education and Research; Novo Nordisk Fonden [NNF14OC0010935] Funding Source: researchfish	Strategic Research Grant from the Swedish Research Council; Helmholtz post-doctoral fellowship program; Emmy-Noether Fellowship(German Research Foundation (DFG)); European Union (ERC starting grant Ciliary Disease); HumEn project from the European Union; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association; Helmholtz Society(Helmholtz Association); Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease; German Research Foundation(German Research Foundation (DFG)); German Center for Diabetes Research (DZD e.V.); Emmy-Noether Program(German Research Foundation (DFG)); Center for Regenerative Therapies Dresden-DFG Research Center for Regenerative Therapies Dresden; Cluster of Excellence (CRTD); DFG-Collaborative Research Center/Transregio; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank A. Raducanu, A. Bottcher and E. Schlussel for comments and discussions; A. Theis, B. Vogel and K. Diemer for technical support; the Human Tissue Laboratory (HTL) of Lund University Diabetes Centre (LUDC) for high-quality RNA sequencing expression data from human pancreatic islets donors; to InSphero for human microislets; the European Consortium for Islet Transplantation (ECIT) for human islets; and R. Scharfmann for the EndoC-beta H1 cell line. The human islet research was supported by a Strategic Research Grant from the Swedish Research Council (2009-1039). A.M. was funded by the Helmholtz post-doctoral fellowship program. This work was supported by an Emmy-Noether Fellowship, the European Union (ERC starting grant Ciliary Disease) and the HumEn project from the European Union's Seventh Framework Programme for Research, Technological Development and Demonstration under grant agreement No. 602587 (http://www.hum-en.eu/). This work was funded (in part) for H.L. and J.B. by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association. We thank the Helmholtz Society, Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease, German Research Foundation and German Center for Diabetes Research (DZD e.V.) for financial support. This work was supported with funds for S.S. from the Emmy-Noether Program, the Center for Regenerative Therapies Dresden-DFG Research Center for Regenerative Therapies Dresden, Cluster of Excellence (CRTD), the DFG-Collaborative Research Center/Transregio 127 and the German Ministry for Education and Research to the German Centre for Diabetes Research and to the Network of Competence for Diabetes.	Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; Chmelova H, 2015, DIABETES, V64, P2148, DOI 10.2337/db14-1055; DALTON AJ, 1955, ANAT REC, V121, P281; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Feuchtinger A, 2015, HISTOCHEM CELL BIOL, V143, P1, DOI 10.1007/s00418-014-1258-2; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Gegg M, 2014, ELIFE, V3, DOI 10.7554/eLife.03842; Golson ML, 2010, OPEN ENDOCRINOL, V4, P66, DOI [10.2174/1874216501004010066, DOI 10.2174/1874216501004010066]; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; HEIMBERG H, 1993, EMBO J, V12, P2873, DOI 10.1002/j.1460-2075.1993.tb05949.x; In't Veld P, 2010, ADV EXP MED BIOL, V654, P1, DOI 10.1007/978-90-481-3271-3_1; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kalwat MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.73; Katsuta H, 2010, DIABETOLOGIA, V53, P128, DOI 10.1007/s00125-009-1570-x; Kitsou-Mylona I, 2008, CELL PHYSIOL BIOCHEM, V22, P557, DOI 10.1159/000185540; Lange A, 2012, DIFFERENTIATION, V83, pS105, DOI 10.1016/j.diff.2011.11.003; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; MEDA P, 1979, J CELL BIOL, V82, P441, DOI 10.1083/jcb.82.2.441; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; ORCI L, 1975, J CLIN INVEST, V56, P1066, DOI 10.1172/JCI108154; R Computing Team, 2014, R LANG ENV STAT COMP; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Razavi R, 2015, DIABETES, V64, P1311, DOI 10.2337/db14-0070; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; SALOMON D, 1986, EXP CELL RES, V162, P507, DOI 10.1016/0014-4827(86)90354-X; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulze T, 2016, ENDOCRINE, V51, P440, DOI 10.1007/s12020-015-0701-z; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; Staiger H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061903; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Wu YJ, 2011, J CLIN INVEST, V121, P2422, DOI 10.1172/JCI45027	44	202	210	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					430	+		10.1038/nature18624	http://dx.doi.org/10.1038/nature18624			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27398620				2022-12-24	WOS:000380344200042
J	Chen, YNP; LaMarche, MJ; Chan, HM; Fekkes, P; Garcia-Fortanet, J; Acker, MG; Antonakos, B; Chen, CHT; Chen, ZL; Cooke, VG; Dobson, JR; Deng, Z; Fei, F; Firestone, B; Fodor, M; Fridrich, C; Gao, H; Grunenfelder, D; Hao, HX; Jacob, J; Ho, S; Hsiao, K; Kang, ZB; Karki, R; Kato, M; Larrow, J; La Bonte, LR; Lenoir, F; Liu, G; Liu, SM; Majumdar, D; Meyer, MJ; Palermo, M; Perez, L; Pu, MY; Price, E; Quinn, C; Shakya, S; Shultz, MD; Slisz, J; Venkatesan, K; Wang, P; Warmuth, M; Williams, S; Yang, GZ; Yuan, J; Zhang, JH; Zhu, P; Ramsey, T; Keen, NJ; Sellers, WR; Stams, T; Fortin, PD				Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.			Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases	NATURE			English	Article							PTPN11; PROTOONCOGENE; TARGET; POTENT	The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase(1). Activating mutations of SHP2 have been associated with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukaemia, lung and breast cancer and neuroblastoma(1-5). SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway(2,3). It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways(6,7). Reduction of SHP2 activity suppresses tumour cell growth and is a potential target of cancer therapy(8,9). Here we report the discovery of a highly potent (IC50 = 0.071 mu M), selective and orally bioavailable small-molecule SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation. SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism. SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumour xenograft models. Together, these data demonstrate that pharmacological inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.	[Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.] Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA	Novartis	Sellers, WR; Stams, T; Fortin, PD (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	william.sellers@novartis.com; travis.stams@novartis.com; pafortin@gmail.com	Stams, Travis/R-5730-2019; Shakya, Subarna/AAD-1059-2019	Price, Edmund/0000-0001-6495-4725; Dobson, Jason/0000-0002-2306-2250; Fortin, Pascal/0000-0001-9796-791X; Kato, Mitsunori/0000-0002-8426-2504; Acker, Michael/0000-0002-3565-9601; Grunenfelder, Denise/0000-0002-0334-2167	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number DE-AC02-06CH11357.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Bricogne G, 2009, BUSTER VERSION 2 8 0; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Clare JJ, 2000, DRUG DISCOV TODAY, V5, P506, DOI 10.1016/S1359-6446(00)01570-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/NCHEMBIO.1427, 10.1038/nchembio.1427]; Grosskopf S, 2015, CHEMMEDCHEM, V10, P815, DOI 10.1002/cmdc.201500015; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; He RJ, 2015, ACS MED CHEM LETT, V6, P782, DOI 10.1021/acsmedchemlett.5b00118; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Schneeberger VE, 2015, ONCOTARGET, V6, P6191, DOI 10.18632/oncotarget.3356; Scott LM, 2011, BIOORG MED CHEM LETT, V21, P730, DOI 10.1016/j.bmcl.2010.11.117; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Szczepankiewicz BG, 2003, J AM CHEM SOC, V125, P4087, DOI 10.1021/ja0296733; Weisberg E, 2015, MOL CANCER THER, V14, P2249, DOI 10.1158/1535-7163.MCT-15-0429; Zeng LF, 2014, J MED CHEM, V57, P6594, DOI 10.1021/jm5006176; Zhao HY, 2004, BIOORG MED CHEM LETT, V14, P5543, DOI 10.1016/j.bmcl.2004.08.063	29	452	470	12	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					148	+		10.1038/nature18621	http://dx.doi.org/10.1038/nature18621			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362227				2022-12-24	WOS:000379015600042
J	Zhang, R; Miner, JJ; Gorman, MJ; Rausch, K; Ramage, H; White, JP; Zuiani, A; Zhang, P; Fernandez, E; Zhang, Q; Dowd, KA; Pierson, TC; Cherry, S; Diamond, MS				Zhang, Rong; Miner, Jonathan J.; Gorman, Matthew J.; Rausch, Keiko; Ramage, Holly; White, James P.; Zuiani, Adam; Zhang, Ping; Fernandez, Estefania; Zhang, Qiang; Dowd, Kimberly A.; Pierson, Theodore C.; Cherry, Sara; Diamond, Michael S.			A CRISPR screen defines a signal peptide processing pathway required by flaviviruses	NATURE			English	Article							WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; HEPATITIS-C VIRUS; MONOCLONAL-ANTIBODIES; ENVELOPE PROTEIN; HUMAN-CELLS; INFECTION; GENES; NEUTRALIZATION; IDENTIFICATION	Flaviviruses infect hundreds of millions of people annually, and no antiviral therapy is available(1,2). We performed a genome-wide CRISPR/Cas9-based screen to identify host genes that, when edited, resulted in reduced flavivirus infection. Here, we validated nine human genes required for flavivirus infectivity, and these were associated with endoplasmic reticulum functions including translocation, protein degradation, and N-linked glycosylation. In particular, a subset of endoplasmic reticulum-associated signal peptidase complex (SPCS) proteins was necessary for proper cleavage of the flavivirus structural proteins (prM and E) and secretion of viral particles. Loss of SPCS1 expression resulted in markedly reduced yield of all Flaviviridae family members tested (West Nile, dengue, Zika, yellow fever, Japanese encephalitis, and hepatitis C viruses), but had little impact on alphavirus, bunyavirus, or rhabdovirus infection or the surface expression or secretion of diverse host proteins. We found that SPCS1 dependence could be bypassed by replacing the native prM protein leader sequences with a class I major histocompatibility complex (MHC) antigen leader sequence. Thus, SPCS1, either directly or indirectly via its interactions with host proteins, preferentially promotes the processing of specific protein cargo, and Flaviviridae have a unique dependence on this signal peptide processing pathway. SPCS1 and other signal processing pathway members could represent pharmacological targets for inhibiting infection by the expanding number of flaviviruses of medical concern.	[Zhang, Rong; Miner, Jonathan J.; Gorman, Matthew J.; White, James P.; Zuiani, Adam; Zhang, Ping; Fernandez, Estefania; Zhang, Qiang; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Rausch, Keiko; Ramage, Holly; Cherry, Sara] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhang, Ping] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510080, Guangdong, Peoples R China; [Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA	Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.	diamond@borcim.wustl.edu	Diamond, Michael/AAH-1733-2019; Zhang, Rong/J-5434-2018	Diamond, Michael/0000-0002-8791-3165; cherry, sara/0000-0003-3956-6610; Dowd, Kimberly/0000-0003-3641-6852; Zhang, Rong/0000-0003-2941-4808; Ramage, Holly/0000-0002-0390-6786; Zuiani, Adam/0000-0002-2625-6595	NIH [U19 AI083019, U19 AI106772, R01 AI104972, T32 AI007163]; Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences [UL1 TR000448]; Washington University Institute of Clinical and Translational Sciences from the National Institute of General Medical Sciences [P41 GM103422-35]; NIAID; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000957, R01AI095500, R01AI074951, R01AI104972, ZIAAI001209, U19AI083019, T32AI007163, U19AI106772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences; Washington University Institute of Clinical and Translational Sciences from the National Institute of General Medical Sciences; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants U19 AI083019 (M.S.D.), U19 AI106772 (M.S.D.), R01 AI104972 (M.S.D.), and T32 AI007163 (E.F.) and by the Washington University Institute of Clinical and Translational Sciences (UL1 TR000448 from the National Center for Advancing Translational Sciences and P41 GM103422-35 from the National Institute of General Medical Sciences). T.C.P and K.A.D are supported by the intramural program of NIAID. We thank R. Kuhn, A. Garcia-Sastre, H. Zhao, D. Fremont, X. Wang, and R. Townsend for reagents, experimental advice, and data analysis; P. Erdmann-Gilmore, R. Connors, Y. Mi, and H. Lin for expert technical assistance; and X. de Lamballerie and the European Virus Archive goes Global (EVAg) for consenting to the use of H/PF/2013 ZIKV strain for this study under a material transfer agreement with the EVAg parter, Aix-Marseille Universite.	BARTH BU, 1995, J CELL BIOL, V128, P283, DOI 10.1083/jcb.128.3.283; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brien J. D, 2013, CURR PROTOC MICROBIO, V31; CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991; Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Fuchs A, 2011, VIROLOGY, V412, P101, DOI 10.1016/j.virol.2011.01.003; Gowen BG, 2015, ELIFE, V4, DOI 10.7554/eLife.08474; Hackett BA, 2015, P NATL ACAD SCI USA, V112, P7797, DOI 10.1073/pnas.1424098112; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lin TY, 2012, J VIROL, V86, P3501, DOI 10.1128/JVI.06435-11; Lindenbach BD, 2013, FIELDS VIROLOGY, P712; Lober C, 2001, VIROLOGY, V289, P224, DOI 10.1006/viro.2001.1171; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Meyer HA, 1997, J BIOL CHEM, V272, P13159, DOI 10.1074/jbc.272.20.13159; Miner JJ, 2011, J BIOL CHEM, V286, P9577, DOI 10.1074/jbc.M110.208777; Mishin VP, 2001, VIRUS RES, V81, P113, DOI 10.1016/S0168-1702(01)00371-9; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Rose PP, 2011, CELL HOST MICROBE, V10, P97, DOI 10.1016/j.chom.2011.06.009; Sabo MC, 2011, J VIROL, V85, P7005, DOI 10.1128/JVI.00586-11; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Suzuki R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003589; Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weaver Scott C, 2016, Antiviral Res, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914	49	245	261	4	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					164	+		10.1038/nature18625	http://dx.doi.org/10.1038/nature18625			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27383988	Green Accepted, Bronze			2022-12-24	WOS:000379015600045
J	Neves, J; Zhu, J; Sousa-Victor, P; Konjikusic, M; Riley, R; Chew, S; Qi, YY; Jasper, H; Lamba, DA				Neves, Joana; Zhu, Jie; Sousa-Victor, Pedro; Konjikusic, Mia; Riley, Rebeccah; Chew, Shereen; Qi, Yanyan; Jasper, Heinrich; Lamba, Deepak A.			Immune modulation by MANF promotes tissue repair and regenerative success in the retina	SCIENCE			English	Article							NEUROTROPHIC FACTOR; MICROGLIAL ACTIVATION; BLOOD-CELLS; DROSOPHILA; DEGENERATION; MACROPHAGES; MOUSE; SURVIVAL; DNA; DIFFERENTIATION	Regenerative therapies are limited by unfavorable environments in aging and diseased tissues. A promising strategy to improve success is to balance inflammatory and anti-inflammatory signals and enhance endogenous tissue repair mechanisms. Here, we identified a conserved immune modulatory mechanism that governs the interaction between damaged retinal cells and immune cells to promote tissue repair. In damaged retina of flies and mice, platelet-derived growth factor (PDGF)-like signaling induced mesencephalic astrocyte-derived neurotrophic factor (MANF) in innate immune cells. MANF promoted alternative activation of innate immune cells, enhanced neuroprotection and tissue repair, and improved the success of photoreceptor replacement therapies. Thus, immune modulation is required during tissue repair and regeneration. This approach may improve the efficacy of stem-cell-based regenerative therapies.	[Neves, Joana; Zhu, Jie; Sousa-Victor, Pedro; Konjikusic, Mia; Riley, Rebeccah; Chew, Shereen; Qi, Yanyan; Jasper, Heinrich; Lamba, Deepak A.] Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA	Buck Institute for Research on Aging	Jasper, H; Lamba, DA (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	hjasper@buckinstitute.org; dlamba@buckinstitute.org	Sousa-Victor, Pedro/AER-5744-2022	Mendes Neves, Joana/0000-0002-1027-3489; Chew, Shereen/0000-0002-7285-6604	NIH [EY018177, EY025779]; Amarantus Biosciences Inc.; Foundation for Retinal Research; Glenn Foundation for Medical Research; NATIONAL EYE INSTITUTE [R01EY018177, R01EY025779] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amarantus Biosciences Inc.; Foundation for Retinal Research; Glenn Foundation for Medical Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We acknowledge Amarantus Biosciences Inc. for kindly supplying the hrMANF protein used in these studies. Work in H.J.'s laboratory is supported by NIH grant EY018177, and some of the fly work was supported by Amarantus Biosciences Inc. Work in D.A.L.'s laboratory is supported by NIH grant EY025779 and the Foundation for Retinal Research. J.N. is supported by the Glenn Foundation for Medical Research. The full RNA-seq data set is provided as supplementary materials. J.N., H.J., and D.A.L. are the inventors and the Buck Institute for Research on Aging is the applicant for an international patent application for the use of MANF as an enhancer of cell replacement therapies.	Abrams EW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077618; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Babcock DT, 2008, P NATL ACAD SCI USA, V105, P10017, DOI 10.1073/pnas.0709951105; Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110; Belacortu Y, 2011, DEV DYNAM, V240, P2379, DOI 10.1002/dvdy.22753; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Cao XG, 2011, PATHOL INT, V61, P528, DOI 10.1111/j.1440-1827.2011.02695.x; Chen LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08133; Chen M, 2013, INVEST OPHTH VIS SCI, V54, P682, DOI 10.1167/iovs.12-10888; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; DOHERTY TM, 1993, J IMMUNOL, V151, P7151; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; DZIENNIS S, 1995, BLOOD, V85, P319; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Gust J, 2011, INVEST OPHTH VIS SCI, V52, P5266, DOI 10.1167/iovs.10-6329; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Jassim OW, 2003, EMBO J, V22, P5622, DOI 10.1093/emboj/cdg543; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Karpac J, 2011, DEV CELL, V20, P841, DOI 10.1016/j.devcel.2011.05.011; KEELER C, 1966, J HERED, V57, P47, DOI 10.1093/oxfordjournals.jhered.a107462; Kelsey EM, 2012, J CELL SCI, V125, P1393, DOI 10.1242/jcs.095323; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Luo X, 2007, EMBO J, V26, P380, DOI 10.1038/sj.emboj.7601484; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Nadella R, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0209-0; Neves J, 2015, DEV CELL, V32, P9, DOI 10.1016/j.devcel.2014.11.028; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Pearson RA, 2014, VISUAL NEUROSCI, V31, P333, DOI 10.1017/S0952523814000200; Peng B, 2014, J NEUROSCI, V34, P8139, DOI 10.1523/JNEUROSCI.5200-13.2014; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; PITTLER SJ, 1993, P NATL ACAD SCI USA, V90, P9616, DOI 10.1073/pnas.90.20.9616; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Razzell W, 2011, DIS MODEL MECH, V4, P569, DOI 10.1242/dmm.006825; Reynolds J, 2014, EXP EYE RES, V123, P151, DOI 10.1016/j.exer.2013.07.010; Samson ML, 2000, J BIOL CHEM, V275, P31107, DOI 10.1074/jbc.M001346200; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Sinenko SA, 2004, ONCOGENE, V23, P9120, DOI 10.1038/sj.onc.1208156; Song ZW, 2000, MOL CELL BIOL, V20, P2907, DOI 10.1128/MCB.20.8.2907-2914.2000; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; Stratoulias V, 2015, CELL MOL LIFE SCI, V72, P1989, DOI 10.1007/s00018-014-1789-7; Tang ZS, 2010, J EXP MED, V207, P867, DOI 10.1084/jem.20091704; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Wang LH, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00113; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; West EL, 2010, STEM CELLS, V28, P1997, DOI 10.1002/stem.520; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384; Yang S, 2014, NEURON, V81, P349, DOI 10.1016/j.neuron.2013.12.002; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhang C, 2005, MOL VIS, V11, P887; Zhao H, 2016, MOL NEUROBIOL, V53, P187, DOI 10.1007/s12035-014-9000-6	78	140	146	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294							aaf3646	10.1126/science.aaf3646	http://dx.doi.org/10.1126/science.aaf3646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365452	Green Accepted			2022-12-24	WOS:000378816200029
J	Sotgiu, G; Tiberi, S; D'Ambrosio, L; Centis, R; Zumla, A; Migliori, GB				Sotgiu, Giovanni; Tiberi, Simon; D'Ambrosio, Lia; Centis, Rosella; Zumla, Alimuddin; Migliori, Giovanni Battista			WHO recommendations on shorter treatment of multidrug-resistant tuberculosis	LANCET			English	Editorial Material							HOST-DIRECTED THERAPIES; REGIMENS; DRUGS		[Sotgiu, Giovanni] Univ Sassari, Clin Epidemiol & Med Stat Unit, Dept Biomed Sci, Res Med Educ & Profess Dev Unit,AOU Sassari, I-07100 Sassari, Italy; [Tiberi, Simon] Barts Hlth NHS Trust, Div Infect, London, England; [D'Ambrosio, Lia; Centis, Rosella; Migliori, Giovanni Battista] IRCCS, Fdn S Maugeri, Care & Res Inst, I-21049 Tradate, Italy; [D'Ambrosio, Lia] Publ Hlth Consulting Grp, Lugano, Switzerland; [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England; [Zumla, Alimuddin] UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England	University of Sassari; Barts Health NHS Trust; Istituti Clinici Scientifici Maugeri IRCCS; University of London; University College London; University of London; University College London	Migliori, GB (corresponding author), IRCCS, Fdn S Maugeri, Care & Res Inst, I-21049 Tradate, Italy.	giovannibattista.migliori@fsm.it	Migliori, Giovanni Battista/AAB-8589-2020; Tiberi, Simon/I-2552-2019; Sotgiu, Giovanni/N-1032-2017; Centis, Rosella/E-8882-2018; ZUMLA, Alimuddin/ABA-8208-2020	Migliori, Giovanni Battista/0000-0002-2597-574X; Tiberi, Simon/0000-0001-9424-6551; Sotgiu, Giovanni/0000-0002-1600-4474; Centis, Rosella/0000-0002-8551-3598; ZUMLA, Alimuddin/0000-0002-5111-5735				Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Caminero JA, 2015, EUR RESPIR J, V46, P887, DOI 10.1183/13993003.00432-2015; Ghimire S, 2016, EUR RESPIR J, V47, P1867, DOI 10.1183/13993003.00040-2016; Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312; Piubello A, 2014, INT J TUBERC LUNG D, V18, P1188, DOI 10.5588/ijtld.13.0075; Tiberi S, 2016, EUR RESPIR J, V47, P1758, DOI 10.1183/13993003.00214-2016; Tiberi S, 2016, EUR RESPIR J, V47, P1235, DOI 10.1183/13993003.02146-2015; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Wallis RS, 2016, LANCET INFECT DIS, V16, pE34, DOI 10.1016/S1473-3099(16)00070-0; WHO, 2016, TREATM GUID DRUG RES; World Health Organization, 2016, GLOB TUB REP 2015; World Health Organization (WHO), 2015, MULT RES TUB MDR TB; Zumla A, 2016, LANCET INFECT DIS, V16, pE47, DOI 10.1016/S1473-3099(16)00078-5; [No title captured]	14	37	42	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2486	2487		10.1016/S0140-6736(16)30729-2	http://dx.doi.org/10.1016/S0140-6736(16)30729-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27353670	Green Submitted			2022-12-24	WOS:000377947200007
J	Bettigole, C; Farley, TA				Bettigole, Cheryl; Farley, Thomas A.			The Philadelphia Story: Attacking Behavioral and Social Determinants of Health	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK		[Bettigole, Cheryl; Farley, Thomas A.] Philadelphia Dept Publ Hlth, 1401 JFK Blvd,Room 600, Philadelphia, PA 19102 USA; Philadelphia Dept Publ Hlth, 1101 Market St,9th Floor, Philadelphia, PA 19107 USA		Farley, TA (corresponding author), Philadelphia Dept Publ Hlth, 1401 JFK Blvd,Room 600, Philadelphia, PA 19102 USA.							CDC Division of Diabetes Translation, 2016, LONG TERM TRENDS DIA; de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Gortmaker SL, BRIEF COST EFFECTIVE; Gortmaker SL, 2015, AM J PREV MED, V49, P102, DOI 10.1016/j.amepre.2015.03.032; Gregg EW, 2014, LANCET DIABETES ENDO, V2, P867, DOI 10.1016/S2213-8587(14)70161-5; Karoly LA, 2005, PROVEN BENEFITS EARL; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; U.S. Department of Agriculture Economic Research Service, 2016, REP FOOD AV PER CAP	9	3	3	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2016	165	8					593	+		10.7326/M16-1570	http://dx.doi.org/10.7326/M16-1570			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6BM	27429182				2022-12-24	WOS:000385946600022
J	Vermeij, WP; Dolle, MET; Reiling, E; Jaarsma, D; Payan-Gomez, C; Bombardieri, CR; Wu, H; Roks, AJM; Botter, SM; van der Eerden, BC; Youssef, SA; Kuiper, RV; Nagarajah, B; van Oostrom, CT; Brandt, RMC; Barnhoorn, S; Imholz, S; Pennings, JLA; de Bruin, A; Gyenis, A; Pothof, J; Vijg, J; van Steeg, H; Hoeijmakers, JHJ				Vermeij, W. P.; Dolle, M. E. T.; Reiling, E.; Jaarsma, D.; Payan-Gomez, C.; Bombardieri, C. R.; Wu, H.; Roks, A. J. M.; Botter, S. M.; van der Eerden, B. C.; Youssef, S. A.; Kuiper, R. V.; Nagarajah, B.; van Oostrom, C. T.; Brandt, R. M. C.; Barnhoorn, S.; Imholz, S.; Pennings, J. L. A.; de Bruin, A.; Gyenis, A.; Pothof, J.; Vijg, J.; van Steeg, H.; Hoeijmakers, J. H. J.			Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice	NATURE			English	Article							CALORIC RESTRICTION; NUCLEAR ABNORMALITIES; COCKAYNE-SYNDROME; GROWTH; DEGENERATION; COMPONENT; MODELS; CANCER; P53	Mice deficient in the DNA excision-repair gene Ercc1 (Ercc1(Delta/-)) show numerous accelerated ageing features that limit their lifespan to 4-6 months(1-4). They also exhibit a 'survival response', which suppresses growth and enhances cellular maintenance. Such a response resembles the anti-ageing response induced by dietary restriction (also known as caloric restriction)(1,5). Here we report that a dietary restriction of 30% tripled the median and maximal remaining lifespans of these progeroid mice, strongly retarding numerous aspects of accelerated ageing. Mice undergoing dietary restriction retained 50% more neurons and maintained full motor function far beyond the lifespan of mice fed ad libitum. Other DNA-repair-deficient, progeroid Xpg(-/-) (also known as Ercc5(-/-)) mice, a model of Cockayne syndrome(6), responded similarly. The dietary restriction response in Ercc1(Delta/-) mice closely resembled the effects of dietary restriction in wild-type animals. Notably, liver tissue from Ercc1(Delta/-) mice fed ad libitum showed preferential extinction of the expression of long genes, a phenomenon we also observed in several tissues ageing normally. This is consistent with the accumulation of stochastic, transcription-blocking lesions that affect long genes more than short ones. Dietary restriction largely prevented this declining transcriptional output and reduced the number of gamma H2AX DNA damage foci, indicating that dietary restriction preserves genome function by alleviating DNA damage. Our findings establish the Ercc1(Delta/-) mouse as a powerful model organism for health-sustaining interventions, reveal potential for reducing endogenous DNA damage, facilitate a better understanding of the molecular mechanism of dietary restriction and suggest a role for counterintuitive dietary-restriction-like therapy for human progeroid genome instability syndromes and possibly neurodegeneration in general.	[Vermeij, W. P.; Reiling, E.; Payan-Gomez, C.; Bombardieri, C. R.; Botter, S. M.; Brandt, R. M. C.; Barnhoorn, S.; Gyenis, A.; Pothof, J.; Hoeijmakers, J. H. J.] Erasmus Univ, Dept Mol Genet, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Dolle, M. E. T.; Reiling, E.; Nagarajah, B.; van Oostrom, C. T.; Imholz, S.; Pennings, J. L. A.; van Steeg, H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, POB 1, NL-3720 BA Bilthoven, Netherlands; [Jaarsma, D.] Erasmus Univ, Med Ctr Rotterdam, Dept Neurosci, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Payan-Gomez, C.] Univ Rosario, Fac Ciencias Nat & Matemat, Carrera 24,63C-69, Bogota, Colombia; [Wu, H.; Roks, A. J. M.] Erasmus Univ, Div Vasc Med & Pharmacol, Dept Internal Med, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Botter, S. M.] Balgrist Univ Hosp, Lab Orthoped Res, Forchstr 340, CH-8008 Zurich, Switzerland; [van der Eerden, B. C.] Erasmus Univ, Dept Internal Med, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Youssef, S. A.; Kuiper, R. V.; de Bruin, A.] Univ Utrecht, Dept Pathobiol, Dutch Mol Pathol Ctr, Fac Vet Med, POB 80125, NL-3508 TC Utrecht, Netherlands; [de Bruin, A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Div Mol Genet, POB 30001, NL-9700 RB Groningen, Netherlands; [Vijg, J.] Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [van Steeg, H.] Leiden Univ, Med Ctr, Dept Human Genet, POB 9600, NL-2300 RC Leiden, Netherlands; [Hoeijmakers, J. H. J.] Univ Cologne, CECAD Forschungszentrum, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Kuiper, R. V.] Karolinska Inst, Dept Lab Med, SE-17177 Stockholm, Sweden	Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Universidad del Rosario; Erasmus University Rotterdam; Erasmus MC; University of Zurich; Erasmus University Rotterdam; Erasmus MC; Utrecht University; University of Groningen; Yeshiva University; Albert Einstein College of Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cologne; Karolinska Institutet	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Dept Mol Genet, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands.; Dolle, MET (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, POB 1, NL-3720 BA Bilthoven, Netherlands.	martijn.dolle@rivm.nl; j.hoeijmakers@erasmusmc.nl	de Bruin, Alain/AAL-9195-2020; van der Eerden, Bram CJ/I-7496-2012; Hoeijmakers, Jan/AAX-6972-2021; Payan-Gomez, Cesar/G-8589-2016	van der Eerden, Bram CJ/0000-0003-4403-6497; Brandt, Renata M. C./0000-0003-0514-5623; Dolle, Martijn/0000-0001-6137-6544; Vermeij, Wilbert/0000-0002-9690-1385; Roks, Anton J.M./0000-0001-7155-1756; Payan-Gomez, Cesar/0000-0002-0633-1332; Pennings, Jeroen L.A./0000-0002-9188-6358; Gyenis, Akos/0000-0002-8104-7681; Kuiper, Raoul/0000-0001-5645-2389	National Institute of Health (NIH)/National Institute of Ageing (NIA) [1PO1 AG-17242-02]; National Institute for Public Health and the Environment; Ministry of Health, Welfare and Sport of The Netherlands [S/340005]; European Research Council; European commission [FP7-Health-2008-200880]; DNA Repair [LSHG-CT-2005-512113]; EU ITN Address [GA-316390]; KWO Dutch Cancer Society [5030]; Dutch CAA Foundation; Royal Academy of Arts and Sciences of the Netherlands; European Community [HEALTH-F2-2010-259893]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	National Institute of Health (NIH)/National Institute of Ageing (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Public Health and the Environment; Ministry of Health, Welfare and Sport of The Netherlands; European Research Council(European Research Council (ERC)European Commission); European commission(European CommissionEuropean Commission Joint Research Centre); DNA Repair; EU ITN Address; KWO Dutch Cancer Society; Dutch CAA Foundation; Royal Academy of Arts and Sciences of the Netherlands; European Community(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. de With, J. Rigters, E. Haasdijk, S. Gabriels, E. J. M. Stynenbosch, N. van Vliet, Y. van Loon, J. Baan and the animal caretakers for general assistance with mouse experiments. We thank A. H. J. Danser and J. P. van Leeuwen for support. We acknowledge financial support from the National Institute of Health (NIH)/National Institute of Ageing (NIA) (1PO1 AG-17242-02), the National Institute for Public Health and the Environment and the Ministry of Health, Welfare and Sport of The Netherlands (S/340005), European Research Council Advanced Grant DamAge and Proof of Concept Grant Dementia to J. H. J. H., the European commission FP7 Markage (FP7-Health-2008-200880), DNA Repair (LSHG-CT-2005-512113), EU ITN Address (GA-316390), the KWO Dutch Cancer Society (5030), the Dutch CAA Foundation and the Royal Academy of Arts and Sciences of the Netherlands (academia professorship to J. H. J. H.). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number HEALTH-F2-2010-259893. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhoorn S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004686; Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Borgesius NZ, 2011, J NEUROSCI, V31, P12543, DOI 10.1523/JNEUROSCI.1589-11.2011; Botter SM, 2009, OSTEOARTHR CARTILAGE, V17, P636, DOI 10.1016/j.joca.2008.09.018; Campisi J, 2014, INTERD T GERONT GERI, V39, P45, DOI 10.1159/000358899; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; de Graaf EL, 2013, MOL CELL PROTEOMICS, V12, P1350, DOI 10.1074/mcp.M112.024950; de Waard MC, 2010, ACTA NEUROPATHOL, V120, P461, DOI 10.1007/s00401-010-0715-9; Derks KWJ, 2015, RNA BIOL, V12, P30, DOI 10.1080/15476286.2015.1017202; Dolle MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Jaarsma D, 2013, MECH AGEING DEV, V134, P180, DOI 10.1016/j.mad.2013.04.003; Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Navarro F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132767; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Partridge L, 2007, NATURE, V450, P165, DOI 10.1038/450165a; Raj DDA, 2014, NEUROBIOL AGING, V35, P2147, DOI 10.1016/j.neurobiolaging.2014.03.025; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Stranahan AM, 2012, J ALZHEIMERS DIS, V30, pS5, DOI 10.3233/JAD-2011-110899; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; Vermeij WP, 2016, ANNU REV PHARMACOL, V56, P427, DOI 10.1146/annurev-pharmtox-010814-124316; Waarsing JH, 2004, J BONE MINER RES, V19, P1640, DOI 10.1359/JBMR.040705; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002; Wilson BT, 2016, GENET MED, V18, P483, DOI 10.1038/gim.2015.110	46	141	146	4	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					427	+		10.1038/nature19329	http://dx.doi.org/10.1038/nature19329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27556946	Green Accepted, Green Published			2022-12-24	WOS:000383098000059
J	Marcinkiewcz, CA; Mazzone, CM; D'Agostino, G; Halladay, LR; Hardaway, JA; DiBerto, JF; Navarro, M; Burnham, N; Cristiano, C; Dorrier, CE; Tipton, GJ; Ramakrishnan, C; Kozicz, T; Deisseroth, K; Thiele, TE; McElligott, ZA; Holmes, A; Heisler, LK; Kash, TL				Marcinkiewcz, Catherine A.; Mazzone, Christopher M.; D'Agostino, Giuseppe; Halladay, Lindsay R.; Hardaway, J. Andrew; DiBerto, Jeffrey F.; Navarro, Montserrat; Burnham, Nathan; Cristiano, Claudia; Dorrier, Cayce E.; Tipton, Gregory J.; Ramakrishnan, Charu; Kozicz, Tamas; Deisseroth, Karl; Thiele, Todd E.; McElligott, Zoe A.; Holmes, Andrew; Heisler, Lora K.; Kash, Thomas L.			Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala	NATURE			English	Article							STRIA TERMINALIS; BED NUCLEUS; CITALOPRAM; FLUOXETINE	Serotonin (also known as 5-hydroxytryptamine (5-HT)) is a neurotransmitter that has an essential role in the regulation of emotion. However, the precise circuits have not yet been defined through which aversive states are orchestrated by 5-HT. Here we show that 5-HT from the dorsal raphe nucleus (5-HTDRN) enhances fear and anxiety and activates a subpopulation of corticotropin-releasing factor (CRF) neurons in the bed nucleus of the stria terminal's (CRFBNST,) in mice. Specifically, 5-HTDRN projections to the BNST, via actions at 5-HT2C receptors (5-HT(2C)Rs), engage a CRFBNST inhibitory microcircuit that silences anxiolytic BNST outputs to the ventral tegmental area and lateral hypothalamus. Furthermore, we demonstrate that this CRFBNST inhibitory circuit underlies aversive behaviour following acute exposure to selective serotonin reuptake inhibitors (SSRIs). This early aversive effect is mediated via the corticotrophin-releasing factor type 1 receptor (CRF1R, also known as CRHR1), given that CRF1R antagonism is sufficient to prevent acute SSRI-induced enhancements in aversive learning. These results reveal an essential 5-HTDRN -> CRFBNST circuit governing fear and anxiety, and provide a potential mechanistic explanation for the clinical observation of early adverse events to SSRI treatment in some patients with anxiety disorders(1,2).	[Marcinkiewcz, Catherine A.; Mazzone, Christopher M.; Hardaway, J. Andrew; DiBerto, Jeffrey F.; Dorrier, Cayce E.; Tipton, Gregory J.; Thiele, Todd E.; McElligott, Zoe A.; Kash, Thomas L.] Univ North Carolina Chapel Hill, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Mazzone, Christopher M.; Kash, Thomas L.] Univ North Carolina Chapel Hill, Sch Med, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; [D'Agostino, Giuseppe; Cristiano, Claudia; Heisler, Lora K.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB25 2ZD, Scotland; [Halladay, Lindsay R.; Holmes, Andrew] NIAAA, NIH, Rockville, MD 20852 USA; [Navarro, Montserrat; Burnham, Nathan; Thiele, Todd E.; Kash, Thomas L.] Univ North Carolina Chapel Hill, Coll Arts & Sci, Dept Psychol & Neurosci, Chapel Hill, NC 27599 USA; [Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kozicz, Tamas] Tulane Univ, Hayward Genet Ctr, New Orleans, LA 70112 USA; [Kozicz, Tamas] Radboud Univ Nijmegen, Med Ctr, Dept Anat, NL-6500 HB Nijmegen, Netherlands; [McElligott, Zoe A.] Univ North Carolina Chapel Hill, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA; [Kash, Thomas L.] Univ North Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Aberdeen; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Stanford University; Tulane University; Radboud University Nijmegen; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Marcinkiewcz, CA (corresponding author), Univ North Carolina Chapel Hill, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA.		Kash, Thomas/G-9625-2013; Marcinkiewcz, Catherine/X-2339-2019; Cristiano, Claudia/ABH-2794-2021; McElligott, Zoe/AAX-5415-2021; Halladay, Lindsay/AAC-9950-2020; D'Agostino, Giuseppe/F-3399-2012	Marcinkiewcz, Catherine/0000-0001-7161-7815; Cristiano, Claudia/0000-0002-4806-1764; Halladay, Lindsay/0000-0003-2232-6709; Heisler, Lora/0000-0002-7731-1419; D'Agostino, Giuseppe/0000-0002-3502-4251	NIH [AA019454, AA011605, K01AA023555]; Wellcome Trust [098012]; Biotechnology and Biological Sciences Research Council [BB/K001418/1]; Alcohol Beverage Medical Research Fund; NIAAA [AA021319-02, F31AA023440]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH076694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA021319, K01AA023555, ZIAAA000411, R01AA019454, P50AA011605, P60AA011605, F31AA023440] Funding Source: NIH RePORTER; BBSRC [BB/K001418/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alcohol Beverage Medical Research Fund; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We acknowledge B. Roth for providing DREADD viral constructs and Sert<SUP>Cre</SUP> mice, and B. Lowell for providing Crf<SUP>Cre</SUP> mice. We also thank A. Lopez, D. Perron, and A. Kendra for technical assistance with stereotaxic surgeries on mice, B. Geenen for technical assistance with immunohistochemistry and E. Dankoski for technical assistance with the FSCV. This work was supported by NIH grants AA019454, AA011605 (T.L.K.), the Wellcome Trust (098012) and the Biotechnology and Biological Sciences Research Council grant (BB/K001418/1) (L.K.H.) and by NIH grant K01AA023555 and the Alcohol Beverage Medical Research Fund (Z.A.M.). C.A.M. was supported by a postdoctoral NIAAA F32 fellowship (AA021319-02). C.M.M. is supported by a predoctoral NIAAA F31 fellowship (F31AA023440).	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Belzung C, 2001, BEHAV PHARMACOL, V12, P151, DOI 10.1097/00008877-200105000-00001; Burghardt NS, 2007, BIOL PSYCHIAT, V62, P1111, DOI 10.1016/j.biopsych.2006.11.023; Burke LK, 2016, MOL METAB, V5, P245, DOI 10.1016/j.molmet.2016.01.005; Dabrowska J, 2011, PSYCHONEUROENDOCRINO, V36, P1312, DOI 10.1016/j.psyneuen.2011.03.003; Dekeyne A, 2000, NEUROPHARMACOLOGY, V39, P1114, DOI 10.1016/S0028-3908(99)00268-3; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/nmeth.2996, 10.1038/NMETH.2996]; GORMAN JM, 1987, J CLIN PSYCHOPHARM, V7, P329; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Huang MM, 2010, J PHARMACOL EXP THER, V332, P298, DOI 10.1124/jpet.109.159186; Javelot Herve, 2011, Depress Res Treat, V2011, P531435, DOI 10.1155/2011/531435; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Liu J, 2010, PSYCHOPHARMACOLOGY, V207, P535, DOI 10.1007/s00213-009-1684-3; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Mombereau C, 2010, INT J NEUROPSYCHOPH, V13, P321, DOI 10.1017/S1461145709990630; Olive MF, 2002, PHARMACOL BIOCHEM BE, V72, P213, DOI 10.1016/S0091-3057(01)00748-1; PHELIX CF, 1992, BRAIN RES BULL, V28, P943, DOI 10.1016/0361-9230(92)90217-L; Ravinder S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.137; WESTENBERG HGM, 1989, PSYCHOPATHOLOGY, V22, P68, DOI 10.1159/000284628	20	232	233	11	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					97	101		10.1038/nature19318	http://dx.doi.org/10.1038/nature19318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556938	Green Submitted, Green Accepted			2022-12-24	WOS:000382426900046
J	Tan, CH; McNaughton, PA				Tan, Chun-Hsiang; McNaughton, Peter A.			The TRPM2 ion channel is required for sensitivity to warmth	NATURE			English	Article							2-AMINOETHOXYDIPHENYL BORATE; CAPSAICIN-RECEPTOR; MICE LACKING; CA2+ INFLUX; ADP-RIBOSE; HEAT; TRPV2; THERMOSENSATION; NEURONS; SENSOR	Thermally activated ion channels are known to detect the entire thermal range from extreme heat (TRPV2), painful heat (TRPV1, TRPM3 and ANO1), non-painful warmth (TRPV3 and TRPV4) and non-painful coolness (TRPM8) through to painful cold (TRPA1)(1-7). Genetic deletion of each of these ion channels, however, has only modest effects on thermal behaviour in mice(6-12), with the exception of TRPM8, the deletion of which has marked effects on the perception of moderate coolness in the range 10-25 degrees C-13. The molecular mechanism responsible for detecting non-painful warmth, in particular, is unresolved. Here we used calcium imaging to identify a population of thermally sensitive somatosensory neurons which do not express any of the known thermally activated TRP channels. We then used a combination of calcium imaging, electrophysiology and RNA sequencing to show that the ion channel generating heat sensitivity in these neurons is TRPM2. Autonomic neurons, usually thought of as exclusively motor, also express TRPM2 and respond directly to heat. Mice in which TRPM2 had been genetically deleted showed a striking deficit in their sensation of non-noxious warm temperatures, consistent with the idea that TRPM2 initiates a 'warm' signal which drives cool-seeking behaviour.	[Tan, Chun-Hsiang; McNaughton, Peter A.] Kings Coll London, Wolfson Ctr Age Related Dis, Guys Campus, London SE1 1UL, England; [Tan, Chun-Hsiang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan	University of London; King's College London; Kaohsiung Medical University; Kaohsiung Medical University Hospital	McNaughton, PA (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Guys Campus, London SE1 1UL, England.	peter.mcnaughton@kcl.ac.uk		Tan, Chun-Hsiang/0000-0001-6950-4678; McNaughton, Peter/0000-0003-1946-9610	BBSRC (UK); Raymond & Beverley Sackler studentship; BBSRC [BB/L002787/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L002787/1] Funding Source: researchfish	BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Raymond & Beverley Sackler studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Tolkovsky for help and advice, R.-L. Yu for assistance with experiments, Y. Mori for Trpm2<SUP>-/-</SUP> mice and for the cDNA for mouse TRPM2, S. Birren for MAH cells, J. Wood for loan of the thermal-preference test apparatus, S. Skerratt for PF-4674114, and E. Smith, J. Btesh, D. Andersson, and T. Buijs for their comments on the manuscript. Initial experiments were performed in the Department of Pharmacology, University of Cambridge. Supported by a grant from the BBSRC (UK) to P.A.McN. and a Raymond & Beverley Sackler studentship to C.-H.T.	Ariza-McNaughton L, 2002, INT REV NEUROBIOL, V47, P239; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang SM, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-37; Jang Y, 2014, PFLUG ARCH EUR J PHY, V466, P1987, DOI 10.1007/s00424-013-1436-4; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Miyamoto T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1371; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nagy I, 1999, NEUROSCIENCE, V88, P995, DOI 10.1016/S0306-4522(98)00535-1; Naziroglu M, 2011, J MEMBRANE BIOL, V241, P69, DOI 10.1007/s00232-011-9363-9; Schmid D, 2011, NEUROSCI LETT, V488, P168, DOI 10.1016/j.neulet.2010.11.022; Togashi K, 2008, BRIT J PHARMACOL, V153, P1324, DOI 10.1038/sj.bjp.0707675; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vennekens R., 2007, V179, P269; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758	31	150	153	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					460	+		10.1038/nature19074	http://dx.doi.org/10.1038/nature19074			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27533035	Green Submitted, Green Accepted			2022-12-24	WOS:000382646600042
J	Blouin, CM; Hamon, Y; Gonnord, P; Boularan, C; Kagan, J; de Lesegno, CV; Ruez, R; Mailfert, S; Bertaux, N; Loew, D; Wunder, C; Johannes, L; Vogt, G; Contreras, FX; Marguet, D; Casanova, JL; Gales, C; He, HT; Lamaze, C				Blouin, Cedric M.; Hamon, Yannick; Gonnord, Pauline; Boularan, Cedric; Kagan, Jeremy; de Lesegno, Christine Viaris; Ruez, Richard; Mailfert, Sebastien; Bertaux, Nicolas; Loew, Damarys; Wunder, Christian; Johannes, Ludger; Vogt, Guillaume; Contreras, Francesc-Xabier; Marguet, Didier; Casanova, Jean-Laurent; Gales, Celine; He, Hai-Tao; Lamaze, Christophe			Glycosylation-Dependent IFN-gamma R Partitioning in Lipid and Actin Nanodomains Is Critical for JAK Activation	CELL			English	Article							PLASMA-MEMBRANE; INTERFERON-GAMMA; SIGNAL-TRANSDUCTION; GLYCAN INTERACTIONS; PROTEIN COMPLEXES; RECEPTOR COMPLEX; LIVING CELLS; ORGANIZATION; SUSCEPTIBILITY; MECHANISMS	Understanding how membrane nanoscale organization controls transmembrane receptors signaling activity remains a challenge. We studied interferon-gamma receptor (IFN-gamma R) signaling in fibroblasts from homozygous patients with a T168N mutation in IFNGR2. By adding a neo-N-glycan on IFN-gamma R2 subunit, this mutation blocks IFN-gamma activity by unknown mechanisms. We show that the lateral diffusion of IFN-gamma R2 is confined by sphingolipid/cholesterol nanodomains. In contrast, the IFN-gamma R2 T168N mutant diffusion is confined by distinct actin nanodomains where conformational changes required for Janus-activated tyrosine kinase/signal transducer and activator of transcription (JAK/STAT) activation by IFN-gamma could not occur. Removing IFN-gamma R2 T168N-bound galectins restored lateral diffusion in lipid nanodomains and JAK/STAT signaling in patient cells, whereas adding galectins impaired these processes in control cells. These experiments prove the critical role of dynamic receptor interactions with actin and lipid nanodomains and reveal a new function for receptor glycosylation and galectins. Our study establishes the physiological relevance of membrane nanodomains in the control of transmembrane receptor signaling in vivo.	[Blouin, Cedric M.; Kagan, Jeremy; de Lesegno, Christine Viaris; Ruez, Richard; Wunder, Christian; Johannes, Ludger; Lamaze, Christophe] PSL Res Univ, Inst Curie, CNRS UMR3666, INSERM U1143, F-75005 Paris, France; [Hamon, Yannick; Mailfert, Sebastien; Marguet, Didier; He, Hai-Tao] Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, INSERM, Marseille, France; [Gonnord, Pauline] Ctr Physiol Toulouse Purpan CPTP, INSERM U1043, F-31300 Toulouse, France; [Boularan, Cedric; Gales, Celine] Univ Toulouse III Paul Sabatier, Inst Malad Metabol & Cardiovasc, INSERM U1048, F-31432 Toulouse, France; [Bertaux, Nicolas] Aix Marseille Univ, CNRS, Inst Fresnel, Cent Marseille, Marseille, France; [Loew, Damarys] PSL Res Univ, Inst Curie, Prote & Mass Spectrometry Lab, F-75005 Paris, France; [Vogt, Guillaume; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Vogt, Guillaume; Casanova, Jean-Laurent] Imagine Inst, Necker Hosp Sick Children, Necker Branch, Lab Human Genet Infect Dis,INSERM UMR1163, F-75015 Paris, France; [Vogt, Guillaume; Casanova, Jean-Laurent] Univ Paris 05, F-75006 Paris, France; [Contreras, Francesc-Xabier] Univ Basque Country, CSIC, Inst Biofis, POB 644, E-48080 Bilbao, Spain; [Contreras, Francesc-Xabier] Univ Basque Country, Dept Bioquim & Biol Mol, POB 644, E-48080 Bilbao, Spain; [Contreras, Francesc-Xabier] IKERBASQUE Basque Fdn Sci, E-48011 Bilbao, Spain; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol Immunol Unit, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Lamaze, C (corresponding author), PSL Res Univ, Inst Curie, CNRS UMR3666, INSERM U1143, F-75005 Paris, France.; He, HT (corresponding author), Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, INSERM, Marseille, France.	he@ciml.univ-mrs.fr; christophe.lamaze@curie.fr	Johannes, Ludger/W-8593-2019; Marguet, Didier/B-9946-2008; HAMON, Yannick/S-3118-2019; Wunder, Christian/K-8542-2017; Ruez, Richard/A-3479-2013; Johannes, Ludger/M-9778-2017; HE, Hai-Tao/O-6551-2016; Blouin, Cedric M/A-8924-2018; Blouin, Cedric M./Y-7091-2019; Lamaze, Christophe/M-4912-2017; Mailfert, Sébastien/X-6986-2019; HAMON, Yannick YH/N-5372-2016; Contreras, Xabier/AAA-8885-2019; Casanova, Jean-Laurent/I-3418-2017; Marguet, Didier/AGO-5421-2022; VIARIS de LESEGNO, Christine/B-3663-2018	Johannes, Ludger/0000-0002-2168-0004; HAMON, Yannick/0000-0002-7636-2310; Wunder, Christian/0000-0001-9091-0080; Ruez, Richard/0000-0001-5187-2210; Johannes, Ludger/0000-0002-2168-0004; HE, Hai-Tao/0000-0002-6594-290X; Blouin, Cedric M/0000-0003-0800-0948; Blouin, Cedric M./0000-0003-0800-0948; Mailfert, Sébastien/0000-0002-0409-0432; HAMON, Yannick YH/0000-0002-7636-2310; Marguet, Didier/0000-0003-3198-5095; VIARIS de LESEGNO, Christine/0000-0002-2033-1128; Contreras, Xabier/0000-0003-0875-634X; Damarys, Loew/0000-0002-9111-8842; VOGT, Guillaume/0000-0001-8192-1247; LAMAZE, Christophe/0000-0001-5430-2707; Casanova, Jean-Laurent/0000-0002-7782-4169; GALES, Celine/0000-0002-4938-1583	Institut Curie; INSERM; CNRS; Agence Nationale de la Recherche (ANR) [NANOSTAT-15-CE11-0025-01, ANR-10-BLAN-1509, ANR-11-LABX-0054, ANR-10-BLAN-1214, ANR-10-INBS-04-01, ANR-11-IDEX-0001-02]; Institut National du Cancer (INCa) [PLBIO12-203]; Marie Curie Actions-Networks for Initial Training; Spanish Ministry of Economy [BFU2012-33103]; Ligue Nationale contre le Cancer; program "Investissements d'Avenir''	Institut Curie; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Marie Curie Actions-Networks for Initial Training; Spanish Ministry of Economy(Spanish Government); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); program "Investissements d'Avenir''(French National Research Agency (ANR))	We would like to thank Scott Mark for help with the BRET experiments. We are especially thankful to Sandy Schmid for reading of the manuscript and helpful suggestions. The facilities, as well as scientific and technical assistance from staff in the PICT-IBiSA/Nikon Imaging Centre at Institut Curie-CNRS, Paris member of the France-BioImaging National Research Infrastructure, are acknowledged. This work was supported by institutional grants from the Institut Curie, INSERM, CNRS, and by specific grants from Agence Nationale de la Recherche (ANR NANOSTAT-15-CE11-0025-01 to C.L.; ANR-10-BLAN-1509 and ANR-11-LABX-0054 [Investissements d'Avenir-Labex INFORM] to H.-T.H.; ANR-10-BLAN-1214, ANR-10-INBS-04-01 France Bio Imaging and ANR-11-IDEX-0001-02 [Investissements d'Avenir-AMIDEX] to D.M.), Institut National du Cancer (INCa PLBIO12-203 to C.L.), and Marie Curie Actions-Networks for Initial Training (FP7-PEOPLE-2010-ITN to C.L.). This work was supported in part by a grant from the Spanish Ministry of Economy BFU2012-33103 to F.-X.C. C.M.B. was supported by a postdoctoral fellowship from Ligue Nationale contre le Cancer. The Johannes and Lamaze teams received support under the program "Investissements d'Avenir'' launched by the French Government and implemented by ANR with the references Labex Cel-TisPhyBio ANR-10-LBX-0038 part of the IDEX Idex PSL ANR-10-IDEX-0001-02 PSL.	Babon JJ, 2014, BIOCHEM J, V462, P1, DOI 10.1042/BJ20140712; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Billaudeau C, 2013, METHOD ENZYMOL, V519, P277, DOI 10.1016/B978-0-12-405539-1.00010-5; Blouin CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00267; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Chung AW, 2013, J INFECT DIS, V207, P947, DOI 10.1093/infdis/jis920; Claudinon J, 2009, J BIOL CHEM, V284, P24328, DOI 10.1074/jbc.M109.021915; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Dennis JW, 2013, MOL CELL PROTEOMICS, V12, P913, DOI 10.1074/mcp.R112.026989; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Hamdan FF, 2006, CURR PROTOC NEUROSCI, V5, P523, DOI DOI 10.1002/0471142301.NS0523S34; Krause CD, 2002, MOL CELL PROTEOMICS, V1, P805, DOI 10.1074/mcp.M200065-MCP200; Krause CD, 2006, CELL RES, V16, P55, DOI 10.1038/sj.cr.7310008; Kusumi A, 2012, ANNU REV CELL DEV BI, V28, P215, DOI 10.1146/annurev-cellbio-100809-151736; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Marchetti M, 2006, MOL BIOL CELL, V17, P2896, DOI 10.1091/mbc.E06-01-0076; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Raghupathy R, 2015, CELL, V161, P581, DOI 10.1016/j.cell.2015.03.048; Rao MD, 2014, CURR OPIN CELL BIOL, V29, P126, DOI 10.1016/j.ceb.2014.05.007; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; Vogt G, 2008, J EXP MED, V205, P1729, DOI 10.1084/jem.20071987	37	71	73	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					920	934		10.1016/j.cell.2016.07.003	http://dx.doi.org/10.1016/j.cell.2016.07.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27499022	Bronze			2022-12-24	WOS:000382258700015
J	Rousseau, A; Bertolotti, A				Rousseau, Adrien; Bertolotti, Anne			An evolutionarily conserved pathway controls proteasome homeostasis	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ACTIVATED PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; REGULATORY PARTICLE; ASSEMBLY PATHWAY; DEGRADATION; STRESS; CHAPERONE; TORC1; MTOR	The proteasome is essential for the selective degradation of most cellular proteins, but how cells maintain adequate amounts of proteasome is unclear. Here we show that there is an evolutionarily conserved signalling pathway controlling proteasome homeostasis. Central to this pathway is TORC1, the inhibition of which induced all known yeast 19S regulatory particle assembly-chaperones (RACs), as well as proteasome subunits. Downstream of TORC1 inhibition, the yeast mitogen-activated protein kinase, Mpk1, acts to increase the supply of RACs and proteasome subunits under challenging conditions in order to maintain proteasomal degradation and cell viability. This adaptive pathway was evolutionarily conserved, with mTOR and ERK5 controlling the levels of the four mammalian RACs and proteasome abundance. Thus, the central growth and stress controllers, TORC1 and Mpk1/ERK5, endow cells with a rapid and vital adaptive response to adjust proteasome abundance in response to the rising needs of cells. Enhancing this pathway may be a useful therapeutic approach for diseases resulting from impaired proteasomal degradation.	[Rousseau, Adrien; Bertolotti, Anne] MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Bertolotti, A (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	aberto@mrc-lmb.cam.ac.uk		Rousseau, Adrien/0000-0001-8130-5380	Medical Research Council (UK) [MC_U105185860]; EMBO long-term fellowship; MRC [MC_U105185860] Funding Source: UKRI; Medical Research Council [MC_U105185860] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Y. Lee and M. Hochstrasser for the kind gift of Nas2, Nas6, Hsm3 and Rpn14 antibodies; D. H. Wolf for CPY*-HA and Delta ss-CPY*-GFP constructs; T. Maeda for the P-Sch9 antibody; and members of the Bertolotti laboratory for discussion. A.B. is an honorary fellow of the University of Cambridge Clinical Neurosciences Department. This work was supported by the Medical Research Council (UK) MC_U105185860. A.R. is supported by an EMBO long-term fellowship.	Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197; Babour A, 2010, CELL, V142, P256, DOI 10.1016/j.cell.2010.06.006; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Hanssum A, 2014, MOL CELL, V55, P566, DOI 10.1016/j.molcel.2014.06.017; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Knutson BA, 2011, MOL CELL BIOL, V31, P818, DOI 10.1128/MCB.00687-10; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Soulard A, 2007, CELL, V129, P434, DOI 10.1016/j.cell.2007.04.010; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Truman AW, 2006, EUKARYOT CELL, V5, P1914, DOI 10.1128/EC.00263-06; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	41	115	116	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					184	+		10.1038/nature18943	http://dx.doi.org/10.1038/nature18943			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27462806	Green Accepted			2022-12-24	WOS:000381472100030
J	Fuchsberger, C; Flannick, J; Teslovich, TM; Mahajan, A; Agarwala, V; Gaulton, KJ; Ma, C; Fontanillas, P; Moutsianas, L; McCarthy, DJ; Rivas, MA; Perry, JRB; Sim, X; Blackwell, TW; Robertson, NR; Rayner, NW; Cingolani, P; Locke, AE; Tajes, JF; Highland, HM; Dupuis, J; Chines, PS; Lindgren, CM; Hartl, C; Jackson, AU; Chen, H; Huyghe, JR; van de Bunt, M; Pearson, RD; Kumar, A; Muller-Nurasyid, M; Grarup, N; Stringham, HM; Gamazon, ER; Lee, J; Chen, YH; Scott, RA; Below, JE; Chen, P; Huang, J; Go, MJ; Stitzel, ML; Pasko, D; Parker, SCJ; Varga, TV; Green, T; Beer, NL; Day-Williams, AG; Ferreira, T; Fingerlin, T; Horikoshi, M; Hu, C; Huh, I; Ikram, MK; Kim, BJ; Kim, Y; Kim, YJ; Kwon, MS; Lee, J; Lee, S; Lin, KH; Maxwell, TJ; Nagai, Y; Wang, X; Welch, RP; Yoon, J; Zhang, W; Barzilai, N; Voight, BF; Han, BG; Jenkinson, CP; Kuulasmaa, T; Kuusisto, J; Manning, A; Ng, MCY; Palmer, ND; Balkau, B; Stancakova, A; Abboud, HE; Boeing, H; Giedraitis, V; Prabhakaran, D; Gottesman, O; Scott, J; Carey, J; Kwan, P; Grant, G; Smith, JD; Neale, BM; Purcell, S; Butterworth, AS; Howson, JMM; Lee, HM; Lu, YC; Kwak, SH; Zhao, W; Danesh, J; Lam, VKL; Park, KS; Saleheen, D; So, WY; Tam, CHT; Afzal, U; Aguilar, D; Arya, R; Aung, T; Chan, E; Navarro, C; Cheng, CY; Palli, D; Correa, A; Curran, JE; Rybin, D; Farook, VS; Fowler, SP; Freedman, BI; Griswold, M; Hale, DE; Hicks, PJ; Khor, CC; Kumar, S; Lehne, B; Thuillier, D; Lim, WY; Liu, J; van der Schouw, YT; Loh, M; Musani, SK; Puppala, S; Scott, WR; Yengo, L; Tan, ST; Taylor, HA; Thameem, F; Wilson, G; Wong, TY; Njolstad, PR; Levy, JC; Mangino, M; Bonnycastle, LL; Schwarzmayr, T; Fadista, J; Surdulescu, GL; Herder, C; Groves, CJ; Wieland, T; Bork-Jensen, J; Brandslund, I; Christensen, C; Koistinen, HA; Doney, ASF; Kinnunen, L; Esko, T; Farmer, AJ; Hakaste, L; Hodgkiss, D; Kravic, J; Lyssenko, V; Hollensted, M; Jorgensen, ME; Jorgensen, T; Ladenvall, C; Justesen, JM; Karajamaki, A; Kriebel, J; Rathmann, W; Lannfelt, L; Lauritzen, T; Narisu, N; Linneberg, A; Melander, O; Milani, L; Neville, M; Orho-Melander, M; Qi, L; Qi, QB; Roden, M; Rolandsson, O; Swift, A; Rosengren, AH; Stirrups, K; Wood, AR; Mihailov, E; Blancher, C; Carneiro, MO; Maguire, J; Poplin, R; Shakir, K; Fennell, T; DePristo, M; de Angelis, MH; Deloukas, P; Gjesing, AP; Jun, G; Nilsson, P; Murphy, J; Onofrio, R; Thorand, B; Hansen, T; Meisinger, C; Hu, FB; Isomaa, B; Karpe, F; Liang, LM; Peters, A; Huth, C; O'Rahilly, SP; Palmer, CNA; Pedersen, O; Rauramaa, R; Tuomilehto, J; Salomaa, V; Watanabe, RM; Syvanen, AC; Bergman, RN; Bharadwaj, D; Bottinger, EP; Cho, YS; Chandak, GR; Chan, JCN; Chia, KS; Daly, MJ; Ebrahim, SB; Langenberg, C; Elliott, P; Jablonski, KA; Lehman, DM; Jia, WP; Ma, RCW; Pollin, TI; Sandhu, M; Tandon, N; Froguel, P; Barroso, I; Teo, YY; Zeggini, E; Loos, RJF; Small, KS; Ried, JS; DeFronzo, RA; Grallert, H; Glaser, B; Metspalu, A; Wareham, NJ; Walker, M; Banks, E; Gieger, C; Ingelsson, E; Im, HK; Illig, T; Franks, PW; Buck, G; Trakalo, J; Buck, D; Prokopenko, I; Magi, R; Lind, L; Farjoun, Y; Owen, KR; Gloyn, AL; Strauch, K; Tuomi, T; Kooner, JS; Lee, JY; Park, T; Donnelly, P; Morris, AD; Hattersley, AT; Bowden, DW; Collins, FS; Atzmon, G; Chambers, JC; Spector, TD; Laakso, M; Strom, TM; Bell, GI; Blangero, J; Duggirala, R; Tai, ES; McVean, G; Hanis, CL; Wilson, JG; Seielstad, M; Frayling, TM; Meigs, JB; Cox, NJ; Sladek, R; Lander, ES; Gabriel, S; Burtt, NP; Mohlke, KL; Meitinger, T; Groop, L; Abecasis, G; Florez, JC; Scott, LJ; Morris, AP; Kang, HM; Boehnke, M; Altshuler, D; McCarthy, MI				Fuchsberger, Christian; Flannick, Jason; Teslovich, Tanya M.; Mahajan, Anubha; Agarwala, Vineeta; Gaulton, Kyle J.; Ma, Clement; Fontanillas, Pierre; Moutsianas, Loukas; McCarthy, Davis J.; Rivas, Manuel A.; Perry, John R. B.; Sim, Xueling; Blackwell, Thomas W.; Robertson, Neil R.; Rayner, N. William; Cingolani, Pablo; Locke, Adam E.; Tajes, Juan Fernandez; Highland, Heather M.; Dupuis, Josee; Chines, Peter S.; Lindgren, Cecilia M.; Hartl, Christopher; Jackson, Anne U.; Chen, Han; Huyghe, Jeroen R.; van de Bunt, Martijn; Pearson, Richard D.; Kumar, Ashish; Mueller-Nurasyid, Martina; Grarup, Niels; Stringham, Heather M.; Gamazon, Eric R.; Lee, Jaehoon; Chen, Yuhui; Scott, Robert A.; Below, Jennifer E.; Chen, Peng; Huang, Jinyan; Go, Min Jin; Stitzel, Michael L.; Pasko, Dorota; Parker, Stephen C. J.; Varga, Tibor V.; Green, Todd; Beer, Nicola L.; Day-Williams, Aaron G.; Ferreira, Teresa; Fingerlin, Tasha; Horikoshi, Momoko; Hu, Cheng; Huh, Iksoo; Ikram, Mohammad Kamran; Kim, Bong-Jo; Kim, Yongkang; Kim, Young Jin; Kwon, Min-Seok; Lee, Juyoung; Lee, Selyeong; Lin, Keng-Han; Maxwell, Taylor J.; Nagai, Yoshihiko; Wang, Xu; Welch, Ryan P.; Yoon, Joon; Zhang, Weihua; Barzilai, Nir; Voight, Benjamin F.; Han, Bok-Ghee; Jenkinson, Christopher P.; Kuulasmaa, Teemu; Kuusisto, Johanna; Manning, Alisa; Ng, Maggie C. Y.; Palmer, Nicholette D.; Balkau, Beverley; Stancakova, Alena; Abboud, Hanna E.; Boeing, Heiner; Giedraitis, Vilmantas; Prabhakaran, Dorairaj; Gottesman, Omri; Scott, James; Carey, Jason; Kwan, Phoenix; Grant, George; Smith, Joshua D.; Neale, Benjamin M.; Purcell, Shaun; Butterworth, Adam S.; Howson, Joanna M. M.; Lee, Heung Man; Lu, Yingchang; Kwak, Soo-Heon; Zhao, Wei; Danesh, John; Lam, Vincent K. L.; Park, Kyong Soo; Saleheen, Danish; So, Wing Yee; Tam, Claudia H. T.; Afzal, Uzma; Aguilar, David; Arya, Rector; Aung, Tin; Chan, Edmund; Navarro, Carmen; Cheng, Ching-Yu; Palli, Domenico; Correa, Adolfo; Curran, Joanne E.; Rybin, Denis; Farook, Vidya S.; Fowler, Sharon P.; Freedman, Barry I.; Griswold, Michael; Hale, Daniel Esten; Hicks, Pamela J.; Khor, Chiea-Chuen; Kumar, Satish; Lehne, Benjamin; Thuillier, Dorothee; Lim, Wei Yen; Liu, Jianjun; van der Schouw, Yvonne T.; Loh, Marie; Musani, Solomon K.; Puppala, Sobha; Scott, William R.; Yengo, Loic; Tan, Sian-Tsung; Taylor, Herman A., Jr.; Thameem, Farook; Wilson, Gregory, Sr.; Wong, Tien Yin; Njolstad, Pal Rasmus; Levy, Jonathan C.; Mangino, Massimo; Bonnycastle, Lori L.; Schwarzmayr, Thomas; Fadista, Joao; Surdulescu, Gabriela L.; Herder, Christian; Groves, Christopher J.; Wieland, Thomas; Bork-Jensen, Jette; Brandslund, Ivan; Christensen, Cramer; Koistinen, Heikki A.; Doney, Alex S. F.; Kinnunen, Leena; Esko, Tonu; Farmer, Andrew J.; Hakaste, Liisa; Hodgkiss, Dylan; Kravic, Jasmina; Lyssenko, Valeriya; Hollensted, Mette; Jorgensen, Marit E.; Jorgensen, Torben; Ladenvall, Claes; Justesen, Johanne Marie; Karajamaki, Annemari; Kriebel, Jennifer; Rathmann, Wolfgang; Lannfelt, Lars; Lauritzen, Torsten; Narisu, Narisu; Linneberg, Allan; Melander, Olle; Milani, Lili; Neville, Matt; Orho-Melander, Marju; Qi, Lu; Qi, Qibin; Roden, Michael; Rolandsson, Olov; Swift, Amy; Rosengren, Anders H.; Stirrups, Kathleen; Wood, Andrew R.; Mihailov, Evelin; Blancher, Christine; Carneiro, Mauricio O.; Maguire, Jared; Poplin, Ryan; Shakir, Khalid; Fennell, Timothy; DePristo, Mark; de Angelis, Martin Hrabe; Deloukas, Panos; Gjesing, Anette P.; Jun, Goo; Nilsson, Peter; Murphy, Jacquelyn; Onofrio, Robert; Thorand, Barbara; Hansen, Torben; Meisinger, Christa; Hu, Frank B.; Isomaa, Bo; Karpe, Fredrik; Liang, Liming; Peters, Annette; Huth, Cornelia; O'Rahilly, Stephen P.; Palmer, Colin N. A.; Pedersen, Oluf; Rauramaa, Rainer; Tuomilehto, Jaakko; Salomaa, Veikko; Watanabe, Richard M.; Syvanen, Ann-Christine; Bergman, Richard N.; Bharadwaj, Dwaipayan; Bottinger, Erwin P.; Cho, Yoon Shin; Chandak, Giriraj R.; Chan, Juliana C. N.; Chia, Kee Seng; Daly, Mark J.; Ebrahim, Shah B.; Langenberg, Claudia; Elliott, Paul; Jablonski, Kathleen A.; Lehman, Donna M.; Jia, Weiping; Ma, Ronald C. W.; Pollin, Toni I.; Sandhu, Manjinder; Tandon, Nikhil; Froguel, Philippe; Barroso, Ines; Teo, Yik Ying; Zeggini, Eleftheria; Loos, Ruth J. F.; Small, Kerrin S.; Ried, Janina S.; DeFronzo, Ralph A.; Grallert, Harald; Glaser, Benjamin; Metspalu, Andres; Wareham, Nicholas J.; Walker, Mark; Banks, Eric; Gieger, Christian; Ingelsson, Erik; Im, Hae Kyung; Illig, Thomas; Franks, Paul W.; Buck, Gemma; Trakalo, Joseph; Buck, David; Prokopenko, Inga; Magi, Reedik; Lind, Lars; Farjoun, Yossi; Owen, Katharine R.; Gloyn, Anna L.; Strauch, Konstantin; Tuomi, Tiinamaija; Kooner, Jaspal Singh; Lee, Jong-Young; Park, Taesung; Donnelly, Peter; Morris, Andrew D.; Hattersley, Andrew T.; Bowden, Donald W.; Collins, Francis S.; Atzmon, Gil; Chambers, John C.; Spector, Timothy D.; Laakso, Markku; Strom, Tim M.; Bell, Graeme I.; Blangero, John; Duggirala, Ravindranath; Tai, E. Shyong; McVean, Gilean; Hanis, Craig L.; Wilson, James G.; Seielstad, Mark; Frayling, Timothy M.; Meigs, James B.; Cox, Nancy J.; Sladek, Rob; Lander, Eric S.; Gabriel, Stacey; Burtt, Noel P.; Mohlke, Karen L.; Meitinger, Thomas; Groop, Leif; Abecasis, Goncalo; Florez, Jose C.; Scott, Laura J.; Morris, Andrew P.; Kang, Hyun Min; Boehnke, Michael; Altshuler, David; McCarthy, Mark I.			The genetic architecture of type 2 diabetes	NATURE			English	Article							GENOME-WIDE ASSOCIATION; PROTEIN COMPLEXES; RARE VARIANTS; LOW-FREQUENCY; RISK; SUSCEPTIBILITY; LOCI; HERITABILITY; METAANALYSIS; ANNOTATION	The genetic architecture of common traits, including the number, frequency, and effect sizes of inherited variants that contribute to individual risk, has been long debated. Genome-wide association studies have identified scores of common variants associated with type 2 diabetes, but in aggregate, these explain only a fraction of the heritability of this disease. Here, to test the hypothesis that lower-frequency variants explain much of the remainder, the GoT2D and T2D-GENES consortia performed whole-genome sequencing in 2,657 European individuals with and without diabetes, and exome sequencing in 12,940 individuals from five ancestry groups. To increase statistical power, we expanded the sample size via genotyping and imputation in a further 111,548 subjects. Variants associated with type 2 diabetes after sequencing were overwhelmingly common and most fell within regions previously identified by genome-wide association studies. Comprehensive enumeration of sequence variation is necessary to identify functional alleles that provide important clues to disease pathophysiology, but large-scale sequencing does not support the idea that lower-frequency variants have a major role in predisposition to type 2 diabetes.	[Fuchsberger, Christian; Teslovich, Tanya M.; Ma, Clement; Sim, Xueling; Blackwell, Thomas W.; Locke, Adam E.; Jackson, Anne U.; Huyghe, Jeroen R.; Stringham, Heather M.; Lin, Keng-Han; Welch, Ryan P.; Kwan, Phoenix; Jun, Goo; Abecasis, Goncalo; Scott, Laura J.; Kang, Hyun Min; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Fuchsberger, Christian] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Fuchsberger, Christian] Univ Lubeck, European Acad Bolzano Bozen EURAC, Ctr Biomed, Bolzano, Italy; [Flannick, Jason; Agarwala, Vineeta; Fontanillas, Pierre; Lindgren, Cecilia M.; Hartl, Christopher; Green, Todd; Manning, Alisa; Carey, Jason; Grant, George; Neale, Benjamin M.; Purcell, Shaun; Esko, Tonu; Carneiro, Mauricio O.; Maguire, Jared; Poplin, Ryan; Shakir, Khalid; Fennell, Timothy; DePristo, Mark; Murphy, Jacquelyn; Onofrio, Robert; Banks, Eric; Gabriel, Stacey; Burtt, Noel P.; Florez, Jose C.; Altshuler, David] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Flannick, Jason; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Mahajan, Anubha; Gaulton, Kyle J.; Moutsianas, Loukas; McCarthy, Davis J.; Rivas, Manuel A.; Perry, John R. B.; Robertson, Neil R.; Rayner, N. William; Tajes, Juan Fernandez; Lindgren, Cecilia M.; van de Bunt, Martijn; Pearson, Richard D.; Kumar, Ashish; Chen, Yuhui; Ferreira, Teresa; Horikoshi, Momoko; Ingelsson, Erik; Prokopenko, Inga; Gloyn, Anna L.; Donnelly, Peter; McVean, Gilean; Morris, Andrew P.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Med, Oxford, England; [Agarwala, Vineeta] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [McCarthy, Davis J.; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford, England; [Perry, John R. B.; Pasko, Dorota; Wood, Andrew R.; Frayling, Timothy M.] Univ Exeter, Sch Med, Genet Complex Traits, Exeter, Devon, England; [Perry, John R. B.; Scott, Robert A.; Langenberg, Claudia; Wareham, Nicholas J.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Perry, John R. B.; Mangino, Massimo; Surdulescu, Gabriela L.; Hodgkiss, Dylan; Small, Kerrin S.; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Robertson, Neil R.; Rayner, N. William; van de Bunt, Martijn; Beer, Nicola L.; Horikoshi, Momoko; Levy, Jonathan C.; Groves, Christopher J.; Neville, Matt; Karpe, Fredrik; Prokopenko, Inga; Owen, Katharine R.; Gloyn, Anna L.; McCarthy, Mark I.] Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Rayner, N. William; Day-Williams, Aaron G.; Danesh, John; Stirrups, Kathleen; Sandhu, Manjinder; Barroso, Ines; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Dept Human Genet, Hinxton, Cambs, England; [Cingolani, Pablo] McGill Univ, Sch Comp Sci, Montreal, PQ, Canada; [Cingolani, Pablo; Nagai, Yoshihiko; Sladek, Rob] McGill Univ, Montreal, PQ, Canada; [Cingolani, Pablo; Nagai, Yoshihiko; Sladek, Rob] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Highland, Heather M.] Univ Texas Hlth Sci Ctr Houston, Univ Texas Grad Sch Biomed Sci Houston, Human Genet Ctr, Houston, TX 77030 USA; [Dupuis, Josee; Chen, Han; Rybin, Denis] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Dupuis, Josee] NHLBI, Framingham Heart Study, Framingham, MA USA; [Chines, Peter S.; Bonnycastle, Lori L.; Narisu, Narisu; Swift, Amy; Collins, Francis S.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Chen, Han; Liang, Liming] Harvard Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Kumar, Ashish] Univ Basel, Swiss Trop & Publ Hlth Inst, Chron Dis Epidemiol, Basel, Switzerland; [Mueller-Nurasyid, Martina; Ried, Janina S.; Gieger, Christian; Strauch, Konstantin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, Munich, Germany; [Mueller-Nurasyid, Martina; Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Mueller-Nurasyid, Martina; Peters, Annette] Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany; [Grarup, Niels; Bork-Jensen, Jette; Hollensted, Mette; Justesen, Johanne Marie; Gjesing, Anette P.; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Gamazon, Eric R.; Im, Hae Kyung; Cox, Nancy J.] Univ Chicago, Dept Med, Med Genet Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Lee, Jaehoon; Huh, Iksoo; Kim, Yongkang; Lee, Selyeong; Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Below, Jennifer E.; Maxwell, Taylor J.; Jun, Goo; Hanis, Craig L.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Human Genet Ctr, Houston, TX 77030 USA; [Chen, Peng; Wang, Xu; Cheng, Ching-Yu; Khor, Chiea-Chuen; Lim, Wei Yen; Liu, Jianjun; Chia, Kee Seng; Teo, Yik Ying; Tai, E. Shyong] Natl Univ Hlth Syst, Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Huang, Jinyan; Hu, Frank B.; Liang, Liming] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Go, Min Jin; Kim, Bong-Jo; Kim, Young Jin; Lee, Juyoung; Han, Bok-Ghee; Lee, Jong-Young] Korea Natl Inst Hlth, Ctr Genome Sci, Cheongju, Chungcheongbuk, South Korea; [Stitzel, Michael L.] Jackson Lab Genom Med, Farmington, CT USA; [Parker, Stephen C. J.] Univ Michigan, Dept Computat Med, Ann Arbor, MI USA; [Parker, Stephen C. J.] Univ Michigan, Dept Bioinformat & Human Genet, Ann Arbor, MI USA; [Varga, Tibor V.; Franks, Paul W.] Lund Univ, Genet & Mol Epidemiol Unit, Lund Univ Diabet Ctr, Dept Clin Sci, Malmo, Sweden; [Fingerlin, Tasha] Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Hu, Cheng; Jia, Weiping] Shanghai Jiao Tong Univ, Peoples Hosp 6, Shanghai Diabet Inst, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Ikram, Mohammad Kamran; Aung, Tin; Cheng, Ching-Yu; Khor, Chiea-Chuen; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Ikram, Mohammad Kamran; Aung, Tin; Cheng, Ching-Yu; Khor, Chiea-Chuen; Wong, Tien Yin] Natl Univ Hlth Syst, Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore; [Ikram, Mohammad Kamran; Aung, Tin; Cheng, Ching-Yu; Wong, Tien Yin] Duke NUS Grad Med Sch, Eye Acad Clin Programme, Singapore, Singapore; [Kwon, Min-Seok; Yoon, Joon; Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Nagai, Yoshihiko; Sladek, Rob] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Nagai, Yoshihiko] McGill Univ Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Zhang, Weihua; Afzal, Uzma; Lehne, Benjamin; Loh, Marie; Scott, William R.; Elliott, Paul; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Zhang, Weihua; Tan, Sian-Tsung; Kooner, Jaspal Singh; Chambers, John C.] Ealing Hosp NHS Trust, Dept Cardiol, Southall, Middx, England; [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Dept Genet, New York, NY USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Jenkinson, Christopher P.; Abboud, Hanna E.; Fowler, Sharon P.; Thameem, Farook; Lehman, Donna M.; DeFronzo, Ralph A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Jenkinson, Christopher P.] South Texas Vet Hlth Care Syst, Res, San Antonio, TX USA; [Kuulasmaa, Teemu; Kuusisto, Johanna; Stancakova, Alena; Laakso, Markku] Univ Eastern Finland, Internal Med, Inst Clin Med, Fac Hlth Sci, Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Kuopio, Finland; [Ng, Maggie C. Y.; Palmer, Nicholette D.; Hicks, Pamela J.; Bowden, Donald W.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Ng, Maggie C. Y.; Palmer, Nicholette D.; Hicks, Pamela J.; Bowden, Donald W.] Wake Forest Sch Med, Ctr Diabet Res, Winston Salem, NC USA; [Palmer, Nicholette D.; Hicks, Pamela J.; Bowden, Donald W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Balkau, Beverley] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Nuthetal, Germany; [Giedraitis, Vilmantas; Lannfelt, Lars] Uppsala Univ, Geriatr, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Prabhakaran, Dorairaj; Ebrahim, Shah B.] Ctr Chron Dis Control, New Delhi, India; [Gottesman, Omri; Lu, Yingchang; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Scott, James; Tan, Sian-Tsung; Kooner, Jaspal Singh] Univ London Imperial Coll Sci Technol & Med, Cardiovasc Sci, Natl Heart & Lung Inst, Hammersmith Campus, London, England; [Smith, Joshua D.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Neale, Benjamin M.; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Neale, Benjamin M.; Purcell, Shaun; Florez, Jose C.] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Purcell, Shaun] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Psychiat, New York, NY 10029 USA; [Butterworth, Adam S.; Howson, Joanna M. M.; Danesh, John; Sandhu, Manjinder] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Lee, Heung Man; Lam, Vincent K. L.; So, Wing Yee; Tam, Claudia H. T.; Chan, Juliana C. N.; Ma, Ronald C. W.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Kwak, Soo-Heon; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Zhao, Wei] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [Park, Kyong Soo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Park, Kyong Soo] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Saleheen, Danish] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Aguilar, David] Baylor Coll Med, Div Cardiovasc, Houston, TX 77030 USA; [Arya, Rector; Hale, Daniel Esten] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA; [Chan, Edmund; Tai, E. Shyong] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Navarro, Carmen] IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Navarro, Carmen] Univ Murcia, CIBERESP, Murcia, Spain; [Navarro, Carmen] Univ Murcia, Sch Med, Unit Prevent Med & Publ Hlth, E-30001 Murcia, Spain; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Florence, Italy; [Correa, Adolfo; Taylor, Herman A., Jr.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Curran, Joanne E.; Kumar, Satish; Blangero, John] Univ Texas Rio Grande Valley, Reg Acad Hlth Ctr, South Texas Diabet & Obes Inst, Brownsville, TX USA; [Farook, Vidya S.; Puppala, Sobha; Duggirala, Ravindranath] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Freedman, Barry I.] Wake Forest Sch Med, Nephrol Sect, Dept Internal Med, Winston Salem, NC USA; [Griswold, Michael] Univ Mississippi, Med Ctr, Ctr Biostat & Bioinformat, Jackson, MS 39216 USA; [Khor, Chiea-Chuen] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Khor, Chiea-Chuen; Liu, Jianjun] ASTAR, Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Thuillier, Dorothee; Yengo, Loic; Froguel, Philippe] Univ Lille, Lille Pasteur Inst, CNRS UMR8199, Lille, France; [van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Loh, Marie] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Loh, Marie] ASTAR, TLGM, Singapore, Singapore; [Musani, Solomon K.] Univ Mississippi, Med Ctr, Jackson Heart Study, Jackson, MS 39216 USA; [Wilson, Gregory, Sr.] Jackson State Univ, Coll Publ Serv, Jackson, MS USA; [Njolstad, Pal Rasmus] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, Bergen, Norway; [Njolstad, Pal Rasmus] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Schwarzmayr, Thomas; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Fadista, Joao; Kravic, Jasmina; Lyssenko, Valeriya; Ladenvall, Claes; Rosengren, Anders H.; Groop, Leif] Lund Univ, Ctr Diabet, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Herder, Christian; Kriebel, Jennifer; Roden, Michael; de Angelis, Martin Hrabe; Thorand, Barbara; Meisinger, Christa; Peters, Annette; Huth, Cornelia; Grallert, Harald] German Ctr Diabet Res DZD, Neuherberg, Germany; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Brandslund, Ivan] Vejle Hosp, Dept Clin Biochem, Vejle, Denmark; [Christensen, Cramer] Vejle Hosp, Dept Internal Med & Endocrinol, Vejle, Denmark; [Koistinen, Heikki A.; Kinnunen, Leena; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland; [Koistinen, Heikki A.; Hakaste, Liisa; Tuomi, Tiinamaija] Univ Helsinki, Abdominal Ctr Endocrinol, Helsinki, Finland; [Koistinen, Heikki A.; Hakaste, Liisa; Tuomi, Tiinamaija] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Koistinen, Heikki A.] Minerva Fdn, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Dept Med, Helsinki, Finland; [Doney, Alex S. F.] Ninewells Hosp & Med Sch, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee, Scotland; [Esko, Tonu; Milani, Lili; Mihailov, Evelin; Metspalu, Andres; Magi, Reedik; Morris, Andrew P.] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Esko, Tonu; Altshuler, David] Harvard Med Sch, Dept Genet, Boston, MA USA; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Farmer, Andrew J.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Hakaste, Liisa; Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Hakaste, Liisa; Tuomi, Tiinamaija] Univ Helsinki, Res Programs Unit, Diabet & Obes, Helsinki, Finland; [Jorgensen, Marit E.] Steno Diabet Ctr, Gentofte, Denmark; [Jorgensen, Torben; Linneberg, Allan] Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Inst Hlth Sci, Dept Publ Hlth, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Med, Aalborg, Denmark; [Karajamaki, Annemari] Vaasa Cent Hosp, Dept Primary Hlth Care, Vaasa, Finland; [Karajamaki, Annemari] Vaasa Hlth Care Ctr, Ctr Diabet, Vaasa, Finland; [Kriebel, Jennifer; Thorand, Barbara; Meisinger, Christa; Peters, Annette; Huth, Cornelia; Grallert, Harald; Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Kriebel, Jennifer; Grallert, Harald; Gieger, Christian; Illig, Thomas] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Lauritzen, Torsten] Aarhus Univ, Sect Gen Practice, Dept Publ Hlth, Aarhus, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Melander, Olle] Lund Univ, Dept Clin Sci Hypertens & Cardiovasc, Malmo, Sweden; [Neville, Matt; Karpe, Fredrik; Owen, Katharine R.; Gloyn, Anna L.; McCarthy, Mark I.] Oxford Univ Hosp Trust, Oxford NIHR Biomed Res Ctr, Oxford, England; [Orho-Melander, Marju] Lund Univ, Dept Clin Sci Diabet & Cardiovasc Dis, Genet Epidemiol, Malmo, Sweden; [Qi, Lu; Qi, Qibin; Hu, Frank B.; Franks, Paul W.] Harvard Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Qi, Lu] Harvard Med Sch, Boston, MA USA; [Qi, Qibin] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Roden, Michael] Univ Dusseldorf, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Rolandsson, Olov; Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Blancher, Christine; Buck, Gemma; Trakalo, Joseph; Buck, David] Univ Oxford, Nuffield Dept Med, Oxford Genom Ctr, High Throughput Genom,Wellcome Trust Ctr Human Ge, Oxford, England; [de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Expt Genet, Neuherberg, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Deloukas, Panos] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Nilsson, Peter] Lund Univ, Dept Clin Sci, Med, Malmo, Sweden; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Isomaa, Bo] Dept Social Serv & Hlth Care, Pietarsaari, Finland; [O'Rahilly, Stephen P.; Barroso, Ines] Univ Cambridge, Inst Metab Sci, Metab Res Labs, Cambridge, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Pat Macpherson Ctr Pharmacogenet & Pharmacogen, Dundee, Scotland; [Rauramaa, Rainer] Kuopio Res Inst Exercise Med, Fdn Res Hlth Exercise & Nutr, Kuopio, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah, Saudi Arabia; [Tuomilehto, Jaakko] Autonomous Univ Madrid, Univ Hosp LaPaz, Inst Invest Sanitaria Hosp Univ LaPaz IdiPAZ, Madrid, Spain; [Tuomilehto, Jaakko; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Watanabe, Richard M.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [Watanabe, Richard M.] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA USA; [Watanabe, Richard M.] Univ Southern Calif, Keck Sch Med, Dabet & Obes Res Inst, Los Angeles, CA USA; [Syvanen, Ann-Christine] Uppsala Univ, Mol Med & Sci Life Lab, Dept Med Sci, Uppsala, Sweden; [Bergman, Richard N.] Cedars Sinai Diabet & Obes Res Inst, Los Angeles, CA USA; [Bharadwaj, Dwaipayan] CSIR IGIB, Funct Genom Unit, New Delhi, India; [Cho, Yoon Shin] Hallym Univ, Dept Biomed Sci, Chunchon, South Korea; [Chandak, Giriraj R.] CSIR Ctr Cellular & Mol Biol, Hyderabad, Telangana, India; [Chan, Juliana C. N.; Ma, Ronald C. W.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Chan, Juliana C. N.; Ma, Ronald C. W.] Chinese Univ Hong Kong, Hong Kong Inst Diabet & Obes, Hong Kong, Hong Kong, Peoples R China; [Elliott, Paul] Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England; [Jablonski, Kathleen A.] George Washington Univ, Biostat Ctr, Rockville, MD USA; [Pollin, Toni I.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Pollin, Toni I.] Univ Maryland, Sch Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Tandon, Nikhil] All India Inst Med Sci, Dept Endocrinol & Metab, New Delhi, India; [Froguel, Philippe; Prokopenko, Inga] Imperial Coll London, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Teo, Yik Ying] Natl Univ Singapore, Inst Life Sci, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore, Singapore; [Glaser, Benjamin] Hadassah Hebrew Univ Med Ctr, Endocrinol & Metab Serv, Jerusalem, Israel; [Walker, Mark] Newcastle Univ, Inst Cellular Med, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England; [Ingelsson, Erik] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, NH, Germany; [Illig, Thomas] Hannover Med Sch, Inst Human Genet, Hannover, NH, Germany; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Farjoun, Yossi] Broad Inst, Data Sci & Data Engn, Cambridge, MA USA; [Tuomi, Tiinamaija; Groop, Leif] Univ Helsinki, FIMM, Helsinki, Finland; [Kooner, Jaspal Singh; Chambers, John C.] Imperial Coll London, Imperial Coll Healthcare NHS Trust, London, England; [Morris, Andrew D.] Ninewells Hosp & Med Sch, Ctr Mol Med, Clin Res Ctr, Dundee, Scotland; [Morris, Andrew D.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Hattersley, Andrew T.] Univ Exeter, Sch Med, Exeter, Devon, England; [Atzmon, Gil] Univ Haifa, Dept Nat Sci, Haifa, Israel; [Strom, Tim M.; Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Bell, Graeme I.] Univ Chicago, Dept Med Genet, Chicago, IL 60637 USA; [Bell, Graeme I.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Tai, E. Shyong] Duke NUS Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [McVean, Gilean] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Seielstad, Mark] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Seielstad, Mark] Blood Syst Res Inst, San Francisco, CA USA; [Meigs, James B.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Meigs, James B.] Harvard Med Sch, Dept Med, Boston, MA USA; [Sladek, Rob] McGill Univ, Dept Med, Div Endocrinol & Metab, Montreal, PQ, Canada; [Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Florez, Jose C.; Altshuler, David] Harvard Med Sch, Dept Med, Boston, MA USA; [Florez, Jose C.; Altshuler, David] Massachusetts Gen Hosp, Dept Med, Diabet Unit, Diabet Res Ctr, Boston, MA 02114 USA; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Altshuler, David] MIT, Dept Biol, Cambridge, MA USA	University of Michigan System; University of Michigan; Medical University of Innsbruck; European Academy of Bozen-Bolzano; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Massachusetts Institute of Technology (MIT); University of Oxford; University of Exeter; University of Cambridge; University of London; King's College London; University of Oxford; Wellcome Trust Sanger Institute; McGill University; McGill University; University of Texas System; University of Texas Health Science Center Houston; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Harvard T.H. Chan School of Public Health; University of Basel; Swiss Tropical & Public Health Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Novo Nordisk Foundation; University of Copenhagen; University of Chicago; Seoul National University (SNU); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National University of Singapore; Harvard University; Harvard T.H. Chan School of Public Health; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Jackson Laboratory; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Lund University; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Shanghai Jiao Tong University; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Seoul National University (SNU); McGill University; McGill University; Imperial College London; Yeshiva University; Yeshiva University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Wake Forest University; Wake Forest University; Wake Forest University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Uppsala University; Icahn School of Medicine at Mount Sinai; Imperial College London; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; University of Cambridge; Chinese University of Hong Kong; Seoul National University (SNU); University of Pennsylvania; University of Cambridge; Seoul National University (SNU); Seoul National University (SNU); University of Pennsylvania; Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio; National University of Singapore; Hospital Clinico Universitario Virgen de la Arrixaca; Murcia Regional Health Council; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Murcia; University of Murcia; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Rio Grande Valley; Texas Biomedical Research Institute; Wake Forest University; University of Mississippi; University of Mississippi Medical Center; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Utrecht University; Utrecht University Medical Center; University of Oulu; Agency for Science Technology & Research (A*STAR); University of Mississippi; University of Mississippi Medical Center; Jackson State University; University of Bergen; University of Bergen; Haukeland University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Lund University; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of Southern Denmark; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Lillebaelt Hospital; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Dundee; University of Tartu; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Oxford; Folkhalsan Research Center; University of Helsinki; Steno Diabetes Center; University of Copenhagen; Aalborg University; Vaasa Central Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Aarhus University; Rigshospitalet; University of Copenhagen; Lund University; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Lund University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yeshiva University; Heinrich Heine University Dusseldorf; Umea University; University of Oxford; Wellcome Centre for Human Genetics; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of London; Queen Mary University London; King Abdulaziz University; Lund University; University of Southern Denmark; University of Cambridge; University of Dundee; Danube University Krems; King Abdulaziz University; Autonomous University of Madrid; Finland National Institute for Health & Welfare; University of Southern California; University of Southern California; University of Southern California; Uppsala University; Cedars Sinai Medical Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Hallym University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Chinese University of Hong Kong; Chinese University of Hong Kong; Imperial College London; George Washington University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; All India Institute of Medical Sciences (AIIMS) New Delhi; Imperial College London; National University of Singapore; National University of Singapore; Hebrew University of Jerusalem; Newcastle University - UK; Uppsala University; Hannover Medical School; Hannover Medical School; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Imperial College London; University of Dundee; University of Edinburgh; University of Exeter; University of Haifa; Technical University of Munich; University of Chicago; University of Chicago; National University of Singapore; University of Oxford; University of Mississippi; University of Mississippi Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; McGill University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Liverpool; Massachusetts Institute of Technology (MIT)	Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.; McCarthy, MI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Med, Oxford, England.; McCarthy, MI (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.	boehnke@umich.edu; mark.mccarthy@drl.ox.ac.uk	Rosengren, Anders/GZL-3068-2022; Gamazon, Eric/I-6873-2018; Palmer, Colin NA/C-7053-2008; Fadista, Joao/AAM-4870-2020; Pedersen, Oluf/AAG-8015-2020; Blangero, John/ABA-7175-2021; Huth, Cornelia/B-5350-2014; Justesen, Johanne Marie/AAY-4210-2021; de Angelis, Martin Hrabe/F-5531-2012; O'Rahilly, Stephen/ABF-6509-2020; van der Schouw, Yvonne T./F-8327-2014; Mägi, Reedik/AAJ-9679-2021; Langenberg, Claudia/ABG-9067-2021; Aguilar, David/GZM-1928-2022; Glaser, Benjamin/F-8411-2017; Narisu, Narisu/T-6908-2019; Dina, Christian R/D-3535-2015; Franks, Paul/AAA-3300-2020; Mangino, Massimo/F-5134-2011; Kim, Yongkang/AAC-7436-2020; Prabhakaran, Dorairaj/B-4147-2011; Wong, Tien Yin/AAC-9724-2020; Ma, Ronald/C-2788-2009; Roden, Michael/AAD-3843-2019; Daly, Mark J/B-2453-2017; Loos, Ruth/GON-5877-2022; Hu, Cheng/C-3346-2008; Grarup, Niels/K-2807-2015; Cheng, Ching-Yu/Y-2229-2019; FROGUEL, Philippe/O-6799-2017; Meisinger, Christine/B-5358-2014; Milani, Lili/N-1097-2019; Justesen, Johanne Marie/L-6023-2015; Wood, Andrew R/AAB-3807-2019; Gjesing, Anette/ACC-7521-2022; Müller-Nurasyid, Martina/I-8735-2018; Deloukas, Panos/B-2922-2013; Altshuler, David M/A-4476-2009; Prokopenko, Inga/AAU-9895-2020; Park, Kyong Soo/C-2265-2008; Peters, Annette/A-6117-2011; Pedersen, Oluf/Z-1731-2019; Manning, Alisa Knodle/ABC-7711-2021; Meigs, James/P-3927-2019; Stancakova, Alena/AAN-6723-2020; Sladek, Robert/R-2391-2019; Jørgensen, Torben/Z-1335-2018; Prokopenko, Inga/H-3241-2014; Doney, Alexander SF/P-7437-2017; Yengo, Loic/D-2692-2017; Parker, Stephen/ABF-1063-2021; Kinnunen, Leena/B-7059-2012; Sim, Xueling/AAZ-6652-2020; Lee, Jong-Young/M-6319-2013; Loos, Ruth J F/Q-2862-2016; Fuchsberger, Christian/ABD-7127-2021; Grallert, Harald/B-3424-2013; Horikoshi, Momoko/AAF-9034-2019; Meitinger, Thomas/O-1318-2015; Varga, Tibor/AAE-8035-2020; Jun, Goo/F-1941-2017; McCarthy, Davis James/B-5332-2018; Kim, Young-jin/GSD-3168-2022; Liu, Jianjun/AAK-4989-2020; Locke, Adam/K-2000-2019; Kriebel, Jennifer/N-4782-2017; Seielstad, Mark/T-7841-2019; Rivas, Manuel/ABE-8173-2020; Study, GoDARTS/K-9448-2016; Below, Jennifer E/W-2179-2018; Chan, Juliana/B-7918-2016; HUANG, Jinyan/AAK-3065-2020; Thorand, Barbara/B-5349-2014; Jun, Goo/M-5235-2016; McCarthy, Mark/M-3763-2015; Koistinen, Heikki/J-7313-2016; Rosengren, Anders/E-8371-2012	Gamazon, Eric/0000-0003-4204-8734; Palmer, Colin NA/0000-0002-6415-6560; Fadista, Joao/0000-0003-2539-634X; Huth, Cornelia/0000-0003-2421-433X; Justesen, Johanne Marie/0000-0002-0484-8522; de Angelis, Martin Hrabe/0000-0002-7898-2353; O'Rahilly, Stephen/0000-0003-2199-4449; van der Schouw, Yvonne T./0000-0002-4605-435X; Langenberg, Claudia/0000-0002-5017-7344; Aguilar, David/0000-0002-0916-2722; Glaser, Benjamin/0000-0003-4711-5000; Dina, Christian R/0000-0002-7722-7348; Mangino, Massimo/0000-0002-2167-7470; Kim, Yongkang/0000-0002-8837-2620; Prabhakaran, Dorairaj/0000-0002-3172-834X; Wong, Tien Yin/0000-0002-8448-1264; Ma, Ronald/0000-0002-1227-803X; Daly, Mark J/0000-0002-0949-8752; Hu, Cheng/0000-0003-4314-2386; Grarup, Niels/0000-0001-5526-1070; Cheng, Ching-Yu/0000-0003-0655-885X; FROGUEL, Philippe/0000-0003-2972-0784; Milani, Lili/0000-0002-5323-3102; Justesen, Johanne Marie/0000-0002-0484-8522; Wood, Andrew R/0000-0003-1726-948X; Gjesing, Anette/0000-0003-4580-1576; Müller-Nurasyid, Martina/0000-0003-3793-5910; Deloukas, Panos/0000-0001-9251-070X; Altshuler, David M/0000-0002-7250-4107; Park, Kyong Soo/0000-0003-3597-342X; Peters, Annette/0000-0001-6645-0985; Pedersen, Oluf/0000-0002-3321-3972; Meigs, James/0000-0002-2439-2657; Stancakova, Alena/0000-0002-1375-0252; Sladek, Robert/0000-0002-2730-1204; Prokopenko, Inga/0000-0003-1624-7457; Doney, Alexander SF/0000-0002-6210-5620; Yengo, Loic/0000-0002-4272-9305; Kinnunen, Leena/0000-0001-8739-4812; Sim, Xueling/0000-0002-1233-7642; Lee, Jong-Young/0000-0002-0092-9958; Loos, Ruth J F/0000-0002-8532-5087; Fuchsberger, Christian/0000-0002-5918-8947; Jun, Goo/0000-0003-0891-0204; McCarthy, Davis James/0000-0002-2218-6833; Liu, Jianjun/0000-0002-3255-3019; Locke, Adam/0000-0001-6227-198X; Kriebel, Jennifer/0000-0003-4270-018X; Rivas, Manuel/0000-0003-1457-9925; Below, Jennifer E/0000-0002-1346-1872; Chan, Juliana/0000-0003-1325-1194; HUANG, Jinyan/0000-0002-8053-0209; Thorand, Barbara/0000-0002-8416-6440; Jun, Goo/0000-0003-0891-0204; Jorgensen, Marit Eika/0000-0001-8356-5565; Curran, Joanne/0000-0002-6898-155X; Lindgren, Cecilia/0000-0002-4903-9374; Chen, Han/0000-0002-9510-4923; McCarthy, Mark/0000-0002-4393-0510; van de Bunt, Martijn/0000-0002-6744-6125; Seielstad, Mark/0000-0001-5783-1401; Meitinger, Thomas/0000-0002-8838-8403; Hansen, Torben/0000-0001-8748-3831; Ikram, Mohammad Kamran/0000-0003-0173-9571; Venkatasubramanian, Siddharth/0000-0002-5860-0768; V. Varga, Tibor/0000-0002-2383-699X; Hartl, Christopher/0000-0003-3352-4356; Dupuis, Josee/0000-0003-2871-3603; Donnelly, Peter/0000-0001-9495-3408; Kumar, Ashish/0000-0002-7075-5930; Chandak, Giriraj Ratan/0000-0002-3095-9453; Yoon, Joon/0000-0002-9509-119X; Zhao, Wei/0000-0002-8301-9297; Navarro, Carmen/0000-0001-8896-7483; Melander, Olle/0000-0002-2581-484X; Karajamaki, Annemari/0000-0001-9115-5611; Koistinen, Heikki/0000-0001-7870-070X; Bharadwaj, Dwaipayan/0000-0001-5268-8482; Jorgensen, Torben/0000-0001-9453-2830; Gloyn, Anna/0000-0003-1205-1844; Below, Jennifer/0000-0002-6372-6402; Scott, William/0000-0001-5467-114X; Gieger, Christian/0000-0001-6986-9554; Khor, Chiea Chuen/0000-0002-1128-4729; Franks, Paul/0000-0002-0520-7604; Brandslund, Ivan/0000-0002-4203-5442; Tuomi, Tiinamaija/0000-0002-8306-6202; Magi, Reedik/0000-0002-2964-6011; Butterworth, Adam/0000-0002-6915-9015; Voight, Benjamin/0000-0002-6205-9994; Linneberg, Allan/0000-0002-0994-0184; Hollensted, Mette/0000-0001-5572-3183; Moutsianas, Loukas/0000-0001-5453-345X; tumino, rosario/0000-0003-2666-414X; Bergman, Richard/0000-0003-1539-4471; Howson, Joanna/0000-0001-7618-0050; Buck, Gemma/0000-0001-5289-1050; Mahajan, Anubha/0000-0001-5585-3420; Elliott, Paul/0000-0002-7511-5684; Barroso, Ines/0000-0001-5800-4520; Hattersley, Andrew/0000-0001-5620-473X; Loh, Marie/0000-0003-3626-8466; Rosengren, Anders/0000-0002-9333-5736; Blangero, John/0000-0001-6250-5723; Meisinger, Christa/0000-0002-9026-6544; Small, Kerrin/0000-0003-4566-0005; Tai, E Shyong/0000-0003-2929-8966; Fowler, Sharon/0000-0003-1117-683X	Medical Research Council [MC_U106179472, MC_PC_13046, MC_UU_12015/2, MC_UU_12012/5/B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10077, NF-SI-0611-10219, NF-SI-0507-10228, NF-SI-0611-10136, NF-SI-0507-10380, NF-SI-0513-10109, ACF-2009-18-005, NF-SI-0611-10099, NF-SI-0514-10027] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1016167, NNF11OC1014855, NNF15OC0016416, NNF13OC0005781] Funding Source: researchfish; MRC [MC_U106179472, G0601966, G0800270, MR/L01341X/1, G0700931, MR/K002414/1, MC_UU_12015/2, G0601261, MC_UU_12015/1, MC_UU_12012/5] Funding Source: UKRI; British Heart Foundation [RG/14/5/30893, SP/04/002, SP/09/002] Funding Source: Medline; CIHR Funding Source: Medline; Medical Research Council [G0700931, G0601966, MC_UU_12012/5, G0800270, MC_UU_12015/1, MR/K002414/1, G0900747-‐91070, MR/L01341X/1, G0601261] Funding Source: Medline; NCI NIH HHS [K12CA139160] Funding Source: Medline; NHGRI NIH HHS [U01HG005773, U54 HG003067, R56 HG000376, U54HG003067, T32 HG000040, R01 HG000376, U01 HG005773] Funding Source: Medline; NHLBI NIH HHS [HHSN268201300048C, R01HL102830, HHSN268201300047C, T32 HL007055, HHSN268201300049C, HHSN268201300046C, R01 HL102830, HHSN268201300050C] Funding Source: Medline; NIA NIH HHS [R01 AG042188, P01AG027734, P30 AG038072, P01 AG027734, R01AG046949, 1R01AG042188, P30AG038072, R01 AG046949] Funding Source: Medline; NIDDK NIH HHS [R01DK062370, R01 DK101478, DK072193, R01 DK073541, R01 DK066358, RC2 DK088389, P30DK020595, K24 DK080140, R01DK098032, U01 DK085526, RC2DK088389, R00DK092251, U01 DK085584, DK085584, DK085545, U01 DK078616, DK088389, DK085526, DK098032, U01 DK062370, DK085501, P30 DK020572, R01DK073541, RC2-‐DK088389, P30 DK020595, P60 DK020595, R01 DK072193, R01 DK093757, U01 DK085501, K24 DK110550, P60DK20595, U01DK085501, DK093757, R00 DK099240, 1RC2DK088389, R00 DK092251, U01 DK085524, K24DK080140, DK085524, R01DK066358, U01 DK085545, R01 DK106236, R01 DK098032, U01DK085526] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753, T32GM007753] Funding Source: Medline; NIH HHS [S10 OD018522] Funding Source: Medline; NIMHD NIH HHS [U54 MD007588] Funding Source: Medline; NIMH NIH HHS [R01 MH101820, R01MH101820, R01 MH090937, R01MH090937] Funding Source: Medline; Wellcome Trust [098381, 085475, 095552, 084723, 095101, 092447, 090532, 064890, 100956, 090367, 086596, 098051, 083948, 098017] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K12CA139160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102830, T32HL007055] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005773, U54HG003067, R56HG000376, R01HG000376, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB015611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085545, R01DK066358, RC2DK088389, K24DK080140, K24DK110550, P30DK020595, R00DK099240, U01DK085584, R01DK106236, U01DK085501, U01DK062370, U01DK085524, R01DK062370, R01DK093757, P30DK020572, R00DK092251, P60DK020595, R01DK073541, R01DK098032, R01DK101478, R01DK072193, U01DK078616, U01DK085526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101820, R01MH090937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042188, P30AG038072, R01AG046949, P01AG027734] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007588] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); CIHR(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Estrada K, 2014, JAMA-J AM MED ASSOC, V311, P2305, DOI 10.1001/jama.2014.6511; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Goldstein DB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001008; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kooptiwut S, 2012, J DIABETES COMPLICAT, V26, P343, DOI 10.1016/j.jdiacomp.2012.03.025; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lambert BW, 2008, BIOINFORMATICS, V24, P1821, DOI 10.1093/bioinformatics/btn317; Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Ma RCW, 2013, DIABETOLOGIA, V56, P1291, DOI 10.1007/s00125-013-2874-4; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Mahdessian H, 2014, P NATL ACAD SCI USA, V111, P8913, DOI 10.1073/pnas.1323785111; Majithia AR, 2014, P NATL ACAD SCI USA, V111, P13127, DOI 10.1073/pnas.1410428111; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Oppelt A, 2013, EMBO REP, V14, P57, DOI 10.1038/embor.2012.183; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; RICE WR, 1990, BIOMETRICS, V46, P303, DOI 10.2307/2531435; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiagalingam A, 1997, GENOMICS, V45, P630, DOI 10.1006/geno.1997.5001; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Willemsen G, 2015, TWIN RES HUM GENET, V18, P762, DOI 10.1017/thg.2015.83; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	68	655	673	6	319	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					41	+		10.1038/nature18642	http://dx.doi.org/10.1038/nature18642			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27398621	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000380999200026
J	Swart, EC; Serra, V; Petroni, G; Nowacki, M				Swart, Estienne Carl; Serra, Valentina; Petroni, Giulio; Nowacki, Mariusz			Genetic Codes with No Dedicated Stop Codon: Context-Dependent Translation Termination	CELL			English	Article							STYLONYCHIA-LEMNAE; TRANSFER-RNAS; READ-THROUGH; CILIATE; REASSIGNMENT; MECHANISM; TETRAHYMENA; EVOLUTION; MULTIPLE; SEQUENCE	The prevailing view of the nuclear genetic code is that it is largely frozen and unambiguous. Flexibility in the nuclear genetic code has been demonstrated in ciliates that reassign standard stop codons to amino acids, resulting in seven variant genetic codes, including three previously undescribed ones reported here. Surprisingly, in two of these species, we find efficient translation of all 64 codons as standard amino acids and recognition of either one or all three stop codons. How, therefore, does the translation machinery interpret a "stop'' codon? We provide evidence, based on ribosomal profiling and "stop'' codon depletion shortly before coding sequence ends, that mRNA 30 ends may contribute to distinguishing stop from sense in a context-dependent manner. We further propose that such context-dependent termination/readthrough suppression near transcript ends enables genetic code evolution.	[Swart, Estienne Carl; Nowacki, Mariusz] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Serra, Valentina; Petroni, Giulio] Univ Pisa, Dept Biol, I-56126 Pisa, Italy	University of Bern; University of Pisa	Nowacki, M (corresponding author), Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland.	mariusz.nowacki@izb.unibe.ch	Petroni, Giulio/B-6086-2008; Nowacki, Mariusz/E-4485-2011	Petroni, Giulio/0000-0001-9572-9897; Nowacki, Mariusz/0000-0003-4894-2905; Serra, Valentina/0000-0002-2887-993X	European Research Council (ERC) (EPIGENOME); National Center of Competence in Research (NCCR) RNA and Disease; European COST Action [BM1102]	European Research Council (ERC) (EPIGENOME)(European Research Council (ERC)); National Center of Competence in Research (NCCR) RNA and Disease(Swiss National Science Foundation (SNSF)); European COST Action	We thank Letizia Modeo for collecting C. magnum, Vittorio Boscaro for the original C. magnum RNA isolation, Sophie Braga-Lagache and Manfred Heller from the Mass Spectrometry and Proteomics Laboratory at the Children's University Hospital in Bern for mass spectrometry support, Deis Haxholli for initial genetic code inspections and the M.N. lab members for support and discussion. This research was supported by grants from the European Research Council (ERC) (EPIGENOME) and National Center of Competence in Research (NCCR) RNA and Disease to M.N., and the European COST Action BM1102. Cluster computing was performed at the Vital-IT Center for High-Performance Computing (http://www.vital-it.ch) of the Swiss Institute of Bioinformatics.	Aeschlimann SH, 2014, GENOME BIOL EVOL, V6, P1707, DOI 10.1093/gbe/evu139; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Aoki K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-210; Atkins JF, 2007, NATURE, V448, P1004, DOI 10.1038/4481004a; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Baejen C, 2014, MOL CELL, V55, P745, DOI 10.1016/j.molcel.2014.08.005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Blanchet S, 2014, NUCLEIC ACIDS RES, V42, P10061, DOI 10.1093/nar/gku663; CARON F, 1985, NATURE, V314, P185, DOI 10.1038/314185a0; Chen X, 2014, CELL, V158, P1187, DOI 10.1016/j.cell.2014.07.034; Chung BY, 2015, RNA, V21, P1731, DOI 10.1261/rna.052548.115; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Coyne RS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r100; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; Dutilh BE, 2011, BIOINFORMATICS, V27, P1929, DOI 10.1093/bioinformatics/btr316; Edgcomb VP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00055; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Eliseev B, 2011, NUCLEIC ACIDS RES, V39, P599, DOI 10.1093/nar/gkq759; Feng JM, 2015, MOL PHYLOGENET EVOL, V90, P104, DOI 10.1016/j.ympev.2015.05.007; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gentekaki E, 2014, MOL PHYLOGENET EVOL, V78, P36, DOI 10.1016/j.ympev.2014.04.020; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; HANYU N, 1986, EMBO J, V5, P1307, DOI 10.1002/j.1460-2075.1986.tb04360.x; Harrell L, 2002, NUCLEIC ACIDS RES, V30, P2011, DOI 10.1093/nar/30.9.2011; HELFTENBEIN E, 1985, NUCLEIC ACIDS RES, V13, P415, DOI 10.1093/nar/13.2.415; HIRSH, 1971, J MOL BIOL, V58, P439, DOI 10.1016/0022-2836(71)90362-7; HIRSH D, 1971, J MOL BIOL, V58, P459, DOI 10.1016/0022-2836(71)90363-9; HOROWITZ S, 1985, P NATL ACAD SCI USA, V82, P2452, DOI 10.1073/pnas.82.8.2452; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Keeling PJ, 1996, EMBO J, V15, P2285, DOI 10.1002/j.1460-2075.1996.tb00581.x; Kini HK, 2016, RNA, V22, P61, DOI 10.1261/rna.053447.115; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Koonin EV, 2009, IUBMB LIFE, V61, P99, DOI 10.1002/iub.146; KUCHINO Y, 1985, P NATL ACAD SCI USA, V82, P4758, DOI 10.1073/pnas.82.14.4758; Lekomtsev S, 2007, P NATL ACAD SCI USA, V104, P10824, DOI 10.1073/pnas.0703887104; Lemke EA, 2014, CHEMBIOCHEM, V15, P1691, DOI 10.1002/cbic.201402362; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lozupone CA, 2001, CURR BIOL, V11, P65, DOI 10.1016/S0960-9822(01)00028-8; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Muhlhausen S., 2016, GENOME RES; Nasim MT, 2000, J BIOL CHEM, V275, P14846, DOI 10.1074/jbc.275.20.14846; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; OSAWA S, 1989, J MOL EVOL, V28, P271, DOI 10.1007/BF02103422; PREER JR, 1985, NATURE, V314, P188, DOI 10.1038/314188a0; Roy B, 2015, P NATL ACAD SCI USA, V112, P3038, DOI 10.1073/pnas.1424127112; Salas-Marco J, 2006, MOL CELL BIOL, V26, P438, DOI 10.1128/MCB.26.2.438-447.2006; Sanchez-Silva R, 2003, CURR BIOL, V13, P442, DOI 10.1016/S0960-9822(03)00126-X; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; SCHNEIDER SU, 1989, MOL GEN GENET, V218, P445, DOI 10.1007/BF00332408; SCHULTZ DW, 1994, J MOL BIOL, V235, P1377, DOI 10.1006/jmbi.1994.1094; Sengupta S, 2015, J MOL EVOL, V80, P229, DOI 10.1007/s00239-015-9686-8; Sladic RT, 2004, EUR J BIOCHEM, V271, P450, DOI 10.1046/j.1432-1033.2003.03945.x; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; TOURANCHEAU AB, 1995, EMBO J, V14, P3262, DOI 10.1002/j.1460-2075.1995.tb07329.x; TUITE MF, 1982, MOL CELL BIOL, V2, P490, DOI 10.1128/MCB.2.5.490; Vallabhaneni H, 2009, RNA, V15, P889, DOI 10.1261/rna.1508109; Wang RL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21139; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	62	96	99	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					691	702		10.1016/j.cell.2016.06.020	http://dx.doi.org/10.1016/j.cell.2016.06.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27426948	Green Published, hybrid			2022-12-24	WOS:000380546500019
J	Minami, CA; Stulberg, JJ; Hungness, ES				Minami, Christina A.; Stulberg, Jonah J.; Hungness, Eric S.			Partnering Behavioral Modification With Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OBESITY	Postoperative Behavioral Variables and Weight Change 3 Years After Bariatric Surgery James E. Mitchell, MD; Nicholas J. Christian, PhD; David R. Flum, MD, MPH; Alfons Pomp, MD; Walter J. Pories, MD; Bruce M. Wolfe, MD; Anita P. Courcoulas, MD, MPH; Steven H. Belle, PhD, MScHyg IMPORTANCE Severe obesity (body mass index >= 35 [calculated as weight in kilograms divided by height in meters squared]) is associated with significant medical comorbidity and increased mortality. Bariatric surgery induces weight loss, the extent of which can vary. Postoperative predictors of weight loss have not been adequately examined. OBJECTIVE To describe postoperative eating behaviors and weight control and their effects on 3-year change in weight. DESIGN, SETTING, AND PARTICIPANTS The Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study is a multicenter observational cohort study at 10 US hospitals in 6 geographically diverse clinical centers. Adults undergoing first-time bariatric surgical procedures as part of routine clinical care were recruited between 2006 and 2009 and followed up until September 2012. Participants completed detailed surveys regarding eating andweight control behaviors prior to surgery and then annually after surgery for 3 years. MAIN OUTCOMES AND MEASURES Twenty-five postoperative behaviors related to eating behavior, eating problems, weight control practices, and the problematic use of alcohol, smoking, and illegal drugs. Behaviors examined were divided into those that were never present (preoperatively or postoperatively), those that were always present (preoperatively and postoperatively), and those that underwent a healthy change after surgery (development of a positive behavior or omission of a negative behavior). RESULTS The sample included a total of 2022 participants (median age, 47 years [interquartile range, 38-55 years]; median BMI, 46 [interquartile range, 42-51]; 78% women): 1513 who had undergone Roux-en-Y gastric bypass and 509 who had undergone laparoscopic adjustable gastric banding. If we consider the cumulative effects of the 3 behaviors that explain most of the variability (16%) in 3-year percent weight change following Roux-en-Y gastric bypass, ie, weekly self-weighing, continuing to eat when feeling full more than once a week, and eating continuously during the day, a participant who postoperatively started to self-weigh, stopped eating when feeling full, and stopped eating continuously during the day after surgery would be predicted to lose a mean (SE) of 38.8% (0.8%) of their baseline weight. This average is about 14% greater weight loss compared with participants who made no positive changes in these variables (mean [SE], -24.6%[1.6%]; mean difference, -14.2%; 95% CI, -18.7% to -9.8%; P < .001) and 6% greater weight loss compared with participants who always reported positive on these healthy behaviors (mean [SE], -33.2%[0.6%]; mean difference, -5.7%; 95% CI, -7.8% to -3.5%; P <.001). CONCLUSIONS AND RELEVANCE The results suggest the importance of assessing behaviors related to eating behavior, eating problems, weight control practices, and the problematic use of alcohol, smoking, and illegal drugs in bariatric surgery candidates and patients who have undergone bariatric surgery, and they suggest that the utility of programs to modify problematic eating behaviors and eating patterns should be addressed in research.	[Minami, Christina A.; Stulberg, Jonah J.] Northwestern Univ, Feinberg Sch Med, Surg Outcomes & Qual Improvement Ctr, Dept Surg, Chicago, IL 60611 USA; [Minami, Christina A.; Stulberg, Jonah J.] Northwestern Mem Hosp, Chicago, IL 60611 USA; [Minami, Christina A.; Stulberg, Jonah J.] Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, 633 N St Clair,20th Floor, Chicago, IL 60611 USA; [Stulberg, Jonah J.; Hungness, Eric S.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern Memorial Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Minami, CA (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, 633 N St Clair,20th Floor, Chicago, IL 60611 USA.	christina-minami@northwestern.edu		Hungness, Eric/0000-0002-2027-2121; Stulberg, Jonah/0000-0001-9971-8693				Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Courcoulas AP, 2013, JAMA-J AM MED ASSOC, V310, P2416, DOI 10.1001/jama.2013.280928; Mitchell JE, 2016, JAMA SURG; Wadden TA, 2014, JAMA-J AM MED ASSOC, V312, P1779, DOI 10.1001/jama.2014.14173; Zuckoff A, 2012, SURG OBES RELAT DIS, V8, P514, DOI 10.1016/j.soard.2012.05.002	5	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2016	316	4					448	+		10.1001/jama.2016.9033	http://dx.doi.org/10.1001/jama.2016.9033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR9MV	27458950				2022-12-24	WOS:000380221700023
J	Fink, G; Szewczak-Harris, A; Lowe, J				Fink, Gero; Szewczak-Harris, Andrzej; Lowe, Jan			SnapShot: The Bacterial Cytoskeleton	CELL			English	Editorial Material							CELL-DIVISION; ARCHAEA		[Fink, Gero; Szewczak-Harris, Andrzej; Lowe, Jan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Fink, G (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.		Löwe, Jan/X-6998-2019	Lowe, Jan/0000-0002-5218-6615; Harris, Andrzej/0000-0003-4885-7401	MRC [MC_U105184326] Funding Source: UKRI; Medical Research Council [MC_U105184326] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Duggin IG, 2015, NATURE, V519, P362, DOI 10.1038/nature13983; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Ettema TJG, 2011, MOL MICROBIOL, V80, P1052, DOI 10.1111/j.1365-2958.2011.07635.x; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500	10	4	5	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					522	+	522.e1	10.1016/j.cell.2016.06.057	http://dx.doi.org/10.1016/j.cell.2016.06.057			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27419875	Bronze			2022-12-24	WOS:000380255400027
J	Kawakatsu, T; Huang, SSC; Jupe, F; Sasaki, E; Schmitz, RJ; Urich, MA; Castanon, R; Nery, JR; Barragan, C; He, YP; Chen, HM; Dubin, M; Lee, CR; Wang, CM; Bemm, F; Becker, C; O'Neil, R; O'Malley, RC; Quarless, DX; Schork, NJ; Weigel, D; Nordborg, M; Ecker, JR				Kawakatsu, Taiji; Huang, Shao-shan Carol; Jupe, Florian; Sasaki, Eriko; Schmitz, Robert J.; Urich, Mark A.; Castanon, Rosa; Nery, Joseph R.; Barragan, Cesar; He, Yupeng; Chen, Huaming; Dubin, Manu; Lee, Cheng-Ruei; Wang, Congmao; Bemm, Felix; Becker, Claude; O'Neil, Ryan; O'Malley, Ronan C.; Quarless, Danjuma X.; Schork, Nicholas J.; Weigel, Detlef; Nordborg, Magnus; Ecker, Joseph R.		1001 Genomes Consortium	Epigenomic Diversity in a Global Collection of Arabidopsis thaliana Accessions	CELL			English	Article							EPIGENETIC NATURAL VARIATION; DNA METHYLATION; GENES; PATTERNS; SEQUENCE; FAMILY; PLANTS	The epigenome orchestrates genome accessibility, functionality, and three-dimensional structure. Because epigenetic variation can impact transcription and thus phenotypes, it may contribute to adaptation. Here, we report 1,107 high-quality single-base resolution methylomes and 1,203 transcriptomes from the 1001 Genomes collection of Arabidopsis thaliana. Although the genetic basis of methylation variation is highly complex, geographic origin is a major predictor of genome-wide DNA methylation levels and of altered gene expression caused by epialleles. Comparison to cistrome and epicistrome datasets identifies associations between transcription factor binding sites, methylation, nucleotide variation, and co-expression modules. Physical maps for nine of the most diverse genomes reveal how transposons and other structural variants shape the epigenome, with dramatic effects on immunity genes. The 1001 Epigenomes Project provides a comprehensive resource for understanding how variation in DNA methylation contributes to molecular and non-molecular phenotypes in natural populations of the most studied model plant.	[Kawakatsu, Taiji; Huang, Shao-shan Carol; Jupe, Florian; Ecker, Joseph R.; 1001 Genomes Consortium] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Kawakatsu, Taiji; Huang, Shao-shan Carol; Jupe, Florian; Schmitz, Robert J.; Urich, Mark A.; Castanon, Rosa; Nery, Joseph R.; Barragan, Cesar; He, Yupeng; Chen, Huaming; O'Neil, Ryan; O'Malley, Ronan C.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Kawakatsu, Taiji] Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Tsukuba, Ibaraki 3058602, Japan; [Schmitz, Robert J.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Sasaki, Eriko; Dubin, Manu; Lee, Cheng-Ruei; Nordborg, Magnus] Austrian Acad Sci, Gregor Mendel Inst, Vienna Bioctr, A-1030 Vienna, Austria; [Wang, Congmao; Bemm, Felix; Becker, Claude; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Wang, Congmao] Zhejiang Acad Agr Sci, Inst Digital Agr, Hangzhou 310021, Zhejiang, Peoples R China; [Quarless, Danjuma X.; Schork, Nicholas J.] J Craig Venter Inst, Human Biol, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; National Institute of Agrobiological Sciences - Japan; University System of Georgia; University of Georgia; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Max Planck Society; Zhejiang Academy of Agricultural Sciences; J. Craig Venter Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.; Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Ecker, JR (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ecker@salk.edu	Becker, Claude/H-9011-2019; Korte, Arthur/H-3190-2019; Schmitz, Robert/AAY-7659-2020; Weigel, Detlef/AAR-3312-2021; Nery, Joseph/AAE-8422-2019; Pico, Xavier/E-5697-2016; Ecker, Joseph R/B-9144-2008; Weigel, Detlef/C-1418-2008; Andrade, Jorge/H-3104-2019; Alonso-Blanco, Carlos/F-8864-2016; Weigel, Detlef/GSJ-0799-2022; Chae, Eunyoung/AAA-6997-2021; Novikova, Polina Yu./AAZ-9233-2020; Grimm, Dominik/L-9088-2019	Becker, Claude/0000-0003-3406-4670; Korte, Arthur/0000-0003-0831-1463; Schmitz, Robert/0000-0001-7538-6663; Nery, Joseph/0000-0003-0153-5659; Pico, Xavier/0000-0003-2849-4922; Ecker, Joseph R/0000-0001-5799-5895; Weigel, Detlef/0000-0002-2114-7963; Andrade, Jorge/0000-0003-3210-2186; Alonso-Blanco, Carlos/0000-0002-4738-5556; Weigel, Detlef/0000-0002-2114-7963; Chae, Eunyoung/0000-0002-0889-9837; Novikova, Polina Yu./0000-0002-4552-4575; Grimm, Dominik/0000-0003-2085-4591; Exposito-Alonso, Moises/0000-0001-5711-0700; Bemm, Felix/0000-0001-6557-4898; Lee, Cheng-Ruei/0000-0002-1913-9964; Kawakatsu, Taiji/0000-0002-6871-9199; Horton, Matthew/0000-0002-7537-0730; Svardal, Hannes/0000-0001-7866-7313; Platzer, Alexander/0000-0002-2318-8806; Rowan, Beth/0000-0001-7240-4889; Nordborg, Magnus/0000-0001-7178-9748; Nagele, Thomas/0000-0002-5896-238X; Ding, Wei/0000-0001-5401-879X; Dubin, Manu/0000-0003-2374-2456; Schork, Nicholas/0000-0003-0920-5013; omalley, ronan/0000-0002-4907-0339; Korte, Pamela/0000-0002-7835-4998; Bergelson, Joy/0000-0001-7893-7387; Weckwerth, Wolfram/0000-0002-9719-6358; Jupe, Florian/0000-0001-5741-4931; Chen, Huaming/0000-0001-5289-7882; Mott, Richard/0000-0002-1022-9330; Farlow, Ashley/0000-0003-3789-6456	Japan Society for the Promotion of Sciences Research Abroad Fellowship; Human Frontier Science Program long-term fellowship; National Institutes of Health [R00GM100000]; Austrian Science Fund; DFG (SPP ADAPTOMICS); ERC (MAXMAP); ERC (IMMUNEMESIS); National Science Foundation [MCB 0929402, MCB 1122246]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM100000] Funding Source: NIH RePORTER	Japan Society for the Promotion of Sciences Research Abroad Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program long-term fellowship(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); DFG (SPP ADAPTOMICS)(German Research Foundation (DFG)); ERC (MAXMAP); ERC (IMMUNEMESIS); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Ecker laboratory for assistance of sample preparation and Matthew D. Schultz for assistance of methylome analyses. T.K. was supported by the Japan Society for the Promotion of Sciences Research Abroad Fellowship. F.J. is supported by a Human Frontier Science Program long-term fellowship. This research was supported by grants from the National Institutes of Health (R00GM100000 to R.J.S.), a collaborative grant from Austrian Science Fund and DFG (SPP ADAPTOMICS to M.N. and D.W.), the ERC (MAXMAP to M.N. and IMMUNEMESIS to D.W.), and the National Science Foundation (MCB 0929402 and MCB 1122246 to J.R.E.). J.R.E. is an investigator of the Howard Hughes Medical Institute and Gordon and Betty Moore Foundation (GBMF 3034). We acknowledge the Texas Advanced Computing Center at the University of Texas at Austin for providing computing resources.	Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bewick AJ, 2016, P NATL ACAD SCI USA, V113, P9111, DOI 10.1073/pnas.1604666113; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chae E, 2014, CELL, V159, P1341, DOI 10.1016/j.cell.2014.10.049; Cortijo S, 2014, SCIENCE, V343, P1145, DOI 10.1126/science.1248127; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Dubin MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05255; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; Gkountela S, 2015, CELL, V161, P1425, DOI 10.1016/j.cell.2015.05.012; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Hagmann J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004920; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Inagaki S, 2012, Cold Spring Harb Symp Quant Biol, V77, P155, DOI 10.1101/sqb.2013.77.016212; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Kawashima T, 2014, NAT REV GENET, V15, P613, DOI 10.1038/nrg3685; Kooke R, 2015, PLANT CELL, V27, P337, DOI 10.1105/tpc.114.133025; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Niederhuth CE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1059-0; Nuthikattu S, 2013, PLANT PHYSIOL, V162, P116, DOI 10.1104/pp.113.216481; O'Malley RC, 2016, CELL, V165, P1280, DOI 10.1016/j.cell.2016.04.038; Pecinka A, 2013, TRENDS PLANT SCI, V18, P625, DOI 10.1016/j.tplants.2013.07.005; Pignatta D, 2014, ELIFE, V3, DOI 10.7554/eLife.03198; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Rodriguez-Leal D, 2015, PLANT CELL, V27, P1034, DOI 10.1105/tpc.114.133009; Saucet SB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7338; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Schmitz RJ, 2012, TRENDS PLANT SCI, V17, P149, DOI 10.1016/j.tplants.2012.01.001; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Secco D, 2015, ELIFE, V4, DOI 10.7554/eLife.09343; Seymour DK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004785; Shen X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004842; Sterken R, 2009, PLANT CELL, V21, P2987, DOI 10.1105/tpc.109.067017; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Takuno S, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.222, 10.1038/nplants.2015.222]; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Teixeira FK, 2009, EMBO J, V28, P997, DOI 10.1038/emboj.2009.87; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	59	331	340	11	181	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					492	505		10.1016/j.cell.2016.06.044	http://dx.doi.org/10.1016/j.cell.2016.06.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27419873	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000380255400024
J	Laursen, L				Laursen, Lucas			PALLIATIVE CARE The other opioid issue	NATURE			English	Editorial Material																			0	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					S16	S17		10.1038/535S16a	http://dx.doi.org/10.1038/535S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27410527	Bronze			2022-12-24	WOS:000379912600011
J	Thackeray, SJ; Henrys, PA; Hemming, D; Bell, JR; Botham, MS; Burthe, S; Helaouet, P; Johns, DG; Jones, ID; Leech, DI; Mackay, EB; Massimino, D; Atkinson, S; Bacon, PJ; Brereton, TM; Carvalho, L; Clutton-Brock, TH; Duck, C; Edwards, M; Elliott, JM; Hall, SJG; Harrington, R; Pearce-Higgins, JW; Hoye, TT; Kruuk, LEB; Pemberton, JM; Sparks, TH; Thompson, PM; White, I; Winfield, IJ; Wanless, S				Thackeray, Stephen J.; Henrys, Peter A.; Hemming, Deborah; Bell, James R.; Botham, Marc S.; Burthe, Sarah; Helaouet, Pierre; Johns, David G.; Jones, Ian D.; Leech, David I.; Mackay, Eleanor B.; Massimino, Dario; Atkinson, Sian; Bacon, Philip J.; Brereton, Tom M.; Carvalho, Laurence; Clutton-Brock, Tim H.; Duck, Callan; Edwards, Martin; Elliott, J. Malcolm; Hall, Stephen J. G.; Harrington, Richard; Pearce-Higgins, James W.; Hoye, Toke T.; Kruuk, Loeske E. B.; Pemberton, Josephine M.; Sparks, Tim H.; Thompson, Paul M.; White, Ian; Winfield, Ian J.; Wanless, Sarah			Phenological sensitivity to climate across taxa and trophic levels	NATURE			English	Article							FRESH-WATER; SPRING PHYTOPLANKTON; RESPONSES; CONSTRAINTS; MISMATCH; TRENDS; STREAM; SHIFTS; BIRD	Differences in phenological responses to climate change among species can desynchronise ecological interactions and thereby threaten ecosystem function. To assess these threats, we must quantify the relative impact of climate change on species at different trophic levels. Here, we apply a Climate Sensitivity Profile approach to 10,003 terrestrial and aquatic phenological data sets, spatially matched to temperature and precipitation data, to quantify variation in climate sensitivity. The direction, magnitude and timing of climate sensitivity varied markedly among organisms within taxonomic and trophic groups. Despite this variability, we detected systematic variation in the direction and magnitude of phenological climate sensitivity. Secondary consumers showed consistently lower climate sensitivity than other groups. We used mid-century climate change projections to estimate that the timing of phenological events could change more for primary consumers than for species in other trophic levels (6.2 versus 2.5-2.9 days earlier on average), with substantial taxonomic variation (1.1-14.8 days earlier on average).	[Thackeray, Stephen J.; Henrys, Peter A.; Jones, Ian D.; Mackay, Eleanor B.; Winfield, Ian J.] Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lib Ave, Lancaster LA1 4AP, England; [Hemming, Deborah] Met Off, FitzRoy Rd, Exeter EX1 3PB, Devon, England; [Bell, James R.; Harrington, Richard] Rothamsted Res, Harpenden AL5 2JQ, Herts, England; [Botham, Marc S.] Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England; [Burthe, Sarah; Carvalho, Laurence; Wanless, Sarah] Ctr Ecol & Hydrol, Bush Estate, Penicuik EH26 0QB, Midlothian, Scotland; [Helaouet, Pierre; Johns, David G.; Edwards, Martin] Sir Alister Hardy Fdn Ocean Sci, The Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England; [Leech, David I.; Massimino, Dario; Pearce-Higgins, James W.] British Trust Ornithol, The Nunnery, Thetford IP24 2PU, Norfolk, England; [Atkinson, Sian] Woodland Trust, Kempton Way, Grantham NG31 6LL, Lincolnshire, England; [Bacon, Philip J.] Futtie Pk, Aberdeen AB31 4RX, Scotland; [Brereton, Tom M.] Butterfly Conservat, Wareham BH20 5QP, Dorset, England; [Clutton-Brock, Tim H.] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England; [Duck, Callan] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews KY16 8LB, Fife, Scotland; [Elliott, J. Malcolm] Freshwater Biol Assoc, Ambleside LA22 0LP, Cumbria, England; [Hall, Stephen J. G.] Lincoln Univ, Riseholme Hall,Riseholme Pk, Lincoln LN2 2LG, Lincolnshire, England; [Hoye, Toke T.] Aarhus Univ, Aarhus Inst Adv Studies, Dept Biosci, Hoegh Guldbergs Gade 6B, Aarhus, Denmark; [Hoye, Toke T.] Aarhus Univ, Arctic Res Ctr, Hoegh Guldbergs Gade 6B, DK-8000 Aarhus C, Denmark; [Kruuk, Loeske E. B.; Pemberton, Josephine M.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland; [Kruuk, Loeske E. B.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2612, Australia; [Sparks, Tim H.] Coventry Univ, Fac Engn & Comp, Priory St, Coventry CV1 5FB, W Midlands, England; [Sparks, Tim H.] Poznan Univ Life Sci, Inst Zool, Wojska Polskiego 71C, PL-60625 Poznan, Poland; [Thompson, Paul M.] Univ Aberdeen, George St, Cromarty IV11 8YJ, Ross Shire, Scotland; [White, Ian] Peoples Trust Endangered Species, 15 Cloisters House,8 Battersea Pk Rd, London SW8 4BG, England	Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); Met Office - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH); British Trust for Ornithology; University of Cambridge; University of St Andrews; Freshwater Biological Association (FBA); University of Lincoln; Aarhus University; Aarhus University; University of Edinburgh; Australian National University; Coventry University; Poznan University of Life Sciences; University of Aberdeen	Thackeray, SJ (corresponding author), Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lib Ave, Lancaster LA1 4AP, England.	sjtr@ceh.ac.uk	Henrys, Peter/K-3321-2012; Bell, James/C-2247-2009; Jones, Ian/E-5507-2015; Høye, Toke Thomas/A-7701-2008; Kruuk, Loeske/AAB-8714-2019; Massimino, Dario/A-8113-2010; Hoye, Toke T./ABF-7808-2020; Thompson, Paul M/B-6742-2009; Pemberton, Josephine M/F-3100-2010; Kruuk, Loeske E. B./J-3295-2012; Carvalho, Laurence/D-3276-2009; Mackay, Eleanor B/F-5490-2013; Burthe, Sarah J/Q-9505-2016; Mackay, Eleanor/AAP-5437-2020; Winfield, Ian J/I-6085-2012; Thackeray, Stephen J/D-2415-2013	Henrys, Peter/0000-0003-4758-1482; Bell, James/0000-0003-1640-6120; Jones, Ian/0000-0002-6898-1429; Høye, Toke Thomas/0000-0001-5387-3284; Kruuk, Loeske/0000-0001-8588-1123; Massimino, Dario/0000-0002-5855-4060; Hoye, Toke T./0000-0001-5387-3284; Thompson, Paul M/0000-0001-6195-3284; Kruuk, Loeske E. B./0000-0001-8588-1123; Carvalho, Laurence/0000-0002-9768-9902; Mackay, Eleanor B/0000-0001-5697-7062; Burthe, Sarah J/0000-0001-8871-3432; Mackay, Eleanor/0000-0001-5697-7062; Winfield, Ian J/0000-0001-9296-5114; Thackeray, Stephen J/0000-0003-3274-2706; Helaouet, Pierre/0000-0001-6102-7379; Johns, David/0000-0003-3270-6764; Sparks, Tim/0000-0003-4382-7051; Hall, Stephen/0000-0003-2666-1715	Natural Environment Research Council (NERC) [NE/J02080X/1]; BBSRC; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005195, BBS/E/C/00005191] Funding Source: researchfish; Natural Environment Research Council [NE/J02080X/1, ceh020002, NE/L00688X/1, NE/J020451/1, NE/I030062/1, SAH01001, NE/J020362/1, NE/I024925/1, NE/M003035/1, smru10001] Funding Source: researchfish; BBSRC [BBS/E/C/00005191, BBS/E/C/00005195] Funding Source: UKRI; NERC [NE/J02080X/1, NE/J020362/1, NE/J020451/1, SAH01001, NE/M003035/1, ceh020002, NE/I024925/1] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Natural Environment Research Council (NERC) grant NE/J02080X/1. We thank O. Mountford for assigning species traits for plants, H. Feuchtmayr for extracting plankton data for analysis and N. Dodd for air and water temperature data from the Tarland Burn. We also thank P Vender, the staff and many volunteers and contributors, including Science and Advice for Scottish Agriculture, to the Rothamsted Insect Survey (RIS) over the last half century. The RIS is a National Capability strategically funded by BBSRC. The consortium represented by the authorship list hold long-term data that represent a considerable investment in scientific endeavour. Whilst we are committed to sharing these data for scientific research, users are requested to collaborate before publication of these data to ensure accurate biological interpretation.	Amano T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3017; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Burthe S, 2012, MAR ECOL PROG SER, V454, P119, DOI 10.3354/meps09520; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Doi H, 2008, CLIM RES, V36, P181, DOI 10.3354/cr00741; ELLIOTT JM, 1984, J ANIM ECOL, V53, P327, DOI 10.2307/4360; Feuchtmayr H, 2012, FRESHWATER BIOL, V57, P331, DOI 10.1111/j.1365-2427.2011.02671.x; IPCC, 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; Jones ID, 2008, FRESHWATER BIOL, V53, P393, DOI 10.1111/j.1365-2427.2007.01902.x; Jonsson T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6992; Miller-Rushing AJ, 2010, PHILOS T R SOC B, V365, P3177, DOI 10.1098/rstb.2010.0148; Mohseni O, 1998, WATER RESOUR RES, V34, P2685, DOI 10.1029/98WR01877; Nakazawa T, 2012, OIKOS, V121, P489, DOI 10.1111/j.1600-0706.2011.20171.x; Nussey DH, 2005, BIOL LETT-UK, V1, P457, DOI 10.1098/rsbl.2005.0352; Ohlberger J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0938; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perry M, 2005, INT J CLIMATOL, V25, P1041, DOI 10.1002/joc.1161; Phillimore AB, 2012, P NATL ACAD SCI USA, V109, DOI 10.1073/pnas.1203538109; Phillimore AB, 2010, P NATL ACAD SCI USA, V107, P8292, DOI 10.1073/pnas.0913792107; Pope KS, 2013, GLOBAL CHANGE BIOL, V19, P1518, DOI 10.1111/gcb.12130; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reed TE, 2013, SCIENCE, V340, P488, DOI 10.1126/science.1232870; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Scheffer M, 2015, SCIENCE, V347, P1317, DOI 10.1126/science.aaa3769; Thackeray SJ, 2008, J ECOL, V96, P523, DOI 10.1111/j.1365-2745.2008.01355.x; Thackeray SJ, 2012, FRESHWATER BIOL, V57, P345, DOI 10.1111/j.1365-2427.2011.02614.x; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; van de Pol M, 2011, AM NAT, V177, P698, DOI 10.1086/659101; van Emden H.F., 2007, APHIDS CROP PESTS, P717; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980	41	472	488	23	499	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					241	U94		10.1038/nature18608	http://dx.doi.org/10.1038/nature18608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27362222	Green Accepted, Green Submitted			2022-12-24	WOS:000379912600048
J	Moreau, P; Rajkumar, SV				Moreau, Philippe; Rajkumar, S. Vincent			Multiple myeloma-translation of trial results into reality	LANCET			English	Editorial Material							PROGNOSTIC VALUE; LENALIDOMIDE; DEXAMETHASONE; CARFILZOMIB		[Moreau, Philippe] Univ Hosp Hotel Dieu, Dept Hematol, Nantes, France; [Rajkumar, S. Vincent] Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Nantes Universite; CHU de Nantes; Mayo Clinic	Rajkumar, SV (corresponding author), Mayo Clin, Div Hematol, Rochester, MN 55905 USA.	rajkumar.vincent@mayo.edu	Rajkumar, S. Vincent/AAV-1834-2021	Rajkumar, S. Vincent/0000-0002-5862-1833; moreau, philippe/0000-0003-1780-8746				Hebraud B, 2014, LEUKEMIA, V28, P675, DOI 10.1038/leu.2013.225; Jakubowiak AJ, 2012, BLOOD, V120, P1801, DOI 10.1182/blood-2012-04-422683; Kantarjian H, 2015, MAYO CLIN PROC, V90, P500, DOI 10.1016/j.mayocp.2015.01.014; Kumar S, 2012, BLOOD, V119, P2100, DOI 10.1182/blood-2011-11-390658; Liberati A, 2011, LANCET, V378, P1777, DOI 10.1016/S0140-6736(11)61772-8; Martinez-Lopez J, 2014, BLOOD, V123, P3073, DOI 10.1182/blood-2014-01-550020; McCarthy PL, 2012, NEW ENGL J MED, V366, P1770, DOI 10.1056/NEJMoa1114083; Moreau P, 2016, NEW ENGL J MED, V374, P1621, DOI 10.1056/NEJMoa1516282; Moreau Philippe, 2015, Am Soc Clin Oncol Educ Book, pe504, DOI 10.14694/EdBook_AM.2015.35.e504; Paiva B, 2015, HAEMATOLOGICA, V100, pE53, DOI 10.3324/haematol.2014.115162; Palumbo A, 2015, J CLIN ONCOL, V33, P3459, DOI 10.1200/JCO.2014.60.2466; Rajan AM, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.92; Rajkumar SV, 2016, AM J HEMATOL, V91, P90, DOI 10.1002/ajh.24236; Rajkumar SV, 2016, MAYO CLIN PROC, V91, P101, DOI 10.1016/j.mayocp.2015.11.007; Stewart AK, 2015, NEW ENGL J MED, V372, P142, DOI 10.1056/NEJMoa1411321; US Food and Drug Administration, 2015, IX; US Food and Drug Administration, 2015, DAR INJ; US Food and Drug Administration, 2015, EL	18	26	28	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2016	388	10040					111	113		10.1016/S0140-6736(16)30954-0	http://dx.doi.org/10.1016/S0140-6736(16)30954-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5TZ	27411865				2022-12-24	WOS:000379269200011
J	Lazarus, C; Guichard, M; Philippe, JM; Paux, T; Vallet, B				Lazarus, Clement; Guichard, Marie; Philippe, Jean-Marc; Paux, Thierry; Vallet, Benoit			The French experience of the threat posed by Zika virus	LANCET			English	Editorial Material									[Lazarus, Clement; Guichard, Marie; Philippe, Jean-Marc] Gen Directorate Hlth, Publ Hlth Emergency Operat Ctr, F-75007 Paris, France; [Paux, Thierry] Gen Directorate Hlth, Monitoring & Hlth Safety Dept, F-75007 Paris, France; [Lazarus, Clement; Guichard, Marie; Philippe, Jean-Marc; Paux, Thierry; Vallet, Benoit] Gen Directorate Hlth, Minist Hlth, F-75007 Paris, France		Vallet, B (corresponding author), Gen Directorate Hlth, Minist Hlth, F-75007 Paris, France.	benoit.vallet@sante.gouv.fr						Altona Diagnostics EN, REALSTAR ZIK VIR RT; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Conseil National Professionnel de Gynecologie et Obstetrique, ZIK GROSS; Delfraissy JF, 2016, LANCET, V387, P2183, DOI 10.1016/S0140-6736(16)30059-9; European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR; Haut Conseil de la Sante Publique, 2016, INF VIR ZIK PRIS CHA; Haut Conseil de la Sante Publique, 2016, INF VIR ZIK INSCR LI; Haut Conseil de la Sante Publique, 2016, MES GEST UT DELT DEP; Haut Conseil de la Sante Publique, 2016, PERS ATT VIR ZIK ACT; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; Ministere des Aff aires etrangeres et du Developpement international, 2016, CONS VOYAG; Ministere des Aff aires Sociales et de la Sante, 2015, MAL VIR ZIK MAL INF; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	13	2	2	0	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2016	388	10039					9	11		10.1016/S0140-6736(16)30509-8	http://dx.doi.org/10.1016/S0140-6736(16)30509-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP9PM	27397775	Bronze			2022-12-24	WOS:000378828400008
J	Stahl, PL; Salmen, F; Vickovic, S; Lundmark, A; Navarro, JF; Magnusson, J; Giacomello, S; Asp, M; Westholm, JO; Huss, M; Mollbrink, A; Linnarsson, S; Codeluppi, S; Borg, A; Ponten, F; Costea, PI; Sahlen, P; Mulder, J; Bergmann, O; Lundeberg, J; Frisen, J				Stahl, Patrik L.; Salmen, Fredrik; Vickovic, Sanja; Lundmark, Anna; Navarro, Jose Fernandez; Magnusson, Jens; Giacomello, Stefania; Asp, Michaela; Westholm, Jakub O.; Huss, Mikael; Mollbrink, Annelie; Linnarsson, Sten; Codeluppi, Simone; Borg, Ake; Ponten, Fredrik; Costea, Paul Igor; Sahlen, Pelin; Mulder, Jan; Bergmann, Olaf; Lundeberg, Joakim; Frisen, Jonas			Visualization and analysis of gene expression in tissue sections by spatial transcriptomics	SCIENCE			English	Article							CELL RNA-SEQ; ORGANIZATION	Analysis of the pattern of proteins or messenger RNAs (mRNAs) in histological tissue sections is a cornerstone in biomedical research and diagnostics. This typically involves the visualization of a few proteins or expressed genes at a time. We have devised a strategy, which we call "spatial transcriptomics," that allows visualization and quantitative analysis of the transcriptome with spatial resolution in individual tissue sections. By positioning histological sections on arrayed reverse transcription primers with unique positional barcodes, we demonstrate high-quality RNA-sequencing data with maintained two-dimensional positional information from the mouse brain and human breast cancer. Spatial transcriptomics provides quantitative gene expression data and visualization of the distribution of mRNAs within tissue sections and enables novel types of bioinformatics analyses, valuable in research and diagnostics.	[Stahl, Patrik L.; Navarro, Jose Fernandez; Magnusson, Jens; Bergmann, Olaf; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Stahl, Patrik L.; Salmen, Fredrik; Vickovic, Sanja; Lundmark, Anna; Navarro, Jose Fernandez; Giacomello, Stefania; Asp, Michaela; Mollbrink, Annelie; Costea, Paul Igor; Sahlen, Pelin; Lundeberg, Joakim] KTH Royal Inst Technol, Div Gene Technol, Sci Life Lab, SE-10691 Stockholm, Sweden; [Lundmark, Anna] Karolinska Inst, Div Periodontol, Dept Dent Med, SE-14104 Huddinge, Sweden; [Westholm, Jakub O.; Huss, Mikael] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Box 1031, SE-17121 Solna, Sweden; [Linnarsson, Sten; Codeluppi, Simone] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurosci, SE-17177 Stockholm, Sweden; [Codeluppi, Simone] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Borg, Ake] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, SE-22381 Lund, Sweden; [Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Mulder, Jan] Karolinska Inst, Dept Neurosci, Sci Life Lab, SE-17177 Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology; Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska Institutet; Lund University; Uppsala University; Karolinska Institutet	Lundeberg, J (corresponding author), KTH Royal Inst Technol, Div Gene Technol, Sci Life Lab, SE-10691 Stockholm, Sweden.	joakim.lundeberg@scilifelab.se	Bergmann, Olaf/A-5706-2009; Linnarsson, Sten/HCH-3909-2022; huang, dezhi/ABC-6566-2021; Sahlen, Pelin/AAJ-1824-2021; Mulder, Jan/G-3909-2011; Vickovic, Sanja/AAD-6473-2022; Mulder, Jan/AAG-9761-2021; Salmen, Fredrik/J-6899-2016	Bergmann, Olaf/0000-0003-1065-4107; Mulder, Jan/0000-0003-3717-5018; Vickovic, Sanja/0000-0003-0985-9885; Salmen, Fredrik/0000-0001-8728-3709; Huss, Mikael/0000-0003-0839-2451; Fernandez Navarro, Jose/0000-0002-4035-5258; Giacomello, Stefania/0000-0003-0738-1574; Costea, Paul Igor/0000-0003-1645-3947; Magnusson, Jens/0000-0002-3928-8959; Westholm, Jakub/0000-0002-6849-6220	Knut och Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; Swedish Research Council; Swedish Cancer Society; Karolinska Institute; Tobias Stiftelsen; Torsten Soderbergs Stiftelse; Ragnar Soderbergs Stiftelse; StratRegen; Ake Wiberg Foundation; Jeansson Foundations; BioProject [PRJNA316587]	Knut och Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; Torsten Soderbergs Stiftelse; Ragnar Soderbergs Stiftelse; StratRegen; Ake Wiberg Foundation; Jeansson Foundations; BioProject	We thank K. Meletis and M. Nilsson for discussions. This study was supported by Knut och Alice Wallenberg Foundation, the Swedish Foundation for Strategic Research, the Swedish Research Council, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, Torsten Soderbergs Stiftelse, Ragnar Soderbergs Stiftelse, StratRegen, Ake Wiberg Foundation, and the Jeansson Foundations. P.L.S. was supported by a postdoctoral fellowship from the Swedish Research Council. We thank the Swedish National Genomics Infrastructure hosted at SciLifeLab, as well as the Swedish National Infrastructure for Computing-Uppsala Multidisciplinary Center for Advanced Computational Science and Bioinformatics Long-Term Support for providing sequencing and computational assistance and infrastructure. The sequencing data are deposited at the National Center for Biotechnology Information, NIH, with BioProject ID PRJNA316587. Gene counts and scripts can be downloaded from www.spatialtranscriptomicsresearch.org. P.L.S., F.S., J.L., and J.F. are authors on patents applied for by Spatial Transcriptomics AB covering the technology.	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Combs PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071820; Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Grun D, 2015, CELL, V163, P799, DOI 10.1016/j.cell.2015.10.039; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Kittaneh Muaiad, 2013, Biomark Cancer, V5, P61, DOI 10.4137/BIC.S9455; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mahfouz A, 2015, METHODS, V73, P79, DOI 10.1016/j.ymeth.2014.10.004; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zechel S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0486-z	16	899	947	70	392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					78	82		10.1126/science.aaf2403	http://dx.doi.org/10.1126/science.aaf2403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365449				2022-12-24	WOS:000378816200040
J	Verba, KA; Wang, RYR; Arakawa, A; Liu, YX; Shirouzu, M; Yokoyama, S; Agard, DA				Verba, Kliment A.; Wang, Ray Yu-Ruei; Arakawa, Akihiko; Liu, Yanxin; Shirouzu, Mikako; Yokoyama, Shigeyuki; Agard, David A.			STRUCTURAL BIOLOGY Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase	SCIENCE			English	Article							EUKARYOTIC PROTEIN-KINASES; MOLECULAR CHAPERONE HSP90; CRYSTAL-STRUCTURE; COMPLEX; BINDING; CDC37; CLIENT; DOMAIN; TRANSITIONS; ACTIVATION	The Hsp90 molecular chaperone and its Cdc37 cochaperone help stabilize and activate more than half of the human kinome. However, both the mechanism by which these chaperones assist their "client" kinases and the reason why some kinases are addicted to Hsp90 while closely related family members are independent are unknown. Our structural understanding of these interactions is lacking, as no full-length structures of human Hsp90, Cdc37, or either of these proteins with a kinase have been elucidated. Here we report a 3.9 angstrom cryo-electron microscopy structure of the Hsp90-Cdc37-Cdk4 kinase complex. Surprisingly, the two lobes of Cdk4 are completely separated with the beta 4-beta 5 sheet unfolded. Cdc37 mimics part of the kinase N lobe, stabilizing an open kinase conformation by wedging itself between the two lobes. Finally, Hsp90 clamps around the unfolded kinase beta 5 strand and interacts with exposed N- and C-lobe interfaces, protecting the kinase in a trapped unfolded state. On the basis of this structure and an extensive amount of previously collected data, we propose unifying conceptual and mechanistic models of chaperone-kinase interactions.	[Verba, Kliment A.; Wang, Ray Yu-Ruei; Liu, Yanxin; Agard, David A.] Univ Calif San Francisco, HHMI, San Francisco, CA 94158 USA; [Verba, Kliment A.; Wang, Ray Yu-Ruei; Liu, Yanxin; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Arakawa, Akihiko; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; RIKEN	Agard, DA (corresponding author), Univ Calif San Francisco, HHMI, San Francisco, CA 94158 USA.; Agard, DA (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu	Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015; Liu, Yanxin/D-8633-2011	Yokoyama, Shigeyuki/0000-0003-3133-7338; Liu, Yanxin/0000-0002-2253-3698	Protein Structure Initiative-Biology grant [U01 GM098254]; American Association for Cancer Research-Breast Cancer Research Foundation grant [218084]; HHMI Helen Hay Whitney Foundation; HHMI International Student Research Fellowship; HHMI; NIH National Institute of General Medical Sciences [9 P41 GM103310]; NSF [ACI-1053575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, U01GM098254] Funding Source: NIH RePORTER	Protein Structure Initiative-Biology grant; American Association for Cancer Research-Breast Cancer Research Foundation grant; HHMI Helen Hay Whitney Foundation; HHMI International Student Research Fellowship; HHMI(Howard Hughes Medical Institute); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of NRAMM-Scripps for help with collecting data; Y. Fan for the yeast expression vector; N. Ohbayashi and M. Niino (RIKEN Center for Life Science Technologies) for help with Sf9 protein expression; N. F. Rebbe (University of North Carolina at Chapel Hill) and E. Laue (University of Cambridge) for the plasmids encoding human HSP90b and Cdc37, respectively; D.A.A.'s lab members for helpful discussions; and N. Jura for reading the manuscript. Support for this work was provided by Protein Structure Initiative-Biology grant U01 GM098254 (to D. A. A.), American Association for Cancer Research-Breast Cancer Research Foundation grant 218084 for Translational Breast Cancer Research (to D. A. A.), a gift from the Cabala family (to D. A. A.), an HHMI Helen Hay Whitney Foundation Fellowship (to Y.L.), an HHMI International Student Research Fellowship (to K.A.V.), and the HHMI (to D. A. A.). Some of the work presented here was conducted at NRAMM, which is supported by a grant from the NIH National Institute of General Medical Sciences (9 P41 GM103310). Some of the work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by NSF grant ACI-1053575.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Boczek EE, 2015, P NATL ACAD SCI USA, V112, pE3189, DOI 10.1073/pnas.1424342112; BRUGGE J, 1983, MOL CELL BIOL, V3, P9, DOI 10.1128/MCB.3.1.9; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Eckl JM, 2015, J BIOL CHEM, V290, P30843, DOI 10.1074/jbc.M115.693150; Eckl JM, 2013, J BIOL CHEM, V288, P16032, DOI 10.1074/jbc.M112.439257; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Hartson SD, 1999, BIOCHEMISTRY-US, V38, P3837, DOI 10.1021/bi983027s; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lachowiec J, 2015, MOL BIOL EVOL, V32, P91, DOI 10.1093/molbev/msu270; Lavery LA, 2014, MOL CELL, V53, P330, DOI 10.1016/j.molcel.2013.12.023; Liu WJ, 2015, BIOCHEMISTRY-US, V54, P1493, DOI 10.1021/bi501129g; Mayer MP, 2015, MOL CELL, V58, P8, DOI 10.1016/j.molcel.2015.02.022; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Tsutsumi S, 2012, P NATL ACAD SCI USA, V109, P2937, DOI 10.1073/pnas.1114414109; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	34	241	245	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1542	1547		10.1126/science.aaf5023	http://dx.doi.org/10.1126/science.aaf5023			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339980	Green Accepted, Green Submitted			2022-12-24	WOS:000378346500035
J	Galej, WP; Wilkinson, ME; Fica, SM; Oubridge, C; Newman, AJ; Nagai, K				Galej, Wojciech P.; Wilkinson, Max E.; Fica, Sebastian M.; Oubridge, Chris; Newman, Andrew J.; Nagai, Kiyoshi			Cryo-EM structure of the spliceosome immediately after branching	NATURE			English	Article							PRE-MESSENGER-RNA; U4/U6.U5 TRI-SNRNP; CRYSTAL-STRUCTURE; ACTIVE-SITE; IN-VITRO; U6 SNRNA; CONFORMATIONAL REARRANGEMENT; SACCHAROMYCES-CEREVISIAE; ELECTRON CRYOMICROSCOPY; CATALYTIC ACTIVATION	Precursor mRNA (pre-mRNA) splicing proceeds by two consecutive transesterification reactions via a lariat-intron intermediate. Here we present the 3.8 angstrom cryo-electron microscopy structure of the spliceosome immediately after lariat formation. The 5'-splice site is cleaved but remains close to the catalytic Mg2+ site in the U2/U6 small nuclear RNA (snRNA) triplex, and the 5'-phosphate of the intron nucleotide G(+1) is linked to the branch adenosine 2' OH. The 5'-exon is held between the Prp8 amino-terminal and linker domains, and base-pairs with U5 snRNA loop 1. Non-Watson-Crick interactions between the branch helix and 5'-splice site dock the branch adenosine into the active site, while intron nucleotides + 3 to + 6 base-pair with the U6 snRNA ACAGAGA sequence. Isy1 and the step-one factors Yju2 and Cwc25 stabilize docking of the branch helix. The intron downstream of the branch site emerges between the Prp8 reverse transcriptase and linker domains and extends towards the Prp16 helicase, suggesting a plausible mechanism of remodelling before exon ligation.	[Galej, Wojciech P.; Wilkinson, Max E.; Fica, Sebastian M.; Oubridge, Chris; Newman, Andrew J.; Nagai, Kiyoshi] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Galej, WP; Nagai, K (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	wgalej@mrc-lmb.cam.ac.uk; kn@mrc-lmb.cam.ac.uk		Wilkinson, Max/0000-0003-4738-9503; Oubridge, Chris/0000-0001-8492-8305; Galej, Wojciech/0000-0001-8859-5229	Medical Research Council [MC_U105184330]; Rutherford Memorial Cambridge Scholarship; EMBO fellowship; Marie Sklodowska-Curie fellowship; MRC [MC_U105184330] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rutherford Memorial Cambridge Scholarship; EMBO fellowship(European Molecular Biology Organization (EMBO)); Marie Sklodowska-Curie fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank K. Nguyen, X.-C. Bai and S. Scheres for their help and advice on data collection and processing; C. Savva, S. Chen, K. R. Vinothkumar, G. McMullan, J. Grimmett and T. Darling for smooth running of the EM and computing facilities; the mass spectrometry facility for help with protein identification, A. Brown, P. Emsley, G. Murshudov and J. Llacer for help and advice with model building and refinement; L. Langer and the members of the spliceosome group for help and advice throughout the project. We thank J. Lowe, V. Ramakrishnan, D. Barford and R. Henderson for their continuing support, S. Scheres, C. Plaschka and L. Strittmatter for critical reading of the manuscript and J. Vilardell for a generous gift of reagent. The project was supported by the Medical Research Council (MC_U105184330). M.E.W. was supported by a Rutherford Memorial Cambridge Scholarship, S.M.F. by EMBO and Marie Sklodowska-Curie fellowships.	Abelson J, 2010, NAT STRUCT MOL BIOL, V17, P504, DOI 10.1038/nsmb.1767; Alexandrov A, 2012, P NATL ACAD SCI USA, V109, P21313, DOI 10.1073/pnas.1219725110; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Barbosa I, 2012, NAT STRUCT MOL BIOL, V19, P983, DOI 10.1038/nsmb.2380; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Buchwald G, 2013, P NATL ACAD SCI USA, V110, pE4611, DOI 10.1073/pnas.1314684110; Burge CB, 1999, RNA WORLD, P525; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen HC, 2013, MOL CELL BIOL, V33, P514, DOI 10.1128/MCB.01093-12; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen WJ, 2014, RNA, V20, P308, DOI 10.1261/rna.040980.113; Chiu YF, 2009, MOL CELL BIOL, V29, P5671, DOI 10.1128/MCB.00773-09; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; Cordin O, 2012, CURR OPIN CELL BIOL, V24, P431, DOI 10.1016/j.ceb.2012.03.004; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fica SM, 2014, NAT STRUCT MOL BIOL, V21, P464, DOI 10.1038/nsmb.2815; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Garrey SM, 2014, RNA, V20, P1337, DOI 10.1261/rna.044602.114; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Grainger RJ, 2009, RNA, V15, P2161, DOI 10.1261/rna.1908309; Hardin JW, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1011; Hilliker AK, 2007, GENE DEV, V21, P821, DOI 10.1101/gad.1536107; KANDELSLEWIS S, 1993, SCIENCE, V262, P2035, DOI 10.1126/science.8266100; Kim CH, 1996, RNA, V2, P995; Konarska MM, 2006, MOL CELL, V21, P543, DOI 10.1016/j.molcel.2006.01.017; Krishnan R, 2013, NAT STRUCT MOL BIOL, V20, P1450, DOI 10.1038/nsmb.2704; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Le Hir H, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.7; LESSER CF, 1993, SCIENCE, V262, P1982, DOI 10.1126/science.8266093; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; LIN RJ, 1985, J BIOL CHEM, V260, P4780; Lu PL, 2012, BIOCHEM J, V441, P591, DOI 10.1042/BJ20111385; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Marcia M, 2012, CELL, V151, P497, DOI 10.1016/j.cell.2012.09.033; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Ohi MD, 2002, RNA, V8, P798, DOI 10.1017/S1355838202025050; Ohrt T, 2013, RNA, V19, P902, DOI 10.1261/rna.039024.113; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Rasche N, 2012, EMBO J, V31, P1591, DOI 10.1038/emboj.2011.502; Robart AR, 2014, NATURE, V514, P193, DOI 10.1038/nature13790; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schreieck A, 2014, NAT STRUCT MOL BIOL, V21, P175, DOI 10.1038/nsmb.2753; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; Schwer B, 2008, MOL CELL, V30, P743, DOI 10.1016/j.molcel.2008.05.003; Semlow DR, 2016, CELL, V164, P985, DOI 10.1016/j.cell.2016.01.025; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; Steckelberg AL, 2012, CELL REP, V2, P454, DOI 10.1016/j.celrep.2012.08.017; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Nguyen THD, 2016, CURR OPIN STRUC BIOL, V36, P48, DOI 10.1016/j.sbi.2015.12.005; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Tsai RT, 2005, GENE DEV, V19, P2991, DOI 10.1101/gad.1377405; Tseng CK, 2011, RNA, V17, P145, DOI 10.1261/rna.2459611; UMEN JG, 1995, RNA, V1, P584; van Nues RW, 2001, GENETICS, V157, P1451; van Roon AMM, 2015, ANGEW CHEM INT EDIT, V54, P4861, DOI 10.1002/anie.201412210; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	84	155	158	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					197	+		10.1038/nature19316	http://dx.doi.org/10.1038/nature19316			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27459055	Green Accepted			2022-12-24	WOS:000382539100040
J	Ho, MY; Shen, GZ; Canniffe, DP; Zhao, C; Bryant, DA				Ho, Ming-Yang; Shen, Gaozhong; Canniffe, Daniel P.; Zhao, Chi; Bryant, Donald A.			Light-dependent chlorophyll f synthase is a highly divergent paralog of PsbA of photosystem II	SCIENCE			English	Article							FAR-RED LIGHT; HALOMICRONEMA-HONGDECHLORIS; AGMENELLUM-QUADRUPLICATUM; WATER OXIDATION; PCC 7002; CYANOBACTERIA; PHOTOSYNTHESIS; EVOLUTION; SYNECHOCOCCUS; OXYGEN	Chlorophyll f (Chl f) permits some cyanobacteria to expand the spectral range for photosynthesis by absorbing far-red light. We used reverse genetics and heterologous expression to identify the enzyme for Chl f synthesis. Null mutants of "super-rogue" psbA4 genes, divergent paralogs of psbA genes encoding the D1 core subunit of photosystem II, abolished Chl f synthesis in two cyanobacteria that grow in far-red light. Heterologous expression of the psbA4 gene, which we rename chlF, enables Chl f biosynthesis in Synechococcus sp. PCC 7002. Because the reaction requires light, Chl f synthase is probably a photo-oxidoreductase that employs catalytically useful Chl a molecules, tyrosine Y-Z, and plastoquinone (as does photosystem II) but lacks a Mn4Ca1O5 cluster. Introduction of Chl f biosynthesis into crop plants could expand their ability to use solar energy.	[Ho, Ming-Yang; Shen, Gaozhong; Canniffe, Daniel P.; Zhao, Chi; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Ho, Ming-Yang; Bryant, Donald A.] Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Bryant, Donald A.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Bryant, DA (corresponding author), Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA.; Bryant, DA (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.; Bryant, DA (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore.	dab14@psu.edu		Canniffe, Daniel/0000-0002-5022-0437; Ho, Ming-Yang/0000-0002-4961-931X	NSF [MCB-1021725]; European Commission Marie Sklodowska-Curie Global Fellowship [660652]; Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC 0001035]; PARC; Div Of Molecular and Cellular Bioscience [1021725, 1613022] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); European Commission Marie Sklodowska-Curie Global Fellowship; Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); PARC; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by NSF grant MCB-1021725 (D.A.B.) and European Commission Marie Sklodowska-Curie Global Fellowship 660652 (D.P.C.). This research was also conducted under the auspices of the Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC 0001035. M.-Y.H., G.S., C.Z., and D.A.B. were partly supported by PARC and partly supported by NSF. We thank R. E. Blankenship, A. N. Glazer, J. H. Golbeck, C. N. Hunter, J. C. Lagarias, and J. T. J. Lecomte for reading, commenting, and offering suggestions to improve the draft manuscript; J. Miller for his expert assistance in performing and interpreting the mass spectral data for Chls and pheophytins; H. Zhang for assistance with the proteomic analyses; and W. Cui for assistance in depositing the proteomics data in the PRIDE database. All data are available in the supplementary materials. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the data set identifier PXD004458.	Airs RL, 2014, FEBS LETT, V588, P3770, DOI 10.1016/j.febslet.2014.08.026; Allakhverdiev SI, 2016, BIOCHEMISTRY-MOSCOW+, V81, P201, DOI 10.1134/S0006297916030020; [Anonymous], [No title captured]; Armenta RE, 2006, J AGR FOOD CHEM, V54, P9752, DOI 10.1021/jf061260o; Behrendt L, 2015, ISME J, V9, P2108, DOI 10.1038/ismej.2015.14; Blankenship RE, 2013, CURR OPIN CHEM BIOL, V17, P457, DOI 10.1016/j.cbpa.2013.03.031; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Bryant DA, 2013, ADV BOT RES, V66, P99, DOI 10.1016/B978-0-12-397923-0.00004-7; Canniffe DP, 2013, BIOCHEM J, V450, P397, DOI 10.1042/BJ20121723; Cardona T, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00257; Cardona T, 2015, PHOTOSYNTH RES, V126, P111, DOI 10.1007/s11120-014-0065-x; Cardona T, 2015, MOL BIOL EVOL, V32, P1310, DOI 10.1093/molbev/msv024; Chen M, 2014, ANNU REV BIOCHEM, V83, P317, DOI 10.1146/annurev-biochem-072711-162943; Chen M, 2011, TRENDS PLANT SCI, V16, P427, DOI 10.1016/j.tplants.2011.03.011; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; DUBBS JM, 1991, MOL MICROBIOL, V5, P3073, DOI 10.1111/j.1365-2958.1991.tb01867.x; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Elbert W, 2012, NAT GEOSCI, V5, P459, DOI 10.1038/ngeo1486; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Gabruk M, 2015, BIOCHEMISTRY-US, V54, P5255, DOI 10.1021/acs.biochem.5b00704; Gan Fei, 2015, Life-Basel, V5, P4, DOI 10.3390/life5010004; Gan F, 2015, ENVIRON MICROBIOL, V17, P3450, DOI 10.1111/1462-2920.12992; Gan F, 2014, SCIENCE, V345, P1312, DOI 10.1126/science.1256963; Garcia-Pichel F., 2003, ALGOLOGICAL STUDIES, V109, P213, DOI DOI 10.1127/1864-1318/2003/0109-0213; GLAZER AN, 1975, ARCH MICROBIOL, V104, P15, DOI 10.1007/BF00447294; Grotjohann I, 2005, PHOTOSYNTH RES, V85, P51, DOI 10.1007/s11120-005-1440-4; Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; LAMBERT DH, 1986, J BACTERIOL, V165, P654, DOI 10.1128/jb.165.2.654-656.1986; Li YQ, 2016, BBA-BIOENERGETICS, V1857, P107, DOI 10.1016/j.bbabio.2015.10.009; Li YQ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00067; Li YQ, 2013, J PHYS CHEM B, V117, P11309, DOI 10.1021/jp402413d; Li YQ, 2012, BBA-BIOENERGETICS, V1817, P1292, DOI 10.1016/j.bbabio.2012.02.026; Ludwig M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00041; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Miyashita H., 2014, J PHYS CHEM BIOPHYS, V4, P149, DOI [10.4172/2161- 0398.1000149, DOI 10.4172/2161-0398.1000149]; Murray JW, 2012, PHOTOSYNTH RES, V110, P177, DOI 10.1007/s11120-011-9714-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raven J.A, 2013, AQUATIC PHOTOSYNTHES; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Schliep M, 2010, J BIOL CHEM, V285, P28450, DOI 10.1074/jbc.M110.146753; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; Speight M., 2010, MARINE ECOLOGY CONCE; STEVENS SE, 1980, P NATL ACAD SCI-BIOL, V77, P6052, DOI 10.1073/pnas.77.10.6052; Tsukatani Y, 2012, J BIOL CHEM, V287, P5720, DOI 10.1074/jbc.M111.323329; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Willows RD, 2013, ORG LETT, V15, P1588, DOI 10.1021/ol400327j; Xu Y, 2011, METHODS MOL BIOL, V684, P273, DOI [10.1007/978.1.60761.925.3_21, 10.1007/978-1-60761-925-3_21]; Zhao C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01303; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102	52	108	113	7	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302							aaf9178	10.1126/science.aaf9178	http://dx.doi.org/10.1126/science.aaf9178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27386923				2022-12-24	WOS:000381867700028
J	Damgaard, RB; Walker, JA; Marco-Casanova, P; Morgan, NV; Titheradge, HL; Elliott, PR; McHale, D; Maher, ER; McKenzie, ANJ; Komander, D				Damgaard, Rune Busk; Walker, Jennifer A.; Marco-Casanova, Paola; Morgan, Neil V.; Titheradge, Hannah L.; Elliott, Paul R.; McHale, Duncan; Maher, Eamonn R.; McKenzie, Andrew N. J.; Komander, David			The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity	CELL			English	Article							NF-KAPPA-B; LINEAR UBIQUITIN; MET1-LINKED UBIQUITINATION; SHARPIN CONTROLS; LUBAC; INNATE; ACTIVATION; HOIP; IMMUNODEFICIENCY; AUTOINFLAMMATION	Methionine-1 (M1)-linked ubiquitin chains regulate the activity of NF-kappa B, immune homeostasis, and responses to infection. The importance of negative regulators of M1-linked chains in vivo remains poorly understood. Here, we show that the M1-specific deubiquitinase OTULIN is essential for preventing TNF-associated systemic inflammation in humans and mice. A homozygous hypomorphic mutation in human OTULIN causes a potentially fatal autoinflammatory condition termed OTULIN-related autoinflammatory syndrome (ORAS). Four independent OTULIN mouse models reveal that OTULIN deficiency in immune cells results in cell-type-specific effects, ranging from over-production of inflammatory cytokines and autoimmunity due to accumulation of M1-linked polyubiquitin and spontaneous NF-kB activation in myeloid cells to downregulation of M1-polyubiquitin signaling by degradation of LUBAC in B and T cells. Remarkably, treatment with anti-TNF neutralizing antibodies ameliorates inflammation in ORAS patients and rescues mouse phenotypes. Hence, OTULIN is critical for restraining life-threatening spontaneous inflammation and maintaining immune homeostasis.	[Damgaard, Rune Busk; Walker, Jennifer A.; Marco-Casanova, Paola; Elliott, Paul R.; McKenzie, Andrew N. J.; Komander, David] MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England; [Morgan, Neil V.] Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Titheradge, Hannah L.] Birmingham Womens NHS Fdn Trust, Dept Clin Genet, Birmingham B15 2TG, W Midlands, England; [Titheradge, Hannah L.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Maher, Eamonn R.] UCB Pharma, New Med, Slough SL1 3WE, Berks, England; [Maher, Eamonn R.] Univ Cambridge, Dept Med Genet, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Maher, Eamonn R.] Cambridge NIHR Biomed Res Ctr, Cambridge Biomed Campus, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; University of Birmingham; University of Birmingham; UCB Pharma SA; University of Cambridge	McKenzie, ANJ; Komander, D (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.; Maher, ER (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.; Maher, ER (corresponding author), Cambridge NIHR Biomed Res Ctr, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	erm1000@medschl.cam.ac.uk; anm@mrc-lmb.cam.ac.uk; dk@mrc-lmb.cam.ac.uk	MAHER, EAMONN R/A-9507-2008; Morgan, Neil V/A-5475-2009; Damgaard, Rune/AAX-4661-2021	MAHER, EAMONN R/0000-0002-6226-6918; Morgan, Neil V/0000-0001-6433-5692; Damgaard, Rune Busk/0000-0002-1709-6534; Elliott, Paul/0000-0002-7641-2103	Medical Research Council [U105192732, U105178805]; European Research Council [309756]; Lister Institute for Preventive Medicine; EMBO Young Investigator Program; Marie-Sklodowska Curie Individual Fellowship from European Commission [MC-IF-654019]; Corpus Christi College Cambridge; Wellcome Trust [100963/Z/13/Z]; WellChild; UCB; Medical Research Council [MC_U105178805, MC_U105192732] Funding Source: researchfish; MRC [MC_U105192732, MC_U105178805] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Lister Institute for Preventive Medicine; EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Marie-Sklodowska Curie Individual Fellowship from European Commission; Corpus Christi College Cambridge; Wellcome Trust(Wellcome Trust); WellChild; UCB(UCB Pharma SA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank The Wellcome Trust Sanger Institute, the EUCOMM Consortium, and the Mutant Mouse and Resource & Research Centers (MMRRC) for Otulin-targeted ES cells. We would also like to thank Helen Jolin for help with mouse colony management and genotyping; Richard Pannell, Angela Middleton, Richard Berks, Xinping Gong, and Ares and Biomed staff for assistance with animal procedures and experiments; Kirstin Keusekotten for help with initial stages of the project; Flow Cytometry Core staff for technical assistance; Louise Tee for assistance with human genetic studies; the late Louise Brueton for clinical genetic assessments; Chris Johnson for assistance with biophysics techniques; Juan Garaycoechea for providing MEFs; Neil Grant for help with photographic images; and Menna Clatworthy for helpful discussions. This work was supported by the Medical Research Council (U105192732 and U105178805), the European Research Council (309756), the Lister Institute for Preventive Medicine, and the EMBO Young Investigator Program (to D.K.); a Marie-Sklodowska Curie Individual Fellowship from the European Commission (MC-IF-654019) and a Research Fellowship from Corpus Christi College Cambridge (to R.B.D.); and Wellcome Trust (to N.V.M., E.R.M., and A.N.J.M [100963/Z/13/Z]), WellChild (to N.V.M. and E.R.M.), and UCB (to H.L.T., D.M. and E.R.M.). Figures 1E, 2B, 3K, and 7H were produced using Servier Medical Art (www.servier.com). D.K. is part of the DUB Alliance that includes Cancer Research Technology and FORMA Therapeutics. D.M. is an employee of UCB.	Boisson B, 2015, J EXP MED, V212, P939, DOI 10.1084/jem.20141130; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Clark GR, 2014, J CLIN ENDOCR METAB, V99, pE2046, DOI 10.1210/jc.2014-1659; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Draber P, 2015, CELL REP, V13, P2258, DOI 10.1016/j.celrep.2015.11.009; Elliott PR, 2014, MOL CELL, V54, P335, DOI 10.1016/j.molcel.2014.03.018; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Fiil BK, 2014, FEBS J, V281, P4337, DOI 10.1111/febs.12944; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hrdinka M, 2016, CELL REP, V14, P2846, DOI 10.1016/j.celrep.2016.02.062; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2014, NAT REV MOL CELL BIO, V15, P503, DOI 10.1038/nrm3836; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumari S, 2014, ELIFE, V3, DOI 10.7554/eLife.03422; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacDuff DA, 2015, ELIFE, V4, DOI 10.7554/eLife.04494; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Morrison PJ, 2013, MUCOSAL IMMUNOL, V6, P1143, DOI 10.1038/mi.2013.11; Park Y, 2016, NAT IMMUNOL, V17, P286, DOI 10.1038/ni.3352; Peltzer N, 2014, CELL REP, V9, P153, DOI 10.1016/j.celrep.2014.08.066; Redecke V, 2016, IMMUNOLOGY, V148, P216, DOI 10.1111/imm.12604; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sasaki Y, 2013, EMBO J, V32, P2463, DOI 10.1038/emboj.2013.184; Satpathy S., 2015, MOL SYST BIOL, V11, P810, DOI [10.15252/msb.20145880, DOI 10.15252/MSB.20145880]; Schaeffer V, 2014, MOL CELL, V54, P349, DOI 10.1016/j.molcel.2014.03.016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yang YB, 2016, CANCER CELL, V29, P494, DOI 10.1016/j.ccell.2016.03.006	43	178	182	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1215	+		10.1016/j.cell.2016.07.019	http://dx.doi.org/10.1016/j.cell.2016.07.019			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27523608	Green Published, hybrid			2022-12-24	WOS:000382259500018
J	Johnston, CP; Smith, RT; Allmendinger, S; MacMillan, DWC				Johnston, Craig P.; Smith, Russell T.; Allmendinger, Simon; MacMillan, David W. C.			Metallaphotoredox-catalysed sp(3)-sp(3) cross-coupling of carboxylic acids with alkyl halides	NATURE			English	Article							PHOTOREDOX CATALYSIS; VISIBLE-LIGHT; ROOM-TEMPERATURE; NICKEL CATALYSIS; ARYL HALIDES; REAGENTS; BROMIDES; IODIDES; COMPLEX; DESIGN	In the past 50 years, cross-coupling reactions mediated by transition metals have changed the way in which complex organic molecules are synthesized. The predictable and chemoselective nature of these transformations has led to their widespread adoption across many areas of chemical research(1). However, the construction of a bond between two sp(3)-hybridized carbon atoms, a fundamental unit of organic chemistry, remains an important yet elusive objective for engineering cross-coupling reactions(2). In comparison to related procedures with sp(2)-hybridized species, the development of methods for sp(3)-sp(3) bond formation via transition metal catalysis has been hampered historically by deleterious side-reactions, such as beta-hydride elimination with palladium catalysis or the reluctance of alkyl halides to undergo oxidative addition(3,4.) To address this issue, nickel-catalysed cross-coupling processes can be used to form sp(3)-sp(3) bonds that utilize organometallic nucleophiles and alkyl electrophiles(5-7). In particular, the coupling of alkyl halides with pre-generated organozinc(8,9), Grignard(10) and organoborane(11) species has been used to furnish diverse molecular structures. However, the manipulations required to produce these activated structures is inefficient, leading to poor step-and atom-economies. Moreover, the operational difficulties associated with making and using these reactive coupling partners, and preserving them through a synthetic sequence, has hindered their widespread adoption. A generically useful sp(3)-sp(3) coupling technology that uses bench-stable, native organic functional groups, without the need for pre-functionalization or substrate derivatization, would therefore be valuable. Here we demonstrate that the synergistic merger of photoredox and nickel catalysis enables the direct formation of sp(3)-sp(3) bonds using only simple carboxylic acids and alkyl halides as the nucleophilic and electrophilic coupling partners, respectively. This metallaphotoredox protocol is suitable for many primary and secondary carboxylic acids. The merit of this coupling strategy is illustrated by the synthesis of the pharmaceutical tirofiban in four steps from commercially available starting materials.	[Johnston, Craig P.; Smith, Russell T.; Allmendinger, Simon; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu		Johnston, Craig P./0000-0003-2459-1872	NIHGMS [R01 GM093213-01]; Marie Curie Actions [PIOF-GA-2013-627695]; Deutsche Forschungsgemeinschaft (DFG) [AL 1860/2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093213] Funding Source: NIH RePORTER	NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marie Curie Actions(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by NIHGMS (R01 GM093213-01); we acknowledge gifts from Merck, AbbVie, and Bristol-Myers Squibb. C.P.J. thanks Marie Curie Actions for an international outgoing fellowship (PIOF-GA-2013-627695). S.A. thanks the Deutsche Forschungsgemeinschaft (DFG) for a postdoctoral fellowship (AL 1860/2-1).	de Meijere A., 2004, METAL CATALYZED CROS, V2nd, DOI 10.1002/9783527619535; Durandetti M, 1996, NEW J CHEM, V20, P659; Fabry DC, 2014, ANGEW CHEM INT EDIT, V53, P10228, DOI 10.1002/anie.201400560; Geist E, 2014, NAT PROD REP, V31, P441, DOI 10.1039/c3np70108e; Giovannini R, 1998, ANGEW CHEM INT EDIT, V37, P2387, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2387::AID-ANIE2387>3.0.CO;2-M; Gutierrez O, 2015, J AM CHEM SOC, V137, P4896, DOI 10.1021/ja513079r; Haas D, 2016, ACS CATAL, V6, P1540, DOI 10.1021/acscatal.5b02718; HARTMAN GD, 1992, J MED CHEM, V35, P4640, DOI 10.1021/jm00102a020; Huihui KMM, 2016, J AM CHEM SOC, V138, P5016, DOI 10.1021/jacs.6b01533; Jana R, 2011, CHEM REV, V111, P1417, DOI 10.1021/cr100327p; Jeffrey JL, 2015, SCIENCE, V349, P1532, DOI 10.1126/science.aac8555; Kalyani D, 2011, J AM CHEM SOC, V133, P18566, DOI 10.1021/ja208068w; Lin XF, 2008, J ORG CHEM, V73, P3680, DOI 10.1021/jo702497p; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Lowry MS, 2005, CHEM MATER, V17, P5712, DOI 10.1021/cm051312+; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Phapale VB, 2009, CHEM SOC REV, V38, P1598, DOI 10.1039/b805648j; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Qin T, 2016, SCIENCE, V352, P801, DOI 10.1126/science.aaf6123; Ren P, 2011, J AM CHEM SOC, V133, P7084, DOI 10.1021/ja200270k; Sahoo B, 2013, J AM CHEM SOC, V135, P5505, DOI 10.1021/ja400311h; Saito B, 2007, J AM CHEM SOC, V129, P9602, DOI 10.1021/ja074008l; Schley ND, 2014, J AM CHEM SOC, V136, P16588, DOI 10.1021/ja508718m; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Tellis JC, 2014, SCIENCE, V345, P433, DOI 10.1126/science.1253647; Terao J, 2002, J AM CHEM SOC, V124, P4222, DOI 10.1021/ja025828v; Terrett JA, 2015, NATURE, V524, P330, DOI 10.1038/nature14875; Zhou JR, 2003, J AM CHEM SOC, V125, P14726, DOI 10.1021/ja0389366; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	30	293	292	22	363	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					322	325		10.1038/nature19056	http://dx.doi.org/10.1038/nature19056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535536	Green Accepted			2022-12-24	WOS:000381804900033
J	Stafford, N				Stafford, Ned			Vitamin D supplements poison dozens of Danish children	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mayor S, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4061; Miljo-og Fodevareministeriet, 2016, BEW DANG D DROPS	2	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4534	10.1136/bmj.i4534	http://dx.doi.org/10.1136/bmj.i4534			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27530440				2022-12-24	WOS:000381806200016
J	Maxwell, S; Fuller, RA; Brooks, TM; Watson, JEM				Maxwell, Sean; Fuller, Richard A.; Brooks, Thomas M.; Watson, James E. M.			The ravages of guns, nets and bulldozers	NATURE			English	Editorial Material							IUCN RED LIST; CLIMATE-CHANGE		[Maxwell, Sean; Watson, James E. M.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [Fuller, Richard A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Brooks, Thomas M.] Int Union Conservat Nat, Gland, Switzerland; [Watson, James E. M.] Wildlife Conservat Soc, Global Conservat Program, New York, NY USA	University of Queensland; University of Queensland; Wildlife Conservation Society	Maxwell, S (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia.	smaxwell@uq.edu.au	Watson, James Edward Maxwell/D-8779-2013; Fuller, Richard/B-7971-2008	Watson, James Edward Maxwell/0000-0003-4942-1984; Fuller, Richard/0000-0001-9468-9678	Division Of Environmental Biology [1136586] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Brooks TM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.7; Cote IM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2592; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; Keith DA, 2014, CONSERV BIOL, V28, P810, DOI 10.1111/cobi.12234; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Martin TG, 2016, NAT CLIM CHANGE, V6, P122, DOI 10.1038/nclimate2918; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947	10	838	856	22	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					143	145		10.1038/536143a	http://dx.doi.org/10.1038/536143a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SV	27510207	Bronze			2022-12-24	WOS:000381472100010
J	Ito, Y; Ofengeim, D; Najafov, A; Das, S; Saberi, S; Li, Y; Hitomi, J; Zhu, H; Chen, HB; Mayo, L; Geng, JF; Amin, P; DeWitt, JP; Mookhtiar, AK; Florez, M; Ouchida, AT; Fan, JB; Pasparakis, M; Kelliher, MA; Ravits, J; Yuan, JY				Ito, Yasushi; Ofengeim, Dimitry; Najafov, Ayaz; Das, Sudeshna; Saberi, Shahram; Li, Ying; Hitomi, Junichi; Zhu, Hong; Chen, Hongbo; Mayo, Lior; Geng, Jiefei; Amin, Palak; DeWitt, Judy Park; Mookhtiar, Adnan Kasim; Florez, Marcus; Ouchida, Amanda Tomie; Fan, Jian-bing; Pasparakis, Manolis; Kelliher, Michelle A.; Ravits, John; Yuan, Junying			RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; KAPPA-B ACTIVATION; MOTOR-NEURON DEATH; CELL-DEATH; SELF-DESTRUCTION; OPTINEURIN; KINASE; IDENTIFICATION; MICE; REGENERATION	Mutations in the optineurin (OPTN) gene have been implicated in both familial and sporadic amyotrophic lateral sclerosis (ALS). However, the role of this protein in the central nervous system (CNS) and how it may contribute to ALS pathology are unclear. Here, we found that optineurin actively suppressed receptor-interacting kinase 1 (RIPK1)-dependent signaling by regulating its turnover. Loss of OPTN led to progressive dysmyelination and axonal degeneration through engagement of necroptotic machinery in the CNS, including RIPK1, RIPK3, and mixed lineage kinase domain-like protein (MLKL). Furthermore, RIPK1- and RIPK3-mediated axonal pathology was commonly observed in SOD1(G93A) transgenic mice and pathological samples from human ALS patients. Thus, RIPK1 and RIPK3 play a critical role in mediating progressive axonal degeneration. Furthermore, inhibiting RIPK1 kinase may provide an axonal protective strategy for the treatment of ALS and other human degenerative diseases characterized by axonal degeneration.	[Ito, Yasushi; Ofengeim, Dimitry; Najafov, Ayaz; Li, Ying; Hitomi, Junichi; Zhu, Hong; Chen, Hongbo; Geng, Jiefei; Amin, Palak; DeWitt, Judy Park; Mookhtiar, Adnan Kasim; Florez, Marcus; Ouchida, Amanda Tomie; Yuan, Junying] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Das, Sudeshna] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Cambridge, MA 02139 USA; [Saberi, Shahram; Ravits, John] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Saberi, Shahram; Ravits, John] Univ Calif San Diego, Dept Neurosci, ALS Translat Res Program, La Jolla, CA 92093 USA; [Li, Ying; Yuan, Junying] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, 26 QiuYue Rd, Shanghai 201210, Peoples R China; [Mayo, Lior] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Fan, Jian-bing] Illumina Inc, San Diego, CA 92122 USA; [Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Kelliher, Michelle A.] Univ Massachusetts, Dept Canc Biol, Sch Med, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Illumina; University of Cologne; University of Massachusetts System; University of Massachusetts Worcester	Yuan, JY (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.; Yuan, JY (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, 26 QiuYue Rd, Shanghai 201210, Peoples R China.	jyuan@hms.harvard.edu	Najafov, Ayaz/AAY-9135-2021; Chen, Hongbo/P-5263-2019; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; m, Lior/AGK-3671-2022	Najafov, Ayaz/0000-0002-1350-2056; Chen, Hongbo/0000-0002-9084-7277; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; m, Lior/0000-0002-1296-6692; Zhu, Hong/0000-0002-2575-4031; Amin, Palak/0000-0001-5617-8703; Li, Ying/0000-0002-3506-1255; Das, Sudeshna/0000-0002-9486-6811	National Institute of Neurological Disorders and Stroke, NIH [1R01NS082257]; National Institute on Aging, NIH [1R01AG047231]; National Science and Technology Major Project of China [2014ZX09102001-002]; State Key Program of National Natural Science of China [31530041]; National Institute of Allergy and Infectious Diseases [2RO1AI075118]; European Research Council [323040]; Daiichi Sankyo Foundation of Life Science (Japan); Nakatomi Foundation (Japan); Mochida Memorial Foundation for Medical and Pharmaceutical Research (Japan); Japan Society for the Promotion of Science (Japan); National Multiple Sclerosis Society; National Multiple Sclerosis Society Career Transition Award; Huazhong University of Science and Technology, Wuhan, China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047231] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science and Technology Major Project of China; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Research Council(European Research Council (ERC)European Commission); Daiichi Sankyo Foundation of Life Science (Japan); Nakatomi Foundation (Japan); Mochida Memorial Foundation for Medical and Pharmaceutical Research (Japan); Japan Society for the Promotion of Science (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Multiple Sclerosis Society Career Transition Award(National Multiple Sclerosis Society); Huazhong University of Science and Technology, Wuhan, China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Caldarone of the NeuroBehavior Laboratory, Harvard Institute of Medicine, for conducting mouse behavior analysis; J. Walters at the Harvard Medical School Nikon microscope facility for fluorescence microscopy; and M. Ericsson of the Electron Microscopy Facility at Harvard Medical School for analysis. This work was supported in part by grants from the National Institute of Neurological Disorders and Stroke (1R01NS082257) and the National Institute on Aging (1R01AG047231), NIH; and by the National Science and Technology Major Project of China (2014ZX09102001-002) and State Key Program of National Natural Science of China (no. 31530041) (to J.Y.); National Institute of Allergy and Infectious Diseases (2RO1AI075118) (to M.A.K.); European Research Council Advanced Grants (grant agreement no. 323040) (to M.P.) and Target ALS (to J.R.). Y.I. was supported in part by postdoctoral fellowships from Japan (Daiichi Sankyo Foundation of Life Science, The Nakatomi Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and Japan Society for the Promotion of Science). D.O. was supported by a postdoctoral fellowship from the National Multiple Sclerosis Society and a National Multiple Sclerosis Society Career Transition Award. H.C. was supported by a grant from Huazhong University of Science and Technology, Wuhan, China. Ripk3<SUP>-/-</SUP> mice and K48 ubiquitin antibodies are available from V. Dixit under a material transfer agreement with Genentech. Ripk1<SUP>D138N</SUP> mice are available from M. Pasparakis of University of Cologne, Germany, under a material transfer agreement with University of Cologne. J.Y. is an inventor on U.S. patent 7,491,743 B2 held by Harvard University that covers 7-Cl-O-Nec-1.	Beeldman E, 2015, AMYOTROPH LAT SCL FR, V16, P410, DOI 10.3109/21678421.2015.1066821; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Deng HX, 2011, ARCH NEUROL-CHICAGO, V68, P1057, DOI 10.1001/archneurol.2011.178; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Munitic I, 2013, J IMMUNOL, V191, P6231, DOI 10.4049/jimmunol.1301696; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Osawa T, 2011, NEUROPATHOLOGY, V31, P569, DOI 10.1111/j.1440-1789.2011.01199.x; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Peschon JJ, 1998, J IMMUNOL, V160, P943; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; SASAKI S, 1992, J NEUROL SCI, V110, P114, DOI 10.1016/0022-510X(92)90017-F; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	34	323	340	11	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					603	608		10.1126/science.aaf6803	http://dx.doi.org/10.1126/science.aaf6803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493188	Green Accepted			2022-12-24	WOS:000381560900045
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: NHS continuing care is a mess	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Appleby J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1563; Barker K., 2014, NEW SETTLEMENT HLTH; *COMM FUND CAR SUP, 2011, SUMM RESP CALL EV; *DEP HLTH, 2007, FRAM ASS NHS CONT HE; *DEP HLTH, 2012, NAT FRAM NHS FUND CO; HAYWARD C, 2014, BBC NEWS; McNicoll A., 2013, COMMUNITY CARE; *NHS BENCHM, 2015, OLD PEOPL AC CAR SET; *NHS ENGL, 2015, MONTH DEL TRANS CAR; POWELL T, 2014, SOCIAL POLICY NOTE S; Thompson J., 2015, DELAYED TRANSFERS CA; 2015, INDEPENDENT AGE FACT	12	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2016	354								i4214	10.1136/bmj.i4214	http://dx.doi.org/10.1136/bmj.i4214			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9DD	27495806	Bronze, Green Published			2022-12-24	WOS:000381081800001
J	Krakauer, EL; Rajagopal, MR				Krakauer, Eric L.; Rajagopal, M. R.			End-of-life care across the world: a global moral failing	LANCET			English	Editorial Material									[Krakauer, Eric L.] Harvard Med Sch, Ctr Palliat Care, Boston, MA 02115 USA; [Krakauer, Eric L.] Massachusetts Gen Hosp, Div Palliat Care, Boston, MA 02114 USA; [Rajagopal, M. R.] WHO Collaborating Ctr Training & Policy Access Pa, Pallium India, Thiruvananthapuram, Kerala, India	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Krakauer, EL (corresponding author), Harvard Med Sch, Ctr Palliat Care, Boston, MA 02115 USA.; Krakauer, EL (corresponding author), Massachusetts Gen Hosp, Div Palliat Care, Boston, MA 02114 USA.	eric_krakauer@hms.harvard.edu						Chalkidou K, 2014, LANCET ONCOL, V15, pE119, DOI 10.1016/S1470-2045(13)70547-3; DesRosiers T, 2014, J PAIN SYMPTOM MANAG, V47, P786, DOI 10.1016/j.jpainsymman.2013.05.021; Economist Intelligence Unit, 2015, 2015 QUAL DEATH IND; Economist Intelligence Unit, 2010, 2010 QUAL DEATH IND; Gomez-Batiste X, 2012, J PAIN SYMPTOM MANAG, V43, P783, DOI 10.1016/j.jpainsymman.2011.05.006; Krakauer EL, 2007, SUBJECTIVITY ETHNOGR; Krakauer EL, 2008, J PAIN SYMPTOM MANAG, V36, P505, DOI 10.1016/j.jpainsymman.2007.11.015; World Health Organization, 2014, GLOBAL ATLAS PALLIAT; World Health Organization (WHO), DEF PALL CAR	9	4	4	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					444	446						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2EK	27507744				2022-12-24	WOS:000380559400007
J	Cronk, Q				Cronk, Quentin			Plant extinctions take time	SCIENCE			English	Editorial Material							DEBT		[Cronk, Quentin] Univ British Columbia, Beaty Biodivers Res Ctr, Vancouver, BC, Canada	University of British Columbia	Cronk, Q (corresponding author), Univ British Columbia, Beaty Biodivers Res Ctr, Vancouver, BC, Canada.	quentin.cronk@ubc.ca		Cronk, Quentin/0000-0002-4027-7368				Cronk Q.C.B., 2000, ENDEMIC FLORA ST HEL; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Downey PO, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw047; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Groombridge JJ, 2001, J ANIM ECOL, V70, P401, DOI 10.1046/j.1365-2656.2001.00502.x; Hanski I, 2000, ANN ZOOL FENN, V37, P271; He FL, 2013, ECOLOGY, V94, P1905, DOI 10.1890/12-1795.1; Hylander K, 2013, TRENDS ECOL EVOL, V28, P341, DOI 10.1016/j.tree.2013.01.010; Janzen DH, 2001, ENCY BIODIVERSITY, DOI [10.1016/B978-0-12-384719-5.00085-X, DOI 10.1016/B978-0-12-384719-5.00085-X]; JENKINS M, 1992, GLOBAL BIODIVERSITY; REID WV, 1992, TROPICAL DEFORESTATION AND SPECIES EXTINCTION, P55; Royal Botanic Gardens Kew, 2016, STAT WORLDS PLANTS; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013	15	56	56	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					446	447		10.1126/science.aag1794	http://dx.doi.org/10.1126/science.aag1794			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471294				2022-12-24	WOS:000380583600022
J	Williams, JL; Kendall, BE; Levine, JM				Williams, Jennifer L.; Kendall, Bruce E.; Levine, Jonathan M.			Rapid evolution accelerates plant population spread in fragmented experimental landscapes	SCIENCE			English	Article							DISPERSAL; INVASIONS; STOCHASTICITY	Predicting the speed of biological invasions and native species migrations requires an understanding of the ecological and evolutionary dynamics of spreading populations. Theory predicts that evolution can accelerate species' spread velocity, but how landscape patchiness-an important control over traits under selection-influences this process is unknown. We manipulated the response to selection in populations of a model plant species spreading through replicated experimental landscapes of varying patchiness. After six generations of change, evolving populations spread 11% farther than nonevolving populations in continuously favorable landscapes and 200% farther in the most fragmented landscapes. The greater effect of evolution on spread in patchier landscapes was consistent with the evolution of dispersal and competitive ability. Accounting for evolutionary change may be critical when predicting the velocity of range expansions.	[Williams, Jennifer L.] Univ British Columbia, Dept Geog, 1984 West Mall, Vancouver, BC V6T 1Z2, Canada; [Williams, Jennifer L.] Univ British Columbia, Biodivers Res Ctr, 1984 West Mall, Vancouver, BC V6T 1Z2, Canada; [Kendall, Bruce E.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Levine, Jonathan M.] Swiss Fed Inst Technol, Inst Integrat Biol, Univ Str 16, CH-8092 Zurich, Switzerland	University of British Columbia; University of British Columbia; University of California System; University of California Santa Barbara; Swiss Federal Institutes of Technology Domain; ETH Zurich	Williams, JL (corresponding author), Univ British Columbia, Dept Geog, 1984 West Mall, Vancouver, BC V6T 1Z2, Canada.; Williams, JL (corresponding author), Univ British Columbia, Biodivers Res Ctr, 1984 West Mall, Vancouver, BC V6T 1Z2, Canada.	jennifer.williams@geog.ubc.ca	Kendall, Bruce/C-1871-2008; Levine, Jonathan/A-7167-2014; Williams, Jennifer L/H-1717-2011; Williams, Jennifer/AAG-9660-2019	Kendall, Bruce/0000-0003-1782-8106; Williams, Jennifer L/0000-0002-4497-4961; Williams, Jennifer/0000-0002-4497-4961; Levine, Jonathan/0000-0003-2857-7904	Swiss National Science Foundation [31003A_141025, IZK0Z3_163497]; U.S. NSF [DEB-1120865]; Natural Sciences and Engineering Research Council of Canada	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank S. Giovanettina, R. Guidon, A. Bieger, M. Clerc, and other members of the ETH Zurich Plant Ecology group for help with performing the experiments and F. Altermatt, A. Angert, T. Miller, and the Plant Ecology group for providing comments on the manuscript. J.M.L., J.L.W., and B.E.K. acknowledge support from the Swiss National Science Foundation (grants 31003A_141025 and IZK0Z3_163497), B.E.K. from the U.S. NSF (grant DEB-1120865), and J.L.W. from the Natural Sciences and Engineering Research Council of Canada. Data described in the paper are available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.q7605.	ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Chuang A, 2016, GLOBAL CHANGE BIOL, V22, P494, DOI 10.1111/gcb.13107; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fakheran S, 2010, P NATL ACAD SCI USA, V107, P19120, DOI 10.1073/pnas.1010846107; Fronhofer EA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7844; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hughes CL, 2007, ECOL ENTOMOL, V32, P437, DOI 10.1111/j.1365-2311.2007.00890.x; Kilkenny FF, 2013, EVOLUTION, V67, P722, DOI 10.1111/j.1558-5646.2012.01829.x; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Lindenmayer DB, 2013, HABITAT FRAGMENTATIO; Melbourne BA, 2009, SCIENCE, V325, P1536, DOI 10.1126/science.1176138; Miller TEX, 2013, ECOL LETT, V16, P354, DOI 10.1111/ele.12049; Pachepsky E, 2011, AM NAT, V177, P18, DOI 10.1086/657438; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perkins TA, 2013, ECOL LETT, V16, P1079, DOI 10.1111/ele.12136; Phillips BL, 2010, J EVOLUTION BIOL, V23, P2595, DOI 10.1111/j.1420-9101.2010.02118.x; Phillips BL, 2015, BIOL INVASIONS, V17, P1949, DOI 10.1007/s10530-015-0849-8; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; SHIGESADA N, 1986, THEOR POPUL BIOL, V30, P143, DOI 10.1016/0040-5809(86)90029-8; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Simmons AD, 2004, AM NAT, V164, P378, DOI 10.1086/423430; Snyder RE, 2003, ECOLOGY, V84, P1333, DOI 10.1890/0012-9658(2003)084[1333:HDSCSB]2.0.CO;2; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Travis JMJ, 2010, DIVERS DISTRIB, V16, P690, DOI 10.1111/j.1472-4642.2010.00674.x; Williams JL, 2016, AM NAT, V188, P15, DOI 10.1086/686685; Williamson M., 1996, BIOL INVASIONS	28	80	80	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					482	485		10.1126/science.aaf6268	http://dx.doi.org/10.1126/science.aaf6268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471303	Green Submitted			2022-12-24	WOS:000380583600039
J	Choi, E; Zhang, XL; Xing, C; Yu, HT				Choi, Eunhee; Zhang, Xiangli; Xing, Chao; Yu, Hongtao			Mitotic Checkpoint Regulators Control Insulin Signaling and Metabolic Homeostasis	CELL			English	Article							MAD2; RECEPTOR; PROTEIN; CDC20; RESISTANCE; KINETOCHORES; ANEUPLOIDY; INHIBITOR; LONGEVITY; GENE	Insulin signaling regulates many facets of animal physiology. Its dysregulation causes diabetes and other metabolic disorders. The spindle checkpoint proteins MAD2 and BUBR1 prevent precocious chromosome segregation and suppress aneuploidy. The MAD2 inhibitory protein p31(comet) promotes checkpoint inactivation and timely chromosome segregation. Here, we show that whole-body p31(comet) knockout mice die soon after birth and have reduced hepatic glycogen. Liver-specific ablation of p31(comet) causes insulin resistance, hyperinsulinemia, glucose intolerance, and hyperglycemia and diminishes the plasma membrane localization of the insulin receptor (IR) in hepatocytes. MAD2 directly binds to IR and facilitates BUBR1-dependent recruitment of the clathrin adaptor AP2 to IR. p31(comet) blocks the MAD2-BUBR1 interaction and prevents spontaneous clathrin-mediated IR endocytosis. BUBR1 deficiency enhances insulin sensitivity in mice. BUBR1 depletion in hepatocytes or the expression of MAD2-binding-deficient IR suppresses the metabolic phenotypes of p31(comet) ablation. Our findings establish a major IR regulatory mechanism and link guardians of chromosome stability to nutrient metabolism.	[Choi, Eunhee; Yu, Hongtao] Univ Texas Southwestern Med Ctr, Howard Hughes Med Inst, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Zhang, Xiangli; Xing, Chao] Univ Texas Southwestern Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Bioinformat Core, 6001 Forest Pk Rd, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, HT (corresponding author), Univ Texas Southwestern Med Ctr, Howard Hughes Med Inst, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu	Choi, Eunhee/AAM-2772-2020	Choi, Eunhee/0000-0003-3286-6477; Xing, Chao/0000-0002-1838-0502	Clayton Foundation; NIH [UL1TR001105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	Clayton Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank Xuemin Zhang for assistance with generating the p31<SUP>F/F</SUP> mice, Jan van Deursen for providing the Bub1b<SUP>H/H</SUP> mice and other reagents, Mayuko Hara for performing ITC, Bing Li for preparing BUBR1N, Min Kim for advice on adenovirus production, Ralph DeBerardinis for providing 293FT and HepG2 cells, Vanessa Schmid and Rachel Bruce for single-cell sequencing, John Shelton and James Richardson for advice on histological analysis, and Xuelian Luo for advice on protein purification. We are grateful to anonymous reviewers for suggesting the genetic suppression experiments. This work is supported, in part, by grants from the Clayton Foundation (to H.Y.) and the NIH (UL1TR001105 to C.X.). H.Y. is an HHMI Investigator.	Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Boucher J, 2014, COLD SPRING HARB PER, V6; Cayrol C, 2002, BIOCHEM BIOPH RES CO, V298, P720, DOI 10.1016/S0006-291X(02)02522-6; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Girard J, 1998, BIOCHEM SOC T, V26, P69, DOI 10.1042/bst0260069; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Izawa D, 2015, NATURE, V517, P631, DOI 10.1038/nature13911; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Knouse KA, 2014, P NATL ACAD SCI USA, V111, P13409, DOI 10.1073/pnas.1415287111; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Malureanu L, 2010, J CELL BIOL, V191, P313, DOI 10.1083/jcb.201003090; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nelson KK, 1999, BIOCHEM J, V343, P673, DOI 10.1042/0264-6021:3430673; ONeill TJ, 1997, J BIOL CHEM, V272, P10035; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048	36	61	62	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					567	581		10.1016/j.cell.2016.05.074	http://dx.doi.org/10.1016/j.cell.2016.05.074			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27374329	Bronze, Green Accepted			2022-12-24	WOS:000380546500010
J	Tecuapetla, F; Jin, X; Lima, SQ; Costa, RM				Tecuapetla, Fatuel; Jin, Xin; Lima, Susana Q.; Costa, Rui M.			Complementary Contributions of Striatal Projection Pathways to Action Initiation and Execution	CELL			English	Article							BASAL GANGLIA CIRCUITRY; GLOBUS-PALLIDUS; DISTINCT ROLES; NEURONS; MOVEMENTS; REINFORCEMENT; CONNECTIONS; INFORMATION; MODULATION; DISORDERS	The performance of an action relies on the initiation and execution of appropriate movement sequences. Two basal ganglia pathways have been classically hypothesized to regulate this process via opposing roles in movement facilitation and suppression. By using a series of state-dependent optogenetic manipulations, we dissected the contributions of each pathway and found that both the direct striatonigral pathway and the indirect striatopallidal pathway are necessary for smooth initiation and the execution of learned action sequences. Optogenetic inhibition or stimulation of each pathway before sequence initiation increased the latency for initiation: manipulations of the striatonigral pathway activity slowed action initiation, and those of the striatopallidal pathway aborted action initiation. The inhibition of each pathway after initiation also impaired ongoing execution. Furthermore, the subtle activation of striatonigral neurons sustained the performance of learned sequences, while striatopallidal manipulations aborted ongoing performance. These results suggest a supportive versus permissive model, where patterns of coordinated activity, rather than the relative amount of activity in these pathways, regulate movement initiation and execution.	[Tecuapetla, Fatuel; Lima, Susana Q.; Costa, Rui M.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Ave Brasilia, P-1400038 Lisbon, Portugal; [Tecuapetla, Fatuel] Univ Nacl Autonoma Mexico, Neuropatol Mol, Inst Fisiol Celular, Ciudad Univ,Circuito Exterior S-N, Ciudad De Mexico 04510, DF, Mexico; [Jin, Xin] Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA	Fundacao Champalimaud; Universidad Nacional Autonoma de Mexico; Salk Institute	Tecuapetla, F; Costa, RM (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Ave Brasilia, P-1400038 Lisbon, Portugal.; Tecuapetla, F (corresponding author), Univ Nacl Autonoma Mexico, Neuropatol Mol, Inst Fisiol Celular, Ciudad Univ,Circuito Exterior S-N, Ciudad De Mexico 04510, DF, Mexico.	fatuel@ifc.unam.mx; rui.costa@neuro.fchampalimaud.org		Costa, Rui M./0000-0003-0495-8374; Tecuapetla, Fatuel/0000-0002-9191-6553; Lima, Susana/0000-0003-2446-9869	FCT fellowship; Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico) [220412]; Direccion General de Asuntos del Personal Academico, UNAM Grant [IA200815]; European Research Council Consolidator Grant; HHMI International Early Career Scientist Grant; ERA-Net NEURON grant; Simons Foundation [294295]	FCT fellowship(Portuguese Foundation for Science and Technology); Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, UNAM Grant; European Research Council Consolidator Grant(European Research Council (ERC)); HHMI International Early Career Scientist Grant; ERA-Net NEURON grant; Simons Foundation	We thank C.R. Gerfen and Gensat for the BAC transgenic mouse lines used in this study, J. Alves da Silva, G. Dugue, M. Lorincz, M. Correia, J. Almeida, and A. Vaz for electrophysiology, genotyping, and histology support, G. Martins for comments on the manuscript, and J.O. Ramirez-Jarquin for setting up the Cre lines at UNAM. This work was supported by an FCT fellowship, a Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico) grant (220412), and a Direccion General de Asuntos del Personal Academico, UNAM Grant (IA200815) to F.T. and a European Research Council Consolidator Grant, an HHMI International Early Career Scientist Grant, an ERA-Net NEURON grant, and a Simons Foundation grant (SFARI #294295) to R.M.C.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Cazorla M, 2014, NEURON, V81, P153, DOI 10.1016/j.neuron.2013.10.041; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Desmurget M, 2008, J NEUROPHYSIOL, V99, P1057, DOI 10.1152/jn.01010.2007; Durieux PF, 2012, EMBO J, V31, P640, DOI 10.1038/emboj.2011.400; Gallistel C. R., 1980, AM J PSYCHOL, V94, P190; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Goldberg JH, 2012, J NEUROPHYSIOL, V108, P1403, DOI 10.1152/jn.00056.2012; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; Isomura Y, 2013, J NEUROSCI, V33, P10209, DOI 10.1523/JNEUROSCI.0381-13.2013; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Nishizawa K, 2012, J NEUROSCI, V32, P13421, DOI 10.1523/JNEUROSCI.1969-12.2012; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Sano H, 2013, J NEUROSCI, V33, P7583, DOI 10.1523/JNEUROSCI.4932-12.2013; Saunders A, 2015, NATURE, V521, P85, DOI 10.1038/nature14179; Schmidt R, 2013, NAT NEUROSCI, V16, P1118, DOI 10.1038/nn.3456; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Tecuapetla F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5315; Tecuapetla F, 2009, J NEUROSCI, V29, P8977, DOI 10.1523/JNEUROSCI.6145-08.2009; Yin HH, 2010, J NEUROSCI, V30, P14719, DOI 10.1523/JNEUROSCI.3989-10.2010; Yin HH, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.023.2009; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	42	177	180	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					703	715		10.1016/j.cell.2016.06.032	http://dx.doi.org/10.1016/j.cell.2016.06.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27453468	Bronze			2022-12-24	WOS:000380546500020
J	Bale, JB; Gonen, S; Liu, YX; Sheffler, W; Ellis, D; Thomas, C; Cascio, D; Yeates, TO; Gonen, T; King, NP; Baker, D				Bale, Jacob B.; Gonen, Shane; Liu, Yuxi; Sheffler, William; Ellis, Daniel; Thomas, Chantz; Cascio, Duilio; Yeates, Todd O.; Gonen, Tamir; King, Neil P.; Baker, David			Accurate design of megadalton-scale two-component icosahedral protein complexes	SCIENCE			English	Article							COMPUTATIONAL DESIGN; VIRUS; SYMMETRY; ASSEMBLIES; NANOMATERIALS; PRINCIPLES; INTERFACES; RESOLUTION; HOMODIMER; CONTAINER	Nature provides many examples of self-and co-assembling protein-based molecular machines, including icosahedral protein cages that serve as scaffolds, enzymes, and compartments for essential biochemical reactions and icosahedral virus capsids, which encapsidate and protect viral genomes and mediate entry into host cells. Inspired by these natural materials, we report the computational design and experimental characterization of co-assembling, two-component, 120-subunit icosahedral protein nanostructures with molecular weights (1.8 to 2.8 megadaltons) and dimensions (24 to 40 nanometers in diameter) comparable to those of small viral capsids. Electron microscopy, small-angle x-ray scattering, and x-ray crystallography show that 10 designs spanning three distinct icosahedral architectures form materials closely matching the design models. In vitro assembly of icosahedral complexes from independently purified components occurs rapidly, at rates comparable to those of viral capsids, and enables controlled packaging of molecular cargo through charge complementarity. The ability to design megadalton-scale materials with atomic-level accuracy and controllable assembly opens the door to a new generation of genetically programmable protein-based molecular machines.	[Bale, Jacob B.; Gonen, Shane; Sheffler, William; King, Neil P.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Bale, Jacob B.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Gonen, Shane; Gonen, Tamir] Janelia Res Campus, Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Liu, Yuxi; Cascio, Duilio; Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Ellis, Daniel; King, Neil P.; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Thomas, Chantz] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Cascio, Duilio; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Cascio, Duilio] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Cascio, Duilio] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	King, NP; Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; King, NP; Baker, D (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	neilking@uw.edu; dabaker@uw.edu	Baker, David/K-8941-2012; Ellis, Daniel/GWN-0700-2022; Liu, Yuxi/AAS-7299-2020	Baker, David/0000-0001-7896-6217; Liu, Yuxi/0000-0003-1439-9000; Bale, Jacob/0000-0003-2444-5875; Yeates, Todd/0000-0001-5709-9839; Gonen, Shane/0000-0002-4829-3151	DOE [DE-FC02-02ER63421, DE-AC02-06CH11357]; National Center for Research Resources [5P41RR015301-10]; National Institute of General Medical Sciences of the National Institutes of Health [8 P41 GM103403-10]; DOE Office of Biological and Environmental Research Integrated Diffraction Analysis program; NIH project MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering) [RO1GM105404]; Howard Hughes Medical Institute; Janelia Research Campus visitor program; Bill and Melinda Gates Foundation; Takeda Pharmaceutical Company; NSF [CHE-1332907, DGE-0718124]; Air Force Office of Scientific Research [FA950-12-10112]; Defense Advanced Research Projects Agency [W911NF-14-1-0162]; Whitcome Fellowship through the UCLA Molecular Biology Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404, P41GM103403] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Biological and Environmental Research Integrated Diffraction Analysis program(United States Department of Energy (DOE)); NIH project MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Janelia Research Campus visitor program; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Whitcome Fellowship through the UCLA Molecular Biology Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Sawaya and M. Collazo for their assistance with crystallography, conducted at the UCLA-DOE X-ray Crystallization and Crystallography Core Facilities, which are supported by DOE grant DE-FC02-02ER63421. We thank M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov, and F. Murphy at Northeastern Collaborative Access Team beamlines 24-ID-E and 24-ID-C at the Advanced Photon Source (APS), which are supported by grants from the National Center for Research Resources (5P41RR015301-10) and the National Institute of General Medical Sciences (8 P41 GM103403-10) of the National Institutes of Health. Use of the APS is supported by DOE under contract no. DE-AC02-06CH11357. We thank the staff at the Advanced Light Source SIBYLS beamline at Lawrence Berkeley National Laboratory, including K. Burnett, G. Hura, M. Hammel, J. Tanamachi, and J. Tainer for the services provided through the mail-in SAXS program, which is supported by the DOE Office of Biological and Environmental Research Integrated Diffraction Analysis program and the NIH project MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering; grant no. RO1GM105404). We also thank U. Nattermann for help with EM, Y. Hsia for assistance with light-scattering experiments, C. Stafford for mass spectroscopy assistance, B. Nickerson for assistance with in vitro assembly experiments, and G. Rocklin for providing scripts used in data analysis. This work was supported by the Howard Hughes Medical Institute (S.G., D.C., T.G., and D.B.) and its Janelia Research Campus visitor program (S.G.), the Bill and Melinda Gates Foundation (D.B. and N.P.K.), Takeda Pharmaceutical Company (N.P.K.), NSF (grant no. CHE-1332907 to D.B. and T.O.Y.), the Air Force Office of Scientific Research (grant no. FA950-12-10112 to D.B.), and the Defense Advanced Research Projects Agency (grant no. W911NF-14-1-0162 to D.B. and N.P.K.). Y.L. was supported by a Whitcome Fellowship through the UCLA Molecular Biology Institute, and J.B.B. was supported by a NSF graduate research fellowship (grant no. DGE-0718124). Coordinates and structure factors were deposited in the Protein Data Bank with accession codes 5IM5 (I53-40), 5IM4 (I52-32), and 5IM6 (I32-28). J.B.B., W.S., N.P.K., D.E., and D.B. have filed a nonprovisional U.S. patent application, no. 14/930,792, related to the work presented herein.	Bale JB, 2015, PROTEIN SCI, V24, P1695, DOI 10.1002/pro.2748; Boyle AL, 2012, J AM CHEM SOC, V134, P15457, DOI 10.1021/ja3053943; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Der BS, 2012, J AM CHEM SOC, V134, P375, DOI 10.1021/ja208015j; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936; Gonen S, 2015, SCIENCE, V348, P1365, DOI 10.1126/science.aaa9897; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Hsia Y, 2016, NATURE, V535, P136, DOI 10.1038/nature18010; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; King NP, 2013, CURR OPIN STRUC BIOL, V23, P632, DOI 10.1016/j.sbi.2013.06.002; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Lai YT, 2014, NAT CHEM, V6, P1065, DOI [10.1038/NCHEM.2107, 10.1038/nchem.2107]; Lai YT, 2012, TRENDS CELL BIOL, V22, P653, DOI 10.1016/j.tcb.2012.08.004; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Lin TW, 1999, VIROLOGY, V265, P20, DOI 10.1006/viro.1999.0038; Lin TW, 2000, J VIROL, V74, P493, DOI 10.1128/JVI.74.1.493-504.2000; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Raman S., 2009, OPEN NANOMED J, V2, P15, DOI DOI 10.2174/1875933500902010015; Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007; Ringler P, 2003, SCIENCE, V302, P106, DOI 10.1126/science.1088074; Salgado EN, 2010, ACCOUNTS CHEM RES, V43, P661, DOI 10.1021/ar900273t; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Stranges PB, 2011, P NATL ACAD SCI USA, V108, P20562, DOI 10.1073/pnas.1115124108; Usui K, 2009, PROTEIN SCI, V18, P960, DOI 10.1002/pro.106; Voet ARD, 2014, P NATL ACAD SCI USA, V111, P15102, DOI 10.1073/pnas.1412768111; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081; Zandi R, 2004, P NATL ACAD SCI USA, V101, P15556, DOI 10.1073/pnas.0405844101; Zlotnick A, 2000, VIROLOGY, V277, P450, DOI 10.1006/viro.2000.0619; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a; Zschoche R, 2015, J AM CHEM SOC, V137, P16121, DOI 10.1021/jacs.5b10588	37	312	319	7	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2016	353	6297					389	394		10.1126/science.aaf8818	http://dx.doi.org/10.1126/science.aaf8818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HB	27463675	Green Accepted, Green Submitted			2022-12-24	WOS:000380583400043
J	Roquet, N; Soleimany, AP; Ferris, AC; Aaronson, S; Lu, TK				Roquet, Nathaniel; Soleimany, Ava P.; Ferris, Alyssa C.; Aaronson, Scott; Lu, Timothy K.			Synthetic recombinase-based state machines in living cells	SCIENCE			English	Article							SITE-SPECIFIC RECOMBINATION; EMBRYONIC STEM-CELLS; GENETIC LOGIC GATES; MAMMALIAN-CELLS; REGULATORY NETWORKS; FLUORESCENT PROTEIN; CIRCUITS; INTEGRATION; DIFFERENTIATION; DESIGN	State machines underlie the sophisticated functionality behind human-made and natural computing systems that perform order-dependent information processing. We developed a recombinase-based framework for building state machines in living cells by leveraging chemically controlled DNA excision and inversion operations to encode states in DNA sequences. This strategy enables convenient readout of states (by sequencing and/or polymerase chain reaction) as well as complex regulation of gene expression. We validated our framework by engineering state machines in Escherichia coli that used one, two, or three chemical inputs to control up to 16 DNA states. These state machines were capable of recording the temporal order of all inputs and performing multi-input, multi-output control of gene expression. We also developed a computational tool for the automated design of gene regulation programs using recombinase-based state machines. Our scalable framework should enable new strategies for recording and studying how combinational and temporal events regulate complex cell functions and for programming sophisticated cell behaviors.	[Roquet, Nathaniel; Soleimany, Ava P.; Ferris, Alyssa C.; Lu, Timothy K.] MIT, Elect Res Lab, Synthet Biol Grp, Cambridge, MA 02139 USA; [Roquet, Nathaniel; Soleimany, Ava P.; Ferris, Alyssa C.; Lu, Timothy K.] MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Roquet, Nathaniel; Soleimany, Ava P.; Ferris, Alyssa C.; Aaronson, Scott; Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Roquet, Nathaniel; Lu, Timothy K.] Harvard Univ, Biophys Program, Boston, MA 02115 USA; [Ferris, Alyssa C.] Wellesley Coll, Biochem Program, Wellesley, MA 02481 USA; [Lu, Timothy K.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Wellesley College; Massachusetts Institute of Technology (MIT)	Lu, TK (corresponding author), MIT, Elect Res Lab, Synthet Biol Grp, Cambridge, MA 02139 USA.; Lu, TK (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lu, TK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.; Lu, TK (corresponding author), Harvard Univ, Biophys Program, Boston, MA 02115 USA.; Lu, TK (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	timlu@mit.edu		Amini, Ava/0000-0002-8601-6040	Ford Foundation Pre-doctoral Fellowships Program and Molecular Biophysics Training Grant [NIH/NIGMS T32 GM008313]; NSF Alan T. Waterman Award [1249349]; Center for Microbiome Informatics and Therapeutics; NIH [DP2 OD008435, P50 GM098792]; Office of Naval Research [N00014-13-1-0424, N0001411110725]; NSF [MCB-1350625]; NSF Expeditions in Computing Program Award [1522074]; Defense Advanced Research Projects Agency [HR0011-15-C-0091]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, P50GM098792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008435] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1522074] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1350625] Funding Source: National Science Foundation	Ford Foundation Pre-doctoral Fellowships Program and Molecular Biophysics Training Grant; NSF Alan T. Waterman Award; Center for Microbiome Informatics and Therapeutics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); NSF Expeditions in Computing Program Award(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The dual recombinase controller was a gift from D. Endy (Addgene plasmid #44456) and is available at Addgene under a material transfer agreement. All plasmids created in this project are also available on Addgene. We thank J. Thomson (USDA-ARS WRRC, Albany, CA) for the a118 gene, A. A. K. Nielsen and C. A. Voigt for the phlF gene, J. Shin and C. A. Voigt for hammerhead ribozyme parts, C. J. McClune and C. A. Voigt for helpful discussions on recombinase systems, and the FAS Division of Science, Research Computing Group, at Harvard University for supporting computations involved in the creation of the GRSM database on the Odyssey cluster. A MAT file containing the GRSM database is provided in database S1. Supported by the Ford Foundation Pre-doctoral Fellowships Program and Molecular Biophysics Training Grant NIH/NIGMS T32 GM008313 (N.R.); the NSF Alan T. Waterman Award, grant 1249349 (S.A.); the Center for Microbiome Informatics and Therapeutics; and NIH grants DP2 OD008435 and P50 GM098792, Office of Naval Research grants N00014-13-1-0424 and N0001411110725, NSF grant MCB-1350625, and an NSF Expeditions in Computing Program Award (1522074) as part of the Living Computing Project. The project or effort depicted was or is also sponsored by the Defense Advanced Research Projects Agency (HR0011-15-C-0091). The content of the information does not necessarily reflect the position or the policy of the U.S. government. T.K.L. and N.R. have filed a patent application based on this work with the US Patent and Trademark Office.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brown WRA, 2011, METHODS, V53, P372, DOI 10.1016/j.ymeth.2010.12.031; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen YJ, 2013, NAT METHODS, V10, P659, DOI [10.1038/NMETH.2515, 10.1038/nmeth.2515]; Colloms SD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1101; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Fokas E, 2012, CANCER METAST REV, V31, P823, DOI 10.1007/s10555-012-9394-4; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gaber R, 2014, NAT CHEM BIOL, V10, P203, DOI [10.1038/nchembio.1433, 10.1038/NCHEMBIO.1433]; Ghosh P, 2005, J MOL BIOL, V349, P331, DOI 10.1016/j.jmb.2005.03.043; Ghosh P, 2008, P NATL ACAD SCI USA, V105, P3238, DOI 10.1073/pnas.0711649105; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Hopcroft J. E., 1979, INTRO AUTOMATA THEOR; Hsiao V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156663; Hsu LM, 2006, BIOCHEMISTRY-US, V45, P8841, DOI 10.1021/bi060247u; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Keravala A, 2006, MOL GENET GENOMICS, V276, P135, DOI 10.1007/s00438-006-0129-5; Lohmueller JJ, 2012, NUCLEIC ACIDS RES, V40, P5180, DOI 10.1093/nar/gks142; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nielsen AA, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145735; Oishi K, 2014, ACS SYNTH BIOL, V3, P652, DOI 10.1021/sb4001799; Olivares EC, 2001, GENE, V278, P167, DOI 10.1016/S0378-1119(01)00711-9; Ortmann CA, 2015, NEW ENGL J MED, V372, P601, DOI 10.1056/NEJMoa1412098; Prochazka L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5729; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Roemhild R, 2015, EVOL APPL, V8, P945, DOI 10.1111/eva.12330; Rowley PA, 2008, NUCLEIC ACIDS RES, V36, P3879, DOI 10.1093/nar/gkn269; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shah J, 2013, APPL ENVIRON MICROB, V79, P7281, DOI 10.1128/AEM.02621-13; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Smith MCA, 2004, MOL MICROBIOL, V51, P1719, DOI 10.1111/j.1365-2958.2003.03942.x; Stoll SM, 2002, J BACTERIOL, V184, P3657, DOI 10.1128/JB.184.13.3657-3663.2002; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Teo WS, 2014, BIOTECHNOL BIOENG, V111, P144, DOI 10.1002/bit.25001; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Yang L, 2014, NAT METHODS, V11, P1261, DOI [10.1038/nmeth.3147, 10.1038/NMETH.3147]; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	59	126	138	8	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2016	353	6297					363	+		10.1126/science.aad8559	http://dx.doi.org/10.1126/science.aad8559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HB	27463678				2022-12-24	WOS:000380583400034
J	Ibiza, S; Garcia-Cassani, B; Ribeiro, H; Carvalho, T; Almeida, L; Marques, R; Misic, AM; Bartow-McKenney, C; Larson, DM; Pavan, WJ; Eberl, G; Grice, EA; Veiga-Fernandes, H				Ibiza, Sales; Garcia-Cassani, Bethania; Ribeiro, Helder; Carvalho, Tania; Almeida, Luis; Marques, Rute; Misic, Ana M.; Bartow-McKenney, Casey; Larson, Denise M.; Pavan, William J.; Eberl, Gerard; Grice, Elizabeth A.; Veiga-Fernandes, Henrique			Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; CITROBACTER-RODENTIUM; TRANSGENIC MICE; SEQUENCING DATA; LAMINA PROPRIA; ENTERIC GLIA; RET; MICROBIOTA; IMMUNITY	Group 3 innate lymphoid cells (ILC3) are major regulators of inflammation and infection at mucosal barriers(1). ILC3 development is thought to be programmed(1), but how ILC3 perceive, integrate and respond to local environmental signals remains unclear. Here we show that ILC3 in mice sense their environment and control gut defence as part of a glial-ILC3-epithelial cell unit orchestrated by neurotrophic factors. We found that enteric ILC3 express the neuroregulatory receptor RET. ILC3-autonomous Ret ablation led to decreased innate interleukin-22 (IL-22), impaired epithelial reactivity, dysbiosis and increased susceptibility to bowel inflammation and infection. Neurotrophic factors directly controlled innate Il22 downstream of the p38 MAPK/ERK-AKT cascade and STAT3 activation. Notably, ILC3 were adjacent to neurotrophic-factor-expressing glial cells that exhibited stellate-shaped projections into ILC3 aggregates. Glial cells sensed microenvironmental cues in a MYD88-dependent manner to control neurotrophic factors and innate IL-22. Accordingly, glial-intrinsic Myd88 deletion led to impaired production of ILC3-derived IL-22 and a pronounced propensity towards gut inflammation and infection. Our work sheds light on a novel multi-tissue defence unit, revealing that glial cells are central hubs of neuron and innate immune regulation by neurotrophic factor signals.	[Ibiza, Sales; Garcia-Cassani, Bethania; Ribeiro, Helder; Carvalho, Tania; Almeida, Luis; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Med Mol, Ave Prof Egas Moniz,Edificio Egas Moniz, P-1649028 Lisbon, Portugal; [Marques, Rute; Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, 25 Rue Docteur Roux, F-75724 Paris, France; [Misic, Ana M.; Bartow-McKenney, Casey; Grice, Elizabeth A.] Univ Penn, Dept Dermatol, Perelman Sch Med, 421 Curie Blvd,1007 Biomed Res Bldg, Philadelphia, PA 19104 USA; [Larson, Denise M.; Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Veiga-Fernandes, Henrique] Champalimaud Ctr Unknown, Champalimaud Res, P-1400038 Lisbon, Portugal; [Marques, Rute] INSERM, U1163, Lab Intestinal Immun, Paris, France; [Marques, Rute] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Marques, Rute] Inst Imagine, Paris, France; [Misic, Ana M.] Univ Penn, Sch Vet Med, Dept Pathobiol, Ctr Host Microbial Interact, Philadelphia, PA 19104 USA	Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Fundacao Champalimaud; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania	Veiga-Fernandes, H (corresponding author), Fac Med Lisbon, Inst Med Mol, Ave Prof Egas Moniz,Edificio Egas Moniz, P-1649028 Lisbon, Portugal.; Veiga-Fernandes, H (corresponding author), Champalimaud Ctr Unknown, Champalimaud Res, P-1400038 Lisbon, Portugal.	jhfernandes@medicina.ulisboa.pt	Carvalho, Tânia/GNM-6203-2022; Eberl, Gerard/A-1160-2013; Carvalho, Tânia/X-2873-2019	Carvalho, Tânia/0000-0002-5283-5013; Pavan, William/0000-0001-8281-5120; Eberl, Gerard/0000-0002-1119-5638; Almeida, Luis/0000-0002-2605-4280; Bartow-McKenney, Casey/0000-0002-8292-6063; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Garcia Cassani, Bethania/0000-0002-1315-133X; Ibiza, Sales/0000-0002-5748-382X; Ribeiro, Helder/0000-0002-7090-9274	MEC, Spain; FCT, Portugal; EU [289720]; EMBO [1648]; ERC, EU [647274]; Kenneth Rainin Foundation, US; Crohn's and Colitis Foundation of America, US; Institut Pasteur; ANR, France; NIH NIAMS [R01 AR060873, T32 AR007465]; Morris Animal Foundation [D14CA-404]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR060873, T32AR007465] Funding Source: NIH RePORTER	MEC, Spain(Spanish Government); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); EU(European Commission); EMBO(European Molecular Biology Organization (EMBO)); ERC, EU; Kenneth Rainin Foundation, US; Crohn's and Colitis Foundation of America, US; Institut Pasteur(European Commission); ANR, France(French National Research Agency (ANR)); NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Morris Animal Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the Histology, Flow Cytometry, Bioimaging and Vivarium services at IMM; Sanjay Jain for providing RetGFP mice. Genentech for providing anti-IL-22 antibody. S.I. was supported by MEC, Spain and FCT, Portugal. B.G.-C. by FP7 (289720), EU. H.V.-F. by EMBO (1648); ERC (647274), EU; Kenneth Rainin Foundation, US; Crohn's and Colitis Foundation of America, US; and FCT, Portugal. G.E. by Institut Pasteur and ANR, France. E.A.G. by NIH NIAMS R01 AR060873. A.M.M. by NIH NIAMS T32 AR007465 and Morris Animal Foundation (D14CA-404).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Almeida ARM, 2014, EUR J IMMUNOL, V44, P3605, DOI 10.1002/eji.201344422; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Brun P, 2013, GASTROENTEROLOGY, V145, P1323, DOI 10.1053/j.gastro.2013.08.047; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Escobar TM, 2014, IMMUNITY, V40, P865, DOI 10.1016/j.immuni.2014.03.014; Fonseca-Pereira D, 2014, NATURE, V514, P98, DOI 10.1038/nature13498; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hoshi M, 2012, DEVELOPMENT, V139, P2405, DOI 10.1242/dev.078667; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Ibiza S, 2006, IMMUNITY, V24, P753, DOI 10.1016/j.immuni.2006.04.006; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Kabouridis PS, 2015, NEURON, V85, P289, DOI 10.1016/j.neuron.2014.12.037; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Almeida ARM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052949; Mich JK, 2014, ELIFE, V3, DOI 10.7554/eLife.02669; Misic AM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-014-0052-7; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; Neunlist M, 2013, NAT REV GASTRO HEPAT, V10, P90, DOI 10.1038/nrgastro.2012.221; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Sanos SL, 2010, METHODS MOL BIOL, V612, P505, DOI 10.1007/978-1-60761-362-6_32; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seamons A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079182; Smith-Hicks CL, 2000, EMBO J, V19, P612, DOI 10.1093/emboj/19.4.612; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yeste A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4753; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	60	212	218	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					440	+		10.1038/nature18644	http://dx.doi.org/10.1038/nature18644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27409807	Green Accepted			2022-12-24	WOS:000380344200044
J	Zar, FA				Zar, Fred Arthur			Review: NAATs diagnose C difficile; vancomycin improves cure, and fidaxomicin reduces recurrence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INFECTION; DIARRHEA		[Zar, Fred Arthur] Univ Illinois, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zar, FA (corresponding author), Univ Illinois, Chicago, IL 60607 USA.							Lee CH, 2016, JAMA-J AM MED ASSOC, V315, P142, DOI 10.1001/jama.2015.18098; Polage CR, 2015, JAMA INTERN MED, V175, P1792, DOI 10.1001/jamainternmed.2015.4114; Rao S, 2011, SCAND J INFECT DIS, V43, P386, DOI 10.3109/00365548.2010.544671; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265	4	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					JC4	JC4		10.7326/ACPJC-2016-165-2-004	http://dx.doi.org/10.7326/ACPJC-2016-165-2-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2GY	27429316				2022-12-24	WOS:000380583100006
J	Hsieh, J; Koseki, M; Molusky, MM; Yakushiji, E; Ichi, I; Westerterp, M; Iqbal, J; Chan, RB; Abramowicz, S; Tascau, L; Takiguchi, S; Yamashita, S; Welch, CL; Di Paolo, G; Hussain, MM; Lefkowitch, JH; Rader, DJ; Tall, AR				Hsieh, Joanne; Koseki, Masahiro; Molusky, Matthew M.; Yakushiji, Emi; Ichi, Ikuyo; Westerterp, Marit; Iqbal, Jahangir; Chan, Robin B.; Abramowicz, Sandra; Tascau, Liana; Takiguchi, Shunichi; Yamashita, Shizuya; Welch, Carrie L.; Di Paolo, Gilbert; Hussain, M. Mahmood; Lefkowitch, Jay H.; Rader, Daniel J.; Tall, Alan R.			TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis	NATURE			English	Article							FATTY LIVER-DISEASE; REVERSE CHOLESTEROL TRANSPORT; INTESTINAL EPITHELIAL-CELLS; ELEMENT-BINDING PROTEIN-1C; X-RECEPTOR; OXIDATION-PRODUCTS; ER STRESS; IN-VIVO; MICE; ALPHA	Cellular mechanisms that mediate steatohepatitis, an increasingly prevalent condition in the Western world for which no therapies are available(1), are poorly understood. Despite the fact that its synthetic agonists induce fatty liver, the liver X receptor (LXR) transcription factor remains a target of interest because of its anti-atherogenic, cholesterol removal, and anti-inflammatory activities. Here we show that tetratricopeptide repeat domain protein 39B (Ttc39b, C9orf52) (T39), a high-density lipoprotein gene discovered in human genome-wide association studies(2), promotes the ubiquitination and degradation of LXR. Chow-fed mice lacking T39 (T39(-/-)) display increased high-density lipoprotein cholesterol levels associated with increased enterocyte ATP-binding cassette transporter A1 (Abca1) expression and increased LXR protein without change in LXR messenger RNA. When challenged with a high fat/high cholesterol/bile salt diet, T39(-/-) mice or mice with hepatocyte-specific T39 deficiency show increased hepatic LXR protein and target gene expression, and unexpectedly protection from steatohepatitis and death. Mice fed a Western-type diet and lacking low-density lipoprotein receptor (Ldlr(-/-)T39(-/-)) show decreased fatty liver, increased high-density lipoprotein, decreased low-density lipoprotein, and reduced atherosclerosis. In addition to increasing hepatic Abcg5/8 expression and limiting dietary cholesterol absorption, T39 deficiency inhibits hepatic sterol regulatory elementbinding protein 1 (SREBP-1, ADD1) processing. This is explained by an increase in microsomal phospholipids containing polyunsaturated fatty acids, linked to an LXRa-dependent increase in expression of enzymes mediating phosphatidylcholine biosynthesis and incorporation of polyunsaturated fatty acids into phospholipids. The preservation of endogenous LXR protein activates a beneficial profile of gene expression that promotes cholesterol removal and inhibits lipogenesis. T39 inhibition could be an effective strategy for reducing both steatohepatitis and atherosclerosis.	[Hsieh, Joanne; Koseki, Masahiro; Molusky, Matthew M.; Yakushiji, Emi; Westerterp, Marit; Abramowicz, Sandra; Tascau, Liana; Welch, Carrie L.; Tall, Alan R.] Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA; [Koseki, Masahiro; Yamashita, Shizuya] Osaka Univ, Grad Sch Med, Cardiovasc Med, Suita, Osaka 5650871, Japan; [Ichi, Ikuyo] Ochanomizu Univ, Fac Core Res, Bunkyo Ku, Tokyo 1128610, Japan; [Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Hlth Sci Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Chan, Robin B.; Di Paolo, Gilbert; Lefkowitch, Jay H.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Takiguchi, Shunichi; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Takiguchi, Shunichi; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA	Columbia University; Osaka University; Ochanomizu University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Hsieh, J (corresponding author), Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA.		Tall, Alan/AAT-8528-2021; Iqbal, Jahangir/B-3903-2014	Iqbal, Jahangir/0000-0002-9021-2271	Manpei Suzuki Diabetes Foundation; Netherlands Organization of Sciences [91715350]; Rosalind Franklin Fellowship from the University Medical Center Groningen; JSPS [15K160203]; Fondation Leducq; National Institutes of Health [HL007343, HL087123, HL119830, HL101864, HL111398, DK46900]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111398, P01HL087123, T32HL007343, R01HL119830, RC2HL101864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046900, R29DK046900, R56DK046900] Funding Source: NIH RePORTER	Manpei Suzuki Diabetes Foundation; Netherlands Organization of Sciences; Rosalind Franklin Fellowship from the University Medical Center Groningen; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fondation Leducq(Leducq Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We express our gratitude to F. Matsuura for support, A. Morishita for advice on liver histology, M. Sakurai and T Yamashita for advice on immunoprecipitation experiments, W. R. Lagor for advice on the reverse cholesterol transport study, M. Ishibashi for advice on animal administration, J. W. Medley for consultation on the coupling reaction, and N. Wang for project discussions. D. J. Gorman and J. So provided technical support, and O. Xu provided technical services for the lipidomics analysis. This work was supported by grants from the Manpei Suzuki Diabetes Foundation (to M.K.), VIDI grant 91715350 from the Netherlands Organization of Sciences (to M.W.), Rosalind Franklin Fellowship from the University Medical Center Groningen (to M.W.), JSPS KAKENHI Grant 15K160203 (to I.I) and the Fondation Leducq (to A.R.T). This work was supported by grants from the National Institutes of Health (T32 training program HL007343, M.M.M.; HL087123 and HL119830, to A.R.T.; HL101864 and HL111398. to D.J.R.; DK46900, to M.M.H.).	Anwar K, 2007, J LIPID RES, V48, P2028, DOI 10.1194/jlr.M700207-JLR200; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Costet P, 2000, J BIOL CHEM, V275, P28240; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Gijbels MJJ, 1999, ATHEROSCLEROSIS, V143, P15, DOI 10.1016/S0021-9150(98)00263-9; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lehrke M, 2005, CELL METAB, V1, P297, DOI 10.1016/j.cmet.2005.04.005; Lo Sasso G, 2010, CELL METAB, V12, P187, DOI 10.1016/j.cmet.2010.07.002; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Musso G, 2010, HEPATOLOGY, V52, P79, DOI 10.1002/hep.23623; Perreault N, 1998, EXP CELL RES, V245, P34, DOI 10.1006/excr.1998.4221; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rong X, 2015, ELIFE, V4; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; SPADY DK, 1983, J LIPID RES, V24, P303; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tomoyori H, 2004, J NUTR, V134, P1690, DOI 10.1093/jn/134.7.1690; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WU AL, 1979, J BIOL CHEM, V254, P7316; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang Y, 2012, J CLIN INVEST, V122, P1688, DOI 10.1172/JCI59817	38	51	54	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					303	U282		10.1038/nature18628	http://dx.doi.org/10.1038/nature18628			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27383786	Green Accepted			2022-12-24	WOS:000379912600061
J	Scialdone, A; Tanaka, Y; Jawaid, W; Moignard, V; Wilson, NK; Macaulay, IC; Marioni, JC; Gottgens, B				Scialdone, Antonio; Tanaka, Yosuke; Jawaid, Wajid; Moignard, Victoria; Wilson, Nicola K.; Macaulay, Iain C.; Marioni, John C.; Gottgens, Berthold			Resolving early mesoderm diversification through single-cell expression profiling	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION; PRIMITIVE STREAK; MOUSE EMBRYOS; RNA-SEQ; HEMOGENIC ENDOTHELIUM; CLONAL ANALYSIS; EPIBLAST CELLS; GERM LAYER; BLOOD	In mammals, specification of the three major germ layers occurs during gastrulation, when cells ingressing through the primitive streak differentiate into the precursor cells of major organ systems. However, the molecular mechanisms underlying this process remain unclear, as numbers of gastrulating cells are very limited. In the mouse embryo at embryonic day 6.5, cells located at the junction between the extra-embryonic region and the epiblast on the posterior side of the embryo undergo an epithelial-to-mesenchymal transition and ingress through the primitive streak. Subsequently, cells migrate, either surrounding the prospective ectoderm contributing to the embryo proper, or into the extra-embryonic region to form the yolk sac, umbilical cord and placenta. Fate mapping has shown that mature tissues such as blood and heart originate from specific regions of the-pre-gastrula epiblast(1), but the plasticity of cells within the embryo and the function of key cell-type-specific transcription factors remain unclear. Here we analyse 1,205 cells from the epiblast and nascent Flk1(+) mesoderm of gastrulating mouse embryos using single-cell RNA sequencing, representing the first transcriptome-wide in vivo view of early mesoderm formation during mammalian gastrulation. Additionally, using knockout mice, we study the function of Tal1, a key haematopoietic transcription factor, and demonstrate, contrary to previous studies performed using retrospective assays(2,3), that Tal1 knockout does not immediately bias precursor cells towards a cardiac fate.	[Scialdone, Antonio; Marioni, John C.] EMBL European Bioinformat Inst EMBL EBI, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Scialdone, Antonio; Macaulay, Iain C.; Marioni, John C.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Tanaka, Yosuke; Jawaid, Wajid; Moignard, Victoria; Wilson, Nicola K.; Gottgens, Berthold] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Tanaka, Yosuke; Jawaid, Wajid; Moignard, Victoria; Wilson, Nicola K.; Gottgens, Berthold] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge, England; [Marioni, John C.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Tanaka, Yosuke] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Tokyo	Marioni, JC (corresponding author), EMBL European Bioinformat Inst EMBL EBI, Wellcome Genome Campus, Cambridge CB10 1SD, England.; Marioni, JC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.; Gottgens, B (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England.; Gottgens, B (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge, England.; Marioni, JC (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England.	marioni@ebi.ac.uk; bg200@cam.ac.uk	Jawaid, Wajid/L-3625-2016	Jawaid, Wajid/0000-0002-4861-6694; Marioni, John/0000-0001-9092-0852; Macaulay, Iain/0000-0002-6761-757X; Scialdone, Antonio/0000-0002-4956-2843; Gottgens, Berthold/0000-0001-6302-5705	Medical Research Council; Cancer Research UK; Biotechnology and Biological Sciences Research Council; Bloodwise; Leukemia and Lymphoma Society; Sanger-EBI Single Cell Centre; Wellcome Trust [105031/D/14/Z]; European Molecular Biology Laboratory; Japan Society for the Promotion of Science; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [MR/M008975/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [22231, 12765] Funding Source: researchfish; Medical Research Council [MC_PC_12009, MR/M008975/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bloodwise; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Sanger-EBI Single Cell Centre; Wellcome Trust(Wellcome Trust); European Molecular Biology Laboratory; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. de Bruijn, A. Martinez-Arias J. Nichols and C. Mulas for discussion, the Cambridge Institute for Medical Research Flow Cytometry facility for their expertise in single-cell index sorting, and S. Lorenz from the Sanger Single Cell Genomics Core for supervising purification of Tal1<SUP>-/-</SUP> sequencing libraries. ChIP-seq reads were processed by R. Hannah. Research in the authors laboratories is supported by the Medical Research Council, Cancer Research UK, the Biotechnology and Biological Sciences Research Council, Bloodwise, the Leukemia and Lymphoma Society, and the Sanger-EBI Single Cell Centre, and by core support grants from the Wellcome Trust to the Cambridge Institute for Medical Research and Wellcome Trust - MRC Cambridge Stem Cell Institute and by core funding from Cancer Research UK and the European Molecular Biology Laboratory. Y.T. was supported by a fellowship from the Japan Society for the Promotion of Science. W.J. is a Wellcome Trust Clinical Research Fellow. A.S. is supported by the Sanger-EBI Single Cell Centre. This work was funded as part of Wellcome Trust Strategic Award 105031/D/14/Z 'Tracing early mammalian lineage decisions by single-cell genomics' awarded to W. Reik, S. Teichmann. J. Nichols, B. Simons, T. Voet, S. Srinivas, L. Vanier, B. Gottgens and J. Marioni.	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angerer P., 2015, BIORXIV; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Batta K, 2014, CELL REP, V9, P1871, DOI 10.1016/j.celrep.2014.11.002; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bheda P, 2014, TRENDS CELL BIOL, V24, P712, DOI 10.1016/j.tcb.2014.08.010; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Brown CB, 2004, DEV BIOL, V267, P190, DOI 10.1016/j.ydbio.2003.10.024; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Burnham K. P., 2002, MODEL SELECTION MULT; Burtscher I, 2009, DEVELOPMENT, V136, P1029, DOI 10.1242/dev.028415; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Chintala S, 2007, BLOOD, V109, P1533, DOI 10.1182/blood-2006-08-040196; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Downs KM, 2004, DEVELOPMENT, V131, P37, DOI 10.1242/dev.00906; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Du JG, 2010, DEV BIOL, V346, P25, DOI 10.1016/j.ydbio.2010.07.008; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Ema M, 2006, BLOOD, V108, P4018, DOI 10.1182/blood-2006-03-012872; Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Goode DK, 2016, DEV CELL, V36, P572, DOI 10.1016/j.devcel.2016.01.024; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Henke C, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0138-8; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Isern J, 2011, BLOOD, V117, P4924, DOI 10.1182/blood-2010-10-313676; Joshi A, 2013, EXP HEMATOL, V41, P354, DOI 10.1016/j.exphem.2012.11.008; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kingsley PD, 2004, BLOOD, V104, P19, DOI 10.1182/blood-2003-12-4162; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lania G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138525; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitsunaga K, 2004, MECH DEVELOP, V121, P237, DOI 10.1016/j.mod.2004.01.006; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Naiche LA, 2011, DEV DYNAM, V240, P2290, DOI 10.1002/dvdy.22731; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; North T, 1999, DEVELOPMENT, V126, P2563; Oginuma M, 2008, DEVELOPMENT, V135, P2555, DOI 10.1242/dev.019877; Org T, 2015, EMBO J, V34, P759, DOI 10.15252/embj.201490542; Padron-Barthe L, 2014, BLOOD, V124, P2523, DOI 10.1182/blood-2013-12-545939; PALIS J, 1995, BLOOD, V86, P156, DOI 10.1182/blood.V86.1.156.bloodjournal861156; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Perea-Gomez A, 1999, DEVELOPMENT, V126, P4499; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Robertson EJ, 2014, SEMIN CELL DEV BIOL, V32, P73, DOI 10.1016/j.semcdb.2014.03.028; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rozbicki E, 2015, NAT CELL BIOL, V17, P397, DOI 10.1038/ncb3138; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 2007, DEV DYNAM, V236, P1450, DOI 10.1002/dvdy.21143; Sanchez-Castillo M, 2015, NUCLEIC ACIDS RES, V43, pD1117, DOI 10.1093/nar/gku895; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Silver L, 1997, BLOOD, V89, P1154, DOI 10.1182/blood.V89.4.1154; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Southwood CM, 1996, DEV DYNAM, V206, P248, DOI 10.1002/(SICI)1097-0177(199607)206:3<248::AID-AJA3>3.0.CO;2-I; Sroczynska Patrycja, 2009, V538, P317, DOI 10.1007/978-1-59745-418-6_16; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tamplin OJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-511; Tanaka Y, 2014, CELL REP, V8, P31, DOI 10.1016/j.celrep.2014.05.055; Tanaka Y, 2012, DEV BIOL, V366, P404, DOI 10.1016/j.ydbio.2012.03.024; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; van der Maaten L., 2013, PREPRINT; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; van Nes J, 2006, DEVELOPMENT, V133, P419, DOI 10.1242/dev.02216; Vincent SD, 2014, HUM MOL GENET, V23, P5087, DOI 10.1093/hmg/ddu232; Weidgang CE, 2013, STEM CELL REP, V1, P248, DOI 10.1016/j.stemcr.2013.08.002; Wilkinson AC, 2013, BIOL OPEN, V2, P1229, DOI 10.1242/bio.20136296; Wilkinson D. G., 1999, SITU HYBRIDIZATION; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089694; YANG JT, 1995, DEVELOPMENT, V121, P549; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596; Zhang HL, 2014, STEM CELLS, V32, P191, DOI 10.1002/stem.1536; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zwart W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-232	105	183	185	1	63	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					289	+		10.1038/nature18633	http://dx.doi.org/10.1038/nature18633			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27383781	Green Accepted			2022-12-24	WOS:000379912600058
J	Dyer, O				Dyer, Owen			Johnson & Johnson is ordered to pay $70m to boy who developed gynecomastia	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kmietowicz Z, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6696	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 11	2016	354								i3846	10.1136/bmj.i3846	http://dx.doi.org/10.1136/bmj.i3846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS1IA	27402539				2022-12-24	WOS:000380347900009
J	Zhao, YG; Ren, JS; Harlos, K; Jones, DM; Zeltina, A; Bowden, TA; Padilla-Parra, S; Fry, EE; Stuart, DI				Zhao, Yuguang; Ren, Jingshan; Harlos, Karl; Jones, Daniel M.; Zeltina, Antra; Bowden, Thomas A.; Padilla-Parra, Sergi; Fry, Elizabeth E.; Stuart, David I.			Toremifene interacts with and destabilizes the Ebola virus glycoprotein	NATURE			English	Article							NIEMANN-PICK C1; SMALL-MOLECULE INHIBITORS; HIV-1 VIRION FUSION; CRYSTAL-STRUCTURE; ENTRY; INFECTION; ANTIBODY; RECEPTOR; CHOLESTEROL; SYSTEM	Ebola viruses (EBOVs) are responsible for repeated outbreaks of fatal infections, including the recent deadly epidemic in West Africa. There are currently no approved therapeutic drugs or vaccines for the disease. EBOV has a membrane envelope decorated by trimers of a glycoprotein (GP, cleaved by furin to form GP1 and GP2 subunits), which is solely responsible for host cell attachment, endosomal entry and membrane fusion(1-7). GP is thus a primary target for the development of antiviral drugs. Here we report the first, to our knowledge, unliganded structure of EBOV GP, and high-resolution complexes of GP with the anticancer drug toremifene and the painkiller ibuprofen. The high-resolution apo structure gives a more complete and accurate picture of the molecule, and allows conformational changes introduced by antibody and receptor binding to be deciphered(8-10). Unexpectedly, both toremifene and ibuprofen bind in a cavity between the attachment (GP1) and fusion (GP2) subunits at the entrance to a large tunnel that links with equivalent tunnels from the other monomers of the trimer at the three-fold axis. Protein-drug interactions with both GP1 and GP2 are predominately hydrophobic. Residues lining the binding site are highly conserved among filoviruses except Marburg virus (MARV), suggesting that MARV may not bind these drugs. Thermal shift assays show up to a 14 degrees C decrease in the protein melting temperature after toremifene binding, while ibuprofen has only a marginal effect and is a less potent inhibitor. These results suggest that inhibitor binding destabilizes GP and triggers premature release of GP2, thereby preventing fusion between the viral and endosome membranes. Thus, these complex structures reveal the mechanism of inhibition and may guide the development of more powerful anti-EBOV drugs.	[Zhao, Yuguang; Ren, Jingshan; Harlos, Karl; Jones, Daniel M.; Zeltina, Antra; Bowden, Thomas A.; Padilla-Parra, Sergi; Fry, Elizabeth E.; Stuart, David I.] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Padilla-Parra, Sergi] Univ Oxford, Cellular Imaging Core, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Stuart, David I.] Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; Diamond Light Source	Stuart, DI (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.; Stuart, DI (corresponding author), Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England.	dave@strubi.ox.ac.uk	Ren, Jingshan/AAT-7729-2021; Padilla-Parra, Sergi/N-8725-2019; Padilla-Parra, Sergi/S-3017-2018	Ren, Jingshan/0000-0003-4015-1404; Padilla-Parra, Sergi/0000-0002-8010-9481; Zeltina, Antra/0000-0002-5485-5480; Stuart, David/0000-0002-3426-4210; Fry, Elizabeth/0000-0001-9754-5303	Biostruct-X project by the EU seventh Framework Programme (FP7) [283570]; Wellcome Trust; UK Medical Research Council [MR/N00065X/1]; Wellcome Trust [090532/Z/09/Z]; Marie Curie Fellowship [658363]; MRC [MR/L009528/1]; Nuffield Department of Medicine Leadership Fellowship; MRC [G1000099, MR/N00065X/1] Funding Source: UKRI; Medical Research Council [MR/N00065X/1, MR/L009528/1, G1000099, G1100525] Funding Source: researchfish	Biostruct-X project by the EU seventh Framework Programme (FP7); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Fellowship(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nuffield Department of Medicine Leadership Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Diamond scientists at I02 and I03 for assistance with data collection, T.S. Walter for help with crystallization and thermal-shift essay. Y.Z. was supported by the Biostruct-X project (283570) funded by the EU seventh Framework Programme (FP7), J.R. by the Wellcome Trust, and D.I.S., E.E.F. and K.H. by the UK Medical Research Council (MR/N00065X/1). This is a contribution from the UK Instruct Centre. The Wellcome Trust Centre for Human Genetics is supported by the Wellcome Trust (grant 090532/Z/09/Z). A.Z. is supported by a Marie Curie Fellowship (658363), T.A.B. is supported by the MRC (MR/L009528/1). SP-P is funded by a Nuffield Department of Medicine Leadership Fellowship. D.I.S. is a Jenner Investigator.	Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326; Brecher M, 2012, J VIROL, V86, P364, DOI 10.1128/JVI.05708-11; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cheng H, 2015, J VIROL, V89, P9932, DOI 10.1128/JVI.01337-15; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Edwards MR, 2015, ACS INFECT DIS, V1, P380, DOI 10.1021/acsinfecdis.5b00053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022; Gregory SM, 2011, P NATL ACAD SCI USA, V108, P11211, DOI 10.1073/pnas.1104760108; Hacke M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8688; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597; Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471; Jones DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13449; Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88; Lea WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036219; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Veljkovic Veljko, 2015, F1000Res, V4, P104, DOI 10.12688/f1000research.6436.1; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; World Health Organisation, 2016, EB SIT REP 30 MARCH; Zhao YG, 2016, FEBS LETT, V590, P605, DOI 10.1002/1873-3468.12089; Zhao YG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5321	41	154	160	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					169	+		10.1038/nature18615	http://dx.doi.org/10.1038/nature18615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362232	Green Submitted, Green Accepted			2022-12-24	WOS:000379015600046
J	Welk, B; McArthur, E; Morrow, SA; MacDonald, P; Hayward, J; Leung, A; Lum, A				Welk, Blayne; McArthur, Eric; Morrow, Sarah A.; MacDonald, Penny; Hayward, Jade; Leung, Andrew; Lum, Andrea			Association Between Gadolinium Contrast Exposure and the Risk of Parkinsonism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Welk, Blayne] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [McArthur, Eric; Hayward, Jade] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Morrow, Sarah A.; MacDonald, Penny] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Leung, Andrew; Lum, Andrea] Univ Western Ontario, Dept Med Imaging, London, ON, Canada	Western University (University of Western Ontario); University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario)	Welk, B (corresponding author), Univ Western Ontario, Dept Surg Epidemiol & Biostat, Div Urol & Epidemiol & Biostat, St Josephs Hlth Care, Room B4-667,268 Grosvenor St, London, ON N6A 4V2, Canada.	bkwelk@gmail.com	Leung, Andrew/AAJ-6850-2020	Leung, Andrew/0000-0003-3349-1574				ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Butt DA, 2014, NEUROEPIDEMIOLOGY, V43, P28, DOI 10.1159/000365590; Errante Y, 2014, INVEST RADIOL, V49, P685, DOI 10.1097/RLI.0000000000000072; Munchau A, 2000, J NEUROL NEUROSUR PS, V69, P494, DOI 10.1136/jnnp.69.4.494; Ramalho J, 2015, AM J NEURORADIOL, DOI [10.3174/ajnr.A4615, DOI 10.3174/AJNR.A4615]; Welk B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5398	6	63	66	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					96	98		10.1001/jama.2016.8096	http://dx.doi.org/10.1001/jama.2016.8096			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2MY	27380348	Bronze			2022-12-24	WOS:000379037600024
J	Briggs, KJ; Koivunen, P; Cao, SG; Backus, KM; Olenchock, BA; Patel, H; Zhang, Q; Signoretti, S; Gerfen, GJ; Richardson, AL; Witkiewicz, AK; Cravatt, BF; Clardy, J; Kaelin, WG				Briggs, Kimberly J.; Koivunen, Peppi; Cao, Shugeng; Backus, Keriann M.; Olenchock, Benjamin A.; Patel, Hetalben; Zhang, Qing; Signoretti, Sabina; Gerfen, Gary J.; Richardson, Andrea L.; Witkiewicz, Agnieszka K.; Cravatt, Benjamin F.; Clardy, Jon; Kaelin, William G., Jr.			Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine	CELL			English	Article							HYDROXYLASE DOMAIN 2; HYPOXIA-INDUCIBLE FACTORS; THERAPEUTIC TARGET; GLUTATHIONE LEVELS; CYSTINE UPTAKE; CELL-DEATH; METASTASIS; EXPRESSION; RECEPTORS; PATHWAY	The HIF transcription factor promotes adaptation to hypoxia and stimulates the growth of certain cancers, including triple-negative breast cancer (TNBC). The HIF alpha subunit is usually prolyl-hydroxylated by EglN family members under normoxic conditions, causing its rapid degradation. We confirmed that TNBC cells secrete glutamate, which we found is both necessary and sufficient for the paracrine induction of HIF1 alpha in such cells under normoxic conditions. Glutamate inhibits the xCT glutamate-cystine antiporter, leading to intracellular cysteine depletion. EglN1, the main HIF alpha prolyl-hydroxylase, undergoes oxidative self-inactivation in the absence of cysteine both in biochemical assays and in cells, resulting in HIF1 alpha accumulation. Therefore, EglN1 senses both oxygen and cysteine.	[Briggs, Kimberly J.; Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Briggs, Kimberly J.; Kaelin, William G., Jr.] Brigham & Womens Hosp, Boston, MA 02215 USA; [Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Bioctr Oulu, FIN-90014 Oulu, Finland; [Cao, Shugeng; Clardy, Jon] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Backus, Keriann M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Olenchock, Benjamin A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Patel, Hetalben; Gerfen, Gary J.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Zhang, Qing] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Signoretti, Sabina; Richardson, Andrea L.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Witkiewicz, Agnieszka K.] Univ Texas Southwestern Med Ctr, Dept Pathol, Dallas, TX 75235 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Cao, Shugeng] Univ Hawaii, Daniel K Inouye Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA; [Richardson, Andrea L.] Johns Hopkins Med, Dept Pathol, 600 N Wolfe St, Baltimore, MD 21287 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of Oulu; Harvard University; Harvard Medical School; Scripps Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Hawaii System; University Hawaii Hilo; Johns Hopkins University; Johns Hopkins Medicine	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Kaelin, WG (corresponding author), Brigham & Womens Hosp, Boston, MA 02215 USA.; Kaelin, WG (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	william_kaelin@dfci.harvard.edu	ZHANG, QING/AGY-7972-2022	ZHANG, QING/0000-0002-6595-8995	NIH; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R37CA087660, P50CA058223, R01CA068490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Kaelin Laboratory for useful discussions, Gang Lu for multiple reagents and cloning advice, Jason Marineau for fractionation advice and reagents, Julie Losman for her FACS expertise, Amanda Silva for performing gavage, and Humayun Sharif and Michael Eck for generating Figure 6I. This work was supported by grants to W.G.K. from the NIH and the Breast Cancer Research Foundation and T32 and F32 NIH training grants to K.J.B. W.G.K. is an HHMI Investigator.	Anderson TMR, 2013, CANCER RES, V73, P5810, DOI 10.1158/0008-5472.CAN-13-0523; Andras IE, 2007, J CEREBR BLOOD F MET, V27, P1431, DOI 10.1038/sj.jcbfm.9600445; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Chowdhury R, 2011, J MOL BIOL, V410, P268, DOI 10.1016/j.jmb.2011.04.075; Chung HS, 2013, CIRC RES, V112, P382, DOI 10.1161/CIRCRESAHA.112.268680; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; ISHII T, 1981, J CELL PHYSIOL, V107, P283, DOI 10.1002/jcp.1041070215; Jacob C, 2011, BIOCHEM SOC T, V39, P1247, DOI 10.1042/BST0391247; JANJIC D, 1992, EUR J BIOCHEM, V210, P297, DOI 10.1111/j.1432-1033.1992.tb17421.x; JUVA K, 1966, ANAL BIOCHEM, V15, P77, DOI 10.1016/0003-2697(66)90249-1; Kaelin WG, 2005, CELL METAB, V1, P357, DOI 10.1016/j.cmet.2005.05.006; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Laurinavicius A, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-27; Lee G, 2016, SCI REP-UK, V6, DOI 10.1038/srep18928; Lu HQ, 2015, P NATL ACAD SCI USA, V112, pE4600, DOI 10.1073/pnas.1513433112; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; MAKOWSKE M, 1982, J BIOL CHEM, V257, P5663; Mecinovic J, 2009, ANAL BIOCHEM, V393, P215, DOI 10.1016/j.ab.2009.06.029; Mehta MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069851; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; MYLLYLA R, 1978, BIOCHEM BIOPH RES CO, V83, P441, DOI 10.1016/0006-291X(78)91010-0; Narang VS, 2007, CHEMOTHERAPY, V53, P210, DOI 10.1159/000100812; Narang VS, 2003, ANTICANCER RES, V23, P4571; North WG, 2010, BREAST CANCER RES TR, V122, P307, DOI 10.1007/s10549-009-0556-1; Nytko KJ, 2011, BLOOD, V117, P5485, DOI 10.1182/blood-2010-09-307637; Schito L, 2012, P NATL ACAD SCI USA, V109, pE2707, DOI 10.1073/pnas.1214019109; Seidlitz EP, 2009, CLIN EXP METASTAS, V26, P781, DOI 10.1007/s10585-009-9277-4; Semenza GL, 2012, TRENDS MOL MED, V18, P534, DOI 10.1016/j.molmed.2012.08.001; Sharma MK, 2010, BIOCHEM BIOPH RES CO, V391, P91, DOI 10.1016/j.bbrc.2009.10.168; Sims B, 2012, STEM CELL RES, V8, P285, DOI 10.1016/j.scr.2011.09.002; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Stepulak A, 2014, J NEURAL TRANSM, V121, P933, DOI 10.1007/s00702-014-1182-6; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Willard SS, 2013, INT J BIOL SCI, V9, P728, DOI 10.7150/ijbs.6475; Wong CCL, 2012, J MOL MED, V90, P803, DOI 10.1007/s00109-011-0855-y; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhong H, 1999, CANCER RES, V59, P5830	50	140	145	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					126	139		10.1016/j.cell.2016.05.042	http://dx.doi.org/10.1016/j.cell.2016.05.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368101	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000380254400016
J	Lee, SS; Tyler, JK				Lee, Siu Sylvia; Tyler, Jessica K.			PHYSIOLOGY Stressed-out chromatin promotes longevity	NATURE			English	Editorial Material							MITOCHONDRIA		[Lee, Siu Sylvia] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Tyler, Jessica K.] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA	Cornell University; Cornell University	Lee, SS (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	sylvia.lee@cornell.edu; jet2021@med.cornell.edu		Tyler, Jessica/0000-0001-9765-1659	NATIONAL CANCER INSTITUTE [R01CA095641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024425] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA095641] Funding Source: Medline; NIA NIH HHS [R01 AG024425] Funding Source: Medline; NIGMS NIH HHS [R01 GM064475] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chang HW, 2015, FREE RADICAL BIO MED, V78, P168, DOI 10.1016/j.freeradbiomed.2014.10.576; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Labbadia J, 2015, MOL CELL, V59, P639, DOI 10.1016/j.molcel.2015.06.027; Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011	10	1	1	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					625	626		10.1038/534625a	http://dx.doi.org/10.1038/534625a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357789	Green Accepted			2022-12-24	WOS:000378676000023
J	Ohto, U; Ishida, H; Krayukhina, E; Uchiyama, S; Inoue, N; Shimizu, T				Ohto, Umeharu; Ishida, Hanako; Krayukhina, Elena; Uchiyama, Susumu; Inoue, Naokazu; Shimizu, Toshiyuki			Structure of IZUMO1-JUNO reveals sperm-oocyte recognition during mammalian fertilization	NATURE			English	Article							CRYSTAL-STRUCTURE; PROTEIN IZUMO; EGG FUSION; ULTRACENTRIFUGATION; FOLATE; JUNO	Fertilization is a fundamental process in sexual reproduction, creating a new individual through the combination of male and female gametes(1-4). The IZUMO1 sperm membrane protein(5) and its counterpart oocyte receptor JUNO(6) have been identified as essential factors for sperm-oocyte interaction and fusion. However, the mechanism underlying their specific recognition remains poorly defined. Here, we show the crystal structures of human IZUMO1, JUNO and the IZUMO1-JUNO complex, establishing the structural basis for the IZUMO1-JUNO-mediated sperm-oocyte interaction. IZUMO1 exhibits an elongated rod-shaped structure comprised of a helical bundle IZUMO domain and an immunoglobulin-like domain that are each firmly anchored to an intervening beta-hairpin region through conserved disulfide bonds. The central beta-hairpin region of IZUMO1 provides the main platform for JUNO binding, while the surface located behind the putative JUNO ligand binding pocket is involved in IZUMO1 binding. Structure-based mutagenesis analysis confirms the biological importance of the IZUMO1-JUNO interaction. This structure provides a major step towards elucidating an essential phase of fertilization and it will contribute to the development of new therapeutic interventions for fertility, such as contraceptive agents.	[Ohto, Umeharu; Ishida, Hanako; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Krayukhina, Elena; Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Uchiyama, Susumu] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan; [Inoue, Naokazu] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan	University of Tokyo; Osaka University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Fukushima Medical University	Ohto, U; Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	umeji@mol.f.u-tokyo.ac.jp; shimizu@mol.f.u-tokyo.ac.jp	UCHIYAMA, Susumu/F-9590-2017	UCHIYAMA, Susumu/0000-0002-5181-179X; Inoue, Naokazu/0000-0002-6187-8293	Japan Agency for Medical Research and Development (AMED); Japanese Ministry of Education, Culture, Sports, Science, and Technology; CREST, JST; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research [26291052] Funding Source: KAKEN	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the beamline staff members at the Photon Factory and SPring-8 for their assistance with data collection. We thank Y. Yamada and D. Liebschner for assistance with S-SAD data collection at PF-1A. This research is supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED). This work was supported by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (U.O., S.U., N.I. and T.S.); CREST, JST (T.S.); the Takeda Science Foundation (U.O., N.I. and T.S.); the Mochida Memorial Foundation for Medical and Pharmaceutical Research (U.O.); and the Daiichi Sankyo Foundation of Life Science (U.O.).	Bianchi E, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0101; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Chen C, 2013, NATURE, V500, P486, DOI 10.1038/nature12327; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans JP, 2012, ANNU REV PHYSIOL, V74, P477, DOI 10.1146/annurev-physiol-020911-153339; Foster D L., 1994, PHYSL REPROD, V2; Han L, 2016, CURR BIOL, V26, pR100, DOI 10.1016/j.cub.2015.12.034; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9858; Inoue N, 2013, DEVELOPMENT, V140, P3221, DOI 10.1242/dev.094854; Inoue N, 2008, BIOCHEM BIOPH RES CO, V377, P910, DOI 10.1016/j.bbrc.2008.10.073; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klinovska K, 2014, INT J MOL SCI, V15, P10652, DOI 10.3390/ijms150610652; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okabe M, 2013, DEVELOPMENT, V140, P4471, DOI 10.1242/dev.090613; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wibowo AS, 2013, P NATL ACAD SCI USA, V110, P15180, DOI 10.1073/pnas.1308827110	29	74	80	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					566	+		10.1038/nature18596	http://dx.doi.org/10.1038/nature18596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309808				2022-12-24	WOS:000378270300057
J	Ersche, KD; Gillan, CM; Jones, PS; Williams, GB; Ward, LHE; Luijten, M; de Wit, S; Sahakian, BJ; Bullmore, ET; Robbins, TW				Ersche, Karen D.; Gillan, Claire M.; Jones, P. Simon; Williams, Guy B.; Ward, Laetitia H. E.; Luijten, Maartje; de Wit, Sanne; Sahakian, Barbara J.; Bullmore, Edward T.; Robbins, Trevor W.			Carrots and sticks fail to change behavior in cocaine addiction	SCIENCE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; DRUG-ADDICTION; REINFORCEMENT; HABITS; DOPAMINE; IMPULSIVITY; SEEKING	Cocaine addiction is a major public health problem that is particularly difficult to treat. Without medically proven pharmacological treatments, interventions to change the maladaptive behavior of addicted individuals mainly rely on psychosocial approaches. Here we report on impairments in cocaine-addicted patients to act purposefully toward a given goal and on the influence of extended training on their behavior. When patients were rewarded for their behavior, prolonged training improved their response rate toward the goal but simultaneously rendered them insensitive to the consequences of their actions. By contrast, overtraining of avoidance behavior had no effect on patient performance. Our findings illustrate the ineffectiveness of punitive approaches and highlight the potential for interventions that focus on improving goal-directed behavior and implementing more desirable habits to replace habitual drug-taking.	[Ersche, Karen D.; Gillan, Claire M.; Jones, P. Simon; Williams, Guy B.; Ward, Laetitia H. E.; Sahakian, Barbara J.; Bullmore, Edward T.; Robbins, Trevor W.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Ersche, Karen D.; Gillan, Claire M.; Jones, P. Simon; Williams, Guy B.; Ward, Laetitia H. E.; Sahakian, Barbara J.; Bullmore, Edward T.; Robbins, Trevor W.] Univ Cambridge, Dept Psychol, Cambridge, England; [Ersche, Karen D.; Gillan, Claire M.; Jones, P. Simon; Williams, Guy B.; Ward, Laetitia H. E.; Sahakian, Barbara J.; Bullmore, Edward T.; Robbins, Trevor W.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Ersche, Karen D.; Gillan, Claire M.; Jones, P. Simon; Williams, Guy B.; Ward, Laetitia H. E.; Sahakian, Barbara J.; Bullmore, Edward T.; Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Gillan, Claire M.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Luijten, Maartje] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [de Wit, Sanne] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Bullmore, Edward T.] Cambridgeshire & Peterborough Natl Hlth Serv Fdn, Cambridge, England; [Bullmore, Edward T.] GlaxoSmithKline R&D, Alternat Discovery & Dev Div, Immunopsychiat Discovery Performance Unit, Stevenage SG1 2NY, Herts, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; New York University; Radboud University Nijmegen; University of Amsterdam; GlaxoSmithKline	Ersche, KD (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.; Ersche, KD (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.; Ersche, KD (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.; Ersche, KD (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England.	ke220@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020; Robbins, Trevor W/A-7551-2008; Gillan, Claire/AAA-7348-2020; Bullmore, Ed/C-1706-2012	Sahakian, Barbara/0000-0001-7352-1745; Gillan, Claire/0000-0001-9065-403X; Bullmore, Ed/0000-0002-8955-8283; Williams, Guy/0000-0001-5223-6654; Robbins, Trevor/0000-0003-0642-5977; Ward, Laetitia/0000-0002-4707-3069; de Wit, Sanne/0000-0003-1438-7085	Sir Henry Wellcome Postdoctoral Fellowship [101521/Z/12/Z]; Medical Research Council [MR/J012084/1]; Wellcome Trust; MRC [MR/J012084/1, G1000183] Funding Source: UKRI; Medical Research Council [G1000183B, G1000183] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10051] Funding Source: researchfish	Sir Henry Wellcome Postdoctoral Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank all volunteers for their participation in this study, as well as the staff at the Mental Health Research Network and the Cambridge BioResource for their assistance with volunteer recruitment. We are especially grateful to N. Flake and S. Whittle for their exceptional commitment in this regard. We also thank the staff at the National Institute for Health Research (NIHR) Clinical Research Facility at Addenbrooke's Hospital for their support throughout this study. We are grateful to S. Abbott, R. Lumsden, Arlt C. Whitelock, I. Lee, and M. Pollard for their assistance. C.M.G. is supported by a Sir Henry Wellcome Postdoctoral Fellowship (101521/Z/12/Z). This work was funded by a grant from the Medical Research Council (MR/J012084/1) and was conducted within the NIHR Cambridge Biomedical Research Centre and the Behavioral and Clinical Neuroscience Institute which is jointly funded by the Medical Research Council and the Wellcome Trust. The data described in his paper are stored at the University of Cambridge's institutional repository, Apollo (http://dx.doi.org/10.17863/CAM.122).	Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Barker JM, 2014, NEUROSCI BIOBEHAV R, V47, P281, DOI 10.1016/j.neubiorev.2014.08.012; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; BENINGER RJ, 1980, J PHARMACOL EXP THER, V213, P623; Corbit LH, 2014, NEUROPSYCHOPHARMACOL, V39, P1893, DOI 10.1038/npp.2014.37; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; de Wit S, 2012, PSYCHOPHARMACOLOGY, V219, P621, DOI 10.1007/s00213-011-2563-2; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gillan CM, 2016, ELIFE, V5, DOI 10.7554/eLife.11305; Gillan CM, 2014, BIOL PSYCHIAT, V75, P631, DOI 10.1016/j.biopsych.2013.02.002; Gillan CM, 2011, AM J PSYCHIAT, V168, P718, DOI 10.1176/appi.ajp.2011.10071062; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Martinez D, 2009, AM J PSYCHIAT, V166, P1170, DOI 10.1176/appi.ajp.2009.08121801; Miles FJ, 2003, BEHAV NEUROSCI, V117, P927, DOI 10.1037/0735-7044.117.5.927; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; Sjoerds Z, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.107; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042	23	139	140	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1468	1471		10.1126/science.aaf3700	http://dx.doi.org/10.1126/science.aaf3700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313048	Green Accepted			2022-12-24	WOS:000377975400051
J	Christie, B				Christie, Bryan			Sixty seconds on ... minimum alcohol price	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							ENGLAND											Alcohol Focus Scotland, PRIC CHECK REV CHEAP; Brennan A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5452; Christie B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6990; Christie B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4756; Christie B, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3425; Hawkes N, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8140; O'Dowd A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4622	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2016	353								i3300	10.1136/bmj.i3300	http://dx.doi.org/10.1136/bmj.i3300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1GZ	27301437				2022-12-24	WOS:000378239800012
J	Franca, GVA; Schuler-Faccini, L; Oliveira, WK; Henriques, CMP; Carmo, EH; Pedi, VD; Nunes, ML; Castro, MC; Serruya, S; Silveira, MF; Barros, FC; Victora, CG				Franca, Giovanny V. A.; Schuler-Faccini, Lavinia; Oliveira, Wanderson K.; Henriques, Claudio M. P.; Carmo, Eduardo H.; Pedi, Vaneide D.; Nunes, Marilia L.; Castro, Marcia C.; Serruya, Suzanne; Silveira, Mariangela F.; Barros, Fernando C.; Victora, Cesar G.			Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation	LANCET			English	Article							INFECTION; OUTBREAK	Background In November, 2015, an epidemic of microcephaly was reported in Brazil, which was later attributed to congenital Zika virus infection. 7830 suspected cases had been reported to the Brazilian Ministry of Health by June 4, 2016, but little is known about their characteristics. We aimed to describe these newborn babies in terms of clinical findings, anthropometry, and survival. Methods We reviewed all 1501 liveborn infants for whom investigation by medical teams at State level had been completed as of Feb 27, 2016, and classified suspected cases into five categories based on neuroimaging and laboratory results for Zika virus and other relevant infections. Definite cases had laboratory evidence of Zika virus infection; highly probable cases presented specific neuroimaging findings, and negative laboratory results for other congenital infections; moderately probable cases had specific imaging findings but other infections could not be ruled out; somewhat probable cases had imaging findings, but these were not reported in detail by the local teams; all other newborn babies were classified as discarded cases. Head circumference by gestational age was assessed with InterGrowth standards. First week mortality and history of rash were provided by the State medical teams. Findings Between Nov 19, 2015, and Feb 27, 2015, investigations were completed for 1501 suspected cases reported to the Brazilian Ministry of Health, of whom 899 were discarded. Of the remainder 602 cases, 76 were definite, 54 highly probable, 181 moderately probable, and 291 somewhat probable of congenital Zika virus syndrome. Clinical, anthropometric, and survival differences were small among the four groups. Compared with these four groups, the 899 discarded cases had larger head circumferences (mean Z scores -1.54 vs -3.13, difference 1.58 [95% CI 1.45-1.72]); lower first-week mortality (14 per 1000 vs 51 per 1000; rate ratio 0.28 [95% CI 0.14-0.56]); and were less likely to have a history of rash during pregnancy (20.7% vs 61.4%, ratio 0.34 [95% CI 0.27-0.42]). Rashes in the third trimester of pregnancy were associated with brain abnormalities despite normal sized heads. One in five definite or probable cases presented head circumferences in the normal range (above -2 SD below the median of the InterGrowth standard) and for one third of definite and probable cases there was no history of a rash during pregnancy. The peak of the epidemic occurred in late November, 2015. Interpretation Zika virus congenital syndrome is a new teratogenic disease. Because many definite or probable cases present normal head circumference values and their mothers do not report having a rash, screening criteria must be revised in order to detect all affected newborn babies. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.	[Franca, Giovanny V. A.; Oliveira, Wanderson K.; Henriques, Claudio M. P.; Carmo, Eduardo H.; Pedi, Vaneide D.; Nunes, Marilia L.] Secretariat Hlth Surveillance Minist Hlth, Brasilia, DF, Brazil; [Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Castro, Marcia C.] Harvard T H Chan Sch Publ Hlth, Boston, MA USA; [Serruya, Suzanne] Latin Amer Ctr Perinatol Women & Reprod Hlth, Montevideo, Uruguay; [Silveira, Mariangela F.; Barros, Fernando C.; Victora, Cesar G.] Univ Fed Pelotas, Programa Posgrad Epidemiol, BR-96020220 Pelotas, RS, Brazil; [Barros, Fernando C.] Univ Catolica Pelotas, Pelotas, RS, Brazil	Universidade Federal do Rio Grande do Sul; Harvard University; Harvard T.H. Chan School of Public Health; Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas	Victora, CG (corresponding author), Univ Fed Pelotas, Programa Posgrad Epidemiol, BR-96020220 Pelotas, RS, Brazil.	cvictora@equidade.org	Henriques, Claudio/AAW-8044-2021; de França, Giovanny Vinícius Araújo/L-7385-2018; Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013; Oliveira, Wanderson/AAF-5182-2019; SCHULER-FACCINI, LAVINIA/C-8309-2013; Castro, Marcia/S-2681-2019	de França, Giovanny Vinícius Araújo/0000-0002-7530-2017; Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Oliveira, Wanderson/0000-0002-9662-1930; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Castro, Marcia/0000-0003-4606-2795; Barros, Fernando/0000-0001-5973-1746	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	CGV holds a Wellcome Trust Senior Investigator Award. We thank the Health Secretaries of the Brazilian states and municipalities; the state Central Laboratories Network National Reference Laboratories; the General Coordination of National Dengue Control Program (CGPNCD/MS); the General Coordination of Surveillance and Response (CGVR/MS); the General Coordination of Public Health Laboratories (CGLAB/MS); the General Coordination of Information and Epidemiological Analysis (CGIAE/MS); the Brazilian Society of Medical Genetics; the Latin American Center for Perinatology, Women and Reproductive Health (CLAP/WR-PAHO/WHO); and the Pan American Health Organization in Washington and the national office in Brazil. Pablo Duran and Andres de Francisco provided inputs in an earlier version of the manuscript; Jose Villar and Eric Ohuma provided advice on the calculations of head circumference Z scores; Dacio de Lyra Rabello Neto, Roberto Carlos Reyes Lecca, Marli Montenegro Silva, and Anthony Stevens carried out the linkage between the microcephaly surveillance system and the National Birth Registration System (SINASC); and Aluisio J D Barros provided statistical analysis advice. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Brazilian Ministry of Health or of the Pan American Health Organization.	Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.3201/eid2206.160062, 10.32032/eid2206.160062]; Brasil. Ministerio da Saude, 2016, REG EV SAUD PUBL RES; Brasil. Ministerio da Saude, 2016, PROT VIG RESP OC MIC, V2 2; Brasil Ministerio da Saude, 2016, INF EP 25; Brasil. Ministerio da Saude, 2016, INF EP 15; Brito C, 2015, ACTA MEDICA PORT, V28, P679; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Centers for Disease Control and Prevention (CDC), CDC CONCL ZIK CAUS M; [DATASUS Brasil. Ministerio da Saude], 2016, SIST NAC NASC VIV; [DATASUS Brasil. Ministerio da Saude], IND MORT TEX MORT NE; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617; Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2; Matijasevich A, 2013, EPIDEMIOL SERV SAUDE, V22, P557, DOI 10.5123/S1679-49742013000400002; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Organizacion Panamericana de la Salud, 2016, GUIA VIG ENF VIR ZIK; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901; Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7; Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; World Health Organization, 2016, ZIK VIR MICR GUILL B	26	384	392	1	67	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					891	897		10.1016/S0140-6736(16)30902-3	http://dx.doi.org/10.1016/S0140-6736(16)30902-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU0RI	27372398	hybrid			2022-12-24	WOS:000381911800027
J	Orchard, RC; Wilen, CB; Doench, JG; Baldridge, MT; McCune, BT; Lee, YCJ; Lee, S; Pruett-Miller, SM; Nelson, CA; Fremont, DH; Virgin, HW				Orchard, Robert C.; Wilen, Craig B.; Doench, John G.; Baldridge, Megan T.; McCune, Broc T.; Lee, Ying-Chiang J.; Lee, Sanghyun; Pruett-Miller, Shondra M.; Nelson, Christopher A.; Fremont, Daved H.; Virgin, Herbert W.			Discovery of a proteinaceous cellular receptor for a norovirus	SCIENCE			English	Article							NORWALK VIRUS-INFECTION; CMRF-35-LIKE MOLECULE-1; SUSCEPTIBILITY; CELLS; PHOSPHATIDYLSERINE; PERSISTENCE; SUFFICIENT; BACTERIA; DISEASE; BINDING	Noroviruses (NoVs) are a leading cause of gastroenteritis globally, yet the host factors required for NoV infection are poorly understood. We identified host molecules that are essential for murine NoV (MNoV)-induced cell death, including CD300lf as a proteinaceous receptor. We found that CD300lf is essential for MNoV binding and replication in cell lines and primary cells. Additionally, Cd300lf(-/-) mice are resistant to MNoV infection. Expression of CD300lf in human cells breaks the species barrier that would otherwise restrict MNoV replication. The crystal structure of the CD300lf ectodomain reveals a potential ligand-binding cleft composed of residues that are critical for MNoV infection. Therefore, the presence of a proteinaceous receptor is the primary determinant of MNoV species tropism, whereas other components of cellular machinery required for NoV replication are conserved between humans and mice.	[Orchard, Robert C.; Wilen, Craig B.; Baldridge, Megan T.; McCune, Broc T.; Lee, Ying-Chiang J.; Lee, Sanghyun; Nelson, Christopher A.; Fremont, Daved H.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Doench, John G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Pruett-Miller, Shondra M.] Washington Univ, Sch Med, Dept Genet, Genome Engn & iPSC Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu	Pruett-Miller, Shondra M./M-9414-2018; Baldridge, Megan/T-7274-2019; Doench, John G/HCI-9570-2022; Doench, John/ABE-6251-2020	Pruett-Miller, Shondra M./0000-0002-3793-585X; Baldridge, Megan/0000-0002-7030-6131; Doench, John G/0000-0002-3707-9889; Doench, John/0000-0002-3707-9889; Lee, Ying-Chiang/0000-0002-0319-1493; Fremont, Daved/0000-0002-8544-2689; Virgin, Herbert/0000-0001-8580-7628	National Cancer Institute Cancer Center [P30 CA091842]; NIH [U19 AI109725, 1F31CA177194, 5T32CA009547]; NATIONAL CANCER INSTITUTE [T32CA009547, P30CA091842, F31CA177194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI128043, U19AI109725, T32AI007163] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Karst and M. Diamond for providing valuable reagents and S. Handley and C. Desai for their helpful discussion and figure generation. We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, for the use of the Genome Engineering and iPSC Center. CD300 constructs, cell lines, and mice are available from H.W.V. under a material transfer agreement with Washington University. The data from this study are tabulated in the main paper and in the supplementary materials. H.W.V., D.H.F., R.C.O., C.B.W., and C.A.N. are inventors on a patent application submitted by Washington University entitled "Receptor for norovirus and uses thereof" (U.S. Provisional Application 62/301,965). The atomic coordinates are deposited in the Protein Data Bank under accession code 5FFL. The Siteman Cancer Center is supported in part by National Cancer Institute Cancer Center Support Grant P30 CA091842. This work was supported by NIH grants U19 AI109725 (H.W.V.), 1F31CA177194 (B.T.M.), and 5T32CA009547 (M.T.B.).	Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Choi SC, 2011, J IMMUNOL, V187, P3483, DOI 10.4049/jimmunol.1101549; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kambhampati A, 2016, CLIN INFECT DIS, V62, P11, DOI 10.1093/cid/civ873; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Marquez JA, 2007, J MOL BIOL, V367, P310, DOI 10.1016/j.jmb.2007.01.011; Newman KL, 2015, EUR J IMMUNOL, V45, P2742, DOI 10.1002/eji.201545512; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Ossiboff RJ, 2007, J VIROL, V81, P13608, DOI 10.1128/JVI.01509-07; Ossiboff RJ, 2010, J VIROL, V84, P5550, DOI 10.1128/JVI.02371-09; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Taube S, 2013, MBIO, V4, DOI 10.1128/mBio.00450-13; Taube S, 2012, J VIROL, V86, P5584, DOI 10.1128/JVI.06854-11; Tian LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4146; Ward VK, 2007, P NATL ACAD SCI USA, V104, P11050, DOI 10.1073/pnas.0700336104; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432	28	163	174	5	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					933	936		10.1126/science.aaf1220	http://dx.doi.org/10.1126/science.aaf1220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27540007	Green Accepted			2022-12-24	WOS:000381867700040
J	Alfieri, C; Chang, LF; Zhang, ZG; Yang, J; Maslen, S; Skehel, M; Barford, D				Alfieri, Claudio; Chang, Leifu; Zhang, Ziguo; Yang, Jing; Maslen, Sarah; Skehel, Mark; Barford, David			Molecular basis of APC/C regulation by the spindle assembly checkpoint	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; MITOTIC CHECKPOINT; PROTEIN BUBR1; SACCHAROMYCES-CEREVISIAE; RECOMBINANT EXPRESSION; CDC20 BINDING; UCSF CHIMERA; PHOSPHORYLATION; MECHANISM; MAD2	In the dividing eukaryotic cell, the spindle assembly checkpoint (SAC) ensures that each daughter cell inherits an identical set of chromosomes. The SAC coordinates the correct attachment of sister chromatid kinetochores to the mitotic spindle with activation of the anaphase-promoting complex (APC/C), the E3 ubiquitin ligase responsible for initiating chromosome separation. In response to unattached kinetochores, the SAC generates the mitotic checkpoint complex (MCC), which inhibits the APC/C and delays chromosome segregation. By cryo-electron microscopy, here we determine the near-atomic resolution structure of a human APC/C-MCC complex (APC/C-MCC). Degron-like sequences of the MCC subunit BubR1 block degron recognition sites on Cdc20, the APC/C coactivator subunit responsible for substrate interactions. BubR1 also obstructs binding of the initiating E2 enzyme UbcH10 to repress APC/C ubiquitination activity. Conformational variability of the complex enables UbcH10 association, and structural analysis shows how the Cdc20 subunit intrinsic to the MCC (Cdc20M(CC)) is ubiquitinated, a process that results in APC/C reactivation when the SAC is silenced.	[Alfieri, Claudio; Chang, Leifu; Zhang, Ziguo; Yang, Jing; Maslen, Sarah; Skehel, Mark; Barford, David] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Barford, D (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	dbarford@mrc-lmb.cam.ac.uk		Zhang, Ziguo/0000-0002-7268-9631; Alfieri, Claudio/0000-0003-3215-1607; Barford, David/0000-0001-8810-950X; Yang, Jing/0000-0002-8984-4503	Cancer Research UK [C576/A14109]; Medical Research Council [MRC_UP_1201/6]; Long Term EMBO Fellowship; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [MC_UP_1201/6] Funding Source: researchfish; MRC [MC_UP_1201/6] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Long Term EMBO Fellowship(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Cancer Research UK grant (C576/A14109) and the Medical Research Council (MRC_UP_1201/6) to D.B. and a Long Term EMBO Fellowship to C.A. We thank members of the Barford group for discussions, X. Bai and S. Scheres for their help with RELION; C. Savva and S. Chen for EM facilities; J. Grimmett and T. Darling for computing and W. Zachariae and J. Pines for their invaluable advice and J. Pines for communicating data before publication.	Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Bolanos-Garcia VM, 2011, STRUCTURE, V19, P1691, DOI 10.1016/j.str.2011.09.017; Brown NG, 2015, P NATL ACAD SCI USA, V112, P5272, DOI 10.1073/pnas.1504161112; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Di Fiore B, 2015, DEV CELL, V32, P358, DOI 10.1016/j.devcel.2015.01.003; Diaz-Martinez LA, 2015, J BIOL CHEM, V290, P2431, DOI 10.1074/jbc.M114.616490; Elowe S, 2010, J CELL SCI, V123, P84, DOI 10.1242/jcs.056507; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Ge S, 2009, CELL CYCLE, V8, P167, DOI 10.4161/cc.8.1.7606; Han JS, 2013, MOL CELL, V51, P92, DOI 10.1016/j.molcel.2013.05.019; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Hegemann B, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001993; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Izawa D, 2015, NATURE, V517, P631, DOI 10.1038/nature13911; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Kaisari S, 2016, P NATL ACAD SCI USA, V113, P966, DOI 10.1073/pnas.1524551113; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelly A, 2014, MOL CELL, V56, P232, DOI 10.1016/j.molcel.2014.09.010; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Labit H, 2012, EMBO J, V31, P3351, DOI 10.1038/emboj.2012.168; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lara-Gonzalez P, 2011, J CELL SCI, V124, P4332, DOI 10.1242/jcs.094763; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lischetti T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6563; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Meyer HJ, 2011, SEMIN CELL DEV BIOL, V22, P544, DOI 10.1016/j.semcdb.2011.03.009; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Uzunova K, 2012, NAT STRUCT MOL BIOL, V19, P1116, DOI 10.1038/nsmb.2412; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Yudkovsky Y, 2000, BIOCHEM BIOPH RES CO, V271, P299, DOI 10.1006/bbrc.2000.2622; Zhang SY, 2016, NATURE, V533, P260, DOI 10.1038/nature17973; Zhang ZG, 2016, METHODS, V95, P13, DOI 10.1016/j.ymeth.2015.10.003; Zhang ZG, 2013, BIOCHEM J, V449, P365, DOI 10.1042/BJ20121374	74	122	125	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					431	+		10.1038/nature19083	http://dx.doi.org/10.1038/nature19083			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27509861	Green Accepted			2022-12-24	WOS:000382646600036
J	Ferguson, NM; Cucunuba, ZM; Dorigatti, I; Nedjati-Gilani, GL; Donnelly, CA; Basanez, MG; Nouvellet, P; Lessler, J				Ferguson, Neil M.; Cucunuba, Zulma M.; Dorigatti, Ilaria; Nedjati-Gilani, Gemma L.; Donnelly, Christl A.; Basanez, Maria-Gloria; Nouvellet, Pierre; Lessler, Justin			Countering the Zika epidemic in Latin America	SCIENCE			English	Editorial Material							VIRUS		[Ferguson, Neil M.; Cucunuba, Zulma M.; Dorigatti, Ilaria; Nedjati-Gilani, Gemma L.; Donnelly, Christl A.; Basanez, Maria-Gloria; Nouvellet, Pierre] Imperial Coll London, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ferguson, NM (corresponding author), Imperial Coll London, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.	neil.ferguson@imperial.ac.uk	Ferguson, Neil/B-8578-2008; Cucunuba, Zulma M/X-5670-2019; Cucunuba, Zulma M./L-4076-2016	Ferguson, Neil/0000-0002-1154-8093; Cucunuba, Zulma M/0000-0002-8165-3198; Cucunuba, Zulma M./0000-0002-8165-3198; Lessler, Justin/0000-0002-9741-8109; Basanez, Maria-Gloria/0000-0001-5031-3361; Dorigatti, Ilaria/0000-0001-9959-0706; nouvellet, pierre/0000-0002-6094-5722	Medical Research Council [MC_PC_15091, MR/K010174/1] Funding Source: Medline; NIGMS NIH HHS [U01 GM110721] Funding Source: Medline; Department of Health Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110721] Funding Source: NIH RePORTER; MRC [MR/K010174/1, MC_PC_15091] Funding Source: UKRI; Medical Research Council [MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI DOI 10.1371/JOURNAL.PNTD.0003655; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Schuck-Paim C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041918; Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1; WHO, 2016, MOSQ VECT CONTR EM R; World Health Organization, 2016, WHO DIR GEN SUMM OUT	11	178	181	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2016	353	6297					353	354		10.1126/science.aag0219	http://dx.doi.org/10.1126/science.aag0219			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS2HB	27417493	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000380583400024
J	Moeller, AH; Caro-Quintero, A; Mjungu, D; Georgiev, AV; Lonsdorf, EV; Muller, MN; Pusey, AE; Peeters, M; Hahn, BH; Ochman, H				Moeller, Andrew H.; Caro-Quintero, Alejandro; Mjungu, Deus; Georgiev, Alexander V.; Lonsdorf, Elizabeth V.; Muller, Martin N.; Pusey, Anne E.; Peeters, Martine; Hahn, Beatrice H.; Ochman, Howard			Cospeciation of gut microbiota with hominids	SCIENCE			English	Article							CHIMPANZEES; EVOLUTION; BACTERIA	The evolutionary origins of the bacterial lineages that populate the human gut are unknown. Here we show that multiple lineages of the predominant bacterial taxa in the gut arose via cospeciation with humans, chimpanzees, bonobos, and gorillas over the past 15 million years. Analyses of strain-level bacterial diversity within hominid gut microbiomes revealed that clades of Bacteroidaceae and Bifidobacteriaceae have been maintained exclusively within host lineages across hundreds of thousands of host generations. Divergence times of these cospeciating gut bacteria are congruent with those of hominids, indicating that nuclear, mitochondrial, and gut bacterial genomes diversified in concert during hominid evolution. This study identifies human gut bacteria descended from ancient symbionts that speciated simultaneously with humans and the African apes.	[Moeller, Andrew H.; Ochman, Howard] Univ Texas Austin, Dept Integrat Biol, 2506 Speedway A5000, Austin, TX 78712 USA; [Moeller, Andrew H.] Univ Calif Berkeley, Miller Inst Basic Res Sci, 2536 Channing Way, Berkeley, CA 94720 USA; [Caro-Quintero, Alejandro] Corpoica CI Tibaitata, Bogota, Colombia; [Mjungu, Deus] Gombe Stream Res Ctr, Kigoma, Tanzania; [Georgiev, Alexander V.] Northwestern Univ, Dept Anthropol, 1810 Hinman Ave, Evanston, IL 60208 USA; [Georgiev, Alexander V.] Harvard Univ, Dept Human Evolutionary Biol, 11 Divin Ave, Cambridge, MA 02138 USA; [Lonsdorf, Elizabeth V.] Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17603 USA; [Lonsdorf, Elizabeth V.] Franklin & Marshall Coll, Biol Fdn Behav Program, LSP 261B, Lancaster, PA 17603 USA; [Muller, Martin N.] Univ New Mexico, Dept Anthropol, MSC01-1040, Albuquerque, NM 87131 USA; [Pusey, Anne E.] Duke Univ, Dept Evolutionary Anthropol, 101 Biol Sci Bldg, Durham, NC 27708 USA; [Peeters, Martine] Univ Montpellier, Inst Rech Dev, F-34394 Montpellier, France; [Hahn, Beatrice H.] Univ Penn, Dept Med, Perelman Sch Med, 409 Johnson Pavil, Philadelphia, PA 19104 USA; [Hahn, Beatrice H.] Univ Penn, Dept Microbiol, Perelman Sch Med, 409 Johnson Pavil, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Austin; University of California System; University of California Berkeley; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Northwestern University; Harvard University; Franklin & Marshall College; Franklin & Marshall College; University of New Mexico; Duke University; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Ochman, H (corresponding author), Univ Texas Austin, Dept Integrat Biol, 2506 Speedway A5000, Austin, TX 78712 USA.	howard.ochman@austin.utexas.edu	; Georgiev, Alexander/C-5061-2015	Hahn, Beatrice/0000-0002-9400-9887; Georgiev, Alexander/0000-0001-5622-3826; Pusey, Anne/0000-0002-2280-8954; Caro-Quintero, Alejandro/0000-0001-8807-671X	NIH [R01 AI091595, R37 AI050529, R01 AI120810, P30 AI045008, R01 GM101209]; NSF [2011119472]; Agence Nationale de Recherche sur le Sida [ANRS 12125/12182/12255/12325]; Jane Goodall Institute; Arthur L. Greene Fund; Harvard University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091595, P30AI045008, R01AI120810, R37AI050529, R01AI050529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118038, R01GM101209] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1457260] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); Jane Goodall Institute; Arthur L. Greene Fund; Harvard University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank N. Moran and A. Goodman for comments on the manuscript and K. Hammond for assistance with preparation of the figures. We also thank the staff of the Prevention of AIDS in Cameroon (PRESICA) project and the Bonobo Conservation Initiative, as well as J.-B. N. Ndjango for field work in Cameroon and the Democratic Republic of the Congo (DRC); field assistants in Gombe National Park for sample collection in Tanzania; the Cameroonian Ministries of Health, Forestry, and Wildlife and Scientific Research and Innovation for permission to collect samples in Cameroon; the Ministries of Health and Environment and the National Ethics Committee for permission to collect samples in the DRC; the Tanzania Commission for Science and Technology; the Tanzania Wildlife Research Institute for permission to conduct research in Gombe National Park; and the Bonobo Conservation Initiative and Vie Sauvage for assistance in the DRC. All human studies were conducted with approval from the Yale University Human Investigation Committee. This work was supported by funding from the NIH (grants R01 AI091595, R37 AI050529, R01 AI120810, P30 AI045008, R01 GM101209), NSF (Graduate Research Fellowship 2011119472 to A.H.M.), Agence Nationale de Recherche sur le Sida (ANRS 12125/12182/12255/12325), Jane Goodall Institute, Arthur L. Greene Fund, and Harvard University. A.H.M. performed analyses and wrote the paper. A.C.-Q. processed samples and prepared libraries for sequencing. D.M., E.V.L., M.N.M., A.V.G., A.E.P., M.P., and B.H.H. provided samples and commented on the manuscript. H.O. provided reagents and wrote the paper. Sequence data have been deposited in the European Nucleotide Archive under accession PRJEB13130.	Bjork A, 2011, MOL BIOL EVOL, V28, P615, DOI 10.1093/molbev/msq227; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caro-Quintero A, 2015, GENOME BIOL EVOL, V7, P3416, DOI 10.1093/gbe/evv234; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Kwong WK, 2014, P NATL ACAD SCI USA, V111, P11509, DOI 10.1073/pnas.1405838111; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Moeller AH, 2014, P NATL ACAD SCI USA, V111, P16431, DOI 10.1073/pnas.1419136111; Moeller AH, 2013, GENOME RES, V23, P1715, DOI 10.1101/gr.154773.113; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002311; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; MUNSON MA, 1991, J BACTERIOL, V173, P6321, DOI 10.1128/jb.173.20.6321-6324.1991; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	24	317	326	14	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2016	353	6297					380	382		10.1126/science.aaf3951	http://dx.doi.org/10.1126/science.aaf3951			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HB	27463672	Green Accepted			2022-12-24	WOS:000380583400040
J	Cinner, JE; Huchery, C; MacNeil, MA; Graham, NAJ; McClanahan, TR; Maina, J; Maire, E; Kittinger, JN; Hicks, CC; Mora, C; Allison, EH; D'Agata, S; Hoey, A; Feary, DA; Crowder, L; Williams, ID; Kulbicki, M; Vigliola, L; Wantiez, L; Edgar, G; Stuart-Smith, RD; Sandin, SA; Green, AL; Hardt, MJ; Beger, M; Friedlander, A; Campbell, SJ; Holmes, KE; Wilson, SK; Brokovich, E; Brooks, AJ; Cruz-Motta, JJ; Booth, DJ; Chabanet, P; Gough, C; Tupper, M; Ferse, SCA; Sumaila, UR; Mouillot, D				Cinner, Joshua E.; Huchery, Cindy; MacNeil, M. Aaron; Graham, Nicholas A. J.; McClanahan, Tim R.; Maina, Joseph; Maire, Eva; Kittinger, John N.; Hicks, Christina C.; Mora, Camilo; Allison, Edward H.; D'Agata, Stephanie; Hoey, Andrew; Feary, David A.; Crowder, Larry; Williams, Ivor D.; Kulbicki, Michel; Vigliola, Laurent; Wantiez, Laurent; Edgar, Graham; Stuart-Smith, Rick D.; Sandin, Stuart A.; Green, Alison L.; Hardt, Marah J.; Beger, Maria; Friedlander, Alan; Campbell, Stuart J.; Holmes, Katherine E.; Wilson, Shaun K.; Brokovich, Eran; Brooks, Andrew J.; Cruz-Motta, Juan J.; Booth, David J.; Chabanet, Pascale; Gough, Charlie; Tupper, Mark; Ferse, Sebastian C. A.; Sumaila, U. Rashid; Mouillot, David			Bright spots among the world's coral reefs	NATURE			English	Article							GRAVITY; MANAGEMENT; DISTANCE	Ongoing declines in the structure and function of the world's coral reefs(1,2) require novel approaches to sustain these ecosystems and the millions of people who depend on them(3). A presently unexplored approach that draws on theory and practice in human health and rural development(4,5) is to systematically identify and learn from the 'outliers'-places where ecosystems are substantially better ('bright spots') or worse ('dark spots') than expected, given the environmental conditions and socioeconomic drivers they are exposed to. Here we compile data from more than 2,500 reefs worldwide and develop a Bayesian hierarchical model to generate expectations of how standing stocks of reef fish biomass are related to 18 socioeconomic drivers and environmental conditions. We identify 15 bright spots and 35 dark spots among our global survey of coral reefs, defined as sites that have biomass levels more than two standard deviations from expectations. Importantly, bright spots are not simply comprised of remote areas with low fishing pressure; they include localities where human populations and use of ecosystem resources is high, potentially providing insights into how communities have successfully confronted strong drivers of change. Conversely, dark spots are not necessarily the sites with the lowest absolute biomass and even include some remote, uninhabited locations often considered near pristine(6). We surveyed local experts about social, institutional, and environmental conditions at these sites to reveal that bright spots are characterized by strong sociocultural institutions such as customary taboos and marine tenure, high levels of local engagement in management, high dependence on marine resources, and beneficial environmental conditions such as deep-water refuges. Alternatively, dark spots are characterized by intensive capture and storage technology and a recent history of environmental shocks. Our results suggest that investments in strengthening fisheries governance, particularly aspects such as participation and property rights, could facilitate innovative conservation actions that help communities defy expectations of global reef degradation.	[Cinner, Joshua E.; Huchery, Cindy; MacNeil, M. Aaron; Graham, Nicholas A. J.; Maire, Eva; Hicks, Christina C.; Hoey, Andrew; Mouillot, David] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [MacNeil, M. Aaron] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia; [MacNeil, M. Aaron] Dalhousie Univ, Dept Math & Stat, Halifax, NS B3H 3J5, Canada; [Graham, Nicholas A. J.; Hicks, Christina C.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [McClanahan, Tim R.; Maina, Joseph; D'Agata, Stephanie; Campbell, Stuart J.; Holmes, Katherine E.] Wildlife Conservat Soc, Global Marine Program, Bronx, NY 10460 USA; [Maina, Joseph; Beger, Maria] Univ Queensland, Ctr Biodivers & Conservat Sci, Australian Res Council Ctr Excellence Environm De, St Lucia, Qld 4074, Australia; [Maina, Joseph; D'Agata, Stephanie] Macquarie Univ, Dept Environm Sci, N Ryde, NSW 2109, Australia; [Maire, Eva; Mouillot, David] Univ Montpellier, IRD CNRS UM IFREMER, UMR 9190, MARBEC, F-34095 Montpellier, France; [Kittinger, John N.; Hicks, Christina C.; Crowder, Larry] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Kittinger, John N.] Conservat Int Hawaii Betty & Gordon Moore Ctr Sci, 7192 Kalaniana Ole Hwy,Suite G230, Honolulu, HI 96825 USA; [Mora, Camilo] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA; [Allison, Edward H.] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98102 USA; [D'Agata, Stephanie; Vigliola, Laurent] Inst Res Dev, UMR IRD UR CNRS ENTROPIE, Lab Excellence LABEX CORAIL, BP A5, Noumea 98848, New Caledonia; [Feary, David A.] Univ Nottingham, Sch Life Sci, Ecol & Evolut Grp, Univ Pk, Nottingham NG7 2RD, England; [Williams, Ivor D.] NOAA Pacific Islands Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI 96818 USA; [Kulbicki, Michel] Univ Perpignan, Labex Corail IRD, UMR Entropie, F-66000 Perpignan, France; [Wantiez, Laurent] Univ New Caledonia, LIVE EA4243, BPR4, Noumea 98851, New Caledonia; [Edgar, Graham; Stuart-Smith, Rick D.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Sandin, Stuart A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Green, Alison L.] Nature Conservancy, Brisbane, Qld 4101, Australia; [Hardt, Marah J.] Future Fish, 7315 Wisconsin Ave,Suite 1000W, Bethesda, MD 20814 USA; [Friedlander, Alan] Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Friedlander, Alan] Natl Geog Soc, Pristine Seas Program, 1145 17th St NW, Washington, DC 20036 USA; [Wilson, Shaun K.] Dept Pk & Wildlife, Perth, WA 6151, Australia; [Wilson, Shaun K.] Univ Western Australia, Oceans Inst, Crawley, WA 6009, Australia; [Brokovich, Eran] Israeli Soc Ecol & Environm Sci, Kehilat New York 19, Tel Aviv, Israel; [Brooks, Andrew J.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Cruz-Motta, Juan J.] Univ Puerto Rico, Recinto Univ Mayaguez, Dept Ciencias Marinas, San Juan, PR 00680 USA; [Booth, David J.] Univ Technol Sydney, Sch Life Sci, Sydney, NSW 2007, Australia; [Chabanet, Pascale] Inst Rech Dev, UMR ENTROPIE, Lab Excellence LABEX CORAIL, CS 41095, St Clothilde 97495, Reunion, France; [Gough, Charlie] Blue Ventures Conservat, 39-41 North Rd, London N7 9DP, England; [Tupper, Mark] Coastal Resources Assoc, St Joseph St, Surigao City 8400, Surigao Del Nor, Philippines; [Ferse, Sebastian C. A.] Leibniz Ctr Trop Marine Ecol ZMT, Fahrenheitstr 6, D-28359 Bremen, Germany; [Sumaila, U. Rashid] Univ British Columbia, Fisheries Econ Res Unit, 2202 Main Mall, Vancouver, BC V6T 1Z4, Canada	James Cook University; Australian Institute of Marine Science; Dalhousie University; Lancaster University; Wildlife Conservation Society; University of Queensland; Macquarie University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Montpellier; Stanford University; University of Hawaii System; University of Hawaii Manoa; University of Washington; University of Washington Seattle; University of Nottingham; Universite Perpignan Via Domitia; Universite Nouvelle Caledonie; University of Tasmania; University of California System; University of California San Diego; Scripps Institution of Oceanography; Nature Conservancy; University of Hawaii System; National Geographic Society; University of Western Australia; University of California System; University of California Santa Barbara; University of Puerto Rico; University of Technology Sydney; Institut de Recherche pour le Developpement (IRD); Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of British Columbia	Cinner, JE (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	Joshua.cinner@jcu.edu.au	Graham, Nicholas AJ/C-8360-2014; Ferse, Sebastian/AAH-8048-2021; Stuart-Smith, Rick/I-5214-2019; Beger, Maria/F-9049-2013; Hoey, Andrew S/B-5457-2015; Beger, Maria/ABC-5975-2022; Cinner, Joshua/AAA-6823-2021; Allison, Edward Hugh/B-8615-2009; Hicks, Christina/M-6182-2015; Edgar, Graham/AAY-3797-2020; Maire, Eva/T-1934-2019; Vigliola, Laurent/J-7107-2016; Stuart-Smith, Rick D/M-1829-2013; MacNeil, M. Aaron/ABD-6444-2021; Dagata, Stéphanie/ABC-7437-2020; Stephanie, D'Agata/AAN-3692-2020; McClanahan, Tim/K-4998-2019; Chabanet, Pascale/L-9470-2017; MacNeil, Aaron/E-8196-2017; Cinner, Joshua e/E-8966-2011; Sumaila, U. Rashid/ABE-6475-2020; Wantiez, Laurent/L-3343-2013	Graham, Nicholas AJ/0000-0002-0304-7467; Ferse, Sebastian/0000-0003-0930-5356; Stuart-Smith, Rick/0000-0002-8874-0083; Beger, Maria/0000-0003-1363-3571; Beger, Maria/0000-0003-1363-3571; Hicks, Christina/0000-0002-7399-4603; Edgar, Graham/0000-0003-0833-9001; Maire, Eva/0000-0002-1032-3394; Vigliola, Laurent/0000-0003-4715-7470; Stuart-Smith, Rick D/0000-0002-8874-0083; MacNeil, M. Aaron/0000-0001-8406-325X; Stephanie, D'Agata/0000-0001-6941-8489; MacNeil, Aaron/0000-0001-8406-325X; Cinner, Joshua e/0000-0003-2675-9317; Wantiez, Laurent/0000-0001-5024-2057; Campbell, Stuart/0000-0002-1158-3200; Chabanet, Pascale/0000-0001-7600-943X; Tupper, Mark/0000-0002-6157-7714; Williams, Ivor/0000-0002-9444-1020; Wilson, Shaun/0000-0002-4590-0948; Maina, Joseph/0000-0003-1268-6137; Cruz Motta, Juan Jose/0000-0001-6117-9014; Booth, David/0000-0002-8256-1412; huchery, cindy/0000-0002-5657-7584; Hoey, Andrew/0000-0002-4261-5594; Allison, Edward/0000-0003-4663-1396	ARC Centre of Excellence for Coral Reef Studies, Stanford University; University of Montpellier; J.E.C.'s Pew Fellowship in Marine Conservation; ARC Australian Research Fellowship; Natural Environment Research Council [ceh010010] Funding Source: researchfish	ARC Centre of Excellence for Coral Reef Studies, Stanford University(Australian Research Council); University of Montpellier; J.E.C.'s Pew Fellowship in Marine Conservation; ARC Australian Research Fellowship(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The ARC Centre of Excellence for Coral Reef Studies, Stanford University, and University of Montpellier funded working group meetings. This work was supported by J.E.C.'s Pew Fellowship in Marine Conservation and ARC Australian Research Fellowship. Thanks to M. Barnes for constructive comments.	Anderson J. E., 2010, THE GRAVITY MODEL; ANDERSON JE, 1979, AM ECON REV, V69, P106; Andrefouet S., 2006, P 10 INT COR REEF S, P1732; Bartholome E., 2002, GLC 2000 GLOBAL LAND; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BLACK WR, 1973, TRANSPORTATION, V2, P299; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Cinner JE, 2011, GLOBAL ENVIRON CHANG, V21, P835, DOI 10.1016/j.gloenvcha.2011.04.012; Cinner J, 2006, ECOL SOC, V11; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Cinner JE, 2016, REG ENVIRON CHANGE, V16, P1133, DOI 10.1007/s10113-015-0832-z; Devillers R, 2015, AQUAT CONSERV, V25, P480, DOI 10.1002/aqc.2445; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dodd SC, 1950, AM SOCIOL REV, V15, P245, DOI 10.2307/2086789; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; Emran M. S., 2008, EXTENT MARKET STAGES, V4534; Falk A, 2013, SCIENCE, V340, P707, DOI 10.1126/science.1231566; Froese R., 2014, FISHBASE; Gelman A., 2014, BAYESIAN DATA ANAL, V2; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Hughes TP, 2013, CONSERV BIOL, V27, P261, DOI 10.1111/j.1523-1739.2012.01957.x; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Levinson FJ, 2007, FOOD NUTR BULL, V28, P259, DOI 10.1177/156482650702800301; Lindfield SJ, 2016, CORAL REEFS, V35, P125, DOI 10.1007/s00338-015-1386-8; LUKERMANN F, 1960, ANN ASSOC AM GEOGR, V50, P493, DOI 10.1111/j.1467-8306.1960.tb00364.x; MacNeil M. Aaron, 2015, P116; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; Maina J., 2011, SPATIAL BEHAV ARTISA; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Nelson A., 2008, TRAVEL TIME MAJOR CI; Noble A., 2005, BRIGHT SPOTS DEMONST, P7; O'Rourke D, 2014, SCIENCE, V344, P1124, DOI 10.1126/science.1248526; Ostrom E., 1990, GOVERNING COMMONS EV; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pascale R. T., 2005, HARVARD BUS REV, V83, P153; Patil A, 2010, J STAT SOFTW, V35, P1; Pressey RL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0280; Pretty JN, 2006, ENVIRON SCI TECHNOL, V40, P1114, DOI 10.1021/es051670d; R Core Team, 2017, LANG ENV STAT COMP; Ravenstein E.G., 1885, J STAT SOC LONDON, V48, P167; Sampson GS, 2015, SCIENCE, V348, P504, DOI 10.1126/science.aaa4639; Sandel M.J, 2012, WHAT MONEY CANT BUY; Schmitt KM, 2009, ENVIRON CONSERV, V36, P289, DOI 10.1017/S0376892910000159; Sternin M, 1997, HEARTH NUTR MODEL AP, P49; Teh LSL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065397; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; York R, 2003, AM SOCIOL REV, V68, P279, DOI 10.2307/1519769	55	296	301	7	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					416	+		10.1038/nature18607	http://dx.doi.org/10.1038/nature18607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27309809	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000380344200039
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Hip fracture care shows the way	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						British Orthopaedic Association British Geriatrics Society, 2007, BLUE BOOK CAR PAT FR; Chamberlain Mark, 2015, BMJ Qual Improv Rep, V4, DOI 10.1136/bmjquality.u204075.w2786; Gupta A, 2014, J ROY COLL PHYS EDIN, V44, P20, DOI 10.4997/JRCPE.2014.105; Hawley S, 2016, AGE AGEING, V45, P236, DOI 10.1093/ageing/afv204; National Hip Fracture Database, NAT HIP FRACT DAT 20; National Osteoporosis Society, MEAS SERV SCOTT HIP; Neuburger J, 2015, MED CARE, V53, P686, DOI 10.1097/MLR.0000000000000383; NHS England, NEW MOD CAR PROGR ON; NHS England, RIGHT CAR PROGR ONG; Oliver D, 2011, OSTEOPOROSIS REV, V19, P7; Simunovic N, 2011, INDIAN J ORTHOP, V45, P27, DOI 10.4103/0019-5413.73660	11	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2016	354								i3979	10.1136/bmj.i3979	http://dx.doi.org/10.1136/bmj.i3979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0WK	27444990	Green Published, Bronze			2022-12-24	WOS:000380317300005
J	Pedersen, HK; Gudmundsdottir, V; Nielsen, HB; Hyotylainen, T; Nielsen, T; Jensen, BAH; Forslund, K; Hildebrand, F; Prifti, E; Falony, G; Le Chatelier, E; Levenez, F; Dore, J; Mattila, I; Plichta, DR; Poho, P; Hellgren, LI; Arumugam, M; Sunagawa, S; Vieira-Silva, S; Jorgensen, T; Holm, JB; Trost, K; Kristiansen, K; Brix, S; Raes, J; Wang, J; Hansen, T; Bork, P; Brunak, S; Oresic, M; Ehrlich, SD; Pedersen, O				Pedersen, Helle Krogh; Gudmundsdottir, Valborg; Nielsen, Henrik Bjorn; Hyotylainen, Tuulia; Nielsen, Trine; Jensen, Benjamin A. H.; Forslund, Kristoffer; Hildebrand, Falk; Prifti, Edi; Falony, Gwen; Le Chatelier, Emmanuelle; Levenez, Florence; Dore, Joel; Mattila, Ismo; Plichta, Damian R.; Poho, Paivi; Hellgren, Lars I.; Arumugam, Manimozhiyan; Sunagawa, Shinichi; Vieira-Silva, Sara; Jorgensen, Torben; Holm, Jacob Bak; Trost, Kajetan; Kristiansen, Karsten; Brix, Susanne; Raes, Jeroen; Wang, Jun; Hansen, Torben; Bork, Peer; Brunak, Soren; Oresic, Matej; Ehrlich, S. Dusko; Pedersen, Oluf		MetaHIT Consortium	Human gut microbes impact host serum metabolome and insulin sensitivity	NATURE			English	Article							SATURATED FATTY-ACIDS; CHAIN AMINO-ACIDS; RESISTANCE; GLUCOSE; ASSOCIATION; METAGENOME; ADIPOCYTE; ABUNDANCE; PROFILES; GENOMES	Insulin resistance is a forerunner state of ischaemic cardiovascular disease and type 2 diabetes. Here we show how the human gut microbiome impacts the serum metabolome and associates with insulin resistance in 277 non-diabetic Danish individuals. The serum metabolome of insulin-resistant individuals is characterized by increased levels of branched-chain amino acids (BCAAs), which correlate with a gut microbiome that has an enriched biosynthetic potential for BCAAs and is deprived of genes encoding bacterial inward transporters for these amino acids. Prevotella copri and Bacteroides vulgatus are identified as the main species driving the association between biosynthesis of BCAAs and insulin resistance, and in mice we demonstrate that P. copri can induce insulin resistance, aggravate glucose intolerance and augment circulating levels of BCAAs. Our findings suggest that microbial targets may have the potential to diminish insulin resistance and reduce the incidence of common metabolic and cardiovascular disorders.	[Pedersen, Helle Krogh; Gudmundsdottir, Valborg; Nielsen, Henrik Bjorn; Plichta, Damian R.; Hellgren, Lars I.; Brix, Susanne; Brunak, Soren] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Hyotylainen, Tuulia] Univ Orebro, SE-70281 Orebro, Sweden; [Hyotylainen, Tuulia; Oresic, Matej] Univ Turku, Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Hyotylainen, Tuulia; Oresic, Matej] Abo Akad Univ, FI-20520 Turku, Finland; [Hyotylainen, Tuulia; Mattila, Ismo; Poho, Paivi; Oresic, Matej] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland; [Nielsen, Trine; Arumugam, Manimozhiyan; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Jensen, Benjamin A. H.; Holm, Jacob Bak; Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Lab Genom & Mol Biomed, DK-2100 Copenhagen, Denmark; [Forslund, Kristoffer; Hildebrand, Falk; Sunagawa, Shinichi; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Hildebrand, Falk; Raes, Jeroen] Vrije Univ Brussel, Dept Biosci Engn, B-1050 Brussels, Belgium; [Hildebrand, Falk; Falony, Gwen; Vieira-Silva, Sara; Raes, Jeroen] VIB, Ctr Biol Dis, B-3000 Louvain, Belgium; [Prifti, Edi; Le Chatelier, Emmanuelle; Levenez, Florence; Dore, Joel; Ehrlich, S. Dusko] Univ Paris Saclay, INRA, MGP MetaGenoPolis, F-78350 Jouy En Josas, France; [Prifti, Edi] Inst Cardiometab & Nutr ICAN, F-75013 Paris, France; [Falony, Gwen; Vieira-Silva, Sara; Raes, Jeroen] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Louvain, Belgium; [Dore, Joel] Univ Paris Saclay, INRA, AgroParisTech, Micalis Inst, F-78350 Jouy En Josas, France; [Mattila, Ismo; Trost, Kajetan; Oresic, Matej] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Poho, Paivi] Univ Helsinki, Fac Pharm, FI-00014 Helsinki, Finland; [Sunagawa, Shinichi] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Jorgensen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Jorgensen, Torben] Glostrup Cty Hosp, Capital Reg, Ctr Hlth, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Kristiansen, Karsten; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Albrahim Ctr Excellence Res H, Jeddah, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Ave Wai Long, Taipa, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Jun] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, DK-5000 Odense, Denmark; [Bork, Peer] Heidelberg Univ, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Bork, Peer] European Mol Biol Lab, D-69120 Heidelberg, Germany; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bork, Peer] Univ Wurzburg, Dept Bioinformat, D-97074 Wurzburg, Germany; [Brunak, Soren] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res Dis Syst Biol, DK-2200 Copenhagen, Denmark; [Ehrlich, S. Dusko] Kings Coll London, Ctr Host Microbiome Interact, Dent Inst Cent Off, Guys Hosp, London SE1 9RT, England	Technical University of Denmark; Orebro University; University of Turku; Abo Akademi University; VTT Technical Research Center Finland; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; European Molecular Biology Laboratory (EMBL); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; KU Leuven; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Steno Diabetes Center; University of Helsinki; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Copenhagen; University of Copenhagen; Beijing Genomics Institute (BGI); King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong; University of Hong Kong; University of Southern Denmark; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; Novo Nordisk Foundation; University of Copenhagen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Brunak, S (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.; Oresic, M (corresponding author), Univ Turku, Turku Ctr Biotechnol, FI-20520 Turku, Finland.; Oresic, M (corresponding author), Abo Akad Univ, FI-20520 Turku, Finland.; Oresic, M (corresponding author), VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland.; Pedersen, O (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark.; Ehrlich, SD (corresponding author), Univ Paris Saclay, INRA, MGP MetaGenoPolis, F-78350 Jouy En Josas, France.; Oresic, M (corresponding author), Steno Diabet Ctr, DK-2820 Gentofte, Denmark.; Pedersen, O (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark.; Brunak, S (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res Dis Syst Biol, DK-2200 Copenhagen, Denmark.; Ehrlich, SD (corresponding author), Kings Coll London, Ctr Host Microbiome Interact, Dent Inst Cent Off, Guys Hosp, London SE1 9RT, England.	soren.brunak@cpr.ku.dk; matej.oresic@gmail.com; dusko.ehrlich@jouy.inra.fr; oluf@sund.ku.dk	Bork, Peer/F-1813-2013; Ehrlich, S./Y-2423-2019; Delorme, Christine/AHA-7246-2022; Borruel, Natalia/AFO-6891-2022; Oresic, Matej/K-7673-2016; LE CHATELIER, Emmanuelle/O-1243-2017; BLOTTIERE, Hervé M/C-6120-2011; Guarner, Francisco/ABF-1192-2020; Ho, Igor Osorio/AAG-8616-2020; raes, jeroen/D-7835-2018; Tap, Julien/E-5760-2010; Arumugam, Manimozhiyan/AAJ-2394-2020; Dore, Joel/ABA-8921-2020; Knol, Jan/AAL-6487-2020; Pedersen, Oluf/AAG-8015-2020; Jensen, Benjamin A. H./M-4661-2014; Falony, Gwen/AAN-5011-2020; Nielsen, Henrik/B-8961-2019; Jørgensen, Torben/Z-1335-2018; Parkhill, Julian/G-4703-2011; Arumugam, Manimozhiyan/E-1211-2011; Prifti, Edi/F-3967-2019; Vieira-Silva, Sara/ABE-1247-2021; Forslund, Sofia K/Y-2393-2019; Sunagawa, Shinichi/Q-5950-2019; Hyötyläinen, Tuulia/AAP-6266-2020; Knol, Jan/A-2178-2010; Guedon, Eric/S-5635-2016; Pedersen, Oluf/Z-1731-2019; Oresic, Matej/AAV-3978-2020; GUEDON, Eric/N-8624-2019; Pedersen, Susanne Brix/B-3484-2009; Holm, Jacob Bak B/B-8677-2019; Rescigno, Maria/J-9704-2012; Brunak, Soren/O-6621-2016; Grarup, Niels/K-2807-2015; Sicheritz-Ponten, Thomas/A-4325-2017; Hildebrand, Falk/K-1914-2014	Bork, Peer/0000-0002-2627-833X; Ehrlich, S./0000-0002-7563-4046; Delorme, Christine/0000-0002-5208-7238; Borruel, Natalia/0000-0002-4449-2292; Oresic, Matej/0000-0002-2856-9165; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; BLOTTIERE, Hervé M/0000-0002-8390-0607; Guarner, Francisco/0000-0002-4051-0836; raes, jeroen/0000-0002-1337-041X; Tap, Julien/0000-0001-8998-5413; Arumugam, Manimozhiyan/0000-0002-0886-9101; Knol, Jan/0000-0002-2103-5961; Jensen, Benjamin A. H./0000-0001-6991-0828; Falony, Gwen/0000-0003-2450-0782; Nielsen, Henrik/0000-0003-2281-5713; Parkhill, Julian/0000-0002-7069-5958; Arumugam, Manimozhiyan/0000-0002-0886-9101; Prifti, Edi/0000-0001-8861-1305; Vieira-Silva, Sara/0000-0002-4616-7602; Sunagawa, Shinichi/0000-0003-3065-0314; Knol, Jan/0000-0002-2103-5961; Guedon, Eric/0000-0002-0901-4447; Pedersen, Oluf/0000-0002-3321-3972; GUEDON, Eric/0000-0002-0901-4447; Pedersen, Susanne Brix/0000-0001-8951-6705; Holm, Jacob Bak B/0000-0003-1756-0875; Poho, Paivi/0000-0001-9963-4027; Rescigno, Maria/0000-0002-6464-509X; Chaysavanh, Manichanh/0000-0002-2287-4003; Hyotylainen, Tuulia/0000-0002-1389-8302; Brunak, Soren/0000-0003-0316-5866; Pedersen, Helle Krogh/0000-0001-9609-7377; Burgdorf, Kristoffer/0000-0001-5814-6844; Forslund, Sofia K/0000-0003-4285-6993; Hansen, Torben/0000-0001-8748-3831; Pelletier, Eric/0000-0003-4228-1712; Varela Castro, Encarna/0000-0001-6334-9320; Plichta, Damian/0000-0002-6555-2557; Grarup, Niels/0000-0001-5526-1070; TORREJON, ANTONIO/0000-0002-3126-1532; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Hildebrand, Falk/0000-0002-0078-8948; Nielsen, Trine/0000-0002-2066-7895; Jorgensen, Torben/0000-0001-9453-2830; Gudmundsdottir, Valborg/0000-0002-7459-1603; Mattila, Ismo/0000-0001-9597-7831; Derrien, Muriel/0000-0001-8841-9153	European Community [HEALTH-F4-2007-201052]; Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp), Metagenopolis grant [ANR-11-DPBS-0001, HEALTH-F4-2012-305312]; Rega institute for Medical Research, KU Leuven; Agency for Innovation by Science and Technology (IWT) [267139]; Fund for Scientific Research Flanders (FWO); Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research) [250114]; EU FP7 Project TORNADO [222720]; European Union [600375]; Innovative Medicines Initiative Joint Undertaking from the European Union [115317]	European Community(European Commission); Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp), Metagenopolis grant; Rega institute for Medical Research, KU Leuven; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research Flanders (FWO)(FWO); Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research)(Academy of Finland); EU FP7 Project TORNADO; European Union(European Commission); Innovative Medicines Initiative Joint Undertaking from the European Union	The authors wish to thank S. Castillo, M. Sysi-Aho, A. Ruskeepaa, U. Lahtinen, A. Forman, T. Lorentzen, B. Andreasen, G. J. Klavsen, M. J. Nielsen, B. Pedersen, M. T. F. Damgaard and L. B. Rosholm for technical assistance, D. R. Mende and J. R. Kultima for their help in data processing and tool provision, C. Ekstom and S. Ditlevsen for statistical and mathematical assistance, respectively, and T. F. Toldsted and G. Lademann for management assistance. C. B. Newgard and A. Vaag are thanked for critical comments on our manuscript. The present study is initiated and funded by the European Community's Seventh Framework Program (FP7/2007-2013): MetaHIT, grant agreement HEALTH-F4-2007-201052. Additional funding came from The Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp, http://www.lucamp.org), Metagenopolis grant ANR-11-DPBS-0001 and FP7 METACARDIS HEALTH-F4-2012-305312. J.R., S.V.-S. and G.F. are funded by the Rega institute for Medical Research, KU Leuven, the Agency for Innovation by Science and Technology (IWT), Marie Curie Actions FP7 People COFUND - Proposal 267139 and the Fund for Scientific Research Flanders (FWO). M.O. is also supported by Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research, Decision No. 250114) and EU FP7 Project TORNADO (project 222720). F. H. has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 600375. The Center for Biological Sequence Analysis and the Novo Nordisk Foundation Center for Basic Metabolic Research have in addition received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115317 (DIRECT), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The Novo Nordisk Foundation Center for Protein Research received funding from the Novo Nordisk Foundation (grant agreement NNF14CC0001). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk).	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Aura Anna-Marja, 2008, Phytochemistry Reviews, V7, P407, DOI 10.1007/s11101-008-9095-3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castillo S, 2011, ANAL CHEM, V83, P3058, DOI 10.1021/ac103308x; CHARON NW, 1974, J BACTERIOL, V117, P203, DOI 10.1128/JB.117.1.203-211.1974; Collins JM, 2011, J LIPID RES, V52, P1683, DOI 10.1194/jlr.M012195; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Dillon SM, 2016, MUCOSAL IMMUNOL, V9, P24, DOI 10.1038/mi.2015.33; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kotronen A, 2009, DIABETOLOGIA, V52, P684, DOI 10.1007/s00125-009-1282-2; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee CC, 2016, DIABETES CARE, V39, P582, DOI 10.2337/dc15-2284; LEE S, 2016, NAT COMMUN, V7; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; MOSTELLER F, 1977, DATA ANAL REGRESSION, P203; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Nygren H, 2011, METHODS MOL BIOL, V708, P247, DOI 10.1007/978-1-61737-985-7_15; Oksanen J, 2022, R PACKAGE VERSION; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; R Development Core Team, 2012, R LANG ENV STAT COMP; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Roberts LD, 2014, LANCET DIABETES ENDO, V2, P65, DOI 10.1016/S2213-8587(13)70143-8; Roberts LD, 2009, PHYSIOL GENOMICS, V39, P109, DOI 10.1152/physiolgenomics.90365.2008; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Seongho K., 2012, PPCOR PARTIAL SEMIPA; Shin AC, 2014, CELL METAB, V20, P898, DOI 10.1016/j.cmet.2014.09.003; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Tso SC, 2013, P NATL ACAD SCI USA, V110, P9728, DOI 10.1073/pnas.1303220110; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Watson E, 2014, CELL, V156, P759, DOI 10.1016/j.cell.2014.01.047; Whittaker J., 1990, GRAPHICAL MODELS APP; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	75	1011	1077	21	612	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					376	+		10.1038/nature18646	http://dx.doi.org/10.1038/nature18646			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27409811				2022-12-24	WOS:000380344200031
J	Turner, J; Lu, H; White, I; King, JC; Phillips, T; Hosking, JS; Bracegirdle, TJ; Marshall, GJ; Mulvaney, R; Deb, P				Turner, John; Lu, Hua; White, Ian; King, John C.; Phillips, Tony; Hosking, J. Scott; Bracegirdle, Thomas J.; Marshall, Gareth J.; Mulvaney, Robert; Deb, Pranab			Absence of 21st century warming on Antarctic Peninsula consistent with natural variability	NATURE			English	Article							ANNULAR MODE; SPLIT JET; ICE-SHELF; SEA-ICE; CLIMATE; TRENDS; IMPACT; OCEAN	Since the 1950s, research stations on the Antarctic Peninsula have recorded some of the largest increases in near-surface air temperature in the Southern Hemisphere(1). This warming has contributed to the regional retreat of glaciers(2), disintegration of floating ice shelves(3) and a 'greening' through the expansion in range of various flora(4). Several interlinked processes have been suggested as contributing to the warming, including stratospheric ozone depletion(5), local sea-ice loss(6), an increase in westerly winds(5,7), and changes in the strength and location of low-high-latitude atmospheric teleconnections(8,9). Here we use a stacked temperature record to show an absence of regional warming since the late 1990s. The annual mean temperature has decreased at a statistically significant rate, with the most rapid cooling during the Austral summer. Temperatures have decreased as a consequence of a greater frequency of cold, east-to-southeasterly winds, resulting from more cyclonic conditions in the northern Weddell Sea associated with a strengthening mid-latitude jet. These circulation changes have also increased the advection of sea ice towards the east coast of the peninsula, amplifying their effects. Our findings cover only 1% of the Antarctic continent and emphasize that decadal temperature changes in this region are not primarily associated with the drivers of global temperature change but, rather, reflect the extreme natural internal variability of the regional atmospheric circulation.	[Turner, John; Lu, Hua; White, Ian; King, John C.; Phillips, Tony; Hosking, J. Scott; Bracegirdle, Thomas J.; Marshall, Gareth J.; Mulvaney, Robert; Deb, Pranab] British Antarctic Survey, NERC, Madingley Rd, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Turner, J (corresponding author), British Antarctic Survey, NERC, Madingley Rd, Cambridge CB3 0ET, England.	jtu@bas.ac.uk	Bracegirdle, Tom/AAD-6060-2020; Lu, Hua/GXA-0276-2022	Lu, Hua/0000-0001-9485-5082; Bracegirdle, Thomas/0000-0002-8868-4739; Turner, John/0000-0002-6111-5122	UK Natural Environment Research Council [NE/K00445X/1]; NERC [NE/K00445X/1] Funding Source: UKRI; Natural Environment Research Council [bas0100032, NE/K00445X/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was financially supported by the UK Natural Environment Research Council under grant NE/K00445X/1. It forms part of the Polar Science for Planet Earth programme of the British Antarctic Survey. We are grateful to D. G. Vaughan for valuable discussions during this study. We are grateful to ECMWF for the provision of reanalysis fields and to the US National Snow and Ice Data Center for the sea-ice data. The data used in this study are available from the authors upon request.	Bals-Elsholz TM, 2001, J CLIMATE, V14, P4191, DOI 10.1175/1520-0442(2001)014<4191:TWSHSJ>2.0.CO;2; Bracegirdle TJ, 2012, J CLIMATE, V25, P7138, DOI 10.1175/JCLI-D-11-00685.1; Bracegirdle TJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008933; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Bromwich DH, 2013, NAT GEOSCI, V6, P139, DOI [10.1038/NGEO1671, 10.1038/ngeo1671]; Burkey J, 2006, NONPARAMETRIC MONOTO; Carrasco J.F., 2013, ATMOSPHERE CLIMATE S, V03, P275, DOI [10.4236/acs.2013.33029, DOI 10.4236/ACS.2013.33029]; Chen B, 1996, MON WEATHER REV, V124, P1711, DOI 10.1175/1520-0493(1996)124<1711:EOTTSJ>2.0.CO;2; Clem KR, 2013, J GEOPHYS RES-ATMOS, V118, P11481, DOI 10.1002/jgrd.50860; Comiso JC, 2000, J CLIMATE, V13, P1674, DOI 10.1175/1520-0442(2000)013<1674:VATIAS>2.0.CO;2; Connolley WM, 1997, CLIM DYNAM, V13, P745, DOI 10.1007/s003820050195; Convey P, 2003, ANTARCT RES SER, V79, P145; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Ding QH, 2011, NAT GEOSCI, V4, P398, DOI [10.1038/ngeo1129, 10.1038/NGEO1129]; Ding QH, 2013, J CLIMATE, V26, P7570, DOI 10.1175/JCLI-D-12-00729.1; Fyfe JC, 2016, NAT CLIM CHANGE, V6, P224, DOI 10.1038/nclimate2938; Gerstengarbe FW, 1999, CLIMATE RES, V11, P97, DOI 10.3354/cr011097; Gillett NP, 2008, NAT GEOSCI, V1, P750, DOI 10.1038/ngeo338; Li XC, 2014, NATURE, V505, P538, DOI 10.1038/nature12945; Li Y, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015822; Lorenz DJ, 2003, J CLIMATE, V16, P1212, DOI 10.1175/1520-0442(2003)16<1212:EFFITN>2.0.CO;2; Ludescher J, 2016, CLIM DYNAM, V46, P263, DOI 10.1007/s00382-015-2582-5; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Marshall GJ, 2006, J CLIMATE, V19, P5388, DOI 10.1175/JCLI3844.1; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Mulvaney R, 2012, NATURE, V489, P141, DOI 10.1038/nature11391; PLUMB RA, 1985, J ATMOS SCI, V42, P217, DOI 10.1175/1520-0469(1985)042<0217:OTTDPO>2.0.CO;2; Santer BD, 2000, J GEOPHYS RES-ATMOS, V105, P7337, DOI 10.1029/1999JD901105; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Thomas ER, 2013, GEOPHYS RES LETT, V40, P5492, DOI 10.1002/2013GL057782; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Trenberth KE, 2015, SCIENCE, V349, P691, DOI 10.1126/science.aac9225; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P911, DOI [10.1038/NCLIMATE2341, 10.1038/nclimate2341]; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Turner J, 2004, INT J CLIMATOL, V24, P1, DOI 10.1002/joc.965; Turner J, 2004, J CLIMATE, V17, P2890, DOI 10.1175/1520-0442(2004)017<2890:TSRPTA>2.0.CO;2; Turner J, 2016, CLIM DYNAM, V46, P2391, DOI 10.1007/s00382-015-2708-9; Turner J, 2013, INT J CLIMATOL, V33, P852, DOI 10.1002/joc.3474; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; VAUGHAN DG, 1993, ANTARCT SCI, V5, P403, DOI 10.1017/S0954102093000537	40	412	419	9	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					411	+		10.1038/nature18645	http://dx.doi.org/10.1038/nature18645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27443743	Green Accepted			2022-12-24	WOS:000380344200038
J	Kimbell, B; Murray, SA; Macpherson, S; Boyd, K				Kimbell, B.; Murray, S. A.; Macpherson, S.; Boyd, K.			Embracing inherent uncertainty in advanced illness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PALLIATIVE CARE; OLDER-ADULTS; LIFE; EXPERIENCES; END; TRANSITIONS; COMMUNITY; SURVIVAL; PATIENT; FRAILTY		[Kimbell, B.; Murray, S. A.; Macpherson, S.; Boyd, K.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Primary Palliat Care Res Grp, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Boyd, K (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Primary Palliat Care Res Grp, Edinburgh EH8 9AG, Midlothian, Scotland.	kirsty.boyd@ed.ac.uk		Boyd, Kirsty/0000-0002-5526-1078				Abarshi E, 2010, PALLIATIVE MED, V24, P166, DOI 10.1177/0269216309351381; Boersma I, 2014, NEUROLOGY, V83, P561, DOI 10.1212/WNL.0000000000000674; Bristowe K, 2015, PALLIATIVE MED, V29, P797, DOI 10.1177/0269216315578990; Buetow S, 2001, FAM PRACT, V18, P117, DOI 10.1093/fampra/18.2.117; Calderwood C., 2016, REALISTIC MED CHIEF; Coleman R, 2014, GATHER ROUND UNDERST; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Creutzfeldt CJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3904; Fried TR, 2010, J AM GERIATR SOC, V58, P2329, DOI 10.1111/j.1532-5415.2010.03184.x; Gill TM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2361; Glare P, 2008, EUR J CANCER, V44, P1146, DOI 10.1016/j.ejca.2008.02.030; Gott M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1773; Jackson VA, 2013, J PALLIAT MED, V16, P894, DOI 10.1089/jpm.2012.0547; Kendall M, 2015, J PAIN SYMPTOM MANAG, V50, P216, DOI 10.1016/j.jpainsymman.2015.02.017; Kimbell B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009241; Lynn J, 2005, HASTINGS CENT REP, V35, pS14, DOI 10.1353/hcr.2005.0096; Mason B, 2016, BMJ SUPPORT PALLIAT, V6, P60, DOI 10.1136/bmjspcare-2013-000639; Mason B, 2013, BRIT J GEN PRACT, V63, pE580, DOI 10.3399/bjgp13X670714; Munday Daniel, 2009, BMJ, V339, pb2391, DOI 10.1136/bmj.b2391; Myers J, 2014, CAN MED ASSOC J, V186, P169, DOI 10.1503/cmaj.131415; NHS England, 2014, ACT END LIF CAR; Nicholson C, 2012, SOC SCI MED, V75, P1426, DOI 10.1016/j.socscimed.2012.06.011; Oishi A, 2014, PALLIATIVE MED, V28, P1081, DOI 10.1177/0269216314531999; Parry R, 2014, BMJ SUPPORT PALLIAT, V4, P331, DOI 10.1136/bmjspcare-2014-000649; Perkins HS, 2007, ANN INTERN MED, V147, P51, DOI 10.7326/0003-4819-147-1-200707030-00008; Piers RD, 2013, PATIENT EDUC COUNS, V90, P323, DOI 10.1016/j.pec.2011.07.008; Pollock K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4855; Seymour JE, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4860; Smith AK, 2013, NEW ENGL J MED, V368, P2448, DOI 10.1056/NEJMp1303295; Stevinson C, 2010, PALLIATIVE MED, V24, P462, DOI 10.1177/0269216310368452; van der Steen JT, 2010, J ALZHEIMERS DIS, V22, P37, DOI 10.3233/JAD-2010-100744; Wilson IC., 2016, END OF LIFE CARE PHY; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	33	19	18	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2016	354								i3802	10.1136/bmj.i3802	http://dx.doi.org/10.1136/bmj.i3802			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0VL	27430629				2022-12-24	WOS:000380314800001
J	Elegheert, J; Kakegawa, W; Clay, JE; Shanks, NF; Behiels, E; Matsuda, K; Kohda, K; Miura, E; Rossmann, M; Mitakidis, N; Motohashi, J; Chang, VT; Siebold, C; Greger, IH; Nakagawa, T; Yuzaki, M; Aricescu, AR				Elegheert, Jonathan; Kakegawa, Wataru; Clay, Jordan E.; Shanks, Natalie F.; Behiels, Ester; Matsuda, Keiko; Kohda, Kazuhisa; Miura, Eriko; Rossmann, Maxim; Mitakidis, Nikolaos; Motohashi, Junko; Chang, Veronica T.; Siebold, Christian; Greger, Ingo H.; Nakagawa, Terunaga; Yuzaki, Michisuke; Aricescu, A. Radu			Structural basis for integration of GluD receptors within synaptic organizer complexes	SCIENCE			English	Article							LONG-TERM DEPRESSION; INHIBITORY PRESYNAPTIC DIFFERENTIATION; CRYSTAL-STRUCTURE; MOTOR COORDINATION; TYROSINE KINASE; D-SERINE; CBLN1; PLASTICITY; DELTA-2; DOMAIN	Ionotropic glutamate receptor (iGluR) family members are integrated into supramolecular complexes that modulate their location and function at excitatory synapses. However, a lack of structural information beyond isolated receptors or fragments thereof currently limits the mechanistic understanding of physiological iGluR signaling. Here, we report structural and functional analyses of the prototypical molecular bridge linking postsynaptic iGluR delta 2 (GluD2) and presynaptic beta-neurexin 1 (beta-NRX1) via Cbln1, a C1q-like synaptic organizer. We show how Cbln1 hexamers "anchor" GluD2 amino-terminal domain dimers to monomeric beta-NRX1. This arrangement promotes synaptogenesis and is essential for D-serine-dependent GluD2 signaling in vivo, which underlies long-term depression of cerebellar parallel fiber-Purkinje cell (PF-PC) synapses and motor coordination in developing mice. These results lead to a model where protein and small-molecule ligands synergistically control synaptic iGluR function.	[Elegheert, Jonathan; Clay, Jordan E.; Behiels, Ester; Mitakidis, Nikolaos; Chang, Veronica T.; Siebold, Christian; Aricescu, A. Radu] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England; [Kakegawa, Wataru; Matsuda, Keiko; Kohda, Kazuhisa; Miura, Eriko; Motohashi, Junko; Yuzaki, Michisuke] Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan; [Shanks, Natalie F.; Nakagawa, Terunaga] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Rossmann, Maxim; Greger, Ingo H.] MRC Lab Mol Biol, Div Neurobiol, Francis Crick Ave, Cambridge CB2 0QH, England	University of Oxford; Wellcome Centre for Human Genetics; Keio University; Vanderbilt University; MRC Laboratory Molecular Biology	Aricescu, AR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.; Yuzaki, M (corresponding author), Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	myuzaki@a5.keio.jp; radu@strubi.ox.ac.uk	Yuzaki, Michisuke/K-5328-2013; Elegheert, Jonathan/AAF-5655-2019; Kakegawa, Wataru/G-5569-2016	Yuzaki, Michisuke/0000-0002-5750-3544; Greger, Ingo/0000-0002-7291-2581; Siebold, Christian/0000-0002-6635-3621; Elegheert, Jonathan/0000-0002-4196-4813; Rossmann, Maxim/0000-0001-8811-3277; Behiels, Ester/0000-0003-0075-7591; Aricescu, Alexandru ARadu/0000-0003-3783-1388	UK Medical Research Council (MRC) [G0700232, L009609, MC_U105174197]; Japan Society for the Promotion of Science [15H05772, 26117515, 26293042]; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Takeda Science Foundation; Yamada Science Foundation; Human Frontier Science Program [RGP0065/2014]; NIH [R01HD061543]; Wellcome Trust [090532/Z/09/Z]; European Molecular Biology Organization [ALTF 1116-2012]; Marie-Curie fellowship [FP7-328531]; Grants-in-Aid for Scientific Research [26430023] Funding Source: KAKEN; Cancer Research UK [14414] Funding Source: researchfish; Medical Research Council [MR/L017776/1, MC_U105174197, MR/L009609/1, G0700232] Funding Source: researchfish; MRC [MR/L009609/1, MR/L017776/1, G0700232, MC_U105174197] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061543] Funding Source: NIH RePORTER	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yamada Science Foundation; Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie-Curie fellowship(European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank staff at Diamond Light Source, T. Walter and K. Harlos for crystallization technical support, N. Scull for assistance with molecular biology, and E.Y. Jones and P. Miller for comments on the manuscript. This work was funded by the UK Medical Research Council (MRC) (G0700232 and L009609 to A.R.A. and MC_U105174197 to I.H.G.), the Japan Society for the Promotion of Science (15H05772 to M.Y. and 26117515, 26293042 to W.K.), the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (to M.Y.), the Takeda Science Foundation (W.K. and M.Y.), the Yamada Science Foundation (W.K.), the Human Frontier Science Program (RGP0065/2014 to M.Y. and A.R.A.), and the NIH (R01HD061543 to T. N.). The Wellcome Trust Centre for Human Genetics is supported by Wellcome Trust grant 090532/Z/09/Z. J.E. was supported by European Molecular Biology Organization (ALTF 1116-2012) and Marie-Curie (FP7-328531) fellowships, C.S. is a Cancer Research UK senior research fellow (C20724/A14414), and A.R.A. is an MRC senior research fellow (MR/L009609/1). Structure factors and coordinates of Cbln1<INF>C</INF>1<INF>q</INF>, Cbln1<SUP>Delta VRSG</SUP> crystal forms 1 and 2, GluD2<INF>ATD</INF>, GluD1<INF>ATD</INF>, and Cbln1<INF>C1q</INF>-GluD2<INF>ATD</INF> are deposited in the Protein Data Bank (PDB codes 5KC5, 5KC6, 5KC7, 5KC8, 5KC9 and 5KCA, respectively).	Aow J, 2015, P NATL ACAD SCI USA, V112, P14711, DOI 10.1073/pnas.1520029112; Auger C, 2010, J PHYSIOL-LONDON, V588, P3063, DOI 10.1113/jphysiol.2010.191080; Bao DS, 2005, J NEUROCHEM, V95, P618, DOI 10.1111/j.1471-4159.2005.03385.x; Clayton A, 2009, J MOL BIOL, V392, P1125, DOI 10.1016/j.jmb.2009.07.082; Dore K, 2015, P NATL ACAD SCI USA, V112, P14705, DOI 10.1073/pnas.1520023112; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Herguedas B, 2016, SCIENCE, V352, DOI 10.1126/science.aad3873; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Ito M, 2014, PROG BRAIN RES, V210, P1, DOI 10.1016/B978-0-444-63356-9.00001-7; Ito-Ishida A, 2012, NEURON, V76, P549, DOI 10.1016/j.neuron.2012.07.027; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008; Kakegawa W, 2007, J PHYSIOL-LONDON, V584, P89, DOI 10.1113/jphysiol.2007.141291; Kakegawa W, 2011, NAT NEUROSCI, V14, P603, DOI 10.1038/nn.2791; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001; Kohda K, 2013, P NATL ACAD SCI USA, V110, pE948, DOI 10.1073/pnas.1218380110; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Matsuda K, 2016, NEURON, V90, P752, DOI 10.1016/j.neuron.2016.04.001; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Naur P, 2007, P NATL ACAD SCI USA, V104, P14116, DOI 10.1073/pnas.0703718104; Rodrigues RJ, 2012, WIRES MEMBRANE TRANS, V1, P399, DOI [10.1002/wmts.35, DOI 10.1002/WMTS.35]; Ryu K, 2012, BIOCHEM BIOPH RES CO, V417, P157, DOI 10.1016/j.bbrc.2011.11.075; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Weilinger NL, 2016, NAT NEUROSCI, V19, P432, DOI 10.1038/nn.4236; Yasumura M, 2012, J NEUROCHEM, V121, P705, DOI 10.1111/j.1471-4159.2011.07631.x; Yelshanskaya MV, 2014, SCIENCE, V345, P1070, DOI 10.1126/science.1256508	36	86	87	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2016	353	6296					295	299		10.1126/science.aae0104	http://dx.doi.org/10.1126/science.aae0104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0EM	27418511	Green Accepted, Green Submitted			2022-12-24	WOS:000379580800051
J	Makin, S				Makin, Simon			IMAGING Show me where it hurts	NATURE			English	Editorial Material							BACK-PAIN											Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Hashmi JA, 2013, BRAIN, V136, P2751, DOI 10.1093/brain/awt211; Ren WJ, 2016, NAT NEUROSCI, V19, P220, DOI 10.1038/nn.4199; Salomons T, 2016, JAMA NEUROL; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Woo CW, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002036	7	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					S8	S9		10.1038/535S8a	http://dx.doi.org/10.1038/535S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR4ZN	27410532	Bronze			2022-12-24	WOS:000379912600007
J	Dev, J; Park, D; Fu, QS; Chen, J; Ha, HJ; Ghantous, F; Herrmann, T; Chang, WT; Liu, ZJ; Frey, G; Seaman, MS; Chen, B; Chou, JJ				Dev, Jyoti; Park, Donghyun; Fu, Qingshan; Chen, Jia; Ha, Heather Jiwon; Ghantous, Fadi; Herrmann, Tobias; Chang, Weiting; Liu, Zhijun; Frey, Gary; Seaman, Michael S.; Chen, Bing; Chou, James J.			Structural basis for membrane anchoring of HIV-1 envelope spike	SCIENCE			English	Article							SPANNING DOMAIN; GLYCOPROTEIN; FUSION; NEUTRALIZATION; RECOGNITION; EXPRESSION; MUTATIONS; MECHANISM; REGION; TRIMER	HIV-1 envelope spike (Env) is a type I membrane protein that mediates viral entry. We used nuclear magnetic resonance to determine an atomic structure of the transmembrane (TM) domain of HIV-1 Env reconstituted in bicelles that mimic a lipid bilayer. The TM forms a well-ordered trimer that protects a conserved membrane-embedded arginine. An aminoterminal coiled-coil and a carboxyl-terminal hydrophilic core stabilize the trimer. Individual mutations of conserved residues did not disrupt the TM trimer and minimally affected membrane fusion and infectivity. Major changes in the hydrophilic core, however, altered the antibody sensitivity of Env. These results show how a TM domain anchors, stabilizes, and modulates a viral envelope spike and suggest that its influence on Env conformation is an important consideration for HIV-1 immunogen design.	[Dev, Jyoti; Fu, Qingshan; Chou, James J.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 250 Longwood Ave, Boston, MA 02115 USA; [Dev, Jyoti; Chang, Weiting] Harvard Med Sch, Virol Program, 250 Longwood Ave, Boston, MA 02115 USA; [Park, Donghyun; Chen, Jia; Ha, Heather Jiwon; Chang, Weiting; Frey, Gary; Chen, Bing] Boston Childrens Hosp, Div Mol Med, 3 Blackfan St, Boston, MA 02115 USA; [Chen, Jia; Frey, Gary; Chen, Bing] Harvard Med Sch, Dept Pediat, 300 Longwood Ave, Boston, MA 02115 USA; [Ghantous, Fadi; Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, 330 Brookline Ave, Boston, MA 02215 USA; [Liu, Zhijun; Chou, James J.] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, B (corresponding author), Boston Childrens Hosp, Div Mol Med, 3 Blackfan St, Boston, MA 02115 USA.; Chen, B (corresponding author), Harvard Med Sch, Dept Pediat, 300 Longwood Ave, Boston, MA 02115 USA.	bchen@crystal.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013; Fu, Qingshan/E-1405-2015; Park, Donghyun/AAA-5338-2022	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344; Fu, Qingshan/0000-0002-7445-2355; Park, Donghyun/0000-0003-2048-6004	NIH [AI084794, GM083680, AI106488, HL103526, AI127193, P41 EB-002026]; Collaboration for AIDS Vaccine Discovery (CAVD) grant [OPP1040741]; Center for HIV/AIDS Vaccine Immunology-Immunogen Design [AI-100645]; Chinese Academy of Sciences [XDB08030301]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127193, R01AI084794, UM1AI100645, R01AI106488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083680] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaboration for AIDS Vaccine Discovery (CAVD) grant; Center for HIV/AIDS Vaccine Immunology-Immunogen Design; Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Harrison and S. Rits-Volloch for generous advice and assistance; D. Barouch, B. Haynes, and A. Carfi for critical reading of the manuscript; and the NIH AIDS Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, for reagents. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The atomic structure coordinate and structural constraints are deposited in the Protein Data Bank under the accession number 5JYN. The chemical-shift values are deposited in the Biological Magnetic Resonance Data Bank under the accession number 30090. This work was supported by NIH grants AI084794 (to B.C. and Dan H. Barouch), GM083680 (to B.C.), AI106488 (to B.C.), HL103526 (to J.J.C.), and AI127193 (to B.C. and J.J.C.), Collaboration for AIDS Vaccine Discovery (CAVD) grant OPP1040741 (to Dan H. Barouch from the Bill and Melinda Gates Foundation), and the Center for HIV/AIDS Vaccine Immunology-Immunogen Design AI-100645 (to Barton F. Haynes). The NMR data were collected at the NMR facility of National Center for Protein Science Shanghai (supported by Chinese Academy of Sciences grant XDB08030301) and Massachusetts Institute of Technology-Harvard Center for Magnetic Resonance (supported by NIH grant P41 EB-002026).	Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; HELSETH E, 1990, J VIROL, V64, P6314, DOI 10.1128/JVI.64.12.6314-6318.1990; Jeffs SA, 2004, VACCINE, V22, P1032, DOI 10.1016/j.vaccine.2003.08.042; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kovacs JM, 2014, P NATL ACAD SCI USA, V111, P18542, DOI 10.1073/pnas.1422269112; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; OWENS RJ, 1994, J VIROL, V68, P570, DOI 10.1128/JVI.68.1.570-574.1994; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROWELL JF, 1995, J IMMUNOL, V155, P473; SANDERS CR, 1992, BIOCHEMISTRY-US, V31, P8898, DOI 10.1021/bi00152a029; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Teese MG, 2015, BIOCHEMISTRY-US, V54, P5125, DOI 10.1021/acs.biochem.5b00495; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; West JT, 2001, J VIROL, V75, P9601, DOI 10.1128/JVI.75.20.9601-9612.2001; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Yue L, 2009, J VIROL, V83, P11588, DOI 10.1128/JVI.00914-09; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	32	139	143	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					172	175		10.1126/science.aaf7066	http://dx.doi.org/10.1126/science.aaf7066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27338706	Green Accepted			2022-12-24	WOS:000379208400040
J	Faber, F; Tran, L; Byndloss, MX; Lopez, CA; Velazquez, EM; Kerrinnes, T; Nuccio, SP; Wangdi, T; Fiehn, O; Tsolis, RM; Baumler, AJ				Faber, Franziska; Tran, Lisa; Byndloss, Mariana X.; Lopez, Christopher A.; Velazquez, Eric M.; Kerrinnes, Tobias; Nuccio, Sean-Paul; Wangdi, Tamding; Fiehn, Oliver; Tsolis, Renee M.; Baumler, Andreas J.			Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion	NATURE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; NITRIC-OXIDE; RESISTANCE; GROWTH; MICROBIOTA; INFECTION	Changes in the gut microbiota may underpin many human diseases, but the mechanisms that are responsible for altering microbial communities remain poorly understood. Antibiotic usage elevates the risk of contracting gastroenteritis caused by Salmonella enterica serovars(1), increases the duration for which patients shed the pathogen in their faeces, and may on occasion produce a bacteriologic and symptomatic relapse(2,3). These antibiotic-induced changes in the gut microbiota can be studied in mice, in which the disruption of a balanced microbial community by treatment with the antibiotic streptomycin leads to an expansion of S. enterica serovars in the large bowel(4). However, the mechanisms by which streptomycin treatment drives an expansion of S. enterica serovars are not fully resolved. Here we show that host-mediated oxidation of galactose and glucose promotes post-antibiotic expansion of S. enterica serovar Typhimurium (S. Typhimurium). By elevating expression of the gene encoding inducible nitric oxide synthase (iNOS) in the caecal mucosa, streptomycin treatment increased post-antibiotic availability of the oxidation products galactarate and glucarate in the murine caecum. S. Typhimurium used galactarate and glucarate within the gut lumen of streptomycin pre-treated mice, and genetic ablation of the respective catabolic pathways reduced S. Typhimurium competitiveness. Our results identify host-mediated oxidation of carbohydrates in the gut as a mechanism for post-antibiotic pathogen expansion.	[Faber, Franziska; Tran, Lisa; Byndloss, Mariana X.; Lopez, Christopher A.; Velazquez, Eric M.; Kerrinnes, Tobias; Nuccio, Sean-Paul; Wangdi, Tamding; Tsolis, Renee M.; Baumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, One Shields Ave, Davis, CA 95616 USA; [Fiehn, Oliver] Univ Calif Davis, Genome Ctr, One Shields Ave, Davis, CA 95616 USA; [Fiehn, Oliver] King Abdulaziz Univ, Dept Biochem, Jeddah 21412, Saudi Arabia	University of California System; University of California Davis; University of California System; University of California Davis; King Abdulaziz University	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, One Shields Ave, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Byndloss, Mariana X/D-9890-2014; Faber, Franziska/B-5601-2017; Velazquez, Eric/AAU-3279-2020; Baumler, Andreas J/H-2301-2011; Byndloss, Mariana Xavier/ABD-5506-2021	Byndloss, Mariana X/0000-0002-2122-4156; Faber, Franziska/0000-0002-8700-6522; Baumler, Andreas J/0000-0001-9152-7809; Byndloss, Mariana Xavier/0000-0002-2122-4156; Tsolis, Renee/0000-0001-9131-6657; Tran, Lisa/0000-0002-0446-2777; Nuccio, Sean-Paul/0000-0002-9683-9278	Public Health Service [OD010931, AI060555, AI096528, AI09799, AI112241, AI112258, AI112445, U24 DK097154 (01), AI112949, AI114922]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060555, R01AI112949, R21AI114922, R21AI112258, R01AI096528, R01AI109799, R56AI112949, F31AI112241, R01AI112445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056765] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010956, T32OD010931] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Public Health Service grants OD010931 (E.M.V.), AI060555 (S.-P.N.), AI096528 (A.J.B.), AI09799 (R.M.T), AI112241 (C.A.L.), AI112258 (R.M.T), AI112445 (A.J.B.), U24 DK097154 (01), AI112949 (A.J.B.) and AI114922 (A.J.B.).	ASERKOFF B, 1969, NEW ENGL J MED, V281, P636, DOI 10.1056/NEJM196909182811202; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; de Souza MVN, 2004, QUIM NOVA, V27, P287, DOI 10.1590/S0100-40422004000200019; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Hwang I, 2015, FASEB J, V29, P2397, DOI 10.1096/fj.14-265983; Kelterborn E., 1989, KAUFFMANN WHITE SCHE, P1; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Lamichhane-Khadka R, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130146; Lamichhane-Khadka R, 2011, J BACTERIOL, V193, P5824, DOI 10.1128/JB.05456-11; LAWES M, 1995, J BACTERIOL, V177, P1383, DOI 10.1128/jb.177.5.1383-1387.1995; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; NELSON JD, 1980, PEDIATRICS, V65, P1125; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Nuccio SP, 2014, MBIO, V5, DOI 10.1128/mBio.00929-14; OZAWA A, 1964, J INFECT DIS, V114, P235, DOI 10.1093/infdis/114.3.235; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PAVIA AT, 1990, J INFECT DIS, V161, P255, DOI 10.1093/infdis/161.2.255; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rivera-Chavez F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003267; Sheldon RA, 2004, ADV SYNTH CATAL, V346, P1051, DOI 10.1002/adsc.200404110; Spees AM, 2013, MBIO, V4, DOI 10.1128/mBio.00430-13; STEFANOVICRACIC M, 1995, J RHEUMATOL, V22, P1922; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Tsolis RM, 1999, INFECT IMMUN, V67, P4879, DOI 10.1128/IAI.67.9.4879-4885.1999; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Winter SE, 2009, INFECT IMMUN, V77, P1904, DOI 10.1128/IAI.01341-08	30	105	109	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					697	+		10.1038/nature18597	http://dx.doi.org/10.1038/nature18597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27309805	Green Accepted			2022-12-24	WOS:000378676000039
J	Munch, C; Harper, JW				Munch, Christian; Harper, J. Wade			Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation	NATURE			English	Article							CANCER-CELL LINE; STRESS-RESPONSE; ACTIVATION; EXPRESSION; PATHWAYS; ELEGANS; ELEMENT; HSP90; UPR	The mitochondrial matrix is unique in that it must integrate the folding and assembly of proteins derived from the nuclear and mitochondrial genomes. In Caenorhabditis elegans, the mitochondrial unfolded protein response (UPRmt) senses matrix protein misfolding and induces a program of nuclear gene expression, including mitochondrial chaperonins, to promote mitochondrial proteostasis(1-3). While misfolded mitochondrial-matrix-localized ornithine transcarbamylase induces chaperonin expression(4-6), our understanding of mammalian UPRmt is rudimentary(7), reflecting a lack of acute triggers for UPRmt activation. This limitation has prevented analysis of the cellular responses to matrix protein misfolding and the effects of UPRmt on mitochondrial translation to control protein folding loads. Here we combine pharmacological inhibitors of matrix-localized HSP90/TRAP1 (ref. 8) or LON protease(9), which promote chaperonin expression, with global transcriptional and proteomic analysis to reveal an extensive and acute response of human cells to UPRmt. This response encompasses widespread induction of nuclear genes, including matrix-localized proteins involved in folding, pre-RNA processing and translation. Functional studies revealed rapid but reversible translation inhibition in mitochondria occurring concurrently with defects in pre-RNA processing caused by transcriptional repression and LON-dependent turnover of the mitochondrial pre-RNA processing nuclease MRPP3 (ref. 10). This study reveals that acute mitochondrial protein folding stress activates both increased chaperone availability within the matrix and reduced matrix-localized protein synthesis through translational inhibition, and provides a framework for further dissection of mammalian UPRmt.	[Munch, Christian; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Munch, Christian/AAW-7256-2020	Munch, Christian/0000-0003-3832-090X; Harper, Jeffrey/0000-0002-6944-7236	National Institutes of Health [R37NS083524]; Biogen, Inc.; EMBO Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS083524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biogen, Inc.(Biogen); EMBO Fellowship(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. C. Altieri for GTPP, J. Paulo and S. P. Gygi for assistance with mass spectrometry, and L. Pontano and S. H. Sui for assistance with RNA-seq. This work was supported by National Institutes of Health grant R37NS083524 and Biogen, Inc. (J.W.H.), and an EMBO Fellowship (C.M.).	Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Bernstein SH, 2012, BLOOD, V119, P3321, DOI 10.1182/blood-2011-02-340075; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Horibe T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000835; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Lamech LT, 2015, J CELL BIOL, V209, P781, DOI 10.1083/jcb.201503107; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Reinhard L, 2015, NUCLEIC ACIDS RES, V43, P5664, DOI 10.1093/nar/gkv481; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zajac M, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-44; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	28	155	162	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					710	+		10.1038/nature18302	http://dx.doi.org/10.1038/nature18302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27350246	Green Accepted			2022-12-24	WOS:000378676000042
J	Appleby, J				Appleby, John			DATA BRIEFING I'm a healthy patient; get me out of here	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Appleby J, 2016, 19 KINGS FUND; Monitor, 2015, MONITOR Q REPORT PER; NHS England, 2016, BED AV OCC DAT OV; NHS England, 2016, DEL TRANSF CAR; NHS England, 2016, A E ATT EM ADM 2016; NHS Providers, 2015, RIGHT PLAC RIGHT TIM; Triggle N., 2016, BBC NEWS	7	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2016	353								i3585	10.1136/bmj.i3585	http://dx.doi.org/10.1136/bmj.i3585			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FV	27356943				2022-12-24	WOS:000379018700003
J	Backus, KM; Correia, BE; Lum, KM; Forli, S; Horning, BD; Gonzalez-Paez, GE; Chatterjee, S; Lanning, BR; Teijaro, JR; Olson, AJ; Wolan, DW; Cravatt, BF				Backus, Keriann M.; Correia, Bruno E.; Lum, Kenneth M.; Forli, Stefano; Horning, Benjamin D.; Gonzalez-Paez, Gonzalo E.; Chatterjee, Sandip; Lanning, Bryan R.; Teijaro, John R.; Olson, Arthur J.; Wolan, Dennis W.; Cravatt, Benjamin F.			Proteome-wide covalent ligand discovery in native biological systems	NATURE			English	Article							INHIBITORS; SITE; SELECTIVITY; DESIGN; DEATH	Small molecules are powerful tools for investigating protein function and can serve as leads for new therapeutics. Most human proteins, however, lack small-molecule ligands, and entire protein classes are considered 'undruggable'(1,2). Fragment-based ligand discovery can identify small-molecule probes for proteins that have proven difficult to target using high-throughput screening of complex compound libraries(1,3). Although reversibly binding ligands are commonly pursued, covalent fragments provide an alternative route to small-molecule probes(4-10), including those that can access regions of proteins that are difficult to target through binding affinity alone(5,10,11). Here we report a quantitative analysis of cysteine-reactive small-molecule fragments screened against thousands of proteins in human proteomes and cells. Covalent ligands were identified for >700 cysteines found in both druggable proteins and proteins deficient in chemical probes, including transcription factors, adaptor/scaffolding proteins, and uncharacterized proteins. Among the atypical ligand-protein interactions discovered were compounds that react preferentially with pro-(inactive) caspases. We used these ligands to distinguish extrinsic apoptosis pathways in human cell lines versus primary human T cells, showing that the former is largely mediated by caspase-8 while the latter depends on both caspase-8 and -10. Fragment-based covalent ligand discovery provides a greatly expanded portrait of the ligandable proteome and furnishes compounds that can illuminate protein functions in native biological systems.	[Backus, Keriann M.; Correia, Bruno E.; Lum, Kenneth M.; Horning, Benjamin D.; Lanning, Bryan R.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92307 USA; [Forli, Stefano; Olson, Arthur J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92307 USA; [Gonzalez-Paez, Gonzalo E.; Chatterjee, Sandip; Wolan, Dennis W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92307 USA; [Teijaro, John R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92307 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Backus, KM; Cravatt, BF (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92307 USA.	kbackus@scripps.edu; cravatt@scripps.edu	Forli, Stefano/AFR-7638-2022	Forli, Stefano/0000-0002-5964-7111; Wolan, Dennis/0000-0001-9879-8353; Gonzalez-Paez, Gonzalo/0000-0003-4708-5753	National Institutes of Health [CA087660, GM090294, GM108208, GM069832]; NATIONAL CANCER INSTITUTE [R01CA087660, R37CA087660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM108208, R01GM069832, R01GM090294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (CA087660 (B.F.C.), GM090294 (B.F.C.), GM108208 (K.M.B.), GM069832 (S.F., A.J.O.)). We thank J. Cisar, K. Mowen, C. Wang, M. Suciu, M. Dix, G. Simon, M. Carrillo, and J. Hulce for experimental assistance, M. Lenardo, L. Zheng and R. Siegel for helpful suggestions, the Marletta and Vogt laboratories at The Scripps Research Institute for sharing instrumentation, and Iterative Threading ASSEmbly Refinement (I-TASSER) for the structural modelling of IMPDH2.	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cardoso R, 2012, PROTEIN SCI, V21, P1885, DOI 10.1002/pro.2172; DeLaBarre B, 2014, CHEM BIOL, V21, P1143, DOI 10.1016/j.chembiol.2014.08.007; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edfeldt FNB, 2011, DRUG DISCOV TODAY, V16, P284, DOI 10.1016/j.drudis.2011.02.002; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Held JM, 2010, MOL CELL PROTEOMICS, V9, P1400, DOI 10.1074/mcp.M900643-MCP200; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Inloes JM, 2014, P NATL ACAD SCI USA, V111, P14924, DOI 10.1073/pnas.1413706111; Jost C, 2014, J MED CHEM, V57, P7590, DOI 10.1021/jm5006918; Kathman SG, 2014, J MED CHEM, V57, P4969, DOI 10.1021/jm500345q; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lafont E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013638; Lannine BR, 2014, NAT CHEM BIOL, V10, P760, DOI [10.1038/NCHEMBIO.1582, 10.1038/nchembio.1582]; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Lim SM, 2014, ANGEW CHEM INT EDIT, V53, P199, DOI 10.1002/anie.201307387; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; London N, 2014, NAT CHEM BIOL, V10, P1066, DOI 10.1038/nchembio.1666; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Miller RM, 2013, J AM CHEM SOC, V135, P5298, DOI 10.1021/ja401221b; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nonoo RH, 2012, CHEMMEDCHEM, V7, P2082, DOI 10.1002/cmdc.201200404; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; Vickers CJ, 2013, J AM CHEM SOC, V135, P12869, DOI 10.1021/ja406399r; Wachmann K, 2010, BIOCHEMISTRY-US, V49, P8307, DOI 10.1021/bi100968m; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Wissner A, 2003, J MED CHEM, V46, P49, DOI 10.1021/jm020241c; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	43	381	390	19	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					570	+		10.1038/nature18002	http://dx.doi.org/10.1038/nature18002			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309814	Green Accepted			2022-12-24	WOS:000378270300058
J	Tang, L; El-Din, TMG; Swanson, TM; Pryde, DC; Scheuer, T; Zheng, N; Catterall, WA				Tang, Lin; El-Din, Tamer M. Gamal; Swanson, Teresa M.; Pryde, David C.; Scheuer, Todd; Zheng, Ning; Catterall, William A.			Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs	NATURE			English	Article							CALCIUM-CHANNELS; SODIUM-CHANNEL; CRYSTAL-STRUCTURE; SKELETAL-MUSCLE; DIHYDROPYRIDINE BINDING; MOLECULAR DETERMINANTS; RECEPTOR; SUBUNIT; PHARMACOLOGY; MECHANISM	Ca2+ antagonist drugs are widely used in therapy of cardiovascular disorders(1,2). Three chemical classes of drugs bind to three separate, but allosterically interacting, receptor sites on Ca(v)1.2 channels, the most prominent voltage-gated Ca2+ (Ca-v) channel type in myocytes in cardiac and vascular smooth muscle'. The 1,4-dihydropyridines are used primarily for treatment of hypertension and angina pectoris and are thought to act as allosteric modulators of voltage-dependent Ca2+ channel activation, whereas phenylalkylamines and benzothiazepines are used primarily for treatment of cardiac arrhythmias and are thought to physically block the pore(1,2). The structural basis for the different binding, action, and therapeutic uses of these drugs remains unknown. Here we present crystallographic and functional analyses of drug binding to the bacterial homotetrameric model Cav channel Ca(v)Ab, which is inhibited by dihydropyridines and phenylalkylamines with nanomolar affinity in a state-dependent manner. The binding site for amlodipine and other dihydropyridines is located on the external, lipid-facing surface of the pore module, positioned at the interface of two subunits. Dihydropyridine binding allosterically induces an asymmetric conformation of the selectivity filter, in which partially dehydrated Ca2+ interacts directly with one subunit and blocks the pore. In contrast, the phenylalkylamine Br-verapamil binds in the central cavity of the pore on the intracellular side of the selectivity filter, physically blocking the ion-conducting pathway. Structure-based mutations of key amino-acid residues confirm drug binding at both sites. Our results define the structural basis for binding of dihydropyridines and phenylalkylamines at their distinct receptor sites on Cav channels and offer key insights into their fundamental mechanisms of action and differential therapeutic uses in cardiovascular diseases.	[Tang, Lin; El-Din, Tamer M. Gamal; Swanson, Teresa M.; Scheuer, Todd; Zheng, Ning; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Tang, Lin; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Pryde, David C.] Curadev Pharma, Discovery Pk, Sandwich CT14 9FF, Kent, England	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Tang, L (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.; Tang, L (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.			Catterall, William/0000-0001-5509-3580	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health [R01 HL112808]; National Research Service Award [T32 GM008268]; Howard Hughes Medical Institute; National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health [R01 NS26254]; Neusentis; Pfizer Inc., Cambridge, UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112808, R01HL117896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health; Neusentis; Pfizer Inc., Cambridge, UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the beamline staff at the Advanced Light Source (BL8.2.1 and BL8.2.2) for their assistance during data collection. Research reported in this publication was supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health under award number R01 HL112808 (W.A.C. and N.Z.), and a National Research Service Award from training grant T32 GM008268 (T.M.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by research grants from the Howard Hughes Medical Institute (N.Z.) and by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health under award number R01 NS26254 (W.A.C.). D.C.P. acknowledges support from Neusentis, Pfizer Inc., Cambridge, UK during the course of this work.	BANGALORE R, 1994, MOL PHARMACOL, V46, P660; Catterall W. A., 2011, VOLTAGE GATED CALCIU; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; Catterall WA, 2015, TRENDS BIOCHEM SCI, V40, P526, DOI 10.1016/j.tibs.2015.07.002; Cheng RCK, 2009, J BIOL CHEM, V284, P28332, DOI 10.1074/jbc.M109.027326; GLOSSMANN H, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1917; HermundstadAM BassettDS, 2013, P NATL ACAD SCI US, V110, P6169, DOI 10.1073/pnas.1219562110; HESCHELER J, 1982, PFLUG ARCH EUR J PHY, V393, P287, DOI 10.1007/BF00581411; HOCKERMAN GH, 1995, J BIOL CHEM, V270, P22119, DOI 10.1074/jbc.270.38.22119; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; HONDEGHEM LM, 1984, ANNU REV PHARMACOL, V24, P387, DOI 10.1146/annurev.pa.24.040184.002131; KASS RS, 1991, J GEN PHYSIOL, V98, P63, DOI 10.1085/jgp.98.1.63; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MURPHY KMM, 1983, P NATL ACAD SCI-BIOL, V80, P860, DOI 10.1073/pnas.80.3.860; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; PETERSON BZ, 1995, J BIOL CHEM, V270, P18201, DOI 10.1074/jbc.270.31.18201; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tikhonov DB, 2009, J BIOL CHEM, V284, P19006, DOI 10.1074/jbc.M109.011296; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yamaguchi S, 2003, MOL PHARMACOL, V64, P235, DOI 10.1124/mol.64.2.235; YATANI A, 1985, CIRC RES, V56, P868, DOI 10.1161/01.RES.56.6.868; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	30	121	121	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					117	121		10.1038/nature19102	http://dx.doi.org/10.1038/nature19102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556947	Green Accepted			2022-12-24	WOS:000382426900050
J	Sousa, CM; Biancur, DE; Wang, XX; Halbrook, CJ; Sherman, MH; Zhang, L; Kremer, D; Hwang, RF; Witkiewicz, AK; Ying, HQ; Asara, JM; Evans, RM; Cantley, LC; Lyssiotis, CA; Kimmelman, AC				Sousa, Cristovao M.; Biancur, Douglas E.; Wang, Xiaoxu; Halbrook, Christopher J.; Sherman, Mara H.; Zhang, Li; Kremer, Daniel; Hwang, Rosa F.; Witkiewicz, Agnes K.; Ying, Haoqiang; Asara, John M.; Evans, Ronald M.; Cantley, Lewis C.; Lyssiotis, Costas A.; Kimmelman, Alec C.			Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion	NATURE			English	Article							CANCER; FIBROBLASTS; GROWTH; PROGRESSION; PROTEIN	Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease characterized by an intense fibrotic stromal response and deregulated metabolism(1-4). The role of the stroma in PDAC biology is complex and it has been shown to play critical roles that differ depending on the biological context(5-10). The stromal reaction also impairs the vasculature, leading to a highly hypoxic, nutrient-poor environment(4,11,12). As such, these tumours must alter how they capture and use nutrients to support their metabolic needs(11,13). Here we show that stroma-associated pancreatic stellate cells (PSCs) are critical for PDAC metabolism through the secretion of non-essential amino acids (NEAA). Specifically, we uncover a previously undescribed role for alanine, which outcompetes glucose and glutamine-derived carbon in PDAC to fuel the tricarboxylic acid (TCA) cycle, and thus NEAA and lipid biosynthesis. This shift in fuel source decreases the tumour's dependence on glucose and serum-derived nutrients, which are limited in the pancreatic tumour microenvironment(4,11). Moreover, we demonstrate that alanine secretion by PSCs is dependent on PSC autophagy, a process that is stimulated by cancer cells. Thus, our results demonstrate a novel metabolic interaction between PSCs and cancer cells, in which PSC-derived alanine acts as an alternative carbon source. This finding highlights a previously unappreciated metabolic network within pancreatic tumours in which diverse fuel sources are used to promote growth in an austere tumour microenvironment.	[Sousa, Cristovao M.; Biancur, Douglas E.; Wang, Xiaoxu; Kimmelman, Alec C.] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Boston, MA 02215 USA; [Halbrook, Christopher J.; Zhang, Li; Kremer, Daniel; Lyssiotis, Costas A.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Sherman, Mara H.; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Hwang, Rosa F.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77230 USA; [Witkiewicz, Agnes K.] UT Southwestern, Dept Pathol, Dallas, TX 75390 USA; [Witkiewicz, Agnes K.] UT Southwestern, Simmons Canc Ctr, Dallas, TX 75390 USA; [Ying, Haoqiang] UT MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Med Sch, Boston, MA 02115 USA; [Cantley, Lewis C.] Weill Cornell Med Coll, Dept Med, Meyer Canc Ctr, New York, NY 10065 USA; [Lyssiotis, Costas A.] Univ Michigan, Sch Med, Div Gastroenterol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kimmelman, Alec C.] NYU, Langone Med Ctr, Perlmutter Canc Ctr, Dept Radiat Oncol, New York, NY 10016 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; Salk Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cornell University; University of Michigan System; University of Michigan; New York University; NYU Langone Medical Center	Kimmelman, AC (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Boston, MA 02215 USA.; Lyssiotis, CA (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.; Lyssiotis, CA (corresponding author), Univ Michigan, Sch Med, Div Gastroenterol, Dept Internal Med, Ann Arbor, MI 48109 USA.; Kimmelman, AC (corresponding author), NYU, Langone Med Ctr, Perlmutter Canc Ctr, Dept Radiat Oncol, New York, NY 10016 USA.	clyssiot@med.umich.edu; alec.kimmelman@nyumc.org	Ying, Haoqiang/AAK-4325-2020; Lyssiotis, Costas A/AAI-1923-2019; Evans, Ronald/AAF-4001-2019	Lyssiotis, Costas A/0000-0001-9309-6141; Evans, Ronald/0000-0002-9986-5965	NIH [5P30CA06516, GM095567, DK097153]; NCI [R01CA157490, R01CA188048]; ACS [RSG-13-298-01-TBG]; Lustgarten Foundation; PanCAN-AACRPathway to Leadership award; Dale F. Frey award from Damon Runyon Cancer Research Foundation [DFS-09-14]; PanCAN-AACR; Stand Up to Cancer Dream Team Translational Cancer Research Grant, a Program of the Entertainment Industry Foundation [SU2C-AACR-DT0509];  [P01CA117969];  [P30CA006516];  [P01CA120964]; NATIONAL CANCER INSTITUTE [T32CA009370, P30CA006516, P30CA046592, R01CA188048, P01CA117969, R01CA157490, P01CA120964, R00CA188259, P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, U24DK097153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095567] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010612] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS(American Cancer Society); Lustgarten Foundation; PanCAN-AACRPathway to Leadership award; Dale F. Frey award from Damon Runyon Cancer Research Foundation; PanCAN-AACR; Stand Up to Cancer Dream Team Translational Cancer Research Grant, a Program of the Entertainment Industry Foundation; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Kimmelman laboratory members for reading the manuscript, A. Yang for help with orthotopic injections, M. Yuan and S. Breitkopf for technical support with mass spectrometry, E. Sicinska for resected PDAC specimens, and the Dana-Farber/Harvard Cancer Center Rodent Histopathology Core for assistance with tissue processing. DFHCC is supported in part by NIH 5P30CA06516. A.C.K. is supported by NIH grant GM095567, NCI grants R01CA157490, R01CA188048, ACS Research Scholar Grant (RSG-13-298-01-TBG), and the Lustgarten Foundation. C.A.L. is supported by a PanCAN-AACRPathway to Leadership award and a Dale F. Frey award from the Damon Runyon Cancer Research Foundation (DFS-09-14). Metabolomics studies performed at the University of Michigan were supported by NIH grant DK097153. L.C.C. was supported by P01CA117969, PanCAN-AACR and the Lustgarten Foundation. J.M.A. was supported by P30CA006516 and P01CA120964. R.M.E. is an investigator of the Howard Hughes Medical Institute and March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute, and is supported in part by grants from The Lustgarten Foundation and a Stand Up to Cancer Dream Team Translational Cancer Research Grant, a Program of the Entertainment Industry Foundation (SU2C-AACR-DT0509).	Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Gore J, 2014, CANCER CELL, V25, P711, DOI 10.1016/j.ccr.2014.05.026; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Sastra Stephen A, 2013, Methods Mol Biol, V980, P249, DOI 10.1007/978-1-62703-287-2_13; Serrao EM, 2016, GUT, V65, P465, DOI 10.1136/gutjnl-2015-310114; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sousa CM, 2014, CARCINOGENESIS, V35, P1441, DOI 10.1093/carcin/bgu097; Tape CJ, 2016, CELL, V165, P910, DOI 10.1016/j.cell.2016.03.029; Trinquier G, 1998, PROTEIN ENG, V11, P153, DOI 10.1093/protein/11.3.153; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Wilson J. S., J GASTROENTEROL H S2, V27, P69; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhao HY, 2016, ELIFE, V5, DOI 10.7554/eLife.10250	29	604	617	11	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					479	+		10.1038/nature19084	http://dx.doi.org/10.1038/nature19084			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27509858	Green Accepted			2022-12-24	WOS:000382646600046
J	Ostrov, N; Landon, M; Guell, M; Kuznetsov, G; Teramoto, J; Cervantes, N; Zhou, M; Singh, K; Napolitano, MG; Moosburner, M; Shrock, E; Pruitt, BW; Conway, N; Goodman, DB; Gardner, CL; Tyree, G; Gonzales, A; Wanner, BL; Norville, JE; Lajoie, MJ; Church, GM				Ostrov, Nili; Landon, Matthieu; Guell, Marc; Kuznetsov, Gleb; Teramoto, Jun; Cervantes, Natalie; Zhou, Minerva; Singh, Kerry; Napolitano, Michael G.; Moosburner, Mark; Shrock, Ellen; Pruitt, Benjamin W.; Conway, Nicholas; Goodman, Daniel B.; Gardner, Cameron L.; Tyree, Gary; Gonzales, Alexandra; Wanner, Barry L.; Norville, Julie E.; Lajoie, Marc J.; Church, George M.			Design, synthesis, and testing toward a 57-codon genome	SCIENCE			English	Article							GENETIC-CODE; ESCHERICHIA-COLI; CHEMICAL-SYNTHESIS; EXPRESSION; BIAS; ORGANISMS; CHROMOSOME; EVOLUTION; USAGE	Recoding-the repurposing of genetic codons-is a powerful strategy for enhancing genomes with functions not commonly found in nature. Here, we report computational design, synthesis, and progress toward assembly of a 3.97-megabase, 57-codon Escherichia coli genome in which all 62,214 instances of seven codons were replaced with synonymous alternatives across all protein-coding genes. We have validated 63% of recoded genes by individually testing 55 segments of 50 kilobases each. We observed that 91% of tested essential genes retained functionality with limited fitness effect. We demonstrate identification and correction of lethal design exceptions, only 13 of which were found in 2229 genes. This work underscores the feasibility of rewriting genomes and establishes a framework for large-scale design, assembly, troubleshooting, and phenotypic analysis of synthetic organisms.	[Ostrov, Nili; Landon, Matthieu; Guell, Marc; Kuznetsov, Gleb; Teramoto, Jun; Cervantes, Natalie; Napolitano, Michael G.; Moosburner, Mark; Shrock, Ellen; Goodman, Daniel B.; Gardner, Cameron L.; Tyree, Gary; Gonzales, Alexandra; Wanner, Barry L.; Norville, Julie E.; Lajoie, Marc J.; Church, George M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Landon, Matthieu] Harvard Univ, Program Syst Biol, Cambridge, MA 02138 USA; [Landon, Matthieu] Mines Paristech, Ecole Mines Paris, F-75272 Paris, France; [Guell, Marc; Pruitt, Benjamin W.; Conway, Nicholas; Goodman, Daniel B.; Church, George M.] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Kuznetsov, Gleb] Harvard Univ, Program Biophys, Boston, MA 02115 USA; [Teramoto, Jun] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Zhou, Minerva; Singh, Kerry] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Napolitano, Michael G.] Harvard Univ, Program Biol & Biomed Sci, Cambridge, MA 02138 USA; [Wanner, Barry L.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Harvard University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard Medical School	Lajoie, MJ; Church, GM (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Church, GM (corresponding author), Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	mlajoie@uw.edu; gchurch@genetics.med.harvard.edu	Güell, Marc/AAB-3054-2021; Güell, Marc/J-2970-2017	Güell, Marc/0000-0003-4000-7912; Güell, Marc/0000-0003-4000-7912; Moosburner, Mark/0000-0002-8672-8742; Gardner, Cameron/0000-0002-7884-4794; Shrock, Ellen/0000-0003-2484-4374; Norville, Julie/0000-0001-9205-8936; Goodman, Daniel/0000-0003-3759-6883; church, george/0000-0001-6232-9969	U.S Department of Energy [DE-FG02-02ER63445]; Defense Advanced Research Projects Agency [BAA-12-64]; NSF [106394]; DOD NDSEG Fellowship; NSF Graduate Research Fellowship; Origins of Life Initiative at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	U.S Department of Energy(United States Department of Energy (DOE)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); DOD NDSEG Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Origins of Life Initiative at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by U.S Department of Energy grant DE-FG02-02ER63445 and Defense Advanced Research Projects Agency grant BAA-12-64. B.L.W. was supported by NSF grant 106394; G.K. was supported by DOD NDSEG Fellowship; D.B.G. was supported by NSF Graduate Research Fellowship; E.S. was supported by the Origins of Life Initiative at Harvard University. We thank Gen9 (D. Leake, I. Saaem, and E. Nickerson), SGI-DNA ( D. Gibson), and Twist (E. Leproust) for DNA synthesis and J. Aach for insightful comments. G.K., M.J.L., M.L., M.G.N., D.B.G., and G.M.C. are inventors on patent application #62350468 submitted by the President and Fellows of Harvard College. The authors declare competing financial interests: Details are available in the supplementary documents of the paper. All FASTQ sequence files have been submitted to the Sequence Read Archive (SRA) at National Center for Biotechnology Information submission number SUB1484507. Plasmids will be available under a materials transfer agreement with Addgene.	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boel G, 2016, NATURE, V529, P358, DOI 10.1038/nature16509; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; CRICK FHC, 1963, SCIENCE, V139, P461, DOI 10.1126/science.139.3554.461; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; KANO A, 1991, J MOL BIOL, V221, P387, DOI 10.1016/0022-2836(91)80061-X; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Ling JQ, 2015, NAT REV MICROBIOL, V13, P707, DOI 10.1038/nrmicro3568; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MACINO G, 1979, P NATL ACAD SCI USA, V76, P3784, DOI 10.1073/pnas.76.8.3784; Mandell DJ, 2015, NATURE, V518, P55, DOI 10.1038/nature14121; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Marliere Philippe, 2009, Syst Synth Biol, V3, P77, DOI 10.1007/s11693-009-9040-9; OBA T, 1991, P NATL ACAD SCI USA, V88, P921, DOI 10.1073/pnas.88.3.921; OSAWA S, 1989, J MOL EVOL, V28, P271, DOI 10.1007/BF02103422; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Yamazaki Yukiko, 2008, V416, P385, DOI 10.1007/978-1-59745-321-9_26; Yona AH, 2013, ELIFE, V2, DOI 10.7554/eLife.01339; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	37	170	195	6	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					819	822		10.1126/science.aaf3639	http://dx.doi.org/10.1126/science.aaf3639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540174				2022-12-24	WOS:000381561400045
J	Jacques, DA; McEwan, WA; Hilditch, L; Price, AJ; Towers, GJ; James, LC				Jacques, David A.; McEwan, William A.; Hilditch, Laura; Price, Amanda J.; Towers, Greg J.; James, Leo C.			HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis	NATURE			English	Article							AMINO-TERMINAL DOMAIN; CRYSTAL-STRUCTURES; PROTEIN; RECOGNITION	During the early stages of infection, the HIV-1 capsid protects viral components from cytosolic sensors and nucleases such as cGAS and TREX, respectively, while allowing access to nucleotides for efficient reverse transcription1. Here we show that each capsid hexamer has a size-selective pore bound by a ring of six arginine residues and a 'molecular iris' formed by the amino-terminal beta-hairpin. The arginine ring creates a strongly positively charged channel that recruits the four nucleotides with on-rates that approach diffusion limits. Progressive removal of pore arginines results in a dose-dependent and concomitant decrease in nucleotide affinity, reverse transcription and infectivity. This positively charged channel is universally conserved in lentiviral capsids despite the fact that it is strongly destabilizing without nucleotides to counteract charge repulsion. We also describe a channel inhibitor, hexacarboxybenzene, which competes for nucleotide binding and efficiently blocks encapsidated reverse transcription, demonstrating the tractability of the pore as a novel drug target.	[Jacques, David A.; McEwan, William A.; Price, Amanda J.; James, Leo C.] MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England; [Hilditch, Laura; Towers, Greg J.] UCL, Infect & Immun, Cruciform Bldg 3-3,90 Gower St, London WC1E 6BT, England; [Price, Amanda J.] Astex Pharmaceut, 436 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0QA, England	MRC Laboratory Molecular Biology; University of London; University College London; Astex Pharmaceuticals	James, LC (corresponding author), MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.; Towers, GJ (corresponding author), UCL, Infect & Immun, Cruciform Bldg 3-3,90 Gower St, London WC1E 6BT, England.	g.towers@ucl.ac.uk; lcj@mrc-lmb.cam.ac.uk		Jacques, David/0000-0002-6426-4510; Towers, Gregory/0000-0002-7707-0264	Medical Research Council (UK) [U105181010]; European Research Council [281627 -IAI]; European Research Council under the European Union; ERC [339223]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Wellcome Trust; NHMRC [GNT1036521]; Emmanuel College, Cambridge; MRC [G9721629, MC_U105181010, MC_PC_12024, G0801172] Funding Source: UKRI; Medical Research Council [MC_PC_12024, MC_U105181010] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); European Research Council under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Wellcome Trust(Wellcome TrustEuropean Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Emmanuel College, Cambridge; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (UK; U105181010), the European Research Council (281627 -IAI), the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013), ERC grant agreement number 339223 and the National Institute for Health Research University College London Hospitals Biomedical Research Centre. G.J.T. was supported by a Wellcome Trust Senior Biomedical Research Fellowship, D.A.J. by an NHMRC Early Career Fellowship (CJ Martin) (GNT1036521) and AJP by a Research Fellowship from Emmanuel College, Cambridge. We thank L. McKeane for her help designing figures.	Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bar-Even A, 2015, BIOCHEMISTRY-US, V54, P4969, DOI 10.1021/acs.biochem.5b00621; Campbell EM, 2015, NAT REV MICROBIOL, V13, P471, DOI 10.1038/nrmicro3503; Cheley S, 2002, CHEM BIOL, V9, P829, DOI 10.1016/S1074-5521(02)00172-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury C, 2015, P NATL ACAD SCI USA, V112, P2990, DOI 10.1073/pnas.1423672112; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; MAGALHAES A, 1994, J PROTEIN CHEM, V13, P195, DOI 10.1007/BF01891978; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mortuza GB, 2008, J MOL BIOL, V376, P1493, DOI 10.1016/j.jmb.2007.12.043; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neves MAC, 2012, J PHYS CHEM B, V116, P7006, DOI 10.1021/jp3009699; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Price AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004459; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Rihn SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003461; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Shah VB, 2011, JOVE-J VIS EXP, V57, P3384; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Warrilow D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013229; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ylinen LMJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001062; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	40	129	130	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					349	+		10.1038/nature19098	http://dx.doi.org/10.1038/nature19098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27509857	Green Accepted, Green Submitted			2022-12-24	WOS:000381804900039
J	Nuttle, X; Giannuzzi, G; Duyzend, MH; Schraiber, JG; Narvaiza, I; Sudmant, PH; Penn, O; Chiatante, G; Malig, M; Huddleston, J; Benner, C; Camponeschi, F; Ciofi-Baffoni, S; Stessman, HAF; Marchetto, MCN; Denman, L; Harshman, L; Baker, C; Raja, A; Penewit, K; Janke, N; Tang, WJ; Ventura, M; Banci, L; Antonacci, F; Akey, JM; Amemiya, CT; Gage, FH; Reymond, A; Eichler, EE				Nuttle, Xander; Giannuzzi, Giuliana; Duyzend, Michael H.; Schraiber, Joshua G.; Narvaiza, Inigo; Sudmant, Peter H.; Penn, Osnat; Chiatante, Giorgia; Malig, Maika; Huddleston, John; Benner, Chris; Camponeschi, Francesca; Ciofi-Baffoni, Simone; Stessman, Holly A. F.; Marchetto, Maria C. N.; Denman, Laura; Harshman, Lana; Baker, Carl; Raja, Archana; Penewit, Kelsi; Janke, Nicolette; Tang, W. Joyce; Ventura, Mario; Banci, Lucia; Antonacci, Francesca; Akey, Joshua M.; Amemiya, Chris T.; Gage, Fred H.; Reymond, Alexandre; Eichler, Evan E.			Emergence of a Homo sapiens-specific gene family and chromosome 16p11.2 CNV susceptibility	NATURE			English	Article							GENOME SEQUENCE; POSITIVE SELECTION; HUMAN BOLA2; HUMANS; AUTISM; IDENTIFICATION; MICRODELETION; NEANDERTHAL; CHIMPANZEES; POPULATION	Genetic differences that specify unique aspects of human evolution have typically been identified by comparative analyses between the genomes of humans and closely related primates(1), including more recently the genomes of archaic hominins(2,3). Not all regions of the genome, however, are equally amenable to such study. Recurrent copy number variation (CNV) at chromosome 16p11.2 accounts for approximately 1% of cases of autism(4,5) and is mediated by a complex set of segmental duplications, many of which arose recently during human evolution. Here we reconstruct the evolutionary history of the locus and identify bolA family member 2 (BOLA2) as a gene duplicated exclusively in Homo sapiens. We estimate that a 95-kilobase-pair segment containing BOLA2 duplicated across the critical region approximately 282 thousand years ago (ka), one of the latest among a series of genomic changes that dramatically restructured the locus during hominid evolution. All humans examined carried one or more copies of the duplication, which nearly fixed early in the human lineage-a pattern unlikely to have arisen so rapidly in the absence of selection (P < 0.0097). We show that the duplication of BOLA2 led to a novel, human-specific in-frame fusion transcript and that BOLA2 copy number correlates with both RNA expression (r = 0.36) and protein level (r = 0.65), with the greatest expression difference between human and chimpanzee in experimentally derived stem cells. Analyses of 152 patients carrying a chromosome 16p11.2 rearrangement show that more than 96% of breakpoints occur within the H. sapiens-specific duplication. In summary, the duplicative transposition of BOLA2 at the root of the H. sapiens lineage about 282 ka simultaneously increased copy number of a gene associated with iron homeostasis and predisposed our species to recurrent rearrangements associated with disease.	[Nuttle, Xander; Duyzend, Michael H.; Schraiber, Joshua G.; Sudmant, Peter H.; Penn, Osnat; Malig, Maika; Huddleston, John; Stessman, Holly A. F.; Denman, Laura; Harshman, Lana; Baker, Carl; Raja, Archana; Penewit, Kelsi; Janke, Nicolette; Akey, Joshua M.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Giannuzzi, Giuliana; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Narvaiza, Inigo; Benner, Chris; Marchetto, Maria C. N.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Chiatante, Giorgia; Ventura, Mario; Antonacci, Francesca] Univ Bari Aldo Moro, Dipartimento Biol, I-70125 Bari, Italy; [Huddleston, John; Raja, Archana; Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Camponeschi, Francesca; Ciofi-Baffoni, Simone; Banci, Lucia] Univ Florence, Dept Chem, Via Lastruccia 3, I-50019 Florence, Italy; [Ciofi-Baffoni, Simone; Banci, Lucia] Univ Florence, Magnet Resonance Ctr CERM, Via Luigi Sacconi 6, I-50019 Florence, Italy; [Tang, W. Joyce; Amemiya, Chris T.] Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA; [Gage, Fred H.] Ctr Acad Res & Training Anthropogeny, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Sudmant, Peter H.] MIT, Program Computat & Syst Biol, Cambridge, MA 02142 USA	University of Washington; University of Washington Seattle; University of Lausanne; Salk Institute; Universita degli Studi di Bari Aldo Moro; Howard Hughes Medical Institute; University of Florence; University of Florence; Benaroya Research Institute; Virginia Mason Medical Center; Massachusetts Institute of Technology (MIT)	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.; Reymond, A (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.; Eichler, EE (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.	alexandre.reymond@unil.ch; eee@gs.washington.edu	Ciofi-Baffoni, Simone/AAH-9778-2021; Camponeschi, Francesca/GWU-8535-2022; Kutalik, Zoltan/HHZ-5697-2022; Ventura, Mario/E-6420-2011; Antonacci, Francesca/F-5457-2013; Giannuzzi, Giuliana/N-7117-2017	Kutalik, Zoltan/0000-0001-8285-7523; Ventura, Mario/0000-0001-7762-8777; Antonacci, Francesca/0000-0002-5833-6186; Reymond, Alexandre/0000-0003-1030-8327; Sudmant, Peter/0000-0002-9573-8248; Akey, Joshua/0000-0002-4411-1330; Stessman, Holly/0000-0002-0764-3493; Giannuzzi, Giuliana/0000-0002-4030-0601; Duyzend, Michael/0000-0002-3941-6447; BANCI, LUCIA/0000-0003-0562-5774; Chiatante, Giorgia/0000-0002-7505-4818; Benner, Christopher/0000-0002-4618-0719	Paul G. Allen Foundation [11631]; Simons Foundation Autism Research Initiative (SFARI) [303241, 274424]; US National Institutes of Health (NIH) [2R01HG002385]; Swiss National Science Foundation [31003A_160203, CRSII33-133044]; NIH [TR01 MH095741]; Helmsley Charitable Fund; Mathers Foundation; JPB Foundation; US National Science Foundation [DGE-1256082]; Faculty of Biology and Medicine, University of Lausanne; US National Institute of Mental Health [1F30MH105055-01]; Human Frontier Science Program postdoctoral fellowship; EC [N653706]; Ente Cassa di Risparmio grant [2013/7201]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095741, F30MH105055] Funding Source: NIH RePORTER	Paul G. Allen Foundation; Simons Foundation Autism Research Initiative (SFARI); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Fund; Mathers Foundation; JPB Foundation; US National Science Foundation(National Science Foundation (NSF)); Faculty of Biology and Medicine, University of Lausanne; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Human Frontier Science Program postdoctoral fellowship(Human Frontier Science Program); EC(European CommissionEuropean Commission Joint Research Centre); Ente Cassa di Risparmio grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank families at the participating Simons Variation in Individuals Project (Simons VIP) and Simons Simplex Collection sites, as well as the Simons VIP Consortium. Approved researchers can obtain the Simons VIP data set, the Simons Simplex Collection data set and/or biospecimens by applying at https://base.sfari.org. We thank M. Chaisson for single-molecule, real-time WGS data, B. Vernot for archaic introgression data, B.J. Nelson and K. Munson for technical assistance, M. L. Gage for editorial comments and T. Brown for assistance with manuscript preparation. This work was supported by the Paul G. Allen Foundation (grant 11631 to E.E.E.), the Simons Foundation Autism Research Initiative (SFARI 303241 to E.E.E. and 274424 to A.R.), the US National Institutes of Health (NIH grant 2R01HG002385 to E.E.E.), the Swiss National Science Foundation (31003A_160203 and CRSII33-133044 to A.R.) and funds from NIH TR01 MH095741, the Helmsley Charitable Fund, the Mathers Foundation and the JPB Foundation (to F.H.G.). X.N. was supported by a US National Science Foundation Graduate Research Fellowship under grant DGE-1256082. G. G. was awarded a Pro-Women Scholarship from the Faculty of Biology and Medicine, University of Lausanne. M.H.D. is supported by US National Institute of Mental Health grant 1F30MH105055-01. O.P. is a recipient of a Human Frontier Science Program postdoctoral fellowship. L. B. is supported by EC grant N653706, project iNEXT. S.C.B. and F.C. were supported by an Ente Cassa di Risparmio grant (2013/7201). E.E.E. is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Antonacci F, 2014, NAT GENET, V46, P1293, DOI 10.1038/ng.3120; Banci L, 2015, J AM CHEM SOC, V137, P16133, DOI 10.1021/jacs.5b10592; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Bray NPH, 2015, NEAR OPTIMAL RNA SEQ; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Haunhorst P, 2013, MOL BIOL CELL, V24, P1895, DOI 10.1091/mbc.E12-09-0648; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Nuttle X, 2014, NAT PROTOC, V9, P1496, DOI 10.1038/nprot.2014.096; Nuttle X, 2013, NAT METHODS, V10, P903, DOI [10.1038/NMETH.2572, 10.1038/nmeth.2572]; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Yang MA, 2014, GENETICS, V198, P1655, DOI 10.1534/genetics.112.145359; Zufferey F, 2012, J MED GENET, V49, P660, DOI 10.1136/jmedgenet-2012-101203; 2012, NATURE, V491, P56, DOI DOI 10.1038/NATURE11632	39	67	68	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					205	+		10.1038/nature19075	http://dx.doi.org/10.1038/nature19075			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487209	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000381472100035
J	Stamatiades, EG; Tremblay, ME; Bohm, M; Crozet, L; Bisht, K; Kao, D; Coelho, C; Fan, XY; Yewdell, WT; Davidson, A; Heeger, PS; Diebold, S; Nimmerjahn, F; Geissmann, F				Stamatiades, Efstathios G.; Tremblay, Marie-Eve; Bohm, Mathieu; Crozet, Lucile; Bisht, Kanchan; Kao, Daniela; Coelho, Carolina; Fan, Xiying; Yewdell, William T.; Davidson, Anne; Heeger, Peter S.; Diebold, Sandra; Nimmerjahn, Falk; Geissmann, Frederic			Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages	CELL			English	Article							FC-GAMMA RECEPTORS; DENDRITIC CELLS; ARTHUS REACTION; BLOOD-VESSELS; ALBUMIN; IDENTIFICATION; COMPLEXES; MOUSE; MONOCYTES; SYSTEM	Small immune complexes cause type III hypersensitivity reactions that frequently result in tissue injury. The responsible mechanisms, however, remain unclear and differ depending on target organs. Here, we identify a kidney-specific anatomical and functional unit, formed by resident macrophages and peritubular capillary endothelial cells, which monitors the transport of proteins and particles ranging from 20 to 700 kDa or 10 to 200 nm into the kidney interstitium. Kidney-resident macrophages detect and scavenge circulating immune complexes "pumped'' into the interstitium via trans-endothelial transport and trigger a Fc gamma RIV-dependent inflammatory response and the recruitment of monocytes and neutrophils. In addition, Fc gamma RIV and TLR pathways synergistically "super-activate'' kidney macrophages when immune complexes contain a nucleic acid. These data identify a physiological function of tissue-resident kidney macrophages and a basic mechanism by which they initiate the inflammatory response to small immune complexes in the kidney.	[Stamatiades, Efstathios G.; Bohm, Mathieu; Crozet, Lucile; Coelho, Carolina; Fan, Xiying; Yewdell, William T.; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Program Immunol, 417 East 68th St, New York, NY 10065 USA; [Stamatiades, Efstathios G.; Bohm, Mathieu; Crozet, Lucile; Coelho, Carolina; Fan, Xiying; Yewdell, William T.; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 417 East 68th St, New York, NY 10065 USA; [Tremblay, Marie-Eve; Bisht, Kanchan] Univ Laval, Dept Mol Med, Laval, PQ G1V 0A6, Canada; [Tremblay, Marie-Eve; Bisht, Kanchan] CHU Quebec, Ctr Rech, Axe Neurosci, Quebec City, PQ G1V 4G2, Canada; [Bohm, Mathieu; Geissmann, Frederic] Kings Coll London, Div Immunol, Infect, London SE1 1UL, England; [Bohm, Mathieu; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat Inflammatory Di, London SE1 1UL, England; [Crozet, Lucile; Geissmann, Frederic] Weill Cornell Grad Sch Med Sci, 1300 York Ave, New York, NY 10065 USA; [Kao, Daniela; Nimmerjahn, Falk] Univ Erlangen Nurnberg, Dept Biol, Erwin Rommel Str 3, D-91058 Erlangen, Germany; [Fan, Xiying] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 417 East 68th St, New York, NY 10065 USA; [Davidson, Anne] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Heeger, Peter S.] Mt Sinai Sch Med, Recanati Miller Transplant Inst, Dept Med, New York, NY 10029 USA; [Heeger, Peter S.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Diebold, Sandra] Natl Inst Biol Stand & Controls, Immunotoxicol Team Div, Potters Bar EN6 3QG, Herts, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Laval University; Laval University; University of London; King's College London; University of London; King's College London; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Erlangen Nuremberg; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Northwell Health; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institute for Biological Standards & Control	Geissmann, F (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 417 East 68th St, New York, NY 10065 USA.; Geissmann, F (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 417 East 68th St, New York, NY 10065 USA.; Geissmann, F (corresponding author), Kings Coll London, Div Immunol, Infect, London SE1 1UL, England.; Geissmann, F (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat Inflammatory Di, London SE1 1UL, England.; Geissmann, F (corresponding author), Weill Cornell Grad Sch Med Sci, 1300 York Ave, New York, NY 10065 USA.	geissmaf@mskcc.org	Bisht, Kanchan/I-4798-2017	Bisht, Kanchan/0000-0002-2575-8913; Stamatiades, Efstathios/0000-0002-2785-9005; Fan, Xiying/0000-0003-3090-381X; Tremblay, Marie-Eve/0000-0003-2863-9626; Coelho, Carolina/0000-0002-7523-3031	National Cancer Institute of the NIH [P30CA008748]; Ludwig Center at the Memorial Sloan Kettering Cancer Center; Wellcome Trust [WT101853MA]; European Research Council [2010-StG-261299]; Oliver Bird Rheumatism Program; Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program [T32 GM07739]; Universite Laval; CHU de Quebec; NIH [R01 AI 071185]; German Research Foundation [GK1660, CRC1181-A07]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI122721, R01AI071185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Center at the Memorial Sloan Kettering Cancer Center; Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Oliver Bird Rheumatism Program; Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program; Universite Laval; CHU de Quebec; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jayanta Chaudari and Doris Herzlinger for helpful discussion of the manuscript, Antonio Pires da Silva Baptista for help with immunofluorescence, and Neil Lipman and the Research Animal Resource Center at MSKCC. This work was supported by the National Cancer Institute of the NIH (P30CA008748), the Ludwig Center at the Memorial Sloan Kettering Cancer Center, a Wellcome Trust Senior Investigator award (WT101853MA), a European Research Council Investigator award (2010-StG-261299) to F.G., and a PhD fellowship from the Oliver Bird Rheumatism Program to E.G.S. X.F. is supported by T32 GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. M.-E.T. is supported by start-up funds from Universite Laval and CHU de Quebec. P.S.H. is supported by NIH grant R01 AI 071185. D.K. and F.N. are supported by grants from the German Research Foundation (GK1660 and CRC1181-A07).	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BELL DR, 1978, J PHYSIOL-LONDON, V279, P621, DOI 10.1113/jphysiol.1978.sp012365; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; BRUNS RR, 1968, J CELL BIOL, V37, P277, DOI 10.1083/jcb.37.2.277; Cao Q, 2015, J AM SOC NEPHROL, V26, P349, DOI 10.1681/ASN.2013121336; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Clatworthy MR, 2014, NAT MED, V20, P1458, DOI 10.1038/nm.3709; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; DAHA MR, 1988, EUR J IMMUNOL, V18, P783, DOI 10.1002/eji.1830180519; Davis RS, 2002, IMMUNOL REV, V190, P123, DOI 10.1034/j.1600-065X.2002.19009.x; Freinkel, 2001, BIOL SKIN; Froehlich H, 2001, CLIN INFECT DIS, V33, P906, DOI 10.1086/322585; Gottschalk C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00435; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hasenberg A, 2015, NAT METHODS, V12, P445, DOI [10.1038/NMETH.3322, 10.1038/nmeth.3322]; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; HUME DA, 1983, J EXP MED, V157, P1704, DOI 10.1084/jem.157.5.1704; Jancar S, 2005, TRENDS IMMUNOL, V26, P48, DOI 10.1016/j.it.2004.11.007; Jonsson F, 2013, J LEUKOCYTE BIOL, V94, P643, DOI 10.1189/jlb.1212623; Kahn P, 2008, ARTHRITIS RHEUM, V58, P2824, DOI 10.1002/art.23764; KALLSKOG O, 1973, ACTA PHYSIOL SCAND, V89, P116, DOI 10.1111/j.1748-1716.1973.tb05502.x; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kao D, 2015, CELL REP, V13, P2376, DOI 10.1016/j.celrep.2015.11.027; Kasperkiewicz M, 2012, J PATHOL, V228, P8, DOI 10.1002/path.4023; Kruger T, 2004, J AM SOC NEPHROL, V15, P613, DOI 10.1097/01.ASN.0000114553.36258.91; Lamprecht P, 1999, ARTHRITIS RHEUM, V42, P2507, DOI 10.1002/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Mancardi DA, 2011, J IMMUNOL, V186, P1899, DOI 10.4049/jimmunol.1003642; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mechetina LV, 2002, IMMUNOGENETICS, V54, P463, DOI 10.1007/s00251-002-0486-0; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; MILICI AJ, 1985, CIRC RES, V56, P709, DOI 10.1161/01.RES.56.5.709; MILICI AJ, 1987, J CELL BIOL, V105, P2603, DOI 10.1083/jcb.105.6.2603; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246; Perdiguero EG, 2013, COLD SH Q B, V78, P91, DOI 10.1101/sqb.2013.78.020032; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; PINTER GG, 1967, J PHYSIOL-LONDON, V192, P761, DOI 10.1113/jphysiol.1967.sp008329; PINTER GG, 1970, EXPERIENTIA, V26, P265, DOI 10.1007/BF01900085; Poteser M, 2004, BRIT J PHARMACOL, V143, P143, DOI 10.1038/sj.bjp.0705897; PREDESCU D, 1993, AM J PHYSIOL, V265, pH725, DOI 10.1152/ajpheart.1993.265.2.H725; Rayner LE, 2013, J MOL BIOL, V425, P506, DOI 10.1016/j.jmb.2012.11.019; SCHIFFERLI JA, 1989, KIDNEY INT, V35, P993, DOI 10.1038/ki.1989.83; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Soos TJ, 2006, KIDNEY INT, V70, P591, DOI 10.1038/sj.ki.5001567; Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Stokol T, 2004, J EXP MED, V200, P835, DOI 10.1084/jem.20040501; Sun WP, 2013, LAB INVEST, V93, P626, DOI 10.1038/labinvest.2013.61; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Sylvestre DL, 1996, IMMUNITY, V5, P387, DOI 10.1016/S1074-7613(00)80264-2; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; van Nieuwenhuijze AEM, 2015, IMMUNOL CELL BIOL, V93, P841, DOI 10.1038/icb.2015.49; Vidarsson G, 1998, CURR OPIN INFECT DIS, V11, P271, DOI 10.1097/00001432-199806000-00002; Vogelpoel LTC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6444; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477	65	111	113	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					991	1003		10.1016/j.cell.2016.06.058	http://dx.doi.org/10.1016/j.cell.2016.06.058			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27477514	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000382258700020
J	Atamian, HS; Creux, NM; Brown, EA; Garner, AG; Blackman, BK; Harmer, SL				Atamian, Hagop S.; Creux, Nicky M.; Brown, Evan A.; Garner, Austin G.; Blackman, Benjamin K.; Harmer, Stacey L.			Circadian regulation of sunflower heliotropism, floral orientation, and pollinator visits	SCIENCE			English	Article							STEM ELONGATION; SOLAR TRACKING; GROWTH; ARABIDOPSIS; CLOCKS	Young sunflower plants track the Sun from east to west during the day and then reorient during the night to face east in anticipation of dawn. In contrast, mature plants cease movement with their flower heads facing east. We show that circadian regulation of directional growth pathways accounts for both phenomena and leads to increased vegetative biomass and enhanced pollinator visits to flowers. Solar tracking movements are driven by antiphasic patterns of elongation on the east and west sides of the stem. Genes implicated in control of phototropic growth, but not clock genes, are differentially expressed on the opposite sides of solar tracking stems. Thus, interactions between environmental response pathways and the internal circadian oscillator coordinate physiological processes with predictable changes in the environment to influence growth and reproduction.	[Atamian, Hagop S.; Creux, Nicky M.; Harmer, Stacey L.] Univ Calif Davis, Dept Plant Biol, One Shields Ave, Davis, CA 95616 USA; [Brown, Evan A.; Garner, Austin G.; Blackman, Benjamin K.] Univ Virginia, Dept Biol, POB 400328, Charlottesville, VA 22904 USA; [Blackman, Benjamin K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of Virginia; University of California System; University of California Berkeley	Harmer, SL (corresponding author), Univ Calif Davis, Dept Plant Biol, One Shields Ave, Davis, CA 95616 USA.	slharmer@ucdavis.edu	Atamian, Hagop S/H-5595-2019; Creux, Nicky/ABB-3215-2020; Garner, Austin/O-6261-2016	Creux, Nicky/0000-0002-4179-6995; Blackman, Benjamin/0000-0003-4936-6153; Garner, Austin/0000-0001-8279-8260	NSF [IOS-1238040]; University of Virginia Harrison Undergraduate Research Award; Division Of Integrative Organismal Systems [1238040] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of Virginia Harrison Undergraduate Research Award; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Agricultural Research Service, North Central Regional Plant Introduction Station) for providing germplasm; the Morven Farm staff, R. Karp, J. Vandenbrink, L. Henry, and N. Infantino for assistance in the field and with video scoring; and J. Maloof for helpful discussions. This work was supported by NSF grant IOS-1238040 (to S.L.H. and B.K.B.) and a University of Virginia Harrison Undergraduate Research Award (to E.A.B.). The supplementary materials contain additional data.	Briggs WR, 2014, PLANT PHYSIOL, V164, P13, DOI 10.1104/pp.113.230573; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Darwin C, 1880, POWER MOVEMENT PLANT; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Fambrini M, 2011, PLANT MOL BIOL, V75, P431, DOI 10.1007/s11103-011-9740-x; FOSTER KR, 1995, PLANT PHYSIOL, V108, P337, DOI 10.1104/pp.108.1.337; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Jouve L, 1999, PLANTA, V209, P136, DOI 10.1007/s004250050615; KEVAN PG, 1975, SCIENCE, V189, P723, DOI 10.1126/science.189.4204.723; Koller D, 2001, PHOTOMOVEMENT, P833, DOI 10.1016/S1568-461X(01)80029-6; Kutschera U, 2016, ANN BOT-LONDON, V117, P1, DOI 10.1093/aob/mcv141; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; Muller LM, 2014, J EXP BOT, V65, P2915, DOI 10.1093/jxb/eru117; Neily WG, 1997, J AM SOC HORTIC SCI, V122, P778, DOI 10.21273/JASHS.122.6.778; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Ren H, 2015, MOL PLANT, V8, P1153, DOI 10.1016/j.molp.2015.05.003; Schaffner JH, 1898, BOT GAZ, V25, P395, DOI 10.1086/327699; SHIBAOKA HIROH, 1959, SCI PAPERS COLL GEN EDUC UNIV TOKYO BIOL, V9, P105; Spartz AK, 2014, PLANT CELL, V26, P2129, DOI 10.1105/tpc.114.126037; STANTON ML, 1989, OECOLOGIA, V78, P477, DOI 10.1007/BF00378737; Stavang JA, 2005, PLANT PHYSIOL, V138, P2344, DOI 10.1104/pp.105.063149; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Vandenbrink JP, 2014, PLANT SCI, V224, P20, DOI 10.1016/j.plantsci.2014.04.006; Arana MV, 2011, P NATL ACAD SCI USA, V108, P9292, DOI 10.1073/pnas.1101050108; Vinterhalter D, 2014, J PLANT GROWTH REGUL, V33, P539, DOI 10.1007/s00344-013-9403-z; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660	27	131	133	12	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					587	590		10.1126/science.aaf9793	http://dx.doi.org/10.1126/science.aaf9793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493185	Green Submitted			2022-12-24	WOS:000381560900041
J	Zhao, Y; Chen, SS; Yoshioka, C; Baconguis, I; Gouaux, E				Zhao, Yan; Chen, Shanshuang; Yoshioka, Craig; Baconguis, Isabelle; Gouaux, Eric			Architecture of fully occupied GluA2 AMPA receptor-TARP complex elucidated by cryo-EM	NATURE			English	Article							2 DISTINCT MECHANISMS; LIGAND-BINDING CORE; GLUTAMATE-RECEPTOR; AUXILIARY SUBUNITS; ACTIVATION; STARGAZIN; DESENSITIZATION; CHANNELS; STATES	Fast excitatory neurotransmission in the mammalian central nervous system is largely carried out by AMPA-sensitive ionotropic glutamate receptors(1). Localized within the postsynaptic density of glutamatergic spines, AMPA receptors are composed of heterotetrameric receptor assemblies associated with auxiliary subunits, the most common of which are transmembrane AMPA receptor regulatory proteins (TARPs). The association of TARPs with AMPA receptors modulates receptor trafficking and the kinetics of receptor gating and pharmacology(2). Here we report the cryo-electron microscopy (cryo-EM) structure of the homomeric rat GluA2 AMPA receptor saturated with TARP gamma 2 subunits, which shows how the TARPs are arranged with four-fold symmetry around the ion channel domain and make extensive interactions with the M1, M2 and M4 transmembrane helices. Poised like partially opened 'hands' underneath the two-fold symmetric ligand-binding domain (LBD) 'clamshells', one pair of TARPs is juxtaposed near the LBD dimer interface, whereas the other pair is near the LBD dimer-dimer interface. The extracellular 'domains' of TARP are positioned to not only modulate LBD clamshell closure, but also affect conformational rearrangements of the LBD layer associated with receptor activation and desensitization, while the TARP transmembrane domains buttress the ion channel pore.	[Zhao, Yan; Chen, Shanshuang; Baconguis, Isabelle; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Yoshioka, Craig] Oregon Hlth & Sci Univ, Dept Biomed Engn, 2730 SW Moody Ave, Portland, OR 97201 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Baconguis, Isabelle/AAH-3790-2021; Gouaux, Eric/Y-4370-2019; Chen, Shanshuang/N-6665-2019; Yoshioka, Craig/ABH-3720-2020	Baconguis, Isabelle/0000-0002-5440-2289; Gouaux, Eric/0000-0002-8549-2360; Chen, Shanshuang/0000-0003-2317-6589; 	American Heart Association [16POST27790099]; NIH [NS038631]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS038631, R01NS038631] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Nakagawa for providing the clone 10 cell line, Z. H. Yu, R. Huang and C. Hong (Janelia Campus) for assistance with microscope operation and data collection and the Advanced Computing Center (OHSU) for computational support. We are grateful to A. Goehring for help with cell culture, the Multiscale Microscopy Core (OHSU) for support with microscopy, L. Vaskalis for assistance with figures, H. Owen for help with proofreading and other Gouaux laboratory members for helpful discussions. S.C. is supported by an American Heart Association postdoctoral fellowship (16POST27790099). This work was supported by the NIH (E.G., NS038631). E.G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker ML, 2007, STRUCTURE, V15, P7, DOI 10.1016/j.str.2006.11.008; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Dawe GB, 2016, NEURON, V89, P1264, DOI 10.1016/j.neuron.2016.01.038; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Herguedas B, 2016, SCIENCE, V352, DOI 10.1126/science.aad3873; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kaae BH, 2007, CHEM BIOL, V14, P1294, DOI 10.1016/j.chembiol.2007.10.012; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; WL D, 2002, PYMOL MOL GRAPHICS S; Zhu SJ, 2016, CELL, V165, P704, DOI 10.1016/j.cell.2016.03.028	48	77	77	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					108	+		10.1038/nature18961	http://dx.doi.org/10.1038/nature18961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27368053	Green Submitted, Green Accepted			2022-12-24	WOS:000380999200040
J	Archer, SK; Shirokikh, NE; Beilharz, TH; Preiss, T				Archer, Stuart K.; Shirokikh, Nikolay E.; Beilharz, Traude H.; Preiss, Thomas			Dynamics of ribosome scanning and recycling revealed by translation complex profiling	NATURE			English	Article							START CODON RECOGNITION; MESSENGER-RNA; EUKARYOTIC TRANSLATION; PROTEIN-SYNTHESIS; GENE-EXPRESSION; INITIATION COMPLEX; YEAST; TERMINATION; MECHANISM; PROMOTES	Regulation of messenger RNA translation is central to eukaryotic gene expression control(1). Regulatory inputs are specified by the mRNA untranslated regions (UTRs) and often target translation initiation. Initiation involves binding of the 40S ribosomal small subunit (SSU) and associated eukaryotic initiation factors (eIFs) near the mRNA 5' cap; the SSU then scans in the 3' direction until it detects the start codon and is joined by the 60S ribosomal large subunit (LSU)(2-5) to form the 80S ribosome. Scanning and other dynamic aspects of the initiation model have remained as conjectures because methods to trap early intermediates were lacking. Here we uncover the dynamics of the complete translation cycle in live yeast cells using translation complex profile sequencing (TCP-seq), a method developed from the ribosome profiling(6) approach. We document scanning by observing SSU footprints along 5' UTRs. Scanning SSU have 5'-extended footprints (up to similar to 75 nucleotides), indicative of additional interactions with mRNA emerging from the exit channel, promoting forward movement. We visualized changes in initiation complex conformation as SSU footprints coalesced into three major sizes at start codons (19, 29 and 37 nucleotides). These share the same 5' start site but differ at the 3' end, reflecting successive changes at the entry channel from an open to a closed state following start codon recognition. We also observe SSU 'lingering' at stop codons after LSU departure. Our results underpin mechanistic models of translation initiation and termination, built on decades of biochemical and structural investigation, with direct genome-wide in vivo evidence. Our approach captures ribosomal complexes at all phases of translation and will aid in studying translation dynamics in diverse cellular contexts. Dysregulation of translation is common in disease and, for example, SSU scanning is a target of anti-cancer drug development(7). TCP-seq will prove useful in discerning differences in mRNA-specific initiation in pathologies and their response to treatment.	[Archer, Stuart K.; Shirokikh, Nikolay E.; Preiss, Thomas] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, EMBL Australia Collaborating Grp, Canberra, ACT 2601, Australia; [Archer, Stuart K.] Monash Univ, Monash Bioinformat Platform, Melbourne, Vic 3800, Australia; [Shirokikh, Nikolay E.] Moscow Reg State Inst Humanities & Social Studies, Kolomna 140410, Russia; [Beilharz, Traude H.] Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Melbourne, Vic 3800, Australia; [Beilharz, Traude H.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Preiss, Thomas] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia	Australian National University; John Curtin School of Medical Research; Monash University; Monash University; Monash University; Victor Chang Cardiac Research Institute	Preiss, T (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, EMBL Australia Collaborating Grp, Canberra, ACT 2601, Australia.; Preiss, T (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia.	thomas.preiss@anu.edu.au	Beilharz, Traude/I-1438-2014; , 周一珉/AAQ-9453-2020; Beilharz, Traude/O-5457-2019; Preiss, Thomas/F-7355-2010	Beilharz, Traude/0000-0002-8942-9502; Beilharz, Traude/0000-0002-8942-9502; Preiss, Thomas/0000-0001-6273-784X; Shirokikh, Nikolay/0000-0001-8249-358X; Archer, Stuart/0000-0003-0450-1243	ARC [DP1300101928]; NHMRC [514904]; Go8 European Fellowship	ARC(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Go8 European Fellowship	This work was supported by an ARC Discovery Grant (DP1300101928) and an NHMRC Senior Research Fellowship (514904) awarded to T.P. N.E.S. was supported by a Go8 European Fellowship. We are grateful to A. G. Hinnebusch, C. G. Proud and R. D. Hannan for discussions and suggestions for this work. We acknowledge technical support from the Australian Cancer Research Foundation Biomolecular Resource Facility (JCSMR, ANU), D. Powell and S. Androulakis at the Monash Bioinformatics Platform.	Archer SK, 2015, RNA BIOL, V12, P248, DOI 10.1080/15476286.2015.1017242; Archer SK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-401; Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Baranov P., 2015, BIORXIV; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fernandez IS, 2013, SCIENCE, V342, P824, DOI 10.1126/science.1240585; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Jackson RJ, 2012, ADV PROTEIN CHEM STR, V86, P45, DOI [10.1016/B978-0-12-386497-0.00002-5, 10.1016/B978-0-12.386497.000002-5]; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; KOZAK M, 1978, J BIOL CHEM, V253, P6568; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; Kressler D, 2012, SCIENCE, V338, P666, DOI 10.1126/science.1226960; Kurata S, 2013, NUCLEIC ACIDS RES, V41, P264, DOI 10.1093/nar/gks958; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lareau LF, 2014, ELIFE, V3, DOI 10.7554/eLife.01257; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Llacer JL, 2015, MOL CELL, V59, P399, DOI 10.1016/j.molcel.2015.06.033; Lomakin IB, 2013, NATURE, V500, P307, DOI 10.1038/nature12355; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; McManus CJ, 2014, GENOME RES, V24, P422, DOI 10.1101/gr.164996.113; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Paek KY, 2015, P NATL ACAD SCI USA, V112, P1041, DOI 10.1073/pnas.1416883112; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Preiss T., 2015, CURR PROTOC HUM GENE, V85; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roque S, 2015, RNA, V21, P124, DOI 10.1261/rna.047282.114; Saini AK, 2014, NUCLEIC ACIDS RES, V42, P9623, DOI 10.1093/nar/gku653; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Spirin AS, 2009, BIOCHEMISTRY-US, V48, P10688, DOI 10.1021/bi901379a; Valasek L, 2007, METHOD ENZYMOL, V429, P163, DOI 10.1016/S0076-6879(07)29008-1; Yamamoto H, 2014, NAT STRUCT MOL BIOL, V21, P721, DOI 10.1038/nsmb.2859; Zhang ZH, 2007, GENOME RES, V17, P503, DOI 10.1101/gr.6049107	45	120	123	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					570	+		10.1038/nature18647	http://dx.doi.org/10.1038/nature18647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27437580				2022-12-24	WOS:000380856600033
J	Wolf, AJ; Reyes, CN; Liang, WB; Becker, C; Shimada, K; Wheeler, ML; Cho, HC; Popescu, NI; Coggeshall, KM; Arditi, M; Underhill, DM				Wolf, Andrea J.; Reyes, Christopher N.; Liang, Wenbin; Becker, Courtney; Shimada, Kenichi; Wheeler, Matthew L.; Cho, Hee Cheol; Popescu, Narcis I.; Coggeshall, K. Mark; Arditi, Moshe; Underhill, David M.			Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan	CELL			English	Article							NLRP3 INFLAMMASOME ACTIVATION; DEPENDENT ANION CHANNELS; ACETYL-D-GLUCOSAMINE; NALP3 INFLAMMASOME; BACILLUS-ANTHRACIS; MURAMYL DIPEPTIDE; PERMEABILITY TRANSITION; STAPHYLOCOCCUS-AUREUS; CASPASE-1 ACTIVATION; IL-1-BETA SECRETION	Degradation of Gram-positive bacterial cell wall peptidoglycan in macrophage and dendritic cell phagosomes leads to activation of the NLRP3 inflammasome, a cytosolic complex that regulates processing and secretion of interleukin (IL)-1 beta and IL-18. While many inflammatory responses to peptidoglycan are mediated by detection of its muramyl dipeptide component in the cytosol by NOD2, we report here that NLRP3 inflammasome activation is caused by release of N-acetylglucosamine that is detected in the cytosol by the glycolytic enzyme hexokinase. Inhibition of hexokinase by N-acetylglucosamine causes its dissociation from mitochondria outer membranes, and we found that this is sufficient to activate the NLRP3 inflammasome. In addition, we observed that glycolytic inhibitors and metabolic conditions affecting hexokinase function and localization induce inflammasome activation. While previous studies have demonstrated that signaling by pattern recognition receptors can regulate metabolic processes, this study shows that a metabolic enzyme can act as a pattern recognition receptor.	[Wolf, Andrea J.; Reyes, Christopher N.; Becker, Courtney; Wheeler, Matthew L.; Underhill, David M.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA; [Wolf, Andrea J.; Shimada, Kenichi; Wheeler, Matthew L.; Arditi, Moshe; Underhill, David M.] Cedars Sinai Med Ctr, Div Immunol, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Liang, Wenbin; Cho, Hee Cheol] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Shimada, Kenichi; Arditi, Moshe] Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA; [Popescu, Narcis I.; Coggeshall, K. Mark] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Liang, Wenbin] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Liang, Wenbin] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1Y 4W7, Canada; [Cho, Hee Cheol] Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA; [Cho, Hee Cheol] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Oklahoma Medical Research Foundation; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Emory University; Emory University	Underhill, DM (corresponding author), Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA.; Underhill, DM (corresponding author), Cedars Sinai Med Ctr, Div Immunol, Dept Biomed Sci, Los Angeles, CA 90048 USA.	david.underhill@csmc.edu	UNDERHILL, DAVID/ABE-2185-2021	Underhill, David/0000-0002-2989-658X; Popescu, Narcis/0000-0002-4809-9885	NIH [GM085796, T32AI089553, AI067995, AI062629]; Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at Cedars-Sinai Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067995, T32AI089553, U19AI062629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085796] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at Cedars-Sinai Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the NIH (GM085796 to D.M.U., T32AI089553 to A.J.W., AI067995 to M.A., and AI062629 to K.M.C.). Further support came from the Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at Cedars-Sinai Medical Center (D.M.U.). Thanks to the laboratory of Dr. Robin Shaw for use of their FemtoJet microinjection system.	Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Aleshin AE, 1998, STRUCTURE, V6, P39, DOI 10.1016/S0969-2126(98)00006-9; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Ferwerda G, 2008, EUR J IMMUNOL, V38, P184, DOI 10.1002/eji.200737103; GERBER G, 1974, EUR J BIOCHEM, V45, P39, DOI 10.1111/j.1432-1033.1974.tb03527.x; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Iyer JK, 2011, J IMMUNOL, V186, P3841, DOI 10.4049/jimmunol.1004058; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; JONAS AJ, 1990, BIOCHEM J, V268, P41, DOI 10.1042/bj2680041; JONAS AJ, 1989, J BIOL CHEM, V264, P4953; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Langer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003706; Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Muller S, 2015, CELL HOST MICROBE, V18, P604, DOI 10.1016/j.chom.2015.10.011; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nomura J, 2015, J IMMUNOL, V195, P5718, DOI 10.4049/jimmunol.1402512; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; SPIRO RG, 1958, J BIOL CHEM, V233, P546; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Tomasello F, 2009, CELL RES, V19, P1363, DOI 10.1038/cr.2009.98; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; WICK AN, 1957, J BIOL CHEM, V224, P963; Wilson MH, 2011, J CEREBR BLOOD F MET, V31, P2019, DOI 10.1038/jcbfm.2011.81; Wolf AJ, 2011, J IMMUNOL, V187, P6002, DOI 10.4049/jimmunol.1100232; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083	49	277	289	3	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					624	636		10.1016/j.cell.2016.05.076	http://dx.doi.org/10.1016/j.cell.2016.05.076			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27374331	Green Accepted, Bronze			2022-12-24	WOS:000380546500014
J	Zhang, H; Liu, T; Zhang, Z; Payne, SH; Zhang, B; McDermott, JE; Zhou, JY; Petyuk, VA; Chen, L; Ray, D; Sun, SS; Yang, F; Chen, LJ; Wang, J; Shah, P; Cha, SW; Aiyetan, P; Woo, S; Tian, Y; Gritsenko, MA; Clauss, TR; Choi, C; Monroe, ME; Thomas, S; Nie, S; Wu, CC; Moore, RJ; Yu, KH; Tabb, DL; Fenyo, D; Bafna, V; Wang, Y; Rodriguez, H; Boja, ES; Hiltke, T; Rivers, RC; Sokoll, L; Zhu, H; Shih, IM; Cope, L; Pandey, A; Zhang, B; Snyder, MP; Levine, DA; Smith, RD; Chan, DW; Rodland, KD				Zhang, Hui; Liu, Tao; Zhang, Zhen; Payne, Samuel H.; Zhang, Bai; McDermott, Jason E.; Zhou, Jian-Ying; Petyuk, Vladislav A.; Chen, Li; Ray, Debjit; Sun, Shisheng; Yang, Feng; Chen, Lijun; Wang, Jing; Shah, Punit; Cha, Seong Won; Aiyetan, Paul; Woo, Sunghee; Tian, Yuan; Gritsenko, Marina A.; Clauss, Therese R.; Choi, Caitlin; Monroe, Matthew E.; Thomas, Stefani; Nie, Song; Wu, Chaochao; Moore, Ronald J.; Yu, Kun-Hsing; Tabb, David L.; Fenyo, David; Bafna, Vineet; Wang, Yue; Rodriguez, Henry; Boja, Emily S.; Hiltke, Tara; Rivers, Robert C.; Sokoll, Lori; Zhu, Heng; Shih, Ie-Ming; Cope, Leslie; Pandey, Akhilesh; Zhang, Bing; Snyder, Michael P.; Levine, Douglas A.; Smith, Richard D.; Chan, Daniel W.; Rodland, Karin D.		CPTAC Investigators	Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer	CELL			English	Article							EPITHELIAL OVARIAN; PHASE-II; HISTONE DEACETYLASE; PROTEIN EXPRESSION; CARCINOMA; REPAIR; BELINOSTAT; STRATEGIES; MUTATIONS; ABUNDANCE	To provide a detailed analysis of the molecular components and underlying mechanisms associated with ovarian cancer, we performed a comprehensive mass-spectrometry-based proteomic characterization of 174 ovarian tumors previously analyzed by The Cancer Genome Atlas (TCGA), of which 169 were high-grade serous carcinomas (HGSCs). Integrating our proteomic measurements with the genomic data yielded a number of insights into disease, such as how different copy-number alternations influence the proteome, the proteins associated with chromosomal instability, the sets of signaling pathways that diverse genome rearrangements converge on, and the ones most associated with short overall survival. Specific protein acetylations associated with homologous recombination deficiency suggest a potential means for stratifying patients for therapy. In addition to providing a valuable resource, these findings provide a view of how the somatic genome drives the cancer proteome and associations between protein and post-translational modification levels and clinical outcomes in HGSC.	[Zhang, Hui; Zhang, Zhen; Zhang, Bai; Zhou, Jian-Ying; Chen, Li; Sun, Shisheng; Chen, Lijun; Shah, Punit; Aiyetan, Paul; Tian, Yuan; Choi, Caitlin; Thomas, Stefani; Sokoll, Lori; Zhu, Heng; Chan, Daniel W.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA; [Liu, Tao; Payne, Samuel H.; McDermott, Jason E.; Petyuk, Vladislav A.; Ray, Debjit; Yang, Feng; Gritsenko, Marina A.; Clauss, Therese R.; Monroe, Matthew E.; Nie, Song; Wu, Chaochao; Moore, Ronald J.; Smith, Richard D.; Rodland, Karin D.] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Wang, Jing; Tabb, David L.; Zhang, Bing] Vanderbilt Univ, Dept Biomed Informat, Sch Med, Nashville, TN 37203 USA; [Cha, Seong Won; Woo, Sunghee] Univ Calif San Diego, Dept Elect & Comp Engn, San Diego, CA 92093 USA; [Yu, Kun-Hsing] Stanford Univ, Biomed Informat Training Program, Sch Med, Stanford, CA 94305 USA; [Yu, Kun-Hsing; Snyder, Michael P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Fenyo, David] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Fenyo, David] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Bafna, Vineet] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92093 USA; [Wang, Yue] Virginia Polytech Inst & State Univ, Bradley Dept Elect & Comp Engn, Arlington, VA 22203 USA; [Rodriguez, Henry; Boja, Emily S.; Hiltke, Tara; Rivers, Robert C.] NCI, Off Canc Clin Prote Res, Bethesda, MD 20892 USA; [Shih, Ie-Ming] Johns Hopkins Med Inst, Dept Gynecol & Obstet, Baltimore, MD 21231 USA; [Cope, Leslie] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21231 USA; [Pandey, Akhilesh] Johns Hopkins Med Inst, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; [Levine, Douglas A.] NYU, Laura & Isaac Perlmutter Canc Ctr, Dept Gynecol Oncol, Langone Med Ctr, New York, NY 10016 USA	Johns Hopkins University; Johns Hopkins Medicine; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Vanderbilt University; University of California System; University of California San Diego; Stanford University; Stanford University; New York University; New York University; University of California System; University of California San Diego; Virginia Polytechnic Institute & State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; New York University; NYU Langone Medical Center	Chan, DW (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA.; Rodland, KD (corresponding author), Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	dchan@jhmi.edu; karin.rodland@pnnl.gov	Pandey, Akhilesh/CAI-9458-2022; Monroe, Matthew/L-1157-2019; Rodland, Karin/R-6186-2019; Payne, Samuel/AAC-6388-2021; Bafna, Vineet/AAY-8111-2020; Thomas, Stefani/AAF-4212-2021; Yu, Kun-Hsing/J-3300-2019; Sun, Shisheng/P-5027-2019; Smith, Richard D/J-3664-2012; sdsd, shihieih/ABE-6190-2020; Ray, Debjit/J-9302-2016	Pandey, Akhilesh/0000-0001-9943-6127; Payne, Samuel/0000-0002-8351-1994; Bafna, Vineet/0000-0002-5810-6241; Thomas, Stefani/0000-0003-1679-5453; Yu, Kun-Hsing/0000-0001-9892-8218; Smith, Richard D/0000-0002-2381-2349; Ray, Debjit/0000-0002-7192-9859; Mani, D. R./0000-0003-3914-133X; Wang, Pei/0000-0002-6890-6453; Aiyetan, Paul/0000-0001-9031-000X; Sun, Shisheng/0000-0002-7242-7164; Tabb, David/0000-0001-7223-578X; Fenyo, David/0000-0001-5049-3825; Wang, Jing/0000-0003-1580-1356; Snyder, Michael/0000-0003-0784-7987; Levine, Douglas/0000-0003-1038-8232; McDermott, Jason/0000-0003-2961-2572; Oberti, Mauricio/0000-0001-7107-2616; McGarvey, Peter/0000-0002-8312-6017; White, Forest/0000-0002-1545-1651; Davies, Sherri/0000-0002-7141-8354	National Cancer Institute (NCI) [U24CA160019, U24CA160036]; NIH [P41GM103493]; DOE [DE-AC05-76RL01830]; NATIONAL CANCER INSTITUTE [U24CA160019, U24CA160036, U24CA160035, U24CA160034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114362, P41GM103493, P41GM103484] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute (NCI) CPTAC awards U24CA160019 and U24CA160036 and by NIH grant P41GM103493. The PNNL proteomics work described herein was performed in the Environmental Molecular Sciences Laboratory, a U.S. Department of Energy (DOE) National Scientific User Facility located at PNNL in Richland, WA. PNNL is a multi-program national laboratory operated by the Battelle Memorial Institute for the DOE under contract DE-AC05-76RL01830. Genomics data for this study were generated by the TCGA Pilot Project, established by the NCI and the National Human Genome Research Institute.	Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cai RL, 2000, J BIOL CHEM, V275, P27909; Collins BC, 2013, NAT METHODS, V10, P1246, DOI [10.1038/NMETH.2703, 10.1038/nmeth.2703]; Cope L, 2013, GYNECOL ONCOL, V128, P500, DOI 10.1016/j.ygyno.2012.11.031; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Dizon DS, 2012, INT J GYNECOL CANCER, V22, P979, DOI 10.1097/IGC.0b013e31825736fd; Fanjul-Fernandez M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3531; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gadducci A, 2015, CRIT REV ONCOL HEMAT, V96, P113, DOI 10.1016/j.critrevonc.2015.05.009; Gong FD, 2013, MUTAT RES-FUND MOL M, V750, P23, DOI 10.1016/j.mrfmmm.2013.07.002; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Koebel Martin, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800077X; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liu J, 2014, CLIN CANCER RES, V20, P5150, DOI 10.1158/1078-0432.CCR-14-1312; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mackay HJ, 2010, EUR J CANCER, V46, P1573, DOI 10.1016/j.ejca.2010.02.047; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Mielcarek M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00042; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Ruggles KV, 2016, MOL CELL PROTEOMICS, V15, P1060, DOI 10.1074/mcp.M115.056226; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Vang R, 2016, INT J GYNECOL PATHOL, V35, P48, DOI 10.1097/PGP.0000000000000207; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Woo S, 2014, PROTEOMICS, V14, P2719, DOI 10.1002/pmic.201400206; Woodbine L, 2014, DNA REPAIR, V16, P84, DOI 10.1016/j.dnarep.2014.02.011; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yang JY, 2013, J CLIN INVEST, V123, P3740, DOI 10.1172/JCI68509; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Yi B, 2015, ONCOL REP, V33, P1201, DOI 10.3892/or.2015.3707; Yu GQ, 2011, BIOINFORMATICS, V27, P1473, DOI 10.1093/bioinformatics/btr183; Zhang B, 2009, BIOINFORMATICS, V25, P526, DOI 10.1093/bioinformatics/btn660; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	44	526	535	8	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					755	765		10.1016/j.cell.2016.05.069	http://dx.doi.org/10.1016/j.cell.2016.05.069			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27372738	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-24	WOS:000380546500024
J	Michalak, AM				Michalak, Anna M.			Study role of climate change in extreme threats to water quality	NATURE			English	Editorial Material									[Michalak, Anna M.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA	Carnegie Institution for Science	Michalak, AM (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA.	michalak@stanford.edu			Div Of Chem, Bioeng, Env, & Transp Sys [1313897] Funding Source: National Science Foundation	Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		[Anonymous], 2003, 21 SESS IPCC VIENN A, DOI DOI 10.4324/9781315270326-109; Cook PF, 2015, SCIENCE, V350, P1545, DOI 10.1126/science.aac5675; Di Liberto T., 2015, CLIMATEWATCH MA 0930; Group on Earth Observations/AquaWatch, 2016, AQUAWATCH 2016 WORK; Kudela R.M., 2015, IOCUNESCO PARIS IOC; Michalak AM, 2013, P NATL ACAD SCI USA, V110, P6448, DOI 10.1073/pnas.1216006110; Paerl HW, 2001, P NATL ACAD SCI USA, V98, P5655, DOI 10.1073/pnas.101097398; Stumpf R., 2015, EXPT LAKE ERIE HARMF, V27; Wilson EK., 2014, CHEM ENG NEWS, V92, P9; Zhu MY, 2014, HARMFUL ALGAE, V39, P310, DOI 10.1016/j.hal.2014.09.003	10	148	153	16	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					349	350		10.1038/535349a	http://dx.doi.org/10.1038/535349a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27443725	Bronze			2022-12-24	WOS:000380344200015
J	Ellebrecht, CT; Bhoj, VG; Nace, A; Choi, EJ; Mao, XM; Cho, MJ; Di Zenzo, G; Lanzavecchia, A; Seykora, JT; Cotsarelis, G; Milone, MC; Payne, AS				Ellebrecht, Christoph T.; Bhoj, Vijay G.; Nace, Arben; Choi, Eun Jung; Mao, Xuming; Cho, Michael Jeffrey; Di Zenzo, Giovanni; Lanzavecchia, Antonio; Seykora, John T.; Cotsarelis, George; Milone, Michael C.; Payne, Aimee S.			Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease	SCIENCE			English	Article							B-CELL; PEMPHIGUS-VULGARIS; PERSISTENCE; ACTIVATION; 4-1BB; DESMOGLEIN-3; MALIGNANCIES; SEGREGATION; INTERFACE; LYMPHOMA	Ideally, therapy for autoimmune diseases should eliminate pathogenic autoimmune cells while sparing protective immunity, but feasible strategies for such an approach have been elusive. Here, we show that in the antibody-mediated autoimmune disease pemphigus vulgaris (PV), autoantigen-based chimeric immunoreceptors can direct T cells to kill autoreactive B lymphocytes through the specificity of the B cell receptor (BCR). We engineered human T cells to express a chimeric autoantibody receptor (CAAR), consisting of the PV autoantigen, desmoglein (Dsg) 3, fused to CD137-CD3 zeta signaling domains. Dsg3 CAAR-T cells exhibit specific cytotoxicity against cells expressing anti-Dsg3 BCRs in vitro and expand, persist, and specifically eliminate Dsg3-specific B cells in vivo. CAAR-T cells may provide an effective and universal strategy for specific targeting of autoreactive B cells in antibody-mediated autoimmune disease.	[Ellebrecht, Christoph T.; Nace, Arben; Choi, Eun Jung; Mao, Xuming; Cho, Michael Jeffrey; Seykora, John T.; Cotsarelis, George; Payne, Aimee S.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Bhoj, Vijay G.; Milone, Michael C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Di Zenzo, Giovanni] IDI IRCCS, Mol & Cellular Biol Lab, I-00167 Rome, Italy; [Lanzavecchia, Antonio] Inst Biomed Res, CH-6500 Bellinzona, Switzerland	University of Pennsylvania; University of Pennsylvania; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Universita della Svizzera Italiana	Payne, AS (corresponding author), Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA.; Milone, MC (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	milone@mail.med.upenn.edu; aimee.payne@uphs.upenn.edu	Di Zenzo, Giovanni/K-1943-2018	Di Zenzo, Giovanni/0000-0001-6106-599X	Penn Institute for Immunology; Dermatology Foundation Charles and Daneen Stiefel Scholar Award; National Institute of Arthritis and Musculoskeletal and Skin Diseases of NIH [R01-AR057001, R01-AR068288, T32-AR007465, F31-AR066456, R01-AR055309]; National Institute of Arthritis and Musculoskeletal and Skin Diseases of NIH (Skin Diseases Research Core grant) [P30-AR057217]; Deutsche Forschungsgemeinschaft [EL711/1-1]; National Cancer Institute of NIH [T32-CA009140]; National Heart, Lung, and Blood Institute of NIH [K12-HL087064]; Italian Ministry of Health [RF10-2309790]; NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007465, P30AR057217, R01AR057001, F30AR065870, F31AR066456, R01AR055309, R01AR068288] Funding Source: NIH RePORTER	Penn Institute for Immunology; Dermatology Foundation Charles and Daneen Stiefel Scholar Award; National Institute of Arthritis and Musculoskeletal and Skin Diseases of NIH; National Institute of Arthritis and Musculoskeletal and Skin Diseases of NIH (Skin Diseases Research Core grant); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Cancer Institute of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Margolis, S. Prouty, T. Dentchev, C.-Y. Tsai, and S. Nunez-Cruz for technical assistance and consultation on the studies and J. R. Stanley for helpful discussions. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. Constructs and cell lines are available from the corresponding authors under a Material Transfer Agreement with the University of Pennsylvania. C.T.E., V.G.B., M.C.M, and A.S.P. have filed patent PCT/US15/28872, 2015, which relates to compositions and methods of chimeric autoantibody receptor T cells. C.T.E. and A.S.P. have filed Provisional Patent Application 62/222,132, 2015, which relates to the VRC01 chimeric antigen receptor. Research reported in this publication was supported in part by the Penn Institute for Immunology (A.S.P. and M.C.M.); the Dermatology Foundation Charles and Daneen Stiefel Scholar Award (A.S.P.); the National Institute of Arthritis and Musculoskeletal and Skin Diseases of NIH (A.S.P., R01-AR057001 and R01-AR068288; M.J.C., T32-AR007465 and F31-AR066456; G.C., R01-AR055309; and Skin Diseases Research Core grant P30-AR057217); Deutsche Forschungsgemeinschaft (C.T.E., EL711/1-1); the National Cancer Institute of NIH (V.G.B., T32-CA009140); the National Heart, Lung, and Blood Institute of NIH (V.G.B., K12-HL087064); and the Italian Ministry of Health (G.D.Z., Ricerca Finalizzata RF10-2309790). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Cho MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5167; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Colliou N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005166; Cruz CRY, 2013, BLOOD, V122, P2965, DOI 10.1182/blood-2013-06-506741; Culton DA, 2015, J INVEST DERMATOL, V135, P1590, DOI 10.1038/jid.2015.54; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; Eming R, 2008, J INVEST DERMATOL, V128, P2850, DOI 10.1038/jid.2008.172; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hammers CM, 2015, J INVEST DERMATOL, V135, P742, DOI 10.1038/jid.2014.291; HENNECKE S, 1993, J BIOL CHEM, V268, P26607; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Lunardon L, 2012, ARCH DERMATOL, V148, P1031, DOI 10.1001/archdermatol.2012.1522; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Ohyama B, 2012, J INVEST DERMATOL, V132, P1158, DOI 10.1038/jid.2011.448; Payne A. S., 2012, DERMATOLOGY GEN MED; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Srivastava S, 2015, TRENDS IMMUNOL, V36, P494, DOI 10.1016/j.it.2015.06.004; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Watanabe K., 2014, BLOOD, V124, P4799, DOI [10.1182/blood.V124.21.4799.4799, DOI 10.1182/BLOOD.V124.21.4799.4799]; Yang SL, 2004, P NATL ACAD SCI USA, V101, P4990, DOI 10.1073/pnas.0400880101; Ye ZM, 2002, NAT MED, V8, P343, DOI 10.1038/nm0402-343; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	37	313	348	9	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					179	184		10.1126/science.aaf6756	http://dx.doi.org/10.1126/science.aaf6756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27365313	Green Accepted			2022-12-24	WOS:000379208400042
J	McInroe, B; Astley, HC; Gong, CH; Kawano, SM; Schiebel, PE; Rieser, JM; Choset, H; Blob, RW; Goldman, DI				McInroe, Benjamin; Astley, Henry C.; Gong, Chaohui; Kawano, Sandy M.; Schiebel, Perrin E.; Rieser, Jennifer M.; Choset, Howie; Blob, Richard W.; Goldman, Daniel I.			Tail use improves performance on soft substrates in models of early vertebrate land locomotors	SCIENCE			English	Article							TERRESTRIAL LOCOMOTION; GRANULAR MEDIA; EVOLUTION; TETRAPODS; LIZARD; ROBOT	In the evolutionary transition from an aquatic to a terrestrial environment, early tetrapods faced the challenges of terrestrial locomotion on flowable substrates, such as sand and mud of variable stiffness and incline. The morphology and range of motion of appendages can be revealed in fossils; however, biological and robophysical studies of modern taxa have shown that movement on such substrates can be sensitive to small changes in appendage use. Using a biological model ( the mudskipper), a physical robot model, granular drag measurements, and theoretical tools from geometric mechanics, we demonstrate how tail use can improve robustness to variable limb use and substrate conditions. We hypothesize that properly coordinated tail movements could have provided a substantial benefit for the earliest vertebrates to move on land.	[McInroe, Benjamin; Astley, Henry C.; Schiebel, Perrin E.; Rieser, Jennifer M.; Goldman, Daniel I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Gong, Chaohui; Choset, Howie] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA; [Kawano, Sandy M.] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN USA; [Blob, Richard W.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Goldman, Daniel I.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Carnegie Mellon University; University of Tennessee System; University of Tennessee Knoxville; Clemson University; University System of Georgia; Georgia Institute of Technology	Goldman, DI (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.; Goldman, DI (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	daniel.goldman@physics.gatech.edu	Kawano, Sandy/AAM-9322-2020	Kawano, Sandy/0000-0002-1856-5566; Blob, Richard/0000-0001-5026-343X	NSF [PoLS PHY-1205878, PHY-1150760, CMMI-1361778, IOS-0517340, IOS-0817794, DBI-1300426]; Army Research Office (ARO) [W911NF-11-1-0514]; ARL MAST CTA; ARO Robotics CTA; NSF National Robotics Initiative [IIS-1426655]; GT UROP; GT PURA Travel Grant; Clemson University Wade Stackhouse Fellowship; University of Tennessee, Knoxville; U.S. Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship [32 CFR 168a]; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Army Research Office (ARO); ARL MAST CTA; ARO Robotics CTA; NSF National Robotics Initiative; GT UROP; GT PURA Travel Grant; Clemson University Wade Stackhouse Fellowship; University of Tennessee, Knoxville; U.S. Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by NSF grants PoLS PHY-1205878, PHY-1150760, and CMMI-1361778, Army Research Office (ARO) grant W911NF-11-1-0514, and the ARL MAST CTA (D.I.G.); ARO Robotics CTA and NSF National Robotics Initiative IIS-1426655 (H.C.); NSF grants IOS-0517340 and IOS-0817794 (R.W.B.); GT UROP and the GT PURA Travel Grant (B.M.); a Clemson University Wade Stackhouse Fellowship, NSF award DBI-1300426, and the University of Tennessee, Knoxville (S.M.K.); and the U.S. Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship, 32 CFR 168a (P.E.S.). The authors declare no conflicts of interest. Data are available from the corresponding author upon request.	Aguilar J, 2016, NAT PHYS, V12, P278, DOI 10.1038/NPHYS3568; Ashley-Ross MA, 2013, INTEGR COMP BIOL, V53, P192, DOI 10.1093/icb/ict048; Blieck A, 2007, GEOL SOC SPEC PUBL, V278, P219, DOI 10.1144/SP278.10; Blob RW, 2001, PALEOBIOLOGY, V27, P14, DOI 10.1666/0094-8373(2001)027<0014:EOHPIN>2.0.CO;2; Clack JA, 1997, PALAEOGEOGR PALAEOCL, V130, P227, DOI 10.1016/S0031-0182(96)00142-3; Clack JA., 2012, GAINING GROUND ORIGI; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Curth S, 2014, ICHNOS, V21, P32, DOI 10.1080/10420940.2013.877006; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; DAVENPORT J, 1990, J FISH BIOL, V37, P175, DOI 10.1111/j.1095-8649.1990.tb05938.x; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Gravish N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128301; HARRIS VERNON A., 1960, PROC ZOOL SOC LONDON, V134, P107; Hatton RL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.078101; Jarvik E., 1952, Meddelelser om Gronland, V114, P1; Jarvik E, 1996, DEVONIAN TETRAPOD IC; JOHNELS ALF G., 1957, OIKOS, V8, P122, DOI 10.2307/3564996; Jusufi A, 2008, P NATL ACAD SCI USA, V105, P4215, DOI 10.1073/pnas.0711944105; Kawano SM, 2013, INTEGR COMP BIOL, V53, P283, DOI 10.1093/icb/ict051; KELLY SD, 1995, J ROBOTIC SYST, V12, P417, DOI 10.1002/rob.4620120607; Li C, 2013, SCIENCE, V339, P1408, DOI 10.1126/science.1229163; Li C, 2009, P NATL ACAD SCI USA, V106, P3029, DOI 10.1073/pnas.0809095106; Libby T, 2012, NATURE, V481, P181, DOI 10.1038/nature10710; Maladen RD, 2009, SCIENCE, V325, P314, DOI 10.1126/science.1172490; Marvi H, 2014, SCIENCE, V346, P224, DOI 10.1126/science.1255718; Mazouchova N, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/026007; Mitarai N, 2006, ADV PHYS, V55, P1, DOI 10.1080/00018730600626065; Nishikawa K, 2007, INTEGR COMP BIOL, V47, P16, DOI 10.1093/icb/icm024; Pace CM, 2014, J FISH BIOL, V84, P639, DOI 10.1111/jfb.12318; Pace CM, 2011, J EXP BIOL, V214, P530, DOI 10.1242/jeb.047902; Pierce SE, 2013, INTEGR COMP BIOL, V53, P209, DOI 10.1093/icb/ict022; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; Qian FF, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/056014; SHAPERE A, 1987, PHYS REV LETT, V58, P2051, DOI 10.1103/PhysRevLett.58.2051; Sharpe SS, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/4/046009; Standen EM, 2014, NATURE, V513, P54, DOI 10.1038/nature13708; Swanson BO, 2004, J EXP BIOL, V207, P4037, DOI 10.1242/jeb.01237	37	56	57	10	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					154	158		10.1126/science.aaf0984	http://dx.doi.org/10.1126/science.aaf0984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27387947				2022-12-24	WOS:000379208400035
J	Dutta, A; Le Magnen, C; Mitrofanova, A; Ouyang, XS; Califano, A; Abate-Shen, C				Dutta, Aditya; Le Magnen, Clementine; Mitrofanova, Antonina; Ouyang, Xuesong; Califano, Andrea; Abate-Shen, Cory			Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation	SCIENCE			English	Article							METHYLTRANSFERASE G9A; LUNG ADENOCARCINOMA; CANCER; NKX3.1; NKX2-1; CELLS; ORIGIN; GENES; UTX	The NKX3.1 homeobox gene plays essential roles in prostate differentiation and prostate cancer. We show that loss of function of Nkx3.1 in mouse prostate results in down-regulation of genes that are essential for prostate differentiation, as well as up-regulation of genes that are not normally expressed in prostate. Conversely, gain of function of Nkx3.1 in an otherwise fully differentiated nonprostatic mouse epithelium (seminal vesicle) is sufficient for respecification to prostate in renal grafts in vivo. In human prostate cells, these activities require the interaction of NKX3.1 with the G9a histone methyltransferase via the homeodomain and are mediated by activation of target genes such as UTY (KDM6c), the male-specific paralog of UTX (KDM6a). We propose that an NKX3.1-G9a-UTY transcriptional regulatory network is essential for prostate differentiation, and we speculate that disruption of such a network predisposes to prostate cancer.	[Dutta, Aditya; Le Magnen, Clementine] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Med,Inst Canc Genet, New York, NY 10032 USA; [Dutta, Aditya; Le Magnen, Clementine] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Urol,Inst Canc Genet, New York, NY 10032 USA; [Mitrofanova, Antonina] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Ouyang, Xuesong] Columbia Univ, Med Ctr, Dept Urol, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Syst Biol,Herbert Irving Comprehens Canc Ctr, Ctr Computat Biol & Bioinformat,Inst Canc Genet, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Biomed Informat,Herbert Irving Comprehens Ca, Ctr Computat Biol & Bioinformat,Inst Canc Genet, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys,Herbert Irving Compreh, Ctr Computat Biol & Bioinformat,Inst Canc Genet, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Dept Urol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Dept Med, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Dept Syst Biol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA; [Mitrofanova, Antonina] Rutgers State Univ, Dept Hlth Informat, 65 Bergen St,Room 350B, Newark, NJ 07101 USA; [Ouyang, Xuesong] Crown Biosci Inc, 6 West Beijing Rd, Taicang 215400, Jiangsu, Peoples R China	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Rutgers State University Newark; Rutgers State University New Brunswick	Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Dept Urol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA.; Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Dept Med, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA.; Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Dept Syst Biol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA.; Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA.	cabateshen@columbia.edu	Le Magnen, Clementine/T-1164-2019; Dutta, Aditya/D-4825-2016	Dutta, Aditya/0000-0001-9007-4262; Califano, Andrea/0000-0003-4742-3679; Le Magnen, Clementine/0000-0002-6084-6054	JP Sulzberger Columbia Genome Center; Proteomics Shared Resource; NIH/NCI [P30 CA013696]; National Cancer Institute [CA154293]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000040]; Swiss National Science Foundation [PBBSP3_146959, P300P3_151158]; Prostate Cancer Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE [R01CA076501, R01CA173481, R01CA183929, P30CA013696, P01CA154293] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER	JP Sulzberger Columbia Genome Center; Proteomics Shared Resource; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Prostate Cancer Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We are grateful to A. Aytes, F. Constantini, E. Gelmann, D. Reinberg, and M. Shen for comments on the manuscript. We thank C. Bieberich (University of Maryland) for Nkx3.1 antisera. We acknowledge support from the JP Sulzberger Columbia Genome Center and the Proteomics Shared Resource, which are shared resources of the Herbert Irving Comprehensive Cancer Center at Columbia University, supported in part by NIH/NCI grant P30 CA013696. This research is supported by funding to C.A.-S. from the National Cancer Institute (CA154293). A. D. was supported in part by the National Center for Advancing Translational Sciences, National Institutes of Health, grant UL1 TR000040. C.L.M. was supported by the Swiss National Science Foundation (PBBSP3_146959 and P300P3_151158). A. M. is a recipient of a Prostate Cancer Foundation Young Investigator Award. C.A.-S. is an American Cancer Society Research Professor supported in part by a generous gift from the F.M. Kirby Foundation.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Burglin T. R., 2015, CHROMOSOMA, V2015, P1; Chaturvedi CP, 2009, P NATL ACAD SCI USA, V106, P18303, DOI 10.1073/pnas.0906769106; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Lau YFC, 2000, MOL CARCINOGEN, V27, P308, DOI 10.1002/(SICI)1098-2744(200004)27:4<308::AID-MC9>3.0.CO;2-R; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Lehnertz B, 2014, GENE DEV, V28, P317, DOI 10.1101/gad.236794.113; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; Li CMC, 2015, GENE DEV, V29, P1850, DOI 10.1101/gad.267393.115; OSTROWSKI MC, 1979, J BIOL CHEM, V254, P383; Ouyang X, 2005, CANCER RES, V65, P6773, DOI 10.1158/0008-5472.CAN-05-1948; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Shpargel K. B., 2012, GENET, V8; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037647; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2014, CELL REP, V8, P1339, DOI 10.1016/j.celrep.2014.08.002; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Zheng SL, 2006, CANCER RES, V66, P69, DOI 10.1158/0008-5472.CAN-05-1550	27	62	63	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1576	1580		10.1126/science.aad9512	http://dx.doi.org/10.1126/science.aad9512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339988	Green Accepted			2022-12-24	WOS:000378346500044
J	Atianand, MK; Hu, WQ; Satpathy, AT; Shen, Y; Ricci, EP; Alvarez-Dominguez, JR; Bhatta, A; Schattgen, SA; McGowan, JD; Blin, J; Braun, JE; Gandhi, P; Moore, MJ; Chang, HY; Lodish, HF; Caffrey, DR; Fitzgerald, KA				Atianand, Maninjay K.; Hu, Wenqian; Satpathy, Ansuman T.; Shen, Ying; Ricci, Emiliano P.; Alvarez-Dominguez, Juan R.; Bhatta, Ankit; Schattgen, Stefan A.; McGowan, Jason D.; Blin, Juliana; Braun, Joerg E.; Gandhi, Pallavi; Moore, Melissa J.; Chang, Howard Y.; Lodish, Harvey F.; Caffrey, Daniel R.; Fitzgerald, Katherine A.			A Long Noncoding RNA lincRNA-EPS Acts as a Transcriptional Brake to Restrain Inflammation	CELL			English	Article							CHROMATIN SITES; EXPRESSION; SUSCEPTIBILITY; ACTIVATION; REPRESSION; EVOLUTION; REVEALS; DISEASE; REGIONS; HNRNPL	Long intergenic noncoding RNAs (lincRNAs) are important regulators of gene expression. Although lincRNAs are expressed in immune cells, their functions in immunity are largely unexplored. Here, we identify an immunoregulatory lincRNA, lincRNA-EPS, that is precisely regulated in macrophages to control the expression of immune response genes (IRGs). Transcriptome analysis of macrophages from lincRNA-EPS-deficient mice, combined with gain-of-function and rescue experiments, revealed a specific role for this lincRNA in restraining IRG expression. Consistently, lincRNA-EPS-deficient mice manifest enhanced inflammation and lethality following endotoxin challenge in vivo. lincRNA-EPS localizes at regulatory regions of IRGs to control nucleosome positioning and repress transcription. Further, lincRNA-EPS mediates these effects by interacting with heterogeneous nuclear ribonucleoprotein L via a CANACA motif located in its 3' end. Together, these findings identify lincRNA-EPS as a repressor of inflammatory responses, highlighting the importance of lincRNAs in the immune system.	[Atianand, Maninjay K.; Bhatta, Ankit; Schattgen, Stefan A.; McGowan, Jason D.; Blin, Juliana; Gandhi, Pallavi; Caffrey, Daniel R.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Program Innate Immun, Worcester, MA 01605 USA; [Hu, Wenqian; Alvarez-Dominguez, Juan R.; Lodish, Harvey F.] MIT, Whitehead Inst, Cambridge, MA 02142 USA; [Satpathy, Ansuman T.; Shen, Ying; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Satpathy, Ansuman T.; Shen, Ying; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Ricci, Emiliano P.; Braun, Joerg E.; Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01655 USA; [Ricci, Emiliano P.; Braun, Joerg E.; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Biochem & Pharmacol, Worcester, MA 01655 USA; [Fitzgerald, Katherine A.] NTNU, Ctr Mol Inflammat Res, Dept Canc Res & Mol Med, N-7491 Trondheim, Norway; [Hu, Wenqian] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ricci, Emiliano P.] Univ Lyon, Ecole Normale Super Lyon, Ctr Int Rech Infectiol, F-69364 Lyon, France	University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Whitehead Institute; Stanford University; Stanford University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU); Mayo Clinic; Ecole Normale Superieure de Lyon (ENS de LYON)	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Program Innate Immun, Worcester, MA 01605 USA.; Fitzgerald, KA (corresponding author), NTNU, Ctr Mol Inflammat Res, Dept Canc Res & Mol Med, N-7491 Trondheim, Norway.	kate.fitzgerald@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Atianand, Maninjay/AAF-7823-2019; Braun, Joerg/N-1277-2019; Ricci, Emiliano/G-7619-2012; Braun, Joerg/G-2617-2012; Hu, Wenqian/H-6094-2019	Atianand, Maninjay/0000-0003-4135-2515; Braun, Joerg/0000-0002-8309-6401; Ricci, Emiliano/0000-0002-9789-5837; Braun, Joerg/0000-0002-8309-6401; Hu, Wenqian/0000-0003-3577-3604; Blin, Juliana/0000-0002-9628-8920; Schattgen, Stefan/0000-0002-6860-5079; Satpathy, Ansuman/0000-0002-5167-537X; Fitzgerald, Kate/0000-0003-3175-609X; Bhatta, Ankit/0000-0002-2420-8805	American Heart Association grant [14POST18930001]; NIH [P50-HG007735, DK068348, AI067497]; Kenneth Rainin Foundation; Lupus Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067497, R37AI067497, T32AI095213, R21AI115448, R56AI067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068348, R01DK047618, R56DK068348] Funding Source: NIH RePORTER	American Heart Association grant(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kenneth Rainin Foundation; Lupus Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We sincerely thank Zhaozhao Jiang and Kelly Army for animal care and technical help, Mona Motwani and Shruti Sharma for help with flow cytometry, Alicia Schep for NucleoATAC analysis, Rui Li for help during initial stages of ATAC-seq library preparation, and all members of the Fitzgerald laboratory as well as Susan Carpenter (UCSC) for their insightful comments. We thank Michael Karin (UCSD) for providing RNA samples, and Scott Schaffer and John Leszyck (UMass, Worcester) for mass spectrometry. This study was supported by American Heart Association grant (14POST18930001) to M.K.A., by NIH grant (P50-HG007735) to H.Y.C., by NIH grant (DK068348) to H.F.L., and by grants from the Kenneth Rainin Foundation, Lupus Research Foundation, and NIH (AI067497) to K.A.F.	Atianand MK, 2014, TRENDS MOL MED, V20, P623, DOI 10.1016/j.molmed.2014.09.002; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Chan J, 2015, J IMMUNOL, V195, P1359, DOI 10.4049/jimmunol.1500264; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Girauda M, 2014, P NATL ACAD SCI USA, V111, P1491, DOI 10.1073/pnas.1323535111; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hacisuleyman E, 2014, NAT STRUCT MOL BIOL, V21, P198, DOI 10.1038/nsmb.2764; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Heyer EE, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1235; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Leary VB, 2015, CELL REP, V11, P474, DOI 10.1016/j.celrep.2015.03.043; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Smale ST, 2013, COLD SH Q B, V78, P61, DOI 10.1101/sqb.2013.78.020313; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012	32	289	311	0	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1672	1685		10.1016/j.cell.2016.05.075	http://dx.doi.org/10.1016/j.cell.2016.05.075			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315481	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000378062000018
J	Sarpatwari, A; Avorn, J; Kesselheim, AS				Sarpatwari, Ameet; Avorn, Jerry; Kesselheim, Aaron S.			State Initiatives to Control Medication Costs - Can Transparency Legislation Help?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sarpatwari, Ameet] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University	Sarpatwari, A (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Anderson Richard, 2014, BBC NEWS; Avorn J, 2015, NEW ENGL J MED, V372, P1877, DOI 10.1056/NEJMp1500848; Barlas Stephen, 2015, P T, V40, P260; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; IMS Institute for Healthcare Informatics, 2016, MED US SPEND US REV	5	19	20	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2301	2304		10.1056/NEJMp1605100	http://dx.doi.org/10.1056/NEJMp1605100			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27305189				2022-12-24	WOS:000377854600001
J	Khan, NA				Khan, Nadia A.			Getting to Lower Systolic Blood Pressure: Beyond Antihypertensive Therapy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Khan, Nadia A.] Univ British Columbia, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada	University of British Columbia	Khan, NA (corresponding author), Univ British Columbia, Ctr Hlth Evaluat & Outcome Sci, 570 4B,1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	nakhanubc@gmail.com						BRUCKERT E, 2011, ARCH CARDIOVASC DIS, V381, P104; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Feldman RD, 2009, HYPERTENSION, V53, P646, DOI 10.1161/HYPERTENSIONAHA.108.123455; Leung AA, 2016, CAN J CARDIOL, V32, P569, DOI 10.1016/j.cjca.2016.02.066; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Myers MG, 2012, CAN J CARDIOL, V28, P341, DOI 10.1016/j.cjca.2011.09.004; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; TURCHIN A, 2009, HYPERTENSION, V53, P646; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050	9	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					661	662		10.7326/M16-1421	http://dx.doi.org/10.7326/M16-1421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27537098				2022-12-24	WOS:000386908600025
J	Venkatakrishnan, AJ; Deupi, X; Lebon, G; Heydenreich, FM; Flock, T; Miljus, T; Balaji, S; Bouvier, M; Veprintsev, DB; Tate, CG; Schertler, GFX; Babu, MM				Venkatakrishnan, A. J.; Deupi, Xavier; Lebon, Guillaume; Heydenreich, Franziska M.; Flock, Tilman; Miljus, Tamara; Balaji, Santhanam; Bouvier, Michel; Veprintsev, Dmitry B.; Tate, Christopher G.; Schertler, Gebhard F. X.; Babu, M. Madan			Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region	NATURE			English	Article							RECEPTOR ACTIVATION; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL INSIGHTS; MECHANISM	Class A G-protein-coupled receptors (GPCRs) are a large family of membrane proteins that mediate a wide variety of physiological functions, including vision, neurotransmission and immune responses(1-4). They are the targets of nearly one-third of all prescribed medicinal drugs(5) such as beta blockers and antipsychotics. GPCR activation is facilitated by extracellular ligands and leads to the recruitment of intracellular G proteins(3,6). Structural rearrangements of residue contacts in the transmembrane domain serve as 'activation pathways' that connect the ligand-binding pocket to the G-protein-coupling region within the receptor. In order to investigate the similarities in activation pathways across class A GPCRs, we analysed 27 GPCRs from diverse subgroups for which structures of active, inactive or both states were available. Here we show that, despite the diversity in activation pathways between receptors, the pathways converge near the G-protein-coupling region. This convergence is mediated by a highly conserved structural rearrangement of residue contacts between transmembrane helices 3, 6 and 7 that releases G-protein-contacting residues. The convergence of activation pathways may explain how the activation steps initiated by diverse ligands enable GPCRs to bind a common repertoire of G proteins.	[Venkatakrishnan, A. J.; Flock, Tilman; Balaji, Santhanam; Tate, Christopher G.; Babu, M. Madan] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Venkatakrishnan, A. J.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA; [Venkatakrishnan, A. J.] Stanford Univ, Dept Comp Sci, 318 Campus Dr, Stanford, CA 94305 USA; [Venkatakrishnan, A. J.] Stanford Univ, Inst Computat & Math Engn, 475 Via Ortega, Stanford, CA 94305 USA; [Deupi, Xavier; Heydenreich, Franziska M.; Miljus, Tamara; Veprintsev, Dmitry B.; Schertler, Gebhard F. X.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Lebon, Guillaume] CNRS, UMR 5203, Inst Genom Fonct, 141 Rue Cardonille, F-34094 Montpellier 05, France; [Lebon, Guillaume] INSERM, U1191, F-34094 Montpellier, France; [Lebon, Guillaume] Univ Montpellier, F-34094 Montpellier, France; [Heydenreich, Franziska M.; Miljus, Tamara; Veprintsev, Dmitry B.; Schertler, Gebhard F. X.] ETH, Dept Biol, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland; [Heydenreich, Franziska M.; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Heydenreich, Franziska M.; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada	MRC Laboratory Molecular Biology; Stanford University; Stanford University; Stanford University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universite de Montreal; Universite de Montreal	Venkatakrishnan, AJ; Babu, MM (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.; Venkatakrishnan, AJ (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.; Venkatakrishnan, AJ (corresponding author), Stanford Univ, Dept Comp Sci, 318 Campus Dr, Stanford, CA 94305 USA.; Venkatakrishnan, AJ (corresponding author), Stanford Univ, Inst Computat & Math Engn, 475 Via Ortega, Stanford, CA 94305 USA.	ajvenkat@stanford.edu; madanm@mrc-lmb.cam.ac.uk	Heydenreich, Franziska M/N-6314-2015; Lebon, Guillaume/AAZ-4486-2020; Veprintsev, Dmitry B/H-2228-2012; Bouvier, Michel/H-2758-2014; Mohan, Babu P./I-7362-2019; Deupi, Xavier/B-2424-2009	Heydenreich, Franziska M/0000-0002-8049-4383; Veprintsev, Dmitry B/0000-0002-3583-5409; Bouvier, Michel/0000-0003-1128-0100; Deupi, Xavier/0000-0003-4572-9316; Guillaume, Lebon/0000-0003-1162-5148; Schertler, Gebhard F.X./0000-0002-5846-6810; Miljus, Tamara/0000-0003-0462-7866; /0000-0003-3398-0968	LMB International Scholarship; St. John's College Benefactor Scholarship; MRC Centenary Early Career Award; Medical Research Council [MC_U105185859, MC_U105197215]; Boehringer Ingelheim Fonds; Heptares Therapeutics Ltd; ATIP-Avenir program; Swiss National Science Foundation [310030_153145, 31003A_146520, 31003A_159748, P1EZP3_165219]; Human Frontiers Science Program [RGP0034/2014]; Canadian Institute for Health Research [MOP-10501]; COST Action [CM1207]; MRC [MC_U105185859, MC_U105197215] Funding Source: UKRI	LMB International Scholarship; St. John's College Benefactor Scholarship; MRC Centenary Early Career Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Heptares Therapeutics Ltd; ATIP-Avenir program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers Science Program(Human Frontier Science Program); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); COST Action(European Cooperation in Science and Technology (COST)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Chothia, G. Chalancon, N. Latysheva, R. Henderson, A. Sente, K. Kruse, A. Singhal and S. Chavali for their comments on this manuscript. We acknowledge LMB International Scholarship (in support of A.J.V.), St. John's College Benefactor Scholarship (A.J.V.), MRC Centenary Early Career Award (A. J. V.), the Medical Research Council (MC_U105185859) (M.M.B., S.B., T.F.); (MC_U105197215) (C.G.T., G.L.), Boehringer Ingelheim Fonds (T.F.), Heptares Therapeutics Ltd (G.L.), ATIP-Avenir program (G.L.), Swiss National Science Foundation (grant number 310030_153145) (G.F.X.S.); (31003A_146520) (X.D.); (31003A_159748) (D.B.V.), Swiss National Science Foundation Doc. Mobility fellowship P1EZP3_165219 (F.M.H.), the Human Frontiers Science Program (RGP0034/2014) (G.F.X.S.), the Canadian Institute for Health Research (MOP-10501) (M.B.) and the COST Action CM1207 (GLISTEN) (X.D., G.F.X.S., C.G.T., G.L.). M.M.B. is a Lister Institute Research Prize Fellow. M. B. holds a Canada Research Chair.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bohm SK, 1997, J BIOL CHEM, V272, P2363; Breton B, 2010, BIOPHYS J, V99, P4037, DOI 10.1016/j.bpj.2010.10.025; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Gabilondo AM, 1996, EUR J PHARMACOL, V307, P243, DOI 10.1016/0014-2999(96)00247-6; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gonzalez A, 2012, CHEMBIOCHEM, V13, P1393, DOI 10.1002/cbic.201200189; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Isom DG, 2015, P NATL ACAD SCI USA, V112, P5702, DOI 10.1073/pnas.1417888112; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lans I, 2015, J STRUCT BIOL, V192, P545, DOI 10.1016/j.jsb.2015.10.019; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sun DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078878; Tello JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038456; Venkatakrishnan AJ, 2014, CURR OPIN STRUC BIOL, V27, P129, DOI 10.1016/j.sbi.2014.08.002; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Yuan SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5733	32	176	181	5	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					484	+		10.1038/nature19107	http://dx.doi.org/10.1038/nature19107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27525504	Green Accepted			2022-12-24	WOS:000382646600047
J	Manrai, AK; Funke, BH; Rehm, HL; Olesen, MS; Maron, BA; Szolovits, P; Margulies, DM; Loscalzo, J; Kohane, IS				Manrai, Arjun K.; Funke, Birgit H.; Rehm, Heidi L.; Olesen, Morten S.; Maron, Bradley A.; Szolovits, Peter; Margulies, David M.; Loscalzo, Joseph; Kohane, Isaac S.			Genetic Misdiagnoses and the Potential for Health Disparities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; MUTATIONS; VARIANTS; PATHOGENICITY; POPULATION; STANDARDS; GENOMICS; DATABASE; RISK	BACKGROUND For more than a decade, risk stratification for hypertrophic cardiomyopathy has been enhanced by targeted genetic testing. Using sequencing results, clinicians routinely assess the risk of hypertrophic cardiomyopathy in a patient's relatives and diagnose the condition in patients who have ambiguous clinical presentations. However, the benefits of genetic testing come with the risk that variants may be misclassified. METHODS Using publicly accessible exome data, we identified variants that have previously been considered causal in hypertrophic cardiomyopathy and that are overrepresented in the general population. We studied these variants in diverse populations and reevaluated their initial ascertainments in the medical literature. We reviewed patient records at a leading genetic-testing laboratory for occurrences of these variants during the near-decade-long history of the laboratory. RESULTS Multiple patients, all of whom were of African or unspecified ancestry, received positive reports, with variants misclassified as pathogenic on the basis of the understanding at the time of testing. Subsequently, all reported variants were recategorized as benign. The mutations that were most common in the general population were significantly more common among black Americans than among white Americans ( P<0.001). Simulations showed that the inclusion of even small numbers of black Americans in control cohorts probably would have prevented these misclassifications. We identified methodologic shortcomings that contributed to these errors in the medical literature. CONCLUSIONS The misclassification of benign variants as pathogenic that we found in our study shows the need for sequencing the genomes of diverse populations, both in asymptomatic controls and the tested patient population. These results expand on current guidelines, which recommend the use of ancestry-matched controls to interpret variants. As additional populations of different ancestry backgrounds are sequenced, we expect variant reclassifications to increase, particularly for ancestry groups that have historically been less well studied. ( Funded by the National Institutes of Health.)	[Manrai, Arjun K.; Margulies, David M.; Kohane, Isaac S.] Harvard Med Sch, Dept Biomed Informat, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Funke, Birgit H.] Harvard Med Sch, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Maron, Bradley A.; Loscalzo, Joseph] Harvard Med Sch, Dept Pathol, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Rehm, Heidi L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Maron, Bradley A.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Maron, Bradley A.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Manrai, Arjun K.; Kohane, Isaac S.] Harvard Massachusetts Inst Technol MIT, Div Hlth Sci & Technol, Cambridge, MA USA; [Funke, Birgit H.; Rehm, Heidi L.] Partners HealthCare Personalized Med, Mol Med Lab, Cambridge, MA USA; [Szolovits, Peter] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Olesen, Morten S.] Univ Copenhagen Hosp, Rigshosp, Lab Mol Cardiol, Dept Cardiol,Heart Ctr, Copenhagen, Denmark; [Olesen, Morten S.] Univ Copenhagen, Dept Biomed Sci, Fac Hlth & Med Sci, Copenhagen, Denmark	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Massachusetts Institute of Technology (MIT); Rigshospitalet; University of Copenhagen; University of Copenhagen	Kohane, IS (corresponding author), 10 Shattuck St, Boston, MA 02115 USA.	isaac_kohane@harvard.edu	olesen, morten/AAC-5752-2021; Loscalzo, Joseph/ABD-8980-2021	Manrai, Arjun/0000-0001-9657-9800; Margulies, David/0000-0002-1294-3386; Rehm, Heidi L./0000-0002-6025-0015; Olesen, Morten Salling/0000-0001-9477-5322	National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007690, T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funded by the National Institutes of Health.	Alfares AA, 2015, GENET MED, V17, P880, DOI [10.1038/gim.2014.205, 10.1038/gim.2015.16]; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andreasen C, 2013, EUR J HUM GENET, V21, P918, DOI 10.1038/ejhg.2012.283; [Anonymous], 2011, PRECISION MED BUILDI; Arimura T, 2007, BIOCHEM BIOPH RES CO, V362, P281, DOI 10.1016/j.bbrc.2007.07.183; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Bick AG, 2012, AM J HUM GENET, V91, P513, DOI 10.1016/j.ajhg.2012.07.017; Drazen JM, 2015, NEW ENGL J MED, V372, P201, DOI 10.1056/NEJMp1415160; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Exome Aggregation Consortium (ExAC), 2016, EXAC BROWS BET; Garcia-Castro M, 2003, CLIN CHEM, V49, P1279, DOI 10.1373/49.8.1279; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Klitzman R, 2013, J GENET COUNS, V22, P90, DOI 10.1007/s10897-012-9504-z; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lo B, 2015, JAMA-J AM MED ASSOC, V313, P793, DOI 10.1001/jama.2015.292; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Manrai AK, 2016, JAMA-J AM MED ASSOC, V315, P1233, DOI 10.1001/jama.2016.1519; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Maron BJ, 2011, AM J CARDIOL, V107, P604, DOI 10.1016/j.amjcard.2010.10.022; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Matsushita Y, 2007, J HUM GENET, V52, P543, DOI 10.1007/s10038-007-0149-y; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Norton N, 2012, CIRC-CARDIOVASC GENE, V5, P167, DOI 10.1161/CIRCGENETICS.111.961805; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; Wilcox AR, 2014, J AM MED INFORM ASSN, V21, pE117, DOI 10.1136/amiajnl-2013-001965	40	409	409	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					655	665		10.1056/NEJMsa1507092	http://dx.doi.org/10.1056/NEJMsa1507092			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4VF	27532831	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000381478600007
J	Carrillo-Reid, L; Yang, WJ; Bando, Y; Peterka, DS; Yuste, R				Carrillo-Reid, Luis; Yang, Weijian; Bando, Yuki; Peterka, Darcy S.; Yuste, Rafael			Imprinting and recalling cortical ensembles	SCIENCE			English	Article							NEURAL-NETWORKS; VISUAL-STIMULI; MOTOR CORTEX; MEMORY; REPRESENTATION; POPULATIONS; ATTRIBUTES	Neuronal ensembles are coactive groups of neurons that may represent building blocks of cortical circuits. These ensembles could be formed by Hebbian plasticity, whereby synapses between coactive neurons are strengthened. Here we report that repetitive activation with two-photon optogenetics of neuronal populations from the visual cortex of awake mice builds neuronal ensembles that recur spontaneously after being imprinted and do not disrupt preexisting ones. Moreover, imprinted ensembles can be recalled by single-cell stimulation and remain coactive on consecutive days. Our results demonstrate the persistent reconfiguration of cortical circuits by two-photon optogenetics into neuronal ensembles that can perform pattern completion.	[Carrillo-Reid, Luis; Yang, Weijian; Bando, Yuki; Peterka, Darcy S.; Yuste, Rafael] Columbia Univ, NeuroTechnol Ctr, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Carrillo-Reid, L (corresponding author), Columbia Univ, NeuroTechnol Ctr, Dept Biol Sci, New York, NY 10027 USA.	lc2998@columbia.edu		Bando, Yuki/0000-0003-3050-4982; Peterka, Darcy/0000-0001-7351-5820; Carrillo-Reid, Luis/0000-0002-0511-2533	National Eye Institute [DP1EY024503, R01EY011787]; National Institute of Mental Health [R01MH101218, R01MH100561, R41MH100895, R44MH109187]; Defense Advanced Research Projects Agency [SIMPLEX N66001-15-C-4032]; Uehara Memorial Foundation; Burroughs Wellcome Fund; U.S. Army Research Laboratory; U.S. Army Research Office [W911NF-12-1-0594]; NATIONAL EYE INSTITUTE [R01EY011787, DP1EY024503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100561, R01MH101218, R41MH100895, R44MH109187] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Uehara Memorial Foundation(Uehara Memorial Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank our laboratory members for help and virus injections, A. Fairhall for comments, and the Stanford Neuroscience Gene Vector and Virus Core for AAVdj virus. This work was supported by the National Eye Institute (grants DP1EY024503 and R01EY011787), National Institute of Mental Health (grants R01MH101218, R01MH100561, R41MH100895, and R44MH109187), and Defense Advanced Research Projects Agency (grant SIMPLEX N66001-15-C-4032). Y.B. holds a fellowship from Uehara Memorial Foundation. W.Y. holds a Career Award at the Scientific Interface from Burroughs Wellcome Fund. This material is based on work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office (contract W911NF-12-1-0594, Multidisciplinary University Research Initiative). We declare no competing financial interests. Author contributions: L.C.-R. and R.Y. came up with the concept for this work. L.C.-R., D.S.P., W.Y., and R.Y. designed the methodology. L.C.-R., W.Y., and Y.B. carried out the investigation. L.C.-R. wrote the original draft. L.C.-R. and R.Y. reviewed and edited the paper. D.S.P., W.Y., and L.C.-R. provided the resources for this work. R.Y. acquired funding. All of the data are archived in the NeuroTechnology Center at Columbia University.	Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Cao VY, 2015, NEURON, V86, P1385, DOI 10.1016/j.neuron.2015.05.022; Carrillo-Reid L, 2008, J NEUROPHYSIOL, V99, P1435, DOI 10.1152/jn.01131.2007; Carrillo-Reid L, 2015, J NEUROSCI, V35, P8813, DOI 10.1523/JNEUROSCI.5214-14.2015; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hunsaker MR, 2013, NEUROSCI BIOBEHAV R, V37, P36, DOI 10.1016/j.neubiorev.2012.09.014; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kampa BM, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00018; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Miller JEK, 2014, P NATL ACAD SCI USA, V111, pE4053, DOI 10.1073/pnas.1406077111; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; ROLLS ET, 1994, PROG BRAIN RES, V102, P335; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Yuste R, 2015, NAT REV NEUROSCI, V16, P487, DOI 10.1038/nrn3962	27	137	138	7	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					691	694		10.1126/science.aaf7560	http://dx.doi.org/10.1126/science.aaf7560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516599	Green Accepted			2022-12-24	WOS:000381561200038
J	Hjerpe, R; Bett, JS; Keuss, MJ; Solovyova, A; McWilliams, TG; Johnson, C; Sahu, I; Varghese, J; Wood, N; Wightman, M; Osborne, G; Bates, GP; Glickman, MH; Trost, M; Knebel, A; Marchesi, F; Kurz, T				Hjerpe, Roland; Bett, John S.; Keuss, Matthew J.; Solovyova, Alexandra; McWilliams, Thomas G.; Johnson, Clare; Sahu, Indrajit; Varghese, Joby; Wood, Nicola; Wightman, Melanie; Osborne, Georgina; Bates, Gillian P.; Glickman, Michael H.; Trost, Matthias; Knebel, Axel; Marchesi, Francesco; Kurz, Thimo			UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome	CELL			English	Article							POLYUBIQUITIN-BINDING PROTEIN; INTERACTION NETWORK; NUCLEAR; RAD23; HSP70; UBIQUITINATION; IDENTIFICATION; DEGRADATION; RECEPTORS; PROMOTES	Clearance of misfolded and aggregated proteins is central to cell survival. Here, we describe a new pathway for maintaining protein homeostasis mediated by the proteasome shuttle factor UBQLN2. The 26S proteasome degrades polyubiquitylated substrates by recognizing them through stoichiometrically bound ubiquitin receptors, but substrates are also delivered by reversibly bound shuttles. We aimed to determine why these parallel delivery mechanisms exist and found that UBQLN2 acts with the HSP70-HSP110 disaggregase machinery to clear protein aggregates via the 26S proteasome. UBQLN2 recognizes client-bound HSP70 and links it to the proteasome to allow for the degradation of aggregated and misfolded proteins. We further show that this process is active in the cell nucleus, where another system for aggregate clearance, autophagy, does not act. Finally, we found that mutations in UBQLN2, which lead to neurodegeneration in humans, are defective in chaperone binding, impair aggregate clearance, and cause cognitive deficits in mice.	[Hjerpe, Roland; Bett, John S.; Kurz, Thimo] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Henry Wellcome Lab Cell Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Hjerpe, Roland; Bett, John S.; Keuss, Matthew J.; McWilliams, Thomas G.; Johnson, Clare; Varghese, Joby; Wood, Nicola; Wightman, Melanie; Trost, Matthias; Knebel, Axel; Kurz, Thimo] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Sir James Black Ctr, Dow St, Dundee DD1 5EH, Scotland; [Solovyova, Alexandra] Newcastle Univ Prot & Proteome Anal, Devonshire Bldg,Devonshire Terrace, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sahu, Indrajit; Glickman, Michael H.] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Osborne, Georgina; Bates, Gillian P.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, 8th Floor Tower Wing, London SE1 9RT, England; [Marchesi, Francesco] Univ Glasgow, Coll Med Vet & Life Sci, Sch Vet Med, 464 Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland	University of Glasgow; University of Dundee; Technion Israel Institute of Technology; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Glasgow	Bett, JS; Kurz, T (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Henry Wellcome Lab Cell Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.; Bett, JS; Kurz, T (corresponding author), Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Sir James Black Ctr, Dow St, Dundee DD1 5EH, Scotland.	johnsbett@yahoo.co.uk; thimo.kurz@glasgow.ac.uk	Marchesi, Francesco/ABF-9255-2021; Trost, Matthias/A-9999-2009; Bates, Gillian/E-1146-2012	Marchesi, Francesco/0000-0003-1179-5788; Trost, Matthias/0000-0002-5732-700X; Bates, Gillian/0000-0002-4041-6305; Sahu, Indrajit/0000-0002-4143-0600; Glickman, Michael/0000-0002-1222-8104; Kurz, Thimo/0000-0003-0700-6993; Osborne, Georgina/0000-0001-8308-3179; McWilliams, Thomas/0000-0002-9570-4152; Wood, Nicola/0000-0002-3347-6625; Knebel, Axel/0000-0002-9197-6054; Solovyova, Alexandra/0000-0002-5682-7037	Medical Research Council [MRC_MC_UU_12016/7]; ERC [ERC_243019]; University of Glasgow Leadership Fellowship and Tenovus Scotland grant; CDHI foundation; Israel Science Foundation [ISF 909.14]; Division of Signal Transduction Therapy Unit; Medical Research Council [MC_UU_12016/5, MC_UP_A500_1020, MC_UU_12016/7] Funding Source: researchfish; MRC [MC_UP_A500_1020, MC_UU_12016/7, MC_UU_12016/5] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); University of Glasgow Leadership Fellowship and Tenovus Scotland grant; CDHI foundation; Israel Science Foundation(Israel Science Foundation); Division of Signal Transduction Therapy Unit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge technical support of the MRC Protein Phosphorylation and Ubiquitylation Unit, Elaine Forsyth for assistance with mouse work, the DNA Sequencing Service (coordinated by Nicholas Helps), Thomas Macartney and other members of the cloning team (coordinated by Rachel Toth and Mark Peggie), and the Protein Purification Team and Antibody Production Team (coordinated by Hilary McLauchlan and James Hastie). We thank Prof. Mike Cheetham (UCL) for providing HTT constructs and Prof. Ron Kopito (Stanford University) for providing GFPu-NLS cells. Special thanks to Dr. Katsuaki Inoue (beamline B21, Diamond Light Source, Didcot, UK) for help with SAXS data collection and primary data treatment and the Diamond Light Source for beamtime granted (proposal SM-5025-1). We thank Prof. Jeremy H. Lakey and Dr. Helen Waller for help in carrying out CD experiments, Mrs. Lynn Stevenson and Ms. Lynn Oxford (Veterinary Diagnostic Services, School of Veterinary Medicine, University of Glasgow) for their technical assistance with immunohistochemistry, and Dr. Ian Ganley and Dr. Michael Munson for advice on autophagy-related experiments and for providing ATG5 KO cells and LC3 antibodies. We thank Professor Kazuhiro Nagata (Kyoto Sangyo University) for providing HSP105 KO cells. We thank John MacLeod for his assistance in anaesthetizing mice and Amnon Golan for aiding in purification and characterization of 26S proteasome from human cells. This work was supported by the Medical Research Council (MRC_MC_UU_12016/7), an ERC Starting Investigator Grant to T.K. (ERC_243019), a University of Glasgow Leadership Fellowship and Tenovus Scotland grant (to J.S.B.), the CDHI foundation (to G.B.), an Israel Science Foundation (ISF 909.14) grant (to M.H.G.), as well as the pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck, Janssen Pharmaceutica, and Pfizer).	Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Eggers DK, 1997, MOL BIOL CELL, V8, P1559, DOI 10.1091/mbc.8.8.1559; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fahed AC, 2014, ANN NEUROL, V75, P793, DOI 10.1002/ana.24164; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Ganguly A, 2008, HUM MOL GENET, V17, P293, DOI 10.1093/hmg/ddm305; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Kaye FJ, 2000, FEBS LETT, V467, P348, DOI 10.1016/S0014-5793(00)01135-2; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marin I, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-63; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Mori F, 2012, ACTA NEUROPATHOL, V124, P149, DOI 10.1007/s00401-012-0999-z; Nakamura J, 2008, STROKE, V39, P2853, DOI 10.1161/STROKEAHA.107.506188; Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884; Osaka M, 2015, HUM MOL GENET, V24, P1617, DOI 10.1093/hmg/ddu575; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rutherford NJ, 2013, BRAIN RES, V1524, P62, DOI 10.1016/j.brainres.2013.06.006; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VELAZQUEZ JM, 1984, CELL, V36, P655, DOI 10.1016/0092-8674(84)90345-3; Vengoechea J, 2013, AMYOTROPH LAT SCL FR, V14, P615, DOI 10.3109/21678421.2013.824001; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Williams K. L., 2012, NEUROBIOL AGING, V33, pe3, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2012.05.008, 10.1016/j.neurobiolaging.2012.05.008]; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhang HQ, 2015, STRUCTURE, V23, P472, DOI 10.1016/j.str.2015.01.003	40	183	184	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					935	949		10.1016/j.cell.2016.07.001	http://dx.doi.org/10.1016/j.cell.2016.07.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27477512	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000382258700016
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Clean eating and the cult of healthism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				British Dietetic Association, 2014, DIET NUTR NUTR THER	1	11	11	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2016	354								i4095	10.1136/bmj.i4095	http://dx.doi.org/10.1136/bmj.i4095			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS6YZ	27456087	Bronze, Green Published			2022-12-24	WOS:000380930800002
J	Anthony, KW; Macintyre, S				Anthony, Katey Walter; Macintyre, Sally			BIOGEOCHEMISTRY Nocturnal escape route for marsh gas	NATURE			English	Editorial Material							METHANE EMISSIONS; FRESH-WATER; EXCHANGE; MODEL		[Anthony, Katey Walter] Univ Alaska Fairbanks, Water & Environm Res Ctr, Fairbanks, AK 99775 USA; [Macintyre, Sally] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of Alaska System; University of Alaska Fairbanks; University of California System; University of California Santa Barbara	Anthony, KW (corresponding author), Univ Alaska Fairbanks, Water & Environm Res Ctr, Fairbanks, AK 99775 USA.	kmwalteranthony@alaska.edu; sally.macintyre@ucsb.edu						Bastviken D, 2011, SCIENCE, V331, P50, DOI 10.1126/science.1196808; Bohn TJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045450; CRILL PM, 1988, J GEOPHYS RES-ATMOS, V93, P1564, DOI 10.1029/JD093iD02p01564; MacIntyre S., 1995, BIOGENIC TRACE GASES, P52; MacIntyre S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044164; MORRISSEY LA, 1992, J GEOPHYS RES-ATMOS, V97, P16661, DOI 10.1029/92JD00063; Poindexter C. M., 2016, GEOPHYS RES LETT; Riley WJ, 2011, BIOGEOSCIENCES, V8, P1925, DOI 10.5194/bg-8-1925-2011; Shukla P.R., 2022, CLIMATE CHANGE 2013; Walter BP, 2000, GLOBAL BIOGEOCHEM CY, V14, P745, DOI 10.1029/1999GB001204; Wang BB, 2015, J GEOPHYS RES-OCEANS, V120, P2129, DOI 10.1002/2014JC010253; WHITING GJ, 1991, J GEOPHYS RES-ATMOS, V96, P13067, DOI 10.1029/91JD01248; Zappa CJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028790	13	12	12	1	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					363	365		10.1038/535363a	http://dx.doi.org/10.1038/535363a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27443738				2022-12-24	WOS:000380344200028
J	Matyskiela, ME; Lu, G; Ito, T; Pagarigan, B; Lu, CC; Miller, K; Fang, W; Wang, NY; Nguyen, D; Houston, J; Carmel, G; Tran, T; Riley, M; Nosaka, L; Lander, GC; Gaidarova, S; Xu, SC; Ruchelman, AL; Handa, H; Carmichael, J; Daniel, TO; Cathers, BE; Lopez-Girona, A; Chamberlain, PP				Matyskiela, Mary E.; Lu, Gang; Ito, Takumi; Pagarigan, Barbra; Lu, Chin-Chun; Miller, Karen; Fang, Wei; Wang, Nai-Yu; Nguyen, Derek; Houston, Jack; Carmel, Gilles; Tran, Tam; Riley, Mariko; Nosaka, Lyn'Al; Lander, Gabriel C.; Gaidarova, Svetlana; Xu, Shuichan; Ruchelman, Alexander L.; Handa, Hiroshi; Carmichael, James; Daniel, Thomas O.; Cathers, Brian E.; Lopez-Girona, Antonia; Chamberlain, Philip P.			A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase	NATURE			English	Article							LENALIDOMIDE; TARGET; DEGRADATION; PROTEINS; COMPLEX; IKAROS; POMALIDOMIDE; RECOGNITION; THALIDOMIDE; HYDROXYPROLINE	Immunomodulatory drugs bind to cereblon (CRBN) to confer differentiated substrate specificity on the CRL4(CRBN) E3 ubiquitin ligase. Here we report the identification of a new cereblon modulator, CC-885, with potent anti-tumour activity. The anti-tumour activity of CC-885 is mediated through the cereblon-dependent ubiquitination and degradation of the translation termination factor GSPT1. Patient-derived acute myeloid leukaemia tumour cells exhibit high sensitivity to CC-885, indicating the clinical potential of this mechanism. Crystallographic studies of the CRBN-DDB1-CC-885-GSPT1 complex reveal that GSPT1 binds to cereblon through a surface turn containing a glycine residue at a key position, interacting with both CC-885 and a 'hotspot' on the cereblon surface. Although GSPT1 possesses no obvious structural, sequence or functional homology to previously known cereblon substrates, mutational analysis and modelling indicate that the cereblon substrate Ikaros uses a similar structural feature to bind cereblon, suggesting a common motif for substrate recruitment. These findings define a structural degron underlying cereblon 'neosubstrate' selectivity, and identify an anti-tumour target rendered druggable by cereblon modulation.	[Matyskiela, Mary E.; Lu, Gang; Pagarigan, Barbra; Lu, Chin-Chun; Miller, Karen; Fang, Wei; Wang, Nai-Yu; Nguyen, Derek; Houston, Jack; Carmel, Gilles; Tran, Tam; Riley, Mariko; Gaidarova, Svetlana; Xu, Shuichan; Ruchelman, Alexander L.; Carmichael, James; Daniel, Thomas O.; Cathers, Brian E.; Lopez-Girona, Antonia; Chamberlain, Philip P.] Celgene Corp, 10300 Campus Point Dr,Suite 100, San Diego, CA 92121 USA; [Ito, Takumi; Handa, Hiroshi] Tokyo Med Univ, Dept Nanoparticle Translat Res, Shinjuku Ku, Tokyo 1608402, Japan; [Nosaka, Lyn'Al; Lander, Gabriel C.] Scripps Res Inst, San Diego, CA 92121 USA	Bristol-Myers Squibb; Celgene Corporation; Tokyo Medical University; Scripps Research Institute	Lu, G; Chamberlain, PP (corresponding author), Celgene Corp, 10300 Campus Point Dr,Suite 100, San Diego, CA 92121 USA.	glu@celgene.com; pchamberlain@celgene.com		Lander, Gabriel C./0000-0003-4921-1135; Ito, Takumi/0000-0002-9997-2664; Cathers, Brian/0000-0003-2793-7533	National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23102002]; JST, PRESTO; MEXT [26750374]	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST, PRESTO(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Thanks to G. Reyes, C. Havens, P. Jackson and H. Hadjivassiliou for discussions relating to this manuscript, and P Jackson, J. Hansen, M. Correa, B. Fahr, M. Abbasian, E. Ambing, E. Rychak, D. Mendy and K. Hughes for technical assistance. We thank K. Motamedchaboki (Proteomics Core, Sanford Burnham Prebys Medical Discovery Institute) for mass spectrometry-based proteomic analysis. Thanks to J. Ballesteros and P Hernandez at Vivia for patient sample testing. Parts of this work were conducted at the Advanced Light Source. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract No. DE-AC02-05CH11231. This work was also supported by Grant-in-Aid for Scientific Research on Innovative Areas "Chemical Biology of Natural Products" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (23102002 to H.H.), by JST, PRESTO (T.I.) and by Grant-in-Aid for Young Scientists (B) from MEXT (26750374 to T.I).	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bennett TA, 2014, CL LYMPH MYELOM LEUK, V14, P305, DOI 10.1016/j.clml.2013.11.006; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chauvin C, 2007, MOL CELL BIOL, V27, P5619, DOI 10.1128/MCB.00035-07; Cheng Z, 2009, GENE DEV, V23, P1106, DOI 10.1101/gad.1770109; Deshaies RJ, 2015, NAT CHEM BIOL, V11, P634, DOI 10.1038/nchembio.1887; Dijon M, 2008, BLOOD, V111, P1138, DOI 10.1182/blood-2007-07-098202; Dimopoulos MA, 2015, NAT REV CLIN ONCOL, V12, P42, DOI 10.1038/nrclinonc.2014.200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; KIKUCHI Y, 1988, EMBO J, V7, P1175, DOI 10.1002/j.1460-2075.1988.tb02928.x; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Petzold G., 2016, NATURE, V532, P127, DOI DOI 10.1038/NATURE16979;PMID:26909574; Preis A, 2014, CELL REP, V8, P59, DOI 10.1016/j.celrep.2014.04.058; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	34	263	284	10	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					252	+		10.1038/nature18611	http://dx.doi.org/10.1038/nature18611			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27338790				2022-12-24	WOS:000379912600050
J	Kong, XR; Kigozi, G; Ssekasanvu, J; Nalugoda, F; Nakigozi, G; Ndyanabo, A; Lutalo, T; Reynolds, SJ; Ssekubugu, R; Kagaayi, J; Bugos, E; Chang, LW; Nanlesta, P; Mary, G; Berman, A; Quinn, TC; Serwadda, D; Wawer, MJ; Gray, RH				Kong, Xiangrong; Kigozi, Godfrey; Ssekasanvu, Joseph; Nalugoda, Fred; Nakigozi, Gertrude; Ndyanabo, Anthony; Lutalo, Tom; Reynolds, Steven J.; Ssekubugu, Robert; Kagaayi, Joseph; Bugos, Eva; Chang, Larry W.; Nanlesta, Pilgrim; Mary, Grabowski; Berman, Amanda; Quinn, Thomas C.; Serwadda, David; Wawer, Maria J.; Gray, Ronald H.			Association of Medical Male Circumcision and Antiretroviral Therapy Scale-up With Community HIV Incidence in Rakai, Uganda	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVENTION; MEN; ACQUISITION; INFECTION; COVERAGE; TRIAL; RISK	IMPORTANCE Medical male circumcision (MMC) and antiretroviral therapy (ART) are proven HIV prevention interventions, but there are limited data on the population-level effect of scale-up of these interventions in sub-Saharan Africa. Such evaluation is important for planning and resource allocation. OBJECTIVE To examine whether increasing community MMC and ART coverage was associated with reduced community HIV incidence in Rakai District, Uganda. DESIGN, SETTING, AND PARTICIPANTS Using person-level data from population-based surveys conducted from 1999 through 2013 in 45 rural Rakai communities, community-level ART and MMC coverage, sociodemographics, sexual behaviors, and HIV prevalence and incidence were estimated in 3 periods: prior to the availability of ART and MMC (1999-2004), during early availability of ART and MMC (2004-2007), and during mature program scale-up (2007-2013). EXPOSURES Community MMC coverage in males and ART coverage in HIV-positive persons of the opposite sex based on self-reported MMC status and ART use. MAIN OUTCOMES AND MEASURES Adjusted incidence rate ratios (IRRs) for sex-specific community HIV incidence estimated using multivariable Poisson regression with generalized estimating equations. RESULTS From 1999 through 2013, 44 688 persons participated in 1 or more surveys (mean age at the first survey, 24.6 years [range, 15-49]; female, 56.5%; mean survey participation rate, 92.6%[95% CI, 92.4%-92.7%]). Median community MMC coverage increased from 19% to 39%, and median community ART coverage rose from 0% to 21% in males and from 0% to 26% in females. Median community HIV incidence declined from 1.25 to 0.84 per 100 person-years in males, and from 1.25 to 0.99 per 100 person-years in females. Among males, each 10% increase in community MMC coverage was associated with an adjusted IRR of 0.87 (95% CI, 0.82-0.93). Comparing communities with MMC coverage more than 40% (mean male community incidence, 1.03 per 100 person-years) with communities with coverage of 10% or less (mean male incidence, 1.69 per 100 person-years), the adjusted IRR was 0.61 (95% CI, 0.43-0.88). For each 10% increase in female self-reported ART coverage, there was no significant reduction in male HIV incidence (adjusted IRR, 0.95 [95% CI, 0.81-1.13]). Comparing communities with female ART coverage more than 20%(mean male incidence, 0.87 per 100 person-years) to communities with female ART coverage of 20% or less (mean male incidence, 1.17 per 100 person-years), the adjusted IRR was 0.77 (95% CI, 0.61-0.98). Neither MMC nor male ART coverage was associated with lower female community HIV incidence. CONCLUSIONS AND RELEVANCE In Rakai, Uganda, increasing community MMC and female ART coverage was associated with lower community HIV incidence in males. If similar associations are found elsewhere, this would support further scale-up of MMC and ART for HIV prevention in sub-Saharan Africa.	[Kong, Xiangrong; Ssekasanvu, Joseph; Bugos, Eva; Chang, Larry W.; Mary, Grabowski; Wawer, Maria J.; Gray, Ronald H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Kong, Xiangrong] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Kigozi, Godfrey; Ssekasanvu, Joseph; Nalugoda, Fred; Nakigozi, Gertrude; Ndyanabo, Anthony; Lutalo, Tom; Ssekubugu, Robert; Kagaayi, Joseph; Serwadda, David; Wawer, Maria J.; Gray, Ronald H.] Rakai Hlth Sci Program, Entebbe, Uganda; [Reynolds, Steven J.; Chang, Larry W.; Quinn, Thomas C.] Johns Hopkins Sch Med, Baltimore, MD USA; [Reynolds, Steven J.; Quinn, Thomas C.] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Nanlesta, Pilgrim] Populat Council, Washington, DC USA; [Berman, Amanda] Johns Hopkins, Ctr Commun Programs, Baltimore, MD USA; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rakai Health Sciences Program; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Population Council; Johns Hopkins University; Makerere University	Kong, XR (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 627 N Washington St, Baltimore, MD 21205 USA.	xkong4@jhu.edu		Reynolds, Steven/0000-0002-5403-2759; Berman, Amanda/0000-0001-6283-595X	National Institutes of Health (NIH) [K25AI114461, U01AI100031, R01HD050180, U01AI075115, R01 HD070769]; Division of Intramural Research at the National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation [081113, 22006.03]; Johns Hopkins Center for AIDS Research [JHU CFAR P30AI094189]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070769] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050180] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, U01AI075115, ZIAAI000361, K25AI114461, U01AI100031, ZIAAI001040] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research at the National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Johns Hopkins Center for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institutes of Health (NIH, K25AI114461, U01AI100031, R01HD050180, U01AI075115, R01 HD070769), the Division of Intramural Research at the National Institute of Allergy and Infectious Diseases, the Bill and Melinda Gates Foundation (#081113, 22006.03), and the Johns Hopkins Center for AIDS Research (JHU CFAR P30AI094189).	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Barnighausen T, 2012, P NATL ACAD SCI USA, V109, P21271, DOI 10.1073/pnas.1209017110; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Donoval BA, 2006, AM J CLIN PATHOL, V125, P386, DOI 10.1309/JVHQVDJDYKM58EPH; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Grabowski MK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001610; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Johnson KE, 2009, AIDS, V23, P1807, DOI 10.1097/QAD.0b013e32832efdf1; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; Kong XR, 2013, AIDS, V27, P662, DOI 10.1097/QAD.0b013e32835c557c; Larmarange J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123345; McClelland RS, 2015, AIDS, V29, P2279, DOI 10.1097/QAD.0000000000000829; Mills EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001167; Nakigozi G, 2011, AIDS CARE, V23, P764, DOI 10.1080/09540121.2010.525614; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Smith MK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001260; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014	24	28	29	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2016	316	2					182	190		10.1001/jama.2016.7292	http://dx.doi.org/10.1001/jama.2016.7292			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ9CW	27404186	Bronze, Green Accepted			2022-12-24	WOS:000379509000014
J	Meara, E; Horwitz, JR; Powell, W; McClelland, L; Zhou, WP; O'Malley, AJ; Morden, NE				Meara, Ellen; Horwitz, Jill R.; Powell, Wilson; McClelland, Lynn; Zhou, Weiping; O'Malley, A. James; Morden, Nancy E.			State Legal Restrictions and Prescription-Opioid Use among Disabled Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRESCRIBING PATTERNS; MONITORING PROGRAMS; DRUG OVERDOSE; UNITED-STATES; TRENDS; MORTALITY; LAWS; FLORIDA; DEATHS; IMPACT	BACKGROUND In response to rising rates of opioid abuse and overdose, U.S. states enacted laws to restrict the prescribing and dispensing of controlled substances. The effect of these laws on opioid use is unclear. METHODS We tested associations between prescription-opioid receipt and state controlled-substances laws. Using Medicare administrative data for fee-for-service disabled beneficiaries 21 to 64 years of age who were alive throughout the calendar year (8.7 million person-years from 2006 through 2012) and an original data set of laws (e.g., prescription-drug monitoring programs), we examined the annual prevalence of beneficiaries with four or more opioid prescribers, prescriptions yielding a daily morphine-equivalent dose (MED) of more than 120 mg, and treatment for nonfatal prescription-opioid overdose. We estimated how opioid outcomes varied according to eight types of laws. RESULTS From 2006 through 2012, states added 81 controlled-substance laws. Opioid receipt and potentially hazardous prescription patterns were common. In 2012 alone, 47% of beneficiaries filled opioid prescriptions (25% in one to three calendar quarters and 22% in every calendar quarter); 8% had four or more opioid prescribers; 5% had prescriptions yielding a daily MED of more than 120 mg in any calendar quarter; and 0.3% were treated for a nonfatal prescription-opioid overdose. We observed no significant associations between opioid outcomes and specific types of laws or the number of types enacted. For example, the percentage of beneficiaries with a prescription yielding a daily MED of more than 120 mg did not decline after adoption of a prescription-drug monitoring program (0.27 percentage points; 95% confidence interval, -0.05 to 0.59). CONCLUSIONS Adoption of controlled-substance laws was not associated with reductions in potentially hazardous use of opioids or overdose among disabled Medicare beneficiaries, a population particularly at risk.	[Meara, Ellen; Powell, Wilson; Zhou, Weiping; O'Malley, A. James; Morden, Nancy E.] Dartmouth Inst Hlth Policy & Clin Practice, WTRB Level 5,1 Med Ctr Dr, Lebanon, NH 03756 USA; [Meara, Ellen; Horwitz, Jill R.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Horwitz, Jill R.; McClelland, Lynn] Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90024 USA	Dartmouth College; National Bureau of Economic Research; University of California System; University of California Los Angeles	Meara, E (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, WTRB Level 5,1 Med Ctr Dr, Lebanon, NH 03756 USA.	ellen.r.meara@dartmouth.edu		Meara, Ellen/0000-0003-0211-1970	National Institute on Aging; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019783, U01AG046830] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institute on Aging and others.	[Anonymous], 2002, PRESCR DRUGS STAT MO; [Anonymous], 2014, OP PAINK PRESCR YOU; [Anonymous], 2016, PREV PRESCR DRUG OV; [Anonymous], 2014, 2014 NASCSA SURV CON; [Anonymous], 2012, 2006 2011 RXHCC MOD; Arlotta C. J., 2015, FORBES; Bachhuber MA, 2014, JAMA INTERN MED, V174, P1668, DOI 10.1001/jamainternmed.2014.4005; Baehren DF, 2010, ANN EMERG MED, V56, P19, DOI 10.1016/j.annemergmed.2009.12.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betses M, 2013, NEW ENGL J MED, V369, P989, DOI 10.1056/NEJMp1308222; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Bonito AJ, 2008, CREATION NEW RACE ET; Braden JB, 2010, ARCH INTERN MED, V170, P1425, DOI 10.1001/archinternmed.2010.273; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, 2012, PRESCR DRUG OV STAT; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; D'Onofrio G, 2015, JAMA-J AM MED ASSOC, V313, P1636, DOI 10.1001/jama.2015.3474; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Davis C. S., 2015, LEG INT RED OV MORT; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Franklin GM, 2005, AM J IND MED, V48, P91, DOI 10.1002/ajim.20191; Haegerich TM, 2014, DRUG ALCOHOL DEPEN, V145, P34, DOI 10.1016/j.drugalcdep.2014.10.001; Haffajee RL, 2015, JAMA-J AM MED ASSOC, V313, P891, DOI 10.1001/jama.2014.18514; Jena AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1393; Johnson H, 2014, MMWR-MORBID MORTAL W, V63, P569; Kilby A., 2015, OPIOIDS MASSES WELFA; Larrick AK, 2014, REQUEST COMMENTS ENH; McDonald JH, 2015, HDB BIOL STAT, P254; Morden NE, 2014, MED CARE, V52, P852, DOI 10.1097/MLR.0000000000000183; National Alliance for Model State Drug Laws, 2014, STAT REQ PRESCR DISP; National Center for Health Statistics; Centers for Disease Control and Prevention; U. S Department of Health and Human Services, 2015, MULT CAUS DEATH 1999; Pacula RL, 2015, J POLICY ANAL MANAG, V34, P7, DOI 10.1002/pam.21804; Panis C, 2000, SSA PROGRAM DATA USE; Paulozzi LJ, 2015, MMWR SURVEILL SUMM, V64, P1, DOI 10.15585/mmwr.ss6409a1; Prescription Drug Monitoring Program Center of Excellence, 2014, PRESCR DRUG MON PROG; Reifler LM, 2012, PAIN MED, V13, P434, DOI 10.1111/j.1526-4637.2012.01327.x; Robst J, 2007, HEALTH CARE FINANC R, V28, P15; Rutkow L, 2015, JAMA INTERN MED, V175, P1642, DOI 10.1001/jamainternmed.2015.3931	39	156	156	2	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2016	375	1					44	53		10.1056/NEJMsa1514387	http://dx.doi.org/10.1056/NEJMsa1514387			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ1ZP	27332619	Green Accepted, Bronze			2022-12-24	WOS:000379000200004
J	Antonovsky, N; Gleizer, S; Noor, E; Zohar, Y; Herz, E; Barenholz, U; Zelcbuch, L; Amram, S; Wides, A; Tepper, N; Davidi, D; Bar-On, Y; Bareia, T; Wernick, DG; Shani, I; Malitsky, S; Jona, G; Bar-Even, A; Milo, R				Antonovsky, Niv; Gleizer, Shmuel; Noor, Elad; Zohar, Yehudit; Herz, Elad; Barenholz, Uri; Zelcbuch, Lior; Amram, Shira; Wides, Aryeh; Tepper, Naama; Davidi, Dan; Bar-On, Yinon; Bareia, Tasneem; Wernick, David G.; Shani, Ido; Malitsky, Sergey; Jona, Ghil; Bar-Even, Arren; Milo, Ron			Sugar Synthesis from CO2 in Escherichia coli	CELL			English	Article							GENETIC SELECTION; RUBISCO; EVOLUTION; BIOLOGY; ADAPTATION; EXPRESSION; CONVERSION; MICROBES; PATHWAYS; FIXATION	Can a heterotrophic organism be evolved to synthesize biomass from CO2 directly? So far, non-native carbon fixation in which biomass precursors are synthesized solely from CO2 has remained an elusive grand challenge. Here, we demonstrate how a combination of rational metabolic rewiring, recombinant expression, and laboratory evolution has led to the biosynthesis of sugars and other major biomass constituents by a fully functional Calvin-Benson-Bassham (CBB) cycle in E. coli. In the evolved bacteria, carbon fixation is performed via a non-native CBB cycle, while reducing power and energy are obtained by oxidizing a supplied organic compound (e.g., pyruvate). Genome sequencing reveals that mutations in flux branchpoints, connecting the non-native CBB cycle to biosynthetic pathways, are essential for this phenotype. The successful evolution of a non-native carbon fixation pathway, though not yet resulting in net carbon gain, strikingly demonstrates the capacity for rapid trophic-mode evolution of metabolism applicable to biotechnology.	[Antonovsky, Niv; Gleizer, Shmuel; Noor, Elad; Zohar, Yehudit; Herz, Elad; Barenholz, Uri; Zelcbuch, Lior; Amram, Shira; Wides, Aryeh; Davidi, Dan; Bar-On, Yinon; Bareia, Tasneem; Wernick, David G.; Shani, Ido; Malitsky, Sergey; Bar-Even, Arren; Milo, Ron] Weizmann Inst Sci, Dept Plant & Environm Sci, IL-7610001 Rehovot, Israel; [Tepper, Naama] Technion, Dept Comp Sci, Israel Inst Technol, IL-3200003 Haifa, Israel; [Jona, Ghil] Weizmann Inst Sci, Dept Biol Serv, IL-7610001 Rehovot, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Weizmann Institute of Science	Milo, R (corresponding author), Weizmann Inst Sci, Dept Plant & Environm Sci, IL-7610001 Rehovot, Israel.	ron.milo@weizmann.ac.il	Malitsky, Sergey/ABC-2545-2020; Noor, Elad/AAN-9042-2020	Malitsky, Sergey/0000-0003-4619-7219; Noor, Elad/0000-0001-8776-4799; Bar-On, Yinon/0000-0001-8477-609X; Bar-Even, Arren/0000-0002-1039-4328; Milo, Ron/0000-0003-1641-2299; Jona, Ghil/0000-0002-4526-6182; Gleizer, Shmuel/0000-0001-9774-0504	European Research Council [SYMPAC 260392, NOVCARBFIX 646827]; Helmsley Charitable Foundation; Larson Charitable Foundation; Estate of David Arthur Barton; Anthony Stalbow Charitable Trust; Stella Gelerman, Canada; United States-Israel Education Foundation	European Research Council(European Research Council (ERC)European Commission); Helmsley Charitable Foundation; Larson Charitable Foundation; Estate of David Arthur Barton; Anthony Stalbow Charitable Trust; Stella Gelerman, Canada; United States-Israel Education Foundation	We thank Ichiro Matsumura for kindly supplying the prkA plasmid and Michal Shapira for kindly supplying the R. rubrum culture. We also thank Amir Aharoni, Asaph Aharoni, Uri Alon, Gil Amitai, Abdussalam Azem, Naama Barkai, Sima Benjamin, Sonjia Billerbeck, Dvora Biran, Elad Chomski, Ahuva Cooperstein, Daniel Dar, Michal Dayagi, Shani Doron, Noa Dvir, Avigdor Eldar, David Fell, Avi Flamholz, Shay Fleishon, Idan Frumkin, Shlomit Gilad, Pierre Goloubinoff, Michael Gurevitz, Jacob Hanna, Tami Hayon, Lee-Or Herzog, Keren Kahil, Miriam Kaltenbach, Mechael Kanovsky, Aaron Kaplan, Leeat Keren, Roy Kishony, Hagar Kroytoro, Rob Last, Paola Laurino, Tali Lavy, Ronen Levi, Ayelet Levin, Yishai Levin, Avi Levy, Hannes Link, Adar Lopez, Yehuda Marcus, Barak Marcus, Adi Millman, Uri Moran, Oliver Mueller-Cajar, Yotam Nadav, Amnon Naziri, Ravit Netzer, Gal Ofir, Nigel Orme, Rob Phillips, Uri Pick, Noa Rippel, Orel Rivni, Liat Rockah, Ilana Rogachev, Eliora Ron, Dave Savage, Alon Savidor, Efrat Schwartz, Lior Shachar, Tali Shalit, Tomer Shlomi, Rotem Sorek, Zvika Tamari, Dan Tawfik, Noam Vardi, Adi Volpert, Alon Wellner, Sagit Yahav, Dan Yakir, Oren Yishai, and Yonatan Zegman for support and feedback on this research. This work was funded by the European Research Council (projects SYMPAC 260392 and NOVCARBFIX 646827), Dana and Yossie Hollander, the Helmsley Charitable Foundation, the Larson Charitable Foundation, the Estate of David Arthur Barton, the Anthony Stalbow Charitable Trust, and Stella Gelerman, Canada. R.M. is the Charles and Louise Gartner professional chair and an EMBO young investigator program member. D.G.W. is supported by the United States-Israel Education Foundation.	Bar-Even A, 2010, P NATL ACAD SCI USA, V107, P8889, DOI 10.1073/pnas.0907176107; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; BASSHAM JA, 1954, J AM CHEM SOC, V76, P1760, DOI 10.1021/ja01636a012; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Church GM, 2014, NAT REV MOL CELL BIO, V15, P289, DOI 10.1038/nrm3767; Deatherage DE, 2014, METHODS MOL BIOL, V1151, P165, DOI 10.1007/978-1-4939-0554-6_12; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Durao P, 2015, NAT CHEM BIOL, V11, P148, DOI [10.1038/nchembio.1715, 10.1038/NCHEMBIO.1715]; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; Fast AG, 2015, CURR OPIN BIOTECH, V33, P60, DOI 10.1016/j.copbio.2014.11.014; Foster PL, 2015, P NATL ACAD SCI USA, V112, pE5990, DOI 10.1073/pnas.1512136112; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Gong FY, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0268-1; Grenier F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01038-14; Kleeb AC, 2007, P NATL ACAD SCI USA, V104, P13907, DOI 10.1073/pnas.0705379104; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Lovley DR, 2011, ENV MICROBIOL REP, V3, P27, DOI 10.1111/j.1758-2229.2010.00211.x; Maddamsetti R, 2015, GENETICS, V200, P619, DOI 10.1534/genetics.115.176677; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Muller JEN, 2015, METAB ENG, V28, P190, DOI 10.1016/j.ymben.2014.12.008; Mueller-Cajar O, 2008, BIOCHEM J, V414, P205, DOI 10.1042/BJ20080668; Neidhardt F.C., 1987, ESCHERICHIA COLI SAL, VI; NEIDHARDT FC, 1987, ESCHERICHIA COLI SAL, V2; Notley-McRobb L, 2003, P ROY SOC B-BIOL SCI, V270, P843, DOI 10.1098/rspb.2002.2295; NOVICK A, 1950, P NATL ACAD SCI USA, V36, P708, DOI 10.1073/pnas.36.12.708; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Parikh MR, 2006, PROTEIN ENG DES SEL, V19, P113, DOI 10.1093/protein/gzj010; Quandt EM, 2015, ELIFE, V4, DOI 10.7554/eLife.09696; Reznik E, 2010, J THEOR BIOL, V266, P536, DOI 10.1016/j.jtbi.2010.07.023; Sauer U, 2001, Adv Biochem Eng Biotechnol, V73, P129; Shih PM, 2014, J BIOL CHEM, V289, P9493, DOI 10.1074/jbc.C113.543132; Siegel JB, 2015, P NATL ACAD SCI USA, V112, P3704, DOI 10.1073/pnas.1500545112; Whitaker WB, 2015, CURR OPIN BIOTECH, V33, P165, DOI 10.1016/j.copbio.2015.01.007; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Zelcbuch L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt151; Zhuang ZY, 2013, BIORESOURCE TECHNOL, V150, P79, DOI 10.1016/j.biortech.2013.09.116	38	182	192	29	199	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					115	125		10.1016/j.cell.2016.05.064	http://dx.doi.org/10.1016/j.cell.2016.05.064			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27345370	Green Published, hybrid			2022-12-24	WOS:000380254400015
J	Saredi, G; Huang, HD; Hammond, CM; Alabert, C; Bekker-Jensen, S; Forne, I; Reveron-Gomez, N; Foster, BM; Mlejnkova, L; Bartke, T; Cejka, P; Mailand, N; Imhof, A; Patel, DJ; Groth, A				Saredi, Giulia; Huang, Hongda; Hammond, Colin M.; Alabert, Constance; Bekker-Jensen, Simon; Forne, Ignasi; Reveron-Gomez, Nazaret; Foster, Benjamin M.; Mlejnkova, Lucie; Bartke, Till; Cejka, Petr; Mailand, Niels; Imhof, Axel; Patel, Dinshaw J.; Groth, Anja			H4K20me0 marks post-replicative chromatin and recruits the TONSL-MMS22L DNA repair complex	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; MMS22L-NFKBIL2 COMPLEX; MMS22L-TONSL COMPLEX; CELL-CYCLE; METHYLATION; CHAPERONE; BINDING; BARD1; STABILITY; PROTEINS	After DNA replication, chromosomal processes including DNA repair and transcription take place in the context of sister chromatids. While cell cycle regulation can guide these processes globally, mechanisms to distinguish pre- and post-replicative states locally remain unknown. Here we reveal that new histones incorporated during DNA replication provide a signature of post-replicative chromatin, read by the human TONSL-MMS22L(1-4) homologous recombination complex. We identify the TONSL ankyrin repeat domain (ARD) as a reader of histone H4 tails unmethylated at K20 (H4K20me0), which are specific to new histones incorporated during DNA replication and mark post-replicative chromatin until the G2/M phase of the cell cycle. Accordingly, TONSL-MMS22L binds new histones H3-H4 both before and after incorporation into nucleosomes, remaining on replicated chromatin until late G2/M. H4K20me0 recognition is required for TONSL-MMS22L binding to chromatin and accumulation at challenged replication forks and DNA lesions. Consequently, TONSL ARD mutants are toxic, compromising genome stability, cell viability and resistance to replication stress. Together, these data reveal a histone-reader-based mechanism for recognizing the post-replicative state, offering a new angle to understand DNA repair with the potential for targeted cancer therapy.	[Saredi, Giulia; Hammond, Colin M.; Alabert, Constance; Reveron-Gomez, Nazaret; Groth, Anja] Univ Copenhagen, BRIC, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Saredi, Giulia; Hammond, Colin M.; Alabert, Constance; Reveron-Gomez, Nazaret; Groth, Anja] Univ Copenhagen, Ctr Epigenet, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Huang, Hongda; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Bekker-Jensen, Simon; Mailand, Niels] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Forne, Ignasi; Imhof, Axel] Univ Munich, Dept Mol Biol, Biomed Ctr, D-80336 Munich, Germany; [Forne, Ignasi; Imhof, Axel] Univ Munich, Ctr Integrated Prot Sci Munich, D-80336 Munich, Germany; [Foster, Benjamin M.; Bartke, Till] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, CSC, Du Cane Rd, London W12 0NN, England; [Foster, Benjamin M.; Bartke, Till] Univ London Imperial Coll Sci Technol & Med, Fac Med, ICS, Du Cane Rd, London W12 0NN, England; [Mlejnkova, Lucie; Cejka, Petr] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland	University of Copenhagen; University of Copenhagen; Memorial Sloan Kettering Cancer Center; Novo Nordisk Foundation; University of Copenhagen; University of Munich; University of Munich; Imperial College London; Imperial College London; University of Zurich	Groth, A (corresponding author), Univ Copenhagen, BRIC, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark.; Groth, A (corresponding author), Univ Copenhagen, Ctr Epigenet, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark.; Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; anja.groth@bric.ku.dk	Imhof, Axel/AAU-5313-2021; Groth, Anja/AAH-5386-2019; Foster, Benjamin/AGK-6443-2022	Imhof, Axel/0000-0003-2993-8249; Groth, Anja/0000-0003-0577-1771; Foster, Benjamin/0000-0003-0670-2321; Saredi, Giulia/0000-0002-0798-0959; Cejka, Petr/0000-0002-9087-032X; Hammond, Colin/0000-0003-0571-5710; Reveron-Gomez, Nazaret/0000-0001-7347-781X; Mlejnkova, Lucie/0000-0002-7390-2123	European Commission; Leukemia and Lymphoma Society; STARR foundation; European Research Council (ERC) [281765]; Danish National Research Foundation to the Center for Epigenetics [DNRF82]; Danish Cancer Society; Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; European Commission [257082]; DFG Excellence Clusters CIPSM; SyNergy; DFG Collaborative Research Center [1064]; Medical Research Council and the European Research Council (ERC) [309952]; MRC [MC_UP_1102/2] Funding Source: UKRI; Medical Research Council [MC_UP_1102/2] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0012839] Funding Source: researchfish; The Danish Cancer Society [R124-A7922] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); STARR foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); Danish National Research Foundation to the Center for Epigenetics; Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre); DFG Excellence Clusters CIPSM(German Research Foundation (DFG)); SyNergy; DFG Collaborative Research Center(German Research Foundation (DFG)); Medical Research Council and the European Research Council (ERC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation Center for Protein Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the beam staff at the synchrotrons at the Argonne National Laboratory (NE-CAT) for technical assistance. We thank J. Rouse, D. Durocher, G. Legube and C. Storgaard Sorensen for reagents, G. Montoya for assistance with circular dichroism, C. B. Stromme, A. Strandsby, K. Nakamura, S.-b. Lee and M. Hodl for help with experiments, and Y. Antoku for assistance with microscopy. We thank J. Lukas for comments on the manuscript and Z. Jasencakova for illustrations. G.S. was supported by European Commission Marie Curie ITN FP7 'aDDRess'. D.J.P. was supported in part by grants from the Leukemia and Lymphoma Society and the STARR foundation. A. G. is an EMBO Young Investigator and her research is supported by the European Research Council (ERC StG, no. 281765), the Danish National Research Foundation to the Center for Epigenetics (DNRF82), the Danish Cancer Society, the Danish Medical Research Council, the Novo Nordisk Foundation and the Lundbeck Foundation. A. I. is supported by the European Commission FP7 Network of Excellence EpiGeneSys (project 257082), the DFG Excellence Clusters CIPSM and SyNergy, as well as the DFG Collaborative Research Center 1064 (projects A3 and Z3). T.B. is supported by the Medical Research Council and the European Research Council (ERC StG, no. 309952).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alabert C, 2015, GENE DEV, V29, P585, DOI 10.1101/gad.256354.114; Alabert C, 2014, NAT CELL BIOL, V16, P281, DOI 10.1038/ncb2918; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Bodor DL, 2013, MOL BIOL CELL, V24, P923, DOI 10.1091/mbc.E13-01-0034; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Campos EI, 2015, MOL CELL, V60, P697, DOI 10.1016/j.molcel.2015.08.005; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fox D, 2008, J BIOL CHEM, V283, P21179, DOI 10.1074/jbc.M802333200; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Huang HD, 2015, NAT STRUCT MOL BIOL, V22, P618, DOI 10.1038/nsmb.3055; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Ishitobi M, 2003, CANCER LETT, V200, P1, DOI 10.1016/S0304-3835(03)00387-2; Jakobsen JS, 2013, GENOME RES, V23, P592, DOI 10.1101/gr.146399.112; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kalashnikova AA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1022; Laufer M, 2007, J BIOL CHEM, V282, P34325, DOI 10.1074/jbc.M705198200; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; O'Connell BC, 2010, MOL CELL, V40, P645, DOI 10.1016/j.molcel.2010.10.022; O'Donnell L, 2010, MOL CELL, V40, P619, DOI 10.1016/j.molcel.2010.10.024; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Piwko W, 2010, EMBO J, V29, P4210, DOI 10.1038/emboj.2010.304; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Richet N, 2015, NUCLEIC ACIDS RES, V43, P1905, DOI 10.1093/nar/gkv021; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007	41	119	121	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					714	+		10.1038/nature18312	http://dx.doi.org/10.1038/nature18312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27338793	Green Accepted, Green Submitted			2022-12-24	WOS:000378676000043
J	Wehr, R; Munger, JW; McManus, JB; Nelson, DD; Zahniser, MS; Davidson, EA; Wofsy, SC; Saleska, SR				Wehr, R.; Munger, J. W.; McManus, J. B.; Nelson, D. D.; Zahniser, M. S.; Davidson, E. A.; Wofsy, S. C.; Saleska, S. R.			Seasonality of temperate forest photosynthesis and daytime respiration	NATURE			English	Article							GROSS PRIMARY PRODUCTION; ECOSYSTEM CARBON EXCHANGE; TERM EDDY COVARIANCE; WATER-USE EFFICIENCY; TERRESTRIAL ECOSYSTEMS; CO2; FLUORESCENCE; ASSIMILATION; VEGETATION; FLUXES	Terrestrial ecosystems currently offset one-quarter of anthropogenic carbon dioxide (CO2) emissions because of a slight imbalance between global terrestrial photosynthesis and respiration(1). Understanding what controls these two biological fluxes is therefore crucial to predicting climate change(2). Yet there is no way of directly measuring the photosynthesis or daytime respiration of a whole ecosystem of interacting organisms; instead, these fluxes are generally inferred from measurements of net ecosystem-atmosphere CO2 exchange (NEE), in a way that is based on assumed ecosystem-scale responses to the environment. The consequent view of temperate deciduous forests (an important CO2 sink) is that, first, ecosystem respiration is greater during the day than at night; and second, ecosystem photosynthetic light-use efficiency peaks after leaf expansion in spring and then declines(3), presumably because of leaf ageing or water stress. This view has underlain the development of terrestrial biosphere models used in climate prediction(4,5) and of remote sensing indices of global biosphere productivity(5,6). Here, we use new isotopic instrumentation(7) to determine ecosystem photosynthesis and daytime respiration(8) in a temperate deciduous forest over a three-year period. We find that ecosystem respiration is lower during the day than at night-the first robust evidence of the inhibition of leaf respiration by light(9-11) at the ecosystem scale. Because they do not capture this effect, standard approaches(12,13) overestimate ecosystem photosynthesis and daytime respiration in the first half of the growing season at our site, and inaccurately portray ecosystem photosynthetic light-use efficiency. These findings revise our understanding of forest-atmosphere carbon exchange, and provide a basis for investigating how leaf-level physiological dynamics manifest at the canopy scale in other ecosystems.	[Wehr, R.; Saleska, S. R.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Munger, J. W.; Wofsy, S. C.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Munger, J. W.; Wofsy, S. C.] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA; [McManus, J. B.; Nelson, D. D.; Zahniser, M. S.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Davidson, E. A.] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA	University of Arizona; Harvard University; Harvard University; Aerodyne Research; University System of Maryland; University of Maryland Center for Environmental Science	Wehr, R; Saleska, SR (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	rawehr@email.arizona.edu; saleska@email.arizona.edu	Munger, J William/H-4502-2013; Davidson, Eric A/K-4984-2013; Saleska, Scott R/K-1733-2016	Munger, J William/0000-0002-1042-8452; Davidson, Eric A/0000-0002-8525-8697; Saleska, Scott R/0000-0002-4974-3628; Wehr, Richard/0000-0002-0806-9390	US Department Of Energy (DOE), Office of Science, Terrestrial Ecosystem Science (TES) program [DE-SC0006741]; Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona; National Science Foundation (NSF); DOE TES program; NSF LTER program	US Department Of Energy (DOE), Office of Science, Terrestrial Ecosystem Science (TES) program(United States Department of Energy (DOE)); Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona; National Science Foundation (NSF)(National Science Foundation (NSF)); DOE TES program; NSF LTER program	This research was supported by the US Department Of Energy (DOE), Office of Science, Terrestrial Ecosystem Science (TES) program (award DE-SC0006741), and the Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona. Soil chamber data were acquired with the help of K. Savage at the Woods Hole Research Center, under the DOE award. The Harvard Forest Environmental Measurements Site infrastructure is a component of the Harvard Forest Long-Term Ecological Research (LTER) site, supported by the National Science Foundation (NSF), and is additionally supported by the DOE TES program. Below-canopy PAR, soil temperature and soil moisture data were provided by E. Nicoll at the Harvard Forest, supported by the NSF LTER program. OCS data and SIF data were provided by the authors of refs 40 and 41, respectively.	Bassow SL, 1998, ECOLOGY, V79, P2660, DOI 10.1890/0012-9658(1998)079[2660:HECACL]2.0.CO;2; Beer C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003233; Billmark Kaycie A., 2009, P143, DOI 10.1007/978-1-4419-0026-5_6; Bowling DR, 2001, GLOBAL CHANGE BIOL, V7, P127, DOI 10.1046/j.1365-2486.2001.00400.x; Commane R, 2015, P NATL ACAD SCI USA, V112, P14162, DOI 10.1073/pnas.1504131112; CONSTABLE GA, 1980, AUST J PLANT PHYSIOL, V7, P89, DOI 10.1071/PP9800089; dePury DGG, 1997, PLANT CELL ENVIRON, V20, P537, DOI 10.1111/j.1365-3040.1997.00094.x; Dillen SY, 2012, AGR FOREST METEOROL, V160, P60, DOI 10.1016/j.agrformet.2012.03.001; Falge E, 2002, AGR FOREST METEOROL, V113, P53, DOI 10.1016/S0168-1923(02)00102-8; Fassbinder JJ, 2012, AGR FOREST METEOROL, V153, P154, DOI 10.1016/j.agrformet.2011.09.020; GATZ DF, 1995, ATMOS ENVIRON, V29, P1185, DOI 10.1016/1352-2310(94)00210-C; Giasson MA, 2013, ECOSPHERE, V4, DOI 10.1890/ES13.00183.1; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; Grassi G, 2005, TREE PHYSIOL, V25, P349, DOI 10.1093/treephys/25.3.349; Heskel MA, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00120.1; Keenan TF, 2014, ECOL APPL, V24, P1478, DOI 10.1890/13-0652.1; Knohl A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002301; Knohl A, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000663; KOK B, 1949, BIOCHIM BIOPHYS ACTA, V3, P625, DOI 10.1016/0006-3002(49)90136-5; Lai CT, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003369; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Ogee J, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001995; Ogee J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002166; Parazoo NC, 2014, GLOBAL CHANGE BIOL, V20, P3103, DOI 10.1111/gcb.12652; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Restrepo-Coupe N, 2013, AGR FOREST METEOROL, V182, P128, DOI 10.1016/j.agrformet.2013.04.031; Savage K, 2013, GLOBAL CHANGE BIOL, V19, P1151, DOI 10.1111/gcb.12108; Schimel D, 2015, GLOBAL CHANGE BIOL, V21, P1762, DOI 10.1111/gcb.12822; Stocker T.F., 2013, CLIMATE CHANGE 2013, P1535; Stockli R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000562; Sun J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111744; Tang XG, 2014, SCI REP-UK, V4, DOI 10.1038/srep07483; Turner DP, 2003, REMOTE SENS ENVIRON, V88, P256, DOI 10.1016/j.rse.2003.06.005; van der Tol C, 2014, J GEOPHYS RES-BIOGEO, V119, P2312, DOI 10.1002/2014JG002713; Wehr R, 2015, AGR FOREST METEOROL, V214, P515, DOI 10.1016/j.agrformet.2015.09.009; Wehr R, 2013, AGR FOREST METEOROL, V181, P69, DOI 10.1016/j.agrformet.2013.07.002; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314; Wu J, 2016, SCIENCE, V351, P972, DOI 10.1126/science.aad5068; Yakir D, 1996, NATURE, V380, P515, DOI 10.1038/380515a0; Yang X, 2015, GEOPHYS RES LETT, V42, P2977, DOI 10.1002/2015GL063201; Yuan WP, 2014, AGR FOREST METEOROL, V192, P108, DOI 10.1016/j.agrformet.2014.03.007; Zhang J, 2006, PLANT CELL ENVIRON, V29, P483, DOI 10.1111/j.1365-3040.2005.01425.x; Zobitz JM, 2008, GLOBAL CHANGE BIOL, V14, P1785, DOI 10.1111/j.1365-2486.2008.01609.x	43	152	162	20	408	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					680	+		10.1038/nature17966	http://dx.doi.org/10.1038/nature17966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357794				2022-12-24	WOS:000378676000035
J	Iwasaki, S; Floor, SN; Ingolia, NT				Iwasaki, Shintaro; Floor, Stephen N.; Ingolia, Nicholas T.			Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor	NATURE			English	Article							MESSENGER-RNA; NUCLEOTIDE RESOLUTION; INITIATION-FACTORS; IN-VIVO; HELICASE; BINDING; SILVESTROL; CANCER; ROLES; MODEL	Rocaglamide A (RocA) typifies a class of protein synthesis inhibitors that selectively kill aneuploid tumour cells and repress translation of specific messenger RNAs1-4. RocA targets eukaryotic initiation factor 4A (eIF4A), an ATP-dependent DEAD-box RNA helicase; its messenger RNA selectivity is proposed to reflect highly structured 5' untranslated regions that depend strongly on eIF4A-mediated unwinding(5). However, rocaglate treatment may not phenocopy the loss of eIF4A activity, as these drugs actually increase the affinity between eIF4A and RNA(1,2,6). Here we show that secondary structure in 5' untranslated regions is only a minor determinant for RocA selectivity and that RocA does not repress translation by reducing eIF4A availability. Rather, in vitro and in cells, RocA specifically clamps eIF4A onto polypurine sequences in an ATP-independent manner. This artificially clamped eIF4A blocks 43S scanning, leading to premature, upstream translation initiation and reducing protein expression from transcripts bearing the RocA-eIF4A target sequence. In elucidating the mechanism of selective translation repression by this lead anti-cancer compound, we provide an example of a drug stabilizing sequence-selective RNA-protein interactions.	[Iwasaki, Shintaro; Floor, Stephen N.; Ingolia, Nicholas T.] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr RNA Syst Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ingolia, NT (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr RNA Syst Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ingolia@berkeley.edu	Iwasaki, Shintaro/AAO-7743-2021; Iwasaki, Shintaro/D-1472-2017	Iwasaki, Shintaro/0000-0001-7724-3754; Iwasaki, Shintaro/0000-0001-7724-3754; Floor, Stephen/0000-0002-9965-9694	Damon Runyon Cancer Research Foundation [DRR-37-15]; Searle Scholars Program [11-SSP-229]; National Institute of General Medical Sciences of the National Institutes of Health [P50GM102706]; National Institutes of Health S10 Instrumentation Grants [S10RR029668, S10RR027303, OD018174]; Human Frontier Science Program long-term fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668, S10RR027303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018174] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Searle Scholars Program; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health S10 Instrumentation Grants; Human Frontier Science Program long-term fellowship(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to J. Tanaka for providing hippuristanol, to Y. Tomari for sharing DNA constructs, to H. Asahara and University of California, Berkeley DNA sequencing facility for help with the toeprinting assay, and to A. Pinder and F. Tan for support with deep sequencing analysis. We also thank the members of Ingolia, Lareau, and Tomari laboratories for discussion and technical support. N.T.I. is a Damon-Runyon-Rachleff Innovator supported in part by the Damon Runyon Cancer Research Foundation (DRR-37-15), the Searle Scholars Program (11-SSP-229), and the National Institute of General Medical Sciences of the National Institutes of Health (P50GM102706). This work used the Vincent J. Coates Genomics Sequencing Laboratory at University of California, Berkeley, supported by National Institutes of Health S10 Instrumentation Grants S10RR029668, S10RR027303, and OD018174. S.I. is a recipient of Human Frontier Science Program long-term fellowship. S.N.F. is a Howard Hughes Medical Institute Fellow of the Helen Hay Whitney Foundation.	ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arribere JA, 2013, GENOME RES, V23, P977, DOI 10.1101/gr.150342.112; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Dmitriev SE, 2003, FEBS LETT, V533, P99, DOI 10.1016/S0014-5793(02)03776-6; Galicia-Vazquez G, 2012, RNA, V18, P1373, DOI 10.1261/rna.033209.112; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Liu T, 2012, J MED CHEM, V55, P8859, DOI 10.1021/jm3011542; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Medenbach J, 2011, CELL, V145, P902, DOI 10.1016/j.cell.2011.05.005; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Sadlish H, 2013, ACS CHEM BIOL, V8, P1519, DOI 10.1021/cb400158t; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shirokikh NE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1025; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485	37	143	146	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					558	+		10.1038/nature17978	http://dx.doi.org/10.1038/nature17978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309803	Green Submitted, Green Accepted			2022-12-24	WOS:000378270300055
J	Constantinescu, AO; O'Reilly, JX; Behrens, TEJ				Constantinescu, Alexandra O.; O'Reilly, Jill X.; Behrens, Timothy E. J.			Organizing conceptual knowledge in humans with a gridlike code	SCIENCE			English	Article							MEMORY; REPRESENTATION; NAVIGATION; FUTURE; CELLS; MAP	It has been hypothesized that the brain organizes concepts into a mental map, allowing conceptual relationships to be navigated in a manner similar to that of space. Grid cells use a hexagonally symmetric code to organize spatial representations and are the likely source of a precise hexagonal symmetry in the functional magnetic resonance imaging signal. Humans navigating conceptual two-dimensional knowledge showed the same hexagonal signal in a set of brain regions markedly similar to those activated during spatial navigation. This gridlike signal is consistent across sessions acquired within an hour and more than a week apart. Our findings su::est that global relational codes may be used to organize nonspatial conceptual representations and that these codes may have a hexagonal gridlike pattern when conceptual knowledge is laid out in two continuous dimensions.	[Constantinescu, Alexandra O.; O'Reilly, Jill X.; Behrens, Timothy E. J.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, Oxford OX3 9DU, England; [O'Reilly, Jill X.] Univ Oxford, Dept Expt Psychol, 9 South Parks Rd, Oxford OX1 3UD, England; [O'Reilly, Jill X.] Radboud Univ Nijmegen, Donders Inst, NL-6525 ED Nijmegen, Netherlands; [Behrens, Timothy E. J.] UCL, Wellcome Trust Ctr Neuroimaging, 12 Queen Sq, London WC1N 3BG, England	University of Oxford; University of Oxford; Radboud University Nijmegen; University of London; University College London	Constantinescu, AO; Behrens, TEJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, Oxford OX3 9DU, England.; Behrens, TEJ (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, 12 Queen Sq, London WC1N 3BG, England.	alexandra.constantinescu@magd.ox.ac.uk; behrens@fmrib.ox.ac.uk		O'Reilly, Jill/0000-0002-6998-455X; Behrens, Timothy/0000-0003-0048-1177	Wellcome Trust [099715/Z/12/Z, WT104765MA]; Medical Research Council [MR/L019639/1]; James S. McDonnell Foundation [JSMF220020372]; MRC [MR/L019639/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); James S. McDonnell Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank N. Burgess, Z. Kurth-Nelson, H. Barron, L. Hunt, M. Garvert, and T. Muller for helpful discussions and comments on this manuscript as well as the anonymous peer reviewers who greatly improved the manuscript. We thank S. Jbabdi for help with data collection and analysis, as well as A. Winkler and L. Griffanti for guidance. We also thank all participants for Vainteering in this study. The study was supported by a Wellcome Trust 4-year Ph.D. studentship (099715/Z/12/Z) to A.O.C., a Medical Research Council Career Development Award (MR/L019639/1) to J.X.O.R., and a Wellcome Trust Senior Research Fellowship (WT104765MA) together with a James S. McDonnell Foundation Award (JSMF220020372) to T.E.J.B. The authors declare no conflicts of interest. At raw data are archived at the Oxford Centre for Functional MRI of the Brain.	[Anonymous], 2014, ADV NEURAL INFORM PR; Aronov D., 2016, P COMP SYST NEUR M T, VT-29, P41; Barron HC, 2013, NAT NEUROSCI, V16, P1492, DOI 10.1038/nn.3515; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Benoit RG, 2014, P NATL ACAD SCI USA, V111, P16550, DOI 10.1073/pnas.1419274111; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Clithero JA, 2014, SOC COGN AFFECT NEUR, V9, P1289, DOI 10.1093/scan/nst106; Davis T, 2014, CEREB CORTEX, V24, P1720, DOI 10.1093/cercor/bht014; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Dordek Y, 2016, ELIFE, V5, DOI 10.7554/eLife.10094; Eichenbaum H, 2014, NEURON, V83, P764, DOI 10.1016/j.neuron.2014.07.032; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Horner AJ, 2016, CURR BIOL, V26, P842, DOI 10.1016/j.cub.2016.01.042; Jacobs J, 2013, NAT NEUROSCI, V16, P1188, DOI 10.1038/nn.3466; Kraus BJ, 2015, NEURON, V88, P578, DOI 10.1016/j.neuron.2015.09.031; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; Kunz L, 2015, SCIENCE, V350, P430, DOI 10.1126/science.aac8128; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Stensola T, 2015, NATURE, V518, P207, DOI 10.1038/nature14151; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626	27	310	310	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1464	1468		10.1126/science.aaf0941	http://dx.doi.org/10.1126/science.aaf0941			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO7PV	27313047	Green Submitted, Green Accepted			2022-12-24	WOS:000377975400050
J	Frieden, TR; Schuchat, A; Petersen, LR				Frieden, Thomas R.; Schuchat, Anne; Petersen, Lyle R.			Zika Virus 6 Months Later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Frieden, Thomas R.; Schuchat, Anne; Petersen, Lyle R.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA.	tfrieden@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1; Centers for Disease Control and Prevention, 2016, ZIK VIR; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3; Pacheco O, 2016, NEW ENGL J MED, DOI [DOI 10.1056/NEJM0A1604037, 10.1056/NEJMoa1604037]; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338	6	30	30	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2016	316	14					1443	1444		10.1001/jama.2016.11941	http://dx.doi.org/10.1001/jama.2016.11941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY1TC	27532277	Bronze			2022-12-24	WOS:000384876300011
J	Wang, SY; Su, JH; Beliveau, BJ; Bintu, B; Moffitt, JR; Wu, CT; Zhuang, XW				Wang, Siyuan; Su, Jun-Han; Beliveau, Brian J.; Bintu, Bogdan; Moffitt, Jeffrey R.; Wu, Chao-ting; Zhuang, Xiaowei			Spatial organization of chromatin domains and compartments in single chromosomes	SCIENCE			English	Article							OLIGOPAINT FISH PROBES; IN-SITU HYBRIDIZATION; INACTIVE X-CHROMOSOME; CONFORMATION CAPTURE; INTERPHASE NUCLEUS; DROSOPHILA GENOME; 3D GENOME; REVEALS; TRANSCRIPTION; PRINCIPLES	The spatial organization of chromatin critically affects genome function. Recent chromosome-conformation-capture studies have revealed topologically associating domains (TADs) as a conserved feature of chromatin organization, but how TADs are spatially organized in individual chromosomes remains unknown. Here, we developed an imaging method for mapping the spatial positions of numerous genomic regions along individual chromosomes and traced the positions of TADs in human interphase autosomes and X chromosomes. We observed that chromosome folding deviates from the ideal fractal-globule model at large length scales and that TADs are largely organized into two compartments spatially arranged in a polarized manner in individual chromosomes. Active and inactive X chromosomes adopt different folding and compartmentalization configurations. These results suggest that the spatial organization of chromatin domains can change in response to regulation.	[Wang, Siyuan; Su, Jun-Han; Bintu, Bogdan; Moffitt, Jeffrey R.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Dept Phys, Cambridge, MA 02138 USA; [Beliveau, Brian J.; Wu, Chao-ting] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Beliveau, Brian J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02446 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Dept Phys, Cambridge, MA 02138 USA.; Wu, CT (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	twu@genetics.med.harvard.edu; zhuang@chemistry.harvard.edu		Wang, Siyuan (Steven)/0000-0001-6550-4064; Beliveau, Brian/0000-0003-1314-3118	National Institutes of Health; Jane Coffin Childs Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106412, R01GM105637, R01GM096450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Harada, K. H. Chen, A. Boettiger, and G. Nir for helpful discussions. This work is supported in part by the National Institutes of Health (to X.Z. and C.W.). S.W. is supported in part by a Jane Coffin Childs Fellowship. X.Z. is a Howard Hughes Medical Institute Investigator.	Beliveau BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8147; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Deng XX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0728-8; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; Fabre PJ, 2015, P NATL ACAD SCI USA, V112, P13964, DOI 10.1073/pnas.1517972112; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Galupa R, 2015, CURR OPIN GENET DEV, V31, P57, DOI 10.1016/j.gde.2015.04.002; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Halverson JD, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/022601; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Horakova AH, 2012, HUM MOL GENET, V21, P4367, DOI 10.1093/hmg/dds270; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Imakaev MV, 2015, SOFT MATTER, V11, P665, DOI 10.1039/c4sm02099e; Lessing D, 2013, ANNU REV GENOM HUM G, V14, P85, DOI 10.1146/annurev-genom-091212-153530; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lowenstein MG, 2004, MOL BIOL CELL, V15, P5678, DOI 10.1091/mbc.E04-04-0289; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276 aab2276, 10.1126/science.aab2276]; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Naughton C, 2010, MOL CELL, V40, P397, DOI 10.1016/j.molcel.2010.10.013; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; Williamson I, 2014, GENE DEV, V28, P2778, DOI 10.1101/gad.251694.114; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239	40	294	302	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					598	602		10.1126/science.aaf8084	http://dx.doi.org/10.1126/science.aaf8084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27445307	Green Accepted			2022-12-24	WOS:000381560900044
J	Byrne, EFX; Sircar, R; Miller, PS; Hedger, G; Luchetti, G; Nachtergaele, S; Tully, MD; Mydock-McGrane, L; Covey, DF; Rambo, RP; Sansom, MSP; Newstead, S; Rohatgi, R; Siebold, C				Byrne, Eamon F. X.; Sircar, Ria; Miller, Paul S.; Hedger, George; Luchetti, Giovanni; Nachtergaele, Sigrid; Tully, Mark D.; Mydock-McGrane, Laurel; Covey, Douglas F.; Rambo, Robert P.; Sansom, Mark S. P.; Newstead, Simon; Rohatgi, Rajat; Siebold, Christian			Structural basis of Smoothened regulation by its extracellular domains	NATURE			English	Article								Developmental signals of the Hedgehog (Hh) and Wnt families are transduced across the membrane by Frizzled-class G-protein-coupled receptors (GPCRs) composed of both a heptahelical transmembrane domain (TMD) and an extracellular cysteine-rich domain (CRD). How the large extracellular domains of GPCRs regulate signalling by the TMD is unknown. We present crystal structures of the Hh signal transducer and oncoprotein Smoothened, a GPCR that contains two distinct ligand-binding sites: one in its TMD and one in the CRD. The CRD is stacked atop the TMD, separated by an intervening wedge-like linker domain. Structure-guided mutations show that the interface between the CRD, linker domain and TMD stabilizes the inactive state of Smoothened. Unexpectedly, we find a cholesterol molecule bound to Smoothened in the CRD binding site. Mutations predicted to prevent cholesterol binding impair the ability of Smoothened to transmit native Hh signals. Binding of a clinically used antagonist, vismodegib, to the TMD induces a conformational change that is propagated to the CRD, resulting in loss of cholesterol from the CRD-linker domain-TMD interface. Our results clarify the structural mechanism by which the activity of a GPCR is controlled by ligand-regulated interactions between its extracellular and transmembrane domains.	[Byrne, Eamon F. X.; Miller, Paul S.; Siebold, Christian] Univ Oxford, Div Structural Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Sircar, Ria; Luchetti, Giovanni; Nachtergaele, Sigrid; Rohatgi, Rajat] Stanford Univ, Sch Med, Dept Biochem & Med, Stanford, CA 94305 USA; [Hedger, George; Sansom, Mark S. P.; Newstead, Simon] Univ Oxford, Dept Bioch, Oxford OX1 3QU, England; [Tully, Mark D.; Rambo, Robert P.] Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot OX1 0DE, Oxon, England; [Mydock-McGrane, Laurel; Covey, Douglas F.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	University of Oxford; Wellcome Centre for Human Genetics; Stanford University; University of Oxford; Diamond Light Source; Washington University (WUSTL)	Rohatgi, R (corresponding author), Stanford Univ, Sch Med, Dept Biochem & Med, Stanford, CA 94305 USA.	rrohatgi@stanford.edu; christian@strubi.ox.ac.uk	Sansom, Mark S.P./C-5157-2009; Tully, Mark D/AAU-8320-2021	Sansom, Mark S.P./0000-0001-6360-7959; Tully, Mark D/0000-0001-5450-9900; Newstead, Simon/0000-0001-7432-2270; Miller, Paul/0000-0002-6512-9441; Siebold, Christian/0000-0002-6635-3621; Byrne, Eamon/0000-0001-7513-5944	Cancer Research UK [C20724/A14414]; US National Institutes of Health [GM106078, HL067773]; Wellcome Trust [102890/Z/13/Z, 092970/Z/10/Z, 090532/Z/09/Z]; Taylor Family Institute for Psychiatric Research; NDM Oxford; Medical Research Council UK; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, R35GM118082, R01GM106078] Funding Source: NIH RePORTER; Cancer Research UK [14414] Funding Source: researchfish; Medical Research Council [1514534] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Taylor Family Institute for Psychiatric Research; NDM Oxford; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the staff of beamlines I24 and B21 (MX10627) at the DLS, UK for assistance. We thank S. Masiulis, D. Staunton, K. Jungnickel, A. R. Aricescu and G. Schertler for discussions. The work was supported by Cancer Research UK (C20724/A14414), the US National Institutes of Health (GM106078, HL067773), the Wellcome Trust (102890/Z/13/Z, 092970/Z/10/Z and 090532/Z/09/Z), and the Taylor Family Institute for Psychiatric Research. Further support by NDM Oxford (E.F.X.B.), Medical Research Council UK (G.H.), Ford Foundation (G.L.) and National Science Foundation (S.Na.) is acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Bailey EC, 2002, J BIOL CHEM, V277, P33632, DOI 10.1074/jbc.M202203200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bazan JF, 2009, CELL, V138, P1055, DOI 10.1016/j.cell.2009.09.006; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blassberg R, 2016, HUM MOL GENET, V25, P693, DOI 10.1093/hmg/ddv507; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Chung S.-K., 1998, KOR J MED CHEM, V8, P14; Ciepla P, 2014, CHEM SCI, V5, P4249, DOI 10.1039/c4sc01600a; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; *GLOB PHAS LTD, 2011, BUSTER V2102; Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Monticelli L, 2008, J COMPUT CHEM, V29, P1740, DOI 10.1002/jcc.20935; Myers BR, 2013, DEV CELL, V26, P346, DOI 10.1016/j.devcel.2013.07.015; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nedelcu D, 2013, NAT CHEM BIOL, V9, P557, DOI [10.1038/NCHEMBIO.1290, 10.1038/nchembio.1290]; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Pol-Fachin L, 2014, J COMPUT CHEM, V35, P2087, DOI 10.1002/jcc.23721; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rana R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3965; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Schrodinger L., 2020, PYMOL; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Sharpe HJ, 2015, NAT CHEM BIOL, V11, P246, DOI [10.1038/NCHEMBIO.1776, 10.1038/nchembio.1776]; Sharpe HJ, 2015, CANCER CELL, V27, P327, DOI 10.1016/j.ccell.2015.02.001; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stansfeld PJ, 2015, STRUCTURE, V23, P1350, DOI 10.1016/j.str.2015.05.006; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WINTER G, 2009, NAT PROTOC, V43, P186; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zoonens M, 2014, J MEMBRANE BIOL, V247, P759, DOI 10.1007/s00232-014-9666-8	87	230	231	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					517	522		10.1038/nature18934	http://dx.doi.org/10.1038/nature18934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27437577	Green Accepted, Green Submitted			2022-12-24	WOS:000380856600044
J	Staus, DP; Strachan, RT; Manglik, A; Pani, B; Kahsai, AW; Kim, TH; Wingler, LM; Ahn, S; Chatterjee, A; Masoudi, A; Kruse, AC; Pardon, E; Steyaert, J; Weis, WI; Prosser, RS; Kobilka, BK; Costa, T; Lefkowitz, RJ				Staus, Dean P.; Strachan, Ryan T.; Manglik, Aashish; Pani, Biswaranjan; Kahsai, Alem W.; Kim, Tae Hun; Wingler, Laura M.; Ahn, Seungkirl; Chatterjee, Arnab; Masoudi, Ali; Kruse, Andrew C.; Pardon, Els; Steyaert, Jan; Weis, William I.; Prosser, R. Scott; Kobilka, Brian K.; Costa, Tommaso; Lefkowitz, Robert J.			Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation	NATURE			English	Article							TERNARY COMPLEX MODEL; BETA(2)-ADRENERGIC RECEPTOR; CONFORMATIONS; EFFICACY; BINDING; STATE	G-protein-coupled receptors (GPCRs) modulate many physiological processes by transducing a variety of extracellular cues into intracellular responses. Ligand binding to an extracellular orthosteric pocket propagates conformational change to the receptor cytosolic region to promote binding and activation of downstream signalling effectors such as G proteins and beta-arrestins. It is well known that different agonists can share the same binding pocket but evoke unique receptor conformations leading to a wide range of downstream responses ('efficacy')(1). Furthermore, increasing biophysical evidence, primarily using the beta(2)-adrenergic receptor (beta(2)AR) as a model system, supports the existence of multiple active and inactive conformational states(2-5). However, how agonists with varying efficacy modulate these receptor states to initiate cellular responses is not well understood. Here we report stabilization of two distinct beta(2)AR conformations using single domain camelid antibodies (nanobodies)-a previously described positive allosteric nanobody (Nb80)(6,7) and a newly identified negative allosteric nanobody (Nb60). We show that Nb60 stabilizes a previously unappreciated low-affinity receptor state which corresponds to one of two inactive receptor conformations as delineated by X-ray crystallography and NMR spectroscopy. We find that the agonist isoprenaline has a 15,000-fold higher affinity for beta(2)AR in the presence of Nb80 compared to the affinity of isoprenaline for beta(2)AR in the presence of Nb60, highlighting the full allosteric range of a GPCR. Assessing the binding of 17 ligands of varying efficacy to the beta(2)AR in the absence and presence of Nb60 or Nb80 reveals large ligand-specific effects that can only be explained using an allosteric model which assumes equilibrium amongst at least three receptor states. Agonists generally exert efficacy by stabilizing the active Nb80-stabilized receptor state (R-80). In contrast, for a number of partial agonists, both stabilization of R-80 and destabilization of the inactive, Nb60-bound state (R-60) contribute to their ability to modulate receptor activation. These data demonstrate that ligands can initiate a wide range of cellular responses by differentially stabilizing multiple receptor states.	[Staus, Dean P.; Pani, Biswaranjan; Kahsai, Alem W.; Wingler, Laura M.; Ahn, Seungkirl; Chatterjee, Arnab; Masoudi, Ali; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Strachan, Ryan T.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Manglik, Aashish; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Kim, Tae Hun; Prosser, R. Scott] Univ Toronto, Dept Chem, 3359 Mississauga Rd North, Mississauga, ON L5L 1C6, Canada; [Kruse, Andrew C.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium; [Pardon, Els; Steyaert, Jan] VIB, Struct Biol Res Ctr, Pl Laan 2, B-1050 Brussels, Belgium; [Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Costa, Tommaso] Ist Super Sanita, Dept Pharmacol, I-00161 Rome, Italy; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Stanford University; University of Toronto; University Toronto Mississauga; Harvard University; Harvard Medical School; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Stanford University; Istituto Superiore di Sanita (ISS); Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Costa, T (corresponding author), Ist Super Sanita, Dept Pharmacol, I-00161 Rome, Italy.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.; Lefkowitz, RJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	kobilka@stanford.edu; tommaso.costa@iss.it; lefko001@receptor-biol.duke.edu	Pani, Biswaranjan/GLT-9217-2022; Weis, William I/G-1437-2011; steyaert, jan/GQP-7811-2022; Steyaert, Jan/H-4662-2011; Wingler, Laura/ABA-4466-2020; costa, tommaso/AAD-3714-2019; Lefkowitz, Robert/AAW-2649-2021	Weis, William I/0000-0002-5583-6150; Steyaert, Jan/0000-0002-3825-874X; Wingler, Laura/0000-0002-3688-5088; costa, tommaso/0000-0002-8729-3357; Pardon, Els/0000-0002-2466-0172	National Institute of Health [NS028471, T32HL007101, HL16037, HL70631]; Stanford Medical Scientist Training Program; American Heart Association; Italian Ministry of Health [RF-2011-02351158]; Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL070631, T32HL007101, R01HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Medical Scientist Training Program; American Heart Association(American Heart Association); Italian Ministry of Health(Ministry of Health, Italy); Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Capel and X. Jiang for technical assistance. Administrative and secretarial support were provided by V. Ronk, K. Harley, D. Addison, and Q. Lennon. We acknowledge support from the National Institute of Health grants NS028471 (B.K.K.), T32HL007101 (D.P.S., L.M.W.), HL16037 and HL70631 (R.J.L.), from the Stanford Medical Scientist Training Program and the American Heart Association (A.M.), Italian Ministry of Health, grant RF-2011-02351158 (T.C.), and from the Mathers Foundation (B.K.K. and W.I.W.). R.J.L. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D, 2006, TRENDS PHARMACOL SCI, V27, P149, DOI 10.1016/j.tips.2006.01.008; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; EHLERT FJ, 1985, MOL PHARMACOL, V28, P410; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Mashalidis EH, 2013, NAT PROTOC, V8, P2309, DOI 10.1038/nprot.2013.130; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Onaran HO, 2014, TRENDS PHARMACOL SCI, V35, P639, DOI 10.1016/j.tips.2014.09.010; Onaran HO, 2009, CURR PROTEIN PEPT SC, V10, P110, DOI 10.2174/138920309787847644; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pradines JR, 2001, J MATH BIOL, V43, P313, DOI 10.1007/s002850100086; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Shi LC, 2014, P NATL ACAD SCI USA, V111, P2140, DOI 10.1073/pnas.1318476111; Staus DP, 2014, MOL PHARMACOL, V85, P472, DOI 10.1124/mol.113.089516; Strachan RT, 2014, J BIOL CHEM, V289, P14211, DOI 10.1074/jbc.M114.548131; Vezzi V, 2013, J BIOL CHEM, V288, P23964, DOI 10.1074/jbc.M113.474452; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WREGGETT KA, 1984, MOL PHARMACOL, V26, P214	36	194	200	3	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					448	+		10.1038/nature18636	http://dx.doi.org/10.1038/nature18636			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27409812	Green Accepted, Green Published, Green Submitted			2022-12-24	WOS:000380344200046
J	Menke, A; Casagrande, S; Cowie, CC				Menke, Andy; Casagrande, Sarah; Cowie, Catherine C.			Prevalence of Diabetes in Adolescents Aged 12 to 19 Years in the United States, 2005-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							TYPE-2; YOUTH		[Menke, Andy; Casagrande, Sarah] Social & Sci Syst, 8757 Georgia Ave,12th Floor, Silver Spring, MD 20910 USA; [Cowie, Catherine C.] NIDDK, NIH, Bethesda, MD USA	Social & Scientific Systems; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Menke, A (corresponding author), Social & Sci Syst, 8757 Georgia Ave,12th Floor, Silver Spring, MD 20910 USA.	amenke@s-3.com			PHS HHS [GS10F0381L] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Demmer RT, 2013, AM J EPIDEMIOL, V178, P1106, DOI 10.1093/aje/kwt088; Klingensmith GJ, 2016, DIABETES CARE, V39, P122, DOI 10.2337/dc15-1206; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; West NA, 2009, DIABETES CARE, V32, P175, DOI 10.2337/dc08-1442; Zipf G, 2013, VITAL HLTH STAT, V56, P1	6	45	45	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2016	316	3					344	345		10.1001/jama.2016.8544	http://dx.doi.org/10.1001/jama.2016.8544			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR3LN	27434447	Bronze			2022-12-24	WOS:000379804800023
J	Callaway, E				Callaway, Ewen			THE VISUALIZATIONS TRANSFORMING BIOLOGY	NATURE			English	Editorial Material																			0	8	8	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					187	188		10.1038/535187a	http://dx.doi.org/10.1038/535187a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27383989	hybrid			2022-12-24	WOS:000379015600050
J	Sankar, TS; Wastuwidyaningtyas, BD; Dong, YX; Lewis, SA; Wang, JD				Sankar, T. Sabari; Wastuwidyaningtyas, Brigitta D.; Dong, Yuexin; Lewis, Sarah A.; Wang, Jue D.			The nature of mutations induced by replication-transcription collisions	NATURE			English	Article							ESCHERICHIA-COLI PLASMIDS; BACILLUS-SUBTILIS; DNA-REPLICATION; RNA-POLYMERASE; MAXIMUM-LIKELIHOOD; GENOME INSTABILITY; STRUCTURAL BASIS; FORK MOVEMENT; E. COLI; GENE	The DNA replication and transcription machineries share a common DNA template and thus can collide with each other co-directionally or head-on(1,2). Replication-transcription collisions can cause replication fork arrest, premature transcription termination, DNA breaks, and recombination intermediates threatening genome integrity(1-10). Collisions may also trigger mutations, which are major contributors to genetic disease and evolution(5,7,11). However, the nature and mechanisms of collision-induced mutagenesis remain poorly understood. Here we reveal the genetic consequences of replication-transcription collisions in actively dividing bacteria to be two classes of mutations: duplications/deletions and base substitutions in promoters. Both signatures are highly deleterious but are distinct from the previously well-characterized base substitutions in the coding sequence. Duplications/deletions are probably caused by replication stalling events that are triggered by collisions; their distribution patterns are consistent with where the fork first encounters a transcription complex upon entering a transcription unit. Promoter substitutions result mostly from head-on collisions and frequently occur at a nucleotide that is conserved in promoters recognized by the major sigma factor in bacteria. This substitution is generated via adenine deamination on the template strand in the promoter open complex, as a consequence of head-on replication perturbing transcription initiation. We conclude that replication-transcription collisions induce distinct mutation signatures by antagonizing replication and transcription, not only in coding sequences but also in gene regulatory elements.	[Sankar, T. Sabari; Dong, Yuexin; Wang, Jue D.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Sankar, T. Sabari; Wastuwidyaningtyas, Brigitta D.; Lewis, Sarah A.; Wang, Jue D.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Wisconsin System; University of Wisconsin Madison; Baylor College of Medicine	Wang, JD (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Wang, JD (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	wang@bact.wisc.edu	Wang, Jue/GVU-0480-2022	Thirupathy, Sabari Sankar/0000-0003-0692-8769; Wang, Jue/0000-0003-1503-170X; Lewis, Sarah/0000-0002-5568-955X; Dong, Yuexin/0000-0002-7471-8053	National Institutes of Health Director's New Innovator Award [DP2OD004433]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084003] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004433] Funding Source: NIH RePORTER	National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Robleto, R. Yasbin and L. Simmons for strains, M. Cox, R. Gourse, C. Hittinger, R. Landick, K. Wasserman, C. Gross, M. Laub, S. Rosenberg, L. Simmons and the Wang laboratory for discussions and comments on the manuscript. This work was supported by the National Institutes of Health Director's New Innovator Award DP2OD004433 to J.D.W.	Aamodt RM, 2004, J BIOL CHEM, V279, P13601, DOI 10.1074/jbc.M314277200; Bruand C, 2001, MOL MICROBIOL, V39, P1248, DOI 10.1111/j.1365-2958.2001.02312.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fijalkowska IJ, 1998, P NATL ACAD SCI USA, V95, P10020, DOI 10.1073/pnas.95.17.10020; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Gao F, 2007, BIOINFORMATICS, V23, P1866, DOI 10.1093/bioinformatics/btm255; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kunkel TA, 2009, COLD SH Q B, V74, P91, DOI 10.1101/sqb.2009.74.027; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lippert MJ, 2011, P NATL ACAD SCI USA, V108, P698, DOI 10.1073/pnas.1012363108; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LU AL, 1983, P NATL ACAD SCI-BIOL, V80, P4639, DOI 10.1073/pnas.80.15.4639; Luria SE, 1943, GENETICS, V28, P491; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Million-Weaver S, 2015, P NATL ACAD SCI USA, V112, pE1096, DOI 10.1073/pnas.1416651112; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; Paul S, 2013, NATURE, V495, P512, DOI 10.1038/nature11989; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Reijns MAM, 2015, NATURE, V518, P502, DOI 10.1038/nature14183; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; SCHAAPER RM, 1986, J MOL BIOL, V189, P273, DOI 10.1016/0022-2836(86)90509-7; Schroeder JW, 2016, CURR BIOL, V26, P692, DOI 10.1016/j.cub.2016.01.016; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Ter Beek A, 2008, J BACTERIOL, V190, P1751, DOI 10.1128/JB.01516-07; VASANTHA N, 1980, J BACTERIOL, V144, P1119, DOI 10.1128/JB.144.3.1119-1125.1980; VILETTE D, 1992, EMBO J, V11, P3629, DOI 10.1002/j.1460-2075.1992.tb05447.x; VILETTE D, 1995, MOL MICROBIOL, V17, P493, DOI 10.1111/j.1365-2958.1995.mmi_17030493.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshiyama K, 2001, J MOL BIOL, V307, P1195, DOI 10.1006/jmbi.2001.4557; ZAMENHOF S, 1961, J BACTERIOL, V81, P111, DOI 10.1128/JB.81.1.111-117.1961; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	48	78	78	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					178	+		10.1038/nature18316	http://dx.doi.org/10.1038/nature18316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362223	Green Accepted			2022-12-24	WOS:000379015600048
J	Aydin, H; Sultana, A; Li, S; Thavalingam, A; Lee, JE				Aydin, Halil; Sultana, Azmiri; Li, Sheng; Thavalingam, Annoj; Lee, Jeffrey E.			Molecular architecture of the human sperm IZUMO1 and egg JUNO fertilization complex	NATURE			English	Article							STRUCTURE REFINEMENT; STRUCTURAL BASIS; FUSION; MASS; GLYCOPROTEIN; RESOLUTION; CRYSTALS; EXCHANGE; ADHESION; INSIGHTS	Fertilization is an essential biological process in sexual reproduction and comprises a series of molecular interactions between the sperm and egg(1,2). The fusion of the haploid spermatozoon and oocyte is the culminating event in mammalian fertilization, enabling the creation of a new, genetically distinct diploid organism(3,4). The merger of two gametes is achieved through a two-step mechanism in which the sperm protein IZUMO1 on the equatorial segment of the acrosome-reacted sperm recognizes its receptor, JUNO, on the egg surface(4-6). This recognition is followed by the fusion of the two plasma membranes. IZUMO1 and JUNO proteins are indispensable for fertilization, as constitutive knockdown of either protein results in mice that are healthy but infertile(5,6). Despite their central importance in reproductive medicine, the molecular architectures of these proteins and the details of their functional roles in fertilization are not known. Here we present the crystal structures of human IZUMO1 and JUNO in unbound and bound conformations. The human IZUMO1 structure exhibits a distinct boomerang shape and provides structural insights into the IZUMO family of proteins(7). Human IZUMO1 forms a high-affinity complex with JUNO and undergoes a major conformational change within its N-terminal domain upon binding to the egg-surface receptor. Our results provide insights into the molecular basis of sperm-egg recognition, cross-species fertilization, and the barrier to polyspermy, thereby promising benefits for the rational development of non-hormonal contraceptives and fertility treatments for humans and other mammals.	[Aydin, Halil; Sultana, Azmiri; Thavalingam, Annoj; Lee, Jeffrey E.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Toronto; University of California System; University of California San Diego	Lee, JE (corresponding author), Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada.	jeff.lee@utoronto.ca			CIHR [MOP-115066]; NSERC [RGPIN 435607-13]; Ontario Early Researcher Award [ER-13-09-116]; Canada Research Chair; NIH [1U19AI117905, R01 GM020501, R01 AI101436]; University of Toronto; Ontario Graduate Scholarships; NSERC USRA; NSERC; National Research Council of Canada; CIHR; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; US Department of Energy (Office of Basic Energy Sciences) through the Integrated Diffraction Analysis Technologies program [DE-AC02-05CH11231]; DOE Office of Biological and Environmental Research; NIH project MINOS [R01GM105404]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101436, U19AI117905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, R01GM105404] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Toronto(University of Toronto); Ontario Graduate Scholarships(Ontario Graduate Scholarship); NSERC USRA(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council of Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; US Department of Energy (Office of Basic Energy Sciences) through the Integrated Diffraction Analysis Technologies program(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH project MINOS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a CIHR Operating Grant (MOP-115066), an NSERC Discovery Grant (RGPIN 435607-13), an Ontario Early Researcher Award (ER-13-09-116), and a Canada Research Chair to J.E.L. S.L. is supported by grants from NIH (1U19AI117905, R01 GM020501 and R01 AI101436). Support for stipends was provided by University of Toronto and Ontario Graduate Scholarships to H.A. and an NSERC USRA to A.T. We thank W. Houry, T. Moraes and C. Spring for access to circular dichroism, SEC-MALS and SPR systems, respectively. This work is based upon X-ray data collected at beamline 08ID-1 at the Canadian Light Source (CLS) and Structural Genomics Consortium (SGC), and SAXS data acquired at the Advanced Light Source (ALS) SIBYLS beamline 12.3.1. The CLS is supported by NSERC, National Research Council of Canada, CIHR, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. The ALS is a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the US Department of Energy (Office of Basic Energy Sciences) through the Integrated Diffraction Analysis Technologies program (DE-AC02-05CH11231), supported by the DOE Office of Biological and Environmental Research; additional support comes from NIH project MINOS (R01GM105404). We thank F. Azimi, J. Cook, A. Dong and N. Ly for technical support, and E. Ollmann Saphire, A. S. Rocca and G. Bikopoulos for critical reading of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Chen C, 2013, NATURE, V500, P486, DOI 10.1038/nature12327; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Dauter Z, 2003, ACTA CRYSTALLOGR D, V59, P2004, DOI 10.1107/S0907444903021085; Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans JP, 2012, ANNU REV PHYSIOL, V74, P477, DOI 10.1146/annurev-physiol-020911-153339; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FISHER RG, 1980, ACTA CRYSTALLOGR A, V36, P755, DOI 10.1107/S0567739480001520; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Grayson Phil, 2012, Int J Evol Biol, V2012, P958164, DOI 10.1155/2012/958164; Gupta SK, 2012, CELL TISSUE RES, V349, P665, DOI 10.1007/s00441-011-1319-y; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Han L, 2016, CURR BIOL, V26, pR100, DOI 10.1016/j.cub.2015.12.034; Han L, 2010, CELL, V143, P404, DOI 10.1016/j.cell.2010.09.041; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9858; Inoue N, 2013, DEVELOPMENT, V140, P3221, DOI 10.1242/dev.094854; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim E, 2008, INT J DEV BIOL, V52, P677, DOI 10.1387/ijdb.072528ek; Klinovska K, 2014, INT J MOL SCI, V15, P10652, DOI 10.3390/ijms150610652; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; MARQUARDT T, 1992, J CELL BIOL, V117, P505, DOI 10.1083/jcb.117.3.505; Marsh JJ, 2013, BIOCHEMISTRY-US, V52, P5491, DOI 10.1021/bi4007995; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Sathiyamoorthy K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004309; Sheerin DJ, 2011, BIOCHEM J, V435, P629, DOI 10.1042/BJ20101941; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; Sultana A., 2015, CURR PROT PROTEIN SC, V79; Sutovsky P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001045; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wibowo AS, 2013, P NATL ACAD SCI USA, V110, P15180, DOI 10.1073/pnas.1308827110; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yanagimachi R., 1994, Zygote, V2, P371; YEATES TO, 1988, ACTA CRYSTALLOGR A, V44, P142, DOI 10.1107/S0108767387009632; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	54	77	83	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					562	+		10.1038/nature18595	http://dx.doi.org/10.1038/nature18595			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309818	Green Accepted			2022-12-24	WOS:000378270300056
J	Parikh, RB; Prasad, V				Parikh, Ravi B.; Prasad, Vinay			Blood-Based Screening for Colon Cancer A Disruptive Innovation or Simply a Disruption?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLORECTAL-CANCER; COLONOSCOPY		[Parikh, Ravi B.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Prasad, Vinay] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Prasad, Vinay] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Harvard University; Brigham & Women's Hospital; Oregon Health & Science University; Oregon Health & Science University	Prasad, V (corresponding author), Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	prasad@ohsu.edu		Prasad, Vinayak/0000-0002-6110-8221				Adler A, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-183; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; FDA Center for Devices and Radiological Health Medical Devices Advisory Committee, 2014, MOL CLIN GEN PAN; Food and Drug Administration Molecular and Clinical Genetics Panel, 2014, FDA EX SUMM EP AG EP; Johnson DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098238; Lee JK, 2009, J GEN INTERN MED, V24, P1192, DOI 10.1007/s11606-009-1087-5; Neugut AI, 2010, JAMA-J AM MED ASSOC, V304, P461, DOI 10.1001/jama.2010.1001; Prasad V, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6080; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133	9	22	23	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2519	2520		10.1001/jama.2016.7914	http://dx.doi.org/10.1001/jama.2016.7914			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27305625	Bronze			2022-12-24	WOS:000378306700011
J	Rehm, CD; Penalvo, JL; Afshin, A; Mozaffarian, D				Rehm, Colin D.; Penalvo, Jose L.; Afshin, Ashkan; Mozaffarian, Dariush			Dietary Intake Among US Adults, 1999-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; UNITED-STATES; MEAT CONSUMPTION; RISK; TRENDS; OBESITY; METAANALYSIS; NUTRIENTS; REDUCTION; STROKE	IMPORTANCE Most studies of US dietary trends have evaluated major macronutrients or only a few dietary factors. Understanding trends in summary measures of diet quality for multiple individual foods and nutrients, and the corresponding disparities among population subgroups, is crucial to identify challenges and opportunities to improve dietary intake for all US adults. OBJECTIVE To characterize trends in overall diet quality and multiple dietary components related to major diseases among US adults, including by age, sex, race/ethnicity, education, and income. DESIGN, SETTING, AND PARTICIPANTS Repeated cross-sectional investigation using 24-hour dietary recalls in nationally representative samples including 33 932 noninstitutionalized US adults aged 20 years or older from 7 National Health and Nutrition Examination Survey (NHANES) cycles (1999-2012). The sample size per cycle ranged from 4237 to 5762. EXPOSURES Calendar year and population sociodemographic subgroups. MAIN OUTCOMES AND MEASURES Survey-weighted, energy-adjusted mean consumption and proportion meeting targets of the American Heart Association (AHA) 2020 continuous diet scores, AHA score components (primary: total fruits and vegetables, whole grains, fish and shellfish, sugar-sweetened beverages, and sodium; secondary: nuts, seeds, and legumes, processed meat, and saturated fat), and other individual food groups and nutrients. RESULTS Several overall dietary improvements were identified (P < .01 for trend for each). The AHA primary diet score (maximum of 50 points) improved from 19.0 to 21.2 (an improvement of 11.6%). The AHA secondary diet score (maximum of 80 points) improved from 35.1 to 38.5 (an improvement of 9.7%). Changes were attributable to increased consumption between 1999-2000 and 2011-2012 of whole grains (0.43 servings/d; 95% CI, 0.34-0.53 servings/d) and nuts or seeds (0.25 servings/d; 95% CI, 0.18-0.34 servings/d) (fish and shellfish intake also increased slightly) and to decreased consumption of sugar-sweetened beverages (0.49 servings/d; 95% CI, 0.28-0.70 servings/d). No significant trend was observed for other score components, including total fruits and vegetables, processed meat, saturated fat, or sodium. The estimated percentage of US adults with poor diets (defined as < 40% adherence to the primary AHA diet score components) declined from 55.9% to 45.6%, whereas the percentage with intermediate diets (defined as 40% to 79.9% adherence to the primary AHA diet score components) increased from 43.5% to 52.9%. Other dietary trends included increased consumption of whole fruit (0.15 servings/d; 95% CI, 0.05-0.26 servings/d) and decreased consumption of 100% fruit juice (0.11 servings/d; 95% CI, 0.04-0.18 servings/d). Disparities in diet quality were observed by race/ethnicity, education, and income level; for example, the estimated percentage of non-Hispanic white adults with a poor diet significantly declined (53.9% to 42.8%), whereas similar improvements were not observed for non-Hispanic black or Mexican American adults. There was little evidence of reductions in these disparities and some evidence of worsening by income level. CONCLUSIONS AND RELEVANCE In nationally representative US surveys conducted between 1999 and 2012, several improvements in self-reported dietary habits were identified, with additional findings suggesting persistent or worsening disparities based on race/ethnicity, education level, and income level. These findings may inform discussions on emerging successes, areas for greater attention, and corresponding opportunities to improve the diets of individuals living in the United States.	[Rehm, Colin D.] Montefiore Med Ctr, Off Community & Populat Hlth, 111 E 210th St, Bronx, NY 10467 USA; [Rehm, Colin D.; Penalvo, Jose L.; Afshin, Ashkan; Mozaffarian, Dariush] Tufts Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA; [Afshin, Ashkan] Univ Washington, Dept Global Hlth, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), Tufts Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.	dariush.mozaffarian@tufts.edu	Penalvo, Jose L./AAA-9210-2020; REHM, COLIN D./J-1215-2019; Mozaffarian, Dariush/ABC-2822-2020	Penalvo, Jose L./0000-0003-0096-6238; REHM, COLIN D./0000-0002-7644-0040; 	National Heart, Lung, and Blood Institute [5R01HL115189]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115189] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant 5R01HL115189 from the National Heart, Lung, and Blood Institute.	Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; Aune D, 2013, EUR J EPIDEMIOL, V28, P845, DOI 10.1007/s10654-013-9852-5; Bowman S. A., USDA FOOD PATTERNS E; Bowman SA., MYPYRAMID EQUIVALENT; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cho SS, 2013, AM J CLIN NUTR, V98, P594, DOI 10.3945/ajcn.113.067629; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Ford ES, 2013, AM J CLIN NUTR, V97, P848, DOI 10.3945/ajcn.112.052662; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; Kipnis V, 2009, BIOMETRICS, V65, P1003, DOI 10.1111/j.1541-0420.2009.01223.x; Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943; Kuklina Elena V, 2013, NCHS Data Brief, P1; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Slining MM, 2013, J ACAD NUTR DIET, V113, P1683, DOI 10.1016/j.jand.2013.06.001; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; USDA, DIET GUID AM 2015 20; Wang DD, 2014, JAMA INTERN MED, V174, P1587, DOI 10.1001/jamainternmed.2014.3422; Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366; Willett W., 2013, MONOGRAPHS EPIDEMIOL, V3rd	34	384	391	8	73	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2542	2553		10.1001/jama.2016.7491	http://dx.doi.org/10.1001/jama.2016.7491			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27327801	Green Accepted, Bronze			2022-12-24	WOS:000378306700018
J	Lee, N				Lee, Naomi			The Lancet Technology: pharming blood	LANCET			English	Editorial Material												naomi.lee@lancet.com							0	1	1	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2496	2496		10.1016/S0140-6736(16)30800-5	http://dx.doi.org/10.1016/S0140-6736(16)30800-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27353675				2022-12-24	WOS:000377947200014
J	Kuffer, A; Lakkaraju, AKK; Mogha, A; Petersen, SC; Airich, K; Doucerain, C; Marpakwar, R; Bakirci, P; Senatore, A; Monnard, A; Schiavi, C; Nuvolone, M; Grosshans, B; Hornemann, S; Bassilana, F; Monk, KR; Aguzzi, A				Kuffer, Alexander; Lakkaraju, Asvin K. K.; Mogha, Amit; Petersen, Sarah C.; Airich, Kristina; Doucerain, Cedric; Marpakwar, Rajlakshmi; Bakirci, Pamela; Senatore, Assunta; Monnard, Arnaud; Schiavi, Carmen; Nuvolone, Mario; Grosshans, Bianka; Hornemann, Simone; Bassilana, Frederic; Monk, Kelly R.; Aguzzi, Adriano			The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6	NATURE			English	Article							PERIPHERAL MYELIN MAINTENANCE; SCHWANN-CELL DEVELOPMENT; GPR126; ZEBRAFISH; APOPTOSIS; NEURONS; DOMAIN; MICE; RNA	Ablation of the cellular prion protein PrPC leads to a chronic demyelinating polyneuropathy affecting Schwann cells. Neuron-restricted expression of PrPC prevents the disease(1), suggesting that PrPC acts in trans through an unidentified Schwann cell receptor. Here we show that the cAMP concentration in sciatic nerves from PrPC-deficient mice is reduced, suggesting that PrPC acts via a G protein-coupled receptor (GPCR). The amino-terminal flexible tail (residues 23-120) of PrPC triggered a concentration-dependent increase in cAMP in primary Schwann cells, in the Schwann cell line SW10, and in HEK293T cells overexpressing the GPCR Adgrg6 (also known as Gpr126). By contrast, naive HEK293T cells and HEK293T cells expressing several other GPCRs did not react to the flexible tail, and ablation of Gpr126 from SW10 cells abolished the flexible tail-induced cAMP response. The flexible tail contains a polycationic cluster (KKRPKPG) similar to the GPRGKPG motif of the Gpr126 agonist type-IV collagen(2). A KKRPKPG-containing PrPC-derived peptide (FT23-50) sufficed to induce a Gpr126-dependent cAMP response in cells and mice, and improved myelination in hypomorphic gpr126 mutant zebrafish (Danio rerio). Substitution of the cationic residues with alanines abolished the biological activity of both FT23-50 and the equivalent type-IV collagen peptide. We conclude that PrPC promotes myelin homeostasis through flexible tail-mediated Gpr126 agonism. As well as clarifying the physiological role of PrPC, these observations are relevant to the pathogenesis of demyelinating polyneuropathies-common debilitating diseases for which there are limited therapeutic options.	[Kuffer, Alexander; Lakkaraju, Asvin K. K.; Airich, Kristina; Doucerain, Cedric; Marpakwar, Rajlakshmi; Bakirci, Pamela; Senatore, Assunta; Monnard, Arnaud; Schiavi, Carmen; Nuvolone, Mario; Hornemann, Simone; Aguzzi, Adriano] Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Mogha, Amit; Petersen, Sarah C.; Monk, Kelly R.] Washington Univ, Sch Med, Dept Dev Biol, 660 South Euclid Ave,Campus Box 8103, St Louis, MO 63110 USA; [Mogha, Amit; Petersen, Sarah C.; Monk, Kelly R.] Hope Ctr Neurol Disorders, 660 South Euclid Ave,Campus Box 8103, St Louis, MO 63110 USA; [Grosshans, Bianka; Bassilana, Frederic] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland	University of Zurich; Washington University (WUSTL); Novartis	Aguzzi, A (corresponding author), Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Nuvolone, Mario/K-4763-2018	Nuvolone, Mario/0000-0001-8334-1684; Marpakwar, Rajlakshmi/0000-0002-6683-0571; Bassilana, Frederic/0000-0003-2063-8450; Petersen, Sarah/0000-0003-4540-4909; Aguzzi, Adriano/0000-0002-0344-6708; Lakkaraju, Asvin/0000-0001-8752-148X	European Research Council; European Union; Swiss National Research Foundation; Sinergia grant [147660]; Clinical Research Priority Program 'Small RNAs'; Clinical Research Priority Program 'Human Hemato-Lymphatic Diseases'; SystemsX.ch; EU Joint Programme on Neurodegenerative Disease Research (JPND) CureALS and REfrAME; Novartis Research Foundation; MD/PhD fellowship from the Swiss National Science Foundation; Synapsis Foundation; NIH [F32 NS087786, NS079445]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS087786, R01NS079445] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Sinergia grant; Clinical Research Priority Program 'Small RNAs'; Clinical Research Priority Program 'Human Hemato-Lymphatic Diseases'; SystemsX.ch; EU Joint Programme on Neurodegenerative Disease Research (JPND) CureALS and REfrAME; Novartis Research Foundation; MD/PhD fellowship from the Swiss National Science Foundation; Synapsis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Moos, P. Schwarz, C. Tiberi, C. Sturzenegger, V. Escalante, M. Delic, C. Johnson and Z. Spence for technical help; J. Bremer for discussions; V. Beck, M.-A. Wulf, K. Frontzek, T. Johnson, T. O'Connor, A. Lau and C. Rehwald for help in performing experiments; and X. Piao for antibodies against Gpr126. A. A. is the recipient of support from an Advanced Grant of the European Research Council (Prion2020), a European Union Framework 7 Grant (NEURINOX), the Swiss National Research Foundation, Sinergia grant #147660, the Clinical Research Priority Programs 'Small RNAs' and 'Human Hemato-Lymphatic Diseases', SystemsX.ch, the EU Joint Programme on Neurodegenerative Disease Research (JPND) CureALS and REfrAME, and the Novartis Research Foundation. A.K. was supported by an MD/PhD fellowship from the Swiss National Science Foundation. A.K.K.L. is supported by a grant from the Synapsis Foundation. S.H. is a recipient of a SystemsX. ch grant. This work was supported by NIH grants F32 NS087786 to S.C.P. and NS079445 to K.R.M.	Altmeppen HC, 2015, ELIFE, V4, DOI 10.7554/eLife.04260; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Dametto P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117412; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Hornemann S, 2009, FEBS J, V276, P2359, DOI 10.1111/j.1742-4658.2009.06968.x; Ishida C, 2005, J NEUROL NEUROSUR PS, V76, P325, DOI 10.1136/jnnp.2003.035154; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Nuvolone M, 2016, J EXP MED, V213, P313, DOI 10.1084/jem.20151610; Paavola KJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005347; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Pogoda HM, 2006, DEV BIOL, V298, P118, DOI 10.1016/j.ydbio.2006.06.021; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulz JB, 1996, J NEUROSCI, V16, P4696; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	29	129	129	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					464	+		10.1038/nature19312	http://dx.doi.org/10.1038/nature19312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27501152	Green Published, Green Accepted			2022-12-24	WOS:000382646600043
J	Larocca, RA; Abbink, P; Peron, JPS; Zanotto, PMD; Iampietro, MJ; Badamchi-Zadeh, A; Boyd, M; Ng'ang'a, D; Kirilova, M; Nityanandam, R; Mercado, NB; Li, ZF; Moseley, ET; Bricault, CA; Borducchi, EN; Giglio, PB; Jetton, D; Neubauer, G; Nkolola, JP; Maxfield, LF; De La Barrera, RA; Jarman, RG; Eckels, KH; Michael, NL; Thomas, SJ; Barouch, DH				Larocca, Rafael A.; Abbink, Peter; Peron, Jean Pierre S.; Zanotto, Paolo M. de A.; Iampietro, M. Justin; Badamchi-Zadeh, Alexander; Boyd, Michael; Ng'ang'a, David; Kirilova, Marinela; Nityanandam, Ramya; Mercado, Noe B.; Li, Zhenfeng; Moseley, Edward T.; Bricault, Christine A.; Borducchi, Erica N.; Giglio, Patricia B.; Jetton, David; Neubauer, George; Nkolola, Joseph P.; Maxfield, Lori F.; De La Barrera, Rafael A.; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.; Barouch, Dan H.			Vaccine protection against Zika virus from Brazil	NATURE			English	Article							NEUTRALIZING ANTIBODY; HEALTHY-ADULTS; CHALLENGE; IMMUNOGENICITY; INFECTION; AMERICA; SAFETY; MODEL; MICE	Zika virus (ZIKV) is a flavivirus that is responsible for the current epidemic in Brazil and the Americas(1,2). ZIKV has been causally associated with fetal microcephaly, intrauterine growth restriction, and other birth defects in both humans(3-8) and mice(9-11). The rapid development of a safe and effective ZIKV vaccine is a global health priority(1,2), but very little is currently known about ZIKV immunology and mechanisms of immune protection. Here we show that a single immunization with a plasmid DNA vaccine or a purified inactivated virus vaccine provides complete protection in susceptible mice against challenge with a strain of ZIKV involved in the outbreak in northeast Brazil. This ZIKV strain has recently been shown to cross the placenta and to induce fetal microcephaly and other congenital malformations in mice(11). We produced DNA vaccines expressing ZIKV pre-membrane and envelope (prM-Env), as well as a series of deletion mutants. The prM-Env DNA vaccine, but not the deletion mutants, afforded complete protection against ZIKV, as measured by absence of detectable viraemia following challenge, and protective efficacy correlated with Env-specific antibody titers. Adoptive transfer of purified IgG from vaccinated mice conferred passive protection, and depletion of CD4 and CD8 T lymphocytes in vaccinated mice did not abrogate this protection. These data demonstrate that protection against ZIKV challenge can be achieved by single-shot subunit and inactivated virus vaccines in mice and that Env-specific antibody titers represent key immunologic correlates of protection. Our findings suggest that the development of a ZIKV vaccine for humans is likely to be achievable.	[Larocca, Rafael A.; Abbink, Peter; Iampietro, M. Justin; Badamchi-Zadeh, Alexander; Boyd, Michael; Ng'ang'a, David; Kirilova, Marinela; Nityanandam, Ramya; Mercado, Noe B.; Li, Zhenfeng; Moseley, Edward T.; Bricault, Christine A.; Borducchi, Erica N.; Giglio, Patricia B.; Jetton, David; Neubauer, George; Nkolola, Joseph P.; Maxfield, Lori F.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Peron, Jean Pierre S.; Zanotto, Paolo M. de A.] Univ Sao Paulo, BR-05508000 Sao Paulo, Brazil; [De La Barrera, Rafael A.; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade de Sao Paulo; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	dbarouch@bidmc.harvard.edu	de A. Zanotto, Paolo M./B-9286-2019; Peron, Jean Pierre S/F-9248-2012; Barouch, Dan/Y-3918-2019; Mercado, Noe/ABE-8247-2020	de A. Zanotto, Paolo M./0000-0002-8167-0625; Mercado, Noe/0000-0001-7769-7326; Jetton, David/0000-0002-1615-9986; Peron, Jean Pierre/0000-0003-1638-8866; Thomas, Stephen/0000-0002-8368-7682; Maxfield, Lori/0000-0002-7595-6205	Ragon Institute of MGH, MIT, and Harvard; National Institutes of Health [AI095985, AI096040, AI100663, AI124377]; Sao Paulo Research Foundation [FAPESP 2011/18703-2, 2014/17766-9]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, U19AI096040, U19AI095985, UM1AI124377] Funding Source: NIH RePORTER	Ragon Institute of MGH, MIT, and Harvard; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Vasconcelos, K. Modjarrad, R. Olson, K. Kabra, C. Kannadka, C. Springer, G. Ballarini, G. Alter, K. Stephenson, F. Stephens, B. Lee, J. Jimenez, A. Chandrashekar, P. Penaloza and C. Cabral for generous advice, assistance and reagents. We acknowledge support from the Ragon Institute of MGH, MIT, and Harvard, the National Institutes of Health (AI095985, AI096040, AI100663, AI124377), and the Sao Paulo Research Foundation (FAPESP 2011/18703-2, 2014/17766-9). The views expressed in this manuscript are those of the authors and do not represent the official views of the Department of the Army or the Department of Defense.	Brasil P., 2016, N ENGL J MED; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; DEMICHELI V, 2000, COCHRANE DB SYST REV; Demicheli V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000977.pub2; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650; Martinez LJ, 2015, AM J TROP MED HYG, V93, P454, DOI 10.4269/ajtmh.14-0819; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Tartaglia LJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005431; Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361	30	371	417	1	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					474	+		10.1038/nature18952	http://dx.doi.org/10.1038/nature18952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27355570	Green Accepted, Green Submitted			2022-12-24	WOS:000382646600045
J	Yao, RF; Ming, ZH; Yan, LM; Li, SH; Wang, F; Ma, S; Yu, CT; Yang, M; Chen, L; Chen, LH; Li, YW; Yan, C; Miao, D; Sun, ZY; Yan, JB; Sun, YN; Wang, L; Chu, JF; Fan, SL; He, W; Deng, HT; Nan, FJ; Li, JY; Rao, ZH; Lou, ZY; Xie, DX				Yao, Ruifeng; Ming, Zhenhua; Yan, Liming; Li, Suhua; Wang, Fei; Ma, Sui; Yu, Caiting; Yang, Mai; Chen, Li; Chen, Linhai; Li, Yuwen; Yan, Chun; Miao, Di; Sun, Zhongyuan; Yan, Jianbin; Sun, Yuna; Wang, Lei; Chu, Jinfang; Fan, Shilong; He, Wei; Deng, Haiteng; Nan, Fajun; Li, Jiayang; Rao, Zihe; Lou, Zhiyong; Xie, Daoxin			DWARF14 is a non-canonical hormone receptor for strigolactone	NATURE			English	Article							ARABIDOPSIS-THALIANA; STRUCTURAL BASIS; PERCEPTION; RICE; DEGRADATION; INHIBITION; KARRIKIN; RECOGNITION; MECHANISM; REPRESSOR	Classical hormone receptors reversibly and non-covalently bind active hormone molecules, which are generated by biosynthetic enzymes, to trigger signal transduction. The alpha/beta hydrolase DWARF14 (D14), which hydrolyses the plant branching hormone strigolactone and interacts with the F-box protein D3/MAX2, is probably involved in strigolactone detection(1-3). However, the active form of strigolactone has yet to be identified and it is unclear which protein directly binds the active form of strigolactone, and in which manner, to act as the genuine strigolactone receptor. Here we report the crystal structure of the strigolactone-induced AtD14-D3-ASK1 complex, reveal that Arabidopsis thaliana (At) D14 undergoes an open-to-closed state transition to trigger strigolactone signalling, and demonstrate that strigolactone is hydrolysed into a covalently linked intermediate molecule (CLIM) to initiate a conformational change of AtD14 to facilitate interaction with D3. Notably, analyses of a highly branched Arabidopsis mutant d14-5 show that the AtD14(G158E) mutant maintains enzyme activity to hydrolyse strigolactone, but fails to efficiently interact with D3/MAX2 and loses the ability to act as a receptor that triggers strigolactone signalling in planta. These findings uncover a mechanism underlying the allosteric activation of AtD14 by strigolactone hydrolysis into CLIM, and define AtD14 as a non-canonical hormone receptor with dual functions to generate and sense the active form of strigolactone.	[Yao, Ruifeng; Li, Suhua; Wang, Fei; Ma, Sui; Yu, Caiting; Yang, Mai; Chen, Li; Li, Yuwen; Yan, Chun; Miao, Di; Sun, Zhongyuan; Yan, Jianbin; Fan, Shilong; Deng, Haiteng; Xie, Daoxin] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Yao, Ruifeng; Li, Suhua; Wang, Fei; Ma, Sui; Yu, Caiting; Yang, Mai; Chen, Li; Li, Yuwen; Yan, Chun; Miao, Di; Sun, Zhongyuan; Yan, Jianbin; Fan, Shilong; Deng, Haiteng; Xie, Daoxin] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Ming, Zhenhua; Yan, Liming; Rao, Zihe; Lou, Zhiyong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Ming, Zhenhua; Yan, Liming; Rao, Zihe; Lou, Zhiyong] Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing 100084, Peoples R China; [Chen, Linhai; Nan, Fajun] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Sun, Yuna; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Wang, Lei; Chu, Jinfang; Li, Jiayang] Chinese Acad Sci, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Wang, Lei; Chu, Jinfang; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing 100101, Peoples R China; [He, Wei] Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Tsinghua University	Xie, DX (corresponding author), Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China.; Xie, DX (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.; Rao, ZH; Lou, ZY (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Rao, ZH; Lou, ZY (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing 100084, Peoples R China.; Rao, ZH (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.	raozh@mail.tsinghua.edu.cn; louzy@mail.tsinghua.edu.cn; daoxinlab@mail.tsinghua.edu.cn	Yan, Liming/AAE-6898-2019; Li, yu/HHZ-5236-2022; Yao, Ruifeng/C-9177-2017; Yan, JianBin/AAE-3494-2022; Rao, Zihe/HCH-6944-2022; xie, daoxin d/C-8646-2017; Yan, Jianbin/GLT-7566-2022; li, yuwen/HGU-6435-2022; Li, Jiayang/AAG-4377-2020; Chen, Linhai/AAW-9332-2020; Chen, Linhai/S-8485-2016	Yao, Ruifeng/0000-0002-0367-6423; Yan, Jianbin/0000-0001-7934-8808; yan, li ming/0000-0003-0648-9604; Li, Suhua/0000-0001-6825-6203; Deng, Haiteng/0000-0001-9496-1280; CHEN, LI/0000-0002-1108-7645; Chen, Linhai/0000-0002-7152-3533; Fan, Shilong/0000-0001-9272-2438	National Natural Science Foundation of China [91417302, 81322023, 31421001, 91335204]; Ministry of Science and Technology [2013CB911100, 2016YFA0500500]; Ministry of Agriculture [2014ZX08011006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	We thank the staff (J. He, Q. Wang and F. Yu) at the Shanghai Synchrotron Radiation Facility (SSRF) beamline BL17U and the staff at Tsukuba Photon Factory beamline NE3A for help with data collection. We also thank G. Liu (School of Pharmaceutical Sciences), Z. Yin and H. Fu (Department of Chemistry) at Tsinghua University, B. Xia and P. Ding (School of Life Sciences), T. Luo (College of Chemistry and Molecular Engineering) at Peking University for valuable suggestions on chemistry analysis; Y. Ding, W. Wang and Y. Tian (Drug Facility, School of Pharmaceutical Sciences) at Tsinghua University for help with D-OH quantitation. This work was supported by the National Natural Science Foundation of China (Grant no. 91417302, 81322023, 31421001 and 91335204), the Ministry of Science and Technology (grant number 2013CB911100 and 2016YFA0500500), and the Ministry of Agriculture (grant number 2014ZX08011006).	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Chevalier F, 2014, PLANT CELL, V26, P1134, DOI 10.1105/tpc.114.122903; Conn CE, 2015, SCIENCE, V349, P540, DOI 10.1126/science.aab1140; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Hothorn M, 2011, NAT CHEM BIOL, V7, P766, DOI 10.1038/nchembio.667; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Kagiyama M, 2013, GENES CELLS, V18, P147, DOI 10.1111/gtc.12025; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Norman A.W., 2014, HORMONES; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Toh S, 2015, SCIENCE, V350, P203, DOI 10.1126/science.aac9476; Tsuchiya Y, 2015, SCIENCE, V349, P864, DOI 10.1126/science.aab3831; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Umehara M, 2015, PLANT CELL PHYSIOL, V56, P1059, DOI 10.1093/pcp/pcv028; Wang L, 2015, PLANT CELL, V27, P3128, DOI 10.1105/tpc.15.00605; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Zhao LH, 2015, CELL RES, V25, P1219, DOI 10.1038/cr.2015.122; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878	30	277	301	33	356	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					469	+		10.1038/nature19073	http://dx.doi.org/10.1038/nature19073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27479325				2022-12-24	WOS:000382646600044
J	Fleischman, W; Agrawal, S; King, M; Venkatesh, AK; Krumholz, HM; McKee, D; Brown, D; Ross, JS				Fleischman, William; Agrawal, Shantanu; King, Marissa; Venkatesh, Arjun K.; Krumholz, Harlan M.; McKee, Douglas; Brown, Douglas; Ross, Joseph S.			Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDUSTRY PAYMENTS; RADIATION ONCOLOGISTS; DRUG COMPANIES; POPULATION; DISCLOSURE; MEDICARE; INSIGHTS; TIES	OBJECTIVE To examine the association between payments made by the manufacturers of pharmaceuticals to physicians and prescribing by physicians within hospital referral regions. DESIGN Cross sectional analysis of 2013 and 2014 Open Payments and Medicare Part D prescribing data for two classes of commonly prescribed, commonly marketed drugs: oral anticoagulants and non-insulin diabetes drugs, overall and stratified by physician and payment type. Setting 306 hospital referral regions, United States. Participants 45 949 454 Medicare Part D prescriptions written by 623 886 physicians to 10 513 173 patients for two drug classes: oral anticoagulants and non-insulin diabetes drugs. Main outcome measures Proportion, or market share, of marketed oral anticoagulants and non-insulin diabetes drugs prescribed by physicians among all drugs in each class and within hospital referral regions. Results Among 306 hospital referral regions, there were 977 407 payments to physicians totaling $61 026 140 (46 pound 174 600; (sic)54 632 500) related to oral anticoagulants, and 1 787 884 payments totaling $108 417 616 related to non-insulin diabetes drugs. The median market share of the hospital referral regions was 21.6% for marketed oral anticoagulants and 12.6% for marketed non-insulin diabetes drugs. Among hospital referral regions, one additional payment (median value $13, interquartile range, $10-$18) was associated with 94 (95% confidence interval 76 to 112) additional days filled of marketed oral anticoagulants and 107 (89 to 125) additional days filled of marketed non-insulin diabetes drugs (P<0.001). Payments to specialists were associated with greater prescribing of marketed drugs than payments to non-specialists (212 v 100 additional days filled per payment of marketed oral anticoagulants, 331 v 114 for marketed non-insulin diabetes drugs, P<0.001). Payments for speaker and consulting fees for non-insulin diabetes drugs were associated with greater prescribing of marketed drugs than payments for food and beverages or educational materials (484 v 110, P<0.001). Conclusions and study limitations Payments by the manufacturers of pharmaceuticals to physicians were associated with greater regional prescribing of marketed drugs among Medicare Part D beneficiaries. Payments to specialists and payments for speaker and consulting fees were predominantly associated with greater regional prescribing of marketed drugs than payments to non-specialists or payments for food and beverages, gifts, or educational materials. As a cross sectional, ecological study, we cannot prove causation between payments to physicians and increased prescribing. Furthermore, our findings should be interpreted only at the regional level. Our study is limited to prescribing by physicians and the two drug classes studied.	[Fleischman, William] Yale Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, SHM IE61, New Haven, CT 06510 USA; [Agrawal, Shantanu; Brown, Douglas] US Dept HHS, Ctr Medicare & Medicaid Serv, Washington, DC USA; [King, Marissa] Yale Sch Management, New Haven, CT USA; [Venkatesh, Arjun K.] Yale Sch Med, Dept Emergency Med, SHM IE61, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Sch Med, Sect Cardiovasc Med, Dept Med, SHM IE61, New Haven, CT 06510 USA; [McKee, Douglas] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Sch Med, Dept Med, Sect Gen Internal Med, SHM IE61, New Haven, CT USA	Robert Wood Johnson Foundation (RWJF); Yale University; Centers for Medicare & Medicaid Services; Yale University; Yale University; Yale University; Yale University; Yale University	Fleischman, W (corresponding author), Yale Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, SHM IE61, New Haven, CT 06510 USA.	WFleischmanwf3@buffalo.edu	Fleischman, William/Q-8686-2019; , Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001862, UL1TR001863] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Ahmed R, 2016, AM J TRANSPLANT, V16, P292, DOI 10.1111/ajt.13427; [Anonymous], 2014, 2014 PHYSICIAN SPECI; Austad KE, 2013, J GEN INTERN MED, V28, P1064, DOI 10.1007/s11606-013-2361-0; Bowman M A, 1988, J Contin Educ Health Prof, V8, P13, DOI 10.1002/chp.4750080104; Campbell D, 2015, READY OR NOT FULL SP; Campbell EG, 2007, NEW ENGL J MED, V357, P1796, DOI 10.1056/NEJMp078141; Centers for Medicare & Medicaid Services, MONTHLY CONTRACT AND; Centers for Medicare & Medicaid Services, OPEN PAYMENTS DATA S; Chang JS, 2015, OPHTHALMOLOGY, V122, P656, DOI 10.1016/j.ophtha.2014.11.003; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Cvetanovich GL, 2015, J BONE JOINT SURG AM, V97A, P1288, DOI 10.2106/JBJS.N.01093; Dailey G, 2001, CLIN THER, V23, P1311, DOI 10.1016/S0149-2918(01)80110-7; Donohue JM, 2012, NEW ENGL J MED, V366, P530, DOI 10.1056/NEJMsa1104816; Fleischman W, 2016, ANN EMERG MED, V68, P153, DOI 10.1016/j.annemergmed.2016.01.014; Halperin EC, 2004, INT J RADIAT ONCOL, V59, P1477, DOI 10.1016/j.ijrobp.2004.01.052; Hoadley J, 2014, MEDICARE PART D IN I; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; Jairam V, 2016, INT J RADIAT ONCOL, V94, P19, DOI 10.1016/j.ijrobp.2015.09.004; Kassirer JP, 2000, JAMA-J AM MED ASSOC, V284, P2156, DOI 10.1001/jama.284.17.2156; King M, 2013, HEALTH PLACE, V20, P32, DOI 10.1016/j.healthplace.2012.11.007; Marshall DC, 2016, MAYO CLIN PROC, V91, P84, DOI 10.1016/j.mayocp.2015.10.016; Moynihan R, 2008, BRIT MED J, V336, P1402, DOI 10.1136/bmj.39575.675787.651; Narayanan S, 2005, J MARKETING RES, V42, P278, DOI 10.1509/jmkr.2005.42.3.278; National Center for Health Statistics (US), 2014, HLTH US; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; Ornstein C, 2015, VYING FOR MARKET SHA; Ornstein C, 2014, AS FULL DISCLOSURE N; Rathi VK, 2015, OTOLARYNG HEAD NECK, V152, P993, DOI 10.1177/0194599815573718; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Ross JS, 2007, JAMA-J AM MED ASSOC, V297, P1216, DOI 10.1001/jama.297.11.1216; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Steensma DP, 2015, J CLIN ONCOL, V33, P3213, DOI 10.1200/JCO.2015.63.1275; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; WAUD DR, 1992, NEW ENGL J MED, V327, P351, DOI 10.1056/NEJM199207303270511; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Yeh JS, 2016, JAMA INTERN MED, V176, P763, DOI 10.1001/jamainternmed.2016.1709	36	63	63	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2016	354								i4189	10.1136/bmj.i4189	http://dx.doi.org/10.1136/bmj.i4189			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9HB	27540015	Green Published, hybrid			2022-12-24	WOS:000381806600002
J	Kramer, NJ; Carlomagno, Y; Zhang, YJ; Almeida, S; Cook, CN; Gendron, TF; Prudencio, M; Van Blitterswijk, M; Belzil, V; Couthouis, J; Paul, JW; Goodman, LD; Daughrity, L; Chew, J; Garrett, A; Pregent, L; Jansen-West, K; Tabassian, LJ; Rademakers, R; Boylan, K; Graff-Radford, NR; Josephs, KA; Parisi, JE; Knopman, DS; Petersen, RC; Boeve, BF; Deng, N; Feng, Y; Cheng, TH; Dickson, DW; Cohen, SN; Bonini, NM; Link, CD; Gao, FB; Petrucelli, L; Gitler, AD				Kramer, Nicholas J.; Carlomagno, Yari; Zhang, Yong-Jie; Almeida, Sandra; Cook, Casey N.; Gendron, Tania F.; Prudencio, Mercedes; Van Blitterswijk, Marka; Belzil, Veronique; Couthouis, Julien; Paul, Joseph West, III; Goodman, Lindsey D.; Daughrity, Lillian; Chew, Jeannie; Garrett, Aliesha; Pregent, Luc; Jansen-West, Karen; Tabassian, Lilia J.; Rademakers, Rosa; Boylan, Kevin; Graff-Radford, Neill R.; Josephs, Keith A.; Parisi, Joseph E.; Knopman, David S.; Petersen, Ronald C.; Boeve, Bradley F.; Deng, Ning; Feng, Yanan; Cheng, Tzu-Hao; Dickson, Dennis W.; Cohen, Stanley N.; Bonini, Nancy M.; Link, Christopher D.; Gao, Fen-Biao; Petrucelli, Leonard; Gitler, Aaron D.			Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts	SCIENCE			English	Article							DIPEPTIDE-REPEAT PROTEINS; NUCLEAR-RNA FOCI; HEXANUCLEOTIDE REPEAT; FRONTOTEMPORAL DEMENTIA; GGGGCC REPEAT; EXPANSION; ALS; ELONGATION; TOXICITY; FTD	An expanded hexanucleotide repeat in C9orf72 causes amyotrophic lateral sclerosis and frontotemporal dementia (c9FTD/ALS). Therapeutics are being developed to target RNAs containing the expanded repeat sequence (GGGGCC); however, this approach is complicated by the presence of antisense strand transcription of expanded GGCCCC repeats. We found that targeting the transcription elongation factor Spt4 selectively decreased production of both sense and antisense expanded transcripts, as well as their translated dipeptide repeat (DPR) products, and also mitigated degeneration in animal models. Knockdown of SUPT4H1, the human Spt4 ortholog, similarly decreased production of sense and antisense RNA foci, as well as DPR proteins, in patient cells. Therapeutic targeting of a single factor to eliminate c9FTD/ALS pathological features offers advantages over approaches that require targeting sense and antisense repeats separately.	[Kramer, Nicholas J.; Couthouis, Julien; Paul, Joseph West, III; Deng, Ning; Feng, Yanan; Cohen, Stanley N.; Gitler, Aaron D.] Stanford Univ, Sch Med, Dept Geriatr, Stanford, CA 94305 USA; [Kramer, Nicholas J.] Stanford Univ, Sch Med, Neurosci Grad Program, Stanford, CA USA; [Carlomagno, Yari; Zhang, Yong-Jie; Cook, Casey N.; Gendron, Tania F.; Prudencio, Mercedes; Van Blitterswijk, Marka; Belzil, Veronique; Daughrity, Lillian; Chew, Jeannie; Garrett, Aliesha; Pregent, Luc; Jansen-West, Karen; Tabassian, Lilia J.; Rademakers, Rosa; Dickson, Dennis W.; Petrucelli, Leonard] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Almeida, Sandra; Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Goodman, Lindsey D.] Univ Penn, Dept Biol, Philadelphia, PA USA; [Goodman, Lindsey D.] Univ Penn, Neurosci Grad Program, Philadelphia, PA USA; [Boylan, Kevin; Graff-Radford, Neill R.; Petersen, Ronald C.; Boeve, Bradley F.] Mayo Clin, Dept Neurol, Jacksonville, FL USA; [Josephs, Keith A.; Parisi, Joseph E.; Knopman, David S.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Cheng, Tzu-Hao] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan; [Link, Christopher D.] Univ Colorado, Dept Integrat Physiol, Boulder, CO USA	Stanford University; Stanford University; Mayo Clinic; University of Massachusetts System; University of Massachusetts Worcester; University of Pennsylvania; University of Pennsylvania; Mayo Clinic; Mayo Clinic; National Yang Ming Chiao Tung University; University of Colorado System; University of Colorado Boulder	Gitler, AD (corresponding author), Stanford Univ, Sch Med, Dept Geriatr, Stanford, CA 94305 USA.; Petrucelli, L (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	petrucelli.leonard@mayo.edu; agitler@stanford.edu	COUTHOUIS, Julien/G-3895-2012; van Blitterswijk, Marka/AAL-4126-2021; van Blitterswijk, Marka/H-7274-2012	COUTHOUIS, Julien/0000-0002-2378-4595; van Blitterswijk, Marka/0000-0002-3054-7053; van Blitterswijk, Marka/0000-0002-3054-7053; DENG, NING/0000-0002-1321-5508; O'Raw, Aliesha/0000-0002-6618-3036; Goodman, Lindsey/0000-0002-9255-3811; Gitler, Aaron/0000-0001-8603-1526; Prudencio, Mercedes/0000-0002-4894-4858	NIH [R01NS065317, R01NS09386501, R01NS073660, R01AG026251, R21NS079807, R21NS094489, R01NS063964, R01NS077402, R21NS084528, P01NS084974, R01NS088689, R01ES20395, R01NS085812, R01NS079725]; Mayo Clinic Foundation; Alzheimer's Association [NIRP-14-304425]; Amyotrophic Lateral Sclerosis Association; National Science Foundation Graduate Research Fellowship; Robert Packard Center for ALS Research at Johns Hopkins; Target ALS; Association for Frontotemporal Degeneration; Stanford University; Glenn Foundation; Hoffmann-La Roche, Inc.; Merck, Inc.; Genentech, Inc.; Biogen, Inc.; Eli Lilly Co.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065317, R21NS079807, P01NS084974, R01NS063964, R35NS097263, R01NS085812, R01NS088689, R01NS093865, R01NS077402, R21NS094489, R01NS073660, R01NS079725, R21NS084528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026251] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021580] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Foundation; Alzheimer's Association(Alzheimer's Association); Amyotrophic Lateral Sclerosis Association; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Robert Packard Center for ALS Research at Johns Hopkins; Target ALS; Association for Frontotemporal Degeneration; Stanford University(Stanford University); Glenn Foundation; Hoffmann-La Roche, Inc.(Hoffmann-La Roche); Merck, Inc.(Merck & Company); Genentech, Inc.(Roche HoldingGenentech); Biogen, Inc.(Biogen); Eli Lilly Co.(Eli Lilly); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Cerza and Y. Zu for technical support. This work was supported by NIH grants R01NS065317 (A.D.G.), R01NS09386501 (A.D.G., L.P.), R01NS073660 (A.D.G., N.M.B.), R01AG026251 (L.P.), R21NS079807 (Y.-J.Z.), R21NS094489 (C.N.C.), R01NS063964 (L.P.), R01NS077402 (L.P.), R21NS084528 (L.P.), P01NS084974 (L.P.), R01NS088689 (L.P.), R01ES20395 (L.P.), R01NS085812 (S.N.C. and T.-H.C.), R01NS079725 (F.-B.G.), Mayo Clinic Foundation (L.P.), Alzheimer's Association [NIRP-14-304425 (Y.-J.Z.)], Amyotrophic Lateral Sclerosis Association (Y.-J.Z, T.F.G., M.P., L.P., F.-B.G.), the National Science Foundation Graduate Research Fellowship (N.J.K.), the Robert Packard Center for ALS Research at Johns Hopkins (L.P., A.D.G., F.-B.G.), Target ALS (L.P., A.D.G., N.B., F.-B.G.), Association for Frontotemporal Degeneration (S.A.), Stanford University (S.N.C.), and the Glenn Foundation (A.D.G., N.M.B). The induced pluripotent stem cell (iPSC) lines are available from the Gao laboratory under a material transfer agreement with the University of Massachusetts Medical School. R.C.P. has paid consulting relationships with Hoffmann-La Roche, Inc.; Merck, Inc.; Genentech, Inc.; Biogen, Inc.; and Eli Lilly & Co. RNA sequencing data are deposited with the National Center for Biotechnology Information Gene Expression Omnibus (GSE83484).	Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Cheng HM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005043; Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Gendron TF, 2015, ACTA NEUROPATHOL, V130, P559, DOI 10.1007/s00401-015-1474-4; Gendron TF, 2014, ACTA NEUROPATHOL, V127, P359, DOI 10.1007/s00401-013-1237-z; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu CR, 2012, CELL, V148, P690, DOI 10.1016/j.cell.2011.12.032; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Tran H, 2015, NEURON, V87, P1207, DOI 10.1016/j.neuron.2015.09.015; van Blitterswijk M, 2015, ACTA NEUROPATHOL, V130, P863, DOI 10.1007/s00401-015-1480-6; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	27	91	94	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					708	712		10.1126/science.aaf7791	http://dx.doi.org/10.1126/science.aaf7791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516603	Green Accepted			2022-12-24	WOS:000381561200043
J	Garcia-Caceres, C; Quarta, C; Varela, L; Gao, YQ; Gruber, T; Legutko, B; Jastroch, M; Johansson, P; Ninkovic, J; Yi, CX; Thuc, OL; Szigeti-Buck, K; Cai, WK; Meyer, CW; Pfluger, PT; Fernandez, AM; Luquet, S; Woods, SC; Torres-Aleman, I; Kahn, CR; Gotz, M; Horvath, TL; Tschop, MH				Garcia-Caceres, Cristina; Quarta, Carmelo; Varela, Luis; Gao, Yuanqing; Gruber, Tim; Legutko, Beata; Jastroch, Martin; Johansson, Pia; Ninkovic, Jovica; Yi, Chun-Xia; Thuc, Ophelia Le; Szigeti-Buck, Klara; Cai, Weikang; Meyer, Carola W.; Pfluger, Paul T.; Fernandez, Ana M.; Luquet, Serge; Woods, Stephen C.; Torres-Aleman, Ignacio; Kahn, C. Ronald; Goetz, Magdalena; Horvath, Tamas L.; Tschoep, Matthias H.			Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability	CELL			English	Article							BODY-WEIGHT; NEURONAL DYSFUNCTION; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; BARRIER; LEPTIN; CELLS; TRANSPORTER; CIRCUITS; MICE	We report that astrocytic insulin signaling co-regulates hypothalamic glucose sensing and systemic glucose metabolism. Postnatal ablation of insulin receptors (IRs) in glial fibrillary acidic protein (GFAP)-expressing cells affects hypothalamic astrocyte morphology, mitochondrial function, and circuit connectivity. Accordingly, astrocytic IR ablation reduces glucose-induced activation of hypothalamic proopio-melanocortin (POMC) neurons and impairs physiological responses to changes in glucose availability. Hypothalamus-specific knockout of astrocytic IRs, as well as postnatal ablation by targeting glutamate aspartate transporter (GLAST)-expressing cells, replicates such alterations. A normal response to altering directly CNS glucose levels in mice lacking astrocytic IRs indicates a role in glucose transport across the blood-brain barrier (BBB). This was confirmed in vivo in GFAP-IR KO mice by using positron emission tomography and glucose monitoring in cerebral spinal fluid. We conclude that insulin signaling in hypothalamic astrocytes co-controls CNS glucose sensing and systemic glucose metabolism via regulation of glucose uptake across the BBB.	[Garcia-Caceres, Cristina; Quarta, Carmelo; Gao, Yuanqing; Gruber, Tim; Legutko, Beata; Jastroch, Martin; Yi, Chun-Xia; Thuc, Ophelia Le; Meyer, Carola W.; Pfluger, Paul T.; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr HDC, D-85764 Neuherberg, Germany; [Garcia-Caceres, Cristina; Quarta, Carmelo; Gao, Yuanqing; Gruber, Tim; Legutko, Beata; Jastroch, Martin; Yi, Chun-Xia; Thuc, Ophelia Le; Meyer, Carola W.; Pfluger, Paul T.; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Garcia-Caceres, Cristina; Quarta, Carmelo; Gao, Yuanqing; Gruber, Tim; Legutko, Beata; Jastroch, Martin; Yi, Chun-Xia; Thuc, Ophelia Le; Meyer, Carola W.; Pfluger, Paul T.; Tschoep, Matthias H.] Tech Univ Munich, Div Metab Dis, D-80333 Munich, Germany; [Varela, Luis; Szigeti-Buck, Klara; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Johansson, Pia; Ninkovic, Jovica; Goetz, Magdalena] Helmholtz Zentrum Munchen, Inst Stem Cell Res Ctr, D-85764 Neuherberg, Germany; [Johansson, Pia; Ninkovic, Jovica; Goetz, Magdalena] Ludwigs Maximilians Univ, Biomed Ctr, Physiol Genom, D-80336 Munich, Germany; [Johansson, Pia; Ninkovic, Jovica; Goetz, Magdalena] Ludwigs Maximilians Univ, Biomed Ctr, 7SYNERGY, Excellence Cluster Syst Neurol, D-80336 Munich, Germany; [Cai, Weikang; Kahn, C. Ronald] Brigham & Womens Hosp, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02115 USA; [Cai, Weikang; Kahn, C. Ronald] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Cai, Weikang; Kahn, C. Ronald] Harvard Med Sch, Boston, MA 02115 USA; [Fernandez, Ana M.; Torres-Aleman, Ignacio] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Luquet, Serge] Univ Paris Diderot, Sorbonne Paris Cite, Unite Biol Fonct & Adaptat, CNRS UMR 8251, F-75205 Paris, France; [Woods, Stephen C.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, 2170 Galbraith Ave, Cincinnati, OH 45237 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Yale University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University System of Ohio; University of Cincinnati	Tschop, MH (corresponding author), Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr HDC, D-85764 Neuherberg, Germany.; Tschop, MH (corresponding author), Helmholtz Zentrum Munchen, German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany.; Tschop, MH (corresponding author), Tech Univ Munich, Div Metab Dis, D-80333 Munich, Germany.	tschoep@helmholtz-muenchen.de	Ninkovic, Jovica/AAH-5220-2019; Luquet, serge/AAT-1809-2021; Yi, Chun-Xia/J-4068-2016; Kahn, Ronald/AAY-2435-2021; Cai, Weikang/K-2394-2019; Jastroch, Martin/I-7494-2017; Pfluger, Paul T/A-3770-2019; Varela, Luis/ABG-7581-2020; Quarta, Carmelo/AAC-1629-2020; Torres-Aleman, Ignacio/A-1613-2008; García-Cáceres, Cristina/O-6601-2016	Ninkovic, Jovica/0000-0002-4381-0041; Luquet, serge/0000-0001-8668-6645; Yi, Chun-Xia/0000-0003-1184-4615; Kahn, Ronald/0000-0002-7583-9228; Pfluger, Paul T/0000-0002-8118-7588; Varela, Luis/0000-0001-7794-7241; Torres-Aleman, Ignacio/0000-0001-8107-7947; García-Cáceres, Cristina/0000-0001-6376-9448; Le Thuc, Ophelia/0000-0001-8154-9916; Fernandez, Ana M./0000-0001-5160-3854; Cai, Weikang/0000-0001-5638-0805; Quarta, Carmelo/0000-0002-1352-4239	Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases; Humboldt Foundation; Initiative and Networking Fund of the Helmholtz Association; Deutsches Zentrum fur DiabetesForschung (DZD); Institute of Advanced Studies of Technische Universitat Munchen (IAS-TUM Hans-Fischer); DFG [SFB 1123, SFB 870, SFB 1757]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, R01DK033201, P30DK036836] Funding Source: NIH RePORTER	Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases; Humboldt Foundation(Alexander von Humboldt Foundation); Initiative and Networking Fund of the Helmholtz Association; Deutsches Zentrum fur DiabetesForschung (DZD); Institute of Advanced Studies of Technische Universitat Munchen (IAS-TUM Hans-Fischer); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Heicko Lickert and Silke Morin for helpful discussion and support and Lewis Norris, Clarita Mergen, Veronica Casquero Garcia, Olavi Jarvinen, and Nicole Wiegert for excellent technical assistance. This work was funded, in part, by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, the Humboldt Foundation (to M.H.T.), through the Initiative and Networking Fund of the Helmholtz Association and Deutsches Zentrum fur DiabetesForschung (DZD). This work also received funding from the Institute of Advanced Studies of Technische Universitat Munchen (IAS-TUM Hans-Fischer Senior Fellowship to T.L.H.) and from DFG funding (SFB 1123 to M.H.T; SFB 870 and SPP 1757 to M.G.).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Baltzer C, 2010, MITOCHONDRION, V10, P589, DOI 10.1016/j.mito.2010.07.009; Barros LF, 2007, GLIA, V55, P1222, DOI 10.1002/glia.20375; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cranston I, 1998, J CEREBR BLOOD F MET, V18, P130, DOI 10.1097/00004647-199802000-00002; De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010; FRANK HJL, 1986, DIABETES, V35, P654, DOI 10.2337/diabetes.35.6.654; Fuente-Martin E, 2012, J CLIN INVEST, V122, P3900, DOI 10.1172/JCI64102; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Garcia-Caceres C, 2012, MOL METAB, V1, P37, DOI 10.1016/j.molmet.2012.07.001; Goldman S, 2003, TRENDS NEUROSCI, V26, P590, DOI 10.1016/j.tins.2003.09.011; Hasselbalch SG, 1999, DIABETES, V48, P1915, DOI 10.2337/diabetes.48.10.1915; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Kim JG, 2014, NAT NEUROSCI, V17, P908, DOI 10.1038/nn.3725; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; Klepper J, 2002, EUR J PEDIATR, V161, P295, DOI 10.1007/s00431-002-0939-3; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Mandl J, 2009, TRENDS ENDOCRIN MET, V20, P194, DOI 10.1016/j.tem.2009.01.003; McMinn JE, 2005, AM J PHYSIOL-ENDOC M, V289, pE403, DOI 10.1152/ajpendo.00535.2004; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nolte C, 2001, GLIA, V33, P72; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Simpson IA, 2001, J BIOL CHEM, V276, P12725, DOI 10.1074/jbc.M010897200; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; SMITH GP, 1969, AM J PHYSIOL, V217, P1083, DOI 10.1152/ajplegacy.1969.217.4.1083; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; TORANALLERAND CD, 1991, BRAIN RES, V558, P296; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Zeltser LM, 2012, NAT NEUROSCI, V15, P1336, DOI 10.1038/nn.3219	40	269	272	2	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					867	880		10.1016/j.cell.2016.07.028	http://dx.doi.org/10.1016/j.cell.2016.07.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518562	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000382258700011
J	Masselink, W; Cole, NJ; Fenyes, F; Berger, S; Sonntag, C; Wood, A; Nguyen, PD; Cohen, N; Knopf, F; Weidinger, G; Hall, TE; Currie, PD				Masselink, Wouter; Cole, Nicholas J.; Fenyes, Fruzsina; Berger, Silke; Sonntag, Carmen; Wood, Alasdair; Nguyen, Phong D.; Cohen, Naomi; Knopf, Franziska; Weidinger, Gilbert; Hall, Thomas E.; Currie, Peter D.			A somitic contribution to the apical ectodermal ridge is essential for fin formation	NATURE			English	Article							FLUORESCENT PROTEIN; ZEBRAFISH; LIMB; ORIGIN; CELLS; CHICK; EMBRYOS; MUSCLE; FISH; BUD	The transition from fins to limbs was an important terrestrial adaptation, but how this crucial evolutionary shift arose developmentally is unknown. Current models focus on the distinct roles of the apical ectodermal ridge (AER) and the signalling molecules that it secretes during limb and fin outgrowth. In contrast to the limb AER, the AER of the fin rapidly transitions into the apical fold and in the process shuts off AER-derived signals that stimulate proliferation of the precursors of the appendicular skeleton(1-10). The differing fates of the AER during fish and tetrapod development have led to the speculation that fin-fold formation was one of the evolutionary hurdles to the AER-dependent expansion of the fin mesenchyme required to generate the increased appendicular structure evident within limbs(11). Consequently, a heterochronic shift in the AER-to-apical-fold transition has been postulated to be crucial for limb evolution(11). The ability to test this model has been hampered by a lack of understanding of the mechanisms controlling apical fold induction(11,12). Here we show that invasion by cells of a newly identified somite-derived lineage into the AER in zebrafish regulates apical fold induction. Ablation of these cells inhibits apical fold formation, prolongs AER activity and increases the amount of fin bud mesenchyme, suggesting that these cells could provide the timing mechanism proposed in Thorogood's clock model of the fin-to-limb transition(11). We further demonstrate that apical-fold-inducing cells are progressively lost during gnathostome evolution; the absence of such cells within the tetrapod limb suggests that their loss may have been a necessary prelude to the attainment of limb-like structures in Devonian sarcopterygian fish.	[Masselink, Wouter; Fenyes, Fruzsina; Berger, Silke; Sonntag, Carmen; Wood, Alasdair; Nguyen, Phong D.; Cohen, Naomi; Hall, Thomas E.; Currie, Peter D.] Monash Univ, Australian Regenerat Med Inst, Level 1,15 Innovat Walk,Wellington Rd, Clayton, Vic 3800, Australia; [Cole, Nicholas J.] Macquarie Univ, Fac Med & Heath Sci, MND & Neurodegenerat Dis Res Program, N Ryde, NSW 2109, Australia; [Knopf, Franziska] Univ Oxford, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England; [Weidinger, Gilbert] Univ Ulm, Inst Biochem & Mol Biol, Albert Einstein Allee 11, D-89081 Ulm, Germany; [Currie, Peter D.] Monash Univ, EMBL Australia Melbourne Node, Level 1,Bldg 75,Wellington Rd, Clayton, Vic 3800, Australia; [Masselink, Wouter; Knopf, Franziska] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Fetscherstr 105, D-01307 Dresden, Germany	Australian Regenerative Medicine Institute; Monash University; Macquarie University; University of Oxford; Ulm University; Monash University; German Research Foundation (DFG); Technische Universitat Dresden	Currie, PD (corresponding author), Monash Univ, Australian Regenerat Med Inst, Level 1,15 Innovat Walk,Wellington Rd, Clayton, Vic 3800, Australia.; Currie, PD (corresponding author), Monash Univ, EMBL Australia Melbourne Node, Level 1,Bldg 75,Wellington Rd, Clayton, Vic 3800, Australia.	peter.currie@monash.edu	cole, nicholas/M-7010-2016; Weidinger, Gilbert/A-8342-2010; Knopf, Franziska/AAK-5848-2021; Hall, Thomas/J-2125-2014	Weidinger, Gilbert/0000-0003-3599-6760; Knopf, Franziska/0000-0002-0420-7477; Nguyen, Phong Dang/0000-0003-1889-3276; Sonntag, Carmen/0000-0003-2560-1710; Hall, Thomas/0000-0002-7718-7614; Masselink, Wouter/0000-0002-4085-3206; Cole, Nicholas/0000-0003-1006-2662; Currie, Peter/0000-0001-8874-8862	NHMRC; Snow Foundation; BitFury.org; ARC [DP110101482]; State Government of Victoria; Australian Federal Government	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Snow Foundation; BitFury.org; ARC(Australian Research Council); State Government of Victoria; Australian Federal Government(Australian Government)	The authors acknowledge E. McGlinn for expert advice, C. Wicking for comments on the manuscript, E. Tanaka for advice and technical support, Fishcore for expert zebrafish care, M. Morsch, V. Oorschot and the Monash electron microscopy facility for expert technical advice, Monash Micro Imaging for microscope availability and maintenance, S. Chow for technical assistance, M. Voz for reagents, T. Carney for fish lines and J. Joss for lungfish rearing and expertise. P.D.C. is supported by an NHMRC Principal Research Fellowship. N.J.C. is supported by The Snow Foundation and BitFury.org. This work was supported by an ARC Discovery Grant DP110101482. The Australian Regenerative Medicine Institute is supported by funds from the State Government of Victoria and the Australian Federal Government.	Altabef M, 1997, DEVELOPMENT, V124, P4547; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Berger J, 2014, DIS MODEL MECH, V7, P1407, DOI 10.1242/dmm.017376; CHEVALLIER A, 1977, J EMBRYOL EXP MORPH, V41, P245; CHRIST B, 1977, ANAT EMBRYOL, V150, P171, DOI 10.1007/BF00316649; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Cole NJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001168; DANE PJ, 1985, J EMBRYOL EXP MORPH, V87, P145; Duran I, 2011, DEV BIOL, V354, P160, DOI 10.1016/j.ydbio.2011.03.014; Fallon J. F., 1977, DEVELOPMENT, V51, P241; Fischer S, 2003, DEVELOPMENT, V130, P3515, DOI 10.1242/dev.00537; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; GERAUDIE J, 1977, J MORPHOL, V151, P353, DOI 10.1002/jmor.1051510304; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Grandel H, 2000, DEVELOPMENT, V127, P4169; Gurevich DB, 2016, SCIENCE, V353, DOI 10.1126/science.aad9969; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Hatta K, 2006, NAT PROTOC, V1, P960, DOI 10.1038/nprot.2006.96; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; JURAND A, 1965, PROC R SOC SER B-BIO, V162, P387, DOI 10.1098/rspb.1965.0045; Kimmel RA, 2000, GENE DEV, V14, P1377; Lee RTH, 2013, DEVELOPMENT, V140, P2923, DOI 10.1242/dev.093534; Mayeuf-Louchart A, 2014, P NATL ACAD SCI USA, V111, P8844, DOI 10.1073/pnas.1407606111; Neyt C, 2000, NATURE, V408, P82, DOI 10.1038/35040549; Nguyen-Chi ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003014; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Nguyen PD, 2014, NATURE, V512, P314, DOI 10.1038/nature13678; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Proulx K, 2010, DEV BIOL, V348, P34, DOI 10.1016/j.ydbio.2010.08.036; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; THOROGOOD P, 1991, NATO ADV SCI I A-LIF, V205, P347; TODT WL, 1984, J EMBRYOL EXP MORPH, V80, P21; Webb AE, 2007, DEV BIOL, V311, P369, DOI 10.1016/j.ydbio.2007.08.034; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WOOD A, 1982, ANAT REC, V204, P349, DOI 10.1002/ar.1092040408; Yano T, 2013, J ANAT, V222, P100, DOI 10.1111/j.1469-7580.2012.01491.x; Yano T, 2012, DEVELOPMENT, V139, P2916, DOI 10.1242/dev.075572; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137	43	14	14	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					542	+		10.1038/nature18953	http://dx.doi.org/10.1038/nature18953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27437584				2022-12-24	WOS:000380856600027
J	Meyer, S; Woodward, M; Hertel, C; Vlaicu, P; Haque, Y; Karner, J; Macagno, A; Onuoha, SC; Fishman, D; Peterson, H; Metskula, K; Uibo, R; Jantti, K; Hokynar, K; Wolff, ASB; Krohn, K; Ranki, A; Peterson, P; Kisand, K; Hayday, A				Meyer, Steffen; Woodward, Martin; Hertel, Christina; Vlaicu, Philip; Haque, Yasmin; Karner, Jaanika; Macagno, Annalisa; Onuoha, Shimobi C.; Fishman, Dmytro; Peterson, Hedi; Metskula, Kaja; Uibo, Raivo; Jantti, Kirsi; Hokynar, Kati; Wolff, Anette S. B.; Krohn, Kai; Ranki, Annamari; Peterson, Part; Kisand, Kai; Hayday, Adrian		APECED Patient Collaborative	AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies	CELL			English	Article							SYNDROME TYPE-I; POLYENDOCRINE SYNDROME TYPE-1; CHRONIC MUCOCUTANEOUS CANDIDIASIS; NONOBESE DIABETIC MICE; B-CELLS; ADDISONS-DISEASE; CYTOCHROME-P450 ENZYMES; TOLERANCE INDUCTION; INTERFERON-ALPHA; GENE	APS1/APECED patients are defined by defects in the autoimmune regulator (AIRE) that mediates central T cell tolerance to many self-antigens. AIRE deficiency also affects B cell tolerance, but this is incompletely understood. Here we show that most APS1/APECED patients displayed B cell autoreactivity toward unique sets of approximately 100 self-proteins. Thereby, autoantibodies from 81 patients collectively detected many thousands of human proteins. The loss of B cell tolerance seemingly occurred during antibody affinity maturation, an obligatorily T cell-dependent step. Consistent with this, many APS1/APECED patients harbored extremely high-affinity, neutralizing autoantibodies, particularly against specific cytokines. Such antibodies were biologically active in vitro and in vivo, and those neutralizing type I interferons (IFNs) showed a striking inverse correlation with type I diabetes, not shown by other anti-cytokine antibodies. Thus, naturally occurring human autoantibodies may actively limit disease and be of therapeutic utility.	[Meyer, Steffen; Hertel, Christina; Vlaicu, Philip] ImmunoQure AG, Konigsallee 90, D-2012 Dusseldorf, Germany; [Woodward, Martin; Haque, Yasmin; Hayday, Adrian] Kings Coll London, Peter Gorer Dept Immunobiol, London SE19RT, England; [Karner, Jaanika; Peterson, Part; Kisand, Kai] Univ Tartu, Inst Biomed & Translat Med, Mol Pathol, Ravila 19, EE-50411 Tartu, Estonia; [Macagno, Annalisa; Onuoha, Shimobi C.] ImmunoQure Res AG, Wagistr 14, CH-8952 Schlieren, Switzerland; [Fishman, Dmytro; Peterson, Hedi] Univ Tartu, Inst Comp Sci, Liivi 2, EE-50409 Tartu, Estonia; [Fishman, Dmytro; Peterson, Hedi] Quretec Ltd, Ulikooli 6A, EE-51003 Tartu, Estonia; [Metskula, Kaja; Uibo, Raivo] Univ Tartu, Inst Biomed & Translat Med, Dept Immunol, Ravila 19, EE-50411 Tartu, Estonia; [Jantti, Kirsi; Hokynar, Kati; Krohn, Kai] Clin Res Inst HUCH Ltd, Haartmaninkatu 8, Helsinki 00290, Finland; [Wolff, Anette S. B.] Univ Bergen, Dept Clin Sci, Lab Bldg,8th Floor, N-5021 Bergen, Norway; [Ranki, Annamari] Univ Helsinki, Dept Dermatol Allergol & Venereol, Inst Clin Med, Skin & Allergy Hosp,Cent Hosp, Meilahdentie 2, Helsinki 00250, Finland	University of Tartu; University of Tartu; University of Tartu; University of Bergen; University of Helsinki; Helsinki University Central Hospital	Hayday, A (corresponding author), Kings Coll London, Peter Gorer Dept Immunobiol, London SE19RT, England.; Kisand, K (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Mol Pathol, Ravila 19, EE-50411 Tartu, Estonia.	kai.kisand@ut.ee; adrian.hayday@kcl.ac.uk	Peterson, Pärt/A-5788-2009; Kisand, Kai/J-3483-2015; Podkrajsek, Katarina Trebusak/AAE-2910-2019; Kärner, Jaanika/Q-5989-2017; Wolff, Anette/AAN-5981-2020; Peterson, Hedi/F-4920-2017; Peterson, Hedi/ABA-3355-2020	Peterson, Pärt/0000-0001-6755-791X; Kisand, Kai/0000-0002-5426-4648; Podkrajsek, Katarina Trebusak/0000-0002-0154-3547; Kärner, Jaanika/0000-0002-3548-5023; Peterson, Hedi/0000-0001-9951-5116; Peterson, Hedi/0000-0001-9951-5116; HAYDAY, ADRIAN/0000-0002-9495-5793; Battelino, Tadej/0000-0002-0273-4732; Wolff, Anette Susanne Boe/0000-0002-8485-2248; Uibo, Raivo/0000-0002-2298-1300	ImmunoQure AG; Wellcome Trust; CRUK; Estonian Research Council [IUT2-2]; European Union [2014-2020.4.01.15-0012]	ImmunoQure AG; Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); Estonian Research Council(Estonian Research Council); European Union(European Commission)	We are indebted to patients; to the Finnish APECED and Addison patients' association; and to attending physicians and carers. We thank M. Rothe, P. Adler, A. Remm, M. Pihlap, M. Karlsberg, A. Tallqvist, M. Tuukkanen, L. Prassmayer, M. Wordehoff, A. Peters, R. Repke, B. Mathis, and particularly E. Stuart and K. Henco for critical insight and support. We thank staff of the Biological Services Unit at King's College London. Funding was by the following: ImmunoQure AG, the Wellcome Trust, and CRUK (to A.H.) and Estonian Research Council grant IUT2-2 and European Union Project 2014-2020.4.01.15-0012 (to J.K., P.P., and K. Kisand). P.P., K. Krohn, K. Kisand, A.R., and A.H. are cofounders and shareholders of ImmunoQure AG, and A.M., C.H., P.V., S.C.O., and S.M. were/are employees of ImmunoQure AG.	Ambrosi A, 2012, EUR J IMMUNOL, V42, P2274, DOI 10.1002/eji.201242653; Brink R, 2014, CURR OPIN IMMUNOL, V28, P97, DOI 10.1016/j.coi.2014.03.001; Carrero JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059701; Cho MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5167; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Downes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012646; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; FOULIS AK, 1987, LANCET, V2, P1423; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Geng LP, 1998, P NATL ACAD SCI USA, V95, P10055, DOI 10.1073/pnas.95.17.10055; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Hargreaves CE, 2013, J IMMUNOL, V190, P5373, DOI 10.4049/jimmunol.1203412; Hetemaki I, 2016, J IMMUNOL, V196, P2955, DOI 10.4049/jimmunol.1500301; HUANG XJ, 1995, DIABETES, V44, P658, DOI 10.2337/diabetes.44.6.658; Husebye ES, 2009, J INTERN MED, V265, P514, DOI 10.1111/j.1365-2796.2009.02090.x; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kinnunen T, 2013, BLOOD, V121, P1595, DOI 10.1182/blood-2012-09-457465; Kisand K, 2008, BLOOD, V112, P2657, DOI 10.1182/blood-2008-03-144634; Kisand K, 2015, J CLIN IMMUNOL, V35, P463, DOI 10.1007/s10875-015-0176-y; Kisand K, 2011, EUR J IMMUNOL, V41, P1517, DOI 10.1002/eji.201041253; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kluger N, 2015, CLIN IMMUNOL, V158, P212, DOI 10.1016/j.clim.2015.03.012; KROHN K, 1992, LANCET, V339, P770, DOI 10.1016/0140-6736(92)91894-E; Landegren N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20104; Lefranc MP, 2003, NUCLEIC ACIDS RES, V31, P307, DOI 10.1093/nar/gkg085; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Meager A, 1997, LANCET, V350, P1596, DOI 10.1016/S0140-6736(05)64012-3; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Meloni A, 2012, J CLIN ENDOCR METAB, V97, P1114, DOI 10.1210/jc.2011-2461; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Piccoli L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8375; Pillai S, 2011, CURR OPIN IMMUNOL, V23, P721, DOI 10.1016/j.coi.2011.10.007; Poliani PL, 2010, AM J PATHOL, V176, P1104, DOI 10.2353/ajpath.2010.090956; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Sboner A, 2009, J PROTEOME RES, V8, P5451, DOI 10.1021/pr900412k; Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328; Ubelhart R, 2015, EUR J IMMUNOL, V45, P2971, DOI 10.1002/eji.201444622; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; UIBO R, 1994, J CLIN ENDOCR METAB, V78, P323, DOI 10.1210/jc.78.2.323; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Welcher AA, 2015, ARTHRITIS RHEUMATOL, V67, P2713, DOI 10.1002/art.39248; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; WINQVIST O, 1993, J CLIN INVEST, V92, P2377, DOI 10.1172/JCI116843; Wolff ASB, 2013, J CLIN IMMUNOL, V33, P1341, DOI 10.1007/s10875-013-9938-6; Wolff ASB, 2007, J CLIN ENDOCR METAB, V92, P595, DOI 10.1210/jc.2006-1873; Wolff ASB, 2014, J IMMUNOL, V193, P3880, DOI 10.4049/jimmunol.1401068; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285; Zucchelli S, 2005, IMMUNITY, V22, P385, DOI 10.1016/j.immuni.2005.01.015	57	158	162	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					582	595		10.1016/j.cell.2016.06.024	http://dx.doi.org/10.1016/j.cell.2016.06.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27426947	Green Published, hybrid			2022-12-24	WOS:000380546500011
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: End of life care in hospital is everyone's business	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Bowden J, 2013, J ROY COLL PHYS EDIN, V43, P24, DOI 10.4997/JRCPE.2013.105; Curie Marie, 2015, TRIGGERS PALLIATIVE; Leadership Alliance for the Care of Dying People, 2014, ON CHANC GET IT RIGH; National Council for Palliative Care, 2016, STAFF PREP CAR CAP C; National Palliative and End of Life Care Partnership, 2014, AMB PALL END LIF CAR; NHS England, 2016, COMM PERS CTR END LI; Office for National Statistics, 2015, DEATHS REG ENGL WAL; Pollock K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4855; Royal College of Physicians of London, 2015, CENS CONS PHYS HIGH; Royal College of Physicians of London, 2014, END LIF CAR AUD DYIN	10	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2016	354								i3888	10.1136/bmj.i3888	http://dx.doi.org/10.1136/bmj.i3888			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS1JA	27417270	Bronze, Green Published			2022-12-24	WOS:000380350500008
J	Mayor, S				Mayor, Susan			Cancer risk is higher in years before and shortly after type 2 diabetes diagnosis, study shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lega IC, 2016, CANCER-AM CANCER SOC, V122, P2731, DOI 10.1002/cncr.30095	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 11	2016	354								i3832	10.1136/bmj.i3832	http://dx.doi.org/10.1136/bmj.i3832			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS1IA	27401748				2022-12-24	WOS:000380347900006
J	Cappell, SD; Chung, MY; Jaimovich, A; Spencer, SL; Meyer, T				Cappell, Steven D.; Chung, Mingyu; Jaimovich, Ariel; Spencer, Sabrina L.; Meyer, Tobias			Irreversible APC(Cdh1) Inactivation Underlies the Point of No Return for Cell-Cycle Entry	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; RESTRICTION POINT; PHASE; PROLIFERATION; DEGRADATION; QUIESCENCE; DYNAMICS; DECISION; SPINDLE; KINASE	Proliferating cells must cross a point of no return before they replicate their DNA and divide. This commitment decision plays a fundamental role in cancer and degenerative diseases and has been proposed to be mediated by phosphorylation of retinoblastoma (Rb) protein. Here, we show that inactivation of the anaphase-promoting complex/cyclosome (APC(Cdh1)) has the necessary characteristics to be the point of no return for cell-cycle entry. Our study shows that APC(Cdh1) inactivation is a rapid, bistable switch initiated shortly before the start of DNA replication by cyclin E/Cdk2 and made irreversible by Emi1. Exposure to stress between Rb phosphorylation and APC(Cdh1) inactivation, but not after APC(Cdh1) inactivation, reverted cells to a mitogen-sensitive quiescent state, from which they can later re-enter the cell cycle. Thus, APC(Cdh1) inactivation is the commitment point when cells lose the ability to return to quiescence and decide to progress through the cell cycle.	[Cappell, Steven D.; Chung, Mingyu; Jaimovich, Ariel; Spencer, Sabrina L.; Meyer, Tobias] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Spencer, Sabrina L.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Stanford University; University of Colorado System; University of Colorado Boulder	Cappell, SD; Meyer, T (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	scappell@stanford.edu; tobias1@stanford.edu	Cappell, Steven/O-4072-2018	Cappell, Steven/0000-0002-2885-7327; Chung, Mingyu/0000-0003-1718-6203; Meyer, Tobias/0000-0003-4339-3804; SPENCER, SABRINA/0000-0002-5798-3007	Damon Runyon Cancer Research Foundation [DRG-2141-12, DRG-2043-10]; American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship [PF-13-304-01-CCG]; NIH [GM118377, GM030179, P50GM107615]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118377, P50GM107615, R01GM030179] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Hee Wong Yang, Jia-yun Chen, Sean Collins, Feng-Chiao Tsai, Sam Bandara, Nalin Ratnayeke, Roy Wollman, Karlene Cimprich, James Ferrell, and Charles Sherr for helpful discussions, Philipp Kaldis for supplying the Cdk2<SUP>-/-</SUP> MEFs, and the Stanford Shared FACS Facility for cell sorting. S.D.C. and S.L.S. were supported by the Damon Runyon Cancer Research Foundation (DRG-2141-12 and DRG-2043-10). S.L.S. was also supported by an American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship (PF-13-304-01-CCG). T.M. was supported by NIH grants GM118377, GM030179, and P50GM107615.	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Borel F, 2002, J CELL SCI, V115, P2829; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Eguren M, 2011, SEMIN CELL DEV BIOL, V22, P572, DOI 10.1016/j.semcdb.2011.03.010; Erol A, 2011, CELL CYCLE, V10, P3239, DOI 10.4161/cc.10.19.17460; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Floyd S, 2008, CURR BIOL, V18, P1649, DOI 10.1016/j.cub.2008.09.058; Fukushima H, 2013, CELL REP, V4, P803, DOI 10.1016/j.celrep.2013.07.031; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; PlanasSilva MD, 1997, CURR OPIN CELL BIOL, V9, P768, DOI 10.1016/S0955-0674(97)80076-2; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sigl R, 2009, J CELL SCI, V122, P4208, DOI 10.1242/jcs.054197; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Walker A, 2008, J CELL SCI, V121, P2319, DOI 10.1242/jcs.031591; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xu LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034616; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yuan X, 2014, MOL BIOL CELL, V25, P441, DOI 10.1091/mbc.E13-08-0480; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	37	119	120	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					167	180		10.1016/j.cell.2016.05.077	http://dx.doi.org/10.1016/j.cell.2016.05.077			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368103	Bronze, Green Accepted			2022-12-24	WOS:000380254400019
J	Rogelj, J; den Elzen, M; Hohne, N; Fransen, T; Fekete, H; Winkler, H; Chaeffer, RS; Ha, F; Riahi, K; Meinshausen, M				Rogelj, Joeri; den Elzen, Michel; Hoehne, Niklas; Fransen, Taryn; Fekete, Hanna; Winkler, Harald; Chaeffer, Roberto S.; Ha, Fus; Riahi, Keywan; Meinshausen, Malte			Paris Agreement climate proposals need a boost to keep warming well below 2 degrees C	NATURE			English	Article							GREENHOUSE-GAS EMISSIONS; CO2 EMISSIONS; TARGETS; TECHNOLOGY; SCENARIOS	The Paris climate agreement aims at holding global warming to well below 2 degrees Celsius and to "pursue efforts" to limit it to 1.5 degrees Celsius. To accomplish this, countries have submitted Intended Nationally Determined Contributions (INDCs) outlining their post-2020 climate action. Here we assess the effect of current INDCs on reducing aggregate greenhouse gas emissions, its implications for achieving the temperature objective of the Paris climate agreement, and potential options for overachievement. The INDCs collectively lower greenhouse gas emissions compared to where current policies stand, but still imply a median warming of 2.6-3.1 degrees Celsius by 2100. More can be achieved, because the agreement stipulates that targets for reducing greenhouse gas emissions are strengthened over time, both in ambition and scope. Substantial enhancement or over-delivery on current INDCs by additional national, sub-national and non-state actions is required to maintain a reasonable chance of meeting the target of keeping warming well below 2 degrees Celsius.	[Rogelj, Joeri; Riahi, Keywan] Int Inst Appl Syst Anal, ENE Program, A-2361 Laxenburg, Austria; [Rogelj, Joeri] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland; [den Elzen, Michel] PBL Netherlands Environm Assessment Agcy, Bilthoven, Netherlands; [Hoehne, Niklas; Fekete, Hanna] NewClimate Inst, Cologne, Germany; [Hoehne, Niklas] Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands; [Fransen, Taryn] World Resources Inst, Washington, DC 20006 USA; [Winkler, Harald] Univ Cape Town, Energy Res Ctr, ZA-7925 Cape Town, South Africa; [Chaeffer, Roberto S.] Univ Fed Rio de Janeiro COPPE UFRJ, Rio De Janeiro, Brazil; [Ha, Fus] Natl Ctr Climate Change Strategy & Int Cooperat, Beijing, Peoples R China; [Riahi, Keywan] Graz Univ Technol, A-8010 Graz, Austria; [Meinshausen, Malte] Univ Melbourne, Australian German Climate & Energy Coll, Sch Earth Sci, Melbourne, Vic, Australia; [Meinshausen, Malte] Potsdam Inst Climate Impact Res PIK, PRIMAP Grp, Potsdam, Germany	International Institute for Applied Systems Analysis (IIASA); Swiss Federal Institutes of Technology Domain; ETH Zurich; Wageningen University & Research; University of Cape Town; Graz University of Technology; University of Melbourne; Potsdam Institut fur Klimafolgenforschung	den Elzen, M (corresponding author), PBL Netherlands Environm Assessment Agcy, Bilthoven, Netherlands.; Hohne, N (corresponding author), NewClimate Inst, Cologne, Germany.; Hohne, N (corresponding author), Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands.	Michel.denElzen@pbl.nl; n.hoehne@newclimate.org	Elzen, Michel den/M-2779-2016; Meinshausen, Malte/AAG-6505-2019; Meinshausen, Malte/AAG-7985-2019; Rogelj, Joeri/I-7108-2012; Höhne, Niklas/AAZ-2422-2020; Schaeffer, Roberto/F-9262-2012; Schaeffer, Roberto/AAY-4357-2020; Meinshausen, Malte/A-7037-2011; Elzen, Michel den/AAM-8272-2021; Winkler, Harald/AAF-6226-2020; Riahi, Keywan/B-6426-2011; Höhne, Niklas/L-8971-2013	Elzen, Michel den/0000-0002-5128-8150; Meinshausen, Malte/0000-0003-4048-3521; Rogelj, Joeri/0000-0003-2056-9061; Höhne, Niklas/0000-0001-9246-8759; Schaeffer, Roberto/0000-0002-3709-7323; Meinshausen, Malte/0000-0003-4048-3521; Elzen, Michel den/0000-0002-5128-8150; Riahi, Keywan/0000-0001-7193-3498; Winkler, Harald/0000-0002-5826-4071; Fekete, Hanna/0000-0002-5273-9347; fu, sha/0000-0002-8061-0348	European Union [642147]; Australian Research Council (ARC) [FT130100809]	European Union(European Commission); Australian Research Council (ARC)(Australian Research Council)	We thank all involved in the UNEP Emissions Gap Report, in particular J. McGlade, J. Alcamo and B. Metz, the members of the steering committee, all its authors, and the secretariat at UNEP-DTU, in particular A. Olhoff and J. Christensen. We acknowledge and are grateful for the data contributions of, and discussion with, all the global and national modelling groups, in particular M. Rocha, B. Hare, M. Schaeffer (Climate Analytics, Germany, Climate Action Tracker), L. Jeffery (PIK, Germany, Climate Action Tracker), P van Breevoort (Ecofys, The Netherlands, Climate Action Tracker), A. Admiraal, M. Roelfsema, H. van Soest (PBL, The Netherlands), N. Forsell (IIASA, Austria), L. Cozzi, F. Kesicke (IEA, France), J. Cranston Turner, R. Boyd (LSE, UK), S. Dockweiler (DEA, Denmark), L. Siegel, E. Sawin (Climate Interactive, USA), A. Kitous, K. Keramidas, G. Grassi (JRC, European Commission). G. Iyer (PNNL, USA), and the UNFCCC Secretariat. Without their contributions, this Perspective would have had a much more limited data basis, We thank S. Sterl (NewClimate Institute, Germany) and M. Roelfsema (PBL, The Netherlands) for assistance with data analysis, M. Strubegger (IIASA, Austria) for providing load factor estimates, V. Krey and O. Fricko (IIASA, Austria) for providing capture efficiencies for negative emissions technologies, and J. Cook for critical feedback on the manuscript and figures. We acknowledge and thank the International Institute for Applied Systems Analysis (IIASA) for hosting and maintaining the IPCC AR5 Scenario Database. J.R., N.H. and K.R. received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No, 642147 (CD-LINKS). M.M. is the recipient of an Australian Research Council (ARC) Future Fellowship (grant number FT130100809).	Admiraal A., 2015, 1879 PBL; Armstrong J. S., 2012, FORECASTING DICT; Blanco G, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P351; Blok K, 2012, NAT CLIM CHANGE, V2, P471, DOI 10.1038/nclimate1602; Boden T. A., 2013, GLOBAL REGIONAL NATL, DOI [10.3334/CDIAC/00001_V2013, DOI 10.3334/CDIAC/00001_V2013]; Boyd R., 2015, INTENDED NATL DETERM; Cames M., 2015, DIR GEN INT POLICIES; Clarke L, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P413; Climate Analytics Ecofys NewClimate Institute & PIK, 2015, CLIM PLEDG WILL BRIN; Climate Interactive, 2015, CLIM SCOR; Coelho ST, 2012, GLOBAL ENERGY ASSESS, P1459, DOI DOI 10.1017/CB09780511793677.026; Creutzig F, 2015, GCB BIOENERGY, V7, P916, DOI 10.1111/gcbb.12205; Cronin C., 2015, FASTER CLEANER DECAR; Damassa T., 2015, WORKING PAPER; Day T., 2015, PREPARATION INTENDED; DEA, 2015, AN 2030 EM GAP; den Elzen M., 2015, 1631 PBL; den Elzen M, 2016, ENERG POLICY, V89, P224, DOI 10.1016/j.enpol.2015.11.030; Eom J, 2015, TECHNOL FORECAST SOC, V90, P73, DOI 10.1016/j.techfore.2013.09.017; Fawcett AA, 2015, SCIENCE, V350, P1168, DOI 10.1126/science.aad5761; Fekete H., 2015, IMPACT GOOD PRACTICE; Friedlingstein P, 2014, NAT GEOSCI, V7, P709, DOI [10.1038/NGEO2248, 10.1038/ngeo2248]; Global Wind Energy Council, 2015, GLOB STAT; Grassi G, 2015, 27561 EUR, DOI 10.2788/096422; Hsu A, 2015, NAT CLIM CHANGE, V5, P501, DOI 10.1038/nclimate2594; ICAO, 2014, 10022 ICAO; IEA, 2014, WORLD EN OUTL 2014; IEA-International Energy Agency, 2015, WORLD EN OUTL 2015; IPCC, 2014, CLIMATE CHANGE 2014; IPCC, 2005, SPECIAL REPORT CARBO; IPCC, 2011, SPEC REP REN EN SOUR; Iyer GC, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125002; Iyer GC, 2015, NAT CLIM CHANGE, V5, P436, DOI [10.1038/nclimate2553, 10.1038/NCLIMATE2553]; JRC/PBL, 2014, EDGAR VERS 4 2FT2012; Kitous A., 2015, ANAL SCENARIOS INTEG, P1; Knutti R, 2016, NAT GEOSCI, V9, P13, DOI 10.1038/NGEO2595; Knutti R, 2015, CLIMATIC CHANGE, V133, P361, DOI 10.1007/s10584-015-1340-3; Kriegler E, 2015, TECHNOL FORECAST SOC, V90, P24, DOI 10.1016/j.techfore.2013.09.021; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P349, DOI 10.5194/essd-7-349-2015; Luderer G, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034033; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Meinshausen M., 2015, INDC FACTSHEETS; Meinshausen M, 2015, NAT CLIM CHANGE, V5, P1098, DOI [10.1038/nclimate2826, 10.1038/NCLIMATE2826]; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Obersteiner M, 2001, SCIENCE, V294, P786; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Randalls S, 2010, WIRES CLIM CHANGE, V1, P598, DOI 10.1002/wcc.62; Riahi K, 2015, TECHNOL FORECAST SOC, V90, P8, DOI 10.1016/j.techfore.2013.09.016; Roehrl RA, 2000, TECHNOL FORECAST SOC, V63, P231, DOI 10.1016/S0040-1625(99)00112-2; Roelfsema M., 2015, 1188 PBL; Rogelj J, 2016, NAT GEOSCI, V9, P187, DOI 10.1038/ngeo2668; Rogelj J, 2016, NAT CLIM CHANGE, V6, P245, DOI 10.1038/NCLIMATE2868; Rogelj J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/10/105007; Rogelj J, 2015, NAT CLIM CHANGE, V5, P519, DOI 10.1038/nclimate2572; Rogelj J, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/031003; Rogelj J, 2013, NAT CLIM CHANGE, V3, P405, DOI [10.1038/nclimate1758, 10.1038/NCLIMATE1758]; Rogelj J, 2013, NATURE, V493, P79, DOI 10.1038/nature11787; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Rogelj J, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024002; Scott V, 2015, NAT CLIM CHANGE, V5, P419, DOI 10.1038/NCLIMATE2578; Sha F, 2015, ANAL CHINAS INDC; Shukla P.R., 2022, CLIMATE CHANGE 2013; Smith P, 2016, NAT CLIM CHANGE, V6, P42, DOI [10.1038/NCLIMATE2870, 10.1038/nclimate2870]; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; SolarPower Europe, 2015, GLOB MARK OUTL SOL P; Stocker T.F., 2013, CLIMATE CHANGE 2013, P1535; UNEP, 2015, DEW1917NA UNEP; UNEP, 2015, EM GAP REP 2015; UNFCCC, 2015, FCCCCP20157; UNFCCC, 2015, INDCS COMM PART; UNFCCC, 2015, ADOPTION PARIS AGREE; UNFCCC, 1992, FCCCINFORMAL84; UNFCCC, 2002, FCCCCP20028, P7; Upham P, 2011, INT J GREENH GAS CON, V5, P1359, DOI 10.1016/j.ijggc.2011.06.005; Weischer Lutz, 2012, REV EUROPEAN COMMUNI, V21, P177, DOI DOI 10.1111/REEL.12007; World Resources Institute, 2015, PAR CONTR MAP	78	1611	1669	129	1006	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					631	639		10.1038/nature18307	http://dx.doi.org/10.1038/nature18307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357792	Green Accepted			2022-12-24	WOS:000378676000026
J	Zhao, WD; Hamid, E; Shin, W; Wen, PJ; Krystofiak, ES; Villarreal, SA; Chiang, HC; Kachar, B; Wu, LG				Zhao, Wei-Dong; Hamid, Edaeni; Shin, Wonchul; Wen, Peter J.; Krystofiak, Evan S.; Villarreal, Seth A.; Chiang, Hsueh-Cheng; Kachar, Bechara; Wu, Ling-Gang			Hemi-fused structure mediates and controls fusion and fission in live cells	NATURE			English	Article							MEMBRANE FISSION; CHROMAFFIN CELLS; CA2+-TRIGGERED EXOCYTOSIS; SNARE COMPLEX; PORES; VESICLES; ENDOCYTOSIS; TOMOGRAPHY; PROTEINS; INTERMEDIATE	Membrane fusion and fission are vital for eukaryotic life(1-5). For three decades, it has been proposed that fusion is mediated by fusion between the proximal leaflets of two bilayers (hemi-fusion) to produce a hemi-fused structure, followed by fusion between the distal leaflets, whereas fission is via hemi-fission, which also produces a hemi-fused structure, followed by full fission(1,4,6-10). This hypothesis remained unsupported owing to the lack of observation of hemi-fusion or hemi-fission in live cells. A competing fusion hypothesis involving protein-lined pore formation has also been proposed(2,11-15). Here we report the observation of a hemi-fused Omega-shaped structure in live neuroendocrine chromaffin cells and pancreatic beta-cells, visualized using confocal and super-resolution stimulated emission depletion microscopy. This structure is generated from fusion pore opening or closure (fission) at the plasma membrane. Unexpectedly, the transition to full fusion or fission is determined by competition between fusion and calcium/dynamin-dependent fission mechanisms, and is notably slow (seconds to tens of seconds) in a substantial fraction of the events. These results provide key missing evidence in support of the hemi-fusion and hemi-fission hypothesis in live cells, and reveal the hemi-fused intermediate as a key structure controlling fusion and fission, as fusion and fission mechanisms compete to determine the transition to fusion or fission.	[Zhao, Wei-Dong; Hamid, Edaeni; Shin, Wonchul; Wen, Peter J.; Villarreal, Seth A.; Chiang, Hsueh-Cheng; Wu, Ling-Gang] NINDS, 35 Convent Dr,Room 2B-1012, Bethesda, MD 20892 USA; [Krystofiak, Evan S.; Kachar, Bechara] NIDCD, 35A Convent Dr,Room 3D-824, Bethesda, MD 20892 USA; [Chiang, Hsueh-Cheng] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, 1 Univ Rd, Tainan 701, Taiwan	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Cheng Kung University	Wu, LG (corresponding author), NINDS, 35 Convent Dr,Room 2B-1012, Bethesda, MD 20892 USA.	wul@ninds.nih.gov		Zhao, Wei-Dong/0000-0003-0029-4400	National Institute of Neurological Disorders and Stroke Intramural Research Program [ZIA NS003009-13, ZIA NS003105-08]; National Institute on Deafness and Other Communication Disorders (NIDCD) Intramural Research Program [Z01-DC000002]; National Institute on Deafness and Other Communication Disorders (NIDCD) Intramural Research Program (NIDCD Advanced Imaging Core ZIC) [DC000081]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003105, ZIANS003009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000002, ZIADC000009, ZICDC000081, ZIADC000002] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Deafness and Other Communication Disorders (NIDCD) Intramural Research Program; National Institute on Deafness and Other Communication Disorders (NIDCD) Intramural Research Program (NIDCD Advanced Imaging Core ZIC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank T. Balla, G. Miesenbock, and D.-S. Wang for providing the construct containing the GFP-fused PH domain of PLC delta 1, the VAMP2-pHluorin construct, and dynamin siRNA, respectively; C. Smith for technical support with STED microscopy; and S. Cheng and V. Crocker for their electron microscopy technical support. This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Research Program (ZIA NS003009-13 and ZIA NS003105-08) and National Institute on Deafness and Other Communication Disorders (NIDCD) Intramural Research Program (Z01-DC000002 and NIDCD Advanced Imaging Core ZIC DC000081).	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Chang CW, 2015, J NEUROSCI, V35, P5772, DOI 10.1523/JNEUROSCI.3983-14.2015; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chiang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4356; Diao JJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00109; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; Gao JH, 2009, AM J TRANSL RES, V1, P312; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Han X, 2005, BIOPHYS J, V88, pL20, DOI 10.1529/biophysj.104.056739; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Jackson MB, 2010, J MEMBRANE BIOL, V235, P89, DOI 10.1007/s00232-010-9258-1; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jung JH, 2016, P NATL ACAD SCI USA, V113, pE1098, DOI 10.1073/pnas.1523054113; KOZLOV MM, 1983, BIOFIZIKA+, V28, P242; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lomasney JW, 1996, J BIOL CHEM, V271, P25316, DOI 10.1074/jbc.271.41.25316; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Pinto da Silva P., 1977, J CELL BIOL, V73, P161; Revelo NH, 2014, J CELL BIOL, V205, P591, DOI 10.1083/jcb.201402066; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Vardjan N, 2007, J NEUROSCI, V27, P4737, DOI 10.1523/JNEUROSCI.0351-07.2007; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; Wong JL, 2007, DEV CELL, V12, P653, DOI 10.1016/j.devcel.2007.02.007; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Zampighi GA, 2006, BIOPHYS J, V91, P2910, DOI 10.1529/biophysj.106.084814	34	80	81	4	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					548	+		10.1038/nature18598	http://dx.doi.org/10.1038/nature18598			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309816	Green Accepted			2022-12-24	WOS:000378270300053
J	Blanco, S; Bandiera, R; Popis, M; Hussain, S; Lombard, P; Aleksic, J; Sajini, A; Tanna, H; Cortes-Garrido, R; Gkatza, N; Dietmann, S; Frye, M				Blanco, Sandra; Bandiera, Roberto; Popis, Martyna; Hussain, Shobbir; Lombard, Patrick; Aleksic, Jelena; Sajini, Abdulrahim; Tanna, Hinal; Cortes-Garrido, Rosana; Gkatza, Nikoletta; Dietmann, Sabine; Frye, Michaela			Stem cell function and stress response are controlled by protein synthesis	NATURE			English	Article							OPEN READING FRAMES; METHYLTRANSFERASE MISU NSUN2; RNA METHYLTRANSFERASE; GENE-EXPRESSION; MESSENGER-RNA; TRANSLATIONAL REGULATION; TGF-BETA; IN-VIVO; METHYLATION; IDENTIFICATION	Whether protein synthesis and cellular stress response pathways interact to control stem cell function is currently unknown. Here we show that mouse skin stem cells synthesize less protein than their immediate progenitors in vivo, even when forced to proliferate. Our analyses reveal that activation of stress response pathways drives both a global reduction of protein synthesis and altered translational programmes that together promote stem cell functions and tumorigenesis. Mechanistically, we show that inhibition of post-transcriptional cytosine-5 methylation locks tumour-initiating cells in this distinct translational inhibition programme. Paradoxically, this inhibition renders stem cells hypersensitive to cytotoxic stress, as tumour regeneration after treatment with 5-fluorouracil is blocked. Thus, stem cells must revoke translation inhibition pathways to regenerate a tissue or tumour.	[Blanco, Sandra; Bandiera, Roberto; Popis, Martyna; Lombard, Patrick; Aleksic, Jelena; Sajini, Abdulrahim; Cortes-Garrido, Rosana; Gkatza, Nikoletta; Dietmann, Sabine; Frye, Michaela] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Dept Genet, Cambridge CB2 1QR, England; [Hussain, Shobbir] Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England; [Tanna, Hinal] Univ Cambridge, CR UK, Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England	University of Cambridge; University of Bath; CRUK Cambridge Institute; University of Cambridge	Frye, M (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Dept Genet, Cambridge CB2 1QR, England.	mf364@cam.ac.uk	Sajini, Abdulrahim/AAU-9806-2020; Blanco, Sandra/B-2070-2017	Sajini, Abdulrahim/0000-0002-8600-3899; Blanco, Sandra/0000-0001-7352-9392; Garrido, Rosana/0000-0001-9420-1142; Dietmann, Sabine./0000-0001-6672-8457; Frye, Michaela/0000-0002-5636-6840	Cancer Research UK; Worldwide Cancer Research; Medical Research Council (MRC); European Research Council; EMBO; Wellcome Trust; MRC; MRC [MR/M01939X/1, G0801904] Funding Source: UKRI; Cancer Research UK [15181] Funding Source: researchfish; Medical Research Council [MC_PC_12009, G0801904, MR/M01939X/1] Funding Source: researchfish; British Skin Foundation [5010] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Worldwide Cancer Research; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); British Skin Foundation	We thank J. Marioni and D. Odom for their advice on analysing the sequencing data. This work was funded by Cancer Research UK, Worldwide Cancer Research, the Medical Research Council (MRC), the European Research Council, and EMBO. Research in M.F.'s laboratory is supported by a core support grant from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Cambridge Stem Cell Institute.	Abbasi-Moheb L, 2012, AM J HUM GENET, V90, P847, DOI 10.1016/j.ajhg.2012.03.021; Atsumi N, 2008, BIOCHEM BIOPH RES CO, V373, P36, DOI 10.1016/j.bbrc.2008.05.163; Baranov PV, 2016, NAT METHODS, V13, P123, DOI 10.1038/nmeth.3738; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Frye M, 2010, CANCER LETT, V289, P71, DOI 10.1016/j.canlet.2009.08.004; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fuchs E, 2015, J CELL BIOL, V209, P629, DOI 10.1083/jcb.201503129; Gebetsberger J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/260909; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; HIRAI Y, 1989, DEVELOPMENT, V105, P271; Hussain S, 2013, GENOME BIOL, V14, DOI 10.1186/gb4143; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Hussain S, 2013, MOL CELL BIOL, V33, P1561, DOI 10.1128/MCB.01523-12; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Joshi Rajiv S, 2011, Int J Trichology, V3, P57, DOI 10.4103/0974-7753.82119; Kao RYT, 2002, P NATL ACAD SCI USA, V99, P10066, DOI 10.1073/pnas.152342999; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; Lin HC, 2014, CLIN ORAL INVEST, V18, P1277, DOI 10.1007/s00784-013-1088-y; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Martinez FJ, 2012, J MED GENET, V49, P380, DOI 10.1136/jmedgenet-2011-100686; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Owens DM, 2003, J CELL SCI, V116, P3783, DOI 10.1242/jcs.00725; Plikus MV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015198; Ruggero D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012336; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Schleich S, 2014, NATURE, V512, P208, DOI 10.1038/nature13401; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Tang H, 2015, AGING-US, V7, P1143, DOI 10.18632/aging.100860; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Xing JY, 2015, MOL CELL BIOL, V35, P4043, DOI 10.1128/MCB.00742-15; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang XT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1692	60	235	242	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					335	+		10.1038/nature18282	http://dx.doi.org/10.1038/nature18282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27306184	Green Accepted			2022-12-24	WOS:000377856800025
J	Berwick, DM; Downey, AS; Cornett, EA				Berwick, Donald M.; Downey, Autumn S.; Cornett, Elizabeth A.			A National Trauma Care System to Achieve Zero Preventable Deaths After Injury Recommendations From a National Academies of Sciences, Engineering, and Medicine Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Berwick, Donald M.] Inst Healthcare Improvement, Cambridge, MA USA; [Downey, Autumn S.; Cornett, Elizabeth A.] Natl Acad Sci Engn & Med, Washington, DC USA	Institute for Healthcare Improvement; National Academies of Sciences, Engineering & Medicine	Berwick, DM (corresponding author), Inst Healthcare Improvement, Editorial Affairs, 20 Univ Rd,Seventh Floor, Cambridge, MA 02138 USA.	donberwick@gmail.com						Blackbourne LH, 2013, J TRAUMA ACUTE CARE, V74, P705, DOI 10.1097/TA.0b013e31828174f3; Blackbourne LH, 2013, J TRAUMA ACUTE CARE, V74, P347, DOI 10.1097/01.ta.0000426020.38942.d4; Blackbourne LH, 2012, J TRAUMA ACUTE CARE, V73, pS372, DOI 10.1097/TA.0b013e3182755662; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Ireland MW, 1921, J AMER MED ASSOC, V76, P763; Kwon AM, 2014, EUR J TRAUMA EMERG S, V40, P279, DOI 10.1007/s00068-013-0364-5; National Academies of Sciences Engineering and Medicine, 2016, NAT TRAUM CAR SYST I; Rasmussen Todd E, 2015, J Trauma Acute Care Surg, V79, pS61, DOI 10.1097/TA.0000000000000795; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Smith M., 2013, BUSINESS MODELS RESP	10	37	44	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					927	928		10.1001/jama.2016.8524	http://dx.doi.org/10.1001/jama.2016.8524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27315351				2022-12-24	WOS:000382460200013
J	Walley, JW; Sartor, RC; Shen, ZX; Schmitz, RJ; Wu, KJ; Urich, MA; Nery, JR; Smith, LG; Schnable, JC; Ecker, JR; Briggs, SP				Walley, Justin W.; Sartor, Ryan C.; Shen, Zhouxin; Schmitz, Robert J.; Wu, Kevin J.; Urich, Mark A.; Nery, Joseph R.; Smith, Laurie G.; Schnable, James C.; Ecker, Joseph R.; Briggs, Steven P.			Integration of omic networks in a developmental atlas of maize	SCIENCE			English	Article							MESSENGER-RNA; REGULATORY NETWORKS; PROTEIN EXPRESSION; CELL-LINE; REVEALS; LEAF; INFERENCE; COEXPRESSION; DISCOVERY; ABUNDANCE	Coexpression networks and gene regulatory networks (GRNs) are emerging as important tools for predicting functional roles of individual genes at a system-wide scale. To enable network reconstructions, we built a large-scale gene expression atlas composed of 62,547 messenger RNAs (mRNAs), 17,862 nonmodified proteins, and 6227 phosphoproteins harboring 31,595 phosphorylation sites quantified across maize development. Networks in which nodes are genes connected on the basis of highly correlated expression patterns of mRNAs were very different from networks that were based on coexpression of proteins. Roughly 85% of highly interconnected hubs were not conserved in expression between RNA and protein networks. However, networks from either data type were enriched in similar ontological categories and were effective in predicting known regulatory relationships. Integration of mRNA, protein, and phosphoprotein data sets greatly improved the predictive power of GRNs.	[Walley, Justin W.; Sartor, Ryan C.; Shen, Zhouxin; Wu, Kevin J.; Smith, Laurie G.; Briggs, Steven P.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Walley, Justin W.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA; [Schmitz, Robert J.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Schmitz, Robert J.; Urich, Mark A.; Nery, Joseph R.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Schnable, James C.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA; [Ecker, Joseph R.] Howard Hughes Med Inst, Salk Inst Biol Studies, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Schmitz, Robert J.] Davison Life Sci, Dept Genet, 120 East Green St, Athens, GA 30602 USA	University of California System; University of California San Diego; Iowa State University; Salk Institute; Salk Institute; University of Nebraska System; University of Nebraska Lincoln; Howard Hughes Medical Institute; Salk Institute	Briggs, SP (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	sbriggs@ucsd.edu	Nery, Joseph/AAE-8422-2019; Schmitz, Robert/AAY-7659-2020; Ecker, Joseph R/B-9144-2008; Walley, Justin/E-5594-2015	Nery, Joseph/0000-0003-0153-5659; Schmitz, Robert/0000-0001-7538-6663; Ecker, Joseph R/0000-0001-5799-5895; Walley, Justin/0000-0001-7553-2237	NSF [0924023, MCB-0929402, MCB1122246]; NIH National Research Service Award Postdoctoral Fellowship [F32GM096707]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3034]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096707] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Walbot for tassel and anther tissues, F. Hochholdinger for root tissues, and J. Fowler for pollen tissues. This work was supported by the NSF (grant 0924023 to S.P.B. and grants MCB-0929402 and MCB1122246 to J.R.E.), an NIH National Research Service Award Postdoctoral Fellowship (F32GM096707 to J.W.W.), and the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (grant GBMF3034 to J.R.E.). Sequence data can be downloaded from the National Center for Biotechnology Information's Sequence Read Archive (accession number GSE50191). Raw mass spectra have been deposited at the Mass Spectrometry Interactive Virtual Environment (MassIVE) repository (accession numbers MSV000079290 and MSV000079303). Normalized expression data have been integrated into the genome browser and individual gene model pages at the central Maize Genetics and Genomics Database (www.maizegdb.org/).	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Baerenfaller K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.39; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Bolduc N, 2012, GENE DEV, V26, P1685, DOI 10.1101/gad.193433.112; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Facette MR, 2013, PLANT CELL, V25, P2798, DOI 10.1105/tpc.113.112227; Gallavotti A, 2010, DEVELOPMENT, V137, P2849, DOI 10.1242/dev.051748; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Krouk G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-123; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li CB, 2015, PLANT CELL, V27, P532, DOI 10.1105/tpc.114.134858; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marcon C, 2015, PLANT PHYSIOL, V168, P233, DOI 10.1104/pp.15.00138; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Schnable JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017855; SCHNEEBERGER RG, 1995, GENE DEV, V9, P2292, DOI 10.1101/gad.9.18.2292; Schrynemackers Marie, 2013, Frontiers in Genetics, V4, P262, DOI 10.3389/fgene.2013.00262; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Walley JW, 2013, P NATL ACAD SCI USA, V110, pE4808, DOI 10.1073/pnas.1319113110; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100	35	221	224	8	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					814	818		10.1126/science.aag1125	http://dx.doi.org/10.1126/science.aag1125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540173	Green Accepted			2022-12-24	WOS:000381561400044
J	Regenstein, M; Nocella, K; Jewers, MM; Mullan, F				Regenstein, Marsha; Nocella, Kiki; Jewers, Mariellen Malloy; Mullan, Fitzhugh			The Cost of Residency Training in Teaching Health Centers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Regenstein, Marsha; Jewers, Mariellen Malloy; Mullan, Fitzhugh] George Washington Univ, Dept Hlth Policy & Management, Milken Inst, Sch Publ Hlth, Washington, DC USA; [Nocella, Kiki] KCN Consulting, Valencia, CA USA; [Nocella, Kiki] Educ Hlth Ctr Initiat, Seattle, WA USA	George Washington University	Regenstein, M (corresponding author), George Washington Univ, Dept Hlth Policy & Management, Milken Inst, Sch Publ Hlth, Washington, DC USA.							Chen C, 2012, ACAD MED, V87, P1752, DOI 10.1097/ACM.0b013e3182720f4d; Evaluation and initial assessment of HRSA teaching health centers, 2015, OMB CONTR NUMB 0906; Phillips RL, 2013, ACAD MED, V88, P1934, DOI 10.1097/ACM.0000000000000025	3	27	29	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					612	614		10.1056/NEJMp1607866	http://dx.doi.org/10.1056/NEJMp1607866			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT4VF	27376580				2022-12-24	WOS:000381478600002
J	Wise, J				Wise, Jacqui			MEDICINE AND THE MEDIA No "breakthrough" in Alzheimer's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacquiyoung1@gmail.com						Bodkin Henry, 2016, TELEGRAPH; Herber M., 2016, FORBES; Pollack Andrew, 2016, NY TIMES; Smyth C, 2016, TIMES; Spencer B., 2016, DAILY MAIL; Whalen J, 2016, WALL STREET J	6	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4474	10.1136/bmj.i4474	http://dx.doi.org/10.1136/bmj.i4474			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27531826				2022-12-24	WOS:000381806200007
J	Drake, JM; Paull, EO; Graham, NA; Lee, JK; Smith, BA; Titz, B; Stoyanova, T; Faltermeier, CM; Uzunangelov, V; Carlin, DE; Fleming, DT; Wong, CK; Newton, Y; Sudha, S; Vashisht, AA; Huang, JT; Wohlschlegel, JA; Graeber, TG; Witte, ON; Stuart, JM				Drake, Justin M.; Paull, Evan O.; Graham, Nicholas A.; Lee, John K.; Smith, Bryan A.; Titz, Bjoern; Stoyanova, Tanya; Faltermeier, Claire M.; Uzunangelov, Vladislav; Carlin, Daniel E.; Fleming, Daniel Teo; Wong, Christopher K.; Newton, Yulia; Sudha, Sud; Vashisht, Ajay A.; Huang, Jiaoti; Wohlschlegel, James A.; Graeber, Thomas G.; Witte, Owen N.; Stuart, Joshua M.			Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer	CELL			English	Article							MUTATIONAL LANDSCAPE; ENRICHMENT ANALYSIS; INCREASED SURVIVAL; BETA-CATENIN; CELL-GROWTH; ACTIVATION; IDENTIFICATION; EZH2; HETEROGENEITY; PROGRESSION	We used clinical tissue from lethal metastatic castration-resistant prostate cancer (CRPC) patients obtained at rapid autopsy to evaluate diverse genomic, transcriptomic, and phosphoproteomic datasets for pathway analysis. Using Tied Diffusion through Interacting Events (TieDIE), we integrated differentially expressed master transcriptional regulators, functionally mutated genes, and differentially activated kinases in CRPC tissues to synthesize a robust signaling network consisting of druggable kinase pathways. Using MSigDB hallmark gene sets, six major signaling pathways with phosphorylation of several key residues were significantly enriched in CRPC tumors after incorporation of phosphoproteomic data. Individual autopsy profiles developed using these hallmarks revealed clinically relevant pathway information potentially suitable for patient stratification and targeted therapies in late stage prostate cancer. Here, we describe phosphorylation-based cancer hallmarks using integrated personalized signatures (pCHIPS) that shed light on the diversity of activated signaling pathways in metastatic CRPC while providing an integrative, pathway-based reference for drug prioritization in individual patients.	[Drake, Justin M.; Smith, Bryan A.; Stoyanova, Tanya; Witte, Owen N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Graham, Nicholas A.; Titz, Bjoern; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; [Graham, Nicholas A.; Titz, Bjoern; Graeber, Thomas G.; Witte, Owen N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Lee, John K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Lee, John K.; Faltermeier, Claire M.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Huang, Jiaoti; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Witte, Owen N.] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Huang, Jiaoti; Witte, Owen N.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Sudha, Sud] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Paull, Evan O.; Uzunangelov, Vladislav; Carlin, Daniel E.; Fleming, Daniel Teo; Wong, Christopher K.; Newton, Yulia; Stuart, Joshua M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Drake, Justin M.] Rutgers Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Drake, Justin M.] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA; [Graham, Nicholas A.] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Stoyanova, Tanya] Stanford Univ, Canary Ctr Stanford Canc Early Detect, Dept Radiol, Palo Alto, CA 94304 USA; [Carlin, Daniel E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Huang, Jiaoti] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of California System; University of California Santa Cruz; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Southern California; Stanford University; University of California System; University of California San Diego; Duke University	Drake, JM; Witte, ON (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Witte, ON (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Witte, ON (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.; Witte, ON (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.; Stuart, JM (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.; Drake, JM (corresponding author), Rutgers Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA.; Drake, JM (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA.	justin.drake@cinj.rutgers.edu; owenwitte@mednet.ucla.edu; jstuart@ucsc.edu	Titz, Bjoern/G-6317-2017; Graham, Nicholas A./X-2738-2019; Graham, Nicholas/GYD-5066-2022	Titz, Bjoern/0000-0003-4414-4105; Graham, Nicholas A./0000-0002-6811-1941; Graham, Nicholas/0000-0002-6811-1941; Drake, Justin/0000-0002-8329-7748; Huang, Jiaoti/0000-0003-1195-1998; Lee, John/0000-0002-6570-2180; Stuart, Joshua/0000-0002-2171-565X; Graeber, Thomas/0000-0001-8574-9181	Department of Defense Prostate Cancer Research Program [W81XWH-14-1-0148, W81XWH-12-1-0206]; Prostate Cancer Foundation Young Investigator Award; New Jersey Health Foundation Research grant; UCLA Scholars in Oncologic Molecular Imaging (SOMI) program, NIH [R25T CA098010]; Specialty Training and Advanced Research (STAR) Program at UCLA; Tower Cancer Research Foundation Career Development Award; UCLA Tumor Immunology Training grant [T32 CA009120]; American Cancer Society [PF-16-082-01-TBE]; NIH/National Cancer Institute [4R00CA184397]; UCLA Medical Scientist Training Program; NIH [5R01CA172603-02, 2P30CA016042-39, 1R01CA181242-01A1, 1R01CA195505, GM089778]; UCLA SPORE in prostate cancer; Prostate Cancer Foundation Honorable A. David Mazzone Special Challenge Award; UCLA Jonsson Comprehensive Cancer Center Impact Grant; NCI/NIH [P01 CA168585, U24CA143858, 1R01CA180778]; American Cancer Society Research Scholar Award [RSG-12-257-01-TBE]; Cal-Tech-UCLA Joint Center for Translational Medicine; UCLA Jonsson Cancer Center Foundation; National Center for Advancing Translational Sciences UCLA CTSI grant [UL1TR000124]; Concern Foundation CONquer CanCER Now Award; NHGRI/NIH [5U54HG006097]; NIGMS/NIH [5R01GM109031]; Zimmerman Family; Concern Foundation; Prostate Cancer Foundation Challenge Award; NATIONAL CANCER INSTITUTE [P01CA168585, R25CA098010, P30CA016042, R01CA180778, R01CA195505, R01CA172603, R03CA230819, T32CA009120, R00CA184397, R01CA181242, U24CA143858, P50CA092131] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109031, R01GM089778] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Research Program(United States Department of Defense); Prostate Cancer Foundation Young Investigator Award; New Jersey Health Foundation Research grant; UCLA Scholars in Oncologic Molecular Imaging (SOMI) program, NIH; Specialty Training and Advanced Research (STAR) Program at UCLA; Tower Cancer Research Foundation Career Development Award; UCLA Tumor Immunology Training grant; American Cancer Society(American Cancer Society); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UCLA Medical Scientist Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA SPORE in prostate cancer; Prostate Cancer Foundation Honorable A. David Mazzone Special Challenge Award; UCLA Jonsson Comprehensive Cancer Center Impact Grant; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Research Scholar Award(American Cancer Society); Cal-Tech-UCLA Joint Center for Translational Medicine; UCLA Jonsson Cancer Center Foundation; National Center for Advancing Translational Sciences UCLA CTSI grant; Concern Foundation CONquer CanCER Now Award; NHGRI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Zimmerman Family; Concern Foundation; Prostate Cancer Foundation Challenge Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the O.N.W. and J.M.S. labs for helpful comments and discussion on the manuscript and the University of Michigan for supplying material from their rapid autopsy program. J.M.D. is supported by the Department of Defense Prostate Cancer Research Program W81XWH-14-1-0148, Prostate Cancer Foundation Young Investigator Award, and a New Jersey Health Foundation Research grant. N.A.G. is supported by UCLA Scholars in Oncologic Molecular Imaging (SOMI) program, NIH grant R25T CA098010. J.K.L. is supported by Specialty Training and Advanced Research (STAR) Program at UCLA, Prostate Cancer Foundation Young Investigator Award, and Tower Cancer Research Foundation Career Development Award. B.A.S. is supported by the UCLA Tumor Immunology Training grant T32 CA009120, American Cancer Society Postdoctoral Fellowship PF-16-082-01-TBE, and Prostate Cancer Foundation Young Investigator Award. T.S. is supported by Prostate Cancer Foundation Young Investigator Award and NIH/National Cancer Institute K99 Pathway to Independence Award 4R00CA184397. C.M.F. is supported by the UCLA Medical Scientist Training Program. J.H. is supported by NIH grants 5R01CA172603-02, 2P30CA016042-39, 1R01CA181242-01A1, 1R01CA195505, the Department of Defense Prostate Cancer Research Program W81XWH-12-1-0206, UCLA SPORE in prostate cancer, Prostate Cancer Foundation Honorable A. David Mazzone Special Challenge Award, and UCLA Jonsson Comprehensive Cancer Center Impact Grant. J.A.W. is supported by NIH GM089778. T.G.G. is supported by the NCI/NIH P01 CA168585, an American Cancer Society Research Scholar Award RSG-12-257-01-TBE, the Cal-Tech-UCLA Joint Center for Translational Medicine, the UCLA Jonsson Cancer Center Foundation, the National Center for Advancing Translational Sciences UCLA CTSI grant UL1TR000124, and a Concern Foundation CONquer CanCER Now Award. J.M.S. is supported by NCI/NIH U24CA143858, NCI/NIH 1R01CA180778, NHGRI/NIH 5U54HG006097, and NIGMS/NIH 5R01GM109031 grants. O.N.W. is an Investigator of the Howard Hughes Medical Institute and is supported by the Zimmerman Family, the Concern Foundation, and by a Prostate Cancer Foundation Challenge Award.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Alvarez M.J., 2015, USING VIPER PACKAGE; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Casado P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003573; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chen JC, 2014, CELL, V159, P402, DOI 10.1016/j.cell.2014.09.021; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Deeb SJ, 2012, MOL CELL PROTEOMICS, V11, P77, DOI 10.1074/mcp.M111.015362; Drake JM, 2013, P NATL ACAD SCI USA, V110, pE4762, DOI 10.1073/pnas.1319948110; Drake JM, 2012, P NATL ACAD SCI USA, V109, P1643, DOI 10.1073/pnas.1120985109; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gioeli D, 1999, CANCER RES, V59, P279; Gonzalez ME, 2011, CANCER RES, V71, P2360, DOI 10.1158/0008-5472.CAN-10-1933; Goodwin JF, 2015, CANCER CELL, V28, P97, DOI 10.1016/j.ccell.2015.06.004; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Huang SSC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002887; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Khurana E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002886; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee JK, 2016, CANCER CELL, V29, P536, DOI 10.1016/j.ccell.2016.03.001; Lia WL, 2014, P NATL ACAD SCI USA, V111, P1521, DOI 10.1073/pnas.1320638111; Lu S, 1997, CANCER RES, V57, P4511; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Newman RH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.12; Ning XH, 2015, CANCER LETT, V359, P198, DOI 10.1016/j.canlet.2015.01.005; Pandey M, 2014, TOXICOL APPL PHARM, V280, P296, DOI 10.1016/j.taap.2014.08.015; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Paull EO, 2013, BIOINFORMATICS, V29, P2757, DOI 10.1093/bioinformatics/btt471; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Smith BA, 2015, P NATL ACAD SCI USA, V112, pE6544, DOI 10.1073/pnas.1518007112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang GX, 2006, J CELL BIOCHEM, V99, P382, DOI 10.1002/jcb.20847; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yu G, 2015, MOL CANCER RES, V13, P348, DOI 10.1158/1541-7786.MCR-14-0384-T; Zimman A, 2010, J PROTEOME RES, V9, P2812, DOI 10.1021/pr901194x	54	135	136	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					1041	1054		10.1016/j.cell.2016.07.007	http://dx.doi.org/10.1016/j.cell.2016.07.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27499020	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000382258700024
J	Chaudhry, HJ; Hengerer, AS; Snyder, GB				Chaudhry, Humayun J.; Hengerer, Arthur S.; Snyder, Gregory B.			Medical Board Expectations for Physicians Recommending Marijuana	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chaudhry, Humayun J.; Snyder, Gregory B.] Federat State Med Boards, 400 Fuller Wiser Rd,Ste 300, Euless, TX 76039 USA; [Hengerer, Arthur S.] Univ Rochester, Dept Otolaryngol Head & Neck Surg, Rochester, NY USA	University of Rochester	Chaudhry, HJ (corresponding author), Federat State Med Boards, 400 Fuller Wiser Rd,Ste 300, Euless, TX 76039 USA.	hchaudhry@fsmb.org						Chaudhry HJ, 2015, JAMA-J AM MED ASSOC, V313, P1791, DOI 10.1001/jama.2015.4017; Hasin DS, 2015, JAMA PSYCHIAT, V72, P1235, DOI 10.1001/jamapsychiatry.2015.1858; Hill KP, 2015, JAMA-J AM MED ASSOC, V313, P2474, DOI 10.1001/jama.2015.6199	3	16	16	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					577	578		10.1001/jama.2016.7741	http://dx.doi.org/10.1001/jama.2016.7741			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27308872				2022-12-24	WOS:000380985600005
J	Shaw, AJ; Lam, FH; Hamilton, M; Consiglio, A; MacEwen, K; Brevnova, EE; Greenhagen, E; LaTouf, WG; South, CR; van Dijken, H; Stephanopoulos, G				Shaw, A. Joe; Lam, Felix H.; Hamilton, Maureen; Consiglio, Andrew; MacEwen, Kyle; Brevnova, Elena E.; Greenhagen, Emily; LaTouf, W. Greg; South, Colin R.; van Dijken, Hans; Stephanopoulos, Gregory			Metabolic engineering of microbial competitive advantage for industrial fermentation processes	SCIENCE			English	Article							ETHANOL; CLONING	Microbial contamination is an obstacle to widespread production of advanced biofuels and chemicals. Current practices such as process sterilization or antibiotic dosage carry excess costs or encourage the development of antibiotic resistance. We engineered Escherichia coli to assimilate melamine, a xenobiotic compound containing nitrogen. After adaptive laboratory evolution to improve pathway efficiency, the engineered strain rapidly outcompeted a control strain when melamine was supplied as the nitrogen source. We additionally engineered the yeasts Saccharomyces cerevisiae and Yarrowia lipolytica to assimilate nitrogen from cyanamide and phosphorus from potassium phosphite, and they outcompeted contaminating strains in several low-cost feedstocks. Supplying essential growth nutrients through xenobiotic or ecologically rare chemicals provides microbial competitive advantage with minimal external risks, given that engineered biocatalysts only have improved fitness within the customized fermentation environment.	[Shaw, A. Joe; Hamilton, Maureen; Consiglio, Andrew; MacEwen, Kyle; Brevnova, Elena E.; Greenhagen, Emily; LaTouf, W. Greg; South, Colin R.; van Dijken, Hans; Stephanopoulos, Gregory] Novogy, 85 Bolton St, Cambridge, MA 02140 USA; [Lam, Felix H.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Brevnova, Elena E.] Total New Energies USA, 5858 Horton St, Emeryville, CA 94608 USA; [Brevnova, Elena E.] Evelo Therapeut, 620 Mem Dr, Cambridge, MA 02139 USA; [Greenhagen, Emily] Ginkgo Bioworks, 27 Drydock Ave, Boston, MA 02210 USA; [South, Colin R.] Proterro, 66 Palmer Ave, Bronxville, NY 10708 USA	Massachusetts Institute of Technology (MIT)	Shaw, AJ (corresponding author), Novogy, 85 Bolton St, Cambridge, MA 02140 USA.	jshaw@novogyinc.com		Lam, Felix/0000-0001-6585-3360	Novogy; Total New Energies; U.S. Department of Energy [DE-SC0008744]	Novogy; Total New Energies(Total SA); U.S. Department of Energy(United States Department of Energy (DOE))	We thank O. Vidalin and V. Rajgarhia for managerial support, D. Crabtree and J. Afshar for analytical support, H. Blitzblau and V. Tsakraklides for helpful comments, Cereal Process Technologies and the National Corn to Ethanol Research Center for materials and insight into corn fractionation processes, Beta Renewables for wheat straw hydrolysate, and Phibro for the yeast Ethanol Red. This work was supported by Novogy and Total New Energies. F.H.L. and G.S. were supported in part by the U.S. Department of Energy (grant DE-SC0008744). A.J.S., C.R.S., H.v.D., E.G., M.H., W.G.L., A.C., K.M., and Novogy have filed patent applications [WO2014107660 (A3), WO2015031441 (A3), and WO2015157431 (A3)] that relate to the use of ROBUST pathways for fermentation selective advantage. PROESA wheat straw hydrolysate is available from Biochemtex under a material transfer agreement. Data are available in the supplementary materials, and strains are available by request. A.J.S., F.H.L., E.E.B., E.G., W.G.L., C.R.S., H.v.D., and G.S. participated in the design of the experiments and/or the interpretation of the results. A.J.S., F.H.L., M.H., A.C., K.M., E.E.B., and E.G. participated in the acquisition and/or analysis of data. A.J.S., F.H.L., and G.S. participated in drafting and/or revising the manuscript.	Bischoff KM, 2007, J IND MICROBIOL BIOT, V34, P739, DOI 10.1007/s10295-007-0250-4; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Costas AMG, 2001, J BIOL CHEM, V276, P17429, DOI 10.1074/jbc.M011764200; Dashko S, 2014, FEMS YEAST RES, V14, P826, DOI 10.1111/1567-1364.12161; de Jong B, 2012, CURR OPIN BIOTECH, V23, P624, DOI 10.1016/j.copbio.2011.11.021; EATON RW, 1991, J BACTERIOL, V173, P1215, DOI 10.1128/jb.173.3.1215-1222.1991; Friedlander J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0492-3; Fulton LM, 2015, BIOFUEL BIOPROD BIOR, V9, P476, DOI 10.1002/bbb.1559; Giguere R. J., U. S. Patent, Patent No. [US8113447 B1, 8113447]; Grayson Michelle, 2011, Nature, V474, pS1, DOI 10.1038/474S01a; Gronenberg LS, 2013, CURR OPIN CHEM BIOL, V17, P462, DOI 10.1016/j.cbpa.2013.03.037; Hede K, 2014, NATURE, V509, pS2, DOI 10.1038/509S2a; Hynes SH, 1997, J IND MICROBIOL BIOT, V18, P284, DOI 10.1038/sj.jim.2900381; Ingledew WM, 2009, ENCY IND BIOTECHNOLO, P1; Lane Melanie M., 2010, Fungal Biology Reviews, V24, P17, DOI 10.1016/j.fbr.2010.01.001; MAIERGREINER UH, 1991, P NATL ACAD SCI USA, V88, P4260, DOI 10.1073/pnas.88.10.4260; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; Narendranath N. V., 2009, ALCOHOL TXB, P337; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Rajagopalan S, 2005, APPL BIOCHEM BIOTECH, V120, P37, DOI 10.1385/ABAB:120:1:37; Seffernick JL, 2010, J BACTERIOL, V192, P1106, DOI 10.1128/JB.01243-09; Shapir N, 2007, J BACTERIOL, V189, P674, DOI 10.1128/JB.01257-06; Walker GM, 2011, J I BREWING, V117, P3, DOI 10.1002/j.2050-0416.2011.tb00438.x; Westfall PJ, 2011, CURR OPIN BIOTECH, V22, P344, DOI 10.1016/j.copbio.2011.04.023	24	85	91	4	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					583	586		10.1126/science.aaf6159	http://dx.doi.org/10.1126/science.aaf6159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493184				2022-12-24	WOS:000381560900040
J	Questa, JI; Song, J; Geraldo, N; An, HL; Dean, C				Questa, Julia I.; Song, Jie; Geraldo, Nuno; An, Hailong; Dean, Caroline			Arabidopsis transcriptional repressor VAL1 triggers Polycomb silencing at FLC during vernalization	SCIENCE			English	Article							EPIGENETIC REGULATION; PROTEIN; COLD; SWITCH; MATURATION; PROMOTERS; MOTIF	The determinants that specify the genomic targets of Polycomb silencing complexes are still unclear. Polycomb silencing of Arabidopsis FLOWERING LOCUS C ( FLC) accelerates flowering and involves a cold-dependent epigenetic switch. Here we identify a single point mutation at an intragenic nucleation site within FLC that prevents this epigenetic switch from taking place. The mutation blocks nucleation of plant homeodomain-Polycomb repressive complex 2 ( PHD-PRC2) and indicates a role for the transcriptional repressor VAL1 in the silencing mechanism. VAL1 localizes to the nucleation region in vivo, promoting histone deacetylation and FLC transcriptional silencing, and interacts with components of the conserved apoptosis-and splicing-associated protein ( ASAP) complex. Sequence-specific targeting of transcriptional repressors thus recruits the machinery for PHD-PRC2 nucleation and epigenetic silencing.	[Questa, Julia I.; Song, Jie; Geraldo, Nuno; An, Hailong; Dean, Caroline] Norwich Res Pk, Dept Cell & Dev Biol, John Innes Ctr, Norwich NR4 7UH, Norfolk, England; [Song, Jie] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [An, Hailong] Shandong Agr Univ, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Imperial College London; Shandong Agricultural University	Dean, C (corresponding author), Norwich Res Pk, Dept Cell & Dev Biol, John Innes Ctr, Norwich NR4 7UH, Norfolk, England.	caroline.dean@jic.ac.uk	Qüesta, Julia I/B-5333-2019	Qüesta, Julia I/0000-0002-0462-8423; Dean, Caroline/0000-0002-6555-3525	UK Biotechnology and Biological Sciences Research Council; European Research Council; BBSRC [BBS/E/J/000CA537] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA537] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all members of the Dean and Howard research groups for discussions. We are grateful to G. Saalbach for assistance with mass spectrometry, M. Suzuki for providing val1 and val2 lines, J. Irwin for the Brassica FLC sequences, J. Long for the hda19-1 line, and A. Pendle for the 35S::GFP-AtSAP18 plasmid. We thank V. Coustham, B. Rutjens, and J. Mylne for contributions at the early phase of this project. The Dean laboratory is supported by the UK Biotechnology and Biological Sciences Research Council and a European Research Council Advanced Investigator grant. The and a European Research Council Advanced Investigator grant. The supplementary materials contain additional data.	Angel A, 2015, P NATL ACAD SCI USA, V112, P4146, DOI 10.1073/pnas.1503100112; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; Csorba T, 2014, P NATL ACAD SCI USA, V111, P16160, DOI 10.1073/pnas.1419030111; Derkacheva M, 2014, J EXP BOT, V65, P2769, DOI 10.1093/jxb/ert410; Finnegan EJ, 2015, PLANT J, V84, P875, DOI 10.1111/tpj.13044; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Hill K, 2008, PLANT J, V53, P172, DOI 10.1111/j.1365-313X.2007.03336.x; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mylne J, 2004, COLD SPRING HARB SYM, V69, P457, DOI 10.1101/sqb.2004.69.457; Nag R, 2005, PLANT MOL BIOL, V59, P821, DOI 10.1007/s11103-005-1387-z; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Reidt W, 2000, PLANT J, V21, P401, DOI 10.1046/j.1365-313x.2000.00686.x; Boer DR, 2014, CELL, V156, P577, DOI 10.1016/j.cell.2013.12.027; Schwerk C, 2003, MOL CELL BIOL, V23, P2981, DOI 10.1128/MCB.23.8.2981-2990.2003; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Singh KK, 2010, RNA, V16, P2442, DOI 10.1261/rna.2304410; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Sun B, 2014, SCIENCE, V343, P505, DOI 10.1126/science.1248559; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Yang C, 2013, CURR BIOL, V23, P1324, DOI 10.1016/j.cub.2013.05.050; Yang HC, 2014, CURR BIOL, V24, P1793, DOI 10.1016/j.cub.2014.06.047; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	29	145	151	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					485	488		10.1126/science.aaf7354	http://dx.doi.org/10.1126/science.aaf7354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471304	Green Submitted			2022-12-24	WOS:000380583600040
J	Banani, SF; Rice, AM; Peeples, WB; Lin, Y; Jain, S; Parker, R; Rosen, MK				Banani, Salman F.; Rice, Allyson M.; Peeples, William B.; Lin, Yuan; Jain, Saumya; Parker, Roy; Rosen, Michael K.			Compositional Control of Phase-Separated Cellular Bodies	CELL			English	Article							PML NUCLEAR-BODIES; STRESS GRANULES; LIQUID DROPLETS; RNA; PROTEIN; BINDING; PHOSPHORYLATION; TRANSITION; DYNAMICS; DAXX	Cellular bodies such as P bodies and PML nuclear bodies (PML NBs) appear to be phase-separated liquids organized by multivalent interactions among proteins and RNA molecules. Although many components of various cellular bodies are known, general principles that define body composition are lacking. We modeled cellular bodies using several engineered multivalent proteins and RNA. In vitro and in cells, these scaffold molecules form phase-separated liquids that concentrate low valency client proteins. Clients partition differently depending on the ratio of scaffolds, with a sharp switch across the phase diagram diagonal. Composition can switch rapidly through changes in scaffold concentration or valency. Natural PML NBs and P bodies show analogous partitioning behavior, suggesting how their compositions could be controlled by levels of PML SUMOylation or cellular mRNA concentration, respectively. The data suggest a conceptual framework for considering the composition and control thereof of cellular bodies assembled through heterotypic multivalent interactions.	[Banani, Salman F.; Rice, Allyson M.; Peeples, William B.; Lin, Yuan; Rosen, Michael K.] UT Southwestern Med Ctr, Dept Biophys, Dallas, TX 75390 USA; [Banani, Salman F.; Rice, Allyson M.; Peeples, William B.; Lin, Yuan; Rosen, Michael K.] UT Southwestern Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Jain, Saumya; Parker, Roy] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Rosen, MK (corresponding author), UT Southwestern Med Ctr, Dept Biophys, Dallas, TX 75390 USA.; Rosen, MK (corresponding author), UT Southwestern Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu		Rice, Allyson/0000-0002-2781-0439	Howard Hughes Medical Institute; HCIA program of HHMI; NIH [R01-GM56322]; Welch Foundation [I-1544]; Sara and Frank McKnight Graduate Fellowship; NSF [1000196079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322, R01GM045443] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); HCIA program of HHMI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Sara and Frank McKnight Graduate Fellowship; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Louie Kerr, Kate Luby-Phelps, and Abhijit Bugde for assistance with imaging; Chad Brautigam and Thomas Scheuermann for assistance with ITC; Mark Kittisopikul for helpful discussions regarding image analysis, numerical fitting, and statistical testing; Pier Paolo Scaglioni for providing PML<SUP>-/-</SUP> cells; Rama Ranganathan for critical reading of the manuscript; and members of the Rosen lab for helpful discussions. This work was supported by the Howard Hughes Medical Institute, the HCIA program of HHMI, grants from the NIH (R01-GM56322) and Welch Foundation (I-1544), a Sara and Frank McKnight Graduate Fellowship (to S.F.B.), and the NSF (1000196079; to A.M.R.).	Antolini F, 2003, PROTEIN EXPRES PURIF, V29, P94, DOI 10.1016/S1046-5928(03)00004-4; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Brand Peter, 2010, PMC Biophys, V3, P3, DOI 10.1186/1757-5036-3-3; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cappadocia L, 2015, STRUCTURE, V23, P126, DOI 10.1016/j.str.2014.10.015; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Chalupnikova K, 2008, J BIOL CHEM, V283, P35186, DOI 10.1074/jbc.M804857200; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chen YCM, 2008, MOL BIOL CELL, V19, P3147, DOI 10.1091/mbc.E08-01-0035; Chung I, 2011, J CELL SCI, V124, P3603, DOI 10.1242/jcs.084681; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Dellaire G, 2006, J CELL SCI, V119, P1034, DOI 10.1242/jcs.02817; Dundr M, 2004, J CELL BIOL, V164, P831, DOI 10.1083/jcb.200311121; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Everett RD, 1999, J CELL SCI, V112, P4581; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Fong KW, 2013, J CELL BIOL, V203, P149, DOI 10.1083/jcb.201303145; Fromm SA, 2014, ANGEW CHEM INT EDIT, V53, P7354, DOI 10.1002/anie.201402885; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; Handwerger KE, 2005, MOL BIOL CELL, V16, P202, DOI 10.1091/mbc.E04-08-0742; Hattersley N, 2011, MOL BIOL CELL, V22, P78, DOI 10.1091/mbc.E10-06-0504; He XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123882; Huang SY, 2014, J BIOMOL NMR, V60, P275, DOI 10.1007/s10858-014-9869-4; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; ISHOV AM, 1999, J CELL BIOL, V147, P221, DOI [10.1083/jcb.147.2.221, DOI 10.1083/JCB.147.2.221]; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jain S, 2013, ADV EXP MED BIOL, V768, P23, DOI 10.1007/978-1-4614-5107-5_3; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Mitrea DM, 2016, ELIFE, V5, DOI 10.7554/eLife.13571; Mohamad N, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-44; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Muller S, 1999, J VIROL, V73, P5137; Nisole S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00125; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Rojas-Fernandez A, 2014, MOL CELL, V53, P880, DOI 10.1016/j.molcel.2014.02.031; Sahin U, 2014, J CELL BIOL, V204, P931, DOI 10.1083/jcb.201305148; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	67	546	551	10	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					651	663		10.1016/j.cell.2016.06.010	http://dx.doi.org/10.1016/j.cell.2016.06.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27374333	Green Accepted, Bronze			2022-12-24	WOS:000380546500016
J	Zhang, J; Tan, LB; Ren, YQ; Liang, JW; Lin, R; Feng, QR; Zhou, JF; Hu, F; Ren, J; Wei, C; Yu, T; Zhuang, YH; Bettler, B; Wang, FC; Luo, MM				Zhang, Juen; Tan, Lubin; Ren, Yuqi; Liang, Jingwen; Lin, Rui; Feng, Qiru; Zhou, Jingfeng; Hu, Fei; Ren, Jing; Wei, Chao; Yu, Tao; Zhuang, Yinghua; Bettler, Bernhard; Wang, Fengchao; Luo, Minmin			Presynaptic Excitation via GABAB Receptors in Habenula Cholinergic Neurons Regulates Fear Memory Expression	CELL			English	Article							CA2+ CHANNELS; TRANSMISSION; CIRCUITS; HIPPOCAMPAL; INHIBITION; BACLOFEN; SUBUNIT; ANXIETY; LOCALIZATION; EXTINCTION	Fear behaviors are regulated by adaptive mechanisms that dampen their expression in the absence of danger. By studying circuits and the molecular mechanisms underlying this adaptive response, we show that cholinergic neurons of the medial habenula reduce fear memory expression through GABA(B) presynaptic excitation. Ablating these neurons or inactivating their GABA(B) receptors impairs fear extinction in mice, whereas activating the neurons or their axonal GABA(B) receptors reduces conditioned fear. Although considered exclusively inhibitory, here, GABA(B) mediates excitation by amplifying presynaptic Ca2+ entry through Ca-v2.3 channels and potentiating co-release of glutamate, acetylcholine, and neurokinin B to excite interpeduncular neurons. Activating the receptors for these neurotransmitters or enhancing neurotransmission with a phosphodiesterase inhibitor reduces fear responses of both wild-type and GABA(B) mutant mice. We identify the role of an extra-amygdalar circuit and presynaptic GABA(B) receptors in fear control, suggesting that boosting neurotransmission in this pathway might ameliorate some fear disorders.	[Zhang, Juen; Tan, Lubin; Luo, Minmin] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Zhang, Juen; Tan, Lubin; Ren, Yuqi; Liang, Jingwen; Lin, Rui; Feng, Qiru; Zhou, Jingfeng; Hu, Fei; Ren, Jing; Wei, Chao; Yu, Tao; Zhuang, Yinghua; Wang, Fengchao; Luo, Minmin] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Ren, Yuqi; Lin, Rui; Zhou, Jingfeng] Peking Univ, PTN Grad Program, Sch Life Sci, Beijing 100081, Peoples R China; [Bettler, Bernhard] Univ Basel, Inst Physiol, Dept Biomed, Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	Tsinghua University; National Institute of Biological Sciences, Beijing; Peking University; University of Basel	Luo, MM (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Luo, MM (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	luominmin@nibs.ac.cn	bettler, bernhard/AAO-8018-2020; Ren, Jing/ABA-8444-2020	Hu, Fei/0000-0001-7827-9548; , Jingwen/0000-0002-9402-2010; Bettler, Bernhard/0000-0003-0842-8207; Lin, Rui/0000-0003-1044-883X; Luo, Minmin/0000-0003-3535-6624; Ren, Jing/0000-0002-6665-7457	China MOST [2012CB837701, 2012YQ03026005, 2013ZX0950910, 2015BAI08B02]; NNSFC [91432114]; Beijing Municipal Government	China MOST(Ministry of Science and Technology, China); NNSFC(National Natural Science Foundation of China (NSFC)); Beijing Municipal Government	We thank G. Feng (Massachusetts Institute of Technology) for the ChAT-ChR2-EYFP and VGAT-ChR2-EYFP transgenic mice, D. Duan (University of Missouri) for advice on AAV virus preparation, Y. Li (Peking University) for anti-synaptophysin1 antibody, and P. Sterling (University of Pennsylvania), G. Marsicano (INSERM), and D. Perkel (University of Washington) for comments and discussions. M.L. is supported by China MOST (2012CB837701, 2012YQ03026005, 2013ZX0950910, 2015BAI08B02), NNSFC (91432114), and the Beijing Municipal Government.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; Dorocic IP, 2014, NEURON, V83, P663, DOI 10.1016/j.neuron.2014.07.002; Drake RG, 2003, ANN PHARMACOTHER, V37, P1177, DOI 10.1345/aph.1C465; DUTAR P, 1988, NEURON, V1, P585, DOI 10.1016/0896-6273(88)90108-0; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Frahmm S, 2015, ELIFE, V4, DOI 10.7554/eLife.11396; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Goto M, 2001, J COMP NEUROL, V438, P86, DOI 10.1002/cne.1303; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Hsu YWA, 2013, J NEUROSCI, V33, P18022, DOI 10.1523/JNEUROSCI.2927-13.2013; Hu F, 2012, P NATL ACAD SCI USA, V109, P17681, DOI 10.1073/pnas.1209185109; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Kajikawa Y, 2001, P NATL ACAD SCI USA, V98, P8054, DOI 10.1073/pnas.141031298; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kobayashi Y, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00017; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee A, 2010, CURR BIOL, V20, P2211, DOI 10.1016/j.cub.2010.11.025; Li Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10503; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Manteghi AA, 2014, J CLIN PSYCHOPHARM, V34, P240, DOI 10.1097/JCP.0000000000000089; Margeta-Mitrovic M, 1999, J COMP NEUROL, V405, P299, DOI 10.1002/(SICI)1096-9861(19990315)405:3<299::AID-CNE2>3.0.CO;2-6; MARKSTEINER J, 1992, J COMP NEUROL, V317, P341, DOI 10.1002/cne.903170403; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; NEWBERRY NR, 1984, NATURE, V308, P450, DOI 10.1038/308450a0; Parajuli LK, 2012, J NEUROSCI, V32, P13555, DOI 10.1523/JNEUROSCI.1142-12.2012; Qin C, 2009, NEUROSCIENCE, V161, P827, DOI 10.1016/j.neuroscience.2009.03.085; Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038; Sochivko D, 2002, J PHYSIOL-LONDON, V542, P699, DOI 10.1113/jphysiol.2002.020677; Soria-Gomez E, 2015, NEURON, V88, P306, DOI 10.1016/j.neuron.2015.08.035; Stein DJ, 2000, INT CLIN PSYCHOPHARM, V15, pS31, DOI 10.1097/00004850-200008002-00006; Stephenson-Jones M, 2012, P NATL ACAD SCI USA, V109, pE164, DOI 10.1073/pnas.1119348109; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; VanElzakker MB, 2014, NEUROBIOL LEARN MEM, V113, P3, DOI 10.1016/j.nlm.2013.11.014; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; WU LG, 1995, J PHYSIOL-LONDON, V485, P649, DOI 10.1113/jphysiol.1995.sp020759; Yamaguchi T, 2013, NEURON, V78, P537, DOI 10.1016/j.neuron.2013.02.035; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	50	91	96	5	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					716	728		10.1016/j.cell.2016.06.026	http://dx.doi.org/10.1016/j.cell.2016.06.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27426949	Bronze			2022-12-24	WOS:000380546500021
J	van den Belt-Dusebout, AW; Spaan, M; Lambalk, CB; Kortman, M; Laven, JSE; van Santbrink, EJP; van der Westerlaken, LAJ; Cohlen, BJ; Braat, DDM; Smeenk, JMJ; Land, JA; Goddijn, M; van Golde, RJT; van Rumste, MM; Schats, R; Jozwiak, K; Hauptmann, M; Rookus, MA; Burger, CW; van Leeuwen, FE				van den Belt-Dusebout, Alexandra W.; Spaan, Mandy; Lambalk, Cornelis B.; Kortman, Marian; Laven, Joop S. E.; van Santbrink, Evert J. P.; van der Westerlaken, Lucette A. J.; Cohlen, Ben J.; Braat, Didi D. M.; Smeenk, Jesper M. J.; Land, Jolande A.; Goddijn, Mariette; van Golde, Ron J. T.; van Rumste, Minouche M.; Schats, Roel; Jozwiak, Katarzyna; Hauptmann, Michael; Rookus, Matti A.; Burger, Curt W.; van Leeuwen, Flora E.			Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FERTILITY DRUGS; IVF; WOMEN; PREGNANCY; GONADOTROPIN; EXPOSURE; REGISTRY; HORMONE; HEALTH; COHORT	IMPORTANCE Previous studies of breast cancer risk after in vitro fertilization (IVF) treatment were inconclusive due to limited follow-up. OBJECTIVE To assess long-term risk of breast cancer after ovarian stimulation for IVF. DESIGN, SETTING, AND PARTICIPANTS Historical cohort (OMEGA study) with complete follow-up through December 2013 for 96% of the cohort. The cohort included 19 158 women who started IVF treatment between 1983 and 1995 (IVF group) and 5950 women starting other fertility treatments between 1980 and 1995 (non-IVF group) from all 12 IVF clinics in the Netherlands. The median age at end of follow-up was 53.8 years for the IVF group and 55.3 years for the non-IVF group. EXPOSURES Information on ovarian stimulation for IVF, other fertility treatments, and potential confounders was collected from medical records and through mailed questionnaires. MAIN OUTCOMES AND MEASURES Incidence of invasive and in situ breast cancers in women who underwent fertility treatments was obtained through linkage with the Netherlands Cancer Registry (1989-2013). Breast cancer risk in the IVF group was compared with risks in the general population (standardized incidence ratios [SIRs]) and the non-IVF group (hazard ratios [HRs]). RESULTS Among 25 108 women (mean age at baseline, 32.8 years; mean number of IVF cycles, 3.6), 839 cases of invasive breast cancer and 109 cases of in situ breast cancer occurred after a median follow-up of 21.1 years. Breast cancer risk in IVF-treated women was not significantly different from that in the general population (SIR, 1.01 [95% CI, 0.93-1.09]) and from the risk in the non-IVF group (HR, 1.01 [95% CI, 0.86-1.19]). The cumulative incidences of breast cancer at age 55 were 3.0% for the IVF group and 2.9% for the non-IVF group (P = .85). The SIR did not increase with longer time since treatment (>= 20 years) in the IVF group (0.92 [95% CI, 0.73-1.15]) or in the non-IVF group (1.03 [95% CI, 0.82-1.29]). Risk was significantly lower for those who underwent 7 or more IVF cycles (HR, 0.55 [95% CI, 0.39-0.77]) vs 1 to 2 IVF cycles and after poor response to the first IVF cycle (HR, 0.77 [95% CI, 0.61-0.96] for <4 vs >= 4 collected oocytes). CONCLUSIONS AND RELEVANCE Among women undergoing fertility treatment in the Netherlands between 1980 and 1995, IVF treatment compared with non-IVF treatment was not associated with increased risk of breast cancer after a median follow-up of 21 years. Breast cancer risk among IVF-treated women was also not significantly different from that in the general population. These findings are consistent with absence of a significant increase in long-term risk of breast cancer among IVF-treated women.	[van den Belt-Dusebout, Alexandra W.; Spaan, Mandy; Jozwiak, Katarzyna; Hauptmann, Michael; Rookus, Matti A.; van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Lambalk, Cornelis B.; Schats, Roel] Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands; [Kortman, Marian] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Laven, Joop S. E.; Burger, Curt W.] Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands; [van Santbrink, Evert J. P.] Reinier de Graaf Hosp, Dept Reprod Med, Voorburg, Netherlands; [van der Westerlaken, Lucette A. J.] Leiden Univ, Med Ctr, Dept Obstet Gynecol & Reprod Med, Leiden, Netherlands; [Cohlen, Ben J.] Isala Clin, Dept Obstet & Gynecol, Zwolle, Netherlands; [Braat, Didi D. M.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, Nijmegen, Netherlands; [Smeenk, Jesper M. J.] St Elizabeth Hosp, Dept Obstet & Gynecol, Tilburg, Netherlands; [Land, Jolande A.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Goddijn, Mariette] Acad Med Ctr, Dept Obstet & Gynecol, Ctr Reprod Med, Amsterdam, Netherlands; [van Golde, Ron J. T.] Maastricht Univ, Med Ctr, Dept Obstet & Gynecol, Maastricht, Netherlands; [van Rumste, Minouche M.] Catharina Hosp, Dept Obstet & Gynecol, Eindhoven, Netherlands	Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Reinier de Graaf Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Isala Clinics; Radboud University Nijmegen; Elisabeth-TweeSteden Ziekenhuis (ETZ); University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Catharina Hospital	van Leeuwen, FE (corresponding author), Netherlands Canc Inst, Dept Epidemiol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	f.v.leeuwen@nki.nl	Hauptmann, Michael/AAQ-8420-2021; Braat, D.D.M./H-8017-2014	Hauptmann, Michael/0000-0001-8539-0148; Lambalk, Cornelis/0000-0003-3947-5129; Goddijn, Mariette/0000-0001-9928-9673; Jozwiak, Katarzyna/0000-0002-9614-6586; Smeenk, Jesper/0000-0002-3053-0358	Dutch Cancer Society [NKI 2006-3631]; Health Research and Development Counsel [28-2540]; Dutch Ministry of Health	Dutch Cancer Society(KWF Kankerbestrijding); Health Research and Development Counsel; Dutch Ministry of Health	This work was supported by the Dutch Cancer Society (NKI 2006-3631); the Health Research and Development Counsel (28-2540); and the Dutch Ministry of Health.	Albrektsen G, 2005, BRIT J CANCER, V92, P167, DOI 10.1038/sj.bjc.6602302; Beckers NGM, 2000, HUM REPROD, V15, P43, DOI 10.1093/humrep/15.1.43; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; BERNSTEIN L, 1995, CANCER EPIDEM BIOMAR, V4, P437; Bernstein L, 2002, J MAMMARY GLAND BIOL, V7, P3, DOI 10.1023/A:1015714305420; Boukaidi SA, 2012, FERTIL STERIL, V97, P440, DOI 10.1016/j.fertnstert.2011.11.020; Breslow N E, 1987, IARC Sci Publ, P1; Brinton LA, 2013, FERTIL STERIL, V99, P1189, DOI 10.1016/j.fertnstert.2012.12.029; Burkman RT, 2003, FERTIL STERIL, V79, P844, DOI 10.1016/S0015-0282(02)04950-6; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Cooley A, 2012, HUM REPROD, V27, P146, DOI 10.1093/humrep/der378; De Boer E J, 2004, Ned Tijdschr Geneeskd, V148, P1448; de Boer EJ, 2003, HUM REPROD, V18, P1544, DOI 10.1093/humrep/deg278; Forman D, 2014, IARC SCI PUBL, VX; Hensher D, 1979, BEHAV TRAVEL MODELLI; Jensen A, 2007, CANCER EPIDEM BIOMAR, V16, P1400, DOI 10.1158/1055-9965.EPI-07-0075; Joo BS, 2010, FERTIL STERIL, V93, P442, DOI 10.1016/j.fertnstert.2009.02.066; Katz D, 2008, BREAST J, V14, P517, DOI 10.1111/j.1524-4741.2008.00641.x; Klip H, 2001, HUM REPROD, V16, P2451, DOI 10.1093/humrep/16.11.2451; Krul IM, 2015, EUR J CANCER, V51, P112, DOI 10.1016/j.ejca.2014.10.018; Li F, 2013, STAT MED, V32, P3373, DOI 10.1002/sim.5786; Lo Russo G, 2013, EXPERT REV ANTICANC, V13, P149, DOI [10.1586/era.12.181, 10.1586/ERA.12.181]; Pappo I, 2008, ANN SURG ONCOL, V15, P1048, DOI 10.1245/s10434-007-9800-2; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Reigstad MM, 2015, INT J CANCER, V136, P1140, DOI 10.1002/ijc.29069; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; RUSSO IH, 1994, INT J ONCOL, V4, P297; Russo J, 2005, CLIN CANCER RES, V11, p931S; Sergentanis TN, 2014, HUM REPROD UPDATE, V20, P106, DOI 10.1093/humupd/dmt034; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21332, 10.3322/caac.21590, 10.3322/caac.21708]; Spaan M, 2015, HUM REPROD, V30, P1216, DOI 10.1093/humrep/dev023; Stewart LM, 2015, WOMENS HEALTH, V11, P7, DOI [10.2217/whe.14.58, 10.2217/WHE.14.58]; Stewart LM, 2012, FERTIL STERIL, V98, P334, DOI 10.1016/j.fertnstert.2012.04.019; Sunderam S, 2014, MMWR SURVEILL SUMM, V63, P1; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van Leeuwen FE, 2011, HUM REPROD, V26, P3456, DOI 10.1093/humrep/der322; VANDENBRANDT PA, 1990, INT J EPIDEMIOL, V19, P553; Venn A, 1999, LANCET, V354, P1586, DOI 10.1016/S0140-6736(99)05203-4; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; Zreik TG, 2010, BREAST CANCER RES TR, V124, P13, DOI 10.1007/s10549-010-1140-4	40	45	46	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2016	316	3					300	312		10.1001/jama.2016.9389	http://dx.doi.org/10.1001/jama.2016.9389			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR3LN	27434442	Bronze			2022-12-24	WOS:000379804800018
J	Mogil, JS				Mogil, Jeffrey S.			PERSPECTIVE Equality need not be painful	NATURE			English	Editorial Material							SEX-DIFFERENCES; ANALGESIA; STRESS		[Mogil, Jeffrey S.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Mogil, Jeffrey S.] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada	McGill University; McGill University	Mogil, JS (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.; Mogil, JS (corresponding author), McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada.	jeffrey.mogil@mcgill.ca	Mogil, Jeffrey/AAA-9611-2019	Mogil, Jeffrey/0000-0003-1359-5720				Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; MOGIL JS, 1993, PAIN, V53, P17, DOI 10.1016/0304-3959(93)90050-Y; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]	8	34	36	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					S7	S7		10.1038/535S7a	http://dx.doi.org/10.1038/535S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR4ZN	27410531	Bronze			2022-12-24	WOS:000379912600006
J	Watson, R				Watson, Rory			Health groups demand closure of Europe's coal fired power stations	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2016, EUROPES DARK CLOUD C; Vidal J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6885	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2016	354								i3752	10.1136/bmj.i3752	http://dx.doi.org/10.1136/bmj.i3752			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EG	27381196				2022-12-24	WOS:000379580200013
J	Mayor, S				Mayor, Susan			GPs should have direct access to wider range of tests for suspected cancer, says NICE	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, 2015, SUSP CANC REC REF NG; National Institute for Health and Care Excellence, 2016, SUSP CANC QUAL STAND	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2016	354								i3686	10.1136/bmj.i3686	http://dx.doi.org/10.1136/bmj.i3686			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EA	27378684				2022-12-24	WOS:000379579600003
J	Golden, SA; Heshmati, M; Flanigan, M; Christoffel, DJ; Guise, K; Pfau, ML; Aleyasin, H; Menard, C; Zhang, HX; Hodes, GE; Bregman, D; Khibnik, L; Tai, J; Rebusi, N; Krawitz, B; Chaudhury, D; Walsh, JJ; Han, MH; Shapiro, ML; Russo, SJ				Golden, Sam A.; Heshmati, Mitra; Flanigan, Meghan; Christoffel, Daniel J.; Guise, Kevin; Pfau, Madeline L.; Aleyasin, Hossein; Menard, Caroline; Zhang, Hongxing; Hodes, Georgia E.; Bregman, Dana; Khibnik, Lena; Tai, Jonathan; Rebusi, Nicole; Krawitz, Brian; Chaudhury, Dipesh; Walsh, Jessica J.; Han, Ming-Hu; Shapiro, Matt L.; Russo, Scott J.			Basal forebrain projections to the lateral habenula modulate aggression reward	NATURE			English	Article							DEEP BRAIN-STIMULATION; OPTOGENETIC INHIBITION; SOCIAL DEFEAT; NEURONS; DEPRESSION; NUCLEUS; STRESS; BEHAVIOR; ACTIVATION; EXPERIENCE	Maladaptive aggressive behaviour is associated with a number of neuropsychiatric disorders(1) and is thought to result partly from the inappropriate activation of brain reward systems in response to aggressive or violent social stimuli(2). Nuclei within the ventromedial hypothalamus(3-5), extended amygdala(6) and limbic(7) circuits are known to encode initiation of aggression; however, little is known about the neural mechanisms that directly modulate the motivational component of aggressive behaviour(8). Here we established a mouse model to measure the valence of aggressive inter-male social interaction with a smaller subordinate intruder as reinforcement for the development of conditioned place preference (CPP). Aggressors develop a CPP, whereas non-aggressors develop a conditioned place aversion to the intruder-paired context. Furthermore, we identify a functional GABAergic projection from the basal forebrain (BF) to the lateral habenula (lHb) that bi-directionally controls the valence of aggressive interactions. Circuit-specific silencing of GABAergic BF-lHb terminals of aggressors with halorhodopsin (NpHR3.0) increases lHb neuronal firing and abolishes CPP to the intruder-paired context. Activation of GABAergic BF-lHb terminals of non-aggressors with channelrhodopsin (ChR2) decreases lHb neuronal firing and promotes CPP to the intruder-paired context. Finally, we show that altering inhibitory transmission at BF-lHb terminals does not control the initiation of aggressive behaviour. These results demonstrate that the BF-lHb circuit has a critical role in regulating the valence of inter-male aggressive behaviour and provide novel mechanistic insight into the neural circuits modulating aggression reward processing.	[Golden, Sam A.; Heshmati, Mitra; Flanigan, Meghan; Guise, Kevin; Pfau, Madeline L.; Aleyasin, Hossein; Menard, Caroline; Hodes, Georgia E.; Bregman, Dana; Khibnik, Lena; Tai, Jonathan; Rebusi, Nicole; Krawitz, Brian; Han, Ming-Hu; Shapiro, Matt L.; Russo, Scott J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Golden, Sam A.; Heshmati, Mitra; Flanigan, Meghan; Guise, Kevin; Pfau, Madeline L.; Aleyasin, Hossein; Menard, Caroline; Hodes, Georgia E.; Bregman, Dana; Khibnik, Lena; Tai, Jonathan; Rebusi, Nicole; Krawitz, Brian; Han, Ming-Hu; Shapiro, Matt L.; Russo, Scott J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Golden, Sam A.; Heshmati, Mitra; Flanigan, Meghan; Guise, Kevin; Pfau, Madeline L.; Krawitz, Brian] Icahn Sch Med Mt Sinai, Grad Program Neurosci, New York, NY 10029 USA; [Christoffel, Daniel J.; Walsh, Jessica J.] Stanford Univ, Med Ctr, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA; [Zhang, Hongxing; Chaudhury, Dipesh; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Zhang, Hongxing; Chaudhury, Dipesh; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Inst Syst Biomed, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stanford University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Russo, SJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.; Russo, SJ (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.	scott.russo@mssm.edu	Menard, Caroline/AAV-4017-2020; Core, Vector/CAF-4832-2022; Han, Ming-Hu/G-8836-2012; Russo, Scott/R-7107-2019; Hodes, Georgia/L-8022-2016	Menard, Caroline/0000-0001-8202-7378; Russo, Scott/0000-0002-6470-1805; Hodes, Georgia/0000-0002-1551-2178; Christoffel, Dan/0000-0002-6303-5134; Flanigan, Meghan/0000-0002-3185-7459; Golden, Sam/0000-0002-2104-2272; Walsh, Jessica/0000-0001-8466-8451	US National Institutes of Health [R01 MH090264, P50 MH096890, P50 AT008661-01, R01 MH092306, T32 MH087004, T32 MH096678, F30 MH100835, F31 MH105217]; National Institute of General Medical Sciences [1FI2GM117583-01]; Natural National Science Foundation of China [81200862]; National Center for Complementary & Integrative Health [P50AT008661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [FI2GM117583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092306, T32MH096678, R01MH073689, R01MH090264, F30MH100835, P50MH096890, T32MH087004, R01MH104559, F31MH105217, R21MH112081] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by US National Institutes of Health grants R01 MH090264, P50 MH096890 and P50 AT008661-01 (S.J.R.), R01 MH092306 (M.H.H.), T32 MH087004 (M.L.P., M.H. and M.F.), T32 MH096678 (M.L.P.), F30 MH100835 (M.H.), F31 MH105217 (M.L.P.), National Institute of General Medical Sciences 1FI2GM117583-01 (S.A.G.) and the Natural National Science Foundation of China 81200862 (H.Z.). We would like to thank K. Miczek and Y. Shaham for their input.	Anderson DJ, 2012, BIOL PSYCHIAT, V71, P1081, DOI 10.1016/j.biopsych.2011.11.012; Aquili L, 2014, LEARN MEMORY, V21, P223, DOI 10.1101/lm.034199.113; Beck Anne, 2014, Curr Top Behav Neurosci, V17, P443, DOI 10.1007/7854_2013_258; Bewernick BH, 2012, NEUROPSYCHOPHARMACOL, V37, P1975, DOI 10.1038/npp.2012.44; Callaway EM, 2015, J NEUROSCI, V35, P8979, DOI 10.1523/JNEUROSCI.0409-15.2015; Chandra R, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00013; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Felton TM, 1999, NEUROREPORT, V10, P883, DOI 10.1097/00001756-199903170-00039; Friedman AK, 2014, SCIENCE, V344, P313, DOI 10.1126/science.1249240; Glenn AL, 2012, BIOL PSYCHIAT, V72, P817, DOI 10.1016/j.biopsych.2012.04.027; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Golden SA, 2013, NAT MED, V19, P337, DOI 10.1038/nm.3090; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kudryavtseva NN, 2002, BEHAV BRAIN RES, V133, P83, DOI 10.1016/S0166-4328(01)00443-0; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lecca S, 2014, EUR J NEUROSCI, V39, P1170, DOI 10.1111/ejn.12480; LEE EHY, 1988, BEHAV BRAIN RES, V30, P265, DOI 10.1016/0166-4328(88)90169-6; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lobo MK, 2013, J NEUROSCI, V33, P18381, DOI 10.1523/JNEUROSCI.1875-13.2013; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Maroteaux M, 2012, J NEUROSCI, V32, P12641, DOI 10.1523/JNEUROSCI.2405-12.2012; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; Miczek K A, 1984, Prog Clin Biol Res, V167, P1; Quina LA, 2015, J COMP NEUROL, V523, P32, DOI 10.1002/cne.23662; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; Shelton L, 2012, J NEUROPHYSIOL, V107, P2633, DOI 10.1152/jn.00012.2012; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; TAKAHASHI A, 2013, CURR TOP BEHAV NEURO, V17, P3, DOI DOI 10.1007/7854_2013_263; Unger EK, 2015, CELL REP, V10, P453, DOI 10.1016/j.celrep.2014.12.040; WASMAN M, 1962, ARCH NEUROL-CHICAGO, V6, P220, DOI 10.1001/archneur.1962.00450210048005; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yetnikoff L, 2015, J COMP NEUROL, V523, P2426, DOI 10.1002/cne.23797; Yu Q, 2014, MOL PSYCHIATR, V19, P635, DOI 10.1038/mp.2014.45; Zahm DS, 2013, J COMP NEUROL, V521, P50, DOI 10.1002/cne.23157	44	120	120	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					688	+		10.1038/nature18601	http://dx.doi.org/10.1038/nature18601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357796	Green Accepted			2022-12-24	WOS:000378676000037
J	Tilg, H				Tilg, Herbert			A Gut Feeling about Thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ATHEROSCLEROSIS; RISK		[Tilg, Herbert] Med Univ Innsbruck, Dept Internal Med Gastroenterol Endocrinol & Meta, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Tilg, H (corresponding author), Med Univ Innsbruck, Dept Internal Med Gastroenterol Endocrinol & Meta, A-6020 Innsbruck, Austria.							Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Warrier M, 2015, CELL REP; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	5	37	46	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2494	2496		10.1056/NEJMcibr1604458	http://dx.doi.org/10.1056/NEJMcibr1604458			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1TG	27332910				2022-12-24	WOS:000378271700015
J	Lewnard, JA; Gonsalves, G; Ko, AI				Lewnard, Joseph A.; Gonsalves, Gregg; Ko, Albert I.			Low Risk of International Zika Virus Spread due to the 2016 Olympics in Brazil	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RIO-DE-JANEIRO; GAMES		Global Hlth Justice Partnership, Yale Sch Publ Hlth, New Haven, CT USA; Yale Univ, Yale Law Sch, New Haven, CT USA; Minist Saude, Salvador, BA, Brazil; [Lewnard, Joseph A.; Ko, Albert I.] Yale Sch Publ Hlth, 60 Coll St,Suite 710, New Haven, CT 06520 USA; [Gonsalves, Gregg] Yale Global Hlth Justice Partnership, POB 208215, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Lewnard, JA (corresponding author), Yale Sch Publ Hlth, 60 Coll St,Suite 710, New Haven, CT 06520 USA.	joseph.lewnard@yale.edu	Ko, Albert/P-2343-2015	Ko, Albert/0000-0001-9023-2339; Gonsalves, Gregg/0000-0002-5789-9841	FOGARTY INTERNATIONAL CENTER [R01TW009504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121207] Funding Source: NIH RePORTER; FIC NIH HHS [R01 TW009504] Funding Source: Medline; NIAID NIH HHS [R01 AI121207] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Attaran A, COMMUNICATION; Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US 2015; Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003; Eberhardt KA, 2016, TRAVEL MED INFECT DI, V14, P212, DOI 10.1016/j.tmaid.2016.05.014; Lessler J, 2016, B WORLD HEALTH ORGAN, P1; Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X; Secretaria de Vigilancia em Saude (Ministerio da Saude do Brasil), 2015, B EPIDEMIOL, V46, P1; Secretaria de Vigilancia em Saude-Ministerio da Saude, PROT VIG RESP OC MIC; Secretaria Nacional de Politicas de Turismo, 2015, AN EST TUR 2015	9	13	13	1	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					286	+		10.7326/M16-1628	http://dx.doi.org/10.7326/M16-1628			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27454521	Green Accepted			2022-12-24	WOS:000381267200019
J	Jourjine, N; Mullaney, BC; Mann, K; Scott, K				Jourjine, Nicholas; Mullaney, Brendan C.; Mann, Kevin; Scott, Kristin			Coupled Sensing of Hunger and Thirst Signals Balances Sugar and Water Consumption	CELL			English	Article							DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; OSMOTIC REGULATION; ADULT DROSOPHILA; NUTRIENT SENSOR; HOMEOSTASIS; DOPAMINE; NANCHUNG; CHANNELS; NEURONS	Hunger and thirst are ancient homeostatic drives for food and water consumption. Although molecular and neural mechanisms underlying these drives are currently being uncovered, less is known about how hunger and thirst interact. Here, we use molecular genetic, behavioral, and anatomical studies in Drosophila to identify four neurons that modulate food and water consumption. Activation of these neurons promotes sugar consumption and restricts water consumption, whereas inactivation promotes water consumption and restricts sugar consumption. By calciumimaging studies, we show that these neurons are directly regulated by a hormone signal of nutrient levels and by osmolality. Finally, we identify a hormone receptor and an osmolality-sensitive ion channel that underlie this regulation. Thus, a small population of neurons senses internal signals of nutrient and water availability to balance sugar and water consumption. Our results suggest an elegant mechanism by which interoceptive neurons oppositely regulate homeostatic drives to eat and drink.	[Jourjine, Nicholas; Mullaney, Brendan C.; Mann, Kevin; Scott, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Jourjine, Nicholas; Mullaney, Brendan C.; Mann, Kevin; Scott, Kristin] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Mann, Kevin] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Scott, K (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	kscott@berkeley.edu			NIH [R01 DK098747]; NSF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098747, F32DK009874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The K.S. lab provided comments on the manuscript. Dr. B. Rubinksy provided materials for osmolality measurements. This work was supported by a grant from the NIH (R01 DK098747 to K.S.) and an NSF predoctoral fellowship (to N.J.).	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Albers MA, 2004, J EXP BIOL, V207, P2313, DOI 10.1242/jeb.01024; ARAV A, 1994, AM J PHYSIOL-REG I, V267, pR1646, DOI 10.1152/ajpregu.1994.267.6.R1646; Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; Bjordal M, 2014, CELL, V156, P510, DOI 10.1016/j.cell.2013.12.024; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Candy DJ, 2002, INSECT BIOCHEM MOLEC, V32, P1361, DOI 10.1016/S0965-1748(02)00056-5; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dethier V., 1976, THE HUNGRY FLY; Dus M, 2015, NEURON, V87, P139, DOI 10.1016/j.neuron.2015.05.032; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; GUTMAN Y, 1969, PHYSIOL BEHAV, V4, P311, DOI 10.1016/0031-9384(69)90181-4; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Harris DT, 2015, NEURON, V86, P1449, DOI 10.1016/j.neuron.2015.05.026; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Inagaki HK, 2014, NEURON, V84, P806, DOI 10.1016/j.neuron.2014.09.032; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Limmer S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00365; Lin SW, 2014, NAT NEUROSCI, V17, P1536, DOI 10.1038/nn.3827; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Liu YT, 2015, J COMP NEUROL, V523, P1840, DOI 10.1002/cne.23768; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; Mietlicki EG, 2009, PHYSIOL BEHAV, V96, P37, DOI 10.1016/j.physbeh.2008.08.004; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Na JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003175; Paluzzi JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086386; Pool AH, 2014, NEURON, V83, P164, DOI 10.1016/j.neuron.2014.05.006; Sellami A, 2011, GEN COMP ENDOCR, V170, P582, DOI 10.1016/j.ygcen.2010.11.015; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Zhang W, 2013, P NATL ACAD SCI USA, V110, P13612, DOI 10.1073/pnas.1312477110	43	77	77	3	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					855	866		10.1016/j.cell.2016.06.046	http://dx.doi.org/10.1016/j.cell.2016.06.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27477513	Green Accepted, Bronze			2022-12-24	WOS:000382258700010
J	Zhao, HY; Fernandez, E; Dowd, KA; Speer, SD; Platt, DJ; Gorman, MJ; Govero, J; Nelson, CA; Pierson, TC; Diamond, MS; Fremont, DH				Zhao, Haiyan; Fernandez, Estefania; Dowd, Kimberly A.; Speer, Scott D.; Platt, Derek J.; Gorman, Matthew J.; Govero, Jennifer; Nelson, Christopher A.; Pierson, Theodore C.; Diamond, Michael S.; Fremont, Daved H.			Structural Basis of Zika Virus-Specific Antibody Protection	CELL			English	Article							WEST-NILE-VIRUS; CROSS-REACTIVE ANTIBODIES; DENGUE VIRUS; DOMAIN-III; MONOCLONAL-ANTIBODY; FUSION-LOOP; NEUTRALIZATION; RECOGNITION; INFECTION; MOUSE	Zika virus (ZIKV) infection during pregnancy has emerged as a global public health problem because of its ability to cause severe congenital disease. Here, we developed six mouse monoclonal antibodies (mAbs) against ZIKV including four (ZV-48, ZV-54, ZV-64, and ZV-67) that were ZIKV specific and neutralized infection of African, Asian, and American strains to varying degrees. X-ray crystallographic and competition binding analyses of Fab fragments and scFvs defined three spatially distinct epitopes in DIII of the envelope protein corresponding to the lateral ridge (ZV-54 and ZV-67), C-C' loop (ZV-48 and ZV-64), and ABDE sheet (ZV-2) regions. In vivo passive transfer studies revealed protective activity of DIII-lateral ridge specific neutralizing mAbs in a mouse model of ZIKV infection. Our results suggest that DIII is targeted by multiple type-specific antibodies with distinct neutralizing activity, which provides a path for developing prophylactic antibodies for use in pregnancy or designing epitope-specific vaccines against ZIKV.	[Zhao, Haiyan; Gorman, Matthew J.; Nelson, Christopher A.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Fernandez, Estefania; Platt, Derek J.; Govero, Jennifer; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.; Fremont, Daved H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Fremont, Daved H.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Nelson, Christopher A.; Diamond, Michael S.; Fremont, Daved H.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA; [Dowd, Kimberly A.; Speer, Scott D.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS; Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.; Diamond, MS; Fremont, DH (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.	diamond@borcim.wustl.edu; fremont@wustl.edu	Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Fremont, Daved/0000-0002-8544-2689; Platt, Derek/0000-0003-0766-4590; Dowd, Kimberly/0000-0003-3641-6852	NIH [R01 AI073755, R01 AI104972, T32 AI007163]; NIAID [HHSN272201400018C, HHSN272201200026C]; NIH Research Education Program [R25 HG006687]; NIAID; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R25HG006687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073755, ZIAAI001209, T32AI007163, R01AI104972] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Research Education Program; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01 AI073755 (to M.S.D. and D.H.F) and R01 AI104972 (to M.S.D.), and NIAID contracts HHSN272201400018C (to D.H.F. and M.S.D) and HHSN272201200026C (CSGID; to D.H.F.). E.F. and D.J.P. were supported by an NIH Pre-doctoral training grant award (T32 AI007163) and the NIH Research Education Program (R25 HG006687), respectively. K.A.D., S.D.S., and T.C.P. were funded by the intramural program of NIAID. We acknowledge Jay Nix (MBC 4.2.2 beamline at ALS Berkeley) for aid in remote data collection. M.S.D. consults for Inbios, Visterra, Sanofi, and Takeda Pharmaceuticals, is on the Scientific Advisory Boards of Moderna and OraGene, and has received research grants from Moderna, Sanofi, and Visterra.	Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15; Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111; Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14; Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107; Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103; Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055; Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Oehler E, 2014, Euro Surveill, V19; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Pierson TC., 2013, FIELDS VIROLOGY, V6th ed., P747; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116; Shi B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-30; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Smith S.A., 2013, MBIO, V4, pe13; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11	53	261	283	3	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					1016	1027		10.1016/j.cell.2016.07.020	http://dx.doi.org/10.1016/j.cell.2016.07.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27475895	Green Accepted, Bronze			2022-12-24	WOS:000382258700022
J	Afkarian, M; Zelnick, LR; Hall, YN; Heagerty, PJ; Tuttle, K; Weiss, NS; de Boer, IH				Afkarian, Maryam; Zelnick, Leila R.; Hall, Yoshio N.; Heagerty, Patrick J.; Tuttle, Katherine; Weiss, Noel S.; de Boer, Ian H.			Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; UNITED-STATES; COMPLICATIONS TRIAL; RENAL-INSUFFICIENCY; SERUM CREATININE; GLUCOSE CONTROL; BLOOD-PRESSURE; FOLLOW-UP; ALBUMINURIA; PROGRESSION	IMPORTANCE Diabetic kidney disease is the leading cause of chronic and end-stage kidney disease in the United States and worldwide. Changes in demographics and treatments may affect the prevalence and clinical manifestations of diabetic kidney disease. OBJECTIVE To characterize the clinical manifestations of kidney disease among US adults with diabetes over time. DESIGN, SETTING, AND PARTICIPANTS Serial cross-sectional studies of adults aged 20 years or older with diabetes mellitus participating in National Health and Nutrition Examination Surveys from 1988 through 2014. EXPOSURES Diabetes was defined as hemoglobin A(1c) greater than 6.5% or use of glucose-lowering medications. MAIN OUTCOMES AND MEASURES Albuminuria (urine albumin-to-creatinine ratio >= 30 mg/g), macroalbuminuria (urine albumin-to-creatinine ratio >= 300 mg/g), reduced estimated glomerular filtration rate (eGFR<60 mL/min/1.73 m(2)), and severely reduced eGFR (<30 mL/min/1.73 m(2)), incorporating data on biological variability to estimate the prevalence of persistent abnormalities. RESULTS There were 6251 adults with diabetes included (1431 from 1988-1994, 1443 from 1999-2004, 1280 from 2005-2008, and 2097 from 2009-2014). The prevalence of any diabetic kidney disease, defined as persistent albuminuria, persistent reduced eGFR, or both, did not significantly change over time from 28.4%(95% CI, 23.8%-32.9%) in 1988-1994 to 26.2%(95% CI, 22.6%-29.9%) in 2009-2014 (prevalence ratio, 0.95 [95% CI, 0.86-1.06] adjusting for age, sex, and race/ethnicity; P=.39 for trend). However, the prevalence of albuminuria decreased progressively over time from 20.8%(95% CI, 16.3%-25.3%) in 1988-1994 to 15.9%(95% CI, 12.7%-19.0%) in 2009-2014 (adjusted prevalence ratio, 0.76 [95% CI, 0.65-0.89]; P<.001 for trend). In contrast, the prevalence of reduced eGFR increased from 9.2%(95% CI, 6.2%-12.2%) in 1988-1994 to 14.1%(95% CI, 11.3%-17.0%) in 2009-2014 (adjusted prevalence ratio, 1.61 [95% CI, 1.33-1.95] comparing 2009-2014 with 1988-1994; P<.001 for trend), with a similar pattern for severely reduced eGFR (adjusted prevalence ratio, 2.86 [95% CI, 1.38-5.91]; P=.004 for trend). Significant heterogeneity in the temporal trend for albuminuria was noted by age (P=.049 for interaction) and race/ethnicity (P=.007 for interaction), with a decreasing prevalence of albuminuria observed only among adults younger than 65 years and non-Hispanic whites, whereas the prevalence of reduced GFR increased without significant differences by age or race/ethnicity. In 2009-2014, approximately 8.2 million adults with diabetes (95% CI, 6.5-9.9 million adults) had albuminuria, reduced eGFR, or both. CONCLUSIONS AND RELEVANCE Among US adults with diabetes from 1988 to 2014, the overall prevalence of diabetic kidney disease did not change significantly, whereas the prevalence of albuminuria declined and the prevalence of reduced eGFR increased.	[Afkarian, Maryam; Zelnick, Leila R.; Hall, Yoshio N.; Tuttle, Katherine; de Boer, Ian H.] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [Afkarian, Maryam; Zelnick, Leila R.; Hall, Yoshio N.; Tuttle, Katherine; de Boer, Ian H.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Heagerty, Patrick J.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Tuttle, Katherine] Providence Hlth Care, Spokane, WA USA; [Tuttle, Katherine] Univ Washington, Sch Med, Inst Translat Hlth Sci, Seattle, WA USA; [Weiss, Noel S.; de Boer, Ian H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	de Boer, IH (corresponding author), 325 Ninth Ave,Box 359606, Seattle, WA 98104 USA.	deboer@u.washington.edu	Hall, Yoshio/AAP-5723-2021; de Boer, Ian/GYJ-3282-2022	Tuttle, Katherine/0000-0002-2235-0103; Zelnick, Leila/0000-0002-8461-5111	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK087726, R01DK088762, R01DK099199, K23DK089017, R01DK104706]; National Institute of Clinical and Translational Sciences of the National Institutes of Health [UL1TR000423]; American Diabetes Association [4-15-CKD-20]; Northwest Kidney Centers; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002319, UL1TR000423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104706, R01DK088762, R01DK087726, R01DK099199, K23DK089017] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Clinical and Translational Sciences of the National Institutes of Health; American Diabetes Association(American Diabetes Association); Northwest Kidney Centers; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funding by grants R01DK087726, R01DK088762, R01DK099199, K23DK089017, and R01DK104706 from the National Institute of Diabetes and Digestive and Kidney Diseases, grant UL1TR000423 from the National Institute of Clinical and Translational Sciences, components of the National Institutes of Health, grant 4-15-CKD-20 from the American Diabetes Association, and unrestricted funding from Northwest Kidney Centers.	[Anonymous], LANG ENV STAT COMP; Bojestig M, 1996, DIABETES CARE, V19, P313, DOI 10.2337/diacare.19.4.313; Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258; Centers for Disease Control and Prevention (U.S.), NAT HLTH NUTR EX SUR; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Costacou T, 2007, AM J KIDNEY DIS, V50, P721, DOI 10.1053/j.ajkd.2007.08.005; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; de Boer IH, 2014, LANCET DIABETES ENDO, V2, P793, DOI 10.1016/S2213-8587(14)70155-X; de Boer IH, 2014, J AM SOC NEPHROL, V25, P2342, DOI 10.1681/ASN.2013091004; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Molitch ME, 2015, KIDNEY INT, V87, P20, DOI 10.1038/ki.2014.128; Molitch ME, 2010, DIABETES CARE, V33, P1536, DOI 10.2337/dc09-1098; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Perkins BA, 2010, KIDNEY INT, V77, P57, DOI 10.1038/ki.2009.399; Rossing P, 2005, KIDNEY INT, V68, P1446, DOI 10.1111/j.1523-1755.2005.00556.x; Rubin DB, 2004, MULTIPLE IMPUTATION; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Thomas MC, 2009, DIABETES CARE, V32, P1497, DOI 10.2337/dc08-2186; TSALAMANDRIS C, 1994, DIABETES, V43, P649, DOI 10.2337/diabetes.43.5.649; Tuttle KR, 2014, DIABETES CARE, V37, P2864, DOI 10.2337/dc14-1296; TUTTLE KR, 1990, SEMIN NEPHROL, V10, P184	31	565	598	3	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					602	610		10.1001/jama.2016.10924	http://dx.doi.org/10.1001/jama.2016.10924			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532915	Green Accepted, Bronze			2022-12-24	WOS:000380985600013
J	Bird, JG; Zhang, Y; Tian, Y; Panova, N; Barvik, I; Greene, L; Liu, M; Buckley, B; Krasny, L; Lee, JK; Kaplan, CD; Ebright, RH; Nickels, BE				Bird, Jeremy G.; Zhang, Yu; Tian, Yuan; Panova, Natalya; Barvik, Ivan; Greene, Landon; Liu, Min; Buckley, Brian; Krasny, Libor; Lee, Jeehiun K.; Kaplan, Craig D.; Ebright, Richard H.; Nickels, Bryce E.			The mechanism of RNA 5 ' capping with NAD(+), NADH and desphospho-CoA	NATURE			English	Article							II TRIGGER LOOP; BACTERIAL RNA; STRUCTURAL BASIS; POLYMERASE; TRANSCRIPTION; SELECTION; SIMILARITIES; DEGRADATION; CLEAVAGE; SEQUENCE	The chemical nature of the 5' end of RNA is a key determinant of RNA stability, processing, localization and translation efficiency(1,2), and has been proposed to provide a layer of 'epitranscriptomic' gene regulation(3). Recently it has been shown that some bacterial RNA species carry a 5'-end structure reminiscent of the 5' 7-methylguanylate 'cap' in eukaryotic RNA. In particular, RNA species containing a 5'-end nicotinamide adenine dinucleotide (NAD+) or 3'-desphospho-coenzyme A (dpCoA) have been identified in both Gram-negative and Gram-positive bacteria(3-6). It has been proposed that NAD(+), reduced NAD(+) (NADH) and dpCoA caps are added to RNA after transcription initiation, in a manner analogous to the addition of 7-methylguanylate caps(6-8). Here we show instead that NAD(+), NADH and dpCoA are incorporated into RNA during transcription initiation, by serving as non-canonical initiating nucleotides (NCINs) for de novo transcription initiation by cellular RNA polymerase (RNAP). We further show that both bacterial RNAP and eukaryotic RNAP II incorporate NCIN caps, that promoter DNA sequences at and upstream of the transcription start site determine the efficiency of NCIN capping, that NCIN capping occurs in vivo, and that NCIN capping has functional consequences. We report crystal structures of transcription initiation complexes containing NCIN-capped RNA products. Our results define the mechanism and structural basis of NCIN capping, and suggest that NCIN-mediated 'ab initio capping' may occur in all organisms.	[Bird, Jeremy G.; Nickels, Bryce E.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Bird, Jeremy G.; Zhang, Yu; Ebright, Richard H.; Nickels, Bryce E.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Bird, Jeremy G.; Zhang, Yu; Ebright, Richard H.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Tian, Yuan; Lee, Jeehiun K.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Panova, Natalya; Krasny, Libor] Czech Acad Sci, Inst Microbiol, Vvi, Videnska 1083, Prague 14220 4, Czech Republic; [Barvik, Ivan] Charles Univ Prague, Fac Math & Phys, Inst Phys, Ke Karlovu 5, CR-12116 Prague 2, Czech Republic; [Greene, Landon] Bristol Myers Squibb Co, Analyt & Bioanalyt Dev, One Squibb Dr, New Brunswick, NJ 08903 USA; [Liu, Min; Buckley, Brian] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; [Kaplan, Craig D.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Bristol-Myers Squibb; Rutgers State University New Brunswick; Texas A&M University System; Texas A&M University College Station	Nickels, BE (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA.; Ebright, RH; Nickels, BE (corresponding author), Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA.; Ebright, RH (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu; bnickels@waksman.rutgers.edu	Krasny, Libor/H-2429-2014; Barvik, Ivan/G-8906-2014; Ebright, Richard/O-3321-2019; Kaplan, Craig/AAO-4500-2021; Zhang, Yu/AAV-5722-2021; Nickels, Bryce/AAF-2549-2020	Krasny, Libor/0000-0002-4120-4347; Ebright, Richard/0000-0001-8915-7140; Kaplan, Craig/0000-0002-7518-695X; Zhang, Yu/0000-0002-1778-8389; Bird, Jeremy/0000-0003-2690-8474; Nickels, Bryce/0000-0001-7449-8831	NSF [CHE-1361462]; Welch Foundation [A-1763]; Czech Science Foundation [15-05228S]; NIH [NIEHS P30 ES005022, GM097260, GM041376, GM088343, GM096454, GM115910]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097260, R01GM096454, R01GM041376, R01GM115910, R01GM088343, P41GM111244, R37GM041376] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); Czech Science Foundation(Grant Agency of the Czech Republic); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Woychik for MazF-mt3 protein. Work was supported by NSF grant CHE-1361462 (J.K.L.), Welch Foundation Grant A-1763 (C.D.K.), Czech Science Foundation 15-05228S (L.K., N.P.), and NIH grants NIEHS P30 ES005022, GM097260 (C.D.K.), GM041376 (R.H.E.), GM088343 (B.E.N.), GM096454 (B.E.N.), and GM115910 (B.E.N.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Cabart P, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.28869; Cahova H, 2015, NATURE, V519, P374, DOI 10.1038/nature14020; Chen YG, 2009, NAT CHEM BIOL, V5, P879, DOI 10.1038/nchembio.235; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Decker KB, 2013, ANNU REV MICROBIOL, V67, P113, DOI 10.1146/annurev-micro-092412-155756; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Goldman SR, 2015, ELIFE, V4, DOI 10.7554/eLife.10514; Hui MP, 2014, ANNU REV GENET, V48, P537, DOI 10.1146/annurev-genet-120213-092340; Jaschke A, 2016, CURR OPIN MICROBIOL, V30, P44, DOI 10.1016/j.mib.2015.12.009; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kowtoniuk WE, 2009, P NATL ACAD SCI USA, V106, P7768, DOI 10.1073/pnas.0900528106; Luciano DJ, 2015, TRENDS BIOCHEM SCI, V40, P245, DOI 10.1016/j.tibs.2015.03.004; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Murakami KS, 2015, BIOMOLECULES, V5, P848, DOI 10.3390/biom5020848; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perdue SA, 2010, MOL MICROBIOL, V78, P636, DOI 10.1111/j.1365-2958.2010.07347.x; Schifano JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4538; Shuman S, 2015, RNA, V21, P735, DOI 10.1261/rna.049973.115; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vvedenskaya IO, 2015, MOL CELL, V60, P953, DOI 10.1016/j.molcel.2015.10.029; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Xu WL, 2004, J BACTERIOL, V186, P8380, DOI 10.1128/JB.186.24.8380-8384.2004; Zhang Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02450; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	33	107	110	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					444	+		10.1038/nature18622	http://dx.doi.org/10.1038/nature18622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27383794	Green Accepted			2022-12-24	WOS:000380344200045
J	Durbin, AP				Durbin, Anna P.			A Dengue Vaccine	CELL			English	Editorial Material									[Durbin, Anna P.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Durbin, AP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	adurbin1@jhu.edu							0	14	16	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					1	1		10.1016/j.cell.2016.06.036	http://dx.doi.org/10.1016/j.cell.2016.06.036			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368091	Bronze			2022-12-24	WOS:000380254400001
J	Oestergaard, LB; Christiansen, MN; Schmiegelow, MD; Skov, RL; Andersen, PS; Petersen, A; Aasbjerg, K; Gerds, TA; Andersen, PK; Torp-Pedersen, C				Oestergaard, Louise B.; Christiansen, Mia N.; Schmiegelow, Michelle D.; Skov, Robert L.; Andersen, Paal S.; Petersen, Andreas; Aasbjerg, Kristian; Gerds, Thomas A.; Andersen, Per K.; Torp-Pedersen, Christian			Familial Clustering of Staphylococcus aureus Bacteremia in First-Degree Relatives A Danish Nationwide Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PYOGENIC BACTERIAL-INFECTIONS; POPULATION-BASED COHORT; ENVIRONMENTAL-INFLUENCES; METHICILLIN RESISTANCE; 30-DAY MORTALITY; BINDING LECTIN; RISK-FACTORS; DISEASE; EPIDEMIOLOGY; SUSCEPTIBILITY	Background: A genetic predisposition to Staphylococcus aureus bacteremia has been demonstrated in animals, suggesting that genetic differences might influence susceptibility to S aureus in humans. Objective: To determine whether a history of S aureus bacteremia in first-degree relatives increases the rate of the disease, and whether this rate is affected by the type of family relationship (that is, parent or sibling) or by how the relative acquired the infection. Design: Register-based nationwide cohort study (1992 to 2011). Setting: Denmark. Participants: First-degree relatives (children or siblings) of patients previously hospitalized with S aureus bacteremia. Measurements: Poisson regression models were used to calculate standardized incidence ratios (SIRs) of S aureus bacteremia, with the incidence rate in the population as a reference. Results: 34 774 individuals (the exposed cohort) with a firstdegree relative (index case patient) previously hospitalized with S aureus bacteremia were followed up for a median of 7.8 years (interquartile range, 3.6 to 13.0). A higher rate of S aureus bacteremia was observed among these first-degree relatives (SIR, 2.49 [95% CI, 1.95 to 3.19]) than in the background population. The estimate was significantly higher if the index case patient was a sibling (SIR, 5.01 [CI, 3.30 to 7.62]) than a parent (SIR, 1.96 [CI, 1.45 to 2.67]; interaction P < 0.0001). No interaction was observed regarding the sex of the first-degree relative (interaction P for parents = 0.85; interaction P for siblings = 0.92). Stratifying by disease acquisition revealed the highest rates in individuals exposed to index case patients with non-hospital-acquired infection. Few were infected with genetically identical bacteremia isolates. Limitation: The rarity of the outcome limited the number of variables in the multiple regression analysis, and whether nonsignificant interactions were true or caused by insufficient statistical power remains uncertain. Conclusion: A significant familial clustering of S aureus bacteremia was found, with the greatest relative rate of disease observed in individuals exposed to siblings with a history of the disease.	Aalborg Univ, Aalborg, Denmark; [Oestergaard, Louise B.] Copenhagen Univ Hosp Herlev Gentofte, Dept Cardiol, Kildegaardsvej 28,Post 635, DK-2900 Hellerup, Denmark; [Skov, Robert L.] Statens Serum Inst, Microbiol & Infect Control, Artillerivej 5, DK-2300 Copenhagen S, Denmark; [Andersen, Paal S.] Statens Serum Inst, Microbiol & Infect Control, 5 Artillerivej,47-217, DK-2300 Copenhagen S, Denmark; [Petersen, Andreas] Statens Serum Inst, Microbiol & Infect Control, 5 Artillerivej,46-104, DK-2300 Copenhagen S, Denmark; [Christiansen, Mia N.] Rigshosp, Afd 944, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Aasbjerg, Kristian] Aalborg Univ Hosp, Dept Ophthalmol, Hobrovej 18-22,POB365, DK-9000 Aalborg, Denmark; [Gerds, Thomas A.; Andersen, Per K.] Biostat Sect, Farimagsgade 5 Opg B,POB 2099, DK-1014 Copenhagen K, Denmark; [Torp-Pedersen, Christian] Dept Hlth Sci & Technol, Niels Jernes Vej 12,Room A5-208, DK-9220 Aalborg O, Denmark	Aalborg University; Statens Serum Institut; Statens Serum Institut; Statens Serum Institut; Rigshospitalet; University of Copenhagen; Aalborg University; Aalborg University Hospital	Oestergaard, LB (corresponding author), Copenhagen Univ Hosp Herlev Gentofte, Dept Cardiol, Kildegaardsvej 28,Post 635, DK-2900 Hellerup, Denmark.	l_bruun@hotmail.com	Andersen, Paal S/H-2087-2015; Skov, Robert/ABB-3105-2020	Andersen, Paal S/0000-0001-5656-0427; Skov, Robert/0000-0002-6079-5381; Gerds, Thomas Alexander/0000-0002-5955-816X; Petersen, Andreas/0000-0002-6864-0624	Danish Heart Foundation [R99-A6001]; Christian Larsen and Judge Ellen Larsen Foundation	Danish Heart Foundation; Christian Larsen and Judge Ellen Larsen Foundation	By grant R99-A6001 from the Danish Heart Foundation and a scholarship from the Christian Larsen and Judge Ellen Larsen Foundation, a minor fund supporting research in the fields of infectious diseases and cancer.; The Danish Heart Foundation and the Christian Larsen and Judge Ellen Larsen Foundation.	Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Bassetti M, 2012, CLIN MICROBIOL INFEC, V18, P862, DOI 10.1111/j.1469-0691.2011.03679.x; Bellis MA, 2005, J EPIDEMIOL COMMUN H, V59, P749, DOI 10.1136/jech.2005.036517; Ben-Ari J, 2012, EXPERT REV ANTI-INFE, V10, P881, DOI [10.1586/ERI.12.77, 10.1586/eri.12.77]; Blenstrup LT, 2011, SCAND J PUBLIC HEALT, V39, P79, DOI 10.1177/1403494811399957; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Clayton D., 2013, STAT MODELS EPIDEMIO; de Kraker MEA, 2013, CLIN MICROBIOL INFEC, V19, P860, DOI 10.1111/1469-0691.12028; EMBIL J, 1994, INFECT CONT HOSP EP, V15, P646; FINE PEM, 1981, INT J LEPROSY, V49, P437; Gaist D, 1997, DAN MED BULL, V44, P445; Haralambous E, 2003, EPIDEMIOL INFECT, V130, P413, DOI 10.1017/S0950268803008513; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; Hjuler T, 2008, AM J EPIDEMIOL, V167, P814, DOI 10.1093/aje/kwm376; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Johnson NV, 2012, G3-GENES GENOM GENET, V2, P693, DOI 10.1534/g3.112.002501; Keynan Y, 2013, CRIT CARE CLIN, V29, P547, DOI 10.1016/j.ccc.2013.03.008; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Lesens O, 2005, INFECT CONT HOSP EP, V26, P204, DOI 10.1086/502527; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maguire GP, 1998, J HOSP INFECT, V38, P273, DOI 10.1016/S0195-6701(98)90076-7; MALATY HM, 1994, ANN INTERN MED, V120, P982, DOI 10.7326/0003-4819-120-12-199406150-00002; Mejer N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-260; Melzer M, 2013, J HOSP INFECT, V84, P143, DOI 10.1016/j.jhin.2012.12.013; Nelson CL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-83; Nielsen LH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0740-8; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Regev-Yochay G, 2009, PEDIATR INFECT DIS J, V28, P960, DOI 10.1097/INF.0b013e3181a90883; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Smit J, 2016, EUR J ENDOCRINOL, V174, P631, DOI 10.1530/EJE-16-0023; Sogaard M, 2011, CLIN INFECT DIS, V52, P61, DOI 10.1093/cid/ciq069; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Statens Serum Institut, 2013, STAPH AUR BACT CAS D; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Tran CT, 2007, CLIN EXP IMMUNOL, V148, P101, DOI 10.1111/j.1365-2249.2007.03324.x; Turnidge JD, 2009, MED J AUSTRALIA, V191, P368, DOI 10.5694/j.1326-5377.2009.tb02841.x; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Yan Q, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004149; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	45	10	10	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2016	165	6					390	+		10.7326/M15-2762	http://dx.doi.org/10.7326/M15-2762			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW9FR	27379577				2022-12-24	WOS:000383962000014
J	Meng, FK; Li, XB; Torker, S; Shi, Y; Shen, X; Hoveyda, AH				Meng, Fanke; Li, Xiben; Torker, Sebastian; Shi, Ying; Shen, Xiao; Hoveyda, Amir H.			Catalytic enantioselective 1,6-conjugate additions of propargyl and allyl groups	NATURE			English	Article							CONJUGATE ALLYLATION; ASYMMETRIC 1,6-ADDITION; ORGANIC-SYNTHESIS; ALDEHYDES; REAGENTS; LIGANDS; IRIDIUM	Conjugate (or 1,4-) additions of carbanionic species to alpha,beta-unsaturated carbonyl compounds are vital to research in organic and medicinal chemistry, and there are several chiral catalysts that facilitate the catalytic enantioselective additions of nucleophiles to enoates(1). Nonetheless, catalytic enantioselective 1,6-conjugate additions are uncommon, and ones that incorporate readily functionalizable moieties, such as propargyl or allyl groups, into acyclic alpha,beta,gamma,delta-doubly unsaturated acceptors are unknown(2). Chemical transformations that could generate a new bond at the C6 position of a dienoate are particularly desirable because the resulting products could then be subjected to further modifications. However, such reactions, especially when dienoates contain two equally substituted olefins, are scarce(3) and are confined to reactions promoted by a phosphine-copper catalyst (with an alkyl Grignard reagent(4,5), dialkylzinc or trialkylaluminium compounds(6,7)), a diene-iridium catalyst (with arylboroxines)(8,9), or a bisphosphine-cobalt catalyst (with monosilyl-acetylenes)(10). 1,6-Conjugate additions are otherwise limited to substrates where there is full substitution at the C4 position(11). It is unclear why certain catalysts favour bond formation at C6, and-although there are a small number of catalytic enantioselective conjugate allyl additions(12-15)-related 1,6-additions and processes involving a propargyl unit are non-existent. Here we show that an easily accessible organocopper catalyst can promote 1,6-conjugate additions of propargyl and 2-boryl-substituted allyl groups to acyclic dienoates with high selectivity. A commercially available allenyl-boron compound or a monosubstituted allene may be used. Products can be obtained in up to 83 per cent yield, >98:2 diastereomeric ratio (for allyl additions) and 99:1 enantiomeric ratio. We elucidate the mechanistic details, including the origins of high site selectivity (1,6-versus 1,4-) and enantioselectivity as a function of the catalyst structure and reaction type, by means of density functional theory calculations. The utility of the approach is highlighted by an application towards enantioselective synthesis of the anti-HIV agent (-)-equisetin.	[Meng, Fanke; Li, Xiben; Torker, Sebastian; Shi, Ying; Shen, Xiao; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA	Boston College	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	shi, ying/R-4974-2019	Shen, Xiao/0000-0002-8675-1213; Shi, Ying/0000-0002-9263-4320	United States National Institutes of Health, Institute of General Medical Sciences [GM-47480]; National Science Foundation [CHE-1362763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047480, R01GM057212, R37GM047480] Funding Source: NIH RePORTER; Division Of Chemistry [1362763] Funding Source: National Science Foundation	United States National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the United States National Institutes of Health, Institute of General Medical Sciences (GM-47480) and the National Science Foundation (CHE-1362763). We are grateful to A. Iimuro for experimental assistance.	Alexakis A, 2014, COPPER-CATALYZED ASYMMETRIC SYNTHESIS, P33; Ardolino MJ, 2014, J AM CHEM SOC, V136, P7092, DOI 10.1021/ja502280w; Becker J, 2013, ORG LETT, V15, P5982, DOI 10.1021/ol4028418; de Maria PD, 2007, SYNTHESIS-STUTTGART, P1439, DOI 10.1055/s-2007-966024; den Hartog T, 2008, ANGEW CHEM INT EDIT, V47, P398, DOI 10.1002/anie.200703702; den Hartog T, 2010, TETRAHEDRON-ASYMMETR, V21, P1574, DOI 10.1016/j.tetasy.2010.04.057; Denmark SE, 2008, ANGEW CHEM INT EDIT, V47, P1560, DOI 10.1002/anie.200604943; Henon H, 2008, ANGEW CHEM INT EDIT, V47, P9122, DOI 10.1002/anie.200803735; Hornillos V, 2013, J AM CHEM SOC, V135, P2140, DOI 10.1021/ja312487r; Jang H, 2011, J AM CHEM SOC, V133, P7859, DOI 10.1021/ja2007643; Keith JA, 2007, J AM CHEM SOC, V129, P11876, DOI 10.1021/ja070516j; Krautwald S, 2014, J AM CHEM SOC, V136, P3020, DOI 10.1021/ja5003247; Kuang YL, 2011, ORG LETT, V13, P3814, DOI 10.1021/ol201312y; Magrez-Chiquet M, 2013, CHEM-EUR J, V19, P13663, DOI 10.1002/chem.201302649; Meng FK, 2014, NATURE, V513, P367, DOI 10.1038/nature13735; Nishimura T, 2012, CHEM COMMUN, V48, P973, DOI 10.1039/c2cc16973h; Nishimura T, 2010, J AM CHEM SOC, V132, P7872, DOI 10.1021/ja1034842; Pelz NF, 2004, J AM CHEM SOC, V126, P16328, DOI 10.1021/ja044167u; Quasdorf KW, 2014, NATURE, V516, P181, DOI 10.1038/nature14007; Sawano T, 2012, J AM CHEM SOC, V134, P18936, DOI 10.1021/ja309756k; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Shizuka M, 2008, ANGEW CHEM INT EDIT, V47, P5049, DOI 10.1002/anie.200800628; Sieber JD, 2008, J AM CHEM SOC, V130, P4978, DOI 10.1021/ja710922h; Silva EMP, 2012, SYNTHESIS-STUTTGART, V44, P3109, DOI 10.1055/s-0032-1316778; TAKAI K, 1995, SYNLETT, P963; Tissot M, 2014, COPPER-CATALYZED ASYMMETRIC SYNTHESIS, P69; Tissot M, 2013, CHEM-EUR J, V19, P11352, DOI 10.1002/chem.201300538; Yanagida Y, 2011, ANGEW CHEM INT EDIT, V50, P7910, DOI 10.1002/anie.201102467; Yoshikai N, 2012, CHEM REV, V112, P2339, DOI 10.1021/cr200241f; Yuki K, 2001, TETRAHEDRON LETT, V42, P2517, DOI 10.1016/S0040-4039(01)00217-9	30	89	90	1	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					387	393		10.1038/nature19063	http://dx.doi.org/10.1038/nature19063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27479320	Green Accepted			2022-12-24	WOS:000383098000051
J	Abbink, P; Larocca, RA; De La Barrera, RA; Bricault, CA; Moseley, ET; Boyd, M; Kirilova, M; Li, ZF; Ng'ang'a, D; Nanayakkara, O; Nityanandam, R; Mercado, NB; Borducchi, EN; Agarwal, A; Brinkman, AL; Cabral, C; Chandrashekar, A; Giglio, PB; Jetton, D; Jimenez, J; Lee, BC; Mojta, S; Molloy, K; Shetty, M; Neubauer, GH; Stephenson, KE; Peron, JPS; Zanotto, PMD; Misamore, J; Finneyfrock, B; Lewis, MG; Alter, G; Modjarrad, K; Jarman, RG; Eckels, KH; Michael, NL; Thomas, SJ; Barouch, DH				Abbink, Peter; Larocca, Rafael A.; De La Barrera, Rafael A.; Bricault, Christine A.; Moseley, Edward T.; Boyd, Michael; Kirilova, Marinela; Li, Zhenfeng; Ng'ang'a, David; Nanayakkara, Ovini; Nityanandam, Ramya; Mercado, Noe B.; Borducchi, Erica N.; Agarwal, Arshi; Brinkman, Amanda L.; Cabral, Crystal; Chandrashekar, Abishek; Giglio, Patricia B.; Jetton, David; Jimenez, Jessica; Lee, Benjamin C.; Mojta, Shanell; Molloy, Katherine; Shetty, Mayuri; Neubauer, George H.; Stephenson, Kathryn E.; Peron, Jean Pierre S.; Zanotto, Paolo M. de A.; Misamore, Johnathan; Finneyfrock, Brad; Lewis, Mark G.; Alter, Galit; Modjarrad, Kayvon; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.; Barouch, Dan H.			Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys	SCIENCE			English	Article							INFECTION; ANTIBODIES; MICE	Zika virus (ZIKV) is responsible for a major ongoing epidemic in the Americas and has been causally associated with fetal microcephaly. The development of a safe and effective ZIKV vaccine is therefore an urgent global health priority. Here we demonstrate that three different vaccine platforms protect against ZIKV challenge in rhesus monkeys. A purified inactivated virus vaccine induced ZIKV-specific neutralizing antibodies and completely protected monkeys against ZIKV strains from both Brazil and Puerto Rico. Purified immunoglobulin from vaccinated monkeys also conferred passive protection in adoptive transfer studies. A plasmid DNA vaccine and a single-shot recombinant rhesus adenovirus serotype 52 vector vaccine, both expressing ZIKV premembrane and envelope, also elicited neutralizing antibodies and completely protected monkeys against ZIKV challenge. These data support the rapid clinical development of ZIKV vaccines for humans.	[Abbink, Peter; Larocca, Rafael A.; Bricault, Christine A.; Moseley, Edward T.; Boyd, Michael; Kirilova, Marinela; Li, Zhenfeng; Ng'ang'a, David; Nanayakkara, Ovini; Nityanandam, Ramya; Mercado, Noe B.; Borducchi, Erica N.; Agarwal, Arshi; Brinkman, Amanda L.; Cabral, Crystal; Chandrashekar, Abishek; Giglio, Patricia B.; Jetton, David; Jimenez, Jessica; Lee, Benjamin C.; Mojta, Shanell; Molloy, Katherine; Shetty, Mayuri; Neubauer, George H.; Stephenson, Kathryn E.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [De La Barrera, Rafael A.; Modjarrad, Kayvon; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Peron, Jean Pierre S.; Zanotto, Paolo M. de A.] Univ Sao Paulo, BR-05508000 Sao Paulo, Brazil; [Misamore, Johnathan; Finneyfrock, Brad; Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Alter, Galit; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Modjarrad, Kayvon] Henry M Jackson Fdn, Bethesda, MD 20817 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Universidade de Sao Paulo; BIOQUAL Inc.; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	dbarouch@bidmc.harvard.edu	Chandrashekar, Abishek/P-2610-2019; Barouch, Dan/Y-3918-2019; de A. Zanotto, Paolo M./B-9286-2019; Peron, Jean Pierre S/F-9248-2012; Mercado, Noe/ABE-8247-2020	Chandrashekar, Abishek/0000-0001-7821-5552; de A. Zanotto, Paolo M./0000-0002-8167-0625; Brinkman, Amanda/0000-0002-2845-6494; Peron, Jean Pierre/0000-0003-1638-8866; Jetton, David/0000-0002-1615-9986; Mercado, Noe/0000-0001-7769-7326; Stephenson, Kathryn/0000-0002-3440-4105; Thomas, Stephen/0000-0002-8368-7682	U.S. Military Research and Materiel Command; U.S. Military HIV Research Program; Henry M. Jackson Foundation [W81XWH-11-2-0174]; National Institutes of Health [AI095985, AI096040, AI100663, AI124377]; Ragon Institute of MGH; MIT; Harvard; Sao Paulo Research Foundation (FAPESP) [2011/18703-2, 2014/17766-9]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096040, UM1AI124377, U19AI095985, UM1AI100663] Funding Source: NIH RePORTER	U.S. Military Research and Materiel Command; U.S. Military HIV Research Program; Henry M. Jackson Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH; MIT; Harvard; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Mascola, B. Graham, H. Marston, P. Vasconcelos, N. Collins, R. Olson, K. Kabra, C. Springer, G. Ballarini, N. Botero, K. Chandrika, G. Donofrio, M. Robb, D. Weiss, A. Cook, J. Campbell, S. Hetzel, U. Reimer, H. Wenschuh, T. Suscovich, C. Linde, R. Lu, L. Peter, J. Le Suer, P. Gandhi, M. Iampietro, K. Visitsunthorn, A. Badamchi-Zadeh, L. Maxfield, and F. Stephens for generous advice, assistance, and reagents. The data from this study are tabulated in the main paper and in the supplementary materials. P. A., R. A. L., D. H. B., R. G. J., K.H.E., and S. J. T. are co-inventors on pending patent applications related to ZIKV vaccines, antigens, and vectors, and licensure discussions with industry partners are currently ongoing. P. A. and D. H. B. are cofounders and equity holders in AVVI Biotech. ZIKV challenge stocks and vaccine constructs are available with appropriate material transfer agreements. We acknowledge support from the U.S. Military Research and Materiel Command and the U.S. Military HIV Research Program through its cooperative agreement with the Henry M. Jackson Foundation (W81XWH-11-2-0174); the National Institutes of Health (grants AI095985, AI096040, AI100663, and AI124377); the Ragon Institute of MGH, MIT, and Harvard; and the Sao Paulo Research Foundation (FAPESP; grants 2011/18703-2 and 2014/17766-9). The views expressed in this manuscript are those of the authors and do not represent the official views of the Department of the Army or the Department of Defense.	Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Demicheli V., 2000, COCHRANE DB SYST REV, V2000; Demicheli V., 2009, COCHRANE DB SYST REV, V2009; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Martinez LJ, 2015, AM J TROP MED HYG, V93, P454, DOI 10.4269/ajtmh.14-0819; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Stephenson KE, 2015, J IMMUNOL METHODS, V416, P105, DOI 10.1016/j.jim.2014.11.006; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505	30	362	387	0	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2016	353	6304					1129	1132		10.1126/science.aah6157	http://dx.doi.org/10.1126/science.aah6157			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0RN	27492477	Green Accepted			2022-12-24	WOS:000382626800047
J	Dhawan, NS; Scopton, AP; Dar, AC				Dhawan, Neil S.; Scopton, Alex P.; Dar, Arvin C.			Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling	NATURE			English	Article							KINASE SUPPRESSOR; MEK INHIBITION; COMPLEX REVEALS; GENE ENCODES; C-ELEGANS; ACTIVATION; PROTEIN; MECHANISM; BRAF; SCAFFOLD	Deregulation of the Ras-mitogen activated protein kinase (MAPK) pathway is an early event in many different cancers and a key driver of resistance to targeted therapies'. Sustained signalling through this pathway is caused most often by mutations in K-Ras, which biochemically favours the stabilization of active RAF signalling complexes'. Kinase suppressor of Ras (KSR) is a MAPK scaffold(3-5) that is subject to allosteric regulation through dimerization with RAF(6,7). Direct targeting of KSR could have important therapeutic implications for cancer; however, testing this hypothesis has been difficult owing to a lack of small-molecule antagonists of KSR function. Guided by KSR mutations that selectively suppress oncogenic, but not wild-type, Ras signalling, we developed a class of compounds that stabilize a previously unrecognized inactive state of KSR. These compounds, exemplified by APS-2-79, modulate KSR-dependent MAPK signalling by antagonizing RAF heterodimerization as well as the conformational changes required for phosphorylation and activation of KSR-bound MEK (mitogen-activated protein kinase kinase). Furthermore, APS-2-79 increased the potency of several MEK inhibitors specifically within Ras mutant cell lines by antagonizing release of negative feedback signalling, demonstrating the potential of targeting KSR to improve the efficacy of current MAPK inhibitors. These results reveal conformational switching in KSR as a druggable regulator of oncogenic Ras, and further suggest co-targeting of enzymatic and scaffolding activities within Ras-MAPK signalling complexes as a therapeutic strategy for overcoming Ras-driven cancers.	[Dhawan, Neil S.; Scopton, Alex P.; Dar, Arvin C.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA; [Dhawan, Neil S.; Scopton, Alex P.; Dar, Arvin C.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Struct & Chem Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Dhawan, NS (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA.; Dhawan, NS (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Struct & Chem Biol, New York, NY 10029 USA.				NIH [1DP2CA186570-01]; Damon Runyon-Rachleff Foundation; NATIONAL CANCER INSTITUTE [P30CA196521, DP2CA186570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon-Rachleff Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Shokat, R. Fisher, R. Cagan, S. Aaronson, M. Lazarus, E. Bernstein, and members of the Dar laboratory for comments on the manuscript; A. Maldonado and L. Silber for technical support; and staff at the Advanced Photon Source (Beamline 23-ID-B) for help with X-ray diffraction experiments. The Dar laboratory is supported by innovation awards from the NIH (1DP2CA186570-01) and Damon Runyon-Rachleff Foundation. A.C.D. is a Pew-Stewart Scholar in Cancer Research and Young Investigator of the Pershing-Square Sohn Cancer Research Alliance.	Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Chapman PB, 2014, CANCER CELL, V26, P603, DOI 10.1016/j.ccell.2014.10.017; Douziech M, 2006, GENE DEV, V20, P807, DOI 10.1101/gad.1390406; Fernandez MR, 2012, MOL CELL BIOL, V32, P3718, DOI 10.1128/MCB.06754-11; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Karim FD, 1996, GENETICS, V143, P315; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lavoie H, 2013, NAT CHEM BIOL, V9, P428, DOI [10.1038/NCHEMBIO.1257, 10.1038/nchembio.1257]; Le Borgne M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057137; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sos ML, 2014, CELL REP, V8, P1037, DOI 10.1016/j.celrep.2014.07.010; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Stewart S, 1999, MOL CELL BIOL, V19, P5523; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Xie T, 2014, NAT CHEM BIOL, V10, P1006, DOI 10.1038/nchembio.1658; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377	27	60	61	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					112	116		10.1038/nature19327	http://dx.doi.org/10.1038/nature19327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556948	Green Submitted, Green Accepted			2022-12-24	WOS:000382426900049
J	Streich, FC; Lima, CD				Streich, Frederick C., Jr.; Lima, Christopher D.			Capturing a substrate in an activated RING E3/E2-SUMO complex	NATURE			English	Article							E3 LIGASE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; SUMO MODIFICATION; UBIQUITIN; PCNA; UBC9; MECHANISM; CONJUGATION; INSIGHTS	Post-translational protein modification by ubiquitin (Ub) and ubiquitin-like (Ubl) proteins such as small ubiquitinlike modifier (SUMO) regulates processes including protein homeostasis, the DNA damage response, and the cell cycle. Proliferating cell nuclear antigen (PCNA) is modified by Ub or poly-Ub at lysine (Lys) 164 after DNA damage to recruit repair factors. Yeast PCNA is modified by SUMO on Lys164 and Lys127 during S-phase to recruit the anti-recombinogenic helicase Srs2. Lys164 modification requires specialized E2/E3 enzyme pairs for SUMO or Ub conjugation. For SUMO, Lys164 modification is strictly dependent on the E3 ligase Siz1, suggesting the E3 alters E2 specificity to promote Lys164 modification. The structural basis for substrate interactions in activated E3/E2-Ub/Ubl complexes remains unclear. Here we report an engineered E2 protein and cross-linking strategies that trap an E3/E2-Ubl/substrate complex for structure determination, illustrating how an E3 can bypass E2 specificity to force-feed a substrate lysine into the E2 active site.	[Streich, Frederick C., Jr.; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA; [Lima, Christopher D.] Howard Hughes Med Inst, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.; Lima, CD (corresponding author), Howard Hughes Med Inst, 1275 York Ave, New York, NY 10065 USA.	limac@mskcc.org		Lima, Christopher/0000-0002-9163-6092; Streich Jr, Frederick/0000-0002-7549-424X	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [P41 GM103403]; NIH-ORIP (Office of Research Infrastructure Programs) High-End Shared Instrument grant) at the Advanced Photon Source [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NIH/NIGMS [GM065872, GM118080]; NIH/National Cancer Institute [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM065872, R35GM118080] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP (Office of Research Infrastructure Programs) High-End Shared Instrument grant) at the Advanced Photon Source; DOE Office of Science(United States Department of Energy (DOE)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research at NE-CAT beamlines was funded by P41 GM103403 (National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)), S10 RR029205 (NIH-ORIP (Office of Research Infrastructure Programs) High-End Shared Instrument grant) at the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory (DE-AC02-06CH11357). Research was supported in part by GM065872 and GM118080 (NIH/NIGMS, C.D.L.) and P30CA008748 (NIH/National Cancer Institute). The content is the authors' responsibility and does not represent the official views of the NIH. C.D.L. is a Howard Hughes Medical Institute Investigator.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bosanac I, 2011, J MOL BIOL, V408, P420, DOI 10.1016/j.jmb.2011.03.011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buetow L, 2015, MOL CELL, V58, P297, DOI 10.1016/j.molcel.2015.02.017; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mascle XH, 2013, J BIOL CHEM, V288, P36312, DOI 10.1074/jbc.M113.486845; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page RC, 2012, BIOCHEMISTRY-US, V51, P4175, DOI 10.1021/bi300058m; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Parker JL, 2008, EMBO J, V27, P2422, DOI 10.1038/emboj.2008.162; Parker JL, 2012, NUCLEIC ACIDS RES, V40, P11380, DOI 10.1093/nar/gks892; Parker JL, 2009, EMBO J, V28, P3657, DOI 10.1038/emboj.2009.303; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Streich FC, 2014, ANNU REV BIOPHYS, V43, P357, DOI 10.1146/annurev-biophys-051013-022958; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wright JD, 2016, NAT STRUCT MOL BIOL, V23, P45, DOI 10.1038/nsmb.3142; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Yunus Ali A., 2009, V497, P167, DOI 10.1007/978-1-59745-566-4_11	53	58	60	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					304	+		10.1038/nature19071	http://dx.doi.org/10.1038/nature19071			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27509863	Green Accepted			2022-12-24	WOS:000381804900029
J	Agua-Agum, J; Allegranzi, B; Ariyarajah, A; Aylward, RB; Blake, IM; Barboza, P; Bausch, D; Brennan, RJ; Clement, P; Coffey, P; Cori, A; Donnelly, CA; Dorigatti, I; Drury, P; Durski, K; Dye, C; Eckmanns, T; Ferguson, NM; Fraser, C; Garcia, E; Garske, T; Gasasira, A; Gurry, C; Gutierrez, GJ; Hamblion, E; Hinsley, W; Holden, R; Holmes, D; Hugonnet, S; Jombart, T; Kelley, E; Santhana, R; Mahmoud, N; Mills, HL; Mohamed, Y; Musa, E; Naidoo, D; Nedjati-Gilani, G; Newton, E; Norton, I; Nouvellet, P; Perkins, D; Perkins, M; Riley, S; Schumacher, D; Shah, A; Tang, M; Varsaneux, O; Van Kerkhove, MD				Agua-Agum, Junerlyn; Allegranzi, Benedetta; Ariyarajah, Archchun; Aylward, R. Bruce; Blake, Isobel M.; Barboza, Philippe; Bausch, Daniel; Brennan, Richard J.; Clement, Peter; Coffey, Pasqualina; Cori, Anne; Donnelly, Christl A.; Dorigatti, Ilaria; Drury, Patrick; Durski, Kara; Dye, Christopher; Eckmanns, Tim; Ferguson, Neil M.; Fraser, Christophe; Garcia, Erika; Garske, Tini; Gasasira, Alex; Gurry, Celine; Gutierrez, Giovanna Jaramillo; Hamblion, Esther; Hinsley, Wes; Holden, Robert; Holmes, David; Hugonnet, Stephane; Jombart, Thibaut; Kelley, Edward; Santhana, Ravi; Mahmoud, Nuha; Mills, Harriet L.; Mohamed, Yasmine; Musa, Emmanuel; Naidoo, Dhamari; Nedjati-Gilani, Gemma; Newton, Emily; Norton, Ian; Nouvellet, Pierre; Perkins, Devin; Perkins, Mark; Riley, Steven; Schumacher, Dirk; Shah, Anita; Minh Tang; Varsaneux, Olivia; Van Kerkhove, Maria D.		WHO Ebola Response Team	After Ebola in West Africa - Unpredictable Risks, Preventable Epidemics	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS DISEASE OUTBREAK; SEXUAL TRANSMISSION; RAPID RESPONSE; REMOTE AREAS; LIBERIA; INTERVENTIONS; DYNAMICS; NIGERIA; COUNTY	Between December 2013 and April 2016, the largest epidemic of Ebola virus disease (EVD) to date generated more than 28,000 cases and more than 11,000 deaths in the large, mobile populations of Guinea, Liberia, and Sierra Leone. Tracking the rapid rise and slower decline of the West African epidemic has reinforced some common understandings about the epidemiology and control of EVD but has also generated new insights. Despite having more information about the geographic distribution of the disease, the risk of human infection from animals and from survivors of EVD remains unpredictable over a wide area of equatorial Africa. Until human exposure to infection can be anticipated or avoided, future outbreaks will have to be managed with the classic approach to EVD control - extensive surveillance, rapid detection and diagnosis, comprehensive tracing of contacts, prompt patient isolation, supportive clinical care, rigorous efforts to prevent and control infection, safe and dignified burial, and engagement of the community. Empirical and modeling studies conducted during the West African epidemic have shown that large epidemics of EVD are preventable - a rapid response can interrupt transmission and restrict the size of outbreaks, even in densely populated cities. The critical question now is how to ensure that populations and their health services are ready for the next outbreak, wherever it may occur. Health security across Africa and beyond depends on committing resources to both strengthen national health systems and sustain investment in the next generation of vaccines, drugs, and diagnostics.	[Agua-Agum, Junerlyn; Allegranzi, Benedetta; Ariyarajah, Archchun; Aylward, R. Bruce; Barboza, Philippe; Bausch, Daniel; Brennan, Richard J.; Clement, Peter; Coffey, Pasqualina; Drury, Patrick; Durski, Kara; Dye, Christopher; Eckmanns, Tim; Garcia, Erika; Gasasira, Alex; Gurry, Celine; Gutierrez, Giovanna Jaramillo; Hamblion, Esther; Holden, Robert; Holmes, David; Hugonnet, Stephane; Kelley, Edward; Santhana, Ravi; Mahmoud, Nuha; Mohamed, Yasmine; Musa, Emmanuel; Naidoo, Dhamari; Newton, Emily; Norton, Ian; Perkins, Devin; Schumacher, Dirk; Shah, Anita; Minh Tang; Varsaneux, Olivia] WHO, Ave Appia, CH-1211 Geneva 27, Switzerland; [Perkins, Mark] Fdn Innovat New Diagnost, Geneva, Switzerland; [Blake, Isobel M.; Cori, Anne; Donnelly, Christl A.; Dorigatti, Ilaria; Ferguson, Neil M.; Fraser, Christophe; Garske, Tini; Hinsley, Wes; Jombart, Thibaut; Mills, Harriet L.; Nedjati-Gilani, Gemma; Nouvellet, Pierre; Riley, Steven; Van Kerkhove, Maria D.] Imperial Coll London, WHO Collaborating Ctr Infect Dis Modelling, Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol,Med Res Council, London, England; [Eckmanns, Tim; Schumacher, Dirk] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Van Kerkhove, Maria D.] Inst Pasteur, Ctr Global Hlth, Paris, France	World Health Organization; Foundation For Innovative New Diagnostics; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Robert Koch Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Dye, C (corresponding author), WHO, Ave Appia, CH-1211 Geneva 27, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022; Fraser, Christophe/A-8109-2008; Coffey, Pasqualina/AAB-7169-2019; Ferguson, Neil/B-8578-2008; Cori, Anne/AFL-1641-2022	Fraser, Christophe/0000-0003-2399-9657; Ferguson, Neil/0000-0002-1154-8093; Cori, Anne/0000-0002-8443-9162; varsaneux, olivia/0000-0003-3249-0721; Blake, Isobel/0000-0002-3977-1318; nouvellet, pierre/0000-0002-6094-5722; Shah, Anita A./0000-0003-1865-2085; Hamblion, Esther/0000-0003-4250-3696; Newton, Emily/0000-0002-9581-7085; Dorigatti, Ilaria/0000-0001-9959-0706	MRC [MR/K010174/1, MR/J008761/1] Funding Source: UKRI; Medical Research Council [MR/J008761/1, MR/K010174/1] Funding Source: Medline; Medical Research Council [1109359, G0600719B, MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Abramowitz SA, 2015, LANCET, V385, P330, DOI 10.1016/S0140-6736(15)60119-2; Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; [Anonymous], 2016, EB VIR DIS OUTBR RES; [Anonymous], 2016, RES RES; [Anonymous], 2010, TECHN GUID INT DIS S; Ansumana R, 2015, NEW ENGL J MED, V372, P587, DOI 10.1056/NEJMc1413685; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Blackley DJ, 2015, MMWR-MORBID MORTAL W, V64, P175; Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594; Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479; Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR; Deen GF, 2015, N ENGL J MED, DOI 10.1056/NEJMoa1511410; Dhillon RS, 2015, NEW ENGL J MED, V373, P787, DOI 10.1056/NEJMp1508413; Fasina FO, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.40.20920; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Kateh F, 2015, MMWR-MORBID MORTAL W, V64, P188; Kerstiens B, 1999, J INFECT DIS, V179, pS263, DOI 10.1086/514320; Kucharski AJ, 2015, P NATL ACAD SCI USA, V112, P14366, DOI 10.1073/pnas.1508814112; Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]; Lindblade KA, 2015, EMERG INFECT DIS, V21, P1800, DOI 10.3201/eid2110.150912; Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6; Nyenswah T, 2015, MMWR-MORBID MORTAL W, V64, P500; Nyenswah T, 2014, MMWR-MORBID MORTAL W, V63, P1082; Okware SI, 2015, AFR HEALTH SCI, V15, P312, DOI 10.4314/ahs.v15i1.45; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Pigott DM, 2014, ELIFE, V3, DOI 10.7554/eLife.04395; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Scarpino SV, 2015, CLIN INFECT DIS, V60, P1079, DOI 10.1093/cid/ciu1131; Sharma A, 2014, MMWR-MORBID MORTAL W, V63, P1067; Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867; Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612; Stadler T, 2014, PLOS CURR, P6, DOI DOI 10.1371/CURRENTS.OUTBREAKS; Thorson A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008859; Tom-Aba D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131000; Van Kerkhove MD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.19; Vetter Pauline, 2016, Lancet Infect Dis, V16, pe82, DOI 10.1016/S1473-3099(16)00077-3; WHO, 2015, OR 2014 EB EP; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, 2014, HIGH LEV M BUILD RES; World Health Organization (WHO), 2014, EB RESP PACK APPR AR	43	170	171	0	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					587	596		10.1056/NEJMsr1513109	http://dx.doi.org/10.1056/NEJMsr1513109			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU4OT	27509108	Green Published, Bronze			2022-12-24	WOS:000382193100015
J	Schibich, D; Gloge, F; Pohner, I; Bjorkholm, P; Wade, RC; von Heijne, G; Bukau, B; Kramer, G				Schibich, Daniela; Gloge, Felix; Poehner, Ina; Bjorkholm, Patrik; Wade, Rebecca C.; von Heijne, Gunnar; Bukau, Bernd; Kramer, Guenter			Global profiling of SRP interaction with nascent polypeptides	NATURE			English	Article							TRIGGER FACTOR; PROTEIN TRANSLOCATION; MEMBRANE-PROTEIN; RECOGNITION; LOCALIZATION; PATHWAY; SECA	Signal recognition particle (SRP) is a universally conserved protein-RNA complex that mediates co-translational protein translocation and membrane insertion by targeting translating ribosomes to membrane translocons(1). The existence of parallel co- and post-translational transport pathways(2), however, raises the question of the cellular substrate pool of SRP and the molecular basis of substrate selection. Here we determine the binding sites of bacterial SRP within the nascent proteome of Escherichia coli at amino acid resolution, by sequencing messenger RNA footprints of ribosome-nascent-chain complexes associated with SRP. SRP, on the basis of its strong preference for hydrophobic transmembrane domains (TMDs), constitutes a compartment-specific targeting factor for nascent inner membrane proteins (IMPs) that efficiently excludes signal-sequence-containing precursors of periplasmic and outer membrane proteins. SRP associates with hydrophobic TMDs enriched in consecutive stretches of hydrophobic and bulky aromatic amino acids immediately on their emergence from the ribosomal exit tunnel. By contrast with current models, N-terminal TMDs are frequently skipped and TMDs internal to the polypeptide sequence are selectively recognized. Furthermore, SRP binds several TMDs in many multi-spanning membrane proteins, suggesting cycles of SRP-mediated membrane targeting. SRP-mediated targeting is not accompanied by a transient slowdown of translation and is not influenced by the ribosome-associated chaperone trigger factor (TF), which has a distinct substrate pool and acts at different stages during translation. Overall, our proteome-wide data set of SRP-binding sites reveals the underlying principles of pathway decisions for nascent chains in bacteria, with SRP acting as the dominant triaging factor, sufficient to separate IMPs from substrates of the SecA-SecB post-translational translocation and TF-assisted cytosolic protein folding pathways.	[Schibich, Daniela; Gloge, Felix; Wade, Rebecca C.; Bukau, Bernd; Kramer, Guenter] Univ Heidelberg ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany; [Schibich, Daniela; Gloge, Felix; Bukau, Bernd; Kramer, Guenter] German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Poehner, Ina; Wade, Rebecca C.] HITS gGmbH, Heidelberg Inst Theoret Studies, Schloss Wolfsbrunnenweg 35, D-69118 Heidelberg, Germany; [Bjorkholm, Patrik; von Heijne, Gunnar] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Bjorkholm, Patrik; von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, S-17121 Solna, Sweden; [Bjorkholm, Patrik] Uppsala Univ, Dept Mol Evolut Cell & Mol Biol, S-75236 Uppsala, Sweden; [Wade, Rebecca C.] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Neuenheimer Feld 205, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Heidelberg Institute for Theoretical Studies; Stockholm University; Stockholm University; Uppsala University; Ruprecht Karls University Heidelberg	Bukau, B; Kramer, G (corresponding author), Univ Heidelberg ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.; Bukau, B; Kramer, G (corresponding author), German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	bukau@zmbh.uni-heidelberg.de; g.kramer@zmbh.uni-heidelberg.de	von Heijne, Gunnar/AAH-9389-2019; Wade, Rebecca/L-1489-2019; von Heijne, Gunnar/F-5576-2011	Wade, Rebecca/0000-0001-5951-8670; von Heijne, Gunnar/0000-0002-4490-8569; Pohner, Ina/0000-0002-2801-8902; Kramer, Gunter/0000-0001-7552-8393; Bukau, Bernd/0000-0003-0521-7199	Klaus Tschira Foundation; Deutsche Forschungsgemeinschaft [SFB638, FOR1805]; Human Frontier Science Program grant; Swedish Research Council	Klaus Tschira Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program grant(Human Frontier Science Program); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank members of the Bukau laboratory for valuable contributions; C. Glasser for support with data analysis; and H. Bernstein for providing plasmid pHQ4. Sequencing was done at the Genomics & Proteomics Core (DKFZ) facility. I.P. and R.C.W. acknowledge support from the Klaus Tschira Foundation. This work was supported by research grants from the Deutsche Forschungsgemeinschaft (SFB638 and FOR1805) to G.K. and B.B., a Human Frontier Science Program grant to B.B. and a grant from the Swedish Research Council to G.v.H.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Ariosa A, 2015, P NATL ACAD SCI USA, V112, pE3169, DOI 10.1073/pnas.1422594112; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Bischoff L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5103; Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Bornemann T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5180; BUKAU B, 1993, J GEN MICROBIOL, V139, P95, DOI 10.1099/00221287-139-1-95; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Castanie-Cornet MP, 2014, BBA-MOL CELL RES, V1843, P1442, DOI 10.1016/j.bbamcr.2013.11.007; Clarke DJ, 1996, MOL MICROBIOL, V20, P1273, DOI 10.1111/j.1365-2958.1996.tb02646.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Fluman N, 2014, ELIFE, V3, DOI 10.7554/eLife.03440; Fontaine F, 2011, J BIOL CHEM, V286, P32464, DOI 10.1074/jbc.M111.245696; Gamerdinger M, 2015, SCIENCE, V348, P201, DOI 10.1126/science.aaa5335; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2015, SCIENCE, V348, P182, DOI 10.1126/science.aab1335; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuroiwa T, 1996, J BIOL CHEM, V271, P6423, DOI 10.1074/jbc.271.11.6423; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; Lim B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001735; Nakatogawa H, 2005, GENE DEV, V19, P436, DOI 10.1101/gad.1259505; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rutkowska A, 2009, FEBS LETT, V583, P2407, DOI 10.1016/j.febslet.2009.06.041; SAAF A, 1995, MOL MEMBR BIOL, V12, P209, DOI 10.3109/09687689509027509; SCHLENSTEDT G, 1992, J BIOL CHEM, V267, P24328; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743	35	86	86	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					219	+		10.1038/nature19070	http://dx.doi.org/10.1038/nature19070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487212				2022-12-24	WOS:000381472100038
J	Strilic, B; Yang, LD; Albarran-Juarez, J; Wachsmuth, L; Han, K; Muller, UC; Pasparakis, M; Offermanns, S				Strilic, Boris; Yang, Lida; Albarran-Juarez, Julian; Wachsmuth, Laurens; Han, Kang; Mueller, Ulrike C.; Pasparakis, Manolis; Offermanns, Stefan			Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; LUNG METASTASIS; MIGRATION; DR6; INFLAMMATION; ACTIVATION; INSIGHTS	Metastasis is the leading cause of cancer-related death in humans. It is a complex multistep process during which individual tumour cells spread primarily through the circulatory system to colonize distant organs(1-3). Once in the circulation, tumour cells remain vulnerable, and their metastatic potential largely depends on a rapid and efficient way to escape from the blood stream by passing the endothelial barrier(4-9). Evidence has been provided that tumour cell extravasation resembles leukocyte transendothelial migration(7-9). However, it remains unclear how tumour cells interact with endothelial cells during extravasation and how these processes are regulated on a molecular level. Here we show that human and murine tumour cells induce programmed necrosis (necroptosis) of endothelial cells, which promotes tumour cell extravasation and metastasis. Treatment of mice with the receptor-interacting serine/threonine-protein kinase 1 (RIPK1)-inhibitor necrostatin-1 or endothelial-cell-specific deletion of RIPK3 reduced tumour-cell-induced endothelial necroptosis, tumour cell extravasation and metastasis. In contrast, pharmacological caspase inhibition or endothelial-cell-specific loss of caspase-8 promoted these processes. We furthermore show in vitro and in vivo that tumour-cell-induced endothelial necroptosis leading to extravasation and metastasis requires amyloid precursor protein expressed by tumour cells and its receptor, death receptor 6 (DR6), on endothelial cells as the primary mediators of these effects. Our data identify a new mechanism underlying tumour cell extravasation and metastasis, and suggest endothelial DR6-mediated necroptotic signalling pathways as targets for anti-metastatic therapies.	[Strilic, Boris; Yang, Lida; Albarran-Juarez, Julian; Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Ludwigstr 43, D-61231 Bad Nauheim, Germany; [Wachsmuth, Laurens; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Wachsmuth, Laurens; Pasparakis, Manolis] Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Han, Kang; Mueller, Ulrike C.] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Dept Bioinformat & Funct Gen, Neuenheimer Feld 364, D-69120 Heidelberg, Germany; [Offermanns, Stefan] JW Goethe Univ Frankfurt, Fac Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany	Max Planck Society; University of Cologne; University of Cologne; Ruprecht Karls University Heidelberg; Goethe University Frankfurt	Strilic, B; Offermanns, S (corresponding author), Max Planck Inst Heart & Lung Res, Dept Pharmacol, Ludwigstr 43, D-61231 Bad Nauheim, Germany.; Offermanns, S (corresponding author), JW Goethe Univ Frankfurt, Fac Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	boris.strilic@mpi-bn.mpg.de; stefan.offermanns@mpi-bn.mpg.de	Han, Kang/X-1334-2019; Pasparakis, Manolis/H-9292-2017; Juarez, Julian Albarran/K-6623-2019; Pasparakis, Manolis/N-4350-2019; Offermanns, Stefan/L-3313-2017	Pasparakis, Manolis/0000-0002-9870-0966; Juarez, Julian Albarran/0000-0003-2493-1435; Pasparakis, Manolis/0000-0002-9870-0966; Offermanns, Stefan/0000-0001-8676-6805; Wachsmuth, Laurens/0000-0003-1701-9384; HAN, KANG/0000-0002-9940-7075	German Cancer Aid; Max Planck Society; China Scholarship Council; Deutsche Forschungsgemeinschaft [MU 1457/9-2, SFB670, SFB829]; European Research Council [323040]; Worldwide Cancer Research [15-0228]; Helmholtz Alliance Preclinical Comprehensive Cancer Center	German Cancer Aid(Deutsche Krebshilfe); Max Planck Society(Max Planck SocietyFoundation CELLEX); China Scholarship Council(China Scholarship Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Worldwide Cancer Research; Helmholtz Alliance Preclinical Comprehensive Cancer Center	We thank S. Fulda and our friends and colleagues for comments on the manuscript. We also thank S. Hummer for secretarial help and C. Ringel, J. Hoffmann, I.-M. Gross, D. Magalei and M. Winkels for technical help. This work was supported by the German Cancer Aid and the Max Planck Society. K.H. was supported by the China Scholarship Council. U.C.M. was supported by a grant from the Deutsche Forschungsgemeinschaft (MU 1457/9-2). M.P. received funding from the European Research Council (grant agreement 323040), the Deutsche Forschungsgemeinschaft (SFB670, SFB829), Worldwide Cancer Research (grant 15-0228) and the Helmholtz Alliance Preclinical Comprehensive Cancer Center.	Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hick M, 2015, ACTA NEUROPATHOL, V129, P21, DOI 10.1007/s00401-014-1368-x; Huang G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.378; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Korhonen H, 2009, J EXP MED, V206, P411, DOI 10.1084/jem.20082150; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Labelle M, 2012, CANCER DISCOV, V2, P1091, DOI 10.1158/2159-8290.CD-12-0329; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu JQ, 2001, IMMUNITY, V15, P23, DOI 10.1016/S1074-7613(01)00162-5; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni0815-889b, 10.1038/ni.3206]; Sivaraj KK, 2013, DEV CELL, V25, P427, DOI 10.1016/j.devcel.2013.04.008; Takagi K, 2013, CANCER SCI, V104, P1532, DOI 10.1111/cas.12239; Takai E, 2012, J CELL SCI, V125, P5051, DOI 10.1242/jcs.104976; Takayama KI, 2009, CANCER RES, V69, P137, DOI 10.1158/0008-5472.CAN-08-3633; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Xu K, 2015, GENE DEV, V29, P785, DOI 10.1101/gad.257675.114; Yang ZL, 2012, ONCOL LETT, V3, P1227, DOI 10.3892/ol.2012.639; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zhou W, 2014, SEMIN CELL DEV BIOL, V35, P14, DOI 10.1016/j.semcdb.2014.07.013	36	274	285	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					215	+		10.1038/nature19076	http://dx.doi.org/10.1038/nature19076			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487218				2022-12-24	WOS:000381472100037
J	Upshur, R				Upshur, Ross			Unresolved issues in Canada's law on physician-assisted dying	LANCET			English	Editorial Material									[Upshur, Ross] Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Family & Community Med, Toronto, ON M5T 3M7, Canada; [Upshur, Ross] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON M5T 3M7, Canada; [Upshur, Ross] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Upshur, R (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Family & Community Med, Toronto, ON M5T 3M7, Canada.; Upshur, R (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON M5T 3M7, Canada.; Upshur, R (corresponding author), Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.	ross.upshur@utoronto.ca						[Anonymous], 2016, GLOBE MAIL; Canadian Medical Association, 2015, CMA UPD ASS DYING PO; Government of Canada Department of Justice, 2015, CONS PHYS ASS DYING; Kirkey S., 2015, NATL POST; Parliament of Canada, 2016, MED ASS DYING PAT CT; Provincial Territorial Expert Advisory Group on Physician Assisted Dying, 2015, FIN REP NOV 30 PROV; Schuklenk U, 2011, BIOETHICS, V25, P1, DOI 10.1111/j.1467-8519.2011.01939.x; Stone L, 2016, GLOBE MAIL; Truth and Reconciliation Commission of Canada, 2015, HON TRUTH REC FUT SU	9	10	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					545	547		10.1016/S0140-6736(16)31255-7	http://dx.doi.org/10.1016/S0140-6736(16)31255-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27511772				2022-12-24	WOS:000380756600010
J	Giorgetti, L; Lajoie, BR; Carter, AC; Attia, M; Zhan, Y; Xu, J; Chen, CJ; Kaplan, N; Chang, HY; Heard, E; Dekker, J				Giorgetti, Luca; Lajoie, Bryan R.; Carter, Ava C.; Attia, Mikael; Zhan, Ye; Xu, Jin; Chen, Chong Jian; Kaplan, Noam; Chang, Howard Y.; Heard, Edith; Dekker, Job			Structural organization of the inactive X chromosome in the mouse	NATURE			English	Article							GENE-EXPRESSION; XIST RNA; CHROMATIN; REVEALS; BINDING; CTCF; RECONSTRUCTION; CONFORMATION; ARCHITECTURE; TERRITORIES	X-chromosome inactivation (XCI) involves major reorganization of the X chromosome as it becomes silent and heterochromatic. During female mammalian development, XCI is triggered by upregulation of the non-coding Xist RNA from one of the two X chromosomes. Xist coats the chromosome in cis and induces silencing of almost all genes via its A-repeat region(1,2), although some genes (constitutive escapees) avoid silencing in most cell types, and others (facultative escapees) escape XCI only in specific contexts(3). A role for Xist in organizing the inactive X (Xi) chromosome has been proposed(4-6). Recent chromosome conformation capture approaches have revealed global loss of local structure on the Xi chromosome and formation of large mega-domains, separated by a region containing the DXZ4 macrosatellite(7-10). However, the molecular architecture of the Xi chromosome, in both the silent and expressed regions, remains unclear. Here we investigate the structure, chromatin accessibility and expression status of the mouse Xi chromosome in highly polymorphic clonal neural progenitors (NPCs) and embryonic stem cells. We demonstrate a crucial role for Xist and the DXZ4-containing boundary in shaping Xi chromosome structure using allele-specific genome-wide chromosome conformation capture (Hi-C) analysis, an assay for transposase-accessible chromatin with high throughput sequencing (ATAC-seq) and RNA sequencing. Deletion of the boundary disrupts mega-domain formation, and induction of Xist RNA initiates formation of the boundary and the loss of DNA accessibility. We also show that in NPCs, the Xi chromosome lacks active/inactive compartments and topologically associating domains (TADs), except around genes that escape XCI. Escapee gene clusters display TAD-like structures and retain DNA accessibility at promoter-proximal and CTCF-binding sites. Furthermore, altered patterns of facultative escape genes in different neural progenitor clones are associated with the presence of different TAD-like structures after XCI. These findings suggest a key role for transcription and CTCF in the formation of TADs in the context of the Xi chromosome in neural progenitors.	[Giorgetti, Luca; Attia, Mikael; Chen, Chong Jian; Heard, Edith] PSL Res Univ, Inst Curie, CNRS, UMR3215,INSERM,U934, 26 Rue Ulm, F-75248 Paris 05, France; [Lajoie, Bryan R.; Zhan, Ye; Kaplan, Noam; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol, 368 Plantat St, Worcester, MA 01605 USA; [Carter, Ava C.; Xu, Jin; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Carter, Ava C.; Xu, Jin; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Heard, Edith] Coll France, 11 Pl Marcelin Berthelot, F-75005 Paris, France; [Dekker, Job] Univ Massachusetts, Howard Hughes Med Inst, Sch Med, 368 Plantat St, Worcester, MA 01605 USA; [Giorgetti, Luca] Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Massachusetts System; University of Massachusetts Worcester; Stanford University; Stanford University; UDICE-French Research Universities; PSL Research University Paris; College de France; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Friedrich Miescher Institute for Biomedical Research	Heard, E (corresponding author), PSL Res Univ, Inst Curie, CNRS, UMR3215,INSERM,U934, 26 Rue Ulm, F-75248 Paris 05, France.; Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol, 368 Plantat St, Worcester, MA 01605 USA.; Heard, E (corresponding author), Coll France, 11 Pl Marcelin Berthelot, F-75005 Paris, France.; Dekker, J (corresponding author), Univ Massachusetts, Howard Hughes Med Inst, Sch Med, 368 Plantat St, Worcester, MA 01605 USA.	edith.heard@curie.fr; job.dekker@umassmed.edu	Kaplan, Noam/A-3544-2011; Kaplan, Noam/K-4383-2019; Heard, Edith/D-7197-2017; Xu, Jin/M-9532-2016	Kaplan, Noam/0000-0001-9940-1987; Kaplan, Noam/0000-0001-9940-1987; Heard, Edith/0000-0001-8052-7117; Xu, Jin/0000-0003-0944-9835; Carter, Ava/0000-0002-1892-8742	National Institutes of Health [P50-HG007735]; Scleroderma Research Foundation; National Human Genome Research Institute [R01 HG003143]; National Institutes of Health Common Fund, National Institute of Diabetes and Digestive and Kidney Diseases [U54 DK107980]; Human Frontier Science Program; EMBO Fellowship; ERC [671027]; EU FP7 grant SYBOSS (EU) [242129]; EU FP7 grant MODHEP (EU) [259743]; La Ligue; Fondation de France; Labex DEEP part of the IDEX Idex PSL [ANR-11-LBX-0044, ANR-10-IDEX-0001-02 PSL]; ABS4NGS [ANR-11-BINF-0001]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143, P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG047126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health Common Fund, National Institute of Diabetes and Digestive and Kidney Diseases; Human Frontier Science Program(Human Frontier Science Program); EMBO Fellowship(European Molecular Biology Organization (EMBO)); ERC(European Research Council (ERC)European Commission); EU FP7 grant SYBOSS (EU); EU FP7 grant MODHEP (EU); La Ligue; Fondation de France(Fondation de France); Labex DEEP part of the IDEX Idex PSL; ABS4NGS; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Heard, Dekker, and Chang laboratories for their help and critical insights; PICT-IBiSA@BDD (UMR3215/U934) Imaging facility of the Institut Curie. L.G. would like to thank L. Mirny for discussing gyration tensor analysis. Supported by grants from the National Institutes of Health (P50-HG007735) and Scleroderma Research Foundation (to H.Y.C.), from the National Human Genome Research Institute (R01 HG003143) and the National Institutes of Health Common Fund, National Institute of Diabetes and Digestive and Kidney Diseases (U54 DK107980) to J.D., the Human Frontier Science Program to N.K., an EMBO Fellowship to L.G., an ERC Advanced Investigator award (ERC-2014-AdG no. 671027), EU FP7 grants SYBOSS (EU 7th Framework G.A. no. 242129) and MODHEP (EU 7th Framework G.A. no. 259743), La Ligue, Fondation de France, Labex DEEP (ANR-11-LBX-0044) part of the IDEX Idex PSL (ANR-10-IDEX-0001-02 PSL) and ABS4NGS (ANR-11-BINF-0001) to E.H.J.D. is an investigator of the Howard Hughes Medical Institute.	Berletch JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005079; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chadwick BP, 2008, GENOME RES, V18, P1259, DOI 10.1101/gr.075713.107; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Corbel C, 2013, DEVELOPMENT, V140, P861, DOI 10.1242/dev.087429; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Deng XX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0728-8; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Eckersley-Maslin MA, 2014, DEV CELL, V28, P351, DOI 10.1016/j.devcel.2014.01.017; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Gendre AV, 2014, DEV CELL, V28, P366, DOI 10.1016/j.devcel.2014.01.016; GIACALONE J, 1992, NAT GENET, V1, P137, DOI 10.1038/ng0592-137; Horakova AH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r70; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/nmeth.2148, 10.1038/NMETH.2148]; Lajoie BR, 2015, METHODS, V72, P65, DOI 10.1016/j.ymeth.2014.10.031; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Martynoga B, 2013, GENE DEV, V27, P1769, DOI 10.1101/gad.216804.113; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276 aab2276, 10.1126/science.aab2276]; Naughton C, 2010, MOL CELL, V40, P397, DOI 10.1016/j.molcel.2010.10.013; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Peeters SB, 2014, BIOESSAYS, V36, P746, DOI 10.1002/bies.201400032; Rao SSP, 2015, CELL, V162, P687, DOI 10.1016/j.cell.2015.07.024; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Schulz EG, 2014, CELL STEM CELL, V14, P203, DOI 10.1016/j.stem.2013.11.022; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Teller K, 2011, NUCLEUS-PHILA, V2, P465, DOI 10.4161/nucl.2.5.17862; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0618-0; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	38	230	234	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					575	+		10.1038/nature18589	http://dx.doi.org/10.1038/nature18589			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27437574	Green Accepted			2022-12-24	WOS:000380856600034
J	Schiff, GD; Seoane-Vazquez, E; Wright, A				Schiff, Gordon D.; Seoane-Vazquez, Enrique; Wright, Adam			Incorporating Indications into Medication Ordering - Time to Enter the Age of Reason	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schiff, Gordon D.; Wright, Adam] Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA; [Schiff, Gordon D.; Wright, Adam] Harvard Med Sch, Boston, MA 02115 USA; [Seoane-Vazquez, Enrique] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schiff, GD (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA.; Schiff, GD (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							[Anonymous], 1833, BOSTON MED SURG J, V9, P98; Brigham Project Team on AHRQ En- hancing Medication Safety CPOE Safety and Quality by Indications Based Prescribing, 2015, WEB SER AHRQ; Kuntz JL, 2014, PATIENT EDUC COUNS, V97, P310, DOI 10.1016/j.pec.2014.08.021; Persell SD, 2004, AM J HEALTH-SYST PH, V61, P2523, DOI 10.1093/ajhp/61.23.2523; Zargarzadeh AH, 2011, INT J CLIN PHARM-NET, V33, P252, DOI 10.1007/s11096-011-9488-z	5	41	42	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2016	375	4					306	309		10.1056/NEJMp1603964	http://dx.doi.org/10.1056/NEJMp1603964			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS0UV	27464201	Green Published			2022-12-24	WOS:000380313200004
J	Chaudhuri, AR; Callen, E; Ding, X; Gogola, E; Duarte, AA; Lee, JE; Wong, N; Lafarga, V; Calvo, JA; Panzarino, NJ; John, S; Day, A; Crespo, AV; Shen, BH; Starnes, LM; de Ruiter, JR; Daniel, JA; Konstantinopoulos, PA; Cortez, D; Cantor, SB; Fernandez-Capetillo, O; Ge, K; Jonkers, J; Rottenberg, S; Sharan, SK; Nussenzweig, A				Chaudhuri, Arnab Ray; Callen, Elsa; Ding, Xia; Gogola, Ewa; Duarte, Alexandra A.; Lee, Ji-Eun; Wong, Nancy; Lafarga, Vanessa; Calvo, Jennifer A.; Panzarino, Nicholas J.; John, Sam; Day, Amanda; Crespo, Anna Vidal; Shen, Binghui; Starnes, Linda M.; de Ruiter, Julian R.; Daniel, Jeremy A.; Konstantinopoulos, Panagiotis A.; Cortez, David; Cantor, Sharon B.; Fernandez-Capetillo, Oscar; Ge, Kai; Jonkers, Jos; Rottenberg, Sven; Sharan, Shyam K.; Nussenzweig, Andre			Replication fork stability confers chemoresistance in BRCA-deficient cells	NATURE			English	Article							HOMOLOGY-DIRECTED REPAIR; CONDITIONAL MOUSE MODEL; MUTANT-CELLS; DNA-DAMAGE; 53BP1; RECOMBINATION; RESISTANCE; RESECTION; RIF1; PTIP	Cells deficient in the Brca1 and Brca2 genes have reduced capacity to repair DNA double-strand breaks by homologous recombination and consequently are hypersensitive to DNA-damaging agents, including cisplatin and poly(ADP-ribose) polymerase (PARP) inhibitors. Here we show that loss of the MLL3/4 complex protein, PTIP, protects Brca1/2-deficient cells from DNA damage and rescues the lethality of Brca2-deficient embryonic stem cells. However, PTIP deficiency does not restore homologous recombination activity at double-strand breaks. Instead, its absence inhibits the recruitment of the MRE11 nuclease to stalled replication forks, which in turn protects nascent DNA strands from extensive degradation. More generally, acquisition of PARP inhibitors and cisplatin resistance is associated with replication fork protection in Brca2-deficient tumour cells that do not develop Brca2 reversion mutations. Disruption of multiple proteins, including PARP1 and CHD4, leads to the same end point of replication fork protection, highlighting the complexities by which tumour cells evade chemotherapeutic interventions and acquire drug resistance.	[Chaudhuri, Arnab Ray; Callen, Elsa; Wong, Nancy; John, Sam; Day, Amanda; Crespo, Anna Vidal; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Ding, Xia; Sharan, Shyam K.] NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21702 USA; [Gogola, Ewa; Duarte, Alexandra A.; de Ruiter, Julian R.; Jonkers, Jos; Rottenberg, Sven] Netherlands Canc Inst, Div Mol Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Ding, Xia; Gogola, Ewa; de Ruiter, Julian R.; Jonkers, Jos; Rottenberg, Sven] Netherlands Canc Inst, Canc Genom Ctr, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Lee, Ji-Eun; Ge, Kai] NIDDK, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Lafarga, Vanessa; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid 28029, Spain; [Calvo, Jennifer A.; Panzarino, Nicholas J.; Cantor, Sharon B.] Univ Massachusetts, Sch Med, UMASS Mem Canc Ctr, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Shen, Binghui] City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Starnes, Linda M.; Daniel, Jeremy A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Konstantinopoulos, Panagiotis A.] Harvard Med Sch, Dana Farber Canc Inst, Dept Gynecol Med Oncol, Boston, MA 02215 USA; [Cortez, David] Vanderbilt Univ, Dept Biochem, Sch Med, 2215 Garland Ave, Nashville, TN 37232 USA; [Rottenberg, Sven] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Langgassstr 122, CH-3012 Bern, Switzerland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Netherlands Cancer Institute; Netherlands Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Massachusetts System; University of Massachusetts Worcester; University Massachusetts Worcester Hospital; City of Hope; Beckman Research Institute of City of Hope; Novo Nordisk Foundation; University of Copenhagen; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Vanderbilt University; University of Bern	Nussenzweig, A (corresponding author), NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Lee, Ji-Eun/F-7891-2011; Fernandez-Capetillo, Oscar/H-3508-2015; Ge, Kai/H-2810-2019; Jonkers, Jos/AAG-3246-2019; Daniel, Jeremy/S-4729-2016	Lee, Ji-Eun/0000-0002-3768-7016; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Ge, Kai/0000-0002-7442-5138; Jonkers, Jos/0000-0002-9264-9792; Daniel, Jeremy/0000-0002-1981-5571; Shen, Binghui/0000-0002-4408-407X; Starnes, Linda/0000-0002-7322-9928; Gogola, Ewa/0000-0002-5733-770X; Rottenberg, Sven/0000-0003-2044-9844	Intramural Research Program of the National Institutes of Health (NIH), the National Cancer Institute; Center for Cancer Research; Department of Defense [11557134]; Netherlands Organization for Scientific Research; Dutch Cancer Society; Swiss National Science Foundation; Swiss National Science Foundation [PBZHP3 147302]; Human Frontier Science Program Long-Term Fellowship [LT000393/2013]; NIH [R01 CA176166-01A1, R01CA085344]; Novo Nordisk Foundation [NNF14CC0001]; NATIONAL CANCER INSTITUTE [R01CA085344, ZIABC010959, ZIABC011311, R01CA176166, ZIABC010283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075003, ZIADK075017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116616] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), the National Cancer Institute; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Bhandoola for discussions; K. Wolcott for flow cytometry; R. Faryabi for help with statistical analysis; T. de Lange for Rif1<SUP>f/f</SUP> mice, J. Tainer for PFM39, R. Brosh for WRNi and J. Petrini for Mre11 antibodies. This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), the National Cancer Institute and the Center for Cancer Research, and by a Department of Defense grant to A.N. (BCRP DOD Idea Expansion Award, grant 11557134), and the Netherlands Organization for Scientific Research, the Dutch Cancer Society and the Swiss National Science Foundation to S.V. A.R.C. was supported by a Prospective Researcher Award from Swiss National Science Foundation (PBZHP3 147302) and Human Frontier Science Program Long-Term Fellowship (LT000393/2013). S.C. was supported by NIH grant R01 CA176166-01A1; B.S. was supported by NIH grant R01CA085344; and J.A.D. was supported by a grant to the Center for Protein Research from the Novo Nordisk Foundation (NNF14CC0001).	Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Chen H, 2015, P NATL ACAD SCI USA, V112, pE1880, DOI 10.1073/pnas.1503331112; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Ding X., 2016, NATURE COMMUN; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Guillemette S, 2015, GENE DEV, V29, P489, DOI 10.1101/gad.256214.114; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kuznetsov SG, 2008, NAT MED, V14, P875, DOI 10.1038/nm.1719; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Liu WP, 2016, EBIOMEDICINE, V6, P73, DOI 10.1016/j.ebiom.2016.02.043; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Pathania S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6496; Pathania S, 2011, MOL CELL, V44, P235, DOI 10.1016/j.molcel.2011.09.002; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Puddu F, 2015, EMBO J, V34, P1509, DOI 10.15252/embj.201590973; Rottenberg S, 2007, P NATL ACAD SCI USA, V104, P12117, DOI 10.1073/pnas.0702955104; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Starnes LM, 2016, GENE DEV, V30, P149, DOI 10.1101/gad.268797.115; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Willis NA, 2014, NATURE, V510, P556, DOI 10.1038/nature13295; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	44	475	477	7	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					382	+		10.1038/nature18325	http://dx.doi.org/10.1038/nature18325			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27443740	Green Accepted, Green Submitted			2022-12-24	WOS:000380344200032
J	Hilborn, R				Hilborn, Ray			Marine biodiversity needs more than protection	NATURE			English	Editorial Material							FISHERIES; RESERVES		[Hilborn, Ray] Univ Washington, Sch Aquat & Fisheries Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hilborn, R (corresponding author), Univ Washington, Sch Aquat & Fisheries Sci, Seattle, WA 98195 USA.	rayh@uw.edu						Christie P, 2014, GOVERNANCE OF MARINE FISHERIES AND BIODIVERSITY CONSERVATION: INTERACTION AND COEVOLUTION, P332; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Klein CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17539; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; LUBCHENCO J, 2002, SCI MARINE RESERVES; Lubchenco J, 2015, SCIENCE, V350, P382, DOI 10.1126/science.aad5443; Ocean Studies Board, 2014, EV EFF FISH STOCK RE	9	72	72	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					224	226		10.1038/535224a	http://dx.doi.org/10.1038/535224a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR4ZN	27411619	Bronze			2022-12-24	WOS:000379912600027
J	Friedland, G				Friedland, Gerald			Marking Time in the Global HIV/AIDS Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Friedland, Gerald] Yale Sch Med, Dept Internal Med, AIDS Program, Infect Dis Sect, New Haven, CT 06510 USA	Yale University	Friedland, G (corresponding author), Yale Sch Med, AIDS Program, 135 Coll St, New Haven, CT 06510 USA.	gerald.friedland@yale.edu						Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; *JOINT UN PROGR HI, 2000, REP GLOB HIV AIDS EP; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; US Centers for Disease Control and Prevention, 2016, TOD HIV AIDS EP	5	6	7	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2016	316	2					145	146		10.1001/jama.2016.9006	http://dx.doi.org/10.1001/jama.2016.9006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ9CW	27404179				2022-12-24	WOS:000379509000007
J	Dyer, C				Dyer, Clare			Nurofen advertisement was misleading, says watchdog	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Coopes A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6852	1	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3669	10.1136/bmj.i3669	http://dx.doi.org/10.1136/bmj.i3669			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27363717				2022-12-24	WOS:000379019700022
J	Jongsma, MLM; Berlin, I; Wijdeven, RHM; Janssen, L; Janssen, GMC; Garstka, MA; Janssen, H; Mensink, M; van Veelen, PA; Spaapen, RM; Neefjes, J				Jongsma, Marlieke L. M.; Berlin, Ilana; Wijdeven, Ruud H. M.; Janssen, Lennert; Janssen, George M. C.; Garstka, Malgorzata A.; Janssen, Hans; Mensink, Mark; van Veelen, Peter A.; Spaapen, Robbert M.; Neefjes, Jacques			An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport	CELL			English	Article							CHOLESTEROL; TRAFFICKING; RECRUITMENT; CONTACTS; BINDING; DYNEIN; GLUT4; T6BP; RILP	Through a network of progressively maturing vesicles, the endosomal system connects the cell's interior with extracellular space. Intriguingly, this network exhibits a bilateral architecture, comprised of a relatively immobile perinuclear vesicle "cloud" and a highly dynamic peripheral contingent. How this spatiotemporal organization is achieved and what function(s) it curates is unclear. Here, we reveal the endoplasmic reticulum (ER)-located ubiquitin ligase Ring finger protein 26 (RNF26) as the global architect of the entire endosomal system, including the trans-Golgi network (TGN). To specify perinuclear vesicle coordinates, catalytically competent RNF26 recruits and ubiquitinates the scaffold p62/sequestosome 1 (p62/SQSTM1), in turn attracting ubiquitin-binding domains (UBDs) of various vesicle adaptors. Consequently, RNF26 restrains fast transport of diverse vesicles through a common molecular mechanism operating at the ER membrane, until the deubiquitinating enzyme USP15 opposes RNF26 activity to allow vesicle release into the cell's periphery. By drawing the endosomal system's architecture, RNF26 orchestrates endosomal maturation and trafficking of cargoes, including signaling receptors, in space and time.	[Jongsma, Marlieke L. M.; Berlin, Ilana; Wijdeven, Ruud H. M.; Janssen, Lennert; Garstka, Malgorzata A.; Janssen, Hans; Mensink, Mark; Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Janssen, George M. C.; van Veelen, Peter A.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, POB 9600, NL-2300 RC Leiden, Netherlands; [Jongsma, Marlieke L. M.; Spaapen, Robbert M.] Sanquin Res & Landsteiner Lab AMC UvA, Dept Immunopathol, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands; [Neefjes, Jacques] Leiden Univ, Med Ctr, Dept Chem Immunol, POB 9600, NL-2300 RC Leiden, Netherlands	Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Berlin, I; Neefjes, J (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.; Neefjes, J (corresponding author), Leiden Univ, Med Ctr, Dept Chem Immunol, POB 9600, NL-2300 RC Leiden, Netherlands.	i.berlin@nki.nl; j.neefjes@nki.nl	Spaapen, Robbert/AAF-9105-2021; Garstka, Malgorzata A./AAU-4401-2020; Neefjes, Jacques J.C./H-8780-2017	Garstka, Malgorzata A./0000-0003-2896-7275; Neefjes, Jacques J.C./0000-0001-6763-2211; Spaapen, Robbert/0000-0002-1329-8606; Janssen, Lennert/0000-0001-9705-0204; Mensink, Mark/0000-0002-2470-6919; van Veelen, Peter/0000-0002-7898-9408	ICI; NWO Gravitation project - Ministry of Education, Culture and Science of the Netherlands; ERC Advanced Grant; long-term EMBO fellowships	ICI; NWO Gravitation project - Ministry of Education, Culture and Science of the Netherlands; ERC Advanced Grant(European Research Council (ERC)); long-term EMBO fellowships	We thank J. Borst for valuable discussions and critical reading of the manuscript and B. van den Broek for help with the Cell Profiler software. We also thank the NKI Protein Production Facility and L. Oomen and L. Brocks for Microscopy Facility support, and particularly L. Oomen for advice on TrackMate software. This work was supported by the ICI, an NWO Gravitation project funded by the Ministry of Education, Culture and Science of the Netherlands and an ERC Advanced Grant awarded to J.N. I.B. and M.G. were recipients of long-term EMBO fellowships.	Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Ling L, 2000, P NATL ACAD SCI USA, V97, P9567, DOI 10.1073/pnas.170279097; Lippai M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832704; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Morriswood B, 2007, J CELL SCI, V120, P2574, DOI 10.1242/jcs.007005; Paul P, 2011, CELL, V145, P268, DOI 10.1016/j.cell.2011.03.023; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Pulido IR, 2011, TRAFFIC, V12, P1371, DOI 10.1111/j.1600-0854.2011.01248.x; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Sadacca LA, 2013, MOL BIOL CELL, V24, P2544, DOI 10.1091/mbc.E13-02-0103; Schroeder CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03351; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sorkin A, 2007, MOL CELL, V26, P771, DOI 10.1016/j.molcel.2007.06.003; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; Valderrama F, 1998, EUR J CELL BIOL, V76, P9, DOI 10.1016/S0171-9335(98)80012-5; van der Kant R, 2014, J CELL SCI, V127, P929, DOI 10.1242/jcs.137539; van der Kant R, 2013, J CELL SCI, V126, P3462, DOI 10.1242/jcs.129270; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Watts C, 2012, BBA-PROTEINS PROTEOM, V1824, P14, DOI 10.1016/j.bbapap.2011.07.006; Wubbolts R, 1999, J CELL SCI, V112, P785; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	32	129	130	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					152	166		10.1016/j.cell.2016.05.078	http://dx.doi.org/10.1016/j.cell.2016.05.078			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368102	hybrid, Green Published			2022-12-24	WOS:000380254400018
J	Green, DR				Green, Douglas R.			A BH3 Mimetic for Killing Cancer Cells	CELL			English	Editorial Material									[Green, Douglas R.] St Jude Childrens Res Inst, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Green, DR (corresponding author), St Jude Childrens Res Inst, Dept Immunol, Memphis, TN 38105 USA.	douglas.green@stjude.org	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096208] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM096208] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	63	65	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1560	1560		10.1016/j.cell.2016.05.080	http://dx.doi.org/10.1016/j.cell.2016.05.080			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315468	Bronze			2022-12-24	WOS:000378062000003
J	Zaza, S; Kann, L; Barrios, LC				Zaza, Stephanie; Kann, Laura; Barrios, Lisa C.			Lesbian, Gay, and Bisexual Adolescents Population Estimate and Prevalence of Health Behaviors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zaza, Stephanie; Kann, Laura; Barrios, Lisa C.] US Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E-75, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Barrios, LC (corresponding author), US Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, 1600 Clifton Rd NE,Mailstop E-75, Atlanta, GA 30329 USA.	lbarrios@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Frost D.M., 2013, HDB PSYCHOL SEXUAL O, P252, DOI DOI 10.1093/ACPROF:OSO/9780199765218.003.0018; Institute of Medicine, 2011, HLTH LESB GAY BISEX; Kann L, 2016, MMWR SURVEILL SUMM, V65, P1; Kann L, 2016, MMWR-MORBID MORTAL W, V65, P106, DOI 10.15585/mmwr.mm6505a2; Mustanski B, 2014, AM J PUBLIC HEALTH, V104, P218, DOI 10.2105/AJPH.2013.301625; Trust for America's Health, 2014, ADDR SOC DET HLTH IN	6	68	67	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2355	2356		10.1001/jama.2016.11683	http://dx.doi.org/10.1001/jama.2016.11683			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE8OE	27532437	Green Accepted			2022-12-24	WOS:000389884600011
J	Khare, S; Nagle, AS; Biggart, A; Lai, YH; Liang, F; Davis, LC; Barnes, SW; Mathison, CJN; Myburgh, E; Gao, MY; Gillespie, JR; Liu, XZ; Tan, JL; Stinson, M; Rivera, IC; Ballard, J; Yeh, V; Groessl, T; Federe, G; Koh, HXY; Venable, JD; Bursulaya, B; Shapiro, M; Mishra, PK; Spraggon, G; Brock, A; Mottram, JC; Buckner, FS; Rao, SPS; Wen, BG; Walker, JR; Tuntland, T; Molteni, V; Glynne, RJ; Supek, F				Khare, Shilpi; Nagle, Advait S.; Biggart, Agnes; Lai, Yin H.; Liang, Fang; Davis, Lauren C.; Barnes, S. Whitney; Mathison, Casey J. N.; Myburgh, Elmarie; Gao, Mu-Yun; Gillespie, J. Robert; Liu, Xianzhong; Tan, Jocelyn L.; Stinson, Monique; Rivera, Ianne C.; Ballard, Jaime; Yeh, Vince; Groessl, Todd; Federe, Glenn; Koh, Hazel X. Y.; Venable, John D.; Bursulaya, Badry; Shapiro, Michael; Mishra, Pranab K.; Spraggon, Glen; Brock, Ansgar; Mottram, Jeremy C.; Buckner, Frederick S.; Rao, Srinivasa P. S.; Wen, Ben G.; Walker, John R.; Tuntland, Tove; Molteni, Valentina; Glynne, Richard J.; Supek, Frantisek			Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness	NATURE			English	Article							TRYPANOSOMA-CRUZI; RANDOMIZED-TRIAL; DRUG DISCOVERY; BENZNIDAZOLE; POSACONAZOLE; BORTEZOMIB; INFECTION; SYSTEM; GENE; CURE	Chagas disease, leishmaniasis and sleeping sickness affect 20 million people worldwide and lead to more than 50,000 deaths annually(1). The diseases are caused by infection with the kinetoplastid parasites Trypanosoma cruzi, Leishmania spp. and Trypanosoma brucei spp., respectively. These parasites have similar biology and genomic sequence, suggesting that all three diseases could be cured with drugs that modulate the activity of a conserved parasite target(2). However, no such molecular targets or broad spectrum drugs have been identified to date. Here we describe a selective inhibitor of the kinetoplastid proteasome (GNF6702) with unprecedented in vivo efficacy, which cleared parasites from mice in all three models of infection. GNF6702 inhibits the kinetoplastid proteasome through a non-competitive mechanism, does not inhibit the mammalian proteasome or growth of mammalian cells, and is well-tolerated in mice. Our data provide genetic and chemical validation of the parasite proteasome as a promising therapeutic target for treatment of kinetoplastid infections, and underscore the possibility of developing a single class of drugs for these neglected diseases.	[Khare, Shilpi; Nagle, Advait S.; Biggart, Agnes; Lai, Yin H.; Liang, Fang; Davis, Lauren C.; Barnes, S. Whitney; Mathison, Casey J. N.; Gao, Mu-Yun; Liu, Xianzhong; Tan, Jocelyn L.; Stinson, Monique; Rivera, Ianne C.; Ballard, Jaime; Yeh, Vince; Groessl, Todd; Federe, Glenn; Venable, John D.; Bursulaya, Badry; Shapiro, Michael; Spraggon, Glen; Brock, Ansgar; Wen, Ben G.; Walker, John R.; Tuntland, Tove; Molteni, Valentina; Glynne, Richard J.; Supek, Frantisek] Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA; [Myburgh, Elmarie; Mottram, Jeremy C.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland; [Myburgh, Elmarie; Mottram, Jeremy C.] Univ York, Dept Biol, Ctr Immunol & Infect, Wentworth Way, York YO10 5DD, N Yorkshire, England; [Gillespie, J. Robert; Buckner, Frederick S.] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Koh, Hazel X. Y.; Rao, Srinivasa P. S.] Novartis Inst Trop Dis, 10 Biopolis Rd, Singapore 138670, Singapore	Novartis; University of Glasgow; University of York - UK; University of Washington; University of Washington Seattle; Novartis	Supek, F (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.	fsupek@gnf.org	Gillespie, J. Robert/AAA-2496-2019; Buckner, Frederick/AAF-3938-2020	Buckner, Frederick/0000-0001-7796-6477; Myburgh, Elmarie/0000-0002-2007-5902; Mottram, Jeremy/0000-0001-5574-3766; Mathison, Casey/0000-0002-1310-826X	Wellcome Trust [091038/Z/09/Z, 104976/Z/14/Z, 104111/15/Z]; NIH [AI106850]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097177, R01AI106850] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the Wellcome Trust (091038/Z/09/Z to R.J.G. and F.S., and 104976/Z/14/Z, 104111/15/Z to J.C.M. and E.M.) and NIH (AI106850 to F.S.B.). We thank S. Croft, R. Don, L. Gredsted, A. Hudson and J. Mendlein for discussions, R. Tarleton for T. cruzi CL strain, and G. Cross for T. brucei Lister 427 strain. We thank A. Kreusch for help with proteasome purification, and F. Luna for help with T. cruzi whole-genome sequencing. We acknowledge technical assistance of O. Faghih in generating the plasmids for ectopic expression of PSMB4 in T. cruzi, R. Ritchie for IVIS in vivo imaging, and A. Mak, J. Matzen and P. Anderson for execution of high-throughput screens. We thank J. Isbell and T. Hollenbeck for profiling GNF6702 in ADME assays.	[Anonymous], 2012, WHO TECHN REP SER; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Bilbe G, 2015, SCIENCE, V348, P974, DOI 10.1126/science.aaa3683; Buckner FS, 1996, ANTIMICROB AGENTS CH, V40, P2592, DOI 10.1128/AAC.40.11.2592; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; Chatelain E, 2015, J BIOMOL SCREEN, V20, P22, DOI 10.1177/1087057114550585; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; Dorlo TPC, 2008, ANTIMICROB AGENTS CH, V52, P2855, DOI 10.1128/AAC.00014-08; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Fernandez Y, 2006, J BIOL CHEM, V281, P1107, DOI 10.1074/jbc.M511607200; HARIHARAN S, 1993, MOL BIOCHEM PARASIT, V57, P15, DOI 10.1016/0166-6851(93)90240-X; Hotez PJ, 2015, SCIENCE, V348, P296, DOI 10.1126/science.348.6232.296-b; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kalvass JC, 2001, DRUG METAB DISPOS, V29, P1332; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Khare S, 2015, ANTIMICROB AGENTS CH, V59, P6385, DOI 10.1128/AAC.00689-15; Khare S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005058; Li C, 2013, DRUG DISCOV TODAY, V18, P71, DOI 10.1016/j.drudis.2012.09.004; Li H, 2016, NATURE, V530, P233, DOI 10.1038/nature16936; Li XM, 2010, JNCI-J NATL CANCER I, V102, P1069, DOI 10.1093/jnci/djq198; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; McGwire BS, 2014, QJM-INT J MED, V107, P7, DOI 10.1093/qjmed/hct116; McLatchie AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002571; Melby PC, 2001, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1902S28; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574; Myburgh E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002384; Nagle AS, 2014, CHEM REV, V114, P11305, DOI 10.1021/cr500365f; Nelson KG, 2006, ANTIMICROB AGENTS CH, V50, P1238, DOI 10.1128/AAC.50.4.1238-1244.2006; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Sacks D, 2004, IMMUNOL REV, V201, P225, DOI 10.1111/j.0105-2896.2004.00185.x; Steverding D, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-29; Sundar S, 2015, EXPERT OPIN PHARMACO, V16, P237, DOI 10.1517/14656566.2015.973850; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Viotti R, 2014, ANTIMICROB AGENTS CH, V58, P635, DOI 10.1128/AAC.01662-13; Viotti R, 2009, EXPERT REV ANTI-INFE, V7, P157, DOI 10.1586/14787210.7.2.157; Wang JL, 2009, CHEM BIODIVERS, V6, P1887, DOI 10.1002/cbdv.200900117; Waters NJ, 2008, J PHARM SCI-US, V97, P4586, DOI 10.1002/jps.21317; WHO, 2010, WHO TECH REP SER, V949, P1; Wilk S., 2001, CURR PROTOC PROTEIN; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yardley V, 2000, INT J ANTIMICROB AG, V13, P243, DOI 10.1016/S0924-8579(99)00133-8; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	46	232	234	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					229	+		10.1038/nature19339	http://dx.doi.org/10.1038/nature19339			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27501246	Green Accepted			2022-12-24	WOS:000382539100047
J	Manglik, A; Lin, H; Aryal, DK; McCorvy, JD; Dengler, D; Corder, G; Levit, A; Kling, RC; Bernat, V; Hubner, H; Huang, XP; Sassano, MF; Giguere, PM; Lober, S; Duan, D; Scherrer, G; Kobilka, BK; Gmeiner, P; Roth, BL; Shoichet, BK				Manglik, Aashish; Lin, Henry; Aryal, Dipendra K.; McCorvy, John D.; Dengler, Daniela; Corder, Gregory; Levit, Anat; Kling, Ralf C.; Bernat, Viachaslau; Huebner, Harald; Huang, Xi-Ping; Sassano, Maria F.; Giguere, Patrick M.; Loeber, Stefan; Duan, Da; Scherrer, Gregory; Kobilka, Brian K.; Gmeiner, Peter; Roth, Bryan L.; Shoichet, Brian K.			Structure-based discovery of opioid analgesics with reduced side effects	NATURE			English	Article							A(2A) RECEPTOR ANTAGONISTS; PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; MORPHINE ANALGESIA; LIGAND DISCOVERY; BIASED AGONISM; MICE; PAIN; IDENTIFICATION; MODEL	Morphine is an alkaloid from the opium poppy used to treat pain. The potentially lethal side effects of morphine and related opioids-which include fatal respiratory depression-are thought to be mediated by mu-opioid-receptor (mu OR) signalling through the beta-arrestin pathway or by actions at other receptors. Conversely, G-protein mu OR signalling is thought to confer analgesia. Here we computationally dock over 3 million molecules against the mu OR structure and identify new scaffolds unrelated to known opioids. Structure-based optimization yields PZM21-a potent G(i) activator with exceptional selectivity for mu OR and minimal beta-arrestin-2 recruitment. Unlike morphine, PZM21 is more efficacious for the affective component of analgesia versus the reflexive component and is devoid of both respiratory depression and morphine-like reinforcing activity in mice at equi-analgesic doses. PZM21 thus serves as both a probe to disentangle mu OR signalling and a therapeutic lead that is devoid of many of the side effects of current opioids.	[Manglik, Aashish; Scherrer, Gregory; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lin, Henry; Levit, Anat; Duan, Da; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Aryal, Dipendra K.; McCorvy, John D.; Huang, Xi-Ping; Sassano, Maria F.; Giguere, Patrick M.; Roth, Bryan L.] UNC Chapel Hill Med Sch, Dept Pharmacol, Chapel Hill, NC 27514 USA; [Dengler, Daniela; Kling, Ralf C.; Bernat, Viachaslau; Huebner, Harald; Loeber, Stefan; Gmeiner, Peter] Univ Erlangen Nurnberg, Dept Chem & Pharm, Schuhstr 19, D-91052 Erlangen, Germany; [Corder, Gregory; Scherrer, Gregory] Stanford Univ, Sch Med, Stanford Neurosci Inst, Dept Anesthesiol Perioperat & Pain Med,Neurosurg, Stanford, CA 94305 USA; [Kling, Ralf C.] Paracelsus Med Univ, Inst Physiol & Pathophysiol, D-90419 Nurnberg, Germany	Stanford University; University of California System; University of California San Francisco; University of Erlangen Nuremberg; Stanford University	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.; Roth, BL (corresponding author), UNC Chapel Hill Med Sch, Dept Pharmacol, Chapel Hill, NC 27514 USA.; Gmeiner, P (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Schuhstr 19, D-91052 Erlangen, Germany.	kobilka@stanford.edu; peter.gmeiner@fau.de; bryan_roth@med.unc.edu; shoichet@cgl.ucsf.edu	Roth, Bryan/ABE-7032-2020; Gmeiner, Peter/N-5275-2015; Roth, Bryan L/F-3928-2010; Bernat, Viachaslau/I-7606-2015	Roth, Bryan/0000-0002-0561-6520; Scherrer, Gregory/0000-0002-1983-5126; Gmeiner, Peter/0000-0002-4127-197X; Bernat, Viachaslau/0000-0003-4741-7420; Kobilka, Brian/0000-0001-5958-3990; Dengler, Daniela/0000-0002-3886-2621	US National Institutes of Health [GM106990, DA036246, GM59957]; National Institutes of Mental Health Psychoactive Drug Screening Program; Michael Hooker Distinguished Professorship; German Research Foundation [Gm 13/10, GRK 1910]; Stanford University Medical Scientist Training Program [T32GM007365]; American Heart Association [12PRE8120001];  [DA017204];  [DA035764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059957, T32GM067547, U19GM106990, T32GM007365, T32GM008294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH104974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204, R37DA036246, P01DA035764] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Mental Health Psychoactive Drug Screening Program; Michael Hooker Distinguished Professorship; German Research Foundation(German Research Foundation (DFG)); Stanford University Medical Scientist Training Program; American Heart Association(American Heart Association); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by the US National Institutes of Health grants GM106990 (B.K.K., B.K.S. and P.G.), DA036246 (B.K.K.), GM59957 (B.K.S.), and the National Institutes of Mental Health Psychoactive Drug Screening Program (B.L.R.) and DA017204 (B.L.R., D.A.), DA035764 (B.L.R.) and the Michael Hooker Distinguished Professorship (B.L.R.) and the German Research Foundation Grants Gm 13/10 and GRK 1910 (P.G). A.M. received support from the Stanford University Medical Scientist Training Program (T32GM007365) and the American Heart Association (12PRE8120001).	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Balter RE, 2013, J PHARMACOL TOX MET, V67, P162, DOI 10.1016/j.vascn.2013.02.003; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2003, J NEUROSCI, V23, P10265; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Carlsson J, 2010, J MED CHEM, V53, P3748, DOI 10.1021/jm100240h; Case DA., 2015, AMBER 2015; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P769, DOI 10.1289/ehp.0901631; de Graaf C, 2011, J MED CHEM, V54, P8195, DOI 10.1021/jm2011589; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Estes WK, 1941, J EXP PSYCHOL, V29, P390, DOI 10.1037/h0062283; ESTES WK, 1948, J EXP PSYCHOL, V38, P173, DOI 10.1037/h0057525; Fenalti G, 2015, NAT STRUCT MOL BIOL, V22, P265, DOI 10.1038/nsmb.2965; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Goetz A, 2011, J MOL BIOL, V414, P611, DOI 10.1016/j.jmb.2011.10.015; GOGAS KR, 1991, NEUROSCIENCE, V42, P617, DOI 10.1016/0306-4522(91)90031-I; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Han S, 2015, CELL, V162, P363, DOI 10.1016/j.cell.2015.05.057; Hiller C, 2013, J MED CHEM, V56, P5130, DOI 10.1021/jm400520c; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Huang XP, 2010, ASSAY DRUG DEV TECHN, V8, P727, DOI 10.1089/adt.2010.0331; Hubner H, 2000, J MED CHEM, V43, P756, DOI 10.1021/jm991098z; HUGHES J, 1975, NATURE, V258, P577, DOI 10.1038/258577a0; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; KISSIN I, 1991, ANESTHESIOLOGY, V74, P166, DOI 10.1097/00000542-199101000-00025; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lane JR, 2008, J PHARMACOL EXP THER, V325, P319, DOI 10.1124/jpet.107.134296; Langmead CJ, 2012, J MED CHEM, V55, P1904, DOI 10.1021/jm201455y; Le Bars D, 2001, PHARMACOL REV, V53, P597; Li C, 2016, NEUROPSYCHOPHARMACOL, V41, P2122, DOI 10.1038/npp.2016.12; LORD JAH, 1977, NATURE, V267, P495, DOI 10.1038/267495a0; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Moller D, 2014, J MED CHEM, V57, P4861, DOI 10.1021/jm5004039; Montandon G, 2016, ANESTHESIOLOGY, V124, P641, DOI 10.1097/ALN.0000000000000984; Muchmore SW, 2008, J CHEM INF MODEL, V48, P941, DOI 10.1021/ci7004498; Mysinger MM, 2012, P NATL ACAD SCI USA, V109, P5517, DOI 10.1073/pnas.1120431109; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nakajima K, 2015, NEUROMETHODS, V108, P29, DOI 10.1007/978-1-4939-2944-3_2; Negri A, 2013, J CHEM INF MODEL, V53, P521, DOI 10.1021/ci400019t; Nickolls SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083691; Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138; Powers RA, 2002, STRUCTURE, V10, P1013, DOI 10.1016/S0969-2126(02)00799-2; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Rajagopal S, 2013, NAT REV DRUG DISCOV, V12, DOI 10.1038/nrd3954-c1; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; RESCORLA RA, 1965, J COMP PHYSIOL PSYCH, V59, P406, DOI 10.1037/h0022060; SANBERG PR, 1988, BEHAV NEUROSCI, V102, P748, DOI 10.1037/0735-7044.102.5.748; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weichert D, 2014, P NATL ACAD SCI USA, V111, P10744, DOI 10.1073/pnas.1410415111; Weiss DR, 2013, ACS CHEM BIOL, V8, P1018, DOI 10.1021/cb400103f; WOOLF CJ, 1984, PAIN, V18, P325, DOI 10.1016/0304-3959(84)90045-9; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	75	554	573	17	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					185	+		10.1038/nature19112	http://dx.doi.org/10.1038/nature19112			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27533032	Green Submitted, Green Accepted			2022-12-24	WOS:000382539100038
J	Osberger, TJ; Rogness, DC; Kohrt, JT; Stepan, AF; White, MC				Osberger, Thomas J.; Rogness, Donald C.; Kohrt, Jeffrey T.; Stepan, Antonia F.; White, M. Christina			Oxidative diversification of amino acids and peptides by small-molecule iron catalysis	NATURE			English	Article							DIVERSITY-ORIENTED SYNTHESIS; NONRIBOSOMAL PEPTIDES; FUNCTIONALIZATION; SELECTIVITY; DISCOVERY; STRATEGY; ENZYMES; BONDS	Secondary metabolites synthesized by non-ribosomal peptide synthetases display diverse and complex topologies and possess a range of biological activities(1,2). Much of this diversity derives from a synthetic strategy that entails pre-3 and post-assembly(2) oxidation of both the chiral amino acid building blocks and the assembled peptide scaffolds. The vancomycin biosynthetic pathway is an excellent example of the range of oxidative transformations that can be performed by the iron-containing enzymes involved in its biosynthesis(4). However, because of the challenges associated with using such oxidative enzymes to carry out chemical transformations in vitro, chemical syntheses guided by these principles have not been fully realized in the laboratory(5). Here we report that two small-molecule iron catalysts are capable of facilitating the targeted C-H oxidative modification of amino acids and peptides with preservation of a-centre chirality. Oxidation of proline to 5-hydroxyproline furnishes a versatile intermediate that can be transformed to rigid arylated derivatives or flexible linear carboxylic acids, alcohols, olefins and amines in both monomer and peptide settings. The value of this C-H oxidation strategy is demonstrated in its capacity for generating diversity: four 'chiral pool' amino acids are transformed to twenty-one chiral unnatural amino acids representing seven distinct functional group arrays; late-stage C-H functionalizations of a single proline-containing tripeptide furnish eight tripeptides, each having different unnatural amino acids. Additionally, a macrocyclic peptide containing a proline turn element is transformed via late-stage C-H oxidation to one containing a linear unnatural amino acid.	[Osberger, Thomas J.; Rogness, Donald C.; White, M. Christina] Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA; [Kohrt, Jeffrey T.] Groton Labs, Pfizer Worldwide Res & Dev, Eastern Point Rd, Groton, CT 06340 USA; [Stepan, Antonia F.] Pfizer Worldwide Res & Dev, Worldwide Med Chem, Cambridge, MA 02139 USA	University of Illinois System; University of Illinois Urbana-Champaign; Pfizer; Pfizer	White, MC (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.	mcwhite7@illinois.edu		Osberger, Thomas/0000-0003-3737-4666	NIH/National Institute of General Medical Sciences [GM112492]; Pfizer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112492] Funding Source: NIH RePORTER	NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pfizer(Pfizer); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by the NIH/National Institute of General Medical Sciences (GM112492) and a grant from Pfizer to study the modification of natural products and medicinal compounds. T.J.O. is a Springborn Graduate Fellow. We thank L. Zhu for assistance with nuclear magnetic resonance spectroscopy, D. Gray and J. Bertke for X-ray crystallographic studies, A. I. Greenwood and J. Zhao for calculations on product (-)-10, W. A. van der Donk for use of his HPLC instrument, X. Yang and X. Zhao for assistance with Marfey's reagent for chiral amino acid analysis of tripeptide (-)-53, C. Jiang for preliminary studies of amino acid oxidations, and G. S. Snapper for substrate synthesis.	Beckmann HSG, 2013, NAT CHEM, V5, P861, DOI [10.1038/NCHEM.1729, 10.1038/nchem.1729]; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Dangel BD, 2001, J AM CHEM SOC, V123, P8149, DOI 10.1021/ja016280f; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Gong W, 2014, J AM CHEM SOC, V136, P16940, DOI 10.1021/ja510233h; Gormisky PE, 2013, J AM CHEM SOC, V135, P14052, DOI 10.1021/ja407388y; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Lau YH, 2014, CHEM SCI, V5, P1804, DOI 10.1039/c4sc00045e; Miller SJ, 1996, J AM CHEM SOC, V118, P9606, DOI 10.1021/ja961626l; Najera C, 1999, TETRAHEDRON-ASYMMETR, V10, P2245, DOI 10.1016/S0957-4166(99)00213-X; Ratnikov MO, 2013, J AM CHEM SOC, V135, P9475, DOI 10.1021/ja402479r; Rauk A, 1999, BIOCHEMISTRY-US, V38, P9089, DOI 10.1021/bi990249x; Rella MR, 2007, J ORG CHEM, V72, P525, DOI 10.1021/jo061910n; Saladino R, 1999, J ORG CHEM, V64, P8468, DOI 10.1021/jo990185w; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Scola PM, 2014, J MED CHEM, V57, P1730, DOI 10.1021/jm500297k; Seiple IB, 2014, ANGEW CHEM INT EDIT, V53, P4642, DOI 10.1002/anie.201400928; Shaw MH, 2016, SCIENCE, V352, P1304, DOI 10.1126/science.aaf6635; Stevenazzi A, 2014, BIOORG MED CHEM LETT, V24, P5349, DOI 10.1016/j.bmcl.2014.10.016; Turner NJ, 2011, CHEM REV, V111, P4073, DOI 10.1021/cr200111v; UCHIDA K, 1990, BIOCHEM BIOPH RES CO, V169, P265, DOI 10.1016/0006-291X(90)91463-3; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Wang P, 2012, CURR OPIN CHEM BIOL, V16, P362, DOI 10.1016/j.cbpa.2012.04.008; White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062; White MC, 2012, SCIENCE, V335, P807, DOI 10.1126/science.1207661; Yudin AK, 2015, CHEM SCI, V6, P30, DOI 10.1039/c4sc03089c; Zuo ZW, 2014, J AM CHEM SOC, V136, P5257, DOI 10.1021/ja501621q	30	165	167	10	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					214	219		10.1038/nature18941	http://dx.doi.org/10.1038/nature18941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27479323	Green Accepted			2022-12-24	WOS:000382539100044
J	Fearnside, PM				Fearnside, Philip M.			Brazilian politics threaten environmental policies	SCIENCE			English	Editorial Material							AMAZON		[Fearnside, Philip M.] Natl Inst Res Amazonia INPA, BR-69067375 Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia	Fearnside, PM (corresponding author), Natl Inst Res Amazonia INPA, BR-69067375 Manaus, Amazonas, Brazil.	pmfearn@inpa.gov.br	Fearnside, Philip M/GQA-6023-2022; Fearnside, Philip M/D-6559-2011	Fearnside, Philip M/0000-0003-3672-9082; Fearnside, Philip M/0000-0003-3672-9082				[Anonymous], 2016, BANCADA TENTA REVERT, pA; [Anonymous], 2014, SENADOR ELEITO MAIS; Baquero M., 2015, REV DEBATES, V9, P139; Barcelos I., 2016, FOLHA SAO PAULO, pB; Bergamon M., 2016, FOLHA SAO PAULO, pA; CFBio (Conselho Federal de Biologia), 2016, CFBIO ENTREGA OFICIO; Fearnside PM, 2007, ENVIRON MANAGE, V39, P601, DOI 10.1007/s00267-006-0149-2; Fearnside PM, 2014, WATER ALTERN, V7, P256; FEARNSIDE PM, 1995, ENVIRON CONSERV, V22, P7, DOI 10.1017/S0376892900034020; FEARNSIDE PM, 2015, GLOBAL LAND PROJ NEW, V0012, P00022; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Hernndez FD, 2011, NOVOS CAD NAEA, V14, P79; ISA, 2016, NOTA TECNICO JURIDIC; LIMA Gilsileide Cristina Barros, 2016, THESIS, P101; Lopes R. J., 2011, FOLHA SAO PAULO; Metzger JP, 2010, SCIENCE, V329, P276, DOI 10.1126/science.329.5989.276-b; [Ministerio Publico Federal Grupo de Trabalho Intercameral], 2016, NOTA TECNICA A PEC 6; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; OEco, 2015, RURALISTAS NAO DESIS; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Zucco C, 2011, LEGIS STUD QUART, V36, P363, DOI 10.1111/j.1939-9162.2011.00019.x	21	117	119	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					746	748		10.1126/science.aag0254	http://dx.doi.org/10.1126/science.aag0254			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5ZE	27540150				2022-12-24	WOS:000381561400018
J	Huskamp, HA; Iglehart, JK				Huskamp, Haiden A.; Iglehart, John K.			Mental Health and Substance-Use Reforms - Milestones Reached, Challenges Ahead	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRIMARY-CARE; MEDICAL-CARE; DISORDERS; ILLNESS; DEPRESSION; INSURANCE; QUALITY; PREVALENCE; MANAGEMENT; DISEASE		[Huskamp, Haiden A.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Huskamp, HA (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.							Alakeson V, 2010, HEALTH AFFAIR, V29, P867, DOI 10.1377/hlthaff.2010.0080; American Medical Association, 2016, AMA SEEKS INCR COV A; [Anonymous], 2007, ACT PLAN BEH HLTH WO; [Anonymous], 2011, HOM PROGR RES; [Anonymous], 2012, ASS BEH HLTH WELLN; [Anonymous], 2015, C MED CHIP; [Anonymous], 2015, 2015 STAT HLTH CAR Q; [Anonymous], 2012, MED BEN PHYS SERV 20; [Anonymous], LONG ROAD AH ACH TRU; Baird M, 2014, ANN FAM MED, V12, P183, DOI 10.1370/afm.1634; Barry CL, 2003, HEALTH AFFAIR, V22, P127, DOI 10.1377/hlthaff.22.5.127; Barry CL, 2015, HEALTH AFFAIR, V34, P2077, DOI 10.1377/hlthaff.2015.0685; Bishop TF, 2014, JAMA PSYCHIAT, V71, P176, DOI 10.1001/jamapsychiatry.2013.2862; Bishop TF, 2016, HLTH AFF MILLWOOD, V35, P271; Burns ME, 2015, PSYCHIAT SERV, V66, P221, DOI 10.1176/appi.ps.201400440; Busch AB, 2016, HEALTH AFFAIR, V35, P1247, DOI 10.1377/hlthaff.2015.1669; Centers for Disease Control and Prevention, INJ PREV CONTR OP OV; Centers for Disease Control and Prevention, 2015, INJ PREV CONTR OP OV; Coleman WL, 2009, PEDIATRICS, V124, P410, DOI 10.1542/peds.2009-1061; Creedon TB, 2016, HEALTH AFFAIR, V35, P1017, DOI 10.1377/hlthaff.2016.0098; Crowley RA, 2015, ANN INTERN MED, V163, P298, DOI 10.7326/M15-0510; CUNNINGHAM PJ, 2006, 16 CTR STUD HLTH SYS; Druss BG, 2006, GEN HOSP PSYCHIAT, V28, P145, DOI 10.1016/j.genhosppsych.2005.10.006; Edlund MJ, 2004, MED CARE, V42, P1158, DOI 10.1097/00005650-200412000-00002; Frank R. G., 2006, BETTER NOT WELL MENT; Frank RG, 2003, PSYCHIAT SERV, V54, P682, DOI 10.1176/appi.ps.54.5.682; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Golberstein E, 2015, AM J PSYCHIAT, V172, P182, DOI 10.1176/appi.ajp.2014.14030375; Goldman HH, 2006, NEW ENGL J MED, V354, P1378, DOI 10.1056/NEJMsa053737; Huetteman E., 2015, NY TIMES; Kathol RG, 2010, PSYCHOSOM MED, V72, P511, DOI 10.1097/PSY.0b013e3181e2c4a0; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Kilbourne AM, 2008, J GEN INTERN MED, V23, P1628, DOI 10.1007/s11606-008-0720-z; McGinty EE, 2015, SCHIZOPHR RES, V165, P227, DOI 10.1016/j.schres.2015.04.010; Mechanic D., 2014, MENTAL HLTH SOCIAL P; Milbank D., 2015, WASHINGTON POST; Murphy T., 2015, WALL STREET J; Prins SJ, 2014, PSYCHIAT SERV, V65, P862, DOI 10.1176/appi.ps.201300166; Scharf D.M., 2014, EVALUATION SAMHSA PR; Stanton E., 2016, INTEGRATION 2016 BEA; Statement of Harold Kudler M.D., 2015, COMMUNICATION; Steadman HJ, 2009, PSYCHIAT SERV, V60, P761, DOI 10.1176/ps.2009.60.6.761; Substance Abuse and Mental Health Services Administration, 2014, RES 2013 NAT SURV DR; Substance Abuse and Mental Health Services Administration, CAN WE LIV LONG INT; Substance Abuse and Mental Health Services Administration, 2015, REC SERV BEH HLTH PR; Substance Abuse and Mental Health Services Administration, 2014, PROJ NAT EXP TREATM; Swanson JW, 2015, ANN EPIDEMIOL, V25, P366, DOI 10.1016/j.annepidem.2014.03.004; Thomas KC, 2009, PSYCHIAT SERV, V60, P1323, DOI 10.1176/ps.2009.60.10.1323; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Zezima K., 2015, WASHINGTON POST	50	14	14	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					688	695		10.1056/NEJMhpr1601861	http://dx.doi.org/10.1056/NEJMhpr1601861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT4VF	27532837				2022-12-24	WOS:000381478600014
J	Baheerathan, A; Chauhan, D; Koizia, L; O'Neal, H				Baheerathan, Aravindhan; Chauhan, Devkishan; Koizia, Louis; O'Neal, Hugh			EASILY MISSED? Idiopathic normal pressure hydrocephalus	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS		[Baheerathan, Aravindhan] Univ Coll London Hosp, Dept Neurol, London WC1E 6AG, England; [Chauhan, Devkishan] Kingston Hosp, Dept Med, Kingston Upon Thames KT2 7QB, Surrey, England; [Koizia, Louis] Northwick Pk Hosp & Clin Res Ctr, Dept Med, Harrow HA1 3UJ, Middx, England; [O'Neal, Hugh] Worthing Dist Hosp, Care Elderly Dept, Worthing BN11 2DH, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London	Baheerathan, A (corresponding author), Univ Coll London Hosp, Dept Neurol, London WC1E 6AG, England.	a.baheerathan89@gmail.com						Conn HO, 2007, CLIN MED, V7, P296, DOI 10.7861/clinmedicine.7-3-296; Jaraj D, 2014, NEUROLOGY, V82, P1449, DOI 10.1212/WNL.0000000000000342; Kiefer M, 2012, DTSCH ARZTEBL INT, V109, P15, DOI 10.3238/arztebl.2012.0015; Malm J., 2006, PRACT NEUROL, V6, P14, DOI DOI 10.1136/JNNP.2006.088351; Malm J, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-22; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; Pradhan S, 2008, GERIATRIC MED, V10, P589; Pujari S, 2008, J NEUROL NEUROSUR PS, V79, P1282, DOI 10.1136/jnnp.2007.123620; Razay G, 2013, ALZHEIMERS DEMENT, V9, DOI [10.1016/j.jalz.2013.05.1530, DOI 10.1016/J.JALZ.2013.05.1530]; Sasaki Makoto, 2008, Brain and Nerve (Tokyo), V60, P241; Shprecher D, 2008, CURR NEUROL NEUROSCI, V8, P371, DOI 10.1007/s11910-008-0058-2; Toma AK, 2013, ACTA NEUROCHIR, V155, P1977, DOI 10.1007/s00701-013-1835-5; Williams MA, 2013, NEUROL CLIN PRACT, V3, P375, DOI DOI 10.1212/CPJ.0B013-3182A78F6B	13	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2016	354								i3974	10.1136/bmj.i3974	http://dx.doi.org/10.1136/bmj.i3974			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GZ	27534774				2022-12-24	WOS:000381806400001
J	Martinez-Patino, MJ; Vilain, E; Bueno-Guerra, N				Jose Martinez-Patino, Maria; Vilain, Eric; Bueno-Guerra, Nereida			The unfinished race: 30 years of gender verification in sport	LANCET			English	Editorial Material							FEMALE; HYPERANDROGENISM		[Jose Martinez-Patino, Maria] Univ Vigo, Fac Educ Sci & Sports, Vigo, Galicia, Spain; [Vilain, Eric] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Vilain, Eric] CNRS, Int Joint Unit Epigenet Data Polit, Paris, France; [Bueno-Guerra, Nereida] Univ Barcelona, Dept Psychol & Clin Psychobiol, Barcelona 08025, Cataluna, Spain; [Bueno-Guerra, Nereida] Max Planck Inst Evolutionary Anthropol, Dept Dev Psychol, Leipzig, Saxony, Germany	Universidade de Vigo; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); University of Barcelona; Max Planck Society	Bueno-Guerra, N (corresponding author), Univ Barcelona, Dept Psychol & Clin Psychobiol, Barcelona 08025, Cataluna, Spain.; Bueno-Guerra, N (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev Psychol, Leipzig, Saxony, Germany.	nereidabuenoguerra@gmail.com	Bueno, Nereida/K-2743-2015; MARTINEZ-PATIÑO, MARIA JOSE/K-7359-2014	Bueno, Nereida/0000-0003-1442-7905; MARTINEZ-PATIÑO, MARIA JOSE/0000-0003-2721-9240				Allen DB, 2016, HORM RES PAEDIAT, V85, P278, DOI 10.1159/000444054; Arboleda VA, 2014, NAT REV ENDOCRINOL, V10, P603, DOI 10.1038/nrendo.2014.130; Bermon S, 2014, J CLIN ENDOCR METAB, V99, P4328, DOI 10.1210/jc.2014-1391; DREGER A., 2012, ATLANTIC; Elsas LJ, 2000, GENET MED, V2, P249, DOI 10.1097/00125817-200007000-00008; INTERNATIONAL ASSOCIATION OF ATHLETICS FEDERATIONS, 2011, REG GOV EL FEM HYP C; International Olympic Committee, 2015, OL CHART; International Olympic Committee, 2015, CONS M SEX REASS HYP; Karkazis K, 2012, AM J BIOETHICS, V12, P3, DOI 10.1080/15265161.2012.680533; Martinez-Patino MJ, 2005, LANCET, V366, pS38, DOI 10.1016/S0140-6736(05)67841-5; Sanchez FJ, 2013, J SEX RES, V50, P112, DOI 10.1080/00224499.2012.752429; Tucker R., 2009, S AFR J SPORTS MED, V21, P147, DOI [10.17159/2078-516X/2009/v21i4a283, DOI 10.17159/2078-516X/2009/V21I4A283]; World Anti-Doping Agency, 2015, PROH LIST 2015	13	5	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					541	543		10.1016/S0140-6736(16)30963-1	http://dx.doi.org/10.1016/S0140-6736(16)30963-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27511770				2022-12-24	WOS:000380756600008
J	Wallden, M; Fange, D; Lundius, EG; Baltekin, O; Elf, J				Wallden, Mats; Fange, David; Lundius, Ebba Gregorsson; Baltekin, Ozden; Elf, Johan			The Synchronization of Replication and Division Cycles in Individual E. coli Cells	CELL			English	Article							CHROMOSOME-REPLICATION; DNA-REPLICATION; INITIATION; SIZE; GROWTH; MODEL; K-12; ORGANIZATION; HOMEOSTASIS; MOVEMENT	Isogenic E. coli cells growing in a constant environment display significant variability in growth rates, division sizes, and generation times. The guiding principle appears to be that each cell, during one generation, adds a size increment that is uncorrelated to its birth size. Here, we investigate the mechanisms underlying this "adder'' behavior by mapping the chromosome replication cycle to the division cycle of individual cells using fluorescence microscopy. We have found that initiation of chromosome replication is triggered at a fixed volume per chromosome independent of a cell's birth volume and growth rate. Each initiation event is coupled to a division event after a growth-rate-dependent time. We formalize our findings in a model showing that cell-to-cell variation in division timing and cell size is mainly driven by variations in growth rate. The model also explains why fast-growing cells display adder behavior and correctly predict deviations from the adder behavior at slow growth.	[Wallden, Mats; Fange, David; Lundius, Ebba Gregorsson; Baltekin, Ozden; Elf, Johan] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Husargatan 3, S-75124 Uppsala, Sweden	Uppsala University	Elf, J (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Husargatan 3, S-75124 Uppsala, Sweden.	johan.elf@icm.uu.se			European Research Council; Vetenskapsradet; Knut and Alice Wallenberg Foundation	European Research Council(European Research Council (ERC)European Commission); Vetenskapsradet(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	We thank Gustaf Ullman, Alexis Boucharin, Erik Marklund, and Prune Leroy for valuable support in programming, data analysis, and cloning; Sajith Kecheril and Carolina Whalby for providing image analysis code; Bill Soderstrom for providing EC442; Benedict Michelle for providing JJC5350; and Torsten Waldminghaus and Daniel Schindler for providing DS116. This work was supported by the European Research Council, Vetenskapsradet, and the Knut and Alice Wallenberg Foundation.	Adiciptaningrum A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18261; Amir A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.208102; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; Campos M, 2014, CELL, V159, P1433, DOI 10.1016/j.cell.2014.11.022; Chai Q, 2014, J BIOL CHEM, V289, P11342, DOI 10.1074/jbc.M114.557348; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; Donachie WD, 2003, CURR OPIN MICROBIOL, V6, P146, DOI 10.1016/S1369-5274(03)00026-2; Edelstein Arthur D, 2014, J Biol Methods, V1; Hammar P, 2014, NAT GENET, V46, P405, DOI 10.1038/ng.2905; HANSEN FG, 1991, RES MICROBIOL, V142, P161, DOI 10.1016/0923-2508(91)90025-6; HELMSTETTER CE, 1987, J BACTERIOL, V169, P3489, DOI 10.1128/jb.169.8.3489-3494.1987; Hill NS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002549; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Kasho K, 2013, P NATL ACAD SCI USA, V110, P936, DOI 10.1073/pnas.1212070110; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Magnusson KEG, 2015, IEEE T MED IMAGING, V34, P911, DOI 10.1109/TMI.2014.2370951; Michelsen O, 2003, MICROBIOL-SGM, V149, P1001, DOI 10.1099/mic.0.26058-0; Osella M, 2014, P NATL ACAD SCI USA, V111, P3431, DOI 10.1073/pnas.1313715111; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Paulsson JP, 2000, J MOL BIOL, V297, P179, DOI 10.1006/jmbi.2000.3526; Pritchard R.H., 1968, DNA SYNTHESIS, P1; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Sadanandan S., 2014, IEEE J-STSP, V10, P174; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Skarstad K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012922; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Soderstrom B, 2014, MOL MICROBIOL, V92, P1, DOI 10.1111/mmi.12534; SOMPAYRAC L, 1973, NATURE-NEW BIOL, V241, P133, DOI 10.1038/newbio241133a0; Taheri-Araghi S, 2015, CURR BIOL, V25, P385, DOI 10.1016/j.cub.2014.12.009; Ullman G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0025; Voorn WJ, 1998, ARCH MICROBIOL, V169, P43; Waldminghaus T, 2012, NUCLEIC ACIDS RES, V40, P5465, DOI 10.1093/nar/gks187; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; WOLD S, 1994, EMBO J, V13, P2097, DOI 10.1002/j.1460-2075.1994.tb06485.x	42	166	167	3	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					729	739		10.1016/j.cell.2016.06.052	http://dx.doi.org/10.1016/j.cell.2016.06.052			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471967	Bronze			2022-12-24	WOS:000380546500022
J	Perry, M; Kinoshita, M; Saldi, G; Huo, L; Arikawa, K; Desplan, C				Perry, Michael; Kinoshita, Michiyo; Saldi, Giuseppe; Huo, Lucy; Arikawa, Kentaro; Desplan, Claude			Molecular logic behind the three-way stochastic choices that expand butterfly colour vision	NATURE			English	Article							2 VISUAL PIGMENTS; HISTOLOGICAL LOCALIZATION; PHOTORECEPTOR CELLS; EXPRESSION; DROSOPHILA; EYE; RECEPTOR; RETINA; OPSINS; GENE	Butterflies rely extensively on colour vision to adapt to the natural world. Most species express a broad range of colour-sensitive Rhodopsin proteins in three types of ommatidia (unit eyes), which are distributed stochastically across the retina(1-3). The retinas of Drosophila melanogaster use just two main types, in which fate is controlled by the binary stochastic decision to express the transcription factor Spineless in R7 photoreceptors(4). We investigated how butterflies instead generate three stochastically distributed ommatidial types, resulting in a more diverse retinal mosaic that provides the basis for additional colour comparisons and an expanded range of colour vision. We show that the Japanese yellow swallowtail (Papilio xuthus, Papilionidae) and the painted lady (Vanessa cardui, Nymphalidae) butterflies have a second R7-like photoreceptor in each ommatidium. Independent stochastic expression of Spineless in each R7-like cell results in expression of a blue-sensitive (SpinelessON) or an ultraviolet (UV)-sensitive (Spineless(OFF)) Rhodopsin. In P. xuthus these choices of blue/blue, blue/UV or UV/UV sensitivity in the two R7 cells are coordinated with expression of additional Rhodopsin proteins in the remaining photoreceptors, and together define the three types of ommatidia. Knocking out spineless using CRISPR/Cas9 (refs 5, 6) leads to the loss of the blue-sensitive fate in R7-like cells and transforms retinas into homogeneous fields of UV/UV-type ommatidia, with corresponding changes in other coordinated features of ommatidial type. Hence, the three possible outcomes of Spineless expression define the three ommatidial types in butterflies. This developmental strategy allowed the deployment of an additional red-sensitive Rhodopsin in P. xuthus, allowing for the evolution of expanded colour vision with a greater variety of receptors(7,8). This surprisingly simple mechanism that makes use of two binary stochastic decisions coupled with local coordination may prove to be a general means of generating an increased diversity of developmental outcomes.	[Perry, Michael; Huo, Lucy; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA; [Kinoshita, Michiyo; Arikawa, Kentaro] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Lab Neuroethol, SOKENDAI, Hayama, Kanagawa 2400115, Japan; [Saldi, Giuseppe; Desplan, Claude] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates	New York University; Graduate University for Advanced Studies - Japan	Desplan, C (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.; Desplan, C (corresponding author), New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates.	cd38@nyu.edu		Perry, Michael/0000-0002-5977-8031; Desplan, Claude/0000-0002-6914-1413; Arikawa, Kentaro/0000-0002-4365-0762; Kinoshita, Michiyo/0000-0002-5818-9622	NIH [EY13010]; Center for Genomics and Systems Biology of NYU Abu Dhabi; JSPS [26251036, 20167232]; NIH Ruth L. Kirschstein NRSA; JSPS Short Term Fellowship award; Revson Biomedical Research Foundation Postdoctoral Fellowship; NATIONAL EYE INSTITUTE [R01EY013010, K99EY027016, P30EY013079] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Genomics and Systems Biology of NYU Abu Dhabi; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS Short Term Fellowship award; Revson Biomedical Research Foundation Postdoctoral Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank members of the Desplan and Arikawa laboratories for discussion, and especially M. Wernet and J. Rister for suggestions We thank M. Friedrich for clarifying insect eye homologies, A. Stolfi for discussing CRISPR/Cas9 protocols, C. Merlin for discussing butterfly injection technique, and J. Bothma for discussion. We thank A. Monteiro for providing anti-Sal and K. Shi at Genscript for help with antibody design. This work was supported by NIH grant EY13010 and the Center for Genomics and Systems Biology of NYU Abu Dhabi to C.D., and the JSPS Kakenhi grant numbers 26251036 and 20167232 to K.A. M.P. was supported by an NIH Ruth L. Kirschstein NRSA, a JSPS Short Term Fellowship award, and the Revson Biomedical Research Foundation Postdoctoral Fellowship.	Arikawa K, 1997, J EXP BIOL, V200, P2501; Arikawa K, 1999, VISION RES, V39, P1, DOI 10.1016/S0042-6989(98)00070-4; Arikawa K, 1999, ZOOL SCI, V16, P17, DOI 10.2108/zsj.16.17; Arikawa K, 2003, J COMP PHYSIOL A, V189, P791, DOI 10.1007/s00359-003-0454-7; Arikawa K, 2003, J NEUROSCI, V23, P4527; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2008, J EXP BIOL, V211, P1805, DOI 10.1242/jeb.013045; BURGESS EA, 1990, MOL GEN GENET, V221, P347, DOI 10.1007/BF00259398; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chou WH, 1999, DEVELOPMENT, V126, P607; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; de Celis JF, 1999, DEVELOPMENT, V126, P2653; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Friedrich M, 2011, J EXP ZOOL PART B, V316B, P484, DOI 10.1002/jez.b.21424; Hsiao HY, 2012, JOVE-J VIS EXP, DOI 10.3791/4347; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnston RJ, 2011, CELL, V145, P956, DOI 10.1016/j.cell.2011.05.003; Kinoshita M, 2015, J COMP NEUROL, V523, P162, DOI 10.1002/cne.23674; Kinoshita M, 2014, J COMP PHYSIOL A, V200, P513, DOI 10.1007/s00359-014-0903-5; Kitamoto J, 2000, J EXP BIOL, V203, P2887; Kitamoto J, 1998, J EXP BIOL, V201, P1255; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; READY DF, 1989, TRENDS NEUROSCI, V12, P102, DOI 10.1016/0166-2236(89)90166-5; Rister J, 2013, DEVELOPMENT, V140, P493, DOI 10.1242/dev.079095; Rister J, 2011, DEV NEUROBIOL, V71, P1212, DOI 10.1002/dneu.20905; Stoehr AM, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-6; Takemura SY, 2005, J COMP NEUROL, V483, P341, DOI 10.1002/cne.20446; Thanawala SU, 2013, DEV CELL, V25, P93, DOI 10.1016/j.devcel.2013.02.016; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; Wernet MF, 2015, TRENDS GENET, V31, P316, DOI 10.1016/j.tig.2015.04.006; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Xie B, 2007, DEVELOPMENT, V134, P4243, DOI 10.1242/dev.012781	36	61	66	5	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					280	+		10.1038/nature18616	http://dx.doi.org/10.1038/nature18616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27383790	Green Submitted, Green Accepted			2022-12-24	WOS:000379912600056
J	Powers, JT; Tsanov, KM; Pearson, DS; Roels, F; Spina, CS; Ebright, R; Seligson, M; de Soysa, Y; Cahan, P; Theissen, J; Tu, HC; Han, A; Kurek, KC; LaPier, GS; Osborne, JK; Ross, SJ; Cesana, M; Collins, JJ; Berthold, F; Daley, GQ				Powers, John T.; Tsanov, Kaloyan M.; Pearson, Daniel S.; Roels, Frederik; Spina, Catherine S.; Ebright, Richard; Seligson, Marc; de Soysa, Yvanka; Cahan, Patrick; Theissen, Jessica; Tu, Ho-Chou; Han, Areum; Kurek, Kyle C.; LaPier, Grace S.; Osborne, Jihan K.; Ross, Samantha J.; Cesana, Marcella; Collins, James J.; Berthold, Frank; Daley, George Q.			Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COMPETITIVE ENDOGENOUS RNA; GENE-EXPRESSION; N-MYC; CANCER; TUMOR; LIN28B; CELLS; MIRNA; AMPLIFICATION	Poor prognosis in neuroblastoma is associated with genetic amplification of MYCN. MYCN is itself a target of let-7, a tumour suppressor family of microRNAs implicated in numerous cancers. LIN28B, an inhibitor of let-7 biogenesis, is overexpressed in neuroblastoma and has been reported to regulate MYCN. Here we show, however, that LIN28B is dispensable in MYCN-amplified neuroblastoma cell lines, despite de-repression of let-7. We further demonstrate that MYCN messenger RNA levels in amplified disease are exceptionally high and sufficient to sponge let-7, which reconciles the dispensability of LIN28B. We found that genetic loss of let-7 is common in neuroblastoma, inversely associated with MYCN amplification, and independently associated with poor outcomes, providing a rationale for chromosomal loss patterns in neuroblastoma. We propose that let-7 disruption by LIN28B, MYCN sponging, or genetic loss is a unifying mechanism of neuroblastoma development with broad implications for cancer pathogenesis.	[Powers, John T.; Tsanov, Kaloyan M.; Pearson, Daniel S.; Ebright, Richard; Seligson, Marc; de Soysa, Yvanka; Cahan, Patrick; Tu, Ho-Chou; Han, Areum; LaPier, Grace S.; Osborne, Jihan K.; Ross, Samantha J.; Cesana, Marcella; Daley, George Q.] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Roels, Frederik; Theissen, Jessica; Berthold, Frank] Univ Hosp Koln, Dept Pediat Oncol, D-50937 Cologne, Germany; [Spina, Catherine S.; Collins, James J.] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Kurek, Kyle C.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02215 USA; [Collins, James J.] Broad Inst MIT & Harvard, MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Daley, George Q.] Dana Farber Canc Inst, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Daley, George Q.] Boston Childrens Hosp, Boston, MA 02115 USA; [Daley, George Q.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; University of Cologne; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Daley, GQ (corresponding author), Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Dana Farber Canc Inst, Stem Cell Transplantat Program, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	george.daley@childrens.harvard.edu	/AAD-2039-2020; Powers, John/AAO-1018-2020; Cesana, Marcella/AAC-2697-2022; Tsanov, Kaloyan M/J-6852-2012	/0000-0001-9007-4844; Cesana, Marcella/0000-0002-9099-8681; Cahan, Patrick/0000-0003-3652-2540; DE SOYSA, TARJA/0000-0003-1394-3086; Spina, Catherine/0000-0001-6067-5024	National Institutes of Health [R01GM107536]; Alex's Lemonade Stand Foundation; Ellison Medical Foundation; National Institute of General Medical Sciences [T32GM007753]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107536, T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G.Q.D. is supported by National Institutes of Health grant R01GM107536, Alex's Lemonade Stand Foundation, and the Ellison Medical Foundation. G.Q.D. is an affiliate member of the Broad Institute, and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. J.T.P. was supported by Alex's Lemonade Stand Foundation. K.M.T. was supported as a Howard Hughes Medical Institute International Student Research Fellow and as a Herchel Smith Graduate Fellow. D.S.P. and R.E. were supported by award number T32GM007753 from the National Institute of General Medical Sciences.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Baeyens KJ, 1996, P NATL ACAD SCI USA, V93, P12851, DOI 10.1073/pnas.93.23.12851; Barone G, 2013, CLIN CANCER RES, V19, P5814, DOI 10.1158/1078-0432.CCR-13-0680; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beckers A, 2015, ONCOTARGET, V6, P5204, DOI 10.18632/oncotarget.2477; Blandino G, 2014, FEBS LETT, V588, P2639, DOI 10.1016/j.febslet.2014.03.033; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; Breen CJ, 2000, CANCER GENET CYTOGEN, V120, P44, DOI 10.1016/S0165-4608(99)00252-6; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cesana M, 2013, P NATL ACAD SCI USA, V110, P7112, DOI 10.1073/pnas.1305322110; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Ejeskar K, 1998, BRIT J CANCER, V77, P1787, DOI 10.1038/bjc.1998.297; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hackett CS, 2003, CANCER RES, V63, P5266; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Iwakawa R, 2013, GENE CHROMOSOME CANC, V52, P802, DOI 10.1002/gcc.22076; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Madison BB, 2013, GENE DEV, V27, P2233, DOI 10.1101/gad.224659.113; Maris JM, 2001, MED PEDIATR ONCOL, V36, P24, DOI 10.1002/1096-911X(20010101)36:1<24::AID-MPO1007>3.0.CO;2-7; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nguyen LH, 2014, CANCER CELL, V26, P248, DOI 10.1016/j.ccr.2014.06.018; Patro R, 2015, BIORXIV; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pugh TJ, 2014, ONCOGENE, V33, P5295, DOI 10.1038/onc.2014.150; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rakheja D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5802; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Spitz R, 2006, GENE CHROMOSOME CANC, V45, P1130, DOI 10.1002/gcc.20376; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Theissen J, 2014, GENE CHROMOSOME CANC, V53, P639, DOI 10.1002/gcc.22174; Theriault BL, 2014, CLIN EXP OPHTHALMOL, V42, P33, DOI 10.1111/ceo.12132; Tu HC, 2015, GENE DEV, V29, P1074, DOI 10.1101/gad.256693.114; Urbach A, 2014, GENE DEV, V28, P971, DOI 10.1101/gad.237149.113; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392	58	134	143	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					246	U112		10.1038/nature18632	http://dx.doi.org/10.1038/nature18632			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27383785	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000379912600049
J	Kumar, M; Wightman, R; Atanassov, I; Gupta, A; Hurst, CH; Hemsley, PA; Turner, S				Kumar, Manoj; Wightman, Raymond; Atanassov, Ivan; Gupta, Anjali; Hurst, Charlotte H.; Hemsley, Piers A.; Turner, Simon			S-Acylation of the cellulose synthase complex is essential for its plasma membrane localization	SCIENCE			English	Article							SECONDARY CELL-WALLS; ARABIDOPSIS; MICROTUBULES; PROTEINS; VISUALIZATION; PLANTS	Plant cellulose microfibrils are synthesized by a process that propels the cellulose synthase complex (CSC) through the plane of the plasma membrane. How interactions between membranes and the CSC are regulated is currently unknown. Here, we demonstrate that all catalytic subunits of the CSC, known as cellulose synthase A (CESA) proteins, are S-acylated. Analysis of Arabidopsis CESA7 reveals four cysteines in variable region 2 (VR2) and two cysteines at the carboxy terminus (CT) as S-acylation sites. Mutating both the VR2 and CTcysteines permits CSC assembly and trafficking to the Golgi but prevents localization to the plasma membrane. Estimates suggest that a single CSC contains more than 100 S-acyl groups, which greatly increase the hydrophobic nature of the CSC and likely influence its immediate membrane environment.	[Kumar, Manoj; Atanassov, Ivan; Gupta, Anjali; Turner, Simon] Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Wightman, Raymond] Univ Cambridge, Sainsbury Lab, Microscopy Core Facil, Bateman St, Cambridge CB2 1LR, England; [Hurst, Charlotte H.; Hemsley, Piers A.] Univ Dundee, Sch Life Sci, Div Plant Sci, Dow St, Dundee DD1 5EH, Scotland; [Hurst, Charlotte H.; Hemsley, Piers A.] James Hutton Inst, Cell & Mol Sci, Invergowrie DD2 5DA, Scotland; [Atanassov, Ivan] AgroBioInst, 8 Dragan Tzankov Blvd, Sofia 1164, Bulgaria	University of Manchester; University of Cambridge; University of Dundee; James Hutton Institute; Agricultural Academy - Bulgaria	Turner, S (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.; Hemsley, PA (corresponding author), Univ Dundee, Sch Life Sci, Div Plant Sci, Dow St, Dundee DD1 5EH, Scotland.; Hemsley, PA (corresponding author), James Hutton Inst, Cell & Mol Sci, Invergowrie DD2 5DA, Scotland.	p.a.hemsley@dundee.ac.uk; simon.turner@manchester.ac.uk	Wightman, Raymond/G-1054-2017	Wightman, Raymond/0000-0003-1295-4875; Hurst, Charlotte/0000-0002-4424-3480; Atanassov, Ivan/0000-0002-7771-3629; Turner, Simon/0000-0003-4859-1068; Hemsley, Piers/0000-0003-2950-0634	Biotechnology and Biological Sciences Research Council [BB/H012923/1, BB/M004031/1, BB/M024911/1]; Gatsby Charitable Foundation; BBSRC [BB/M004031/1, BB/M024911/1, BB/H012923/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C511064/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Ogas for a critical reading of the manuscript. H. Hofte kindly provided antibodies against CESA1 and CESA6. The work was funded by Biotechnology and Biological Sciences Research Council grants BB/H012923/1 and BB/M004031/1 to S.T. and BB/M024911/1 to P.A.H. The Microscopy Facility at the Sainsbury Laboratory is supported by the Gatsby Charitable Foundation. The authors declare no conflict of interest. M.K., R.W., I.A., A.G., C.H.H., and P.A.H. carried out the experimental work. M.K., P.A.H., and S.T. wrote the manuscript and conceived the experiments. Supplementary materials contain additional data. S.T. would like to dedicate this manuscript to physicist Roy Turner (1931-2016) for his support, encouragement, and help with advanced mathematics.	Atanassov II, 2009, J BIOL CHEM, V284, P3833, DOI 10.1074/jbc.M807456200; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Diotallevi F, 2007, BIOPHYS J, V92, P2666, DOI 10.1529/biophysj.106.099473; Fernandes AN, 2011, P NATL ACAD SCI USA, V108, pE1195, DOI 10.1073/pnas.1108942108; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Hemsley PA, 2015, NEW PHYTOL, V205, P476, DOI 10.1111/nph.13085; Hemsley PA, 2013, NEW PHYTOL, V197, P805, DOI 10.1111/nph.12077; Konrad SSA, 2015, TRENDS PLANT SCI, V20, P351, DOI 10.1016/j.tplants.2015.03.016; Kumar M, 2015, PHYTOCHEMISTRY, V112, P91, DOI 10.1016/j.phytochem.2014.07.009; Monier S, 1996, FEBS LETT, V388, P143, DOI 10.1016/0014-5793(96)00519-4; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Sethaphong L, 2013, P NATL ACAD SCI USA, V110, P7512, DOI 10.1073/pnas.1301027110; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Vergara CE, 2001, PLANT MOL BIOL, V47, P145, DOI 10.1023/A:1010631431620; Watanabe Y, 2015, SCIENCE, V350, P198, DOI 10.1126/science.aac7446; Wightman R, 2008, PLANT J, V54, P794, DOI 10.1111/j.1365-313X.2008.03444.x	19	48	54	0	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					166	169		10.1126/science.aaf4009	http://dx.doi.org/10.1126/science.aaf4009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27387950	Green Submitted, Green Accepted			2022-12-24	WOS:000379208400038
J	Vinogradova, Y; Coupland, C; Brindle, P; Hippisley-Cox, J				Vinogradova, Yana; Coupland, Carol; Brindle, Peter; Hippisley-Cox, Julia			Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DANISH POPULATION; HEART-DISEASE; LOW-RISK; ADHERENCE; THERAPY; NONADHERENCE; INEQUALITIES; CHOLESTEROL; PREDICTORS; PREVENTION	OBJECTIVES To estimate rates of discontinuation and restarting of statins, and to identify patient characteristics associated with either discontinuation or restarting. DESIGN Prospective open cohort study. SETTING 664 general practices contributing to the Clinical Practice Research Datalink in the United Kingdom. Data extracted in October 2014. PARTICIPANTS Incident statin users aged 25-84 years identified between January 2002 and September 2013. Patients with statin prescriptions divided into two groups: primary prevention and secondary prevention (those already diagnosed with cardiovascular disease). Patients with statin prescriptions in the 12 months before study entry were excluded. MAIN OUTCOME MEASURES Discontinuation of statin treatment (first 90 day gap after the estimated end date of a statin prescription), and restarting statin treatment for those who discontinued (defined as any subsequent prescription between discontinuation and study end). RESULTS Of 431 023 patients prescribed statins as primary prevention with a median follow-up time of 137 weeks, 47% (n = 204 622) discontinued treatment and 72% (n = 147 305) of those who discontinued restarted. Of 139 314 patients prescribed statins as secondary prevention with median follow-up time of 182 weeks, 41% (n = 57 791) discontinued treatment and 75% (43 211) of those who discontinued restarted. Younger patients (aged = 50 years), older patients (>= 75 years), women, and patients with chronic liver disease were more likely to discontinue statins and less likely to restart. However, patients in ethnic minority groups, current smokers, and patients with type 1 diabetes were more likely to discontinue treatment but then were more likely to restart, whereas patients with hypertension and type 2 diabetes were less likely to discontinue treatment and more likely to restart if they did discontinue. These results were mainly consistent in the primary prevention and secondary prevention groups. CONCLUSIONS Although a large proportion of statin users discontinue, many of them restart. For many patient groups previously considered as "stoppers," the problem of statin treatment " stopping" could be part of the wider issue of poor adherence. Identification of patient groups associated with completely stopping or stop-starting behaviour has positive implications for patients and doctors as well as suggesting areas for future research.	[Vinogradova, Yana; Coupland, Carol; Hippisley-Cox, Julia] Univ Nottingham, Div Primary Care, Univ Pk, Nottingham NG2 7RD, England; [Brindle, Peter] Bristol Clin Commissioning Grp, Avon Primary Care Res Collaborat, Bristol, Avon, England; [Brindle, Peter] Univ Bristol, Bristol, Avon, England	University of Nottingham; University of Bristol	Vinogradova, Y (corresponding author), Univ Nottingham, Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	Yana.Vinogradova@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306; Vinogradova, Yana/0000-0002-3030-5257	ClinRisk	ClinRisk	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any additional organisation for the submitted work; JH-C is a professor of clinical epidemiology at the University of Nottingham and unpaid director of QResearch, a not-for-profit organisation that is a joint partnership between the University of Nottingham and EMIS (Egton Medical Information System; commercial IT supplier for 60% of general practices in the UK); JH-C is also a paid director of ClinRisk, which produces open and closed source software to ensure the reliable and updatable implementation of clinical risk algorithms (including QRISK2) within clinical computer systems to help improve patient care; no other relationships or activities that could appear to have influenced the submitted work.	Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Caspard H, 2005, CLIN THER, V27, P1639, DOI 10.1016/j.clinthera.2005.10.005; Casula M, 2012, PATIENT PREFER ADHER, V6, P805, DOI 10.2147/PPA.S29092; Daskalopoulou SS, 2008, EUR HEART J, V29, P2083, DOI 10.1093/eurheartj/ehn346; Ferrajolo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112037; Granger BB, 2013, EUR J CARDIOVASC NUR, V12, P276, DOI 10.1177/1474515112447734; Halava H, 2014, CAN MED ASSOC J, V186, pE449, DOI 10.1503/cmaj.131807; Hippisley-Cox J, 2001, BMJ-BRIT MED J, V322, P832, DOI 10.1136/bmj.322.7290.832; Hippisley-Cox J, 2007, HEART, V93, P1256, DOI 10.1136/hrt.2006.110171; Hippisley-Cox Julia, 2010, BMJ, V340, pc2197, DOI 10.1136/bmj.c2197; Ingebrigtsen TS, 2015, THORAX, V70, P33, DOI 10.1136/thoraxjnl-2014-205795; Jensen MT, 2016, DIABETES RES CLIN PR, V111, P51, DOI 10.1016/j.diabres.2015.10.022; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Larsen J, 2002, BRIT J CLIN PHARMACO, V53, P375, DOI 10.1046/j.1365-2125.2002.01563.x; Lemstra M, 2012, CAN J CARDIOL, V28, P574, DOI 10.1016/j.cjca.2012.05.007; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Mancini GBJ, 2013, CAN J CARDIOL, V29, P1553, DOI 10.1016/j.cjca.2013.09.023; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; Mauskop Alexander, 2011, Curr Cardiol Rep, V13, P553, DOI 10.1007/s11886-011-0221-2; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; National Institute for Health and Care Excellence, 2014, LIP MOD CARD RISK AS; National Institute for Health and Care Excellence, 2008, LIP MOD CARD RISK AS; Nielsen SF, 2016, EUR HEART J, V37, P908, DOI 10.1093/eurheartj/ehv641; Pastori D, 2015, DIGEST LIVER DIS, V47, P4, DOI 10.1016/j.dld.2014.07.170; Prasad V, 2014, ANN INTERN MED, V160, P867, DOI 10.7326/M13-2974; Rosenbaum D, 2013, NUTR METAB CARDIOVAS, V23, P871, DOI 10.1016/j.numecd.2012.04.012; Royal Pharmaceutical Society of Great Britain British Medical Association, 2013, BRIT NAT FORM 66; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Schedlbauer A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004371.pub3; Smeeth L, 2003, QJM-INT J MED, V96, P337, DOI 10.1093/qjmed/hcg064; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Svensson E, 2015, CLIN EPIDEMIOL, V7, P213, DOI 10.2147/CLEP.S78145; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Trusler D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4350; Vinogradova Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008701; Warren JR, 2013, PHARMACOEPIDEM DR S, V22, P1298, DOI 10.1002/pds.3526; Young RP, 2009, EUR RESPIR REV, V18, P222, DOI 10.1183/09059180.00005309; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	41	77	77	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2016	353								i3305	10.1136/bmj.i3305	http://dx.doi.org/10.1136/bmj.i3305			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FP	27353261	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000379018000003
J	Gulland, A				Gulland, Anne			France's air pollution causes 48 000 deaths a year	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Sante Public France, 2016, IMP EXP CHRON PART F	1	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2016	353								i3523	10.1136/bmj.i3523	http://dx.doi.org/10.1136/bmj.i3523			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BX	27337979				2022-12-24	WOS:000378724000010
J	Elmore, JG; Tosteson, ANA; Pepe, MS; Longton, GM; Nelson, HD; Geller, B; Carney, PA; Onega, T; Allison, KH; Jackson, SL; Weaver, DL				Elmore, Joann G.; Tosteson, Anna N. A.; Pepe, Margaret S.; Longton, Gary M.; Nelson, Heidi D.; Geller, Berta; Carney, Patricia A.; Onega, Tracy; Allison, Kimberly H.; Jackson, Sara L.; Weaver, Donald L.			Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGICAL PATHOLOGY; VARIABILITY; REVIEWS; LESIONS; SLIDES	OBJECTIVE To evaluate the potential effect of second opinions on improving the accuracy of diagnostic interpretation of breast histopathology. DESIGN Simulation study. SETTING 12 different strategies for acquiring independent second opinions. PARTICIPANTS Interpretations of 240 breast biopsy specimens by 115 pathologists, one slide for each case, compared with reference diagnoses derived by expert consensus. MAIN OUTCOME MEASURES Misclassification rates for individual pathologists and for 12 simulated strategies for second opinions. Simulations compared accuracy of diagnoses from single pathologists with that of diagnoses based on pairing interpretations from first and second independent pathologists, where resolution of disagreements was by an independent third pathologist. 12 strategies were evaluated in which acquisition of second opinions depended on initial diagnoses, assessment of case difficulty or borderline characteristics, pathologists' clinical volumes, or whether a second opinion was required by policy or desired by the pathologists. The 240 cases included benign without atypia (10% non-proliferative, 20% proliferative without atypia), atypia (30%), ductal carcinoma in situ (DCIS, 30%), and invasive cancer (10%). Overall misclassification rates and agreement statistics depended on the composition of the test set, which included a higher prevalence of difficult cases than in typical practice. RESULTS Misclassification rates significantly decreased (P<0.001) with all second opinion strategies except for the strategy limiting second opinions only to cases of invasive cancer. The overall misclassification rate decreased from 24.7% to 18.1% when all cases received second opinions (P<0.001). Obtaining both first and second opinions from pathologists with a high volume (>= 10 breast biopsy specimens weekly) resulted in the lowest misclassification rate in this test set (14.3%, 95% confidence interval 10.9% to 18.0%). Obtaining second opinions only for cases with initial interpretations of atypia, DCIS, or invasive cancer decreased the over-interpretation of benign cases without atypia from 12.9% to 6.0%. Atypia cases had the highest misclassification rate after single interpretation (52.2%), remaining at more than 34% in all second opinion scenarios. CONCLUSION Second opinions can statistically significantly improve diagnostic agreement for pathologists' interpretations of breast biopsy specimens; however, variability in diagnosis will not be completely eliminated, especially for breast specimens with atypia.	[Elmore, Joann G.; Jackson, Sara L.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Pepe, Margaret S.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Longton, Gary M.] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, 1124 Columbia St, Seattle, WA 98104 USA; [Nelson, Heidi D.] Providence Hlth & Serv Oregon, Providence Canc Ctr, Portland, OR USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Dept Med Informat, Portland, OR 97201 USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Dept Clin Epidemiol & Med, Portland, OR 97201 USA; [Geller, Berta] Univ Vermont, Dept Family Med, Burlington, VT USA; [Carney, Patricia A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Onega, Tracy] Geisel Sch Med Dartmouth, Community & Family Med, Lebanon, NH USA; [Allison, Kimberly H.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Weaver, Donald L.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Weaver, Donald L.] Univ Vermont, UVM Canc Ctr, Burlington, VT USA	University of Washington; University of Washington Seattle; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Oregon Health & Science University; Oregon Health & Science University; University of Vermont; Oregon Health & Science University; Dartmouth College; Stanford University; University of Vermont; University of Vermont	Elmore, JG (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.	jelmore@uw.edu			National Cancer Institute [R01 CA140560, R01 CA172343, K05 CA104699]; National Cancer Institute funded Breast Cancer Surveillance Consortium [HHSN261201100031C]; NATIONAL CANCER INSTITUTE [R01CA172343, P30CA023108] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute funded Breast Cancer Surveillance Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (R01 CA140560, R01 CA172343, and K05 CA104699) and by the National Cancer Institute funded Breast Cancer Surveillance Consortium (HHSN261201100031C). The content is solely the responsibility of the authors and does not necessarily represent the vices of the National Cancer Institute or the National Institutes of Hearth.	Allison KH, 2014, HISTOPATHOLOGY, V65, P240, DOI 10.1111/his.12387; [Anonymous], 2015, IMPR DIAGN HLTH CAR; [Anonymous], 2000, ERR IS HUMAN BUILDIN; Bleiweiss IJ, 2012, J CLIN ONCOL, V30, P2175, DOI 10.1200/JCO.2012.42.1255; Davidson NE, 2015, JAMA-J AM MED ASSOC, V313, P1109, DOI 10.1001/jama.2015.1945; Dinnes J, 2001, BREAST, V10, P455, DOI 10.1054/brst.2001.0350; Elmore JG, 2016, ANN INTERN MED, V164, P649, DOI 10.7326/M15-0964; Elmore JG, 2015, JAMA-J AM MED ASSOC, V314, P83, DOI 10.1001/jama.2015.6239; Elmore JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI 10.1001/jama.2015.1405; Frable WJ, 2006, ARCH PATHOL LAB MED, V130, P620; Geller BM, 2014, J CLIN PATHOL, V67, P955, DOI 10.1136/jclinpath-2014-202290; Helmer O., 1964, SYSTEMATIC USE EXPER; Hofvind S, 2009, RADIOLOGY, V253, P652, DOI 10.1148/radiol.2533090210; Kennecke HF, 2012, J CLIN ONCOL, V30, P2227, DOI 10.1200/JCO.2011.38.9247; Khazai L, 2015, J SURG ONCOL, V111, P192, DOI 10.1002/jso.23788; Kronz JD, 1999, CANCER, V86, P2426, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2426::AID-CNCR34>3.0.CO;2-3; Manion E, 2008, AM J SURG PATHOL, V32, P732, DOI 10.1097/PAS.0b013e31815a04f5; Marco V, 2014, BREAST J, V20, P295, DOI 10.1111/tbj.12252; Middleton LP, 2014, J ONCOL PRACT, V10, P275, DOI 10.1200/JOP.2013.001204; Nakhleh RE, 2010, ARCH PATHOL LAB MED, V134, P740, DOI 10.1043/1543-2165-134.5.740; Newman EA, 2006, CANCER, V107, P2346, DOI 10.1002/cncr.22266; Onega T, 2014, J DIGIT IMAGING, V27, P642, DOI 10.1007/s10278-014-9683-2; Oster NV, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-3; Romanoff AM, 2014, ANN SURG ONCOL, V21, P3504, DOI 10.1245/s10434-014-3792-5; ROSAI J, 1991, AM J SURG PATHOL, V15, P209, DOI 10.1097/00000478-199103000-00001; SCHNITT SJ, 1992, AM J SURG PATHOL, V16, P1133, DOI 10.1097/00000478-199212000-00001; Silverstein M, 2009, J AM COLL SURGEONS, V208, P78, DOI 10.1016/j.jamcollsurg.2008.09.022; Silverstein Melvin J, 2009, J Am Coll Surg, V209, P504, DOI 10.1016/j.jamcollsurg.2009.07.006; Staradub VL, 2002, ANN SURG ONCOL, V9, P982, DOI 10.1245/ASO.2002.03.056; Tomaszewski JE, 2000, AM J CLIN PATHOL, V114, P329, DOI 10.1093/ajcp/114.3.329; Tsung JSH, 2004, AM J SURG PATHOL, V28, P399, DOI 10.1097/00000478-200403000-00015	31	20	20	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i3069	10.1136/bmj.i3069	http://dx.doi.org/10.1136/bmj.i3069			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27334105	Green Published, hybrid			2022-12-24	WOS:000378723500004
J	Buganim, Y				Buganim, Yosef			Back to basics Refined nuclear reprogramming techniques yield higher-quality stem cells	SCIENCE			English	Editorial Material									[Buganim, Yosef] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Buganim, Yosef] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel	Massachusetts Institute of Technology (MIT); Whitehead Institute; Hebrew University of Jerusalem	Buganim, Y (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA.; Buganim, Y (corresponding author), Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel.							Benchetrit H, 2015, CELL STEM CELL, V17, P543, DOI 10.1016/j.stem.2015.08.006; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Sebban S, 2016, TRENDS CELL BIOL, V26, P65, DOI 10.1016/j.tcb.2015.08.006	4	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1401	1401		10.1126/science.aag1215	http://dx.doi.org/10.1126/science.aag1215			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313030				2022-12-24	WOS:000377975400027
J	Wootten, D; Reynolds, CA; Smith, KJ; Mobarec, JC; Koole, C; Savage, EE; Pabreja, K; Simms, J; Sridhar, R; Furness, SGB; Liu, MJ; Thompson, PE; Miller, LJ; Christopoulos, A; Sexton, PM				Wootten, Denise; Reynolds, Christopher A.; Smith, Kevin J.; Mobarec, Juan C.; Koole, Cassandra; Savage, Emilia E.; Pabreja, Kavita; Simms, John; Sridhar, Rohan; Furness, Sebastian G. B.; Liu, Mengjie; Thompson, Philip E.; Miller, Laurence J.; Christopoulos, Arthur; Sexton, Patrick M.			The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism	CELL			English	Article							GLUCAGON-LIKE PEPTIDE-1; PROTEIN-COUPLED RECEPTOR; CLASS-B GPCR; BINDING; ACTIVATION; LIGANDS; REGIONS; LOOPS	Ligand-directed signal bias offers opportunities for sculpting molecular events, with the promise of better, safer therapeutics. Critical to the exploitation of signal bias is an understanding of the molecular events coupling ligand binding to intracellular signaling. Activation of class B G protein-coupled receptors is driven by interaction of the peptide N terminus with the receptor core. To understand how this drives signaling, we have used advanced analytical methods that enable separation of effects on pathway-specific signaling from those that modify agonist affinity and mapped the functional consequence of receptor modification onto three-dimensional models of a receptor-ligand complex. This yields molecular insights into the initiation of receptor activation and the mechanistic basis for biased agonism. Our data reveal that peptide agonists can engage different elements of the receptor extracellular face to achieve effector coupling and biased signaling providing a foundation for rational design of biased agonists.	[Wootten, Denise; Koole, Cassandra; Savage, Emilia E.; Pabreja, Kavita; Sridhar, Rohan; Furness, Sebastian G. B.; Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Liu, Mengjie; Thompson, Philip E.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Reynolds, Christopher A.; Smith, Kevin J.; Mobarec, Juan C.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Koole, Cassandra] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave, New York, NY 10065 USA; [Simms, John] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Miller, Laurence J.] Mayo Clin Scottsdale, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Monash University; Monash University; University of Essex; Rockefeller University; Aston University; Mayo Clinic; Mayo Clinic Phoenix	Wootten, D; Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia.	denise.wootten@monash.edu; patrick.sexton@monash.edu	Christopoulos, Arthur/B-6207-2013; Furness, Sebastian/Q-9068-2018; Wootten, Denise/ABD-5703-2021; Sexton, Patrick M/B-1319-2008; Reynolds, Christopher/G-1036-2010	Christopoulos, Arthur/0000-0003-4442-3294; Furness, Sebastian/0000-0001-8655-8221; Wootten, Denise/0000-0003-4563-1642; Sexton, Patrick M/0000-0001-8902-2473; Reynolds, Christopher/0000-0001-9267-5141; Liu, Mengjie (Oscar)/0000-0003-1944-5301; Thompson, Philip/0000-0002-5910-7625; Simms, John/0000-0002-4675-0902; Mobarec, Juan Carlos/0000-0001-9482-4294	National Health and Medical Research Council of Australia (NHMRC) project [1061044, 1065410]; NHMRC program [1055134]; Biotechnology and Biological Sciences Research Council of the United Kingdom project [BB/M006883/1]; Medical Research Council (UK) Research Leader Fellowship [G1001812]; Biotechnology and Biological Sciences Research Council [BB/M007529/1, BB/M006883/1, BB/G000719/1] Funding Source: researchfish; Medical Research Council [G1001812] Funding Source: researchfish; BBSRC [BB/M006883/1, BB/G000719/1, BB/M007529/1] Funding Source: UKRI; MRC [G1001812] Funding Source: UKRI	National Health and Medical Research Council of Australia (NHMRC) project(National Health and Medical Research Council (NHMRC) of Australia); NHMRC program(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council of the United Kingdom project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK) Research Leader Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Health and Medical Research Council of Australia (NHMRC) project grants (1061044 and 1065410) and NHMRC program grant (1055134); Biotechnology and Biological Sciences Research Council of the United Kingdom project grant (BB/M006883/1); and Medical Research Council (UK) Research Leader Fellowship (G1001812) (C.A.R.). D.W. is a NHMRC Career Development Fellow. P.M.S. is a NHMRC Principal Research Fellow, and A.C. is a NHMRC Senior Principal Research Fellow. C.K. is a NHMRC CJ Martin Postdoctoral Fellow.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barwell J, 2011, BBA-MOL CELL RES, V1813, P1906, DOI 10.1016/j.bbamcr.2011.06.005; Bergwitz C, 1997, J BIOL CHEM, V272, P28861, DOI 10.1074/jbc.272.46.28861; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; Coopman K, 2010, J PHARMACOL EXP THER, V334, P795, DOI 10.1124/jpet.110.166009; Couvineau A, 2012, CURR DRUG TARGETS, V13, P103, DOI 10.2174/138945012798868434; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Dong MQ, 2012, FASEB J, V26, P5092, DOI 10.1096/fj.12-212399; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Reid TS., 2013, CLIN DIABETES, V31, P148, DOI DOI 10.2337/DIACLIN.31.4.148; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Wootten D, 2013, MOL PHARMACOL, V83, P822, DOI 10.1124/mol.112.084525; Zhang HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9918	25	99	99	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1632	1643		10.1016/j.cell.2016.05.023	http://dx.doi.org/10.1016/j.cell.2016.05.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315480	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000378062000015
J	Pimentel, D; Donlea, JM; Albot, CBT; Ong, SMS; Hurston, AJFT; Miesenbock, G				Pimentel, Diogo; Donlea, Jeffrey M.; Albot, Clifford B. T.; Ong, Seoho M. S.; Hurston, Alexander J. F. T.; Miesenbock, Gero			Operation of a homeostatic sleep switch	NATURE			English	Article							TARGETED GENE-EXPRESSION; POTASSIUM CHANNELS; DROSOPHILA-MELANOGASTER; DOPAMINERGIC MODULATION; REMOTE-CONTROL; REDUCED SLEEP; VOLTAGE-CLAMP; NEURONS; MEMORY; BEHAVIOR	Sleep disconnects animals from the external world, at considerable risks and costs that must be offset by a vital benefit. Insight into this mysterious benefit will come from understanding sleep homeostasis: to monitor sleep need, an internal bookkeeper must track physiological changes that are linked to the core function of sleep(1). In Drosophila, a crucial component of the machinery for sleep homeostasis is a cluster of neurons innervating the dorsal fan-shaped body (dFB) of the central complex(2,3). Artificial activation of these cells induces sleep(2), whereas reductions in excitability cause insomnia(3,4). dFB neurons in sleep-deprived flies tend to be electrically active, with high input resistances and long membrane time constants, while neurons in rested flies tend to be electrically silent(3). Correlative evidence thus supports the simple view that homeostatic sleep control works by switching sleep-promoting neurons between active and quiescent states(3). Here we demonstrate state switching by dFB neurons, identify dopamine as a neuromodulator that operates the switch, and delineate the switching mechanism. Arousing dopamine(4-8) caused transient hyperpolarization of dFB neurons within tens of milliseconds and lasting excitability suppression within minutes. Both effects were transduced by Dop1R2 receptors and mediated by potassium conductances. The switch to electrical silence involved the downregulation of voltage-gated A-type currents carried by Shaker and Shab, and the upregulation of voltage-independent leak currents through a two-pore-domain potassium channel that we term Sandman. Sandman is encoded by the CG8713 gene and translocates to the plasma membrane in response to dopamine. dFB-restricted interference with the expression of Shaker or Sandman decreased or increased sleep, respectively, by slowing the repetitive discharge of dFB neurons in the ON state or blocking their entry into the OFF state. Biophysical changes in a small population of neurons are thus linked to the control of sleep-wake state.	[Pimentel, Diogo; Donlea, Jeffrey M.; Albot, Clifford B. T.; Ong, Seoho M. S.; Hurston, Alexander J. F. T.; Miesenbock, Gero] Univ Oxford, Ctr Neural Circuits & Behav, Tinsley Bldg,Mansfield Rd, Oxford OX1 3SR, England	University of Oxford	Miesenbock, G (corresponding author), Univ Oxford, Ctr Neural Circuits & Behav, Tinsley Bldg,Mansfield Rd, Oxford OX1 3SR, England.	gero.miesenboeck@cncb.ox.ac.uk		Miesenboeck, Gero/0000-0003-2940-3228; Song, Seo Ho/0000-0003-2970-2746	Wellcome Trust; Gatsby Charitable Foundation; Oxford Martin School; National Institutes of Health; Human Frontier Science Program; MRC [G0700888] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; Oxford Martin School; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Birman, R. Davis, B. Dickson, V. Jayaraman, L. Luo, G. Roman, G. Rubin, the Bloomington Stock Center, and the Vienna Drosophila Resource Center for flies. This work was supported by grants (to G.M.) from the Wellcome Trust, the Gatsby Charitable Foundation, the Oxford Martin School, and the National Institutes of Health. J.M.D. was the recipient of a postdoctoral fellowship from the Human Frontier Science Program; S. M. S. is a Commonwealth Scholar.	ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; BAXTER DA, 1989, J NEUROPHYSIOL, V62, P665, DOI 10.1152/jn.1989.62.3.665; BOKOCH GM, 1984, J BIOL CHEM, V259, P3560; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Donlea JM, 2014, NEURON, V81, P860, DOI 10.1016/j.neuron.2013.12.013; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Marder E, 2002, NEURAL NETWORKS, V15, P479, DOI 10.1016/S0893-6080(02)00043-6; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Reale V, 1997, J NEUROSCI, V17, P6545; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	42	137	138	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					333	+		10.1038/nature19055	http://dx.doi.org/10.1038/nature19055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27487216	Green Accepted, Green Submitted			2022-12-24	WOS:000381804900036
J	Vaccarella, S; Franceschi, S; Bray, F; Wild, CP; Plummer, M; Dal Maso, L				Vaccarella, Salvatore; Franceschi, Silvia; Bray, Freddie; Wild, Christopher P.; Plummer, Martyn; Dal Maso, Luigino			Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vaccarella, Salvatore; Franceschi, Silvia; Bray, Freddie; Wild, Christopher P.; Plummer, Martyn] Int Agcy Res Canc, Lyon, France; [Dal Maso, Luigino] Aviano Natl Canc Inst, CRO Ctr Riferimento Oncol, Canc Epidemiol Unit, Aviano, Italy	World Health Organization; International Agency for Research on Cancer (IARC); IRCCS Aviano (CRO)	Vaccarella, S (corresponding author), Int Agcy Res Canc, Lyon, France.		franceschi, silvia/M-2452-2014; dal maso, luigino/J-3616-2018; Wild, Christopher/ABC-6260-2020	franceschi, silvia/0000-0003-4181-8071; dal maso, luigino/0000-0001-6163-200X; Wild, Christopher/0000-0003-0249-8669; Bray, Freddie/0000-0002-3248-7787; Plummer, Martyn/0000-0001-5130-6497; Vaccarella, Salvatore/0000-0002-2516-2167				Davies L, 2015, ENDOCR PRACT, V21, P686, DOI 10.4158/EP14466.DSCR; Ito Y, 2014, THYROID, V24, P27, DOI 10.1089/thy.2013.0367; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Tsuda T, 2016, EPIDEMIOLOGY, V27, P316, DOI 10.1097/EDE.0000000000000385; Vaccarella S, 2015, THYROID, V25, P1127, DOI 10.1089/thy.2015.0116	5	581	629	3	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					614	617		10.1056/NEJMp1604412	http://dx.doi.org/10.1056/NEJMp1604412			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT4VF	27532827				2022-12-24	WOS:000381478600003
J	Tang, AH; Chen, HW; Li, TP; Metzbower, SR; MacGillavry, HD; Blanpied, TA				Tang, Ai-Hui; Chen, Haiwen; Li, Tuo P.; Metzbower, Sarah R.; MacGillavry, Harold D.; Blanpied, Thomas A.			A trans-synaptic nanocolumn aligns neurotransmitter release to receptors	NATURE			English	Article							CA2+ CHANNELS; IMAGING REVEALS; AMPA RECEPTORS; ACTIVE ZONE; MICROSCOPY; SYNAPSES; PROBABILITY; HIPPOCAMPUS; ENDOCYTOSIS; DEPRESSION	Synaptic transmission is maintained by a delicate, sub-synaptic molecular architecture, and even mild alterations in synapse structure drive functional changes during experience-dependent plasticity and pathological disorders(1,2). Key to this architecture is how the distribution of presynaptic vesicle fusion sites corresponds to the position of receptors in the postsynaptic density. However, while it has long been recognized that this spatial relationship modulates synaptic strength(3), it has not been precisely described, owing in part to the limited resolution of light microscopy. Using localization microscopy, here we show that key proteins mediating vesicle priming and fusion are mutually co-enriched within nanometre-scale subregions of the presynaptic active zone. Through development of a new method to map vesicle fusion positions within single synapses in cultured rat hippocampal neurons, we find that action-potential-evoked fusion is guided by this protein gradient and occurs preferentially in confined areas with higher local density of Rab3-interacting molecule (RIM) within the active zones. These presynaptic RIM nanoclusters closely align with concentrated postsynaptic receptors and scaffolding proteins(4-6), suggesting the existence of a trans-synaptic molecular 'nanocolumn'. Thus, we propose that the nanoarchitecture of the active zone directs action-potential-evoked vesicle fusion to occur preferentially at sites directly opposing postsynaptic receptor-scaffold ensembles. Remarkably, NMDA receptor activation triggered distinct phases of plasticity in which postsynaptic reorganization was followed by trans-synaptic nanoscale realignment. This architecture suggests a simple organizational principle of central nervous system synapses to maintain and modulate synaptic efficiency.	[Tang, Ai-Hui; Chen, Haiwen; Li, Tuo P.; Metzbower, Sarah R.; Blanpied, Thomas A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Tang, Ai-Hui; Chen, Haiwen; Li, Tuo P.; Metzbower, Sarah R.; Blanpied, Thomas A.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Chen, Haiwen; Li, Tuo P.] Univ Maryland, Sch Med, Med Scientist Training Program, Baltimore, MD 21201 USA; [MacGillavry, Harold D.] Univ Utrecht, Fac Sci, Dept Biol, Cell Biol, NL-3584 CH Utrecht, Netherlands	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Utrecht University	Tang, AH; Blanpied, TA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.; Tang, AH; Blanpied, TA (corresponding author), Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA.	tangaihui@gmail.com; tblanpied@som.umaryland.edu	Tang, Ai-Hui/D-4311-2009	Tang, Ai-Hui/0000-0003-3715-6714; Blanpied, Thomas/0000-0003-4957-557X; MacGillavry, Harold/0000-0002-6153-3586; Li, Tuo Peter/0000-0002-4302-9538	 [F30-MH105111];  [F30-MH102891];  [F31-MH105105];  [T32-GM008181];  [R01-MH080046];  [NS090644]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106000, T32GM008181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080046, R37MH080046, F30MH102891, F31MH105105, F30MH105111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS090644] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010352] Funding Source: NIH RePORTER	; ; ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Thompson, T. Abrams, S. Jurado and G. Wittenberg for advice and comments, P. Kaeser for advice on RIM expression and RIM antibodies, Y. Araki and R. Huganir for advice on chemLTP, and S. S. Divakaruni for advice and initial tests of chemLTP. We thank P. Kaeser for the gift of RIM1-mVenus, T. Ryan for vGlut1-pHluorin-mCherry, G. Augustine for Syn1a-CFP, and M. Contreras for technical assistance. This work was supported by F30-MH105111 to H.C., F30-MH102891 to T.P.L., F31-MH105105 to S.R.M., T32-GM008181 to H.C. and S. R. M., R01-MH080046 and NS090644 to T.A.B, and a gift from the Kahlert Foundation to T.A.B.	Araki Y, 2015, NEURON, V85, P173, DOI 10.1016/j.neuron.2014.12.023; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Betzig E, 2015, ANGEW CHEM INT EDIT, V54, P8034, DOI 10.1002/anie.201501003; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Davis GW, 2015, ANNU REV PHYSIOL, V77, P251, DOI 10.1146/annurev-physiol-021014-071740; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Ermolyuk YS, 2013, NAT NEUROSCI, V16, P1754, DOI 10.1038/nn.3563; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Franks KM, 2003, J NEUROSCI, V23, P3186; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Fukata Y, 2013, J CELL BIOL, V202, P145, DOI 10.1083/jcb.201302071; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Geisler C, 2012, OPT EXPRESS, V20, P7274, DOI 10.1364/OE.20.007274; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kavalali ET, 2011, PHYSIOLOGY, V26, P45, DOI 10.1152/physiol.00040.2010; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Leitz J, 2014, ELIFE, V3, DOI 10.7554/eLife.03658; Levet F, 2015, NAT METHODS, V12, P1065, DOI [10.1038/NMETH.3579, 10.1038/nmeth.3579]; Lisman J., 2006, SCI STKE, V2006, pr; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; MacGillavry HD, 2013, NEURON, V78, P615, DOI 10.1016/j.neuron.2013.03.009; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Mlodzianoski MJ, 2011, OPT EXPRESS, V19, P15009, DOI 10.1364/OE.19.015009; Murthy VN, 2000, P NATL ACAD SCI USA, V97, P901, DOI 10.1073/pnas.97.2.901; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Nakamura Y, 2015, NEURON, V85, P145, DOI 10.1016/j.neuron.2014.11.019; Park H, 2012, SCIENCE, V335, P1362, DOI 10.1126/science.1216937; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneider R, 2015, NEURON, V86, P672, DOI 10.1016/j.neuron.2015.03.050; Scimemi A, 2012, J NEUROSCI, V32, P18157, DOI 10.1523/JNEUROSCI.3827-12.2012; Simonson PD, 2011, NANO LETT, V11, P5090, DOI 10.1021/nl203560r; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Tarr TB, 2013, TRENDS NEUROSCI, V36, P14, DOI 10.1016/j.tins.2012.09.009; Tarusawa E, 2009, J NEUROSCI, V29, P12896, DOI 10.1523/JNEUROSCI.6160-08.2009; Thompson MA, 2012, ANNU REV BIOPHYS, V41, P321, DOI 10.1146/annurev-biophys-050511-102250; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Volk L, 2015, ANNU REV NEUROSCI, V38, P127, DOI 10.1146/annurev-neuro-071714-033821; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Xie XP, 1997, P NATL ACAD SCI USA, V94, P6983, DOI 10.1073/pnas.94.13.6983	50	318	320	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					210	+		10.1038/nature19058	http://dx.doi.org/10.1038/nature19058			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27462810	Green Accepted			2022-12-24	WOS:000381472100036
J	Latorre-Pellicer, A; Moreno-Loshuertos, R; Lechuga-Vieco, AV; Sanchez-Cabo, F; Torroja, C; Acin-Perez, R; Calvo, E; Aix, E; Gonzalez-Guerra, A; Logan, A; Bernad-Miana, ML; Romanos, E; Cruz, R; Cogliati, S; Sobrino, B; Carracedo, A; Perez-Martos, A; Fernandez-Silva, P; Ruiz-Cabello, J; Murphy, MP; Flores, I; Vazquez, J; Enriquez, JA				Latorre-Pellicer, Ana; Moreno-Loshuertos, Raquel; Victoria Lechuga-Vieco, Ana; Sanchez-Cabo, Fatima; Torroja, Carlos; Acin-Perez, Rebeca; Calvo, Enrique; Aix, Esther; Gonzalez-Guerra, Andres; Logan, Angela; Luisa Bernad-Miana, Maria; Romanos, Eduardo; Cruz, Raquel; Cogliati, Sara; Sobrino, Beatriz; Carracedo, Angel; Perez-Martos, Acisclo; Fernandez-Silva, Patricio; Ruiz-Cabello, Jesus; Murphy, Michael P.; Flores, Ignacio; Vazquez, Jesus; Antonio Enriquez, Jose			Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing	NATURE			English	Article							DISEASE; EXPRESSION; MTDNA; COGNITION; GENOME; CELLS; CHAIN	Human mitochondrial DNA (mtDNA) shows extensive within-population sequence variability(1). Many studies suggest that mtDNA variants may be associated with ageing or diseases(2-4), although mechanistic evidence at the molecular level is lacking(5,6). Mitochondrial replacement has the potential to prevent transmission of disease-causing oocyte mtDNA. However, extension of this technology requires a comprehensive understanding of the physiological relevance of mtDNA sequence variability and its match with the nuclear-encoded mitochondrial genes. Studies in conplastic animals(7-9) allow comparison of individuals with the same nuclear genome but different mtDNA variants, and have provided both supporting and refuting evidence that mtDNA variation influences organismal physiology. However, most of these studies did not confirm the conplastic status, focused on younger animals, and did not investigate the full range of physiological and phenotypic variability likely to be influenced by mitochondria. Here we systematically characterized conplastic mice throughout their lifespan using transcriptomic, proteomic, metabolomic, biochemical, physiological and phenotyping studies. We show that mtDNA haplotype profoundly influences mitochondrial proteostasis and reactive oxygen species generation, insulin signalling, obesity, and ageing parameters including telomere shortening and mitochondrial dysfunction, resulting in profound differences in health longevity between conplastic strains.	[Latorre-Pellicer, Ana; Victoria Lechuga-Vieco, Ana; Sanchez-Cabo, Fatima; Torroja, Carlos; Acin-Perez, Rebeca; Calvo, Enrique; Aix, Esther; Gonzalez-Guerra, Andres; Cogliati, Sara; Ruiz-Cabello, Jesus; Flores, Ignacio; Vazquez, Jesus; Antonio Enriquez, Jose] Ctr Nacl Invest Cardiovasc Carlos III, Madrid 28029, Spain; [Latorre-Pellicer, Ana; Cruz, Raquel; Carracedo, Angel] Univ Santiago de Compostela, CIBERER, Grp Med Xenom, Santiago De Compostela 15782, Spain; [Moreno-Loshuertos, Raquel; Perez-Martos, Acisclo; Fernandez-Silva, Patricio; Antonio Enriquez, Jose] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; [Victoria Lechuga-Vieco, Ana; Ruiz-Cabello, Jesus] CIBERES, C Melchor Fernandez Almagro 3, Madrid 28029, Spain; [Logan, Angela; Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England; [Luisa Bernad-Miana, Maria; Romanos, Eduardo] Inst Aragones Ciencias Salud, SAI Biomed & Biomat & Phenotyp Unit, Zaragoza 50009, Spain; [Sobrino, Beatriz; Carracedo, Angel] Complexo Hosp Univ Santiago, SERGAS, Fdn Publ Gallega Med Xenom, Santiago De Compostela 15706, Spain; [Carracedo, Angel] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia; [Ruiz-Cabello, Jesus] Univ Complutense Madrid, Madrid 28606, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complexo Hospitalario Universitario de Santiago de Compostela; King Abdulaziz University; Complutense University of Madrid	Enriquez, JA (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III, Madrid 28029, Spain.; Enriquez, JA (corresponding author), Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain.	jaenriquez@cnic.es	Cogliati, Sara/H-6156-2015; Vazquez, Jesus/B-7697-2015; Cogliati, Sara/GLR-0692-2022; Ruiz-Cabello, Jesus/A-9570-2012; Torroja, Carlos/N-6022-2014; Romanos, Eduardo/T-3794-2017; Gonzalez-Guerra, Andres/R-2003-2018; Flores, Ignacio/E-8304-2016; Enríquez, J.A./M-8468-2016; Pellicer, Ana Latorre/A-8601-2019; Acin-Perez, Rebeca/AAU-4913-2020; Moreno-Loshuertos, Raquel/H-4545-2015; Sanchez-Cabo, Fatima/AAC-5563-2020; Silva, Patricio Fernandez/U-2256-2017; Rey, Beatriz Sobrino/ABB-8518-2020; Cogliati, Sara/ABC-2688-2020; Carracedo, Angel/D-4257-2012; Murphy, Michael/C-2120-2009	Cogliati, Sara/0000-0002-0374-3489; Vazquez, Jesus/0000-0003-1461-5092; Cogliati, Sara/0000-0002-0374-3489; Ruiz-Cabello, Jesus/0000-0001-8681-5056; Torroja, Carlos/0000-0001-8914-3400; Romanos, Eduardo/0000-0002-9918-3374; Flores, Ignacio/0000-0001-8789-6396; Enríquez, J.A./0000-0002-3671-2961; Pellicer, Ana Latorre/0000-0002-4703-6620; Acin-Perez, Rebeca/0000-0001-9553-8337; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Silva, Patricio Fernandez/0000-0001-8971-7355; Carracedo, Angel/0000-0003-1085-8986; Moreno Loshuertos, Raquel/0000-0002-6600-1618; Gonzalez-Guerra, Andres/0000-0003-1230-5293; Murphy, Michael/0000-0003-1115-9618; Lechuga-Vieco, Ana Victoria/0000-0001-5546-9752; Sobrino Rey, Beatriz/0000-0002-6605-9377; CRUZ, RAQUEL/0000-0002-6964-8898	MEyC [SAF2015-65633-R, CSD2007-00020, SAF2012-38449, BIO2012-37926, BIO2015-67580-P]; Madrid [CAM/P2010/BMD-2402]; EU [PCIG10-GA-2011-304217, FP7-PEOPLE-2012-ITN-GA-317433]; ISC III [PI09-00946, PI12/01297, PI13-01136, PI11-00078, PRB2 (IPT13/0001), RIC ((RD12/0042/0045), RETICS (RD12/0042/00056)]; MEyC; Pro-CNIC Foundation; SO-Center of Excellence [SEV-2015-0505]; Medical Research Council [MC_U105663142] Funding Source: researchfish; MRC [MC_U105663142] Funding Source: UKRI	MEyC; Madrid; EU(European Commission); ISC III(Instituto de Salud Carlos III); MEyC; Pro-CNIC Foundation; SO-Center of Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Lopez-Otin for critical reading; C. Jimenez for management; the Transgenesis Unit of the CNIC and M. Cueva for mouse work, A. Molina and R. Doohan for histology, the Genomics Unit of the CNIC for RNA-seq; ICTS-CNME (UCM) for technical support; J. Amigo and X. Bello for NGS bioinformatics support; and S. Bartlett for English editing. Supported by grants from the MEyC (SAF2015-65633-R, CSD2007-00020, SAF2012-38449, BIO2012-37926 and BIO2015-67580-P), the Madrid (CAM/P2010/BMD-2402), the EU (PCIG10-GA-2011-304217 and FP7-PEOPLE-2012-ITN-GA-317433), the ISC III (PI09-00946, PI12/01297, PI13-01136 and PI11-00078, PRB2 (IPT13/0001, ProteoRed), RIC ((RD12/0042/0045) and RETICS (RD12/0042/00056)). The CNIC is supported by the MEyC and the Pro-CNIC Foundation and is a SO-Center of Excellence (SEV-2015-0505).	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Amo T, 2008, GENE, V411, P69, DOI 10.1016/j.gene.2008.01.007; Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Chinnery PF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004315; Cocheme HM, 2012, NAT PROTOC, V7, P946, DOI 10.1038/nprot.2012.035; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Garcia-Marques F, 2016, MOL CELL PROTEOMICS, V15, P1740, DOI 10.1074/mcp.M115.055905; Guaras A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Logan A, 2014, BBA-GEN SUBJECTS, V1840, P923, DOI 10.1016/j.bbagen.2013.05.026; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Martinez-Bartolome S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067; Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108	30	248	259	2	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					561	+		10.1038/nature18618	http://dx.doi.org/10.1038/nature18618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27383793				2022-12-24	WOS:000380856600031
J	Crow, JM				Crow, James Mitchell			BIOMEDICINE Move over, morphine	NATURE			English	Editorial Material																		Fleet J, 2015, BJOG-INT J OBSTET GY, V122, P983, DOI 10.1111/1471-0528.13249; Zadina JE, 2016, NEUROPHARMACOLOGY, V105, P215, DOI 10.1016/j.neuropharm.2015.12.024; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	3	6	6	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					S4	S6		10.1038/535S4a	http://dx.doi.org/10.1038/535S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27410530				2022-12-24	WOS:000379912600004
J	Manchado, E; Weissmueller, S; Morris, JP; Chen, CC; Wullenkord, R; Lujambio, A; de Stanchina, E; Poirier, JT; Gainor, JF; Corcoran, RB; Engelman, JA; Rudin, CM; Rosen, N; Lowe, SW				Manchado, Eusebio; Weissmueller, Susann; Morris, John P.; Chen, Chi-Chao; Wullenkord, Ramona; Lujambio, Amaia; de Stanchina, Elisa; Poirier, John T.; Gainor, Justin F.; Corcoran, Ryan B.; Engelman, Jeffrey A.; Rudin, Charles M.; Rosen, Neal; Lowe, Scott W.			A combinatorial strategy for treating KRAS-mutant lung cancer	NATURE			English	Article							MEK INHIBITION; MEDIATED REACTIVATION; SELECTIVE INHIBITOR; FEEDBACK ACTIVATION; ACQUIRED-RESISTANCE; COLON-CANCER; RAS; POTENT; BRAF; DISCOVERY	Therapeutic targeting of KRAS-mutant lung adenocarcinoma represents a major goal of clinical oncology. KRAS itself has proved difficult to inhibit, and the effectiveness of agents that target key KRAS effectors has been thwarted by activation of compensatory or parallel pathways that limit their efficacy as single agents. Here we take a systematic approach towards identifying combination targets for trametinib, a MEK inhibitor approved by the US Food and Drug Administration, which acts downstream of KRAS to suppress signalling through the mitogen-activated protein kinase (MAPK) cascade. Informed by a short-hairpin RNA screen, we show that trametinib provokes a compensatory response involving the fibroblast growth factor receptor 1 (FGFR1) that leads to signalling rebound and adaptive drug resistance. As a consequence, genetic or pharmacological inhibition of FGFR1 in combination with trametinib enhances tumour cell death in vitro and in vivo. This compensatory response shows distinct specificities: it is dominated by FGFR1 in KRAS-mutant lung and pancreatic cancer cells, but is not activated or involves other mechanisms in KRAS wild-type lung and KRAS-mutant colon cancer cells. Importantly, KRAS-mutant lung cancer cells and patients' tumours treated with trametinib show an increase in FRS2 phosphorylation, a biomarker of FGFR activation; this increase is abolished by FGFR1 inhibition and correlates with sensitivity to trametinib and FGFR inhibitor combinations. These results demonstrate that FGFR1 can mediate adaptive resistance to trametinib and validate a combinatorial approach for treating KRAS-mutant lung cancer.	[Manchado, Eusebio; Weissmueller, Susann; Morris, John P.; Chen, Chi-Chao; Wullenkord, Ramona; Lujambio, Amaia; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Weissmueller, Susann] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Chen, Chi-Chao] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Lujambio, Amaia] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Liver Canc Program, Tisch Canc Inst, New York, NY 10029 USA; [de Stanchina, Elisa; Poirier, John T.; Rudin, Charles M.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA; [Poirier, John T.; Rudin, Charles M.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Gainor, Justin F.; Corcoran, Ryan B.; Engelman, Jeffrey A.] Massachusetts Gen Hosp, Dept Med, Ctr Canc, Boston, MA 02114 USA; [Gainor, Justin F.; Corcoran, Ryan B.; Engelman, Jeffrey A.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA.; Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA.; Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.; Lowe, SW (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	rosenn@mskcc.org; lowes@mskcc.org	Rosen, Neal/ABF-2677-2020; Gainor, Justin/T-5411-2019; Rudin, Charles/R-2530-2019	Rudin, Charles/0000-0001-5204-3465; Lujambio, Amaia/0000-0002-2798-1481; Poirier, John/0000-0001-9795-5644	National Cancer Institute; Center of Experimental Therapeutics; Stand Up To Cancer grant from the American Association for Cancer Research; Cancer Center Support grant; Jane Coffin Childs Memorial Fund for Medical Research; National Institutes of Health/National Cancer Institute [K99/R00]; Watson School of Biological Sciences; Bayer Foundation; EMBO Long-Term fellowship; Geoffrey Beene Cancer Research Center; NATIONAL CANCER INSTITUTE [R01CA169351, P50CA127003, P30CA008748, P01CA129243] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center of Experimental Therapeutics; Stand Up To Cancer grant from the American Association for Cancer Research; Cancer Center Support grant; Jane Coffin Childs Memorial Fund for Medical Research; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Watson School of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bayer Foundation(Bayer AG); EMBO Long-Term fellowship(European Molecular Biology Organization (EMBO)); Geoffrey Beene Cancer Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Sanchez-Cespedes, R. Somwar, and H. Varmus for sharing cell lines; S. Tian, J. Ahn, M. Taylor, A. Shroff, and J. Plevy for technical assistance; C. J. Sherr, L. E. Dow, P Lito, T Kastenhuber, and J. Leibold for advice on experimental design and/or for editing the manuscript: and other members of the Lowe laboratory for advice and discussions. This work was supported by a program project grant from the National Cancer Institute (S.W.L.. N.R.). a grant from the Center of Experimental Therapeutics (S.W.L., N.R.), a Stand Up To Cancer grant from the American Association for Cancer Research (N.R., J.A.E., C.R.), and a Cancer Center Support grant to MSKCC. E.M. was supported by The Jane Coffin Childs Memorial Fund for Medical Research and a K99/R00 grant from the National Institutes of Health/National Cancer Institute. S.W. was supported by the Annette Kade Fellowship from the Watson School of Biological Sciences. R.W. was supported by a Carl-Duisberg Fellowship from the Bayer Foundation. A.L. was supported by an EMBO Long-Term fellowship. E.d.S. received support through the Geoffrey Beene Cancer Research Center. S.W.L. is the Geoffrey Beene Chair of Cancer Biology and a Howard Hughes Medical Institute investigator.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Li F, 2015, CANCER DISCOV, V5, P438, DOI 10.1158/2159-8290.CD-14-0763; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Poirier JT, 2015, ONCOGENE, V34, P5869, DOI 10.1038/onc.2015.38; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Saborowski M, 2014, GENE DEV, V28, P85, DOI 10.1101/gad.232082.113; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Taylor James, 2007, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s19; Traer E, 2014, BLOOD, V123, P1516, DOI 10.1182/blood-2013-07-518381; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	36	264	269	0	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					647	+		10.1038/nature18600	http://dx.doi.org/10.1038/nature18600			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27338794	Green Submitted, Green Accepted			2022-12-24	WOS:000378676000028
J	Birchenough, GMH; Nystrom, EEL; Johansson, MEV; Hansson, GC				Birchenough, George M. H.; Nystrom, Elisabeth E. L.; Johansson, Malin E. V.; Hansson, Gunnar C.			INNATE IMMUNITY A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion	SCIENCE			English	Article							ACTIVATION	Innate immune signaling pathways contribute to the protection of host tissue when bacterially challenged. Colonic goblet cells are responsible for generating the two mucus layers that physically separate the luminalmicrobiota from the host epithelium. Analysis of colonic tissues from multiple mouse strains allowed us to identify a "sentinel" goblet cell (senGC) localized to the colonic crypt entrance. This cell nonspecifically endocytoses and reacts to the TLR2/1, TLR4, and TLR5 ligands by activating the Nlrp6 inflammasome downstream of TLR-and MyD88-dependent Nox/Duox reactive oxygen species synthesis. This triggers calcium ion-dependent compound exocytosis ofMuc2 mucin fromthe senGC and generates an intercellular gap junction signal; in turn, this signal induces Muc2 secretion from adjacent goblet cells in the upper crypt, which expels bacteria. Thus, senGCs guard and protect the colonic crypt from bacterial intruders that have penetrated the inner mucus layer.	[Birchenough, George M. H.; Nystrom, Elisabeth E. L.; Johansson, Malin E. V.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, S-40530 Gothenburg, Sweden	University of Gothenburg	Hansson, GC (corresponding author), Univ Gothenburg, Dept Med Biochem, S-40530 Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Hansson, Gunnar C./AAF-7324-2019; Johansson, Malin E. V./HCH-7451-2022; Hansson, Gunnar C/A-1236-2009	Hansson, Gunnar C./0000-0002-1900-1869; Hansson, Gunnar C/0000-0002-1900-1869; Johansson, Malin E. V./0000-0002-4237-6677	Swedish Research Council; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; Lundberg Foundation; Sahlgren's University Hospital (ALF); Torsten Soderbergs Stiftelse; National Institute of Allergy and Infectious Diseases [U01AI095473]; Swedish Foundation for Strategic Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lundberg Foundation(European Commission); Sahlgren's University Hospital (ALF); Torsten Soderbergs Stiftelse; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Swedish Research Council, Swedish Cancer Foundation, Knut and Alice Wallenberg Foundation, Lundberg Foundation, Sahlgren's University Hospital (ALF), Torsten Soderbergs Stiftelse, National Institute of Allergy and Infectious Diseases grant U01AI095473, and Swedish Foundation for Strategic Research. We thank the Gothenburg Centre for Cellular Imaging for technical help, F. Svensson for generating the RedMUC2<SUP>98trTg</SUP> mice, and W.-D. Hardt and the Mucosal Immunobiology and Vaccine Center at the University of Gothenburg for mouse strains.	Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; COLONY PC, 1987, ANAT REC, V218, P365, DOI 10.1002/ar.1092180403; Demon D, 2014, MUCOSAL IMMUNOL, V7, P1480, DOI 10.1038/mi.2014.36; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Halm DR, 1999, AM J PHYSIOL-CELL PH, V277, pC501, DOI 10.1152/ajpcell.1999.277.3.C501; Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Johansson MEV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041009; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Knoop KA, 2015, MUCOSAL IMMUNOL, V8, P198, DOI 10.1038/mi.2014.58; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Panday A, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.89; Patel KK, 2013, EMBO J, V32, P3130, DOI 10.1038/emboj.2013.233; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; SPECIAN RD, 1980, J CELL BIOL, V85, P626, DOI 10.1083/jcb.85.3.626; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	26	297	311	10	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1535	1542		10.1126/science.aaf7419	http://dx.doi.org/10.1126/science.aaf7419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339979	Green Accepted			2022-12-24	WOS:000378346500034
J	Chick, JM; Munger, SC; Simecek, P; Huttlin, EL; Choi, K; Gatti, DM; Raghupathy, N; Svenson, KL; Churchill, GA; Gygi, SP				Chick, Joel M.; Munger, Steven C.; Simecek, Petr; Huttlin, Edward L.; Choi, Kwangbom; Gatti, Daniel M.; Raghupathy, Narayanan; Svenson, Karen L.; Churchill, Gary A.; Gygi, Steven P.			Defining the consequences of genetic variation on a proteome-wide scale	NATURE			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; COLLABORATIVE CROSS; ABUNDANCE; MOUSE; EXPRESSION; RESOURCE; QUANTIFICATION; DISSECTION	Genetic variation modulates protein expression through both transcriptional and post-transcriptional mechanisms. To characterize the consequences of natural genetic diversity on the proteome, here we combine a multiplexed, mass spectrometry-based method for protein quantification with an emerging outbred mouse model containing extensive genetic variation from eight inbred founder strains. By measuring genome-wide transcript and protein expression in livers from 192 Diversity outbred mice, we identify 2,866 protein quantitative trait loci (pQTL) with twice as many local as distant genetic variants. These data support distinct transcriptional and post-transcriptional models underlying the observed pQTL effects. Using a sensitive approach to mediation analysis, we often identified a second protein or transcript as the causal mediator of distant pQTL. Our analysis reveals an extensive network of direct protein-protein interactions. Finally, we show that local genotype can provide accurate predictions of protein abundance in an independent cohort of collaborative cross mice.	[Chick, Joel M.; Huttlin, Edward L.; Gygi, Steven P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Munger, Steven C.; Simecek, Petr; Choi, Kwangbom; Gatti, Daniel M.; Raghupathy, Narayanan; Svenson, Karen L.; Churchill, Gary A.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	Harvard University; Harvard Medical School; Jackson Laboratory	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.; Churchill, GA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	gary.churchill@jax.org; steven_gygi@hms.harvard.edu	Simecek, Petr/ABG-4683-2021; Churchill, Gary/AAY-7496-2020; Simecek, Petr/R-3449-2019	Churchill, Gary/0000-0001-9190-9284; Simecek, Petr/0000-0002-2922-7183; Huttlin, Edward/0000-0002-1822-1173; Choi, Kwangbom/0000-0002-4637-4249; Raghupathy, Narayanan/0000-0002-2275-3674	Harvard Medical School; Jackson Laboratory; National Institutes of Health (NIH) [P50GM076468, F32HD074299, GM67945, U41HG006673]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD074299] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070683, R01GM067945, P50GM076468] Funding Source: NIH RePORTER	Harvard Medical School; Jackson Laboratory; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Somes and M. Strobel for breeding the mice; S. Ciciotte, S. Daigle, J. Pereira, C. Snow, R. Lynch and H. Munger for extracting RNA and performing RNA-seq experiments; and A. Manichaikul for discussion on mediation analysis. Collaborative Cross strains used in this study were imported to JAX from the Systems Genetics Core Facility at the University of North Carolina (USA)<SUP>38</SUP>. Previous to their relocation to UNC, CC lines CC001, CC003 and CC017 were generated and bred at Oak Ridge National Laboratory (USA)<SUP>39</SUP>; CC line CC004 was generated and bred at Tel Aviv University (Israel)<SUP>40</SUP>. Research reported here was supported by Harvard Medical School, The Jackson Laboratory, and National Institutes of Health (NIH) grants under awards P50GM076468 (to G.A.C.), F32HD074299 (to S. C. M.), GM67945 (to S.P.G.) and U41HG006673 (to S.P.G. and E.L.H).	Albert FW, 2014, NATURE, V506, P494, DOI 10.1038/nature12904; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2012, G3-GENES GENOM GENET, V2, P199, DOI 10.1534/g3.111.001818; Cheng R, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-66; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; DAMERVAL C, 1994, GENETICS, V137, P289; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Gatti DM, 2014, G3-GENES GENOM GENET, V4, P1623, DOI 10.1534/g3.114.013748; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iraqi FA, 2008, MAMM GENOME, V19, P379, DOI 10.1007/s00335-008-9113-1; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Khan Z, 2009, P NATL ACAD SCI USA, V106, P15544, DOI 10.1073/pnas.0904100106; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; Liu YT, 1998, J BIOL CHEM, V273, P7920, DOI 10.1074/jbc.273.14.7920; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Munger SC, 2014, GENETICS, V198, P59, DOI 10.1534/genetics.114.165886; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Skelly DA, 2013, GENOME RES, V23, P1496, DOI 10.1101/gr.155762.113; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Threadgill DW, 2012, GENETICS, V190, P291, DOI 10.1534/genetics.111.138032; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; van Weering JRT, 2012, EMBO J, V31, P4466, DOI 10.1038/emboj.2012.283; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Welsh CE, 2012, MAMM GENOME, V23, P706, DOI 10.1007/s00335-012-9410-6; Welsh CE, 2012, G3-GENES GENOM GENET, V2, P191, DOI 10.1534/g3.111.001784; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Wu YB, 2014, CELL, V158, P1415, DOI 10.1016/j.cell.2014.07.039; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	58	194	195	3	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					500	+		10.1038/nature18270	http://dx.doi.org/10.1038/nature18270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309819	Green Accepted			2022-12-24	WOS:000378270300043
J	LaRocque, RL; Ryan, ET				LaRocque, Regina L.; Ryan, Edward T.			Personal Actions to Minimize Mosquito-Borne Illnesses, Including Zika Virus	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[LaRocque, Regina L.; Ryan, Edward T.] Massachusetts Gen Hosp, Div Infect Dis, Jackson 504,55 Fruit St, Boston, MA 02114 USA; Harvard Univ, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University	Ryan, ET (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Jackson 504,55 Fruit St, Boston, MA 02114 USA.	etryan@mgh.harvard.edu			NCEZID CDC HHS [U01 CK000175, U01 CK000490] Funding Source: Medline	NCEZID CDC HHS		Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617; Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150; Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035	5	7	7	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2016	165	8					589	+		10.7326/M16-1397	http://dx.doi.org/10.7326/M16-1397			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6BM	27399646				2022-12-24	WOS:000385946600020
J	Lopez, D; Luque-Fernandez, MA; Steele, A; Adler, GK; Turchin, A; Vaidya, A				Lopez, Diana; Luque-Fernandez, Miguel Angel; Steele, Amy; Adler, Gail K.; Turchin, Alexander; Vaidya, Anand			"Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							SUBCLINICAL CUSHINGS-SYNDROME; PREVALENCE; CORTISOL; DIAGNOSIS; MORTALITY	Background: Benign adrenal tumors are commonly discovered on abdominal imaging. Most are classified as nonfunctional and are considered to pose no health risk, but some are considered functional because they secrete hormones that increase risk for metabolic and cardiovascular diseases. Objective: To evaluate the hypothesis that nonfunctional adrenal tumors (NFATs) increase risk for cardiometabolic outcomes compared with absence of adrenal tumors. Design: Cohort study. Setting: Integrated hospital system. Participants: Participants with benign NFATs ("exposed"; n = 166) and those with no adrenal tumor ("unexposed"; n = 740), with at least 3 years of follow-up. Measurements: Medical records were reviewed from the time of abdominal imaging for development of incident outcomes (hypertension, composite diabetes [prediabetes or type 2 diabetes], hyperlipidemia, cardiovascular events, and chronic kidney disease) (mean, 7.7 years). Primary analyses evaluated independent associations between exposure status and incident outcomes by using adjusted generalized linear models. Secondary analyses evaluated relationships between NFATs and cortisol physiology. Results: Participants with NFATs had significantly higher risk for incident composite diabetes than those without adrenal tumors (30 of 110 [27.3%] vs. 72 of 615 [11.7%] participants; absolute risk, 15.6% [95% CI, 6.9% to 24.3%]; adjusted risk ratio, 1.87 [CI, 1.17 to 2.98]). No significant associations between NFATs and other outcomes were observed. Higher "normal" postdexa-methasone cortisol levels (<= 50 nmol/L) were associated with larger NFAT size and higher prevalence of type 2 diabetes. Limitation: Potential bias in the selection of participants and ascertainment of outcomes. Conclusion: Participants with NFATs had a significantly higher risk for diabetes than those without adrenal tumors. These results should prompt a reassessment of whether the classification of benign adrenal tumors as "nonfunctional" adequately reflects the continuum of hormone secretion and metabolic risk they may harbor.	[Lopez, Diana; Adler, Gail K.; Turchin, Alexander; Vaidya, Anand] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA; Harvard Sch Publ Hlth, Boston, MA USA; Harvard Clin Res Inst Boston, Boston, MA USA; [Luque-Fernandez, Miguel Angel] London Sch Hyg & Trop Med, Dept Epidemiol & Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England; [Steele, Amy] Univ Calif Davis, Sch Med, 2138 Univ Pk Dr, Sacramento, CA 95817 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Davis	Vaidya, A (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Ctr Adrenal Disorders, 221 Longwood Ave,RFB 287, Boston, MA 02115 USA.	anandvaidya@bwh.harvard.edu	FERNANDEZ, MIGUEL ANGEL LUQUE/L-4053-2015; FERNANDEZ, MIGUEL ANGEL LUQUE/AAZ-5017-2020; FERNANDEZ, MIGUEL ANGEL LUQUE/AAK-7183-2021	FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164	National Heart, Lung, and Blood Institute of the National Institutes of Health [K24 HL103845, K23HL111771]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01 DK107407]; Doris Duke Charitable Foundation [2015085]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL103845, K23HL111771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107407] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Adler was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under award K24 HL103845. Dr. Vaidya was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award R01 DK107407; by grant 2015085 from the Doris Duke Charitable Foundation; and by the National Heart, Lung, and Blood Institute of the National Institutes of Health under award K23HL111771.	Al-Thani H, 2015, N AM J MED SCI, V7, P212, DOI 10.4103/1947-2714.157482; Androulakis II, 2014, J CLIN ENDOCR METAB, V99, P2754, DOI 10.1210/jc.2013-4064; [Anonymous], 2002, NIH CONSENS STATE SC, V19, P1; Arlt W, 2011, J CLIN ENDOCR METAB, V96, P3775, DOI 10.1210/jc.2011-1565; Bovio S, 2006, J ENDOCRINOL INVEST, V29, P298, DOI 10.1007/BF03344099; Brett K M, 2001, Vital Health Stat 13, P1; Chiodini I, 2011, J CLIN ENDOCR METAB, V96, P1223, DOI 10.1210/jc.2010-2722; Debono M, 2014, J CLIN ENDOCR METAB, V99, P4462, DOI 10.1210/jc.2014-3007; Di Dalmazi G, 2014, LANCET DIABETES ENDO, V2, P396, DOI 10.1016/S2213-8587(13)70211-0; Di Dalmazi G, 2012, EUR J ENDOCRINOL, V166, P669, DOI 10.1530/EJE-11-1039; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; HEDELAND H, 1968, ACTA MED SCAND, V184, P211; Lacroix A, 2015, LANCET, V386, P913, DOI 10.1016/S0140-6736(14)61375-1; Mantero F, 2000, J CLIN ENDOCR METAB, V85, P637, DOI 10.1210/jc.85.2.637; Marczak L, 2016, JAMA-J AM MED ASSOC, V315, P241, DOI DOI 10.1001/JAMA.2015.17599; Morelli V, 2014, J CLIN ENDOCR METAB, V99, P827, DOI 10.1210/jc.2013-3527; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Nieman LK, 2015, J CLIN ENDOCR METAB, V100, P2807, DOI 10.1210/jc.2015-1818; Nieman LK, 2010, J CLIN ENDOCR METAB, V95, P4106, DOI 10.1210/jc.2010-0457; Organisation for Economic Co-operation and Development, 2013, HLTH GLANC 2013 OECD; Patrova J, 2015, ENDOCR PRACT, V21, P870, DOI 10.4158/EP15618.OR; Peppa M, 2010, METABOLISM, V59, P1435, DOI 10.1016/j.metabol.2010.01.007; Rossi R, 2000, J CLIN ENDOCR METAB, V85, P1440, DOI 10.1210/jc.85.4.1440; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Terzolo M, 2011, EUR J ENDOCRINOL, V164, P851, DOI 10.1530/EJE-10-1147; Tuna MM, 2014, J ENDOCRINOL INVEST, V37, P765, DOI 10.1007/s40618-014-0106-5; Young WF, 2000, ENDOCRIN METAB CLIN, V29, P159, DOI 10.1016/S0889-8529(05)70122-5; Young WF, 2007, NEW ENGL J MED, V356, P601, DOI 10.1056/NEJMcp065470; Zeiger MA, 2009, ENDOCR PRACT, V15, P450, DOI 10.4158/EP.15.5.450	29	69	69	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2016	165	8					533	+		10.7326/M16-0547	http://dx.doi.org/10.7326/M16-0547			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6BM	27479926	Green Accepted			2022-12-24	WOS:000385946600013
J	Hirsch, JA; Chandra, RV				Hirsch, Joshua A.; Chandra, Ronil V.			Resurrection of evidence for vertebroplasty?	LANCET			English	Editorial Material							NEUROINTERVENTIONAL SURGERY; PERCUTANEOUS VERTEBROPLASTY; VERTEBRAL AUGMENTATION; RANDOMIZED-TRIAL; FRACTURES; SOCIETY; SPINE		[Hirsch, Joshua A.] Massachusetts Gen Hosp, Neuroendovasc Program, Boston, MA 02114 USA; [Hirsch, Joshua A.] Massachusetts Gen Hosp, NeuroIntervent Spine Serv, Boston, MA 02114 USA; [Hirsch, Joshua A.] Harvard Med Sch, Boston, MA 02115 USA; [Chandra, Ronil V.] Monash Hlth, Monash Imaging, Diagnost & Intervent Neuroradiol, Melbourne, Vic, Australia; [Chandra, Ronil V.] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Chandra, Ronil V.] Monash Univ, Dept Surg, Melbourne, Vic, Australia	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Monash University; Monash University	Hirsch, JA (corresponding author), Massachusetts Gen Hosp, Neuroendovasc Program, Boston, MA 02114 USA.; Hirsch, JA (corresponding author), Massachusetts Gen Hosp, NeuroIntervent Spine Serv, Boston, MA 02114 USA.; Hirsch, JA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	jahirsch@mgh.harvard.edu	Chandra, Ronil/GPK-0357-2022	Chandra, Ronil/0000-0001-7555-2297				Barr JD, 2014, J VASC INTERV RADIOL, V25, P171, DOI 10.1016/j.jvir.2013.10.001; Blasco J, 2012, J BONE MINER RES, V27, P1159, DOI 10.1002/jbmr.1564; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Chandra RV, 2014, J NEUROINTERV SURG, V6, DOI 10.1136/neurintsurg-2013-011012; Clark W, 2016, LANCET; Farrokhi MR, 2011, J NEUROSURG-SPINE, V14, P561, DOI 10.3171/2010.12.SPINE10286; Hochmuth K, 2006, EUR RADIOL, V16, P998, DOI 10.1007/s00330-005-0067-3; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Kaufmann TJ, 2006, AM J NEURORADIOL, V27, P1933; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Manchikanti L, 2013, J NEUROINTERV SURG, V5, P467, DOI 10.1136/neurintsurg-2012-010337; Medical Services Advisory Committee, 2011, 271 MED SERV ADV COM; The National Institute for Health and Clinical Excellence, 2013, NICE TECHN APPR GUID; Wilson DJ, 2011, EUR RADIOL, V21, P1772, DOI 10.1007/s00330-011-2115-5	14	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2016	388	10052					1356	1357		10.1016/S0140-6736(16)31356-3	http://dx.doi.org/10.1016/S0140-6736(16)31356-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DX5FD	27544375				2022-12-24	WOS:000384404300009
J	Maitre, JL; Turlier, H; Illukkumbura, R; Eismann, B; Niwayama, R; Nedelec, F; Hiiragi, T				Maitre, Jean-Leon; Turlier, Herve; Illukkumbura, Rukshala; Eismann, Bjoern; Niwayama, Ritsuya; Nedelec, Francois; Hiiragi, Takashi			Asymmetric division of contractile domains couples cell positioning and fate specification	NATURE			English	Article							POLARITY; FORCES; 16-CELL; YAP/TAZ	During pre-implantation development, the mammalian embryo self-organizes into the blastocyst, which consists of an epithelial layer encapsulating the inner-cell mass (ICM) giving rise to all embryonic tissues(1). In mice, oriented cell division, apicobasal polarity and actomyosin contractility are thought to contribute to the formation of the ICM2-5. However, how these processes work together remains unclear. Here we show that asymmetric segregation of the apical domain generates blastomeres with different contractilities, which triggers their sorting into inner and outer positions. Three-dimensional physical modelling of embryo morphogenesis reveals that cells internalize only when differences in surface contractility exceed a predictable threshold. We validate this prediction using biophysical measurements, and successfully redirect cell sorting within the developing blastocyst using maternal myosin (Myh9)-knockout chimaeric embryos. Finally, we find that loss of contractility causes blastomeres to show ICM-like markers, regardless of their position. In particular, contractility controls Yap subcellular localization(6), raising the possibility that mechanosensing occurs during blastocyst lineage specification. We conclude that contractility couples the positioning and fate specification of blastomeres. We propose that this ensures the robust self-organization of blastomeres into the blastocyst, which confers remarkable regulative capacities to mammalian embryos.	[Maitre, Jean-Leon; Turlier, Herve; Illukkumbura, Rukshala; Eismann, Bjoern; Niwayama, Ritsuya; Nedelec, Francois; Hiiragi, Takashi] European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Maitre, Jean-Leon] Inst Curie, CNRS, INSERM, U934,UMR 3215,Mech Mammalian Dev Grp, 26 Rue Ulm, Paris 05, France; [Eismann, Bjoern] Bioquant, Neuenheimer Feld 267, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Ruprecht Karls University Heidelberg	Maitre, JL; Hiiragi, T (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.; Maitre, JL (corresponding author), Inst Curie, CNRS, INSERM, U934,UMR 3215,Mech Mammalian Dev Grp, 26 Rue Ulm, Paris 05, France.	jean-leon.maitre@curie.fr; hiiragi@embl.de	Nedelec, Francois/AAC-1673-2019; Turlier, Hervé/Y-7600-2019; Nedelec, Francois J/H-3317-2011; Maître, Jean-Léon/C-4372-2017	Nedelec, Francois/0000-0002-8141-5288; Turlier, Hervé/0000-0002-9332-9125; Nedelec, Francois J/0000-0002-8141-5288; Maître, Jean-Léon/0000-0002-3688-1474; Hiiragi, Takashi/0000-0003-4964-7203; Illukkumbura, Rukshala/0000-0002-2131-678X	Marie Curie individual fellowships; Research Executive Agency [329044, 656306, 326701]; Bettencourt-Schueller foundation; EMBL; European Research Council; VolkswagenStifftung; Joachim Herz foundation	Marie Curie individual fellowships(European Commission); Research Executive Agency; Bettencourt-Schueller foundation; EMBL; European Research Council(European Research Council (ERC)European Commission); VolkswagenStifftung(Volkswagen); Joachim Herz foundation	We are grateful to the Hiiragi laboratory members and the European Molecular Biology Laboratory (EMBL) animal facility for their support. We thank F. Da and C. Batty for discussions on the simulations. We thank Y. Bellaiche for comments on an earlier version of the manuscript. Marie Curie individual fellowships under FP7 and H2020 programs support J.-L.M., H.T. and R.N. under Research Executive Agency grant agreements 329044, 656306 and 326701, respectively. H.T. acknowledges support from the Bettencourt-Schueller and Joachim Herz foundations. The Hiiragi laboratory is supported by EMBL, the European Research Council and VolkswagenStifftung.	Anani S, 2014, DEVELOPMENT, V141, P2813, DOI 10.1242/dev.107276; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Benham-Pyle BW, 2015, SCIENCE, V348, P1024, DOI 10.1126/science.aaa4559; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Da F, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2601097.2601146; Dard N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008171; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Guzowski J, 2012, SOFT MATTER, V8, P7269, DOI 10.1039/c2sm25838b; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hirate Y, 2015, DEV GROWTH DIFFER, V57, P544, DOI 10.1111/dgd.12235; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Johnson MH, 2009, ANNU REV CELL DEV BI, V25, P483, DOI 10.1146/annurev.cellbio.042308.113348; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; JOHNSON MH, 1983, DEV BIOL, V95, P211, DOI 10.1016/0012-1606(83)90019-2; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; LEHTONEN E, 1980, J EMBRYOL EXP MORPH, V58, P231; Maitre JL, 2015, NAT CELL BIOL, V17, P849, DOI 10.1038/ncb3185; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Samarage CR, 2015, DEV CELL, V34, P435, DOI 10.1016/j.devcel.2015.07.004; Shin JW, 2014, CELL STEM CELL, V14, P81, DOI 10.1016/j.stem.2013.10.009; Wang AB, 2010, P NATL ACAD SCI USA, V107, P14645, DOI 10.1073/pnas.1004023107; Watanabe T, 2014, DEVELOPMENT, V141, P2279, DOI 10.1242/dev.103267; Wennekamp S, 2013, NAT REV MOL CELL BIO, V14, P452, DOI 10.1038/nrm3602	28	206	209	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					344	+		10.1038/nature18958	http://dx.doi.org/10.1038/nature18958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27487217	Green Accepted, Green Submitted			2022-12-24	WOS:000381804900038
J	Chio, IIC; Jafarnejad, SM; Ponz-Sarvise, M; Park, Y; Rivera, K; Palm, W; Wilson, J; Sangar, V; Hao, Y; Ohlund, D; Wright, K; Filippini, D; Lee, EJ; Da Silva, B; Schoepfer, C; Wilkinson, JE; Buscaglia, JM; DeNicola, GM; Tiriac, H; Hammell, M; Crawford, HC; Schmidt, EE; Thompson, CB; Pappin, DJ; Sonenberg, N; Tuveson, DA				Chio, Iok In Christine; Jafarnejad, Seyed Mehdi; Ponz-Sarvise, Mariano; Park, Youngkyu; Rivera, Keith; Palm, Wilhelm; Wilson, John; Sangar, Vineet; Hao, Yuan; Oehlund, Daniel; Wright, Kevin; Filippini, Dea; Lee, Eun Jung; Da Silva, Brandon; Schoepfer, Christina; Wilkinson, John Erby; Buscaglia, Jonathan M.; DeNicola, Gina M.; Tiriac, Herve; Hammell, Molly; Crawford, Howard C.; Schmidt, Edward E.; Thompson, Craig B.; Pappin, Darryl J.; Sonenberg, Nahum; Tuveson, David A.			NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer	CELL			English	Article							SIGNALING PATHWAYS; DUCTAL ADENOCARCINOMA; OXIDATIVE STRESS; REDOX PROTEOMICS; INITIATION; KRAS; RAS; COMPLEX; KINASE; AKT	Pancreatic cancer is a deadly malignancy that lacks effective therapeutics. We previously reported that oncogenic Kras induced the redox master regulator Nfe2l2/Nrf2 to stimulate pancreatic and lung cancer initiation. Here, we show that NRF2 is necessary to maintain pancreatic cancer proliferation by regulating mRNA translation. Specifically, loss of NRF2 led to defects in autocrine epidermal growth factor receptor (EGFR) signaling and oxidation of specific translational regulatory proteins, resulting in impaired cap-dependent and cap-independent mRNA translation in pancreatic cancer cells. Combined targeting of the EGFR effector AKT and the glutathione antioxidant pathway mimicked Nrf2 ablation to potently inhibit pancreatic cancer ex vivo and in vivo, representing a promising synthetic lethal strategy for treating the disease.	[Chio, Iok In Christine; Ponz-Sarvise, Mariano; Park, Youngkyu; Rivera, Keith; Wilson, John; Hao, Yuan; Oehlund, Daniel; Wright, Kevin; Filippini, Dea; Lee, Eun Jung; Da Silva, Brandon; Schoepfer, Christina; Tiriac, Herve; Hammell, Molly; Pappin, Darryl J.; Tuveson, David A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chio, Iok In Christine; Ponz-Sarvise, Mariano; Park, Youngkyu; Oehlund, Daniel; Wright, Kevin; Filippini, Dea; Lee, Eun Jung; Da Silva, Brandon; Schoepfer, Christina; Tiriac, Herve; Tuveson, David A.] Lustgarten Fdn Pancreat Canc Res Lab, Cold Spring Harbor, NY 11724 USA; [Jafarnejad, Seyed Mehdi; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Jafarnejad, Seyed Mehdi; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Palm, Wilhelm; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Sangar, Vineet] Inst Syst Biol, 401 Terry Ave N, Seattle, WA 98109 USA; [Wilkinson, John Erby; Crawford, Howard C.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wilkinson, John Erby; Crawford, Howard C.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Buscaglia, Jonathan M.] SUNY Stony Brook, Sch Med, Dept Med, Div Gastroenterol, Stony Brook, NY 11794 USA; [DeNicola, Gina M.] Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY 10021 USA; [Schmidt, Edward E.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59718 USA; [Ponz-Sarvise, Mariano] Univ Navarra Clin, CIMA, IDISNA, Dept Oncol, Pamplona 31008, Spain	Cold Spring Harbor Laboratory; McGill University; McGill University; Memorial Sloan Kettering Cancer Center; Institute for Systems Biology (ISB); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cornell University; Montana State University System; Montana State University Bozeman; University of Navarra	Tuveson, DA (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.; Tuveson, DA (corresponding author), Lustgarten Fdn Pancreat Canc Res Lab, Cold Spring Harbor, NY 11724 USA.	dtuveson@cshl.edu	Jafarnejad, Sadegh/D-2075-2018; Ohlund, Daniel/AFR-9335-2022; Ponz-Sarvise, Mariano/H-4104-2017; Palm, Wilhelm/AAS-6255-2021	Ohlund, Daniel/0000-0002-5847-2778; Ponz-Sarvise, Mariano/0000-0002-3240-729X; Hammell, Molly/0000-0003-0405-8392; Hao, Yuan/0000-0002-1588-0587; Jafarnejad, Seyed Mehdi/0000-0002-5129-7081; Tiriac, Herve/0000-0001-5039-6750; Rivera, Keith/0000-0003-2979-9576; DeNicola, Gina/0000-0001-6611-6696; Filippini, Dea/0000-0002-4792-613X	Cancer Center Support grant [5P30CA045508, P30CA008748]; CSHL Association; NIH [5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-01, 5U01CA168409-3, 1R01CA190092-01, AG040020, CA152559, R01 CA159222]; Carcinoid Foundation; PCUK; David Rubinstein Center for Pancreatic Cancer Research at MSKCC; Stand Up to Cancer/KWF; STARR Foundation [I7-A718]; DOD [W81XWH-13-PRCRP-IA]; Precision Medicine Research Associates; Damon Runyon Cancer Research Foundation [DRG-2165-13]; Human Frontier Science Program [LT000190/2013]; Cancer Research Society; CCSRI [702317]; Canadian Institute of Health Research; Swedish Research Council [537-2013-7277]; Sociedad Espanola de Oncologia Medica (SEOM); Hope Funds for Cancer Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA159222, U10CA180944, P30CA045508, P30CA008748, R01CA201318, P50CA101955, R21CA152559, R01CA190092, U01CA168409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG055022, R01AG040020] Funding Source: NIH RePORTER	Cancer Center Support grant; CSHL Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carcinoid Foundation; PCUK; David Rubinstein Center for Pancreatic Cancer Research at MSKCC; Stand Up to Cancer/KWF; STARR Foundation; DOD(United States Department of Defense); Precision Medicine Research Associates; Damon Runyon Cancer Research Foundation; Human Frontier Science Program(Human Frontier Science Program); Cancer Research Society; CCSRI; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Sociedad Espanola de Oncologia Medica (SEOM); Hope Funds for Cancer Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J.R. Prigge, Montana State University, for developing the anti-Nrf2 antibody and Dr. L. Baker for critical review of the manuscript. This work was performed with the CSHL Mass Spectrometry, Animal and Tissue Imaging, and Bioinformatics Shared Resources, which are supported by Cancer Center Support grant 5P30CA045508. D.A.T. is a distinguished scholar of the Lustgarten Foundation (LF) and director of the LF-designated Laboratory of Pancreatic Cancer Research. D.A.T. is supported by the CSHL Association; the NIH (5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-01, 5U01CA168409-3, and 1R01CA190092-01); the Carcinoid Foundation; PCUK; the David Rubinstein Center for Pancreatic Cancer Research at MSKCC; Stand Up to Cancer/KWF; the STARR Foundation (I7-A718), the DOD (W81XWH-13-PRCRP-IA); and the Precision Medicine Research Associates. We are also grateful for support from the following: the Damon Runyon Cancer Research Foundation (Shirley Stein fellow, DRG-2165-13, to I.I.C.C.); the Human Frontier Science Program (LT000190/2013 to I.I.C.C.); the Cancer Research Society and CCSRI (702317, N.S.); the Canadian Institute of Health Research (to S.M.J.); NIH (grants AG040020 and CA152559 to E.E.S.; grant R01 CA159222 to H.C.C.); the Swedish Research Council (537-2013-7277 to D.O.), the Sociedad Espanola de Oncologia Medica (SEOM; to M.P.-S.); and the Hope Funds for Cancer Research Fellowship (to W.P). This work was performed with the MSKCC Molecular Cytology Core, which is supported by Cancer Center Support grant P30CA008748. C.B.T. is a founder of Agios Pharmaceuticals and a member of its scientific advisory board. C.B.T. also serves on the board of directors of Merck.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Belalcazar Andrea D, 2014, ISRN Biochem, V2013, P637897; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Brandes N, 2011, J BIOL CHEM, V286, P41893, DOI 10.1074/jbc.M111.296236; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Fan XM, 2014, DRUG METAB DISPOS, V42, P1532, DOI 10.1124/dmd.114.059394; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; JOHNSON LF, 1975, CELL, V4, P69, DOI 10.1016/0092-8674(75)90135-X; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Ke BB, 2013, J HEPATOL, V59, P1200, DOI 10.1016/j.jhep.2013.07.016; Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; Mavrakis KJ, 2008, CELL CYCLE, V7, P2791, DOI 10.4161/cc.7.18.6683; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Molife LR, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-1; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; Patel MR, 2013, J THORAC ONCOL, V8, P1142, DOI 10.1097/JTO.0b013e31829ce963; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789; Permyakov SE, 2012, AMINO ACIDS, V42, P1435, DOI 10.1007/s00726-011-0843-0; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Sethuraman M, 2004, J PROTEOME RES, V3, P1228, DOI 10.1021/pr049887e; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Socinski MA, 2004, CLIN CANCER RES, V10, p4210S, DOI 10.1158/1078-0432.CCR-040009; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Talalay P, 2007, P NATL ACAD SCI USA, V104, P17500, DOI 10.1073/pnas.0708710104; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6095; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zhao X, 2014, CANCER RES, V74, P2455, DOI 10.1158/0008-5472.CAN-13-3009	56	218	227	5	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					963	976		10.1016/j.cell.2016.06.056	http://dx.doi.org/10.1016/j.cell.2016.06.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27477511	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000382258700018
J	Din, MO; Danino, T; Prindle, A; Skalak, M; Selimkhanov, J; Allen, K; Julio, E; Atolia, E; Tsimring, LS; Bhatia, SN; Hasty, J				Din, M. Omar; Danino, Tal; Prindle, Arthur; Skalak, Matt; Selimkhanov, Jangir; Allen, Kaitlin; Julio, Ellixis; Atolia, Eta; Tsimring, Lev S.; Bhatia, Sangeeta N.; Hasty, Jeff			Synchronized cycles of bacterial lysis for in vivo delivery	NATURE			English	Article							CANCER; SALMONELLA	The widespread view of bacteria as strictly pathogenic has given way to an appreciation of the prevalence of some beneficial microbes within the human body(1-3). It is perhaps inevitable that some bacteria would evolve to preferentially grow in environments that harbour disease and thus provide a natural platform for the development of engineered therapies(4-6). Such therapies could benefit from bacteria that are programmed to limit bacterial growth while continually producing and releasing cytotoxic agents in situ(7-10). Here we engineer a clinically relevant bacterium to lyse synchronously at a threshold population density and to release genetically encoded cargo. Following quorum lysis, a small number of surviving bacteria reseed the growing population, thus leading to pulsatile delivery cycles. We used microfluidic devices to characterize the engineered lysis strain and we demonstrate its potential as a drug delivery platform via co-culture with human cancer cells in vitro. As a proof of principle, we tracked the bacterial population dynamics in ectopic syngeneic colorectal tumours in mice via a luminescent reporter. The lysis strain exhibits pulsatile population dynamics in vivo, with mean bacterial luminescence that remained two orders of magnitude lower than an unmodified strain. Finally, guided by previous findings that certain bacteria can enhance the efficacy of standard therapies(11), we orally administered the lysis strain alone or in combination with a clinical chemotherapeutic to a syngeneic mouse transplantation model of hepatic colorectal metastases. We found that the combination of both circuit-engineered bacteria and chemotherapy leads to a notable reduction of tumour activity along with a marked survival benefit over either therapy alone. Our approach establishes a methodology for leveraging the tools of synthetic biology to exploit the natural propensity for certain bacteria to colonize disease sites.	[Din, M. Omar; Prindle, Arthur; Selimkhanov, Jangir; Julio, Ellixis; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Danino, Tal; Skalak, Matt; Allen, Kaitlin; Atolia, Eta; Bhatia, Sangeeta N.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Tsimring, Lev S.; Hasty, Jeff] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Bhatia, Sangeeta N.] Broad Inst Harvard & MIT, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] Brigham & Womens Hosp, Dept Med, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] MIT, Elect Engn & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] MIT, Marble Ctr Canc Nanomed, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] MIT, Ludwig Ctr Mol Oncol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Hasty, Jeff] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Danino, Tal] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA	University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of California System; University of California San Diego; Columbia University	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.; Hasty, J (corresponding author), Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA.; Hasty, J (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	jhasty@eng.ucsd.edu	Din, Omar/AAK-8962-2020	Allen, Kaitlin/0000-0001-8036-1110; Tsimring, Lev/0000-0003-0709-3548; Atolia, Eta/0000-0001-7366-464X	National Institute of General Medical Sciences of the National Institutes of Health [R01GM069811]; San Diego Center for Systems Biology [P50 GM085764]; Koch Institute Support Grant from the National Cancer Institute (Swanson Biotechnology Center) [P30-CA14051]; Core Center Grant from the National Institute of Environmental Health Sciences [P30-ES002109]; Ludwig Center for Molecular Oncology at MIT; Amar G. Bose Research Grant; Misrock Postdoctoral fellowship; NIH Pathway to Independence Award NIH [K99 CA197649-01]; Department of Defense National Defense Science and Engineering Graduate Fellowship; Helen Hay Whitney Foundation; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [K99CA197649, P30CA014051, DP1CA174420, R00CA197649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811, P50GM085764] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); San Diego Center for Systems Biology; Koch Institute Support Grant from the National Cancer Institute (Swanson Biotechnology Center); Core Center Grant from the National Institute of Environmental Health Sciences; Ludwig Center for Molecular Oncology at MIT; Amar G. Bose Research Grant; Misrock Postdoctoral fellowship; NIH Pathway to Independence Award NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense National Defense Science and Engineering Graduate Fellowship(United States Department of Defense); Helen Hay Whitney Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The UCSD team was supported by the National Institute of General Medical Sciences of the National Institutes of Health (R01GM069811) and the San Diego Center for Systems Biology (P50 GM085764). The MIT team was supported by a Koch Institute Support Grant (P30-CA14051) from the National Cancer Institute (Swanson Biotechnology Center), a Core Center Grant (P30-ES002109) from the National Institute of Environmental Health Sciences, the Ludwig Center for Molecular Oncology at MIT and an Amar G. Bose Research Grant. T.D. was supported by the Misrock Postdoctoral fellowship and the NIH Pathway to Independence Award NIH (K99 CA197649-01). A.P. was supported by the Department of Defense National Defense Science and Engineering Graduate Fellowship and holds a Simons Foundation Fellowship of the Helen Hay Whitney Foundation and a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. S.N.B. is an HHMI Investigator. We would like to thank R. Johnson for help with constructing microfluidic devices, H. Fleming for help with editing the manuscript, and H. Ding of The Barbara K. Ostrom (1978) Bioinformatics and Computing Facility in the Swanson Biotechnology Center for help with the statistical tests carried out in this study. We would also like to thank L. You for providing the lysis gene used in this study.	Baban Chwanrow K, 2010, Bioeng Bugs, V1, P385, DOI 10.4161/bbug.1.6.13146; Chen RW, 2013, CANCER RES, V73, P1352, DOI 10.1158/0008-5472.CAN-12-1979; Cheong I, 2006, SCIENCE, V314, P1308, DOI 10.1126/science.1130651; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; Danino T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3519; Danino T, 2013, JOVE-J VIS EXP, DOI 10.3791/50540; Danino T, 2012, ACS SYNTH BIOL, V1, P465, DOI 10.1021/sb3000639; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; GERDES K, 1988, BIO-TECHNOL, V6, P1402, DOI 10.1038/nbt1288-1402; Hoption Cann SA, 2003, MED J, V79, P672; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Loeffler M, 2009, CANCER IMMUNOL IMMUN, V58, P769, DOI 10.1007/s00262-008-0555-9; Marguet P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011909; Pawelek JM, 1997, CANCER RES, V57, P4537; Prindle A, 2012, ACS SYNTH BIOL, V1, P458, DOI 10.1021/sb300060e; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Ryan RM, 2009, GENE THER, V16, P329, DOI 10.1038/gt.2008.188; Thaiss CA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005113; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; WOOD T K, 1990, Biotechnology Techniques, V4, P39, DOI 10.1007/BF00156608; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744; YOUNG KD, 1982, J VIROL, V44, P993, DOI 10.1128/JVI.44.3.993-1002.1982	29	321	340	35	445	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					81	+		10.1038/nature18930	http://dx.doi.org/10.1038/nature18930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27437587	Green Submitted, Green Accepted			2022-12-24	WOS:000380999200034
J	Patel, MR; Armstrong, PW; Bhatt, DL; Braunwald, E; Camm, AJ; Fox, KAA; Harrington, RA; Hiatt, WR; James, SK; Kirtane, AJ; Leon, MB; Lincoff, AM; Mahaffey, KW; Mauri, L; Mehran, R; Mehta, SR; Montalescot, G; Nicholls, SJ; Perkovic, V; Peterson, ED; Pocock, SJ; Roe, MT; Sabatine, MS; Sekeres, M; Solomon, SD; Steg, G; Stone, GW; Van de Werf, F; Wallentin, L; White, HD; Gibson, CM				Patel, Manesh R.; Armstrong, Paul W.; Bhatt, Deepak L.; Braunwald, Eugene; Camm, A. John; Fox, Keith A. A.; Harrington, Robert A.; Hiatt, William R.; James, Stefan K.; Kirtane, Ajay J.; Leon, Martin B.; Lincoff, A. Michael; Mahaffey, Kenneth W.; Mauri, Laura; Mehran, Roxana; Mehta, Shamir R.; Montalescot, Gilles; Nicholls, Stephen J.; Perkovic, Vlado; Peterson, Eric D.; Pocock, Stuart J.; Roe, Matthew T.; Sabatine, Marc S.; Sekeres, Mikkael; Solomon, Scott D.; Steg, Gabriel; Stone, Gregg W.; Van de Werf, Frans; Wallentin, Lars; White, Harvey D.; Gibson, C. Michael		Acad Res Org Consortium Continuing	Sharing Data from Cardiovascular Clinical Trials - A Proposal	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Arellano-Rodrigo, Eduardo/H-4094-2015; Brugaletta, Salvatore/E-1310-2018; Ruiz-Artacho, PEDRO/I-3100-2018; Díaz, José Luis JLDD Díaz/Q-2523-2015; Peterson, Eric David/ABF-5033-2021; Mehran, Roxana/ABF-4160-2021; Sabatine, Marc/AAJ-6751-2020; Arellano-Rodrigo, Eduardo/R-7079-2019; Rafalskiy, Vladimir V/G-3172-2013; Pilgrim, Thomas/AAS-9120-2021; James, Stefan K/J-4554-2014; Fox, keith A A/I-3742-2013; Apartsin, Konstantin/ACA-8088-2022; Malynovsky, Yaroslav/T-1898-2017; Aleksandr, Legkonogov/P-8914-2015; Perkovic, Vlado/AAY-1933-2021; Apartsin, Konstantin A/B-9179-2017; Patel, Manesh/AAC-5385-2019; mauri, laura/GPS-4868-2022; Thijs, Vincent/C-3647-2009; Apartsin, Konstantin/ABC-5678-2020; Gibson, C. Michael/AAE-8212-2019; martin-loeches, Prof. Ignacio/Q-6645-2018	Arellano-Rodrigo, Eduardo/0000-0001-6236-7826; Brugaletta, Salvatore/0000-0001-5845-1435; Ruiz-Artacho, PEDRO/0000-0002-5680-9883; Sabatine, Marc/0000-0002-0691-3359; Arellano-Rodrigo, Eduardo/0000-0001-6236-7826; Rafalskiy, Vladimir V/0000-0002-2503-9580; Pilgrim, Thomas/0000-0001-8721-4068; Apartsin, Konstantin/0000-0003-0577-9001; Malynovsky, Yaroslav/0000-0002-9118-1104; Aleksandr, Legkonogov/0000-0002-5551-4872; Apartsin, Konstantin A/0000-0003-0577-9001; Thijs, Vincent/0000-0002-6614-8417; Apartsin, Konstantin/0000-0003-0577-9001; Kunecki, Marcin/0000-0003-4077-7378; Fox, Keith/0000-0002-0140-2752; Meelu, Omar/0000-0002-3481-2731; Armstrong, Paul/0000-0002-0460-3445; Van de Werf, Frans/0000-0001-9479-7767; Rincon, Luis M./0000-0003-1819-5742; Obaitan, Itegbemie/0000-0001-5002-6821; STEG, Philippe Gabriel/0000-0001-6896-2941; Sekeres, Mikkael/0000-0003-2009-6524; martin-loeches, Prof. Ignacio/0000-0002-5834-4063; Nicholls, Stephen/0000-0002-9668-4368				Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Navar AM, 2016, JAMA-J AM MED ASSOC, V315, P1283, DOI 10.1001/jama.2016.2374; Strom BL, 2014, NEW ENGL J MED, V371, P2052, DOI 10.1056/NEJMp1411794; Taichman DB, 2016, NEW ENGL J MED, V374, P384, DOI 10.1056/NEJMe1515172; [No title captured]	5	35	37	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					407	409		10.1056/NEJMp1605260	http://dx.doi.org/10.1056/NEJMp1605260			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS7AN	27518659	Green Published, Bronze			2022-12-24	WOS:000380934900004
J	Coulais, C; Teomy, E; de Reus, K; Shokef, Y; van Hecke, M				Coulais, Corentin; Teomy, Eial; de Reus, Koen; Shokef, Yair; van Hecke, Martin			Combinatorial design of textured mechanical metamaterials	NATURE			English	Article							NEGATIVE POISSONS RATIO; ARTIFICIAL SPIN ICE; FRUSTRATION	The structural complexity of metamaterials is limitless, but, in practice, most designs comprise periodic architectures that lead to materials with spatially homogeneous features(1-11). More advanced applications in soft robotics, prosthetics and wearable technology involve spatially textured mechanical functionality, which requires aperiodic architectures. However, a naive implementation of such structural complexity invariably leads to geometrical frustration (whereby local constraints cannot be satisfied everywhere), which prevents coherent operation and impedes functionality. Here we introduce a combinatorial strategy for the design of aperiodic, yet frustration-free, mechanical metamaterials that exhibit spatially textured functionalities. We implement this strategy using cubic building blocks-voxels-that deform anisotropically, a local stacking rule that allows cooperative shape changes by guaranteeing that deformed building blocks fit together as in a three-dimensional jigsaw puzzle, and three-dimensional printing. These aperiodic metamaterials exhibit long-range holographic order, whereby the two-dimensional pixelated surface texture dictates the three-dimensional interior voxel arrangement. They also act as programmable shape-shifters, morphing into spatially complex, but predictable and designable, shapes when uniaxially compressed. Finally, their mechanical response to compression by a textured surface reveals their ability to perform sensing and pattern analysis. Combinatorial design thus opens up a new avenue towards mechanical metamaterials with unusual order and machine-like functionalities.	[Coulais, Corentin; de Reus, Koen; van Hecke, Martin] Leiden Univ, Huygens Kamerlingh Onnes Lab, POB 9504, NL-2300 RA Leiden, Netherlands; [Coulais, Corentin; van Hecke, Martin] FOM Inst AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands; [Teomy, Eial; Shokef, Yair] Tel Aviv Univ, Sch Mech Engn, IL-69978 Tel Aviv, Israel; [Teomy, Eial; Shokef, Yair] Tel Aviv Univ, Sackler Ctr Computat Mol & Mat Sci, IL-69978 Tel Aviv, Israel	Leiden University; Leiden University - Excl LUMC; AMOLF; Tel Aviv University; Tel Aviv University	Coulais, C (corresponding author), Leiden Univ, Huygens Kamerlingh Onnes Lab, POB 9504, NL-2300 RA Leiden, Netherlands.; Coulais, C (corresponding author), FOM Inst AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	coulais@amolf.nl	Coulais, Corentin/P-3920-2015; Teomy, Eial/G-4253-2018; Shokef, Yair/C-3452-2009	Coulais, Corentin/0000-0002-3174-5836; Teomy, Eial/0000-0002-2409-3489; Shokef, Yair/0000-0002-1195-4614; van Hecke, Martin/0000-0002-9550-6607	Netherlands Organisation for Scientific Research through VICI [NWO-680-47-609]; Netherlands Organisation for Scientific Research through VENI [NWO-680-47-445]; Israel Science Foundation [617/12, 1730/12]	Netherlands Organisation for Scientific Research through VICI; Netherlands Organisation for Scientific Research through VENI; Israel Science Foundation(Israel Science Foundation)	We are grateful to J. Mesman for technical support. We thank R. Golkov, Y. Kamir, G. Kosa, K. Kuipers, F. Leoni, W. Noorduin and V. Vitelli for discussions. We acknowledge funding from the Netherlands Organisation for Scientific Research through grants VICI No. NWO-680-47-609 (M.v.H. and C.C.) and VENI No. NWO-680-47-445 (C.C.) and from the Israel Science Foundation through grant numbers 617/12 and 1730/12 (E.T and Y.S.).	Babaee S, 2013, ADV MATER, V25, P5044, DOI 10.1002/adma.201301986; Buckmann T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5130; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Cho Y, 2014, P NATL ACAD SCI USA, V111, P17390, DOI 10.1073/pnas.1417276111; Coulais C, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.044301; Florijn B, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.175503; Grima JN, 2000, J MATER SCI LETT, V19, P1563, DOI 10.1023/A:1006781224002; Grunbaum B., 1987, TILINGS PATTERNS; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; Kadic M, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/12/126501; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038; Leong TG, 2009, P NATL ACAD SCI USA, V106, P703, DOI 10.1073/pnas.0807698106; Liu ZY, 2000, SCIENCE, V289, P1734, DOI 10.1126/science.289.5485.1734; Mezard M., 1987, SPIN GLASS THEORY IN; Mullin T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.084301; Nicolaou ZG, 2012, NAT MATER, V11, P608, DOI [10.1038/NMAT3331, 10.1038/nmat3331]; Nisoli C, 2013, REV MOD PHYS, V85, P1473, DOI 10.1103/RevModPhys.85.1473; Overvelde JTB, 2015, P NATL ACAD SCI USA, V112, P10863, DOI 10.1073/pnas.1504947112; Paulose J, 2015, P NATL ACAD SCI USA, V112, P7639, DOI 10.1073/pnas.1502939112; Sadoc J.-F., 1999, GEOMETRICAL FRUSTRAT; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Schenk M, 2013, P NATL ACAD SCI USA, V110, P3276, DOI 10.1073/pnas.1217998110; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Silverberg JL, 2014, SCIENCE, V345, P647, DOI 10.1126/science.1252876; Waitukaitis S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.055503; Wang RF, 2006, NATURE, V439, P303, DOI 10.1038/nature04447; WANNIER GH, 1950, PHYS REV, V79, P357, DOI 10.1103/PhysRev.79.357; Ware TH, 2015, SCIENCE, V347, P982, DOI 10.1126/science.1261019; Zykov V, 2005, NATURE, V435, P163, DOI 10.1038/435163a	30	195	201	39	353	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					529	+		10.1038/nature18960	http://dx.doi.org/10.1038/nature18960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27466125	Green Submitted			2022-12-24	WOS:000380856600024
J	Weir, HJ; Mair, WB				Weir, Heather J.; Mair, William B.			SnapShot: Neuronal Regulation of Aging	CELL			English	Editorial Material									[Weir, Heather J.; Mair, William B.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Weir, HJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.			Mair, William/0000-0002-0661-1342	NATIONAL INSTITUTE ON AGING [R01AG044346] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG044346] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alcedo Joy, 2013, Frontiers in Genetics, V4, P71, DOI 10.3389/fgene.2013.00071; Burkewitz K, 2015, CELL, V160, P842, DOI 10.1016/j.cell.2015.02.004; Schinzel R, 2015, CURR OPIN CELL BIOL, V33, P102, DOI 10.1016/j.ceb.2015.01.006; Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143	5	5	5	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					784	+		10.1016/j.cell.2016.07.022	http://dx.doi.org/10.1016/j.cell.2016.07.022			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471972	Bronze			2022-12-24	WOS:000380546500030
J	Solomon, S; Ivy, DJ; Kinnison, D; Mills, MJ; Neely, RR; Schmidt, A				Solomon, Susan; Ivy, Diane J.; Kinnison, Doug; Mills, Michael J.; Neely, Ryan R., III; Schmidt, Anja			Emergence of healing in the Antarctic ozone layer	SCIENCE			English	Article							BREWER-DOBSON CIRCULATION; STRATOSPHERIC OZONE; DATA SETS; VARIABILITY; DEPLETION; RECOVERY; TRENDS; SIMULATIONS; CLIMATE; SULFUR	Industrial chlorofluorocarbons that cause ozone depletion have been phased out under the Montreal Protocol. A chemically driven increase in polar ozone (or "healing") is expected in response to this historic agreement. Observations and model calculations together indicate that healing of the Antarctic ozone layer has now begun to occur during the month of September. Fingerprints of September healing since 2000 include (i) increases in ozone column amounts, (ii) changes in the vertical profile of ozone concentration, and (iii) decreases in the areal extent of the ozone hole. Along with chemistry, dynamical and temperature changes have contributed to the healing but could represent feedbacks to chemistry. Volcanic eruptions have episodically interfered with healing, particularly during 2015, when a record October ozone hole occurred after the Calbuco eruption.	[Solomon, Susan; Ivy, Diane J.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Kinnison, Doug; Mills, Michael J.] Natl Ctr Atmospher Res, Atmospher Chem Observat & Modeling Lab, POB 3000, Boulder, CO 80305 USA; [Neely, Ryan R., III; Schmidt, Anja] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Neely, Ryan R., III] Univ Leeds, Natl Ctr Atmospher Sci, Leeds, W Yorkshire, England	Massachusetts Institute of Technology (MIT); National Center Atmospheric Research (NCAR) - USA; University of Leeds; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Leeds	Solomon, S (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	solos@mit.edu	Mills, Michael/B-5068-2010; Schmidt, Anja/ABD-7113-2021; Neely, Ryan/F-8702-2010; Schmidt, Anja/C-9617-2012	Mills, Michael/0000-0002-8054-1346; Schmidt, Anja/0000-0001-8759-2843; Neely, Ryan/0000-0003-4560-4812; 	NSF Frontiers in Earth System Dynamics grant [OCE-1338814]; NSF Atmospheric Chemistry grant [AGS-1539972]; University of Leeds; NCAR visiting scientist grant; Natural Environment Research Council [NE/N006038/1]; NSF; Office of Science of the U.S. Department of Energy; NERC [ncas10003, NE/N006038/1] Funding Source: UKRI; Natural Environment Research Council [ncas10003] Funding Source: researchfish; Div Atmospheric & Geospace Sciences [1539972] Funding Source: National Science Foundation	NSF Frontiers in Earth System Dynamics grant; NSF Atmospheric Chemistry grant; University of Leeds; NCAR visiting scientist grant; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank S. Tilmes (NCAR) for help with the MERRA (Modern-Era Retrospective Analysis for Research and Applications) data. D.K. and S. S. were partially supported by NSF Frontiers in Earth System Dynamics grant OCE-1338814, and D.J.I. was supported by NSF Atmospheric Chemistry grant AGS-1539972. A. S. was supported by an Academic Research Fellowship from the University of Leeds, an NCAR visiting scientist grant, and Natural Environment Research Council grant NE/N006038/1. NCAR is sponsored by NSF. WACCM is a component of CESM, which is supported by NSF and the Office of Science of the U.S. Department of Energy. We are grateful to D. Fahey, B. Hassler, W. D. McKenna, and the anonymous reviewers for helpful comments. Instructions for access to data reported in this paper are given in the supplementary materials.	Arfeuille F, 2013, ATMOS CHEM PHYS, V13, P11221, DOI 10.5194/acp-13-11221-2013; Braesicke P, 2013, ATMOS CHEM PHYS, V13, P10677, DOI 10.5194/acp-13-10677-2013; Bruhl C, 2015, J GEOPHYS RES-ATMOS, V120, P2103, DOI 10.1002/2014JD022430; Butchart N, 2014, REV GEOPHYS, V52, P157, DOI 10.1002/2013RG000448; Chehade W, 2014, ATMOS CHEM PHYS, V14, P7059, DOI 10.5194/acp-14-7059-2014; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Forster PMD, 1997, CLIM DYNAM, V13, P547, DOI 10.1007/s003820050182; Harris NRP, 2015, ATMOS CHEM PHYS, V15, P9965, DOI 10.5194/acp-15-9965-2015; Hassler B, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045542; Hopfner M, 2015, ATMOS CHEM PHYS, V15, P7017, DOI 10.5194/acp-15-7017-2015; Hofmann DJ, 1997, J GEOPHYS RES-ATMOS, V102, P8931, DOI 10.1029/96JD03749; HOFMANN DJ, 1993, J GEOPHYS RES-ATMOS, V98, P18555, DOI 10.1029/93JD02092; Kunz A, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016686; Kuttippurath J, 2015, ATMOS CHEM PHYS, V15, P10385, DOI 10.5194/acp-15-10385-2015; Kuttippurath J, 2013, ATMOS CHEM PHYS, V13, P1625, DOI 10.5194/acp-13-1625-2013; Li F, 2008, J CLIMATE, V21, P40, DOI 10.1175/2007JCLI1663.1; Livesey NJ, 2015, ATMOS CHEM PHYS, V15, P9945, DOI 10.5194/acp-15-9945-2015; Marsh DR, 2013, J CLIMATE, V26, P7372, DOI 10.1175/JCLI-D-12-00558.1; McLandress C, 2009, J CLIMATE, V22, P1516, DOI 10.1175/2008JCLI2679.1; McPeters RD, 2013, J GEOPHYS RES-ATMOS, V118, P8032, DOI 10.1002/jgrd.50597; Meul S, 2015, ATMOS CHEM PHYS, V15, P6897, DOI 10.5194/acp-15-6897-2015; Mills MJ, 2016, J GEOPHYS RES-ATMOS, V121, P2332, DOI 10.1002/2015JD024290; Newchurch MJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003471; Newman PA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025232; Portmann RW, 1996, J GEOPHYS RES-ATMOS, V101, P22991, DOI 10.1029/96JD02608; Salby M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047266; Scaife AA, 2005, J ATMOS SCI, V62, P629, DOI 10.1175/JAS-3334.1; Shepherd TG, 2014, NAT GEOSCI, V7, P443, DOI [10.1038/ngeo2155, 10.1038/NGEO2155]; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; Solomon S, 2015, J GEOPHYS RES-ATMOS, V120, P7958, DOI 10.1002/2015JD023365; Tabazadeh A, 2002, P NATL ACAD SCI USA, V99, P2609, DOI 10.1073/pnas.052518199; Tummon F, 2015, ATMOS CHEM PHYS, V15, P3021, DOI 10.5194/acp-15-3021-2015; Vernier JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047563; WMO, 2015, WMO ANT OZ B 2015; World Meteorological Organization/United Nations Environment Programme (WMO/UNEP), 2014, 55 WMOUNEP; Yang ES, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009675	36	328	332	40	296	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2016	353	6296					269	274		10.1126/science.aae0061	http://dx.doi.org/10.1126/science.aae0061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0EM	27365314	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000379580800044
J	Thomas, JA				Thomas, Jeremy A.			Butterfly communities under threat	SCIENCE			English	Editorial Material							CONSERVATION; DECLINES		[Thomas, Jeremy A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Thomas, JA (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.	jeremy.thomas@zoo.ox.ac.uk						Baker D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157423; Brown KS, 2000, BIOTROPICA, V32, P934, DOI 10.1646/0006-3606(2000)032[0934:AFBIFL]2.0.CO;2; Conrad KF, 2006, BIOL CONSERV, V132, P279, DOI 10.1016/j.biocon.2006.04.020; Fox R, 2015, STATE UKS BUTTERFLIE; Habel JC, 2016, CONSERV BIOL, V30, P754, DOI 10.1111/cobi.12656; Jepsen S, 2015, CONSERVATION STATUS; Lewis OT, 2011, J INSECT CONSERV, V15, P121, DOI 10.1007/s10841-010-9329-8; New T. R., 2012, INSECT CONSERVATION; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Sands D. P. A., 2012, CONSERVATION RICHMON, P1; Swengel SR, 2011, J INSECT CONSERV, V15, P327, DOI 10.1007/s10841-010-9323-1; Thomas JA, 2011, J INSECT CONSERV, V15, P241, DOI 10.1007/s10841-010-9341-z; Thomas JA, 2009, SCIENCE, V325, P80, DOI 10.1126/science.1175726; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	15	79	81	16	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2016	353	6296					216	218		10.1126/science.aaf8838	http://dx.doi.org/10.1126/science.aaf8838			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0EM	27418487	Green Submitted			2022-12-24	WOS:000379580800018
J	Holmes, D				Holmes, David			THE PAIN DRAIN	NATURE			English	Editorial Material																			0	21	23	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					S2	S3		10.1038/535S2a	http://dx.doi.org/10.1038/535S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UE	27410529	Bronze			2022-12-24	WOS:000452215900001
J	McNulty, M; Cifu, AS; Pitrak, D				McNulty, Moira; Cifu, Adam S.; Pitrak, David			HIV Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[McNulty, Moira; Pitrak, David] Univ Chicago, Sect Infect Dis & Global Hlth, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA; [Cifu, Adam S.] Univ Chicago, Sect Gen Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	McNulty, M (corresponding author), Univ Chicago, Sect Infect Dis & Global Hlth, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	moira.mcnulty@uchospitals.edu						[Anonymous], SCREENING HIV SYSTEM; Bares S, 2016, PUBLIC HEALTH REP, V131, P107, DOI 10.1177/00333549161310S113; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Chou R, 2005, ANN INTERN MED, V143, P55, DOI 10.7326/0003-4819-143-1-200507050-00010; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Office of National AIDS Policy WHDPC, 2015, NAT HIV AIDS STRAT U; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Skarbinski J, 2015, JAMA INTERN MED, V175, P588, DOI 10.1001/jamainternmed.2014.8180	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2016	316	2					213	214		10.1001/jama.2016.2661	http://dx.doi.org/10.1001/jama.2016.2661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ9CW	27404189				2022-12-24	WOS:000379509000017
J	Hsia, Y; Bale, JB; Gonen, S; Shi, D; Sheffler, W; Fong, KK; Nattermann, U; Xu, CF; Huang, PS; Ravichandran, R; Yi, S; Davis, TN; Gonen, T; King, NP; Baker, D				Hsia, Yang; Bale, Jacob B.; Gonen, Shane; Shi, Dan; Sheffler, William; Fong, Kimberly K.; Nattermann, Una; Xu, Chunfu; Huang, Po-Ssu; Ravichandran, Rashmi; Yi, Sue; Davis, Trisha N.; Gonen, Tamir; King, Neil P.; Baker, David			Design of a hyperstable 60-subunit protein icosahedron	NATURE			English	Article							VIRUS-LIKE PARTICLES; ELECTRON-MICROSCOPY; IMAGE-ANALYSIS; GENERATION; VISUALIZATION; NANOMATERIALS; RESOLUTION; SYMMETRY; ALDOLASE; SYSTEM	The icosahedron is the largest of the Platonic solids, and icosahedral protein structures are widely used in biological systems for packaging and transport(1,2). There has been considerable interest in repurposing such structures(3-5) for applications ranging from targeted delivery to multivalent immunogen presentation. The ability to design proteins that self-assemble into precisely specified, highly ordered icosahedral structures would open the door to a new generation of protein containers with properties custom-tailored to specific applications. Here we describe the computational design of a 25-nanometre icosahedral nanocage that self-assembles from trimeric protein building blocks. The designed protein was produced in Escherichia coli, and found by electron microscopy to assemble into a homogenous population of icosahedral particles nearly identical to the design model. The particles are stable in 6.7 molar guanidine hydrochloride at up to 80 degrees Celsius, and undergo extremely abrupt, but reversible, disassembly between 2 molar and 2.25 molar guanidinium thiocyanate. The icosahedron is robust to genetic fusions: one or two copies of green fluorescent protein (GFP) can be fused to each of the 60 subunits to create highly fluorescent 'standard candles' for use in light microscopy, and a designed protein pentamer can be placed in the centre of each of the 20 pentameric faces to modulate the size of the entrance/exit channels of the cage. Such robust and customizable nanocages should have considerable utility in targeted drug delivery(6), vaccine design(7) and synthetic biology(8).	[Hsia, Yang; Bale, Jacob B.; Gonen, Shane; Sheffler, William; Fong, Kimberly K.; Nattermann, Una; Xu, Chunfu; Huang, Po-Ssu; Ravichandran, Rashmi; Yi, Sue; Davis, Trisha N.; King, Neil P.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Hsia, Yang; Bale, Jacob B.; Gonen, Shane; Sheffler, William; Nattermann, Una; Xu, Chunfu; Huang, Po-Ssu; Ravichandran, Rashmi; Yi, Sue; King, Neil P.; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Hsia, Yang; Gonen, Shane; Nattermann, Una] Univ Washington, Grad Program Biol Phys Struct & Design, Seattle, WA 98195 USA; [Bale, Jacob B.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Gonen, Shane; Shi, Dan; Gonen, Tamir] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	dabaker@uw.edu	Baker, David/K-8941-2012; Davis, Trisha/F-8584-2010; Xu, Chunfu/B-5963-2012	Baker, David/0000-0001-7896-6217; Huang, Possu/0000-0002-7948-2895; Xu, Chunfu/0000-0002-8668-0566; Gonen, Shane/0000-0002-4829-3151; Bale, Jacob/0000-0003-2444-5875	Howard Hughes Medical Institute; JRC; National Science Foundation [CHE-1332907]; UW/Hutch CCSG Pilot Award NCI [5 P30 CA015704-41]; Takeda Pharmaceutical Company; Bill and Melinda Gates Foundation [OPP1120319]; National Institutes of Health (NIH) [P41 GM103533]; Defense Advanced Research Projects Agency [W911NF-14-1-0162]; Air Force Office of Scientific Research (AFOSR) [AFOSR FA950-12-10112]; NIH [T32GM008268]; PHS National Research Service Award from NIGMS [T32GM007270]; NSF Graduate Research Fellowship [DGE-0718124]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040506, P41GM103533, T32GM008268, P01GM105537, T32GM007270] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JRC; National Science Foundation(National Science Foundation (NSF)); UW/Hutch CCSG Pilot Award NCI; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS National Research Service Award from NIGMS; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (D.B. and T.G.), the JRC visitor programme (S.G.), the National Science Foundation CHE-1332907 (D.B.), a UW/Hutch CCSG Pilot Award NCI 5 P30 CA015704-41 (D.B. and N.P.K.), Takeda Pharmaceutical Company (N.P.K.), the Bill and Melinda Gates Foundation OPP1120319 (D.B. and N.P.K.), the National Institutes of Health (NIH) P41 GM103533 (T.N.D.), the Defense Advanced Research Projects Agency (D.B. and N.P.K., grant no. W911NF-14-1-0162) and the Air Force Office of Scientific Research (AFOSR) AFOSR FA950-12-10112 (D.B.). Y.H. was supported in part by a NIH Molecular Biology Training Grant (T32GM008268). U.N. was supported in part by a PHS National Research Service Award (T32GM007270) from NIGMS. J.B.B. was supported in part by an NSF Graduate Research Fellowship (DGE-0718124). We thank the Janelia Research Campus Cryo-EM Facility and J. de la Cruz for their assistance with the Titan Krios.	Andrews BT, 2007, J MOL BIOL, V373, P476, DOI 10.1016/j.jmb.2007.07.071; Baalousha M, 2013, NAT NANOTECHNOL, V8, P308, DOI 10.1038/nnano.2013.78; Bauler P, 2010, J PHYS CHEM LETT, V1, P1332, DOI 10.1021/jz1002007; Boyle AL, 2012, J AM CHEM SOC, V134, P15457, DOI 10.1021/ja3053943; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Cortese K, 2009, J HISTOCHEM CYTOCHEM, V57, P1103, DOI 10.1369/jhc.2009.954214; Der BS, 2012, J AM CHEM SOC, V134, P375, DOI 10.1021/ja208015j; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Effio CL, 2015, BIOTECHNOL J, V10, P715, DOI 10.1002/biot.201400392; Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fullerton SWB, 2006, BIOORGAN MED CHEM, V14, P3002, DOI 10.1016/j.bmc.2005.12.022; Griffiths JS, 2002, BIOORGAN MED CHEM, V10, P545, DOI 10.1016/S0968-0896(01)00307-8; Howorka S, 2011, CURR OPIN BIOTECH, V22, P485, DOI 10.1016/j.copbio.2011.05.003; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Lai YT, 2014, NAT CHEM, V6, P1065, DOI [10.1038/NCHEM.2107, 10.1038/nchem.2107]; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ma YJ, 2012, ADV DRUG DELIVER REV, V64, P811, DOI 10.1016/j.addr.2012.01.005; Muller EGD, 2005, MOL BIOL CELL, V16, P3341, DOI 10.1091/mbc.E05-03-0214; Nannenga B. L., 2013, CURRENT PROTOCOLS PR; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perlmutter JD, 2015, ANNU REV PHYS CHEM, V66, P217, DOI 10.1146/annurev-physchem-040214-121637; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raman S., 2009, OPEN NANOMED J, V2, P15, DOI DOI 10.2174/1875933500902010015; Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007; RITSERT K, 1995, J MOL BIOL, V253, P151, DOI 10.1006/jmbi.1995.0542; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimogawa MM, 2010, CELL CYCLE, V9, P3619, DOI 10.4161/cc.9.17.12907; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Smith ML, 2006, VIROLOGY, V348, P475, DOI 10.1016/j.virol.2005.12.039; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Usui K, 2009, PROTEIN SCI, V18, P960, DOI 10.1002/pro.106; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Zandi R, 2004, P NATL ACAD SCI USA, V101, P15556, DOI 10.1073/pnas.0405844101; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k; ZULAUF M, 1992, J CRYST GROWTH, V122, P102, DOI 10.1016/0022-0248(92)90232-8	43	231	239	6	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					136	+		10.1038/nature18010	http://dx.doi.org/10.1038/nature18010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27309817	Green Accepted			2022-12-24	WOS:000379015600039
J	Liu, X; Zhang, ZB; Ruan, JB; Pan, YD; Magupalli, VG; Wu, H; Lieberman, J				Liu, Xing; Zhang, Zhibin; Ruan, Jianbin; Pan, Youdong; Magupalli, Venkat Giri; Wu, Hao; Lieberman, Judy			Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores	NATURE			English	Article							MIXED LINEAGE KINASE; LISTERIA-MONOCYTOGENES; INTRACELLULAR BACTERIA; CASPASE-1 ACTIVATION; NLRP3 INFLAMMASOME; CELL-DEATH; INTERLEUKIN-1-BETA; GRANULYSIN; GRANZYMES; PERFORIN	Inflammatory caspases (caspases 1, 4, 5 and 11) are activated in response to microbial infection and danger signals. When activated, they cleave mouse and human gasdermin D (GSDMD) after Asp276 and Asp275, respectively, to generate an N-terminal cleavage product (GSDMD-NT) that triggers inflammatory death (pyroptosis) and release of inflammatory cytokines such as interleukin-1 beta(1,2). Cleavage removes the C-terminal fragment (GSDMD-CT), which is thought to fold back on GSDMD-NT to inhibit its activation. However, how GSDMD-NT causes cell death is unknown. Here we show that GSDMD-NT oligomerizes in membranes to form pores that are visible by electron microscopy. GSDMD-NT binds to phosphatidylinositol phosphates and phosphatidylserine (restricted to the cell membrane inner leaflet) and cardiolipin (present in the inner and outer leaflets of bacterial membranes). Mutation of four evolutionarily conserved basic residues blocks GSDMD-NT oligomerization, membrane binding, pore formation and pyroptosis. Because of its lipid-binding preferences, GSDMD-NT kills from within the cell, but does not harm neighbouring mammalian cells when it is released during pyroptosis. GSDMD-NT also kills cell-free bacteria in vitro and may have a direct bactericidal effect within the cytosol of host cells, but the importance of direct bacterial killing in controlling in vivo infection remains to be determined.	[Liu, Xing; Zhang, Zhibin; Ruan, Jianbin; Magupalli, Venkat Giri; Wu, Hao; Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Liu, Xing; Zhang, Zhibin; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Ruan, Jianbin; Magupalli, Venkat Giri; Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Pan, Youdong] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA; [Pan, Youdong] Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, 75 Francis St, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wu, H; Lieberman, J (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Lieberman, J (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.; Wu, H (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	wu@crystal.harvard.edu; judy.lieberman@childrens.harvard.edu	Lieberman, Judy/A-2717-2015	Zhang, Zhibin/0000-0003-1349-2713; Magupalli, Venkat/0000-0003-4638-3062; Ruan, Jianbin/0000-0001-5843-8273	US NIH [R01AI123265]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD087988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123265, R01AI124491] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US NIH grant R01AI123265 (J.L.).	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Cervantes J, 2008, CELL MICROBIOL, V10, P41, DOI 10.1111/j.1462-5822.2007.01012.x; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Dotiwala F, 2016, NAT MED, V22, P210, DOI 10.1038/nm.4023; FINZEL BC, 1989, J MOL BIOL, V209, P779, DOI 10.1016/0022-2836(89)90606-2; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; MONTAL M, 1995, ANNU REV BIOPH BIOM, V24, P31, DOI 10.1146/annurev.bb.24.060195.000335; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Walch M, 2014, CELL, V157, P1309, DOI 10.1016/j.cell.2014.03.062; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Warren SE, 2008, J IMMUNOL, V180, P7558, DOI 10.4049/jimmunol.180.11.7558; WILSCHUT J, 1979, NATURE, V281, P690, DOI 10.1038/281690a0; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2	29	1367	1458	26	357	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					153	+		10.1038/nature18629	http://dx.doi.org/10.1038/nature18629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27383986	Green Accepted			2022-12-24	WOS:000379015600043
J	Twomey, EC; Yelshanskaya, MV; Grassucci, RA; Frank, J; Sobolevsky, AI				Twomey, Edward C.; Yelshanskaya, Maria V.; Grassucci, Robert A.; Frank, Joachim; Sobolevsky, Alexander I.			Elucidation of AMPA receptor-stargazin complexes by cryo-electron microscopy	SCIENCE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; AUXILIARY SUBUNITS; ACTIVATION; DESENSITIZATION; STOICHIOMETRY; TRAFFICKING; MECHANISM; TARPS; ARCHITECTURE; PROTEINS	AMPA-subtype ionotropic glutamate receptors (AMPARs) mediate fast excitatory neurotransmission and contribute to high cognitive processes such as learning and memory. In the brain, AMPAR trafficking, gating, and pharmacology is tightly controlled by transmembrane AMPAR regulatory proteins (TARPs). Here, we used cryo-electron microscopy to elucidate the structural basis of AMPAR regulation by one of these auxiliary proteins, TARP gamma 2, or stargazin (STZ). Our structures illuminate the variable interaction stoichiometry of the AMPAR-TARP complex, with one or two TARP molecules binding one tetrameric AMPAR. Analysis of the AMPAR-STZ binding interfaces suggests that electrostatic interactions between the extracellular domains of AMPAR and STZ play an important role in modulating AMPAR function through contact surfaces that are conserved across AMPARs and TARPs. We propose a model explaining how TARPs stabilize the activated state of AMPARs and how the interactions between AMPARs and their auxiliary proteins control fast excitatory synaptic transmission.	[Twomey, Edward C.; Yelshanskaya, Maria V.; Grassucci, Robert A.; Frank, Joachim; Sobolevsky, Alexander I.] Columbia Univ, Dept Biochem & Mol Biophys, 650 West 168th St, New York, NY 10032 USA; [Twomey, Edward C.] Columbia Univ, Integrated Program Cellular Mol & Biomed Studies, 650 West 168th St, New York, NY 10032 USA; [Frank, Joachim] Columbia Univ, Dept Biol Sci, 650 West 168th St, New York, NY 10032 USA; [Frank, Joachim] Howard Hughes Med Inst, 650 West 168th St, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Frank, J; Sobolevsky, AI (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 West 168th St, New York, NY 10032 USA.; Frank, J (corresponding author), Columbia Univ, Dept Biol Sci, 650 West 168th St, New York, NY 10032 USA.; Frank, J (corresponding author), Howard Hughes Med Inst, 650 West 168th St, New York, NY 10032 USA.	jf2192@cumc.columbia.edu; as4005@cumc.columbia.edu		Twomey, Edward/0000-0002-1855-1586	NIH [T32 GM008224, GM008281, R01 NS083660, R01 GM029169]; Pew Scholar Award in Biomedical Sciences; Schaefer Research Scholar Award; Klingenstein Fellowship Award in the Neurosciences; Irma T. Hirschl Career Scientist Award; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281, R01GM029169, T32GM008224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083660, F31NS093838] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Award in Biomedical Sciences; Schaefer Research Scholar Award; Klingenstein Fellowship Award in the Neurosciences(Klingenstein Philanthropies); Irma T. Hirschl Career Scientist Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Z. H. Yu, C. Hong, and R. Huang for assistance with data collection at the Howard Hughes Medical Institute Janelia Research Campus, M. Fislage (J.F. laboratory) for assistance with the initial cryo-EM preparation and critical reading of the manuscript, and H. Kao (J.F. laboratory) for computational support. We are grateful for manuscript edits and comments provided by K. Saotome and A. K. Singh (A.I.S. laboratory) and advice on image processing provided by I.S. Fernandez (Columbia), Z. Liu (J.F. laboratory), O.B. Clarke (Hendrickson laboratory, Columbia), A. des Georges (City University of New York), and members of J.F.'s laboratory. E.C.T. was supported by NIH training grants T32 GM008224 and GM008281. A.I.S. was supported by NIH (R01 NS083660), the Pew Scholar Award in Biomedical Sciences, the Schaefer Research Scholar Award, the Klingenstein Fellowship Award in the Neurosciences, and the Irma T. Hirschl Career Scientist Award. J.F. was supported by the Howard Hughes Medical Institute and NIH (R01 GM029169). Cryo-EM density maps have been deposited in the EM Data Bank under accession numbers EMD-8229 (GluA2-0xSTZ), EMD-8230 (GluA2-1xSTZ), EMD-8231 (GluA2-2xSTZ), and EMD-8232 (GluA2). Model coordinates have been deposited in the Protein Data Bank under accession numbers 5KBS (GluA2-0xSTZ), 5KBT (GluA2-1xSTZ), 5KBU (GluA2-2xSTZ), and 5KBV (GluA2).	Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carbone AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10178; Chapman AG, 2000, J NUTR, V130, p1043S, DOI 10.1093/jn/130.4.1043S; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Dawe GB, 2016, NEURON, V89, P1264, DOI 10.1016/j.neuron.2016.01.038; Dong H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1362; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Hastie P, 2013, P NATL ACAD SCI USA, V110, P5163, DOI 10.1073/pnas.1218765110; Howe JR, 2015, J PHYSIOL-LONDON, V593, P61, DOI 10.1113/jphysiol.2014.273904; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2010, TRENDS NEUROSCI, V33, P241, DOI 10.1016/j.tins.2010.02.004; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; MacLean DM, 2014, J GEN PHYSIOL, V144, P503, DOI 10.1085/jgp.201411287; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Morrell CN, 2008, J EXP MED, V205, P575, DOI 10.1084/jem.20071474; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rogawski MA, 2013, ACTA NEUROL SCAND, V127, P9, DOI 10.1111/ane.12099; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; Sobolevsky AI, 2015, J PHYSIOL-LONDON, V593, P29, DOI 10.1113/jphysiol.2013.264911; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uzunova G, 2014, CURR NEUROPHARMACOL, V12, P71, DOI 10.2174/1570159X113116660046; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Yelshanskaya MV, 2014, SCIENCE, V345, P1070, DOI 10.1126/science.1256508; Zhang F, 2013, STROKE, V44, P170, DOI 10.1161/STROKEAHA.112.667253; Zhang W, 2014, EUR J NEUROSCI, V39, P1138, DOI 10.1111/ejn.12519	36	87	87	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					83	86		10.1126/science.aaf8411	http://dx.doi.org/10.1126/science.aaf8411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365450	Green Accepted			2022-12-24	WOS:000378816200041
J	Ungar, PS; Hlusko, LJ				Ungar, P. S.; Hlusko, L. J.			The evolutionary path of least resistance	SCIENCE			English	Editorial Material							ENAMEL THICKNESS; BOISEI		[Ungar, P. S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA; [Hlusko, L. J.] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA	University of Arkansas System; University of Arkansas Fayetteville; University of California System; University of California Berkeley	Ungar, PS (corresponding author), Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA.	pungar@uark.edu		Hlusko, Leslea/0000-0003-0189-6390				Hlusko LJ, 2011, J EXP ZOOL PART B, V316B, P21, DOI 10.1002/jez.b.21378; Hlusko LJ, 2004, AM J PHYS ANTHROPOL, V124, P223, DOI 10.1002/ajpa.10353; Horvath JE, 2014, J HUM EVOL, V73, P75, DOI 10.1016/j.jhevol.2014.01.005; Kato A, 2014, AM J PHYS ANTHROPOL, V155, P447, DOI 10.1002/ajpa.22593; Lucas P., 2004, DENT FUNCTIONAL MORP; Pampush JD, 2013, J HUM EVOL, V64, P216, DOI 10.1016/j.jhevol.2013.01.009; Salazar-Ciudad I, 2012, CURR OPIN GENET DEV, V22, P585, DOI 10.1016/j.gde.2012.10.006; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Smith AL, 2015, ANAT REC, V298, P145, DOI 10.1002/ar.23073; Ungar PS, 2011, SCIENCE, V334, P190, DOI 10.1126/science.1207701; WALKER A, 1986, NATURE, V322, P517, DOI 10.1038/322517a0	11	24	25	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					29	30		10.1126/science.aaf8398	http://dx.doi.org/10.1126/science.aaf8398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365438				2022-12-24	WOS:000378816200021
J	Tsu, V; Jeronimo, J				Tsu, Vivien; Jeronimo, Jose			Saving the World's Women from Cervical Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tsu, Vivien; Jeronimo, Jose] PATH, Seattle, WA USA		Tsu, V (corresponding author), PATH, Seattle, WA USA.							Bloom DE, 2011, GLOBAL EC BURDEN NON; Campos NG, 2015, PAPILLOMAVIRUS RES, V1, P38, DOI 10.1016/j.pvr.2015.05.003; GLOBOCAN, 2013, GLOBOCAN 2012 ESTIMA; Markowitz LE, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1968; Schiffman M, 2016, J LOW GENIT TRACT DI, V20, P1, DOI 10.1097/LGT.0000000000000170	5	48	56	2	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2509	2511		10.1056/NEJMp1604113	http://dx.doi.org/10.1056/NEJMp1604113			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP8DD	27355529	Bronze			2022-12-24	WOS:000378727200001
J	Glen, J; Constanti, M; Brohi, K				Glen, Jessica; Constanti, Margaret; Brohi, Karim		Guideline Development Grp	Assessment and initial management of major trauma: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Glen, Jessica; Constanti, Margaret] Royal Coll Physicians, Natl Guideline Ctr, London NW1 4LE, England; [Brohi, Karim] Queen Mary Univ London, Barts & London Sch Med, Ctr Trauma Sci, London, England	Royal College of Physicians; University of London; Queen Mary University London	Brohi, K (corresponding author), Queen Mary Univ London, Barts & London Sch Med, Ctr Trauma Sci, London, England.	k.brohi@qmul.ac.uk						[Anonymous], 2012, ADV TRAUM LIF SUPP A; National Audit Office, 2010, MAJ TRAUM CAR ENGL, P2009; National Institute for Health and Care Excellence, 2016, MAJ TRAUM SERV DEL; National Institute for Health and Care Excellence, 2016, FRACT COMPL ASS MAN; National Institute for Health and Care Excellence, 2016, MAJ TRAUM ASS IN MAN; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; National Institute for Health and Care Excellence, 2016, SPIN INJ ASS IN MAN; Stanworth SJ, 2016, BRIT J SURG, V103, P357, DOI 10.1002/bjs.10052	8	29	31	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i3051	10.1136/bmj.i3051	http://dx.doi.org/10.1136/bmj.i3051			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27333868				2022-12-24	WOS:000378723500003
J	Eisenstein, M				Eisenstein, Michael			A SIMPLER TWIST OF FATE	NATURE			English	Editorial Material							FIBROBLASTS											Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Cao N., 2016, SCIENCE; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Rackham OJL, 2016, NAT GENET, V48, P331, DOI 10.1038/ng.3487; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhang ML, 2016, CELL STEM CELL, V18, P653, DOI 10.1016/j.stem.2016.03.020	8	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					421	423		10.1038/534421a	http://dx.doi.org/10.1038/534421a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27306187	Bronze			2022-12-24	WOS:000377856800043
J	Sauaia, A; Gonzalez, E; Moore, HB; Bol, K; Moore, EE				Sauaia, Angela; Gonzalez, Eduardo; Moore, Hunter B.; Bol, Kirk; Moore, Ernest E.			Fatality and Severity of Firearm Injuries in a Denver Trauma Center, 2000-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SCORE		[Sauaia, Angela] Univ Colorado, Sch Publ Hlth, Aurora, CO USA; [Gonzalez, Eduardo; Moore, Hunter B.] Univ Colorado, Sch Med, Aurora, CO USA; [Bol, Kirk] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Denver, CO USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado Department of Public Health & Environment; Denver Health Medical Center	Sauaia, A (corresponding author), Univ Colorado Denver, 13011 E 17th Pl,Room E-3360-C, Aurora, CO 80045 USA.	angela.sauaia@ucdenver.edu		Bol, Kirk/0000-0002-9208-6424				ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Gun Violence Archive, 2022, SUMM LEDG; Kellermann AL, 2013, JAMA-J AM MED ASSOC, V309, P549, DOI 10.1001/jama.2012.208207; Rubin R, 2016, JAMA-J AM MED ASSOC, V315, P1689, DOI 10.1001/jama.2016.1707; Schluter PJ, 2010, J TRAUMA, V68, P761, DOI 10.1097/TA.0b013e3181d3223b	6	26	27	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2465	2467		10.1001/jama.2016.5978	http://dx.doi.org/10.1001/jama.2016.5978			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27299622	Bronze			2022-12-24	WOS:000377656900025
J	Jordan, NV; Bardia, A; Wittner, BS; Benes, C; Ligorio, M; Zheng, Y; Yu, M; Sundaresan, TK; Licausi, JA; Desai, R; O'Keefe, RM; Ebright, RY; Boukhali, M; Sil, S; Onozato, ML; Iafrate, AJ; Kapur, R; Sgroi, D; Ting, DT; Toner, M; Ramaswamy, S; Haas, W; Maheswaran, S; Haber, DA				Jordan, Nicole Vincent; Bardia, Aditya; Wittner, Ben S.; Benes, Cyril; Ligorio, Matteo; Zheng, Yu; Yu, Min; Sundaresan, Tilak K.; Licausi, Joseph A.; Desai, Rushil; O'Keefe, Ryan M.; Ebright, Richard Y.; Boukhali, Myriam; Sil, Srinjoy; Onozato, Maristela L.; Iafrate, Anthony J.; Kapur, Ravi; Sgroi, Dennis; Ting, David T.; Toner, Mehmet; Ramaswamy, Sridhar; Haas, Wilhelm; Maheswaran, Shyamala; Haber, Daniel A.			HER2 expression identifies dynamic functional states within circulating breast cancer cells	NATURE			English	Article							TUMOR-CELLS; STEM-CELLS; SIGNALING PATHWAYS; HEDGEHOG PATHWAY; NOTCH; INHIBITOR; TUMORIGENESIS; TRASTUZUMAB; RECURRENCE; AXIS	Circulating tumour cells in women with advanced oestrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer acquire a HER2-positive subpopulation after multiple courses of therapy(1,2). In contrast to HER2-amplified primary breast cancer, which is highly sensitive to HER2-targeted therapy, the clinical significance of acquired HER2 heterogeneity during the evolution of metastatic breast cancer is unknown. Here we analyse circulating tumour cells from 19 women with ER+/HER2(-) primary tumours, 84% of whom had acquired circulating tumour cells expressing HER2. Cultured circulating tumour cells maintain discrete HER2(+) and HER2(-) subpopulations: HER2+ circulating tumour cells are more proliferative but not addicted to HER2(-), consistent with activation of multiple signalling pathways; HER2(-) circulating tumour cells show activation of Notch and DNA damage pathways, exhibiting resistance to cytotoxic chemotherapy, but sensitivity to Notch inhibition. HER2(+) and HER2(-) circulating tumour cells interconvert spontaneously, with cells of one phenotype producing daughters of the opposite within four cell doublings. Although HER2(+) and HER2(-) circulating tumour cells have comparable tumour initiating potential, differential proliferation favours the HER2(+) state, while oxidative stress or cytotoxic chemotherapy enhances transition to the HER2(-) phenotype. Simultaneous treatment with paclitaxel and Notch inhibitors achieves sustained suppression of tumorigenesis in orthotopic circulating tumour cell-derived tumour models. Together, these results point to distinct yet interconverting phenotypes within patient-derived circulating tumour cells, contributing to progression of breast cancer and acquisition of drug resistance.	[Jordan, Nicole Vincent; Bardia, Aditya; Wittner, Ben S.; Benes, Cyril; Ligorio, Matteo; Zheng, Yu; Yu, Min; Sundaresan, Tilak K.; Licausi, Joseph A.; Desai, Rushil; O'Keefe, Ryan M.; Ebright, Richard Y.; Boukhali, Myriam; Sil, Srinjoy; Onozato, Maristela L.; Iafrate, Anthony J.; Sgroi, Dennis; Ting, David T.; Ramaswamy, Sridhar; Haas, Wilhelm; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Bardia, Aditya; Wittner, Ben S.; Benes, Cyril; Sundaresan, Tilak K.; Ting, David T.; Ramaswamy, Sridhar; Haas, Wilhelm; Haber, Daniel A.] Harvard Med Sch, Dept Med, Boston, MA 02114 USA; [Ligorio, Matteo; Toner, Mehmet; Maheswaran, Shyamala] Harvard Med Sch, Dept Surg, Boston, MA 02114 USA; [Onozato, Maristela L.; Iafrate, Anthony J.; Sgroi, Dennis] Harvard Med Sch, Dept Pathol, Boston, MA 02114 USA; [Kapur, Ravi; Toner, Mehmet] Harvard Med Sch, Ctr Bioengn Med, Boston, MA 02114 USA; [Kapur, Ravi; Toner, Mehmet] Harvard Med Sch, Shriners Hosp, Boston, MA 02114 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Yu, Min] Univ Southern Calif, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90033 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Southern California	Jordan, NV (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.		Sgroi, Dennis/AAV-2487-2021; Ting, David/F-4389-2017	Ting, David/0000-0002-3261-2322; Sil, Srinjoy/0000-0002-6722-4311; Yu, Min/0000-0002-3969-8720	National Institutes of Health (NIH) [2RO1CA129933]; Howard Hughes Medical Institute; Breast Cancer Research Foundation; National Foundation for Cancer Research; Wellcome Trust [102696]; NIH [2U01EB012493, T32 CA009361]; Susan G. Komen Foundation [PDF16376429, K12 5K12CA087723]; NATIONAL CANCER INSTITUTE [T32CA009361, R01CA129933, F32CA009361, K12CA087723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB012493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Breast Cancer Research Foundation; National Foundation for Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients who participated in this study. This work was supported by National Institutes of Health (NIH) 2RO1CA129933, the Howard Hughes Medical Institute, the Breast Cancer Research Foundation, the National Foundation for Cancer Research (DAH) and Wellcome Trust 102696 (C.B.), NIH Quantum 2U01EB012493 (M.T., D.A.H.), T32 CA009361, Susan G. Komen Foundation PDF16376429 (N.V.J.), K12 5K12CA087723 (A.B.) and T32GM007753 (RYE.). We thank D. Dombrowski (NIH 1S100D1016372-01) for expert flow cytometry.	Abravanel DL, 2015, J CLIN INVEST, V125, P2484, DOI 10.1172/JCI74883; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bidard FC, 2015, J CLIN ONCOL, V33, P1622, DOI 10.1200/JCO.2014.57.9714; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Houssami N, 2011, BREAST CANCER RES TR, V129, P659, DOI 10.1007/s10549-011-1632-x; Ignatiadis M, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.SABCS14-OT1-2-02; Ithimakin S, 2013, CANCER RES, V73, P1635, DOI 10.1158/0008-5472.CAN-12-3349; Kim EJ, 2014, CLIN CANCER RES, V20, P5937, DOI 10.1158/1078-0432.CCR-14-1269; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Krop I, 2012, J CLIN ONCOL, V30, P2307, DOI 10.1200/JCO.2011.39.1540; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pandya K, 2011, BRIT J CANCER, V105, P796, DOI 10.1038/bjc.2011.321; Schramm A., 2015, ASCO M, V33; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Wakabayashi N, 2014, MOL CELL BIOL, V34, P653, DOI 10.1128/MCB.01408-13; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533	25	233	239	16	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					102	106		10.1038/nature19328	http://dx.doi.org/10.1038/nature19328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556950	Green Accepted, Green Submitted			2022-12-24	WOS:000382426900047
J	Wan, RX; Yan, CY; Bai, R; Huang, GXY; Shi, YG				Wan, Ruixue; Yan, Chuangye; Bai, Rui; Huang, Gaoxingyu; Shi, Yigong			Structure of a yeast catalytic step I spliceosome at 3.4 angstrom resolution	SCIENCE			English	Article							U4/U6.U5 TRI-SNRNP; METAL-ION CATALYSIS; CRYO-EM STRUCTURE; SMALL NUCLEAR-RNA; 3-DIMENSIONAL STRUCTURE; ACTIVE-SITE; 19 COMPLEX; 2ND STEP; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE	Each cycle of pre-messenger RNA splicing, carried out by the spliceosome, comprises two sequential transesterification reactions, which result in the removal of an intron and the joining of two exons. Here we report an atomic structure of a catalytic step I spliceosome (known as the C complex) from Saccharomyces cerevisiae, as determined by cryo-electron microscopy at an average resolution of 3.4 angstroms. In the structure, the 2'-OH of the invariant adenine nucleotide in the branch point sequence (BPS) is covalently joined to the phosphate at the 5' end of the 5' splice site (5' SS), forming an intron lariat. The freed 5' exon remains anchored to loop I of U5 small nuclear RNA (snRNA), and the 5' SS and BPS of the intron form duplexes with conserved U6 and U2 snRNA sequences, respectively. Specific placement of these RNA elements at the catalytic cavity of Prp8 is stabilized by 15 protein components, including Snu114 and the splicing factors Cwc21, Cwc22, Cwc25, and Yju2. These features, representing the conformation of the spliceosome after the first-step reaction, predict structural changes that are needed for the execution of the second-step transesterification reaction.	[Wan, Ruixue; Yan, Chuangye; Bai, Rui; Huang, Gaoxingyu; Shi, Yigong] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology [2014ZX09507003006]; National Natural Science Foundation of China [31130002, 31321062]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for providing facility support. The computation was completed on the "Explorer 100" cluster system of Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from the Ministry of Science and Technology (grant 2014ZX09507003006) and the National Natural Science Foundation of China (grants 31130002 and 31321062). For the C complex structure, the atomic coordinates have been deposited in the Protein Data Bank with accession code 5GMK, and the EM maps have been deposited in the Electron Microscopy Database with accession codes EMD-9525, EMD-9526, and EMD-9527. We declare no competing financial interests. Correspondence and requests for materials should be addressed to Y.S.	Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Albers M, 2003, RNA, V9, P138, DOI 10.1261/rna.2119903; Anokhina M, 2013, EMBO J, V32, P2804, DOI 10.1038/emboj.2013.198; Azubel M, 2004, MOL CELL, V15, P833, DOI 10.1016/j.molcel.2004.07.022; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2010, RNA, V16, P2384, DOI 10.1261/rna.2456210; Boehringer D, 2004, NAT STRUCT MOL BIOL, V11, P463, DOI 10.1038/nsmb761; Burns CG, 1999, P NATL ACAD SCI USA, V96, P13789, DOI 10.1073/pnas.96.24.13789; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Chen WJ, 2014, CURR OPIN STRUC BIOL, V24, P141, DOI 10.1016/j.sbi.2014.01.009; Chen WJ, 2014, RNA, V20, P308, DOI 10.1261/rna.040980.113; Chiang TW, 2013, MOL CELL BIOL, V33, P1746, DOI 10.1128/MCB.00035-13; Chiu YF, 2009, MOL CELL BIOL, V29, P5671, DOI 10.1128/MCB.00773-09; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Golas MM, 2010, MOL CELL, V40, P927, DOI 10.1016/j.molcel.2010.11.023; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Grainger RJ, 2009, RNA, V15, P2161, DOI 10.1261/rna.1908309; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Horowitz DS, 2012, WIRES RNA, V3, P331, DOI 10.1002/wrna.112; IGEL AH, 1988, NATURE, V334, P450, DOI 10.1038/334450a0; Ilagan JO, 2013, RNA, V19, P400, DOI 10.1261/rna.034223.112; Jurica MS, 2004, NAT STRUCT MOL BIOL, V11, P265, DOI 10.1038/nsmb728; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Khanna M, 2009, RNA, V15, P2174, DOI 10.1261/rna.1790509; Konarska MM, 2006, MOL CELL, V21, P543, DOI 10.1016/j.molcel.2006.01.017; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; Koodathingal P, 2010, MOL CELL, V39, P385, DOI 10.1016/j.molcel.2010.07.014; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Liu YC, 2007, MOL CELL BIOL, V27, P5403, DOI 10.1128/MCB.00346-07; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; McGrail JC, 2009, NUCLEIC ACIDS RES, V37, P4205, DOI 10.1093/nar/gkp341; McPheeters DS, 2003, MOL CELL BIOL, V23, P4174, DOI 10.1128/MCB.23.12.4174-4186.2003; Moore M. J., 1993, COLD SPRING HARBOR L, P303; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Newman AJ, 1995, RNA, V1, P968; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; Ohi MD, 2007, P NATL ACAD SCI USA, V104, P3195, DOI 10.1073/pnas.0611591104; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pomeranz Krummel Daniel A, 2009, Nature, V458, P475, DOI 10.1038/nature07851; Rasche N, 2012, EMBO J, V31, P1591, DOI 10.1038/emboj.2011.502; Saha D, 2012, J BIOL CHEM, V287, P5390, DOI 10.1074/jbc.M111.298547; Sander B, 2006, MOL CELL, V24, P267, DOI 10.1016/j.molcel.2006.08.021; Schneider C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005539; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Tseng CK, 2008, SCIENCE, V320, P1782, DOI 10.1126/science.1158993; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wolf E, 2009, EMBO J, V28, P2283, DOI 10.1038/emboj.2009.171; WYATT JR, 1992, GENE DEV, V6, P2542, DOI 10.1101/gad.6.12b.2542; Xu DM, 2001, MOL CELL BIOL, V21, P1011, DOI 10.1128/MCB.21.4.1011-1023.2001; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhou LJ, 2014, NATURE, V506, P116, DOI 10.1038/nature12803	73	143	150	3	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					895	904		10.1126/science.aag2235	http://dx.doi.org/10.1126/science.aag2235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27445308				2022-12-24	WOS:000381867700032
J	Chailangkarn, T; Trujillo, CA; Freitas, BC; Hrvoj-Mihic, B; Herai, RH; Yu, DN; Brown, TT; Marchetto, MC; Bardy, C; McHenry, L; Stefanacci, L; Jarvinen, A; Searcy, YM; DeWitt, M; Wong, W; Lai, P; Ard, MC; Hanson, KL; Romero, S; Jacobs, B; Dale, AM; Dai, L; Korenberg, JR; Gage, FH; Bellugi, U; Halgren, E; Semendeferi, K; Muotri, AR				Chailangkarn, Thanathom; Trujillo, Cleber A.; Freitas, Beatriz C.; Hrvoj-Mihic, Branka; Herai, Roberto H.; Yu, Diana N.; Brown, Timothy T.; Marchetto, Maria C.; Bardy, Cedric; McHenry, Lauren; Stefanacci, Lisa; Jarvinen, Anna; Searcy, Yvonne M.; DeWitt, Michelle; Wong, Wenny; Lai, Philip; Ard, M. Colin; Hanson, Kari L.; Romero, Sarah; Jacobs, Bob; Dale, Anders M.; Dai, Li; Korenberg, Julie R.; Gage, Fred H.; Bellugi, Ursula; Halgren, Eric; Semendeferi, Katerina; Muotri, Alysson R.			A human neurodevelopmental model for Williams syndrome	NATURE			English	Article							PLURIPOTENT STEM-CELLS; PROSPECTIVE MOTION CORRECTION; HUMAN CEREBRAL-CORTEX; SURFACE-BASED ANALYSIS; HUMAN-FETUS; GENE; BRAIN; MRI; FRIZZLED-9; NEURONS	Williams syndrome is a genetic neurodevelopmental disorder characterized by an uncommon hypersociability and a mosaic of retained and compromised linguistic and cognitive abilities. Nearly all clinically diagnosed individuals with Williams syndrome lack precisely the same set of genes, with breakpoints in chromosome band 7q11.23 (refs 1-5). The contribution of specific genes to the neuroanatomical and functional alterations, leading to behavioural pathologies in humans, remains largely unexplored. Here we investigate neural progenitor cells and cortical neurons derived from Williams syndrome and typically developing induced pluripotent stem cells. Neural progenitor cells in Williams syndrome have an increased doubling time and apoptosis compared with typically developing neural progenitor cells. Using an individual with atypical Williams syndrome(6,7), we narrowed this cellular phenotype to a single gene candidate, frizzled 9 (FZD9). At the neuronal stage, layer V/VI cortical neurons derived from Williams syndrome were characterized by longer total dendrites, increased numbers of spines and synapses, aberrant calcium oscillation and altered network connectivity. Morphometric alterations observed in neurons from Williams syndrome were validated after Golgi staining of postmortem layer V/VI cortical neurons. This model of human induced pluripotent stem cells(8) fills the current knowledge gap in the cellular biology of Williams syndrome and could lead to further insights into the molecular mechanism underlying the disorder and the human social brain.	[Chailangkarn, Thanathom; Trujillo, Cleber A.; Freitas, Beatriz C.; Herai, Roberto H.; Stefanacci, Lisa; Romero, Sarah; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, UCSD Stem Cell Program, Dept Pediat,Rady Childrens Hosp San Diego, La Jolla, CA 92037 USA; [Chailangkarn, Thanathom; Trujillo, Cleber A.; Freitas, Beatriz C.; Herai, Roberto H.; Stefanacci, Lisa; Romero, Sarah; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92037 USA; [Chailangkarn, Thanathom; Trujillo, Cleber A.; Freitas, Beatriz C.; Herai, Roberto H.; Stefanacci, Lisa; Romero, Sarah; Muotri, Alysson R.] CARTA, La Jolla, CA 92093 USA; [Chailangkarn, Thanathom] Natl Ctr Genet Engn & Biotechnol BIOTEC, Virol & Cell Technol Lab, Pathum Thani 12120, Thailand; [Hrvoj-Mihic, Branka; Stefanacci, Lisa; Hanson, Kari L.; Semendeferi, Katerina] Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA; [Herai, Roberto H.] Pontificia Univ Catolica Parana PUCPR, Grad Program Hlth Sci, Sch Med, Curitiba, Parana, Brazil; [Yu, Diana N.; Marchetto, Maria C.; Bardy, Cedric; McHenry, Lauren; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Brown, Timothy T.; Dale, Anders M.; Halgren, Eric] Univ Calif San Diego, Multimodal Imaging Lab, La Jolla, CA 92093 USA; [Brown, Timothy T.; Ard, M. Colin; Halgren, Eric] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Brown, Timothy T.] Univ Calif San Diego, Ctr Human Dev, La Jolla, CA 92093 USA; [Bardy, Cedric] Flinders Univ S Australia, SAHMRI Mind & Brain Theme, Sch Med, Lab Human Neurophysiol & Genet, Adelaide, SA 5000, Australia; [Jarvinen, Anna; Searcy, Yvonne M.; DeWitt, Michelle; Wong, Wenny; Lai, Philip; Bellugi, Ursula] Salk Inst Biol Studies, Lab Cognit Neurosci, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Jacobs, Bob] Colorado Coll, Dept Psychol, Colorado Springs, CO 80903 USA; [Dale, Anders M.] Univ Calif San Diego, Sch Med, Dept Radiol, La Jolla, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Dai, Li; Korenberg, Julie R.] Univ Utah, Dept Pediat, Salt Lake City, UT 84108 USA; [Dai, Li; Korenberg, Julie R.] Univ Utah, Inst Brain, Salt Lake City, UT 84108 USA; [Gage, Fred H.; Halgren, Eric; Semendeferi, Katerina; Muotri, Alysson R.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA; [Semendeferi, Katerina; Muotri, Alysson R.] Univ Calif San Diego, Neurosci Grad Program, Sch Med, La Jolla, CA 92093 USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of California System; University of California San Diego; Pontificia Universidade Catolica do Parana; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); Salk Institute; Colorado College; University of California System; University of California San Diego; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; University of California System; University of California San Diego	Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, UCSD Stem Cell Program, Dept Pediat,Rady Childrens Hosp San Diego, La Jolla, CA 92037 USA.; Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92037 USA.; Muotri, AR (corresponding author), CARTA, La Jolla, CA 92093 USA.; Semendeferi, K (corresponding author), Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA.; Semendeferi, K; Muotri, AR (corresponding author), Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA.; Semendeferi, K; Muotri, AR (corresponding author), Univ Calif San Diego, Neurosci Grad Program, Sch Med, La Jolla, CA 92093 USA.	ksemende@ucsd.edu; muotri@ucsd.edu	Wong, Wenny/I-4411-2015; Bardy, Cedric/F-1182-2019; Herai, Roberto/HII-2648-2022	Wong, Wenny/0000-0003-4039-6882; Bardy, Cedric/0000-0001-8321-0852; Herai, Roberto/0000-0001-9885-2735; Semendeferi, Katerina/0000-0002-9867-9554; Hanson, Kari/0000-0001-7508-7751	California Institute for Regenerative Medicine (CIRM) [TR2-01814, TR4-06747]; National Institutes of Health (NIH) [P01 NICHD033113]; NIH Director's New Innovator Award Program [1-DP2-OD006495-01, R01MH094753, R01MH103134, U19MH107367, U19MH106434, R01MH095741]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Grant; JPB Foundation; Paul G. Allen Family Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; G. Harold & Leila Y. Mathers Foundation; Royal Thai Government Scholarship; CIRM postdoctoral fellowship; Rita L. Atkinson Graduate fellowship; University of California San Diego Kavli Institute for Brain and Mind; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094753, T32MH020002, R56MH109587, U19MH107367, R01MH095741, R01MH100175, R01MH103134, U19MH106434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC007361] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006495] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award Program; National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Grant; JPB Foundation; Paul G. Allen Family Foundation; Leona M. and Harry B. Helmsley Charitable Trust; G. Harold & Leila Y. Mathers Foundation; Royal Thai Government Scholarship; CIRM postdoctoral fellowship; Rita L. Atkinson Graduate fellowship; University of California San Diego Kavli Institute for Brain and Mind; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the California Institute for Regenerative Medicine (CIRM) TR2-01814 and TR4-06747, the National Institutes of Health (NIH) through P01 NICHD033113, NIH Director's New Innovator Award Program 1-DP2-OD006495-01, R01MH094753, R01MH103134, U19MH107367, U19MH106434, R01MH095741, a National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Grant to A.R.M., grants from the Bob and Mary Jane Engman, the JPB Foundation, Paul G. Allen Family Foundation, the Leona M. and Harry B. Helmsley Charitable Trust grant 2012-PG-MED002, Annette C. Merle-Smith, the G. Harold & Leila Y. Mathers Foundation, the Royal Thai Government Scholarship to T.C., a CIRM postdoctoral fellowship to C.A.T., the Rita L. Atkinson Graduate fellowship to B. H.-M and the University of California San Diego Kavli Institute for Brain and Mind. Human tissue was obtained from the University of Maryland Brain and Tissue Bank, which is a brain and tissue repository of the NIH NeuroBioBank. We acknowledge K. Jepsen for the DNA bead arrays and members of the Willert laboratory for assistance with the Wnt pathway experiments. We thank all the participants and their families.	Adamo A, 2015, NAT GENET, V47, P132, DOI 10.1038/ng.3169; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Brown TT, 2010, NEUROIMAGE, V53, P139, DOI 10.1016/j.neuroimage.2010.06.017; Chailangkarn T, 2012, CURR OPIN NEUROBIOL, V22, P785, DOI 10.1016/j.conb.2012.04.004; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075682; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Doyle TF, 2004, AM J MED GENET A, V124A, P263, DOI 10.1002/ajmg.a.20416; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fujimoto T, 2009, INT J ONCOL, V35, P861, DOI 10.3892/ijo_00000400; Fujimura N, 2007, J BIOL CHEM, V282, P1225, DOI 10.1074/jbc.M605851200; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hermann BP, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125757; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Jacobs B, 2003, ANN NEUROL, V54, P126, DOI 10.1002/ana.10620; JACOBS B, 1993, J COMP NEUROL, V327, P83, DOI 10.1002/cne.903270107; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; Jarvinen-Pasley A, 2008, DEV PSYCHOPATHOL, V20, P1, DOI 10.1017/S0954579408000011; JAY V, 1990, DEV BRAIN RES, V54, P291, DOI 10.1016/0165-3806(90)90153-P; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Kuperman JM, 2011, PEDIATR RADIOL, V41, P1578, DOI 10.1007/s00247-011-2205-1; Lawless JF, 2005, BIOMETRIKA, V92, P529, DOI 10.1093/biomet/92.3.529; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Lian XJ, 2014, STEM CELL REP, V3, P804, DOI 10.1016/j.stemcr.2014.09.005; Livak KJ, 2013, METHODS, V59, P71, DOI 10.1016/j.ymeth.2012.10.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marinho PA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09834; MARINPAD.M, 1972, BRAIN RES, V44, P625, DOI 10.1016/0006-8993(72)90324-1; MARINPADILLA M, 1970, BRAIN RES, V23, P185, DOI 10.1016/0006-8993(70)90038-7; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; RILEY JN, 1979, BRAIN RES BULL, V4, P127, DOI 10.1016/0361-9230(79)90067-4; Semendeferi K, 2011, CEREB CORTEX, V21, P1485, DOI 10.1093/cercor/bhq191; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Srinivasan K, 2012, P NATL ACAD SCI USA, V109, P19071, DOI 10.1073/pnas.1216793109; TAKASHIMA S, 1981, BRAIN RES, V225, P1, DOI 10.1016/0006-8993(81)90314-0; UYLINGS HBM, 1986, J NEUROSCI METH, V18, P127, DOI 10.1016/0165-0270(86)90116-0; Van Raay TJ, 2001, DEV GENES EVOL, V211, P453, DOI 10.1007/s004270100174; Vuksic M, 2002, PEDIATR NEUROL, V27, P36, DOI 10.1016/S0887-8994(02)00380-6; White N, 2010, MAGN RESON MED, V63, P91, DOI 10.1002/mrm.22176; WILLIAMS RS, 1978, J NEUROPATH EXP NEUR, V37, P13, DOI 10.1097/00005072-197801000-00002; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao CJ, 2005, DEVELOPMENT, V132, P2917, DOI 10.1242/dev.01871	59	111	112	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					338	+		10.1038/nature19067	http://dx.doi.org/10.1038/nature19067			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27509850	Green Submitted, Green Accepted			2022-12-24	WOS:000381804900037
J	Freitag, A; Constanti, M; O'Flynn, N; Faust, SN				Freitag, Andreas; Constanti, Margaret; O'Flynn, Norma; Faust, Saul N.		Guideline Dev Grp	GUIDELINES Suspected sepsis: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Freitag, Andreas; Constanti, Margaret; O'Flynn, Norma] Royal Coll Physicians, Natl Guideline Ctr, London NW1 4LE, England; [Faust, Saul N.] Univ Southampton, Fac Med, NIHR Wellcome Trust Clin Res Facil, Paediat Immunol & Infect Dis, Southampton, Hants, England; [Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, Paediat Immunol & Infect Dis, Southampton, Hants, England	Royal College of Physicians; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Faust, SN (corresponding author), Univ Southampton, Fac Med, NIHR Wellcome Trust Clin Res Facil, Paediat Immunol & Infect Dis, Southampton, Hants, England.; Faust, SN (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Paediat Immunol & Infect Dis, Southampton, Hants, England.	s.faust@soton.ac.uk	Faust, Saul/J-9779-2014	Faust, Saul/0000-0003-3410-7642				National Institute for Health and Care Excellence, 2015, MEN BACT MEN SEPT 16; National Institute for Health and Care Excellence, 2013, FEV 5S ASS IN MAN CL; National Institute for Health and Care Excellence, 2016, SEPS REC DIAGN EARL, pNG51; National Institute for Health and Care Excellence, 2014, NEUTR SEPS PREV MAN; Parliamentary and Health Service Ombudsman, 2013, TIM ACT SEV SEPS RAP; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287	6	14	15	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2016	354								i4030	10.1136/bmj.i4030	http://dx.doi.org/10.1136/bmj.i4030			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UB	27514867	Green Accepted, Green Published			2022-12-24	WOS:000381475500001
J	Goncalves, KA; Silberstein, L; Li, SP; Severe, N; Hu, MFG; Yang, HL; Scadden, DT; Hu, GF				Goncalves, Kevin A.; Silberstein, Lev; Li, Shuping; Severe, Nicolas; Hu, Miaofen G.; Yang, Hailing; Scadden, David T.; Hu, Guo-fu			Angiogenin Promotes Hematopoietic Regeneration by Dichotomously Regulating Quiescence of Stem and Progenitor Cells	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSFER-RNA HALVES; SELF-RENEWAL; GENE-EXPRESSION; CORD BLOOD; PROLIFERATION; MAINTENANCE; STRESS; IDENTIFICATION; EXPANSION	Regulation of stem and progenitor cell populations is critical in the development, maintenance, and regeneration of tissues. Here, we define a novelmechanism by which a niche-secreted RNase, angiogenin (ANG), distinctively alters the functional characteristics of primitive hematopoietic stem/progenitor cells (HSPCs) compared with lineage-committed myeloid-restricted progenitor (MyePro) cells. Specifically, ANG reduces the proliferative capacity of HSPC while simultaneously increasing proliferation of MyePro cells. Mechanistically, ANG induces cell-type-specific RNA-processing events: tRNAderived stress-induced small RNA (tiRNA) generation in HSPCs and rRNA induction in MyePro cells, leading to respective reduction andincrease inprotein synthesis. Recombinant ANG protein improves survival of irradiated animals and enhances hematopoietic regeneration of mouse and human HSPCs in transplantation. Thus, ANG plays a non-cell-autonomous role in regulation of hematopoiesis by simultaneously preserving HSPC stemness and promoting MyePro proliferation. These cell-type-specific functions of ANG suggest considerable therapeutic potential.	[Goncalves, Kevin A.; Li, Shuping; Hu, Miaofen G.; Yang, Hailing; Hu, Guo-fu] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Goncalves, Kevin A.; Yang, Hailing; Hu, Guo-fu] Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Cellular & Mol Physiol, Boston, MA 02111 USA; [Silberstein, Lev; Severe, Nicolas; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02445 USA; [Silberstein, Lev; Severe, Nicolas; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Silberstein, Lev; Severe, Nicolas; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Tufts Medical Center; Tufts University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Hu, GF (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA.; Hu, GF (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Cellular & Mol Physiol, Boston, MA 02111 USA.; Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02445 USA.; Scadden, DT (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Scadden, DT (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	david_scadden@harvard.edu; guo-fu.hu@tufts.edu	Gonçalves, Ana Katherine/AAO-4019-2020; GONÇALVES, ANA/K-2300-2017	Gonçalves, Ana Katherine/0000-0002-8351-5119; GONÇALVES, ANA/0000-0002-8351-5119	NIH [F31HL128127, R01DK107784, R01HL096372, R01CA105241, R01NS065237]; Sackler Dean's Fellow award; Sackler Families Collaborative Cancer Biology award; Leukemia & Lymphoma Research UK/Leukemia & Lymphoma Society fellowships; NSFC [81272674]; DoD [W81XWH-15-1-0207]; NATIONAL CANCER INSTITUTE [R01CA105241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL096372, R01HL097794, F31HL128127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234, R01DK107784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065237] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sackler Dean's Fellow award; Sackler Families Collaborative Cancer Biology award; Leukemia & Lymphoma Research UK/Leukemia & Lymphoma Society fellowships; NSFC(National Natural Science Foundation of China (NSFC)); DoD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Kathryn Folz-Donahue, Steven Kwok, Allen Parmalee, Laura Prickett-Rice, and Meredith Weglarz for assistance with cell sorting and Dr. Alenka Lovy for assistance with microscopy. Aged WT mice were kindly provided by NIH/NIA, and Osx and Ocn cDNA were gifts kindly provided by Dr. Deepak Balani and Dr. Henry Kronenberg. This work was supported by NIH fellowship F31HL128127 (to K.A.G.), a Sackler Dean's Fellow award (to K.A.G.), a Sackler Families Collaborative Cancer Biology award (to K.A.G. and G.H.), Leukemia & Lymphoma Research UK/Leukemia & Lymphoma Society fellowships (to L.S.), NSFC grant #81272674 (to S.L.), NIH grants R01DK107784 and R01HL096372 (to D.T.S.), DoD Award W81XWH-15-1-0207 (to G.H.), and NIH grants R01CA105241 and R01NS065237 (to G.H.). D.T.S. is a consultant and stockholder for Magenta Therapeutics and Fate Therapeutics and a consultant for Bone Therapeutics, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, and Apotex. G.H. is a consultant and stockholder of Fuyuan Biopharmaceuticals and Karma Pharmaceuticals.	Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Frelin C, 2013, NAT IMMUNOL, V14, P1037, DOI 10.1038/ni.2692; HALLAHAN TW, 1991, P NATL ACAD SCI USA, V88, P2222, DOI 10.1073/pnas.88.6.2222; Himburg HA, 2014, J CLIN INVEST, V124, P4753, DOI 10.1172/JCI76838; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; LEE FS, 1989, BIOCHEMISTRY-US, V28, P225, DOI 10.1021/bi00427a031; Li PL, 2015, NATURE, V523, P468, DOI 10.1038/nature14569; Li Shuping, 2010, Int J Biochem Mol Biol, V1, P26; Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; MOROIANU J, 1994, BIOCHEM BIOPH RES CO, V203, P1765, DOI 10.1006/bbrc.1994.2391; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nakamura-Ishizu A, 2014, DEVELOPMENT, V141, P4656, DOI 10.1242/dev.106575; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pizzo E, 2013, J CELL SCI, V126, P4308, DOI 10.1242/jcs.134551; Saikia M, 2014, MOL CELL BIOL, V34, P2450, DOI 10.1128/MCB.00136-14; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Silberstein L., 2016, CELL STEM CELL; Singh VK, 2015, CYTOKINE, V71, P22, DOI 10.1016/j.cyto.2014.08.003; Smith AR, 2009, BRIT J HAEMATOL, V147, P246, DOI 10.1111/j.1365-2141.2009.07828.x; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103	45	109	114	3	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					894	906		10.1016/j.cell.2016.06.042	http://dx.doi.org/10.1016/j.cell.2016.06.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518564	Bronze, Green Accepted			2022-12-24	WOS:000382258700013
J	Barba-Spaeth, G; Dejnirattisai, W; Rouvinski, A; Vaney, MC; Medits, I; Sharma, A; Simon-Loriere, E; Sakuntabhai, A; Cao-Lormeau, VM; Haouz, A; England, P; Stiasny, K; Mongkolsapaya, J; Heinz, FX; Screaton, GR; Rey, FA				Barba-Spaeth, Giovanna; Dejnirattisai, Wanwisa; Rouvinski, Alexander; Vaney, Marie-Christine; Medits, Iris; Sharma, Arvind; Simon-Loriere, Etienne; Sakuntabhai, Anavaj; Cao-Lormeau, Van-Mai; Haouz, Ahmed; England, Patrick; Stiasny, Karin; Mongkolsapaya, Juthathip; Heinz, Franz X.; Screaton, Gavin R.; Rey, Felix A.			Structural basis of potent Zika-dengue virus antibody cross-neutralization	NATURE			English	Article							REACTIVE ANTIBODIES; FUSION-LOOP; IN-VIVO; FLAVIVIRUSES; MATURATION; INFECTION; ENHANCEMENT; RECOGNITION; DYNAMICS; RECEPTOR	Zika virus is a member of the Flavivirus genus that had not been associated with severe disease in humans until the recent outbreaks, when it was linked to microcephaly in newborns in Brazil and to Guillain-Barre syndrome in adults in French Polynesia. Zika virus is related to dengue virus, and here we report that a subset of antibodies targeting a conformational epitope isolated from patients with dengue virus also potently neutralize Zika virus. The crystal structure of two of these antibodies in complex with the envelope protein of Zika virus reveals the details of a conserved epitope, which is also the site of interaction of the envelope protein dimer with the precursor membrane (prM) protein during virus maturation. Comparison of the Zika and dengue virus immunocomplexes provides a lead for rational, epitope-focused design of a universal vaccine capable of eliciting potent cross-neutralizing antibodies to protect simultaneously against both Zika and dengue virus infections.	[Barba-Spaeth, Giovanna; Rouvinski, Alexander; Vaney, Marie-Christine; Sharma, Arvind; Rey, Felix A.] Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris 15, France; [Barba-Spaeth, Giovanna; Rouvinski, Alexander; Vaney, Marie-Christine; Sharma, Arvind; Rey, Felix A.] CNRS, UMR Virol 3569, F-75724 Paris 15, France; [Dejnirattisai, Wanwisa; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London W12 0NN, England; [Medits, Iris; Stiasny, Karin; Heinz, Franz X.] Med Univ Vienna, Dept Virol, Kinderspitalgasse 15, A-1095 Vienna, Austria; [Simon-Loriere, Etienne; Sakuntabhai, Anavaj] Inst Pasteur, Unite Genet Fonct Malad Infect, Dept Genomes & Genet, F-75724 Paris 15, France; [Simon-Loriere, Etienne; Sakuntabhai, Anavaj] CNRS, URA 3012, F-75724 Paris 15, France; [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, F-98713 Papeete, Tahiti, France; [Haouz, Ahmed] Inst Pasteur, Plateforme Cristallog CiTech, Dept Biol Struct & Chim, F-75724 Paris 15, France; [Haouz, Ahmed; England, Patrick] CNRS, UMR 3528, F-75724 Paris 15, France; [England, Patrick] Inst Pasteur, Plateforme Biophys Macromol & Leurs Interact, CiTech, Dept Biol Struct & Chim, F-75724 Paris 15, France; [Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok 10700, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Imperial College London; Medical University of Vienna; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University	Rey, FA (corresponding author), Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris 15, France.; Rey, FA (corresponding author), CNRS, UMR Virol 3569, F-75724 Paris 15, France.; Screaton, GR (corresponding author), Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London W12 0NN, England.; Heinz, FX (corresponding author), Med Univ Vienna, Dept Virol, Kinderspitalgasse 15, A-1095 Vienna, Austria.	franz.x.heinz@meduniwien.ac.at; g.screaton@imperial.ac.uk; felix.rey@pasteur.fr	Cao-Lormeau, Van-Mai/H-4879-2018; de Villers, Thierry/AAF-3646-2021; Sharma, Arvind/ABG-2614-2021; Rey, Felix/B-6497-2012	Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Sharma, Arvind/0000-0002-7029-9867; Screaton, Gavin/0000-0002-3549-4309; Medits, Iris/0000-0003-3891-7335; Barba Spaeth, Giovanna/0000-0003-2069-9501; ENGLAND, Patrick/0000-0001-6410-5918; HAOUZ, Ahmed/0000-0003-1196-1635; , Etienne/0000-0001-8420-7743; Rey, Felix/0000-0002-9953-7988; Stiasny, Karin/0000-0002-1902-8674	European Commission [282 378FP7]; "Integrative Biology of Emerging Infectious Diseases" Labex (Laboratoire d'Excellence (French Government's "Investissements d'Avenir" program) [ANR-10-LABX-62-IBEID]; transnational ANR/FWF grant [FlaviStem/I1378]; Medical Research Council, UK; National Institute for Health Research Biomedical Research Centre, Funding Scheme, UK; NEUTRAVIR grant from Region ile-de-France (DIM-Maladies Infectieuses); MRC [G0801508, G0400720] Funding Source: UKRI; Austrian Science Fund (FWF) [I 1378] Funding Source: researchfish; Medical Research Council [G0400720, G0801508] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); "Integrative Biology of Emerging Infectious Diseases" Labex (Laboratoire d'Excellence (French Government's "Investissements d'Avenir" program)(French National Research Agency (ANR)); transnational ANR/FWF grant(French National Research Agency (ANR)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre, Funding Scheme, UK; NEUTRAVIR grant from Region ile-de-France (DIM-Maladies Infectieuses); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. van Kerkhove, the 'working group ZIKA' and our colleagues in the Unite de Virologie Structurale at Institut Pasteur for help and discussions; the staff at the crystallogenesis platform and the recombinant proteins platform of the Institut Pasteur; P. Sylvestre and the Risk Prevention Unit of the Institut Pasteur for their biosafety expertise; W. Shepard and P. Legrand for help during data collection and for discussions; the staff at beamlines PX1 and PX2 at SOLEIL synchrotron (Saclay, France), at beamline ID23-2 of the European Synchrotron Radiation Facility (Grenoble, France) and at beamline PX1 of the Swiss Light Source synchrotron (Villigen, Switzerland); G. Bricogne for suggestions on processing anisotropic diffraction data; A. Reiter and H. Prechler for help in recombinant sE production. G.R.S. is a Wellcome Trust Senior Investigator. We acknowledge support from the European Commission FP7 Programme for the DENFREE project under Grant Agreement number 282 378FP7 (F.A.R., J.M., G.R.S. and A. Sa.); the "Integrative Biology of Emerging Infectious Diseases" Labex (Laboratoire d'Excellence) grant number ANR-10-LABX-62-IBEID (French Government's "Investissements d'Avenir" program) (F.A.R.); the transnational ANR/FWF grant FlaviStem/I1378 (F.A.R. and K.S.), the Medical Research Council, UK (J.M.); the National Institute for Health Research Biomedical Research Centre, Funding Scheme, UK (G.R.S.); and the NEUTRAVIR grant from Region ile-de-France (DIM-Maladies Infectieuses) (P.E., A. H. and F.A.R.)	Backovic M, 2010, PROTEIN ENG DES SEL, V23, P169, DOI 10.1093/protein/gzp088; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bricogne G., 2016, BUSTER VERSION 2 10; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Dejnirattisai W., 2016, NAT IMMUNOL; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gilmartin AA, 2012, PROTEIN ENG DES SEL, V25, P59, DOI 10.1093/protein/gzr058; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindenbach B., 2013, FLAVIVIRIDAE VIRUSES, V1, P1101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11; Vratskikh O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003458; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang W, 2013, J STRUCT BIOL, V183, P86, DOI 10.1016/j.jsb.2013.04.005; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463	45	352	369	5	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					48	+		10.1038/nature18938	http://dx.doi.org/10.1038/nature18938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27338953	Green Submitted, Bronze			2022-12-24	WOS:000380999200027
J	Verdegaal, EME; de Miranda, NFCC; Visser, M; Harryvan, T; van Buuren, MM; Andersen, RS; Hadrup, SR; van der Minne, CE; Schotte, R; Spits, H; Haanen, JBAG; Kapiteijn, EHW; Schumacher, TN; van der Burg, SH				Verdegaal, Els M. E.; de Miranda, Noel F. C. C.; Visser, Marten; Harryvan, Tom; van Buuren, Marit M.; Andersen, Rikke S.; Hadrup, Sine R.; van der Minne, Caroline E.; Schotte, Remko; Spits, Hergen; Haanen, John B. A. G.; Kapiteijn, Ellen H. W.; Schumacher, Ton N.; van der Burg, Sjoerd H.			Neoantigen landscape dynamics during human melanoma-T cell interactions	NATURE			English	Article							EXOME ANALYSIS REVEALS; METASTATIC MELANOMA; CANCER-IMMUNOTHERAPY; PD-1 BLOCKADE; ANTIGENS; THERAPY; LYMPHOCYTES; RESPONSES; TUMORS; RECOGNITION	Recognition of neoantigens that are formed as a consequence of DNA damage is likely to form a major driving force behind the clinical activity of cancer immunotherapies such as T-cell checkpoint blockade and adoptive T-cell therapy(1-7). Therefore, strategies to selectively enhance T-cell reactivity against genetically defined neoantigens(1,8-11) are currently under development. In mouse models, T-cell pressure can sculpt the antigenicity of tumours, resulting in the emergence of tumours that lack defined mutant antigens(12,13). However, whether the T-cell-recognized neoantigen repertoire in human cancers is constant over time is unclear. Here we analyse the stability of neoantigen-specific T-cell responses and the antigens they recognize in two patients with stage IV melanoma treated by adoptive T-cell transfer. The T-cell-recognized neoantigens can be selectively lost from the tumour cell population, either by overall reduced expression of the genes or loss of the mutant alleles. Notably, loss of expression of T-cell-recognized neoantigens was accompanied by development of neoantigen-specific T-cell reactivity in tumour-infiltrating lymphocytes. These data demonstrate the dynamic interactions between cancer cells and T cells, which suggest that T cells mediate neoantigen immunoediting, and indicate that the therapeutic induction of broad neoantigen-specific T-cell responses should be used to avoid tumour resistance.	[Verdegaal, Els M. E.; Visser, Marten; Harryvan, Tom; van der Minne, Caroline E.; Haanen, John B. A. G.; Kapiteijn, Ellen H. W.; van der Burg, Sjoerd H.] Leiden Univ, Med Ctr, Dept Med Oncol, NL-2300 RC Leiden, Netherlands; [de Miranda, Noel F. C. C.] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [van Buuren, Marit M.; Haanen, John B. A. G.; Schumacher, Ton N.] Netherlands Canc Inst, Dept Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Andersen, Rikke S.; Hadrup, Sine R.] Herlev Univ Hosp, Dept Hematol, Ctr Canc Immune Therapy, DK-2730 Herlev, Denmark; [Schotte, Remko; Spits, Hergen] AIMM Therapeut, NL-1105 BA Amsterdam, Netherlands; [Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [van Buuren, Marit M.] Neon Therapeut, Cambridge, MA 02142 USA; [Andersen, Rikke S.] Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat Res, DK-5000 Odense, Denmark; [Hadrup, Sine R.] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, DK-1870 Copenhagen, Denmark	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; University of Copenhagen; Herlev & Gentofte Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Southern Denmark; Technical University of Denmark	Verdegaal, EME (corresponding author), Leiden Univ, Med Ctr, Dept Med Oncol, NL-2300 RC Leiden, Netherlands.	E.Verdegaal@lumc.nl	Haanen, John/AAD-8534-2022; Kapiteijn, Ellen/AAK-6065-2020; Schumacher, Ton/Y-2432-2019; de Miranda, NFCC/I-2520-2015; Verdegaal, Elizabeth/Y-2597-2018; Haanen, John/AAD-8578-2022; Spits, Hergen/N-2581-2019; van der Burg, Sjoerd H/T-1875-2017; Hadrup, Sine Reker/P-3388-2014; Andersen, Rikke/GRS-3064-2022	Haanen, John/0000-0001-5884-7704; Kapiteijn, Ellen/0000-0002-4814-6426; Schumacher, Ton/0000-0003-0517-8804; de Miranda, NFCC/0000-0001-6122-1024; Verdegaal, Elizabeth/0000-0002-4449-8707; Spits, Hergen/0000-0003-3269-8338; van der Burg, Sjoerd H/0000-0002-6556-0354; Hadrup, Sine Reker/0000-0002-5937-4344; 	Dutch Cancer Society [UL 2012-5544, NKI 2012-5463, UVA 2010-4822]; Anticancer Fund; Dutch Cancer Society Queen Wilhelmina Award NKI [2013-6122]; Fight Colorectal Cancer-Michael's Mission-AACR Fellowship; Alpe d'HuZes/KWF Bas Mulder Award	Dutch Cancer Society(KWF Kankerbestrijding); Anticancer Fund; Dutch Cancer Society Queen Wilhelmina Award NKI; Fight Colorectal Cancer-Michael's Mission-AACR Fellowship; Alpe d'HuZes/KWF Bas Mulder Award	We are grateful to G. J. Liefers for handling of patient material, and T. van Wezel and D. Ruano for the setup of the M13-amplicon sequencing technology. This work was supported by Dutch Cancer Society grant UL 2012-5544 (to E.M.E.V., S.H.v.d.B. and J.B.A.G.H), the Anticancer Fund (to E.M.E.V. and S.H.v.d.B.), Dutch Cancer Society grant NKI 2012-5463 (to T.N.S, J.B.A.G.H. and S.H.v.d.B), the Dutch Cancer Society Queen Wilhelmina Award NKI 2013-6122 (T.N.S), Dutch Cancer Society grant UVA 2010-4822 (to H.S.), Fight Colorectal Cancer-Michael's Mission-AACR Fellowship (2015) and Alpe d'HuZes/KWF Bas Mulder Award (to N.F.C.C.d.M.).	Andersen RS, 2012, CANCER RES, V72, P1642, DOI 10.1158/0008-5472.CAN-11-2614; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Ellebaek E, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-169; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Kawakami Y, 2000, J IMMUNOTHER, V23, P17, DOI 10.1097/00002371-200001000-00004; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lu YC, 2014, CLIN CANCER RES, V20, P3401, DOI 10.1158/1078-0432.CCR-14-0433; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Timm J, 2015, MED MICROBIOL IMMUN, V204, P29, DOI 10.1007/s00430-014-0372-z; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Verdegaal EME, 2011, CANCER IMMUNOL IMMUN, V60, P953, DOI 10.1007/s00262-011-1004-8; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	29	277	288	6	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					91	+		10.1038/nature18945	http://dx.doi.org/10.1038/nature18945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27350335				2022-12-24	WOS:000380999200036
J	Spottiswoode, CN; Begg, KS; Begg, CM				Spottiswoode, Claire N.; Begg, Keith S.; Begg, Colleen M.			Reciprocal signaling in honeyguide-human mutualism	SCIENCE			English	Article							SYMBIOTIC RELATIONSHIP	Greater honeyguides (Indicator indicator) lead human honey-hunters to wild bees' nests, in a rare example of a mutualistic foraging partnership between humans and free-living wild animals. We show experimentally that a specialized vocal sound made by Mozambican honey-hunters seeking bees' nests elicits elevated cooperative behavior from honeyguides. The production of this sound increased the probability of being guided by a honeyguide from about 33 to 66% and the overall probability of thus finding a bees' nest from 17 to 54%, as compared with other animal or human sounds of similar amplitude. These results provide experimental evidence that a wild animal in a natural setting responds adaptively to a human signal of cooperation.	[Spottiswoode, Claire N.] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England; [Spottiswoode, Claire N.] Univ Cape Town, FitzPatrick Inst African Ornithol, Dept Sci & Technol, Natl Res Fdn DST NRF,Ctr Excellence, ZA-7701 Rondebosch, South Africa; [Begg, Keith S.; Begg, Colleen M.] Ratel Trust, Niassa Carnivore Project, Private Bag X18, ZA-7701 Rondebosch, South Africa	University of Cambridge; University of Cape Town	Spottiswoode, CN (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.; Spottiswoode, CN (corresponding author), Univ Cape Town, FitzPatrick Inst African Ornithol, Dept Sci & Technol, Natl Res Fdn DST NRF,Ctr Excellence, ZA-7701 Rondebosch, South Africa.	cns26@cam.ac.uk			Biotechnology and Biological Sciences Research Council David Phillips Research Fellowship [BB/J014109/1]; DST-NRF Centre of Excellence at the FitzPatrick Institute; BBSRC [BB/J014109/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014109/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council David Phillips Research Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DST-NRF Centre of Excellence at the FitzPatrick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank O. Yassene, M. Muamedi, C. Augusto, E. Waiti, M. Marufo, R. Iassine, and A. Jorge for help with fieldwork and interviews; the honey-hunters of Mbamba village for their participation; Administracao Nacional das Areas de Conservacao, Wildlife Conservation Society, and C. Miguel for research permission; Mariri Environmental Centre for logistical support; S. Hoy (Wild & Marr, Cape Town) for equipment loan; and N. Boogert, N. Davies, T. Flower, G. Jamie, R. Magrath, D. Rendall, G. Ruxton, M. Sorensen, B. Wood, and R. Wrangham for advice and comments. C. N. S. was supported by a Biotechnology and Biological Sciences Research Council David Phillips Research Fellowship (BB/J014109/1) and the DST-NRF Centre of Excellence at the FitzPatrick Institute. Data are deposited in Dryad (DOI: 10.5061/dryad.8c65s). All authors conceived the study; K.S.B. and C.M.B. facilitated the fieldwork; C.N.S. collected and analyzed the data and wrote the paper.	BUSNEL RG, 1973, T NEW YORK ACAD SCI, V35, P112, DOI 10.1111/j.2164-0947.1973.tb01511.x; Colson Elizabeth, 1959, 7 TRIBES BRIT CENTRA; DEAN WRJ, 1990, CONSERV BIOL, V4, P99, DOI 10.1111/j.1523-1739.1990.tb00272.x; DOSSANTOS J, 2009, ETHIOPIA ORIENTAL; Friedmann H, 1955, B AM MUS NAT HIST, V208, P1, DOI DOI 10.5479/SI.03629236.208.1; ISACK HA, 1989, SCIENCE, V243, P1343, DOI 10.1126/science.243.4896.1343; ISACK HA, 1987, THESIS; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Popplewell GD, 1938, GEOGR J, V91, P31, DOI 10.2307/1787815; Spottiswoode CN, 2011, P NATL ACAD SCI USA, V108, P17738, DOI 10.1073/pnas.1109630108; Vail AL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2781; Wood BM, 2014, EVOL HUM BEHAV, V35, P540, DOI 10.1016/j.evolhumbehav.2014.07.007	12	33	34	5	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2016	353	6297					387	389		10.1126/science.aaf4885	http://dx.doi.org/10.1126/science.aaf4885			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HB	27463674	Green Accepted			2022-12-24	WOS:000380583400042
J	Pollard, JW				Pollard, Jeffrey W.			Defining Metastatic Cell Latency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TUMOR-METASTASIS; MONOCYTES		[Pollard, Jeffrey W.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	University of Edinburgh	Pollard, JW (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.				NCI NIH HHS [P01 CA100324, R01 CA172451] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA172451, P01CA100324] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ames E, 2014, CANCER IMMUNOL IMMUN, V63, P21, DOI 10.1007/s00262-013-1469-8; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138	5	11	11	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2016	375	3					280	282		10.1056/NEJMcibr1606716	http://dx.doi.org/10.1056/NEJMcibr1606716			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0ZL	27468066	Green Accepted, Green Published			2022-12-24	WOS:000380325400015
J	Lewis, SC; Uchiyama, LF; Nunnari, J				Lewis, Samantha C.; Uchiyama, Lauren F.; Nunnari, Jodi			ER-mitochondria contacts couple mtDNA synthesis with mitochondrial division in human cells	SCIENCE			English	Article							DNA-POLYMERASE-GAMMA; TUBULAR ENDOPLASMIC-RETICULUM; HEREDITARY SPASTIC PARAPLEGIA; REPLICATION; MEMBRANE; NUCLEOIDS; TFAM; TRANSCRIPTION; MAINTENANCE; DYNAMICS	Mitochondrial DNA (mtDNA) encodes RNAs and proteins critical for cell function. In human cells, hundreds to thousands of mtDNA copies are replicated asynchronously, packaged into protein-DNA nucleoids, and distributed within a dynamic mitochondrial network. The mechanisms that govern how nucleoids are chosen for replication and distribution are not understood. Mitochondrial distribution depends on division, which occurs at endoplasmic reticulum (ER)-mitochondria contact sites. These sites were spatially linked to a subset of nucleoids selectively marked by mtDNA polymerase and engaged in mtDNA synthesis-events that occurred upstream of mitochondrial constriction and division machine assembly. Our data suggest that ER tubules proximal to nucleoids are necessary but not sufficient for mtDNA synthesis. Thus, ER-mitochondria contacts coordinate licensing of mtDNA synthesis with division to distribute newly replicated nucleoids to daughter mitochondria.	[Lewis, Samantha C.; Uchiyama, Lauren F.; Nunnari, Jodi] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Nunnari, J (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	jmnunnari@ucdavis.edu		Lewis, Samantha/0000-0001-6306-443X; Uchiyama, Lauren/0000-0002-6574-0064	NIH [R01GM106019, R01GM097432]; NIH Ruth L. Kirschstein Postdoctoral Fellowship [F32GM113388]; UC Davis Provost's Undergraduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106019, R01GM097432, R37GM097432, F32GM113388] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Ruth L. Kirschstein Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis Provost's Undergraduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Nunnari lab and W. Copeland for discussion, and M. Paddy and the University of California (UC), Davis, Department of Molecular and Cellular Biology Microscopy Facility for helpful suggestions. This work is supported by NIH grants R01GM106019 and R01GM097432 (to J.N.), an NIH Ruth L. Kirschstein Postdoctoral Fellowship F32GM113388 (to S.C.L.), and a UC Davis Provost's Undergraduate Research Fellowship (to L.F.U.). J.N. is on the Advisory Board of Mitobridge and declares no financial interest related to this work. The other authors declare that no competing interests exist. All data are included in the main manuscript and supplementary materials.	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380; Cui-Wang TT, 2012, CELL, V148, P309, DOI 10.1016/j.cell.2011.11.056; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Gerhold JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15292; Hu JJ, 2011, CELL, V147, P1226, DOI 10.1016/j.cell.2011.11.022; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Ishihara T, 2015, MOL CELL BIOL, V35, P211, DOI 10.1128/MCB.01054-14; Itoh K, 2013, MOL BIOL CELL, V24, P1842, DOI 10.1091/mbc.E13-03-0125; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Labbe K, 2014, ANNU REV CELL DEV BI, V30, P357, DOI 10.1146/annurev-cellbio-101011-155756; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Murley A, 2016, MOL CELL, V61, P648, DOI 10.1016/j.molcel.2016.01.031; Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; Rugarli EI, 2006, TRENDS MOL MED, V12, P262, DOI 10.1016/j.molmed.2006.04.002; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240	48	321	326	9	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2016	353	6296							aaf5549	10.1126/science.aaf5549	http://dx.doi.org/10.1126/science.aaf5549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0EM	27418514	Green Accepted			2022-12-24	WOS:000379580800041
J	Yang, Y; Yamada, T; Hill, KK; Hemberg, M; Reddy, NC; Cho, HY; Guthrie, AN; Oldenborg, A; Heiney, SA; Ohmae, S; Medina, JF; Holy, TE; Bonni, A				Yang, Yue; Yamada, Tomoko; Hill, Kelly K.; Hemberg, Martin; Reddy, Naveen C.; Cho, Ha Y.; Guthrie, Arden N.; Oldenborg, Anna; Heiney, Shane A.; Ohmae, Shogo; Medina, Javier F.; Holy, Timothy E.; Bonni, Azad			Chromatin remodeling inactivates activity genes and regulates neural coding	SCIENCE			English	Article							MI-2/NURD COMPLEX; HISTONE VARIANTS; DIFFERENTIATION; TRANSCRIPTION; CELLS; PLURIPOTENCY; MECHANISMS; EXPRESSION; GENOME; H3	Activity-dependent transcription influences neuronal connectivity, but the roles and mechanisms of inactivation of activity-dependent genes have remained poorly understood. Genome-wide analyses in the mouse cerebellum revealed that the nucleosome remodeling and deacetylase (NuRD) complex deposits the histone variant H2A.z at promoters of activity-dependent genes, thereby triggering their inactivation. Purification of translating messenger RNAs from synchronously developing granule neurons (Sync-TRAP) showed that conditional knockout of the core NuRD subunit Chd4 impairs inactivation of activity-dependent genes when neurons undergo dendrite pruning. Chd4 knockout or expression of NuRD-regulated activity genes impairs dendrite pruning. Imaging of behaving mice revealed hyperresponsivity of granule neurons to sensorimotor stimuli upon Chd4 knockout. Our findings define an epigenetic mechanism that inactivates activity-dependent transcription and regulates dendrite patterning and sensorimotor encoding in the brain.	[Yang, Yue; Yamada, Tomoko; Hill, Kelly K.; Reddy, Naveen C.; Cho, Ha Y.; Guthrie, Arden N.; Oldenborg, Anna; Holy, Timothy E.; Bonni, Azad] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA; [Hill, Kelly K.] Washington Univ, Sch Med, MD PhD Program, St Louis, MO 63110 USA; [Hemberg, Martin] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Heiney, Shane A.; Ohmae, Shogo; Medina, Javier F.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Yamada, Tomoko] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan	Washington University (WUSTL); Washington University (WUSTL); Wellcome Trust Sanger Institute; Baylor College of Medicine; University of Tsukuba	Bonni, A (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA.	bonni@wustl.edu		Medina, Javier/0000-0001-8708-5315; Yang, Yue/0000-0002-6201-8818; Ohmae, Shogo/0000-0003-1726-4961; Markwalter, Kelly/0000-0002-6879-4228	NIH [NS041021, MH093727]; Mathers Foundation; NIH Medical Scientist Training Program [T32 GM07200]; National Cancer Institute [P30 CA91842]; Institute of Clinical and Translational Sciences-Clinical and Translational Science Awards [UL1TR000448]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068409, R01NS041021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institute of Clinical and Translational Sciences-Clinical and Translational Science Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Bonni laboratory for helpful discussions and critical reading of the manuscript and E. Han for advice in imaging analyses. Supported by NIH grant NS041021 (A.B.), the Mathers Foundation (A.B.), NIH grant MH093727 (J.F.M.), and NIH Medical Scientist Training Program grant T32 GM07200 (K.K.H.). We thank the Genome Technology Access Center at Washington University, which is supported by National Cancer Institute grant P30 CA91842 to the Siteman Cancer Center and by Institute of Clinical and Translational Sciences-Clinical and Translational Science Awards UL1TR000448. The authors declare no conflicts of interest. Raw sequencing data related to this study have been archived in the Gene Expression Omnibus (GEO) database under accession number GSE83253 (available at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83253).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Billings G, 2014, NEURON, V83, P960, DOI 10.1016/j.neuron.2014.07.020; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Heiman M, 2014, NAT PROTOC, V9, P1282, DOI 10.1038/nprot.2014.085; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Qiu Z, 2008, NEURON, V60, P449, DOI 10.1016/j.neuron.2008.10.039; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rhee HS, 2014, CELL, V159, P1377, DOI 10.1016/j.cell.2014.10.054; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Weber CM, 2014, GENE DEV, V28, P672, DOI 10.1101/gad.238873.114; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Yamada T, 2014, NEURON, V83, P122, DOI 10.1016/j.neuron.2014.05.039; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808	26	61	63	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2016	353	6296					300	305		10.1126/science.aad4225	http://dx.doi.org/10.1126/science.aad4225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0EM	27418512	Green Accepted			2022-12-24	WOS:000379580800052
J	Eisenstein, M				Eisenstein, Michael			NEUROPATHY A name for their pain	NATURE			English	Editorial Material							DOUBLE-BLIND											Attal N, 2016, LANCET NEUROL, V15, P555, DOI 10.1016/S1474-4422(16)00017-X; Demant DT, 2014, PAIN, V155, P2263, DOI 10.1016/j.pain.2014.08.014; Freeman R, 2014, PAIN, V155, P367, DOI 10.1016/j.pain.2013.10.023	3	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					S10	S11		10.1038/535S10a	http://dx.doi.org/10.1038/535S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR4ZN	27410524				2022-12-24	WOS:000379912600008
J	Kornprobst, M; Turk, M; Kellner, N; Cheng, JD; Flemming, D; Kos-Braun, I; Kos, M; Thoms, M; Berninghausen, O; Beckmann, R; Hurt, E				Kornprobst, Markus; Turk, Martin; Kellner, Nikola; Cheng, Jingdong; Flemming, Dirk; Kos-Braun, Isabelle; Kos, Martin; Thoms, Matthias; Berninghausen, Otto; Beckmann, Roland; Hurt, Ed			Architecture of the 90S Pre-ribosome: A Structural View on the Birth of the Eukaryotic Ribosome	CELL			English	Article							RNA-PROCESSING COMPLEXES; SACCHAROMYCES-CEREVISIAE; ASSEMBLY EVENTS; CROSS-LINKING; PROTEIN; YEAST; BIOGENESIS; PRECURSORS; DOMAIN; IDENTIFICATION	The 90S pre-ribosome is an early biogenesis intermediate formed during co-transcriptional ribosome formation, composed of similar to 70 assembly factors and several small nucleolar RNAs ( snoRNAs) that associate with nascent pre-rRNA. We report the cryo-EM structure of the Chaetomium thermophilum 90S pre-ribosome, revealing how a network of biogenesis factors including 19 beta-propellers and large a-solenoid proteins engulfs the pre-rRNA. Within the 90S pre-ribosome, we identify the UTP-A, UTP-B, Mpp10-Imp3-Imp4, Bms1-Rcl1, and U3 snoRNP modules, which are organized around 5'-ETS and partially folded 18S rRNA. The U3 snoRNP is strategically positioned at the center of the 90S particle to perform its multiple tasks during pre-rRNA folding and processing. The architecture of the elusive 90S pre-ribosome gives unprecedented structural insight into the early steps of pre-rRNA maturation. Nascent rRNA that is co-transcriptionally folded and given a particular shape by encapsulation within a dedicated mold-like structure is reminiscent of how polypeptides use chaperone chambers for their protein folding.	[Kornprobst, Markus; Kellner, Nikola; Flemming, Dirk; Kos-Braun, Isabelle; Kos, Martin; Thoms, Matthias; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Turk, Martin; Cheng, Jingdong; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Gene Ctr, D-81377 Munich, Germany	Ruprecht Karls University Heidelberg; University of Munich	Hurt, E (corresponding author), Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany.; Beckmann, R (corresponding author), Univ Munich, Gene Ctr, D-81377 Munich, Germany.	beckmann@genzentrum.lmu.de; ed.hurt@bzh.uni-heidelberg.de	/C-3697-2019; Kos, Martin/E-2534-2011; Ed Hurt, Dr./AAE-8874-2019; Flemming, Dirk/AAP-3274-2021; Turk, Martin/CAI-9842-2022	Kos, Martin/0000-0002-3337-9681; Ed Hurt, Dr./0000-0002-4535-8255; Kos-Braun, Isabelle/0000-0002-2380-5720; Thoms, Matthias/0000-0001-8084-6097	Deutsche Forschungsgemeinschaft (DFG) [HU363/10-5, HU363/12-1, GraKo1721, SFB646]; Kekule Fellowship (VCI)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Kekule Fellowship (VCI)	We thank Dieter Kressler and Michael Knob for providing pFA6A-FTpA-natNT2 and pFA6A-Gal1-TRP1 plasmids, respectively. We are grateful to Dr. Pawel Penczek for sharing his vast expertise in image processing and to Susanne Rieder, Charlotte Ungewickell, Sabine Griesel, and Beate Jannack for excellent technical assistance. We further thank Jochen Bassler for software processing of the MS data and Emma Thomson for critical reading of the manuscript. This work was funded by grants from the Deutsche Forschungsgemeinschaft to E.H. (DFG; HU363/10-5, HU363/12-1) and R.B. (GraKo1721 and SFB646). M.K. was funded by a Kekule Fellowship (VCI).	Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Barrio-Garcia C, 2016, NAT STRUCT MOL BIOL, V23, P37, DOI 10.1038/nsmb.3132; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bleichert F, 2006, P NATL ACAD SCI USA, V103, P9464, DOI 10.1073/pnas.0603673103; Chaker-Margot M, 2015, NAT STRUCT MOL BIOL, V22, P920, DOI 10.1038/nsmb.3111; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dutca LM, 2011, NUCLEIC ACIDS RES, V39, P5164, DOI 10.1093/nar/gkr044; Gerczei T, 2009, J MOL BIOL, V390, P991, DOI 10.1016/j.jmb.2009.05.072; Gigova A, 2014, RNA, V20, P1632, DOI 10.1261/rna.043398.113; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Horn DM, 2011, J BIOL CHEM, V286, P34082, DOI 10.1074/jbc.M111.268649; Jakob S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032552; James P, 1996, GENETICS, V144, P1425; Kellner N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20937; Kos M, 2005, MOL CELL, V20, P53, DOI 10.1016/j.molcel.2005.08.022; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Lin JZ, 2011, NATURE, V469, P559, DOI 10.1038/nature09688; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; MOUGEY EB, 1993, GENE DEV, V7, P1609, DOI 10.1101/gad.7.8.1609; NOMURA M, 1968, NATURE, V219, P793, DOI 10.1038/219793b0; Perez-Fernandez J, 2011, NUCLEIC ACIDS RES, V39, P8105, DOI 10.1093/nar/gkr508; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; Sardana R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002083; Sashital DG, 2014, ELIFE, V3, DOI 10.7554/eLife.04491; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Sharma S, 2015, NUCLEIC ACIDS RES, V43, P2242, DOI 10.1093/nar/gkv075; Stelter P, 2015, MOL CELL, V58, P854, DOI 10.1016/j.molcel.2015.03.029; Thomas SR, 2011, NUCLEIC ACIDS RES, V39, P2445, DOI 10.1093/nar/gkq1131; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; Turowski TW, 2015, WIRES RNA, V6, P129, DOI 10.1002/wrna.1263; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; YEH LCC, 1992, J MOL BIOL, V228, P827, DOI 10.1016/0022-2836(92)90867-J; Zhang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086540; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zhang LM, 2016, GENE DEV, V30, P718, DOI 10.1101/gad.274688.115	41	133	135	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					380	393		10.1016/j.cell.2016.06.014	http://dx.doi.org/10.1016/j.cell.2016.06.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27419870	Bronze			2022-12-24	WOS:000380255400016
J	Torjesen, I				Torjesen, Ingrid			Nursery policies on conjunctivitis may encourage GPs to prescribe antibiotics	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Finnikin S, 2016, BRIT J GEN PRACT, V66, pE674, DOI 10.3399/bjgp16X686125	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2016	354								i3754	10.1136/bmj.i3754	http://dx.doi.org/10.1136/bmj.i3754			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EP	27382983				2022-12-24	WOS:000379581100022
J	Krzywinska, E; Dennison, NJ; Lycett, GJ; Krzywinski, J				Krzywinska, Elzbieta; Dennison, Nathan J.; Lycett, Gareth J.; Krzywinski, Jaroslaw			A maleness gene in the malaria mosquito Anopheles gambiae	SCIENCE			English	Article							LUCILIA-CUPRINA DIPTERA; DOSAGE COMPENSATION; SEX DETERMINATION; Y-CHROMOSOME; X-CHROMOSOME; DETERMINING REGION; TRANSFORMER GENE; AEDES-AEGYPTI; DROSOPHILA; RATIO	The molecular pathways controlling gender are highly variable and have been identified in only a few nonmammalian model species. In many insects, maleness is conferred by a Ychromosome-linked M factor of unknown nature. We have isolated and characterized a gene, Yob, for the M factor in the malaria mosquito Anopheles gambiae. Yob, activated at the beginning of zygotic transcription and expressed throughout a male's life, controls male-specific splicing of the doublesex gene. Silencing embryonic Yob expression is male-lethal, whereas ectopic embryonic delivery of Yob transcripts yields male-only broods. This female-killing property may be an invaluable tool for creation of conditional male-only transgenic Anopheles strains for malaria control programs.	[Krzywinska, Elzbieta; Krzywinski, Jaroslaw] Pirbright Inst, Ash Rd, Pirbright GU24 0NF, Surrey, England; [Dennison, Nathan J.; Lycett, Gareth J.; Krzywinski, Jaroslaw] Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Pembroke Pl, Liverpool L3 5QA, Merseyside, England; [Dennison, Nathan J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Liverpool School of Tropical Medicine; University of Liverpool; Imperial College London	Krzywinski, J (corresponding author), Pirbright Inst, Ash Rd, Pirbright GU24 0NF, Surrey, England.; Krzywinski, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	jaroslaw.krzywinski@pirbright.ac.uk		Lycett, Gareth/0000-0002-2422-053X	Liverpool School of Tropical Medicine (LSTM); MRC-LSTM Research Studentship; Wellcome Trust [089045/Z/09/Z]; Pirbright Institute; Biotechnology and Biological Sciences Research Council [BB/F021933/1]; NIH [CRSC120816JKUND, HHSN272200900039C]; BBSRC [BBS/E/I/00001854, BB/F021933/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001854] Funding Source: researchfish	Liverpool School of Tropical Medicine (LSTM); MRC-LSTM Research Studentship; Wellcome Trust(Wellcome TrustEuropean Commission); Pirbright Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank H. Ranson, A. Wilson, and anonymous reviewers for comments and L. Revuelta for technical assistance. This study was supported by funds from the Liverpool School of Tropical Medicine (LSTM), an MRC-LSTM Research Studentship, Wellcome Trust grant 089045/Z/09/Z (J.K. and G.J.L.), and funds from the Pirbright Institute (J.K.). Transgenic mosquitoes used for sexing were developed with Biotechnology and Biological Sciences Research Council grant BB/F021933/1 (G.J.L.). J.K. was partly supported by a subcontract CRSC120816JKUND of the NIH contract HHSN272200900039C. The RNA-sequencing data have been deposited in the Sequence Read Archive repository under the accession numbers SRR953486.1 and SRR953487.1.	Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; BAKER RH, 1979, J HERED, V70, P345, DOI 10.1093/oxfordjournals.jhered.a109271; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; BEDO DG, 1985, CHROMOSOMA, V92, P344, DOI 10.1007/BF00327465; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Concha C, 2009, GENETICS, V182, P785, DOI 10.1534/genetics.109.100982; Criscione F, 2013, INSECT MOL BIOL, V22, P433, DOI 10.1111/imb.12034; Erickson JW, 2007, PLOS BIOL, V5, P2821, DOI 10.1371/journal.pbio.0050332; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; GERGEN JP, 1987, GENETICS, V117, P477; Hall AB, 2016, P NATL ACAD SCI USA, V113, pE2114, DOI 10.1073/pnas.1525164113; Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850; Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Hilfiker A, 1995, DEVELOPMENT, V121, P4017; HIROYOSHI T, 1964, GENETICS, V50, P373; Juhn J, 2006, INSECT MOL BIOL, V15, P363, DOI 10.1111/j.1365-2583.2006.00655.x; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902; Krzywinski J, 2004, GENETICS, V166, P1291, DOI 10.1534/genetics.166.3.1291; Li W.-H., 1997, MOL EVOLUTION, P177; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; LUCCHESI JC, 1981, CHROMOSOMA, V82, P217, DOI 10.1007/BF00286106; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Pane A, 2002, DEVELOPMENT, V129, P3715; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Pritchard DK, 1996, GENE DEV, V10, P1131, DOI 10.1101/gad.10.9.1131; Rose G, 2016, GENOME BIOL EVOL, V8, P411, DOI 10.1093/gbe/evw004; Scali C, 2005, J EXP BIOL, V208, P3701, DOI 10.1242/jeb.01819; Shukla JN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00602; STUART JJ, 1995, GENOME, V38, P673, DOI 10.1139/g95-085; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; WILKINS AS, 1995, BIOESSAYS, V17, P71, DOI 10.1002/bies.950170113; Willhoeft U, 1996, GENETICS, V144, P737	37	69	75	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					67	69		10.1126/science.aaf5605	http://dx.doi.org/10.1126/science.aaf5605			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365445	Green Accepted			2022-12-24	WOS:000378816200036
J	Stott, P				Stott, Peter			How climate change affects extreme weather events Research can increasingly determine the contribution of climate change to extreme events such as droughts	SCIENCE			English	Editorial Material							ATTRIBUTION		[Stott, Peter] Met Off Hadley Ctr, Fitzroy Rd, Exeter EX1 3PB, Devon, England; [Stott, Peter] Univ Exeter, Dept Math, Exeter EX4 4QF, Devon, England	Met Office - UK; Hadley Centre; University of Exeter	Stott, P (corresponding author), Met Off Hadley Ctr, Fitzroy Rd, Exeter EX1 3PB, Devon, England.; Stott, P (corresponding author), Univ Exeter, Dept Math, Exeter EX4 4QF, Devon, England.	peter.stott@metoffice.gov.uk	Stott, Peter/N-1228-2016	Stott, Peter/0000-0003-4853-7686				Bellprat O, 2016, GEOPHYS RES LETT, V43, P2158, DOI 10.1002/2015GL067189; Bindoff NL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P867; Herring SC, 2015, B AM METEOROL SOC, V96, DOI 10.1175/BAMS-EEE_2014_ch1.1; Lott FC, 2016, J CLIMATE, V29, P4565, DOI 10.1175/JCLI-D-15-0566.1; Natl. Acad. Sci. Eng. Med, 2016, ATTRIBUTION EXTREME; Otto FEL, 2016, NAT CLIM CHANGE, V6, P340; Peterson TC, 2012, B AM METEOROL SOC, V93, P1041, DOI 10.1175/BAMS-D-12-00021.1; Schaller N, 2014, B AM METEOROL SOC, V95, pS69; Shepherd TG, 2016, CURR CLIM CHANGE REP, V2, P28, DOI 10.1007/s40641-016-0033-y; Sippel S, 2015, WEATHER CLIM SOC, V7, P224, DOI 10.1175/WCAS-D-14-00045.1; Solow AR, 2015, SCIENCE, V349, P1444, DOI 10.1126/science.aad2132; Stott PA, 2016, WIRES CLIM CHANGE, V7, P23, DOI 10.1002/wcc.380; Sun Y, 2014, NAT CLIM CHANGE, V4, P1082, DOI 10.1038/NCLIMATE2410; Zhang XB, 2013, GEOPHYS RES LETT, V40, P5252, DOI 10.1002/grl.51010	15	278	291	81	402	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1517	1518		10.1126/science.aaf7271	http://dx.doi.org/10.1126/science.aaf7271			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339968				2022-12-24	WOS:000378346500019
J	Irianto, J; Pfeifer, CR; Xia, YT; Discher, DE				Irianto, Jerome; Pfeifer, Charlotte R.; Xia, Yuntao; Discher, Dennis E.			SnapShot: Mechanosensing Matrix	CELL			English	Editorial Material							STIFFNESS		[Irianto, Jerome; Pfeifer, Charlotte R.; Xia, Yuntao; Discher, Dennis E.] Univ Penn, Mol & Cell Biophys Lab, Philadelphia, PA 19104 USA	University of Pennsylvania	Irianto, J (corresponding author), Univ Penn, Mol & Cell Biophys Lab, Philadelphia, PA 19104 USA.		Xia, Yuntao/S-3936-2018	Xia, Yuntao/0000-0002-3011-5859; Irianto, Jerome/0000-0002-4804-7225	NCI NIH HHS [U54 CA193417] Funding Source: Medline; NHLBI NIH HHS [R21 HL128187, R01 HL124106] Funding Source: Medline; NIDDK NIH HHS [P01 DK032094] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA193417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124106, R21HL128187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Majkut S, 2013, CURR BIOL, V23, P2434, DOI 10.1016/j.cub.2013.10.057; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104	10	38	38	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1820	+		10.1016/j.cell.2016.06.002	http://dx.doi.org/10.1016/j.cell.2016.06.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315485	Bronze, Green Accepted			2022-12-24	WOS:000378062000030
J	Kotzin, JJ; Spencer, SP; McCright, SJ; Kumar, DBU; Collet, MA; Mowel, WK; Elliott, EN; Uyar, A; Makiya, MA; Dunagin, MC; Harman, CCD; Virtue, AT; Zhu, S; Bailis, W; Stein, J; Hughes, C; Raj, A; Wherry, EJ; Goff, LA; Klion, AD; Rinn, JL; Williams, A; Flavell, RA; Henao-Mejia, J				Kotzin, Jonathan J.; Spencer, Sean P.; McCright, Sam J.; Kumar, Dinesh B. Uthaya; Collet, Magalie A.; Mowel, Walter K.; Elliott, Ellen N.; Uyar, Asli; Makiya, Michelle A.; Dunagin, Margaret C.; Harman, Christian C. D.; Virtue, Anthony T.; Zhu, Stella; Bailis, Will; Stein, Judith; Hughes, Cynthia; Raj, Arjun; Wherry, E. John; Goff, Loyal A.; Klion, Amy D.; Rinn, John L.; Williams, Adam; Flavell, Richard A.; Henao-Mejia, Jorge			The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan	NATURE			English	Article							CHROMATIN; MACROPHAGES; HOMEOSTASIS; MONOCYTES; BCL-2; DIFFERENTIATION; VERNALIZATION; EXPRESSION; SURVIVAL; PRC2	Neutrophils, eosinophils and 'classical' monocytes collectively account for about 70% of human blood leukocytes and are among the shortest-lived cells in the body(1,2). Precise regulation of the lifespan of these myeloid cells is critical to maintain protective immune responses and minimize the deleterious consequences of prolonged inflammation(1,2). However, how the lifespan of these cells is strictly controlled remains largely unknown. Here we identify a long non-coding RNA that we termed Morrbid, which tightly controls the survival of neutrophils, eosinophils and classical monocytes in response to pro-survival cytokines in mice. To control the lifespan of these cells, Morrbid regulates the transcription of the neighbouring pro-apoptotic gene, Bcl2l11 (also known as Bim), by promoting the enrichment of the PRC2 complex at the Bcl2l11 promoter to maintain this gene in a poised state. Notably, Morrbid regulates this process in cis, enabling allele-specific control of Bcl2l11 transcription. Thus, in these highly inflammatory cells, changes in Morrbid levels provide a locus-specific regulatory mechanism that allows rapid control of apoptosis in response to extracellular pro-survival signals. As MORRBID is present in humans and dysregulated in individuals with hypereosinophilic syndrome, this long non-coding RNA may represent a potential therapeutic target for inflammatory disorders characterized by aberrant short-lived myeloid cell lifespan.	[Kotzin, Jonathan J.; Spencer, Sean P.; McCright, Sam J.; Mowel, Walter K.; Virtue, Anthony T.; Henao-Mejia, Jorge] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kotzin, Jonathan J.; Spencer, Sean P.; McCright, Sam J.; Mowel, Walter K.; Virtue, Anthony T.; Wherry, E. John; Henao-Mejia, Jorge] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Kumar, Dinesh B. Uthaya; Collet, Magalie A.; Elliott, Ellen N.; Uyar, Asli; Zhu, Stella; Williams, Adam] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Kumar, Dinesh B. Uthaya; Williams, Adam] Univ Connecticut, Ctr Hlth, Dept Genet & Genom Sci, Farmington, CT 06032 USA; [Makiya, Michelle A.; Klion, Amy D.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Dunagin, Margaret C.; Raj, Arjun] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Harman, Christian C. D.; Bailis, Will; Stein, Judith; Hughes, Cynthia; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA; [Harman, Christian C. D.; Stein, Judith; Hughes, Cynthia; Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Goff, Loyal A.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Goff, Loyal A.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; [Rinn, John L.] Harvard Med Sch, Biol & Biomed Sci, Boston, MA 02115 USA; [Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Henao-Mejia, Jorge] Childrens Hosp Philadelphia, Div Transplant Immunol, Philadelphia, PA 19104 USA; [Spencer, Sean P.] Massachusetts Gen Hosp, Dept Med, 55 Fruit St, Boston, MA 02114 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Jackson Laboratory; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Yale University; Howard Hughes Medical Institute; Yale University; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Harvard University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Massachusetts General Hospital	Henao-Mejia, J (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; Henao-Mejia, J (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Williams, A (corresponding author), Jackson Lab Genom Med, Farmington, CT 06032 USA.; Williams, A (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Genom Sci, Farmington, CT 06032 USA.; Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.; Flavell, RA (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06510 USA.; Henao-Mejia, J (corresponding author), Childrens Hosp Philadelphia, Div Transplant Immunol, Philadelphia, PA 19104 USA.	adam.williams@jax.org; richard.flavell@yale.edu; jhena@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; Zhu, Shu/P-6163-2018	Zhu, Shu/0000-0002-8163-0869; Mowel, Walter/0000-0003-2393-4300; Raj, Arjun/0000-0002-2915-6960; McCright, Sam/0000-0002-4295-9290; Uthaya Kumar, Dinesh Babu/0000-0001-7210-5811; Goff, Loyal/0000-0003-2875-451X; Spencer, Sean/0000-0002-7328-5399; Makiya, Michelle/0000-0002-5673-3815	Children's Hospital of Philadelphia; IFI; IDOM; COE at the University of Pennsylvania; NIH NIAID [1R21AI110776-01]; Howard Hughes Medical Institute; NIH NIDDK [T32-DK00778017]; NIH NRSA [F30-DK094708]; NSF [1350601]; Division of Intramural Research, NIAID, NIH;  [T32-AI05542803];  [1DP2OD008514];  [1R33EB019767]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055428, R21AI110776, F31AI124538, ZIAAI001130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R33EB019767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780, F30DK094708] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008514] Funding Source: NIH RePORTER	Children's Hospital of Philadelphia; IFI; IDOM; COE at the University of Pennsylvania; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank several of our colleagues for critically reading our manuscript and their suggestions. J.H.-M. was supported by the Children's Hospital of Philadelphia, the IFI and IDOM pilot projects, and the COE at the University of Pennsylvania (J.H.-M.); A.W. and R.A.F. by NIH NIAID 1R21AI110776-01; C.C.D.H. and R.A.F by Howard Hughes Medical Institute; J.J.K. by NIH NIDDK T32-DK00778017; S.P.S. by NIH NRSA F30-DK094708; W.K.M. by T32-AI05542803; A.R. and M.C.D. by New Innovator 1DP2OD008514, 1R33EB019767, NSF CAREER 1350601. This work was funded in part by the Division of Intramural Research, NIAID, NIH (M.A.M. and A.D.K.)	Bouffi C, 2015, J IMMUNOL, V195, P2683, DOI 10.4049/jimmunol.1500510; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Csorba T, 2014, P NATL ACAD SCI USA, V111, P16160, DOI 10.1073/pnas.1419030111; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Henao-Mejia J., 2016, COLD SPRING HARB PRO; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Luo M, 2015, CELL STEM CELL, V16, P426, DOI 10.1016/j.stem.2015.02.002; Maass PG, 2012, J CLIN INVEST, V122, P3990, DOI 10.1172/JCI65508; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Paschos K, 2012, NUCLEIC ACIDS RES, V40, P7233, DOI 10.1093/nar/gks391; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Simon HU, 2010, J ALLERGY CLIN IMMUN, V126, P45, DOI 10.1016/j.jaci.2010.03.042; Villunger A, 2003, BLOOD, V101, P2393, DOI 10.1182/blood-2002-07-2132; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Xing Z, 2014, CELL, V159, P1110, DOI 10.1016/j.cell.2014.10.013; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang H, 2014, J CELL BIOL, V204, P61, DOI 10.1083/jcb.201304152; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	26	170	177	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					239	+		10.1038/nature19346	http://dx.doi.org/10.1038/nature19346			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27525555	Green Accepted			2022-12-24	WOS:000382539100049
J	Huang, PX; Nedelcu, D; Watanabe, M; Jao, C; Kim, Y; Liu, J; Salic, A				Huang, Pengxiang; Nedelcu, Daniel; Watanabe, Miyako; Jao, Cindy; Kim, Youngchang; Liu, Jing; Salic, Adrian			Cellular Cholesterol Directly Activates Smoothened in Hedgehog Signaling	CELL			English	Article							PRIMARY CILIUM; PROTEIN; CELLS; RECEPTOR; PATHWAY; BINDING; OXYSTEROLS; MODULATION; MECHANISM; COMPLEX	In vertebrates, sterols are necessary for Hedgehog signaling, a pathway critical in embryogenesis and cancer. Sterols activate the membrane protein Smoothened by binding its extracellular, cysteine-rich domain (CRD). Major unanswered questions concern the nature of the endogenous, activating sterol and the mechanism by which it regulates Smoothened. We report crystal structures of CRD complexed with sterols and alone, revealing that sterols induce a dramatic conformational change of the binding site, which is sufficient for Smoothened activation and is unique among CRD-containing receptors. We demonstrate that Hedgehog signaling requires sterol binding to Smoothened and define key residues for sterol recognition and activity. We also show that cholesterol itself binds and activates Smoothened. Furthermore, the effect of oxysterols is abolished in Smoothened mutants that retain activation by cholesterol and Hedgehog. We propose that the endogenous Smoothened activator is cholesterol, not oxysterols, and that vertebrate Hedgehog signaling controls Smoothened by regulating its access to cholesterol.	[Huang, Pengxiang; Nedelcu, Daniel; Watanabe, Miyako; Jao, Cindy; Liu, Jing; Salic, Adrian] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Kim, Youngchang] Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA	Harvard University; Harvard Medical School; United States Department of Energy (DOE); Argonne National Laboratory	Salic, A (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	asalic@hms.harvard.edu	Liu, Jing/C-9666-2014; Salic, Adrian/GXG-1611-2022	Liu, Jing/0000-0001-9513-3591; Kim, Youngchang/0000-0002-1610-4889	NIH [RO1 GM092924, GM110041]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110041, R01GM092924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants RO1 GM092924 and GM110041 to A.S. We thank members of the Salic lab for helpful discussions and members of the Structural Biology Center at Argonne National Laboratory for help with data collection at the 19-ID beam line.	Aanstad P, 2009, CURR BIOL, V19, P1034, DOI 10.1016/j.cub.2009.04.053; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Bazan JF, 2009, CELL, V138, P1055, DOI 10.1016/j.cell.2009.09.006; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Carroll JN, 1998, CHEM PHYS LIPIDS, V94, P209, DOI 10.1016/S0009-3084(98)00058-9; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Dorn KV, 2012, DEV CELL, V23, P823, DOI 10.1016/j.devcel.2012.07.004; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; GIMPL G, 1995, BIOCHEMISTRY-US, V34, P13794, DOI 10.1021/bi00042a010; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jao CY, 2015, CHEMBIOCHEM, V16, P611, DOI 10.1002/cbic.201402715; Kim WK, 2007, J BONE MINER RES, V22, P1711, DOI 10.1359/JBMR.070710; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Myers BR, 2013, DEV CELL, V26, P346, DOI 10.1016/j.devcel.2013.07.015; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Nedelcu D, 2013, NAT CHEM BIOL, V9, P557, DOI [10.1038/NCHEMBIO.1290, 10.1038/nchembio.1290]; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tukachinsky H, 2012, CELL REPORTS, V2, P308, DOI 10.1016/j.celrep.2012.07.010; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	44	223	229	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1176	+		10.1016/j.cell.2016.08.003	http://dx.doi.org/10.1016/j.cell.2016.08.003			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27545348	Green Accepted, Bronze			2022-12-24	WOS:000382259500015
J	Evrony, GD				Evrony, Gilad D.			A Wild Rotation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER; DISEASE; HUMANS; DAMAGE; VIRUS; HEART		[Evrony, Gilad D.] Harvard Med Sch, Boston, MA 02115 USA; [Evrony, Gilad D.] Mt Sinai Hosp, New York, NY 10029 USA	Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Evrony, GD (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Evrony, GD (corresponding author), Mt Sinai Hosp, New York, NY 10029 USA.	g.evrony@gmail.com		Evrony, Gilad/0000-0001-7621-2630	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32GM007753, T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abegglen LM, 2015, JAMA-J AM MED ASSOC, V314, P1850, DOI 10.1001/jama.2015.13134; Davis BW, 2014, ILAR J, V55, P59, DOI 10.1093/ilar/ilu017; RACE GJ, 1959, CIRCULATION, V19, P928, DOI 10.1161/01.CIR.19.6.928; Stenvinkel P, 2013, KIDNEY INT, V83, P207, DOI 10.1038/ki.2012.396; SUMMERS J, 1978, P NATL ACAD SCI USA, V75, P4533, DOI 10.1073/pnas.75.9.4533; Susic D, 2011, CARDIORENAL MED, V1, P139, DOI 10.1159/000329334; Varki N, 2009, EVOL APPL, V2, P101, DOI 10.1111/j.1752-4571.2008.00064.x; Weiss RA, 2011, J EXP MED, V208, P2351, DOI 10.1084/jem.20112160; Wood JD, 1998, DIGEST DIS SCI, V43, P1443, DOI 10.1023/A:1018842210330	9	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					713	714		10.1001/jama.2016.4994	http://dx.doi.org/10.1001/jama.2016.4994			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533153	Green Accepted			2022-12-24	WOS:000381514800014
J	Mitchell, SL; Mor, V; Gozalo, PL; Servadio, JL; Teno, JM				Mitchell, Susan L.; Mor, Vincent; Gozalo, Pedro L.; Servadio, Joseph L.; Teno, Joan M.			Tube Feeding in US Nursing Home Residents With Advanced Dementia, 2000-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Mitchell, Susan L.] Harvard Med Sch, Hebrew SeniorLife Inst Aging Res, Boston, MA USA; [Mor, Vincent; Gozalo, Pedro L.; Servadio, Joseph L.] Brown Univ, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA; [Teno, Joan M.] Univ Washington, Cambia Palliat Care Ctr Excellence, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Hebrew SeniorLife; Brown University; University of Washington; University of Washington Seattle	Mitchell, SL (corresponding author), Hebrew SeniorLife Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.	smitchell@hsl.harvard.edu		Servadio, Joseph/0000-0002-9988-5712	NATIONAL INSTITUTE ON AGING [K24AG033640, P01AG027296] Funding Source: NIH RePORTER; NIA NIH HHS [P01AG02729, K24AG033640, K24 AG033640, P01 AG027296] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cegelka A, 2014, J AM GERIATR SOC, V62, P1590, DOI 10.1111/jgs.12924; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Sampson EL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007209.pub2; Teno JM, 2012, J AM GERIATR SOC, V60, P1918, DOI 10.1111/j.1532-5415.2012.04148.x; Thomas KS, 2014, J AGING HEALTH, V26, P250, DOI 10.1177/0898264313513611	6	74	75	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					769	770		10.1001/jama.2016.9374	http://dx.doi.org/10.1001/jama.2016.9374			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533163	Green Accepted, Bronze			2022-12-24	WOS:000381514800024
J	Kojima, Y; Volkmer, JP; McKenna, K; Civelek, M; Lusis, AJ; Miller, CL; Direnzo, D; Nanda, V; Ye, JQ; Connolly, AJ; Schadt, EE; Quertermous, T; Betancur, P; Maegdefessel, L; Matic, LP; Hedin, U; Weissman, IL; Leeper, NJ				Kojima, Yoko; Volkmer, Jens-Peter; McKenna, Kelly; Civelek, Mete; Lusis, Aldons Jake; Miller, Clint L.; Direnzo, Daniel; Nanda, Vivek; Ye, Jianqin; Connolly, Andrew J.; Schadt, Eric E.; Quertermous, Thomas; Betancur, Paola; Maegdefessel, Lars; Matic, Ljubica Perisic; Hedin, Ulf; Weissman, Irving L.; Leeper, Nicholas J.			CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis	NATURE			English	Article							SMOOTH-MUSCLE-CELLS; E-DEFICIENT MICE; APOPTOTIC CELLS; CAROTID ATHEROSCLEROSIS; PLAQUE INSTABILITY; MERTK RECEPTOR; LESIONS; MOUSE; GENE; CD47	Atherosclerosis is the disease process that underlies heart attack and stroke(1). Advanced lesions at risk of rupture are characterized by the pathological accumulation of diseased vascular cells and apoptotic cellular debris(2). Why these cells are not cleared remains unknown(3). Here we show that atherogenesis is associated with upregulation of CD47, a key anti-phagocytic molecule that is known to render malignant cells resistant to programmed cell removal, or 'efferocytosis'(4-7). We find that administration of CD47-blocking antibodies reverses this defect in efferocytosis, normalizes the clearance of diseased vascular tissue, and ameliorates atherosclerosis in multiple mouse models. Mechanistic studies implicate the pro-atherosclerotic factor TNF-alpha as a fundamental driver of impaired programmed cell removal, explaining why this process is compromised in vascular disease. Similar to recent observations in cancer(5), impaired efferocytosis appears to play a pathogenic role in cardiovascular disease, but is not a fixed defect and may represent a novel therapeutic target.	[Kojima, Yoko; Direnzo, Daniel; Nanda, Vivek; Ye, Jianqin; Leeper, Nicholas J.] Stanford Univ, Dept Surg, Sch Med, Div Vasc Surg, Stanford, CA 94305 USA; [Volkmer, Jens-Peter; McKenna, Kelly; Betancur, Paola; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Civelek, Mete; Lusis, Aldons Jake] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Miller, Clint L.; Quertermous, Thomas; Leeper, Nicholas J.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Connolly, Andrew J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Schadt, Eric E.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Maegdefessel, Lars] Karolinska Inst, Dept Med, Stockholm, Sweden; [Matic, Ljubica Perisic; Hedin, Ulf] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University; Stanford University; Icahn School of Medicine at Mount Sinai; Karolinska Institutet; Karolinska Institutet	Leeper, NJ (corresponding author), Stanford Univ, Dept Surg, Sch Med, Div Vasc Surg, Stanford, CA 94305 USA.; Leeper, NJ (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	nleeper@stanford.edu	ye, jian/GQH-3702-2022; Nanda, Vivek/L-8189-2019; Miller, Clint/I-4370-2019; Maegdefessel, Lars/AAW-8243-2020; Maegdefessel, Lars/C-2955-2015	Nanda, Vivek/0000-0003-1724-7168; Civelek, Mete/0000-0002-8141-0284; McKenna, Kelly/0000-0002-9158-822X; Betancur, Paola/0000-0001-9011-4746; Quertermous, Thomas/0000-0002-7645-9067; Hedin, Ulf/0000-0001-9212-3945; Maegdefessel, Lars/0000-0001-5228-2634	National Institutes of Health [R01HL12522401, R01HL12337001, U01HL099999]; Ludwig Center at Stanford; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL120757, U01HL099999, T32HL098049, R01HL109512, R01HL125224, R01HL123370, T32HL094274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center at Stanford; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (R01HL12522401 and R01HL12337001 to NJL and U01HL099999 to ILW) and the Ludwig Center at Stanford. The authors wish to acknowledge J. Knowles for his critical review of the manuscript.	Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Ashley EA, 2006, CIRCULATION, V114, P2644, DOI 10.1161/CIRCULATIONAHA.106.637025; Back M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chen YC, 2013, CIRC RES, V113, P252, DOI 10.1161/CIRCRESAHA.113.301562; Chung IM, 1998, AM J PATHOL, V152, P913; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Garbin U, 2013, CARDIOVASC RES, V97, P125, DOI 10.1093/cvr/cvs301; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Greenberg JD, 2012, NAT REV RHEUMATOL, V8, P13, DOI 10.1038/nrrheum.2011.168; Hagg S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000754; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hopkins PN, 2013, PHYSIOL REV, V93, P1317, DOI 10.1152/physrev.00004.2012; Isenberg JS, 2006, J BIOL CHEM, V281, P26069, DOI 10.1074/jbc.M605040200; Jun J, 2010, ATHEROSCLEROSIS, V209, P381, DOI 10.1016/j.atherosclerosis.2009.10.017; Kinchen JM, 2008, CURR BIOL, V18, pR521, DOI 10.1016/j.cub.2008.04.058; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Kojima Y, 2014, J CLIN INVEST, V124, P1083, DOI 10.1172/JCI70391; Leeper NJ, 2013, ARTERIOSCL THROM VAS, V33, pE1, DOI 10.1161/ATVBAHA.112.300399; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137345; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Perisic L, 2016, J INTERN MED, V279, P293, DOI 10.1111/joim.12448; Perisic L, 2013, ARTERIOSCL THROM VAS, V33, P2432, DOI 10.1161/ATVBAHA.113.301743; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Saksi J, 2011, J MOL MED, V89, P1015, DOI 10.1007/s00109-011-0773-z; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; World Health Organization, 2014, TOP 10 CAUS DEATH; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]	42	292	306	17	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					86	+		10.1038/nature18935	http://dx.doi.org/10.1038/nature18935			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27437576	Green Accepted, Green Submitted			2022-12-24	WOS:000380999200035
J	McCarthy, M				McCarthy, Michael			US officials issue travel alert for Miami area as Zika cases rise to 15	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		US Centers for Disease Control and Prevention, 2016, ADV PEOPL LIV TRAV W	1	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2016	354								i4298	10.1136/bmj.i4298	http://dx.doi.org/10.1136/bmj.i4298			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CS	27488825	Bronze, Green Published			2022-12-24	WOS:000381080600006
J	Spribille, T; Tuovinen, V; Resl, P; Vanderpool, D; Wolinski, H; Aime, MC; Schneider, K; Stabentheiner, E; Toome-Heller, M; Thor, G; Mayrhofer, H; Johannesson, H; McCutcheon, JP				Spribille, Toby; Tuovinen, Veera; Resl, Philipp; Vanderpool, Dan; Wolinski, Heimo; Aime, M. Catherine; Schneider, Kevin; Stabentheiner, Edith; Toome-Heller, Merje; Thor, Goran; Mayrhofer, Helmut; Johannesson, Hanna; McCutcheon, John P.			Basidiomycete yeasts in the cortex of ascomycete macrolichens	SCIENCE			English	Article							PARMELIACEAE; CLASSIFICATION; FUNGI; PHYLOGENY; SYMBIOSES; LICHENS	For over 140 years, lichens have been regarded as a symbiosis between a single fungus, usually an ascomycete, and a photosynthesizing partner. Other fungi have long been known to occur as occasional parasites or endophytes, but the one lichen-one fungus paradigm has seldom been questioned. Here we show that many common lichens are composed of the known ascomycete, the photosynthesizing partner, and, unexpectedly, specific basidiomycete yeasts. These yeasts are embedded in the cortex, and their abundance correlates with previously unexplained variations in phenotype. Basidiomycete lineages maintain close associations with specific lichen species over large geographical distances and have been found on six continents. The structurally important lichen cortex, long treated as a zone of differentiated ascomycete cells, appears to consistently contain two unrelated fungi.	[Spribille, Toby; Resl, Philipp; Schneider, Kevin; Stabentheiner, Edith; Mayrhofer, Helmut] Graz Univ, Inst Plant Sci, NAWI Graz, A-8010 Graz, Austria; [Spribille, Toby; Vanderpool, Dan; McCutcheon, John P.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Tuovinen, Veera; Johannesson, Hanna] Uppsala Univ, Dept Organismal Biol, Norbyvagen 18D, S-75236 Uppsala, Sweden; [Tuovinen, Veera; Thor, Goran] Swedish Univ Agr Sci, Dept Ecol, POB 7044, SE-75007 Uppsala, Sweden; [Wolinski, Heimo] Graz Univ, Inst Mol Biosci, BioTechMed Graz, A-8010 Graz, Austria; [Aime, M. Catherine; Toome-Heller, Merje] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [McCutcheon, John P.] Canadian Inst Adv Res, Program Integrated Microbial Biodivers, Toronto, ON, Canada; [Schneider, Kevin] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Thor, Goran] Minist Primary Ind, Plant Hlth & Environm Lab, Auckland, New Zealand	University of Graz; University of Montana System; University of Montana; Uppsala University; Swedish University of Agricultural Sciences; University of Graz; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Canadian Institute for Advanced Research (CIFAR); University of Glasgow	Spribille, T (corresponding author), Graz Univ, Inst Plant Sci, NAWI Graz, A-8010 Graz, Austria.; Spribille, T (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	toby.spribille@mso.umt.edu	Tuovinen, Veera/GYA-4518-2022; Aime, Mary/S-7621-2018	Vanderpool, Dan/0000-0002-6856-5636; Aime, Mary/0000-0001-8742-6685; Wolinski, Heimo/0000-0002-1583-6092; Toome-Heller, Merje/0000-0001-9177-7218; Tuovinen Nogerius, Veera/0000-0002-8558-3289	University of Montana; Austrian Science Fund grant [P25237]; NSF [IOS-1256680, IOS-1553529]; NSF (EPSCoR award) [NSF-IIA-1443108]; NASA Astrobiology Institute [NNA15BB04A]; NSF Graduate Research Fellowship [DGE-1313190]; Swedish University of Agricultural Sciences Council [2014.3.2.5-5149]; Stiftelsen Oscar och Lili Lamms minne [DO2011-0022]; U.S. National Park Service as part of CESU (Cooperative Ecosystem Studies Units) [P11AC90513]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Direct For Biological Sciences [1256680] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1553529] Funding Source: National Science Foundation; Office of Integrative Activities [1443108] Funding Source: National Science Foundation; Austrian Science Fund (FWF) [P 25237] Funding Source: researchfish	University of Montana; Austrian Science Fund grant; NSF(National Science Foundation (NSF)); NSF (EPSCoR award); NASA Astrobiology Institute; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Swedish University of Agricultural Sciences Council; Stiftelsen Oscar och Lili Lamms minne; U.S. National Park Service as part of CESU (Cooperative Ecosystem Studies Units); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This project was supported by an incubation grant from the University of Montana to J.P.M. and T.S.; by an Austrian Science Fund grant (P25237) to T.S., H.M., and P.R.; by NSF (IOS-1256680, IOS-1553529, and EPSCoR award NSF-IIA-1443108) and NASA Astrobiology Institute (NNA15BB04A) grants to J.P.M.; by a NSF Graduate Research Fellowship (DGE-1313190) to D.V.; by a grant from the Swedish University of Agricultural Sciences Council for Ph.D. Education (2014.3.2.5-5149) to V.T.; and by a grant (DO2011-0022) from Stiftelsen Oscar och Lili Lamms minne to G.T. Specimens from Glacier Bay National Park, Alaska, were collected with the support of the U.S. National Park Service as part of CESU (Cooperative Ecosystem Studies Units) project P11AC90513. We thank D. Armaleo and F. Lutzoni of Duke University for allowing us to use unpublished data from the Cladonia grayi proteome, as well as P. Dyer, P. Crittenden, and D. Archer (University of Nottingham, UK) for access to unpublished data from the Xanthoria parietina genome project, which is conducted together with the U.S. Department of Energy Joint Genome Institute (supported by the Office of Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231). We thank T. Goward, M. Grube, P. Lukasik, J. T. Van Leuven, F. Fernandez-Mendoza, A. Millanes, V. Wagner, and M. Wedin for discussions and L. Bergstrom, C. Gueidan, J. Hermansson, H. Holien, B. Kanz, E. Lagostina, S. Leavitt, B. McCune, J. Nascimbene, C. Printzen, T. Wheeler, and D. Winston for field support and fresh material. C. Bjork, S. Gunnarsson, L. Herritt, M. Hiltunen, W. Obermayer, A. de los Rios, and E. Timdal provided technical help, advice, and photos. We acknowledge the Purdue University Genomic Core Facility for generating transcriptomic data for Cystobasidium minutum and the Institute of Molecular Biosciences-Graz Microscopy Core Facility and S. Kohlwein for providing infrastructural support for imaging. Data are available under accession numbers SRP076577 and SRP073687 in the National Center for Biotechnology Information (NCBI) Sequence Read Archive (transcriptomes), NCBI nucleotide accession numbers KU948728 to KU948928 (single-locus DNA sequences), and the Dryad digital repository at http://dx.doi.org/10.5061/dryad.7qv72 (alignments, scripts, and tree files).	Ahmadjian V, 1993, THE LICHEN SYMBIOSIS; Aime MC, 2006, MYCOLOGIA, V98, P896, DOI 10.3852/mycologia.98.6.896; de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; ANGLESEA D, 1982, LICHENOLOGIST, V14, P29, DOI 10.1017/S0024282982000048; Arnold Norbert, 1996, Zeitschrift fuer Mykologie, V62, P69; Aschenbrenner IA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00180; Bates ST, 2012, LICHENOLOGIST, V44, P137, DOI 10.1017/S0024282911000648; Boluda CG, 2015, LICHENOLOGIST, V47, P279, DOI 10.1017/S0024282915000274; Brodo I.M., 1977, OPERA BOT, V42, P1; Crespo A, 2010, TAXON, V59, P1735, DOI 10.1002/tax.596008; CULBERSON WILLIAM L., 1961, TAXON, V10, P161, DOI 10.2307/1216004; De Bary A., 1879, ERSCHEINUNG SYMBIOSE; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; HALE ME, 1981, LICHENOLOGIST, V13, P1, DOI 10.1017/S0024282981000030; HAWKSWORTH DL, 1988, BOT J LINN SOC, V96, P3, DOI 10.1111/j.1095-8339.1988.tb00623.x; HONEGGER R, 1993, NEW PHYTOL, V125, P659, DOI 10.1111/j.1469-8137.1993.tb03916.x; Honegger R, 2012, FUNGAL ASS, P287, DOI [10.1007/978-3-642-30826-0_15, DOI 10.1007/978-3-642-30826-0_15]; Kalle Elena, 2014, Biomol Detect Quantif, V2, P11; Lindgren H, 2014, LICHENOLOGIST, V46, P681, DOI 10.1017/S0024282914000279; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Millanes AM, 2016, FUNGAL BIOL-UK, V120, P1468, DOI 10.1016/j.funbio.2015.12.003; Olafsdottir ES, 2001, PLANTA MED, V67, P199, DOI 10.1055/s-2001-12012; PETRINI O, 1990, MYCOLOGIA, V82, P444, DOI 10.2307/3760015; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sprib Cyphobasidiales T., 2015, FUNGAL BIOL, P4, DOI [10.1016/j.funbio.2015.12.003, DOI 10.1016/J.FUNBIO.2015.12.003]; Thell A, 2012, NORD J BOT, V30, P641, DOI 10.1111/j.1756-1051.2012.00008.x; U'Ren JM, 2010, MICROB ECOL, V60, P340, DOI 10.1007/s00248-010-9698-2; Velmala S, 2009, LICHENOLOGIST, V41, P231, DOI 10.1017/S0024282909008573; Wang QM, 2015, STUD MYCOL, P27, DOI 10.1016/j.simyco.2015.08.002; Wang QM, 2015, STUD MYCOL, P149, DOI 10.1016/j.simyco.2015.12.002	30	285	313	10	1090	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					488	492		10.1126/science.aaf8287	http://dx.doi.org/10.1126/science.aaf8287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27445309	Green Accepted			2022-12-24	WOS:000380583600041
J	Boke, E; Ruer, M; Wuhr, M; Coughlin, M; Lemaitre, R; Gygi, SP; Alberti, S; Drechsel, D; Hyman, AA; Mitchison, TJ				Boke, Elvan; Ruer, Martine; Wuehr, Martin; Coughlin, Margaret; Lemaitre, Regis; Gygi, Steven P.; Alberti, Simon; Drechsel, David; Hyman, Anthony A.; Mitchison, Timothy J.			Amyloid-like Self-Assembly of a Cellular Compartment	CELL			English	Article							XENOPUS-LAEVIS; GERM PLASM; MITOCHONDRIAL CLOUD; FIBRIL FORMATION; BALBIANI BODY; MOUSE OOCYTES; NEURODEGENERATION; LOCALIZATION; DETERMINANTS; AGGREGATION	Most vertebrate oocytes contain a Balbiani body, a large, non-membrane-bound compartment packed with RNA, mitochondria, and other organelles. Little is known about this compartment, though it specifies germline identity in many non-mammalian vertebrates. We show Xvelo, a disordered protein with an N-terminal prion-like domain, is an abundant constituent of Xenopus Balbiani bodies. Disruption of the prion-like domain of Xvelo, or substitution with a prion-like domain from an unrelated protein, interferes with its incorporation into Balbiani bodies in vivo. Recombinant Xvelo forms amyloid-like networks in vitro. Amyloid-like assemblies of Xvelo recruit both RNA and mitochondria in binding assays. We propose that Xenopus Balbiani bodies form by amyloid-like assembly of Xvelo, accompanied by co-recruitment of mitochondria and RNA. Prion-like domains are found in germ plasm organizing proteins in other species, suggesting that Balbiani body formation by amyloid-like assembly could be a conserved mechanism that helps oocytes function as long-lived germ cells.	[Boke, Elvan; Wuehr, Martin; Coughlin, Margaret; Mitchison, Timothy J.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Ruer, Martine; Lemaitre, Regis; Alberti, Simon; Drechsel, David; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Wuehr, Martin; Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Max Planck Society; Harvard University; Harvard Medical School	Boke, E (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	elvan_boke@hms.harvard.edu	Wühr, Martin/A-2447-2009; Boke, Elvan/O-6725-2017; Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Alberti, Simon/ABB-8277-2021; Alberti, Simon/B-2822-2017	Wühr, Martin/0000-0002-0244-8947; Hyman, Anthony A/0000-0003-3664-154X; Alberti, Simon/0000-0003-4017-6505	Protein Expression facility of the MPI-CBG; Electron Microscopy facility of the MPI-CBG; Image Processing facility of the MPI-CBG; NIH [R01-GM103785, GM39565]; Charles A. King Trust Postdoctoral Fellowship; MaxSynBio consortium - Federal Ministry of Education and Research of Germany; MaxSynBio consortium - Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039565, R01GM103785, R01GM039565] Funding Source: NIH RePORTER	Protein Expression facility of the MPI-CBG; Electron Microscopy facility of the MPI-CBG; Image Processing facility of the MPI-CBG; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust Postdoctoral Fellowship; MaxSynBio consortium - Federal Ministry of Education and Research of Germany; MaxSynBio consortium - Max Planck Society(Max Planck Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the T.J.M. and A.A.H. labs, especially Avinash Patel for helpful discussions, Andrei Pozniakovski for cloning, and Christine Field for help in making extracts. We would like to thank Doris Richter and Sonja Kroschwald for technical assistance. We are grateful to the Protein Expression, Electron Microscopy and Image Processing facilities of the MPI-CBG for their support. We would also like to thank the Nikon Imaging Center at Harvard Medical School for microscopy support. Proteomic analysis was supported by NIH grant R01-GM103785 (PI Marc W. Kirschner). M.W. was supported by the Charles A. King Trust Postdoctoral Fellowship. This work was supported by the MaxSynBio consortium, which is jointly funded by the Federal Ministry of Education and Research of Germany and the Max Planck Society (to A.A.H.) and NIH grant GM39565 (to T.J.M.).	Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; ALMUKHTAR KA, 1971, J EMBRYOL EXP MORPH, V26, P195; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; BALINSKY B. I., 1963, ACTA EMBRYOL ET MORPHOL EXPTL, V6, P55; Berchowitz LE, 2015, CELL, V163, P406, DOI 10.1016/j.cell.2015.08.060; BILLETT FS, 1976, J EMBRYOL EXP MORPH, V36, P697; Bontems F, 2009, CURR BIOL, V19, P414, DOI 10.1016/j.cub.2009.01.038; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; England JL, 2011, ANNU REV PHYS CHEM, V62, P257, DOI 10.1146/annurev-physchem-032210-103531; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Field CM, 2014, METHOD ENZYMOL, V540, P399, DOI 10.1016/B978-0-12-397924-7.00022-4; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gupta T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001073; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Heim AE, 2014, DEVELOPMENT, V141, P842, DOI 10.1242/dev.090449; HERTIG AT, 1968, AM J ANAT, V122, P107, DOI 10.1002/aja.1001220107; HERTIG AT, 1967, J CELL BIOL, V34, P647, DOI 10.1083/jcb.34.2.647; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Houston DW, 2000, CURR TOP DEV BIOL, V50, P155, DOI 10.1016/S0070-2153(00)50008-8; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; KLOC M, 1995, DEVELOPMENT, V121, P287; Kogo N, 2011, DEV BIOL, V349, P462, DOI 10.1016/j.ydbio.2010.11.021; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Lancaster AK, 2014, BIOINFORMATICS, V30, P2501, DOI 10.1093/bioinformatics/btu310; Lei L, 2016, SCIENCE, V352, P95, DOI 10.1126/science.aad2156; Lesch BJ, 2012, NAT REV GENET, V13, P781, DOI 10.1038/nrg3294; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; Marlow FL, 2008, DEV BIOL, V321, P40, DOI 10.1016/j.ydbio.2008.05.557; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Steger K, 2001, ANAT EMBRYOL, V203, P323, DOI 10.1007/s004290100176; Toombs JA, 2012, P NATL ACAD SCI USA, V109, P6519, DOI 10.1073/pnas.1119366109; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Wickner RB, 2013, BIOCHEMISTRY-US, V52, P1514, DOI 10.1021/bi301686a; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Zhou Y, 1996, DEVELOPMENT, V122, P2947	48	201	206	6	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					637	650		10.1016/j.cell.2016.06.051	http://dx.doi.org/10.1016/j.cell.2016.06.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471966	Bronze, Green Accepted			2022-12-24	WOS:000380546500015
J	Gamble, CE; Brule, CE; Dean, KM; Fields, S; Grayhack, EJ				Gamble, Caitlin E.; Brule, Christina E.; Dean, Kimberly M.; Fields, Stanley; Grayhack, Elizabeth J.			Adjacent Codons Act in Concert to Modulate Translation Efficiency in Yeast	CELL			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; QUALITY-CONTROL; IN-VIVO; PROTEIN TRANSLATION; GENE-EXPRESSION; BIAS; RIBOSOME; ELONGATION; GENOME	Translation elongation efficiency is largely thought of as the sum of decoding efficiencies for individual codons. Here, we find that adjacent codon pairs modulate translation efficiency. Deploying an approach in Saccharomyces cerevisiae that scored the expression of over 35,000 GFP variants in which three adjacent codons were randomized, we have identified 17 pairs of adjacent codons associated with reduced expression. For many pairs, codon order is obligatory for inhibition, implying a more complex interaction than a simple additive effect. Inhibition mediated by adjacent codons occurs during translation itself as GFP expression is restored by increased tRNA levels or by non-native tRNAs with exact-matching anticodons. Inhibition operates in endogenous genes, based on analysis of ribosome profiling data. Our findings suggest translation efficiency is modulated by an interplay between tRNAs at adjacent sites in the ribosome and that this concerted effect needs to be considered in predicting the functional consequences of codon choice.	[Gamble, Caitlin E.; Fields, Stanley] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Gamble, Caitlin E.; Fields, Stanley] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Gamble, Caitlin E.] Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Brule, Christina E.; Dean, Kimberly M.; Grayhack, Elizabeth J.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Brule, Christina E.; Dean, Kimberly M.; Grayhack, Elizabeth J.] Univ Rochester, Ctr RNA Biol, Rochester, NY 14642 USA; [Fields, Stanley] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Dean, Kimberly M.] BD Biosci, 2350 Qume Dr, San Jose, CA 95131 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Rochester; University of Rochester; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fields, S (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Fields, S (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.; Grayhack, EJ (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.; Grayhack, EJ (corresponding author), Univ Rochester, Ctr RNA Biol, Rochester, NY 14642 USA.; Fields, S (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	fields@uw.edu; elizabeth_grayhack@urmc.rochester.edu	Grayhack, Elizabeth J/G-4386-2012	Grayhack, Elizabeth J/0000-0003-2400-5490	NSF [MCB-1329545]; NIH [1P41 GM103533]; NIH T32 Training Grant [GM068411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, P41GM103533] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1329545] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Eric Phizicky, Andrew Wolf, Scott Butler, Gloria Culver, Adam Geballe, David Mathews, David Morris, and Yi-Tao Yu for discussions and comments on the manuscript, Jeffrey Hussman for assistance with ribosome profiling data, Josh Hatfield, Shannon Schmitt, Blake Bentley, and Erin Eidschun for assistance with experiments, XiaoJu Zhang and David Mathews for initial help analyzing codon use in the yeast genome, the URMC Flow Cytometry Resource and NCCR (1S10RR0292299-01) for technical support. This work was supported by an NSF grant (MCB-1329545) (to E.J.G.) and an NIH grant (1P41 GM103533) (to S.F.). C.E.B. was also supported by an NIH T32 Training Grant (GM068411), and C.E.G. was supported by an NSF Fellowship. S.F. is an investigator of the Howard Hughes Medical Institute.	Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; BEGGS JD, 1978, NATURE, V275, P104, DOI 10.1038/275104a0; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Chevance FFV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004392; Chu D, 2014, EMBO J, V33, P21, DOI 10.1002/embj.201385651; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Dean KM, 2012, RNA, V18, P2335, DOI 10.1261/rna.035907.112; Demeshkina N, 2010, CURR OPIN STRUC BIOL, V20, P325, DOI 10.1016/j.sbi.2010.03.002; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; Fedorov A, 2002, NUCLEIC ACIDS RES, V30, P1192, DOI 10.1093/nar/30.5.1192; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Hussmann JA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005732; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/nmeth.2834, 10.1038/NMETH.2834]; Lareau LF, 2014, ELIFE, V3, DOI 10.7554/eLife.01257; Letzring DP, 2013, RNA, V19, P1208, DOI 10.1261/rna.039446.113; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Moura G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r28; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; PEDERSEN S, 1984, EMBO J, V3, P2895, DOI 10.1002/j.1460-2075.1984.tb02227.x; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Stadler M, 2011, RNA, V17, P2063, DOI 10.1261/rna.02890211; Subramaniam AR, 2014, CELL, V159, P1200, DOI 10.1016/j.cell.2014.10.043; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Weatheritt RJ, 2013, SCIENCE, V342, P1325, DOI 10.1126/science.1248425; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Wolf AS, 2015, RNA, V21, P935, DOI 10.1261/rna.049080.114; Xu Y, 2013, NATURE, V495, P116, DOI 10.1038/nature11942; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	52	111	113	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					679	690		10.1016/j.cell.2016.05.070	http://dx.doi.org/10.1016/j.cell.2016.05.070			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27374328	Green Accepted, Bronze			2022-12-24	WOS:000380546500018
J	Hayakawa, K; Esposito, E; Wang, XH; Terasaki, Y; Liu, Y; Xing, CH; Ji, XM; Lo, EH				Hayakawa, Kazuhide; Esposito, Elga; Wang, Xiaohua; Terasaki, Yasukazu; Liu, Yi; Xing, Changhong; Ji, Xunming; Lo, Eng H.			Transfer of mitochondria from astrocytes to neurons after stroke	NATURE			English	Article							STROMAL CELLS; CD38; VULNERABILITY; INHIBITION; VESICLES; PROTECTS; RECOVERY	Neurons can release damaged mitochondria and transfer them to astrocytes for disposal and recycling(1). This ability to exchange mitochondria may represent a potential mode of cell-to-cell signalling in the central nervous system. Here we show that astrocytes in mice can also release functional mitochondria that enter neurons. Astrocytic release of extracellular mitochondrial particles was mediated by a calcium-dependent mechanism involving CD38 and cyclic ADP ribose signalling. Transient focal cerebral ischaemia in mice induced entry of astrocytic mitochondria into adjacent neurons, and this entry amplified cell survival signals. Suppression of CD38 signalling by short interfering RNA reduced extracellular mitochondria transfer and worsened neurological outcomes. These findings suggest a new mitochondrial mechanism of neuroglial crosstalk that may contribute to endogenous neuroprotective and neurorecovery mechanisms after stroke.	[Hayakawa, Kazuhide; Esposito, Elga; Wang, Xiaohua; Terasaki, Yasukazu; Liu, Yi; Xing, Changhong; Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Hayakawa, Kazuhide; Esposito, Elga; Wang, Xiaohua; Terasaki, Yasukazu; Liu, Yi; Xing, Changhong; Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Hayakawa, Kazuhide; Esposito, Elga; Wang, Xiaohua; Terasaki, Yasukazu; Liu, Yi; Xing, Changhong; Lo, Eng H.] Harvard Med Sch, Charlestown, MA 02129 USA; [Wang, Xiaohua; Liu, Yi; Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Cerebrovasc Res Ctr, Beijing 100053, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Capital Medical University	Hayakawa, K; Lo, EH (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Charlestown, MA 02129 USA.; Hayakawa, K; Lo, EH (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA.; Hayakawa, K; Lo, EH (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.; Ji, XM (corresponding author), Capital Med Univ, Xuanwu Hosp, Cerebrovasc Res Ctr, Beijing 100053, Peoples R China.	khayakawa1@mgh.harvard.edu; jixunming@vip.163.com; Lo@helix.mgh.harvard.edu	Ji, Xunming/AAN-3370-2021; wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341; Hayakawa, Kazuhide/0000-0002-1229-2413; Liu, Yi/0000-0002-6835-3713	National Institutes of Health (NIH); Rappaport Foundation; China National Natural Science Foundation Award For Distinguished Young Scholars; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094756] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rappaport Foundation; China National Natural Science Foundation Award For Distinguished Young Scholars; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	fThis work was supported in part by grants from the National Institutes of Health (NIH), the Rappaport Foundation, and the China National Natural Science Foundation Award For Distinguished Young Scholars. Electron microscopy was performed in the Center for Systems Biology. Cytometric assessments were supported by the Department of Pathology Flow and Image Cytometry Core. The authors thank J. Felton and J. Zwicker for assistance with qNano analysis.	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bi B, 2011, J NEUROSCI, V31, P9205, DOI 10.1523/JNEUROSCI.0518-11.2011; Bowen S, 2007, EUR J NEUROSCI, V25, P2947, DOI 10.1111/j.1460-9568.2007.05554.x; Bruzzone S, 2004, J NEUROCHEM, V89, P264, DOI 10.1111/j.1471-4159.2003.02326.x; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; Cruz FC, 2013, NAT REV NEUROSCI, V14, P743, DOI 10.1038/nrn3597; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Dehmelt L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-100; Falchi AM, 2013, HISTOCHEM CELL BIOL, V139, P221, DOI 10.1007/s00418-012-1045-x; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hayakawa K, 2012, P NATL ACAD SCI USA, V109, P7505, DOI 10.1073/pnas.1121146109; Hayakawa K, 2010, GLIA, V58, P1007, DOI 10.1002/glia.20982; Hayakawa K, 2010, J CEREBR BLOOD F MET, V30, P871, DOI 10.1038/jcbfm.2009.257; Higashida H, 2012, NEUROCHEM INT, V61, P828, DOI 10.1016/j.neuint.2012.01.030; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Levy A, 2009, J NEUROTRAUM, V26, P1521, DOI 10.1089/neu.2008.0746; Li Y, 2014, GLIA, V62, P1, DOI 10.1002/glia.22585; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Ouyang YB, 2013, GLIA, V61, P1784, DOI 10.1002/glia.22556; Proia P, 2008, INT J MOL MED, V21, P63; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Stetler RA, 2013, J CEREBR BLOOD F MET, V33, P22, DOI 10.1038/jcbfm.2012.158; Vogel R, 2011, ANAL CHEM, V83, P3499, DOI 10.1021/ac200195n; Voloboueva LA, 2007, J NEUROCHEM, V102, P1383, DOI 10.1111/j.1471-4159.2007.04634.x; Wang XF, 2001, J NEUROSCI, V21, P3322, DOI 10.1523/JNEUROSCI.21-10-03322.2001; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Xing C., 2016, PROG NEUROBIOL	37	601	629	12	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					551	+		10.1038/nature18928	http://dx.doi.org/10.1038/nature18928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27466127	Green Accepted, Green Submitted			2022-12-24	WOS:000380856600029
J	Denny, SK; Yang, D; Chuang, CH; Brady, JJ; Lim, JS; Gruner, BM; Chiou, SH; Schep, AN; Baral, J; Hamard, C; Antoine, M; Wislez, M; Kong, CS; Connolly, AJ; Park, KS; Sage, J; Greenleaf, WJ; Winslow, MM				Denny, Sarah K.; Yang, Dian; Chuang, Chen-Hua; Brady, Jennifer J.; Lim, Jing Shan; Gruner, Barbara M.; Chiou, Shin-Heng; Schep, Alicia N.; Baral, Jessika; Hamard, Cecile; Antoine, Martine; Wislez, Marie; Kong, Christina S.; Connolly, Andrew J.; Park, Kwon-Sik; Sage, Julien; Greenleaf, William J.; Winslow, Monte M.			Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility	CELL			English	Article							CELL LUNG-CANCER; TRANSCRIPTION FACTORS; NUCLEAR FACTOR-1; TUMOR-CELLS; GENE; DYNAMICS; ACTIVATION; MIGRATION; ONCOGENE; SURVIVAL	Metastases are the main cause of cancer deaths, but the mechanisms underlying metastatic progression remain poorly understood. We isolated pure populations of cancer cells from primary tumors and metastases from a genetically engineered mouse model of human small cell lung cancer ( SCLC) to investigate the mechanisms that drive the metastatic spread of this lethal cancer. Genome-wide characterization of chromatin accessibility revealed the opening of large numbers of distal regulatory elements across the genome during metastatic progression. These changes correlate with copy number amplification of the Nfib locus, and differentially accessible sites were highly enriched for Nfib transcription factor binding sites. Nfib is necessary and sufficient to increase chromatin accessibility at a large subset of the intergenic regions. Nfib promotes pro-metastatic neuronal gene expression programs and drives the metastatic ability of SCLC cells. The identification of widespread chromatin changes during SCLC progression reveals an unexpected global reprogramming during metastatic progression.	[Denny, Sarah K.; Greenleaf, William J.] Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA; [Yang, Dian; Lim, Jing Shan; Sage, Julien; Winslow, Monte M.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Chuang, Chen-Hua; Brady, Jennifer J.; Gruner, Barbara M.; Chiou, Shin-Heng; Schep, Alicia N.; Baral, Jessika; Sage, Julien; Greenleaf, William J.; Winslow, Monte M.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Kong, Christina S.; Connolly, Andrew J.; Winslow, Monte M.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Sage, Julien; Winslow, Monte M.] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Sage, Julien] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Hamard, Cecile; Antoine, Martine; Wislez, Marie] Univ Paris 06, Hop Tenon, APHP, Serv Pneumol, F-75020 Paris, France; [Park, Kwon-Sik] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Virginia; Stanford University	Greenleaf, WJ (corresponding author), Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA.; Winslow, MM (corresponding author), Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA.; Greenleaf, WJ; Winslow, MM (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Winslow, MM (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Winslow, MM (corresponding author), Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA.; Greenleaf, WJ (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	wjg@stanford.edu; mwinslow@stanford.edu	Grüner, Barbara/AAB-9246-2020; Grüner, Barbara M/T-1298-2018	Grüner, Barbara/0000-0003-0974-4826; Grüner, Barbara M/0000-0003-0974-4826; Denny, Sarah/0000-0001-8753-6040; wislez, marie/0000-0001-7518-7859; Park, Kwon-Sik/0000-0003-3346-9086	Stanford Cancer Institute Cancer Biology Seed Grant; Stanford Cancer Institute [NIH P30-CA124435]; NIH [P50HG007735, R01CA206540, F32-CA189659]; Baxter Foundation Faculty Scholar Grant; Rita Allen Foundation; Human Frontier Science Program; Stanford Biophysics training grant [T32 GM008294]; NSF GRFP; Stanford Graduate Fellowship; TRDRP Dissertation Award [24DT-0001]; American Lung Association Fellowship; Hope Funds for Cancer Research [HFCR-15-06-07]; NATIONAL CANCER INSTITUTE [P30CA124435, R01CA206540, F32CA189659] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294, T32GM007790] Funding Source: NIH RePORTER	Stanford Cancer Institute Cancer Biology Seed Grant; Stanford Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter Foundation Faculty Scholar Grant; Rita Allen Foundation; Human Frontier Science Program(Human Frontier Science Program); Stanford Biophysics training grant; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Stanford Graduate Fellowship(Stanford University); TRDRP Dissertation Award; American Lung Association Fellowship; Hope Funds for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Pauline Chu for technical assistance, Sean Dolan and Alexandra Orantes for administrative support, David Feldser, Nadine Jahchan, Youcef Ouadah, Mark Krasnow, Gerald Crabtree, Namita Bisaria, and members of the M.M.W., W.J.G., and J.S. laboratories for helpful comments. We thank the Stanford Shared FACS Facility. This work was supported by a Stanford Cancer Institute Cancer Biology Seed Grant (to M.M.W., W.J.G., and J.S.) and, in part, by a Stanford Cancer Institute support grant (NIH P30-CA124435), NIH grants (P50HG007735 and R01CA206540), a Baxter Foundation Faculty Scholar Grant, the Rita Allen Foundation, and the Human Frontier Science Program. S.K.D. was supported by a Stanford Biophysics training grant (T32 GM008294) and by the NSF GRFP. D.Y. was supported by a Stanford Graduate Fellowship and by a TRDRP Dissertation Award (24DT-0001). C.-H.C. was funded by an American Lung Association Fellowship. J.J.B. was supported by an NIH grant (F32-CA189659). B.M.G. was supported by a fellowship from the Hope Funds for Cancer Research (HFCR-15-06-07). J.S. is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases. W.J.G. is the scientific co-founder of Epinomics.	Alevizopoulos A, 1995, GENE DEV, V9, P3051, DOI 10.1101/gad.9.24.3051; Augustyn A, 2014, P NATL ACAD SCI USA, V111, P14788, DOI 10.1073/pnas.1410419111; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Betancourt J, 2014, J COMP NEUROL, V522, P6, DOI 10.1002/cne.23373; Blomquist P, 1996, J BIOL CHEM, V271, P153, DOI 10.1074/jbc.271.1.153; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Chen J, 2012, ADV CANCER RES, V114, P1, DOI 10.1016/B978-0-12-386503-8.00001-6; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Foley K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5823; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Grabowska MM, 2014, MOL ENDOCRINOL, V28, P949, DOI 10.1210/me.2013-1213; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Harris L, 2015, DEV DYNAM, V244, P227, DOI 10.1002/dvdy.24182; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Kalemkerian GP, 2013, J NATL COMPR CANC NE, V11, P78, DOI 10.6004/jnccn.2013.0011; Ko SY, 2014, CANCER METAST REV, V33, P101, DOI 10.1007/s10555-013-9459-z; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakazawa K, 2012, ONCOL LETT, V4, P617, DOI 10.3892/ol.2012.792; Osborne JK, 2013, P NATL ACAD SCI USA, V110, P6524, DOI 10.1073/pnas.1303932110; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Sung MH, 2016, NAT METHODS, V13, P222, DOI 10.1038/nmeth.3766; Sung MH, 2014, MOL CELL, V56, P275, DOI 10.1016/j.molcel.2014.08.016; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zaret KS, 2016, CURR OPIN GENET DEV, V37, P76, DOI 10.1016/j.gde.2015.12.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou WJ, 2011, CELL RES, V21, P609, DOI 10.1038/cr.2011.17; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	49	206	211	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					328	342		10.1016/j.cell.2016.05.052	http://dx.doi.org/10.1016/j.cell.2016.05.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27374332	Bronze, Green Accepted			2022-12-24	WOS:000380255400012
J	Barlow, J; Lennox, GD; Ferreira, J; Berenguer, E; Lees, AC; Mac Nally, R; Thomson, JR; Ferraz, SFD; Louzada, J; Oliveira, VHF; Parry, L; Solar, RRD; Vieira, ICG; Aragao, LEOC; Begotti, RA; Braga, RF; Cardoso, TM; de Oliveira, RC; Souza, CM; Moura, NG; Nunes, SS; Siqueira, JV; Pardini, R; Silveira, JM; Vaz-de-Mello, FZ; Veiga, RCS; Venturieri, A; Gardner, TA				Barlow, Jos; Lennox, Gareth D.; Ferreira, Joice; Berenguer, Erika; Lees, Alexander C.; Mac Nally, Ralph; Thomson, James R.; de Barros Ferraz, Silvio Frosini; Louzada, Julio; Fonseca Oliveira, Victor Hugo; Parry, Luke; de Castro Solar, Ricardo Ribeiro; Vieira, Ima C. G.; Aragao, Luiz E. O. C.; Begotti, Rodrigo Anzolin; Braga, Rodrigo F.; Cardoso, Thiago Moreira; de Oliveira, Raimundo Cosme, Jr.; Souza, Carlos M., Jr.; Moura, Nargila G.; Nunes, Samia Serra; Siqueira, Joao Victor; Pardini, Renata; Silveira, Juliana M.; Vaz-de-Mello, Fernando Z.; Stulpen Veiga, Ruan Carlo; Venturieri, Adriano; Gardner, Toby A.			Anthropogenic disturbance in tropical forests can double biodiversity loss from deforestation	NATURE			English	Article							CONSERVATION; DEGRADATION; EXTINCTION; RESPONSES; RISK; FIRE	Concerted political attention has focused on reducing deforestation(1-3), and this remains the cornerstone of most biodiversity conservation strategies(4-6). However, maintaining forest cover may not reduce anthropogenic forest disturbances, which are rarely considered in conservation programmes(6). These disturbances occur both within forests, including selective logging and wildfires(7,8), and at the landscape level, through edge, area and isolation effects(9). Until now, the combined effect of anthropogenic disturbance on the conservation value of remnant primary forests has remained unknown, making it impossible to assess the relative importance of forest disturbance and forest loss. Here we address these knowledge gaps using a large data set of plants, birds and dung beetles (1,538, 460 and 156 species, respectively) sampled in 36 catchments in the Brazilian state of Para. Catchments retaining more than 69-80% forest cover lost more conservation value from disturbance than from forest loss. For example, a 20% loss of primary forest, the maximum level of deforestation allowed on Amazonian properties under Brazil's Forest Code(5), resulted in a 39-54% loss of conservation value: 96-171% more than expected without considering disturbance effects. We extrapolated the disturbance-mediated loss of conservation value throughout Para, which covers 25% of the Brazilian Amazon. Although disturbed forests retained considerable conservation value compared with deforested areas, the toll of disturbance outside Para's strictly protected areas is equivalent to the loss of 92,000-139,000 km(2) of primary forest. Even this lowest estimate is greater than the area deforested across the entire Brazilian Amazon between 2006 and 2015 (ref. 10). Species distribution models showed that both landscape and within-forest disturbances contributed to biodiversity loss, with the greatest negative effects on species of high conservation and functional value. These results demonstrate an urgent need for policy interventions that go beyond the maintenance of forest cover to safeguard the hyper-diversity of tropical forest ecosystems.	[Barlow, Jos; Lennox, Gareth D.; Berenguer, Erika; Louzada, Julio; Fonseca Oliveira, Victor Hugo; Parry, Luke; Silveira, Juliana M.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Barlow, Jos; Lees, Alexander C.; Vieira, Ima C. G.; Moura, Nargila G.] MCTI Museu Paraense Emilio Goeldi, CP 399, BR-66040170 Belem, Para, Brazil; [Barlow, Jos; Louzada, Julio; Fonseca Oliveira, Victor Hugo; Braga, Rodrigo F.; Silveira, Juliana M.] Univ Fed Lavras, Setor Ecologia Conservacao, BR-37200000 Lavras, MG, Brazil; [Ferreira, Joice; Cardoso, Thiago Moreira; de Oliveira, Raimundo Cosme, Jr.; Venturieri, Adriano] EMBRAPA Amazonia Oriental, BR-66095100 Belem, Para, Brazil; [Lees, Alexander C.; Moura, Nargila G.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; [Mac Nally, Ralph; Thomson, James R.] Univ Canberra, Inst Appl Ecol, Bruce, ACT 2617, Australia; [Thomson, James R.] Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, 123 Brown St, Heidelberg, Vic 3084, Australia; [de Barros Ferraz, Silvio Frosini; Begotti, Rodrigo Anzolin] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Esalq USP, Ave Padua Dias 11, BR-13418900 Piracicaba, SP, Brazil; [Parry, Luke] Univ Fed Para UFPA, NAEA, Av Perimetral 1, BR-66075750 Belem, Para, Brazil; [de Castro Solar, Ricardo Ribeiro] Univ Fed Vicosa, Dept Biol Geral, Av PH Rolfs S-N, BR-36570900 Vicosa, MG, Brazil; [Aragao, Luiz E. O. C.] Natl Inst Space Res INPE, Remote Sensing Div, Trop Ecosyst & Environm Sci Grp TREES, Ave Astronautas,1-758 Jd Granja, BR-12227010 Sao Jose Dos Campos, SP, Brazil; [Aragao, Luiz E. O. C.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4RJ, Devon, England; [Souza, Carlos M., Jr.; Nunes, Samia Serra; Siqueira, Joao Victor] IMAZON, Rua Dom Romualdo Seixas 1698, BR-66055200 Belem, Para, Brazil; [Pardini, Renata] Univ Sao Paulo, Inst Biociencias, Rua Matao,Travessa 14,101, BR-05508090 Sao Paulo, Brazil; [Vaz-de-Mello, Fernando Z.] Univ Fed Mato Grosso, Inst Biociencias, Dept Biol & Zool, Av Fernando Correa da Costa 2367, BR-78060900 Cuiaba, MT, Brazil; [Stulpen Veiga, Ruan Carlo] ISASM, Estrada Ribeirao das Voltas S-N, BR-28616010 Lumiar, Nova Friburgo, Brazil; [Gardner, Toby A.] Stockholm Environm Inst, Linnegatan 87D,Box 24218, S-10451 Stockholm, Sweden; [Gardner, Toby A.] Int Inst Sustainabil, Estrada Dona Castorina 124, BR-22460320 Rio De Janeiro, Brazil	Lancaster University; Museu Paraense Emilio Goeldi; Universidade Federal de Lavras; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Cornell University; University of Canberra; Arthur Rylah Institute for Environmental Research (ARI); Universidade de Sao Paulo; Universidade Federal do Para; Universidade Federal de Vicosa; University of Exeter; Universidade de Sao Paulo; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul; Stockholm Environment Institute	Barlow, J (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England.; Barlow, J (corresponding author), MCTI Museu Paraense Emilio Goeldi, CP 399, BR-66040170 Belem, Para, Brazil.; Barlow, J (corresponding author), Univ Fed Lavras, Setor Ecologia Conservacao, BR-37200000 Lavras, MG, Brazil.	josbarlow@gmail.com	Vaz-de-Mello, Fernando Z/A-1023-2009; Ferraz, Silvio FB/C-8851-2012; de Castro Solar, Ricardo Ribeiro/F-2043-2010; Barlow, Jos/HGE-9486-2022; Thomson, Jim/W-2950-2019; Vieira, Ima C.G./H-6897-2012; Oliveira, Victor/C-2719-2015; aragao, luiz eoc/G-8387-2012; Pardini, Renata/C-4095-2012; Fonseca Oliveira, Victor Hugo/ABE-9099-2021; Parry, Luke/ABD-4194-2021; Souza, CARLOS/AAK-8207-2021; Louzada, Julio/F-1265-2010; Barlow, Jos/E-7861-2014; Begotti, Rodrigo Anzolin/Y-9269-2019; Lees, Alexander Charles/S-2443-2019	Vaz-de-Mello, Fernando Z/0000-0001-9697-320X; Ferraz, Silvio FB/0000-0003-1808-5420; de Castro Solar, Ricardo Ribeiro/0000-0001-5627-4017; Vieira, Ima C.G./0000-0003-1233-318X; Oliveira, Victor/0000-0002-0553-0268; aragao, luiz eoc/0000-0002-4134-6708; Pardini, Renata/0000-0002-3769-8401; Fonseca Oliveira, Victor Hugo/0000-0002-0553-0268; Parry, Luke/0000-0003-0330-9516; Souza, CARLOS/0000-0002-0205-6134; Louzada, Julio/0000-0002-1481-3112; Begotti, Rodrigo Anzolin/0000-0001-5363-8743; Lees, Alexander Charles/0000-0001-7603-9081; Mac Nally, Ralph/0000-0002-4473-1636; Nunes, Samia/0000-0002-5460-3312	Brazil (CNPq) [574008/2008-0, 458022/2013-6, 400640/2012-0]; Brazil (Embrapa) [SEG:02.08.06.005.00]; Brazil (Nature Conservancy - Brasil); Brazil (CAPES); UK (Darwin Initiative) [17-023, NE/F01614X/1, NE/G000816/1, NE/F015356/2, NE/l018123/1, NE/K016431/1]; Formas [2013-1571]; Australian Research Council [DP120100797]; NERC [NE/K016431/1, NE/K016385/1, NE/G000816/1, NE/F015356/2] Funding Source: UKRI; Natural Environment Research Council [NE/G000816/1, NE/K016431/1, NE/K016385/1, NE/F015356/2, ceh010010] Funding Source: researchfish	Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazil (Embrapa)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Brazil (Nature Conservancy - Brasil); Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UK (Darwin Initiative); Formas(Swedish Research Council Formas); Australian Research Council(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by grants from Brazil (CNPq 574008/2008-0, 458022/2013-6, and 400640/2012-0; Embrapa SEG:02.08.06.005.00; The Nature Conservancy - Brasil; CAPES scholarships) the UK (Darwin Initiative 17-023; NE/F01614X/1; NE/G000816/1; NE/F015356/2; NE/l018123/1; NE/K016431/1), Formas 2013-1571, and Australian Research Council grant DP120100797. Institutional support was provided by the Herbario IAN in Belem, LBA in Santarem and FAPEMAT. R.M. and J.R.T. were supported by Australian Research Council grant DP120100797. This is paper no. 49 in the Sustainable Amazon Network series.	Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Banks-Leite C, 2014, J APPL ECOL, V51, P849, DOI 10.1111/1365-2664.12272; Barlow J, 2004, ECOL APPL, V14, P1358, DOI 10.1890/03-5077; Barrio Javier, 2011, Rev. peru biol., V18, P225; Berenguer E, 2014, GLOBAL CHANGE BIOL, V20, P3713, DOI 10.1111/gcb.12627; Boucher D., 2014, DEFORESTATION SUCCES; Burivalova Z, 2014, CURR BIOL, V24, P1893, DOI 10.1016/j.cub.2014.06.065; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chen Y, 2011, SCIENCE, V334, P787, DOI 10.1126/science.1209472; Convention on Biological Diversity, 2015, STRAT PLAN BIOD 2011; Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x; Da Silva JMC, 2005, CONSERV BIOL, V19, P689, DOI 10.1111/j.1523-1739.2005.00705.x; Ferraz SFD, 2009, FOREST ECOL MANAG, V257, P1586, DOI 10.1016/j.foreco.2009.01.013; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Gardner TA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0166; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Instituto Nacional de Pesquisas Espaciais (INPE), 2015, PROJ PROD AM DEF DAT; Instituto Nacional de Pesquisas Espaciais (INPE), 2013, TERR DAT 2010; Lees AC, 2013, REV BRAS ORNITOL, V21, P16; Lees AC, 2012, REV BRAS ORNITOL, V20, P93; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Malhi Y, 2014, ANNU REV ENV RESOUR, V39, P125, DOI 10.1146/annurev-environ-030713-155141; Manne LL, 1999, NATURE, V399, P258, DOI 10.1038/20436; Morton DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0163; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Panfil SN, 2016, CONSERV LETT, V9, P143, DOI 10.1111/conl.12188; Parrotta J. A., 2012, UNDERSTANDING RELATI; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Sloan S, 2015, FOREST ECOL MANAG, V352, P134, DOI 10.1016/j.foreco.2015.06.013; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Souza CM, 2013, REMOTE SENS-BASEL, V5, P5493, DOI 10.3390/rs5115493; Zanne A.E., 2009, DRYAD DATA REPOS, DOI [10.5061/dryad.234, DOI 10.5061/DRYAD.234]	37	524	536	39	710	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					144	+		10.1038/nature18326	http://dx.doi.org/10.1038/nature18326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362236	Green Accepted, Green Published			2022-12-24	WOS:000379015600041
J	Healey, JS; Oldgren, J; Ezekowitz, M; Zhu, J; Pais, P; Wang, J; Commerford, P; Jansky, P; Avezum, A; Sigamani, A; Demasceno, A; Reilly, P; Grinvalds, A; Nakamya, J; Aje, A; Almahmeed, W; Moriarty, A; Wallentin, L; Yusuf, S; Connolly, SJ				Healey, Jeff S.; Oldgren, Jonas; Ezekowitz, Michael; Zhu, Jun; Pais, Prem; Wang, Jia; Commerford, Patrick; Jansky, Petr; Avezum, Alvaro; Sigamani, Alben; Demasceno, Albertino; Reilly, Paul; Grinvalds, Alex; Nakamya, Juliet; Aje, Akinyemi; Almahmeed, Wael; Moriarty, Andrew; Wallentin, Lars; Yusuf, Salim; Connolly, Stuart J.		RE-LY Atrial Fibrillation Registry; Cohort Study Investigators	Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study	LANCET			English	Article							EMERGENCY-DEPARTMENT; ORAL ANTICOAGULANTS; GULF SURVEY; FOLLOW-UP; MANAGEMENT; RISK; WARFARIN; METAANALYSIS; GUIDELINES; OUTCOMES	Background Atrial fi brillation is an important cause of morbidity and mortality worldwide, but scant data are available for long- term outcomes in individuals outside North America or Europe, especially in primary care settings. Methods We did a cohort study using a prospective registry of patients in 47 countries who presented to a hospital emergency department with atrial fi brillation or atrial fl utter as a primary or secondary diagnosis. 15 400 individuals were enrolled to determine the occurrence of death and strokes (the primary outcomes) in this cohort over eight geographical regions (North America, western Europe, and Australia; South America; eastern Europe; the Middle East and Mediterranean crescent; sub- Saharan Africa; India; China; and southeast Asia) 1 year after attending the emergency department. Patients from North America, western Europe, and Australia were used as the reference population, and compared with patients from the other seven regions Findings Between Dec 24, 2007, and Oct 21, 2011, we enrolled 15 400 individuals to the registry. Follow- up was complete for 15 361 (99.7%), of whom 1758 (11%) died within 1 year. Fewer deaths occurred among patients presenting to the emergency department with a primary diagnosis of atrial fi brillation compared with patients who had atrial fi brillation as a secondary diagnosis (377 [6%] of 6825 patients vs 1381 [16%] of 8536, p<0.0001). Twice as many patients had died by 1 year in South America (192 [17%] of 1132) and Africa (225 [20%] of 1137) compared with North America, western Europe, and Australia (366 [10%] of 3800, p< 0 0001). Heart failure was the most common cause of death (519 [30%] of 1758); stroke caused 148 (8%) deaths. 604 (4%) of 15361 patients had had a stroke by 1 year; 170 (3%) of 6825 for whom atrial fi brillation was a primary diagnosis and 434 (5%) of 8536 for whom it was a secondary diagnosis (p<0.001). The highest number of strokes occurred in patients in Africa (89 [8%] of 1137), China (143 [7%] of 2023), and southeast Asia (88 [7%] of 1331) and the lowest occurred in India (20 [< 1%] of 2536). 94 (3%) of 3800 patients in North America, western Europe, and Australia had a stroke. Interpretation Marked unexplained inter- regional variations in the occurrence of stroke and mortality suggest that factors other than clinical variables might be important. Prevention of death from heart failure should be a major priority in the treatment of atrial fi brillation.	[Healey, Jeff S.; Wang, Jia; Grinvalds, Alex; Nakamya, Juliet; Yusuf, Salim; Connolly, Stuart J.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Oldgren, Jonas; Wallentin, Lars] Uppsala Clin Res, Uppsala, Sweden; [Ezekowitz, Michael] Lankenau Inst Med Res, Wynnewood, PA USA; [Zhu, Jun] Fuwai Hosp CAMS, Beijing, Peoples R China; [Zhu, Jun] PUMC, Beijing, Peoples R China; [Pais, Prem; Sigamani, Alben] St Johns Med Coll & Bangalore Res Inst, Bangalore, Karnataka, India; [Commerford, Patrick] Univ Cape Town, Dept Med, Cape Town, South Africa; [Jansky, Petr] Univ Hosp Motol, Prague, Czech Republic; [Avezum, Alvaro] Inst Dante Pazzanesse Cardiol, Sao Paulo, Brazil; [Demasceno, Albertino] Eduardo Mondlane Univ, Maputo, Mozambique; [Reilly, Paul] Boehringer Ingelheim GmbH & Co KG, Bieberach, Germany; [Aje, Akinyemi] Univ Coll Hosp, Ibadan, Nigeria; [Almahmeed, Wael] Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates; [Almahmeed, Wael] Cleveland Clin, Abu Dhabi, U Arab Emirates; [Moriarty, Andrew] Craigavon Area Hosp, Craigavon, County Armagh, North Ireland	McMaster University; Population Health Research Institute; Lankenau Medical Center; Lankenau Institute for Medical Research; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; St. John's National Academy of Health Sciences; St. John's Medical College; University of Cape Town; Motol University Hospital; Instituto Dante Pazzanese de Cardiologia; Eduardo Mondlane University; Boehringer Ingelheim; University of Ibadan; University College Hospital, Ibadan; Cleveland Clinic Foundation	Healey, JS (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.; Healey, JS (corresponding author), McMaster Univ, Populat Hlth Res Inst, David Braley Cardiovasc & Stroke Res Inst, Hamilton, ON L8L 2X2, Canada.	Jeff.Healey@phri.ca	Sigamani, Alben/GQH-0406-2022; Avezum, Alvaro/AAP-7687-2020; Ezekowitz, Michael/AAJ-2543-2021	Yusuf, Salim/0000-0003-4776-5601; SIGAMANI, ALBEN/0000-0002-6927-1947; AVEZUM, ALVARO/0000-0002-3073-6890	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	This cohort study was funded by Boehringer Ingelheim. All data collection, management, and analyses were undertaken exclusively by the Population Health Research Institute in Hamilton (ON, Canada).	Atzema CL, 2013, ACAD EMERG MED, V20, P193, DOI 10.1111/acem.12078; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Boriani G, 2016, EUROPACE, V18, P648, DOI 10.1093/europace/euv390; Bungard TJ, 2000, ARCH INTERN MED, V160, P41, DOI 10.1001/archinte.160.1.41; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; Diker E, 1996, AM J CARDIOL, V77, P96, DOI 10.1016/S0002-9149(97)89145-X; Ezekowitz JA, 2005, CAN MED ASSOC J, V172, P189, DOI 10.1503/cmaj.1032017; Friberg L, 2015, EUR HEART J, V36, P297, DOI 10.1093/eurheartj/ehu139; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hannan EL, 2005, MED CARE, V43, P726, DOI 10.1097/01.mlr.0000167802.27044.44; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Healey JS, 2006, CAN J CARDIOL, V22, P485, DOI 10.1016/S0828-282X(06)70265-3; Jones WJ, 2001, STROKE, V32, P2232, DOI 10.1161/hs1001.096191; Kaczorowski J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d442; Kakkar AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063479; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Larsen TB, 2012, CIRC-CARDIOVASC QUAL, V5, P335, DOI 10.1161/CIRCOUTCOMES.111.964023; Le Heuzey JY, 2010, AM J CARDIOL, V105, P687, DOI 10.1016/j.amjcard.2009.10.012; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; McDonald AJ, 2008, ANN EMERG MED, V51, P58, DOI 10.1016/j.annemergmed.2007.03.007; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Neal B, 2000, LANCET, V356, P1955; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Ntep-Gweth M, 2010, EUROPACE, V12, P482, DOI 10.1093/europace/euq006; Oldgren J, 2014, CIRCULATION, V129, P1568, DOI 10.1161/CIRCULATIONAHA.113.005451; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pilote L, 2013, CAN J CARDIOL, V29, P1241, DOI 10.1016/j.cjca.2012.09.021; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; The World Bank, WORLD BANK LIST EC 2; Wann LS, 2011, HEART RHYTHM, V8, P157, DOI 10.1016/j.hrthm.2010.11.047; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; World Bank, 2014, GDP PER CAP CONST 20; Zubaid M, 2015, ANGIOLOGY, V66, P464, DOI 10.1177/0003319714536980; Zubaid M, 2011, CIRC-CARDIOVASC QUAL, V4, P477, DOI 10.1161/CIRCOUTCOMES.110.959700	42	163	170	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2016	388	10050					1161	1169		10.1016/S0140-6736(16)30968-0	http://dx.doi.org/10.1016/S0140-6736(16)30968-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RA	27515684				2022-12-24	WOS:000383703100030
J	Cho, SY; Kang, JM; Ha, YE; Park, GE; Lee, JY; Ko, JH; Lee, JY; Kim, JM; Kang, CI; Jo, IJ; Ryu, JG; Choi, JR; Kim, S; Huh, HJ; Ki, CS; Kang, ES; Peck, KR; Dhong, HJ; Song, JH; Chung, DR; Kim, YJ				Cho, Sun Young; Kang, Ji-Man; Ha, Young Eun; Park, Ga Eun; Lee, Ji Yeon; Ko, Jae-Hoon; Lee, Ji Yong; Kim, Jong Min; Kang, Cheol-In; Jo, Ik Joon; Ryu, Jae Geum; Choi, Jong Rim; Kim, Seonwoo; Huh, Hee Jae; Ki, Chang-Seok; Kang, Eun-Suk; Peck, Kyong Ran; Dhong, Hun-Jong; Song, Jae-Hoon; Chung, Doo Ryeon; Kim, Yae-Jean			MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study	LANCET			English	Article							EAST RESPIRATORY SYNDROME; CORONAVIRUS; TRANSMISSION; SARS	Background In 2015, a large outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection occurred following a single patient exposure in an emergency room at the Samsung Medical Center, a tertiary-care hospital in Seoul, South Korea. We aimed to investigate the epidemiology of MERS-CoV outbreak in our hospital. Methods We identified all patients and health-care workers who had been in the emergency room with the index case between May 27 and May 29, 2015. Patients were categorised on the basis of their exposure in the emergency room: in the same zone as the index case (group A), in different zones except for overlap at the registration area or the radiology suite (group B), and in different zones (group C). We documented cases of MERS-CoV infection, confirmed by real-time PCR testing of sputum samples. We analysed attack rates, incubation periods of the virus, and risk factors for transmission. Findings 675 patients and 218 health-care workers were identified as contacts. MERS-CoV infection was confirmed in 82 individuals (33 patients, eight health-care workers, and 41 visitors). The attack rate was highest in group A (20% [23/117] vs 5% [3/58] in group B vs 1% [4/500] in group C; p<0.0001), and was 2% (5/218) in health-care workers. After excluding nine cases (because of inability to determine the date of symptom onset in six cases and lack of data from three visitors), the median incubation period was 7 days (range 2-17, IQR 5-10). The median incubation period was significantly shorter in group A than in group C (5 days [IQR 4-8] vs 11 days [6-12]; p<0.0001). There were no confirmed cases in patients and visitors who visited the emergency room on May 29 and who were exposed only to potentially contaminated environment without direct contact with the index case. The main risk factor for transmission of MERS-CoV was the location of exposure. Interpretation Our results showed increased transmission potential of MERS-CoV from a single patient in an overcrowded emergency room and provide compelling evidence that health-care facilities worldwide need to be prepared for emerging infectious diseases.	[Cho, Sun Young; Ha, Young Eun; Park, Ga Eun; Lee, Ji Yeon; Ko, Jae-Hoon; Lee, Ji Yong; Kang, Cheol-In; Peck, Kyong Ran; Song, Jae-Hoon; Chung, Doo Ryeon] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Infect Dis,Dept Internal Med, Seoul 135710, South Korea; [Kang, Ji-Man; Kim, Jong Min; Kim, Yae-Jean] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Infect Dis,Dept Paediat, Seoul, South Korea; [Jo, Ik Joon] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Emergency Med, Seoul, South Korea; [Ryu, Jae Geum; Choi, Jong Rim] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Infect Control Off, Seoul, South Korea; [Huh, Hee Jae; Ki, Chang-Seok; Kang, Eun-Suk] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Lab Med & Genet, Seoul, South Korea; [Dhong, Hun-Jong] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Seonwoo] Samsung Biomed Res Inst, Biostat Team, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Chung, DR (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Infect Dis,Dept Internal Med, Seoul 135710, South Korea.; Kim, YJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis & Immunodeficiency,Dept Paediat, Seoul 135710, South Korea.	iddrchung@gmail.com; yaejeankim@skku.edu	Peck, Kyong Ran/AGV-5205-2022; ki, cs/O-5931-2014; Ki, Chang-Seok/G-7559-2014	Ki, Chang-Seok/0000-0001-7679-8731; Peck, Kyong Ran/0000-0002-7464-9780; Lee, Ji Yong/0000-0002-8286-7913; Ko, Jae-Hoon/0000-0002-9490-6609; Huh, Hee Jae/0000-0001-8999-7561	Korea Centers for Disease Control and Prevention; MERS Rapid Response Team of the Public-Private Joint MERS Task Force; WHO; US Centers for Disease Control and Prevention	Korea Centers for Disease Control and Prevention; MERS Rapid Response Team of the Public-Private Joint MERS Task Force; WHO(World Health Organization); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	We express our sincere consolation for the patients and their families who had MERS-CoV infection. We greatly appreciate the efforts of all the hospital employees and their families at the Samsung Medical Center, who worked tirelessly during this outbreak. We also appreciate the cooperation of all other hospitals in South Korea that worked together to overcome the nationwide outbreak. We acknowledge the consultation and support of the Korea Centers for Disease Control and Prevention, the MERS Rapid Response Team of the Public-Private Joint MERS Task Force, WHO, and the US Centers for Disease Control and Prevention. We also sincerely appreciate the discussion and critical feedback from Michael T Osterholm (University of Minnesota, Minneapolis, MN, USA) and Janet A Englund (Seattle Children's Hospital, Seattle, WA, USA).	Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P405; Chowell G, 2014, EPIDEMICS-NETH, V9, P40, DOI 10.1016/j.epidem.2014.09.011; Christian MD, 2004, CLIN INFECT DIS, V38, P1420, DOI 10.1086/420743; Korea Centers for Disease Control and Prevention, 2015, Osong Public Health Res Perspect, V6, P269, DOI 10.1016/j.phrp.2015.08.006; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Middle East respiratory syndrome coronavirus (MERS), 2015, CAS DEF; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Shen Z, 2004, EMERG INFECT DIS, V10, P256, DOI 10.3201/eid1002.030732; van Doremalen N, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.38.20590; World Health Organization, 2020, MIDDLE E RESP SYNDRO; Yang JS, 2015, EMERG INFECT DIS, V21, P2084, DOI 10.3201/eid2111.151016; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	17	209	214	5	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2016	388	10048					994	1001		10.1016/S0140-6736(16)30623-7	http://dx.doi.org/10.1016/S0140-6736(16)30623-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9GL	27402381	Green Published, Bronze			2022-12-24	WOS:000382524400029
J	Lek, M; Karczewski, KJ; Minikel, EV; Samocha, KE; Banks, E; Fennell, T; O'Donnell-Luria, AH; Ware, JS; Hill, AJ; Cummings, BB; Tukiainen, T; Birnbaum, DP; Kosmicki, JA; Duncan, LE; Estrada, K; Zhao, FM; Zou, J; Pierce-Hollman, E; Berghout, J; Cooper, DN; Deflaux, N; DePristo, M; Do, R; Flannick, J; Fromer, M; Gauthier, L; Goldstein, J; Gupta, N; Howrigan, D; Kiezun, A; Kurki, MI; Moonshine, AL; Natarajan, P; Orozeo, L; Peloso, GM; Poplin, R; Rivas, MA; Ruano-Rubio, V; Rose, SA; Ruderfer, DM; Shakir, K; Stenson, PD; Stevens, C; Thomas, BP; Tiao, G; Tusie-Luna, MT; Weisburd, B; Won, HH; Yu, DM; Altshuler, DM; Ardissino, D; Boehnke, M; Danesh, J; Donnelly, S; Elosua, R; Florez, JC; Gabriel, SB; Getz, G; Glatt, SJ; Hultman, CM; Kathiresan, S; Laakso, M; NcCarroll, S; McCarthy, MI; McGovern, D; McPherson, R; Neale, BM; Palotie, A; Purcell, SM; Saleheen, D; Scharf, JM; Sklar, P; Sullivan, PF; Tuomilehto, J; Tsuang, MT; Watkins, HC; Wilson, JG; Daly, MJ; MacArthur, DG				Lek, Monkol; Karczewski, Konrad J.; Minikel, Eric V.; Samocha, Kaitlin E.; Banks, Eric; Fennell, Timothy; O'Donnell-Luria, Anne H.; Ware, James S.; Hill, Andrew J.; Cummings, Beryl B.; Tukiainen, Taru; Birnbaum, Daniel P.; Kosmicki, Jack A.; Duncan, Laramie E.; Estrada, Karol; Zhao, Fengmei; Zou, James; Pierce-Hollman, Emma; Berghout, Joanne; Cooper, David N.; Deflaux, Nicole; DePristo, Mark; Do, Ron; Flannick, Jason; Fromer, Menachem; Gauthier, Laura; Goldstein, Jackie; Gupta, Namrata; Howrigan, Daniel; Kiezun, Adam; Kurki, Mitja I.; Moonshine, Ami Levy; Natarajan, Pradeep; Orozeo, Lorena; Peloso, Gina M.; Poplin, Ryan; Rivas, Manuel A.; Ruano-Rubio, Valentin; Rose, Samuel A.; Ruderfer, Douglas M.; Shakir, Khalid; Stenson, Peter D.; Stevens, Christine; Thomas, Brett P.; Tiao, Grace; Tusie-Luna, Maria T.; Weisburd, Ben; Won, Hong-Hee; Yu, Dongmei; Altshuler, David M.; Ardissino, Diego; Boehnke, Michael; Danesh, John; Donnelly, Stacey; Elosua, Roberto; Florez, Jose C.; Gabriel, Stacey B.; Getz, Gad; Glatt, Stephen J.; Hultman, Christina M.; Kathiresan, Sekar; Laakso, Markku; NcCarroll, Steven; McCarthy, Mark I.; McGovern, Dermot; McPherson, Ruth; Neale, Benjamin M.; Palotie, Aarno; Purcell, Shaun M.; Saleheen, Danish; Scharf, Jeremiah M.; Sklar, Pamela; Sullivan, Patrick F.; Tuomilehto, Jaakko; Tsuang, Ming T.; Watkins, Hugh C.; Wilson, James G.; Daly, Mark J.; MacArthur, Daniel G.		Exome Aggregation Consortium	Analysis of protein-coding genetic variation in 60,706 humans	NATURE			English	Article							HUMAN-POPULATION HISTORY; HUMAN-DISEASE; SEQUENCE VARIANTS; MUTATION; GUIDELINES; EVOLUTION; DISCOVERY; FRAMEWORK; NETWORKS	Large-scale reference data sets of human genetic variation are critical for the medical and functional interpretation of DNA sequence changes. Here we describe the aggregation and analysis of high-quality exome (protein-coding region) DNA sequence data for 60,706 individuals of diverse ancestries generated as part of the Exome Aggregation Consortium (ExAC). This catalogue of human genetic diversity contains an average of one variant every eight bases of the exome, and provides direct evidence for the presence of widespread mutational recurrence. We have used this catalogue to calculate objective metrics of pathogenicity for sequence variants, and to identify genes subject to strong selection against various classes of mutation; identifying 3,230 genes with near-complete depletion of predicted protein-truncating variants, with 72% of these genes having no currently established human disease phenotype. Finally, we demonstrate that these data can be used for the efficient filtering of candidate disease-causing variants, and for the discovery of human 'knockout' variants in protein-coding genes.	[Lek, Monkol; Karczewski, Konrad J.; Minikel, Eric V.; Samocha, Kaitlin E.; O'Donnell-Luria, Anne H.; Hill, Andrew J.; Cummings, Beryl B.; Tukiainen, Taru; Kosmicki, Jack A.; Duncan, Laramie E.; Estrada, Karol; Pierce-Hollman, Emma; Fromer, Menachem; Goldstein, Jackie; Howrigan, Daniel; Thomas, Brett P.; Neale, Benjamin M.; Palotie, Aarno; Daly, Mark J.; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Lek, Monkol; Karczewski, Konrad J.; Minikel, Eric V.; Samocha, Kaitlin E.; Banks, Eric; O'Donnell-Luria, Anne H.; Ware, James S.; Hill, Andrew J.; Cummings, Beryl B.; Tukiainen, Taru; Birnbaum, Daniel P.; Kosmicki, Jack A.; Duncan, Laramie E.; Estrada, Karol; Zou, James; Pierce-Hollman, Emma; Flannick, Jason; Goldstein, Jackie; Gupta, Namrata; Howrigan, Daniel; Kurki, Mitja I.; Natarajan, Pradeep; Peloso, Gina M.; Rivas, Manuel A.; Stevens, Christine; Thomas, Brett P.; Weisburd, Ben; Altshuler, David M.; Donnelly, Stacey; Florez, Jose C.; Gabriel, Stacey B.; Kathiresan, Sekar; Neale, Benjamin M.; Palotie, Aarno; Scharf, Jeremiah M.; Daly, Mark J.; MacArthur, Daniel G.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lek, Monkol] Univ Sydney, Sch Paediat & Child Hlth, Sydney, NSW 2145, Australia; [Lek, Monkol] Childrens Hosp VVestmead, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia; [Minikel, Eric V.; Samocha, Kaitlin E.; Cummings, Beryl B.; Palotie, Aarno] Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Samocha, Kaitlin E.; Kosmicki, Jack A.; Duncan, Laramie E.; Fromer, Menachem; Goldstein, Jackie; Howrigan, Daniel; Rose, Samuel A.; Yu, Dongmei; NcCarroll, Steven; Neale, Benjamin M.; Scharf, Jeremiah M.; Daly, Mark J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [O'Donnell-Luria, Anne H.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Ware, James S.; NcCarroll, Steven] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Ware, James S.] Imperial Coll London, Natl Heart & Lung Inst, London SW7 2AZ, England; [Ware, James S.] Royal Brompton Hosp, NIHR Royal Brompton Cardiovasc Biomed Res Unit, London SW3 6NP, England; [Ware, James S.] Imperial Coll London, MRC Clin Sci Ctr, London SW7 2AZ, England; [Hill, Andrew J.; Zhao, Fengmei] Univ Washington, Genome Sci, Seattle, WA 98195 USA; [Kosmicki, Jack A.] Harvard Med Sch, Program Bioinformat & Integrat Genom, Boston, MA 02115 USA; [Berghout, Joanne] Jackson Lab, Mouse Genome Informat, 600 Main St, Bar Harbor, ME 04609 USA; [Berghout, Joanne] Univ Arizona, Ctr Biomed Informat & Biostat, Tucson, AZ 85721 USA; [Cooper, David N.; Stenson, Peter D.] Cardiff Univ, Inst Med Genet, Cardiff CF10 3XQ, S Glam, Wales; [Deflaux, Nicole] Google, Mountain View, CA 94043 USA; [DePristo, Mark; Gauthier, Laura; Kiezun, Adam; Moonshine, Ami Levy; Poplin, Ryan; Ruano-Rubio, Valentin; Shakir, Khalid; Tiao, Grace; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Do, Ron; Fromer, Menachem; Ruderfer, Douglas M.; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Fennell, Timothy; Do, Ron; Fromer, Menachem; Ruderfer, Douglas M.; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Do, Ron] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Do, Ron] Icahn Sch Med Mt Sinai, Ctr Stat Genet, New York, NY 10029 USA; [Flannick, Jason] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Fromer, Menachem; Ruderfer, Douglas M.; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Kurki, Mitja I.; Yu, Dongmei; Scharf, Jeremiah M.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Natarajan, Pradeep; Florez, Jose C.; Getz, Gad; Kathiresan, Sekar] Harvard Med Sch, Boston, MA 02115 USA; [Natarajan, Pradeep; Peloso, Gina M.; Yu, Dongmei; Florez, Jose C.; Kathiresan, Sekar; Scharf, Jeremiah M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Natarajan, Pradeep; Peloso, Gina M.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Orozeo, Lorena] Inst Nacl Med Genom, Immunogen & Metab Dis Lab, Mexico City 14610, DF, Mexico; [Tusie-Luna, Maria T.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mol Biol & Genom Med Unit, Mexico City 14080, DF, Mexico; [Won, Hong-Hee] Sungkyunkwan Univ, Samsung Med Ctr, Samsung Adv Inst Hlth Sci & Technol SAIHST, Seoul, South Korea; [Yu, Dongmei; Scharf, Jeremiah M.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Altshuler, David M.] Vertex Pharmaceut, Boston, MA 02210 USA; [Ardissino, Diego] Univ Hosp, Dept Cardiol, I-43100 Parma, Italy; [Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Danesh, John] Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Elosua, Roberto] Hosp Mar Med Res Inst, Cardiovasc Epidemiol & Genet, Barcelona 08003, Spain; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Glatt, Stephen J.] SUNY Upstate Med Univ, Psychiat Genet Epidemiol & Neurobiol Lab, Syracuse, NY 13210 USA; [Glatt, Stephen J.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Glatt, Stephen J.] SUNY Upstate Med Univ, Dept Neurobiol & Physiol, Syracuse, NY 13210 USA; [Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio 70211, Finland; [Laakso, Markku] Kuopio Univ Hosp, Kuopio 70211, Finland; [McCarthy, Mark I.; Watkins, Hugh C.] Univ Oxford, Wellcome Trust Ctr Human Genet, S Parks Rd, Oxford OX1 2JD, England; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX1 2JD, England; [McCarthy, Mark I.] Oxford Univ Hosp Fdn Trust, Oxford NIHR Biomed Res Ctr, Oxford OX1 2JD, England; [McGovern, Dermot] Cedars Sinai Med Ctr, Inflammatory Bowel Dis & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [McPherson, Ruth] Univ Ottawa, Atherogen Lab, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, SF-00100 Helsinki, Finland; [Saleheen, Danish] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Saleheen, Danish] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, SF-00100 Helsinki, Finland; [Tsuang, Ming T.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Watkins, Hugh C.] Univ Oxford, Racicliffe Dept Med, S Parks Rd, Oxford OX1 2JD, England; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Sydney; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Imperial College London; Royal Brompton Hospital; Imperial College London; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Jackson Laboratory; University of Arizona; Cardiff University; Google Incorporated; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Instituto Nacional de Medicina Genomica; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Harvard University; Massachusetts General Hospital; Vertex Pharmaceuticals; University of Parma; University Hospital of Parma; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Karolinska Institutet; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Cedars Sinai Medical Center; University of Ottawa; University of Ottawa Heart Institute; University of Helsinki; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet; University of Helsinki; University of California System; University of California San Diego; University of Oxford; University of Mississippi; University of Mississippi Medical Center	MacArthur, DG (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	danmac@broadinstitute.org	Rivas, Manuel/ABE-8173-2020; Duncan, Laramie/AAG-6605-2019; Won, Hong-Hee/D-2672-2011; Duncan, Laramie/AAW-5306-2021; Altshuler, David M/A-4476-2009; Natarajan, Pradeep/H-9764-2019; Ware, James S/G-5139-2012; Bergen, Sarah/I-8313-2012; Berghout, Joanne/M-5493-2017; Kurki, Mitja/GWM-5671-2022; Bjørkhaug, Lise/AAA-4356-2021; Daly, Mark J/B-2453-2017; Pinheiro, Maísa/E-7424-2012; Ardissino, Diego/AAC-4041-2022; Cooper, David N/H-4384-2011; Ruderfer, Douglas M/M-5795-2016; Magnusson, Patrik/C-4458-2017; McCarthy, Mark/M-3763-2015	Rivas, Manuel/0000-0003-1457-9925; Won, Hong-Hee/0000-0001-5719-0552; Altshuler, David M/0000-0002-7250-4107; Natarajan, Pradeep/0000-0001-8402-7435; Ware, James S/0000-0002-6110-5880; Bergen, Sarah/0000-0002-5888-0034; Berghout, Joanne/0000-0002-9250-9159; Bjørkhaug, Lise/0000-0002-9695-4559; Daly, Mark J/0000-0002-0949-8752; Cooper, David N/0000-0002-8943-8484; Ruderfer, Douglas M/0000-0002-2365-386X; Mercader, Josep M/0000-0001-8494-3660; Rose, Samuel/0000-0001-9701-0050; Tukiainen, Taru/0000-0002-5404-8398; Garcia-Ortiz, Humberto/0000-0002-0453-980X; Orozco, Lorena/0000-0002-5801-9180; Deflaux, Nicole/0000-0002-9421-8048; Meitinger, Thomas/0000-0002-8838-8403; Moran, Jennifer/0000-0002-5664-4716; Posthuma, Danielle/0000-0001-7582-2365; Hopewell, Jemma/0000-0002-3870-8018; Grados, Marco/0000-0002-6189-6264; Barr, Cathy/0000-0003-0361-0106; Blangero, John/0000-0001-6250-5723; Marrugat, Jaume/0000-0003-3320-554X; Fuchsberger, Christian/0000-0002-5918-8947; Samocha, Kaitlin/0000-0002-1704-3352; Magnusson, Patrik/0000-0002-7315-7899; McCarthy, Mark/0000-0002-4393-0510; Palotie, Aarno/0000-0002-2527-5874; Cummings, Beryl/0000-0001-6346-1646; Revilla Monsalve, Maria Cristina/0000-0002-6202-1160; MacArthur, Daniel/0000-0002-5771-2290; Kyriakou, Theodosios/0000-0001-7794-8789; solinas, emilia/0000-0003-3532-1317; Yu, Dongmei/0000-0001-7901-4365; Watkins, Hugh/0000-0002-5287-9016; O'Donnell-Luria, Anne/0000-0001-6418-9592; ELOSUA, ROBERTO/0000-0001-8235-0095; Duncan, Laramie/0000-0003-1131-661X; Hattersley, Andrew/0000-0001-5620-473X; Huerta-Chagoya, Alicia/0000-0001-6218-3904; Minikel, Eric Vallabh/0000-0003-2206-1608; Goel, Anuj/0000-0003-2307-4021	British Heart Foundation [FS/14/55/30806] Funding Source: Medline; CIHR [MOP77682, MOP82810, MOP136936] Funding Source: Medline; Medical Research Council [MR/L003120/1, G0801418, G0601261, MC_UP_1102/20, G0800509] Funding Source: Medline; NHGRI NIH HHS [5 U54 HG003067-13, U54HG003067, U41 HG000330, 5U54HG003067-11] Funding Source: Medline; NHLBI NIH HHS [HHSN268201300047C, K01 HL125751, HHSN268201300048C, T32 HL007208, R01HL107816, HHSN268201300050C, HHSN268201300049C, R01HL24799, HHSN268201300046C, K01HL125751] Funding Source: Medline; NIA NIH HHS [P30 AG038072] Funding Source: Medline; NIDDK NIH HHS [U01 DK085545, U54 DK105566, U01-DK085545, RC2F DK088389, R01DK098032, RC2DK088389, DK085545, U01 DK085526, U01 DK085524, U01 DK085584, R01DK062370, U01DK085526, R01 DK098032, P30 DK043351, DK088389, DK098032, U01 DK062370, RC2-DK088389, U01 DK085501, P30 DK020572, 1RC2DK088389] Funding Source: Medline; NIGMS NIH HHS [R01 GM104371, F32GM115208] Funding Source: Medline; NIMH NIH HHS [MH077139, MH089905, R01 MH077139, R01MH085521, MH095034, MH094421, U01 MH094432, 2P50MH066392-05A1, R01MH085560] Funding Source: Medline; NINDS NIH HHS [NS40024-09S1, U01 NS040024, U01 NS40024-09S1, NS085048, K02 NS085048] Funding Source: Medline; PHS HHS [NIMHRC2MH089905] Funding Source: Medline; Wellcome Trust [090367, 098381, 090532] Funding Source: Medline; Medical Research Council [MR/L010305/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10027, NF-SI-0513-10087, NF-SI-0507-10228, NF-SI-0611-10099, NF-SI-0611-10219] Funding Source: researchfish; Wellcome Trust [107469/Z/15/Z] Funding Source: researchfish; MRC [G0601261, G0800509, MR/L003120/1, G0801418, MC_UP_1102/20] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024799, R01HL107816, T32HL007208, K01HL125751] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U41HG000330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085526, P30DK043351, U01DK085545, RC2DK088389, U01DK062370, U54DK105566, R01DK062370, U01DK085501, P30DK020572, U01DK085584, R01DK098032, U01DK085524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104371, F32GM115208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089905, U01MH094421, R01MH095034, R01MH077139, U01MH094432, R01MH085560, R01MH085521, P50MH066392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS085048, U01NS040024, R01NS040024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038072] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); CIHR(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Chagnon P, 2002, AM J HUM GENET, V71, P1443, DOI 10.1086/344580; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dewey FE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005496; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kathiresan S, 2015, J AM COLL CARDIOL, V65, P1562, DOI 10.1016/j.jacc.2015.02.049; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Narasimhan V. M., 2016, SCIENCE; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Ruderfer D. M., 2016, NATURE GENET; Saleheen D., 2015, HUMAN KNOCKOUTS COHO; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	40	6503	6586	22	411	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					285	+		10.1038/nature19057	http://dx.doi.org/10.1038/nature19057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535533	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-24	WOS:000381804900026
J	Cohen, IG; Adashi, EY				Cohen, I. Glenn; Adashi, Eli Y.			The FDA is prohibited from going germline	SCIENCE			English	Editorial Material									[Cohen, I. Glenn] Harvard Univ, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Med Sci, Providence, RI 02903 USA	Harvard University; Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, Med Sci, Providence, RI 02903 USA.	eli_adashi@brown.edu						Adashi E. Y., 2012, JAMA FORUM REPROD FR; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Brennan Z., 2016, FDA SHOULD ALL MIT R; National Academies of Sciences Engineering and Medicine, 2016, PROJ SCI MED ETH CON; National Academies of Sciences Engineering and Medicine, 2015, HUM GEN ED INT SUMM; National Academies of Sciences Engineering and Medicine, 2016, MIT REPL TECHN ETH S; Rodriguez S, 2011, AM J BIOETHICS, V11, P20, DOI [10.1080/15265161.2010.546472, 10.1080/15265161.2011.563162]	7	28	28	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					545	546		10.1126/science.aag2960	http://dx.doi.org/10.1126/science.aag2960			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5YZ	27493171				2022-12-24	WOS:000381560900020
J	Dyer, O				Dyer, Owen			Ontario plans to stop funding high dose opioids	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Friesen KJ, 2016, CAN MED ASSOC J, V188, P648, DOI 10.1503/cmaj.150961; Gomes T, 2014, ADDICTION, V109, P1482, DOI 10.1111/add.12598; Ray WA, 2016, JAMA-J AM MED ASSOC, V315, P2415, DOI 10.1001/jama.2016.7789	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2016	354								i4300	10.1136/bmj.i4300	http://dx.doi.org/10.1136/bmj.i4300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CS	27488880				2022-12-24	WOS:000381080600007
J	Arendt, D; King, N; Carroll, SB; Wittkopp, P; Koonin, E; Kruglyak, L				Arendt, Detlev; King, Nicole; Carroll, Sean B.; Wittkopp, Patricia; Koonin, Eugene; Kruglyak, Leonid			Big Questions in Evolution	CELL			English	Editorial Material									[Arendt, Detlev] European Mol Biol Lab, Grenoble, France; [King, Nicole] Univ Calif Berkeley, HHMI, Berkeley, CA 94720 USA; [Carroll, Sean B.] Univ Wisconsin, HHMI, Madison, WI 53706 USA; [Wittkopp, Patricia] Univ Michigan, Ann Arbor, MI 48109 USA; [Koonin, Eugene] NIH, Bethesda, MD USA; [Kruglyak, Leonid] Univ Calif Los Angeles, HHMI, Los Angeles, CA 90024 USA	European Molecular Biology Laboratory (EMBL); Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Arendt, D (corresponding author), European Mol Biol Lab, Grenoble, France.								0	1	1	2	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					528	529		10.1016/j.cell.2016.07.021	http://dx.doi.org/10.1016/j.cell.2016.07.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471959	Bronze			2022-12-24	WOS:000380546500003
J	Nelson, KE; Rosella, LC; Mahant, S; Guttmann, A				Nelson, Katherine E.; Rosella, Laura C.; Mahant, Sanjay; Guttmann, Astrid			Survival and Surgical Interventions for Children With Trisomy 13 and 18	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH PREVALENCE; NATURAL-HISTORY; UNITED-STATES; TRISOMIES 13; INFANTS; CARE; MANAGEMENT; DEFECTS; TEXAS; AGE	IMPORTANCE Trisomy 13 and 18 are genetic diagnoses with characteristic physical features, organ anomalies, and neurodevelopmental disability. Most children with these disorders die shortly after birth, although limited data suggest some children survive longer. Surgeries are controversial, and little evidence is available about outcomes. OBJECTIVE To describe survival and utilization of any type of surgery among children with trisomy 13 and 18 born over a 21-year period in Ontario, Canada. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study used linked health administrative databases to identify children born in Ontario between April 1, 1991, and March 31, 2012, with a diagnosis code for trisomy 13 or 18 on a hospital record in the first year of life. Survival was calculated from birth and death dates; children living on March 31, 2013, were censored at their last clinical encounter. EXPOSURES All procedures classified as occurring in an operating room through March 31, 2013, were categorized as major, intermediate, or minor surgeries. MAIN OUTCOMES AND MEASURES Survival and surgical procedure utilization. RESULTS The cohorts included 174 children with trisomy 13 (mean [SD] birth weight, 2.5 [0.7] kg; 98 [56.3%] female); and 254 children with trisomy 18 (mean birth weight, 1.8 [0.7] kg; 157 [61.8%] female), with follow-up times of 0 to more than 7000 days. Median (interquartile range [IQR]) survival times were 12.5 (2-195) days for trisomy 13 and 9 (2-92) days for trisomy 18. Mean 1-year survival for trisomy 13 was 19.8%(95% CI, 14.2%-26.1%) and 12.6%(95% CI, 8.9%-17.1%) for trisomy 18. Ten-year survival for trisomy 13 was 12.9% (95% CI, 8.4%-18.5%) and 9.8%(95% CI, 6.4%-14.0%) for trisomy 18. Survival did not change over the study period. Forty-one children (23.6%) with trisomy 13 and 35 children (13.8%) with trisomy 18 underwent surgeries, ranging from myringotomy to complex cardiac repair. Median age at first surgery for trisomy 13 was 92 (IQR, 30.5-384.5) days and for trisomy 18, it was 205.5 (IQR, 20.0-518.0) days. Kaplan-Meier curves showed 1-year survival after first surgery of 70.7%(95% CI, 54.3%-82.2%; n = 23) for trisomy 13 and 68.6%(95% CI, 50.5%-81.2%; n = 29) for trisomy 18. CONCLUSIONS AND RELEVANCE Among children born with trisomy 13 or 18 in Ontario, early mortality was the most common outcome, but 10% to 13% survived for 10 years. Among children who underwent surgical interventions, 1-year survival was high.	[Nelson, Katherine E.] Hosp Sick Children, Pediat Adv Care Team, Toronto, ON, Canada; [Nelson, Katherine E.; Mahant, Sanjay; Guttmann, Astrid] Hosp Sick Children, Div Paediat Med, Dept Paediat, Toronto, ON, Canada; [Nelson, Katherine E.; Mahant, Sanjay; Guttmann, Astrid] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rosella, Laura C.; Guttmann, Astrid] Inst Clin Evaluat Sci, G1 06,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Mahant, Sanjay] CanChild Ctr Childhood Disabil Res, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; McMaster University	Guttmann, A (corresponding author), Inst Clin Evaluat Sci, G1 06,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	astrid.guttmann@ices.on.ca		Nelson, Katherine/0000-0002-8975-2262	Norman Saunders Complex Care Initiative at the Hospital for Sick Children, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC); Canadian Child Health Clinician Scientist Program; Clinician Scientist Training Program from the Hospital for Sick Children, Toronto, Canada; Canadian Institutes for Health Research Applied Chair in Reproductive and Child Health Services and Policy Research	Norman Saunders Complex Care Initiative at the Hospital for Sick Children, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canadian Child Health Clinician Scientist Program; Clinician Scientist Training Program from the Hospital for Sick Children, Toronto, Canada; Canadian Institutes for Health Research Applied Chair in Reproductive and Child Health Services and Policy Research	This study was funded by a grant from the Norman Saunders Complex Care Initiative at the Hospital for Sick Children, Toronto, Ontario, Canada. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI) and Service Canada. Dr Nelson reports receipt of support through the Canadian Child Health Clinician Scientist Program and the Clinician Scientist Training Program from the Hospital for Sick Children, Toronto, Canada. Dr Guttmann reports receipt of support from the Canadian Institutes for Health Research Applied Chair in Reproductive and Child Health Services and Policy Research.	BATY BJ, 1994, AM J MED GENET, V49, P189, DOI 10.1002/ajmg.1320490205; Boss RD, 2013, PEDIATRICS, V132, P161, DOI 10.1542/peds.2012-3643; Brewer C M, 2002, J Med Genet, V39, pe54, DOI 10.1136/jmg.39.9.e54; Bruns DA, 2013, J GENET DISOR GENET, V02, DOI [10.4172/2327-5790.1000103, DOI 10.4172/2327-5790.1000103]; Bruns D, 2014, AM J MED GENET A, V164, P610, DOI 10.1002/ajmg.a.36318; Bruns DA, 2015, AM J MED GENET A, V167, P1807, DOI 10.1002/ajmg.a.37102; Carey JC, 2012, CURR OPIN PEDIATR, V24, P672, DOI 10.1097/MOP.0b013e3283595031; Darling EK, 2014, PEDIATRICS, V134, pE1017, DOI 10.1542/peds.2014-1146; GOLDSTEIN H, 1988, CLIN GENET, V34, P366; Healthcare Cost and Utilization Project, PROC CLASS 2009 AG H; Irving C, 2011, J MATERN-FETAL NEO M, V24, P137, DOI 10.3109/14767051003758879; Janvier A, 2012, PEDIATRICS, V130, P293, DOI 10.1542/peds.2012-0151; Janvier A, 2011, PEDIATRICS, V127, P754, DOI 10.1542/peds.2010-1971; Jones KL., 2013, SMITHS RECOGNIZABLE, P14; Juurlink D, 2006, CANADIAN I HLTH INFO, P1; Kobayashi J, 2010, GEN THORAC CARDIOVAS, V58, P223, DOI 10.1007/s11748-009-0431-3; Kralji B, 2000, ONTARIO MED REV, V10, P33; Lorenz JM, 2014, CURR OPIN PEDIATR, V26, P169, DOI 10.1097/MOP.0000000000000076; Merritt TA, 2011, NEOREVIEWS, V13, pe40, DOI [10.1542/neo.13-1-e40, DOI 10.1542/NE0.13-1-E40]; Meyer RE, 2016, AM J MED GENET A, V170, P825, DOI 10.1002/ajmg.a.37495; Naguib KK, 1999, INT J EPIDEMIOL, V28, P711, DOI 10.1093/ije/28.4.711; Nelson KE, 2012, PEDIATRICS, V129, P869, DOI 10.1542/peds.2011-2139; Nembhard WN, 2001, TERATOLOGY, V64, P267, DOI 10.1002/tera.1073; Niedrist D, 2006, AM J MED GENET A, V140A, P952, DOI 10.1002/ajmg.a.31172; Nishi E, 2014, AM J MED GENET A, V164, P324, DOI 10.1002/ajmg.a.36294; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pont SJ, 2006, AM J MED GENET A, V140A, P1749, DOI 10.1002/ajmg.a.31382; Rasmussen SA, 2003, PEDIATRICS, V111, P777, DOI 10.1542/peds.111.4.777; ROOT S, 1994, AM J MED GENET, V49, P170, DOI 10.1002/ajmg.1320490203; Savva GM, 2010, PRENATAL DIAG, V30, P57, DOI 10.1002/pd.2403; Tennant PWG, 2010, LANCET, V375, P649, DOI 10.1016/S0140-6736(09)61922-X; Vendola C, 2010, AM J MED GENET A, V152A, P360, DOI 10.1002/ajmg.a.33156; Wang CN, 2009, ARCH PEDIAT ADOL MED, V163, P608, DOI 10.1001/archpediatrics.2009.36; Wang Y, 2011, BIRTH DEFECTS RES A, V91, P995, DOI 10.1002/bdra.22858; Wu JH, 2013, AM J MED GENET A, V161, P2512, DOI 10.1002/ajmg.a.36127; WYLLIE JP, 1994, ARCH DIS CHILD, V71, P343, DOI 10.1136/adc.71.4.343; YOUNG ID, 1986, ARCH DIS CHILD, V61, P1035, DOI 10.1136/adc.61.10.1035	37	102	103	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2016	316	4					420	428		10.1001/jama.2016.9819	http://dx.doi.org/10.1001/jama.2016.9819			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR9MV	27458947	Bronze			2022-12-24	WOS:000380221700020
J	Phan, KM; Nguyen, KH; Crum-Cianflone, NF				Phan, Kim M.; Nguyen, Katherine H.; Crum-Cianflone, Nancy F.			Cutaneous Necrosis of the Ears	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANTIPHOSPHOLIPID SYNDROME; UPDATE; PATHOGENESIS; ANTIBODIES; CRITERIA		[Phan, Kim M.; Nguyen, Katherine H.; Crum-Cianflone, Nancy F.] Scripps Mercy Hosp, Dept Grad Med Educ, 4077 Fifth Ave,MER35, San Diego, CA 92103 USA		Phan, KM (corresponding author), Scripps Mercy Hosp, Dept Grad Med Educ, 4077 Fifth Ave,MER35, San Diego, CA 92103 USA.	phan.kim@scrippshealth.org						BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Chighizola CB, 2015, CURR OPIN RHEUMATOL, V27, P476, DOI 10.1097/BOR.0000000000000200; DODD HJ, 1985, CLIN EXP DERMATOL, V10, P581, DOI 10.1111/j.1365-2230.1985.tb00627.x; ENG AM, 1994, SEMIN THROMB HEMOST, V20, P71, DOI 10.1055/s-2007-1001891; Jou IM, 1996, CLIN RHEUMATOL, V15, P394, DOI 10.1007/BF02230365; Lawrence LA, 2014, ALLERGY RHINOL, V5, pE132, DOI 10.2500/ar.2014.5.0101; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Paira S, 1999, J RHEUMATOL, V26, P1197	9	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2016	316	4					450	451		10.1001/jama.2016.7847	http://dx.doi.org/10.1001/jama.2016.7847			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR9MV	27458951				2022-12-24	WOS:000380221700024
J	Basta, NE; Mahmoud, AAF; Wolfson, J; Ploss, A; Heller, BL; Hanna, S; Johnsen, P; Izzo, R; Grenfell, BT; Findlow, J; Bai, XL; Borrow, R				Basta, Nicole E.; Mahmoud, Adel A. F.; Wolfson, Julian; Ploss, Alexander; Heller, Brigitte L.; Hanna, Sarah; Johnsen, Peter; Izzo, Robin; Grenfell, Bryan T.; Findlow, Jamie; Bai, Xilian; Borrow, Ray			Immunogenicity of a Meningococcal B Vaccine during a University Outbreak	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SERUM BACTERICIDAL ACTIVITY; SEROGROUP-B; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; STRAIN COVERAGE; INTERLABORATORY STANDARDIZATION; DISEASE RECOMMENDATIONS; OBSERVER-BLIND; 4CMENB; PREVENTION	BACKGROUND In December 2013, a multicomponent meningococcal serogroup B (4CMenB) vaccine was used before licensure on the basis of special consideration by the Food and Drug Administration to respond to an outbreak of Neisseria meningitidis B at a U.S. university. Data suggested that vaccination would control the outbreak because isolates expressed antigens that were closely related to the vaccine antigens (factor H-binding protein [fHbp] and neisserial heparin-binding antigen). We quantified the immune responses induced by 4CMenB during the outbreak. METHODS We conducted a seroprevalence survey among students to assess vaccination status and collect serum specimens to quantify titers of serum bactericidal antibodies (SBA) with an assay that included human complement (hSBA). We compared the proportion of vaccinated and unvaccinated participants who were seropositive for the outbreak strain and for one closely related reference strain (44/76-SL, which included fHbp) and one mismatched reference strain (5/99, which included neisserial adhesin A), both of which were used in vaccine development. Seropositivity was defined as an hSBA titer of 4 or higher. RESULTS Among the 499 participants who received two doses of the 4CMenB vaccine 10 weeks apart, 66.1% (95% confidence interval [CI], 61.8 to 70.3) were seropositive for the outbreak strain, although the geometric mean titer was low at 7.6 (95% CI, 6.7 to 8.5). Among a random subgroup of 61 vaccinees who also received two doses but did not have a detectable protective response to the outbreak strain, 86.9% (95% CI, 75.8 to 94.2) were seropositive for the 44/76-SL strain, for which there was a geometric mean titer of 17.4 (95% CI, 13.0 to 23.2), whereas 100% of these vaccinees (95% CI, 94.1 to 100) were seropositive for the 5/99 strain and had a higher geometric mean titer (256.3; 95% CI, 187.3 to 350.7). The response to the outbreak strain was moderately correlated with the response to the 44/76-SL strain (Pearson's correlation, 0.64; P<0.001) but not with the response to the 5/99 strain (Pearson's correlation, -0.06; P = 0.43). CONCLUSIONS Eight weeks after the second dose of the 4CMenB vaccine was administered, there was no evidence of an hSBA response against the outbreak strain in 33.9% of vaccinees, although no cases of meningococcal disease caused by N. meningitidis B were reported among vaccinated students. (Funded by Princeton University and others.)	[Basta, Nicole E.; Wolfson, Julian] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Basta, Nicole E.; Mahmoud, Adel A. F.; Ploss, Alexander; Heller, Brigitte L.; Hanna, Sarah; Johnsen, Peter; Izzo, Robin; Grenfell, Bryan T.] Princeton Univ, Princeton, NJ 08544 USA; [Basta, Nicole E.; Grenfell, Bryan T.] Natl Inst Hlth Res, Bethesda, MD USA; [Basta, Nicole E.; Grenfell, Bryan T.] Natl Inst Policy Infect Dis Dynam, Bethesda, MD USA; [Findlow, Jamie; Bai, Xilian; Borrow, Ray] Manchester Royal Infirm, Vaccine Evaluat Unit, Publ Hlth England, Manchester, Lancs, England	University of Minnesota System; University of Minnesota Twin Cities; Princeton University; National Institutes of Health (NIH) - USA; Public Health England; University of Manchester	Basta, NE (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, 1300 Second St S,Ste 300, Minneapolis, MN 55454 USA.	nebasta@umn.edu	Ploss, Alexander/ABG-2330-2020	Ploss, Alexander/0000-0001-9322-7252	Program on U.S. Health Policy at Princeton University; Health Grand Challenge at Princeton University; National Institutes of Health (NIH) Early Independence Award from the Office of the Director [1DP5OD009162]; Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate of the Department of Homeland Security; NIH Fogarty International Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879, P2CHD041023] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009162] Funding Source: NIH RePORTER	Program on U.S. Health Policy at Princeton University; Health Grand Challenge at Princeton University(Princeton University); National Institutes of Health (NIH) Early Independence Award from the Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate of the Department of Homeland Security(United States Department of Homeland Security (DHS)); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by grants from the Program on U.S. Health Policy at Princeton University and the Health Grand Challenge at Princeton University (to Dr. Basta), a National Institutes of Health (NIH) Early Independence Award from the Office of the Director (1DP5OD009162, to Dr. Basta), and a grant from the Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate of the Department of Homeland Security and the NIH Fogarty International Center (to Drs. Basta and Grenfell).	Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Borrow R, 2005, CLIN DIAGN LAB IMMUN, V12, P970, DOI 10.1128/CDLI.12.8.970-976.2005; Borrow R, 2006, HDB MENINGOCOCCAL DI, P323; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Claus H, 2012, VACCINE, V30, P155, DOI 10.1016/j.vaccine.2011.11.050; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Santolaya ME, 2012, LANCET, V379, P617, DOI 10.1016/S0140-6736(11)61713-3; Findlow J, 2015, VACCINE, V33, P3322, DOI 10.1016/j.vaccine.2015.05.027; FINNE J, 1983, LANCET, V2, P355; Folaranmi T, 2015, MMWR-MORBID MORTAL W, V64, P608; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Khatami A, 2010, EXPERT REV VACCINES, V9, P285, DOI 10.1586/ERV.10.3; MacNeil JR, 2015, MMWR-MORBID MORTAL W, V64, P1171, DOI 10.15585/mmwr.mm6441a3; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; McNamara LA, 2015, PEDIATRICS, V135, P798, DOI 10.1542/peds.2014-4015; Medini D, 2015, VACCINE, V33, P2629, DOI 10.1016/j.vaccine.2015.04.015; Nolan T, 2015, VACCINE, V33, P4437, DOI 10.1016/j.vaccine.2015.06.011; O'Ryan M, 2014, DRUGS, V74, P15, DOI 10.1007/s40265-013-0155-7; Oviedo-Orta E, 2015, VACCINE, V33, P3628, DOI 10.1016/j.vaccine.2015.06.046; Plikaytis BD, 2012, CLIN VACCINE IMMUNOL, V19, P1609, DOI 10.1128/CVI.00202-12; Poland GA, 2010, CLIN INFECT DIS, V50, pS45, DOI 10.1086/648964; Poolman JT, 2015, EXPERT REV VACCINES, V14, P1277, DOI 10.1586/14760584.2015.1071670; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Rossi R, 2015, CLIN VACCINE IMMUNOL, V22, P1227, DOI 10.1128/CVI.00474-15; Strikas RA, 2015, MMWR-MORBID MORTAL W, V64, P93; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9	28	59	60	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2016	375	3					220	228		10.1056/NEJMoa1514866	http://dx.doi.org/10.1056/NEJMoa1514866			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0ZL	27468058	Green Accepted, Bronze			2022-12-24	WOS:000380325400005
J	Baldridge, RD; Rapoport, TA				Baldridge, Ryan D.; Rapoport, Tom A.			Autoubiquitination of the Hrd1 Ligase Triggers Protein Retrotranslocation in ERAD	CELL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; QUALITY-CONTROL; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; UBIQUITIN; DISLOCATION; COMPLEX; MECHANISMS	Misfolded proteins of the ER are retrotranslocated to the cytosol, where they are polyubiquitinated, extracted from the membrane, and degraded by the proteasome. To investigate how the ER-associated Degradation ( ERAD) machinery can accomplish retrotranslocation of a misfolded luminal protein domain across a lipid bilayer, we have reconstituted retrotranslocation with purified S. cerevisiae proteins, using proteoliposomes containing the multispanning ubiquitin ligase Hrd1. Retrotranslocation of the luminal domain of a membrane-spanning substrate is triggered by autoubiquitination of Hrd1. Substrate ubiquitination is a subsequent event, and the Cdc48 ATPase that completes substrate extraction from the membrane is not required for retrotranslocation. Ubiquitination of lysines in Hrd1's RING-finger domain is required for substrate retrotranslocation in vitro and for ERAD in vivo. Our results suggest that Hrd1 forms a ubiquitin-gated protein-conducting channel.	[Baldridge, Ryan D.; Rapoport, Tom A.] Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA; [Baldridge, Ryan D.; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Baldridge, RD; Rapoport, TA (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.; Baldridge, RD; Rapoport, TA (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	ryan_baldridge@hms.harvard.edu; tom_rapoport@hms.harvard.edu		Baldridge, Ryan/0000-0001-7158-7812	NIH/NIGMS [R01GM052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Nicholas Bodnar, Stefan Schoebel, and Alexander Stein for help with some in vitro experiments and Neil Blok, Stefan Schoebel, Alexander Stein, and Xudong Wu for their critical reading of the manuscript. We also thank the ICCB-Longwood Screening Facility at Harvard Medical School for access to the M5 plate reader. This work is supported by the NIH/NIGMS Award R01GM052586. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. R.D.B. is the Fraternal Order of Eagles Fellow of the Damon Runyon Cancer Research Foundation, DRG-2184-14. T.A.R. is a Howard Hughes Medical Institute Investigator.	Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Collinson I., 2015, PHILOS T R SOC LON B, P370; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Khmelinskii A, 2014, NATURE, V516, P410, DOI 10.1038/nature14096; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Mehnert M, 2014, NAT CELL BIOL, V16, P77, DOI 10.1038/ncb2882; Morris LL, 2014, J BIOL CHEM, V289, P19053, DOI 10.1074/jbc.M114.576652; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wang GL, 1999, MOL CELL BIOL, V19, P342; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2013, J BIOL CHEM, V288, P23295, DOI 10.1074/jbc.M113.482018; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852	43	119	120	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					394	407		10.1016/j.cell.2016.05.048	http://dx.doi.org/10.1016/j.cell.2016.05.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27321670	Green Accepted, Bronze			2022-12-24	WOS:000380255400017
J	Kissig, M; Shapira, SN; Seale, P				Kissig, Megan; Shapira, Suzanne N.; Seale, Patrick			SnapShot: Brown and Beige Adipose Thermogenesis	CELL			English	Editorial Material							FAT		[Kissig, Megan] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Kissig, M (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.				NIDDK NIH HHS [R01 DK103008] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103008] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Shao ML, 2016, CELL METAB, V23, P1167, DOI 10.1016/j.cmet.2016.04.023	4	29	36	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					258	U296		10.1016/j.cell.2016.06.038	http://dx.doi.org/10.1016/j.cell.2016.06.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368105	Green Accepted, Bronze			2022-12-24	WOS:000380254400026
J	Metzger, MJ; Villalba, A; Carballal, MJ; Iglesias, D; Sherry, J; Reinisch, C; Muttray, AF; Baldwin, SA; Goff, SP				Metzger, Michael J.; Villalba, Antonio; Carballal, Maria J.; Iglesias, David; Sherry, James; Reinisch, Carol; Muttray, Annette F.; Baldwin, Susan A.; Goff, Stephen P.			Widespread transmission of independent cancer lineages within multiple bivalve species	NATURE			English	Article							HEMIC NEOPLASIA; CERASTODERMA-EDULE; MYTILUS-TROSSULUS; EVOLUTION; POPULATIONS; VENERIDAE; SEQUENCE; DISEASES; MUSSELS; CELLS	Most cancers arise from oncogenic changes in the genomes of somatic cells, and while the cells may migrate by metastasis, they remain within that single individual. Natural transmission of cancer cells from one individual to another has been observed in two distinct cases in mammals (Tasmanian devils(1) and dogs(2,3)), but these are generally considered to be rare exceptions in nature. The discovery of transmissible cancer in soft-shell clams (Mya arenaria)(4) suggested that this phenomenon might be more widespread. Here we analyse disseminated neoplasia in mussels (Mytilus trossulus), cockles (Cerastoderma edule), and golden carpet shell clams (Polititapes aureus) and find that neoplasias in all three species are attributable to independent transmissible cancer lineages. In mussels and cockles, the cancer lineages are derived from their respective host species; however, unexpectedly, cancer cells in P. aureus are all derived from Venerupis corrugata, a different species living in the same geographical area. No cases of disseminated neoplasia have thus far been found in V. corrugata from the same region. These findings show that transmission of cancer cells in the marine environment is common in multiple species, that it has originated many times, and that while most transmissible cancers are found spreading within the species of origin, cross-species transmission of cancer cells can occur.	[Metzger, Michael J.; Goff, Stephen P.] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA; [Metzger, Michael J.; Goff, Stephen P.] Howard Hughes Med Inst, New York, NY 10032 USA; [Villalba, Antonio; Carballal, Maria J.; Iglesias, David] Conselleria Mar, Ctr Invest Marinas, Xunta De Galicia 36620, Vilanova De Aro, Spain; [Villalba, Antonio] Univ Alcala de Henares, Dept Life Sci, E-28871 Alcala De Henares, Spain; [Sherry, James; Reinisch, Carol] Environm Canada, Water Sci & Technol Directorate, Burlington, ON L7R 4A6, Canada; [Muttray, Annette F.; Baldwin, Susan A.] Univ British Columbia, Chem & Biol Engn, Vancouver, BC V6T 1Z3, Canada; [Muttray, Annette F.] SLR Consulting Canada Ltd, Vancouver, BC V6J 1V4, Canada; [Goff, Stephen P.] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Universidad de Alcala; Environment & Climate Change Canada; University of British Columbia; Columbia University	Goff, SP (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.; Goff, SP (corresponding author), Howard Hughes Med Inst, New York, NY 10032 USA.; Goff, SP (corresponding author), Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA.	spg1@cumc.columbia.edu	Iglesias, David/F-9123-2013; Goff, Stephen P/K-6337-2014; Villalba, Antonio/E-3621-2013; Metzger, Michael/AAA-3635-2022	Iglesias, David/0000-0003-2127-7757; Goff, Stephen P/0000-0003-0693-5547; Villalba, Antonio/0000-0001-8049-0502; Metzger, Michael/0000-0001-7855-1388	Howard Hughes Medical Institute and Training Grant [T32 CA009503]; Conselleria do Mar da Xunta de Galicia, through the project PGIDIT-CIMA [13/03]; NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER	Howard Hughes Medical Institute and Training Grant; Conselleria do Mar da Xunta de Galicia, through the project PGIDIT-CIMA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M.J.M. and S.P.G. were supported by the Howard Hughes Medical Institute and Training Grant T32 CA009503. D.I., M.J.C., and A.V. were supported by the Conselleria do Mar da Xunta de Galicia, through the project PGIDIT-CIMA 13/03. We thank J. Ausio for help in collection of M. trossulus from Vancouver Island.	Arriagada G, 2014, P NATL ACAD SCI USA, V111, P14175, DOI 10.1073/pnas.1409945111; Barber BJ, 2004, AQUAT LIVING RESOUR, V17, P449, DOI 10.1051/alr:2004052; Canapa A, 2003, MAR BIOL, V142, P1125, DOI 10.1007/s00227-003-1048-1; Carballal MJ, 2013, J INVERTEBR PATHOL, V112, P16, DOI 10.1016/j.jip.2012.10.003; Carballal ML, 2015, J INVERTEBR PATHOL, V131, P83, DOI 10.1016/j.jip.2015.06.004; Carballal MJ, 2001, J INVERTEBR PATHOL, V78, P87, DOI 10.1006/jipa.2001.5049; COCKRILL JM, 1979, AM J VET RES, V40, P409; Diaz S, 2010, DIS AQUAT ORGAN, V90, P215, DOI 10.3354/dao02231; Diaz S., 2016, J FISH DIS; Dungern V., 1912, MUNCHEN MED WOCHEN, P238; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Howard D., 2004, NOAA TECHNICAL MEMOR, V5; Iglesias D., 2006, THESIS; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; KENT ML, 1991, J INVERTEBR PATHOL, V57, P435, DOI 10.1016/0022-2011(91)90148-J; Martinez L, 2009, CONSERV GENET RESOUR, V1, P107, DOI 10.1007/s12686-009-9026-7; Mateo D. R., 2015, J FISH DIS; Metzger MJ, 2015, CELL, V161, P255, DOI 10.1016/j.cell.2015.02.042; MOORE JD, 1991, J INVERTEBR PATHOL, V58, P231, DOI 10.1016/0022-2011(91)90067-Z; Muehlenbachs A, 2015, NEW ENGL J MED, V373, P1845, DOI 10.1056/NEJMoa1505892; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Muttray AF, 2008, MAR ENVIRON RES, V66, P412, DOI 10.1016/j.marenvres.2008.06.004; Oliverio M, 2001, J MOLLUS STUD, V67, P243, DOI 10.1093/mollus/67.2.243; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pye RJ, 2016, P NATL ACAD SCI USA, V113, P374, DOI 10.1073/pnas.1519691113; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Rodzen JA, 2002, GENOME, V45, P1064, DOI [10.1139/g02-083, 10.1139/G02-083]; Salvi D, 2012, MOL PHYLOGENET EVOL, V65, P792, DOI 10.1016/j.ympev.2012.07.017; Samso A., 1965, THESIS; Sticker A., 1906, Z KREBSFORSCH, V4, P227; Strakova A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0168-9; Vassilenko E, 2014, J INVERTEBR PATHOL, V117, P68, DOI 10.1016/j.jip.2014.02.002; Vassilenko EI, 2010, MUTAT RES-GEN TOX EN, V701, P145, DOI 10.1016/j.mrgentox.2010.06.001; Villalba A, 2001, DIS AQUAT ORGAN, V46, P213, DOI 10.3354/dao046213; Wade H, 1908, J PATHOL BACTERIOL, V12, P384, DOI 10.1002/path.1700120221	36	111	115	3	126	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					705	+		10.1038/nature18599	http://dx.doi.org/10.1038/nature18599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27338791	Green Accepted			2022-12-24	WOS:000378676000041
J	Shigeoka, T; Jung, H; Jung, J; Turner-Bridger, B; Ohk, J; Lin, JLQJ; Amieux, PS; Holt, CE				Shigeoka, Toshiaki; Jung, Hosung; Jung, Jane; Turner-Bridger, Benita; Ohk, Jiyeon; Lin, Julie Qiaojin; Amieux, Paul S.; Holt, Christine E.			Dynamic Axonal Translation in Developing and Mature Visual Circuits	CELL			English	Article							LOCAL PROTEIN-SYNTHESIS; MESSENGER-RNA LOCALIZATION; RETINAL GROWTH CONES; INTRAAXONAL TRANSLATION; CHEMOTROPIC RESPONSES; SYMPATHETIC NEURONS; SYNAPTIC PLASTICITY; BINDING PROTEIN; REVEALS; SIGNAL	Local mRNA translation mediates the adaptive responses of axons to extrinsic signals, but direct evidence that it occurs in mammalian CNS axons in vivo is scant. We developed an axon-TRAP-RiboTag approach in mouse that allows deep-sequencing analysis of ribosome-bound mRNAs in the retinal ganglion cell axons of the developing and adult retinotectal projection in vivo. The embryonic-to-postnatal axonal translatome comprises an evolving subset of enriched genes with axon-specific roles, suggesting distinct steps in axon wiring, such as elongation, pruning, and synaptogenesis. Adult axons, remarkably, have a complex translatome with strong links to axon survival, neurotransmission, and neurodegenerative disease. Translationally coregulated mRNA subsets share common upstream regulators, and sequence elements generated by alternative splicing promote axonal mRNA translation. Our results indicate that intricate regulation of compartment-specific mRNA translation in mammalian CNS axons supports the formation and maintenance of neural circuits in vivo.	[Shigeoka, Toshiaki; Turner-Bridger, Benita; Lin, Julie Qiaojin; Holt, Christine E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England; [Jung, Hosung; Jung, Jane; Ohk, Jiyeon] Yonsei Univ, Coll Med, Brain Res Inst, Dept Anat, Seoul 03722, South Korea; [Jung, Hosung; Jung, Jane; Ohk, Jiyeon] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea; [Amieux, Paul S.] Bastyr Univ, Res Inst, Kenmore, WA 98028 USA	University of Cambridge; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Holt, CE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.; Jung, H (corresponding author), Yonsei Univ, Coll Med, Brain Res Inst, Dept Anat, Seoul 03722, South Korea.; Jung, H (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea.	hosungjung@yonsei.ac.kr; ceh33@cam.ac.uk	Jung, Hosung/A-4401-2012; Amieux, Paul/AAG-4102-2021; Lin, Julie Qiaojin/AAY-5309-2020; Lin, Qiaojin/ABA-3382-2020	Jung, Hosung/0000-0002-5059-8050; Lin, Julie Qiaojin/0000-0002-2669-6478; Lin, Qiaojin/0000-0002-2669-6478; Holt, Christine Elizabeth/0000-0003-2829-121X; Turner-Bridger, Benita/0000-0003-3718-3632	Wellcome Trust Programme Grant [085314/Z/08/Z]; European Research Council Advanced Grant [322817]; Cambridge Wellcome Trust PhD programme in Developmental Biology; Gates Cambridge Scholarship; Basic Science Research Program [NRF-2013R1A1A1009625, NRF-2014K2A7A1036305]; Biomedical Technology Development Program [NRF-2013M3A9D5072551]; Brain Research Program through the NRF by the Korean government (MSIP) [NRF-2015M3C7A1028396]; Yonsei University Future-Leading Research Initiative [2015-22-0095]; faculty research grant from Yonsei University College of Medicine [6-2013-0064-2-1]	Wellcome Trust Programme Grant(Wellcome Trust); European Research Council Advanced Grant(European Research Council (ERC)); Cambridge Wellcome Trust PhD programme in Developmental Biology; Gates Cambridge Scholarship; Basic Science Research Program; Biomedical Technology Development Program; Brain Research Program through the NRF by the Korean government (MSIP); Yonsei University Future-Leading Research Initiative; faculty research grant from Yonsei University College of Medicine	We apologize to authors of key papers, which we could not cite due to space limitations. We thank W. Harris for many valuable discussions and critical reading of the manuscript. We thank A. Riccio for myr-d2EGFP; J. Skepper for EM; Gihoon Son for advice on IPA; M. Minett for advice on mouse genetics; and K. Mooslehner, A. Dwivedy, and Jeeun Song for technical assistance. This work was supported by Wellcome Trust Programme Grant (085314/Z/08/Z), European Research Council Advanced Grant (322817) to C.E.H., Cambridge Wellcome Trust PhD programme in Developmental Biology (to B.T.-B.), Gates Cambridge Scholarship (to J.Q.L.), Basic Science Research Program (NRF-2013R1A1A1009625 and NRF-2014K2A7A1036305), Biomedical Technology Development Program (NRF-2013M3A9D5072551), Brain Research Program (NRF-2015M3C7A1028396) funded through the NRF by the Korean government (MSIP), Yonsei University Future-Leading Research Initiative of 2015 (2015-22-0095), and a faculty research grant from Yonsei University College of Medicine for 2013 (6-2013-0064-2-1) to H.J.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Andreassi C, 2010, NAT NEUROSCI, V13, P291, DOI 10.1038/nn.2486; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Baleriola J, 2014, CELL, V158, P1159, DOI 10.1016/j.cell.2014.07.001; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Campbell DS, 2013, J CELL BIOL, V203, P657, DOI 10.1083/jcb.201303072; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Cosker KE, 2016, NAT NEUROSCI, V19, P690, DOI 10.1038/nn.4280; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Darnell JC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012344; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Ellis JM, 2013, MOL CELL BIOL, V33, P1869, DOI 10.1128/MCB.01548-12; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Graber TE, 2013, P NATL ACAD SCI USA, V110, P16205, DOI 10.1073/pnas.1307747110; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hillefors M, 2007, CELL MOL NEUROBIOL, V27, P701, DOI 10.1007/s10571-007-9148-y; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ji SJ, 2012, NEURON, V74, P95, DOI 10.1016/j.neuron.2012.02.022; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim E, 2015, BMB REP, V48, P139, DOI 10.5483/BMBRep.2015.48.3.010; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; Kun A, 2007, J NEUROSCI RES, V85, P2087, DOI 10.1002/jnr.21340; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Preitner N, 2014, CELL, V158, P368, DOI 10.1016/j.cell.2014.05.042; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Sasaki Y, 2014, DEV NEUROBIOL, V74, P397, DOI 10.1002/dneu.22113; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Spillane M, 2013, CELL REP, V5, P1564, DOI 10.1016/j.celrep.2013.11.022; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Verheijen MHG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087255; Walker BA, 2012, GENE THER, V19, P947, DOI 10.1038/gt.2011.217; Yoon BC, 2012, CELL, V148, P752, DOI 10.1016/j.cell.2011.11.064; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhang KX, 2016, CELL REP, V14, P1258, DOI 10.1016/j.celrep.2015.12.102; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	53	246	247	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					181	192		10.1016/j.cell.2016.05.029	http://dx.doi.org/10.1016/j.cell.2016.05.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27321671	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000380254400020
J	Hu, JC; Laviana, A; Sedrakyan, A				Hu, Jim C.; Laviana, Aaron; Sedrakyan, Art			High-Intensity Focused Ultrasound for Prostate Cancer Novelty or Innovation?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THERAPY		[Hu, Jim C.] Weill Cornell Med, Dept Urol, 525 E 68th St,Starr 946, New York, NY 10065 USA; [Laviana, Aaron] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Sedrakyan, Art] Weill Cornell Med, Dept Healthcare Policy & Res, 525 E 68th St,Starr 946, New York, NY 10065 USA	Cornell University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University	Hu, JC (corresponding author), Weill Cornell Med, Dept Urol, 525 E 68th St,Starr 946, New York, NY 10065 USA.	jch9011@med.cornell.edu			FDA HHS [U01 FD005478] Funding Source: Medline; FOOD AND DRUG ADMINISTRATION [U01FD005478] Funding Source: NIH RePORTER	FDA HHS; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)		Ahmed HU, 2015, EUR UROL, V68, P927, DOI 10.1016/j.eururo.2015.01.030; Cooperberg MR, 2015, JAMA-J AM MED ASSOC, V314, P80, DOI 10.1001/jama.2015.6036; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Laviana AA, 2016, CANCER-AM CANCER SOC, V122, P447, DOI 10.1002/cncr.29743; Lee SM, 2014, DOCTORS PAY UNAPPROV; Rewcastle JC, 2014, IMAGE GUIDED PROSTAT, P255; Sinnott M, 2012, PROSTATE, V72, P1179, DOI 10.1002/pros.22467; US Food and Drug Administration (FDA), 2015, PUBL WORKSH AUA FDA; Warmuth M, 2010, EUR UROL, V58, P803, DOI 10.1016/j.eururo.2010.09.009	9	7	8	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2659	2660		10.1001/jama.2016.5002	http://dx.doi.org/10.1001/jama.2016.5002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27367874				2022-12-24	WOS:000378709300011
J	Simoes-Costa, M; Bronner, ME				Simoes-Costa, Marcos; Bronner, Marianne E.			Reprogramming of avian neural crest axial identity and cell fate	SCIENCE			English	Article							EVOLUTION; REVEALS; NEURONS	Neural crest populations along the embryonic body axis of vertebrates differ in developmental potential and fate, so that only the cranial neural crest can contribute to the craniofacial skeleton in vivo. We explored the regulatory program that imbues the cranial crest with its specialized features. Using axial-level specific enhancers to isolate and perform genome-wide profiling of the cranial versus trunk neural crest in chick embryos, we identified and characterized regulatory relationships between a set of cranial-specific transcription factors. Introducing components of this circuit into neural crest cells of the trunk alters their identity and endows these cells with the ability to give rise to chondroblasts in vivo. Our results demonstrate that gene regulatory circuits that support the formation of particular neural crest derivatives may be used to reprogram specific neural crest-derived cell types.	[Simoes-Costa, Marcos; Bronner, Marianne E.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Simoes-Costa, Marcos] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	California Institute of Technology; Cornell University	Bronner, ME (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mbronner@caltech.edu	Simoes-Costa, Marcos/AAX-4780-2020	Bronner, Marianne/0000-0003-4274-1862	NIH [DE024157, HD037105, K99DE024232]; Pew Fellows Program in Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024157, K99DE024232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Fellows Program in Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Tan-Cabugao, M. Stone, B. Jun, and D. S. E. Koo for technical assistance. The Caltech Millard and Muriel Jacobs Genetics and Genomics Laboratory provided sequencing and bioinformatics support. We are indebted to D. Perez, K. Beadle, and R. Diamond for cell- sorting assistance at the Caltech Flow Cytometry Cell Sorting Facility. We also thank M. Barembaum for the Sox8 and Tfap2b expression constructs. This work was supported by NIH grants DE024157 and HD037105 to M. E. B. M. S.-C. was funded by a fellowship from the Pew Fellows Program in Biomedical Sciences and by NIH grant K99DE024232. The supplementary materials contain additional data.	Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Dyachuk V, 2014, SCIENCE, V345, P82, DOI 10.1126/science.1253281; Green SA, 2015, NATURE, V520, P474, DOI 10.1038/nature14436; Le Douarin N.M., 1982, NEURAL CREST; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; LELIEVRE CS, 1980, DEV BIOL, V77, P362, DOI 10.1016/0012-1606(80)90481-9; Lwigale PY, 2004, DEVELOPMENT, V131, P1979, DOI 10.1242/dev.01106; Simoes-Costa M, 2015, DEV CELL, V34, P544, DOI 10.1016/j.devcel.2015.06.024; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Simoes-Costa M, 2014, GENOME RES, V24, P281, DOI 10.1101/gr.161182.113; Simoes-Costa M, 2013, GENOME RES, V23, P1069, DOI 10.1101/gr.157586.113; Simoes-Costa MS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003142; Uesaka T, 2015, J NEUROSCI, V35, P9879, DOI 10.1523/JNEUROSCI.1239-15.2015	13	87	87	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1570	1573		10.1126/science.aaf2729	http://dx.doi.org/10.1126/science.aaf2729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339986	Green Accepted			2022-12-24	WOS:000378346500042
J	Watson, J				Watson, James			Bring climate change back from the future	NATURE			English	Editorial Material									[Watson, James] Univ Queensland, Brisbane, Qld, Australia; [Watson, James] Soc Conservat Biol, Brisbane, Qld, Australia; [Watson, James] Wildlife Conservat Soc, Sci & Res Initiat, Brisbane, Qld, Australia	University of Queensland	Watson, J (corresponding author), Univ Queensland, Brisbane, Qld, Australia.; Watson, J (corresponding author), Soc Conservat Biol, Brisbane, Qld, Australia.; Watson, J (corresponding author), Wildlife Conservat Soc, Sci & Res Initiat, Brisbane, Qld, Australia.	jwatson@wcs.org	Watson, James Edward Maxwell/D-8779-2013	Watson, James Edward Maxwell/0000-0003-4942-1984					0	17	17	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					437	437		10.1038/534437a	http://dx.doi.org/10.1038/534437a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP1SS	27337304	Bronze			2022-12-24	WOS:000378270300005
J	Cambronne, XA; Stewart, ML; Kim, D; Jones-Brunette, AM; Morgan, RK; Farrens, DL; Cohen, MS; Goodman, RH				Cambronne, Xiaolu A.; Stewart, Melissa L.; Kim, DongHo; Jones-Brunette, Amber M.; Morgan, Rory K.; Farrens, David L.; Cohen, Michael S.; Goodman, Richard H.			Biosensor reveals multiple sources for mitochondrial NAD(+)	SCIENCE			English	Article							NICOTINAMIDE; COMPARTMENTATION; TRANSPORTER; METABOLISM	Nicotinamide adenine dinucleotide (NAD(+)) is an essential substrate for sirtuins and poly(adenosine diphosphate-ribose) polymerases (PARPs), which are NAD(+)-consuming enzymes localized in the nucleus, cytosol, and mitochondria. Fluctuations in NAD(+) concentrations within these subcellular compartments are thought to regulate the activity of NAD(+)-consuming enzymes; however, the challenge in measuring compartmentalized NAD(+) in cells has precluded direct evidence for this type of regulation. We describe the development of a genetically encoded fluorescent biosensor for directly monitoring free NAD(+) concentrations in subcellular compartments. We found that the concentrations of free NAD(+) in the nucleus, cytoplasm, and mitochondria approximate the Michaelis constants for sirtuins and PARPs in their respective compartments. Systematic depletion of enzymes that catalyze the final step of NAD(+) biosynthesis revealed cell-specific mechanisms for maintaining mitochondria! NAD(+) concentrations.	[Cambronne, Xiaolu A.; Stewart, Melissa L.; Kim, DongHo; Goodman, Richard H.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Jones-Brunette, Amber M.; Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Morgan, Rory K.; Cohen, Michael S.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Cambronne, XA (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.; Cohen, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA.	ang@ohsu.edu; cohenmic@ohsu.edu	Cambronne, Xiaolu Ang/GRY-7149-2022	Cambronne, Xiaolu Ang/0000-0002-3547-448X; Morgan, Rory/0000-0003-0194-0304	Pew Charitable Trust; NIH [NS088629, UL1TR000128, P30NS061800, P30CA069533]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800, R01NS088629] Funding Source: NIH RePORTER	Pew Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NAD<SUP>+</SUP> sensors are available from Oregon Health & Science University (OHSU) under a material transfer agreement with the authors. We thank D. Piston for guidance and the cpVenus construct: C. Brenner and M. Michaud for NR, E. Cambronne for the Enterococcus fecalis isolate, J. Wiedrick and S. Markwardt for statistical help G. Mandel for critical reading of the manuscript, and P. Brehm, J. and C. Galbraith, H. Zhang, and R. Hanson for helpful discussions. Imaging, flow cytometry: and high-performance liquid chromatography were supported by OHSU core facilities. This work was supported by the Pew Charitable Trust and the NIH (grants NS088629, UL1TR000128, P30NS061800, and P30CA069533). X.A.C., M.L.S., M.S.C. and R.H.G. are inventors on pawns PCT/US15/62003 for the NAD<SUP>+</SUP> sensor. Materials and methods are described in the supplementary materials.	Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; Gajiwala KS, 2004, STRUCTURE, V12, P1449, DOI 10.1016/j.str.2004.05.017; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hicks AN, 2013, NEUROUROL URODYNAM, V32, P1130, DOI 10.1002/nau.22372; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Tantama M, 2012, PROG BRAIN RES, V196, P235, DOI 10.1016/B978-0-444-59426-6.00012-4; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200	16	223	229	12	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1474	1477		10.1126/science.aad5168	http://dx.doi.org/10.1126/science.aad5168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313049	Green Accepted			2022-12-24	WOS:000377975400053
J	Morisaki, T; Lyon, K; DeLuca, KF; DeLuca, JG; English, BP; Zhang, ZJ; Lavis, LD; Grimm, JB; Viswanathan, S; Looger, LL; Lionnet, T; Stasevich, TJ				Morisaki, Tatsuya; Lyon, Kenneth; DeLuca, Keith F.; DeLuca, Jennifer G.; English, Brian P.; Zhang, Zhengjian; Lavis, Luke D.; Grimm, Jonathan B.; Viswanathan, Sarada; Looger, Loren L.; Lionnet, Timothee; Stasevich, Timothy J.			Real-time quantification of single RNA translation dynamics in living cells	SCIENCE			English	Article							GENE-EXPRESSION; TRANSCRIPTION; MICROSCOPY; INITIATION; POLYSOMES; MOLECULE; YEAST	Although messenger RNA (mRNA) translation is a fundamental biological process, it has never been imaged in real time in vivo with single-molecule precision. To achieve this, we developed nascent chain tracking (NCT), a technique that uses multi-epitope tags and antibody-based fluorescent probes to quantify protein synthesis dynamics at the single-mRNA level. NCT reveals an elongation rate of similar to 10 amino acids per second, with initiation occurring stochastically every similar to 30 seconds. Polysomes contain similar to 1 ribosome every 200 to 900 nucleotides and are globular rather than elongated in shape. By developing multicolor probes, we showed that most polysomes act independently; however, a small fraction (similar to 5%) form complexes in which two distinct mRNAs can be translated simultaneously. The sensitivity and versatility of NCT make it a powerful new tool for quantifying mRNA translation kinetics.	[Morisaki, Tatsuya; Lyon, Kenneth; DeLuca, Keith F.; DeLuca, Jennifer G.; Stasevich, Timothy J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [English, Brian P.; Zhang, Zhengjian; Lavis, Luke D.; Grimm, Jonathan B.; Viswanathan, Sarada; Looger, Loren L.; Lionnet, Timothee] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA	Colorado State University; Howard Hughes Medical Institute	Stasevich, TJ (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	tim.stasevich@colostate.edu	English, Brian P/O-8156-2016	English, Brian P/0000-0002-4037-6294; Morisaki, Tatsuya/0000-0001-7401-4673; Lionnet, Timothee/0000-0003-1508-0202	Colorado State University	Colorado State University	This work was supported by start-up funds from Colorado State University. We thank R. Cohen, F. Scavone, H. Kimura, S. DiPietro, A. Ambrosio, L Stargell, A. Thurston, and J. Chao for help with experiments. We thank Wu et al. (25) for sharing their preliminary data and. the Transcription Imaging Consortium at the Janelia Research Campus of the Howard Hughes Medical Institute for creating the environment that made our interactions and discussions possible. T.M. and T.J.S. planned, analyzed, and carried out all experiments except for microinjections. T.J.S., I.M. and K.L. wrote the manuscript. K.L. helped with plasmid costruction and transfections cell culture analysis, Western blotting and figures. K.F.D. and J.G.D. performed microinjections. B.P.E. provided guidance to the multicolor single-molecule microscopy. Z.Z. purified Halo-MCP. L.L.L. and S.V. provided HA and FLAG SM constructs. L.D.L. and J.B.G. provided fluorophores. T.L. provided help with experimental design.	Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; Chao J. A., 2012, COLD SPRING HARB PER, V4; Christensen AK, 1999, ANAT REC, V255, P116, DOI 10.1002/(SICI)1097-0185(19990601)255:2<116::AID-AR2>3.0.CO;2-O; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Halstead JM, 2015, SCIENCE, V347, P1367, DOI 10.1126/science.aaa3380; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson R, 2015, RNA, V21, P652, DOI 10.1261/rna.049908.115; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Mueller F, 2012, BIOPHYS J, V102, P1656, DOI 10.1016/j.bpj.2012.02.029; PALMITER RD, 1975, CELL, V4, P189, DOI 10.1016/0092-8674(75)90167-1; Shieh YW, 2015, SCIENCE, V350, P678, DOI 10.1126/science.aac8171; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Viero G, 2015, J CELL BIOL, V208, P581, DOI 10.1083/jcb.201406040; Viswanathan S, 2015, NAT METHODS, V12, P568, DOI 10.1038/nmeth.3365; WARNER JR, 1962, SCIENCE, V138, P1399, DOI 10.1126/science.138.3548.1399; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Wu B, 2016, SCIENCE, V352, P1430, DOI 10.1126/science.aaf1084; Yang JR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001910; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	26	209	215	4	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1425	1429		10.1126/science.aaf0899	http://dx.doi.org/10.1126/science.aaf0899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313040				2022-12-24	WOS:000377975400041
J	Thienpont, B; Steinbacher, J; Zhao, H; D'Anna, F; Kuchnio, A; Ploumakis, A; Ghesquiere, B; Van Dyck, L; Boeckx, B; Schoonjans, L; Hermans, E; Amant, F; Kristensen, VN; Koh, KP; Mazzone, M; Coleman, ML; Carell, T; Carmeliet, P; Lambrechts, D				Thienpont, Bernard; Steinbacher, Jessica; Zhao, Hui; D'Anna, Flora; Kuchnio, Anna; Ploumakis, Athanasios; Ghesquiere, Bart; Van Dyck, Laurien; Boeckx, Bram; Schoonjans, Luc; Hermans, Els; Amant, Frederic; Kristensen, Vessela N.; Koh, Kian Peng; Mazzone, Massimiliano; Coleman, Mathew L.; Carell, Thomas; Carmeliet, Peter; Lambrechts, Diether			Tumour hypoxia causes DNA hyper-methylation by reducing TET activity	NATURE			English	Article							CANCER; 5-METHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; HYDROXYLASES; METASTASIS; EXPRESSION; MUTATIONS; PHENOTYPE; SUCCINATE; FUMARATE	Hypermethylation of the promoters of tumour suppressor genes represses transcription of these genes, conferring growth advantages to cancer cells. How these changes arise is poorly understood. Here we show that the activity of oxygen-dependent ten-eleven translocation (TET) enzymes is reduced by tumour hypoxia in human and mouse cells. TET enzymes catalyse DNA demethylation through 5-methylcytosine oxidation. This reduction in activity occurs independently of hypoxia-associated alterations in TET expression, proliferation, metabolism, hypoxia-inducible factor activity or reactive oxygen species, and depends directly on oxygen shortage. Hypoxia-induced loss of TET activity increases hypermethylation at gene promoters in vitro. In patients, tumour suppressor gene promoters are markedly more methylated in hypoxic tumour tissue, independent of proliferation, stromal cell infiltration and tumour characteristics. Our data suggest that up to half of hypermethylation events are due to hypoxia, with these events conferring a selective advantage. Accordingly, increased hypoxia in mouse breast tumours increases hypermethylation, while restoration of tumour oxygenation abrogates this effect. Tumour hypoxia therefore acts as a novel regulator of DNA methylation.	[Thienpont, Bernard; Zhao, Hui; D'Anna, Flora; Kuchnio, Anna; Ghesquiere, Bart; Van Dyck, Laurien; Boeckx, Bram; Schoonjans, Luc; Mazzone, Massimiliano; Carmeliet, Peter; Lambrechts, Diether] VIB, Vesalius Res Ctr, B-3000 Leuven, Belgium; [Thienpont, Bernard; Zhao, Hui; D'Anna, Flora; Van Dyck, Laurien; Boeckx, Bram; Lambrechts, Diether] Katholieke Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Leuven, Belgium; [Steinbacher, Jessica; Carell, Thomas] Univ Munich, Dept Chem & Pharm, Ctr Integrat Prot Sci, Marchioninistr 15, D-81377 Munich, Germany; [Kuchnio, Anna; Schoonjans, Luc; Carmeliet, Peter] Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Vasc Metab, B-3000 Leuven, Belgium; [Ploumakis, Athanasios; Coleman, Mathew L.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Hermans, Els; Amant, Frederic] Katholieke Univ Leuven, Dept Oncol, Univ Hosp Leuven, Gynecol Oncol, B-3000 Leuven, Belgium; [Kristensen, Vessela N.] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Akershus Univ Hosp, Dept Clin Mol Biol EpiGen, N-0318 Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Fac Med, Inst Clin Med, Postboks 1171, N-0318 Oslo, Norway; [Koh, Kian Peng] Katholieke Univ Leuven, Dept Dev & Regenerat, B-3000 Leuven, Belgium; [Koh, Kian Peng] Katholieke Univ Leuven, Stem Cell Inst Leuven, B-3000 Leuven, Belgium; [Mazzone, Massimiliano] Katholieke Univ Leuven, Dept Oncol, Lab Mol Oncol & Angiogenesis, B-3000 Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; University of Munich; KU Leuven; University of Birmingham; KU Leuven; University Hospital Leuven; University of Oslo; University of Oslo; University of Oslo; KU Leuven; KU Leuven; KU Leuven	Thienpont, B; Lambrechts, D (corresponding author), VIB, Vesalius Res Ctr, B-3000 Leuven, Belgium.; Thienpont, B; Lambrechts, D (corresponding author), Katholieke Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Leuven, Belgium.	bernard.thienpont@vib-kuleuven.be; diether.lambrechts@vib-kuleuven.be	Carell, Thomas/G-4799-2012; Amant, Frédéric/W-7436-2019; Coleman, Mathew L/C-1676-2014; Thienpont, Bernard/AAG-5423-2019; Lambrechts, Diether/AAJ-3167-2020; Ghesquiere, Bart/HGU-8736-2022; Carmeliet, Peter/AAQ-5140-2020; Koh, Kian Peng/S-6279-2016; Van Dyck, Laurien/I-4018-2016	Carell, Thomas/0000-0001-7898-2831; Amant, Frédéric/0000-0002-5452-4905; Coleman, Mathew L/0000-0001-6020-9023; Lambrechts, Diether/0000-0002-3429-302X; Ghesquiere, Bart/0000-0003-1547-1705; Carmeliet, Peter/0000-0001-7961-1821; Koh, Kian Peng/0000-0003-2523-5175; Van Dyck, Laurien/0000-0002-1373-7656; D'Anna, Flora/0000-0003-4665-6673; Mazzone, Massimiliano/0000-0001-8824-4015; Thienpont, Bernard/0000-0002-8772-6845	FWO-F; ERC [CHAMELEON 617595, EU-ERC269073, CHAMELEO 334420]; FWO-F [G065615N, G070615N]; IUAP [P7/03]; Flemish Government (Methusalem); DFG [EXC114, CA275/8-5, GRK2062/1, SPP1784]; Biotechnology and Biological Sciences Research Council [1734215] Funding Source: researchfish; Medical Research Council [MR/N021053/1] Funding Source: researchfish; MRC [MR/N021053/1] Funding Source: UKRI	FWO-F(FWO); ERC(European Research Council (ERC)European Commission); FWO-F(FWO); IUAP; Flemish Government (Methusalem); DFG(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. Peuteman, T. Van Brussel, J. Serneels and K. Kurz for assistance, C. Chang for NucPE1, G.-L Xu for Tet-triple knockout ES cells. H.Z. and B.T. hold FWO-F postdoctoral fellowships. This work was supported by funding from the ERC (CHAMELEON 617595 to D.L; EU-ERC269073 to P.C.; CHAMELEO 334420 to B.T.), from the FWO-F (G065615N, G070615N) to D.L, from the IUAP (P7/03) and the Flemish Government (Methusalem) to RC., and from the DFG (EXC114 (CiPSM), grants CA275/8-5, GRK2062/1 and SPP1784) to T.C.	Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Heist RS, 2015, P NATL ACAD SCI USA, V112, P1547, DOI 10.1073/pnas.1424024112; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kuchnio A, 2015, CELL REP, V12, P992, DOI 10.1016/j.celrep.2015.07.010; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Laukka T, 2016, J BIOL CHEM, V291, P4256, DOI 10.1074/jbc.M115.688762; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Mariani CJ, 2014, CELL REP, V7, P1343, DOI 10.1016/j.celrep.2014.04.040; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Ploumakis A, 2015, MOL CELL, V58, P729, DOI 10.1016/j.molcel.2015.05.026; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Struhl K, 2014, ELIFE, V3, DOI 10.7554/eLife.02475; Taberlay PC, 2014, GENOME RES, V24, P1421, DOI 10.1101/gr.163485.113; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Zhao BL, 2014, NUCLEIC ACIDS RES, V42, P1593, DOI 10.1093/nar/gkt1090	32	368	383	4	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					63	68		10.1038/nature19081	http://dx.doi.org/10.1038/nature19081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27533040	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000382426900038
J	Matcovitch-Natan, O; Winter, DR; Giladi, A; Aguilar, SV; Spinrad, A; Sarrazin, S; Ben-Yehuda, H; David, E; Gonzalez, FZ; Perrin, P; Keren-Shaul, H; Gury, M; Lara-Astaiso, D; Thaiss, CA; Cohen, M; Halpern, KB; Baruch, K; Deczkowska, A; Lorenzo-Vivas, E; Itzkovitz, S; Elinav, E; Sieweke, MH; Schwartz, M; Amit, I				Matcovitch-Natan, Orit; Winter, Deborah R.; Giladi, Amir; Aguilar, Stephanie Vargas; Spinrad, Amit; Sarrazin, Sandrine; Ben-Yehuda, Hila; David, Eyal; Gonzalez, Fabiola Zelada; Perrin, Pierre; Keren-Shaul, Hadas; Gury, Meital; Lara-Astaiso, David; Thaiss, Christoph A.; Cohen, Merav; Halpern, Keren Bahar; Baruch, Kuti; Deczkowska, Aleksandra; Lorenzo-Vivas, Erika; Itzkovitz, Shalev; Elinav, Eran; Sieweke, Michael H.; Schwartz, Michal; Amit, Ido			Microglia development follows a stepwise program to regulate brain homeostasis	SCIENCE			English	Article							TISSUE-RESIDENT MACROPHAGES; HEMATOPOIETIC STEM-CELLS; HUMAN GENOME; MYELOID PROGENITORS; IMMUNE INVOLVEMENT; LANGERHANS CELLS; GENE-EXPRESSION; CHOROID-PLEXUS; SELF-RENEWAL; ADULT LIFE	Microglia, the resident myeloid cells of the central nervous system, play important roles in life-long brain maintenance and in pathology. Despite their importance, their regulatory dynamics during brain development have not been fully elucidated. Using genome-wide chromatin and expression profiling coupled with single-cell transcriptomic analysis throughout development, we found that microglia undergo three temporal stages of development in synchrony with the brain-early, pre-, and adult microglia-which are under distinct regulatory circuits. Knockout of the gene encoding the adult microglia transcription factor MAFB and environmental perturbations, such as those affecting the microbiome or prenatal immune activation, led to disruption of developmental genes and immune response pathways. Together, our work identifies a stepwise microglia developmental program integrating immune response pathways that may be associated with several neurodevelopmental disorders.	[Matcovitch-Natan, Orit; Winter, Deborah R.; Giladi, Amir; Spinrad, Amit; David, Eyal; Keren-Shaul, Hadas; Gury, Meital; Lara-Astaiso, David; Thaiss, Christoph A.; Lorenzo-Vivas, Erika; Elinav, Eran; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Matcovitch-Natan, Orit; Spinrad, Amit; Ben-Yehuda, Hila; Cohen, Merav; Baruch, Kuti; Deczkowska, Aleksandra; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [Aguilar, Stephanie Vargas; Sarrazin, Sandrine; Gonzalez, Fabiola Zelada; Perrin, Pierre; Sieweke, Michael H.] Univ Aix Marseille, CIML, UM2, Campus Luminy, Marseille, France; [Aguilar, Stephanie Vargas; Sarrazin, Sandrine; Gonzalez, Fabiola Zelada; Perrin, Pierre; Sieweke, Michael H.] INSERM, U1104, Marseille, France; [Aguilar, Stephanie Vargas; Sarrazin, Sandrine; Gonzalez, Fabiola Zelada; Perrin, Pierre; Sieweke, Michael H.] CNRS, UMR7280, Marseille, France; [Aguilar, Stephanie Vargas; Sieweke, Michael H.] Helmholt Gemeinschaft MDC, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Halpern, Keren Bahar; Itzkovitz, Shalev] Weizmann Inst Sci, Dept Cell Biol, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Weizmann Institute of Science	Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.; Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel.; Sieweke, MH (corresponding author), Univ Aix Marseille, CIML, UM2, Campus Luminy, Marseille, France.; Sieweke, MH (corresponding author), INSERM, U1104, Marseille, France.; Sieweke, MH (corresponding author), CNRS, UMR7280, Marseille, France.; Sieweke, MH (corresponding author), Helmholt Gemeinschaft MDC, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	sieweke@ciml.univ-mrs.fr; michal.schwartz@weizmann.ac.il; ido.amit@weizmann.ac.il	Winter, Deborah R./AAQ-9253-2020; Sieweke, Michael/AAR-7515-2020; Elinav, Eran/ABE-8881-2020	Winter, Deborah R./0000-0003-1806-673X; Sieweke, Michael/0000-0002-3228-9537; Elinav, Eran/0000-0002-5775-2110; Spinrad, Amit/0000-0003-0158-6464; Lorenzo Vivas, Erika/0000-0002-8150-5902; Vargas Aguilar, Stephanie/0000-0002-6584-0209	European Research Council [309788]; Israeli Science Foundation [1782/11]; European Commission Seventh Framework Programme (EC FP7) BLUEPRINT consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; Israeli Ministry of Science, Technology and Space; David and Fela Shapell Family Foundation; National Human Genome Research Institute Center for Excellence in Genome Science [1P50HG006193]; Alan and Laraine Fischer Career Development Chair; Advanced European Research Council [232835]; EC FP7 HEALTH-2011 program [279017]; Agence Nationale de la Recherche [ANR BLAN07-1_205752, ANR-11-BSV3-026-01]; Fondation pour la Recherche Medicale [DEq. 20071210559, DEq. 20110421320]; InCA (French National Cancer Institute) [13-10/405/AB-LC-HS]; European Molecular Biology Organization (EMBO) [ALT766-2014]; EC FP7 (Marie Curie Actions) [GA-2012-600394]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Israeli Science Foundation(Israel Science Foundation); European Commission Seventh Framework Programme (EC FP7) BLUEPRINT consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; Israeli Ministry of Science, Technology and Space(Ministry of Science, Technology and Space (MOST), Israel); David and Fela Shapell Family Foundation; National Human Genome Research Institute Center for Excellence in Genome Science; Alan and Laraine Fischer Career Development Chair; Advanced European Research Council(European Research Council (ERC)); EC FP7 HEALTH-2011 program; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); InCA (French National Cancer Institute)(Institut National du Cancer (INCA) France); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); EC FP7 (Marie Curie Actions); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the I. A. and M.S. laboratories for discussions, T. Wiesel for artwork, M. Barad from the CIML flow cytometry platform for assistance with microglia sorting, and M. Azoulay and O. Rozenberg for animal handling. Research in the I. A. laboratory is supported by the European Research Council (grant 309788); the Israeli Science Foundation (grant 1782/11); the European Commission Seventh Framework Programme (EC FP7) BLUEPRINT consortium; the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; a Minerva Stiftung research grant; the Israeli Ministry of Science, Technology and Space; the David and Fela Shapell Family Foundation; and the National Human Genome Research Institute Center for Excellence in Genome Science (grant 1P50HG006193). I.A. holds the Alan and Laraine Fischer Career Development Chair. Research in the M.S. laboratory is supported by the Advanced European Research Council (grant 232835) and by the EC FP7 HEALTH-2011 program (grant 279017). M.S. holds the Maurice and Ilse Katz Professorial Chair in Neuroimmunology. M.H.S. was supported by grants from the Agence Nationale de la Recherche (grants ANR BLAN07-1_205752 and ANR-11-BSV3-026-01), the Fondation pour la Recherche Medicale (DEq. 20071210559 and DEq. 20110421320), and InCA (French National Cancer Institute; grant 13-10/405/AB-LC-HS). M.H.S. is a Berlin Institute of Health Einstein fellow and an INSERM-Helmholtz group leader. D.R.W. is supported by the European Molecular Biology Organization (EMBO; ALT766-2014) and the EC FP7 (Marie Curie Actions, EMBOCOFUND2012, GA-2012-600394). ATAC-seq, ChIP-seq, bulk RNA-seq, and single-cell RNA-seq data are deposited in the Genome Expression Omnibus under accession number GSE79819.	AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; BRADY G, 1995, CURR BIOL, V5, P909, DOI 10.1016/S0960-9822(95)00181-3; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Calaminus SDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051361; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24; Gate D, 2010, J NEURAL TRANSM, V117, P961, DOI 10.1007/s00702-010-0422-7; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Giovanoli S, 2016, BRAIN BEHAV IMMUN, V55, P25, DOI 10.1016/j.bbi.2015.09.015; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Halpern KB, 2015, MOL CELL, V58, P147, DOI 10.1016/j.molcel.2015.01.027; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim H, 2010, NAT IMMUNOL, V11, P743, DOI 10.1038/ni.1897; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2008, NEUROPSYCHOPHARMACOL, V33, P441, DOI 10.1038/sj.npp.1301413; Meyer U, 2006, BRAIN BEHAV IMMUN, V20, P378, DOI 10.1016/j.bbi.2005.11.003; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nirschl CJ, 2013, CLIN CANCER RES, V19, P4917, DOI 10.1158/1078-0432.CCR-12-1972; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Winter DR, 2014, IMMUNOL REV, V261, P9, DOI 10.1111/imr.12200; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	82	627	635	9	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301							aad8670	10.1126/science.aad8670	http://dx.doi.org/10.1126/science.aad8670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27338705				2022-12-24	WOS:000381561400037
J	Ding, Y; Berrocal, A; Morita, T; Longden, KD; Stern, DL				Ding, Yun; Berrocal, Augusto; Morita, Tomoko; Longden, Kit D.; Stern, David L.			Natural courtship song variation caused by an intronic retroelement in an ion channel gene	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; TISSUE-SPECIFIC EXPRESSION; DROSOPHILA-MELANOGASTER; C. ELEGANS; BEHAVIOR; EVOLUTION; LOCUS; MICE	Animal species display enormous variation for innate behaviours, but little is known about how this diversity arose. Here, using an unbiased genetic approach, we map a courtship song difference between wild isolates of Drosophila simulans and Drosophila mauritiana to a 966 base pair region within the slowpoke (slo) locus, which encodes a calcium-activated potassium channel(1). Using the reciprocal hemizygosity test(2), we confirm that slo is the causal locus and resolve the causal mutation to the evolutionarily recent insertion of a retroelement in a slo intron within D. simulans. Targeted deletion of this retroelement reverts the song phenotype and alters slo splicing. Like many ion channel genes, slo is expressed widely in the nervous system and influences a variety of behaviours(3,4); slo-null males sing little song with severely disrupted features. By contrast, the natural variant of slo alters a specific component of courtship song, illustrating that regulatory evolution of a highly pleiotropic ion channel gene can cause modular changes in behaviour.	[Ding, Yun; Berrocal, Augusto; Morita, Tomoko; Longden, Kit D.; Stern, David L.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Berrocal, Augusto] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Stern, DL (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	sternd@janelia.hhmi.org		Ding, Yun/0000-0001-8915-8434; Longden, Kit/0000-0002-7686-6447				Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Arthur BJ, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-11; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Atkinson NS, 2000, J NEUROSCI, V20, P2988; Bassett AR, 2014, J GENET GENOMICS, V41, P7, DOI 10.1016/j.jgg.2013.12.004; BECKER MN, 1995, J NEUROSCI, V15, P6250; Bendesky A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003157; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Brenner R, 1996, J NEUROSCI, V16, P1827; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cande J, 2014, CELL REP, V8, P362, DOI 10.1016/j.celrep.2014.06.023; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; Garrigan D, 2012, GENOME RES, V22, P1499, DOI 10.1101/gr.130922.111; Gleason JM, 2002, HEREDITY, V89, P1, DOI 10.1038/sj.hdy.6800099; GOTZ KG, 1987, J EXP BIOL, V128, P35; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Greenwood AK, 2013, CURR BIOL, V23, P1884, DOI 10.1016/j.cub.2013.07.058; Huttunen S, 2004, HEREDITY, V92, P263, DOI 10.1038/sj.hdy.6800406; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Stern D. L., 2016, PREPRINT; Stern DL, 2014, TRENDS GENET, V30, P547, DOI 10.1016/j.tig.2014.09.006; Stern DL, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-38; Turner TL, 2013, MOL BIOL EVOL, V30, P2113, DOI 10.1093/molbev/mst111; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; Williams MA, 2001, HEREDITY, V86, P68, DOI 10.1046/j.1365-2540.2001.00811.x; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yu JY, 2006, GENES BRAIN BEHAV, V5, P329, DOI 10.1111/j.1601-183X.2005.00164.x	30	73	72	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					329	+		10.1038/nature19093	http://dx.doi.org/10.1038/nature19093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27509856				2022-12-24	WOS:000381804900035
J	Muto, V; Jaspar, M; Meyer, C; Kusse, C; Chellappa, SL; Degueldre, C; Balteau, E; Shaffii-Le Bourdiec, A; Luxen, A; Middleton, B; Archer, SN; Phillips, C; Collette, F; Vandewalle, G; Dijk, DJ; Maquet, P				Muto, Vincenzo; Jaspar, Mathieu; Meyer, Christelle; Kusse, Caroline; Chellappa, Sarah L.; Degueldre, Christian; Balteau, Evelyne; Shaffii-Le Bourdiec, Anahita; Luxen, Andre; Middleton, Benita; Archer, Simon N.; Phillips, Christophe; Collette, Fabienne; Vandewalle, Gilles; Dijk, Derk-Jan; Maquet, Pierre			Local modulation of human brain responses by circadian rhythmicity and sleep debt	SCIENCE			English	Article							CLOCK GENE-EXPRESSION; PERFORMANCE; MELATONIN; PHASE; WAKEFULNESS; NEURONS	Human performance is modulated by circadian rhythmicity and homeostatic sleep pressure. Whether and how this interaction is represented at the regional brain level has not been established. We quantified changes in brain responses to a sustained-attention task during 13 functional magnetic resonance imaging sessions scheduled across the circadian cycle, during 42 hours of wakefulness and after recovery sleep, in 33 healthy participants. Cortical responses showed significant circadian rhythmicity, the phase of which varied across brain regions. Cortical responses also significantly decreased with accrued sleep debt. Subcortical areas exhibited primarily a circadian modulation that closely followed the melatonin profile. These findings expand our understanding of the mechanisms involved in maintaining cognition during the day and its deterioration during sleep deprivation and circadian misalignment.	[Muto, Vincenzo; Jaspar, Mathieu; Meyer, Christelle; Kusse, Caroline; Chellappa, Sarah L.; Degueldre, Christian; Balteau, Evelyne; Shaffii-Le Bourdiec, Anahita; Luxen, Andre; Phillips, Christophe; Collette, Fabienne; Vandewalle, Gilles; Maquet, Pierre] Univ Liege, GIGA Cyclotron Res Ctr Vivo Imaging, Liege, Belgium; [Muto, Vincenzo; Jaspar, Mathieu; Meyer, Christelle; Kusse, Caroline; Chellappa, Sarah L.; Degueldre, Christian; Balteau, Evelyne; Shaffii-Le Bourdiec, Anahita; Luxen, Andre; Phillips, Christophe; Collette, Fabienne; Vandewalle, Gilles; Maquet, Pierre] Walloon Excellence Life Sci & Biotechnol WELBIO, Liege, Belgium; [Muto, Vincenzo; Jaspar, Mathieu; Collette, Fabienne] Univ Liege, Psychol & Cognit Neurosci Res Unit, Liege, Belgium; [Middleton, Benita] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England; [Archer, Simon N.; Dijk, Derk-Jan] Univ Surrey, Fac Hlth & Med Sci, Sleep Res Ctr, Guildford, Surrey, England; [Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Maquet, Pierre] CHU Liege, Dept Neurol, Liege, Belgium	University of Liege; WELBIO; University of Liege; University of Surrey; University of Surrey; University of Liege; University of Liege	Maquet, P (corresponding author), Univ Liege, GIGA Cyclotron Res Ctr Vivo Imaging, Liege, Belgium.; Maquet, P (corresponding author), Walloon Excellence Life Sci & Biotechnol WELBIO, Liege, Belgium.; Maquet, P (corresponding author), CHU Liege, Dept Neurol, Liege, Belgium.	pmaquet@ulg.ac.be	Muto, Vincenzo/AAS-5220-2020; Phillips, Christophe/M-3025-2017	Muto, Vincenzo/0000-0001-5100-9927; Chellappa, Sarah L./0000-0002-6190-464X; Vandewalle, Gilles/0000-0003-2483-2752; Phillips, Christophe/0000-0002-4990-425X	Fonds National de la Recherche Scientifique (Belgium); Actions de Recherche Concertee of the Wallonia-Brussels Federation; University of Liege; Fondation Medicale Reine Elisabeth; Fondation Simone et Pierre Clerdent; Bial Foundation; FEDER-Radiomed; Royal Society Wolfson Research Merit Award	Fonds National de la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertee of the Wallonia-Brussels Federation; University of Liege(University of Liege); Fondation Medicale Reine Elisabeth; Fondation Simone et Pierre Clerdent; Bial Foundation(Bial Foundation); FEDER-Radiomed; Royal Society Wolfson Research Merit Award(Royal Society of London)	Supported by Fonds National de la Recherche Scientifique (Belgium), Actions de Recherche Concertee of the Wallonia-Brussels Federation, University of Liege research funds, Fondation Medicale Reine Elisabeth, Fondation Simone et Pierre Clerdent, Bial Foundation, FEDER-Radiomed, and a Royal Society Wolfson Research Merit Award (D.-J.D.). We thank B. Guillaume for help in setting up the SWE analysis, E. Lambot and A. Golabek for assistance in data collection, and C. Schmidt for valuable feedback on the manuscript. Data are archived on CRC servers and available upon request. The authors report no conflict of interest.	Achermann P, 2004, AVIAT SPACE ENVIR MD, V75, pA37; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Bixler E, 2009, SLEEP MED, V10, pS3, DOI 10.1016/j.sleep.2009.07.005; Chee MWL, 2008, CURR OPIN NEUROL, V21, P417, DOI 10.1097/WCO.0b013e3283052cf7; Chun LE, 2015, J BIOL RHYTHM, V30, P417, DOI 10.1177/0748730415598608; Czeisler CA., 2011, PRINCIPLES PRACTICE, V5th ed., P402; Dijk DJ, 1997, J PHYSIOL-LONDON, V505, P851, DOI 10.1111/j.1469-7793.1997.851ba.x; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Guillaume B, 2014, NEUROIMAGE, V94, P287, DOI 10.1016/j.neuroimage.2014.03.029; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; Pevet P, 2011, J PHYSIOL-PARIS, V105, P170, DOI 10.1016/j.jphysparis.2011.07.001; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Wyatt JK, 2004, SLEEP, V27, P374, DOI 10.1093/sleep/27.3.374; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Yu X, 2014, CURR BIOL, V24, P2838, DOI 10.1016/j.cub.2014.10.019	20	105	108	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					687	690		10.1126/science.aad2993	http://dx.doi.org/10.1126/science.aad2993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516598	Green Submitted, Green Published			2022-12-24	WOS:000381561200037
J	Saxton, RA; Chantranupong, L; Knockenhauer, KE; Schwartz, TU; Sabatini, DM				Saxton, Robert A.; Chantranupong, Lynne; Knockenhauer, Kevin E.; Schwartz, Thomas U.; Sabatini, David M.			Mechanism of arginine sensing by CASTOR1 upstream of mTORC1	NATURE			English	Article							SIGNAL INTEGRATION; TUMOR-SUPPRESSOR; RAG GTPASES; ACT DOMAIN; KINASE; COMPLEX; SUFFICIENCY; EVOLUTION; PROTEINS; RAPTOR	The mechanistic Target of Rapamycin Complex 1 (mTORC1) is a major regulator of eukaryotic growth that coordinates anabolic and catabolic cellular processes with inputs such as growth factors and nutrients, including amino acids(1-3). In mammals arginine is particularly important, promoting diverse physiological effects such as immune cell activation, insulin secretion, and muscle growth, largely mediated through activation of mTORC1 (refs 4-7). Arginine activates mTORC1 upstream of the Rag family of GTPases(8), through either the lysosomal amino acid transporter SLC38A9 or the GATOR2-interacting Cellular Arginine Sensor for mTORC1 (CASTOR1)(9-12). However, the mechanism by which the mTORC1 pathway detects and transmits this arginine signal has been elusive. Here, we present the 1.8 angstrom crystal structure of arginine-bound CASTOR1. Homodimeric CASTOR1 binds arginine at the interface of two Aspartate kinase, Chorismate mutase, TyrA (ACT) domains, enabling allosteric control of the adjacent GATOR2-binding site to trigger dissociation from GATOR2 and downstream activation of mTORC1. Our data reveal that CASTOR1 shares substantial structural homology with the lysine-binding regulatory domain of prokaryotic aspartate kinases, suggesting that the mTORC1 pathway exploited an ancient, amino-acid-dependent allosteric mechanism to acquire arginine sensitivity. Together, these results establish a structural basis for arginine sensing by the mTORC1 pathway and provide insights into the evolution of a mammalian nutrient sensor.	[Saxton, Robert A.; Chantranupong, Lynne; Knockenhauer, Kevin E.; Schwartz, Thomas U.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Saxton, Robert A.; Chantranupong, Lynne; Sabatini, David M.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Saxton, Robert A.; Chantranupong, Lynne; Sabatini, David M.] Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Saxton, Robert A.; Chantranupong, Lynne; Sabatini, David M.] Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Saxton, Robert A.; Chantranupong, Lynne; Sabatini, David M.] Harvard & Massachusetts Inst Technol, Broad Inst, 415 Main St, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Schwartz, TU; Sabatini, DM (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Harvard & Massachusetts Inst Technol, Broad Inst, 415 Main St, Cambridge, MA 02142 USA.	tus@mit.edu; sabatini@wi.mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; /0000-0002-1446-7256; Saxton, Robert/0000-0001-9777-8270	National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NIH [R01CA103866, AI47389, F31 CA180271]; US Department of Defense [W81XWH-07-0448]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA103866, F31CA180271] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, P41GM103403] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Sabatini and Schwartz laboratories for helpful insights. This work is based on research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. This work has been supported by grants from NIH (R01CA103866 and AI47389) and the US Department of Defense (W81XWH-07-0448) to D.M.S. Fellowship support was provided by NIH to L.C. (F31 CA180271). D.M.S. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Ban H, 2004, INT J MOL MED, V13, P537; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Coyle SM, 2013, CELL, V154, P875, DOI 10.1016/j.cell.2013.07.019; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dumas R, 2012, ARCH BIOCHEM BIOPHYS, V519, P186, DOI 10.1016/j.abb.2011.10.016; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLOYD JC, 1966, J CLIN INVEST, V45, P1487, DOI 10.1172/JCI105456; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Robin AY, 2010, J MOL BIOL, V399, P283, DOI 10.1016/j.jmb.2010.04.014; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	41	172	181	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					229	+		10.1038/nature19079	http://dx.doi.org/10.1038/nature19079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487210	Green Accepted, Green Published			2022-12-24	WOS:000381472100040
J	Howe, MW; Dombeck, DA				Howe, M. W.; Dombeck, D. A.			Rapid signalling in distinct dopaminergic axons during locomotion and reward	NATURE			English	Article								Dopaminergic projection axons from the midbrain to the striatum are crucial for motor control, as their degeneration in Parkinson disease results in profound movement deficits. Paradoxically, most recording methods report rapid phasic dopamine signalling (similar to 100-ms bursts) in response to unpredicted rewards, with little evidence for movement-related signalling. The leading model posits that phasic signalling in striatum-targeting dopamine neurons drives reward-based learning, whereas slow variations in firing (tens of seconds to minutes) in these same neurons bias animals towards or away from movement. However, current methods have provided little evidence to support or refute this model. Here, using new optical recording methods, we report the discovery of rapid phasic signalling in striatum-targeting dopaminergic axons that is associated with, and capable of triggering, locomotion in mice. Axons expressing these signals were largely distinct from those that responded to unexpected rewards. These results suggest that dopaminergic neuromodulation can differentially impact motor control and reward learning with sub-second precision, and indicate that both precise signal timing and neuronal subtype are important parameters to consider in the treatment of dopamine-related disorders.	[Howe, M. W.; Dombeck, D. A.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University	Howe, MW (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	markhowe72@gmail.com; d-dombeck@northwestern.edu		Dombeck, Daniel/0000-0003-2576-5918	Klingenstein Foundation; McKnight Foundation; Whitehall Foundation; Chicago Biomedical Consortium; Searle Funds at Chicago Community Trust; Northwestern University; National Institutes of Health [T32 AG20506]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506] Funding Source: NIH RePORTER	Klingenstein Foundation(Klingenstein Philanthropies); McKnight Foundation; Whitehall Foundation; Chicago Biomedical Consortium; Searle Funds at Chicago Community Trust; Northwestern University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Graybiel and members of the Dombeck laboratory for comments on the manuscript, and V. Jayaraman, R. Kerr, D. Kim, L. Looger and K. Svoboda from the GENIE Project for GCaMP6. This work was supported by Klingenstein Foundation, McKnight Foundation, Whitehall Foundation, Chicago Biomedical Consortium with support from the Searle Funds at Chicago Community Trust, Northwestern University, National Institutes of Health (T32 AG20506).	Barter JW, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00039; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CARLSSON A, 1964, ACTA NEUROVEG, V26, P484, DOI 10.1007/BF01252144; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Dodson PD, 2016, P NATL ACAD SCI USA, V113, pE2180, DOI 10.1073/pnas.1515941113; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hamid AA, 2016, NAT NEUROSCI, V19, P117, DOI 10.1038/nn.4173; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Heys JG, 2014, NEURON, V84, P1079, DOI 10.1016/j.neuron.2014.10.048; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; HORNYKIEWICZ O, 1962, DEUT MED WOCHENSCHR, V87, P1807, DOI 10.1055/s-0028-1114024; Howe MW, 2013, NATURE, V500, P575, DOI 10.1038/nature12475; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Miri A, 2011, NAT NEUROSCI, V14, P1150, DOI 10.1038/nn.2888; Miyashita T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00008; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Parker NF, 2016, NAT NEUROSCI, V19, P845, DOI 10.1038/nn.4287; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Poulin JF, 2014, CELL REP, V9, P930, DOI 10.1016/j.celrep.2014.10.008; Puryear CB, 2010, BEHAV NEUROSCI, V124, P234, DOI 10.1037/a0018865; Robinson DL, 2003, CLIN CHEM, V49, P1763, DOI 10.1373/49.10.1763; Roeper J, 2013, TRENDS NEUROSCI, V36, P336, DOI 10.1016/j.tins.2013.03.003; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sheffield MEJ, 2015, NATURE, V517, P200, DOI 10.1038/nature13871; Steinbeck JA, 2015, NAT BIOTECHNOL, V33, P204, DOI 10.1038/nbt.3124; Steinberg EE, 2013, BRAIN RES, V1511, P46, DOI 10.1016/j.brainres.2012.09.036; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Turner TJ, 2004, J NEUROSCI, V24, P11328, DOI 10.1523/JNEUROSCI.1559-04.2004; Wang L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4925; WOODWARD JJ, 1988, BRAIN RES, V473, P91, DOI 10.1016/0006-8993(88)90319-8	57	259	261	4	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					505	510		10.1038/nature18942	http://dx.doi.org/10.1038/nature18942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27398617	Green Accepted			2022-12-24	WOS:000380856600040
J	Rashid, AJ; Yan, C; Mercaldo, V; Hsiang, HLL; Park, S; Cole, CJ; De Cristofaro, A; Yu, J; Ramakrishnan, C; Lee, SY; Deisseroth, K; Frankland, PW; Josselyn, SA				Rashid, Asim J.; Yan, Chen; Mercaldo, Valentina; Hsiang, Hwa-Lin (Liz); Park, Sungmo; Cole, Christina J.; De Cristofaro, Antonietta; Yu, Julia; Ramakrishnan, Charu; Lee, Soo Yeun; Deisseroth, Karl; Frankland, Paul W.; Josselyn, Sheena A.			Competition between engrams influences fear memory formation and recall	SCIENCE			English	Article							AMYGDALA; NEURONS; EXCITABILITY; CONSOLIDATION; ALLOCATION; NETWORKS; CIRCUITS; CELLS; TIME	Collections of cells called engrams are thought to represent memories. Although there has been progress in identifying and manipulating single engrams, little is known about how multiple engrams interact to influence memory. In lateral amygdala (LA), neurons with increased excitability during training outcompete their neighbors for allocation to an engram. We examined whether competition based on neuronal excitability also governs the interaction between engrams. Mice received two distinct fear conditioning events separated by different intervals. LA neuron excitability was optogenetically manipulated and revealed a transient competitive process that integrates memories for events occurring closely in time (coallocating overlapping populations of neurons to both engrams) and separates memories for events occurring at distal times (disallocating nonoverlapping populations to each engram).	[Rashid, Asim J.; Yan, Chen; Mercaldo, Valentina; Hsiang, Hwa-Lin (Liz); Park, Sungmo; Cole, Christina J.; De Cristofaro, Antonietta; Yu, Julia; Frankland, Paul W.; Josselyn, Sheena A.] Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Rashid, Asim J.; Yan, Chen; Mercaldo, Valentina; Hsiang, Hwa-Lin (Liz); Park, Sungmo; Cole, Christina J.; Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Dept Psychol, Toronto, ON M5G 3G3, Canada; [Rashid, Asim J.; Yan, Chen; Mercaldo, Valentina; Hsiang, Hwa-Lin (Liz); Park, Sungmo; Cole, Christina J.; Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Rashid, Asim J.; Yan, Chen; Mercaldo, Valentina; Hsiang, Hwa-Lin (Liz); Park, Sungmo; Cole, Christina J.; Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; [Ramakrishnan, Charu; Lee, Soo Yeun; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; Stanford University	Frankland, PW; Josselyn, SA (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Frankland, PW; Josselyn, SA (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5G 3G3, Canada.; Frankland, PW; Josselyn, SA (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada.; Frankland, PW; Josselyn, SA (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada.	paul.frankland@sickkids.ca; sheena.josselyn@sickkids.ca	Mercaldo, Valentina/AAA-6000-2019	Park, Sung Mo/0000-0001-8352-3533	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Brain Canada; Brain and Behavior Research Foundation; National Institute of Mental Health; National Institute on Drug Abuse; Wiegers Family Fund; Howard Hughes Medical Institute; U.S. Army Research Laboratory and Defense Advanced Research Projects Agency [W911NF-14-2-0013]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH119421] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Brain Canada; Brain and Behavior Research Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Wiegers Family Fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Army Research Laboratory and Defense Advanced Research Projects Agency; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Roth for reagents, N. Insel and B. Richards for comments on previous versions of this manuscript, and the Josselyn and Frankland labs for general comments. This work was supported by Canadian Institutes of Health Research (S.A.J., P.W.F.), Natural Sciences and Engineering Research Council of Canada (S.A.J., P.W.F.), Brain Canada (S.A.J., P.W.F.), and Brain and Behavior Research Foundation (S.A.J.) grants. K.D. is supported by the National Institute of Mental Health, National Institute on Drug Abuse, the Wiegers Family Fund, Howard Hughes Medical Institute, and the U.S. Army Research Laboratory and Defense Advanced Research Projects Agency (Cooperative Agreement no. W911NF-14-2-0013). Data are archived in the Dryad repository http://dx.doi.org/10.5061/dryad.5tp75.	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Gouty-Colomer LA, 2016, MOL PSYCHIATR, V21, P364, DOI 10.1038/mp.2015.18; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kim D, 2013, J NEUROSCI, V33, P14354, DOI 10.1523/JNEUROSCI.2430-13.2013; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 2003, ANN NY ACAD SCI, V985, P106; Mei Y, 2012, BIOL PSYCHIAT, V71, P1033, DOI 10.1016/j.biopsych.2012.02.019; MONACO L, 1995, P NATL ACAD SCI USA, V92, P10673, DOI 10.1073/pnas.92.23.10673; Oh MM, 2003, J NEUROPHYSIOL, V90, P2171, DOI 10.1152/jn.01177.2002; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Shoemaker PA, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00012; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Thompson LT, 1996, J NEUROPHYSIOL, V76, P1836, DOI 10.1152/jn.1996.76.3.1836; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; Trouche S, 2013, NEURON, V80, P1054, DOI 10.1016/j.neuron.2013.07.047; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Woodruff AR, 2007, J NEUROSCI, V27, P553, DOI 10.1523/JNEUROSCI.3686-06.2007; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	25	177	180	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2016	353	6297					383	387		10.1126/science.aaf0594	http://dx.doi.org/10.1126/science.aaf0594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HB	27463673	Green Accepted			2022-12-24	WOS:000380583400041
J	Newbold, T; Hudson, LN; Arnell, AP; Contu, S; De Palma, A; Ferrier, S; Hill, SLL; Hoskins, AJ; Lysenko, I; Phillips, HRP; Burton, VJ; Chng, CWT; Emerson, S; Gao, D; Pask-Hale, G; Hutton, J; Jung, M; Sanchez-Ortiz, K; Simmons, BI; Whitmee, S; Zhang, HB; Scharlemann, JPW; Purvis, A				Newbold, Tim; Hudson, Lawrence N.; Arnell, Andrew P.; Contu, Sara; De Palma, Adriana; Ferrier, Simon; Hill, Samantha L. L.; Hoskins, Andrew J.; Lysenko, Igor; Phillips, Helen R. P.; Burton, Victoria J.; Chng, Charlotte W. T.; Emerson, Susan; Gao, Di; Pask-Hale, Gwilym; Hutton, Jon; Jung, Martin; Sanchez-Ortiz, Katia; Simmons, Benno I.; Whitmee, Sarah; Zhang, Hanbin; Scharlemann, Jorn P. W.; Purvis, Andy			Has land use pushed terrestrial biodiversity beyond the planetary boundary? A global assessment	SCIENCE			English	Article							BIRD SPECIES RICHNESS; FRUIT-FEEDING BUTTERFLIES; ANTHROPOGENIC ENVIRONMENTAL-CHANGES; PLANT COMMUNITY COMPOSITION; LOWLAND DIPTEROCARP FOREST; CARABID BEETLE ASSEMBLAGES; BOMBUS SPP. HYMENOPTERA; SARISKA-TIGER RESERVE; VOLANT SMALL MAMMALS; RAIN-FOREST	Land use and related pressures have reduced local terrestrial biodiversity, but it is unclear how the magnitude of change relates to the recently proposed planetary boundary ("safe limit"). We estimate that land use and related pressures have already reduced local biodiversity intactness-the average proportion of natural biodiversity remaining in local ecosystems-beyond its recently proposed planetary boundary across 58.1% of the world's land surface, where 71.4% of the human population live. Biodiversity intactness within most biomes (especially grassland biomes), most biodiversity hotspots, and even some wilderness areas is inferred to be beyond the boundary. Such widespread transgression of safe limits suggests that biodiversity loss, if unchecked, will undermine efforts toward long-term sustainable development.	[Newbold, Tim; Arnell, Andrew P.; Hill, Samantha L. L.; Hutton, Jon; Scharlemann, Jorn P. W.] World Conservat Monitoring Ctr, United Nations Environm Programme, 219 Huntingdon Rd, Cambridge CB3 0DL, England; [Newbold, Tim; Whitmee, Sarah] UCL, Dept Genet Evolut & Environm, Ctr Biodivers & Environm Res, Gower St, London WC1E 6BT, England; [Hudson, Lawrence N.; Contu, Sara; De Palma, Adriana; Hill, Samantha L. L.; Phillips, Helen R. P.; Burton, Victoria J.; Chng, Charlotte W. T.; Emerson, Susan; Gao, Di; Pask-Hale, Gwilym; Sanchez-Ortiz, Katia; Simmons, Benno I.; Zhang, Hanbin; Purvis, Andy] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England; [De Palma, Adriana; Lysenko, Igor; Phillips, Helen R. P.; Simmons, Benno I.; Purvis, Andy] Imperial Coll London, Dept Life Sci, Silwood Pk, London SL5 7PY, England; [Ferrier, Simon; Hoskins, Andrew J.] Commonwealth Sci & Ind Res Org CSIRO Land & Water, Canberra, ACT 2601, Australia; [Hutton, Jon] World Wildlife Fund WWF Int, Luc Hoffmann Inst, CH-1196 Gland, Switzerland; [Jung, Martin] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, Univ Pk 15, DK-2100 Copenhagen O, Denmark; [Jung, Martin; Scharlemann, Jorn P. W.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	University of London; University College London; Natural History Museum London; Imperial College London; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Copenhagen; University of Sussex	Newbold, T (corresponding author), World Conservat Monitoring Ctr, United Nations Environm Programme, 219 Huntingdon Rd, Cambridge CB3 0DL, England.; Newbold, T (corresponding author), UCL, Dept Genet Evolut & Environm, Ctr Biodivers & Environm Res, Gower St, London WC1E 6BT, England.	t.newbold@ucl.ac.uk	Burton, Victoria J. J/N-8750-2014; Newbold, Tim/R-8958-2019; Newbold, Tim/D-1524-2012; Purvis, Andy/A-7529-2008; De Palma, Adriana/H-9591-2019; Jung, Martin/C-3996-2014; Ferrier, Simon/C-1490-2009; Hoskins, Andrew/T-2694-2019; Scharlemann, Jorn/A-4737-2008; Hudson, Lawrence/H-2918-2013; Simmons, Benno/I-9174-2014	Burton, Victoria J. J/0000-0003-0122-3292; Newbold, Tim/0000-0001-7361-0051; Newbold, Tim/0000-0001-7361-0051; Purvis, Andy/0000-0002-8609-6204; De Palma, Adriana/0000-0002-5345-4917; Jung, Martin/0000-0002-7569-1390; Ferrier, Simon/0000-0001-7884-2388; Hoskins, Andrew/0000-0001-8907-6682; Scharlemann, Jorn/0000-0002-2834-6367; Phillips, Helen/0000-0002-7435-5934; Hudson, Lawrence/0000-0003-4072-7469; Simmons, Benno/0000-0002-2751-9430; Whitmee, Sarah/0000-0001-9161-868X	UK Natural Environment Research Council (NERC) [NE/J011193/2, NE/L002515/1]; Biotechnology and Biological Sciences Research Council [BB/F017324/1]; Hans Rausing Ph.D. scholarship; United Nations Environment Programme World Conservation Monitoring Centre; NERC [NE/J011193/2, NE/M014533/1, NE/J011193/1] Funding Source: UKRI; Natural Environment Research Council [NE/J011193/1, NE/M014533/1, NE/J011193/2, 1509232] Funding Source: researchfish	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Hans Rausing Ph.D. scholarship; United Nations Environment Programme World Conservation Monitoring Centre; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the hundreds of researchers who contributed their data to the PREDICTS project and G. Mace and N. Burgess for helpful comments on an earlier draft. This work was funded by the UK Natural Environment Research Council (NERC, grants NE/J011193/2 and NE/L002515/1), the Biotechnology and Biological Sciences Research Council (grant BB/F017324/1), a Hans Rausing Ph.D. scholarship, and the United Nations Environment Programme World Conservation Monitoring Centre. This is a contribution from the Imperial College Grand Challenges in Ecosystem and the Environment Initiative and the Sussex Sustainability Research Programme. PREDICTS is endorsed by the Group on Earth Observations Biodiversity Observation Network (GEO-BON). The underlying biodiversity data can be downloaded from the Natural History Museum's Data Portal (http://dx.doi.org/10.5519/0073893).	Aben J, 2008, BIRD CONSERV INT, V18, P363, DOI 10.1017/S0959270908007326; Adum GB, 2013, CONSERV BIOL, V27, P354, DOI 10.1111/cobi.12006; Aguilar Barquero Virginia, 2009, Rev. biol. trop, V57, P83; Alcala EL, 2004, ENVIRON CONSERV, V31, P254, DOI 10.1017/S0376892904001407; Alcayaga OE, 2013, REV COLOMB ENTOMOL, V39, P150; Alignier A, 2013, ANN FOREST SCI, V70, P601, DOI 10.1007/s13595-013-0301-0; Andersen AN, 2011, AUSTRAL ECOL, V36, P497, DOI 10.1111/j.1442-9993.2010.02151.x; Arbelaez-Cortes E, 2011, REV MEX BIODIVERS, V82, P639; Armbrecht I, 2006, ECOL ENTOMOL, V31, P403, DOI 10.1111/j.1365-2311.2006.00802.x; Arroyo J, 2005, J NAT HIST, V39, P3453, DOI 10.1080/00222930500240346; Azhar B, 2013, IBIS, V155, P297, DOI 10.1111/ibi.12025; Azman NM, 2011, TROP LIFE SCI RES, V22, P45; Azpiroz AB, 2009, CONDOR, V111, P21, DOI 10.1525/cond.2009.080111; Baeten L, 2010, RESTOR ECOL, V18, P379, DOI 10.1111/j.1526-100X.2009.00627.x; Baeten L, 2010, J ECOL, V98, P1447, DOI 10.1111/j.1365-2745.2010.01711.x; Baldi A, 2005, AGR ECOSYST ENVIRON, V108, P251, DOI 10.1016/j.agee.2005.02.006; Banksi JE, 2007, PAN-PAC ENTOMOL, V83, P152, DOI 10.3956/0031-0603-83.2.152; BARAL SK, BANKO JANAKARI, V19, P3; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2007, J APPL ECOL, V44, P1001, DOI 10.1111/j.1365-2664.2007.01347.x; Barlow J, 2007, BIOL CONSERV, V136, P212, DOI 10.1016/j.biocon.2006.11.021; Barratt BIP, 2012, J ROY SOC NEW ZEAL, V42, P217, DOI 10.1080/03036758.2011.559664; Barratt BIP, 2005, J ROY SOC NEW ZEAL, V35, P287, DOI 10.1080/03014223.2005.9517785; Barrico L, 2012, LANDSCAPE URBAN PLAN, V106, P88, DOI 10.1016/j.landurbplan.2012.02.011; Bartolommei P, 2013, REND LINCEI-SCI FIS, V24, P13, DOI 10.1007/s12210-012-0211-3; Basset Y, 2008, CONSERV BIOL, V22, P1552, DOI 10.1111/j.1523-1739.2008.01017.x; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baur B, 2006, BIOL CONSERV, V132, P261, DOI 10.1016/j.biocon.2006.04.018; Benedick S, 2006, J APPL ECOL, V43, P967, DOI 10.1111/j.1365-2664.2006.01209.x; Berg A, 2011, BIOL CONSERV, V144, P2819, DOI 10.1016/j.biocon.2011.07.035; Bernard H, 2009, MAMM STUDY, V34, P85, DOI 10.3106/041.034.0204; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bicknell J, 2010, FOREST ECOL MANAG, V259, P2267, DOI 10.1016/j.foreco.2010.02.027; Bihn JH, 2008, BIOL CONSERV, V141, P733, DOI 10.1016/j.biocon.2007.12.028; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Blake RJ, 2011, PEST MANAG SCI, V67, P377, DOI 10.1002/ps.2136; Blanche KR, 2006, J APPL ECOL, V43, P1182, DOI 10.1111/j.1365-2664.2006.01230.x; Blanche R, 2005, J ECON ENTOMOL, V98, P1193, DOI 10.1603/0022-0493-98.4.1193; BOCON R, 2010, THESIS HUNGARIAN ACA; Bosing BM, 2014, J ARID ENVIRON, V104, P124, DOI 10.1016/j.jaridenv.2014.02.011; Borges PAV, 2006, J BIOGEOGR, V33, P169, DOI 10.1111/j.1365-2699.2005.01324.x; Borges SH, 2007, J TROP ECOL, V23, P469, DOI 10.1017/S0266467407004105; Bos MM, 2007, BIODIVERS CONSERV, V16, P2429, DOI 10.1007/s10531-007-9196-0; Boutin C, 2009, ECOSCIENCE, V16, P492, DOI 10.2980/16-4-3250; Bouyer J, 2007, BIOL CONSERV, V138, P73, DOI 10.1016/j.biocon.2007.04.001; Bragagnolo C, 2007, BIOL CONSERV, V139, P389, DOI 10.1016/j.biocon.2007.07.008; Brandt JS, 2013, BIOL CONSERV, V166, P34, DOI 10.1016/j.biocon.2013.06.014; Brearley FQ, 2011, J TROP ECOL, V27, P413, DOI 10.1017/S0266467411000149; Breedt JAD, 2013, AFR J RANGE FOR SCI, V30, P161, DOI 10.2989/10220119.2013.816367; Brito I, 2012, SOIL TILL RES, V121, P63, DOI 10.1016/j.still.2012.01.012; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brunet J, 2011, FOREST ECOL MANAG, V262, P1863, DOI 10.1016/j.foreco.2011.08.007; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Buczkowski G, 2010, BIOL INVASIONS, V12, P3343, DOI 10.1007/s10530-010-9727-6; Buddle Christopher M., 2008, Canadian Entomologist, V140, P437, DOI 10.4039/N07-Ls01; Buscardo E, 2008, BIODIVERS CONSERV, V17, P1057, DOI 10.1007/s10531-007-9275-2; Cabra-Garcia J, 2012, BIODIVERS CONSERV, V21, P1493, DOI 10.1007/s10531-012-0259-5; Caceres NC, 2010, J NAT HIST, V44, P491, DOI 10.1080/00222930903477768; Cagle NL, 2008, BIOL CONSERV, V141, P744, DOI 10.1016/j.biocon.2008.01.003; Calvino-Cancela M, 2012, FOREST ECOL MANAG, V270, P153, DOI 10.1016/j.foreco.2012.01.019; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carpenter D, 2012, BIODIVERS CONSERV, V21, P3385, DOI 10.1007/s10531-012-0369-0; Carrijo TF, 2009, J INSECT CONSERV, V13, P575, DOI 10.1007/s10841-008-9205-y; Cassano CR, 2014, BIOL CONSERV, V169, P14, DOI 10.1016/j.biocon.2013.10.006; Castro H, 2010, AGR ECOSYST ENVIRON, V137, P183, DOI 10.1016/j.agee.2010.02.002; Castro-Luna AA, 2007, ANIM CONSERV, V10, P219, DOI 10.1111/j.1469-1795.2007.00097.x; Cerezo A, 2011, BIODIVERS CONSERV, V20, P2649, DOI 10.1007/s10531-011-0096-y; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chapman AD, 2009, NUMBERS LIVING SPECI; Chapman KA, 2007, BIOL CONSERV, V135, P527, DOI 10.1016/j.biocon.2006.10.050; Chauvat M, 2007, ECOGRAPHY, V30, P183, DOI [10.1111/j.2007.0906-7590.04888.x, 10.1111/j.0906-7590.2007.04888.x]; Chris O, 2013, AFR J ECOL, V51, P244, DOI 10.1111/aje.12029; Christensen M, 2009, BIODIVERS CONSERV, V18, P2205, DOI 10.1007/s10531-009-9583-9; CIESIN/IFPRI/CIAT, 2011, GLOB RUR URB MAPP PR; *CIESIN ITOS U GEO, 2013, GLOB ROADS OP ACC DA, DOI DOI 10.7927/H4VD6WCT); Clark RJ, 2004, NEW ZEAL J AGR RES, V47, P247, DOI 10.1080/00288233.2004.9513592; Clarke FM, 2005, J APPL ECOL, V42, P409, DOI 10.1111/j.1365-2664.2005.01024.x; Cleary DFR, 2006, DIVERS DISTRIB, V12, P409, DOI 10.1111/j.1366-9516.2006.00256.x; Cleary DFR, 2004, OIKOS, V105, P426, DOI 10.1111/j.0030-1299.2004.12219.x; Cockle KL, 2005, BIODIVERS CONSERV, V14, P3265, DOI 10.1007/s10531-004-0446-0; Connop S, 2011, INSECT CONSERV DIVER, V4, P212, DOI 10.1111/j.1752-4598.2010.00116.x; Craig MD, 2014, FOREST ECOL MANAG, V318, P142, DOI 10.1016/j.foreco.2014.01.011; Craig MD, 2012, J APPL ECOL, V49, P919, DOI 10.1111/j.1365-2664.2012.02152.x; Craig MD, 2009, WILDLIFE RES, V36, P509, DOI 10.1071/WR09014; *CTR INT FOR RES, 2013, MULT LANDSC ASS PHIL; *CTR INT FOR RES, 2013, MULT LANDSC ASS CAM; Cunningham SA, 2013, AUSTRAL ECOL, V38, P456, DOI 10.1111/j.1442-9993.2012.02432.x; D'Aniello B, 2011, BIODIVERS CONSERV, V20, P1731, DOI 10.1007/s10531-011-0058-4; D'Cruze N, 2011, ANIM CONSERV, V14, P542, DOI 10.1111/j.1469-1795.2011.00459.x; Danquah Emmanuel, 2012, Journal of Biodiversity and Environmental Sciences, V2, P50; Darvill B, 2004, OIKOS, V107, P471, DOI 10.1111/j.0030-1299.2004.13510.x; DASILVA PG, 2011, THESIS U FEDERAL SAN; Davis ALV, 2005, ENVIRON ENTOMOL, V34, P1081, DOI 10.1603/0046-225X(2005)034[1081:EODOAS]2.0.CO;2; Dawson J, 2011, TROP CONSERV SCI, V4, P317, DOI 10.1177/194008291100400309; Carvalho Anelena Lima de, 2010, Acta Amaz., V40, P657, DOI 10.1590/S0044-59672010000400004; de Sassi C, 2012, ECOLOGY, V93, P1892, DOI 10.1890/11-1839.1; De Souza VM, 2008, REV BRAS ZOOL, V25, P49, DOI 10.1590/S0101-81752008000100008; de Thoisy B, 2010, BIODIVERS CONSERV, V19, P1567, DOI 10.1007/s10531-010-9787-z; Alguacil MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034887; Delabie JHC, 2009, CR BIOL, V332, P673, DOI 10.1016/j.crvi.2009.01.006; Devineau JL, 2009, BIODIVERS CONSERV, V18, P2075, DOI 10.1007/s10531-008-9574-2; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diekotter T, 2006, BIODIVERS CONSERV, V15, P57, DOI 10.1007/s10531-004-2932-9; Dolia J, 2008, ANIM CONSERV, V11, P26, DOI 10.1111/j.1469-1795.2007.00143.x; Domínguez Erwin, 2012, Anales Instituto Patagonia (Chile), V40, P37, DOI 10.4067/S0718-686X2012000200003; Dominguez-Haydar Y, 2011, RESTOR ECOL, V19, P178, DOI 10.1111/j.1526-100X.2010.00735.x; Dumont B, 2009, GRASS FORAGE SCI, V64, P92, DOI 10.1111/j.1365-2494.2008.00674.x; Dures SG, 2010, BIOL CONSERV, V143, P768, DOI 10.1016/j.biocon.2009.12.019; Edenius L, 2011, AMBIO, V40, P521, DOI 10.1007/s13280-011-0137-5; Otavo SE, 2013, REV BIOL TROP, V61, P735; Eigenbrod F, 2008, LANDSCAPE ECOL, V23, P159, DOI 10.1007/s10980-007-9174-7; Elek Z, 2007, ACTA OECOL, V32, P104, DOI 10.1016/j.actao.2007.03.008; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Endo W, 2010, BIOTROPICA, V42, P251, DOI 10.1111/j.1744-7429.2009.00546.x; ESRI, 2011, ARCGIS DESKT REL 10; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Faruk A, 2013, CONSERV BIOL, V27, P615, DOI 10.1111/cobi.12062; Farwig N, 2008, FOREST ECOL MANAG, V255, P3885, DOI 10.1016/j.foreco.2008.03.042; Farwig N, 2009, LANDSCAPE ECOL, V24, P919, DOI 10.1007/s10980-009-9376-2; Fayle TM, 2010, BASIC APPL ECOL, V11, P337, DOI 10.1016/j.baae.2009.12.009; Fensham RJ, 2012, AUSTRAL ECOL, V37, P183, DOI 10.1111/j.1442-9993.2011.02261.x; Fermon H, 2005, BIODIVERS CONSERV, V14, P333, DOI 10.1007/s10531-004-5354-9; Fernandez IC, 2013, URBAN ECOSYST, V16, P377, DOI 10.1007/s11252-012-0272-1; Fiera Cristina, 2008, Travaux du Museum National d'Histoire Naturelle Grigore Antipa, V51, P363; Fierro MM, 2012, NEOTROP ENTOMOL, V41, P95, DOI 10.1007/s13744-011-0009-5; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Firincioglu HK, 2009, J ARID ENVIRON, V73, P1149, DOI 10.1016/j.jaridenv.2009.05.012; Flaspohler DJ, 2010, BIOL CONSERV, V143, P280, DOI 10.1016/j.biocon.2009.10.009; FOWLER RE, 2014, THESIS U BIRMINGHAM; Franzen M, 2008, ECOGRAPHY, V31, P698, DOI 10.1111/j.1600-0587.2008.05110.x; Fredriksson GM, 2007, BIODIVERS CONSERV, V16, P1823, DOI 10.1007/s10531-006-9075-0; Freire GD, 2011, J ARACHNOL, V39, P263, DOI 10.1636/CP10-85.1; Frizzo TLM, 2013, BIOTROPICA, V45, P644, DOI 10.1111/btp.12045; Fukuda D, 2009, RAFFLES B ZOOL, V57, P213; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Furlani D, 2009, ZOOL SCI, V26, P197, DOI 10.2108/zsj.26.197; Gaigher R, 2010, J INSECT CONSERV, V14, P595, DOI 10.1007/s10841-010-9286-2; Garcia KP, 2013, MAMMALIA, V77, P195, DOI 10.1515/mammalia-2011-0134; GARCÍA-R. JUAN CARLOS, 2007, Caldasia, V29, P363; Garden JG, 2010, LANDSCAPE ECOL, V25, P1013, DOI 10.1007/s10980-010-9476-z; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gardner TA, 2007, CONSERV BIOL, V21, P775, DOI 10.1111/j.1523-1739.2007.00659.x; Garmendia A, 2013, J TROP ECOL, V29, P331, DOI 10.1017/S0266467413000370; Gaublomme E, 2008, BIOL CONSERV, V141, P2585, DOI 10.1016/j.biocon.2008.07.022; Ge BM, 2012, REV CHIL HIST NAT, V85, P219, DOI 10.4067/S0716-078X2012000200008; Gendreau-Berthiaume B, 2012, FORESTRY, V85, P551, DOI 10.1093/forestry/cps051; Gheler-Costa C, 2012, MAMMALIA, V76, P185, DOI 10.1515/mammalia-2011-0109; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Giordani P, 2012, PLANT BIOSYST, V146, P628, DOI 10.1080/11263504.2011.654136; Giordani P, 2010, BIBL LICHENOL, V105, P139; Giordano S, 2004, PLANT ECOL, V170, P1, DOI 10.1023/B:VEGE.0000019025.36121.5d; Golodets C, 2010, PLANT SOIL, V329, P365, DOI 10.1007/s11104-009-0164-1; Gomes LGL, 2008, BIOL CONSERV, V141, P860, DOI 10.1016/j.biocon.2008.01.007; Gottschalk MS, 2007, NEOTROP ENTOMOL, V36, P848, DOI 10.1590/S1519-566X2007000600005; Gould RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059356; Goulson D, 2008, BIODIVERS CONSERV, V17, P3269, DOI 10.1007/s10531-008-9428-y; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Gove AD, 2005, BIOL CONSERV, V126, P328, DOI 10.1016/j.biocon.2005.06.008; Granjon L, 2011, MAMM BIOL, V76, P583, DOI 10.1016/j.mambio.2011.06.003; Grass I, 2013, OECOLOGIA, V173, P913, DOI 10.1007/s00442-013-2688-6; Gray CL, 2014, ECOL EVOL, V4, P1049, DOI 10.1002/ece3.1003; [谷卫彬 Gu Weibin], 2004, [生物多样性, Chinese Biodiversity], V12, P262; Gunawardene NR, 2010, FOREST ECOL MANAG, V259, P555, DOI 10.1016/j.foreco.2009.11.012; Gutierrez AG, 2009, FOREST ECOL MANAG, V258, P376, DOI 10.1016/j.foreco.2009.03.011; Gutierrez-Lamus Doris L., 2004, Caldasia, V26, P245; Haarmeyer DH, 2010, BIOL CONSERV, V143, P588, DOI 10.1016/j.biocon.2009.11.008; Hashim NR, 2010, ASIAN MYRMECOL, V3, P5; Hassan S. N., 2013, British Journal of Applied Science and Technology, V3, P48; Hatfield RG, 2007, BIOL CONSERV, V139, P150, DOI 10.1016/j.biocon.2007.06.019; Hautier Y, 2015, SCIENCE, V348, P336, DOI 10.1126/science.aaa1788; Hawes J, 2009, J TROP ECOL, V25, P281, DOI 10.1017/S0266467409006038; Helden AJ, 2004, BASIC APPL ECOL, V5, P367, DOI 10.1016/j.baae.2004.06.004; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Hernandez L, 2012, INTERCIENCIA, V37, P891; Hietz P, 2005, CONSERV BIOL, V19, P391, DOI 10.1111/j.1523-1739.2005.00145.x; Higuera D, 2010, CALDASIA, V32, P161; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hilje B, 2012, BIOL CONSERV, V146, P170, DOI 10.1016/j.biocon.2011.12.007; Hoffmann A, 2005, BELG J ZOOL, V135, P91; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Horgan FG, 2009, BIODIVERS CONSERV, V18, P3519, DOI 10.1007/s10531-009-9658-7; Hornung E, 2007, EUR J SOIL BIOL, V43, P158, DOI 10.1016/j.ejsobi.2007.01.001; Hoskins AJ, 2016, ECOL EVOL, V6, P3040, DOI 10.1002/ece3.2104; Hu C, 2008, EXP AGR, V44, P485, DOI 10.1017/S0014479708006716; Hudson LN, 2014, ECOL EVOL, V4, P4701, DOI 10.1002/ece3.1303; Hung NFLM, 2008, J ARACHNOL, V36, P394, DOI 10.1636/CT07-136.1; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Hylander K, 2004, CONSERV BIOL, V18, P1052, DOI 10.1111/j.1523-1739.2004.00199.x; Hylander K, 2012, J APPL ECOL, V49, P1316, DOI 10.1111/j.1365-2664.2012.02218.x; Hylander K, 2009, CONSERV BIOL, V23, P400, DOI 10.1111/j.1523-1739.2008.01097.x; Ims RA, 2012, BIOL CONSERV, V149, P2, DOI 10.1016/j.biocon.2012.02.008; Isaacs-Cubides PJ, 2011, NAT CONSERVACAO, V9, P39, DOI 10.4322/natcon.2011.004; Ishitani M, 2003, ECOGRAPHY, V26, P481, DOI 10.1034/j.1600-0587.2003.03436.x; Jacobs CT, 2010, J INSECT CONSERV, V14, P389, DOI 10.1007/s10841-010-9270-x; Jalilova Gulnaz, 2013, Biodiversity, V14, P97, DOI 10.1080/14888386.2013.789399; Johnson MF, 2008, J MED ENTOMOL, V45, P1023, DOI 10.1603/0022-2585(2008)45[1023:LUAMDI]2.0.CO;2; Jolli Virat, 2011, Ring, V33, P37; Jonsell M, 2012, BIODIVERS CONSERV, V21, P619, DOI 10.1007/s10531-011-0203-0; Joubert L, 2009, S AFR J BOT, V75, P526, DOI 10.1016/j.sajb.2009.05.002; Julier HE, 2009, J ECON ENTOMOL, V102, P563, DOI 10.1603/029.102.0214; Jung TS, 2011, MAMM BIOL, V76, P678, DOI 10.1016/j.mambio.2011.08.002; Kapoor V, 2008, J INSECT CONSERV, V12, P53, DOI 10.1007/s10841-006-9062-5; Kappes H, 2012, METEOROL Z, V21, P525, DOI 10.1127/0941-2948/2012/0361; Kati V, 2012, J INSECT CONSERV, V16, P807, DOI 10.1007/s10841-012-9467-2; Katovai E, 2012, BIOL CONSERV, V145, P214, DOI 10.1016/j.biocon.2011.11.008; Kazerani F., 2013, Arxius de Miscellania Zoologica, V11, P134; Kessler M, 2005, BIODIVERS CONSERV, V14, P547, DOI 10.1007/s10531-004-3914-7; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Kittle Andrew M., 2012, Cat News, V56, P28; Kohler F, 2008, J APPL ECOL, V45, P753, DOI 10.1111/j.1365-2664.2007.01394.x; Koivula M, 2004, J INSECT CONSERV, V8, P297, DOI 10.1007/s10841-004-0296-9; Kolb A, 2004, J VEG SCI, V15, P199, DOI 10.1111/j.1654-1103.2004.tb02255.x; Korosi A, 2012, INSECT CONSERV DIVER, V5, P57, DOI 10.1111/j.1752-4598.2011.00153.x; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Krauss J, 2004, BIODIVERS CONSERV, V13, P1427, DOI 10.1023/B:BIOC.0000021323.18165.58; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kumar R, 2005, ENVIRON CONSERV, V32, P248, DOI 10.1017/S0376892905002316; Kurz DJ, 2014, BIOL CONSERV, V170, P246, DOI 10.1016/j.biocon.2013.12.027; Kutt AS, 2012, RANGELAND J, V34, P173, DOI 10.1071/RJ11049; Kutt AS, 2007, J TROP ECOL, V23, P95, DOI 10.1017/S0266467406003579; Lachat T, 2006, BIODIVERS CONSERV, V15, P3, DOI 10.1007/s10531-004-1234-6; Lantschner MV, 2008, BIODIVERS CONSERV, V17, P969, DOI 10.1007/s10531-007-9243-x; Latta SC, 2011, CONDOR, V113, P24, DOI 10.1525/cond.2011.090252; Legare JP, 2011, SILVA FENN, V45, P937, DOI 10.14214/sf.79; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Lehouck V, 2009, OIKOS, V118, P1023, DOI 10.1111/j.1600-0706.2009.17300.x; Lentini PE, 2012, BIOL CONSERV, V149, P84, DOI 10.1016/j.biocon.2012.02.004; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Li SN, 2013, AGROFOREST SYST, V87, P1117, DOI 10.1007/s10457-013-9624-y; Liow LH, 2001, J APPL ECOL, V38, P180, DOI 10.1046/j.1365-2664.2001.00582.x; LITCHWARK SA, 2013, THESIS U CANTERBURY; Littlewood NA, 2012, INSECT CONSERV DIVER, V5, P67, DOI 10.1111/j.1752-4598.2011.00135.x; Littlewood NA, 2008, INSECT CONSERV DIVER, V1, P151, DOI 10.1111/j.1752-4598.2008.00021.x; Liu YH, 2012, RESTOR ECOL, V20, P234, DOI 10.1111/j.1526-100X.2010.00755.x; Lo-Man-Hung NF, 2011, J ARACHNOL, V39, P296, DOI 10.1636/CP10-89.1; Longacre Angelika, 2005, Journal of Bioinformatics and Computational Biology, V3, P1243, DOI 10.1142/S0219720005001600; Lopez-Quintero CA, 2012, BIODIVERS CONSERV, V21, P2221, DOI 10.1007/s10531-012-0280-8; Louhaichi M, 2009, INT J AGRIC BIOL, V11, P681; Lucas-Borja ME, 2011, LAND DEGRAD DEV, V22, P383, DOI 10.1002/ldr.1014; Luja VH, 2008, BIOTROPICA, V40, P747, DOI 10.1111/j.1744-7429.2008.00439.x; Mace GM, 2014, GLOBAL ENVIRON CHANG, V28, P289, DOI 10.1016/j.gloenvcha.2014.07.009; Macip-Rios R, 2008, REV MEX BIODIVERS, V79, P185; MacSwiney MC, 2007, BIOL CONSERV, V136, P499, DOI 10.1016/j.biocon.2006.12.021; Maeto K, 2004, FOREST ECOL MANAG, V187, P213, DOI 10.1016/S0378-1127(03)00333-5; Magura T, 2010, LANDSCAPE ECOL, V25, P621, DOI 10.1007/s10980-009-9445-6; Mallari NAD, 2011, ORYX, V45, P234, DOI 10.1017/S0030605310001031; Malone L, 2010, J APICULT RES, V49, P284, DOI 10.3896/IBRA.1.49.3.09; Malonza Patrick K., 2012, Herpetotropicos, V7, P7; Malumbres-Olarte J, 2014, BIOL INVASIONS, V16, P2311, DOI 10.1007/s10530-014-0666-5; Marin-Spiotta E, 2007, ECOL APPL, V17, P828, DOI 10.1890/06-1268; MARSH C, 2005, THESIS IMPERIAL COLL; Marsh CJ, 2010, BIOL CONSERV, V143, P1364, DOI 10.1016/j.biocon.2010.03.010; Marshall EJP, 2006, AGR ECOSYST ENVIRON, V113, P36, DOI 10.1016/j.agee.2005.08.036; Martin PS, 2012, FOREST ECOL MANAG, V282, P185, DOI 10.1016/j.foreco.2012.07.002; Matsumoto T, 2009, BIODIVERS CONSERV, V18, P3139, DOI 10.1007/s10531-009-9632-4; Mayfield MM, 2006, J ECOL, V94, P522, DOI 10.1111/j.1365-2745.2006.01108.x; McCarthy JL, 2010, MT RES DEV, V30, P295, DOI 10.1659/MRD-JOURNAL-D-09-00080.1; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McNamara S, 2012, FOREST ECOL MANAG, V281, P93, DOI 10.1016/j.foreco.2012.06.004; McShea WJ, 2009, BIOL CONSERV, V142, P3108, DOI 10.1016/j.biocon.2009.08.009; Meijer SS, 2011, J INSECT CONSERV, V15, P505, DOI 10.1007/s10841-010-9330-2; Meyer B, 2007, ENTOMOL GEN, V30, P173; Meyer B, 2009, BASIC APPL ECOL, V10, P178, DOI 10.1016/j.baae.2008.01.001; Mico E, 2013, BIODIVERS CONSERV, V22, P889, DOI 10.1007/s10531-013-0456-x; Milder JC, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00003.1; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Moir ML, 2005, FOREST ECOL MANAG, V217, P294, DOI 10.1016/j.foreco.2005.06.012; Moreno-Mateos D, 2011, ACTA ORNITHOL, V46, P173, DOI 10.3161/000164511X625946; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Muchane M. N., 2012, International Journal of Biodiversity and Conservation, V4, P500; Mudri-Stojnic S, 2012, ARCH BIOL SCI, V64, P777, DOI 10.2298/ABS1202777S; Munyekenye FB, 2008, OSTRICH, V79, P37, DOI 10.2989/OSTRICH.2008.79.1.4.361; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2004, ANIM CONSERV, V7, P93, DOI 10.1017/S1367943003001185; Naithani A, 2012, BIOLOGIA, V67, P800, DOI 10.2478/s11756-012-0068-z; Nakamura Akihiro, 2003, Ecological Management & Restoration, V4, pS20, DOI 10.1046/j.1442-8903.4.s.3.x; Nakashima Y, 2013, AFR ZOOL, V48, P395, DOI 10.3377/004.048.0212; Naoe S, 2012, J FOREST RES-JPN, V17, P219, DOI 10.1007/s10310-011-0296-z; Navarrete D, 2008, BIODIVERS CONSERV, V17, P2869, DOI 10.1007/s10531-008-9402-8; Navarro I. L., 2011, Revista Colombiana de Ciencia Animal, V3, P102; Ndang'ang'a PK, 2013, OSTRICH, V84, P171, DOI 10.2989/00306525.2013.860929; Nelson A, 2008, CHRISTIAN TRAVEL PLA; Neuschulz EL, 2011, OIKOS, V120, P1371, DOI 10.1111/j.1600-0706.2011.19097.x; Newbold T., 2012, AFRICAN SCI, V4, P155, DOI DOI 10.1111/J.1365-2028.2010.01206.X; Newbold T, 2016, ECOGRAPHY, V39, P1151, DOI 10.1111/ecog.01932; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Urbina-Cardona JN, 2008, CALDASIA, V30, P479; Nicolas V, 2009, BIODIVERS CONSERV, V18, P2043, DOI 10.1007/s10531-008-9572-4; Nielsen A, 2011, ECOL RES, V26, P969, DOI 10.1007/s11284-011-0852-1; Noske NM, 2008, BASIC APPL ECOL, V9, P4, DOI 10.1016/j.baae.2007.06.014; NOREIKA N, 2009, INSECT SPECIES, V21, P68; Noreika N, 2012, J INSECT CONSERV, V16, P867, DOI 10.1007/s10841-012-9474-3; Norfolk O, 2013, BASIC APPL ECOL, V14, P659, DOI 10.1016/j.baae.2013.10.004; Norfolk O, 2012, AGR ECOSYST ENVIRON, V162, P8, DOI 10.1016/j.agee.2012.08.007; Noriega J.A., 2007, Universitas Scientiarum, V12, P51; Noriega Jorge Ari, 2012, Actualidades Biologicas (Medellin), V34, P43; NORTON DA, 2006, NZ J ECOL, V892, P335; Numa C, 2012, RANGELAND ECOL MANAG, V65, P137, DOI 10.2111/REM-D-10-00050.1; O'Connor TG, 2005, J APPL ECOL, V42, P975, DOI 10.1111/j.1365-2664.2005.01065.x; O'Dea N, 2007, BIODIVERS CONSERV, V16, P1131, DOI 10.1007/s10531-006-9095-9; O'Farrell PJ, 2008, AFR ZOOL, V43, P117, DOI 10.3377/1562-7020(2008)43[117:SMDADO]2.0.CO;2; Oertli S, 2005, EUR J ENTOMOL, V102, P53, DOI 10.14411/eje.2005.008; Ozden O, 2008, BIODIVERS CONSERV, V17, P2821, DOI 10.1007/s10531-008-9382-8; Ofori-Boateng C, 2013, BIOTROPICA, V45, P94, DOI 10.1111/j.1744-7429.2012.00887.x; Oliveira DE, 2013, SOCIOBIOLOGY, V60, P190; Oliver TH, 2015, TRENDS ECOL EVOL, V30, P673, DOI 10.1016/j.tree.2015.08.009; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Osgathorpe LM, 2012, APIDOLOGIE, V43, P113, DOI 10.1007/s13592-011-0083-z; Otto CRV, 2012, FOREST ECOL MANAG, V284, P241, DOI 10.1016/j.foreco.2012.07.016; Page NV, 2010, PLANT ECOL, V206, P237, DOI 10.1007/s11258-009-9638-8; Paradis S, 2011, FOREST ECOL MANAG, V262, P2079, DOI 10.1016/j.foreco.2011.08.032; Paritsis J, 2008, FOREST ECOL MANAG, V255, P1575, DOI 10.1016/j.foreco.2007.11.015; Parra-H A, 2007, REV BIOL TROP, V55, P931; Parry L, 2009, CONSERV BIOL, V23, P1270, DOI 10.1111/j.1523-1739.2009.01224.x; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Pelegrin N, 2012, J ARID ENVIRON, V79, P13, DOI 10.1016/j.jaridenv.2011.11.004; Peres CA, 2006, BIODIVERS CONSERV, V15, P2627, DOI 10.1007/s10531-005-5406-9; Pethiyagoda RS, 2012, WILDLIFE RES, V39, P641, DOI 10.1071/WR12079; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pincheira-Ulbrich J, 2012, B SOC ARGENT BOT, V47, P411; Pineda E, 2004, BIOL CONSERV, V117, P499, DOI 10.1016/j.biocon.2003.08.009; Pinheiro J, 2000, MIXED EFFECTS MODELS; Poggio SL, 2013, AGR ECOSYST ENVIRON, V166, P55, DOI 10.1016/j.agee.2012.01.013; Politi N, 2012, BIODIVERS CONSERV, V21, P3131, DOI 10.1007/s10531-012-0358-3; Pons P, 2005, ANIM CONSERV, V8, P183, DOI 10.1017/S1367943005001940; Poveda K, 2012, J APPL ECOL, V49, P513, DOI 10.1111/j.1365-2664.2012.02120.x; Power EF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038073; Power EF, 2011, J APPL ECOL, V48, P561, DOI 10.1111/j.1365-2664.2010.01949.x; Presley SJ, 2008, J APPL ECOL, V45, P14, DOI 10.1111/j.1365-2664.2007.01373.x; Proenca VM, 2010, ACTA OECOL, V36, P219, DOI 10.1016/j.actao.2010.01.002; Quaranta Marino, 2004, Bulletin of Insectology, V57, P11; Quintero C, 2010, BIODIVERS CONSERV, V19, P257, DOI 10.1007/s10531-009-9720-5; R Core Team, 2021, R LANG ENV STAT COMP; Rader R, 2014, DIVERS DISTRIB, V20, P908, DOI 10.1111/ddi.12221; Ranganathan J, 2008, P NATL ACAD SCI USA, V105, P17852, DOI 10.1073/pnas.0808874105; Ranganathan J, 2007, ECOL APPL, V17, P1499, DOI 10.1890/06-0285.1; Raub F, 2014, J ARACHNOL, V42, P52, DOI 10.1636/P13-47.1; Redpath N, 2010, BIOL CONSERV, V143, P492, DOI 10.1016/j.biocon.2009.11.019; Reid JL, 2012, BIOTROPICA, V44, P350, DOI 10.1111/j.1744-7429.2011.00814.x; Reis YT, 2007, IHERINGIA SER ZOOL, V97, P229, DOI 10.1590/S0073-47212007000300001; Reuter HI, 2012, DIGITAL SOIL ASSESSMENTS AND BEYOND, P287; Rey-Benayas JM, 2010, FOREST ECOL MANAG, V260, P87, DOI 10.1016/j.foreco.2010.04.004; Reynolds C, 2013, AFR ZOOL, V48, P228, DOI 10.3377/004.048.0217; Ribeiro DB, 2012, J INSECT CONSERV, V16, P733, DOI 10.1007/s10841-012-9458-3; Richardson BA, 2005, J ANIM ECOL, V74, P926, DOI 10.1111/j.1365-2656.2005.00990.x; Robles CA, 2011, LANDSCAPE URBAN PLAN, V100, P129, DOI 10.1016/j.landurbplan.2010.12.003; Rodrigues MM, 2013, BRAZ J BIOL, V73, P211, DOI 10.1590/S1519-69842013000100023; Rombke J, 2009, PESQUI AGROPECU BRAS, V44, P1040, DOI 10.1590/S0100-204X2009000800037; Romero-Duque LP, 2007, FOREST ECOL MANAG, V253, P38, DOI 10.1016/j.foreco.2007.07.002; ROSSELLI L, 2011, THESIS U NACL COLOMB; Rousseau L, 2013, ECOL INDIC, V27, P71, DOI 10.1016/j.ecolind.2012.11.020; Rubio AV, 2011, EUR J WILDLIFE RES, V57, P195, DOI 10.1007/s10344-010-0434-5; Safian S, 2011, J INSECT CONSERV, V15, P351, DOI 10.1007/s10841-010-9343-x; Sakchoowong W, 2008, ENTOMOL SCI, V11, P301, DOI 10.1111/j.1479-8298.2008.00281.x; Saldana-Vazquez RA, 2010, BIODIVERS CONSERV, V19, P2111, DOI 10.1007/s10531-010-9829-6; Sam K, 2014, J FIELD ORNITHOL, V85, P152, DOI 10.1111/jofo.12057; Samnegard U, 2011, BIOL CONSERV, V144, P2602, DOI 10.1016/j.biocon.2011.07.008; Sandifer PA, 2015, ECOSYST SERV, V12, P1, DOI 10.1016/j.ecoser.2014.12.007; Santana J, 2012, J APPL ECOL, V49, P632, DOI 10.1111/j.1365-2664.2012.02141.x; Savage J, 2011, WETLANDS, V31, P125, DOI 10.1007/s13157-010-0133-8; Schilthuizen M, 2005, CONSERV BIOL, V19, P949; Scholes RJ, 2005, NATURE, V434, P45, DOI 10.1038/nature03289; Schon NL, 2008, APPL SOIL ECOL, V40, P218, DOI 10.1016/j.apsoil.2008.04.007; Schon NL, 2010, APPL SOIL ECOL, V46, P209, DOI 10.1016/j.apsoil.2010.08.011; Schuepp C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052109; Schuepp C, 2011, OECOLOGIA, V165, P713, DOI 10.1007/s00442-010-1746-6; Schumann K, 2011, BIOL CONSERV, V144, P2369, DOI 10.1016/j.biocon.2011.06.018; Scott DM, 2006, BIOL CONSERV, V127, P72, DOI 10.1016/j.biocon.2005.07.014; Scott KA, 2010, AUSTRAL ECOL, V35, P858, DOI 10.1111/j.1442-9993.2009.02091.x; Sedlock JL, 2008, ACTA CHIROPTEROL, V10, P349, DOI 10.3161/150811008X414926; Shafie NJ, 2011, TROP LIFE SCI RES, V22, P13; Shahabuddin G, 2007, FOREST ECOL MANAG, V246, P175, DOI 10.1016/j.foreco.2007.03.061; Shannon G, 2008, J TROP ECOL, V24, P281, DOI 10.1017/S0266467408004951; Sheil D, 2002, EXPLORING BIOL DIVER; Sheldon FH, 2010, BIOL CONSERV, V143, P399, DOI 10.1016/j.biocon.2009.11.004; Shuler RE, 2005, J ECON ENTOMOL, V98, P790, DOI 10.1603/0022-0493-98.3.790; Siebert SJ, 2011, PLANT ECOL EVOL, V144, P249, DOI 10.5091/plecevo.2011.501; Silva FAB, 2010, ENVIRON ENTOMOL, V39, P359, DOI 10.1603/EN09180; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; SMITH PARDO ALLAN, 2007, Acta biol.Colomb., V12, P43; Sodhi NS, 2010, CONSERV BIOL, V24, P1290, DOI 10.1111/j.1523-1739.2010.01495.x; Soh MCK, 2006, BIOL CONSERV, V129, P149, DOI 10.1016/j.biocon.2005.10.030; Sosa RA., 2010, REV ASOCIACION ARGEN, V1, P101; Sridhar H, 2008, CURR SCI INDIA, V94, P748; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Stouffer PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020543; Strom L, 2009, BIOL CONSERV, V142, P1580, DOI 10.1016/j.biocon.2009.02.028; Struebig MJ, 2008, BIOL CONSERV, V141, P2112, DOI 10.1016/j.biocon.2008.06.009; Su ZM, 2011, J INSECT CONSERV, V15, P367, DOI 10.1007/s10841-010-9310-6; Suarez-Rubio M, 2009, BIOL CONSERV, V142, P1311, DOI 10.1016/j.biocon.2008.12.035; Sugiura S, 2009, J INSECT CONSERV, V13, P377, DOI 10.1007/s10841-008-9185-y; Summerville KS, 2006, ECOL APPL, V16, P891, DOI 10.1890/1051-0761(2006)016[0891:STAPOL]2.0.CO;2; Summerville KS, 2011, ECOL APPL, V21, P806, DOI 10.1890/10-0715.1; Summerville KS, 2002, ECOL APPL, V12, P820, DOI 10.2307/3060992; Sung YH, 2012, FOREST ECOL MANAG, V270, P71, DOI 10.1016/j.foreco.2012.01.011; Thomas CD, 2013, P NATL ACAD SCI USA, V110, P19187, DOI 10.1073/pnas.1319304110; Threlfall CG, 2012, BIOL CONSERV, V146, P41, DOI 10.1016/j.biocon.2011.11.026; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Tonietto R, 2011, LANDSCAPE URBAN PLAN, V103, P102, DOI 10.1016/j.landurbplan.2011.07.004; Torre I, 2014, BIODIVERS CONSERV, V23, P2579, DOI 10.1007/s10531-014-0740-4; Tuanmu MN, 2014, GLOBAL ECOL BIOGEOGR, V23, P1031, DOI 10.1111/geb.12182; Turner EC, 2009, J TROP ECOL, V25, P23, DOI 10.1017/S0266467408005658; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Uehara-Prado M, 2005, SOCIOBIOLOGY, V45, P915; Uehara-Prado M, 2007, GLOBAL ECOL BIOGEOGR, V16, P43, DOI 10.1111/j.1466-8238.2006.00267.x; Urbina-Cardona JN, 2006, BIOL CONSERV, V132, P61, DOI 10.1016/j.biocon.2006.03.014; Vallan D, 2002, J TROP ECOL, V18, P725, DOI 10.1017/S026646740200247X; Van Asselen S, 2013, GLOBAL CHANGE BIOL, V19, P3648, DOI 10.1111/gcb.12331; Van Vu L, 2011, INT SCH RES NOT, V2011, P1, DOI [10.5402/2011/818545, DOI 10.5402/2011/818545]; Vanbergen AJ, 2005, ECOGRAPHY, V28, P3, DOI 10.1111/j.0906-7590.2005.03991.x; Vasconcelos Heraldo L, 2009, PLoS One, V4, pe7762, DOI 10.1371/journal.pone.0007762; Vassilev K, 2011, PLANT BIOSYST, V145, P654, DOI 10.1080/11263504.2011.601337; Vazquez DP, 2002, AM NAT, V159, P606, DOI 10.1086/339991; VELLEND M, 2013, SD, V110, P19456; Verboven HAF, 2012, LANDSCAPE URBAN PLAN, V106, P158, DOI 10.1016/j.landurbplan.2012.02.015; Verdasca MJ, 2012, BIOL CONSERV, V146, P14, DOI 10.1016/j.biocon.2011.10.031; Verdu JR, 2007, BIOL CONSERV, V140, P308, DOI 10.1016/j.biocon.2007.08.015; Vergara CH, 2009, AGR ECOSYST ENVIRON, V129, P117, DOI 10.1016/j.agee.2008.08.001; Vergara PM, 2004, ORYX, V38, P383, DOI 10.1017/S0030605304000742; Miranda MV, 2010, ORNITOL NEOTROP, V21, P323; Lantschner MV, 2012, FOREST ECOL MANAG, V269, P271, DOI 10.1016/j.foreco.2011.12.045; VIE JC, 2009, WILDLIFE CHANGING WO, V184, P2008; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Virgilio M, 2011, B ENTOMOL RES, V101, P591, DOI 10.1017/S0007485311000216; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Waite E, 2013, EMU, V113, P26, DOI 10.1071/MU11093; Waite EM, 2012, J INSECT CONSERV, V16, P931, DOI 10.1007/s10841-012-9480-5; Walker S, 2014, NEW ZEAL J ECOL, V38, P230; Walker TR, 2006, ECOL INDIC, V6, P369, DOI 10.1016/j.ecolind.2005.03.015; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; Watling JI, 2009, ANIM CONSERV, V12, P467, DOI 10.1111/j.1469-1795.2009.00274.x; Weller B, 2004, BASIC APPL ECOL, V5, P193, DOI 10.1078/1439-1791-00220; Wells K, 2007, J BIOGEOGR, V34, P1087, DOI 10.1111/j.1365-2699.2006.01677.x; Wiafe E. D., 2012, Journal of Ecology and the Natural Environment, V4, P114; Williams CD, 2009, INSECT CONSERV DIVER, V2, P270, DOI 10.1111/j.1752-4598.2009.00064.x; Willig MR, 2007, BIOTROPICA, V39, P737, DOI 10.1111/j.1744-7429.2007.00322.x; Winfree R, 2007, CONSERV BIOL, V21, P213, DOI 10.1111/j.1523-1739.2006.00574.x; Woinarski JCZ, 2009, WILDLIFE RES, V36, P675, DOI 10.1071/WR08128; Woodcock BA, 2007, J APPL ECOL, V44, P60, DOI 10.1111/j.1365-2664.2006.01258.x; Wronski T, 2014, J MOLLUS STUD, V80, P161, DOI 10.1093/mollus/eyu008; Wunderle JM, 2006, BIOTROPICA, V38, P235, DOI 10.1111/j.1744-7429.2006.00138.x; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P1365, DOI 10.1007/s10531-012-0244-z; Yan XL, 2013, ANN FOREST SCI, V70, P845, DOI 10.1007/s13595-013-0323-7; Yan Xiao-Li, 2008, Zhiwu Shengtai Xuebao, V32, P815, DOI 10.3773/j.issn.1005-264x.2008.04.010; Yan Xiaoli, 2008, Shengwu Duoyangxing, V16, P110, DOI 10.3724/SP.J.1003.2008.07349; Yoshikura S, 2011, MAMM STUDY, V36, P189, DOI 10.3106/041.036.0402; Zaitsev AS, 2006, APPL SOIL ECOL, V34, P230, DOI 10.1016/j.apsoil.2006.01.005; Zaitsev AS, 2002, SOIL BIOL BIOCHEM, V34, P1919, DOI 10.1016/S0038-0717(02)00208-0; Zhang JN, 2010, AFR J AGR RES, V5, P2787; Zimmerman G, 2011, FOREST CHRON, V87, P217, DOI 10.5558/tfc2011-009; Zuur Alain F., 2009, P1	455	511	526	63	658	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2016	353	6296					288	291		10.1126/science.aaf2201	http://dx.doi.org/10.1126/science.aaf2201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0EM	27418509	Green Submitted, Green Accepted			2022-12-24	WOS:000379580800049
J	Harrison, P; Hogan, BJ; Floros, L; Davies, E				Harrison, P.; Hogan, B. J.; Floros, L.; Davies, E.		Guideline Dev Grp	GUIDELINES Assessment and management of cirrhosis in people older than 16 years: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harrison, P.] Kings Coll Hosp London, London SE5 9RS, England; [Hogan, B. J.] Guyss & St Thomas Hosp NHS Fdn Trust, Intens Care Med & Hepatol, London, England; [Floros, L.; Davies, E.] Royal Coll Physicians, Natl Guideline Ctr, London NW1 4LE, England	King's College Hospital NHS Foundation Trust; King's College Hospital; Royal College of Physicians	Davies, E (corresponding author), Royal Coll Physicians, Natl Guideline Ctr, London NW1 4LE, England.	Emily.Davies@rcplondon.ac.uk		Hogan, Brian/0000-0002-6902-4380				[Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; National Institute for Health and Care Excellence, 2016, ASS MAN CIRRH CLIN G; National Institute for Health and Care Excellence, 2016, NON FATT LIV DIS NAF; RightCare, 2013, NHS ATL VAR HEALTHC; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9	6	10	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2016	354								i2850	10.1136/bmj.i2850	http://dx.doi.org/10.1136/bmj.i2850			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EP	27383758				2022-12-24	WOS:000379581100002
J	O'Connor, DH; Osorio, JE; Tanuri, A; Kallas, EG				O'Connor, David H.; Osorio, Jorge E.; Tanuri, Amilcar; Kallas, Esper G.			Forging Collaborative Relationships in Brazil: From AIDS to ZIKV	CELL			English	Editorial Material								The Zika virus (ZIKV) outbreak has stimulated collaborations between Brazilians, researchers from other South American countries, and scientists from around the world. The Brazilian response to the HIV/AIDS epidemic demonstrates capabilities that can be applied to the study of ZIKV and provides lessons for developing effective international infectious disease research collaborations.	[O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA; [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53705 USA; [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, BR-2194190 Rio De Janeiro, Brazil; [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, BR-01246903 Sao Paulo, Brazil; [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Dept Infect Dis, BR-01246903 Sao Paulo, Brazil	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade de Sao Paulo	O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.; Kallas, EG (corresponding author), Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, BR-01246903 Sao Paulo, Brazil.; Kallas, EG (corresponding author), Univ Sao Paulo, Sch Med, Dept Infect Dis, BR-01246903 Sao Paulo, Brazil.	dhoconno@wisc.edu; esper.kallas@usp.br	Tanuri, Amilcar/AAM-8601-2021	Kallas, Esper/0000-0003-2026-6925				Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502; Central Intelligence Agency, 2016, WORLD FACTBOOK; Gao GF, 2014, SCIENCE, V346, P666, DOI 10.1126/science.346.6209.666; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Merson MH, 2014, NEW ENGL J MED, V370, P1676, DOI 10.1056/NEJMp1401124; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Office of the United Nations Special Envoy on Ebola, 2016, RES RES 5; Scimago Journal & Country Rank, 2016, COUNTR RANK; Sistema Unico de Saude, 2016, PORT DA SAUD; The World Bank, 2016, WORLD DEV IND REPR H; World Bank, 2016, COUNTR LEND GROUPS; World Bank, 2020, RES DEV EXP GDP; World Health Organization, 2016, SIT REP ZIK VIR DIS; World Health Organization, 2016, WORLD HLTH ORG COUNT	14	1	1	0	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					2	4		10.1016/j.cell.2016.06.023	http://dx.doi.org/10.1016/j.cell.2016.06.023			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368092	Bronze			2022-12-24	WOS:000380254400002
J	von der Ecken, J; Heissler, SM; Pathan-Chhatbar, S; Manstein, DJ; Raunser, S				von der Ecken, Julian; Heissler, Sarah M.; Pathan-Chhatbar, Salma; Manstein, Dietmar J.; Raunser, Stefan			Cryo-EM structure of a human cytoplasmic actomyosin complex at near-atomic resolution	NATURE			English	Article							HEAVY-CHAIN GENE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; DICTYOSTELIUM MYOSIN-II; ACTIN-BINDING SITE; BETA-MYOSIN; FUNCTIONAL-CHARACTERIZATION; DILATED CARDIOMYOPATHY; MUSCLE-CONTRACTION; MISSENSE MUTATION; ATPASE ACTIVITY	The interaction of myosin with actin filaments is the central feature of muscle contraction(1) and cargo movement along actin filaments of the cytoskeleton(2). The energy for these movements is generated during a complex mechanochemical reaction cycle(3,4). Crystal structures of myosin in different states have provided important structural insights into the myosin motor cycle when myosin is detached from F-actin(5-7). The difficulty of obtaining diffracting crystals, however, has prevented structure determination by crystallography of actomyosin complexes. Thus, although structural models exist of F-actin in complex with various myosins(8-11), a high-resolution structure of the F-actin-myosin complex is missing. Here, using electron cryomicroscopy, we present the structure of a human rigor actomyosin complex at an average resolution of 3.9 angstrom. The structure reveals details of the actomyosin interface, which is mainly stabilized by hydrophobic interactions. The negatively charged amino (N) terminus of actin interacts with a conserved basic motif in loop 2 of myosin, promoting cleft closure in myosin. Surprisingly, the overall structure of myosin is similar to rigor-like myosin structures in the absence of F-actin, indicating that F-actin binding induces only minimal conformational changes in myosin. A comparison with pre-powerstroke and intermediate (P-i-release)(7) states of myosin allows us to discuss the general mechanism of myosin binding to F-actin. Our results serve as a strong foundation for the molecular understanding of cytoskeletal diseases, such as autosomal dominant hearing loss and diseases affecting skeletal and cardiac muscles, in particular nemaline myopathy and hypertrophic cardiomyopathy.	[von der Ecken, Julian; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany; [Heissler, Sarah M.; Pathan-Chhatbar, Salma; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Manstein, Dietmar J.] Hannover Med Sch, Div Struct Anal, D-30625 Hannover, Germany; [Heissler, Sarah M.] NHLBI, Lab Mol Physiol, NIH, Bldg 10, Bethesda, MD 20892 USA	Max Planck Society; Hannover Medical School; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Raunser, S (corresponding author), Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany.	stefan.raunser@mpi-dortmund.mpg.de	Raunser, Stefan/AHE-1573-2022; Manstein, Dietmar J./AAG-2640-2019; Manstein, Dietmar J. J/M-1034-2013	Manstein, Dietmar J./0000-0003-0763-0147; Manstein, Dietmar J. J/0000-0003-0763-0147; von der Ecken, Julian/0000-0001-8526-2656; Raunser, Stefan/0000-0001-9373-3016	Max Planck Society; European Research Council under the European Union [615984]; Behrens-Weise foundation; German Research Foundation (DFG) [MA 1081/21-1]	Max Planck Society(Max Planck Society); European Research Council under the European Union(European Research Council (ERC)); Behrens-Weise foundation; German Research Foundation (DFG)(German Research Foundation (DFG))	We thank O. Hofnagel for assistance in cryo sample preparation. We acknowledge R. Matadeen and S. de Carlo for image acquisition at the Netherlands Centre for Nanoscopy in Leiden. We thank R. S. Goody for reading the manuscript. This work was supported by the Max Planck Society, the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013) (grant number 615984) (to S.R.), the Behrens-Weise foundation (to S. R.) and German Research Foundation (DFG) grant MA 1081/21-1 (to D.J.M.). J.v.d.E. is a fellow of Studienstiftung des deutschen Volkes.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Blanchard E, 1999, CIRC RES, V84, P475, DOI 10.1161/01.RES.84.4.475; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COOK RK, 1993, J BIOL CHEM, V268, P2410; Coulton A, 2006, BIOCHEMISTRY-US, V45, P12853, DOI 10.1021/bi0613224; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; CUDA G, 1993, J CLIN INVEST, V91, P2861, DOI 10.1172/JCI116530; Daehmlow S, 2002, BIOCHEM BIOPH RES CO, V298, P116, DOI 10.1016/S0006-291X(02)02374-4; DAUSSE E, 1993, J CLIN INVEST, V92, P2807, DOI 10.1172/JCI116900; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EPSTEIN ND, 1992, CIRCULATION, V86, P345, DOI 10.1161/01.CIR.86.2.345; Erdmann J, 2003, CLIN GENET, V64, P339, DOI 10.1034/j.1399-0004.2003.00151.x; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Greber-Platzer S, 2001, J MOL CELL CARDIOL, V33, P141, DOI 10.1006/jmcc.2000.1287; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Klein JC, 2008, P NATL ACAD SCI USA, V105, P12867, DOI 10.1073/pnas.0802286105; Kojima S, 2001, BIOCHEMISTRY-US, V40, P657, DOI 10.1021/bi0011328; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LANKFORD EB, 1995, J CLIN INVEST, V95, P1409, DOI 10.1172/JCI117795; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Llinas P, 2015, DEV CELL, V33, P401, DOI 10.1016/j.devcel.2015.03.025; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; MILLIGAN RA, 1990, NATURE, V348, P217, DOI 10.1038/348217a0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mohiddin SA, 2003, GENET TEST, V7, P21, DOI 10.1089/109065703321560895; MOOLMAN JC, 1993, HUM MOL GENET, V2, P1731, DOI 10.1093/hmg/2.10.1731; Moolman-Smook JC, 1999, AM J HUM GENET, V65, P1308, DOI 10.1086/302623; Muller M, 2012, CELL MOL LIFE SCI, V69, P3457, DOI 10.1007/s00018-012-1030-5; Munnich S, 2014, FEBS LETT, V588, P4754, DOI 10.1016/j.febslet.2014.11.007; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Murphy CT, 1999, BIOCHEMISTRY-US, V38, P3785, DOI 10.1021/bi9826815; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Ohki T, 2009, BIOCHEM BIOPH RES CO, V383, P146, DOI 10.1016/j.bbrc.2009.03.144; Onishi H, 2006, P NATL ACAD SCI USA, V103, P6136, DOI 10.1073/pnas.0601595103; Perrot A, 2005, J MOL MED-JMM, V83, P468, DOI 10.1007/s00109-005-0635-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Lopez-Blanco JR, 2013, J STRUCT BIOL, V184, P261, DOI 10.1016/j.jsb.2013.08.010; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasaki N, 1999, J BIOL CHEM, V274, P37840, DOI 10.1074/jbc.274.53.37840; Sasaki N, 2000, J BIOL CHEM, V275, P38705, DOI 10.1074/jbc.M001966200; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; UYEDA TQP, 1994, NATURE, V368, P567, DOI 10.1038/368567a0; Van Dijk J, 1999, BIOCHEMISTRY-US, V38, P15078, DOI 10.1021/bi991595h; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P602, DOI 10.1016/j.jacc.2004.04.039; Varkuti BH, 2015, J BIOL CHEM, V290, P1679, DOI 10.1074/jbc.M114.606665; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Villard E, 2005, EUR HEART J, V26, P794, DOI 10.1093/eurheartj/ehi193; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woo A, 2003, HEART, V89, P1179, DOI 10.1136/heart.89.10.1179; Yu B, 2005, J CLIN PATHOL, V58, P479, DOI 10.1136/jcp.2004.021642	78	132	132	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					724	+		10.1038/nature18295	http://dx.doi.org/10.1038/nature18295			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27324845				2022-12-24	WOS:000378676000045
J	Rockstrom, J; Stordalen, GA; Horton, R				Rockstrom, Johan; Stordalen, Gunhild Anker; Horton, Richard			Acting in the Anthropocene: the EAT-Lancet Commission	LANCET			English	Editorial Material									[Rockstrom, Johan] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Stordalen, Gunhild Anker] EAT Fdn, NO-0153 Oslo, Norway; [Horton, Richard] The Lancet, London, England	Stockholm University	Stordalen, GA (corresponding author), EAT Fdn, NO-0153 Oslo, Norway.	gunhild@eatforum.org		Rockstrom, Johan/0000-0001-8988-2983				Bloom DE, 2011, GLOBAL EC BURDEN NON; Erb KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11382; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Garnett T., 2014, WHAT IS SUSTAINABLE, P31; Krausmann F, 2013, P NATL ACAD SCI USA, V110, P10324, DOI 10.1073/pnas.1211349110; Ranganathan J., 2016, WORKING PAPER, DOI DOI 10.1007/s10584-006-9122-6; Springmann M, 2016, P NATL ACAD SCI USA, V113, P4146, DOI 10.1073/pnas.1523119113; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Waters CN, 2016, SCIENCE, V351, P137, DOI 10.1126/science.aad2622; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; WHO, 2001, WORLD HLTH REPORT 20; World Health Organization,, 2015, OB OV; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS	13	28	30	1	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2364	2365		10.1016/S0140-6736(16)30681-X	http://dx.doi.org/10.1016/S0140-6736(16)30681-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1ST	27312291				2022-12-24	WOS:000377560100011
J	Sliwa, K; Anthony, J				Sliwa, Karen; Anthony, John			Late maternal deaths: a neglected responsibility	LANCET			English	Editorial Material							COUNTRIES; INJURIES		[Sliwa, Karen] Univ Cape Town, Hatter Inst Cardiovasc Res Africa, Fac Hlth Sci, SA MRC Cape Heart Ctr, ZA-7925 Cape Town, South Africa; [Anthony, John] Univ Cape Town, Groote Schuur Hosp, Div Obstet & Gynaecol, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Sliwa, K (corresponding author), Univ Cape Town, Hatter Inst Cardiovasc Res Africa, Fac Hlth Sci, SA MRC Cape Heart Ctr, ZA-7925 Cape Town, South Africa.	karen.sliwa-hahnle@uct.ac.za		Sliwa, Karen/0000-0002-8272-0911				Duxbury F., 2014, ABC DOMESTIC SEXUAL, P9; Fuhr DC, 2014, LANCET PSYCHIAT, V1, P213, DOI 10.1016/S2215-0366(14)70282-2; Hilfiker-Kleiner D, 2014, NAT REV CARDIOL, V11, P364, DOI 10.1038/nrcardio.2014.37; Hoyert Donna L, 2007, Vital Health Stat 3, P1; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Knight M, 2015, SAVING LIVES IMPROVI, P22; Kurinczuk Jennifer J., 2015, SAVING LIVES IMPROVI; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Sliwa K, 2016, CIRCULATION, V133, P1199, DOI 10.1161/CIRCULATIONAHA.114.008730; Sliwa K, 2014, EUR J HEART FAIL, V16, P583, DOI 10.1002/ejhf.68; Soma-Pillay P, 2016, CARDIOVASC J AFR, V27, P1; WHO, INT CLASS DIS 2013; World Health Organization, 2012, WHO APPL ICD 10 DEAT; Yamin AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071674	14	32	32	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2072	2073		10.1016/S0140-6736(16)30391-9	http://dx.doi.org/10.1016/S0140-6736(16)30391-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	27301808				2022-12-24	WOS:000376450800009
J	Murphy, D; McCulloch, CE; Lin, F; Banerjee, T; Bragg-Gresham, JL; Eberhardt, MS; Morgenstern, H; Pavkov, ME; Saran, R; Powe, NR; Hsu, CY				Murphy, Daniel; McCulloch, Charles E.; Lin, Feng; Banerjee, Tanushree; Bragg-Gresham, Jennifer L.; Eberhardt, Mark S.; Morgenstern, Hal; Pavkov, Meda E.; Saran, Rajiv; Powe, Neil R.; Hsu, Chi-yuan		Ctr Dis Control Prevention	Trends in Prevalence of Chronic Kidney Disease in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE CONTROL; NATIONAL-HEALTH; TEMPORAL TRENDS; US ADULTS; RISK; HYPERTENSION; PROGRESSION; CREATININE	Background: Trends in the prevalence of chronic kidney disease (CKD) are important for health care policy and planning. Objective: To update trends in CKD prevalence. Design: Repeated cross-sectional study. Setting: NHANES (National Health and Nutrition Examination Survey) for 1988 to 1994 and every 2 years from 1999 to 2012. Participants: Adults aged 20 years or older. Measurements: Chronic kidney disease (stages 3 and 4) was defined as an estimated glomerular filtration rate (eGFR) of 15 to 59 mL/min/1.73 m(2), estimated with the Chronic Kidney Disease Epidemiology Collaboration equation from calibrated serum creatinine measurements. An expanded definition of CKD also included persons with an eGFR of at least 60 mL/min/1.73 m(2) and a 1-time urine albumin-creatinine ratio of at least 30 mg/g. Results: The unadjusted prevalence of stage 3 and 4 CKD increased from the late 1990s to the early 2000s. Since 2003 to 2004, however, the overall prevalence has largely stabilized (for example, 6.9% prevalence in 2003 to 2004 and in 2011 to 2012). There was little difference in adjusted prevalence of stage 3 and 4 CKD overall in 2003 to 2004 versus 2011 to 2012 after age, sex, race/ethnicity, and diabetes mellitus status were controlled for (P = 0.26). Lack of increase in CKD prevalence since the early 2000s was observed in most subgroups and with an expanded definition of CKD that included persons with higher eGFRs and albuminuria. Limitation: Serum creatinine and albuminuria were measured only once in each person. Conclusion: In a reversal of prior trends, there has been no appreciable increase in the prevalence of stage 3 and 4 CKD in the U.S. population overall during the most recent decade.	[Murphy, Daniel] Univ Minnesota, Dept Med, MMC 284 Mayo,8284A Campus Delivery Code, Minneapolis, MN 55455 USA; [McCulloch, Charles E.; Lin, Feng] Univ Calif San Francisco, Epidemiol & Biostat, Sch Med, 550 16th St,Box 0560, San Francisco, CA 94158 USA; [Banerjee, Tanushree; Powe, Neil R.] Priscilla Chan & Mark Zuckerberg San Francisco Ge, 1001 Potrero Ave,ZFGH 10,Box 1364, San Francisco, CA 94110 USA; [Bragg-Gresham, Jennifer L.] Univ Michigan, Internal Med Nephrol, 1455 Washington Hts,Suite 3645, Ann Arbor, MI 48109 USA; [Eberhardt, Mark S.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA; [Morgenstern, Hal] Univ Michigan, Sch Publ Hlth, M5164 SPH 2,1415 Washington Hts, Ann Arbor, MI 48109 USA; [Pavkov, Meda E.] Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30329 USA; [Saran, Rajiv] Univ Michigan, Internal Med Nephrol Kidney Epidemiol & Cost Ctr, 1415 Washington Hts,SPH 1,Suite 3645, Ann Arbor, MI 48109 USA; [Hsu, Chi-yuan] UCSF Sch Med, 533 Parnassus Ave,UC Hall 404,Box 0532, San Francisco, CA 94143 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Hsu, CY (corresponding author), Univ Calif San Francisco, Div Nephrol, 533 Parnassus Ave,U-400,Box 0532, San Francisco, CA 94143 USA.	Neil.Powe@ucsf.edu; hsuchi@medicine.ucsf.edu		Hsu, Chi-yuan/0000-0001-8182-1238	American Society of Nephrology Foundation for Kidney Research Student Scholar Grant Program; Centers for Disease Control and Prevention, and National Institutes of Health; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP003839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK092291] Funding Source: NIH RePORTER	American Society of Nephrology Foundation for Kidney Research Student Scholar Grant Program; Centers for Disease Control and Prevention, and National Institutes of Health; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	American Society of Nephrology Foundation for Kidney Research Student Scholar Grant Program, Centers for Disease Control and Prevention, and National Institutes of Health.	Aitken Grant R, 2014, BMJ Open, V4, pe005480, DOI 10.1136/bmjopen-2014-005480; Bruck K, 2016, J AM SOC NEPHROL, V27, P2135, DOI 10.1681/ASN.2015050542; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782; Foley RN, 2009, CLIN J AM SOC NEPHRO, V4, P965, DOI 10.2215/CJN.05281008; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grams ME, 2013, AM J KIDNEY DIS, V62, P253, DOI 10.1053/j.ajkd.2013.03.013; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Gu Q, 2006, CIRCULATION; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Healthy People 2020, 2016, CHRON KIDN DIS; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hsu CY, 2004, ANN INTERN MED, V141, P95, DOI 10.7326/0003-4819-141-2-200407200-00007; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; Hsu RK, 2013, AM J KIDNEY DIS, V62, P214, DOI 10.1053/j.ajkd.2013.05.003; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Levey AS, 2007, J AM SOC NEPHROL, V18, P374, DOI 10.1681/ASN.2006121305; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Center for Health Statistics, 2013, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2013, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2016, NAT HLTH NUTR EX SUR; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; PARVING HH, 1983, LANCET, V1, P1175; Plantinga LC, 2009, HYPERTENSION, V54, P47, DOI 10.1161/HYPERTENSIONAHA.109.129841; Reule S, 2016, J AM SOC NEPHROL, V27, P1487, DOI 10.1681/ASN.2014090876; Saydah SH, 2013, CLIN CHEM, V59, P675, DOI 10.1373/clinchem.2012.195644; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; Vittinghoff E, 2012, REGRESSION METHODS B, P347; Yoon SS, 2015, HYPERTENSION, V65, P54, DOI 10.1161/HYPERTENSIONAHA.114.04012	41	320	329	6	57	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2016	165	7					473	+		10.7326/M16-0273	http://dx.doi.org/10.7326/M16-0273			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY0EY	27479614	Green Accepted			2022-12-24	WOS:000384771300005
J	Franzen, O; Ermel, R; Cohain, A; Akers, NK; Di Narzo, A; Talukdar, HA; Foroughi-Asl, H; Giambartolomei, C; Fullard, JF; Sukhavasi, K; Koks, S; Gan, LM; Giannarelli, C; Kovacic, JC; Betsholtz, C; Losic, B; Michoel, T; Hao, K; Roussos, P; Skogsberg, J; Ruusalepp, A; Schadt, EE; Bjorkegren, JLM				Franzen, Oscar; Ermel, Raili; Cohain, Ariella; Akers, Nicholas K.; Di Narzo, Antonio; Talukdar, Husain A.; Foroughi-Asl, Hassan; Giambartolomei, Claudia; Fullard, John F.; Sukhavasi, Katyayani; Koks, Sulev; Gan, Li-Ming; Giannarelli, Chiara; Kovacic, Jason C.; Betsholtz, Christer; Losic, Bojan; Michoel, Tom; Hao, Ke; Roussos, Panos; Skogsberg, Josefin; Ruusalepp, Arno; Schadt, Eric E.; Bjorkegren, Johan L. M.			Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; COMMON VARIANTS; METAANALYSIS; EXPRESSION; GWAS; EPISTASIS; PATHWAYS	Genome-wide association studies (GWAS) have identified hundreds of cardiometabolic disease (CMD) risk loci. However, they contribute little to genetic variance, and most downstream gene-regulatory mechanisms are unknown. We genotyped and RNA-sequenced vascular and metabolic tissues from 600 coronary artery disease patients in the Stockholm-Tartu Atherosclerosis Reverse Networks Engineering Task study (STARNET). Gene expression traits associated with CMD risk single-nucleotide polymorphism (SNPs) identified by GWAS were more extensively found in STARNET than in tissue-and disease-unspecific gene-tissue expression studies, indicating sharing of downstream cis-/trans-gene regulation across tissues and CMDs. In contrast, the regulatory effects of other GWAS risk SNPs were tissue-specific; abdominal fat emerged as an important gene-regulatory site for blood lipids, such as for the low-density lipoprotein cholesterol and coronary artery disease risk gene PCSK9. STARNET provides insights into gene-regulatory mechanisms for CMD risk loci, facilitating their translation into opportunities for diagnosis, therapy, and prevention.	[Franzen, Oscar; Cohain, Ariella; Akers, Nicholas K.; Di Narzo, Antonio; Giannarelli, Chiara; Losic, Bojan; Hao, Ke; Roussos, Panos; Schadt, Eric E.; Bjorkegren, Johan L. M.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, One Gustave L Levy Pl, New York, NY 10029 USA; [Franzen, Oscar; Ruusalepp, Arno; Bjorkegren, Johan L. M.] Clin Gene Networks AB, Jungfrugatan 10, S-11444 Stockholm, Sweden; [Ermel, Raili; Sukhavasi, Katyayani; Koks, Sulev; Ruusalepp, Arno; Bjorkegren, Johan L. M.] Univ Tartu, Inst Biomed & Translat Med, Dept Pathophysiol, Biomeedikum, Ravila 19, EE-50411 Tartu, Estonia; [Ermel, Raili; Ruusalepp, Arno] Tartu Univ Hosp, Dept Cardiac Surg, 1a Ludwig Puusepa St, EE-50406 Tartu, Estonia; [Talukdar, Husain A.; Foroughi-Asl, Hassan; Skogsberg, Josefin; Bjorkegren, Johan L. M.] Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, Scheeles Vag 2, S-17177 Stockholm, Sweden; [Giambartolomei, Claudia; Fullard, John F.; Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, One Gustave L Levy Pl, New York, NY 10029 USA; [Giambartolomei, Claudia; Fullard, John F.; Roussos, Panos] Icahn Sch Med Mt Sinai, Friedman Brain Inst, One Gustave L Levy Pl, New York, NY 10029 USA; [Gan, Li-Ming] AstraZeneca, Innovat Med & Early Dev Biotech Unit, Cardiovasc & Metab Dis, Pepparedsleden 1, S-43183 Molndal, Sweden; [Giannarelli, Chiara; Kovacic, Jason C.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, One Gustave L Levy Pl, New York, NY 10029 USA; [Betsholtz, Christer] Novum, Karolinska Inst, AstraZeneca Karolinska Integrated CardioMetab Ctr, S-14157 Huddinge, Sweden; [Betsholtz, Christer] Dept Immunol Genet & Pathol, Dag Hammarskjolds Vag 20, S-75185 Uppsala, Sweden; [Michoel, Tom] Univ Edinburgh, Roslin Inst, Old Coll, Div Genet & Genom, Edinburgh EH8 9YL, Midlothian, Scotland; [Roussos, Panos] JJ Peters VA Med Ctr, MIRECC, Dept Psychiat, 130 West Kingsbridge Rd, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; University of Tartu; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; AstraZeneca; Icahn School of Medicine at Mount Sinai; Karolinska Institutet; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Bjorkegren, JLM (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, One Gustave L Levy Pl, New York, NY 10029 USA.; Bjorkegren, JLM (corresponding author), Clin Gene Networks AB, Jungfrugatan 10, S-11444 Stockholm, Sweden.; Bjorkegren, JLM (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Pathophysiol, Biomeedikum, Ravila 19, EE-50411 Tartu, Estonia.; Bjorkegren, JLM (corresponding author), Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, Scheeles Vag 2, S-17177 Stockholm, Sweden.	johan.bjorkegren@mssm.edu	Sukhavasi, Katyayani/AAA-3640-2021; Koks, Sulev/H-3655-2015	Sukhavasi, Katyayani/0000-0001-5627-0163; Koks, Sulev/0000-0001-6087-6643; Kovacic, Jason/0000-0003-4555-769X; Michoel, Tom/0000-0003-4749-4725; Foroughi Asl, Hassan/0000-0002-6925-9040; Ruusalepp, Arno/0000-0001-5816-8613	University of Tartu [SP1GVARENG]; Estonian Research Council (ETF) [8853]; Astra-Zeneca Translational Science Centre-Karolinska Institutet; Clinical Gene Networks AB (CGN) as an SME of the FP6/FP7 EU [HEALTH-F2-2013-601456]; Leducq transatlantic networks; CAD Genomics; Sphingonet; Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation; American Heart Association [A14SFRN20840000]; National Institutes of Health [NIH NHLBI R01HL125863, NIH NHLBI R01HL71207, R01AG050986, NIH NHLBI K23HL111339, NIH NHLBI K08HL111330]; Veterans Affairs [BX002395]; Swedish Research Council [VR-RF1]; Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX); BBSRC [BBS/E/D/20211551] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211551] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071207, K23HL111339, K08HL111330, R01HL125863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050986] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395] Funding Source: NIH RePORTER	University of Tartu; Estonian Research Council (ETF); Astra-Zeneca Translational Science Centre-Karolinska Institutet; Clinical Gene Networks AB (CGN) as an SME of the FP6/FP7 EU; Leducq transatlantic networks; CAD Genomics; Sphingonet; Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	The STARNET study was supported by the University of Tartu (SP1GVARENG to J.L.M.B.), the Estonian Research Council (ETF grant 8853 to A.R. and J.L.M.B.), the Astra-Zeneca Translational Science Centre-Karolinska Institutet (a joint research program in translational science, to J.L.M.B.), Clinical Gene Networks AB (CGN) as an SME of the FP6/FP7 EU-funded integrated project CVgenes@target (HEALTH-F2-2013-601456), the Leducq transatlantic networks, CAD Genomics (C.G., E.E.S., and J.L.M.B.), Sphingonet (C.B.), the Torsten and Ragnar Soderberg Foundation (C.B.), the Knut and Alice Wallenberg Foundation (C.B.), the American Heart Association (A14SFRN20840000 to J.C.K., E.E.S., and J.L.M.B.), the National Institutes of Health (NIH NHLBI R01HL125863 to J.L.M.B.; NIH NHLBI R01HL71207 to E.E.S.; R01AG050986 to P.R.; NIH NHLBI K23HL111339 to C.G.; NIH NHLBI K08HL111330 to J.C.K.), and the Veterans Affairs (Merit grant BX002395 to P.R.). The DNA genotyping and RNA sequencing were in part performed by the SNP&SEQ technology platform at Science for Life Laboratory the National Genomics Infrastructure (NGI) in Uppsala and Stockholm supported by the Swedish Research Council (VR-RF1), the Knut and Alice Wallenberg Foundation, and Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX). CGN has financially contributed to the STARNET study. J.L.M.B. is the founder and chairman of CGN. J.L.M.B., E.E.S., and A.R. are on the board of directors for CGN. J.L.M.B., T.M., and A.R. own equity in CGN and receive financial compensation from CGN. This work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai. The STARNET data is accessible through the Database of Genotypes and Phenotypes (dbGAP).	An P, 2014, METABOLISM, V63, P461, DOI 10.1016/j.metabol.2013.11.018; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Asl HF, 2015, CIRC-CARDIOVASC GENE, V8, P305, DOI 10.1161/CIRCGENETICS.114.000640; Cui Y, 2013, J AUTOIMMUN, V41, P25, DOI 10.1016/j.jaut.2013.01.008; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Leander K, 2016, CIRCULATION, V133, P1230, DOI 10.1161/CIRCULATIONAHA.115.018531; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Shulman GI, 2014, NEW ENGL J MED, V371, P2237; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Talukdar HA, 2016, CELL SYST, V2, P196, DOI 10.1016/j.cels.2016.02.002; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang IM, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.24; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	153	153	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					827	830		10.1126/science.aad6970	http://dx.doi.org/10.1126/science.aad6970			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540175	Green Accepted			2022-12-24	WOS:000381561400047
J	Stettler, K; Beltramello, M; Espinosa, DA; Graham, V; Cassotta, A; Bianchi, S; Vanzetta, F; Minola, A; Jaconi, S; Mele, F; Foglierini, M; Pedotti, M; Simonelli, L; Dowall, S; Atkinson, B; Percivalle, E; Simmons, CP; Varani, L; Blum, J; Baldanti, F; Cameroni, E; Hewson, R; Harris, E; Lanzavecchia, A; Sallusto, F; Corti, D				Stettler, Karin; Beltramello, Martina; Espinosa, Diego A.; Graham, Victoria; Cassotta, Antonino; Bianchi, Siro; Vanzetta, Fabrizia; Minola, Andrea; Jaconi, Stefano; Mele, Federico; Foglierini, Mathilde; Pedotti, Mattia; Simonelli, Luca; Dowall, Stuart; Atkinson, Barry; Percivalle, Elena; Simmons, Cameron P.; Varani, Luca; Blum, Johannes; Baldanti, Fausto; Cameroni, Elisabetta; Hewson, Roger; Harris, Eva; Lanzavecchia, Antonio; Sallusto, Federica; Corti, Davide			Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection	SCIENCE			English	Article							DENGUE VIRUS; MONOCLONAL-ANTIBODIES; DETERMINANTS; ENHANCEMENT; EPITOPES; BINDING; FEVER; MODEL	Zika virus (ZIKV), a mosquito-borne flavivirus with homology to Dengue virus (DENV), has become a public health emergency. By characterizing memory lymphocytes from ZIKV-infected patients, we dissected ZIKV-specific and DENV-cross-reactive immune responses. Antibodies to nonstructural protein 1 (NS1) were largely ZIKV-specific and were used to develop a serological diagnostic tool. In contrast, antibodies against E protein domain I/II (EDI/II) were cross-reactive and, although poorly neutralizing, potently enhanced ZIKV and DENV infection in vitro and lethally enhanced DENV disease in mice. Memory T cells against NS1 or E proteins were poorly cross-reactive, even in donors preexposed to DENV. The most potent neutralizing antibodies were ZIKV-specific and targeted EDIII or quaternary epitopes on infectious virus. An EDIII-specific antibody protected mice from lethal ZIKV infection, illustrating the potential for antibody-based therapy.	[Stettler, Karin; Beltramello, Martina; Bianchi, Siro; Vanzetta, Fabrizia; Minola, Andrea; Jaconi, Stefano; Cameroni, Elisabetta; Corti, Davide] Humabs BioMed SA, Via Mirasole 1, CH-6500 Bellinzona, Switzerland; [Espinosa, Diego A.; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA USA; [Graham, Victoria; Dowall, Stuart; Atkinson, Barry] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England; [Cassotta, Antonino; Foglierini, Mathilde; Pedotti, Mattia; Simonelli, Luca; Varani, Luca; Lanzavecchia, Antonio; Sallusto, Federica] Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland; [Cassotta, Antonino; Lanzavecchia, Antonio] ETH, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland; [Percivalle, Elena; Baldanti, Fausto] Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy; [Simmons, Cameron P.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX1 2JD, England; [Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Ctr Trop Med, Ho Chi Minh City, Vietnam; [Simmons, Cameron P.] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, 792 Elizabeth St, Melbourne, Vic 3000, Australia; [Blum, Johannes] Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4002 Basel, Switzerland; [Blum, Johannes] Univ Basel, Petersgraben 4, CH-4031 Basel, Switzerland	University of California System; University of California Berkeley; Public Health England; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; IRCCS Fondazione San Matteo; University of Oxford; University of Oxford; University of Melbourne; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Corti, D (corresponding author), Humabs BioMed SA, Via Mirasole 1, CH-6500 Bellinzona, Switzerland.; Sallusto, F (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	federica.sallusto@irb.usi.ch; davide.corti@humabs.ch	percivalle, elena/K-7994-2016; Baldanti, Fausto/J-4924-2018; Espinosa, Diego/AAT-6950-2020; Simmons, Cameron P/ABA-3896-2021; Cassotta, Antonino/AAW-2529-2021	percivalle, elena/0000-0002-3355-1410; Baldanti, Fausto/0000-0002-3358-8969; Simmons, Cameron P/0000-0002-9039-7392; Cassotta, Antonino/0000-0001-8674-4294; Foglierini, Mathilde/0000-0001-7538-4262; Varani, Luca/0000-0002-0963-0987; Espinosa, Diego A./0000-0002-4364-5031; Zatta, Fabrizia/0000-0003-4945-8058; Simonelli, Luca/0000-0001-6331-7716; Atkinson, Barry/0000-0002-1348-7204; Bianchi, Siro/0000-0002-5100-8905	European Union [HEALTH-F3-2011-281803]; European Research Council [323183 PREDICT]; Swiss National Science Foundation [160279]; U.S. National Institutes of Health [R01 AI24493]; Ministero della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente [8020615]; Helmut Horten Foundation; SNF [310030_166445]; Lions Club Monteceneri	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente(Ministry of Health, Italy); Helmut Horten Foundation; SNF; Lions Club Monteceneri	The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The views expressed are those of the authors and not necessarily those of the funding bodies. This work was supported by grants from the European Union (HEALTH-F3-2011-281803-Project IDAMS, "International Research Consortium on Dengue Risk Assessment, Management, and Surveillance" to F.S.), the European Research Council (grant 323183 PREDICT to F.S.), the Swiss National Science Foundation (grant 160279 to A.L.), the U.S. National Institutes of Health (grant R01 AI24493 to E.H.), and the Ministero della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente grant 8020615 (to E.P. and F.B.). A.L. is supported by the Helmut Horten Foundation. A.L. is the scientific founder of Humabs BioMed. D.C., A.L., and F.S. hold shares in Humabs BioMed. F.S. and F.B. are a scientific advisor and a consultant at Humabs BioMed, respectively. The MAbs described in this study are available under a materials transfer agreement with Humabs BioMed SA. L.V. is grateful for financial support by SNF grant 310030_166445 and Lions Club Monteceneri. A.L. is an inventor on a patent related to DENV mAbs described in this study: PCT/IB2009/007372 (Dengue virus neutralizing antibodies and uses thereof). D.C. is an inventor on a patent application held by Humabs BioMed SA related to ZIKV mAbs described in this study: PCT/EP2016/066684 (Novel antibodies specifically binding to Zika virus epitopes and uses thereof). Antibody nucleotide and amino acid sequences for the 68 mAbs described in table S2 have been deposited in GenBank (accession nos. KX496807 to KX496874).	Aliota M. T., 2016, PLOS NEGLECT TROP D, V10; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dowall S. D., 2016, PLOS NEGLECT TROP D, V10; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170; Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; MONATH TP, 1984, AM J TROP MED HYG, V33, P695, DOI 10.4269/ajtmh.1984.33.695; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Ohana B., 2000, CLIN DIAGN LAB IMMUN, V7, P904; Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862; Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11; Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Teoh E. P., 2012, SCI TRANSL MED, V4; Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453	38	519	563	3	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					823	826		10.1126/science.aaf8505	http://dx.doi.org/10.1126/science.aaf8505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27417494				2022-12-24	WOS:000381561400046
J	Odegaard, JI; Lee, MW; Sogawa, Y; Bertholet, AM; Locksley, RM; Weinberg, DE; Kirichok, Y; Deo, RC; Chawla, A				Odegaard, Justin I.; Lee, Min-Woo; Sogawa, Yoshitaka; Bertholet, Ambre M.; Locksley, Richard M.; Weinberg, David E.; Kirichok, Yuriy; Deo, Rahul C.; Chawla, Ajay			Perinatal Licensing of Thermogenesis by IL-33 and ST2	CELL			English	Article							DIET-INDUCED THERMOGENESIS; VISCERAL ADIPOSE-TISSUE; INNATE LYMPHOID TYPE-2; REGULATORY T-CELLS; BEIGE FAT; NONSHIVERING THERMOGENESIS; ORCHESTRATE DEVELOPMENT; UCP1-DEFICIENT MICE; INSULIN-RESISTANCE; BROWN ADIPOCYTES	For placental mammals, the transition from the in utero maternal environment to postnatal life requires the activation of thermogenesis to maintain their core temperature. This is primarily accomplished by induction of uncoupling protein 1 (UCP1) in brown and beige adipocytes, the principal sites for uncoupled respiration. Despite its importance, how placental mammals license their thermogenic adipocytes to participate in postnatal uncoupled respiration is not known. Here, we provide evidence that the "alarmin'' IL-33, a nuclear cytokine that activates type 2 immune responses, licenses brown and beige adipocytes for uncoupled respiration. We find that, in absence of IL-33 or ST2, beige and brown adipocytes develop normally but fail to express an appropriately spliced form of Ucp1 mRNA, resulting in absence of UCP1 protein and impairment in uncoupled respiration and thermoregulation. Together, these data suggest that IL-33 and ST2 function as a developmental switch to license thermogenesis during the perinatal period.	[Odegaard, Justin I.; Lee, Min-Woo; Sogawa, Yoshitaka; Deo, Rahul C.; Chawla, Ajay] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; [Bertholet, Ambre M.; Kirichok, Yuriy; Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Locksley, Richard M.; Deo, Rahul C.; Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Weinberg, David E.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA.; Chawla, A (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.; Chawla, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	ajay.chawla@ucsf.edu		Sogawa, Yoshitaka/0000-0003-1621-0929	NIH [HL076746, DK094641, DK101064, GM107710]; NIH Director's Pioneer Award [DP1AR064158]; NIH Director's Early Independence Award [DP5OD017895]; UCSF Program for Breakthrough Biomedical Research - Sandler Foundation; Hillblom Foundation; UCSF NORC [P30DK098722]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK101064, R01DK094641, P30DK098722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107710] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017895] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Early Independence Award; UCSF Program for Breakthrough Biomedical Research - Sandler Foundation; Hillblom Foundation; UCSF NORC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the A.C. lab and A. Loh for comments on the manuscript, and S. Aboulhouda for assistance with the polysome analysis. The authors' work was supported by grants from NIH (HL076746, DK094641, DK101064), and an NIH Director's Pioneer Award (DP1AR064158) to A.C.; NIH (GM107710) to Y.K.; and an NIH Director's Early Independence Award (DP5OD017895) and the UCSF Program for Breakthrough Biomedical Research (funded in part by the Sandler Foundation) to D.E.W. M.-W.L. was supported by a Postdoctoral Fellowship from the Hillblom Foundation. A.C. was also supported by UCSF NORC grant P30DK098722.	Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Cohen P, 2015, DIABETES, V64, P2346, DOI 10.2337/db15-0318; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Karp CL, 2012, J EXP MED, V209, P1069, DOI 10.1084/jem.20120988; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Klingenberg M, 1999, INT J OBESITY, V23, pS24, DOI 10.1038/sj.ijo.0800939; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Raju TNK, 2012, SEMIN FETAL NEONAT M, V17, P126, DOI 10.1016/j.siny.2012.01.010; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Sattler S, 2013, ARCH IMMUNOL THER EX, V61, P107, DOI 10.1007/s00005-012-0208-8; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Tian XY, 2016, CELL METAB, V23, P165, DOI 10.1016/j.cmet.2015.10.003; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Vosselman MJ, 2013, MOL CELL ENDOCRINOL, V379, P43, DOI 10.1016/j.mce.2013.04.017; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200	44	79	82	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					841	854		10.1016/j.cell.2016.06.040	http://dx.doi.org/10.1016/j.cell.2016.06.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27453471	Green Accepted, Bronze			2022-12-24	WOS:000382258700009
J	Schrader, J; Henneberg, F; Mata, RA; Tittmann, K; Schneider, TR; Stark, H; Bourenkov, G; Chari, A				Schrader, Jil; Henneberg, Fabian; Mata, Ricardo A.; Tittmann, Kai; Schneider, Thomas R.; Stark, Holger; Bourenkov, Gleb; Chari, Ashwin			The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design	SCIENCE			English	Article							CRYSTAL-STRUCTURE; CARFILZOMIB; BORTEZOMIB; SUBSTRATE; APPROVAL; REVEALS	The proteasome is a validated target for anticancer therapy, and proteasome inhibition is employed in the clinic for the treatment of tumors and hematological malignancies. Here, we describe crystal structures of the native human 20S proteasome and its complexes with inhibitors, which either are drugs approved for cancer treatment or are in clinical trials. The structure of the native human 20S proteasome was determined at an unprecedented resolution of 1.8 angstroms. Additionally, six inhibitor-proteasome complex structures were elucidated at resolutions between 1.9 and 2.1 angstroms. Collectively, the high-resolution structures provide new insights into the catalytic mechanisms of inhibition and necessitate a revised description of the proteasome active site. Knowledge about inhibition mechanisms provides insights into peptide hydrolysis and can guide strategies for the development of next-generation proteasome-based cancer therapeutics.	[Schrader, Jil; Henneberg, Fabian; Stark, Holger; Chari, Ashwin] Max Planck Inst Biophys Chem, Dept Struct Dynam, Fassberg 11, D-37077 Gottingen, Germany; [Mata, Ricardo A.] Univ Gottingen, Inst Phys Chem, Tamannstr 6, D-37077 Gottingen, Germany; [Tittmann, Kai] Univ Gottingen, Gottingen Zentrum Mol Biowissensch, Julia Lermontowa Weg 3, D-37077 Gottingen, Germany; [Tittmann, Kai] Univ Gottingen, Schwann Schleiden Forschungszentrum, Julia Lermontowa Weg 3, D-37077 Gottingen, Germany; [Schneider, Thomas R.; Bourenkov, Gleb] DESY, Hamburg Outstn, European Mol Biol Lab, Notkestr 85, D-22603 Hamburg, Germany	Max Planck Society; University of Gottingen; University of Gottingen; University of Gottingen; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Chari, A (corresponding author), Max Planck Inst Biophys Chem, Dept Struct Dynam, Fassberg 11, D-37077 Gottingen, Germany.; Bourenkov, G (corresponding author), DESY, Hamburg Outstn, European Mol Biol Lab, Notkestr 85, D-22603 Hamburg, Germany.	gleb@embl-hamburg.de; ashwin.chari@mpibpc.mpg.de	Mata, Ricardo A./AAC-4850-2020; Bourenkov, Gleb P/C-7794-2017; Chari, Ashwin/ABC-5304-2020; Schneider, Thomas/B-7442-2011	Mata, Ricardo A./0000-0002-2720-3364; Bourenkov, Gleb P/0000-0002-2617-5920; Chari, Ashwin/0000-0001-6220-9828; Schneider, Thomas/0000-0001-6955-7374; Henneberg, Fabian/0000-0003-3444-0947	Deutsche Forschungsgemeinschaft (DFG) [CH1098-1/1, SFB860-TP A5]; European Strategy Forum on Research Infrastructures (ESFRI); Bundesministerium fur Bildung und Forschung (BMBF) [05K2013-624]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Strategy Forum on Research Infrastructures (ESFRI); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank T. Conrad and H. Kohansal for help with HeLa cell culture and extract preparation, respectively. The coordinates for the determined structures are deposited in the Protein Data Bank (PDB accession codes 5LE5, 5LEX, 5LEY, 5LEZ, 5LF0, 5LF1, 5LF3, 5LF4, 5LF6, and 5LF7; these codes are associated with the relevant structures in table S2). We thank A. N. Popov for support at beamline ID23, ESRF Grenoble, France, and M. Cianci for support at beamline P13, PETRA3@DESY, in the initial stages of this project. This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG; CH1098-1/1 to A.C., SFB860-TP A5 to H.S.). H.S. and A.C. received support from an R&D Instruct grant as part of the European Strategy Forum on Research Infrastructures (ESFRI), which is supported by national member subscriptions. The installation of the transfocator system into beamline P14 was supported by Bundesministerium fur Bildung und Forschung (BMBF) grant 05K2013-624 to EMBL. A.C., J.S., F.H., and H.S. have applied for patents regarding the purification method (EP 16 17 3037.9 and USSN 62/345,913) and the next-generation proteasome inhibitor design (EP 16 17 3057.7 and USSN 62/346,203) described in this Report.	Bennett MK, 2008, CURR OPIN DRUG DISC, V11, P616; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Chari A, 2015, NAT METHODS, V12, P859, DOI [10.1038/NMETH.3493, 10.1038/nmeth.3493]; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; da Fonseca PCA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8573; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Grawert MA, 2011, ANGEW CHEM INT EDIT, V50, P542, DOI 10.1002/anie.201005488; Grigoreva TA, 2015, ONCOTARGET, V6, P24733, DOI 10.18632/oncotarget.4619; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Harshbarger W, 2015, STRUCTURE, V23, P418, DOI 10.1016/j.str.2014.11.017; Huber EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10900; Huber EM, 2015, STRUCTURE, V23, P407, DOI 10.1016/j.str.2014.11.019; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Kane RC, 2006, CLIN CANCER RES, V12, P2955, DOI 10.1158/1078-0432.CCR-06-0170; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Lynas JF, 1998, BIOORG MED CHEM LETT, V8, P373, DOI 10.1016/S0960-894X(98)00030-4; Shirley M, 2016, DRUGS, V76, P405, DOI 10.1007/s40265-016-0548-5	19	122	134	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					594	598		10.1126/science.aaf8993	http://dx.doi.org/10.1126/science.aaf8993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493187				2022-12-24	WOS:000381560900043
J	Sheldon, T				Sheldon, Tony			ANTIMICROBIAL RESISTANCE Saving antibiotics for when they are really needed: the Dutch example	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REDUCTION					tonysheldon5@cs.com						[Anonymous], 2016, TACKL DRUG RES INF G; European Ctr Dis Prevention Contro, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.4006, 10.2903/j.efsa.20Y15.4204]; Grave K, 2010, J ANTIMICROB CHEMOTH, V65, P2037, DOI 10.1093/jac/dkq247; Mevius D, 2014, J VERBRAUCH LEBENSM, V9, P177, DOI 10.1007/s00003-014-0874-z; Sheldon T., 2010, BMJ-BRIT MED J, V341, pc5677, DOI [10.1136/bmj.c5677, DOI 10.1136/BMJ.C5677]; Speksnijder DC, 2015, ZOONOSES PUBLIC HLTH, V62, P79, DOI 10.1111/zph.12167; VANBUCHEM FL, 1981, LANCET, V2, P883; ZonMw, 2015, ANT RES PROGR	8	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2016	354								i4192	10.1136/bmj.i4192	http://dx.doi.org/10.1136/bmj.i4192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CS	27488916				2022-12-24	WOS:000381080600002
J	Iorio, F; Knijnenburg, TA; Vis, DJ; Bignell, GR; Menden, MP; Schubert, M; Aben, N; Goncalves, E; Barthorpe, S; Lightfoot, H; Cokelaer, T; Greninger, P; van Dyk, E; Chang, H; de Silva, H; Heyn, H; Deng, XM; Egan, RK; Liu, QS; Mironenko, T; Mitropoulos, X; Richardson, L; Wang, JH; Zhang, TH; Moran, S; Sayols, S; Soleimani, M; Tamborero, D; Lopez-Bigas, N; Ross-Macdonald, P; Esteller, M; Gray, NS; Haber, DA; Stratton, MR; Benes, CH; Wessels, LFA; Saez-Rodriguez, J; McDermott, U; Garnett, MJ				Iorio, Francesco; Knijnenburg, Theo A.; Vis, Daniel J.; Bignell, Graham R.; Menden, Michael P.; Schubert, Michael; Aben, Nanne; Goncalves, Emanuel; Barthorpe, Syd; Lightfoot, Howard; Cokelaer, Thomas; Greninger, Patricia; van Dyk, Ewald; Chang, Han; de Silva, Heshani; Heyn, Holger; Deng, Xianming; Egan, Regina K.; Liu, Qingsong; Mironenko, Tatiana; Mitropoulos, Xeni; Richardson, Laura; Wang, Jinhua; Zhang, Tinghu; Moran, Sebastian; Sayols, Sergi; Soleimani, Maryam; Tamborero, David; Lopez-Bigas, Nuria; Ross-Macdonald, Petra; Esteller, Manel; Gray, Nathanael S.; Haber, Daniel A.; Stratton, Michael R.; Benes, Cyril H.; Wessels, Lodewyk F. A.; Saez-Rodriguez, Julio; McDermott, Ultan; Garnett, Mathew J.			A Landscape of Pharmacogenomic Interactions in Cancer	CELL			English	Article							DRUG-SENSITIVITY; IDENTIFICATION; GENE; MUTATIONS; DISCOVERY; PATTERNS	Systematic studies of cancer genomes have provided unprecedented insights into the molecular nature of cancer. Using this information to guide the development and application of therapies in the clinic is challenging. Here, we report how cancer-driven alterations identified in 11,289 tumors from 29 tissues (integrating somatic mutations, copy number alterations, DNA methylation, and gene expression) can be mapped onto 1,001 molecularly annotated human cancer cell lines and correlated with sensitivity to 265 drugs. We find that cell lines faithfully recapitulate oncogenic alterations identified in tumors, find that many of these associate with drug sensitivity/resistance, and highlight the importance of tissue lineage in mediating drug response. Logic-based modeling uncovers combinations of alterations that sensitize to drugs, while machine learning demonstrates the relative importance of different data types in predicting drug response. Our analysis and datasets are rich resources to link genotypes with cellular phenotypes and to identify therapeutic options for selected cancer sub-populations.	[Iorio, Francesco; Menden, Michael P.; Schubert, Michael; Goncalves, Emanuel; Cokelaer, Thomas; Saez-Rodriguez, Julio] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Iorio, Francesco; Bignell, Graham R.; Barthorpe, Syd; Lightfoot, Howard; Cokelaer, Thomas; Mironenko, Tatiana; Richardson, Laura; Soleimani, Maryam; Stratton, Michael R.; McDermott, Ultan; Garnett, Mathew J.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Knijnenburg, Theo A.] Inst Syst Biol, Seattle, WA 98109 USA; [Knijnenburg, Theo A.; Vis, Daniel J.; Aben, Nanne; van Dyk, Ewald; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Menden, Michael P.; Saez-Rodriguez, Julio] Rhein Westfal TH Aachen, Joint Res Ctr Computat Biomed, Fac Med, D-52057 Aachen, Germany; [Aben, Nanne; Wessels, Lodewyk F. A.] Delft Univ Technol, Dept EEMCS, NL-2628 CD Delft, Netherlands; [Greninger, Patricia; Egan, Regina K.; Mitropoulos, Xeni; Haber, Daniel A.; Benes, Cyril H.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Chang, Han; de Silva, Heshani; Ross-Macdonald, Petra] Bristol Myers Squibb Res & Dev, Genetically Defined Dis & Genom, Hopewell, NJ 08534 USA; [Heyn, Holger; Moran, Sebastian; Sayols, Sergi; Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona CATALONIA, Spain; [Deng, Xianming; Liu, Qingsong; Wang, Jinhua; Zhang, Tinghu; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Deng, Xianming; Liu, Qingsong; Wang, Jinhua; Zhang, Tinghu; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Tamborero, David; Lopez-Bigas, Nuria] IMIM Hosp del Mar Med Res Inst, Res Program Biomed Informat, Barcelona 08003, Spain; [Tamborero, David; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Barcelona 08003, Spain; [Lopez-Bigas, Nuria; Esteller, Manel] ICREA, Barcelona 08010, Catalonia, Spain; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona 08908, Catalonia, Spain; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wessels, Lodewyk F. A.] Canc Genom Netherlands, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Cokelaer, Thomas] Inst Pasteur, USR IP CNRS 3756, C3BI, Bioinformat & Biostat Hub, F-75015 Paris, France; [Deng, Xianming] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, Xiamen 361102, Peoples R China; [Sayols, Sergi] Inst Mol Biol, D-55128 Mainz, Germany	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Institute for Systems Biology (ISB); Netherlands Cancer Institute; RWTH Aachen University; Delft University of Technology; Harvard University; Massachusetts General Hospital; Bristol-Myers Squibb; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; ICREA; University of Barcelona; Howard Hughes Medical Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Xiamen University; Institute of Molecular Biology (IMB)	McDermott, U; Garnett, MJ (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.	um1@sanger.ac.uk; mg12@sanger.ac.uk	Iorio, Francesco/H-3284-2019; Iorio, Francesco/H-3282-2019; Saez-Rodriguez, Julio/H-7114-2019; Gasull, Martina/J-4076-2019; Esteller, Manel/L-5956-2014; Moran, Sebastian/G-5293-2013; Cokelaer, Thomas/AAN-8240-2020; Lopez-Bigas, Nuria/F-6193-2011; tamborero, david/M-5283-2015	Iorio, Francesco/0000-0001-7063-8913; Saez-Rodriguez, Julio/0000-0002-8552-8976; Esteller, Manel/0000-0003-4490-6093; Moran, Sebastian/0000-0003-4192-8983; Cokelaer, Thomas/0000-0001-6286-1138; Lopez-Bigas, Nuria/0000-0003-4925-8988; Lightfoot, Howard/0000-0003-2082-9986; McDermott, Ultan/0000-0001-9032-4700; tamborero, david/0000-0002-7218-2806; Sayols, Sergi/0000-0002-3877-4170; Deng, Xianming/0000-0002-9354-5864; Heyn, Holger/0000-0002-3276-1889; Schubert, Michael/0000-0002-6862-5221; Goncalves, Emanuel/0000-0002-9967-5205	Wellcome Trust [086375, 102696]; European Bioinformatics Institute; Wellcome Trust Sanger Institute post-doctoral (ESPOD) program; National Cancer Institute [U24CA143835]; Netherlands Organization for Scientific Research; People Programme (Marie Curie Actions) of the 7th Framework Programme of the European Union [600388]; Agency of Competitiveness for Companies of the Government of Catalonia (ACCIO); La Fundacio la Marato de TV3; European Research Council [268626]; Ministerio de Ciencia e Innovacion [SAF2011-22803]; Institute of Health Carlos III (ISCIII) under the Integrated Project of Excellence [PIE13/00022]; Spanish Cancer Research Network [RD12/0036/0039]; Health Department of the Catalan Government Generalitat de Catalunya [2014-SGR 633]; Science Department of the Catalan Government Generalitat de Catalunya [2014-SGR 633]; Cellex Foundation; Cancer Research UK Clinician Scientist Fellowship; AstraZeneca; Medical Research Council [1246915] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U24CA143835] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Wellcome Trust(Wellcome Trust); European Bioinformatics Institute; Wellcome Trust Sanger Institute post-doctoral (ESPOD) program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); People Programme (Marie Curie Actions) of the 7th Framework Programme of the European Union; Agency of Competitiveness for Companies of the Government of Catalonia (ACCIO); La Fundacio la Marato de TV3; European Research Council(European Research Council (ERC)European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Institute of Health Carlos III (ISCIII) under the Integrated Project of Excellence; Spanish Cancer Research Network; Health Department of the Catalan Government Generalitat de Catalunya(Generalitat de Catalunya); Science Department of the Catalan Government Generalitat de Catalunya; Cellex Foundation(Foundation CELLEX); Cancer Research UK Clinician Scientist Fellowship(Cancer Research UK); AstraZeneca(AstraZeneca); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA)	This work was funded by the Wellcome Trust (086375 and 102696). F.I. was supported by the European Bioinformatics Institute and Wellcome Trust Sanger Institute post-doctoral (ESPOD) program. T.A.K. was supported by the National Cancer Institute (U24CA143835) and the Netherlands Organization for Scientific Research. D.T. was supported by the People Programme (Marie Curie Actions) of the 7th Framework Programme of the European Union (FP7/2007-2013; 600388) and the Agency of Competitiveness for Companies of the Government of Catalonia (ACCIO). N.L.-B. was supported by La Fundacio la Marato de TV3. M.E. was funded by the European Research Council (268626), the Ministerio de Ciencia e Innovacion (SAF2011-22803), the Institute of Health Carlos III (ISCIII) under the Integrated Project of Excellence (PIE13/00022), the Spanish Cancer Research Network (RD12/0036/0039), the Health and Science Departments of the Catalan Government Generalitat de Catalunya 2014-SGR 633, and the Cellex Foundation. U.M. was supported by a Cancer Research UK Clinician Scientist Fellowship. We thank Aiqing He for expression data and Ilya Shmulevich for assistance with the LOBICO framework. We thank P. Campbell, M. Ranzani, J. Brammeld, M. Petljak, F. Behan, C. Alsinet Armengol, H. Francies, V. Grinkevich, and A. "Lilla" Mupo for useful comments. P. R.-M., H. C., and H.d.S. are employees and shareholders of Bristol-Myers Squibb. Research in the M.J.G. lab is supported in part with funding from AstraZeneca.	[Anonymous], GENOME BIOL, DOI 10.1186/s13059-020-02107-y; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Godin-Heymann N, 2008, MOL CANCER THER, V7, P874, DOI 10.1158/1535-7163.MCT-07-2387; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Knijnenburg T., 2016, BIORXIV; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Parikh JR, 2010, NUCLEIC ACIDS RES, V38, pW109, DOI 10.1093/nar/gkq424; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rubio-Perez C, 2015, CANCER CELL, V27, P382, DOI 10.1016/j.ccell.2015.02.007; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stransky N, 2015, NATURE, V528, P84, DOI 10.1038/nature15736; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; van Dyk E, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt155; Vis DJ, 2016, PHARMACOGENOMICS, V17, P691, DOI 10.2217/pgs.16.15; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wong CC, 2014, NAT GENET, V46, P33, DOI 10.1038/ng.2846; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	34	895	909	14	122	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					740	754		10.1016/j.cell.2016.06.017	http://dx.doi.org/10.1016/j.cell.2016.06.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27397505	Green Published, hybrid			2022-12-24	WOS:000380546500023
J	Raman, AS; White, KI; Ranganathan, R				Raman, Arjun S.; White, K. Ian; Ranganathan, Rama			Origins of Allostery and Evolvability in Proteins: A Case Study	CELL			English	Article							PDZ DOMAINS; EVOLUTION; ROBUSTNESS; SUBSTRATE; BINDING; RECOGNITION; SPECIFICITY; TRYPSIN; SYSTEM	Proteins display the capacity for adaptation to new functions, a property critical for evolvability. But what structural principles underlie the capacity for adaptation? Here, we show that adaptation to a physiologically distinct class of ligand specificity in a PSD95, DLG1, ZO-1 ( PDZ) domain preferentially occurs through class-bridging intermediate mutations located distant from the ligand-binding site. These mutations provide a functional link between ligand classes and demonstrate the principle of "conditional neutrality'' in mediating evolutionary adaptation. Structures show that class-bridging mutations work allosterically to open up conformational plasticity at the active site, permitting novel functions while retaining existing function. More generally, the class-bridging phenotype arises from mutations in an evolutionarily conserved network of coevolving amino acids in the PDZ family ( the sector) that connects the active site to distant surface sites. These findings introduce the concept that allostery in proteins could have its origins not in protein function but in the capacity to adapt.	[Raman, Arjun S.; White, K. Ian; Ranganathan, Rama] Univ Texas Southwestern Med Ctr, Green Ctr Syst Biol, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Ranganathan, Rama] Univ Texas Southwestern Med Ctr, Dept Biophys, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Ranganathan, Rama] Univ Texas Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas Southwestern Med Ctr, Green Ctr Syst Biol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.; Ranganathan, R (corresponding author), Univ Texas Southwestern Med Ctr, Dept Biophys, 6001 Forest Pk Rd, Dallas, TX 75390 USA.; Ranganathan, R (corresponding author), Univ Texas Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu	White, Kristopher Ian/ABA-4166-2021	White, Kristopher Ian/0000-0001-8182-3655	NIH [RO1EY018720-05]; Robert A. Welch Foundation [I-1366]; Green Center for Systems Biology at UT Southwestern Medical Center; NIGMS [T32 GM008203]; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Green Center for Systems Biology at UT Southwestern Medical Center; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the R.R. lab for critical review of the manuscript; M.A. Socolich, F.J. Poelwijk, and S. Subramanian for technical help; and K.A. Reynolds for discussions. We also thank the UT Southwestern Genomics Core for assistance with sequencing and the High Performance Computing Group (Bio-HPC) at UT Southwestern for facilitating the computational simulations. This work was supported by NIH Grant RO1EY018720-05 (to R.R.), Robert A. Welch Foundation Grant I-1366 (to R.R.), and the Green Center for Systems Biology at UT Southwestern Medical Center. A.S.R. and K.I.W. were supported in part through pre-doctoral fellowships (NIGMS T32 GM008203).	Aakre CD, 2015, CELL, V163, P594, DOI 10.1016/j.cell.2015.09.055; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Draghi JA, 2011, NATURE, V474, P45, DOI 10.1038/474045a; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/nmeth.3027, 10.1038/NMETH.3027]; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Harris BZ, 2001, J CELL SCI, V114, P3219; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; HEDSTROM L, 1994, BIOCHEMISTRY-US, V33, P8757, DOI 10.1021/bi00195a017; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lukacs CM, 2000, NAT STRUCT BIOL, V7, P134; Luria SE, 1943, GENETICS, V28, P491; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Morgan RD, 2009, NUCLEIC ACIDS RES, V37, P5222, DOI 10.1093/nar/gkp535; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; Poelwijk FJ, 2011, CELL, V146, P462, DOI 10.1016/j.cell.2011.06.035; Reynolds KA, 2013, METHOD ENZYMOL, V523, P213, DOI 10.1016/B978-0-12-394292-0.00010-2; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Salverda MLM, 2010, FEMS MICROBIOL REV, V34, P1015, DOI 10.1111/j.1574-6976.2010.00222.x; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stiffler MA, 2015, CELL, V160, P882, DOI 10.1016/j.cell.2015.01.035; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665	47	82	83	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					468	480		10.1016/j.cell.2016.05.047	http://dx.doi.org/10.1016/j.cell.2016.05.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27321669	Bronze			2022-12-24	WOS:000380255400022
J	Charbonneau, MR; Blanton, LV; DiGiulio, DB; Relman, DA; Lebrilla, CB; Mills, DA; Gordon, JI				Charbonneau, Mark R.; Blanton, Laura V.; DiGiulio, Daniel B.; Relman, David A.; Lebrilla, Carlito B.; Mills, David A.; Gordon, Jeffrey I.			A microbial perspective of human developmental biology	NATURE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; LOW-BIRTH-WEIGHT; VAGINAL MICROBIOME; AMNIOTIC-FLUID; GUT MICROBIOTA; PRETERM LABOR; SIALIC-ACID; ORAL MICROBIOME; PREGNANT-WOMEN; INFECTION	When most people think of human development, they tend to consider only human cells and organs. Yet there is another facet that involves human-associated microbial communities. A microbial perspective of human development provides opportunities to refine our definitions of healthy prenatal and postnatal growth and to develop innovative strategies for disease prevention and treatment. Given the dramatic changes in lifestyles and disease patterns that are occurring with globalization, we issue a call for the establishment of 'human microbial observatories' designed to examine microbial community development in birth cohorts representing populations with diverse anthropological characteristics, including those undergoing rapid change.	[Charbonneau, Mark R.; Blanton, Laura V.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Charbonneau, Mark R.; Blanton, Laura V.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63110 USA; [DiGiulio, Daniel B.; Relman, David A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [DiGiulio, Daniel B.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Lebrilla, Carlito B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Lebrilla, Carlito B.; Mills, David A.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	Washington University (WUSTL); Washington University (WUSTL); Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA.; Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63110 USA.	jgordon@wustl.edu	Mills, David Andrew/G-2282-2011; Lebrilla, Carlito Bangeles/ABE-6369-2020; Mills, David/GXF-1821-2022	Mills, David Andrew/0000-0003-1913-9865; Relman, David A./0000-0001-8331-1354	US National Institutes of Health [DK30292, HD061923, AT007079, AT008759]; Bill & Melinda Gates Foundation; March of Dimes Foundation; Thomas C. and Joan M. Merigan Endowment at Stanford University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061923] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT008759, R01AT007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); March of Dimes Foundation(March of Dimes); Thomas C. and Joan M. Merigan Endowment at Stanford University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work cited from the authors' laboratories was supported in part by grants from the US National Institutes of Health (DK30292, HD061923, AT007079 and AT008759), the Bill & Melinda Gates Foundation, the March of Dimes Foundation and the Thomas C. and Joan M. Merigan Endowment at Stanford University.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Aldredge DL, 2013, GLYCOBIOLOGY, V23, P664, DOI 10.1093/glycob/cwt007; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Bearfield C, 2002, BJOG-INT J OBSTET GY, V109, P527, DOI 10.1016/S1470-0328(02)01349-6; BENIRSCHKE K, 1960, AMA J DIS CHILD, V99, P714, DOI 10.1001/archpedi.1960.02070030716003; Bhola K, 2008, AUST NZ J OBSTET GYN, V48, P179, DOI 10.1111/j.1479-828X.2008.00833.x; Bisanz JE, 2015, APPL ENVIRON MICROB, V81, P4965, DOI 10.1128/AEM.00780-15; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; BURKE BERTHA S., 1949, JOUR NUTRITION, V38, P453; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365; Chen X, 2015, ADV CARBOHYD CHEM BI, V72, P113, DOI 10.1016/bs.accb.2015.08.002; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; COPPA GV, 1993, PEDIATRICS, V91, P637; Costalonga M, 2014, IMMUNOL LETT, V162, P22, DOI 10.1016/j.imlet.2014.08.017; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Dareng EO, 2016, EPIDEMIOL INFECT, V144, P123, DOI 10.1017/S0950268815000965; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; De Leoz MLA, 2015, J PROTEOME RES, V14, P491, DOI 10.1021/pr500759e; De Leoz MLA, 2012, J PROTEOME RES, V11, P4662, DOI 10.1021/pr3004979; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dogra S, 2015, MBIO, V6, DOI 10.1128/mBio.02419-14; Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23; Frese SA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0091-8; Frese SA, 2015, J PEDIATR GASTR NUTR, V60, P695, DOI 10.1097/MPG.0000000000000798; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gal B, 1997, COMP BIOCHEM PHYS B, V118, P13, DOI 10.1016/S0305-0491(97)00016-3; Garrido D, 2015, SCI REP-UK, V5, DOI 10.1038/srep13517; Garrido D, 2013, MICROBIOL-SGM, V159, P649, DOI 10.1099/mic.0.064113-0; Gordon J., 2013, MICROBE, V8, P152, DOI [10.1128/microbe.8.152.1, DOI 10.1128/MICROBE.8.152.1]; Goyal MS, 2015, P NATL ACAD SCI USA, V112, P14105, DOI 10.1073/pnas.1511465112; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Han YPW, 2006, J CLIN MICROBIOL, V44, P1475, DOI 10.1128/JCM.44.4.1475-1483.2006; Hansen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133320; Harris JW, 1927, AM J OBSTET GYNECOL, V13, P133, DOI 10.1016/S0002-9378(27)90506-7; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Huang YE, 2015, MICROB ECOL, V69, P407, DOI 10.1007/s00248-014-0487-1; Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; K?stner, 1877, ARCH GYNAK, V11, P256, DOI DOI 10.1007/BF01845161; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kim MJ, 2009, LAB INVEST, V89, P924, DOI 10.1038/labinvest.2009.49; Kliman HJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009864; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; KUNZ C, 1993, ACTA PAEDIATR, V82, P903, DOI 10.1111/j.1651-2227.1993.tb12597.x; Levine MM, 2012, CLIN INFECT DIS, V55, pS215, DOI 10.1093/cid/cis761; LEVISON ME, 1977, AM J OBSTET GYNECOL, V127, P80, DOI 10.1016/0002-9378(77)90318-0; Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; MacIntyre DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08988; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; McGuire MK, 2015, ADV NUTR, V6, P112, DOI 10.3945/an.114.007435; Menon R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.027; Mitchell CM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.043; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Ngure FM, 2014, ANN NY ACAD SCI, V1308, P118, DOI 10.1111/nyas.12330; Ninonuevo MR, 2008, J AGR FOOD CHEM, V56, P618, DOI 10.1021/jf071972u; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Prince AL, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.01.193; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Siqueira FM, 2007, J PERIODONTOL, V78, P2266, DOI 10.1902/jop.2007.070196; Stout MJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.018; Stowell SR, 2014, NAT CHEM BIOL, V10, P470, DOI [10.1038/nchembio.1525, 10.1038/NCHEMBIO.1525]; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Sugahara Hirosuke, 2015, Biosci Microbiota Food Health, V34, P87, DOI 10.12938/bmfh.2015-003; Sundekilde UK, 2012, J AGR FOOD CHEM, V60, P6188, DOI 10.1021/jf300015j; Swati P, 2012, ARCH GYNECOL OBSTET, V285, P613, DOI 10.1007/s00404-011-2012-9; Teng F, 2015, CELL HOST MICROBE, V18, P296, DOI 10.1016/j.chom.2015.08.005; Thurl S, 2010, BRIT J NUTR, V104, P1261, DOI 10.1017/S0007114510002072; Totten SM, 2014, ANAL BIOANAL CHEM, V406, P7925, DOI 10.1007/s00216-014-8261-2; Totten SM, 2012, J PROTEOME RES, V11, P6124, DOI 10.1021/pr300769g; Verstraelen H, 2016, PEERJ, V4, DOI 10.7717/peerj.1602; Wang B, 2003, EUR J CLIN NUTR, V57, P1351, DOI 10.1038/sj.ejcn.1601704; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515; Wilson C S, 1985, World Rev Nutr Diet, V45, P68; Wu SA, 2011, J PROTEOME RES, V10, P856, DOI 10.1021/pr101006u; Wu SA, 2010, J PROTEOME RES, V9, P4138, DOI 10.1021/pr100362f; Yonekawa T, 2014, BRAIN, V137, P2670, DOI 10.1093/brain/awu210	100	140	149	3	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					48	55		10.1038/nature18845	http://dx.doi.org/10.1038/nature18845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27383979	Green Accepted			2022-12-24	WOS:000379015600027
J	DeVree, BT; Mahoney, JP; Velez-Ruiz, GA; Rasmussen, SGF; Kuszak, AJ; Edwald, E; Fung, JJ; Manglik, A; Masureel, M; Du, Y; Matt, RA; Pardon, E; Steyaert, J; Kobilka, BK; Sunahara, RK				DeVree, Brian T.; Mahoney, Jacob P.; Velez-Ruiz, Gisselle A.; Rasmussen, Soren G. F.; Kuszak, Adam J.; Edwald, Elin; Fung, Juan-Jose; Manglik, Aashish; Masureel, Matthieu; Du, Yang; Matt, Rachel A.; Pardon, Els; Steyaert, Jan; Kobilka, Brian K.; Sunahara, Roger K.			Allosteric coupling from G protein to the agonist-binding pocket in GPCRs	NATURE			English	Article							BETA-ADRENERGIC-RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; TERNARY COMPLEX MODEL; NEUROTENSIN RECEPTOR; GUANINE-NUCLEOTIDES; ANTAGONIST BINDING; ADENYLATE-CYCLASE; CRYSTAL-STRUCTURE; ACTIVATION; AFFINITY	G-protein-coupled receptors (GPCRs) remain the primary conduit by which cells detect environmental stimuli and communicate with each other(1). Upon activation by extracellular agonists, these seven-transmembrane-domain-containing receptors interact with heterotrimeric G proteins to regulate downstream second messenger and/or protein kinase cascades(1). Crystallographic evidence from a prototypic GPCR, the beta(2)-adrenergic receptor (beta(2)AR), in complex with its cognate G protein, Gs, has provided a model for how agonist binding promotes conformational changes that propagate through the GPCR and into the nucleotide-binding pocket of the G protein a-subunit to catalyse GDP release, the key step required for GTP binding and activation of G proteins(2). The structure also offers hints about how G-protein binding may, in turn, allosterically influence ligand binding. Here we provide functional evidence that G-protein coupling to the beta(2)AR stabilizes a 'closed' receptor conformation characterized by restricted access to and egress from the hormone-binding site. Surprisingly, the effects of G protein on the hormone-binding site can be observed in the absence of a bound agonist, where G-protein coupling driven by basal receptor activity impedes the association of agonists, partial agonists, antagonists and inverse agonists. The ability of bound ligands to dissociate from the receptor is also hindered, providing a structural explanation for the G-protein-mediated enhancement of agonist affinity, which has been observed for many GPCR-G-protein pairs. Our data also indicate that, in contrast to agonist binding alone, coupling of a G protein in the absence of an agonist stabilizes large structural changes in a GPCR. The effects of nucleotide-free G protein on ligand-binding kinetics are shared by other members of the superfamily of GPCRs, suggesting that a common mechanism may underlie G-protein-mediated enhancement of agonist affinity.	[DeVree, Brian T.; Mahoney, Jacob P.; Velez-Ruiz, Gisselle A.; Kuszak, Adam J.; Edwald, Elin; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Rasmussen, Soren G. F.; Fung, Juan-Jose; Manglik, Aashish; Masureel, Matthieu; Du, Yang; Matt, Rachel A.; Kobilka, Brian K.] Stanford Univ, Dept Cellular & Mol Physiol, Palo Alto, CA 94305 USA; [Pardon, Els] VUB, Struct Biol Res Ctr, VIB, Pl Laan 2, B-1050 Brussels, Belgium; [Steyaert, Jan] VUB, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium; [Sunahara, Roger K.] Univ Calif San Diego, Dept Pharmacol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; Stanford University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; University of California System; University of California San Diego	Sunahara, RK (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.; Sunahara, RK (corresponding author), Univ Calif San Diego, Dept Pharmacol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rsunahara@ucsd.edu	steyaert, jan/GQP-7811-2022; DeVree, Brian T/F-6205-2011; Steyaert, Jan/H-4662-2011; Sunahara, Roger/AAJ-8667-2020	Steyaert, Jan/0000-0002-3825-874X; DeVree, Brian/0000-0003-0582-8125; Pardon, Els/0000-0002-2466-0172; Kuszak, Adam/0000-0001-8719-145X; Kobilka, Brian/0000-0001-5958-3990; Matt, Rachel/0000-0002-9944-8897; Rasmussen, Soren/0000-0002-1853-1841	Lundbeck Foundation; Fund for Scientific Research of Flanders (FWO-Vlaanderen); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); National Institute of Neural Disorders and Stroke [RO1-NS28471]; Mather Charitable Foundation; National Institute of General Medical Sciences [RO1-GM083118, U19-GM106990, RO1-GM068603]; National Institutes of Drug Abuse [R21-031418]; Michigan Diabetes Research and Training Center; National Institute of Diabetes and Digestive and Kidney Diseases [P60DK-20572]; University of Michigan Biological Sciences Scholars Program; Rackham School of Graduate Studies; Molecular Biophysics Training Grant [T32GM008270]; Cell and Molecular Biology Training Grant [T32GM007315]; Pharmacological Sciences Training Program [T32GM007767]; AHA Midwest Affiliate Predoctoral Fellowship [13PRE17110027]; Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068603, T32GM007315, U19GM106990, R01GM083118, T32GM008270, T32GM007767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031418] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); National Institute of Neural Disorders and Stroke; Mather Charitable Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Michigan Diabetes Research and Training Center; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Michigan Biological Sciences Scholars Program(University of Michigan System); Rackham School of Graduate Studies; Molecular Biophysics Training Grant; Cell and Molecular Biology Training Grant; Pharmacological Sciences Training Program; AHA Midwest Affiliate Predoctoral Fellowship; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. S. Kobilka for preparation of affinity chromatography reagents and F. S. Thian for help with cell culture. We thank J. Traynor and J. Tesmer for their support and use of their laboratory space for J.P.M. This work was supported by the Lundbeck Foundation (Junior Group Leader Fellowship to S.G.F.R.); Fund for Scientific Research of Flanders (FWO-Vlaanderen) and the Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB) (E.P. and J.S.); National Institute of Neural Disorders and Stroke grant RO1-NS28471 (B.K.K.); the Mather Charitable Foundation (B.K.K.); National Institute of General Medical Sciences grants RO1-GM083118 and U19-GM106990 (B.K.K. and R.K.S.) and RO1-GM068603 (R.K.S.); National Institutes of Drug Abuse R21-031418 (B.K.K. and R.K.S.); Michigan Diabetes Research and Training Center Grant, National Institute of Diabetes and Digestive and Kidney Diseases, P60DK-20572 (R.K.S.); University of Michigan Biological Sciences Scholars Program (R.K.S.) and the Rackham School of Graduate Studies (B.T.D.); Molecular Biophysics Training Grant T32GM008270 (B.T.D.); Cell and Molecular Biology Training Grant T32GM007315 (G.A.V.-R.) and Pharmacological Sciences Training Program T32GM007767 (J.P.M.); and AHA Midwest Affiliate Predoctoral Fellowship 13PRE17110027 (J.P.M.).	Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; BURGISSER E, 1982, P NATL ACAD SCI-BIOL, V79, P1732, DOI 10.1073/pnas.79.6.1732; Bylund DB, 2001, J NEUROSCI METH, V105, P159, DOI 10.1016/S0165-0270(00)00358-7; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Kikkawa H, 1998, MOL PHARMACOL, V53, P128, DOI 10.1124/mol.53.1.128; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Krumm BE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8895; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; LEFKOWITZ RJ, 1977, P NATL ACAD SCI USA, V74, P515, DOI 10.1073/pnas.74.2.515; MAGUIRE ME, 1976, MOL PHARMACOL, V12, P335; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PRATER MR, 1992, MOL PHARMACOL, V42, P765; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; ROSS EM, 1977, J BIOL CHEM, V252, P5761; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Weiss JM, 1996, J THEOR BIOL, V178, P151, DOI 10.1006/jtbi.1996.0014; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	34	158	161	3	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					182	+		10.1038/nature18324	http://dx.doi.org/10.1038/nature18324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362234	Green Submitted, Green Published, Green Accepted			2022-12-24	WOS:000379015600049
J	Marceau, CD; Puschnik, AS; Majzoub, K; Ooi, YS; Brewer, SM; Fuchs, G; Swaminathan, K; Mata, MA; Elias, JE; Sarnow, P; Carette, JE				Marceau, Caleb D.; Puschnik, Andreas S.; Majzoub, Karim; Ooi, Yaw Shin; Brewer, Susan M.; Fuchs, Gabriele; Swaminathan, Kavya; Mata, Miguel A.; Elias, Joshua E.; Sarnow, Peter; Carette, Jan E.			Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens	NATURE			English	Article							HEPATITIS-C VIRUS; HUMAN-CELLS; N-GLYCOSYLATION; DENGUE VIRUS; REPLICATION; INFECTION; PROTEIN; HUR; OLIGOSACCHARYLTRANSFERASE; MEMBRANE	The Flaviviridae are a family of viruses that cause severe human diseases. For example, dengue virus (DENV) is a rapidly emerging pathogen causing an estimated 100 million symptomatic infections annually worldwide(1). No approved antivirals are available to date, and clinical trials with a tetravalent dengue vaccine showed disappointingly low protection rates(2). Hepatitis C virus (HCV) also remains a major medical problem, with 160 million chronically infected patients worldwide and only expensive treatments available(3). Despite distinct differences in their pathogenesis and modes of transmission, the two viruses share common replication strategies(4). A detailed understanding of the host functions that determine viral infection is lacking. Here we use a pooled CRISPR genetic screening strategy(5,6) to comprehensively dissect host factors required for these two highly important Flaviviridae members. For DENV, we identified endoplasmic-reticulum (ER)-associated multi-protein complexes involved in signal sequence recognition, N-linked glycosylation and ER-associated degradation. DENV replication was nearly completely abrogated in cells deficient in the oligosaccharyltransferase (OST) complex. Mechanistic studies pinpointed viral RNA replication and not entry or translation as the crucial step requiring the OST complex. Moreover, we show that viral non-structural proteins bind to the OST complex. The identified ER-associated protein complexes were also important for infection by other mosquito-borne flaviviruses including Zika virus, an emerging pathogen causing severe birth defects(7). By contrast, the most significant genes identified in the HCV screen were distinct and included viral receptors, RNA-binding proteins and enzymes involved in metabolism. We found an unexpected link between intracellular flavin adenine dinucleotide (FAD) levels and HCV replication. This study shows notable divergence in host-dependency factors between DENV and HCV, and illuminates new host targets for antiviral therapy.	[Marceau, Caleb D.; Puschnik, Andreas S.; Majzoub, Karim; Ooi, Yaw Shin; Brewer, Susan M.; Fuchs, Gabriele; Mata, Miguel A.; Sarnow, Peter; Carette, Jan E.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Swaminathan, Kavya; Elias, Joshua E.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Carette, JE (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	carette@stanford.edu		Fuchs, Gabriele/0000-0002-6838-2100; Ooi, Yaw Shin/0000-0001-9014-1365; Sarnow, Peter/0000-0002-2043-2770; Swaminathan, Kavya/0000-0001-7715-5375; Puschnik, Andreas/0000-0002-9605-9458; Majzoub, Karim/0000-0001-7345-6840; Carette, Jan/0000-0002-5187-8070	National Institutes of Health (NIH) [DP2 AI104557]; NIH [AI109662]; David and Lucile Packard Foundation; Stanford Graduate Fellowship; Boehringer Ingelheim Fonds; NSF-GFRP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104557, T32AI007328, U19AI109662] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Stanford Graduate Fellowship(Stanford University); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NSF-GFRP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank T. Brummelkamp, J. Idoyaga and S. Einav for critically reading the manuscript and discussions; X. Ji and the Stanford Functional Genomics Facility; The Stanford Transmission Electron Microscope Facility; The Stanford Shared FACS Facility, and members of the Carette laboratory for discussions and support. S. Einav, K. Kirkegaard, F. Chisari, J. F. Anderson, C. Rice, H. Ploegh, R. Kopito, E. Harris, M. Ivessa, S. Weaver, R. Tesh and E. Campeau are acknowledged for providing materials. The work was funded in part by National Institutes of Health (NIH) DP2 AI104557 (J. E. C.), NIH AI109662 (J. E. C.), David and Lucile Packard Foundation (J. E. C.), Stanford Graduate Fellowship (A.S.P.), Boehringer Ingelheim Fonds (A.S.P.) and NSF-GFRP (C.D.M.).	Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Fuchs G, 2015, P NATL ACAD SCI USA, V112, P319, DOI 10.1073/pnas.1421328111; Fujimura M, 2010, J NUTR, V140, P1722, DOI 10.3945/jn.110.128330; Hasan M, 2015, IMMUNITY, V43, P463, DOI 10.1016/j.immuni.2015.07.022; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Jaffee MB, 2011, BIOCHEMISTRY-US, V50, P7557, DOI 10.1021/bi201018d; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007; Ramage HR, 2015, MOL CELL, V57, P329, DOI 10.1016/j.molcel.2014.12.028; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005; Shwetha S, 2015, J VIROL, V89, P11356, DOI 10.1128/JVI.01714-15; Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Thomas SJ, 2015, AM J PREV MED, V49, pS334, DOI 10.1016/j.amepre.2015.09.006; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	42	258	267	7	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					159	+		10.1038/nature18631	http://dx.doi.org/10.1038/nature18631			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27383987	Green Accepted, Bronze			2022-12-24	WOS:000379015600044
J	D'Orangeville, L; Duchesne, L; Houle, D; Kneeshaw, D; Cote, B; Pederson, N				D'Orangeville, L.; Duchesne, L.; Houle, D.; Kneeshaw, D.; Cote, B.; Pederson, N.			Northeastern North America as a potential refugium for boreal forests in a warming climate	SCIENCE			English	Article							BLACK SPRUCE FORESTS; NET PRIMARY PRODUCTION; EASTERN CANADA; DROUGHT STRESS; TREE GROWTH; CARBON; IMPACTS; PRODUCTIVITY; TEMPERATURES; 20TH-CENTURY	High precipitation in boreal northeastern North America could help forests withstand the expected temperature-driven increase in evaporative demand, but definitive evidence is lacking. Using a network of tree-ring collections from 16,450 stands across 583,000 km(2) of boreal forests in Quebec, Canada, we observe a latitudinal shift in the correlation of black spruce growth with temperature and reduced precipitation, from negative south of 49 degrees N to largely positive to the north of that latitude. Our results su: zest that the positive effect of a warmer climate on growth rates and growing season length north of 49 degrees N outweighs the potential negative effect of lower water availability. Unlike the central and western portions of the continent's boreal forest, northeastern North America may act as a climatic refugium in a warmer climate.	[D'Orangeville, L.; Kneeshaw, D.] Univ Quebec, Ctr Etude Foret, Case Postale 8888,Succursale Ctr Ville, Montreal, PQ H3C 3P8, Canada; [D'Orangeville, L.] Indiana Univ, Dept Biol, 1001 East 3rd St,Jordan Hall 142, Bloomington, IN 47405 USA; [Duchesne, L.; Houle, D.] Minist Forets Faune & Parcs Quebec, Direct Rech Forestiere, 2700 Einstein, Quebec City, PQ G1P 3W8, Canada; [Houle, D.] Consortium Climatol Reg & Adaptat Changements Cli, 550 Sherbrooke W, Montreal, PQ H3A 1B9, Canada; [Cote, B.] McGill Univ, Dept Nat Resource Sci, 21 111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Pederson, N.] Harvard Forest, 324 North Main St, Petersham, MA 01366 USA	University of Quebec; University of Quebec Montreal; Indiana University System; Indiana University Bloomington; Ouranos Consortium; McGill University; Harvard University	D'Orangeville, L (corresponding author), Univ Quebec, Ctr Etude Foret, Case Postale 8888,Succursale Ctr Ville, Montreal, PQ H3C 3P8, Canada.; D'Orangeville, L (corresponding author), Indiana Univ, Dept Biol, 1001 East 3rd St,Jordan Hall 142, Bloomington, IN 47405 USA.	loicdorangeville@gmail.com		D'Orangeville, Loic/0000-0001-7841-7082	NASA Astrobiology Institute Early Career Collaboration Award; National Radio Astronomy Observatory Jansky Postdoctoral Fellowshiip; National Science Foundation; NASA Astrobiology Institute through the Goddard Team [NNX09AH63A, NNX15A133A (NNX09AH63A)]; NSF Astronomy and Astrophysics [AST-1109857]; Australian government;  [AGBT06B-006]	NASA Astrobiology Institute Early Career Collaboration Award; National Radio Astronomy Observatory Jansky Postdoctoral Fellowshiip; National Science Foundation(National Science Foundation (NSF)); NASA Astrobiology Institute through the Goddard Team; NSF Astronomy and Astrophysics; Australian government(Australian GovernmentCGIAR); 	We thank the PRIMOS team, GBT, and Parkes staff for their ongoing support in acquiring the GBT and Parkes data and S. Breen, S. Mader, and J. Reynolds for assistance with Parkes data eduction. acknowledge the support of L. Snyder, J. M. Hollis, and F. Lovas. B.A.M. thanks J. Mangum and J. Corby for helpful discussions. P.B.C. and B.A.M. acknowledge We support of a NASA Astrobiology Institute Early Career Collaboration Award. B.A.M. is funded by a National Radio Astronomy Observatory Jansky Postdoctoral Fellowshiip. R.A.L and I.A.F. are funded by a National Science Foundation Graduate Research Fellowship. P.B.C., I.A.F., and G.A.B. acknowledge support from the NASA Astrobiology Institute through the Goddard Team (M. J. Mumma, PI) under Cooperative Research Agreements NNX09AH63A and NNX15A133A (NNX09AH63A), and the NSF Astronomy and Astrophysics (AST-1109857)grant program. Access to the entire PRIMOS data set, specifics on the observing strategy, and overall frequency coverage information is available at www.cv.nrao.edu/PRIMOS/. The spectra obtained with Parkes are available through this website as well. Data from project AGBT06B-006 are available in the NRAO Archive at https://science.nrao.edu/observing/data-archive. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. The Australia Telescope Compact Array (Parkes Radio Telescope/Mopra Radio Telescope/Long Baseline Array)) is part of the Australia Telescope National Facility, which a funded by the Australian government for operation as a National Facility managed by the Commonwealth Scientific and Industrial Research Organisation (CSIRO).	Babst F, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045705; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Beaudoin A, 2014, CAN J FOREST RES, V44, P521, DOI 10.1139/cjfr-2013-0401; Beck PSA, 2011, ECOL LETT, V14, P373, DOI 10.1111/j.1461-0248.2011.01598.x; Bergeron O, 2007, GLOBAL CHANGE BIOL, V13, P89, DOI 10.1111/j.1365-2486.2006.01281.x; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; D'Orangeville L, 2013, TREE PHYSIOL, V33, P516, DOI 10.1093/treephys/tpt027; de Jong R, 2012, GLOBAL CHANGE BIOL, V18, P642, DOI 10.1111/j.1365-2486.2011.02578.x; Dietze MC, 2014, ANNU REV PLANT BIOL, V65, P667, DOI 10.1146/annurev-arplant-050213-040054; Gamache I, 2004, J ECOL, V92, P835, DOI 10.1111/j.0022-0477.2004.00913.x; Gauthier S, 2015, SCIENCE, V349, P819, DOI 10.1126/science.aaa9092; Girard F, 2011, ECOSCIENCE, V18, P279, DOI 10.2980/18-3-3438; Girardin MP, 2016, GLOBAL CHANGE BIOL, V22, P627, DOI 10.1111/gcb.13072; Girardin MP, 2005, CAN J FOREST RES, V35, P48, DOI 10.1139/X04-144; Havranek W., 1995, ECOPHYSIOLOGY CONIFE, P95, DOI DOI 10.1016/B978-0-08-092593-6.50010-4; Huang JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056758; Huang JG, 2010, GLOBAL CHANGE BIOL, V16, P711, DOI 10.1111/j.1365-2486.2009.01990.x; Kauppi PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111340; Lloyd AH, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045013; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pederson Neil, 2004, Dendrochronologia, V22, P7, DOI 10.1016/j.dendro.2004.09.005; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Schaphoff S, 2016, FOREST ECOL MANAG, V361, P432, DOI 10.1016/j.foreco.2015.11.043; Sevanto S, 2006, TREE PHYSIOL, V26, P749, DOI 10.1093/treephys/26.6.749; Steele SJ, 1997, TREE PHYSIOL, V17, P577; Stocker T. F., 2013, CLIMATE CHANGE 2013; Thrasher B, 2012, HYDROL EARTH SYST SC, V16, P3309, DOI 10.5194/hess-16-3309-2012; Trabucco A., 2009, CGIAR CONSORTIUMFOR; Turcotte A, 2009, AGR FOREST METEOROL, V149, P1403, DOI 10.1016/j.agrformet.2009.03.010; Vaganov EA, 1999, NATURE, V400, P149, DOI 10.1038/22087; Walker XJ, 2015, GLOBAL CHANGE BIOL, V21, P3102, DOI 10.1111/gcb.12893; Wolken JM, 2011, CAN J FOREST RES, V41, P2292, DOI [10.1139/x11-136, 10.1139/X11-136]; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	34	92	93	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1452	1455		10.1126/science.aaf4951	http://dx.doi.org/10.1126/science.aaf4951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313044				2022-12-24	WOS:000377975400047
J	Wu, B; Eliscovich, C; Yoon, YJ; Singer, RH				Wu, Bin; Eliscovich, Carolina; Yoon, Young J.; Singer, Robert H.			Translation dynamics of single mRNAs in live cells and neurons	SCIENCE			English	Article							IN-VIVO; LOCAL TRANSLATION; GENE-EXPRESSION; ENDOPLASMIC-RETICULUM; HIPPOCAMPAL-NEURONS; PROTEIN; FLUORESCENT; SYSTEM; VISUALIZATION; LOCALIZATION	Translation is the fundamental biological process converting mRNA information into proteins. Single-molecule imaging in live cells has illuminated the dynamics of RNA transcription; however, it is not yet applicable to translation. Here, we report single-molecule imaging of nascent peptides (SINAPS) to assess translation in live cells. The approach provides direct readout of initiation, elongation, and location of translation. We show that mRNAs coding for endoplasmic reticulum (ER) proteins are translated when they encounter the ER membrane. Single-molecule fluorescence recovery after photobleaching provides direct measurement of elongation speed (5 amino acids per second). In primary neurons, mRNAs are translated in proximal dendrites but repressed in distal dendrites and display "bursting" translation. This technology provides a tool with which to address the spatiotemporal translation mechanism of single mRNAs in living cells.	[Wu, Bin; Eliscovich, Carolina; Yoon, Young J.; Singer, Robert H.] Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Wu, Bin; Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Yoon, Young J.; Singer, Robert H.] Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Singer, Robert H.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Singer, RH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.; Singer, RH (corresponding author), Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA.; Singer, RH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.; Singer, RH (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	robert.singer@einstein.yu.edu			NIH [NS083085]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank X. Meng for cloning some of the constructs and Western dotting, E. L. Snapp for providing the oxBFP plasmic, and the sequence of CytERM, E. Tutucci for constructive discussion and suggestions, and L Levis for providing JF dyes Halotag. The authors thank I. Morisaki eta). for sharing their preliminary data and the Transcription Imaging Consortium at the Janelia Research Campus of the HHMI for creating the environment for our interactions and discussions. This work was supported by NIH grant NS083085 to R.H.S.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Butko MT, 2012, NAT NEUROSCI, V15, P1742, DOI 10.1038/nn.3246; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Costantini LM, 2012, TRAFFIC, V13, P643, DOI 10.1111/j.1600-0854.2012.01336.x; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; Halstead JM, 2015, SCIENCE, V347, P1367, DOI 10.1126/science.aaa3380; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jan CH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8299; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Morisaki T, 2016, SCIENCE, V352, P1425, DOI 10.1126/science.aaf0899; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Reid DW, 2015, SCIENCE, V348, DOI 10.1126/science.aaa7257; Reid DW, 2015, NAT REV MOL CELL BIO, V16, P221, DOI 10.1038/nrm3958; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Starck SR, 2004, CHEM BIOL, V11, P999, DOI 10.1016/j.chembiol.2004.05.011; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795; Wu B, 2015, CELL, V162, P211, DOI 10.1016/j.cell.2015.05.054; Wu B, 2015, GENE DEV, V29, P876, DOI 10.1101/gad.259358.115; Wu B, 2012, BIOPHYS J, V102, P2936, DOI 10.1016/j.bpj.2012.05.017	38	256	264	7	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1430	1435		10.1126/science.aaf1084	http://dx.doi.org/10.1126/science.aaf1084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313041	Green Accepted			2022-12-24	WOS:000377975400042
J	Huang, YX; Yu, J; Lanzi, A; Yao, X; Andrews, CD; Tsai, L; Gajjar, MR; Sun, M; Seaman, MS; Padte, NN; Ho, DD				Huang, Yaoxing; Yu, Jian; Lanzi, Anastasia; Yao, Xin; Andrews, Chasity D.; Tsai, Lily; Gajjar, Mili R.; Sun, Ming; Seaman, Michael S.; Padte, Neal N.; Ho, David D.			Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity	CELL			English	Article							ANTI-CD4 MONOCLONAL-ANTIBODY; BROADLY NEUTRALIZING ANTIBODIES; IMMUNODEFICIENCY-VIRUS TYPE-1; HUMANIZED MICE; RATIONAL DESIGN; HIV-ANTIBODIES; DISULFIDE REDUCTION; DEPENDENT EPITOPE; RHESUS-MONKEYS; POTENT	While the search for an efficacious HIV-1 vaccine remains elusive, emergence of a new generation of virus-neutralizing monoclonal antibodies (mAbs) has re-ignited the field of passive immunization for HIV-1 prevention. However, the plasticity of HIV-1 demands additional improvements to these mAbs to better ensure their clinical utility. Here, we report engineered bispecific antibodies that are the most potent and broad HIV-neutralizing antibodies to date. One bispecific antibody, 10E8(V2.0)/iMab, neutralized 118 HIV-1 pseudotyped viruses tested with a mean 50% inhibitory concentration (IC50) of 0.002 mu g/mL. 10E8(V2.0)/iMab also potently neutralized 99% of viruses in a second panel of 200 HIV-1 isolates belonging to clade C, the dominant subtype accounting for similar to 50% of new infections worldwide. Importantly, 10E8(V2.0)/iMab reduced virus load substantially in HIV-1-infected humanized mice and also provided complete protection when administered prior to virus challenge. These bispecific antibodies hold promise as novel prophylactic and/or therapeutic agents in the fight against HIV-1.	[Huang, Yaoxing; Yu, Jian; Lanzi, Anastasia; Yao, Xin; Andrews, Chasity D.; Tsai, Lily; Gajjar, Mili R.; Sun, Ming; Padte, Neal N.; Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 First Ave, New York, NY 10016 USA; [Seaman, Michael S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ho, DD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 First Ave, New York, NY 10016 USA.	dho@adarc.org			Bill and Melinda Gates Foundation [OPP50714, OPP1040732, 1032144]; National Institutes of Health [DP1DA033263]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA033263] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Faye Yu, Mar Boente-Carrera, and Natanya Gettie for technical assistance; Brian T. Chait and Paul Dominic B. Olinares for native mass spectroscopy analyses on 10E8 and 10E8/P140; Wendy Chen for assistance with figure preparation; Michel Nussenzweig for providing neutralization data for 3BNC117; Mark Louder and John Mascola for providing neutralization data for the combination of 3BNC117, PG9, 10-1074 and 10E8; and members of the Ho laboratory for helpful discussions. D.D.H. was supported by the Bill and Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (Grants OPP50714 and OPP1040732) and by the National Institutes of Health (Grant DP1DA033263). M.S.S. was supported by the Bill and Melinda Gates Foundation's Comprehensive Ab Vaccine Immune Monitoring Consortium (Grant 1032144). D.D.H. is the scientific founder of TaiMed Biologics, Inc., which owns the commercial rights to ibalizumab. In this capacity, D.D.H. hold less than 1% equity in the company and has a financial conflict of interest. Y.H., J.Y., and D.D.H. are inventors on a patent describing HIV CrossMAbs, including 10E8/iMab and 10E8/P140 and their variants, for HIV-1 prevention and therapy. If the technology were to be licensed, the inventors would benefit financially.	Andrews CD, 2014, SCIENCE, V343, P1151, DOI 10.1126/science.1248707; Baeten JM, 2013, JAIDS-J ACQ IMM DEF, V63, pS122, DOI 10.1097/QAI.0b013e3182986f69; Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; BURKLY LC, 1992, J IMMUNOL, V149, P1779; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Georgiev IS, 2014, J IMMUNOL, V192, P1100, DOI 10.4049/jimmunol.1302515; Goetze AM, 2010, MABS-AUSTIN, V2, P500, DOI 10.4161/mabs.2.5.12897; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Haverick M, 2014, MABS-AUSTIN, V6, P852, DOI 10.4161/mabs.28693; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Hutterer KM, 2013, MABS-AUSTIN, V5, P608, DOI 10.4161/mabs.24725; Jacobson JM, 2009, ANTIMICROB AGENTS CH, V53, P450, DOI 10.1128/AAC.00942-08; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14; Koterba KL, 2012, J BIOTECHNOL, V157, P261, DOI 10.1016/j.jbiotec.2011.11.009; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Lowe D, 2011, ADV PROTEIN CHEM STR, V84, P41, DOI 10.1016/B978-0-12-386483-3.00004-5; Luo XM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001225; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mouquet H, 2012, P NATL ACAD SCI USA, V109, P875, DOI 10.1073/pnas.1120059109; Mullan B., 2011, BMC P S8, V5, P110; Olson W.C., 2003, US patent, Patent No. [US7122185 B2, 7122185]; Pace CS, 2013, P NATL ACAD SCI USA, V110, P13540, DOI 10.1073/pnas.1304985110; Pace CS, 2013, JAIDS-J ACQ IMM DEF, V62, P1, DOI 10.1097/QAI.0b013e3182732746; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reimann KA, 1997, AIDS RES HUM RETROV, V13, P933, DOI 10.1089/aid.1997.13.933; Rosati S, 2014, NAT PROTOC, V9, P967, DOI 10.1038/nprot.2014.057; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Salinas BA, 2010, J PHARM SCI-US, V99, P2962, DOI 10.1002/jps.22056; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Song RJ, 2010, J VIROL, V84, P6935, DOI 10.1128/JVI.00453-10; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun M, 2014, JAIDS-J ACQ IMM DEF, V66, P473, DOI 10.1097/QAI.0000000000000218; Tenorio Allan R, 2011, Curr HIV/AIDS Rep, V8, P1, DOI 10.1007/s11904-010-0068-y; Toma J, 2011, J VIROL, V85, P3872, DOI 10.1128/JVI.02237-10; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110	53	125	132	2	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1621	1631		10.1016/j.cell.2016.05.024	http://dx.doi.org/10.1016/j.cell.2016.05.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315479	Green Accepted, Bronze			2022-12-24	WOS:000378062000014
J	Todorovic, A				Todorovic, Ana			WHAT YOUR PATIENT IS THINKING Palliative care is not just for those who are dying	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rsnow@bmj.com	Todorovic, Ana/ABG-2264-2020						0	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2016	353								i2846	10.1136/bmj.i2846	http://dx.doi.org/10.1136/bmj.i2846			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HF	27306758	Bronze, Green Published			2022-12-24	WOS:000378240400003
J	Perli, SD; Cui, CH; Lu, TK				Perli, Samuel D.; Cui, Cheryl H.; Lu, Timothy K.			Continuous genetic recording with self-targeting CRISPR-Cas in human cells	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; GENOMIC DNA; RNA; CANCER; SUPPRESSION; NETWORKS; MEMORY; RATS	The ability to record molecular events in vivo would enable monitoring of signaling dynamics within cellular niches and critical factors that orchestrate cellular behavior. We present a self-contained analog memory device for longitudinal recording of molecular stimuli into DNA mutations in human cells. This device consists of a self-targeting guide RNA (stgRNA) that repeatedly directs Streptococcus pyogenes Cas9 nuclease activity toward the DNA that encodes the stgRNA, enabling localized, continuous DNA mutagenesis as a function of stgRNA expression. We demonstrate programmable and multiplexed memory storage in human cells triggered by exogenous inducers or inflammation, both in vitro and in vivo. This tool, Mammalian Synthetic Cellular Recorder Integrating Biological Events (mSCRIBE), provides a distinct strategy for investigating cell biology in vivo and enables continuous evolution of targeted DNA sequences.	[Perli, Samuel D.; Cui, Cheryl H.; Lu, Timothy K.] MIT, MIT Synthet Biol Ctr, Synthet Biol Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Perli, Samuel D.; Cui, Cheryl H.; Lu, Timothy K.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Perli, Samuel D.; Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Cui, Cheryl H.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Lu, Timothy K.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Lu, TK (corresponding author), MIT, MIT Synthet Biol Ctr, Synthet Biol Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lu, TK (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.; Lu, TK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.; Lu, TK (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	timlu@mit.edu			National Institutes of Health [DP2 OD008435, P50 GM098792]; Office of Naval Research; National Science Foundation [MCB-1350625]; Defense Advanced Research Projects Agency; Center for Microbiome Informatics and Therapeutics; NSF Expeditions in Computing Program [1522074]; Natural Sciences and Engineering Research Council of Canada; Direct For Biological Sciences [1350625] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [1522074] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Center for Microbiome Informatics and Therapeutics; NSF Expeditions in Computing Program(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The plasmid constructs mentioned in table S2 are available from Addgene via their standard materials transfer agreement. T.K.L., S.D.P., and C.H.C. are inventors on a U.S. patent application (PCT/US2016/032348) submitted by MIT that covers the self-targeting genome editing system. We thank members of the Lu laboratory for helpful discussions. We thank the MIT MicroBioCenter for technical support with next-generation sequencing and the MIT Koch Institute flow cytometry core facility for their technical assistance in cell sorting. This work was supported by the National Institutes of Health (grants DP2 OD008435 and P50 GM098792), the Office of Naval Research (grant N00014-13-1-0424), the National Science Foundation (grant MCB-1350625), the Defense Advanced Research Projects Agency, The Center for Microbiome Informatics and Therapeutics, and NSF Expeditions in Computing Program Award 1522074. C.H.C. was supported by a Natural Sciences and Engineering Research Council of Canada postgraduate fellowship. S.P., C.H.C., and T.K.L. conceived the work. S.D.P. and C.H.C. designed and performed experiments. S.D.P. performed computational analyses on next-generation sequencing data. C.H.C. conducted in vivo animal studies. S.D.P., C.H.C., and T.K.L. designed the experiments and interpreted and analyzed the data. S.D.P., C.H.C., and T.K.L. wrote the paper. Sequences of all of the DNA constructs used in this work are listed in table S2, and their plasmid maps and C++ routines are available at www.rle.mit.edu/sbg/resources/stgRNA.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; ALTSCHUL SF, 1986, B MATH BIOL, V48, P603, DOI 10.1016/S0092-8240(86)90010-8; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; BEMELMANS MHA, 1993, J IMMUNOL, V151, P5554; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kalhor R., 2016, BIORXIV, DOI [10.1101/055863, DOI 10.1101/055863]; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Perli S., 2016, BIORXIV, DOI [10.1101/053058, DOI 10.1101/053058]; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	38	127	143	4	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2016	353	6304							aag0511	10.1126/science.aag0511	http://dx.doi.org/10.1126/science.aag0511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0RN	27540006	Green Submitted			2022-12-24	WOS:000382626800043
J	Weng, JK; Ye, ML; Li, B; Noel, JP				Weng, Jing-Ke; Ye, Mingli; Li, Bin; Noel, Joseph P.			Co-evolution of Hormone Metabolism and Signaling Networks Expands Plant Adaptive Plasticity	CELL			English	Article							ANTHOCYANIDIN REDUCTASE; DIHYDROPHASEIC ACID; MESSENGER-RNA; GERMINATION; RECEPTORS; FEATURES; PROTEIN	Classically, hormones elicit specific cellular responses by activating dedicated receptors. Nevertheless, the biosynthesis and turnover of many of these hormone molecules also produce chemically related metabolites. These molecules may also possess hormonal activities; therefore, one or more may contribute to the adaptive plasticity of signaling outcomes in host organisms. Here, we show that a catabolite of the plant hormone abscisic acid (ABA), namely phaseic acid (PA), likely emerged in seed plants as a signaling molecule that fine-tunes plant physiology, environmental adaptation, and development. This trait was facilitated by both the emergence- selection of a PA reductase that modulates PA concentrations and by the functional diversification of the ABA receptor family to perceive and respond to PA. Our results suggest that PA serves as a hormone in seed plants through activation of a subset of ABA receptors. This study demonstrates that the co-evolution of hormone metabolism and signaling networks can expand organismal resilience.	[Weng, Jing-Ke; Ye, Mingli; Noel, Joseph P.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Weng, Jing-Ke; Ye, Mingli; Noel, Joseph P.] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Li, Bin] Univ Calif San Diego, San Diego Sch Med, Dept Cellular & Mol Med, San Diego, CA 92093 USA; [Weng, Jing-Ke] MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Weng, Jing-Ke] MIT, Dept Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Noel, JP (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.; Noel, JP (corresponding author), Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA.	noel@salk.edu	Weng, Jing-Ke/V-5934-2019; Noel, Joseph P/A-9459-2009	Weng, Jing-Ke/0000-0003-3059-0075; 	National Science Foundation [EEC-0813570]; Pioneer Foundation	National Science Foundation(National Science Foundation (NSF)); Pioneer Foundation	We thank Sean Cutler for providing Arabidopsis mutant seeds of pyr1-1, pyl1-1, pyl2-1, and pyl4-1. This work was supported by the National Science Foundation under award number EEC-0813570 to J.P.N. J.K.W. was supported by a postdoctoral fellowship from the Pioneer Foundation. J.K.W. is a Pew Scholar in the Biomedical Sciences and a Searle Scholar. J.P.N. is an investigator with the Howard Hughes Medical Institute.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Cai L, 2012, NAT PRODUCT BIOPROSP, V2, P150, DOI 10.1007/s13659-012-0009-0; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dupeux F, 2011, EMBO J, V30, P4171, DOI 10.1038/emboj.2011.294; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Gargouri M, 2009, ARCH BIOCHEM BIOPHYS, V491, P61, DOI 10.1016/j.abb.2009.09.010; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Hill R. D., 1992, Seed Science Research, V2, P207, DOI 10.1017/S0960258500001392; HILL RD, 1995, PLANT PHYSIOL, V108, P573, DOI 10.1104/pp.108.2.573; Hopkins R, 2011, NATURE, V469, P411, DOI 10.1038/nature09641; Huang DQ, 2007, PLANT J, V50, P414, DOI 10.1111/j.1365-313X.2007.03056.x; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Kepka M, 2011, PLANT PHYSIOL, V157, P2108, DOI 10.1104/pp.111.182584; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MILBORROW BV, 1982, AUST J PLANT PHYSIOL, V9, P361, DOI 10.1071/PP9820361; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peterson FC, 2010, NAT STRUCT MOL BIOL, V17, P1109, DOI 10.1038/nsmb.1898; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramos MD, 2004, PHYTOCHEMISTRY, V65, P955, DOI 10.1016/j.phytochem.2003.12.007; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Seaborn T, 2010, TRENDS ENDOCRIN MET, V21, P729, DOI 10.1016/j.tem.2010.09.001; SHARKEY TD, 1980, PLANT PHYSIOL, V65, P291, DOI 10.1104/pp.65.2.291; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Theofilopoulos S, 2013, NAT CHEM BIOL, V9, P126, DOI [10.1038/NCHEMBIO.1156, 10.1038/nchembio.1156]; WalkerSimmons MK, 1997, PHYSIOL PLANTARUM, V100, P474, DOI 10.1034/j.1399-3054.1997.1000308.x; WALTON DC, 1973, PLANTA, V112, P87, DOI 10.1007/BF00386035; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zhang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067477	36	96	100	3	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					881	893		10.1016/j.cell.2016.06.027	http://dx.doi.org/10.1016/j.cell.2016.06.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518563	Bronze			2022-12-24	WOS:000382258700012
J	Long, JZ; Svensson, KJ; Bateman, LA; Lin, H; Kamenecka, T; Lokurkar, IA; Lou, J; Rao, RR; Chang, MR; Jedrychowski, MP; Paulo, JA; Gygi, SP; Griffin, PR; Nomura, DK; Spiegelman, BM				Long, Jonathan Z.; Svensson, Katrin J.; Bateman, Leslie A.; Lin, Hua; Kamenecka, Theodore; Lokurkar, Isha A.; Lou, Jesse; Rao, Rajesh R.; Chang, Mi Ra; Jedrychowski, Mark P.; Paulo, Joao A.; Gygi, Steven P.; Griffin, Patrick R.; Nomura, Daniel K.; Spiegelman, Bruce M.			The Secreted Enzyme PM20D1 Regulates Lipidated Amino Acid Uncouplers of Mitochondria	CELL			English	Article							BROWN ADIPOSE-TISSUE; BEIGE FAT; THERMOGENESIS; MICE; ABLATION; IDENTIFICATION; DIPEPTIDASE; PROTEINS; OBESITY; PRDM16	Brown and beige adipocytes are specialized cells that express uncoupling protein 1 ( UCP1) and dissipate chemical energy as heat. These cells likely possess alternative UCP1-independent thermogenic mechanisms. Here, we identify a secreted enzyme, peptidase M20 domain containing 1 ( PM20D1), that is enriched in UCP1(+) versus UCP1(-) adipocytes. We demonstrate that PM20D1 is a bidirectional enzyme in vitro, catalyzing both the condensation of fatty acids and amino acids to generate N-acyl amino acids and also the reverse hydrolytic reaction. N-acyl amino acids directly bind mitochondria and function as endogenous uncouplers of UCP1-independent respiration. Mice with increased circulating PM20D1 have augmented respiration and increased N-acyl amino acids in blood. Lastly, administration of N-acyl amino acids to mice improves glucose homeostasis and increases energy expenditure. These data identify an enzymatic node and a family of metabolites that regulate energy homeostasis. This pathway might be useful for treating obesity and associated disorders.	[Long, Jonathan Z.; Svensson, Katrin J.; Lokurkar, Isha A.; Lou, Jesse; Rao, Rajesh R.; Jedrychowski, Mark P.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Long, Jonathan Z.; Svensson, Katrin J.; Rao, Rajesh R.; Jedrychowski, Mark P.; Paulo, Joao A.; Gygi, Steven P.; Spiegelman, Bruce M.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Bateman, Leslie A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bateman, Leslie A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Bateman, Leslie A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Lin, Hua; Kamenecka, Theodore; Chang, Mi Ra; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Rao, Rajesh R.] Novartis Res Fdn GNF, Genom Inst, San Diego, CA 92121 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Scripps Research Institute; Novartis	Spiegelman, BM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.; Spiegelman, BM (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Nomura, DK (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Nomura, DK (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Nomura, DK (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	dnomura@berkeley.edu; bruce_spiegelman@dfci.harvard.edu	Svensson, Katrin J./AAA-4770-2021; Lin, Hua/U-1529-2019; Paulo, Joao/AAO-3981-2020	Svensson, Katrin J./0000-0001-5376-5128; Paulo, Joao/0000-0002-4291-413X; Long, Jonathan/0000-0003-2631-7463; Lin, Hua/0000-0002-0840-6553	NIH [DK105203, DK098285, R01CA172667, DK5447, DK31405]; Swedish Research Council [PE2013/613]; American Cancer Society [RSG14-242-01-TBE]; JPB Foundation; NATIONAL CANCER INSTITUTE [R01CA172667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054477, R01DK031405, K01DK098285, K99DK105203, R37DK031405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); American Cancer Society(American Cancer Society); JPB Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Marc Kirschner for many critical discussions as well as members of the B.M.S., D.K.N., and P.R.G. labs for helpful comments. We are grateful to Julie J. Johnson and Arbansjit Sandhu at the University of Pennsylvania Vector Core for AAV production. This work was supported by grants to J.Z.L. (NIH DK105203), K.J.S. (Swedish Research Council Postdoctoral Fellowship PE2013/613), J.A.P. (NIH DK098285), D.K.N. (American Cancer Society Research Scholar Award RSG14-242-01-TBE and NIH R01CA172667), and B.M.S. (NIH DK5447, DK31405 and the JPB Foundation). B.M.S. is a consultant for Calico Life Sciences, LLC.	Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; FUKUI T, 1961, J BIOL CHEM, V236, P811; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Katayama K, 1999, BBA-MOL CELL BIOL L, V1440, P205, DOI 10.1016/S1388-1981(99)00124-9; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Nicholls D G, 1978, Experientia Suppl, V32, P89; Niphakis MJ, 2015, CELL, V161, P1668, DOI 10.1016/j.cell.2015.05.045; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; STEGINK LD, 1991, AM J CLIN NUTR, V53, P670, DOI 10.1093/ajcn/53.3.670; Svensson KJ, 2016, CELL METAB, V23, P454, DOI 10.1016/j.cmet.2016.01.008; Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Van Coster RN, 2005, BIOCHEM BIOPH RES CO, V338, P1322, DOI 10.1016/j.bbrc.2005.10.126; Veiga-da-Cunha M, 2014, J BIOL CHEM, V289, P19726, DOI 10.1074/jbc.M114.576579; Wang GX, 2014, NAT MED, V20, P1436, DOI 10.1038/nm.3713; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	30	152	154	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					424	435		10.1016/j.cell.2016.05.071	http://dx.doi.org/10.1016/j.cell.2016.05.071			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27374330	Green Accepted, Bronze			2022-12-24	WOS:000380255400019
J	Jee, J; Rasouly, A; Shamovsky, I; Akivis, Y; Steinman, SR; Mishra, B; Nudler, E				Jee, Justin; Rasouly, Aviram; Shamovsky, Ilya; Akivis, Yonatan; Steinman, Susan R.; Mishra, Bud; Nudler, Evgeny			Rates and mechanisms of bacterial mutagenesis from maximum-depth sequencing	NATURE			English	Article							ESCHERICHIA-COLI; MUTATION-RATE; RARE MUTATIONS; ANTIBIOTICS; SENSITIVITY; SELECTION; GENE	In 1943, Luria and Delbruck used a phage-resistance assay to establish spontaneous mutation as a driving force of microbial diversity(1). Mutation rates are still studied using such assays, but these can only be used to examine the small minority of mutations conferring survival in a particular condition. Newer approaches, such as long-term evolution followed by whole-genome sequencing(2,3), may be skewed by mutational 'hot' or 'cold' spots(3,4). Both approaches are affected by numerous caveats(5-7). Here we devise a method, maximum-depth sequencing (MDS), to detect extremely rare variants in a population of cells through error-corrected, high-throughput sequencing. We directly measure locus-specific mutation rates in Escherichia coli and show that they vary across the genome by at least an order of magnitude. Our data suggest that certain types of nucleotide misincorporation occur 10(4)-fold more frequently than the basal rate of mutations, but are repaired in vivo. Our data also suggest specific mechanisms of antibiotic-induced mutagenesis, including downregulation of mismatch repair via oxidative stress, transcription-replication conflicts, and, in the case of fluoroquinolones, direct damage to DNA.	[Jee, Justin; Rasouly, Aviram; Shamovsky, Ilya; Akivis, Yonatan; Steinman, Susan R.; Nudler, Evgeny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Jee, Justin; Mishra, Bud] NYU, Courant Inst Math Sci, New York, NY 10016 USA; [Rasouly, Aviram; Nudler, Evgeny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; New York University; Howard Hughes Medical Institute; New York University	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.; Mishra, B (corresponding author), NYU, Courant Inst Math Sci, New York, NY 10016 USA.; Nudler, E (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	mishra@nyu.edu; evgeny.nudler@nyumc.org		Nudler, Evgeny/0000-0002-8811-3071; Rasouly, Aviram/0000-0003-2857-6151	Cancer Center Support Grant [P30CA016087]; NIH [R01GM107329]; HHMI; NCI PSOC grant [U54 CA193313]; NYU Medical Scientist Training Program; National Defense Science and Engineering Graduate Fellowship; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107329, T32GM007308] Funding Source: NIH RePORTER	Cancer Center Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NCI PSOC grant; NYU Medical Scientist Training Program; National Defense Science and Engineering Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Heguy and the NYU Genome Technology Center, which is partially supported by the Cancer Center Support Grant, P30CA016087, at the Laura and Isaac Perlmutter Cancer Center. This work used computing resources at the High Performance Computing Facility of the Center for Health Informatics and Bioinformatics at the NYU Langone Medical Center. We thank D. Dwyer and K. Shankarling for materials, and T Artemyev for his contribution. This work was supported by NIH grant R01GM107329 and HHMI (E.N.) and NCI PSOC grant U54 CA193313 (B.M.). J.J. was supported by the NYU Medical Scientist Training Program and a National Defense Science and Engineering Graduate Fellowship.	Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berend D, 2010, PROBAB MATH STAT-POL, V30, P185; Chen XZ, 2013, MOL BIOL EVOL, V30, P1559, DOI 10.1093/molbev/mst060; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Drake JW, 2012, G3-GENES GENOM GENET, V2, P483, DOI 10.1534/g3.111.001842; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; LENSKI RE, 1989, P NATL ACAD SCI USA, V86, P2775, DOI 10.1073/pnas.86.8.2775; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Luria SE, 1943, GENETICS, V28, P491; Martincorena I, 2012, NATURE, V485, P95, DOI 10.1038/nature10995; McDonald MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000622; Merrikh H, 2012, NAT REV MICROBIOL, V10, P449, DOI 10.1038/nrmicro2800; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Pohlhaus JR, 2005, MOL MICROBIOL, V56, P1416, DOI 10.1111/j.1365-2958.2005.04638.x; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Sangurdekar DP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r32; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; Schmitt MW, 2015, NAT METHODS, V12, P423, DOI [10.1038/nmeth.3351, 10.1038/NMETH.3351]; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wielgoss S, 2013, P NATL ACAD SCI USA, V110, P222, DOI 10.1073/pnas.1219574110; Wielgoss S, 2011, G3-GENES GENOM GENET, V1, P183, DOI 10.1534/g3.111.000406; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Zhu LC, 2009, MOL BIOL EVOL, V26, P2353, DOI 10.1093/molbev/msp144	34	69	72	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					693	+		10.1038/nature18313	http://dx.doi.org/10.1038/nature18313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27338792	Green Accepted			2022-12-24	WOS:000378676000038
J	Donald, PR; Van Toorn, R				Donald, Peter Roderick; Van Toorn, Ronald			Use of corticosteroids in tuberculous meningitis	LANCET			English	Editorial Material							THERAPY		[Donald, Peter Roderick; Van Toorn, Ronald] Univ Stellenbosch, Paediat & Child Hlth, Fac Med & Hlth Sci, ZA-8000 Cape Town, South Africa	Stellenbosch University	Donald, PR (corresponding author), Univ Stellenbosch, Paediat & Child Hlth, Fac Med & Hlth Sci, ZA-8000 Cape Town, South Africa.	prd@sun.ac.za	van Toorn, Ronald/AAR-9157-2021	van Toorn, Ronald/0000-0002-2689-065X				Bekker LG, 1998, J INFECT DIS, V178, P580, DOI 10.1086/517479; Datta M, 2015, P NATL ACAD SCI USA, V112, P1827, DOI 10.1073/pnas.1424563112; FITZPATRICK MJ, 1954, AM REV TUBERC PULM, V69, P370; Lammie GA, 2009, J INFECTION, V20, P1; Orme IM, 2014, TUBERCULOSIS, V94, P8, DOI 10.1016/j.tube.2013.07.004; PRASAD K, 2000, COCHRANE DB SYST REV, V3; Prasad K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub4; Schoeman JF, 2004, J CHILD NEUROL, V19, P250, DOI 10.1177/088307380401900402; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2013, LANCET NEUROL, V12, P999, DOI 10.1016/S1474-4422(13)70168-6; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tsenova L, 2002, ANTIMICROB AGENTS CH, V46, P1887, DOI 10.1128/AAC.46.6.1887-1895.2002; Zumla A, 2015, J INTERN MED, V277, P373, DOI 10.1111/joim.12256	13	9	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2585	2587		10.1016/S0140-6736(16)30770-X	http://dx.doi.org/10.1016/S0140-6736(16)30770-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27353808				2022-12-24	WOS:000378390500010
J	Xu, JW; Gui, M; Wang, DH; Xiang, Y				Xu, Jingwei; Gui, Miao; Wang, Dianhong; Xiang, Ye			The bacteriophage phi 29 tail possesses a pore-forming loop for cell membrane penetration	NATURE			English	Article							VIRUS; RELEASE; PEPTIDE; SYSTEM; ENTRY	Most bacteriophages are tailed bacteriophages with an isometric or a prolate head attached to a long contractile, long non-contractile, or short non-contractile tail(1). The tail is a complex machine that plays a central role in host cell recognition and attachment, cell wall and membrane penetration, and viral genome ejection. The mechanisms involved in the penetration of the inner host cell membrane by bacteriophage tails are not well understood. Here we describe structural and functional studies of the bacteriophage phi 29 tail knob protein gene product 9 (gp9). The 2.0 angstrom crystal structure of gp9 shows that six gp9 molecules form a hexameric tube structure with six flexible hydrophobic loops blocking one end of the tube before DNA ejection. Sequence and structural analyses suggest that the loops in the tube could be membrane active. Further biochemical assays and electron microscopy structural analyses show that the six hydrophobic loops in the tube exit upon DNA ejection and form a channel that spans the lipid bilayer of the membrane and allows the release of the bacteriophage genomic DNA, suggesting that cell membrane penetration involves a pore-forming mechanism similar to that of certain non-enveloped eukaryotic viruses(2-4). A search of other phage tail proteins identified similar hydrophobic loops, which indicates that a common mechanism might be used for membrane penetration by prokaryotic viruses. These findings suggest that although prokaryotic and eukaryotic viruses use apparently very different mechanisms for infection, they have evolved similar mechanisms for breaching the cell membrane.	[Xu, Jingwei; Gui, Miao; Wang, Dianhong; Xiang, Ye] Tsinghua Univ, Ctr Infect Dis Res, Collaborat Innovat Ctr Diag & Treatment Infect Di, Dept Basic Med Sci,Sch Med,Beijing Adv Innovat Ct, Beijing 100084, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University	Xiang, Y (corresponding author), Tsinghua Univ, Ctr Infect Dis Res, Collaborat Innovat Ctr Diag & Treatment Infect Di, Dept Basic Med Sci,Sch Med,Beijing Adv Innovat Ct, Beijing 100084, Peoples R China.	yxiang@mail.tsinghua.edu.cn	Gui, Miao/AAU-6300-2021	Xiang, Ye/0000-0003-0230-9522; Gui, Miao/0000-0001-9113-8029; Xu, Jingwei/0000-0003-1833-1513	973 program [2015CB910102]; National Natural Science Foundation of China [31470721, 81550001]; Junior Thousand Talents Program of China [20131770418]; Beijing Advanced Innovation Center for Structural Biology	973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Junior Thousand Talents Program of China; Beijing Advanced Innovation Center for Structural Biology	We thank L. Q. Zhang, N. Yan, H. T. Li, S. L. Fan, N. Gao, C. Z. Zhou, D. L. Anderson and M. G. Rossmann for support; the Tsinghua University Branch of the China National Center for Protein Sciences for the facility support; and the staff at the Shanghai Synchrotron Research Facility beam line BL17U for assistance with data collection. This work was supported by funds from the 973 program (2015CB910102), the National Natural Science Foundation of China (31470721 and 81550001), the Junior Thousand Talents Program of China (20131770418) and the Beijing Advanced Innovation Center for Structural Biology to Y.X.	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson Dwight, 1993, P859; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cardarelli L, 2010, P NATL ACAD SCI USA, V107, P14384, DOI 10.1073/pnas.1005822107; Cohen DN, 2008, J MOL BIOL, V378, P804, DOI 10.1016/j.jmb.2008.02.068; Cohen DN, 2009, J MOL BIOL, V387, P607, DOI 10.1016/j.jmb.2009.02.001; Cowtan K. D., 2000, INT TABLES CRYSTALLO, VF, P507; Doan T, 2013, GENE DEV, V27, P322, DOI 10.1101/gad.209049.112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galloux M, 2010, J BIOL CHEM, V285, P19409, DOI 10.1074/jbc.M109.076083; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jarmer H, 2002, FEMS MICROBIOL LETT, V206, P197, DOI 10.1016/S0378-1097(01)00525-0; Johnson John E, 2010, Curr Top Microbiol Immunol, V343, pv; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Llaguno MC, 2014, J STRUCT BIOL, V185, P405, DOI 10.1016/j.jsb.2014.01.006; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Meijer WJJ, 2001, MICROBIOL MOL BIOL R, V65, P261, DOI 10.1128/MMBR.65.2.261-287.2001; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjwani A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004294; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shukla A, 2014, J VIROL, V88, P12409, DOI 10.1128/JVI.01896-14; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Tang JH, 2008, STRUCTURE, V16, P935, DOI 10.1016/j.str.2008.02.024; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xiang Y, 2008, P NATL ACAD SCI USA, V105, P9552, DOI 10.1073/pnas.0803787105; Xiang Y, 2006, EMBO J, V25, P5229, DOI 10.1038/sj.emboj.7601386; Xiang Y, 2011, P NATL ACAD SCI USA, V108, P4806, DOI 10.1073/pnas.1018097108; Xiang Y, 2009, MOL CELL, V34, P375, DOI 10.1016/j.molcel.2009.04.009	37	19	20	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					544	+		10.1038/nature18017	http://dx.doi.org/10.1038/nature18017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309813				2022-12-24	WOS:000378270300052
J	Mass, E; Ballesteros, I; Farlik, M; Halbritter, F; Gunther, P; Crozet, L; Jacome-Galarza, CE; Handler, K; Klughammer, J; Kobayashi, Y; Gomez-Perdiguero, E; Schultze, JL; Beyer, M; Bock, C; Geissmann, F				Mass, Elvira; Ballesteros, Ivan; Farlik, Matthias; Halbritter, Florian; Guenther, Patrick; Crozet, Lucile; Jacome-Galarza, Christian E.; Haendler, Kristian; Klughammer, Johanna; Kobayashi, Yasuhiro; Gomez-Perdiguero, Elisa; Schultze, Joachim L.; Beyer, Marc; Bock, Christoph; Geissmann, Frederic			Specification of tissue-resident macrophages during organogenesis	SCIENCE			English	Article							RNA-SEQ; GENE-EXPRESSION; FETAL MONOCYTES; PPAR-GAMMA; CELLS; ID3; ALIGNMENT; REVEALS; TRANSCRIPTOMES; INFLAMMATION	Tissue-resident macrophages support embryonic development and tissue homeostasis and repair. The mechanisms that control their differentiation remain unclear. We report here that erythro-myeloid progenitors in mice generate premacrophages (pMacs) that simultaneously colonize the whole embryo from embryonic day 9.5 in a chemokine-receptor-dependent manner. The core macrophage program initiated in pMacs is rapidly diversified as expression of transcriptional regulators becomes tissue-specific in early macrophages. This process appears essential for macrophage specification and maintenance, as inactivation of Id3 impairs the development of liver macrophages and results in selective Kupffer cell deficiency in adults. We propose that macrophage differentiation is an integral part of organogenesis, as colonization of organ anlagen by pMacs is followed by their specification into tissue macrophages, hereby generating the macrophage diversity observed in postnatal tissues.	[Mass, Elvira; Ballesteros, Ivan; Crozet, Lucile; Jacome-Galarza, Christian E.; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Farlik, Matthias; Halbritter, Florian; Klughammer, Johanna; Bock, Christoph] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Guenther, Patrick; Haendler, Kristian; Schultze, Joachim L.; Beyer, Marc] Univ Bonn, Genom & Immunoregulat Life & Med Sci Inst, Bonn, Germany; [Crozet, Lucile; Geissmann, Frederic] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Kobayashi, Yasuhiro] Matsumoto Dent Univ, Inst Oral Sci, 1780 Hiro Oka Gobara Shiojiri, Nagano 3900781, Japan; [Gomez-Perdiguero, Elisa; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England; [Schultze, Joachim L.; Beyer, Marc] German Ctr Neurodegenerat Dis, Single Cell Genom & Epigen Unit, Bonn, Germany; [Schultze, Joachim L.; Beyer, Marc] Univ Bonn, Bonn, Germany; [Bock, Christoph] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Bock, Christoph] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Gomez-Perdiguero, Elisa] Inst Pasteur, Macrophages & Endothelial Cells Grp, Dept Dev & Stem Cell Biol, CNRS,UMR 3738, Paris, France	Memorial Sloan Kettering Cancer Center; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Bonn; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Matsumoto Dental University; University of London; King's College London; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Medical University of Vienna; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Geissmann, F (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.; Geissmann, F (corresponding author), Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA.; Geissmann, F (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England.	geissmaf@mskcc.org	Ballesteros, Iván/AAA-6745-2020; KOBAYASHI, YASUHIRO/AAU-4931-2021; Mass, Elvira/AAH-3805-2019; Schultze, Joachim L./ABA-8176-2020; Beyer, Marc/ABE-1408-2021; Martin, Ivan Ballesteros/G-6623-2017; Perdiguero, Elisa Gomez/U-2120-2018; Bock, Christoph/AAE-7618-2019; Halbritter, Florian/AAI-1000-2019	Mass, Elvira/0000-0003-2318-2356; Schultze, Joachim L./0000-0003-2812-9853; Beyer, Marc/0000-0001-9704-148X; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Bock, Christoph/0000-0001-6091-3088; Halbritter, Florian/0000-0003-2452-4784; Kobayashi, Yasuhiro/0000-0002-0903-3226; Handler, Kristian/0000-0001-5273-5277; Ballesteros, Ivan/0000-0002-6246-2353; Gunther, Patrick/0000-0002-9135-7819; Klughammer, Johanna/0000-0002-3628-9278	National Cancer Institute of the U.S. NIH [P30CA008748]; Wellcome Trust [WT101853MA]; European Research Council [2010-StG-261299]; European Molecular Biology Organization long-term fellowship [ALTF 530-2015]; Deutsche Forschungsgemeinschaft (DFG) [HA 7723/1-1]; Doktorand/inn/enprogramm der Osterreichischen Akademie der Wissenschaften (DOC) Fellowship of the Austrian Academy of Sciences; New Frontiers Group award from the Austrian Academy of Sciences; Excellence Cluster ImmunoSensation; DFG [BE 4427/3-1, SFB 704, SFB 645, INST 217/575-1, INST 217/576-1, INST 217/577-1]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute of the U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Doktorand/inn/enprogramm der Osterreichischen Akademie der Wissenschaften (DOC) Fellowship of the Austrian Academy of Sciences; New Frontiers Group award from the Austrian Academy of Sciences; Excellence Cluster ImmunoSensation; DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Benezra (MSKCC, New York) for the Id3<SUP>-/-</SUP> and Id3<SUP>f/f</SUP> strains. We thank the Biomedical Sequencing Facility at CeMM and the MSKCC Integrated Genomics and Bioinformatics Cores for assistance with next-generation sequencing. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. Sequencing data sets described in this work have been submitted to the Gene Expression Omnibus (GEO) repository (GEO accession number GSE81774). Additionally, a genome browser track hub and additional supplementary data are available at http://macrophage-development.computational-epigenetics.org/. This work was supported by the National Cancer Institute of the U.S. NIH (grant P30CA008748) and by investigator awards from the Wellcome Trust (WT101853MA) and the European Research Council (2010-StG-261299) to F.G. E.M. is supported by a European Molecular Biology Organization long-term fellowship (ALTF 530-2015). F.H. is supported by a Deutsche Forschungsgemeinschaft (DFG) postdoctoral fellowship (HA 7723/1-1). J.K. is supported by a Doktorand/inn/enprogramm der Osterreichischen Akademie der Wissenschaften (DOC) Fellowship of the Austrian Academy of Sciences. C.B. is supported by a New Frontiers Group award from the Austrian Academy of Sciences. M.B. and J.L.S. are members of the Excellence Cluster ImmunoSensation. M.B. is supported by a DFG grant (BE 4427/3-1). J.L.S. is supported by DFG grants SFB 704, SFB 645, INST 217/575-1, INST 217/576-1, and INST 217/577-1.	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Charrad M, 2014, J STAT SOFTW, V61, P1; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glaus P, 2012, BIOINFORMATICS, V28, P1721, DOI 10.1093/bioinformatics/bts260; Gorgani NN, 2008, IMMUNOL CELL BIOL, V86, P246, DOI 10.1038/sj.icb.7100131; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guo ZL, 2011, IMMUNOL LETT, V135, P34, DOI 10.1016/j.imlet.2010.09.009; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jen Y, 1996, DEV DYNAM, V207, P235; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jux B, 2009, J IMMUNOL, V182, P6709, DOI 10.4049/jimmunol.0713344; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li J, 2016, EMBO REP, V17, P178, DOI 10.15252/embr.201540946; Lionakis MS, 2013, J CLIN INVEST, V123, P5035, DOI 10.1172/JCI71307; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Sanchez-Castillo M, 2015, NUCLEIC ACIDS RES, V43, pD1117, DOI 10.1093/nar/gku895; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sheffield NC, 2016, BIOINFORMATICS, V32, P587, DOI 10.1093/bioinformatics/btv612; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhao QS, 2011, DEV BIOL, V349, P53, DOI 10.1016/j.ydbio.2010.10.004	55	441	450	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2016	353	6304							aaf4238	10.1126/science.aaf4238	http://dx.doi.org/10.1126/science.aaf4238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0RN	27492475	Green Accepted			2022-12-24	WOS:000382626800042
J	Gury-BenAri, M; Thaiss, CA; Serafini, N; Winter, DR; Giladi, A; Lara-Astiaso, D; Levy, M; Salame, TM; Weiner, A; David, E; Shapiro, H; Dori-Bachash, M; Pevsner-Fischer, M; Lorenzo-Vivas, E; Keren-Shaul, H; Paul, F; Harmelin, A; Eberl, G; Itzkovitz, S; Tanay, A; Di Santo, JP; Elinav, E; Amit, I				Gury-BenAri, Meital; Thaiss, Christoph A.; Serafini, Nicolas; Winter, Deborah R.; Giladi, Amir; Lara-Astiaso, David; Levy, Maayan; Salame, Tomer Meir; Weiner, Assaf; David, Eyal; Shapiro, Hagit; Dori-Bachash, Mally; Pevsner-Fischer, Meirav; Lorenzo-Vivas, Erika; Keren-Shaul, Hadas; Paul, Franziska; Harmelin, Alon; Eberl, Gerard; Itzkovitz, Shalev; Tanay, Amos; Di Santo, James P.; Elinav, Eran; Amit, Ido			The Spectrum and Regulatory Landscape of Intestinal Innate Lymphoid Cells Are Shaped by the Microbiome	CELL			English	Article							TRANSCRIPTION FACTOR GATA3; ROR-GAMMA-T; RNA-SEQ; FUNCTIONAL PLASTICITY; COMMENSAL MICROFLORA; NKP46(+) CELLS; INFLAMMATION; HOMEOSTASIS; FATE; DIFFERENTIATION	Innate lymphoid cells (ILCs) are critical modulators of mucosal immunity, inflammation, and tissue homeostasis, but their full spectrum of cellular states and regulatory landscapes remains elusive. Here, we combine genome-wide RNA-seq, ChIP-seq, and ATAC-seq to compare the transcriptional and epigenetic identity of small intestinal ILCs, identifying thousands of distinct gene profiles and regulatory elements. Single-cell RNA-seq and flow and mass cytometry analyses reveal compartmentalization of cytokine expression and metabolic activity within the three classical ILC subtypes and highlight transcriptional states beyond the current canonical classification. In addition, using antibiotic intervention and germ-free mice, we characterize the effect of the microbiome on the ILC regulatory landscape and determine the response of ILCs to microbial colonization at the single-cell level. Together, our work characterizes the spectrum of transcriptional identities of small intestinal ILCs and describes how ILCs differentially integrate signals from the microbial microenvironment to generate phenotypic and functional plasticity.	[Gury-BenAri, Meital; Thaiss, Christoph A.; Winter, Deborah R.; Giladi, Amir; Lara-Astiaso, David; Levy, Maayan; Weiner, Assaf; David, Eyal; Shapiro, Hagit; Dori-Bachash, Mally; Pevsner-Fischer, Meirav; Lorenzo-Vivas, Erika; Keren-Shaul, Hadas; Paul, Franziska; Elinav, Eran; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Serafini, Nicolas; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75015 Paris, France; [Serafini, Nicolas; Di Santo, James P.] INSERM, U1223, Paris, France; [Salame, Tomer Meir] Weizmann Inst Sci, Biol Serv Unit, IL-76100 Rehovot, Israel; [Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Eberl, Gerard] Inst Pasteur, Dept Immunol, F-75015 Paris, France; [Eberl, Gerard] CNRS, URA 1961, F-75015 Paris, France; [Itzkovitz, Shalev] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Weizmann Institute of Science; Weizmann Institute of Science; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Elinav, E; Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	eran.elinav@weizmann.ac.il; ido.amit@weizmann.ac.il	Winter, Deborah R./AAQ-9253-2020; Di Santo, James P/M-4298-2014; Eberl, Gerard/A-1160-2013; Shapiro, Hagit/F-8648-2015; Elinav, Eran/ABE-8881-2020; SERAFINI, nicolas/S-5675-2019	Winter, Deborah R./0000-0003-1806-673X; Di Santo, James P/0000-0002-7146-1862; Elinav, Eran/0000-0002-5775-2110; SERAFINI, nicolas/0000-0002-7440-4353; Paul, Franziska/0000-0003-0344-6764; Lorenzo Vivas, Erika/0000-0002-8150-5902; Eberl, Gerard/0000-0002-1119-5638	Boehringer Ingelheim Fonds PhD Fellowship; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of J. Gitlitz; estate of L. Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Center for Scientific Research (CNRS); European Research Council; Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development; Israel Science Foundation; Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation; European Foundation for the Study of Diabetes; European Research Council [309788]; Israel Science foundation [782/11]; BLUEPRINT FP7 consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; National Human Genome Research Institute Center for Excellence in Genome Science [1P50HG006193]; Israeli Ministry of Science, Technology and Space; David and Fela Shapell Family Foundation; Abramson Family Center for Young Scientists; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of J. Gitlitz; estate of L. Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation(Helmholtz Association); European Foundation for the Study of Diabetes; European Research Council(European Research Council (ERC)European Commission); Israel Science foundation(Israel Science Foundation); BLUEPRINT FP7 consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; National Human Genome Research Institute Center for Excellence in Genome Science; Israeli Ministry of Science, Technology and Space(Ministry of Science, Technology and Space (MOST), Israel); David and Fela Shapell Family Foundation; Abramson Family Center for Young Scientists; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the members of I.A.'s and E.E.'s labs for fruitful discussions, Carmit Bar-Nathan for GF mouse care taking, Elena Kartvelishvily for help with electron microscopy, Melanie Flach for technical advice, and Maayan Wigelmann for art work. C.A.T. received a Boehringer Ingelheim Fonds PhD Fellowship. E.E. is supported by Y. and R. Ungar; the Abisch Frenkel Foundation for the Promotion of Life Sciences; the Gurwin Family Fund for Scientific Research; the Leona M. and Harry B. Helmsley Charitable Trust; the Crown Endowment Fund for Immunological Research; the estate of J. Gitlitz; the estate of L. Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; the Adelis Foundation; J.L. and V. Schwartz; A. and G. Markovitz; A. and C. Adelson; the French National Center for Scientific Research (CNRS); D.L. Schwarz; the V.R. Schwartz Research Fellow Chair; L. Steinberg; J.N. Halpern; A. Edelheit, and by grants funded by the European Research Council; a Marie Curie Integration grant; the German-Israeli Foundation for Scientific Research and Development; the Israel Science Foundation; the Minerva Foundation; the Rising Tide Foundation; the Helmholtz Foundation; and the European Foundation for the Study of Diabetes. E.E. is the incumbent of the Rina Gudinski Career Development Chair and a senior fellow of the Canadian Institute For Advanced Research (CIFAR). I. A. is supported by the European Research Council (309788), the I-CORE for chromatin and RNA regulation, and personal grants from the Israel Science foundation (782/11) and the BLUEPRINT FP7 consortium, the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine, a Minerva Stiftung research grant, the National Human Genome Research Institute Center for Excellence in Genome Science (1P50HG006193), the Israeli Ministry of Science, Technology and Space, the David and Fela Shapell Family Foundation, and the Abramson Family Center for Young Scientists. I.A. is the incumbent of the Alan and Laraine Fischer Career Development Chair.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cording S, 2014, FEBS LETT, V588, P4176, DOI 10.1016/j.febslet.2014.03.034; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Eberl G, 2015, NAT IMMUNOL, V16, P1, DOI 10.1038/ni.3059; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Verrier T, 2016, J IMMUNOL, V196, P4731, DOI 10.4049/jimmunol.1502673; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Xu W, 2013, J IMMUNOL, V191, P4489, DOI 10.4049/jimmunol.1301759	61	349	362	11	131	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1231	+		10.1016/j.cell.2016.07.043	http://dx.doi.org/10.1016/j.cell.2016.07.043			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27545347	Bronze			2022-12-24	WOS:000382259500019
J	Chartron, JW; Hunt, KCL; Frydman, J				Chartron, Justin W.; Hunt, Katherine C. L.; Frydman, Judith			Cotranslational signal-independent SRP preloading during membrane targeting	NATURE			English	Article							PROTEIN BIOGENESIS FACTORS; ENDOPLASMIC-RETICULUM; RECOGNITION PARTICLE; GLOBAL ANALYSIS; IN-VIVO; RIBOSOME; TRANSLATION; YEAST; TRANSLOCATION; LOCALIZATION	Ribosome-associated factors must properly decode the limited information available in nascent polypeptides to direct them to their correct cellular fate(1). It is unclear how the low complexity information exposed by the nascent chain suffices for accurate recognition by the many factors competing for the limited surface near the ribosomal exit site(2,3). Questions remain even for the well-studied cotranslational targeting cycle to the endoplasmic reticulum, involving recognition of linear hydrophobic signal sequences or transmembrane domains by the signal recognition particle (SRP)(4,5). Notably, the SRP has low abundance relative to the large number of ribosome-nascent-chain complexes (RNCs), yet it accurately selects those destined for the endoplasmic reticulum(6). Despite their overlapping specificities, the SRP and the cotranslationally acting Hsp70 display precise mutually exclusive selectivity in vivo for their cognate RNCs7,8. To understand cotranslational nascent chain recognition in vivo, here we investigate the cotranslational membrane-targeting cycle using ribosome profiling(9) in yeast cells coupled with biochemical fractionation of ribosome populations. We show that the SRP preferentially binds secretory RNCs before their targeting signals are translated. Non-coding mRNA elements can promote this signal-independent pre-recruitment of SRP. Our study defines the complex kinetic interaction between elongation in the cytosol and determinants in the polypeptide and mRNA that modulate SRP-substrate selection and membrane targeting.	[Chartron, Justin W.; Hunt, Katherine C. L.; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Frydman, Judith] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Frydman, J (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Frydman, J (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Chartron, Justin/L-9096-2019	Chartron, Justin/0000-0003-1734-3424; , judith/0000-0003-2302-6943	NIH NRSA award; NIH; HFSP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056433, R37GM056433] Funding Source: NIH RePORTER	NIH NRSA award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSP(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Walter, J. S. Weissman and C. Jan for discussions; R. Andino and R. Hegde for critical reading of the manuscript. We thank S. Pechmann, K. M. Dalton, E. M. Sontag, P. T. Dolan and other members of the Frydman laboratory for advice on analysis. Sequencing was performed at the UCSF Center for Advanced Technology with assistance from E. Chow, J. Lund and A. Acevedo. J.W.C. is supported by an NIH NRSA award. This work was additionally supported by grants to J.F. from the NIH and HFSP.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Beckert B, 2015, NAT STRUCT MOL BIOL, V22, P767, DOI 10.1038/nsmb.3086; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Bornemann T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5180; Breker M, 2014, NUCLEIC ACIDS RES, V42, pD726, DOI 10.1093/nar/gkt933; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Doerfel LK, 2013, BIOPOLYMERS, V99, P837, DOI 10.1002/bip.22341; Elvekrog MM, 2015, CURR OPIN CHEM BIOL, V29, P79, DOI 10.1016/j.cbpa.2015.09.016; FREIDLIN PJ, 1980, BIOCHEM BIOPH RES CO, V93, P521, DOI 10.1016/0006-291X(80)91108-0; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hainzl T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8163; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Holtkamp W, 2012, NAT STRUCT MOL BIOL, V19, P1332, DOI 10.1038/nsmb.2421; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kraut-Cohen J, 2013, MOL BIOL CELL, V24, P3069, DOI 10.1091/mbc.E13-01-0038; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; NARANDA T, 1994, J BIOL CHEM, V269, P32286; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Nyathi Y, 2015, J CELL BIOL, V210, P287, DOI 10.1083/jcb.201410086; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Voorhees RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07975; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Woolstenhulme CJ, 2015, CELL REP, V11, P13, DOI 10.1016/j.celrep.2015.03.014; Zhang X, 2014, ANNU REV BIOPHYS, V43, P381, DOI 10.1146/annurev-biophys-051013-022653; ZHONG T, 1993, CELL, V73, P1175, DOI 10.1016/0092-8674(93)90646-8	57	100	101	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					224	+		10.1038/nature19309	http://dx.doi.org/10.1038/nature19309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487213	Green Accepted			2022-12-24	WOS:000381472100039
J	Mysorekar, IU; Diamond, MS				Mysorekar, Indira U.; Diamond, Michael S.			Modeling Zika Virus Infection in Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSMISSION; MICE		[Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med & Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mysorekar, IU; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med & Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.	diamond@wusm.wustl.edu	Diamond, Michael/AAH-1733-2019; Mysorekar, Indira U./GRS-4574-2022	Diamond, Michael/0000-0002-8791-3165; Mysorekar, Indira U./0000-0003-3917-8677	NIAID NIH HHS [R01 AI073755] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073755] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; de Paula Freitas B., 2016, JAMA OPHTHALMOL; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Li C., 2016, CELL STEM CELL; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012; Quicke KM, 2016, CELL HOST MICROBE; Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517; Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58	14	71	73	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					481	484		10.1056/NEJMcibr1605445	http://dx.doi.org/10.1056/NEJMcibr1605445			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS7AN	27433842	Bronze, Green Published			2022-12-24	WOS:000380934900015
J	Bakken, TE; Miller, JA; Ding, SL; Sunkin, SM; Smith, KA; Ng, L; Szafer, A; Dalley, RA; Royall, JJ; Lemon, T; Shapouri, S; Aiona, K; Arnold, J; Bennett, JL; Bertagnolli, D; Bickley, K; Boe, A; Brouner, K; Butler, S; Byrnes, E; Caldejon, S; Carey, A; Cate, S; Chapin, M; Chen, J; Dee, N; Desta, T; Dolbeare, TA; Dotson, N; Ebbert, A; Fulfs, E; Gee, G; Gilbert, TL; Goldy, J; Gourley, L; Gregor, B; Gu, GY; Hall, J; Haradon, Z; Haynor, DR; Hejazinia, N; Hoerder-Suabedissen, A; Howard, R; Jochim, J; Kinnunen, M; Kriedberg, A; Kuan, CL; Lau, C; Lee, CK; Lee, F; Luong, L; Mastan, N; May, R; Melchor, J; Mosqueda, N; Mott, E; Ngo, K; Nyhus, J; Oldre, A; Olson, E; Parente, J; Parker, PD; Parry, S; Pendergraft, J; Potekhina, L; Reding, M; Riley, ZL; Roberts, T; Rogers, B; Roll, K; Rosen, D; Sandman, D; Sarreal, M; Shapovalova, N; Shi, S; Sjoquist, N; Sodt, AJ; Townsend, R; Velasquez, L; Wagley, U; Wakeman, WB; White, C; Bennett, C; Wu, J; Young, R; Youngstrom, BL; Wohnoutka, P; Gibbs, RA; Rogers, J; Hohmann, JG; Hawrylycz, MJ; Hevner, RF; Molnar, Z; Phillips, JW; Dang, C; Jones, AR; Amaral, DG; Bernard, A; Lein, ES				Bakken, Trygve E.; Miller, Jeremy A.; Ding, Song-Lin; Sunkin, Susan M.; Smith, Kimberly A.; Ng, Lydia; Szafer, Aaron; Dalley, Rachel A.; Royall, Joshua J.; Lemon, Tracy; Shapouri, Sheila; Aiona, Kaylynn; Arnold, James; Bennett, Jeffrey L.; Bertagnolli, Darren; Bickley, Kristopher; Boe, Andrew; Brouner, Krissy; Butler, Stephanie; Byrnes, Emi; Caldejon, Shiella; Carey, Anita; Cate, Shelby; Chapin, Mike; Chen, Jefferey; Dee, Nick; Desta, Tsega; Dolbeare, Tim A.; Dotson, Nadia; Ebbert, Amanda; Fulfs, Erich; Gee, Garrett; Gilbert, Terri L.; Goldy, Jeff; Gourley, Lindsey; Gregor, Ben; Gu, Guangyu; Hall, Jon; Haradon, Zeb; Haynor, David R.; Hejazinia, Nika; Hoerder-Suabedissen, Anna; Howard, Robert; Jochim, Jay; Kinnunen, Marty; Kriedberg, Ali; Kuan, Chihchau L.; Lau, Christopher; Lee, Chang-Kyu; Lee, Felix; Luong, Lon; Mastan, Naveed; May, Ryan; Melchor, Jose; Mosqueda, Nerick; Mott, Erika; Ngo, Kiet; Nyhus, Julie; Oldre, Aaron; Olson, Eric; Parente, Jody; Parker, Patrick D.; Parry, Sheana; Pendergraft, Julie; Potekhina, Lydia; Reding, Melissa; Riley, Zackery L.; Roberts, Tyson; Rogers, Brandon; Roll, Kate; Rosen, David; Sandman, David; Sarreal, Melaine; Shapovalova, Nadiya; Shi, Shu; Sjoquist, Nathan; Sodt, Andy J.; Townsend, Robbie; Velasquez, Lissette; Wagley, Udi; Wakeman, Wayne B.; White, Cassandra; Bennett, Crissa; Wu, Jennifer; Young, Rob; Youngstrom, Brian L.; Wohnoutka, Paul; Gibbs, Richard A.; Rogers, Jeffrey; Hohmann, John G.; Hawrylycz, Michael J.; Hevner, Robert F.; Molnar, Zoltn; Phillips, John W.; Dang, Chinh; Jones, Allan R.; Amaral, David G.; Bernard, Amy; Lein, Ed S.			A comprehensive transcriptional map of primate brain development	NATURE			English	Article							HUMAN PREFRONTAL CORTEX; HUMAN CEREBRAL-CORTEX; ADULT HUMAN BRAIN; GENE-EXPRESSION; RHESUS-MONKEY; VISUAL-CORTEX; SYNAPTIC DEVELOPMENT; POSITIVE SELECTION; MOLECULAR PATHWAYS; RNA-SEQ	The transcriptional underpinnings of brain development remain poorly understood, particularly in humans and closely related non-human primates. We describe a high-resolution transcriptional atlas of rhesus monkey (Macaca mulatta) brain development that combines dense temporal sampling of prenatal and postnatal periods with fine anatomical division of cortical and subcortical regions associated with human neuropsychiatric disease. Gene expression changes more rapidly before birth, both in progenitor cells and maturing neurons. Cortical layers and areas acquire adult-like molecular profiles surprisingly late in postnatal development. Disparate cell populations exhibit distinct developmental timing of gene expression, but also unexpected synchrony of processes underlying neural circuit construction including cell projection and adhesion. Candidate risk genes for neurodevelopmental disorders including primary microcephaly, autism spectrum disorder, intellectual disability, and schizophrenia show disease-specific spatiotemporal enrichment within developing neocortex. Human developmental expression trajectories are more similar to monkey than rodent, although approximately 9% of genes show human-specific regulation with evidence for prolonged maturation or neoteny compared to monkey.	[Bakken, Trygve E.; Miller, Jeremy A.; Ding, Song-Lin; Sunkin, Susan M.; Smith, Kimberly A.; Ng, Lydia; Szafer, Aaron; Dalley, Rachel A.; Royall, Joshua J.; Lemon, Tracy; Shapouri, Sheila; Aiona, Kaylynn; Arnold, James; Bertagnolli, Darren; Bickley, Kristopher; Boe, Andrew; Brouner, Krissy; Butler, Stephanie; Byrnes, Emi; Caldejon, Shiella; Carey, Anita; Cate, Shelby; Chapin, Mike; Chen, Jefferey; Dee, Nick; Desta, Tsega; Dolbeare, Tim A.; Dotson, Nadia; Ebbert, Amanda; Fulfs, Erich; Gee, Garrett; Gilbert, Terri L.; Goldy, Jeff; Gourley, Lindsey; Gregor, Ben; Gu, Guangyu; Hall, Jon; Haradon, Zeb; Hejazinia, Nika; Howard, Robert; Jochim, Jay; Kinnunen, Marty; Kriedberg, Ali; Kuan, Chihchau L.; Lau, Christopher; Lee, Chang-Kyu; Lee, Felix; Luong, Lon; Mastan, Naveed; May, Ryan; Melchor, Jose; Mosqueda, Nerick; Mott, Erika; Ngo, Kiet; Nyhus, Julie; Oldre, Aaron; Olson, Eric; Parente, Jody; Parker, Patrick D.; Parry, Sheana; Pendergraft, Julie; Potekhina, Lydia; Reding, Melissa; Riley, Zackery L.; Roberts, Tyson; Rogers, Brandon; Roll, Kate; Rosen, David; Sandman, David; Sarreal, Melaine; Shapovalova, Nadiya; Shi, Shu; Sjoquist, Nathan; Sodt, Andy J.; Townsend, Robbie; Velasquez, Lissette; Wagley, Udi; Wakeman, Wayne B.; White, Cassandra; Bennett, Crissa; Wu, Jennifer; Young, Rob; Youngstrom, Brian L.; Wohnoutka, Paul; Hohmann, John G.; Hawrylycz, Michael J.; Phillips, John W.; Dang, Chinh; Jones, Allan R.; Bernard, Amy; Lein, Ed S.] Allen Inst Brain Sci, Seattle, WA 98109 USA; [Bennett, Jeffrey L.; Amaral, David G.] Univ Calif Davis, Dept Psychiat & Behav Sci, Calif Natl Primate Res Ctr, MIND Inst, Sacramento, CA 95817 USA; [Haynor, David R.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Hoerder-Suabedissen, Anna; Molnar, Zoltn] Univ Oxford, Dept Physiol Anat & Genet, South Pk Rd, Oxford OX1 3QX, England; [Gibbs, Richard A.; Rogers, Jeffrey] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gibbs, Richard A.; Rogers, Jeffrey] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Hevner, Robert F.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA	Allen Institute for Brain Science; University of California System; University of California Davis; University of Washington; University of Washington Seattle; University of Oxford; Baylor College of Medicine; Baylor College of Medicine; Seattle Children's Hospital	Lein, ES (corresponding author), Allen Inst Brain Sci, Seattle, WA 98109 USA.	EdL@alleninstitute.org	Bakken, Trygve E./R-4622-2017; Hoerder-Suabedissen, Anna/G-7053-2011; Molnar, Zoltan/J-7281-2012; Ding, Song-Lin/F-7963-2013	Bakken, Trygve E./0000-0003-3373-7386; Molnar, Zoltan/0000-0002-6852-6004; Bennett, Jeffrey/0000-0002-3255-5663; Ding, Song-Lin/0000-0002-7072-5272; Arnold, James/0000-0001-7011-591X; Gilbert, Terri/0000-0002-4986-6898; Parker, Patrick/0000-0001-5217-107X; Dee, Nick/0000-0002-2831-9254; Sjoquist, Nathan/0000-0002-2037-6828; Bernard, Amy/0000-0003-2540-1153	California National Primate Research Center (NIH) [RR00169]; NIH from National Institute of Mental Health [HHSN-271-2008-0047]; Biotechnology and Biological Sciences Research Council [BB/I021833/1] Funding Source: researchfish; Medical Research Council [G0700377, MR/N026039/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; BBSRC [BB/I021833/1] Funding Source: UKRI; MRC [G0700377, MR/N026039/1] Funding Source: UKRI	California National Primate Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from National Institute of Mental Health; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Allen Institute for Brain Science founders, P. G. Allen and J. Allen, for their vision, encouragement, and support. The authors also thank J. Montiel and W. Zhi Wang for their advice on developmental neuroanatomy and experimental design. We also wish to acknowledge the California National Primate Research Center (NIH Award Number RR00169) for providing tissues and Covance Genomics Laboratory (Seattle, Washington) for microarray probe generation, hybridization and scanning. The project was supported by NIH Blueprint for Neuroscience Research contract HHSN-271-2008-0047 (PI: E. Lein, Allen Institute for Brain Science) from the National Institute of Mental Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or the National Institute of Mental Health.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bakken TE, 2015, HUM MOL GENET, V24, P4327, DOI 10.1093/hmg/ddv166; Bar-Joseph Z, 2008, P NATL ACAD SCI USA, V105, P955, DOI 10.1073/pnas.0704723105; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; Berger B, 1996, J COMP NEUROL, V366, P674, DOI 10.1002/(SICI)1096-9861(19960318)366:4<674::AID-CNE8>3.0.CO;2-1; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Bianchi S, 2013, P NATL ACAD SCI USA, V110, P10395, DOI 10.1073/pnas.1301224110; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Caldwell C., 2011, PRIMATES PERSPECTIVE, P652; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; de Lacy N, 2013, ANNU REV CLIN PSYCHO, V9, P555, DOI 10.1146/annurev-clinpsy-050212-185627; Elston GN, 2009, J NEUROSCI, V29, P3271, DOI 10.1523/JNEUROSCI.5216-08.2009; Garcia NVD, 2011, NATURE, V472, P351, DOI 10.1038/nature09865; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; HASEGAWA M, 1992, BRAIN DEV-JPN, V14, P1; Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Iossifov I, 2015, P NATL ACAD SCI USA, V112, pE5600, DOI 10.1073/pnas.1516376112; Jackman SL, 2016, NATURE, V529, P88, DOI 10.1038/nature16507; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu XL, 2012, GENOME RES, V22, P611, DOI 10.1101/gr.127324.111; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; Matsumoto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092695; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Miller JA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-154; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Moretti S, 2014, NUCLEIC ACIDS RES, V42, pD917, DOI 10.1093/nar/gkt1065; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Paxinos G., 2009, RHESUS MONKEY BRAIN; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pirooznia M, 2012, BIOINFORMATICS, V28, P897, DOI 10.1093/bioinformatics/bts040; Pletikos M, 2014, NEURON, V81, P321, DOI 10.1016/j.neuron.2013.11.018; Pouchelon G, 2014, NATURE, V511, P471, DOI 10.1038/nature13390; Price J. L., 1987, HDB CHEM NEUROANATOM, V5, P279; Proux E, 2009, NUCLEIC ACIDS RES, V37, pD404, DOI 10.1093/nar/gkn768; RAKIC P, 1994, PROG BRAIN RES, V102, P227; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1977, PHILOS T R SOC B, V278, P245, DOI 10.1098/rstb.1977.0040; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Scott JA, 2016, BRAIN STRUCT FUNCT, V221, P2847, DOI 10.1007/s00429-015-1076-x; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Sorensen SA, 2015, CEREB CORTEX, V25, P433, DOI 10.1093/cercor/bht243; Stead JDH, 2006, J NEUROSCI, V26, P345, DOI 10.1523/JNEUROSCI.2755-05.2006; Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Thompson CL, 2014, NEURON, V83, P309, DOI 10.1016/j.neuron.2014.05.033; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Verloes A., 2013, GENEREVIEWS; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Winrow CJ, 2009, BRAIN RES, V1271, P1, DOI 10.1016/j.brainres.2009.02.083; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013; Zapala MA, 2006, P NATL ACAD SCI USA, V103, P19430, DOI 10.1073/pnas.0609333103; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zuber V, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1730	83	210	210	7	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					367	+		10.1038/nature18637	http://dx.doi.org/10.1038/nature18637			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27409810	Green Submitted, Green Accepted			2022-12-24	WOS:000380344200030
J	Banerjee, M; Wiebel, JL; Guo, C; Gay, B; Haymart, MR				Banerjee, Mousumi; Wiebel, Jaime L.; Guo, Cui; Gay, Brittany; Haymart, Megan R.			Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTTREATMENT SURVEILLANCE; INCREASING INCIDENCE; THERAPY; TRENDS; MANAGEMENT; EFFICACY; BURDEN; LIVER; RISK	OBJECTIVE To determine whether the use of imaging tests after primary treatment of differentiated thyroid cancer is associated with more treatment for recurrence and fewer deaths from the disease. DESIGN Population based retrospective cohort study. SETTING Surveillance Epidemiology and End Results-Medicare database in the United States. PARTICIPANTS 28 220 patients diagnosed with differentiated thyroid cancer between 1998 and 2011. The study cohort was followed up to 2013, with a median follow-up of 69 months. MAIN OUTCOME MEASURES Treatment for recurrence of differentiated thyroid cancer (additional neck surgery, additional radioactive iodine treatment, or radiotherapy), and deaths due to differentiated thyroid cancer. We conducted propensity score analyses to assess the relation between imaging (neck ultrasound, radioiodine scanning, or positron emission tomography (PET) scanning) and treatment for recurrence (logistic model) and death (Cox proportional hazards model). RESULTS From 1998 until 2011, we saw an increase in incident cancer (rate ratio 1.05, 95% confidence interval 1.05 to 1.06), imaging (1.13, 1.12 to 1.13), and treatment for recurrence (1.01, 1.01 to 1.02); the change in death rate was not significant. In multivariable analysis, use of neck ultrasounds increased the likelihood of additional surgery (odds ratio 2.30, 95% confidence interval 2.05 to 2.58) and additional radioactive iodine treatment (1.45, 1.26 to 1.69). Radioiodine scans were associated with additional surgery (odds ratio 3.39, 95% confidence interval 3.06 to 3.76), additional radioactive iodine treatment (17.83, 14.49 to 22.16), and radiotherapy (1.89, 1.71 to 2.10). Use of PET scans was associated with additional surgery (odds ratio 2.31, 95% confidence interval 2.09 to 2.55), additional radioactive iodine treatment (2.13, 1.89 to 2.40), and radiotherapy (4.98, 4.52 to 5.49). Use of neck ultrasounds or PET scans did not significantly affect disease specific survival (hazard ratio 1.14, 95% confidence interval 0.98 to 1.27, and 0.91, 0.77 to 1.07, respectively). However, radioiodine scans were associated with an improved disease specific survival (hazard ratio 0.70, 95% confidence interval 0.60 to 0.82). CONCLUSIONS The marked rise in use of imaging tests after primary treatment of differentiated thyroid cancer has been associated with an increased treatment for recurrence. However, with the exception of radioiodine scans in presumed iodine avid disease, this association has shown no clear improvement in disease specific survival. These findings emphasize the importance of curbing unnecessary imaging and tailoring imaging after primary treatment to patient risk.	[Banerjee, Mousumi; Guo, Cui] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Banerjee, Mousumi; Haymart, Megan R.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Wiebel, Jaime L.] Endocrine Associates Dallas, Dallas, TX USA; [Gay, Brittany; Haymart, Megan R.] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Haymart, Megan R.] Univ Michigan, Div Hematol Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Haymart, MR (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.; Haymart, MR (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.; Haymart, MR (corresponding author), Univ Michigan, Div Hematol Oncol, Ann Arbor, MI 48109 USA.	meganhay@med.umich.edu		Haymart, Megan/0000-0002-1083-1575	National Institutes of Health [1K07CA154595-02]; National Cancer Institute [5 P30 CA 046592]; Punya Foundation for Thyroid Cancer Research; NATIONAL CANCER INSTITUTE [T32CA083654, P30CA046592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Punya Foundation for Thyroid Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MRH is supported by National Institutes of Health grant 1K07CA154595-02. MB is partly supported by grant 5 P30 CA 046592 from the National Cancer Institute. Support was provided by the Punya Foundation for Thyroid Cancer Research. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Aschebrook-Kilfoy B, 2013, CANCER EPIDEM BIOMAR, V22, P1252, DOI 10.1158/1055-9965.EPI-13-0242; Banerjee M, 2014, J CLIN ENDOCR METAB, V99, P3737, DOI 10.1210/jc.2014-2197; Boltz MM, 2013, SURGERY, V154, P1363, DOI 10.1016/j.surg.2013.06.042; Bresner L, 2015, J CLIN ENDOCR METAB, V100, P977, DOI 10.1210/jc.2014-3169; Butt DA, 2014, NEUROEPIDEMIOLOGY, V43, P28, DOI 10.1159/000365590; Cooper DS, 2010, THYROID, V20, P942, DOI 10.1089/thy.2009.0110.cxn2; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Fritz A, 2000, INT CLASSIFICATION D; Griffeth Landis K, 2005, Proc (Bayl Univ Med Cent), V18, P321; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hollenbeak CS, 2013, EUR J ENDOCRINOL, V168, P549, DOI 10.1530/EJE-12-0848; Huang BS, 2009, RADIOLOGY, V251, P166, DOI 10.1148/radiol.2511081300; Hyder O, 2013, J GASTROINTEST SURG, V17, P1774, DOI 10.1007/s11605-013-2302-6; Hyder O, 2013, SURGERY, V154, P256, DOI 10.1016/j.surg.2013.04.021; Lang BHH, 2013, WORLD J SURG, V37, P2853, DOI 10.1007/s00268-013-2202-7; Misra S, 2013, J SURG ONCOL, V108, P47, DOI 10.1002/jso.23345; Morris LGT, 2013, THYROID, V23, P886, DOI 10.1089/thy.2013.0045; Nixon IJ, 2014, SURGERY, V156, P137, DOI 10.1016/j.surg.2014.03.027; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Roh JL, 2009, AM J SURG, V197, P459, DOI [10.1016/j.amjsurg.2008.04.017, 10.1016/j.amjsurg.2008.06.040]; Sawka AM, 2009, THYROID, V19, P451, DOI 10.1089/thy.2008.0392; Schreinemakers JMJ, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-192; Singh SM, 2017, MED CARE, V55, pE44, DOI 10.1097/MLR.0000000000000274; Smallridge RC, 2014, THYROID, V24, P1501, DOI 10.1089/thy.2014.0043; Song HJ, 2015, EUR J ENDOCRINOL, V173, P399, DOI 10.1530/EJE-15-0296; Sprague BL, 2008, CANCER CAUSE CONTROL, V19, P585, DOI 10.1007/s10552-008-9122-0; Terezakis SA, 2009, INT J RADIAT ONCOL, V73, P795, DOI 10.1016/j.ijrobp.2008.05.012; Tufano RP, 2015, THYROID, V25, P15, DOI 10.1089/thy.2014.0098; Tuttle RM, 2010, THYROID, V20, P1341, DOI 10.1089/thy.2010.0178; Van Nostrand D, 2011, ORAL DIS, V17, P154, DOI 10.1111/j.1601-0825.2010.01726.x; Wang WP, 2000, J CLIN ENDOCR METAB, V85, P1107, DOI 10.1210/jc.85.3.1107; Warren JL, 2002, MED CARE, V40, P55; Wiebel JL, 2015, THYROID, V25, P1026, DOI 10.1089/thy.2015.0062; Wiebel JL, 2015, CANCER-AM CANCER SOC, V121, P1387, DOI 10.1002/cncr.29210; Witkowski ER, 2012, J GASTROINTEST SURG, V16, P121, DOI 10.1007/s11605-011-1699-z	38	15	15	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2016	354								i3839	10.1136/bmj.i3839	http://dx.doi.org/10.1136/bmj.i3839			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0WA	27443325	hybrid, Green Published			2022-12-24	WOS:000380316300005
J	Laxminarayan, R; Amabile-Cuevas, CF; Cars, O; Evans, T; Heymann, DL; Hoffman, S; Holmes, A; Mendelson, M; Sridhar, D; Woolhouse, M; Rottingen, JA				Laxminarayan, Ramanan; Amabile-Cuevas, Carlos F.; Cars, Otto; Evans, Timothy; Heymann, David L.; Hoffman, Steven; Holmes, Alison; Mendelson, Marc; Sridhar, Devi; Woolhouse, Mark; Rottingen, John-Arne			UN High-Level Meeting on antimicrobials-what do we need?	LANCET			English	Editorial Material							ACCESS; RESISTANCE		[Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA; [Laxminarayan, Ramanan] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Laxminarayan, Ramanan] Publ Hlth Fdn India, New Delhi, India; [Amabile-Cuevas, Carlos F.] Fdn Lusara Invest Cient, Mexico City, DF, Mexico; [Cars, Otto] Uppsala Univ, Dept Med Sci, ReAct, Uppsala, Sweden; [Evans, Timothy] World Bank, 1818 H St NW, Washington, DC 20433 USA; [Heymann, David L.] Ctr Global Hlth Secur, Chatham House, London, England; [Hoffman, Steven] Univ Ottawa, Ottawa, ON, Canada; [Holmes, Alison] Imperial Coll, London, England; [Mendelson, Marc] Univ Cape Town, Cape Town, South Africa; [Sridhar, Devi; Woolhouse, Mark] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Rottingen, John-Arne] Norwegian Inst Publ Hlth, Oslo, Norway; [Rottingen, John-Arne] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Rottingen, John-Arne] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Princeton University; Public Health Foundation of India; Uppsala University; The World Bank; University of Ottawa; Imperial College London; University of Cape Town; University of Edinburgh; Norwegian Institute of Public Health (NIPH); University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Laxminarayan, R (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA.; Laxminarayan, R (corresponding author), Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA.; Laxminarayan, R (corresponding author), Publ Hlth Fdn India, New Delhi, India.	ramanan@cddep.org	Laxminarayan, Ramanan/ABD-5050-2021; Amábile-Cuevas, Carlos/HDO-1753-2022	Amábile-Cuevas, Carlos/0000-0001-6806-544X; Mendelson, Marc/0000-0001-6668-3893; Hoffman, Steven/0000-0002-2064-3711; Holmes, Alison/0000-0001-5554-5743				Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5; Heymann DL, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3087; Jasovsky D, 2016, UPSALA J MED SCI, V121, P159, DOI 10.1080/03009734.2016.1195900; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Mendelson M, 2016, LANCET, V387, P188, DOI 10.1016/S0140-6736(15)00547-4; ONeill J., 2016, TACKLING DRUG RESIST; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083	9	54	55	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					218	220		10.1016/S0140-6736(16)31079-0	http://dx.doi.org/10.1016/S0140-6736(16)31079-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27479554	Green Submitted			2022-12-24	WOS:000379736100008
J	Cuylen, S; Blaukopf, C; Politi, AZ; Muller-Reichert, T; Neumann, B; Poser, I; Ellenberg, J; Hyman, AA; Gerlich, DW				Cuylen, Sara; Blaukopf, Claudia; Politi, Antonio Z.; Mueller-Reichert, Thomas; Neumann, Beate; Poser, Ina; Ellenberg, Jan; Hyman, Anthony A.; Gerlich, Daniel W.			Ki-67 acts as a biological surfactant to disperse mitotic chromosomes	NATURE			English	Article							CELL-PROLIFERATION; PROTEIN; ANTIGEN; ORGANIZATION; MICROSCOPY; ANAPHASE; GENOME; DOMAIN; GENES	Eukaryotic genomes are partitioned into chromosomes that form compact and spatially well-separated mechanical bodies during mitosis(1-3). This enables chromosomes to move independently of each other for segregation of precisely one copy of the genome to each of the nascent daughter cells. Despite insights into the spatial organization of mitotic chromosomes(4) and the discovery of proteins at the chromosome surface(3,5,6), the molecular and biophysical bases of mitotic chromosome structural individuality have remained unclear. Here we report that the proliferation marker protein Ki-67 (encoded by the MKI67 gene), a component of the mitotic chromosome periphery, prevents chromosomes from collapsing into a single chromatin mass after nuclear envelope disassembly, thus enabling independent chromosome motility and efficient interactions with the mitotic spindle. The chromosome separation function of human Ki-67 is not confined within a specific protein domain, but correlates with size and net charge of truncation mutants that apparently lack secondary structure. This suggests that Ki-67 forms a steric and electrostatic charge barrier, similar to surface-active agents (surfactants) that disperse particles or phase-separated liquid droplets in solvents. Fluorescence correlation spectroscopy showed a high surface density of Ki-67 and dual-colour labelling of both protein termini revealed an extended molecular conformation, indicating brush-like arrangements that are characteristic of polymeric surfactants. Our study thus elucidates a biomechanical role of the mitotic chromosome periphery in mammalian cells and suggests that natural proteins can function as surfactants in intracellular compartmentalization.	[Cuylen, Sara; Blaukopf, Claudia; Gerlich, Daniel W.] Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria; [Politi, Antonio Z.; Ellenberg, Jan] EMBL, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Mueller-Reichert, Thomas] Tech Univ Dresden, Med Fac Carl Gustav Carus, Expt Ctr, Fetscherstr 74, D-01307 Dresden, Germany; [Neumann, Beate] EMBL, Adv Light Microscopy Facil, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Poser, Ina; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); European Molecular Biology Laboratory (EMBL); Technische Universitat Dresden; Carl Gustav Carus University Hospital; European Molecular Biology Laboratory (EMBL); Max Planck Society	Cuylen, S (corresponding author), Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.		Gerlich, Daniel Wolfram W/A-6991-2016; Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Ellenberg, Jan/I-4688-2014	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Hyman, Anthony A/0000-0003-3664-154X; Neumann, Beate/0000-0002-6899-502X; Politi, Antonio/0000-0003-4788-0933; Ellenberg, Jan/0000-0001-5909-701X	European Community [241548, 258068, 330114]; ERC [281198]; Austrian Science Fund (FWF) project [SFB F34-06]; Human Frontier Science Program Long-Term Postdoctoral Fellowship; Deutsche Forschungsgemeinschaft (DFG) [MU 1423/3-2, MU 1423/8-1]	European Community(European Commission); ERC(European Research Council (ERC)European Commission); Austrian Science Fund (FWF) project(Austrian Science Fund (FWF)); Human Frontier Science Program Long-Term Postdoctoral Fellowship(Human Frontier Science Program); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank the IMBA/IMP BioOptics microscopy facility and Molecular Biology Service, J. Meissner, and M. J. Hossain for technical support, H. Liu and S. Tietscher for generation of plasmids, C. Haering, M. Samwer, W. H. Gerlich, and O. Wueseke for comments on the manuscript, Life Science Editors for editing assistance, and U. Kutay for LAP2 beta-GFP/H2B-mRFP-expressing cells. D.W.G., A.A.H. and J.E. have received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no. 241548 (MitoSys), and A.Z.P., D.W.G. and J.E. under grant agreement no. 258068 (Systems Microscopy). D.G. has received funding from an ERC Starting Grant under agreement no. 281198 (DIVIMAGE), and from the Austrian Science Fund (FWF) project no. SFB F34-06 (Chromosome Dynamics). S.C. has received funding from a Human Frontier Science Program Long-Term Postdoctoral Fellowship and the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no. 330114 (IFF). T.M.R. was supported by Deutsche Forschungsgemeinschaft (DFG): SPP1384 'Mechanisms of Genome Haploidization MU 1423/3-2 and grant MU 1423/8-1.	Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Booth DG, 2014, ELIFE, V3, DOI 10.7554/eLife.01641; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Cidado J, 2016, ONCOTARGET, V7, P6281, DOI 10.18632/oncotarget.7057; Erfle H, 2008, J BIOMOL SCREEN, V13, P575, DOI 10.1177/1087057108320133; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Heriche JK, 2014, MOL BIOL CELL, V25, P2522, DOI 10.1091/mbc.E13-04-0221; Hirano T, 2016, CELL, V164, P847, DOI 10.1016/j.cell.2016.01.033; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Kschonsak M, 2015, BIOESSAYS, V37, P755, DOI 10.1002/bies.201500020; Lukinavicius G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9497; MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Ohta S, 2011, CURR OPIN CELL BIOL, V23, P114, DOI 10.1016/j.ceb.2010.09.009; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rosen MJ, 2012, SURFACTANTS AND INTERFACIAL PHENOMENA, 4TH EDITION, P1, DOI 10.1002/9781118228920; Saiwaki T, 2005, EXP CELL RES, V308, P123, DOI 10.1016/j.yexcr.2005.04.010; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Schmitz MHA, 2009, METHODS MOL BIOL, V545, P113, DOI 10.1007/978-1-60327-993-2_7; Sobecki M, 2016, ELIFE, V5, DOI 10.7554/eLife.13722; Takagi M, 1999, J CELL SCI, V112, P2463; Takagi M, 2001, J BIOL CHEM, V276, P25386, DOI 10.1074/jbc.M102227200; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Vanneste D, 2009, CURR BIOL, V19, P1712, DOI 10.1016/j.cub.2009.09.019; VERHEIJEN R, 1989, J CELL SCI, V92, P531; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zwicker D, 2014, P NATL ACAD SCI USA, V111, pE2636, DOI 10.1073/pnas.1404855111	33	279	285	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					308	+		10.1038/nature18610	http://dx.doi.org/10.1038/nature18610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27362226	Green Accepted			2022-12-24	WOS:000379912600062
J	El-Chichakli, B; von Braun, J; Lang, C; Barben, D; Philp, J				El-Chichakli, Beate; von Braun, Joachim; Lang, Christine; Barben, Daniel; Philp, Jim			Five cornerstones of a global bioeconomy	NATURE			English	Editorial Material									[El-Chichakli, Beate] German Fed Govt, Off Bioecon Council, Berlin, Germany; [von Braun, Joachim] Univ Bonn, Res Dev Ctr, Bonn, Germany; [von Braun, Joachim] Univ Bonn, Econ & Technol Change, Bonn, Germany; [von Braun, Joachim; Lang, Christine] German Fed Govt, Bioecon Council, Berlin, Germany; [Lang, Christine] Tech Univ Berlin, Microbiol & Mol Genet, Berlin, Germany; [Barben, Daniel] Alpen Adria Univ Klagenfurt, Inst Sci Technol & Soc Studies, Klagenfurt, Austria; [Philp, Jim] Org Econ Cooperat & Dev, Paris, France	University of Bonn; University of Bonn; Technical University of Berlin; University of Klagenfurt; Organisation for Economic Co-operation & Development (OECD)	Philp, J (corresponding author), Org Econ Cooperat & Dev, Paris, France.	james.philp@oecd.org	Lang, Christine/U-8855-2019; von Braun, Joachim/AAA-7044-2020	von Braun, Joachim/0000-0001-6571-4838				Biookonomierat, 2015, GLOB VIS BIOEC INT D; Coady D., 2015, LARGE ARE GLOBAL ENE; Communique Global Bioeconomy Summit, 2015, MAK BIOEC WORK SUST; Food and Agriculture Organization of United Nations (FAO), 2014, STAT WORLD FISH AQ 2; Intesa SanPaolo, 2015, 2 INT SANPAOLO; Peplow M, 2015, NAT BIOTECHNOL, V33, P1123, DOI 10.1038/nbt1115-1123; Ronzon T., 2015, BIOECONOMY EUROPEAN; US National Academy of Sciences, 2015, IND BIOL ROADM ACC A; Von Braun J., 2015, FIGHT HUNGER MALNUTR, P240, DOI [10.1093/acprof:oso/9780198733201.003.0011, DOI 10.1093/ACPROF:OSO/9780198733201.003.0011, DOI 10.1093/ACPROF:OSO/9780198733201.001.0001]	9	134	136	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					221	223		10.1038/535221a	http://dx.doi.org/10.1038/535221a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR4ZN	27411618	Bronze			2022-12-24	WOS:000379912600026
J	Reischauer, S; Stone, OA; Villasenor, A; Chi, N; Jin, SW; Martin, M; Lee, MT; Fukuda, N; Marass, M; Witty, A; Fiddes, I; Kuo, T; Chung, WS; Salek, S; Lerrigo, R; Alsio, J; Luo, SJ; Tworus, D; Augustine, SM; Mucenieks, S; Nystedt, B; Giraldez, AJ; Schroth, GP; Andersson, O; Stainier, DYR				Reischauer, Sven; Stone, Oliver A.; Villasenor, Alethia; Chi, Neil; Jin, Suk-Won; Martin, Marcel; Lee, Miler T.; Fukuda, Nana; Marass, Michele; Witty, Alec; Fiddes, Ian; Kuo, Taiyi; Chung, Won-Suk; Salek, Sherveen; Lerrigo, Robert; Alsio, Jessica; Luo, Shujun; Tworus, Dominika; Augustine, Sruthy M.; Mucenieks, Sophie; Nystedt, Bjorn; Giraldez, Antonio J.; Schroth, Gary P.; Andersson, Olov; Stainier, Didier Y. R.			Cloche is a bHLH-PAS transcription factor that drives haemato-vascular specification	NATURE			English	Article							ZEBRAFISH GENE CLOCHE; RNA-SEQ; HEMOGENIC ENDOTHELIUM; RIBOSOMAL-RNA; DIFFERENTIATION; BLOOD; SCL; IDENTIFICATION; PROGENITOR; ACTS	Vascular and haematopoietic cells organize into specialized tissues during early embryogenesis to supply essential nutrients to all organs and thus play critical roles in development and disease. At the top of the haemato-vascular specification cascade lies cloche, a gene that when mutated in zebrafish leads to the striking phenotype of loss of most endothelial and haematopoietic cells(1-4) and a significant increase in cardiomyocyte numbers(5). Although this mutant has been analysed extensively to investigate mesoderm diversification and differentiation(1-7) and continues to be broadly used as a unique avascular model, the isolation of the cloche gene has been challenging due to its telomeric location. Here we used a deletion allele of cloche to identify several new cloche candidate genes within this genomic region, and systematically genome-edited each candidate. Through this comprehensive interrogation, we succeeded in isolating the cloche gene and discovered that it encodes a PAS-domain-containing bHLH transcription factor, and that it is expressed in a highly specific spatiotemporal pattern starting during late gastrulation. Gain-of-function experiments show that it can potently induce endothelial gene expression. Epistasis experiments reveal that it functions upstream of etv2 and tal1, the earliest expressed endothelial and haematopoietic transcription factor genes identified to date. A mammalian cloche orthologue can also rescue blood vessel formation in zebrafish cloche mutants, indicating a highly conserved role in vertebrate vasculogenesis and haematopoiesis. The identification of this master regulator of endothelial and haematopoietic fate enhances our understanding of early mesoderm diversification and may lead to improved protocols for the generation of endothelial and haematopoietic cells in vivo and in vitro.	[Reischauer, Sven; Stone, Oliver A.; Villasenor, Alethia; Chi, Neil; Jin, Suk-Won; Fiddes, Ian; Kuo, Taiyi; Chung, Won-Suk; Salek, Sherveen; Lerrigo, Robert; Alsio, Jessica; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Reischauer, Sven; Stone, Oliver A.; Villasenor, Alethia; Fukuda, Nana; Marass, Michele; Augustine, Sruthy M.; Mucenieks, Sophie; Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, Dept Dev Genet, D-61231 Bad Nauheim, Germany; [Chi, Neil; Witty, Alec] Univ Calif San Diego, Inst Genom Med, Div Cardiol, Dept Med, La Jolla, CA 92037 USA; [Martin, Marcel] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-17121 Solna, Sweden; [Lee, Miler T.; Giraldez, Antonio J.] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA; [Luo, Shujun; Schroth, Gary P.] Illumina, San Diego, CA 92122 USA; [Tworus, Dominika; Andersson, Olov] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Nystedt, Bjorn] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, S-75124 Uppsala, Sweden; [Jin, Suk-Won] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 61005, South Korea; [Jin, Suk-Won] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, New Haven, CT 06511 USA; [Lee, Miler T.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Fiddes, Ian] Univ Calif Santa Cruz, Genom Inst, Santa Cruz, CA 95064 USA; [Fiddes, Ian] Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Kuo, Taiyi] Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA; [Kuo, Taiyi] Columbia Univ Coll Phys & Surg, Berrie Diabet Ctr, 630 W 168th St, New York, NY 10032 USA; [Chung, Won-Suk] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea; [Salek, Sherveen] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21224 USA; [Lerrigo, Robert] Univ Washington, Div Gen Internal Med, Seattle, WA 98104 USA; [Alsio, Jessica] Novartis, CH-4056 Basel, Switzerland; [Luo, Shujun] Personalis, Menlo Pk, CA 94025 USA	University of California System; University of California San Francisco; Max Planck Society; University of California System; University of California San Diego; Stockholm University; Yale University; Illumina; Karolinska Institutet; Uppsala University; Gwangju Institute of Science & Technology (GIST); Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; Columbia University; Columbia University; Korea Advanced Institute of Science & Technology (KAIST); Johns Hopkins University; Johns Hopkins Medicine; University of Washington; University of Washington Seattle	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; Stainier, DYR (corresponding author), Max Planck Inst Heart & Lung Res, Dept Dev Genet, D-61231 Bad Nauheim, Germany.	didier.stainier@mpi-bn.mpg.de	Augustine, Sruthy Maria/R-2147-2019; Reischauer, Sven/AAO-8900-2020; Chung, Won-Suk/B-9011-2016; Stone, Oliver/O-2439-2018	Chung, Won-Suk/0000-0003-1060-9007; Stone, Oliver/0000-0002-4695-4569; Reischauer, Sven/0000-0002-6955-9481; Martin, Marcel/0000-0002-0680-200X; Stainier, Didier/0000-0002-0382-0026; Nystedt, Bjorn/0000-0001-7809-7664; Andersson, Olov/0000-0001-6715-781X; Giraldez, Antonio/0000-0002-6823-137X; Kuo, Taiyi/0000-0001-6167-0284	DFG; AHA; NIH; Ragnar Soderberg Foundation; Swedish Research Council; Packard Foundation; Max Planck Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragnar Soderberg Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Packard Foundation(The David & Lucile Packard Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank all laboratory members who have worked on cloche over the years starting with W. Liao and H. Sawyer (UCSF), as well as J. Collins (Sanger Institute) for help in expanding the GRCz10 assembly, W. Coppieters (Liege), Z. Wang (JGI). X. Chen (BGI), H. Yuan (BGI) for their hard work in trying to resolve the cloche locus, C. Helker, M. Higuchi and C. Gerri for reagents, discussions and reading of the manuscript, A. Borchers (Marburg) for help with Xenopus experiments, and funding from the DFG (S.R.), AHA (S.R., S.-W.J., N.C.), NIH (N.C., A.J.G., D.Y.R.S.), the Ragnar Soderberg Foundation and Swedish Research Council (O.A.), and the Packard Foundation and Max Planck Society (D.Y.R.S.).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; Endoh M, 2002, EMBO J, V21, P6700, DOI 10.1093/emboj/cdf674; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Garrison E., 2012, PREPRINT; Han Y, 2010, STEM CELLS, V28, P799, DOI 10.1002/stem.316; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hirschi KK, 2012, BLOOD, V119, P4823, DOI 10.1182/blood-2011-12-353466; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lacaud G, 2001, ANN NY ACAD SCI, V938, P96; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H., 2013, PREPRINT, DOI DOI 10.48550/ARXIV.1303.3997; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Liao W, 1997, DEVELOPMENT, V124, P381; Liao W, 2000, DEVELOPMENT, V127, P4303; Lin B, 2012, CARDIOVASC RES, V95, P327, DOI 10.1093/cvr/cvs185; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Parker L, 1999, DEVELOPMENT, V126, P2643; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez-Bergeron DL, 2006, DEV CELL, V11, P81, DOI 10.1016/j.devcel.2006.04.018; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; Smith BW, 2013, BLOOD, V122, P376, DOI 10.1182/blood-2012-11-466722; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617; Zhao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-419	53	93	96	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					294	+		10.1038/nature18614	http://dx.doi.org/10.1038/nature18614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27411634				2022-12-24	WOS:000379912600059
J	Avgousti, DC; Herrmann, C; Kulej, K; Pancholi, NJ; Sekulic, N; Petrescu, J; Molden, RC; Blumenthal, D; Paris, AJ; Reyes, ED; Ostapchuk, P; Hearing, P; Seeholzer, SH; Worthen, GS; Black, BE; Garcia, BA; Weitzman, MD				Avgousti, Daphne C.; Herrmann, Christin; Kulej, Katarzyna; Pancholi, Neha J.; Sekulic, Nikolina; Petrescu, Joana; Molden, Rosalynn C.; Blumenthal, Daniel; Paris, Andrew J.; Reyes, Emigdio D.; Ostapchuk, Philomena; Hearing, Patrick; Seeholzer, Steven H.; Worthen, G. Scott; Black, Ben E.; Garcia, Benjamin A.; Weitzman, Matthew D.			A core viral protein binds host nucleosomes to sequester immune danger signals	NATURE			English	Article							TEMPLATE-ACTIVATING FACTOR; CENP-A NUCLEOSOMES; ACUTE LUNG INJURY; ADENOVIRUS CHROMATIN; MASS-SPECTROMETRY; VIRUS-INFECTION; DNA; MOBILITY; CELLS; HMGB1	Viral proteins mimic host protein structure and function to redirect cellular processes and subvert innate defenses(1). Small basic proteins compact and regulate both viral and cellular DNA genomes. Nucleosomes are the repeating units of cellular chromatin and play an important part in innate immune responses(2). Viralen-coded core basic proteins compact viral genomes, but their impact on host chromatin structure and function remains unexplored. Adenoviruses encode a highly basic protein called protein VII that resembles cellular histones(3). Although protein VII binds viral DNA and is incorporated with viral genomes into virus particles(4,5), it is unknown whether protein VII affects cellular chromatin. Here we show that protein VII alters cellular chromatin, leading us to hypothesize that this has an impact on antiviral responses during adenovirus infection in human cells. We find that protein VII forms complexes with nucleosomes and limits DNA accessibility. We identified post-translational modifications on protein VII that are responsible for chromatin localization. Furthermore, proteomic analysis demonstrated that protein VII is sufficient to alter the protein composition of host chromatin. We found that protein VII is necessary and sufficient for retention in the chromatin of members of the high-mobility-group protein B family (HMGB1, HMGB2 and HMGB3). HMGB1 is actively released in response to inflammatory stimuli and functions as a danger signal to activate immune responses(6,7). We showed that protein VII can directly bind HMGB1 in vitro and further demonstrated that protein VII expression in mouse lungs is sufficient to decrease inflammation-induced HMGB1 content and neutrophil recruitment in the bronchoalveolar lavage fluid. Together, our in vitro and in vivo results show that protein VII sequesters HMGB1 and can prevent its release. This study uncovers a viral strategy in which nucleosome binding is exploited to control extracellular immune signalling.	[Avgousti, Daphne C.; Kulej, Katarzyna; Reyes, Emigdio D.; Weitzman, Matthew D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Avgousti, Daphne C.; Herrmann, Christin; Kulej, Katarzyna; Pancholi, Neha J.; Petrescu, Joana; Reyes, Emigdio D.; Weitzman, Matthew D.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Canc Pathobiol, Philadelphia, PA 19104 USA; [Herrmann, Christin; Pancholi, Neha J.] Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Sekulic, Nikolina; Black, Ben E.; Garcia, Benjamin A.] Univ Penn, Dept Biochem Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sekulic, Nikolina; Molden, Rosalynn C.; Black, Ben E.; Garcia, Benjamin A.] Univ Penn, Epigenet Program, Perelman Sch Med, Philadelphia, PA 19104 USA; [Petrescu, Joana] Villanova Univ, Villanova, PA 19085 USA; [Blumenthal, Daniel] Childrens Hosp Philadelphia, Div Cell Pathol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Paris, Andrew J.] Hosp Univ Penn, Div Pulm Allergy & Crit Care Med, 3400 Spruce St, Philadelphia, PA 19104 USA; [Paris, Andrew J.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ostapchuk, Philomena; Hearing, Patrick] SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Seeholzer, Steven H.] Childrens Hosp Philadelphia, Prot & Prote Core, Philadelphia, PA 19104 USA; [Worthen, G. Scott] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Worthen, G. Scott] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sekulic, Nikolina] Univ Oslo, Biotechnol Ctr Oslo, N-0316 Oslo, Norway; [Sekulic, Nikolina] Univ Oslo, Dept Chem, N-0316 Oslo, Norway	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Villanova University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Oslo; University of Oslo	Weitzman, MD (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; Weitzman, MD (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Canc Pathobiol, Philadelphia, PA 19104 USA.	weitzmanm@email.chop.edu	Sekulic, Nikolina/N-5550-2016	Sekulic, Nikolina/0000-0001-7555-3222; Blumenthal, Daniel/0000-0002-9207-5848; Petrescu, Joana/0000-0002-5436-7639; Paris, Andrew/0000-0002-9808-071X; Herrmann, Christin/0000-0003-4885-1384	American Cancer Society; National Institutes of Health [CA097093, AI102577, CA122677, AI118891, GM110174, GM082989]; Institute for Immunology of the University of Pennsylvania; Children's Hospital of Philadelphia;  [T32 CA115299];  [F32 GM112414];  [T32 NS007180]; NATIONAL CANCER INSTITUTE [T32CA115299, R01CA122677, R01CA097093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891, R01AI099479, R21AI102577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082989, F32GM112414, R01GM110174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007180] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Immunology of the University of Pennsylvania; Children's Hospital of Philadelphia; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Weitzman laboratory for insightful discussions and input, especially R. Dilley and B. Simpson for generating reagents. We also thank R. Panetierri and C. Koziol-White for providing precision-cut lung slices. We are grateful to D. Curiel for sharing recombinant protein-VII-GFP vectors and L. Gerace for anti-protein-VII antibodies. We thank the Penn Vector Core for assistance in purifying recombinant vectors, the Penn CDB Microscopy Core for imaging and FRAP assistance, and the CHOP Pathology core for immunostaining of mouse lungs. We thank members of the Black, Garcia and Worthen laboratories for technical help. We thank C. Bassing, I. Brodsky, J. Henao-Mejia, R. Kohli, C. Lopez, A. Resnick, S. Shin, K. Spindler and J. Weitzman for advice and critical reading of the manuscript. D.C.A. was supported in part by T32 CA115299 and F32 GM112414. N.J.P. was supported in part by T32 NS007180. N.S. was supported in part by funding from the American Cancer Society. Research was supported by grants from the National Institutes of Health (CA097093 to M.D.W., AI102577 and CA122677 to P.H., AI118891 and GM110174 to B.A.G., and GM082989 to B.E.B.), the Institute for Immunology of the University of Pennsylvania, and funds from the Children's Hospital of Philadelphia (M.D.W.).	Blumenthal D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11655; CHATTERJEE PK, 1986, EMBO J, V5, P1633, DOI 10.1002/j.1460-2075.1986.tb04406.x; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Das S, 2013, JOVE-J VIS EXP, DOI 10.3791/50318; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Falk SJ, 2015, SCIENCE, V348, P699, DOI 10.1126/science.1259308; FEDOR MJ, 1980, J VIROL, V35, P637, DOI 10.1128/JVI.35.3.637-643.1980; Ferrari R, 2014, CELL HOST MICROBE, V16, P663, DOI 10.1016/j.chom.2014.10.004; Ferrari R, 2009, NAT REV GENET, V10, P290, DOI 10.1038/nrg2539; Gyurcsik B, 2006, BIOCHEMISTRY-US, V45, P303, DOI 10.1021/bi051248+; Haruki H, 2006, J VIROL, V80, P794, DOI 10.1128/JVI.80.2.794-801.2006; Hasson D, 2013, NAT STRUCT MOL BIOL, V20, P687, DOI 10.1038/nsmb.2562; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; Johnson JS, 2004, J VIROL, V78, P6459, DOI 10.1128/JVI.78.12.6459-6468.2004; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Karen KA, 2011, J VIROL, V85, P4135, DOI 10.1128/JVI.02540-10; Khandelia P, 2011, P NATL ACAD SCI USA, V108, P12799, DOI 10.1073/pnas.1103532108; Knipe DM, 2013, VIROLOGY, V435, P141, DOI 10.1016/j.virol.2012.09.023; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kozarsky KF, 1996, NAT GENET, V13, P54, DOI 10.1038/ng0596-54; Koziol-White CJ, 2011, EXPERT REV RESP MED, V5, P767, DOI [10.1586/ERS.11.77, 10.1586/ers.11.77]; Kulej K, 2015, METHODS, V90, P8, DOI 10.1016/j.ymeth.2015.06.008; Le LP, 2006, VIROLOGY, V351, P291, DOI 10.1016/j.virol.2006.03.042; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; LISCHWE MA, 1977, NATURE, V267, P552, DOI 10.1038/267552a0; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; Orazio NI, 2011, J VIROL, V85, P1887, DOI 10.1128/JVI.02134-10; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; REICH NC, 1983, VIROLOGY, V128, P480, DOI 10.1016/0042-6822(83)90274-X; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Sapojnikova N, 2005, BBA-GENE STRUCT EXPR, V1729, P57, DOI 10.1016/j.bbaexp.2005.03.002; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Teves SS, 2012, METHODS MOL BIOL, V833, P421, DOI 10.1007/978-1-61779-477-3_25; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; VAYDA ME, 1983, NUCLEIC ACIDS RES, V11, P441, DOI 10.1093/nar/11.2.441; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; White AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19122; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zaret K., 2005, CURR PROTOC MOL BIOL, V21, P21, DOI 10.1002/0471142727.mb2101s69	51	82	86	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					173	+		10.1038/nature18317	http://dx.doi.org/10.1038/nature18317			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362237	Green Accepted			2022-12-24	WOS:000379015600047
J	Gulliford, MC; Moore, MV; Little, P; Hay, AD; Fox, R; Prevost, AT; Juszczyk, D; Charlton, J; Ashworth, M				Gulliford, Martin C.; Moore, Michael V.; Little, Paul; Hay, Alastair D.; Fox, Robin; Prevost, A. Toby; Juszczyk, Dorota; Charlton, Judith; Ashworth, Mark			Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLUSTER RANDOMIZED-TRIAL; SORE THROAT; COMPLICATIONS; STRATEGIES; PNEUMONIA; ILLNESS; RATES	OBJECTIVE To determine whether the incidence of pneumonia, peritonsillar abscess, mastoiditis, empyema, meningitis, intracranial abscess, and Lemierre's syndrome is higher in general practices that prescribe fewer antibiotics for self limiting respiratory tract infections (RTIs). DESIGN Cohort study. SETTING 610 UK general practices from the UK Clinical Practice Research Datalink. PARTICIPANTS Registered patients with 45.5 million person years of follow-up from 2005 to 2014. EXPOSURES Standardised proportion of RTI consultations with antibiotics prescribed for each general practice, and rate of antibiotic prescriptions for RTIs per 1000 registered patients. MAIN OUTCOME MEASURES Incidence of pneumonia, peritonsillar abscess, mastoiditis, empyema, meningitis, intracranial abscess, and Lemierre's syndrome, adjusting for age group, sex, region, deprivation fifth, RTI consultation rate, and general practice. Results From 2005 to 2014 the proportion of RTI consultations with antibiotics prescribed decreased from 53.9% to 50.5% in men and from 54.5% to 51.5% in women. From 2005 to 2014, new episodes of meningitis, mastoiditis, and peritonsillar abscess decreased annually by 5.3%, 4.6%, and 1.0%, respectively, whereas new episodes of pneumonia increased by 0.4%. Age and sex standardised incidences for pneumonia and peritonsillar abscess were higher for practices in the lowest fourth of antibiotic prescribing compared with the highest fourth. The adjusted relative risk increases for a 10% reduction in antibiotic prescribing were 12.8% (95% confidence interval 7.8% to 17.5%, P<0.001) for pneumonia and 9.9% (5.6% to 14.0%, P<0.001) for peritonsillar abscess. If a general practice with an average list size of 7000 patients reduces the proportion of RTI consultations with antibiotics prescribed by 10%, then it might observe 1.1 (95% confidence interval 0.6 to 1.5) more cases of pneumonia each year and 0.9 (0.5 to 1.3) more cases of peritonsillar abscess each decade. Mastoiditis, empyema, meningitis, intracranial abscess, and Lemierre's syndrome were similar in frequency at low prescribing and high prescribing practices. Conclusions General practices that adopt a policy to reduce antibiotic prescribing for RTIs might expect a slight increase in the incidence of treatable pneumonia and peritonsillar abscess. No increase is likely in mastoiditis, empyema, bacterial meningitis, intracranial abscess, or Lemierre's syndrome. Even a substantial reduction in antibiotic prescribing was predicted to be associated with only a small increase in numbers of cases observed overall, but caution might be required in subgroups at higher risk of pneumonia.	[Gulliford, Martin C.; Prevost, A. Toby; Juszczyk, Dorota; Charlton, Judith; Ashworth, Mark] Kings Coll London, Dept Primary Care & Publ Hlth Sci, Guys Campus, London SE1 1UL, England; [Moore, Michael V.; Little, Paul] Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton, Hants, England; [Hay, Alastair D.] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England; [Fox, Robin] Ctr Hlth, Oxford, England	University of London; King's College London; University of Southampton; University of Bristol	Gulliford, MC (corresponding author), Kings Coll London, Dept Primary Care & Publ Hlth Sci, Guys Campus, London SE1 1UL, England.	martin.gulliford@kcl.ac.uk	Hay, Alastair/L-1818-2019; Moore, Michael/C-3447-2011; Gulliford, Martin C/I-8606-2018	Moore, Michael/0000-0002-5127-4509; Gulliford, Martin C/0000-0003-1898-9075; Ashworth, Mark/0000-0001-6514-9904; Hay, Alastair/0000-0003-3012-375X; Juszczyk, Dorota/0000-0003-2187-8085; Prevost, A. Toby/0000-0003-1723-0796; Little, Paul/0000-0003-3664-1873	UK National Institute for Health Research Health Technology Assessment programme initiative on antimicrobial drug resistance; National Institute of Health Research (NIHR) Biomedical Research Centre at Guy's Hospital; National Institute of Health Research (NIHR) Biomedical Research Centre at St Thomas' Hospital; National Institute for Health Research [RP-PG-0608-10018, CDF-2009-02-10, NIHR-RP-02-12-012] Funding Source: researchfish	UK National Institute for Health Research Health Technology Assessment programme initiative on antimicrobial drug resistance; National Institute of Health Research (NIHR) Biomedical Research Centre at Guy's Hospital; National Institute of Health Research (NIHR) Biomedical Research Centre at St Thomas' Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	The research was supported by the UK National Institute for Health Research Health Technology Assessment programme initiative on antimicrobial drug resistance. The funders did not engage in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, and approval of the manuscript. MCG and ATP were also supported by the National Institute of Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' Hospitals. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health. This study is based in part on data from the Clinical Practice Research Datalink obtained under licence from the UK Medicines and Healthcare products Regulatory Agency. However, the interpretation and conclusions contained in this report are those of the authors alone.	Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; Ashworth M, 2004, J PUBLIC HEALTH-UK, V26, P268, DOI 10.1093/pubmed/fdh160; Bjork H, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0975-z; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Centor RM, 2015, ANN INTERN MED, V162, P241, DOI 10.7326/M14-1305; Chief Medical Officer, 2001, UNUSUAL DISEASE DIAG; Chief Medical Officer, 2011, ANNUAL REPORT OF THE, V2; Coxeter P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010907.pub2; Gonzales R, 2013, JAMA INTERN MED, V173, P267, DOI 10.1001/jamainternmed.2013.1589; Gordon M, 2016, ADVANCED FOREST PLOT; Gulliford M, 2009, J PUBLIC HEALTH-UK, V31, P512, DOI 10.1093/pubmed/fdp081; Gulliford MC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006245; Gulliford MC, 2014, ANN FAM MED, V12, P344, DOI 10.1370/afm.1659; Health and Social Care Information Centre, 2016, NHS UK READ CODES CL; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Howie J G, 1971, J R Coll Gen Pract, V21, P657; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Little P, 1997, BRIT MED J, V315, P350; Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5806; Little P, 2014, LANCET INFECT DIS, V14, P213, DOI 10.1016/S1473-3099(13)70294-9; Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6867; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Lucas PJ, 2015, SCAND J PRIM HEALTH, V33, P11, DOI 10.3109/02813432.2015.1001942; Maes N., 2015, DAILY MAIL; National Institute for Health and Care Excellence, 2008, PRESCRIBING OF ANTIB; Okike IO, 2014, LANCET INFECT DIS, V14, P301, DOI 10.1016/S1473-3099(13)70332-3; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Quan TP, 2016, THORAX, V71, P535, DOI 10.1136/thoraxjnl-2015-207688; R Core Team, 2021, R LANG ENV STAT COMP; Ronnegard L, 2010, R J, V2, P20; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; SINAVE CP, 1989, MEDICINE, V68, P85, DOI 10.1097/00005792-198903000-00002; Spinks Anneliese, 2013, Cochrane Database Syst Rev, pCD000023, DOI 10.1002/14651858.CD000023.pub4; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub3; Stocks N, 2002, FAM PRACT, V19, P375, DOI 10.1093/fampra/19.4.375; Trotter CL, 2008, EMERG INFECT DIS, V14, P727, DOI 10.3201/eid1405.071011; van den Broek d'Obrenan J, 2014, J ANTIMICROB CHEMOTH, V69, P1701, DOI 10.1093/jac/dku005; Van den Bruel A, 2016, ARCH DIS CHILD, V101, P382, DOI 10.1136/archdischild-2015-309228; Venekamp RP, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000219.pub4, 10.1002/14651858.CD000219.pub3]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	42	84	83	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2016	354								i3410	10.1136/bmj.i3410	http://dx.doi.org/10.1136/bmj.i3410			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EA	27378578	hybrid, Green Published			2022-12-24	WOS:000379579600001
J	Weimerskirch, H; Bishop, C; Jeanniard-du-Dot, T; Prudor, A; Sachs, G				Weimerskirch, Henri; Bishop, Charles; Jeanniard-du-Dot, Tiphaine; Prudor, Aurelien; Sachs, Gottfried			Frigate birds track atmospheric conditions over months-long transoceanic flights	SCIENCE			English	Article							STRATEGY	Understanding how animals respond to atmospheric conditions across space is critical for understanding the evolution of flight strategies and long-distance migrations. We studied the three-dimensional movements and energetics of great frigate birds (Fregata minor) and showed that they can stay aloft for months during transoceanic flights. To do this, birds track the edge of the doldrums to take advantage of favorable winds and strong convection. Locally, they use a roller-coaster flight, relying on thermals and wind to soar within a 50- to 600-meter altitude band under cumulus clouds and then glide over kilometers at low energy costs. To deal with the local scarcity of clouds and gain longer gliding distances, birds regularly soar inside cumulus clouds to use their strong updraft, and they can reach altitudes of 4000 meters, where freezing conditions occur.	[Weimerskirch, Henri; Prudor, Aurelien] CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France; [Weimerskirch, Henri; Prudor, Aurelien] Univ Reunion, UMR ENTROPIE 9220, St Denis, Reunion, France; [Bishop, Charles] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Jeanniard-du-Dot, Tiphaine] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Sachs, Gottfried] Tech Univ Munich, Inst Flight Syst Dynam, Garching, Germany	Centre National de la Recherche Scientifique (CNRS); University of La Reunion; Bangor University; University of British Columbia; Technical University of Munich	Weimerskirch, H (corresponding author), CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France.; Weimerskirch, H (corresponding author), Univ Reunion, UMR ENTROPIE 9220, St Denis, Reunion, France.	henriw@cebc.cnrs.fr	Weimerskirch, Henri/F-5562-2013; Jeanniard, Tiphaine/ABF-8836-2020; Weimerskirch, Henri/K-7306-2019	Jeanniard, Tiphaine/0000-0003-1985-8325; Weimerskirch, Henri/0000-0002-0457-586X	European Research Council under the European Community [ERC-2012-ADG_20120314]	European Research Council under the European Community(European Research Council (ERC))	The tracking data presented in the paper are available from the Dryad Digital Repository. We thank the Forces Armees de la Zone Sud de l'Ocean Indien for transport and logistical support on Europa Island and the TAAF Administration for allowing us to work on Europa Island. We thank the fieldworkers involved in the study on Europa, in particular J. B. Pons and R. Weimerskirch; R. Spivey for help with preparing the electrocardiogram and acceleration tags and for the data processing of the heart rate recording; and A. Corbeau for help with data analyses. The study is a contribution to the Program EARLYLIFE funded by a European Research Council Advanced Grant under the European Community's Seven Framework Program FP7/2007-2013 (grant agreement ERC-2012-ADG_20120314 to H.W.). We thank Y. Ropert-Coudert, Y. Cherel, and two anonymous reviewers for helpful comments on earlier versions of the manuscript.	Alerstam T., 1990, P331; Alerstam T, 1993, BIRD MIGRATION; Bishop CM, 2015, SCIENCE, V347, P250, DOI 10.1126/science.1258732; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Jonker HJJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032606; Kranstauber B, 2015, ECOL LETT, V18, P1338, DOI 10.1111/ele.12528; Laing A., 2011, INTRO TROPICAL METEO, V2nd; Lesku JA, 2012, SCIENCE, V337, P1654, DOI 10.1126/science.1220939; Liechti F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3554; MALKUS JS, 1954, J METEOROL, V11, P220; Mohanty U. C, 2014, MONITORING PREDICTIO; Nair US, 1998, J GEOPHYS RES-ATMOS, V103, P11363, DOI 10.1029/98JD00088; NELSON J B, 1975, Living Bird, V14, P113; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PENNYCUICK CJ, 1983, J EXP BIOL, V102, P307; Rattenborg NC, 2006, NATURWISSENSCHAFTEN, V93, P413, DOI 10.1007/s00114-006-0120-3; Rayner J.M.V., 1990, P283; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weimerskirch H, 2004, MAR ECOL PROG SER, V275, P297, DOI 10.3354/meps275297; Weimerskirch H, 2003, NATURE, V421, P333, DOI 10.1038/421333a; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270	23	79	83	20	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					74	78		10.1126/science.aaf4374	http://dx.doi.org/10.1126/science.aaf4374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365448	Green Submitted			2022-12-24	WOS:000378816200039
J	Bagnall, RD; Weintraub, RG; Ingles, J; Duflou, J; Yeates, L; Lam, L; Davis, AM; Thompson, T; Connell, V; Wallace, J; Naylor, C; Crawford, J; Love, DR; Hallam, L; White, J; Lawrence, C; Lynch, M; Morgan, N; James, P; du Sart, D; Puranik, R; Langlois, N; Vohra, J; Winship, I; Atherton, J; McGaughran, J; Skinner, JR; Semsarian, C				Bagnall, R. D.; Weintraub, R. G.; Ingles, J.; Duflou, J.; Yeates, L.; Lam, L.; Davis, A. M.; Thompson, T.; Connell, V.; Wallace, J.; Naylor, C.; Crawford, J.; Love, D. R.; Hallam, L.; White, J.; Lawrence, C.; Lynch, M.; Morgan, N.; James, P.; du Sart, D.; Puranik, R.; Langlois, N.; Vohra, J.; Winship, I.; Atherton, J.; McGaughran, J.; Skinner, J. R.; Semsarian, C.			A Prospective Study of Sudden Cardiac Death among Children and Young Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNEXPLAINED DEATH; MOLECULAR AUTOPSY; LONG-QT; SURVIVING RELATIVES; UNEXPECTED DEATH; CHANNELOPATHIES; PREVALENCE; PREVENTION; ETIOLOGY; DISEASE	BACKGROUND Sudden cardiac death among children and young adults is a devastating event. We performed a prospective, population-based, clinical and genetic study of sudden cardiac death among children and young adults. METHODS We prospectively collected clinical, demographic, and autopsy information on all cases of sudden cardiac death among children and young adults 1 to 35 years of age in Australia and New Zealand from 2010 through 2012. In cases that had no cause identified after a comprehensive autopsy that included toxicologic and histologic studies (unexplained sudden cardiac death), at least 59 cardiac genes were analyzed for a clinically relevant cardiac gene mutation. RESULTS A total of 490 cases of sudden cardiac death were identified. The annual incidence was 1.3 cases per 100,000 persons 1 to 35 years of age; 72% of the cases involved boys or young men. Persons 31 to 35 years of age had the highest incidence of sudden cardiac death (3.2 cases per 100,000 persons per year), and persons 16 to 20 years of age had the highest incidence of unexplained sudden cardiac death (0.8 cases per 100,000 persons per year). The most common explained causes of sudden cardiac death were coronary artery disease (24% of cases) and inherited cardiomyopathies (16% of cases). Unexplained sudden cardiac death (40% of cases) was the predominant finding among persons in all age groups, except for those 31 to 35 years of age, for whom coronary artery disease was the most common finding. Younger age and death at night were independently associated with unexplained sudden cardiac death as compared with explained sudden cardiac death. A clinically relevant cardiac gene mutation was identified in 31 of 113 cases (27%) of unexplained sudden cardiac death in which genetic testing was performed. During follow-up, a clinical diagnosis of an inherited cardiovascular disease was identified in 13% of the families in which an unexplained sudden cardiac death occurred. CONCLUSIONS The addition of genetic testing to autopsy investigation substantially increased the identification of a possible cause of sudden cardiac death among children and young adults.	[Bagnall, R. D.; Ingles, J.; Yeates, L.; Lam, L.; Semsarian, C.] Univ Sydney, Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Locked Bag 6, Newtown, NSW 2042, Australia; [Bagnall, R. D.; Ingles, J.; Duflou, J.; Puranik, R.; Semsarian, C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Duflou, J.] Royal Prince Alfred Hosp, Dept Forens Med, NSW Hlth Pathol, Sydney, NSW, Australia; [Ingles, J.; Yeates, L.; Puranik, R.; Semsarian, C.] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Weintraub, R. G.; Davis, A. M.; Connell, V.; du Sart, D.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Cardiol, Melbourne, Vic, Australia; [Weintraub, R. G.; Davis, A. M.; Connell, V.; du Sart, D.] Univ Melbourne, Melbourne, Vic, Australia; [Davis, A. M.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [James, P.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Thompson, T.; James, P.; Vohra, J.; Winship, I.] Univ Melbourne, Royal Melbourne Hosp, Genet Med, Melbourne, Vic, Australia; [Vohra, J.; Winship, I.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Lynch, M.; Morgan, N.] Victorian Inst Forens Med, Melbourne, Vic, Australia; [Wallace, J.; Naylor, C.] Forens & Sci Serv, Archerlield, QL, Australia; [Naylor, C.; White, J.] Univ Queensland, Brisbane, Qld, Australia; [Atherton, J.; McGaughran, J.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; PathWest, Dept Forens Pathol, Fremantle, WA, Australia; [Hallam, L.] Canberra Hosp, ACT Pathol, Canberra, ACT, Australia; [Lawrence, C.] Univ Tasmania, Royal Hobart Hosp, Hobart, Tas, Australia; [Langlois, N.] Univ Adelaide, Attorney Gen Dept, Adelaide, SA, Australia; [Crawford, J.; Skinner, J. R.] Starship Childrens Hosp, Green Lane Pediat & Congenital Cardiac Serv, Auckland, New Zealand; [Love, D. R.] Auckland City Hosp, LabPLUS, Auckland, New Zealand; [Skinner, J. R.] Univ Auckland, Dept Child Hlth, Auckland 1, New Zealand	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; University of Sydney; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Queensland; Royal Brisbane & Women's Hospital; University of Western Australia; Australian National University; Canberra Hospital; Royal Hobart Hospital; University of Tasmania; University of Adelaide; Starship Children's Hospital; Auckland City Hospital; University of Auckland	Semsarian, C (corresponding author), Univ Sydney, Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Locked Bag 6, Newtown, NSW 2042, Australia.	c.semsarian@centenary.org.au	Ingles, Jodie/J-3113-2019; McGaughran, Julie/A-2563-2012; Atherton, John J/B-9994-2011; Winship, Ingrid M/D-7204-2016; Duflou, Johan/AAK-2331-2020	Ingles, Jodie/0000-0002-4846-7676; Atherton, John J/0000-0003-2271-578X; James, Paul/0000-0002-4361-4657; Winship, Ingrid/0000-0001-8535-6003; Skinner, Jonathan Robert/0000-0002-3653-0412; Duflou, Johan/0000-0001-5863-635X; Love, Donald/0000-0003-4669-8769; Davis, Andrew/0000-0003-2826-8562; McGaughran, Julie/0000-0002-0926-7858; Bagnall, Richard/0000-0002-2476-9864	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funded by the National Health and Medical Research Council of Australia and others.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; Adabag AS, 2010, AM HEART J, V159, P33, DOI 10.1016/j.ahj.2009.10.019; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Bagnall RD, 2014, HEART RHYTHM, V11, P655, DOI 10.1016/j.hrthm.2014.01.017; Bagnall RD, 2010, INT J CARDIOL, V145, P150, DOI 10.1016/j.ijcard.2009.07.009; Behr ER, 2008, EUR HEART J, V29, P1670, DOI 10.1093/eurheartj/ehn219; Corrado D, 2003, CIRCULATION, V108, P3084, DOI 10.1161/01.CIR.0000103130.33451.D2; Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1; de Noronha SV, 2009, HEART, V95, P1409, DOI 10.1136/hrt.2009.168369; Doolan A, 2004, MED J AUSTRALIA, V180, P110, DOI 10.5694/j.1326-5377.2004.tb05830.x; Eckart RE, 2011, J AM COLL CARDIOL, V58, P1254, DOI 10.1016/j.jacc.2011.01.049; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Kumar S, 2013, HEART RHYTHM, V10, P1653, DOI 10.1016/j.hrthm.2013.08.022; Maron BJ, 2007, JAMA-J AM MED ASSOC, V298, P405, DOI 10.1001/jama.298.4.405; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Mellor G, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1078, DOI 10.1161/CIRCEP.114.001854; Napolitano C, 2012, CIRCULATION, V125, P2027, DOI 10.1161/CIRCULATIONAHA.111.055947; Papadakis M, 2013, CIRC-ARRHYTHMIA ELEC, V6, P588, DOI 10.1161/CIRCEP.113.000111; Papadakis M, 2009, EUROPACE, V11, P1353, DOI 10.1093/europace/eup229; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Puranik R, 2005, HEART RHYTHM, V2, P1277, DOI 10.1016/j.hrthm.2005.09.008; Semsarian C, 2015, EUR HEART J, V36, P1290, DOI 10.1093/eurheartj/ehv063; Semsarian C, 2012, HEART RHYTHM, V9, P145, DOI 10.1016/j.hrthm.2011.07.034; Skinner JR, 2008, MED J AUSTRALIA, V189, P539, DOI 10.5694/j.1326-5377.2008.tb02173.x; Skinner JR, 2011, HEART RHYTHM, V8, P412, DOI 10.1016/j.hrthm.2010.11.016; Sweeting J, 2014, PAEDIATR RESPIR REV, V15, P301, DOI 10.1016/j.prrv.2014.09.006; Tan HL, 2005, CIRCULATION, V112, P207, DOI 10.1161/CIRCULATIONAHA.104.522581; Tester DJ, 2007, J AM COLL CARDIOL, V49, P240, DOI 10.1016/j.jacc.2006.10.010; Tester DJ, 2005, CARDIOVASC RES, V67, P388, DOI 10.1016/j.cardiores.2005.02.013; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Tu E, 2011, BRAIN PATHOL, V21, P201, DOI 10.1111/j.1750-3639.2010.00438.x; van Rijsingen IAW, 2012, J AM COLL CARDIOL, V59, P493, DOI 10.1016/j.jacc.2011.08.078; Wilde AAM, 2013, NAT REV CARDIOL, V10, P571, DOI 10.1038/nrcardio.2013.108; Winkel BG, 2012, J CARDIOVASC ELECTR, V23, P1092, DOI 10.1111/j.1540-8167.2012.02371.x; Winkel BG, 2011, EUR HEART J, V32, P983, DOI 10.1093/eurheartj/ehq428	36	423	434	6	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2441	2452		10.1056/NEJMoa1510687	http://dx.doi.org/10.1056/NEJMoa1510687			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1TG	27332903	Bronze			2022-12-24	WOS:000378271700008
J	Genel, M; Simpson, JL; de la Chapelle, A				Genel, Myron; Simpson, Joe Leigh; de la Chapelle, Albert			The Olympic Games and Athletic Sex Assignment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENDER VERIFICATION; SPORTS		[Genel, Myron] Yale Univ, Sch Med, Dept Pediat, Yale Child Hlth Res Ctr, POB 208081, New Haven, CT 06520 USA; [Simpson, Joe Leigh] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Simpson, Joe Leigh] March Dimes Fdn, New York, NY USA; [de la Chapelle, Albert] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA	Yale University; State University System of Florida; Florida International University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Genel, M (corresponding author), Yale Univ, Sch Med, Dept Pediat, Yale Child Hlth Res Ctr, POB 208081, New Haven, CT 06520 USA.	myron.genel@yale.edu						de Hon O, 2015, SPORTS MED, V45, P57, DOI 10.1007/s40279-014-0247-x; DELACHAPELLE A, 1986, JAMA-J AM MED ASSOC, V256, P1920, DOI 10.1001/jama.256.14.1920; DELACHAPELLE A, 1993, P NATL ACAD SCI USA, V90, P4495, DOI 10.1073/pnas.90.10.4495; Ferguson-Smith MA, 2014, SPORTS MED, V44, P1629, DOI 10.1007/s40279-014-0249-8; Genel M, 2005, LANCET, V366, pS41, DOI 10.1016/S0140-6736(05)67843-9; LJUNGQVIST A, 1992, JAMA-J AM MED ASSOC, V267, P850, DOI 10.1001/jama.267.6.850; Rupert JL, 2011, CAN BULL MED HIST, V28, P339, DOI 10.3138/cbmh.28.2.339	7	9	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2016	316	13					1359	1360		10.1001/jama.2016.11850	http://dx.doi.org/10.1001/jama.2016.11850			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX7TC	27490137				2022-12-24	WOS:000384591300013
J	Liu, JY; Ghneim, K; Sok, D; Bosche, WJ; Li, Y; Chipriano, E; Berkemeier, B; Oswald, K; Borducchi, E; Cabral, C; Peter, L; Brinkman, A; Shetty, M; Jimenez, J; Mondesir, J; Lee, B; Giglio, P; Chandrashekar, A; Abbink, P; Colantonio, A; Gittens, C; Baker, C; Wagner, W; Lewis, MG; Li, WJ; Sekaly, RP; Lifson, JD; Burton, DR; Barouch, DH				Liu, Jinyan; Ghneim, Khader; Sok, Devin; Bosche, William J.; Li, Yuan; Chipriano, Elizabeth; Berkemeier, Brian; Oswald, Kelli; Borducchi, Erica; Cabral, Crystal; Peter, Lauren; Brinkman, Amanda; Shetty, Mayuri; Jimenez, Jessica; Mondesir, Jade; Lee, Benjamin; Giglio, Patricia; Chandrashekar, Abishek; Abbink, Peter; Colantonio, Arnaud; Gittens, Courtney; Baker, Chantelle; Wagner, Wendeline; Lewis, Mark G.; Li, Wenjun; Sekaly, Rafick-Pierre; Lifson, Jeffrey D.; Burton, Dennis R.; Barouch, Dan H.			Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus	SCIENCE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; PREDICTING GENE-FUNCTION; CD4(+) T-CELLS; RHESUS-MONKEYS; MONOCLONAL-ANTIBODIES; SIV INFECTION; NEUTRALIZING ANTIBODIES; VAGINAL TRANSMISSION; PASSIVE TRANSFER; IN-VIVO	HIV-1-specific broadly neutralizing antibodies (bNAbs) can protect rhesus monkeys against simian-human immunodeficiency virus (SHIV) challenge. However, the site of antibody interception of virus and the mechanism of antibody-mediated protection remain unclear. We administered a fully protective dose of the bNAb PGT121 to rhesus monkeys and challenged them intravaginally with SHIV-SF162P3. In PGT121-treated animals, we detected low levels of viral RNA and viral DNA in distal tissues for seven days following challenge. Viral RNA-positive tissues showed transcriptomic changes indicative of innate immune activation, and cells from these tissues initiated infection after adoptive transfer into naive hosts. These data demonstrate that bNAb-mediated protection against a mucosal virus challenge can involve clearance of infectious virus in distal tissues.	[Liu, Jinyan; Borducchi, Erica; Cabral, Crystal; Peter, Lauren; Brinkman, Amanda; Shetty, Mayuri; Jimenez, Jessica; Mondesir, Jade; Lee, Benjamin; Giglio, Patricia; Chandrashekar, Abishek; Abbink, Peter; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Ghneim, Khader; Sekaly, Rafick-Pierre] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Sok, Devin; Burton, Dennis R.] Scripps Res Inst, La Jolla, CA 92037 USA; [Bosche, William J.; Li, Yuan; Chipriano, Elizabeth; Berkemeier, Brian; Oswald, Kelli; Lifson, Jeffrey D.] Frederick Natl Lab, AIDS & Canc Virus Program, Leidos Biomed Res, Frederick, MD 21702 USA; [Colantonio, Arnaud] Harvard Med Sch, Boston, MA 02115 USA; [Gittens, Courtney; Baker, Chantelle; Wagner, Wendeline; Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Li, Wenjun] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Burton, Dennis R.; Barouch, Dan H.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Case Western Reserve University; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; BIOQUAL Inc.; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA.	dbarouch@bidmc.harvard.edu	Li, Wenjun/F-5634-2015; Barouch, Dan/Y-3918-2019; Chandrashekar, Abishek/P-2610-2019	Li, Wenjun/0000-0001-5335-7386; Chandrashekar, Abishek/0000-0001-7821-5552; Brinkman, Amanda/0000-0002-2845-6494; Peter, Lauren/0000-0002-2105-7503	National Institutes of Health [AI060354, AI095985, AI096040, AI100645, AI100663, AI124377, HHSN261200800001E]; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI124377, U24AI126683, UM1AI100645, U19AI095985, P30AI060354, UM1AI100663, U19AI096040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Schultz, Q. Dang, M. Pensiero, M. Ferguson, F. Stephens, J. Nkolola, K. Smith, J. Smith, S. Blackmore, L. Parenteau, S. Mathew, S. Levin, C. Shaver, and Z. Pippin for generous advice, assistance, and reagents. The SIVmac239 peptides were obtained from the NIH AIDS Research and Reference Reagent Program. The data presented in this paper are tabulated in the main paper and in the supplementary materials. The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to D.H.B. (dbarouch@bidmc.harvard.edu). We acknowledge support from the National Institutes of Health (AI060354, AI095985, AI096040, AI100645, AI100663, AI124377, HHSN261200800001E) and the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard. Transcriptomics data can be accessed at GEO (GSE83702) and the National Center for Biotechnology Information, NIH (17948367).	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barouch DH, 2016, CELL, V165, P656, DOI 10.1016/j.cell.2016.03.021; Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; dos Santos PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019493; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Li HL, 2011, J VIROL, V85, P11007, DOI 10.1128/JVI.05346-11; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Mostafavi S, 2010, BIOINFORMATICS, V26, P1759, DOI 10.1093/bioinformatics/btq262; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373	31	111	111	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2016	353	6303					1045	1049		10.1126/science.aag0491	http://dx.doi.org/10.1126/science.aag0491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9SU	27540005	Green Accepted			2022-12-24	WOS:000382558900043
J	Guo, F; Yu, JW; Jung, HJ; Abruzzi, KC; Luo, WF; Riffith, LCG; Rosbash, M				Guo, Fang; Yu, Junwei; Jung, Hyung Jae; Abruzzi, Katharine C.; Luo, Weifei; Riffith, Leslie C. G.; Rosbash, Michael			Circadian neuron feedback controls the Drosophila sleep-activity profile	NATURE			English	Article							CLOCK NEURONS; PACEMAKER NEURONS; RHYTHMS; GENE; LIGHT; TEMPERATURE; GLUTAMATE; CIRCUITS; MUTATION; OUTPUT	Little is known about the ability of Drosophila circadian neurons to promote sleep. Here we show, using optogenetic manipulation and video recording, that a subset of dorsal clock neurons (DN1s) are potent sleep-promoting cells that release glutamate to directly inhibit key pacemaker neurons. The pacemakers promote morning arousal by activating these DN1s, implying that a late-day feedback circuit drives midday siesta and night-time sleep. To investigate more plastic aspects of the sleep program, we used a calcium assay to monitor and compare the real-time activity of DN1 neurons in freely behaving males and females. Our results revealed that DN1 neurons were more active in males than in females, consistent with the finding that male flies sleep more during the day. DN1 activity is also enhanced by elevated temperature, consistent with the ability of higher temperatures to increase sleep. These new approaches indicate that DN1s have a major effect on the fly sleep-wake profile and integrate environmental information with the circadian molecular program.	[Guo, Fang; Jung, Hyung Jae; Abruzzi, Katharine C.; Luo, Weifei; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; [Guo, Fang; Jung, Hyung Jae; Abruzzi, Katharine C.; Luo, Weifei; Rosbash, Michael] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Guo, Fang; Yu, Junwei; Jung, Hyung Jae; Abruzzi, Katharine C.; Luo, Weifei; Riffith, Leslie C. G.; Rosbash, Michael] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Guo, Fang; Yu, Junwei; Jung, Hyung Jae; Abruzzi, Katharine C.; Luo, Weifei; Riffith, Leslie C. G.; Rosbash, Michael] Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Brandeis University; Brandeis University	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA.; Rosbash, M (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA.; Rosbash, M (corresponding author), Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02454 USA.; Rosbash, M (corresponding author), Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA.	rosbash@brandeis.edu	Yu, Junwei/ABD-8532-2021	Griffith, Leslie/0000-0003-3164-9876	NIH [R01 MH067284]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Diaz, N. Nguyen, R. Spann and K. Kerr for generous help, and X. Gao and L. Luo for sending us LexAop-LUC flies, and O. Shafer and A. Sehgal for helpful discussion and comments on early versions of this manuscript. This work was supported in part by NIH R01 MH067284 (LCG).	Abruzzi K, 2015, METHOD ENZYMOL, V551, P369, DOI 10.1016/bs.mie.2014.10.025; Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Benito J, 2007, COLD SPRING HARB SYM, V72, P437, DOI 10.1101/sqb.2007.72.009; Cao WH, 2015, SLEEP, V38, P41, DOI 10.5665/sleep.4322; Cavanaugh DJ, 2014, CELL, V157, P689, DOI 10.1016/j.cell.2014.02.024; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Collins B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001959; Collins B, 2012, NEURON, V74, P706, DOI 10.1016/j.neuron.2012.02.034; Diao FQ, 2015, CELL REP, V10, P1410, DOI 10.1016/j.celrep.2015.01.059; Donelson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037250; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Flourakis M, 2015, CELL, V162, P836, DOI 10.1016/j.cell.2015.07.036; Gao XJJ, 2015, NAT NEUROSCI, V18, P917, DOI 10.1038/nn.4016; Garbe DS, 2015, BIOL OPEN, V4, P1558, DOI 10.1242/bio.013011; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Guo F, 2014, ELIFE, V3, DOI 10.7554/eLife.02780; Hamasaka Y, 2007, J COMP NEUROL, V505, P32, DOI 10.1002/cne.21471; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; Haynes PR, 2015, ELIFE, V4, DOI 10.7554/eLife.03868; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Inagaki HK, 2014, NAT METHODS, V11, P325, DOI [10.1038/nmeth.2765, 10.1038/NMETH.2765]; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kunst M, 2014, CURR BIOL, V24, P2652, DOI 10.1016/j.cub.2014.09.077; Liang XT, 2016, SCIENCE, V351, P976, DOI 10.1126/science.aad3997; Liu WW, 2013, P NATL ACAD SCI USA, V110, P10294, DOI 10.1073/pnas.1220560110; Low KH, 2008, NEURON, V60, P1054, DOI 10.1016/j.neuron.2008.10.048; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; MOORE RY, 1983, FED PROC, V42, P2783; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Picot M, 2009, J NEUROSCI, V29, P8312, DOI 10.1523/JNEUROSCI.0279-08.2009; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rieger D, 2007, J BIOL RHYTHM, V22, P387, DOI 10.1177/0748730407306198; Seluzicki A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001810; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky Ralf, 2007, Methods Mol Biol, V362, P131; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Tang CHA, 2010, NEURON, V66, P378, DOI 10.1016/j.neuron.2010.04.015; Tataroglu O, 2014, METHODS, V68, P140, DOI 10.1016/j.ymeth.2014.01.001; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yao Z, 2014, SCIENCE, V343, P1516, DOI 10.1126/science.1251285; Yao ZP, 2012, J NEUROPHYSIOL, V108, P684, DOI 10.1152/jn.00110.2012; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	52	165	167	1	98	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					292	+		10.1038/nature19097	http://dx.doi.org/10.1038/nature19097			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27479324	Green Accepted			2022-12-24	WOS:000381804900027
J	Haque, IS; Lazarin, GA; Kang, HP; Evans, EA; Goldberg, JD; Wapner, RJ				Haque, Imran S.; Lazarin, Gabriel A.; Kang, H. Peter; Evans, Eric A.; Goldberg, James D.; Wapner, Ronald J.			Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FRAGILE-X-SYNDROME; MEDICAL-GENETICS; AMERICAN-COLLEGE; VARIANTS; ASSOCIATION; STATEMENT; DIAGNOSIS; GENOMICS	IMPORTANCE Screening for carrier status of a limited number of single-gene conditions is the current standard of prenatal care. Methods have become available allowing rapid expanded carrier screening for a substantial number of conditions. OBJECTIVES To quantify the modeled risk of recessive conditions identifiable by an expanded carrier screening panel in individuals of diverse racial and ethnic backgrounds and to compare the results with those from current screening recommendations. DESIGN, SETTING, AND PARTICIPANTS Retrospective modeling analysis of results between January 1, 2012, and July 15, 2015, from expanded carrier screening in reproductive-aged individuals without known indication for specific genetic testing, primarily from the United States. Tests were offered by clinicians providing reproductive care. EXPOSURES Individuals were tested for carrier status for up to 94 severe or profound conditions. MAIN OUTCOMES AND MEASURES Risk was defined as the probability that a hypothetical fetus created from a random pairing of individuals (within or across 15 self-reported racial/ethnic categories; there were 11 categories with >5000 samples) would be homozygous or compound heterozygous for 2 mutations presumed to cause severe or profound disease. Severe conditions were defined as those that if left untreated cause intellectual disability or a substantially shortened lifespan; profound conditions were those causing both. RESULTS The study included 346 790 individuals. Among major US racial/ethnic categories, the calculated frequency of fetuses potentially affected by a profound or severe condition ranged from 94.5 per 100 000 (95% CI, 82.4-108.3 per 100 000) for Hispanic couples to 392.2 per 100 000 (95% CI, 366.3-420.2 per 100 000) for Ashkenazi Jewish couples. In most racial/ethnic categories, expanded carrier screening modeled more hypothetical fetuses at risk for severe or profound conditions than did screening based on current professional guidelines (Mann-Whitney P < .001). For Northern European couples, the 2 professional guidelines-based screening panels modeled 55.2 hypothetical fetuses affected per 100 000 (95% CI, 51.3-59.3 per 100 000) and the expanded carrier screening modeled 159.2 fetuses per 100 000 (95% CI, 150.4-168.6 per 100 000). Overall, relative to expanded carrier screening, guideline-based screening ranged from identification of 6%(95% CI, 4%-8%) of hypothetical fetuses affected for East Asian couples to 87%(95% CI, 84%-90%) for African or African American couples. CONCLUSIONS AND RELEVANCE In a population of diverse races and ethnicities, expanded carrier screening may increase the detection of carrier status for a variety of potentially serious genetic conditions compared with current recommendations from professional societies. Prospective studies comparing current standard-of-care carrier screening with expanded carrier screening in at-risk populations are warranted before expanded screening is adopted.	[Haque, Imran S.; Lazarin, Gabriel A.; Kang, H. Peter; Evans, Eric A.; Goldberg, James D.] Counsyl, Dept Med Affairs, San Francisco, CA USA; [Haque, Imran S.; Lazarin, Gabriel A.; Kang, H. Peter; Evans, Eric A.; Goldberg, James D.] Counsyl, Dept Res, San Francisco, CA USA; [Wapner, Ronald J.] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, Div Reprod Genet, New York, NY USA	Columbia University	Haque, IS (corresponding author), 180 Kimball Way, San Francisco, CA 94080 USA.	research@counsyl.com		Wapner, Ronald/0000-0003-0727-1244; Lazarin, Gabriel/0000-0001-5061-8595	Counsyl	Counsyl	This study was funded by Counsyl, a laboratory providing expanded carrier screening.	ACOG Committee on Obstetrics, 2007, Obstet Gynecol, V109, P229; [Anonymous], 2010, Obstet Gynecol, V116, P1008, DOI 10.1097/AOG.0b013e3181fae884; Azimi M, 2016, MOL GENET GENOM MED, V4, P292, DOI 10.1002/mgg3.204; Bailey DB, 2009, PEDIATRICS, V124, P527, DOI 10.1542/peds.2008-2992; Chan M, 2011, J MOL DIAGN, V13, P305, DOI 10.1016/j.jmoldx.2010.12.001; Chen LJ, 2010, J MOL DIAGN, V12, P589, DOI 10.2353/jmoldx.2010.090227; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; Edwards JG, 2015, OBSTET GYNECOL, V125, P653, DOI 10.1097/AOG.0000000000000666; Feero WG, 2016, JAMA-J AM MED ASSOC, V315, P33, DOI 10.1001/jama.2015.17702; Grody WW, 2013, GENET MED, V15, P482, DOI 10.1038/gim.2013.47; Grody WW, 2011, GENET MED, V13, P996, DOI 10.1097/GIM.0b013e31823c49a2; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Henneman L, 2016, EUR J HUM GENET, V24, pE1, DOI 10.1038/ejhg.2015.271; Kang HP, 2016, PEERJ, V4, DOI 10.7717/peerj.2162; Lazarin GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114391; Lazarin GA, 2013, GENET MED, V15, P178, DOI 10.1038/gim.2012.114; McConkie-Rosell Allyn, 2005, J Genet Couns, V14, P249, DOI 10.1007/s10897-005-4802-x; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schaefer TL, 2015, APPL CLIN GENET, V8, P75, DOI 10.2147/TACG.S35673; Seymour CA, 1997, HEALTH TECHNOL ASSES, V1, pi, DOI [DOI 10.3310/hta1110, DOI 10.3310/HTA1110]; Sherman S, 2005, GENET MED, V7, P584, DOI 10.1097/01.GIM.0000182468.22666.dd; Sugarman EA, 2012, EUR J HUM GENET, V20, P27, DOI 10.1038/ejhg.2011.134; Tassone F, 2014, JAMA NEUROL, V71, P355, DOI 10.1001/jamaneurol.2013.4808; Van Driest SL, 2016, JAMA-J AM MED ASSOC, V315, P47, DOI 10.1001/jama.2015.17701; Watson MS, 2006, GENET MED, V8, p1S, DOI 10.1097/01.gim.0000223891.82390.ad	26	114	116	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					734	742		10.1001/jama.2016.11139	http://dx.doi.org/10.1001/jama.2016.11139			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533158	Bronze			2022-12-24	WOS:000381514800019
J	Pokorney, SD; Simon, DN; Thomas, L; Gersh, BJ; Hylek, EM; Piccini, JP; Peterson, ED				Pokorney, Sean D.; Simon, DaJuanicia N.; Thomas, Laine; Gersh, Bernard J.; Hylek, Elaine M.; Piccini, Jonathan P.; Peterson, Eric D.			Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ATRIAL-FIBRILLATION; ANTICOAGULATION; INTENSITY; OUTCOMES; REGISTRY; AF		[Pokorney, Sean D.; Simon, DaJuanicia N.; Thomas, Laine; Piccini, Jonathan P.; Peterson, Eric D.] Duke Univ, Med Ctr, Div Cardiol, DUMC 3236, Durham, NC 27710 USA; [Gersh, Bernard J.] Mayo Clin, Coll Med, Rochester, MN USA; [Hylek, Elaine M.] Boston Univ, Sch Med, Boston, MA 02215 USA	Duke University; Mayo Clinic; Boston University	Peterson, ED (corresponding author), Duke Univ, Med Ctr, Div Cardiol, DUMC 3236, Durham, NC 27710 USA.	eric.peterson@duke.edu	Peterson, Eric David/ABF-5033-2021					Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Lip GYH, 2014, EUR HEART J, V35, P3365, DOI 10.1093/eurheartj/ehu374; Piccini JP, 2011, AM HEART J, V162, P606, DOI 10.1016/j.ahj.2011.07.001; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Singer DE, 2009, CIRC-CARDIOVASC QUAL, V2, P297, DOI 10.1161/CIRCOUTCOMES.108.830232; Wilke T, 2012, THROMB HAEMOSTASIS, V107, P1053, DOI 10.1160/TH11-11-0768	6	33	35	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					661	663		10.1001/jama.2016.9356	http://dx.doi.org/10.1001/jama.2016.9356			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532922				2022-12-24	WOS:000380985600020
J	Lee, ASY; Kranzusch, PJ; Doudna, JA; Cate, JHD				Lee, Amy S. Y.; Kranzusch, Philip J.; Doudna, Jennifer A.; Cate, Jamie H. D.			eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation	NATURE			English	Article							DEPENDENT TRANSLATION; C-JUN; MECHANISM; MODEL; PHOSPHORYLATION	Eukaryotic mRNAs contain a 5' cap structure that is crucial for recruitment of the translation machinery and initiation of protein synthesis. mRNA recognition is thought to require direct interactions between eukaryotic initiation factor 4E (eIF4E) and the mRNA cap. However, translation of numerous capped mRNAs remains robust during cellular stress, early development, and cell cycle progression(1) despite inactivation of eIF4E. Here we describe a cap-dependent pathway of translation initiation in human cells that relies on a previously unknown cap-binding activity of eIF3d, a subunit of the 800-kilodalton eIF3 complex. A 1.4 angstrom crystal structure of the eIF3d cap-binding domain reveals unexpected homology to endonucleases involved in RNA turnover, and allows modelling of cap recognition by eIF3d. eIF3d makes specific contacts with the cap, as exemplified by cap analogue competition, and these interactions are essential for assembly of translation initiation complexes on eIF3-specialized mRNAs(2) such as the cell proliferation regulator c-Jun (also known as JUN). The c-Jun mRNA further encodes an inhibitory RNA element that blocks eIF4E recruitment, thus enforcing alternative cap recognition by eIF3d. Our results reveal a mechanism of cap-dependent translation that is independent of eIF4E, and illustrate how modular RNA elements work together to direct specialized forms of translation initiation.	[Lee, Amy S. Y.; Kranzusch, Philip J.; Doudna, Jennifer A.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Lee, Amy S. Y.; Kranzusch, Philip J.; Doudna, Jennifer A.; Cate, Jamie H. D.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Kranzusch, Philip J.; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.; Cate, Jamie H. D.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Lee, Amy S. Y.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Kranzusch, Philip J.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Kranzusch, Philip J.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Brandeis University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	jcate@lbl.gov			UC Office of the President, Multicampus Research Programs and Initiatives grant [MR-15-328599]; Program for Breakthrough Biomedical Research; Sandler Foundation; NIH [S10RR025622]; NIGMS Center for RNA Systems Biology [P50-GM201706]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706] Funding Source: NIH RePORTER	UC Office of the President, Multicampus Research Programs and Initiatives grant; Program for Breakthrough Biomedical Research; Sandler Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS Center for RNA Systems Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Berger and K. Chat for discussions. X-ray data were collected at Beamline 8.3.1 of the Lawrence Berkeley National Laboratory Advanced Light Source (ALS), supported in part by the UC Office of the President, Multicampus Research Programs and Initiatives grant MR-15-328599 and the Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. The authors are grateful to J. Holton, G. Meigs (ALS), and T. Doukov (SSRL) for help with S-SAD data collection. This work used the Vincent J. Proteomics/Mass Spectrometry Laboratory at UC Berkeley, supported in part by NIH S10 Instrumentation Grant S10RR025622. This work was funded by the NIGMS Center for RNA Systems Biology (P50-GM201706). J.A.D. is an HHMI Investigator. A.S.Y.L. is supported as an American Cancer Society Postdoctoral Fellow (PF-14-108-01-RMC) and P.J.K. is supported as an HHMI Fellow of the Life Sciences Research Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreev DE, 2009, NUCLEIC ACIDS RES, V37, P6135, DOI 10.1093/nar/gkp665; Blau L, 2012, P NATL ACAD SCI USA, V109, pE2875, DOI 10.1073/pnas.1203659109; Chang JH, 2012, NAT STRUCT MOL BIOL, V19, P1011, DOI 10.1038/nsmb.2381; des Georges A, 2015, NATURE, V525, P491, DOI 10.1038/nature14891; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gandin V, 2016, GENOME RES, V26, P636, DOI 10.1101/gr.197566.115; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Kranzusch PJ, 2014, CELL, V158, P1011, DOI 10.1016/j.cell.2014.07.028; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; Lindqvist L, 2008, RNA, V14, P960, DOI 10.1261/rna.971208; Locker N, 2006, RNA, V12, P683, DOI 10.1261/rna.2227906; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; SONENBERG N, 1979, NUCLEIC ACIDS RES, V7, P15, DOI 10.1093/nar/7.1.15; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200	34	174	186	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					96	+		10.1038/nature18954	http://dx.doi.org/10.1038/nature18954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27462815	Green Accepted, Green Submitted			2022-12-24	WOS:000380999200037
J	Wilson, MD; Benlekbir, S; Fradet-Turcotte, A; Sherker, A; Julien, JP; McEwan, A; Noordermeer, SM; Sicheri, F; Rubinstein, JL; Durocher, D				Wilson, Marcus D.; Benlekbir, Samir; Fradet-Turcotte, Amelie; Sherker, Alana; Julien, Jean-Philippe; McEwan, Andrea; Noordermeer, Sylvie M.; Sicheri, Frank; Rubinstein, John L.; Durocher, Daniel			The structural basis of modified nucleosome recognition by 53BP1	NATURE			English	Article							DNA-DAMAGE; CRYO-EM; HOMOLOGOUS RECOMBINATION; H2B MONOUBIQUITINATION; UBIQUITIN; SYSTEM; PARTICLES; HISTONES; BINDING	DNA double-strand breaks (DSBs) elicit a histone modification cascade that controls DNA repair(1-3). This pathway involves the sequential ubiquitination of histones H1 and H2A by the E3 ubiquitin ligases RNF8 and RNF168, respectively(4-8). RNF168 ubiquitinates H2A on lysine 13 and lysine 15 (refs 7, 8) (yielding H2AK13ub and H2AK15ub, respectively), an event that triggers the recruitment of 53BP1 (also known as TP53BP1) to chromatin flanking DSBs(9,10). 53BP1 binds specifically to H2AK15ubcontaining nucleosomes through a peptide segment termed the ubiquitination-dependent recruitment motif (UDR), which requires the simultaneous engagement of histone H4 lysine 20 dimethylation (H4K20me2) by its tandem Tudor domain(10,11). How 53BP1 interacts with these two histone marks in the nucleosomal context, how it recognizes ubiquitin, and how it discriminates between H2AK13ub and H2AK15ub is unknown. Here we present the electron cryomicroscopy (cryo-EM) structure of a dimerized human 53BP1 fragment bound to a H4K20me2-containing and H2AK15ub-containing nucleosome core particle (NCP-ubme) at 4.5 angstrom resolution. The structure reveals that H4K20me2 and H2AK15ub recognition involves intimate contacts with multiple nucleosomal elements including the acidic patch. Ubiquitin recognition by 53BP1 is unusual and involves the sandwiching of the UDR segment between ubiquitin and the NCP surface. The selectivity for H2AK15ub is imparted by two arginine fingers in the H2A amino-terminal tail, which straddle the nucleosomal DNA and serve to position ubiquitin over the NCP-bound UDR segment. The structure of the complex between NCP-ubme and 53BP1 reveals the basis of 53BP1 recruitment to DSB sites and illuminates how combinations of histone marks and nucleosomal elements cooperate to produce highly specific chromatin responses, such as those elicited following chromosome breaks.	[Wilson, Marcus D.; Fradet-Turcotte, Amelie; Sherker, Alana; McEwan, Andrea; Noordermeer, Sylvie M.; Sicheri, Frank; Durocher, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada; [Benlekbir, Samir; Julien, Jean-Philippe; Rubinstein, John L.] Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada; [Sherker, Alana; Sicheri, Frank; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Julien, Jean-Philippe; Sicheri, Frank; Rubinstein, John L.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Julien, Jean-Philippe] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Rubinstein, John L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Fradet-Turcotte, Amelie] Univ Laval, Canc Res Ctr, Oncol Axis CHU Quebec Res Ctr, Hotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada; [Fradet-Turcotte, Amelie] Univ Laval, Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ G1R 2J6, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; Laval University; Laval University	Sicheri, F; Durocher, D (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.; Rubinstein, JL (corresponding author), Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada.; Sicheri, F; Durocher, D (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada.; Sicheri, F; Rubinstein, JL (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.; Rubinstein, JL (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.	sicheri@lunenfeld.ca; john.rubinstein@utoronto.ca; durocher@lunenfeld.ca	Durocher, Daniel/A-7733-2010; Sicheri, Frank/F-8856-2013; Noordermeer, Sylvie M/T-8095-2017; Noordermeer, Sylvie M/F-3517-2012; Fradet-Turcotte, Amelie/G-5790-2017	Durocher, Daniel/0000-0003-3863-8635; Noordermeer, Sylvie M/0000-0003-2737-9690; Noordermeer, Sylvie M/0000-0003-2737-9690; Rubinstein, John/0000-0003-0566-2209; Fradet-Turcotte, Amelie/0000-0002-5431-8650; Wilson, Marcus/0000-0001-9551-5514; Sherker, Alana/0000-0001-5827-4678; Julien, Jean-Philippe/0000-0001-7602-3995	Human Frontiers Science Program fellowship; Dutch Cancer Foundation (KWF); CIHR [FDN143343, FDN143277, MOP81294]; Krembil Foundation	Human Frontiers Science Program fellowship(Human Frontier Science Program); Dutch Cancer Foundation (KWF)(KWF Kankerbestrijding); CIHR(Canadian Institutes of Health Research (CIHR)); Krembil Foundation	We are grateful to R. Szilard for reading the manuscript. We thank M. Forbes for 1D mass spectrometry analysis, C. Davey for providing the '601' DNA, S. Orlicky and D. Ceccarelli for proteins, R. Guenette and E. Strieter for advice on H2A ubiquitination and T. Sixma for discussions. M.D.W. was supported by a Human Frontiers Science Program fellowship. S.M.N. holds a fellowship of the Dutch Cancer Foundation (KWF). J.L.R. is the Canada Research Chair (Tier 1) in Electron Cryomicroscopy and D. D. is a Canada Research Chair (Tier 1) in the Molecular Mechanisms of Genome Integrity. Work was supported by CIHR grants FDN143343 (to D. D.), FDN143277 (to F.S.) and MOP81294 (to J.L.R.), and a Grant-in-Aid from the Krembil Foundation (to D.D.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Arnaudo N, 2013, NAT STRUCT MOL BIOL, V20, P1119, DOI 10.1038/nsmb.2641; Baarends WM, 2007, J CELL SCI, V120, P1841, DOI 10.1242/jcs.03451; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Dantuma NP, 2016, EMBO J, V35, P6, DOI 10.15252/embj.201592595; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Iwasaki W, 2011, BIOCHEMISTRY-US, V50, P7822, DOI 10.1021/bi201021h; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Leung JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004178; Long L, 2014, METHODS, V70, P134, DOI 10.1016/j.ymeth.2014.07.006; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Marr CR, 2014, J STRUCT BIOL, V185, P42, DOI 10.1016/j.jsb.2013.11.002; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAMAGE R, 1994, BIOCHEM J, V299, P151, DOI 10.1042/bj2990151; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; Rufer AC, 2005, ACTA CRYSTALLOGR F, V61, P263, DOI 10.1107/S1744309105004823; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Simon TW, 2014, CRIT REV TOXICOL, V44, P17, DOI 10.3109/10408444.2014.931925; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Weeks SD, 2009, PROTEINS, V77, P753, DOI 10.1002/prot.22568; Zeng M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11364; Zhao JH, 2015, J STRUCT BIOL, V192, P209, DOI 10.1016/j.jsb.2015.06.014	48	148	151	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					100	+		10.1038/nature18951	http://dx.doi.org/10.1038/nature18951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27462807	Green Accepted			2022-12-24	WOS:000380999200038
J	Hameed, MA; Dasgupta, I; Gill, P				Hameed, Mohammed Awais; Dasgupta, Indranil; Gill, Paramjit			10-MINUTE CONSULTATION Poor adherence to antihypertensive drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE; METAANALYSIS		[Hameed, Mohammed Awais; Dasgupta, Indranil] Heart England NHS Fdn Trust, Birmingham, W Midlands, England; [Hameed, Mohammed Awais] Univ Birmingham, Inst Appl Hlth Res, Birmingham B15 2TT, W Midlands, England; [Gill, Paramjit] Univ Birmingham, Primary Care Clin Sci, Birmingham B15 2TT, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham; University of Birmingham	Dasgupta, I (corresponding author), Heart England NHS Fdn Trust, Birmingham, W Midlands, England.	Indranil.dasgupta@heartofengland.nhs.uk	Dasgupta, Indranil/ABC-3409-2020					Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Gupta AK, 2010, HYPERTENSION, V55, P399, DOI 10.1161/HYPERTENSIONAHA.109.139816; Hameed MA, 2016, J HUM HYPERTENS, V30, P83, DOI 10.1038/jhh.2015.38; He F. J., 2013, BMJ, V346; Hyman DJ, 2007, ARCH INTERN MED, V167, P1152, DOI 10.1001/archinte.167.11.1152; KJELLGREN KI, 1995, INT J CARDIOL, V47, P257, DOI 10.1016/0167-5273(94)02203-U; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawson AJ, 2016, J ANAL TOXICOL, V40, P17, DOI 10.1093/jat/bkv102; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; National Institute for Health and Care Excellence, 2011, HYP CLIN MAN PRIM HY; Ren YP, 2014, INT J CARDIOL, V172, P509, DOI 10.1016/j.ijcard.2014.01.051; Sabate E., 2003, ADHERENCE LONG TERM; STEVENS VJ, 1993, ARCH INTERN MED, V153, P849, DOI 10.1001/archinte.153.7.849; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006	15	5	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2016	354								i3268	10.1136/bmj.i3268	http://dx.doi.org/10.1136/bmj.i3268			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0WK	27444756	Green Published			2022-12-24	WOS:000380317300001
J	Urban, N; van den Berg, DLC; Forget, A; Andersen, J; Demmers, JAA; Hunt, C; Ayrault, O; Guillemot, F				Urban, Noelia; van den Berg, Debbie L. C.; Forget, Antoine; Andersen, Jimena; Demmers, Jeroen A. A.; Hunt, Charles; Ayrault, Olivier; Guillemot, Francois			Return to quiescence of mouse neural stem cells by degradation of a proactivation protein	SCIENCE			English	Article							UBIQUITIN LIGASE HUWE1; DIFFERENTIATION; PROLIFERATION; NEUROGENESIS	Quiescence is essential for long-term maintenance of adult stem cells. Niche signals regulate the transit of stem cells from dormant to activated states. Here, we show that the E3-ubiquitin ligase Huwe1 (HECT, UBA, and WWE domain-containing 1) is required for proliferating stem cells of the adult mouse hippocampus to return to quiescence. Huwe1 destabilizes proactivation protein Ascl1 (achaete-scute family bHLH transcription factor 1) in proliferating hippocampal stem cells, which prevents accumulation of cyclin Ds and promotes the return to a resting state. When stem cells fail to return to quiescence, the proliferative stem cell pool becomes depleted. Thus, long-term maintenance of hippocampal neurogenesis depends on the return of stem cells to a transient quiescent state through the rapid degradation of a key proactivation factor.	[Urban, Noelia; van den Berg, Debbie L. C.; Andersen, Jimena; Hunt, Charles; Guillemot, Francois] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England; [Forget, Antoine; Ayrault, Olivier] PSL Res Univ, Inst Curie, CNRS UMR 3347, INSERM U1021, F-91405 Orsay, France; [Forget, Antoine; Ayrault, Olivier] Univ Paris Saclay, Univ Paris Sud, CNRS UMR 3347, INSERM U1021, F-91405 Orsay, France; [Demmers, Jeroen A. A.] Erasmus MC, Prote Ctr, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [Andersen, Jimena] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Ctr Sleep Sci & Med, Stanford, CA USA	Francis Crick Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Erasmus University Rotterdam; Erasmus MC; Stanford University	Urban, N; Guillemot, F (corresponding author), Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England.	noelia.urban@crick.ac.uk; francois.guillemot@crick.ac.uk	Guillemot, Francois/AAV-1482-2021; Forget, Antoine/AAA-4967-2020; Demmers, Jeroen AA/F-4046-2016	Demmers, Jeroen AA/0000-0002-8757-9611; van den Berg, Debbie L.C./0000-0001-6026-8808; Andersen, Jimena/0000-0001-9320-6507; Urban Avellaneda, Noelia/0000-0003-4813-9274	Medical Research Council (MRC); Francis Crick Institute [BZ10089]; Federation of European Biochemical Societies; Netherlands Organisation for Scientific Research (NWO) [184.032.201]; Fondation de France; Wellcome Trust [106187/Z/14/Z]; Biotechnology and Biological Sciences Research Council [BB/K005316/1]; MRC [U117570528]; Medical Research Council [MC_U117570528, MR/M023907/1] Funding Source: researchfish; The Francis Crick Institute [10089, 10309] Funding Source: researchfish; BBSRC [BB/K005316/1] Funding Source: UKRI; MRC [MR/M023907/1, MC_U117570528] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute; Federation of European Biochemical Societies; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Fondation de France(Fondation de France); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully acknowledge L. Chen, A. Achimastou, and E. Lavedeze for technical support; M. del Mar Masdeu, R. Subramaniams, and J. Mor for managing the mouse colony; A. Iavarone and M. Gotz for providing transgenic mice; and I. Crespo, R. Kageyama, and members of the Guillemot laboratory for discussions. The study was conceived and the manuscript was written by N.U. and F.G. Most of the work was performed by N.U.; D.L.C.B., J.A.A.D., and C.H. performed the mass spectrometry analysis; J. A. helped with experiments; and A.F. and O.A. analyzed the polyubiquitination of Ascl1. N.U. was supported by fellowships from the Medical Research Council (MRC) and the Francis Crick Institute, D.L.C.B. was supported by fellowships from the Federation of European Biochemical Societies and the Francis Crick Institute, J.A.A.D. was financed by the Netherlands Organisation for Scientific Research (NWO) project (184.032.201), and A.F. was financed by the Fondation de France. This work was supported by grants from the Wellcome Trust (106187/Z/14/Z), the Biotechnology and Biological Sciences Research Council (BB/K005316/1), the MRC (U117570528), and the Francis Crick Institute (BZ10089) to F.G. The authors declare no conflicts of interest. Additional data is available in the supplementary materials.	Andersen J, 2014, NEURON, V83, P1085, DOI 10.1016/j.neuron.2014.08.004; Ansorg A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-46; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Terskikh VV, 2012, STEM CELL REV REP, V8, P414, DOI 10.1007/s12015-011-9299-6; Zhang J, 2011, GENE DEV, V25, P2610, DOI 10.1101/gad.170605.111; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	18	129	131	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2016	353	6296					292	295		10.1126/science.aaf4802	http://dx.doi.org/10.1126/science.aaf4802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0EM	27418510	Green Submitted, Green Accepted			2022-12-24	WOS:000379580800050
J	Wu, JY; Huang, B; Chen, H; Yin, QZ; Liu, Y; Xiang, YL; Zhang, BJ; Liu, BF; Wang, QJ; Xia, WK; Li, WZ; Li, YY; Ma, J; Peng, X; Zheng, H; Ming, J; Zhang, WH; Zhang, J; Tian, G; Xu, F; Chang, Z; Na, J; Yang, XR; Xie, W				Wu, Jingyi; Huang, Bo; Chen, He; Yin, Qiangzong; Liu, Yang; Xiang, Yunlong; Zhang, Bingjie; Liu, Bofeng; Wang, Qiujun; Xia, Weikun; Li, Wenzhi; Li, Yuanyuan; Ma, Jing; Peng, Xu; Zheng, Hui; Ming, Jia; Zhang, Wenhao; Zhang, Jing; Tian, Geng; Xu, Feng; Chang, Zai; Na, Jie; Yang, Xuerui; Xie, Wei			The landscape of accessible chromatin in mammalian preimplantation embryos	NATURE			English	Article							GENE-EXPRESSION; MOUSE EMBRYO; STEM-CELLS; RNA-SEQ; VISCERAL ENDODERM; TRANSCRIPTION; DIFFERENTIATION; DYNAMICS; REVEALS; GENOME	In mammals, extensive chromatin reorganization is essential for reprogramming terminally committed gametes to a totipotent state during preimplantation development. However, the global chromatin landscape and its dynamics in this period remain unexplored. Here we report a genome-wide map of accessible chromatin in mouse preimplantation embryos using an improved assay for transposase-accessible chromatin with high throughput sequencing (ATAC-seq) approach with CRISPR/Cas9-assisted mitochondrial DNA depletion. We show that despite extensive parental asymmetry in DNA methylomes, the chromatin accessibility between the parental genomes is globally comparable after major zygotic genome activation (ZGA). Accessible chromatin in early embryos is widely shaped by transposable elements and overlaps extensively with putative cis-regulatory sequences. Unexpectedly, accessible chromatin is also found near the transcription end sites of active genes. By integrating the maps of cis-regulatory elements and single-cell transcriptomes, we construct the regulatory network of early development, which helps to identify the key modulators for lineage specification. Finally, we find that the activities of cis-regulatory elements and their associated open chromatin diminished before major ZGA. Surprisingly, we observed many loci showing non-canonical, large open chromatin domains over the entire transcribed units in minor ZGA, supporting the presence of an unusually permissive chromatin state. Together, these data reveal a unique spatiotemporal chromatin configuration that accompanies early mammalian development.	[Wu, Jingyi; Yin, Qiangzong; Xiang, Yunlong; Zhang, Bingjie; Liu, Bofeng; Wang, Qiujun; Xia, Weikun; Li, Yuanyuan; Ma, Jing; Zheng, Hui; Zhang, Wenhao; Xie, Wei] Tsinghua Univ, MOE Key Lab Bioinformat, Ctr Stem Cell Biol & Regenerat Med, THU PKU Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China; [Wu, Jingyi; Liu, Yang; Yang, Xuerui; Xie, Wei] Tsinghua Univ, Sch Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing 100084, Peoples R China; [Huang, Bo] Peking Univ, Acad Adv Interdisciplinary Studies, PKU THU Ctr Life Sci, Beijing 100871, Peoples R China; [Chen, He] Peking Univ, Coll Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing 100871, Peoples R China; [Liu, Yang; Yang, Xuerui] Tsinghua Univ, MOE Key Lab Bioinformat, Ctr Synthet & Syst Biol, THU PKU Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China; [Li, Wenzhi; Ming, Jia; Na, Jie] Tsinghua Univ, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Beijing 100084, Peoples R China; [Peng, Xu; Xu, Feng] ASTAR, Singapore Inst Clin Sci, Singapore 117609, Singapore; [Zhang, Jing; Chang, Zai] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Tian, Geng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Xu, Feng] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore	Tsinghua University; National Institute of Biological Sciences, Beijing; Tsinghua University; Peking University; National Institute of Biological Sciences, Beijing; Peking University; Tsinghua University; Tsinghua University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Tsinghua University; Tsinghua University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Xie, W (corresponding author), Tsinghua Univ, MOE Key Lab Bioinformat, Ctr Stem Cell Biol & Regenerat Med, THU PKU Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China.; Xie, W (corresponding author), Tsinghua Univ, Sch Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing 100084, Peoples R China.	xiewei121@tsinghua.edu.cn	Zhang, Bingjie/FGK-6320-2022; Wu, Jingyi/S-9658-2019; Na, Jie/U-4518-2019; Na, Jie/N-3522-2018; Xia, Weikun/GXG-7930-2022; Xie, Wei/J-1380-2017; huang, bo/A-2690-2017	Zhang, Bingjie/0000-0002-0535-0371; Na, Jie/0000-0003-1820-0548; Na, Jie/0000-0003-1820-0548; Xie, Wei/0000-0003-2126-3849; Yang, Xuerui/0000-0002-7731-2147; Chen, He/0000-0001-9644-8202; Zhang, Wenhao/0000-0002-3739-0415; Liu, Yang/0000-0003-2108-3207; Xu, Feng/0000-0003-2016-7521	National Basic Research Program of China (973 program) [2015CB856201]; National Natural Science Foundation of China [31422031, 31171381, 81472855]; National Basic Research Program of China [2012CB966701]; Beijing Natural Science Foundation [5152014]; Tsinghua University Initiative Scientific Research Program [20131089278, 2014z21046]; THU-PKU Center for Life Sciences; Youth Thousand Scholar Program of China	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Tsinghua University Initiative Scientific Research Program; THU-PKU Center for Life Sciences; Youth Thousand Scholar Program of China	We appreciate B. Ren, D. Leung, H. Yang and the members of the Xie laboratory for comments during preparation of the manuscript. This work is supported by the funding provided by the National Basic Research Program of China (973 program) 2015CB856201 (W.Xie), the National Natural Science Foundation of China 31422031 (W.Xie). 31171381 (J.N.). 81472855 (X.Y.), the National Basic Research Program of China 2012CB966701 (J.N.), the Beijing Natural Science Foundation grant 5152014 (J.N.), Tsinghua University Initiative Scientific Research Program (20131089278, 2014z21046) (X.Y.). the funding from the THU-PKU Center for Life Sciences (W.Xie, X.Y.), and the Youth Thousand Scholar Program of China (W.Xie, X.Y.).	Abe K, 2015, EMBO J, V34, P1523, DOI 10.15252/embj.201490648; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burton A, 2014, NAT REV MOL CELL BIO, V15, P722, DOI 10.1038/nrm3885; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; De Braekeleer E, 2012, LEUKEMIA RES, V36, P945, DOI 10.1016/j.leukres.2012.04.010; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Jedrusik A, 2015, DEV BIOL, V398, P147, DOI 10.1016/j.ydbio.2014.12.004; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Labelle-Dumais C, 2006, DEV DYNAM, V235, P3359, DOI 10.1002/dvdy.20996; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Maza I, 2015, NAT BIOTECHNOL, V33, P769, DOI 10.1038/nbt.3270; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Peng X, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku818; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Randise-Hinchliff CE, 2012, DEV CELL, V23, P919, DOI 10.1016/j.devcel.2012.10.024; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Robbez-Masson L, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0173-5; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wicklow E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004618; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564	50	351	362	14	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					652	+		10.1038/nature18606	http://dx.doi.org/10.1038/nature18606			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27309802				2022-12-24	WOS:000378676000029
J	Ellefson, JW; Gollihar, J; Shroff, R; Shivram, H; Iyer, VR; Ellington, AD				Ellefson, Jared W.; Gollihar, Jimmy; Shroff, Raghav; Shivram, Haridha; Iyer, Vishwanath R.; Ellington, Andrew D.			Synthetic evolutionary origin of a proofreading reverse transcriptase	SCIENCE			English	Article							DEPENDENT DNA-POLYMERASE; 3RD BASE-PAIR; AMPLIFICATION; REPLICATION; FIDELITY; VIRIONS; SYSTEM; URACIL; VIRUS; ACID	Most reverse transcriptase (RT) enzymes belong to a single protein family of ancient evolutionary origin. These polymerases are inherently error prone, owing to their lack of a proofreading (3'-5' exonuclease) domain. To determine if the lack of proofreading is a historical coincidence or a functional limitation of reverse transcription, we attempted to evolve a high-fidelity, thermostable DNA polymerase to use RNA templates efficiently. The evolutionarily distinct reverse transcription xenopolymerase (RTX) actively proofreads on DNA and RNA templates, which greatly improves RT fidelity. In addition, RTX enables applications such as single-enzyme reverse transcription-polymerase chain reaction and direct RNA sequencing without complementary DNA isolation. The creation of RTX confirms that proofreading is compatible with reverse transcription.	[Ellefson, Jared W.; Gollihar, Jimmy; Shroff, Raghav; Shivram, Haridha; Iyer, Vishwanath R.; Ellington, Andrew D.] Univ Texas Austin, Dept Mol Biosci, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Ellefson, JW; Ellington, AD (corresponding author), Univ Texas Austin, Dept Mol Biosci, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA.	jaredwellefson@gmail.com; ellingtonlab@gmail.com		Gollihar, Jimmy/0000-0003-3957-2092	Defense Advanced Research Projects Agency [HR0011-12-2-0001]; National Security Science and Engineering Faculty Fellowship [FA9550-10-1-0169]; NASA [NNX15AF46G]; Welch foundation [F-1654]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Security Science and Engineering Faculty Fellowship; NASA(National Aeronautics & Space Administration (NASA)); Welch foundation(The Welch Foundation)	We thank the University of Texas Genomic Sequencing and Analysis Facility for DNA sequencing support. This work was supported by Defense Advanced Research Projects Agency (HR0011-12-2-0001), National Security Science and Engineering Faculty Fellowship (FA9550-10-1-0169), NASA (NNX15AF46G), and the Welch foundation (F-1654). J.W.E. conceived of the project. J.W.E., J.G., R.S. performed research with contributions from H.S and V.R.I. J.W.E, J.G., R.S., and A.D.E. wrote the manuscript. The authors declare competing financial interests. A.D.E. was a paid consultant for Enzymatics. A provisional patent has been filed on the sequence composition of the reverse transcriptase.	BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Boeke JD, 1997, RETROVIRUSES; Cozens C, 2012, P NATL ACAD SCI USA, V109, P8067, DOI 10.1073/pnas.1120964109; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; DARNELL JE, 1986, P NATL ACAD SCI USA, V83, P1271, DOI 10.1073/pnas.83.5.1271; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Ghadessy FJ, 2001, P NATL ACAD SCI USA, V98, P4552, DOI 10.1073/pnas.071052198; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; HUFF JW, 1964, BIOCHEMISTRY-US, V3, P501, DOI 10.1021/bi00892a006; Jozwiakowski SK, 2011, CHEMBIOCHEM, V12, P35, DOI 10.1002/cbic.201000640; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Malyshev DA, 2012, P NATL ACAD SCI USA, V109, P12005, DOI 10.1073/pnas.1205176109; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Moser MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038371; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Takagi M, 1997, APPL ENVIRON MICROB, V63, P4504, DOI 10.1128/AEM.63.11.4504-4510.1997; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; WANG AHJ, 1982, NATURE, V299, P601, DOI 10.1038/299601a0; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yamashige R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1068; Yang ZY, 2011, J AM CHEM SOC, V133, P15105, DOI 10.1021/ja204910n	27	80	87	9	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1590	1593		10.1126/science.aaf5409	http://dx.doi.org/10.1126/science.aaf5409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339990				2022-12-24	WOS:000378346500047
J	Davis, MM; Gebremariam, A; Ayanian, JZ				Davis, Matthew M.; Gebremariam, Achamyeleh; Ayanian, John Z.			Changes in Insurance Coverage Among Hospitalized Nonelderly Adults After Medicaid Expansion in Michigan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Davis, Matthew M.; Ayanian, John Z.] Univ Michigan, Inst Healthcare Policy & Innovat, 300 NIB,6A18, Ann Arbor, MI 48109 USA; [Gebremariam, Achamyeleh] Univ Michigan Hlth Syst, Child Hlth Evaluat & Res Unit, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Davis, MM (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, 300 NIB,6A18, Ann Arbor, MI 48109 USA.	mattdav@med.umich.edu						Ayanian JZ, 2013, NEW ENGL J MED, V369, P1773, DOI 10.1056/NEJMp1310910; DeLeire T, IMPACT INSURANCE EXP; Deloitte Development, COMM KENT MED EXP RE; Nikpay S, 2016, HEALTH AFFAIR, V35, P106, DOI 10.1377/hlthaff.2015.1144; State Health Reform Assistance Network, IMP MED EXP UNC CAR	5	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2617	2618		10.1001/jama.2016.6303	http://dx.doi.org/10.1001/jama.2016.6303			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27327805	Bronze			2022-12-24	WOS:000378306700025
J	Ouyang, Z; Zheng, H; Xiao, Y; Polasky, S; Liu, J; Xu, W; Wang, Q; Zhang, L; Xiao, Y; Rao, EM; Jiang, L; Lu, F; Wang, XK; Yang, GB; Gong, SH; Wu, BF; Zeng, Y; Yang, W; Daily, GC				Ouyang, Zhiyun; Zheng, Hua; Xiao, Yi; Polasky, Stephen; Liu, Jianguo; Xu, Weihua; Wang, Qiao; Zhang, Lu; Xiao, Yang; Rao, Enming; Jiang, Ling; Lu, Fei; Wang, Xiaoke; Yang, Guangbin; Gong, Shihan; Wu, Bingfang; Zeng, Yuan; Yang, Wu; Daily, Gretchen C.			Improvements in ecosystem services from investments in natural capital	SCIENCE			English	Article							LAND-USE; CHINA; IMPACTS	In response to ecosystem degradation from rapid economic development, China began investing heavily in protecting and restoring natural capital starting in 2000. We report on China's first national ecosystem assessment (2000-2010), designed to quantify and help manage change in ecosystem services, including food production, carbon sequestration, soil retention, sandstorm prevention, water retention, flood mitigation, and provision of habitat for biodiversity. Overall, ecosystem services improved from 2000 to 2010, apart from habitat provision. China's national conservation policies contributed significantly to the increases in those ecosystem services.	[Ouyang, Zhiyun; Zheng, Hua; Xiao, Yi; Xu, Weihua; Zhang, Lu; Xiao, Yang; Rao, Enming; Jiang, Ling; Lu, Fei; Wang, Xiaoke; Gong, Shihan] Chinese Acad Sci, Res Ctr Eco Environm Sci, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China; [Polasky, Stephen] Univ Minnesota, Inst Environm, Dept Appl Econ, St Paul, MN 55108 USA; [Polasky, Stephen] Univ Minnesota, Inst Environm, Nat Capital Project, St Paul, MN 55108 USA; [Liu, Jianguo] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA; [Wang, Qiao] Minist Environm Protect, Satellite Environm Ctr, Beijing 100094, Peoples R China; [Yang, Guangbin] Guizhou Normal Univ, Sch Geog & Environm Sci, Guiyang 550001, Peoples R China; [Wu, Bingfang; Zeng, Yuan] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing 100101, Peoples R China; [Yang, Wu] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Daily, Gretchen C.] Stanford Univ, Dept Biol, Nat Capital Project, Stanford, CA 94305 USA; [Daily, Gretchen C.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Michigan State University; Guizhou Normal University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Zhejiang University; Stanford University; Stanford University	Ouyang, Z (corresponding author), Chinese Acad Sci, Res Ctr Eco Environm Sci, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China.; Daily, GC (corresponding author), Stanford Univ, Dept Biol, Nat Capital Project, Stanford, CA 94305 USA.; Daily, GC (corresponding author), Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA.	zyouyang@rcees.ac.cn; gdaily@stanford.edu	Xiao, Yang/ABC-7068-2020; Polasky, Stephen/AAC-5341-2019; Wu, Bingfang/AAD-7223-2022; Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087; wang, xiao ke/0000-0002-2421-3970; Zheng, Hua/0000-0002-2301-1744; Xiao, Yang/0000-0002-8355-5209	Ministry of Finance of China; international Natural Capital Project	Ministry of Finance of China; international Natural Capital Project	We thank the Ministry of Environmental Protection (MEP) of China and Chinese Academy of Sciences (CAS) for organizing the Project, and experts in 31 provinces for collecting the field data or statistics analysis on this manuscript. This work was supported by the Ministry of Finance of China through the MEP/CAS project "Survey and Assessment of National Ecosystem Changes Between, 2000 and 2010, China" and by the international Natural Capital Project. All the data are available at www.sciencedb.cn/dataSet/handle/73.	[Anonymous], 2005, EC HUM WELL BEING SY; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; China Council for International Cooperation on Environment and Development, 2014, REP I INN EC PROT RE; Ehrlich PR, 2012, NATURE, V486, P68, DOI 10.1038/nature11157; Folke C, 2010, ECOL SOC, V15, DOI 10.5751/es-03610-150420; Fu BJ, 2008, SCIENCE, V321, P611, DOI 10.1126/science.1162213; Hatfield-Dodds S, 2015, NATURE, V527, P49, DOI 10.1038/nature16065; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Liu J., 2013, ENCY BIODIVERSITY, P372, DOI DOI 10.1016/B978-0-12-384719-5.00335-X; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JG, 2010, CRIT REV ENV SCI TEC, V40, P823, DOI 10.1080/10643389.2010.502645; Ministry of Environmental Protection, 2015, NAT EC PROT REDL MIN; Ministry of Environmental Protection of China and Chinese Academy of Sciences, 2015, NAT EC SERV ZON CHIN; Ministry of Transport of China, 2013, NAT ROAD DEV PLANNNN; National Development Reform Commission, 2013, OP ACC CONSTR EC CIV; Sharp R., 2015, INVEST VERSION USERS; Tuanmu MN, 2016, CONSERV BIOL, V30, P827, DOI 10.1111/cobi.12669; UKNEA, 2011, UK NATL ECOSYSTEM AS; Vina A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500965; WAVES (Wealth Accounting and the Valuation of Ecosystem Services), 2015, WAVES ANN REP 2015; Ye Q., 2005, Mitigation and Adaptation Strategies for Global Change, V10, P159, DOI 10.1007/s11027-005-7838-7; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135	25	754	908	215	1647	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1455	1459		10.1126/science.aaf2295	http://dx.doi.org/10.1126/science.aaf2295			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313045				2022-12-24	WOS:000377975400048
